PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Graw, JA; Spies, CD; Wernecke, KD; Braun, JP				Graw, Jan A.; Spies, Claudia D.; Wernecke, Klaus-D.; Braun, Jan-Peter			Managing End-Of-Life Decision Making in Intensive Care Medicine - A Perspective from Charite Hospital, Germany	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; ADVANCE DIRECTIVES; SUSTAINING TREATMENT; SUPPORT; WITHDRAWAL; UNITS; COMMUNICATION; PREFERENCES; STATEMENT; HEALTH	Introduction: End-of-life-decisions (EOLD) have become an important part of modern intensive care medicine. With increasing therapeutic possibilities on the one hand and many ICU-patients lacking decision making capacity or an advance directive on the other the decision making process is a major challenge on the intensive care unit (ICU). Currently, data are poor on factors associated with EOLD in Germany. In 2009, a new law on advance directives binding physicians and the patients surrogate decision makers was enacted in Germany. So far it is unknown if this law influenced proceedings of EOLD making on the ICU. Methods: A retrospective analysis was conducted on all deceased patients (n = 224) in a 22-bed surgical ICU of a German university medical center from 08/2008 to 09/2010. Patient characteristics were compared between patients with an EOLD and those without an EOLD. Patients with an EOLD admitted before and after change of legislation were compared with respect to frequencies of EOLD performance as well as advance directive rates. Results: In total, 166 (74.1%) of deaths occurred after an EOLD. Compared to patients without an EOLD, comorbidities, ICU severity scores, and organ replacement technology did not differ significantly. EOLDs were shared within the caregiverteam and with the patients surrogate decision makers. After law enacting, no differences in EOLD performance or frequency of advance directives (8.9% vs. 9.9%; p = 0.807) were observed except an increase of documentation efforts associated with EOLDs (18.7% vs. 43.6%; p<0.001). Conclusions: In our ICU EOLD proceedings were performed patient-individually. But EOLDs follow a standard of shared decision making within the caregiverteam and the patients surrogate decision makers. Enacting a law on advance directives has not affected the decision making-process in EOLDs nor has it affected populations advance care planning habits. However, it has led to increased EOLD-associated documentation on the ICU.	[Graw, Jan A.; Spies, Claudia D.; Braun, Jan-Peter] Charite, Dept Anesthesiol & Intens Care Med, D-13353 Berlin, Germany; [Graw, Jan A.; Spies, Claudia D.; Braun, Jan-Peter] Charite, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Wernecke, Klaus-D.] Charite, Inst Med Biometry, D-13353 Berlin, Germany; [Wernecke, Klaus-D.] SOSTANA GmbH, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Sostana GmbH	Graw, JA (corresponding author), Charite, Dept Anesthesiol & Intens Care Med, Campus Charite Mitte, D-13353 Berlin, Germany.	jan.graw@charite.de		Spies, Claudia/0000-0002-1062-0495				Braun JP, 2010, ANASTH INTENSIVMED, V51, pS809, DOI 10.3205/000111; Cohen S, 2005, INTENS CARE MED, V31, P1215, DOI 10.1007/s00134-005-2742-x; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; Esteban A, 2001, INTENS CARE MED, V27, P1744, DOI 10.1007/s00134-001-1111-7; Ferrand E, 2001, LANCET, V357, P9, DOI 10.1016/S0140-6736(00)03564-9; Floer B, 2004, DEUT MED WOCHENSCHR, V129, P2343, DOI 10.1055/s-2004-835265; Gerstel E, 2008, AM J RESP CRIT CARE, V178, P798, DOI 10.1164/rccm.200711-1617OC; Goodman MD, 1998, CRIT CARE MED, V26, P701, DOI 10.1097/00003246-199804000-00018; Jox RJ, 2010, J CRIT CARE, V25, P413, DOI 10.1016/j.jcrc.2009.06.012; Kompanje EJO, 2008, INTENS CARE MED, V34, P1593, DOI 10.1007/s00134-008-1172-y; Kon AA, 2010, JAMA-J AM MED ASSOC, V304, P903, DOI 10.1001/jama.2010.1208; Lang FR, 2007, DEUT MED WOCHENSCHR, V132, P2558, DOI 10.1055/s-2007-993097; Levy MM, 2006, CRIT CARE MED, V34, pS306, DOI 10.1097/01.CCM.0000246096.18214.79; Lustbader DR, 2012, CHEST, V141, P787, DOI 10.1378/chest.11-2012; Meissner A, 2010, CRIT CARE MED, V38, P1060, DOI 10.1097/CCM.0b013e3181cd1110; Morrison RS, 1998, J CLIN ETHIC, V9, P118; Murray E, 2007, PATIENT EDUC COUNS, V65, P189, DOI 10.1016/j.pec.2006.07.007; Palker N B, 1995, Nurse Pract, V20, P7; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Prendergast TJ, 2001, CRIT CARE MED, V29, pN34, DOI 10.1097/00003246-200102001-00007; Schaden E, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-19; Scheunemann LP, 2011, CHEST, V139, P543, DOI 10.1378/chest.10-0595; Schimmer C, 2012, INTERACT CARDIOV TH, V14, P294, DOI 10.1093/icvts/ivr119; Silveira MJ, 2010, NEW ENGL J MED, V362, P1211, DOI 10.1056/NEJMsa0907901; SMEDIRA NG, 1990, NEW ENGL J MED, V322, P309, DOI 10.1056/NEJM199002013220506; Spies CD, 2006, ACTA ANAESTH SCAND, V50, P1019, DOI 10.1111/j.1399-6576.2006.01097.x; Spronk PE, 2009, ANESTH ANALG, V109, P841, DOI 10.1213/ane.0b013e3181acc64a; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Thompson BT, 2004, CRIT CARE MED, V32, P1781, DOI 10.1097/01.CCM.0000126895.66850.14; Thorevska N, 2005, J CRIT CARE, V20, P26, DOI 10.1016/j.jcrc.2004.11.002; Truog RD, 2008, CRIT CARE MED, V36, P953, DOI 10.1097/CCM.0B013E3181659096; van Oorschot Birgitt, 2008, Bull Soc Sci Med Grand Duche Luxemb, P443; White DB, 2006, CRIT CARE MED, V34, P2053, DOI 10.1097/01.CCM.0000227654.38708.C1; Wiesing U, 2010, J MED ETHICS, V36, P779, DOI 10.1136/jme.2010.036376; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Zamperetti N, 2010, MINERVA ANESTESIOL, V76, P541	36	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46446	10.1371/journal.pone.0046446	http://dx.doi.org/10.1371/journal.pone.0046446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PQ	23049701	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388500028
J	Spisak, S; Kalmar, A; Galamb, O; Wichmann, B; Sipos, F; Peterfia, B; Csabai, I; Kovalszky, I; Semsey, S; Tulassay, Z; Molnar, B				Spisak, Sandor; Kalmar, Alexandra; Galamb, Orsolya; Wichmann, Barna; Sipos, Ferenc; Peterfia, Balint; Csabai, Istvan; Kovalszky, Ilona; Semsey, Szabolcs; Tulassay, Zsolt; Molnar, Bela			Genome-Wide Screening of Genes Regulated by DNA Methylation in Colon Cancer Development	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; REAL-TIME PCR; TUMOR-SUPPRESSOR GENE; PROMOTER METHYLATION; COLORECTAL-CANCER; MINIMUM INFORMATION; CELL-PROLIFERATION; CARCINOMA; DIFFERENTIATION; MUTATIONS	Tumorigenesis is accompanied by changes in the DNA methylation pattern. Our aim was to test a novel approach for identification of transcripts at whole transcript level which are regulated by DNA methylation. Our approach is based on comparison of data obtained from transcriptome profiling of primary human samples and in vitro cell culture models. Epithelial cells were collected by LCM from normal, adenoma, and tumorous colonic samples. Using gene expression analysis, we identified downregulated genes in the tumors compared to normal tissues. In parallel 3000 upregulated genes were determined in HT-29 colon adenocarcinoma cell culture model after DNA demethylation treatment. Of the 2533 transcripts showing reduced expression in the tumorous samples, 154 had increased expression as a result of DNA demethylation treatment. Approximately 2/3 of these genes had decreased expression already in the adenoma samples. Expression of five genes (GCG, NMES-1, LRMP, FAM161B and PTGDR), was validated using RT-PCR. PTGDR showed ambiguous results, therefore it was further studied to verify the extent of DNA methylation and its effect on the protein level. Results confirmed that our approach is suitable for genome-wide screening of genes which are regulated or inactivated by DNA methylation. Activity of these genes possibly interferes with tumor progression, therefore genes identified can be key factors in the formation and in the progression of the disease.	[Spisak, Sandor; Galamb, Orsolya; Tulassay, Zsolt; Molnar, Bela] Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary; [Kalmar, Alexandra; Galamb, Orsolya; Wichmann, Barna; Sipos, Ferenc; Tulassay, Zsolt; Molnar, Bela] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Peterfia, Balint; Kovalszky, Ilona] Semmelweis Univ, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary; [Csabai, Istvan] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Csabai, Istvan] Eotvos Lorand Univ, Dept Phys Complex Syst, Budapest, Hungary; [Semsey, Szabolcs] Niels Bohr Inst, Ctr Models Life, DK-2100 Copenhagen, Denmark	Hungarian Academy of Sciences; Semmelweis University; Semmelweis University; Johns Hopkins University; Eotvos Lorand University; University of Copenhagen; Niels Bohr Institute	Spisak, S (corresponding author), Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary.	spisak@abc.hu	Semsey, Szabolcs/L-6329-2013; Sipos, Ferenc/GYV-6182-2022; Kovalszky, Ilona/ABH-2832-2020; Csabai, Istvan/F-6045-2011	Kovalszky, Ilona/0000-0002-0179-3378; Csabai, Istvan/0000-0001-9232-9898; Semsey, Szabolcs/0000-0002-4522-5495	National Office for Research and Technology, Hungary [TECH_08-A1/2-2008-0114]; Hungarian National Innovation Office; Danish National Research Foundation	National Office for Research and Technology, Hungary(National Office for Research and Technology); Hungarian National Innovation Office; Danish National Research Foundation(Danmarks Grundforskningsfond)	This study was supported by the National Office for Research and Technology, Hungary (TECH_08-A1/2-2008-0114 grant), by the Hungarian National Innovation Office, and by the Danish National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader S, 1999, ONCOGENE, V18, P8044, DOI 10.1038/sj.onc.1203229; Barrier A, 2005, ONCOGENE, V24, P6155, DOI 10.1038/sj.onc.1208984; Bennett KL, 2011, GENES CHROMOSOMES CA; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bibikova M, 2006, GENOME RES, V16, P1075, DOI 10.1101/gr.5319906; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carmona FJ, 2010, MUTAT RES-FUND MOL M, V693, P53, DOI 10.1016/j.mrfmmm.2010.07.007; Chen L, 2008, LIVER INT, V28, P997, DOI 10.1111/j.1478-3231.2008.01744.x; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; EDEN S, 1994, CURR OPIN GENET DEV, V4, P255, DOI 10.1016/S0959-437X(05)80052-8; FEARON ER, 1992, CANCER SURV, V12, P119; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; Galamb O, 2009, CELL ONCOL, V31, P19, DOI 10.3233/CLO-2009-0458; Gan LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016916; Grady WM, 2005, BIOCHEM SOC T, V33, P684, DOI 10.1042/BST0330684; Grady WM, 2002, ANNU REV GENOM HUM G, V3, P101, DOI 10.1146/annurev.genom.3.022502.103043; Guo Y, 2006, LEUKEMIA, V20, P115, DOI 10.1038/sj.leu.2404019; Heiman E., 2011, ONCOGENE; Herman JG, 1997, CANCER RES, V57, P837; Huang B, 2011, ONCOGENE; Issa JP, 2000, ANN NY ACAD SCI, V910, P140; Karpf AR, 2004, MOL PHARMACOL, V65, P18, DOI 10.1124/mol.65.1.18; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Ku JL, 2004, ONCOGENE, V23, P6736, DOI 10.1038/sj.onc.1207731; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Landegren Ulf, 2009, Hum Mutat, V30, pv, DOI 10.1002/humu.21140; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Liu CL, 2008, CSH PROTOCOLS; Matsuyama T, 2010, INT J CANCER, V127, P2292, DOI 10.1002/ijc.25256; Meyer D, 2006, J STAT SOFTW, V17; Ogoshi K, 2011, GENOMICS, V98, P280, DOI 10.1016/j.ygeno.2011.07.003; Ostrowski J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-413; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Prall F, 2006, HUM PATHOL, V37, P578, DOI 10.1016/j.humpath.2006.01.005; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sanchez-Aguilera A, 2004, BLOOD, V103, P2351, DOI 10.1182/blood-2003-07-2356; Sato N, 2005, CLIN CANCER RES, V11, P4681, DOI 10.1158/1078-0432.CCR-04-2471; Shain EB, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn408; Siedlecki P, 2006, ACTA BIOCHIM POL, V53, P245; Sova P, 2006, CANCER EPIDEM BIOMAR, V15, P114, DOI 10.1158/1055-9965.EPI-05-0323; Spisak S, 2007, ELECTROPHORESIS, V28, P4261, DOI 10.1002/elps.200700539; Spisak Sandor, 2010, Orvosi Hetilap, V151, P805, DOI 10.1556/OH.2010.28867; Spisak Sandor, 2007, Orvosi Hetilap, V148, P1511, DOI 10.1556/OH.2007.28073; Sugino Y, 2007, ONCOGENE, V26, P7401, DOI 10.1038/sj.onc.1210550; Sung JC, 2004, J AM COLL SURGEONS, V199, pS92; Surawska H, 2004, CYTOKINE GROWTH F R, V15, P419, DOI 10.1016/j.cytogfr.2004.09.002; SUZUKI H, 1995, HUM MOL GENET, V4, P1883, DOI 10.1093/hmg/4.10.1883; Traicoff JL, 2003, J BIOMED SCI, V10, P792, DOI 10.1159/000073967; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni012; Uemura M, 2011, ONCOGENE; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wang SY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-163; Wu CC, 2006, EUR J CANCER, V42, P557, DOI 10.1016/j.ejca.2005.11.015; Xiong HH, 2009, J HUAZHONG U SCI-MED, V29, P498, DOI 10.1007/s11596-009-0421-9; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Zhai RH, 2012, NEOPLASIA, V14, P29, DOI 10.1593/neo.111626; Zhang B, 2007, J HUAZHONG U SCI-MED, V27, P543, DOI 10.1007/s11596-007-0517-z; Zhang HJ, 2011, CANCER RES, V71, P3257, DOI 10.1158/0008-5472.CAN-10-2603; Zhang Z, 2006, ONCOGENE, V25, P5436, DOI 10.1038/sj.onc.1209530; Zhou J, 2002, INT J CANCER, V101, P311, DOI 10.1002/ijc.10600	68	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46215	10.1371/journal.pone.0046215	http://dx.doi.org/10.1371/journal.pone.0046215			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049694	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388500021
J	Harriger, L; van den Heuvel, MP; Sporns, O				Harriger, Logan; van den Heuvel, Martijn P.; Sporns, Olaf			Rich Club Organization of Macaque Cerebral Cortex and Its Role in Network Communication	PLOS ONE			English	Article							SMALL-WORLD; FUNCTIONAL CONNECTIVITY; COGNITIVE NEUROSCIENCE; BRAIN; CONSCIOUSNESS; ARCHITECTURE; INFORMATION; PROJECTIONS; CONNECTOME; COLLATION	Graph-theoretical analysis of brain connectivity data has revealed significant features of brain network organization across a range of species. Consistently, large-scale anatomical networks exhibit highly nonrandom attributes including an efficient small world modular architecture, with distinct network communities that are interlinked by hub regions. The functional importance of hubs motivates a closer examination of their mutual interconnections, specifically to examine the hypothesis that hub regions are more densely linked than expected based on their degree alone, i.e. forming a central rich club. Extending recent findings of rich club topology in the cat and human brain, this report presents evidence for the existence of rich club organization in the cerebral cortex of a non-human primate, the macaque monkey, based on a connectivity data set representing a collation of numerous tract tracing studies. Rich club regions comprise portions of prefrontal, parietal, temporal and insular cortex and are widely distributed across network communities. An analysis of network motifs reveals that rich club regions tend to form star-like configurations, indicative of their central embedding within sets of nodes. In addition, rich club nodes and edges participate in a large number of short paths across the network, and thus contribute disproportionately to global communication. As rich club regions tend to attract and disperse communication paths, many of the paths follow a characteristic pattern of first increasing and then decreasing node degree. Finally, the existence of non-reciprocal projections imposes a net directional flow of paths into and out of the rich club, with some regions preferentially attracting and others dispersing signals. Overall, the demonstration of rich club organization in a non-human primate contributes to our understanding of the network principles underlying neural connectivity in the mammalian brain, and further supports the hypothesis that rich club regions and connections have a central role in global brain communication.	[Harriger, Logan; Sporns, Olaf] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA; [van den Heuvel, Martijn P.] Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands; [van den Heuvel, Martijn P.] Rudolf Magnus Inst Neurosci, NL-3508 TA Utrecht, Netherlands	Indiana University System; Indiana University Bloomington; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Sporns, O (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA.	osporns@indiana.edu	Sporns, Olaf/A-1667-2010; van den Heuvel, Martijn/AFR-3213-2022	Sporns, Olaf/0000-0001-7265-4036; van den Heuvel, Martijn/0000-0003-1570-1195	JS McDonnell Foundation; Rudolf Magnus Institute of Neuroscience	JS McDonnell Foundation; Rudolf Magnus Institute of Neuroscience	OS acknowledges support from the JS McDonnell Foundation. MP acknowledges support from the Rudolf Magnus Institute of Neuroscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Hamelin J.I., 2006, ADV NEURAL INFORM PR, P41; Averbeck BB, 2009, J NEUROPHYSIOL, V102, P1911, DOI 10.1152/jn.00519.2009; Baars BJ, 2005, PROG BRAIN RES, V150, P45, DOI 10.1016/S0079-6123(05)50004-9; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bezgin G, 2012, NEUROIMAGE, V62, P67, DOI 10.1016/j.neuroimage.2012.04.013; Boguna M, 2009, NAT PHYS, V5, P74, DOI 10.1038/NPHYS1130; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Bota M, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00002; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferry AT, 2000, J COMP NEUROL, V425, P447, DOI 10.1002/1096-9861(20000925)425:3<447::AID-CNE9>3.0.CO;2-V; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hilgetag CC, 2000, PHILOS T ROY SOC B, V355, P91, DOI 10.1098/rstb.2000.0551; Hilgetag CC, 2004, NEUROINFORMATICS, V2, P353, DOI 10.1385/NI:2:3:353; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Kaiser M, 2004, BIOL CYBERN, V90, P311, DOI 10.1007/s00422-004-0479-1; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kaiser M, 2011, NEUROIMAGE, V57, P892, DOI 10.1016/j.neuroimage.2011.05.025; Kotter R, 2004, NEUROINFORMATICS, V2, P127; Kotter R, 2003, NEURAL NETWORKS, V16, P1261, DOI 10.1016/j.neunet.2003.06.002; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; Markov NT, 2011, CEREB CORTEX, V21, P1254, DOI 10.1093/cercor/bhq201; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Modha DS, 2010, P NATL ACAD SCI USA, V107, P13485, DOI 10.1073/pnas.1008054107; MORECRAFT RJ, 1993, ARCH NEUROL-CHICAGO, V50, P279, DOI 10.1001/archneur.1993.00540030045013; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; Paxinos G., 2000, RHESUS MONKEY BRAIN; Paxinos G., 2008, RHESUS MONKEY BRAIN, V2nd ed; PREUSS TM, 1991, J COMP NEUROL, V310, P429, DOI 10.1002/cne.903100402; Restrepo JG, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.094102; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Sereno MI, 2005, CURR OPIN NEUROBIOL, V15, P135, DOI 10.1016/j.conb.2005.03.014; Shanahan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036579; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O, 2004, NEUROINFORMATICS, V2, P145, DOI 10.1385/NI:2:2:145; Sporns O., 2011, NETWORKS BRAIN; Sporns O, 2012, DISCOVERING HUMAN CO; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stephan KE, 2001, PHILOS T ROY SOC B, V356, P1159, DOI 10.1098/rstb.2001.0908; Telesford QK, 2011, BRAIN CONNECT, V1, P367, DOI [10.1089/brain.2011.0038, 10.1089/brain.2011.0055]; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; Tononi G, 2008, BIOL BULL-US, V215, P216, DOI 10.2307/25470707; van den Heuvel MP, 2012, P NATL ACAD SCI USA, V109, P11372, DOI 10.1073/pnas.1203593109; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Wang QX, 2012, J NEUROSCI, V32, P4386, DOI 10.1523/JNEUROSCI.6063-11.2012; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; YOUNG MP, 1993, P ROY SOC B-BIOL SCI, V252, P13, DOI 10.1098/rspb.1993.0040; Zamora-Lopez G, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00083; Zamora-Lopez Gorka, 2010, Front Neuroinform, V4, P1, DOI 10.3389/neuro.11.001.2010; Zamora-Lopez G, 2009, CHAOS, V19, DOI 10.1063/1.3089559; Zemanova L, 2006, PHYSICA D, V224, P202, DOI 10.1016/j.physd.2006.09.008; Zhao M, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046225; Zlatic V, 2009, EUR PHYS J B, V67, P271, DOI 10.1140/epjb/e2009-00007-9	77	201	202	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46497	10.1371/journal.pone.0046497	http://dx.doi.org/10.1371/journal.pone.0046497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029538	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900176
J	Lindberg, OR; Persson, A; Brederlau, A; Shabro, A; Kuhn, HG				Lindberg, Olle R.; Persson, Asa; Brederlau, Anke; Shabro, Aidin; Kuhn, Hans Georg			EGF-Induced Expansion of Migratory Cells in the Rostral Migratory Stream	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; ADULT SUBVENTRICULAR ZONE; OLFACTORY-BULB; ERM PROTEINS; STEM-CELLS; RADIXIN; NEURONS; NEUROGENESIS; FOREBRAIN; BRAIN	The presence of neural stem cells in the adult brain is currently widely accepted and efforts are made to harness the regenerative potential of these cells. The dentate gyrus of the hippocampal formation, and the subventricular zone (SVZ) of the anterior lateral ventricles, are considered the main loci of adult neurogenesis. The rostral migratory stream (RMS) is the structure funneling SVZ progenitor cells through the forebrain to their final destination in the olfactory bulb. Moreover, extensive proliferation occurs in the RMS. Some evidence suggest the presence of stem cells in the RMS, but these cells are few and possibly of limited differentiation potential. We have recently demonstrated the specific expression of the cytoskeleton linker protein radixin in neuroblasts in the RMS and in oligodendrocyte progenitors throughout the brain. These cell populations are greatly altered after intracerebroventricular infusion of epidermal growth factor (EGF). In the current study we investigate the effect of EGF infusion on the rat RMS. We describe a specific increase of radixin(+)/Olig2(+) cells in the RMS. Negative for NG2 and CNPase, these radixin+/Olig2(+) cells are distinct from typical oligodendrocyte progenitors. The expanded Olig2(+) population responds rapidly to EGF and proliferates after only 24 hours along the entire RMS, suggesting local activation by EGF throughout the RMS rather than migration from the SVZ. In addition, the radixin+/Olig2(+) progenitors assemble in chains in vivo and migrate in chains in explant cultures, suggesting that they possess migratory properties within the RMS. In summary, these results provide insight into the adaptive capacity of the RMS and point to an additional stem cell source for future brain repair strategies.	[Lindberg, Olle R.; Persson, Asa; Brederlau, Anke; Shabro, Aidin; Kuhn, Hans Georg] Univ Gothenburg, Ctr Brain Repair & Rehabil, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Kuhn, HG (corresponding author), Univ Gothenburg, Ctr Brain Repair & Rehabil, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	georg.kuhn@neuro.gu.se	Kuhn, Hans-Georg/L-8127-2014	Kuhn, Hans-Georg/0000-0003-4247-5613; Lindberg, Olle/0000-0001-5646-2501	Swedish Medical Research Council [VR-M 2011-3113]; Swedish Childhood Cancer Foundation [PROJ10/044, NBCNSDoktBidr09/007]; The Swedish Parkinson's Disease Association; Stiftelsen Wilhelm och Martina Lundgrens Vetenskapsfond; Rune oct Ulla Amlovs Stiftelse; Stiftelsen Edit Jacobsons Donationsfond; Stroke-Riksforbundet; Vastra Gotaland regional funds for biomedical research [ALFGBG-146341]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Childhood Cancer Foundation(European Commission); The Swedish Parkinson's Disease Association; Stiftelsen Wilhelm och Martina Lundgrens Vetenskapsfond; Rune oct Ulla Amlovs Stiftelse; Stiftelsen Edit Jacobsons Donationsfond; Stroke-Riksforbundet; Vastra Gotaland regional funds for biomedical research	This work was supported by grants from the Swedish Medical Research Council (VR-M 2011-3113), the Swedish Childhood Cancer Foundation (PROJ10/044 and NBCNSDoktBidr09/007, Vastra Gotaland regional funds for biomedical research (ALFGBG-146341), The Swedish Parkinson's Disease Association, Stiftelsen Wilhelm och Martina Lundgrens Vetenskapsfond, Rune oct Ulla Amlovs Stiftelse, Stiftelsen Edit Jacobsons Donationsfond and Stroke-Riksforbundet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; Alonso M, 2008, J NEUROSCI, V28, P11089, DOI 10.1523/JNEUROSCI.3713-08.2008; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; Belvindrah R, 2007, J NEUROSCI, V27, P2704, DOI 10.1523/JNEUROSCI.2991-06.2007; Chazal G, 2000, J NEUROSCI, V20, P1446; Claperon A, 2012, ONCOGENE, V31, P1376, DOI 10.1038/onc.2011.334; de Chevigny A, 2008, STEM CELLS, V26, P2349, DOI 10.1634/stemcells.2008-0080; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gonzalez-Perez O, 2009, STEM CELLS, V27, P2032, DOI 10.1002/stem.119; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Gritti A, 2002, J NEUROSCI, V22, P437, DOI 10.1523/JNEUROSCI.22-02-00437.2002; Haas MA, 2007, J NEUROSCI RES, V85, P34, DOI 10.1002/jnr.21102; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Ivkovic S, 2008, J NEUROSCI, V28, P914, DOI 10.1523/JNEUROSCI.4327-07.2008; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Lazar CS, 2004, MOL BIOL CELL, V15, P5470, DOI 10.1091/mbc.E04-03-0239; Lindberg OR, 2012, STEM CELLS DEV, V21, P1356, DOI 10.1089/scd.2011.0275; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Marshall CAG, 2005, J NEUROSCI, V25, P7289, DOI 10.1523/JNEUROSCI.1924-05.2005; Ninomiya M, 2006, NEUROSCI LETT, V403, P63, DOI 10.1016/j.neulet.2006.04.039; Paglini G, 1998, J CELL BIOL, V143, P443, DOI 10.1083/jcb.143.2.443; Pencea V, 2003, J COMP NEUROL, V463, P402, DOI 10.1002/cne.10746; Peretto P, 2005, J COMP NEUROL, V487, P407, DOI 10.1002/cne.20576; Persson A, 2010, NEUROSCIENCE, V167, P312, DOI 10.1016/j.neuroscience.2010.01.035; Reczek D, 1997, J CELL BIOL, V139, P169, DOI 10.1083/jcb.139.1.169; Tang PT, 2007, FEBS LETT, V581, P1103, DOI 10.1016/j.febslet.2007.02.013; Thomas LB, 1996, GLIA, V17, P1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	32	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46380	10.1371/journal.pone.0046380	http://dx.doi.org/10.1371/journal.pone.0046380			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029503	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900150
J	Son, NHP; Ananthakrishnan, R; Yu, SQ; Khan, RS; Jiang, HF; Ji, RP; Akashi, H; Li, Q; O'Shea, K; Homma, S; Goldberg, IJ; Ramasamy, R				Son, Ni-Huiping; Ananthakrishnan, Radha; Yu, Shuiqing; Khan, Raffay S.; Jiang, Hongfeng; Ji, Ruiping; Akashi, Hirokazu; Li, Qing; O'Shea, Karen; Homma, Shunichi; Goldberg, Ira J.; Ramasamy, Ravichandran			Cardiomyocyte Aldose Reductase Causes Heart Failure and Impairs Recovery from Ischemia	PLOS ONE			English	Article							FATTY-ACID OXIDATION; ACTIVATED RECEPTOR-ALPHA; CARDIAC-HYPERTROPHY; PPAR-ALPHA; REPERFUSION INJURY; POLYOL PATHWAY; RAT HEARTS; LIPOTOXIC CARDIOMYOPATHY; DIABETIC COMPLICATIONS; GLUCOSE-METABOLISM	Aldose reductase (AR), an enzyme mediating the first step in the polyol pathway of glucose metabolism, is associated with complications of diabetes mellitus and increased cardiac ischemic injury. We investigated whether deleterious effects of AR are due to its actions specifically in cardiomyocytes. We created mice with cardiac specific expression of human AR (hAR) using the a-myosin heavy chain (MHC) promoter and studied these animals during aging and with reduced fatty acid (FA) oxidation. hAR transgenic expression did not alter cardiac function or glucose and FA oxidation gene expression in young mice. However, cardiac overexpression of hAR caused cardiac dysfunction in older mice. We then assessed whether hAR altered heart function during ischemia reperfusion. hAR transgenic mice had greater infarct area and reduced functional recovery than non-transgenic littermates. When the hAR transgene was crossed onto the PPAR alpha knockout background, another example of greater heart glucose oxidation, hAR expressing mice had increased heart fructose content, cardiac fibrosis, ROS, and apoptosis. In conclusion, overexpression of hAR in cardiomyocytes leads to cardiac dysfunction with aging and in the setting of reduced FA and increased glucose metabolism. These results suggest that pharmacological inhibition of AR will be beneficial during ischemia and in some forms of heart failure.	[Ananthakrishnan, Radha; O'Shea, Karen; Ramasamy, Ravichandran] NYU, Sch Med, Dept Med, New York, NY 10003 USA; [Son, Ni-Huiping; Yu, Shuiqing; Khan, Raffay S.; Jiang, Hongfeng; Ji, Ruiping; Akashi, Hirokazu; Li, Qing; Homma, Shunichi; Goldberg, Ira J.] Columbia Univ, Dept Med, Med Ctr, New York, NY USA	New York University; Columbia University	Ramasamy, R (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10003 USA.	ramasr02@nyumc.org	jiang, hongfeng/I-6188-2013	Ramasamy, Ravichandran/0000-0002-3666-3346	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087945, T32HL007343, P01HL054591, R01HL073029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin A, 2008, AM J PHYSIOL-HEART C, V294, pH1823, DOI 10.1152/ajpheart.01210.2007; ALLARD MF, 1994, AM J PHYSIOL, V267, pH742, DOI 10.1152/ajpheart.1994.267.2.H742; Ananthakrishnan R, 2011, EXP GERONTOL, V46, P762, DOI 10.1016/j.exger.2011.05.001; Ananthakrishnan R, 2009, AM J PHYSIOL-HEART C, V296, pH333, DOI 10.1152/ajpheart.01012.2008; BISHOP SP, 1970, AM J PHYSIOL, V218, P153, DOI 10.1152/ajplegacy.1970.218.1.153; Campbell FM, 2002, J BIOL CHEM, V277, P4098, DOI 10.1074/jbc.M106054200; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; COLLIER A, 1991, BRIT J HOSP MED, V45, P38; Crowder CM, 2009, SCIENCE, V324, P343, DOI 10.1126/science.1173278; Dunlop M, 2000, KIDNEY INT, V58, pS3, DOI 10.1046/j.1523-1755.2000.07702.x; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; GABBAY KH, 1966, SCIENCE, V151, P209, DOI 10.1126/science.151.3707.209; GABBAY KH, 1973, NEW ENGL J MED, V288, P831, DOI 10.1056/NEJM197304192881609; Guellich A, 2007, AM J PHYSIOL-HEART C, V293, pH93, DOI 10.1152/ajpheart.00037.2007; HERS HG, 1956, BIOCHIM BIOPHYS ACTA, V22, P202, DOI 10.1016/0006-3002(56)90247-5; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hwang YC, 2001, FASEB J, V15, P243, DOI 10.1096/fj.01-0368fje; Hwang YYC, 2004, FASEB J, V18, P1192, DOI 10.1096/fj.03-1400com; Hyyti OM, 2010, AM J PHYSIOL-HEART C, V299, pH868, DOI 10.1152/ajpheart.00931.2009; Iwata K, 2006, J PHARMACOL SCI, V102, P37, DOI 10.1254/jphs.FP0060218; KAGAYA Y, 1990, CIRCULATION, V81, P1353, DOI 10.1161/01.CIR.81.4.1353; Kaiserova K, 2006, J BIOL CHEM, V281, P15110, DOI 10.1074/jbc.M600837200; Karbowska J, 2003, CELL MOL BIOL LETT, V8, P49; Kates AM, 2003, J AM COLL CARDIOL, V41, P293, DOI 10.1016/S0735-1097(02)02714-6; KINOSHITA JH, 1979, METABOLISM, V28, P462, DOI 10.1016/0026-0495(79)90057-X; Kloner RA, 2008, CIRCULATION, V117, P2423, DOI 10.1161/CIRCULATIONAHA.107.697979; Kolwicz SC, 2011, CARDIOVASC RES, V90, P194, DOI 10.1093/cvr/cvr071; Li Q, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-33; Lionetti V, 2011, CARDIOVASC RES, V90, P202, DOI 10.1093/cvr/cvr038; Major CD, 1999, DIABETES, V48, P1372, DOI 10.2337/diabetes.48.7.1372; MARKUS HB, 1983, BIOCHEM MED METAB B, V29, P31, DOI 10.1016/0006-2944(83)90051-0; Obrosova IG, 2003, DIABETES, V52, P864, DOI 10.2337/diabetes.52.3.864; Obrosova IG, 2005, DIABETES, V54, P234, DOI 10.2337/diabetes.54.1.234; Okere IC, 2006, HYPERTENSION, V48, P1116, DOI 10.1161/01.HYP.0000248430.26229.0f; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Radin NS, 2003, BIOCHEM J, V371, P243, DOI 10.1042/BJ20021878; Ramasamy R, 1997, DIABETES, V46, P292, DOI 10.2337/diabetes.46.2.292; Ramasamy R, 2003, TXB DIABETES MELLITU, P55; Sena S, 2009, J MOL CELL CARDIOL, V46, P910, DOI 10.1016/j.yjmcc.2009.02.014; Shinmura K, 2002, CIRC RES, V91, P240, DOI 10.1161/01.RES.0000029970.97247.57; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; Son NH, 2010, J CLIN INVEST, V120, P3443, DOI 10.1172/JCI40905; Srivastava S, 2009, CIRC RES, V105, P793, DOI 10.1161/CIRCRESAHA.109.200568; Tracey WR, 2000, AM J PHYSIOL-HEART C, V279, pH1447, DOI 10.1152/ajpheart.2000.279.4.H1447; Trueblood N, 1998, AM J PHYSIOL-HEART C, V275, pH75, DOI 10.1152/ajpheart.1998.275.1.H75; Vedantham S, 2011, ARTERIOSCL THROM VAS, V31, P1805, DOI 10.1161/ATVBAHA.111.226902; Vikramadithyan RK, 2005, J CLIN INVEST, V115, P2434, DOI 10.1172/JCI24819; VIVALDI MT, 1985, AM J PATHOL, V121, P522; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801	50	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46549	10.1371/journal.pone.0046549	http://dx.doi.org/10.1371/journal.pone.0046549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029549	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517500108
J	Argilaguet, JM; Perez-Martin, E; Nofrarias, M; Gallardo, C; Accensi, F; Lacasta, A; Mora, M; Ballester, M; Galindo-Cardiel, I; Lopez-Soria, S; Escribano, JM; Reche, PA; Rodriguez, F				Argilaguet, Jordi M.; Perez-Martin, Eva; Nofrarias, Miquel; Gallardo, Carmina; Accensi, Francesc; Lacasta, Anna; Mora, Mercedes; Ballester, Maria; Galindo-Cardiel, Ivan; Lopez-Soria, Sergio; Escribano, Jose M.; Reche, Pedro A.; Rodriguez, Fernando			DNA Vaccination Partially Protects against African Swine Fever Virus Lethal Challenge in the Absence of Antibodies	PLOS ONE			English	Article							CYTOTOXIC T-CELLS; VIRULENCE DETERMINANT; IMMUNE-RESPONSE; PEPTIDE BINDING; DOMESTIC SWINE; VIRAL PROTEIN; PIGS; IMMUNIZATION; EXPRESSION; INFECTION	The lack of available vaccines against African swine fever virus (ASFV) means that the evaluation of new immunization strategies is required. Here we show that fusion of the extracellular domain of the ASFV Hemagglutinin (sHA) to p54 and p30, two immunodominant structural viral antigens, exponentially improved both the humoral and the cellular responses induced in pigs after DNA immunization. However, immunization with the resulting plasmid (pCMV-sHAPQ) did not confer protection against lethal challenge with the virulent E75 ASFV-strain. Due to the fact that CD8(+) T-cell responses are emerging as key components for ASFV protection, we designed a new plasmid construct, pCMV-UbsHAPQ, encoding the three viral determinants above mentioned (sHA, p54 and p30) fused to ubiquitin, aiming to improve Class I antigen presentation and to enhance the CTL responses induced. As expected, immunization with pCMV-UbsHAPQ induced specific T-cell responses in the absence of antibodies and, more important, protected a proportion of immunized-pigs from lethal challenge with ASFV. In contrast with control pigs, survivor animals showed a peak of CD8+ T-cells at day 3 post-infection, coinciding with the absence of viremia at this time point. Finally, an in silico prediction of CTL peptides has allowed the identification of two SLA I-restricted 9-mer peptides within the hemagglutinin of the virus, capable of in vitro stimulating the specific secretion of IFN gamma when using PBMCs from survivor pigs. Our results confirm the relevance of T-cell responses in protection against ASF and open new expectations for the future development of more efficient recombinant vaccines against this disease.	[Argilaguet, Jordi M.; Perez-Martin, Eva; Nofrarias, Miquel; Accensi, Francesc; Lacasta, Anna; Mora, Mercedes; Ballester, Maria; Galindo-Cardiel, Ivan; Lopez-Soria, Sergio; Rodriguez, Fernando] UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain; [Gallardo, Carmina] CISA INIA, Madrid, Spain; [Escribano, Jose M.] INIA, Dept Biotecnol, Madrid, Spain; [Reche, Pedro A.] Univ Computense Madrid UCM, Dept Microbiol 1, Madrid, Spain; [Accensi, Francesc] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain	IRTA; Autonomous University of Barcelona	Rodriguez, F (corresponding author), UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Barcelona, Spain.	fernando.rodriguez@cresa.uab.es	gallardo, Carmina/AAB-2386-2019; Reche, Pedro A/B-1881-2013; Guilabert, Mercedes/U-6135-2019; Rodriguez, Fernando/GLN-3947-2022; Gallardo+Frontaura, Carmina/ABE-6878-2021; Ballester, Maria/H-7277-2013; Argilaguet, Jordi/E-5109-2016; Perez-MArtin, Eva/AFP-6433-2022; Lopez-Soria, Sergio/F-9858-2012; Ballester, Maria/E-7201-2016; Devis, Maria Ballester/AAV-2467-2020; Lacasta, Anna/P-2278-2017; Accensi, Francesc/C-7051-2008	gallardo, Carmina/0000-0003-3293-306X; Reche, Pedro A/0000-0003-3966-5838; Guilabert, Mercedes/0000-0002-0706-9911; Rodriguez, Fernando/0000-0001-7361-8408; Argilaguet, Jordi/0000-0001-5924-2774; Lopez-Soria, Sergio/0000-0001-7134-2014; Ballester, Maria/0000-0002-5413-4640; Devis, Maria Ballester/0000-0002-5413-4640; Nofrarias Espadamala, Miquel/0000-0002-7983-1389; Lacasta, Anna/0000-0001-8381-9844; Perez-Martin, Eva/0000-0002-4355-4367; Accensi, Francesc/0000-0001-9068-0377	Spanish Ministry of Science and Innovation [CDS2006-00007, AGL2007-66441-C03-344 01/GAN, AGL2010-22229-C03-01]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The study has been financed by the CONSOLIDER-"Porcivir'' CDS2006-00007, AGL2007-66441-C03-344 01/GAN and AGL2010-22229-C03-01 research projects from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz C, 1990, J Vet Diagn Invest, V2, P191; ALCARAZ C, 1992, VIRUS RES, V23, P173, DOI 10.1016/0168-1702(92)90076-L; Alonso F, 1997, VIRUS RES, V49, P123, DOI 10.1016/S0168-1702(97)01459-7; Argilaguet JM, 2011, VACCINE, V29, P5379, DOI 10.1016/j.vaccine.2011.05.084; BACHMANN MF, 1994, EUR J IMMUNOL, V24, P2228, DOI 10.1002/eji.1830240944; Barderas MG, 2001, ARCH VIROL, V146, P1681, DOI 10.1007/s007050170056; Barry MA, 2004, IMMUNOL REV, V199, P68, DOI 10.1111/j.0105-2896.2004.00143.x; Beltran-Alcrudo D., 2008, AFRICAN SWINE FEVER, P1; Boinas FS, 2004, J GEN VIROL, V85, P2177, DOI 10.1099/vir.0.80058-0; Borca MV, 1998, J VIROL, V72, P2881, DOI 10.1128/JVI.72.4.2881-2889.1998; BORCA MV, 1994, VIROLOGY, V201, P413, DOI 10.1006/viro.1994.1311; BORCA MV, 1994, VIROLOGY, V199, P463, DOI 10.1006/viro.1994.1146; Boyle JS, 1998, NATURE, V392, P408, DOI 10.1038/32932; Brossay A, 2003, BIOCHEM BIOPH RES CO, V309, P992, DOI 10.1016/j.bbrc.2003.08.099; Burrage TG, 2004, J VIROL, V78, P2445, DOI 10.1128/JVI.78.5.2445-2453.2004; Chapman DAG, 2011, EMERG INFECT DIS, V17, P599, DOI 10.3201/eid1704.101283; COGGINS L, 1968, CORNELL VET, V58, P525; Costard S, 2009, PHILOS T R SOC B, V364, P2683, DOI 10.1098/rstb.2009.0098; Crosby K, 2004, TRANSPLANTATION, V77, P1288, DOI 10.1097/01.TP.0000120377.57543.D8; Dale C. Jane, 2006, V127, P171; Denyer MS, 2006, VET IMMUNOL IMMUNOP, V110, P279, DOI 10.1016/j.vetimm.2005.10.005; Diaz I, 2005, VET IMMUNOL IMMUNOP, V106, P107, DOI 10.1016/j.vetimm.2005.01.005; Diez-Rivero CM, 2010, PROTEINS, V78, P63, DOI 10.1002/prot.22535; Dixon LK, 2004, VET IMMUNOL IMMUNOP, V100, P117, DOI 10.1016/j.vetimm.2004.04.002; FORMAN AJ, 1982, ARCH VIROL, V74, P91, DOI 10.1007/BF01314703; Gomez-Puertas P, 1998, VIROLOGY, V243, P461, DOI 10.1006/viro.1998.9068; GomezPuertas P, 1996, J VIROL, V70, P5689; Gonzalvo F., 1981, AFRICAN SWINE FEVER, P206; GONZALVO FR, 1986, AM J VET RES, V47, P1858; GONZALVO FR, 1986, AM J VET RES, V47, P1249; Hammer GE, 2006, NAT IMMUNOL, V7, P103, DOI 10.1038/ni1286; Heegaard PM, ARCH VIROL, V156, P183; Jenson JS, 2000, J IMMUNOL METHODS, V242, P33, DOI 10.1016/S0022-1759(00)00222-2; King K, 2011, VACCINE, V29, P4593, DOI 10.1016/j.vaccine.2011.04.052; Lafuente EM, 2009, CURR PHARM DESIGN, V15, P3209, DOI 10.2174/138161209789105162; Leitao A, 1998, J VIROL METHODS, V75, P113, DOI 10.1016/S0166-0934(98)00105-0; Lewis T, 2000, J VIROL, V74, P1275, DOI 10.1128/JVI.74.3.1275-1285.2000; Littel-van den Hurk SV, 2004, IMMUNOL REV, V199, P113, DOI 10.1111/j.0105-2896.2004.00140.x; Littel-van den Hurk,SV, 2010, VACCINE, V28, P6445, DOI 10.1016/j.vaccine.2010.07.045; MARTINS CLV, 1993, ARCH VIROL, V129, P211, DOI 10.1007/BF01316896; Mebus C. A., 1988, Advances in Virus Research, V35, P251, DOI 10.1016/S0065-3527(08)60714-9; Moore DM, 1998, J VIROL, V72, P10310, DOI 10.1128/JVI.72.12.10310-10315.1998; Neilan JG, 2004, VIROLOGY, V319, P337, DOI 10.1016/j.virol.2003.11.011; Neilan JG, 2002, J VIROL, V76, P3095, DOI 10.1128/JVI.76.7.3095-3104.2002; ONISK DV, 1994, VIROLOGY, V198, P350, DOI 10.1006/viro.1994.1040; Oura CAL, 2005, J GEN VIROL, V86, P2445, DOI 10.1099/vir.0.81038-0; Oviedo JM, 1997, J VIROL METHODS, V64, P27, DOI 10.1016/S0166-0934(96)02140-4; Perez-Filgueira DA, 2006, J CLIN MICROBIOL, V44, P3114, DOI 10.1128/JCM.00406-06; Radosevic K, 2009, EXPERT REV VACCINES, V8, P577, DOI 10.1586/ERV.09.14; Rahimi P, 2010, EMERG INFECT DIS, V16, P1946, DOI 10.3201/eid1612.100378; Reche Pedro A., 2007, V409, P185, DOI 10.1007/978-1-60327-118-9_13; Rodriguez F, 1997, J VIROL, V71, P8497, DOI 10.1128/JVI.71.11.8497-8503.1997; RODRIGUEZ F, 1994, J VIROL, V68, P7244, DOI 10.1128/JVI.68.11.7244-7252.1994; Rodriguez F, 2001, J VIROL, V75, P7399, DOI 10.1128/JVI.75.16.7399-7409.2001; RODRIGUEZ JM, 1993, J VIROL, V67, P5312; Rowlands RJ, 2008, EMERG INFECT DIS, V14, P1870, DOI 10.3201/eid1412.080591; RuizGonzalvo F, 1996, VIROLOGY, V218, P285, DOI 10.1006/viro.1996.0193; Sanchez Botija C., 1963, ZOOPROFLASSI, V18, P578; SCHLAFER DH, 1984, AM J VET RES, V45, P1367; SELVARAJ P, 1987, NATURE, V326, P400, DOI 10.1038/326400a0; STONE SS, 1967, AM J VET RES, V28, P475; Takashima A, 2001, Curr Protoc Cell Biol, VChapter 2, DOI 10.1002/0471143030.cb0201s00; WARDLEY RC, 1985, VET IMMUNOL IMMUNOP, V9, P201, DOI 10.1016/0165-2427(85)90071-6; WARDLEY RC, 1983, ARCH VIROL, V76, P73, DOI 10.1007/BF01311692; ZSAK L, 1993, VIROLOGY, V196, P596, DOI 10.1006/viro.1993.1515; Zsak L, 1998, J VIROL, V72, P1028, DOI 10.1128/JVI.72.2.1028-1035.1998	66	82	115	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e40942	10.1371/journal.pone.0040942	http://dx.doi.org/10.1371/journal.pone.0040942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049728	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300003
J	Goo, CK; Lim, HY; Ho, QS; Too, HP; Clement, MV; Wong, KP				Goo, Chong Kiat; Lim, Hwee Ying; Ho, Qin Shi; Too, Heng-Phon; Clement, Marie-Veronique; Wong, Kim Ping			PTEN/Akt Signaling Controls Mitochondrial Respiratory Capacity through 4E-BP1	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; DIRECT INHIBITION; TUMOR-SUPPRESSOR; COMPLEXES I; PROTEIN; CELLS; AKT; CANCER; BIOGENESIS; ACTIVATION	Akt, a serine/threonine kinase has been shown to stimulate glycolysis in cancer cells but its role in mitochondrial respiration is unknown. Using PTEN-knockout mouse embryonic fibroblasts (MEFPTEN-/-) with hyper-activated Akt as a cell model, we observed a higher respiratory capacity in MEFPTEN-/- compared to the wildtype (MEFWT). The respiratory phenotype observed in MEFPTEN-/- was reproduced in MEFWT by gene silencing of PTEN which substantiated its role in regulating mitochondrial function. The increased activities of the respiratory complexes (RCs) I, III and IV were retained in the same relative proportions as those present in MEFWT, alluding to a possible co-ordinated regulation by PTEN/Akt. Using LY294002 (a PI3K inhibitor) and Akt inhibitor IV, we showed that the regulation of enzyme activities and protein expressions of the RCs was dependent on PI3K/Akt. There was insignificant difference in the protein expressions of mitochondrial transcription factor: peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 alpha) and its downstream targets, the nuclear respiratory factor 1 (NRF-1) and mitochondrial transcription factor A (mtTFA) between MEFPTEN-/- and MEFWT. Similarly, mRNA levels of the same subunits of the RCs detected in Western blots were not significantly different between MEFPTEN-/- and MEFWT suggesting that the regulation by Akt on mitochondrial function was probably not via gene transcription. On the other hand, a decrease of total 4E-BP1 with a higher expression of its phosphorylated form relative to total 4E-BP1 was found in MEFPTEN-/-, which inferred that the regulation of mitochondrial respiratory activities by Akt was in part through this protein translation pathway. Notably, gene silencing of 4E-BP1 up-regulated the protein expressions of all RCs and the action of 4E-BP1 appeared to be specific to these mitochondrial proteins. In conclusion, PTEN inactivation bestowed a bioenergetic advantage to the cells by up-regulating mitochondrial respiratory capacity through the 4E-BP1-mediated protein translation pathway.	[Goo, Chong Kiat; Lim, Hwee Ying; Ho, Qin Shi; Too, Heng-Phon; Clement, Marie-Veronique; Wong, Kim Ping] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore; [Clement, Marie-Veronique] NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore	National University of Singapore; National University of Singapore	Wong, KP (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117548, Singapore.	bchsitkp@nus.edu.sg			National University of Singapore [R-183-000-261-112]; Biomedical Research Council [09/1/21/19/603]	National University of Singapore(National University of Singapore); Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by research grants from National University of Singapore (R-183-000-261-112 to KPW) and from the Biomedical Research Council (09/1/21/19/603 to MVC and KPW). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Armengol G, 2007, CANCER RES, V67, P7551, DOI 10.1158/0008-5472.CAN-07-0881; Augereau O, 2005, CELL MOL LIFE SCI, V62, P1478, DOI 10.1007/s00018-005-5005-7; BAGGETTO LG, 1992, CANCER RES, V52, P4935; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cridge AG, 2010, NUCLEIC ACIDS RES, V38, P8039, DOI 10.1093/nar/gkq686; de Groof AJC, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-54; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Dudkina NV, 2011, P NATL ACAD SCI USA, V108, P15196, DOI 10.1073/pnas.1107819108; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hobert JA, 2009, GENET MED, V11, P687, DOI 10.1097/GIM.0b013e3181ac9aea; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Koopman Werner J H, 2010, Antioxid Redox Signal, V12, P1431, DOI 10.1089/ars.2009.2743; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lim HW, 2009, BIOCHEM BIOPH RES CO, V389, P187, DOI 10.1016/j.bbrc.2009.08.121; Lim HY, 2011, MITOCHONDRION, V11, P437, DOI 10.1016/j.mito.2010.12.015; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Ng LE, 2006, BIOCHEM BIOPH RES CO, V348, P494, DOI 10.1016/j.bbrc.2006.07.089; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stokoe D, 2001, CURR BIOL, V11, pR502, DOI 10.1016/S0960-9822(01)00303-7; Suzuki A, 2008, CANCER SCI, V99, P209, DOI 10.1111/j.1349-7006.2007.00670.x; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006; Xue L, 2008, P NATL ACAD SCI USA, V105, P2022, DOI 10.1073/pnas.0712059105; Zhang X, 2004, J BIOL CHEM, V279, P43035, DOI 10.1074/jbc.M402759200; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	51	72	76	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45806	10.1371/journal.pone.0045806	http://dx.doi.org/10.1371/journal.pone.0045806			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049865	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300054
J	Jiang, D; Huang, YH; Zhuang, DF; Zhu, YQ; Xu, XL; Ren, HY				Jiang, Dong; Huang, Yaohuan; Zhuang, Dafang; Zhu, Yunqiang; Xu, Xinliang; Ren, Hongyan			A Simple Semi-Automatic Approach for Land Cover Classification from Multispectral Remote Sensing Imagery	PLOS ONE			English	Article							COMPONENTS; AGREEMENT; CHINA	Land cover data represent a fundamental data source for various types of scientific research. The classification of land cover based on satellite data is a challenging task, and an efficient classification method is needed. In this study, an automatic scheme is proposed for the classification of land use using multispectral remote sensing images based on change detection and a semi-supervised classifier. The satellite image can be automatically classified using only the prior land cover map and existing images; therefore human involvement is reduced to a minimum, ensuring the operability of the method. The method was tested in the Qingpu District of Shanghai, China. Using Environment Satellite 1(HJ-1) images of 2009 with 30 m spatial resolution, the areas were classified into five main types of land cover based on previous land cover data and spectral features. The results agreed on validation of land cover maps well with a Kappa value of 0.79 and statistical area biases in proportion less than 6%. This study proposed a simple semi-automatic approach for land cover classification by using prior maps with satisfied accuracy, which integrated the accuracy of visual interpretation and performance of automatic classification methods. The method can be used for land cover mapping in areas lacking ground reference information or identifying rapid variation of land cover regions (such as rapid urbanization) with convenience.	[Jiang, Dong; Huang, Yaohuan; Zhuang, Dafang; Zhu, Yunqiang; Xu, Xinliang; Ren, Hongyan] Chinese Acad Sci, State Key Lab Resources & Environm Informat Syst, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Huang, YH (corresponding author), Chinese Acad Sci, State Key Lab Resources & Environm Informat Syst, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China.	huangyh@lreis.ac.cn			Chinese Academy of Sciences [KZZD-EW-08]; China Postdoctoral Science Foundation [20100480437, 201104133]	Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was financially supported by the Chinese Academy of Sciences (grant KZZD-EW-08), and the China Postdoctoral Science Foundation (20100480437, 201104133). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackman NJM, 2000, STAT MED, V19, P723, DOI 10.1002/(SICI)1097-0258(20000315)19:5<723::AID-SIM379>3.0.CO;2-A; Bovolo F, 2009, IEEE GEOSCI REMOTE S, V6, P33, DOI 10.1109/LGRS.2008.2007429; Chen S., 1998, STUDY INFORM MECH RE; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Compton J, 1985, SCIENCE, V227, P369, DOI DOI 10.1126/SCIENCE.1111772; Dolman A. J., 2003, GLOBAL ENV CHANGE LA; EASTMENT HT, 1982, TECHNOMETRICS, V24, P73, DOI 10.2307/1267581; EKLUNDH L, 1993, INT J REMOTE SENS, V14, P1359, DOI 10.1080/01431169308953962; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foody GM, 2007, PROG PHYS GEOG, V31, P439, DOI 10.1177/0309133307081294; Fortier J, 2011, PHOTOGRAMM ENG REM S, V77, P181, DOI 10.14358/PERS.77.2.181; Friedl MA, 1997, REMOTE SENS ENVIRON, V61, P399, DOI 10.1016/S0034-4257(97)00049-7; Friedl MA, 2002, REMOTE SENS ENVIRON, V83, P287, DOI 10.1016/S0034-4257(02)00078-0; Gong P, 2003, INT J REMOTE SENS, V24, P1303, DOI 10.1080/01431160110115870; Guo Y, 2007, STUDY LAND USE LANDS; Hansen M, 1996, INT J REMOTE SENS, V17, P1075, DOI 10.1080/01431169608949069; Jia XP, 1999, IEEE T GEOSCI REMOTE, V37, P538, DOI 10.1109/36.739109; Lambin EF., 2006, LOCAL PROCESSES GLOB; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Liu J, 2010, CHINESE SCI BULL, V53, P1; Liu J Y, 2005, STUDY SPATIAL TEMPOR; Liu Jiyuan, 2002, Journal of Geographical Sciences, V12, P275; Liu JY, 2003, SCI CHINA SER D, V46, P373; Liu JY, 2005, REMOTE SENS ENVIRON, V98, P442, DOI 10.1016/j.rse.2005.08.012; LOVELAND TR, 1991, PHOTOGRAMM ENG REM S, V57, P1453; Ran YH, 2010, INT J REMOTE SENS, V31, P391, DOI 10.1080/01431160902893451; Rogan J, 2004, PROG PLANN, V61, P301, DOI 10.1016/S0305-9006(03)00066-7; Schneider A, 2010, REMOTE SENS ENVIRON, V114, P1733, DOI 10.1016/j.rse.2010.03.003; Shanghai Bureau of Statistics, 2006, COMP SHANGH 2 AGR CE; Tax DMJ, 2004, MACH LEARN, V54, P45, DOI 10.1023/B:MACH.0000008084.60811.49; Yan HM, 2009, GLOBAL PLANET CHANGE, V67, P13, DOI 10.1016/j.gloplacha.2008.12.012; Zhang B, 2005, J TIANJIN NORMAL U N, V25, P69; ZHANG YS, 2003, J NANJING U, V39, P806; Zhao Y, 2003, APPL PRINCIPLE METHO	34	21	23	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45889	10.1371/journal.pone.0045889	http://dx.doi.org/10.1371/journal.pone.0045889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049886	gold, Green Published			2022-12-27	WOS:000309517300061
J	Perez-Montarelo, D; Hudson, NJ; Fernandez, AI; Ramayo-Caldas, Y; Dalrymple, BP; Reverter, A				Perez-Montarelo, Dafne; Hudson, Nicholas J.; Fernandez, Ana I.; Ramayo-Caldas, Yuliaxis; Dalrymple, Brian P.; Reverter, Antonio			Porcine Tissue-Specific Regulatory Networks Derived from Meta-Analysis of the Transcriptome	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; DIFFERENTIAL EXPRESSION; SKELETAL-MUSCLE; ADIPOSE-TISSUES; PROTEIN; ATLAS; MOUSE; EVOLUTION; REVEALS; PIGS	The processes that drive tissue identity and differentiation remain unclear for most tissue types. So are the gene networks and transcription factors (TF) responsible for the differential structure and function of each particular tissue, and this is particularly true for non model species with incomplete genomic resources. To better understand the regulation of genes responsible for tissue identity in pigs, we have inferred regulatory networks from a meta-analysis of 20 gene expression studies spanning 480 Porcine Affymetrix chips for 134 experimental conditions on 27 distinct tissues. We developed a mixed-model normalization approach with a covariance structure that accommodated the disparity in the origin of the individual studies, and obtained the normalized expression of 12,320 genes across the 27 tissues. Using this resource, we constructed a network, based on the co-expression patterns of 1,072 TF and 1,232 tissue specific genes. The resulting network is consistent with the known biology of tissue development. Within the network, genes clustered by tissue and tissues clustered by site of embryonic origin. These clusters were significantly enriched for genes annotated in key relevant biological processes and confirm gene functions and interactions from the literature. We implemented a Regulatory Impact Factor (RIF) metric to identify the key regulators in skeletal muscle and tissues from the central nervous systems. The normalization of the meta-analysis, the inference of the gene co-expression network and the RIF metric, operated synergistically towards a successful search for tissue-specific regulators. Novel among these findings are evidence suggesting a novel key role of ERCC3 as a muscle regulator. Together, our results recapitulate the known biology behind tissue specificity and provide new valuable insights in a less studied but valuable model species.	[Perez-Montarelo, Dafne; Hudson, Nicholas J.; Dalrymple, Brian P.; Reverter, Antonio] Queensland Biosci Precinct, Commonwealth Sci & Ind Res Org CSIRO Anim Food &, Computat & Syst Biol, Brisbane, Qld, Australia; [Perez-Montarelo, Dafne; Fernandez, Ana I.] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Mejora Genet Anim, Madrid, Spain; [Ramayo-Caldas, Yuliaxis] Univ Autonoma Barcelona, Fac Vet, Dept Ciencia Anim & Aliments, E-08193 Barcelona, Spain	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Autonomous University of Barcelona	Reverter, A (corresponding author), Queensland Biosci Precinct, Commonwealth Sci & Ind Res Org CSIRO Anim Food &, Computat & Syst Biol, Brisbane, Qld, Australia.	Tony.Reverter-Gomez@csiro.au	Caldas, Yuliaxis Ramayo/B-6337-2014; Hudson, Nick/AAF-5644-2020; Hudson, Nicholas J/D-1606-2011; Hudson, Nick/C-1201-2008; Fernández, Ana Isabel/J-3265-2012; Reverter, Antonio/C-9699-2013; Dalrymple, Brian P/F-8721-2010	Caldas, Yuliaxis Ramayo/0000-0002-8142-0159; Hudson, Nick/0000-0002-3549-9396; Hudson, Nicholas J/0000-0002-3549-9396; Fernández, Ana Isabel/0000-0002-1509-5191; Reverter, Antonio/0000-0002-4681-9404; Dalrymple, Brian P/0000-0003-3891-5233	Spanish Ministerio de Ciencia e Innovacion [BES-2009-025417]; Spanish Ministerio de Educacion [AP2008-01450]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Spanish Ministerio de Educacion(Spanish Government)	The authors acknowledge the assistance of the CSIRO Transformational Biology Capability Platform. D. Perez-Montarelo was funded by an FPI PhD grant from the Spanish Ministerio de Ciencia e Innovacion (BES-2009-025417). Y. Ramayo-Caldas was funded by an FPU PhD grant from the Spanish Ministerio de Educacion (AP2008-01450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham O, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-21; Aziz A, 2010, EPIGENETICS-US, V5, P691, DOI 10.4161/epi.5.8.13045; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Budhram-Mahadeo V, 2001, INT J BIOCHEM CELL B, V33, P1027, DOI 10.1016/S1357-2725(01)00069-3; Buza-Vidas N, 2011, BLOOD, V118, P1291, DOI 10.1182/blood-2011-02-338046; Cahan P, 2007, GENE, V401, P12, DOI 10.1016/j.gene.2007.06.016; Canterini S, 2012, CEREBELLUM, V11, P28, DOI 10.1007/s12311-010-0211-8; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; Chen B, 2009, DEV BIOL, V326, P75, DOI 10.1016/j.ydbio.2008.10.039; Chen H, 2009, BMC GENOMICS, P10; Chen HH, 2002, DEVELOPMENT, V129, P4879; Depre C, 2010, AM J PHYSIOL-HEART C, V299, pH752, DOI 10.1152/ajpheart.00147.2010; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fedorova E, 2008, BBA-MOL CELL RES, V1783, P2174, DOI 10.1016/j.bbamcr.2008.07.018; Fernandez-Rodriguez A, 2011, BIOL REPROD, V84, P299, DOI 10.1095/biolreprod.110.085589; Ferraz ALJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-173; Fontanesi L, 2011, MEAT SCI, V88, P604, DOI 10.1016/j.meatsci.2011.02.001; Harhay GP, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r102; Hudson NJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-356; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Ilagan RM, 2011, J CELL PHYSIOL, V226, P2702, DOI 10.1002/jcp.22622; Jameel MN, 2010, AM J PHYSIOL-HEART C, V298, pH1348, DOI 10.1152/ajpheart.01100.2009; Jiang CD, 2010, INT J BIOL SCI, V6, P627, DOI 10.7150/ijbs.6.627; Jongeneel CV, 2005, GENOME RES, V15, P1007, DOI 10.1101/gr.4041005; Jothi R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.52; Kapushesky M, 2011, NUCL ACIDS RES; Lan MS, 2009, FASEB J, V23, P2024, DOI 10.1096/fj.08-125971; Larder R, 2011, J NEUROSCI, V31, P426, DOI 10.1523/JNEUROSCI.1688-10.2011; Li R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-556; Li Y, 2010, INT J BIOL SCI, V6, P350; Lin KM, 2001, LEUKEMIA, V15, P601, DOI 10.1038/sj.leu.2402071; Lkhagvadorj S, 2010, AM J PHYSIOL-REG I, V298, pR494, DOI 10.1152/ajpregu.00632.2009; Lkhagvadorj S, 2009, PHYSIOL GENOMICS, V38, P98, DOI 10.1152/physiolgenomics.90372.2008; Lozano-Velasco E, 2011, DEV BIOL, V357, P165, DOI 10.1016/j.ydbio.2011.06.039; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahoney MG, 1998, BIOL REPROD, V59, P388, DOI 10.1095/biolreprod59.2.388; Marino S, 2003, DEVELOPMENT, V130, P3359, DOI 10.1242/dev.00553; Martijn C, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-27; Mazaud S., 2002, Gene Expression Patterns, V2, P373, DOI 10.1016/S1567-133X(02)00050-9; McKusick V, 2010, ONLINE MENDELIAN INH; Meisel RP, 2012, GENOME RES; Moon JK, 2009, ANIM GENET, V40, P115, DOI 10.1111/j.1365-2052.2008.01798.x; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Nagaraj SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S23; Norris AJ, 2010, J NEUROSCI, V30, P13644, DOI 10.1523/JNEUROSCI.2487-10.2010; Ostrup E, 2010, BIOL REPROD, V83, P277, DOI 10.1095/biolreprod.109.082321; Pei ZL, 2011, P NATL ACAD SCI USA, V108, P1675, DOI 10.1073/pnas.1008824108; Perez-Enciso M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-89; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Pimanda JE, 2010, INT J DEV BIOL, V54, P1201, DOI 10.1387/ijdb.093038jp; Ponsuksili S, 2008, J AGR FOOD CHEM, V56, P10311, DOI 10.1021/jf800881y; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Reverter A, 2005, BIOINFORMATICS, V21, P1112, DOI 10.1093/bioinformatics/bti124; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter A, 2010, BIOINFORMATICS, V26, P896, DOI 10.1093/bioinformatics/btq051; Reverter A, 2008, BIODATA MIN, V1, DOI 10.1186/1756-0381-1-8; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Swindle MM, 2011, VET PATHOL; Technau U, 2003, INT J DEV BIOL, V47, P531; Thomsen MB, 2009, CIRC RES, V104, P1382, DOI 10.1161/CIRCRESAHA.109.196972; Tsai S, 2006, ANIM GENET, V37, P423, DOI 10.1111/j.1365-2052.2006.01460.x; Tsarovina K, 2010, J NEUROSCI, V30, P10833, DOI 10.1523/JNEUROSCI.0175-10.2010; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Wang Y, 2008, BMC GENOMICS, P9; Wang YF, 2007, GENOMICS, V90, P72, DOI 10.1016/j.ygeno.2007.03.018; Williamson C, 2012, MOUSE IMPRINTING DAT; Winter EE, 2004, GENOME RES, V14, P54, DOI 10.1101/gr.1924004; Yang J, 2005, MOL BIOL EVOL, V22, P2113, DOI 10.1093/molbev/msi206; Zeggini E, 2009, PHARMACOGENOMICS, V10, P191, DOI 10.2217/14622416.10.2.191; Zhang LQ, 2005, MOL BIOL EVOL, V22, P2504, DOI 10.1093/molbev/msi240; Zhou QY, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-337	79	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46159	10.1371/journal.pone.0046159	http://dx.doi.org/10.1371/journal.pone.0046159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049964	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300092
J	Ramsey, JM; Gutierrez-Cabrera, AE; Salgado-Ramirez, L; Peterson, AT; Sanchez-Cordero, V; Ibarra-Cerdena, CN				Ramsey, Janine M.; Gutierrez-Cabrera, Ana E.; Salgado-Ramirez, Liliana; Peterson, A. Townsend; Sanchez-Cordero, Victor; Ibarra-Cerdena, Carlos N.			Ecological Connectivity of Trypanosoma cruzi Reservoirs and Triatoma pallidipennis Hosts in an Anthropogenic Landscape with Endemic Chagas Disease	PLOS ONE			English	Article							INFESTANS HEMIPTERA REDUVIIDAE; SYLVATIC TRIATOMINAE; DOMESTIC POPULATIONS; RISK-FACTORS; MEXICO; TRANSMISSION; VECTORS; INFECTION; CHACO; BATS	Traditional methods for Chagas disease prevention are targeted at domestic vector reduction, as well as control of transfusion and maternal-fetal transmission. Population connectivity of Trypanosoma cruzi-infected vectors and hosts, among sylvatic, ecotone and domestic habitats could jeopardize targeted efforts to reduce human exposure. This connectivity was evaluated in a Mexican community with reports of high vector infestation, human infection, and Chagas disease, surrounded by agricultural and natural areas. We surveyed bats, rodents, and triatomines in dry and rainy seasons in three adjacent habitats (domestic, ecotone, sylvatic), and measured T. cruzi prevalence, and host feeding sources of triatomines. Of 12 bat and 7 rodent species, no bat tested positive for T. cruzi, but all rodent species tested positive in at least one season or habitat. Highest T. cruzi infection prevalence was found in the rodents, Baiomys musculus and Neotoma mexicana. In general, parasite prevalence was not related to habitat or season, although the sylvatic habitat had higher infection prevalence than by chance, during the dry season. Wild and domestic mammals were identified as bloodmeals of T. pallidipennis, with 9% of individuals having mixed human (4.8% single human) and other mammal species in bloodmeals, especially in the dry season; these vectors tested >50% positive for T. cruzi. Overall, ecological connectivity is broad across this matrix, based on high rodent community similarity, vector and T. cruzi presence. Cost-effective T. cruzi, vector control strategies and Chagas disease transmission prevention will need to consider continuous potential for parasite movement over the entire landscape. This study provides clear evidence that these strategies will need to include reservoir/host species in at least ecotones, in addition to domestic habitats.	[Ramsey, Janine M.; Gutierrez-Cabrera, Ana E.; Salgado-Ramirez, Liliana; Ibarra-Cerdena, Carlos N.] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico; [Peterson, A. Townsend] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA; [Sanchez-Cordero, Victor; Ibarra-Cerdena, Carlos N.] Univ Nacl Autonoma Mexico, Inst Biol, Mexico City 04510, DF, Mexico	Instituto Nacional de Salud Publica; University of Kansas; Universidad Nacional Autonoma de Mexico	Ibarra-Cerdena, CN (corresponding author), Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico.	Ibarra.cerdena@gmail.com	Ramsey, Janine M./AAS-2220-2021; Peterson, A. Townsend/I-5697-2013	Ramsey, Janine M./0000-0002-5950-0830; Peterson, A. Townsend/0000-0003-0243-2379; Ibarra-Cerdena, Carlos N./0000-0003-4980-4344	Secretaria de Salud; Consejo Nacional de Ciencia y Tecnologia (CONACyt) [MOR-2004-CO2-012]; Universidad Nacional Autonoma de Mexico (PAPIIT project) [225408]; Sistema de Informatica para la Biodiversidad y el Ambiente [SIBA]; Tecnologias para la Universidad de la Informacion y la Computacion; CONACyT	Secretaria de Salud; Consejo Nacional de Ciencia y Tecnologia (CONACyt)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Universidad Nacional Autonoma de Mexico (PAPIIT project); Sistema de Informatica para la Biodiversidad y el Ambiente [SIBA]; Tecnologias para la Universidad de la Informacion y la Computacion; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was funded by the Secretaria de Salud and Consejo Nacional de Ciencia y Tecnologia (CONACyt) project MOR-2004-CO2-012 to JMR, and by the Universidad Nacional Autonoma de Mexico (PAPIIT project 225408 to VS-C, and the Sistema de Informatica para la Biodiversidad y el Ambiente [SIBA], and Tecnologias para la Universidad de la Informacion y la Computacion. AEGC was funded with a scholarship from CONACyT for a M. Sc. degree in vector-borne diseases at the Instituto Nacional de Salud Publica. CNIC is funded with a scholarship from CONACyT for studies at the graduate program in Biomedical Sciences of the Universidad Nacional Autonoma de Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bello-Gutierrez J, 2010, J WILDLIFE DIS, V46, P1000, DOI 10.7589/0090-3558-46.3.1000; Borges EC, 2005, ACTA TROP, V93, P119, DOI 10.1016/j.actatropica.2004.10.002; Brunner JL, 2008, J MED ENTOMOL, V45, P139, DOI 10.1603/0022-2585(2008)45[139:ERCOBB]2.0.CO;2; Cadotte MW, 2006, AM NAT, V167, P913, DOI 10.1086/504850; CAMARGO E P, 1964, Rev Inst Med Trop Sao Paulo, V6, P93; Ceballos G., 2005, MAMIFEROS SILVESTRES, P21; Ceballos LA, 2009, J MED ENTOMOL, V46, P1195, DOI 10.1603/033.046.0530; Chao A., 2005, ENCY STAT SCI, P7909; Cohen JM, 2006, J MED ENTOMOL, V43, P1252, DOI 10.1603/0022-2585(2006)43[1252:IBTPHR]2.0.CO;2; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Condit R, 2000, J VEG SCI, V11, P649, DOI 10.2307/3236572; DALESSANDRO A, 1985, FACTORES BIOL ECOLOG, V2, P377; Davis S, 2005, VECTOR-BORNE ZOONOT, V5, P305, DOI 10.1089/vbz.2005.5.305; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Diosque P, 2004, AM J TROP MED HYG, V71, P590, DOI 10.4269/ajtmh.2004.71.590; Dorn PL, 2007, EMERG INFECT DIS, V13, P605, DOI 10.3201/eid1304.061002; Dumonteil E, 2007, AM J TROP MED HYG, V76, P930, DOI 10.4269/ajtmh.2007.76.930; Enger KS, 2004, J MED ENTOMOL, V41, P760, DOI 10.1603/0022-2585-41.4.760; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Gratz N. G., 1994, P85; Guhl F, 2009, MEM I OSWALDO CRUZ, V104, P71, DOI 10.1590/S0074-02762009000900012; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Ibarra-Cerdena CN, 2009, ACTA TROP, V110, P178, DOI 10.1016/j.actatropica.2008.11.012; Kunz TH, 1989, ECOLOGICAL BEHAV MET, P1; Magallon-Gastelum E, 2001, J MED ENTOMOL, V38, P638, DOI 10.1603/0022-2585-38.5.638; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Maloney J, 2010, J PARASITOL, V96, P353, DOI 10.1645/GE-2312.1; MARINKELLE CJ, 1982, ANN TROP MED PARASIT, V76, P125, DOI 10.1080/00034983.1982.11687517; Mills JN, 2010, VECTOR-BORNE ZOONOT, V10, P547, DOI 10.1089/vbz.2010.1503; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; Mota J, 2007, VECTOR-BORNE ZOONOT, V7, P617, DOI 10.1089/vbz.2007.0106; Murphy Peter G., 1995, P9, DOI 10.1017/CBO9780511753398.002; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Noireau F, 2009, MEM I OSWALDO CRUZ, V104, P60, DOI 10.1590/S0074-02762009000900010; Pfeiler E, 2006, MOL PHYLOGENET EVOL, V41, P209, DOI 10.1016/j.ympev.2006.07.001; Pinto A. da S., 1986, Revista da Sociedade Brasileira de Medicina Tropical, V19, P31; Ramirez CJ, 2005, ACTA TROP, V93, P23, DOI 10.1016/j.actatropica.2004.09.001; Ramsey JM, 2005, MED VET ENTOMOL, V19, P219, DOI 10.1111/j.0269-283X.2005.00563.x; Ramsey JM, 2000, MED VET ENTOMOL, V14, P19, DOI 10.1046/j.1365-2915.2000.00214.x; Ramsey JM, 2003, J MED ENTOMOL, V40, P912, DOI 10.1603/0022-2585-40.6.912; Rolon M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001026; Sanchez-Cordero V, 2000, P NATL ACAD SCI USA, V97, P7074, DOI 10.1073/pnas.97.13.7074; Sanchez-Cordero V, 2003, RATS MICE PEOPLE ROD, P526; Schmunis GA, 2007, ISBT SCI SERIES, V2, P6, DOI 10.1111/j.1751-2824.2007.00052.x; SEMARNAT, 2001, DIARIO OFICIAL  0306; STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0; Thomas ME, 2007, MEM I OSWALDO CRUZ, V102, P559, DOI 10.1590/S0074-02762007005000068; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Villegas-Garcia JC, 2004, ANN TROP MED PARASIT, V98, P529, DOI 10.1179/000349804225003497; Zavala-Velazquez J., 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P289, DOI 10.1590/S0036-46651996000400009	51	47	47	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46013	10.1371/journal.pone.0046013	http://dx.doi.org/10.1371/journal.pone.0046013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049923	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300075
J	Vegge, CS; Brondsted, L; Ligowska-Marzeta, M; Ingmer, H				Vegge, Christina S.; Brondsted, Lone; Ligowska-Marzeta, Malgorzata; Ingmer, Hanne			Natural Transformation of Campylobacter jejuni Occurs Beyond Limits of Growth	PLOS ONE			English	Article							COMPETENCE GENE HOMOLOGS; GUILLAIN-BARRE-SYNDROME; NEISSERIA-GONORRHOEAE; STREPTOCOCCUS-PNEUMONIAE; HELICOBACTER-PYLORI; BACILLUS-SUBTILIS; STRESS TOLERANCE; DNA UPTAKE; VIRULENCE; SYSTEM	Campylobacter jejuni is a human bacterial pathogen. While poultry is considered to be a major source of food borne campylobacteriosis, C. jejuni is frequently found in the external environment, and water is another well-known source of human infections. Natural transformation is considered to be one of the main mechanisms for mediating transfer of genetic material and evolution of the organism. Given the diverse habitats of C. jejuni we set out to examine how environmental conditions and physiological processes affect natural transformation of C. jejuni. We show that the efficiency of transformation is correlated to the growth conditions, but more importantly that transformation occurs at growth-restrictive conditions as well as in the late stationary phase; hence revealing that growth per se is not required for C. jejuni to be competent. Yet, natural transformation of C. jejuni is an energy dependent process, that occurs in the absence of transcription but requires an active translational machinery. Moreover, we show the ATP dependent ClpP protease to be important for transformation, which possibly could be associated with reduced protein glycosylation in the ClpP mutant. In contrast, competence of C. jejuni was neither found to be involved in DNA repair following DNA damage nor to provide a growth benefit. Kinetic studies revealed that several transformation events occur per cell cycle indicating that natural transformation of C. jejuni is a highly efficient process. Thus, our findings suggest that horizontal gene transfer by natural transformation takes place in various habitats occupied by C. jejuni.	[Vegge, Christina S.; Brondsted, Lone; Ligowska-Marzeta, Malgorzata; Ingmer, Hanne] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark	University of Copenhagen	Vegge, CS (corresponding author), Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark.	csv@sund.ku.dk		Ingmer, Hanne/0000-0002-8350-5631; Ligowska-Marzeta, Malgorzata/0000-0002-2693-5141; Brondsted, Lone/0000-0002-7930-5725	Danish Research Council for Technology and Production Sciences	Danish Research Council for Technology and Production Sciences	This work was supported by the Danish Research Council for Technology and Production Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek KT, 2011, APPL ENVIRON MICROB, V77, P57, DOI 10.1128/AEM.01603-10; Bernatchez S, 2005, J BIOL CHEM, V280, P4792, DOI 10.1074/jbc.M407767200; BISWAS GD, 1977, J BACTERIOL, V129, P983, DOI 10.1128/JB.129.2.983-992.1977; BOLTON FJ, 1983, J CLIN PATHOL, V36, P829, DOI 10.1136/jcp.36.7.829; Chen I, 2004, NAT REV MICROBIOL, V2, P241, DOI 10.1038/nrmicro844; Claverys JP, 2006, ANNU REV MICROBIOL, V60, P451, DOI 10.1146/annurev.micro.60.080805.142139; Claverys JP, 2002, FRONT BIOSCI-LANDMRK, V7, pD1798, DOI 10.2741/claverys; Cohn MT, 2007, APPL ENVIRON MICROB, V73, P7803, DOI 10.1128/AEM.00698-07; de Boer P, 2002, MOL MICROBIOL, V44, P351, DOI 10.1046/j.1365-2958.2002.02930.x; Dillard JP, 2001, MOL MICROBIOL, V41, P263, DOI 10.1046/j.1365-2958.2001.02520.x; Dorer MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001026; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Duong T, 2009, CURR OPIN BIOTECH, V20, P158, DOI 10.1016/j.copbio.2009.03.004; Engberg Jorgen, 1998, Clin Microbiol Infect, V4, P648, DOI 10.1111/j.1469-0691.1998.tb00348.x; Finkel SE, 2001, J BACTERIOL, V183, P6288, DOI 10.1128/JB.183.21.6288-6293.2001; Fry BN, 2000, INFECT IMMUN, V68, P2594, DOI 10.1128/IAI.68.5.2594-2601.2000; Gaynor EC, 2004, J BACTERIOL, V186, P503, DOI 10.1128/JB.186.2.503-517.2004; Gilbert M, 2004, INFECT IMMUN, V72, P1162, DOI 10.1128/IAI.72.2.1162-1165.2004; Gubbels SM, 2012, SCAND J INFECT DIS; Hamilton HL, 2006, MOL MICROBIOL, V59, P376, DOI 10.1111/j.1365-2958.2005.04964.x; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Hazeleger WC, 1998, APPL ENVIRON MICROB, V64, P3917; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Jacobs-Reitsma W, 2008, CAMPYLOBACTER, 3RD EDITION, P627; Jeon B, 2008, ANTIMICROB AGENTS CH, V52, P2699, DOI 10.1128/AAC.01607-07; Jeon B, 2007, J BACTERIOL, V189, P7399, DOI 10.1128/JB.01012-07; Johnsborg O, 2007, RES MICROBIOL, V158, P767, DOI 10.1016/j.resmic.2007.09.004; Karagiannis I, 2010, EPIDEMIOL INFECT, V138, P1726, DOI 10.1017/S0950268810002116; Karlyshev AV, 2005, MOL MICROBIOL, V55, P90, DOI 10.1111/j.1365-2958.2004.04374.x; Kim JS, 2008, APPL ENVIRON MICROB, V74, P6121, DOI 10.1128/AEM.01075-08; Knudsen KN, 2006, AVIAN DIS, V50, P10, DOI 10.1637/7376-051005R.1; Lappann M, 2010, MOL MICROBIOL, V75, P1355, DOI 10.1111/j.1365-2958.2010.07054.x; Larsen JC, 2004, J BACTERIOL, V186, P6508, DOI 10.1128/JB.186.19.6508-6514.2004; Lee MD, 2006, AVIAN DIS, V50, P1, DOI 10.1637/7474-111605R.1; Leonard EE, 2003, J INFECT DIS, V187, P691, DOI 10.1086/368268; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; Long CD, 2003, INFECT IMMUN, V71, P6279, DOI 10.1128/IAI.71.11.6279-6291.2003; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Myers JD, 2005, MICROBIOL-SGM, V151, P233, DOI 10.1099/mic.0.27573-0; Nuijten PJM, 2000, INFECT IMMUN, V68, P7137, DOI 10.1128/IAI.68.12.7137-7140.2000; Palchevskiy V, 2006, J BACTERIOL, V188, P3902, DOI 10.1128/JB.01974-05; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2003, FEBS LETT, V554, P224, DOI 10.1016/S0014-5793(03)01164-5; Phongsisay V, 2006, INFECT IMMUN, V74, P1368, DOI 10.1128/IAI.74.2.1368-1372.2006; Poly F, 2004, J BACTERIOL, V186, P4781, DOI 10.1128/JB.186.14.4781-4795.2004; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; Richardson G, 2007, EPIDEMIOL INFECT, V135, P1151, DOI 10.1017/S0950268807007960; Robertson GT, 2002, J BACTERIOL, V184, P3508, DOI 10.1128/JB.184.13.3508-3520.2002; Shane SM, 2003, DIS POULTRY, P615; Shaw FL, 2012, J BACTERIOL; Stingl K, 2010, P NATL ACAD SCI USA, V107, P1184, DOI 10.1073/pnas.0909955107; Thibonnier M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003810; Turgay K, 1998, EMBO J, V17, P6730; VanWagoner TM, 2004, J BACTERIOL, V186, P6409, DOI 10.1128/JB.186.19.6409-6421.2004; Vegge CS, 2009, APPL ENVIRON MICROB, V75, P5308, DOI 10.1128/AEM.00287-09; WANG Y, 1990, J BACTERIOL, V172, P949, DOI 10.1128/JB.172.2.949-955.1990; Wassenaar TM, 1999, MICROBES INFECT, V1, P1023, DOI 10.1016/S1286-4579(99)80520-6; Wiesner RS, 2003, J BACTERIOL, V185, P5408, DOI 10.1128/JB.185.18.5408-5418.2003; Wilson DL, 2003, MICROBIOL-SGM, V149, P3603, DOI 10.1099/mic.0.26531-0	60	24	25	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45467	10.1371/journal.pone.0045467	http://dx.doi.org/10.1371/journal.pone.0045467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049803	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300026
J	Garwood, R; Ross, A; Sotty, D; Chabard, D; Charbonnier, S; Sutton, M; Withers, PJ				Garwood, Russell; Ross, Andrew; Sotty, Daniel; Chabard, Dominique; Charbonnier, Sylvain; Sutton, Mark; Withers, Philip J.			Tomographic Reconstruction of Neopterous Carboniferous Insect Nymphs	PLOS ONE			English	Article							STEM-GROUP; ORIGIN; PHYLOGENY; EVOLUTION; ODONATOPTERA; SYSTEMATICS; MORPHOLOGY; DIVERSITY; BEHAVIOR; ORDER	Two new polyneopteran insect nymphs from the Montceau-les-Mines Lagerstatte of France are presented. Both are preserved in three dimensions, and are imaged with the aid of X-ray micro-tomography, allowing their morphology to be recovered in unprecedented detail. One-Anebos phrixos gen. et sp. nov.-is of uncertain affinities, and preserves portions of the antennae and eyes, coupled with a heavily spined habitus. The other is a roachoid with long antennae and chewing mouthparts very similar in form to the most generalized mandibulate mouthparts of extant orthopteroid insects. Computer reconstructions reveal limbs in both specimens, allowing identification of the segments and annulation in the tarsus, while poorly developed thoracic wing pads suggest both are young instars. This work describes the morphologically best-known Palaeozoic insect nymphs, allowing a better understanding of the juveniles' palaeobiology and palaeoecology. We also consider the validity of evidence from Palaeozoic juvenile insects in wing origin theories. The study of juvenile Palaeozoic insects is currently a neglected field, yet these fossils provide direct evidence on the evolution of insect development. It is hoped this study will stimulate a renewed interest in such work.	[Garwood, Russell; Withers, Philip J.] Univ Manchester, Sch Mat, Manchester, Lancs, England; [Garwood, Russell] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [Ross, Andrew] Natl Museum Scotland, Dept Nat Sci, Edinburgh, Midlothian, Scotland; [Sotty, Daniel] Museum Hist Nat, Autun, Bourgogne, France; [Chabard, Dominique; Charbonnier, Sylvain] Museum Natl Hist Nat, Dept Hist Terre, F-75231 Paris, France; [Sutton, Mark] Univ London Imperial Coll Sci Technol & Med, Dept Earth Sci & Engn, London, England	University of Manchester; University of Manchester; Museum National d'Histoire Naturelle (MNHN); Museum National d'Histoire Naturelle (MNHN); Imperial College London	Garwood, R (corresponding author), Univ Manchester, Sch Mat, Manchester, Lancs, England.	russell.garwood@manchester.ac.uk	Charbonnier, Sylvain/AAU-9571-2020; Withers, Phil/A-6760-2009; /ABG-2074-2021	Withers, Phil/0000-0002-1946-5647; Garwood, Russell/0000-0002-2803-9471	Natural Environment Research Council; EPSRC [EP/I02249X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/I02249X/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Part of this work was funded by a Natural Environment Research Council PhD studentship awarded to RG (http://www.nerc.ac.uk). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson T. Prescott, 2005, P169; Beattie R, 2007, AFR INVERTEBR, V48, P41; Bell W. J., 2007, COCKROACHES ECOLOGY; Bethoux O, 2008, SYST ENTOMOL, V33, P529, DOI 10.1111/j.1365-3113.2008.00419.x; Bethoux O, 2009, J PALEONTOL, V83, P931, DOI 10.1666/08-158.1; Bethoux O, 2009, ANN ZOOL, V59, P141, DOI 10.3161/000345409X463949; Bethoux O, 2009, ZOOL J LINN SOC-LOND, V156, P79, DOI 10.1111/j.1096-3642.2008.00485.x; Bethoux O, 2008, EVOL BIOL, V35, P317, DOI 10.1007/s11692-008-9035-6; Beutel RG, 2008, SYST ENTOMOL, V33, P501, DOI 10.1111/j.1365-3113.2008.00428.x; Beutel Rolf G., 2006, Arthropod Systematics & Phylogeny, V64, P3; Beutel RG, 2011, CLADISTICS, V27, P341, DOI 10.1111/j.1096-0031.2010.00338.x; Bitsch J, 2012, J MORPHOL, V273, P919, DOI 10.1002/jmor.20031; Bradley TJ, 2009, INTEGR COMP BIOL, V49, P590, DOI 10.1093/icb/icp043; BRONGNIART C, 1893, RECHERCHES SERVIR HI; Brusca RC, 2003, INVERTEBRATES; Burnham L, 1994, MEMOIRES SECTION SCI, P187; CARPENTER F M, 1968, Psyche (Cambridge), V75, P295; CARPENTER F. M., 1948, PSYCHE, V55, P41, DOI 10.1155/1948/83246; CARPENTER FM, 1992, SUPERCLASS HEXAPOD R, V3; Carpenter Frank M., 1997, P184; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Charbonnier S, 2008, PALAIOS, V23, P210, DOI 10.2110/palo.2006.p06-078r; Coram Robert A., 2003, Acta Zoologica Cracoviensia, V46, P311; Courel L., 1994, MEMOIRES SECTION SCI, V12, P33; Demoulin G., 1970, Bull. Inst. r. Sci. nat. Belg., V46, P1; Dudley R, 2011, INTEGR COMP BIOL, V51, P926, DOI 10.1093/icb/icr002; Duncan IJ, 2003, PALAIOS, V18, P256, DOI 10.1669/0883-1351(2003)018<0256:DADOTC>2.0.CO;2; Dworkin IM, 2001, EVOL DEV, V3, P424, DOI 10.1046/j.1525-142X.2001.01047.x; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Fursich FT, 2007, PALAEOGEOGR PALAEOCL, V253, P434, DOI 10.1016/j.palaeo.2007.06.012; Garwood RJ, 2012, PALAEONTOL ELECTRON, V15; Garwood R, 2010, BIOL LETTERS, V6, P699, DOI 10.1098/rsbl.2010.0199; Garwood R, 2009, BIOL LETTERS, V5, P841, DOI 10.1098/rsbl.2009.0464; Garwood RJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1458; Garwood RJ, 2011, PALAEONTOLOGY, V54, P145, DOI 10.1111/j.1475-4983.2010.01000.x; Germain D, 2008, GEODIVERSITAS, V30, P669; Grimaldi David, 2005, pi; Grimaldi DA, 2010, ARTHROPOD STRUCT DEV, V39, P191, DOI 10.1016/j.asd.2009.10.008; Gu JJ, 2011, J PALEONTOL, V85, P303, DOI 10.1666/10-085.1; Gullan PJ, 2010, INSECTS OUTLINE ENTO; Handlirsch A, 1911, AM J SCI, V31, P297; Heming BS., 2003, INSECT DEV EVOLUTION; Heyler D., 1994, QUAND MASSIF CENTRAL, V12, P227; Hubbard M.D., 1980, ADV EPHEMEROPTERA BI, P19, DOI DOI 10.1007/978-1-4613-3066-0_2; JARZEMBOWSKI EA, 1987, J GEOL SOC LONDON, V144, P507, DOI 10.1144/gsjgs.144.3.0507; KUKALOVA J, 1968, Psyche (Cambridge), V75, P310; KUKALOVA-PECK J, 1976, Psyche (Cambridge), V83, P79, DOI 10.1155/1976/36962; Kukalova-Peck Jarmila, 2009, Palaeodiversity, P169; KUKALOVAPECK J, 1992, CAN J ZOOL, V70, P2452, DOI 10.1139/z92-330; KUKALOVAPECK J, 1978, J MORPHOL, V156, P53, DOI 10.1002/jmor.1051560104; KUKALOVAPECK J, 1983, CAN J ZOOL, V61, P1618, DOI 10.1139/z83-217; KUKALOVAPECK J, 1987, CAN J ZOOL, V65, P2327, DOI 10.1139/z87-352; KUKALOVAPECK J, 1997, ARTHROPOD RELATIONSH, P249; Labandeira CC, 1997, ANNU REV ECOL SYST, V28, P153, DOI 10.1146/annurev.ecolsys.28.1.153; Labandeira CC, 1996, P NATL ACAD SCI USA, V93, P8470, DOI 10.1073/pnas.93.16.8470; Legg DA, 2012, PALAEONTOL ELECTRON, V15; Linnaeus C, 1758, SYSTEMA NATURAE PER; Nel A, 2007, ANN SOC ENTOMOL FR, V43, P349, DOI 10.1080/00379271.2007.10697531; Nel A, 2009, PALAEONTOGR ABT A, V289, P89; Oudard J., 1980, Bulletin Trimestriel de la Societe d'Histoire Naturelle et des Amis du Museum d'Autun, P37; POPLIN C, 1994, MEMOIRES SECTION SCI, V12; Rehm P, 2011, MOL PHYLOGENET EVOL, V61, P880, DOI 10.1016/j.ympev.2011.09.003; REILLY SM, 1990, EVOLUTION, V44, P1542, DOI 10.1111/j.1558-5646.1990.tb03845.x; Rolfe W.D.I., 1967, PALAEONTOLOGY, V10, P307; SHEAR WA, 1990, CAN J ZOOL, V68, P1807, DOI 10.1139/z90-262; Sinitshenkova N.D., 2002, P388; Sinitshenkova Nina D., 2003, Acta Zoologica Cracoviensia, V46, P381; Staniczek AH, 2011, INSECT SYST EVOL, V42, P101, DOI 10.1163/187631211X578406; Sutton MD, 2012, PALAEONTOL ELECTRON, V15; Trautwein MD, 2012, ANNU REV ENTOMOL, V57, P449, DOI 10.1146/annurev-ento-120710-100538; Wang B, 2010, J PALEONTOL, V84, P774, DOI 10.1666/09-162.1; Whitfield JB, 2008, ANNU REV ENTOMOL, V53, P449, DOI 10.1146/annurev.ento.53.103106.093304; Willmann R., 1998, Systematics Association Special Volume Series, V55, P269; WOOTTON R J, 1972, Palaeontology (Oxford), V15, P662; WOOTTON RJ, 1981, ANNU REV ENTOMOL, V26, P319, DOI 10.1146/annurev.en.26.010181.001535; Wootton RJ, 1972, ESSAYS HYDROBIOLOGY, P69; Zwick P, 2009, AQUAT INSECT, V31, P181, DOI 10.1080/01650420802666827	77	23	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45779	10.1371/journal.pone.0045779	http://dx.doi.org/10.1371/journal.pone.0045779			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049858	gold, Green Submitted, Green Published			2022-12-27	WOS:000309556100077
J	Klein, MI; Xiao, J; Lu, BW; Delahunty, CM; Yates, JR; Koo, H				Klein, Marlise I.; Xiao, Jin; Lu, Bingwen; Delahunty, Claire M.; Yates, John R., III; Koo, Hyun			Streptococcus mutans Protein Synthesis during Mixed-Species Biofilm Development by High-Throughput Quantitative Proteomics	PLOS ONE			English	Article							GLUCAN-BINDING PROTEINS; ORAL STREPTOCOCCI; GENE-EXPRESSION; ACID TOLERANCE; INTRACELLULAR POLYSACCHARIDE; SHOTGUN PROTEOMICS; LIPOTEICHOIC ACID; STRESS TOLERANCE; YEAST PROTEOME; DENTAL-CARIES	Biofilms formed on tooth surfaces are comprised of mixed microbiota enmeshed in an extracellular matrix. Oral biofilms are constantly exposed to environmental changes, which influence the microbial composition, matrix formation and expression of virulence. Streptococcus mutans and sucrose are key modulators associated with the evolution of virulent-cariogenic biofilms. In this study, we used a high-throughput quantitative proteomics approach to examine how S. mutans produces relevant proteins that facilitate its establishment and optimal survival during mixed-species biofilms development induced by sucrose. Biofilms of S. mutans, alone or mixed with Actinomyces naeslundii and Streptococcus oralis, were initially formed onto saliva-coated hydroxyapatite surface under carbohydrate-limiting condition. Sucrose (1%, w/v) was then introduced to cause environmental changes, and to induce biofilm accumulation. Multidimensional protein identification technology (MudPIT) approach detected up to 60% of proteins encoded by S. mutans within biofilms. Specific proteins associated with exopolysaccharide matrix assembly, metabolic and stress adaptation processes were highly abundant as the biofilm transit from earlier to later developmental stages following sucrose introduction. Our results indicate that S. mutans within a mixed-species biofilm community increases the expression of specific genes associated with glucan synthesis and remodeling (gtfBC, dexA) and glucan-binding (gbpB) during this transition (P<0.05). Furthermore, S. mutans up-regulates specific adaptation mechanisms to cope with acidic environments (F1F0-ATPase system, fatty acid biosynthesis, branched chain amino acids metabolism), and molecular chaperones (GroEL). Interestingly, the protein levels and gene expression are in general augmented when S. mutans form mixed-species biofilms (vs. single-species biofilms) demonstrating fundamental differences in the matrix assembly, survival and biofilm maintenance in the presence of other organisms. Our data provide insights about how S. mutans optimizes its metabolism and adapts/survives within the mixed-species community in response to a dynamically changing environment. This reflects the intricate physiological processes linked to expression of virulence by this bacterium within complex biofilms.	[Klein, Marlise I.; Xiao, Jin; Koo, Hyun] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Koo, Hyun] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Xiao, Jin] Sichuan Univ, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Lu, Bingwen; Delahunty, Claire M.; Yates, John R., III] Scripps Res Inst, La Jolla, CA 92037 USA	University of Rochester; University of Rochester; Sichuan University; Scripps Research Institute	Klein, MI (corresponding author), Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA.	Marlise_Klein@urmc.rochester.edu; Hyun_Koo@urmc.rochester.edu	Klein, Marlise Inêz/A-2550-2014	Klein, Marlise Inêz/0000-0002-7916-1557	Training Program in Oral Sciences [R90DE022529]; National Institutes of Health [DE16139, P41 RR011823, U01 DE016267]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016139, R90DE022529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [U01DE016267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER	Training Program in Oral Sciences; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the Training Program in Oral Sciences R90DE022529 (M.I.K.) and research grants DE16139 (H.K.), P41 RR011823 and U01 DE016267 (J.R.Y.) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2003, APPL ENVIRON MICROB, V69, P4760, DOI 10.1128/AEM.69.8.4760-4769.2003; Abranches J, 2008, J BACTERIOL, V190, P2340, DOI 10.1128/JB.01237-07; ALLEN PZ, 1990, ARCH ORAL BIOL, V35, P55, DOI 10.1016/0003-9969(90)90115-Q; Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89, DOI 10.1177/154411130301400203; BENDER GR, 1986, INFECT IMMUN, V53, P331, DOI 10.1128/IAI.53.2.331-338.1986; Bergeron LJ, 2000, J BACTERIOL, V182, P3649, DOI 10.1128/JB.182.13.3649-3654.2000; Bitoun JP, 2011, FEMS MICROBIOL LETT, V320, P110, DOI 10.1111/j.1574-6968.2011.02293.x; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Boyd DA, 2000, J BACTERIOL, V182, P6055, DOI 10.1128/JB.182.21.6055-6065.2000; Browngardt CM, 2004, FEMS MICROBIOL LETT, V240, P75, DOI 10.1016/j.femsle.2004.09.012; Catalan MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016549; Chattoraj P, 2010, J BACTERIOL, V192, P1312, DOI 10.1128/JB.01350-09; CIARDI JE, 1977, SCAND J DENT RES, V85, P387; Cociorva Daniel, 2007, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1304s16; Cury JA, 2007, ANAL BIOCHEM, V365, P208, DOI 10.1016/j.ab.2007.03.021; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Derr AM, 2012, APPL ENVIRON MICROB, V78, P1215, DOI 10.1128/AEM.06890-11; Duque C, 2011, INFECT IMMUN, V79, P786, DOI 10.1128/IAI.00725-10; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fozo EA, 2004, APPL ENVIRON MICROB, V70, P929, DOI 10.1128/AEM.70.2.929-936.2004; Fozo EM, 2007, INFECT IMMUN, V75, P1537, DOI 10.1128/IAI.01938-06; Fozo EM, 2004, J BACTERIOL, V186, P4152, DOI 10.1128/JB.186.13.4152-4158.2004; Fujiwara T, 2000, INFECT IMMUN, V68, P2475, DOI 10.1128/IAI.68.5.2475-2483.2000; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Griswold AR, 2006, J BACTERIOL, V188, P834, DOI 10.1128/JB.188.3.834-841.2006; Griswold AR, 2004, J BACTERIOL, V186, P1902, DOI 10.1128/JB.186.6.1902-1904.2004; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; GUGGENHEIM B, 1974, HELV ODONTOL ACTA, V18, P101; Hayacibara MF, 2004, CARBOHYD RES, V339, P2127, DOI 10.1016/j.carres.2004.05.031; Kajfasz JK, 2010, J BACTERIOL, V192, P2546, DOI 10.1128/JB.00028-10; Klein MI, 2009, APPL ENVIRON MICROB, V75, P837, DOI 10.1128/AEM.01299-08; Klein MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013478; Klein MI, MOL ORAL MI IN PRESS; Koo H, 2006, ANTIMICROB AGENTS CH, V50, P542, DOI 10.1128/AAC.50.2.542-546.2006; Koo H, 2005, J DENT RES, V84, P1016, DOI 10.1177/154405910508401109; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Kuhnert WL, 2004, J BACTERIOL, V186, P8524, DOI 10.1128/JB.186.24.8524-8528.2004; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Lemos JA, 2007, J BACTERIOL, V189, P1582, DOI 10.1128/JB.01655-06; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Len ACL, 2004, MICROBIOL-SGM, V150, P1339, DOI 10.1099/mic.0.27008-0; Len MCL, 2004, MICROBIOL-SGM, V150, P1353, DOI 10.1099/mic.0.26888-0; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; LOESCHE WJ, 1967, ARCH ORAL BIOL, V12, P189, DOI 10.1016/0003-9969(67)90037-4; Lynch DJ, 2007, FEMS MICROBIOL LETT, V268, P158, DOI 10.1111/j.1574-6968.2006.00576.x; Marsh P D, 1994, Adv Dent Res, V8, P263; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Mattos-Graner RO, 2000, J DENT RES, V79, P1371, DOI 10.1177/00220345000790060401; MOORE S, 1954, J BIOL CHEM, V211, P907; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Quivey RG, 2000, ADV MICROB PHYSIOL, V42, P239, DOI 10.1016/S0065-2911(00)42004-7; Sadygov RG, 2002, J PROTEOME RES, V1, P211, DOI 10.1021/pr015514r; Santiago B, 2012, J BACTERIOL, V194, P2010, DOI 10.1128/JB.06737-11; Sheng JY, 2007, FEMS MICROBIOL LETT, V272, P196, DOI 10.1111/j.1574-6968.2007.00744.x; Smith AMV, 2007, CARIES RES, V41, P445, DOI 10.1159/000107930; SPATAFORA G, 1995, INFECT IMMUN, V63, P2556, DOI 10.1128/IAI.63.7.2556-2563.1995; Spatafora GA, 1999, J BACTERIOL, V181, P2363, DOI 10.1128/JB.181.8.2363-2372.1999; Stephen K W, 1971, Caries Res, V5, P28; Svensater G, 2001, FEMS MICROBIOL LETT, V205, P139, DOI 10.1111/j.1574-6968.2001.tb10937.x; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Tanzer JM, 1976, P MICR ASP DENT CAR, P596; Valm AM, 2011, P NATL ACAD SCI USA, V108, P4152, DOI 10.1073/pnas.1101134108; WALKER GJ, 1981, J GEN MICROBIOL, V127, P201; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Welin J, 2003, FEMS MICROBIOL LETT, V227, P287, DOI 10.1016/S0378-1097(03)00693-1; Wen ZZT, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-111; WILSON RF, 1990, CARIES RES, V24, P203, DOI 10.1159/000261266; Xiao J, 2010, J APPL MICROBIOL, V108, P2103, DOI 10.1111/j.1365-2672.2009.04616.x; Xiao J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002623; Xu T, 2006, MOL CELL PROTEOMICS, V5; YAMASHITA Y, 1993, INFECT IMMUN, V61, P3811, DOI 10.1128/IAI.61.9.3811-3817.1993; Yin JL, 2001, IMMUNOL CELL BIOL, V79, P213, DOI 10.1046/j.1440-1711.2001.01002.x; Yoshida A, 2005, APPL ENVIRON MICROB, V71, P2372, DOI 10.1128/AEM.71.5.2372-2380.2005	77	59	62	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45795	10.1371/journal.pone.0045795	http://dx.doi.org/10.1371/journal.pone.0045795			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049864	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100082
J	Seppa, P; Queller, DC; Strassmann, JE				Seppa, Perttu; Queller, David C.; Strassmann, Joan E.			Why Wasp Foundresses Change Nests: Relatedness, Dominance, and Nest Quality	PLOS ONE			English	Article							EUSOCIAL HOVER WASPS; SOCIAL WASP; REPRODUCTIVE STRATEGY; GENETICAL EVOLUTION; POLISTES; SKEW; ASSOCIATIONS; DISPERSAL; CONSEQUENCES; DECISIONS	The costs and benefits of different social options are best understood when individuals can be followed as they make different choices, something that can be difficult in social insects. In this detailed study, we follow overwintered females of the social wasp Polistes carolina through different nesting strategies in a stratified habitat where nest site quality varies with proximity to a foraging area, and genetic relatedness among females is known. Females may initiate nests, join nests temporarily or permanently, or abandon nests. Females can become helpers or egglayers, effectively workers or queens. What they actually do can be predicted by a combination of ecological and relatedness factors. Advantages through increased lifetime success of individuals and nests drives foundresses of the social wasp Polistes from solitary to social nest founding. We studied reproductive options of spring foundresses of P. carolina by monitoring individually-marked wasps and assessing reproductive success of each foundress by using DNA microsatellites. We examined what behavioral decisions foundresses make after relaxing a strong ecological constraint, shortage of nesting sites. We also look at the reproductive consequences of different behaviors. As in other Polistes, the most successful strategy for a foundress was to initiate a nest as early as possible and then accept others as subordinates. A common feature for many P. carolina foundresses was, however, that they reassessed their reproductive options by actively monitoring other nests at the field site and sometimes moving permanently to new nests should that offer better (inclusive) fitness prospects compared to their original nests. A clear motivation for moving to new nests was high genetic relatedness; by the end of the foundress period all females were on nests with full sisters.	[Seppa, Perttu; Queller, David C.; Strassmann, Joan E.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Seppa, P (corresponding author), Univ Helsinki, Dept Biol Sci, Ctr Excellence Biol Interact, Helsinki, Finland.	perttu.seppa@helsinki.fi	Seppä, Perttu/A-9900-2011	Strassmann, Joan/0000-0003-0638-8440; Seppa, Perttu/0000-0001-5393-6943	Academy of Finland [1713]; National Science Foundation [IBN-9210051, DEB-9510126, DEB 0918931]	Academy of Finland(Academy of Finland); National Science Foundation(National Science Foundation (NSF))	This study was supported by grants from the Academy of Finland (1713) to PS, and from National Science Foundation (IBN-9210051, DEB-9510126, and DEB 0918931) to JES and DCQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Crozier R.H., 1996, EVOLUTION SOCIAL INS; Field J, 1999, BEHAV ECOL SOCIOBIOL, V45, P378, DOI 10.1007/s002650050574; Field J, 1998, AM NAT, V151, P545, DOI 10.1086/286140; Field J, 1998, P ROY SOC B-BIOL SCI, V265, P973, DOI 10.1098/rspb.1998.0386; Gadagkar Raghavendra, 1993, P188; Gamboa George J., 1996, P161; GILBERT DA, 1991, J HERED, V82, P378, DOI 10.1093/oxfordjournals.jhered.a111107; Goodnight KF, 1999, MOL ECOL, V8, P1231, DOI 10.1046/j.1365-294x.1999.00664.x; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HAGEN R H, 1988, Psyche (Cambridge), V95, P191, DOI 10.1155/1988/40461; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Heinsohn Robert G., 2004, P67, DOI 10.1017/CBO9780511606816.005; HUGHES CR, 1988, BEHAVIOUR, V107, P1, DOI 10.1163/156853988X00151; Hughes CR, 1993, QUEEN NUMBER SOCIALI, P152; Johnstone RA, 2000, ETHOLOGY, V106, P5, DOI 10.1046/j.1439-0310.2000.00529.x; Koenig Walter D., 2004, P142, DOI 10.1017/CBO9780511606816.010; LORENZI MC, 1995, J INSECT BEHAV, V8, P443, DOI 10.1007/BF01995318; MICHENER C D, 1974, P404; NONACS P, 1995, ECOLOGY, V76, P953, DOI 10.2307/1939359; NONACS P, 1993, BEHAV PROCESS, V30, P47, DOI 10.1016/0376-6357(93)90011-F; Nonacs P, 2006, ANN ZOOL FENN, V43, P443; PARDI L, 1948, PHYSIOL ZOOL, V21, P1; Pardi L, 1942, B ENTOMOL BOLOGNA, V14, P104; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; Queller David C., 1996, P218; QUELLER DC, 1989, P NATL ACAD SCI USA, V86, P3224, DOI 10.1073/pnas.86.9.3224; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Reeve H.K., 1991, P99; Reeve Hudson K., 1993, P45; Rissing S.W., 1988, P179; Rosengren Rainer, 1993, P308; Seppa P, 2002, BEHAV ECOL, V13, P531, DOI 10.1093/beheco/13.4.531; Seppa P, 2011, INSECT SOC, V58, P345, DOI 10.1007/s00040-011-0149-y; Starks PT, 1998, P ROY SOC B-BIOL SCI, V265, P1407, DOI 10.1098/rspb.1998.0449; Starks PT, 2001, ANN ZOOL FENN, V38, P189; Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301; Strassmann J.E., 1987, P379; STRASSMANN JE, 1986, MONIT ZOOL ITAL, V20, P87; Strassmann JE, 1997, MOL ECOL, V6, P97, DOI 10.1046/j.1365-294X.1997.00158.x; STRASSMANN JE, 1981, BEHAV ECOL SOCIOBIOL, V8, P55, DOI 10.1007/BF00302844; Strassmann Joan E.., 1996, P163; Sundstrom L, 2005, ANN ZOOL FENN, V42, P163; Temple HJ, 2009, IBIS, V151, P99, DOI 10.1111/j.1474-919X.2008.00867.x	44	10	10	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45386	10.1371/journal.pone.0045386	http://dx.doi.org/10.1371/journal.pone.0045386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049791	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100042
J	Li, ZZ; Xu, YW; Warner, D; Volkow, ND				Li, Zizhong; Xu, Youwen; Warner, Don; Volkow, Nora D.			Alcohol ADME in Primates Studied with Positron Emission Tomography	PLOS ONE			English	Article							BRAIN ETHANOL-METABOLISM; RAT-BRAIN; SYSTEM PET; ACETALDEHYDE; DEUTERIUM; OXIDATION; LIVER; KINETICS; CONSUMPTION; POLYMORPHISMS	Background and Purpose: The sensitivity to the intoxicating effects of alcohol as well as its adverse medical consequences differ markedly among individuals, which reflects in part differences in alcohol's absorption, distribution, metabolism, and elimination (ADME) properties. The ADME of alcohol in the body and its relationship with alcohol's brain bioavailability, however, is not well understood. Experimental Approach: The ADME of C-11 labeled alcohol, (CH3CH2OH)-C-11, 1 and C-11 and deuterium dual labeled alcohol, (CH3CD2OH)-C-11, 2 in baboons was compared based on the principle that C-D bond is stronger than C-H bond, thus the reaction is slower if C-D bond breaking occurs in a rate-determining metabolic step. The following ADME parameters in peripheral organs and brain were derived from time activity curve (TAC) of positron emission tomography (PET) scans: peak uptake (C-max); peak uptake time (T-max), half-life of peak uptake (T-1/2), the area under the curve (AUC(60min)), and the residue uptake (C-60min). Key Results: For 1 the highest uptake occurred in the kidney whereas for 2 it occurred in the liver. A deuterium isotope effect was observed in the kidneys in both animals studied and in the liver of one animal but not the other. The highest uptake for 1 and 2 in the brain was in striatum and cerebellum but 2 had higher uptake than 1 in all brain regions most evidently in thalamus and cingulate. Alcohol's brain uptake was significantly higher when given intravenously than when given orally and also when the animal was pretreated with a pharmacological dose of alcohol. Conclusion and Implications: The study shows that alcohol metabolism in peripheral organs had a large effect on alcohol's brain bioavailability. This study sets the stage for clinical investigation on how genetics, gender and alcohol abuse affect alcohol's ADME and its relationship to intoxication and medical consequences.	[Li, Zizhong; Xu, Youwen; Warner, Don] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA; [Volkow, Nora D.] NIAAA, Bethesda, MD USA; [Volkow, Nora D.] NIDA, Bethesda, MD 20892 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Li, ZZ (corresponding author), Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA.	Zizhong_li@eisai.com			Brookhaven National Laboratory (LDRD) [03-103]; National Institute on Alcoholism and Alcohol Abuse [5R21AA014018-03]; United States Department of Energy [DE-AC02-98CH1-886]; National Institutes of Health (Intramural Research Program of the National Institute on Alcoholism and Alcohol Abuse); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000551, R21AA014018] Funding Source: NIH RePORTER	Brookhaven National Laboratory (LDRD); National Institute on Alcoholism and Alcohol Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); United States Department of Energy(United States Department of Energy (DOE)); National Institutes of Health (Intramural Research Program of the National Institute on Alcoholism and Alcohol Abuse); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	ZL was supported by a grant from Brookhaven National Laboratory (LDRD#03-103) and he is the author of a grant from National Institute on Alcoholism and Alcohol Abuse (5R21AA014018-03). This research was also funded by United States Department of Energy (DE-AC02-98CH1-886) and National Institutes of Health (Intramural Research Program of the National Institute on Alcoholism and Alcohol Abuse). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalsteinsson E, 2006, NEUROPSYCHOPHARMACOL, V31, P2683, DOI 10.1038/sj.npp.1301023; Amberg R, 2002, BLUTALKOHOL, V39, P11; Beckemeier ME, 1998, J MOL CELL CARDIOL, V30, P2487, DOI 10.1006/jmcc.1998.0812; Bell LC, 1997, J BIOL CHEM, V272, P29643, DOI 10.1074/jbc.272.47.29643; Bell-Parikh LC, 1999, J BIOL CHEM, V274, P23833, DOI 10.1074/jbc.274.34.23833; BERNSTEIN J, 1983, RES COMMUN CHEM PATH, V39, P49; BERNSTEIN J, 1990, RES COMMUN CHEM PATH, V68, P219; Chen CH, 2011, ALCOHOL CLIN EXP RES; Chen JC, 2007, J STUD ALCOHOL DRUGS, V68, P649, DOI 10.15288/jsad.2007.68.649; Christie IC, 2008, ALCOHOL, V42, P269, DOI 10.1016/j.alcohol.2008.03.132; CORRALL RJM, 1974, J BIOL CHEM, V249, P3181; Correa M, 2012, NEUROSCI BIOBEHAV R, V36, P404, DOI 10.1016/j.neubiorev.2011.07.009; CRONHOLM T, 1988, ALCOHOL CLIN EXP RES, V12, P683, DOI 10.1111/j.1530-0277.1988.tb00265.x; CRONHOLM T, 1985, BIOCHEM J, V229, P323, DOI 10.1042/bj2290323; DAMGAARD SE, 1980, BIOCHEM J, V191, P613, DOI 10.1042/bj1910613; DAMGAARD SE, 1981, BIOCHEMISTRY-US, V20, P5662, DOI 10.1021/bi00523a004; Deelchand DK, 2009, J NEUROCHEM, V109, P46, DOI 10.1111/j.1471-4159.2009.05895.x; DEGRAZIA JA, 1975, J NUCL MED, V16, P73; FOWLER JS, 1988, J NEUROCHEM, V51, P1524, DOI 10.1111/j.1471-4159.1988.tb01121.x; FRIEL PN, 1995, ALCOHOL CLIN EXP RES, V19, P1055, DOI 10.1111/j.1530-0277.1995.tb00988.x; Friel PN, 1999, J STUD ALCOHOL, V60, P555, DOI 10.15288/jsa.1999.60.555; Gulyas B, 2002, ACTA NEUROL SCAND, V106, P325, DOI 10.1034/j.1600-0404.2002.01302.x; Guo R, 2010, INT J ENV RES PUB HE, V7, P1285, DOI 10.3390/ijerph7041285; Hetherington HP, 1999, MAGNET RESON MED, V42, P1019, DOI 10.1002/(SICI)1522-2594(199912)42:6<1019::AID-MRM5>3.0.CO;2-Y; Hlastala MP, 1998, J APPL PHYSIOL, V84, P401, DOI 10.1152/jappl.1998.84.2.401; Hommer DW, 2001, AM J PSYCHIAT, V158, P198, DOI 10.1176/appi.ajp.158.2.198; Howard RJ, 2011, ALCOHOL CLIN EXP RES, V35, P1561, DOI 10.1111/j.1530-0277.2011.01502.x; JACOBSON R, 1986, PSYCHOL MED, V16, P547, DOI 10.1017/S003329170001031X; JULKUNEN RJK, 1985, ALCOHOL, V2, P437, DOI 10.1016/0741-8329(85)90111-9; Karahanian E, 2011, ALCOHOL CLIN EXP RES, V35, P606, DOI 10.1111/j.1530-0277.2011.01439.x; KUIKKA J, 1980, J BIOMED ENG, V2, P87, DOI 10.1016/0141-5425(80)90057-6; Li D, 2011, HUM GENET; Li TK, 2001, ALCOHOL CLIN EXP RES, V25, P136, DOI 10.1111/j.1530-0277.2001.tb02138.x; LIEBER CS, 1988, BIOCHEM SOC T, V16, P232, DOI 10.1042/bst0160232; LUNDQUIST F, 1989, PHARMACOL TOXICOL, V65, P45, DOI 10.1111/j.1600-0773.1989.tb01125.x; LUNDQUIST F, 1990, PHARMACOL TOXICOL, V66, P244, DOI 10.1111/j.1600-0773.1990.tb00742.x; MICHOUDET C, 1987, FEBS LETT, V216, P113, DOI 10.1016/0014-5793(87)80767-6; MICHOUDET C, 1987, BIOCHEM PHARMACOL, V36, P3987, DOI 10.1016/0006-2952(87)90468-0; Peng GS, 2007, PHARMACOGENET GENOM, V17, P845, DOI 10.1097/FPC.0b013e3282609e67; RAICHLE ME, 1976, AM J PHYSIOL, V230, P543, DOI 10.1152/ajplegacy.1976.230.2.543; Ramchandani VA, 2001, PATHOL BIOL, V49, P676, DOI 10.1016/S0369-8114(01)00232-2; Ramchandani VA, 2004, NUTR ALCOHOL LINKING; Salaspuro MP, 2003, BEST PRACT RES CL GA, V17, P679, DOI 10.1016/S1521-6918(03)00035-0; Sato N, 2001, ALCOHOL CLIN EXP RES, V25, p40S, DOI 10.1111/j.1530-0277.2001.tb02371.x; Upadhya SC, 2002, ALCOHOL CLIN EXP RES, V26, P856, DOI 10.1097/00000374-200206000-00016; VOLKOW ND, 1990, PSYCHIAT RES-NEUROIM, V35, P39, DOI 10.1016/S0165-1781(06)80006-5; Volkow ND, 2007, J NEUROSCI, V27, P12700, DOI 10.1523/JNEUROSCI.3371-07.2007; Volkow ND, 2006, ARCH GEN PSYCHIAT, V63, P999, DOI 10.1001/archpsyc.63.9.999; Wang GJ, 2000, ALCOHOL CLIN EXP RES, V24, P822, DOI 10.1097/00000374-200006000-00011; WILKINSON PK, 1977, J PHARMACOKINET BIOP, V5, P41, DOI 10.1007/BF01064808; Xiang Y, 2011, NMR BIOMED, V24, P1054, DOI 10.1002/nbm.1653; Yokoyama A, 2003, JPN J CLIN ONCOL, V33, P111, DOI 10.1093/jjco/hyg026; Yokoyama Akira, 2010, Keio Journal of Medicine, V59, P115, DOI 10.2302/kjm.59.115; Zhu W, 2004, ALCOHOL ALCOHOLISM, V39, P53, DOI 10.1093/alcalc/agh023; Zimatkin SM, 2001, ALCOHOL CLIN EXP RES, V25, P982, DOI 10.1097/00000374-200107000-00006; Zimatkin SM, 2001, ALCOHOL CLIN EXP RES, V25, P976, DOI 10.1111/j.1530-0277.2001.tb02305.x	56	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46676	10.1371/journal.pone.0046676	http://dx.doi.org/10.1371/journal.pone.0046676			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049712	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388500039
J	Mokudai, T; Nakamura, K; Kanno, T; Niwano, Y				Mokudai, Takayuki; Nakamura, Keisuke; Kanno, Taro; Niwano, Yoshimi			Presence of Hydrogen Peroxide, a Source of Hydroxyl Radicals, in Acid Electrolyzed Water	PLOS ONE			English	Article							OXIDIZING WATER; HYPOCHLOROUS ACID; ESCHERICHIA-COLI; SPIN-RESONANCE; BACTERICIDAL ACTIVITY; DISINFECTION; SCAVENGERS; INHIBITION; PHOTOLYSIS; EFFICIENCY	Background: Acid electrolyzed water (AEW), which is produced through the electrolysis of dilute sodium chloride (NaCl) or potassium chloride solution, is used as a disinfectant in various fields because of its potent antimicrobial activity. The hydroxyl radical, an oxygen radical species, is often suggested as a putative active ingredient for AEW antimicrobial activity. Methodology/Principal Findings: The aim of the present study is to detect hydroxyl radicals in AEW. The hydroxyl radicals in AEW prepared under different conditions were determined using an electron spin resonance (ESR) technique. A signal from 5,5-dimethyl-1-pyrroline N-oxide (DMPO)-OH, an adduct of DMPO and the hydroxyl radical, was detected in AEW prepared by double or triple electrolyses of 1% NaCl but not of 0.1% NaCl solution. Then the presence of hydrogen peroxide as a proposed source of hydroxyl radicals was examined using a combination of ESR and a Fenton reaction. The DMPO-OH signal was clearly detected, even in AEW prepared by single electrolysis of 0.1% NaCl solution, when ferrous sulfate was added to induce a Fenton reaction, indicating the presence of hydrogen peroxide in the AEW. Since sodium formate, a hydroxyl radical scavenger, did not affect the bactericidal activity of AEW, it is concluded that the radical is unlikely to contribute to the antimicrobial activity of AEW, although a small amount of the radical is produced from hydrogen peroxide. Dimethyl sulfoxide, the other hydroxyl radical scavenger used in the present study, canceled the bactericidal activity of AEW, accompanied by complete depletion of free available chlorine, suggesting that hypochlorous acid is probably a major contributor to the antimicrobial activity. Conclusions: It is strongly suggested that although hydrogen peroxide is present in AEW as a source of hydroxyl radicals, the antimicrobial activity of AEW does not depend on these radicals.	[Mokudai, Takayuki; Nakamura, Keisuke; Kanno, Taro; Niwano, Yoshimi] Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 980, Japan	Tohoku University	Niwano, Y (corresponding author), Tohoku Univ, Grad Sch Dent, Sendai, Miyagi 980, Japan.	y.niwano@m.tohoku.ac.jp	MOKUDAI, TAKAYUKI/AAK-1541-2020; Mokudai, Takayuki/M-1029-2018; Niwnao, Yoshimi/Z-3593-2019	MOKUDAI, TAKAYUKI/0000-0003-4628-6908; Mokudai, Takayuki/0000-0003-4628-6908; 	Ministry of Education, Science, Sports and Culture, Japan [23590144]	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Scientific Research (C), 23590144, 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Haq MM, 2005, FOOD SCI TECHNOL RES, V11, P135, DOI 10.3136/fstr.11.135; ALBRICH JM, 1986, J CLIN INVEST, V78, P177, DOI 10.1172/JCI112548; [Anonymous], 1985, STANDARD METHODS EXA, P309; Arakawa H, 2004, BIOL PHARM BULL, V27, P277, DOI 10.1248/bpb.27.277; BARRETTE WC, 1989, BIOCHEMISTRY-US, V28, P9172, DOI 10.1021/bi00449a032; BECKING LGMB, 1960, J GEOL, V68, P243, DOI 10.1086/626659; BUETTNER GR, 1987, FREE RADICAL BIO MED, V3, P259, DOI 10.1016/S0891-5849(87)80033-3; Cao W, 2009, INT J FOOD MICROBIOL, V130, P88, DOI 10.1016/j.ijfoodmicro.2008.12.021; Fabrizio KA, 2004, MEAT SCI, V68, P463, DOI 10.1016/j.meatsci.2004.04.013; Feliciano L, 2012, J FOOD SCI, V77, pM182, DOI 10.1111/j.1750-3841.2012.02633.x; Guentzel JL, 2008, FOOD MICROBIOL, V25, P36, DOI 10.1016/j.fm.2007.08.003; Handojo A, 2009, J FOOD PROTECT, V72, P1315, DOI 10.4315/0362-028X-72.6.1315; Herskind C, 1988, RADIAT RES, V1114, P28; Hotta K, 2000, J JPN SOC INTENSIVE, V7, P97; HURST JK, 1991, EUR J BIOCHEM, V202, P1275, DOI 10.1111/j.1432-1033.1991.tb16500.x; Ikai H, 2010, ANTIMICROB AGENTS CH, V54, P5086, DOI 10.1128/AAC.00751-10; Kiura H, 2002, J MICROBIOL METH, V49, P285, DOI 10.1016/S0167-7012(01)00385-2; Lee JH, 2004, J GASTROEN HEPATOL, V19, P897, DOI 10.1111/j.1440-1746.2004.03375.x; Lu ZH, 2010, J FOOD PROTECT, V73, P483, DOI 10.4315/0362-028X-73.3.483; Nagamatsu Y, 2001, Dent Mater J, V20, P148; Nakagawara S, 1998, ANAL SCI, V14, P691, DOI 10.2116/analsci.14.691; Nakamura K, 2010, B CHEM SOC JPN, V83, P1037, DOI 10.1246/bcsj.20100078; Nisola GM, 2011, J ENVIRON SCI HEAL A, V46, P263, DOI 10.1080/10934529.2011.535428; Northcutt J, 2007, POULTRY SCI, V86, P2239, DOI 10.1093/ps/86.10.2239; Oomori T, 2000, ANAL SCI, V16, P365, DOI 10.2116/analsci.16.365; PANGANAMALA RV, 1976, PROSTAGLANDINS, V11, P599, DOI 10.1016/0090-6980(76)90063-0; Park YB, 2009, J FOOD SCI, V74, pM185, DOI 10.1111/j.1750-3841.2009.01139.x; PRYOR WA, 1986, ANNU REV PHYSIOL, V48, P657, DOI 10.1146/annurev.ph.48.030186.003301; Rahman SME, 2011, FOOD MICROBIOL, V28, P484, DOI 10.1016/j.fm.2010.10.006; Rahman SME, 2010, INT J FOOD MICROBIOL, V139, P147, DOI 10.1016/j.ijfoodmicro.2010.03.020; Redmond RW, 2006, PHOTOCHEM PHOTOBIOL, V82, P1178, DOI 10.1562/2006-04-14-IR-874; Rodriguez-Garcia O, 2011, J FOOD PROTECT, V74, P1552, DOI 10.4315/0362-028X.JFP-11-047; Sharma RR, 2003, INT J FOOD MICROBIOL, V86, P231, DOI 10.1016/S0168-1605(02)00549-4; Shirato M, 2012, ANTIMICROB AGENTS CH, V56, P295, DOI 10.1128/AAC.05158-11; SIES H, 1992, ANN NY ACAD SCI, V669, P7; Stan SD, 2005, J AGR FOOD CHEM, V53, P4906, DOI 10.1021/jf047918k; SUTHANTHIRAN M, 1984, NATURE, V307, P276, DOI 10.1038/307276a0; Tanaka N, 2000, ARTIF ORGANS, V24, P921, DOI 10.1046/j.1525-1594.2000.06611.x; Tsuchiya K, 2004, J FUNCTIONAL WATER, V2, P75; WINTERBOURN CC, 1987, FREE RADICAL BIO MED, V3, P33, DOI 10.1016/0891-5849(87)90037-2; Yonemori S, 1997, NIPPON KAGAKU KAISHI, P497, DOI 10.1246/nikkashi.1997.497	41	31	30	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46392	10.1371/journal.pone.0046392	http://dx.doi.org/10.1371/journal.pone.0046392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029505	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900152
J	Nalbandian, A; Llewellyn, KJ; Kitazawa, M; Yin, HZ; Badadani, M; Khanlou, N; Edwards, R; Nguyen, C; Mukherjee, J; Mozaffar, T; Watts, G; Weiss, J; Kimonis, VE				Nalbandian, Angele; Llewellyn, Katrina J.; Kitazawa, Masashi; Yin, Hong Z.; Badadani, Mallikarjun; Khanlou, Negar; Edwards, Robert; Christopher Nguyen; Mukherjee, Jogeshwar; Mozaffar, Tahseen; Watts, Giles; Weiss, John; Kimonis, Virginia E.			The Homozygote VCPR155H/R155H Mouse Model Exhibits Accelerated Human VCP-Associated Disease Pathology	PLOS ONE			English	Article							INCLUSION-BODY MYOPATHY; VALOSIN-CONTAINING PROTEIN; PAGET-DISEASE; FRONTOTEMPORAL DEMENTIA; CELL-DEATH; BONE; MUTATIONS; AUTOPHAGY; FAMILY; MITOCHONDRIA	Valosin containing protein (VCP) mutations are the cause of hereditary inclusion body myopathy, Paget's disease of bone, frontotemporal dementia (IBMPFD). VCP gene mutations have also been linked to 2% of isolated familial amyotrophic lateral sclerosis (ALS). VCP is at the intersection of disrupted ubiquitin proteasome and autophagy pathways, mechanisms responsible for the intracellular protein degradation and abnormal pathology seen in muscle, brain and spinal cord. We have developed the homozygous knock-in VCP mouse (VCPR155H/R155H) model carrying the common R155H mutations, which develops many clinical features typical of the VCP-associated human diseases. Homozygote VCPR155H/R155H mice typically survive less than 21 days, exhibit weakness and myopathic changes on EMG. MicroCT imaging of the bones reveal non-symmetrical radiolucencies of the proximal tibiae and bone, highly suggestive of PDB. The VCPR155H/R155H mice manifest prominent muscle, heart, brain and spinal cord pathology, including striking mitochondrial abnormalities, in addition to disrupted autophagy and ubiquitin pathologies. The VCPR155H/R155H homozygous mouse thus represents an accelerated model of VCP disease and can be utilized to elucidate the intricate molecular mechanisms involved in the pathogenesis of VCP-associated neurodegenerative diseases and for the development of novel therapeutic strategies.	[Nalbandian, Angele; Llewellyn, Katrina J.; Badadani, Mallikarjun; Christopher Nguyen; Kimonis, Virginia E.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Kitazawa, Masashi] Univ Calif Merced, Dept Mol & Cell Biol, Merced, CA USA; [Yin, Hong Z.; Mozaffar, Tahseen; Weiss, John] Univ Calif Irvine, Dept Neurol Anat & Neurobiol, Irvine, CA USA; [Khanlou, Negar] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Edwards, Robert] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA; [Mukherjee, Jogeshwar] Univ Calif Irvine, Dept Radiol Sci, Irvine, CA 92717 USA; [Mozaffar, Tahseen] Univ Calif Irvine, Dept Orthoped, Irvine, CA USA; [Watts, Giles] Univ E Anglia, Dept Cell Biol & Biochem, Norwich NR4 7TJ, Norfolk, England	University of California System; University of California Irvine; University of California System; University of California Merced; University of California System; University of California Irvine; University of California System; University of California Los Angeles; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of East Anglia	Kimonis, VE (corresponding author), Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA.	vkimonis@uci.edu	weiss, john/B-4283-2008; Mukherjee, Jogeshwar/O-1320-2013; Mozaffar, Tahseen/AAE-6971-2020; Kitazawa, Masashi/AAI-1721-2021	weiss, john/0000-0001-9323-7813; Mukherjee, Jogeshwar/0000-0003-1009-877X; Kitazawa, Masashi/0000-0003-2165-8197	National Institutes of Health (NIH) [AR050236]; Muscular Dystrophy Association (MDA) [175682]; National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIH/NIAMS) [AR054695];  [NS36548]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR054695, R01AR050236, K99AR054695, R21AR063360, R56AR050236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036548] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIH/NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); ; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grant AR050236 and Muscular Dystrophy Association (MDA) 175682 to VK; and NS36548 to JW; and National Institute of Arthritis, Musculoskeletal and Skin Diseases (NIH/NIAMS) grant AR054695 to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramzon Y, 2012, NEUROBIOL AGING; Badadani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013183; Batlevi Y, 2011, NEUROBIOL DIS, V43, P46, DOI 10.1016/j.nbd.2010.09.009; Bersano A, 2009, NEUROBIOL AGING, V30, P752, DOI 10.1016/j.neurobiolaging.2007.08.009; Brettschneider J, 2012, ACTA NEUROPATHOL; Calvo AFB, 2012, CARIES RES, V46, P31, DOI 10.1159/000335125; CUSTER SK, 2010, HUM MOL GENET; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Djamshidian A, 2009, MUSCLE NERVE, V39, P389, DOI 10.1002/mus.21225; Fanganiello RD, 2011, BRAZ J MED BIOL RES, V44, P374, DOI 10.1590/S0100-879X2011007500028; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Garner TP, 2011, BIOCHEMISTRY-US, V50, P4665, DOI 10.1021/bi200079n; Gomes L. C., 2012, BIOCH BIOPHYS ACTA; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Guyant-Marechal L, 2006, NEUROLOGY, V67, P644, DOI 10.1212/01.wnl.0000225184.14578.d3; Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92; Heinen C, 2010, FEBS LETT, V584, P1585, DOI 10.1016/j.febslet.2010.03.018; Hubbers CU, 2007, BRAIN, V130, P381, DOI 10.1093/brain/awl238; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kim EJ, 2011, ARCH NEUROL-CHICAGO, V68, P787, DOI 10.1001/archneurol.2010.376; Kimonis V., 2007, INCLUSION BODY MYOPA; Kimonis VE, 2005, ALZ DIS ASSOC DIS, V19, pS44, DOI 10.1097/01.wad.0000183081.76820.5a; Kimonis VE, 2000, GENET MED, V2, P232, DOI 10.1097/00125817-200007000-00006; Kimonis VE, 2008, BIOCH BIOPHYS ACTA; Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862; Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256; Kumar KR, 2010, NEUROMUSCULAR DISORD, V20, P330, DOI 10.1016/j.nmd.2010.03.002; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Leigh PN, 2010, NAT REV NEUROL, V6, P191, DOI 10.1038/nrneurol.2010.33; Manzano R, 2011, NEURODEGENER DIS, V8, P386, DOI 10.1159/000324159; Miller TD, 2009, J NEUROL NEUROSUR PS, V80, P583, DOI 10.1136/jnnp.2008.148676; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Nalbandian A, 2012, MUSCLE NERV IN PRESS; Nalbandian A, 2011, J MOL NEUROSCI, V45, P522, DOI 10.1007/s12031-011-9627-y; Ross JM, 2011, JOVE-J VIS EXP, DOI 10.3791/3266; Schroder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407; Shi Z, 2012, EUR J NEUROL, V19, P501, DOI 10.1111/j.1468-1331.2011.03575.x; Spina S, 2008, FASEB J, V22, P5854; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Viassolo V, 2008, CLIN GENET; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Watts GDJ, 2003, NEUROMUSCULAR DISORD, V13, P559, DOI 10.1016/S0960-8966(03)00070-1; Weihl CC, 2006, HUM MOL GENET, V15, P189, DOI 10.1093/hmg/ddi426; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yin H, 2012, CELL DEATH IN PRESS	51	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46308	10.1371/journal.pone.0046308	http://dx.doi.org/10.1371/journal.pone.0046308			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029473	Green Published, gold			2022-12-27	WOS:000309973900130
J	Ogawa, T; Kawashima, N; Ogata, T; Nakazawa, K				Ogawa, Tetsuya; Kawashima, Noritaka; Ogata, Toru; Nakazawa, Kimitaka			Limited Transfer of Newly Acquired Movement Patterns across Walking and Running in Humans	PLOS ONE			English	Article							RUN TRANSITION SPEED; ELECTRICAL-STIMULATION; REDUCED-GRAVITY; MOTOR TASK; LOCOMOTION; LIMB; CEREBELLUM; NETWORKS; DYNAMICS; PHASE	The two major modes of locomotion in humans, walking and running, may be regarded as a function of different speed (walking as slower and running as faster). Recent results using motor learning tasks in humans, as well as more direct evidence from animal models, advocate for independence in the neural control mechanisms underlying different locomotion tasks. In the current study, we investigated the possible independence of the neural mechanisms underlying human walking and running. Subjects were tested on a split-belt treadmill and adapted to walking or running on an asymmetrically driven treadmill surface. Despite the acquisition of asymmetrical movement patterns in the respective modes, the emergence of asymmetrical movement patterns in the subsequent trials was evident only within the same modes (walking after learning to walk and running after learning to run) and only partial in the opposite modes (walking after learning to run and running after learning to walk) (thus transferred only limitedly across the modes). Further, the storage of the acquired movement pattern in each mode was maintained independently of the opposite mode. Combined, these results provide indirect evidence for independence in the neural control mechanisms underlying the two locomotive modes.	[Ogawa, Tetsuya; Kawashima, Noritaka; Ogata, Toru] Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama, Japan; [Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan	University of Tokyo	Ogawa, T (corresponding author), Natl Rehabil Ctr Persons Disabil, Res Inst, Dept Rehabil Movement Funct, Tokorozawa, Saitama, Japan.	ogawa-tetsuya@rehab.go.jp	Ogata, Toru/ADC-3560-2022	Ogata, Toru/0000-0001-9011-8640	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grand-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science to T. Ogawa. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JL, 2008, J EXP BIOL, V211, P1281, DOI 10.1242/jeb.011932; Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; BERKOWITZ A, 1994, J NEUROSCI, V14, P5105; Budick SA, 2000, J EXP BIOL, V203, P2565; Cabelguen JM, 2003, J NEUROSCI, V23, P2434; Cappellini G, 2006, J NEUROPHYSIOL, V95, P3426, DOI 10.1152/jn.00081.2006; Choi JT, 2007, NAT NEUROSCI, V10, P1055, DOI 10.1038/nn1930; DIEDRICH FJ, 1995, J EXP PSYCHOL HUMAN, V21, P183, DOI 10.1037/0096-1523.21.1.183; FARLEY CT, 1992, J APPL PHYSIOL, V73, P2709, DOI 10.1152/jappl.1992.73.6.2709; HODGSON JA, 1994, MED SCI SPORT EXER, V26, P1491; Ikegami T, 2010, J NEUROSCI, V30, P4515, DOI 10.1523/JNEUROSCI.3066-09.2010; Ito S, 1998, BIOL CYBERN, V78, P337, DOI 10.1007/s004220050438; Ivanenko YP, 2007, J NEUROSCI, V27, P11149, DOI 10.1523/JNEUROSCI.2644-07.2007; Kram R, 1997, J EXP BIOL, V200, P821; Lam T, 2003, J NEUROPHYSIOL, V89, P1920, DOI 10.1152/jn.01030.2002; McLean DL, 2008, NAT NEUROSCI, V11, P1419, DOI 10.1038/nn.2225; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Nozaki D, 2006, NAT NEUROSCI, V9, P1364, DOI 10.1038/nn1785; Ogawa T, 2011, SOC NUER ABSTR; Prilutsky BI, 2001, J EXP BIOL, V204, P2277; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Sasaki K, 2006, J BIOMECH, V39, P2005, DOI 10.1016/j.jbiomech.2005.06.019; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; SHIK ML, 1966, BIOPHYS-USSR, V11, P756; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Vasudevan EVL, 2010, J NEUROPHYSIOL, V103, P183, DOI 10.1152/jn.00501.2009; Yanagihara D, 1996, P NATL ACAD SCI USA, V93, P13292, DOI 10.1073/pnas.93.23.13292	27	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46349	10.1371/journal.pone.0046349	http://dx.doi.org/10.1371/journal.pone.0046349			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029490	Green Published, gold			2022-12-27	WOS:000309517500093
J	Allsop, DJ; Copeland, J; Norberg, MM; Fu, SL; Molnar, A; Lewis, J; Budney, AJ				Allsop, David J.; Copeland, Jan; Norberg, Melissa M.; Fu, Shanlin; Molnar, Anna; Lewis, John; Budney, Alan J.			Quantifying the Clinical Significance of Cannabis Withdrawal	PLOS ONE			English	Article							DISORDERS IDENTIFICATION TEST; DEPENDENCE SCALE SDS; TEST AUDIT; ALCOHOL; SEVERITY; SYMPTOMS; ADOLESCENTS; VALIDITY; TOBACCO; RELIABILITY	Background and Aims: Questions over the clinical significance of cannabis withdrawal have hindered its inclusion as a discrete cannabis induced psychiatric condition in the Diagnostic and Statistical Manual of Mental Disorders (DSM IV). This study aims to quantify functional impairment to normal daily activities from cannabis withdrawal, and looks at the factors predicting functional impairment. In addition the study tests the influence of functional impairment from cannabis withdrawal on cannabis use during and after an abstinence attempt. Methods and Results: volunteer sample of 49 non-treatment seeking cannabis users who met DSM-IV criteria for dependence provided daily withdrawal-related functional impairment scores during a one-week baseline phase and two weeks of monitored abstinence from cannabis with a one month follow up. Functional impairment from withdrawal symptoms was strongly associated with symptom severity (p = 0.0001). Participants with more severe cannabis dependence before the abstinence attempt reported greater functional impairment from cannabis withdrawal (p = 0.03). Relapse to cannabis use during the abstinence period was associated with greater functional impairment from a subset of withdrawal symptoms in high dependence users. Higher levels of functional impairment during the abstinence attempt predicted higher levels of cannabis use at one month follow up (p = 0.001). Conclusions: Cannabis withdrawal is clinically significant because it is associated with functional impairment to normal daily activities, as well as relapse to cannabis use. Sample size in the relapse group was small and the use of a non-treatment seeking population requires findings to be replicated in clinical samples. Tailoring treatments to target withdrawal symptoms contributing to functional impairment during a quit attempt may improve treatment outcomes.	[Allsop, David J.; Copeland, Jan; Norberg, Melissa M.] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Natl Cannabis Prevent & Informat Ctr, Sydney, NSW, Australia; [Fu, Shanlin; Molnar, Anna; Lewis, John] Univ Technol Sydney, Sch Chem & Forens Sci, Ctr Forens Sci, Sydney, NSW 2007, Australia; [Budney, Alan J.] Geisel Sch Med Dartmouth, Lebanon, NH USA	University of New South Wales Sydney; University of Technology Sydney; Dartmouth College	Allsop, DJ (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Natl Cannabis Prevent & Informat Ctr, Sydney, NSW, Australia.	d.allsop@unsw.edu.au	Norberg, Melissa/H-8365-2014; Fu, Shanlin/D-8286-2013	Norberg, Melissa/0000-0001-7840-9007; Fu, Shanlin/0000-0002-6238-3612	National Health and Medical Research Council, Australia [1006036]; Australian Government Department of Health and Ageing; National Institute on Drug Abuse [DA15186, DA23526]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015186, R01DA023526] Funding Source: NIH RePORTER	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Dr. Allsop is supported by a project grant (1006036) from the National Health and Medical Research Council, Australia. Funding for the work was provided by the Australian Government Department of Health and Ageing. Dr. Budney's contribution was funded in part by the National Institute on Drug Abuse, DA15186 and DA23526. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, AM J ADDICTION, V17, P199, DOI 10.1080/10550490802019519; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allsop DJ, 2011, DRUG ALCOHOL DEPEN, V119, P123, DOI 10.1016/j.drugalcdep.2011.06.003; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Budney AJ, 2006, CURR OPIN PSYCHIATR, V19, P233, DOI 10.1097/01.yco.0000218592.00689.e5; Budney AJ, 2001, ARCH GEN PSYCHIAT, V58, P917, DOI 10.1001/archpsyc.58.10.917; Budney AJ, 2008, J SUBST ABUSE TREAT, V35, P362, DOI 10.1016/j.jsat.2008.01.002; Cook JM, 2007, GEN HOSP PSYCHIAT, V29, P396, DOI 10.1016/j.genhosppsych.2007.07.001; Copeland J, 2001, J SUBST ABUSE TREAT, V20, P45, DOI 10.1016/S0740-5472(00)00148-3; Copersino ML, 2006, AM J ADDICTION, V15, P8, DOI 10.1080/10550490500418997; Cornelius JR, 2008, ADDICT BEHAV, V33, P1500, DOI 10.1016/j.addbeh.2008.02.001; COTTLER LB, 1995, DRUG ALCOHOL DEPEN, V38, P59, DOI 10.1016/0376-8716(94)01091-X; Crowley TJ, 1998, DRUG ALCOHOL DEPEN, V50, P27, DOI 10.1016/S0376-8716(98)00003-9; Dybek I, 2006, J STUD ALCOHOL, V67, P473, DOI 10.15288/jsa.2006.67.473; Eyer F, 2011, ALCOHOL ALCOHOLISM, V46, P427, DOI 10.1093/alcalc/agr053; FARRELL M, 1994, ADDICTION, V89, P1471, DOI 10.1111/j.1360-0443.1994.tb03745.x; First MB, 2002, STRUCTURED CLIN INTE; Fu SL, 2008, J ANAL TOXICOL, V32, P292, DOI 10.1093/jat/32.4.292; Gates P, 2012, ADDICTION IN PRESS; Gorelick DA, 2012, DRUG ALCOHOL DEPEN, V123, P141, DOI 10.1016/j.drugalcdep.2011.11.007; GOSSOP M, 1992, BRIT J ADDICT, V87, P1527; GOSSOP M, 1995, ADDICTION, V90, P607, DOI 10.1111/j.1360-0443.1995.tb02199.x; Hall W, 1997, LANCET, V349, P1897, DOI 10.1016/S0140-6736(97)04572-8; Haney M, 2008, PSYCHOPHARMACOLOGY, V197, P157, DOI 10.1007/s00213-007-1020-8; Haney Margaret, 2005, Curr Psychiatry Rep, V7, P360, DOI 10.1007/s11920-005-0036-1; Harrell FE, 2001, REGRESSION MODELING; Hasin DS, 2008, J CLIN PSYCHIAT, V69, P1354, DOI 10.4088/JCP.v69n0902; HUGHES JR, 1986, ARCH GEN PSYCHIAT, V43, P289; Ivis FJ, 2000, DRUG ALCOHOL DEPEN, V60, P97, DOI 10.1016/S0376-8716(99)00145-3; Kraemer HC, 2006, ARCH GEN PSYCHIAT, V63, P484, DOI 10.1001/archpsyc.63.5.484; LEVIN K, 2010, ART NEWS, V109, P111; MAGEE L, 1990, AM STAT, V44, P250, DOI 10.2307/2685352; Martin G, 2006, DRUG ALCOHOL DEPEN, V83, P90, DOI 10.1016/j.drugalcdep.2005.10.014; Mattick RP, 1996, LANCET, V347, P97, DOI 10.1016/S0140-6736(96)90215-9; McBride O, 2010, J STUD ALCOHOL DRUGS, V71, P597, DOI 10.15288/jsad.2010.71.597; Musshoff F, 2006, THER DRUG MONIT, V28, P155, DOI 10.1097/01.ftd.0000197091.07807.22; Norberg MM, 2012, DRUG ALCOHOL DEPEN, V121, P247, DOI 10.1016/j.drugalcdep.2011.09.007; Piasecki TM, 2003, J ABNORM PSYCHOL, V112, P14, DOI 10.1037/0021-843X.112.1.14; Piontek D, 2011, ADDICTION, V106, P1137, DOI 10.1111/j.1360-0443.2010.03359.x; Preuss UW, 2010, DRUG ALCOHOL DEPEN, V106, P133, DOI 10.1016/j.drugalcdep.2009.08.008; Reinert DF, 2007, ALCOHOL CLIN EXP RES, V31, P185, DOI 10.1111/j.1530-0277.2006.00295.x; Rubin A, 2006, J STUD ALCOHOL, V67, P454, DOI 10.15288/jsa.2006.67.454; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sobell L. C., 1995, ALCOHOL TIMELINE FOL; Vandrey R, 2005, DRUG ALCOHOL DEPEN, V78, P205, DOI 10.1016/j.drugalcdep.2004.11.001; Vandrey RG, 2008, DRUG ALCOHOL DEPEN, V92, P48, DOI 10.1016/j.drugalcdep.2007.06.010; ZIMMERMAN DW, 1993, J EXP EDUC, V62, P75, DOI 10.1080/00220973.1993.9943832	48	86	89	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e44864	10.1371/journal.pone.0044864	http://dx.doi.org/10.1371/journal.pone.0044864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049760	Green Submitted, gold, Green Published			2022-12-27	WOS:000309517300012
J	Fang, P; Zeng, LL; Shen, H; Wang, LB; Li, BJ; Liu, L; Hu, DW				Fang, Peng; Zeng, Ling-Li; Shen, Hui; Wang, Lubin; Li, Baojuan; Liu, Li; Hu, Dewen			Increased Cortical-Limbic Anatomical Network Connectivity in Major Depression Revealed by Diffusion Tensor Imaging	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; BRAIN STRUCTURAL NETWORKS; FRONTAL WHITE-MATTER; ANTERIOR CINGULATE; PATTERN-CLASSIFICATION; SUBGENUAL CINGULATE; HIPPOCAMPAL VOLUMES; GLUCOSE-METABOLISM; PARIETAL CORTEX; PET FINDINGS	Magnetic resonance imaging studies have reported significant functional and structural differences between depressed patients and controls. Little attention has been given, however, to the abnormalities in anatomical connectivity in depressed patients. In the present study, we aim to investigate the alterations in connectivity of whole-brain anatomical networks in those suffering from major depression by using machine learning approaches. Brain anatomical networks were extracted from diffusion magnetic resonance images obtained from both 22 first-episode, treatment-naive adults with major depressive disorder and 26 matched healthy controls. Using machine learning approaches, we differentiated depressed patients from healthy controls based on their whole-brain anatomical connectivity patterns and identified the most discriminating features that represent between-group differences. Classification results showed that 91.7% (patients = 86.4%, controls = 96.2%; permutation test, p<0.0001) of subjects were correctly classified via leave-one-out cross-validation. Moreover, the strengths of all the most discriminating connections were increased in depressed patients relative to the controls, and these connections were primarily located within the cortical-limbic network, especially the frontal-limbic network. These results not only provide initial steps toward the development of neurobiological diagnostic markers for major depressive disorder, but also suggest that abnormal cortical-limbic anatomical networks may contribute to the anatomical basis of emotional dysregulation and cognitive impairments associated with this disease.	[Fang, Peng; Zeng, Ling-Li; Shen, Hui; Wang, Lubin; Li, Baojuan; Hu, Dewen] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China; [Liu, Li] China Med Univ, Dept Psychiat, Affiliated Hosp 1, Shenyang, Liaoning, Peoples R China	National University of Defense Technology - China; China Medical University	Hu, DW (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	dwhu@nudt.edu.cn	Hu, Dewen/D-1978-2015; Hu, Dewen/AAN-8511-2020	Zeng, Ling-Li/0000-0002-0515-256X	National Important Basic Research Program of China [2011CB707802]; National High-Tech Program of China [2012AA011601]; Graduate Innovation Fund of National University of Defense Technology [B120303]; National Natural Science Foundation of China [61003202, 60835005]	National Important Basic Research Program of China(National Basic Research Program of China); National High-Tech Program of China(National High Technology Research and Development Program of China); Graduate Innovation Fund of National University of Defense Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Important Basic Research Program of China (2011CB707802), the National High-Tech Program of China (2012AA011601), Graduate Innovation Fund of National University of Defense Technology (B120303) and the National Natural Science Foundation of China (61003202, 60835005).	Alexopoulos GS, 2008, AM J PSYCHIAT, V165, P238, DOI 10.1176/appi.ajp.2007.07050744; Andersson J.L.R, 2007, TR07JA2 FMRIB; APA, 2000, DIAGN STAT MAN MENT; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Behrmann M, 2004, CURR OPIN NEUROBIOL, V14, P212, DOI 10.1016/j.conb.2004.03.012; Bennett MR, 2011, PROG NEUROBIOL, V93, P468, DOI 10.1016/j.pneurobio.2011.01.006; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Chen CH, 2007, BIOL PSYCHIAT, V62, P407, DOI 10.1016/j.biopsych.2006.09.018; Costafreda SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006353; Desseilles M, 2009, J NEUROSCI, V29, P1395, DOI 10.1523/JNEUROSCI.3341-08.2009; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2001, CURR OPIN NEUROBIOL, V11, P240, DOI 10.1016/S0959-4388(00)00203-8; Drevets WC, 2002, EUR NEUROPSYCHOPHARM, V12, P527, DOI 10.1016/S0924-977X(02)00102-5; Drevets WC, 2002, PHARMACOL BIOCHEM BE, V71, P431, DOI 10.1016/S0091-3057(01)00687-6; Ebmeier KP, 2006, LANCET, V367, P153, DOI 10.1016/S0140-6736(06)67964-6; Fan Y, 2008, NEUROIMAGE, V41, P277, DOI 10.1016/j.neuroimage.2008.02.043; First M.B., 2016, STRUCTURED CLIN INTE; Frodl T, 2010, BIOL PSYCHIAT, V67, P161, DOI 10.1016/j.biopsych.2009.08.022; Fu CHY, 2008, BIOL PSYCHIAT, V63, P656, DOI 10.1016/j.biopsych.2007.08.020; Geday J, 2001, NEUROIMAGE, V13, pS406; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Grace AA, 2006, NEUROTOX RES, V10, P93, DOI 10.1007/BF03033238; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Grimm S, 2009, NEUROPSYCHOPHARMACOL, V34, P932, DOI 10.1038/npp.2008.81; Gutman DA, 2009, BIOL PSYCHIAT, V65, P276, DOI 10.1016/j.biopsych.2008.09.021; Guy W., 1976, ASSESSMENT MANUAL PS, P218, DOI DOI 10.1186/1471-244X-7-7; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hickie IB, 2007, J AFFECT DISORDERS, V98, P137, DOI 10.1016/j.jad.2006.07.010; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Houenou J, 2007, MOL PSYCHIATR, V12, P1001, DOI 10.1038/sj.mp.4002010; Iturria-Medina Y, 2007, NEUROIMAGE, V36, P645, DOI 10.1016/j.neuroimage.2007.02.012; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P495, DOI 10.1016/j.biopsych.2005.04.035; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.6.899; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; Linden DEJ, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.049.2009; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039516; Liu MJ, 2012, NEUROREPORT, V23, P265, DOI 10.1097/WNR.0b013e32834f60a5; Liu TM, 2011, BRAIN IMAGING BEHAV, V5, P189, DOI 10.1007/s11682-011-9123-6; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; McLaughlin NCR, 2007, INT J DEV NEUROSCI, V25, P215, DOI 10.1016/j.ijdevneu.2007.03.008; Morita M, 2002, COGNITIVE BRAIN RES, V13, P169, DOI 10.1016/S0926-6410(01)00109-4; Nobuhara K, 2004, NEUROPSYCHOBIOLOGY, V50, P48, DOI 10.1159/000077941; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Paulus MP, 2002, BIOL PSYCHIAT, V51, P995, DOI 10.1016/S0006-3223(01)01358-0; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Rizzolatti G, 1997, CURR OPIN NEUROBIOL, V7, P562, DOI 10.1016/S0959-4388(97)80037-2; Robinson EC, 2010, NEUROIMAGE, V50, P910, DOI 10.1016/j.neuroimage.2010.01.019; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Tae WS, 2008, NEURORADIOLOGY, V50, P569, DOI 10.1007/s00234-008-0383-9; Tang YQ, 2007, PSYCHIAT RES-NEUROIM, V156, P83, DOI 10.1016/j.pscychresns.2007.03.005; Taylor WD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003267; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Versace A, 2008, ARCH GEN PSYCHIAT, V65, P1041, DOI 10.1001/archpsyc.65.9.1041; Versace A, 2010, BIOL PSYCHIAT, V68, P560, DOI 10.1016/j.biopsych.2010.04.036; Videbech P, 2001, PSYCHOL MED, V31, P1147, DOI 10.1017/S0033291701004469; Wang LB, 2012, NEUROIMAGE, V61, P931, DOI 10.1016/j.neuroimage.2012.03.080; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhang DG, 2012, BRAIN IMAGING BEHAV, V6, P27, DOI 10.1007/s11682-011-9138-z; Zhu D., 2012, CEREBRAL CO IN PRESS	84	63	67	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45972	10.1371/journal.pone.0045972	http://dx.doi.org/10.1371/journal.pone.0045972			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049910	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300069
J	Hall, RI; Wolfe, BB; Wiklund, JA; Edwards, TWD; Farwell, AJ; Dixon, DG				Hall, Roland I.; Wolfe, Brent B.; Wiklund, Johan A.; Edwards, Thomas W. D.; Farwell, Andrea J.; Dixon, D. George			Has Alberta Oil Sands Development Altered Delivery of Polycyclic Aromatic Compounds to the Peace-Athabasca Delta?	PLOS ONE			English	Article							EARLY-LIFE STAGES; LAKE-SEDIMENTS; ORGANIC-MATTER; FOREST-FIRES; RIVER; HYDROCARBONS; CANADA; WATER; BASIN; GEOCHEMISTRY	Background: The extent to which Alberta oil sands mining and upgrading operations have enhanced delivery of bitumen-derived contaminants via the Athabasca River and atmosphere to the Peace-Athabasca Delta (200 km to the north) is a pivotal question that has generated national and international concern. Accounts of rare health disorders in residents of Fort Chipewyan and deformed fish in downstream ecosystems provided impetus for several recent expert-panel assessments regarding the societal and environmental consequences of this multi-billion-dollar industry. Deciphering relative contributions of natural versus industrial processes on downstream supply of polycyclic aromatic compounds (PACs) has been identified as a critical knowledge gap. But, this remains a formidable scientific challenge because loading from natural processes remains unknown. And, industrial activity occurs in the same locations as the natural bitumen deposits, which potentially confounds contemporary upstream-downstream comparisons of contaminant levels. Methods/Principal Findings: Based on analyses of lake sediment cores, we provide evidence that the Athabasca Delta has been a natural repository of PACs carried by the Athabasca River for at least the past two centuries. We detect no measureable increase in the concentration and proportion of river-transported bitumen-associated indicator PACs in sediments deposited in a flood-prone lake since onset of oil sands development. Results also reveal no evidence that industrial activity has contributed measurably to sedimentary concentration of PACs supplied by atmospheric transport. Conclusions/Significance: Findings suggest that natural erosion of exposed bitumen in banks of the Athabasca River and its tributaries is a major process delivering PACs to the Athabasca Delta, and the spring freshet is a key period for contaminant mobilization and transport. This baseline environmental information is essential for informed management of natural resources and human-health concerns by provincial and federal regulatory agencies and industry, and for designing effective long-term monitoring programs for the lower Athabasca River watershed.	[Hall, Roland I.; Wiklund, Johan A.; Farwell, Andrea J.; Dixon, D. George] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Wolfe, Brent B.] Wilfrid Laurier Univ, Dept Geog & Environm Studies, Waterloo, ON N2L 3C5, Canada; [Edwards, Thomas W. D.] Univ Waterloo, Dept Earth & Environm Sci, Waterloo, ON N2L 3G1, Canada	University of Waterloo; Wilfrid Laurier University; University of Waterloo	Hall, RI (corresponding author), Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada.	rihall@uwaterloo.ca	Hall, Roland/AAO-2164-2020; Hall, Roland I/K-3165-2019	Hall, Roland/0000-0002-0314-6449; Wiklund, Johan/0000-0002-2327-5651	Suncor Energy Ltd.	Suncor Energy Ltd.	The research was supported by Suncor Energy Ltd. (http://www.suncor.com), an oil sands mining and production company. Dr. Jon Fennell (WorleyParsons Canada), a respected consultant to industry and government, and a scientific authority on water-related environmental issues in the oil sands industry, helped obtain the funding for the project. During periodic meetings, Dr. Fennell became familiar with the authors' prior hydroecological research in the Peace-Athabasca Delta. And, the authors' discussed with him the concepts and proposals for the project presented in this paper. He was also aware of challenges faced when trying to get the project funded by more traditional research funding routes. Dr. Fennell presented the concept of the research project the authors had developed to a manager at Suncor Energy Ltd., which provided an introduction that led to development of the funding for this project. During the project, Dr. Fennell acted as a liaison for communications between the authors and staff at Suncor Energy Ltd. The funder had no role in study design, data collection and analysis, or preparation of the manuscript. The agreement between the University of Waterloo and the funder allowed the funder an opportunity to delay publication by up to 18 months, which they did not execute.	Appleby P.C., 2002, TRACKING ENV CHANGE, P171, DOI [DOI 10.1007/0-306-47669-X_9, 10.1007/0-306-47669-X_9]; Ballestra SJ, 1994, IAEA300 MAR ENV LAB; Binford, 1990, J PALEOLIMNOL, V3, P253, DOI DOI 10.1007/BF00219461; Bradley L.J., 1994, J SOIL CONTAM, V3, P349, DOI DOI 10.1080/15320389409383475; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Colavecchia MV, 2006, J TOXICOL ENV HEAL A, V69, P967, DOI 10.1080/15287390500362154; Colavecchia MV, 2004, ENVIRON TOXICOL CHEM, V23, P1709, DOI 10.1897/03-412; Conly F. M., 2002, Journal of Environmental Engineering and Science, V1, P187, DOI 10.1139/s02-013; CURRIE LA, 1968, ANAL CHEM, V40, P586, DOI 10.1021/ac60259a007; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; Dowdeswell L., 2010, REPORT SUBMITTED MIN, P1; Environment Canada, 2011, INT MON PROGR OIL SA; Evans MS, 2002, WAT STUD SER, V11, P365; Gabos S, 2001, CHEMOSPHERE, V43, P709, DOI 10.1016/S0045-6535(00)00424-0; Garcia-Aragon J, 2011, J SOIL SEDIMENT, V11, P679, DOI 10.1007/s11368-011-0345-4; Giesy JP, 2010, P NATL ACAD SCI USA, V107, P951, DOI 10.1073/pnas.0912880107; Glew JR, 1989, J PALEOLIMNOL, V2, P241; Gorley C.K., 2006, GETTING STARTED PRIM; Gosselin P., 2010, ENV HLTH IMPACTS CAN; Government of Alberta, 2006, ALB OIL SANDS; Grice K, 2007, ORG GEOCHEM, V38, P1795, DOI 10.1016/j.orggeochem.2007.07.001; Hall RI, 2004, MULTICENTURY FLOOD C; Headley JV, 2001, ENVIRON FORENSICS, V2, P335, DOI 10.1006/enfo.2001.0064; Headley JV, 2002, J ENVIRON SCI HEAL A, V37, P1159, DOI 10.1081/ESE-120005979; IRWIN RJ, 1997, ENV CONTAMINANTS ENC; Itoh N, 2010, ORG GEOCHEM, V41, P845, DOI 10.1016/j.orggeochem.2010.04.002; Johnston JW, 2010, HOLOCENE, V20, P801, DOI 10.1177/0959683610362816; Jones R, 2010, MAR POLLUT BULL, V60, P1993, DOI 10.1016/j.marpolbul.2010.07.028; Kelly EN, 2010, P NATL ACAD SCI USA, V107, P16178, DOI 10.1073/pnas.1008754107; Kelly EN, 2009, P NATL ACAD SCI USA, V106, P22346, DOI 10.1073/pnas.0912050106; Kersten M, 2002, J ENVIRON MONITOR, V4, P109, DOI 10.1039/b108102k; Mauro D. M., 2006, Land Contamination & Reclamation, V14, P513, DOI 10.2462/09670513.749; McGowan S, 2011, GLOBAL CHANGE BIOL, V17, P1212, DOI 10.1111/j.1365-2486.2010.02304.x; MEYERS PA, 1993, ORG GEOCHEM, V20, P867, DOI 10.1016/0146-6380(93)90100-P; OAG, 2010, OIL SPILLS SHIPS; Peters DL, 2006, HYDROL PROCESS, V20, P4073, DOI 10.1002/hyp.6420; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; RAMDAHL T, 1983, NATURE, V306, P580, DOI 10.1038/306580a0; Robbins J.A., 1978, BIOGEOCHEMISTRY LEAD, V1A, P285; Rosenberg, 2004, OIL SANDS REGIONAL A; Schelske C.L., 1994, J PALEOLIMNOL, V10, P115, DOI [10.1007/BF00682508, DOI 10.1007/BF00682508]; Schindler DW, 2006, P NATL ACAD SCI USA, V103, P7210, DOI 10.1073/pnas.0601568103; Schindler D, 2010, NATURE, V468, P499, DOI 10.1038/468499a; SCRIMGEOUR GJ, 1994, FRESHWATER BIOL, V32, P261, DOI 10.1111/j.1365-2427.1994.tb01125.x; Timoney K, 2002, WETLANDS, V22, P282, DOI 10.1672/0277-5212(2002)022[0282:ADDACS]2.0.CO;2; Timoney K., 2007, STUDY WATER SEDIMENT; Timoney KP, 2011, ENVIRON SCI TECHNOL, V45, P4278, DOI 10.1021/es104375d; Timoney Kevin P., 2009, Open Conservation Biology Journal, V3, P65, DOI 10.2174/1874839200903010065; Tolosa I, 1996, ENVIRON SCI TECHNOL, V30, P2495, DOI 10.1021/es950647x; Vergnoux A, 2011, ENVIRON RES, V111, P193, DOI 10.1016/j.envres.2010.01.008; WAKEHAM SG, 1980, GEOCHIM COSMOCHIM AC, V44, P415, DOI 10.1016/0016-7037(80)90041-1; Wiklund JA, 2012, SCI TOTAL ENVIRON, V433, P379, DOI 10.1016/j.scitotenv.2012.06.074; Wiklund JA, 2012, ECOHYDROLOGY, V5, P351, DOI 10.1002/eco.226; Wolfe BB, 2005, QUATERNARY RES, V64, P147, DOI 10.1016/j.yqres.2005.05.001; Wolfe BB, 2008, ECOHYDROLOGY, V1, P131, DOI 10.1002/eco.13; Wolfe BB, 2007, HYDROL PROCESS, V21, P151, DOI 10.1002/hyp.6229; Wolfe BB, 2006, HYDROL PROCESS, V20, P4131, DOI 10.1002/hyp.6423; Wolfe BB, 2012, ENVIRON REV, V20, P191, DOI [10.1139/A2012-008, 10.1139/a2012-008]; Wolfe BB, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047599; Wolfe BB, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036125; Yang C, 2011, ENVIRON FORENSICS, V12, P173, DOI 10.1080/15275922.2011.574312; Yi Y, 2008, J HYDROL, V350, P1, DOI 10.1016/j.jhydrol.2007.11.008; YUNKER MB, 1993, GEOCHIM COSMOCHIM AC, V57, P3041, DOI 10.1016/0016-7037(93)90292-5; Yunker MB, 2003, ORG GEOCHEM, V34, P1429, DOI 10.1016/S0146-6380(03)00136-0	64	62	62	1	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46089	10.1371/journal.pone.0046089	http://dx.doi.org/10.1371/journal.pone.0046089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049946	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300083
J	Li, YX; Pal, R; Sung, LY; Feng, HZ; Miao, WM; Cheng, SY; Tian, C; Cheng, T				Li, Yanxin; Pal, Rekha; Sung, Li-Ying; Feng, Haizhong; Miao, Weimin; Cheng, Shi-Yuan; Tian, Cindy; Cheng, Tao			An Opposite Effect of the CDK Inhibitor, p18(INK4c) on Embryonic Stem Cells Compared with Tumor and Adult Stem Cells	PLOS ONE			English	Article							NUCLEAR TRANSFER; CYCLE; OCT4; P21(CIP1/WAF1); TUMORIGENESIS; EXPRESSION; CANCER; MICE; PROLIFERATION; PLURIPOTENCY	Self-renewal is a feature common to both adult and embryonic stem (ES) cells, as well as tumor stem cells (TSCs). The cyclin-dependent kinase inhibitor, p18(INK4c), is a known tumor suppressor that can inhibit self-renewal of tumor cells or adult stem cells. Here, we demonstrate an opposite effect of p18 on ES cells in comparison with teratoma cells. Our results unexpectedly showed that overexpression of p18 accelerated the growth of mouse ES cells and embryonic bodies (EB); on the contrary, inhibited the growth of late stage teratoma. Up-regulation of ES cell markers (i.e., Oct4, Nanog, Sox2, and Rex1) were detected in both ES and EB cells, while concomitant down-regulation of various differentiation markers was observed in EB cells. These results demonstrate that p18 has an opposite effect on ES cells as compared with tumor cells and adult stem cells. Mechanistically, expression of CDK4 was significantly increased with overexpression of p18 in ES cells, likely leading to a release of CDK2 from the inhibition by p21 and p27. As a result, self-renewal of ES cells was enhanced. Our current study suggests that targeting p18 in different cell types may yield different outcomes, thereby having implications for therapeutic manipulations of cell cycle machinery in stem cells.	[Li, Yanxin; Miao, Weimin; Cheng, Tao] Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China; [Li, Yanxin; Miao, Weimin; Cheng, Tao] Chinese Acad Med Sci, Blood Dis Hosp, Ctr Stem Cell Med, Tianjin, Peoples R China; [Li, Yanxin; Miao, Weimin; Cheng, Tao] Peking Union Med Coll, Tianjin, Peoples R China; [Li, Yanxin; Pal, Rekha; Cheng, Tao] Univ Pittsburgh, Sch Med, Dept Radiat Oncol, Pittsburgh, PA USA; [Feng, Haizhong; Cheng, Shi-Yuan] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Li, Yanxin; Pal, Rekha; Feng, Haizhong; Cheng, Shi-Yuan; Cheng, Tao] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Sung, Li-Ying] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Tian, Cindy] Univ Connecticut, Dept Anim Sci, Ctr Regenerat Biol, Storrs, CT USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Hematology & Blood Diseases Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Taiwan University; University of Connecticut	Cheng, T (corresponding author), Chinese Acad Med Sci, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China.	chengt@pumc.edu.cn	; Feng, Haizhong/E-5795-2017	SUNG, LI-YING/0000-0003-1221-2476; Feng, Haizhong/0000-0003-3552-6865; Cheng, Tao/0000-0002-5925-2769	Ministry of Science and Technology of China [2011ZX09102-010-04, 2011CB964801, 2010DFB30270, 2010CB945204]; Natural Science Foundation of China [81090410, 90913018, 30825017]; National Institutes of Health [R01-HL070561]; Leukemia & Lymphoma Society [1027-08]; NATIONAL CANCER INSTITUTE [R01CA130966, R01CA159811] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070561] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the grants from the Ministry of Science and Technology of China (2011ZX09102-010-04, 2011CB964801,2010DFB30270 and 2010CB945204), Natural Science Foundation of China (81090410, 90913018 and 30825017) and National Institutes of Health (R01-HL070561) to TC. TC was a recipient of the Scholar Award from the Leukemia & Lymphoma Society (1027-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2003, MOL CELL BIOL, V23, P1269, DOI 10.1128/MCB.23.4.1269-1277.2003; Berg JS, 2007, CELL STEM CELL, V1, P359, DOI 10.1016/j.stem.2007.09.007; Boyer MJ, 2008, GENE THER, V15, P117, DOI 10.1038/sj.gt.3303064; Broxmeyer HE, 2011, STEM CELLS DEV; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Chen Z, 2009, J SURG ONCOL, V99, P414, DOI 10.1002/jso.21270; Cheng T, 2008, GENE THER, V15, P67, DOI 10.1038/sj.gt.3303066; Cheng T, 2004, ONCOGENE, V23, P7256, DOI 10.1038/sj.onc.1207945; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheng T, 2001, BLOOD, V98, P3643, DOI 10.1182/blood.V98.13.3643; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Faast R, 2004, ONCOGENE, V23, P491, DOI 10.1038/sj.onc.1207133; Franklin DS, 2000, MOL CELL BIOL, V20, P6147, DOI 10.1128/MCB.20.16.6147-6158.2000; Franklin DS, 1998, GENE DEV, V12, P2899, DOI 10.1101/gad.12.18.2899; Gilbert DM, 2010, J CELL BIOL, V191, P899, DOI 10.1083/jcb.201007125; Kovalev GI, 2001, J IMMUNOL, V167, P3285, DOI 10.4049/jimmunol.167.6.3285; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; McConnell BB, 1999, MOL CELL BIOL, V19, P1981; Miura T, 2004, AGING CELL, V3, P333, DOI 10.1111/j.1474-9728.2004.00134.x; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pei XH, 2004, MOL CELL BIOL, V24, P6653, DOI 10.1128/mcb.24.15.6653-6664.2004; Pei XH, 2007, CANCER RES, V67, P3162, DOI 10.1158/0008-5472.CAN-06-4517; Pei XH, 2009, CANCER CELL, V15, P389, DOI 10.1016/j.ccr.2009.03.004; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; SAVATIER P, 1994, ONCOGENE, V9, P809; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Sung LY, 2006, NAT GENET, V38, P1323, DOI 10.1038/ng1895; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKEBE N, 2010, NAT REV CLIN ONCOL; Tschan MP, 1999, BRIT J HAEMATOL, V106, P644, DOI 10.1046/j.1365-2141.1999.01617.x; Uziel T, 2006, CELL CYCLE, V5, P363, DOI 10.4161/cc.5.4.2475; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; Yu H, 2006, BLOOD, V107, P1200, DOI 10.1182/blood-2005-02-0685; Yuan YZ, 2006, CANCER RES, V66, P343, DOI 10.1158/0008-5472.CAN-05-2945; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zindy F, 2001, MOL CELL BIOL, V21, P3244, DOI 10.1128/MCB.21.9.3244-3255.2001	44	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45212	10.1371/journal.pone.0045212	http://dx.doi.org/10.1371/journal.pone.0045212			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049777	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300018
J	Maresca, G; Natoli, M; Nardella, M; Arisi, I; Trisciuoglio, D; Desideri, M; Brandi, R; D'Aguanno, S; Nicotra, MR; D'Onofrio, M; Urbani, A; Natali, PG; Del Bufalo, D; Felsani, A; D'Agnano, I				Maresca, Giovanna; Natoli, Manuela; Nardella, Marta; Arisi, Ivan; Trisciuoglio, Daniela; Desideri, Marianna; Brandi, Rossella; D'Aguanno, Simona; Nicotra, Maria Rita; D'Onofrio, Mara; Urbani, Andrea; Natali, Pier Giorgio; Del Bufalo, Donatella; Felsani, Armando; D'Agnano, Igea			LMNA Knock-Down Affects Differentiation and Progression of Human Neuroblastoma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM AMINOPEPTIDASES; LAMIN A/C EXPRESSION; A-TYPE LAMINS; NUCLEAR LAMINS; GENE AMPLIFICATION; XENOPUS-LAEVIS; OVARIAN-CANCER; HUMAN TISSUES; PROTEINS; CARCINOMA	Background: Neuroblastoma (NB) is one of the most aggressive tumors that occur in childhood. Although genes, such as MYCN, have been shown to be involved in the aggressiveness of the disease, the identification of new biological markers is still desirable. The induction of differentiation is one of the strategies used in the treatment of neuroblastoma. A-type lamins are components of the nuclear lamina and are involved in differentiation. We studied the role of Lamin A/C in the differentiation and progression of neuroblastoma. Methodology/Principal Findings: Knock-down of Lamin A/C (LMNA-KD) in neuroblastoma cells blocked retinoic acid-induced differentiation, preventing neurites outgrowth and the expression of neural markers. The genome-wide gene-expression profile and the proteomic analysis of LMNA-KD cells confirmed the inhibition of differentiation and demonstrated an increase of aggressiveness-related genes and molecules resulting in augmented migration/invasion, and increasing the drug resistance of the cells. The more aggressive phenotype acquired by LMNA-KD cells was also maintained in vivo after injection into nude mice. A preliminary immunohistochemistry analysis of Lamin A/C expression in nine primary stages human NB indicated that this protein is poorly expressed in most of these cases. Conclusions/Significance: We demonstrated for the first time in neuroblastoma cells that Lamin A/C plays a central role in the differentiation, and that the loss of this protein gave rise to a more aggressive tumor phenotype.	[Maresca, Giovanna; Natoli, Manuela; Nardella, Marta; Felsani, Armando; D'Agnano, Igea] Santa Lucia Fdn IRCCS, CNR Inst Cell Biol & Neurobiol, Rome, Italy; [Arisi, Ivan; Brandi, Rossella; D'Onofrio, Mara] European Brain Res Inst, EBRI Neurogen IIT Unit, Rome, Italy; [Trisciuoglio, Daniela; Desideri, Marianna; Del Bufalo, Donatella] Regina Elena Inst Canc Res, Expt Chemotherapy Lab, Rome, Italy; [D'Aguanno, Simona; Urbani, Andrea] Univ Roma Tor Vergata, Dept Internal Med, Lab Prote, Santa Lucia Fdn IRCCS, Rome, Italy; [Nicotra, Maria Rita; Natali, Pier Giorgio] Univ G DAnnunzio, Lab CINBO, Chieti, Italy	IRCCS Santa Lucia; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Santa Lucia; University of Rome Tor Vergata; G d'Annunzio University of Chieti-Pescara	Felsani, A (corresponding author), Santa Lucia Fdn IRCCS, CNR Inst Cell Biol & Neurobiol, Rome, Italy.	armando.felsani@cnr.it; igea.dagnano@cnr.it	trisciuoglio, Daniela/H-2131-2016; Arisi, Ivan/AAM-1152-2021; Felsani, Armando/D-1784-2010; trisciuoglio, daniela/AAL-4002-2021; desideri, marianna/K-5771-2016; D'Agnano, Igea/AAR-7282-2020; Del Bufalo, Donatella/AAC-1594-2021; Urbani, Andrea/B-2953-2012; D'Aguanno, Simona/H-2179-2016; Del Bufalo, Donatella/K-8673-2016; Urbani, Andrea/AAD-1675-2022	trisciuoglio, Daniela/0000-0002-7007-7914; Arisi, Ivan/0000-0002-0536-2508; Felsani, Armando/0000-0001-8851-6295; desideri, marianna/0000-0002-4311-9656; Del Bufalo, Donatella/0000-0002-3148-6096; D'Aguanno, Simona/0000-0002-1224-4454; Del Bufalo, Donatella/0000-0002-3148-6096; nardella, marta/0000-0002-9949-2169; D'Agnano, Igea/0000-0002-2646-9224	joint Grant CNR-EBRI "Molecular and cellular mechanisms of brain plasticity"; Italian Association for Cancer Research [IG 10239]	joint Grant CNR-EBRI "Molecular and cellular mechanisms of brain plasticity"; Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This study was partially supported by a joint Grant CNR-EBRI "Molecular and cellular mechanisms of brain plasticity" (AF) and by IG 10239 from Italian Association for Cancer Research (DDB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Belt EJT, 2011, EUR J CANCER, V47, P1837, DOI 10.1016/j.ejca.2011.04.025; BENAVENTE R, 1985, CELL, V41, P177, DOI 10.1016/0092-8674(85)90072-8; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Capo-chichi Callinice D, 2011, Chin J Cancer, V30, P415; Capo-chichi CD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-28; Dorner D, 2007, FEBS J, V274, P1362, DOI 10.1111/j.1742-4658.2007.05695.x; Edsjo A, 2007, SEMIN CANCER BIOL, V17, P248, DOI 10.1016/j.semcancer.2006.04.005; Ellis DJ, 1997, J CELL SCI, V110, P2507; Forloni M, 2010, CANCER RES, V70, P916, DOI 10.1158/0008-5472.CAN-09-2582; Frock RL, 2006, GENE DEV, V20, P486, DOI 10.1101/gad.1364906; Fruci D, 2008, J CELL PHYSIOL, V216, P742, DOI 10.1002/jcp.21454; Goldman Robert D., 2005, V264, P3, DOI 10.1002/0470093765.ch2; Handler A, 2000, J NEUROSCI RES, V60, P311, DOI 10.1002/(SICI)1097-4547(20000501)60:3<311::AID-JNR5>3.0.CO;2-X; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Lammerding Jan, 2005, V264, P264, DOI 10.1002/0470093765.ch18; Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426; Lin F, 1997, EXP CELL RES, V236, P378, DOI 10.1006/excr.1997.3735; Lloyd DJ, 2002, HUM MOL GENET, V11, P769, DOI 10.1093/hmg/11.7.769; McHardy LM, 2005, MOL CANCER THER, V4, P772, DOI 10.1158/1535-7163.MCT-04-0310; Menez J, 2004, ONCOGENE, V23, P2630, DOI 10.1038/sj.onc.1207347; Michalik L, 2007, CELL, V129, P649, DOI 10.1016/j.cell.2007.05.001; Neal CL, 2009, CANCER RES, V69, P3425, DOI 10.1158/0008-5472.CAN-08-2765; Nikolopoulos SN, 2000, ONCOGENE, V19, P380, DOI 10.1038/sj.onc.1203310; PinolRoma S, 1997, SEMIN CELL DEV BIOL, V8, P57, DOI 10.1006/scdb.1996.0122; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Radhakrishnan VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011433; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; RIEMER D, 1995, J CELL SCI, V108, P3189; ROBER RA, 1989, DEVELOPMENT, V105, P365; SCHATTEN G, 1985, P NATL ACAD SCI USA, V82, P4727, DOI 10.1073/pnas.82.14.4727; Schirmer EC, 2008, MUTAT RES-FUND MOL M, V647, P112, DOI 10.1016/j.mrfmmm.2008.07.012; SEEGER RC, 1985, NEW ENGL J MED, V313, P1111, DOI 10.1056/NEJM198510313131802; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Shimada H, 1999, CANCER, V86, P349, DOI 10.1002/(SICI)1097-0142(19990715)86:2<349::AID-CNCR20>3.3.CO;2-P; Shimada H, 2001, CANCER, V92, P2451, DOI 10.1002/1097-0142(20011101)92:9<2451::AID-CNCR1595>3.0.CO;2-S; STICK R, 1985, CELL, V41, P191, DOI 10.1016/0092-8674(85)90073-X; Trisciuoglio D, 2005, J CELL PHYSIOL, V205, P414, DOI 10.1002/jcp.20413; Vlcek S, 2007, BBA-MOL CELL RES, V1773, P661, DOI 10.1016/j.bbamcr.2006.07.002; Willis ND, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002988; Wu ZR, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-8; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234; Yoo BK, 2010, CANCER RES, V70, P3249, DOI 10.1158/0008-5472.CAN-09-4009; Zhang Y, 2010, J INT MED RES, V38, P1042, DOI 10.1177/147323001003800331	44	31	31	7	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45513	10.1371/journal.pone.0045513	http://dx.doi.org/10.1371/journal.pone.0045513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049808	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300029
J	Sato, JR; Hoexter, MQ; Castellanos, XF; Rohde, LA				Sato, Joao Ricardo; Hoexter, Marcelo Queiroz; Castellanos, Xavier Francisco; Rohde, Luis A.			Abnormal Brain Connectivity Patterns in Adults with ADHD: A Coherence Study	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; DEFAULT-MODE; FUNCTIONAL CONNECTIVITY; SUPPORT; NETWORKS; CLASSIFICATION; ADOLESCENTS; PREVALENCE; CHILDREN	Studies based on functional magnetic resonance imaging (fMRI) during the resting state have shown decreased functional connectivity between the dorsal anterior cingulate cortex (dACC) and regions of the Default Mode Network (DMN) in adult patients with Attention-Deficit/Hyperactivity Disorder (ADHD) relative to subjects with typical development (TD). Most studies used Pearson correlation coefficients among the BOLD signals from different brain regions to quantify functional connectivity. Since the Pearson correlation analysis only provides a limited description of functional connectivity, we investigated functional connectivity between the dACC and the posterior cingulate cortex (PCC) in three groups (adult patients with ADHD, n = 21; TD age-matched subjects, n = 21; young TD subjects, n = 21) using a more comprehensive analytical approach - unsupervised machine learning using a one-class support vector machine (OC-SVM) that quantifies an abnormality index for each individual. The median abnormality index for patients with ADHD was greater than for TD age-matched subjects (p = 0.014); the ADHD and young TD indices did not differ significantly (p = 0.480); the median abnormality index of young TD was greater than that of TD age-matched subjects (p = 0.016). Low frequencies below 0.05 Hz and around 0.20 Hz were the most relevant for discriminating between ADHD patients and TD age-matched controls and between the older and younger TD subjects. In addition, we validated our approach using the fMRI data of children publicly released by the ADHD-200 Competition, obtaining similar results. Our findings suggest that the abnormal coherence patterns observed in patients with ADHD in this study resemble the patterns observed in young typically developing subjects, which reinforces the hypothesis that ADHD is associated with brain maturation deficits.	[Sato, Joao Ricardo] Univ Fed ABC, Ctr Math Computat & Cognit, Santo Andre, Brazil; [Sato, Joao Ricardo; Hoexter, Marcelo Queiroz] Univ Fed Sao Paulo, Lab Interdisciplinar Neurociencias Clin, Sao Paulo, Brazil; [Sato, Joao Ricardo; Hoexter, Marcelo Queiroz] Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil; [Rohde, Luis A.] Hosp Clin Porto Alegre, Child & Adolescent Psychiat Div, ADHD Outpatient Program, Porto Alegre, RS, Brazil; [Castellanos, Xavier Francisco] NYU, Ctr Child Study, Phyllis Green & Randolph Cowen Inst Pediat Neuros, New York, NY USA; [Sato, Joao Ricardo; Hoexter, Marcelo Queiroz; Rohde, Luis A.] Inst Nacl Psiquiatria Desenvolvimento, Porto Alegre, RS, Brazil	Universidade Federal do ABC (UFABC); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); New York University	Sato, JR (corresponding author), Univ Fed ABC, Ctr Math Computat & Cognit, Santo Andre, Brazil.	jrsatobr@gmail.com	Hoexter, Marcelo Q/D-7620-2013; Rohde, Luis Augusto P/A-6426-2008; Psiquiatria, Inct/I-1060-2013; Castellanos, Francisco Xavier/K-1892-2014	Hoexter, Marcelo Q/0000-0002-9302-4380; Rohde, Luis Augusto P/0000-0002-4552-4188; Castellanos, Francisco Xavier/0000-0001-9192-9437; Sato, Joao Ricardo/0000-0002-7503-9781	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil; National Institute of Mental Health [R01MH083246]; Novartis; Janssen-Cilag; Abbott; Eli-Lilly; Shire; Bristol-Myers Squibb; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083246] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Novartis(Novartis); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Abbott(Abbott Laboratories); Eli-Lilly(Eli Lilly); Shire; Bristol-Myers Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil. JRS and MQH declared no conflict of interest. XFC received support from National Institute of Mental Health (R01MH083246). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LAR was on the speakers' bureau and/or acted as consultant for Eli-Lilly, Janssen-Cilag, Novartis and Shire in the last three years (less than U$ 10,000 per year and reflecting less than 5% of his gross income per year). He also received travel awards (air tickets + hotel) for taking part of two child psychiatric meetings from Novartis and Janssen-Cilag in 2010. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Abbott, Eli-Lilly, Janssen-Cilag, Novartis, and Shire.; LAR was on the speakers' bureau and/or acted as consultant for Eli-Lilly, Janssen-Cilag, Novartis and Shire in the last three years (less than U$ 10,000 per year and reflecting less than 5% of his gross income per year). He also received travel awards (air tickets + hotel) for taking part in two child psychiatric meetings from Novartis and Janssen-Cilag. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Abbott, Bristol-Myers Squibb, Eli-Lilly, Janssen-Cilag, Novartis, and Shire. None of this research support was used for this specific study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adler L, 2004, PSYCHIAT CLIN N AM, V27, P187, DOI 10.1016/j.psc.2003.12.003; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alderson RM, 2007, J ABNORM CHILD PSYCH, V35, P745, DOI 10.1007/s10802-007-9131-6; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bloomfield P., 1976, Fourier analysis of time series. An introduction; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Bush G, 2005, BIOL PSYCHIAT, V57, P1273, DOI 10.1016/j.biopsych.2005.01.034; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Davis R. A, 1987, TIME SERIES THEORY M; Deragotis LR, 1986, SYMPTOM CHECKLIST 90; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; El-Sayed E, 2003, ACTA PAEDIATR, V92, P776, DOI 10.1080/08035250310002777; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Hardoon DR, 2007, NEUROIMAGE, V37, P1250, DOI 10.1016/j.neuroimage.2007.06.017; Harpin V. A., 2005, ARCH DIS CHILD, V90, P2, DOI DOI 10.1136/ADC.2004.059006; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; KINSBOURNE M, 1973, ANN NY ACAD SCI, V205, P268, DOI 10.1111/j.1749-6632.1973.tb43184.x; LaConte S, 2005, NEUROIMAGE, V26, P317, DOI 10.1016/j.neuroimage.2005.01.048; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mourao-Miranda J, 2011, NEUROIMAGE, V58, P793, DOI 10.1016/j.neuroimage.2011.06.042; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Peters J, 2017, ADAPT COMPUT MACH LE; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rubia K, 1999, AM J PSYCHIAT, V156, P891, DOI 10.1176/ajp.156.6.891; Sakamoto Y, 1986, AKAIKE INFORM CRITER; Sato JR, 2008, NEUROIMAGE, V42, P1473, DOI 10.1016/j.neuroimage.2008.06.024; Sato JR, 2009, NEUROIMAGE, V46, P105, DOI 10.1016/j.neuroimage.2009.01.032; Sato JR, 2009, HUM BRAIN MAPP, V30, P1068, DOI 10.1002/hbm.20569; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Shaw P, 2006, ARCH GEN PSYCHIAT, V63, P540, DOI 10.1001/archpsyc.63.5.540; Song XM, 2009, NEUROIMAGE, V47, P204, DOI 10.1016/j.neuroimage.2009.03.054; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Tax DMJ, 1999, PATTERN RECOGN LETT, V20, P1191, DOI 10.1016/S0167-8655(99)00087-2; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Weissman DH, 2006, NAT NEUROSCI, V9, P971, DOI 10.1038/nn1727; Weissman-Fogel I, 2010, HUM BRAIN MAPP, V31, P1713, DOI 10.1002/hbm.20968; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Yang H, 2011, NEUROSCI LETT, V502, P89, DOI 10.1016/j.neulet.2011.07.028	49	55	61	6	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45671	10.1371/journal.pone.0045671	http://dx.doi.org/10.1371/journal.pone.0045671			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049834	Green Published, gold			2022-12-27	WOS:000309517300042
J	Sung, JM; Lee, CK; Wu-Hsieh, BA				Sung, Jui-Min; Lee, Chien-Kuo; Wu-Hsieh, Betty A.			Intrahepatic Infiltrating NK and CD8 T Cells Cause Liver Cell Death in Different Phases of Dengue Virus Infection	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; MOUSE MODEL; MEDIATED APOPTOSIS; MICE; HEPATOCYTES; CHILDREN; IMMUNOHISTOCHEMISTRY; REPLICATION; LYMPHOCYTES; DISRUPTION	Elevated liver enzyme level is an outstanding feature in patients with dengue. However, the pathogenic mechanism of liver injury has not been clearly demonstrated. In this study, employing a mouse model we aimed to investigate the immunopathogenic mechanism of dengue liver injury. Immunocompetent C57BL/6 mice were infected intravenously with dengue virus strain 16681. Infected mice had transient viremia, detectable viral capsid gene and cleaved caspase 3 in the liver. In the mean time, NK cell and T cell infiltrations peaked at days 1 and 5, respectively. Neutralizing CXCL10 or depletion of Asialo GM1(+) cells reduced cleaved caspase 3 and TUNEL+ cells in the liver at day 1 after infection. CD8(+) T cells infiltrated into the liver at later time point and at which time intrahepatic leukocytes (IHL) exhibited cytotoxicity against DENV-infected targets. Cleaved caspase 3 and TUNEL+ cells were diminished in mice with TCR beta deficiency and in those depleted of CD8(+) T cells, respectively, at day 5 after infection. Moreover, intrahepatic CD8(+) T cells were like their splenic counterparts recognized DENV NS4B(99-107) peptide. Together, these results show that infiltrating NK and CD8(+) T cells cause liver cell death. While NK cells were responsible for cell death at early time point of infection, CD8(+) T cells were for later. CD8(+) T cells that recognize NS4B(99-107) constitute at least one of the major intrahepatic cytotoxic CD8(+) T cell populations.	[Sung, Jui-Min; Lee, Chien-Kuo; Wu-Hsieh, Betty A.] Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan	National Taiwan University	Wu-Hsieh, BA (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Immunol, Taipei 10764, Taiwan.	bwh@ntu.edu.tw	Lee, Chien-Kuo/AAZ-1039-2020	Lee, Chien-Kuo/0000-0001-8189-6045; WU-HSIEH, BETTY AN-YE/0000-0003-1522-2055	National Research Program for Genomic Medicine grants [98, 99, 100-3112-B-002-042]; National Science Council, Republic of China [98-2745-B-002-003]; Natural Health Research Institute [98A1-PDCO-0107094, 99A1-PDCO-0110114]	National Research Program for Genomic Medicine grants; National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Natural Health Research Institute	This work was supported by National Research Program for Genomic Medicine grants (98, 99, 100-3112-B-002-042) and NSC grants (98-2745-B-002-003) from the National Science Council, Republic of China; and Natural Health Research Institute grants (98A1-PDCO-0107094, 99A1-PDCO-0110114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 1999, VIROLOGY, V263, P70, DOI 10.1006/viro.1999.9887; Beatty ME, 2011, AM J TROP MED HYG, V84, P473, DOI 10.4269/ajtmh.2011.10-0521; Beaumier CM, 2010, VIRAL IMMUNOL, V23, P477, DOI 10.1089/vim.2010.0034; Bereczky S, 2010, J GEN VIROL, V91, P1473, DOI 10.1099/vir.0.019034-0; Blaney JE, 2002, VIROLOGY, V300, P125, DOI 10.1006/viro.2002.1528; Chen HC, 2004, J MED VIROL, V73, P419, DOI 10.1002/jmv.20108; Chen JP, 2006, J IMMUNOL, V177, P3185, DOI 10.4049/jimmunol.177.5.3185; Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7; de Macedo FC, 2006, DIAGN MOL PATHOL, V15, P223, DOI 10.1097/01.pdm.0000213462.60645.cd; Franca RFD, 2010, EXP MOL PATHOL, V89, P321, DOI 10.1016/j.yexmp.2010.07.007; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072; He J, 2009, COMP BIOCHEM PHYS B, V153, P216, DOI 10.1016/j.cbpb.2009.03.003; Huerre MR, 2001, VIRCHOWS ARCH, V438, P107; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; KUO CH, 1992, AM J TROP MED HYG, V47, P265, DOI 10.4269/ajtmh.1992.47.265; KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457; Kuruvilla JG, 2007, VIROLOGY, V369, P143, DOI 10.1016/j.virol.2007.06.005; Lee CK, 2000, J IMMUNOL, V165, P3571, DOI 10.4049/jimmunol.165.7.3571; Lee TY, 2009, J HISTOCHEM CYTOCHEM, V57, P469, DOI 10.1369/jhc.2009.952622; Limjindaporn T, 2007, BIOCHEM BIOPH RES CO, V362, P334, DOI 10.1016/j.bbrc.2007.07.194; Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998; Lin YL, 2000, J MED VIROL, V60, P425, DOI 10.1002/(SICI)1096-9071(200004)60:4&lt;425::AID-JMV10&gt;3.0.CO;2-A; Lu MY, 2011, CELL DEATH DIFFER, V18, P925, DOI 10.1038/cdd.2010.160; Marianneau P, 1999, J VIROL, V73, P5201, DOI 10.1128/JVI.73.6.5201-5206.1999; Matsuda T, 2005, J GEN VIROL, V86, P1055, DOI 10.1099/vir.0.80531-0; Nagila A, 2011, BIOCHEM BIOPH RES CO, V410, P428, DOI 10.1016/j.bbrc.2011.05.151; Ochi M, 2004, HEPATOLOGY, V39, P1321, DOI 10.1002/hep.20204; Ozturk B, 2010, J CLIN VIROL, V47, P115, DOI 10.1016/j.jcv.2009.10.015; Paes MV, 2005, VIROLOGY, V338, P236, DOI 10.1016/j.virol.2005.04.042; Quaresma JAS, 2006, VIROLOGY, V345, P22, DOI 10.1016/j.virol.2005.09.058; Rollin PE, 2007, J INFECT DIS, V196, pS364, DOI 10.1086/520613; Ryman KD, 2007, VIROLOGY, V368, P273, DOI 10.1016/j.virol.2007.06.039; Sato K, 2001, EUR J IMMUNOL, V31, P3138, DOI 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B; Souza Luiz José de, 2004, Braz J Infect Dis, V8, P156, DOI 10.1590/S1413-86702004000200006; Suksanpaisan L, 2007, J MED VIROL, V79, P300, DOI 10.1002/jmv.20798; Tan GK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000672; Thongtan T, 2004, J MED VIROL, V72, P436, DOI 10.1002/jmv.20004; Wang WK, 2000, J CLIN MICROBIOL, V38, P3306, DOI 10.1128/JCM.38.9.3306-3310.2000; Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002; Warfield KL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-108; Warfield KL, 2009, J VIROL, V83, P6404, DOI 10.1128/JVI.00126-09; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974	45	36	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46292	10.1371/journal.pone.0046292	http://dx.doi.org/10.1371/journal.pone.0046292			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050007	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300105
J	Wiese, E; Wykowska, A; Zwickel, J; Muller, HJ				Wiese, Eva; Wykowska, Agnieszka; Zwickel, Jan; Mueller, Hermann J.			I See What You Mean: How Attentional Selection Is Shaped by Ascribing Intentions to Others	PLOS ONE			English	Article							VISUAL-ATTENTION; GAZE CUES; SOCIAL COGNITION; MENTAL STATES; ATTRIBUTION; PERCEPTION; MECHANISMS; BELIEFS; BRAIN; EYES	The ability to understand and predict others' behavior is essential for successful interactions. When making predictions about what other humans will do, we treat them as intentional systems and adopt the intentional stance, i.e., refer to their mental states such as desires and intentions. In the present experiments, we investigated whether the mere belief that the observed agent is an intentional system influences basic social attention mechanisms. We presented pictures of a human and a robot face in a gaze cuing paradigm and manipulated the likelihood of adopting the intentional stance by instruction: in some conditions, participants were told that they were observing a human or a robot, in others, that they were observing a human-like mannequin or a robot whose eyes were controlled by a human. In conditions in which participants were made to believe they were observing human behavior (intentional stance likely) gaze cuing effects were significantly larger as compared to conditions when adopting the intentional stance was less likely. This effect was independent of whether a human or a robot face was presented. Therefore, we conclude that adopting the intentional stance when observing others' behavior fundamentally influences basic mechanisms of social attention. The present results provide striking evidence that high-level cognitive processes, such as beliefs, modulate bottom-up mechanisms of attentional selection in a top-down manner.	[Wiese, Eva; Wykowska, Agnieszka; Zwickel, Jan; Mueller, Hermann J.] Univ Munich, Munich, Germany; [Mueller, Hermann J.] Univ London, Birkbeck Coll, London, England	University of Munich; University of London; Birkbeck University London	Wiese, E (corresponding author), Univ Munich, Munich, Germany.	wiese@psy.lmu.de		Wykowska, Agnieszka/0000-0003-3323-7357	German Research Foundation (Deutsche Forschungsgemeinschaft) within the Excellence Cluster Cognition for Technical Systems (CoTeSys) [436]	German Research Foundation (Deutsche Forschungsgemeinschaft) within the Excellence Cluster Cognition for Technical Systems (CoTeSys)	This research was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft [http://www.dfg.de/en/index.jsp]) within the Excellence Cluster Cognition for Technical Systems (CoTeSys [http://www.cotesys.org]), Grant #436, SocGaze. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell F, 2000, COGNITIVE DEV, V15, P1, DOI 10.1016/S0885-2014(00)00014-9; Admoni H., 2011, COGNITIVE SCI, V33, P1983; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; Bayliss AP, 2006, PSYCHOL SCI, V17, P514, DOI 10.1111/j.1467-9280.2006.01737.x; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Dennett DC, 2003, PHILOS MIND CONT REA, P370; Downing PE, 2004, VIS COGN, V11, P71, DOI 10.1080/13506280344000220; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Friesen CK, 2004, J EXP PSYCHOL HUMAN, V30, P319, DOI 10.1037/0096-1523.30.2.319; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Frith CD, 2006, BRAIN RES, V1079, P36, DOI 10.1016/j.brainres.2005.12.126; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; George N, 2008, NEUROPHYSIOL CLIN, V38, P197, DOI 10.1016/j.neucli.2008.03.001; Grezes J, 2004, J NEUROSCI, V24, P5500, DOI 10.1523/JNEUROSCI.0219-04.2004; Grezes J, 2004, NEUROIMAGE, V21, P744, DOI 10.1016/S1053-8119(03)00665-7; Grice Herbert Paul, 1975, SPEECH ACTS, P41, DOI DOI 10.1163/9789004368811_003; Heider F, 1944, AM J PSYCHOL, V57, P246; Hood BM, 1998, PSYCHOL SCI, V9, P131, DOI 10.1111/1467-9280.00024; JONIDES J, 1984, PSYCHOL BULL, V96, P29, DOI 10.1037/0033-2909.96.1.29; Kawai N, 2011, JPN PSYCHOL RES, V53, P292, DOI 10.1111/j.1468-5884.2011.00470.x; Klein AM, 2009, Q J EXP PSYCHOL, V62, P1189, DOI 10.1080/17470210802384214; LESLIE AM, 1988, BRIT J DEV PSYCHOL, V6, P315, DOI 10.1111/j.2044-835X.1988.tb01104.x; Lundqvist D., 1998, KAROLINSKA DIRECTED; Nummenmaa L, 2009, TRENDS COGN SCI, V13, P135, DOI 10.1016/j.tics.2008.12.006; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Quadflieg S, 2004, PSYCHON B REV, V11, P826, DOI 10.3758/BF03196708; Ristic J, 2005, COGNITION, V94, pB55, DOI 10.1016/j.cognition.2004.04.005; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Senju A, 2005, VIS COGN, V12, P127, DOI 10.1080/13506280444000157; Teufel C, 2010, TRENDS COGN SCI, V14, P376, DOI 10.1016/j.tics.2010.05.005; Teufel C, 2010, ATTEN PERCEPT PSYCHO, V72, P695, DOI 10.3758/APP.72.3.695; Teufel C, 2009, CURR BIOL, V19, P1274, DOI 10.1016/j.cub.2009.05.069; Tomasello M., 2010, ORIGINS HUMAN COMMUN; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; Zwickel J, 2009, PSYCHON B REV, V16, P1089, DOI 10.3758/PBR.16.6.1089	40	125	125	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45391	10.1371/journal.pone.0045391	http://dx.doi.org/10.1371/journal.pone.0045391			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049794	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000309517300024
J	Antelo, M; Balaguer, F; Shia, JR; Shen, Y; Hur, K; Moreira, L; Cuatrecasas, M; Bujanda, L; Giraldez, MD; Takahashi, M; Cabanne, A; Barugel, ME; Arnold, M; Roca, EL; Andreu, M; Castellvi-Bel, S; Llor, X; Jover, R; Castells, A; Boland, CR; Goel, A				Antelo, Marina; Balaguer, Francesc; Shia, Jinru; Shen, Yan; Hur, Keun; Moreira, Leticia; Cuatrecasas, Miriam; Bujanda, Luis; Dolores Giraldez, Maria; Takahashi, Masanobu; Cabanne, Ana; Edmundo Barugel, Mario; Arnold, Mildred; Luis Roca, Enrique; Andreu, Montserrat; Castellvi-Bel, Sergi; Llor, Xavier; Jover, Rodrigo; Castells, Antoni; Boland, C. Richard; Goel, Ajay			A High Degree of LINE-1 Hypomethylation Is a Unique Feature of Early-Onset Colorectal Cancer	PLOS ONE			English	Article							REVISED BETHESDA GUIDELINES; ISLAND METHYLATOR PHENOTYPE; MICROSATELLITE INSTABILITY; LYNCH-SYNDROME; CHROMOSOMAL INSTABILITY; DNA HYPOMETHYLATION; YOUNG-PATIENTS; COLON-CANCER; MUTATION; MLH1	Objective: Early-onset colorectal cancer (CRC) represents a clinically distinct form of CRC that is often associated with a poor prognosis. Methylation levels of genomic repeats such as LINE-1 elements have been recognized as independent factors for increased cancer-related mortality. The methylation status of LINE-1 elements in early-onset CRC has not been analyzed previously. Design: We analyzed 343 CRC tissues and 32 normal colonic mucosa samples, including 2 independent cohorts of CRC diagnosed <= 50 years old (n = 188), a group of sporadic CRC >50 years (MSS n = 89; MSI n = 46), and a group of Lynch syndrome CRCs (n = 20). Tumor mismatch repair protein expression, microsatellite instability status, LINE-1 and MLH1 methylation, somatic BRAF V600E mutation, and germline MUTYH mutations were evaluated. Results: Mean LINE-1 methylation levels (+/- SD) in the five study groups were early-onset CRC, 56.6% (8.6); sporadic MSI, 67.1% (5.5); sporadic MSS, 65.1% (6.3); Lynch syndrome, 66.3% (4.5) and normal mucosa, 76.5% (1.5). Early-onset CRC had significantly lower LINE-1 methylation than any other group (p<0.0001). Compared to patients with <65% LINE-1 methylation in tumors, those with >= 65% LINE-1 methylation had significantly better overall survival (p = 0.026, log rank test). Conclusions: LINE-1 hypomethylation constitutes a potentially important feature of early-onset CRC, and suggests a distinct molecular subtype. Further studies are needed to assess the potential of LINE-1 methylation status as a prognostic biomarker for young people with CRC.	[Balaguer, Francesc; Shen, Yan; Hur, Keun; Takahashi, Masanobu; Arnold, Mildred; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Dept Internal Med, Div Gastroenterol,Charles A Sammons Canc Ctr, Dallas, TX USA; [Antelo, Marina; Cabanne, Ana; Edmundo Barugel, Mario; Luis Roca, Enrique] Hosp Gastroenterol Dr CB Udaondo, Pathol Sect, Buenos Aires, DF, Argentina; [Antelo, Marina; Cabanne, Ana; Edmundo Barugel, Mario; Luis Roca, Enrique] Hosp Gastroenterol Dr CB Udaondo, Oncol Sect, Buenos Aires, DF, Argentina; [Balaguer, Francesc; Shen, Yan; Hur, Keun; Takahashi, Masanobu; Arnold, Mildred; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Dallas, TX USA; [Balaguer, Francesc; Moreira, Leticia; Cuatrecasas, Miriam; Dolores Giraldez, Maria; Castellvi-Bel, Sergi; Castells, Antoni] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Dept Gastroenterol,Hosp Clin, Barcelona, Catalonia, Spain; [Shia, Jinru] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Bujanda, Luis] Univ Basque Country, Donostia Hosp, CIBERehd, Dept Gastroenterol, San Sebastian, Spain; [Andreu, Montserrat] Hosp Mar, Deparment Gastroenterol, Barcelona, Spain; [Llor, Xavier] Univ Illinois, Dept Med, Chicago, IL USA; [Llor, Xavier] Univ Illinois, Ctr Canc, Chicago, IL USA; [Jover, Rodrigo] Hosp Gen Univ, Gastroenterol Unit, Alicante, Spain	Baylor University; Baylor University Medical Center; Baylor Scott & White Health; Baylor University; Baylor University Medical Center; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Memorial Sloan Kettering Cancer Center; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University Hospital Donostia; University of Basque Country; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; General University Hospital of Alicante	Balaguer, F (corresponding author), Baylor Univ, Med Ctr, Dept Internal Med, Div Gastroenterol,Charles A Sammons Canc Ctr, Dallas, TX USA.	fprunes@clinic.ub.es; ajay.goel@baylorhealth.edu	Moreira, Leticia/AAN-9863-2021; Andreu, Montserrat/D-9911-2015; Cuatrecasas, Miriam/C-9156-2019; Jover, Rodrigo/ABC-3258-2021; BALAGUER, FRANCESC/G-2389-2016; Bujanda, Luis/AAB-2485-2021; Castells, Antoni/ABC-1002-2021; Giraldez, Maria D/E-7395-2018; Balaguer, Francesc/GPX-7801-2022	Moreira, Leticia/0000-0002-4518-8591; Andreu, Montserrat/0000-0003-4286-1098; Cuatrecasas, Miriam/0000-0003-3063-0110; Jover, Rodrigo/0000-0003-3742-3413; Bujanda, Luis/0000-0002-4353-9968; Castells, Antoni/0000-0001-8431-2033; Giraldez, Maria D/0000-0001-6829-7603; Goel, Ajay/0000-0003-1396-6341; Balaguer, Francesc/0000-0002-0206-0539; Hur, Keun/0000-0002-6944-2718; Shia, Jinru/0000-0002-4351-2511; Castellvi-Bel, Sergi/0000-0003-1217-5097	National Cancer Institute, National Institutes of Health [R01 CA72851, CA129286]; Baylor Research Institute; Fundacion Alfonso Martin Escudero; Instituto de Salud Carlos III [PI10/00384]; CONICET (National Council of Scientific and Technical Investigations); Argentine Ministry of Science and Technology; NATIONAL CANCER INSTITUTE [R01CA129286, R01CA072851] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; Fundacion Alfonso Martin Escudero; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); CONICET (National Council of Scientific and Technical Investigations); Argentine Ministry of Science and Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grants R01 CA72851 and CA129286 from the National Cancer Institute, National Institutes of Health; and funds from the Baylor Research Institute to CRB and AG. FB was supported by a grant from Fundacion Alfonso Martin Escudero and from Instituto de Salud Carlos III (PI10/00384). MA was supported by a "Type I Postgraduate Scholarship" given by the CONICET (National Council of Scientific and Technical Investigations) dependent on the Argentine Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Baba Y, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-125; Balaguer F, 2007, CLIN GASTROENTEROL H, V5, P379, DOI 10.1016/j.cgh.2006.12.025; Boardman LA, 2007, CLIN CANCER RES, V13, P2323, DOI 10.1158/1078-0432.CCR-06-2739; Boland CR, 2010, GASTROENTEROLOGY, V138, p[2197, e2191]; Chan TL, 2001, ONCOGENE, V20, P4871, DOI 10.1038/sj.onc.1204653; Giraldez MD, 2010, CLIN CANCER RES, V16, P5402, DOI 10.1158/1078-0432.CCR-10-1491; Dozois EJ, 2008, MEDICINE, V87, P259, DOI 10.1097/MD.0b013e3181881354; Estecio MRH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000399; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; FEINBERG AP, 1988, CANCER RES, V48, P1159; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Goel A, 2010, CLIN GASTROENTEROL H, V8, P966, DOI 10.1016/j.cgh.2010.06.030; Goel A, 2010, GASTROENTEROLOGY, V138, P1854, DOI 10.1053/j.gastro.2010.01.035; Goel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009393; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Jarvinen HJ, 2009, J CLIN ONCOL, V27, P4793, DOI 10.1200/JCO.2009.23.7784; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Karpf AR, 2005, CANCER RES, V65, P8635, DOI 10.1158/0008-5472.CAN-05-1961; Kastrinos F, 2011, GASTROENTEROLOGY, V140, P73, DOI 10.1053/j.gastro.2010.08.021; Lindor NM, 2006, JAMA-J AM MED ASSOC, V296, P1507, DOI 10.1001/jama.296.12.1507; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; Ogino S, 2008, INT J CANCER, V122, P2767, DOI 10.1002/ijc.23470; Ogino S, 2008, J NATL CANCER I, V100, P1734, DOI 10.1093/jnci/djn359; Ollikainen M, 2007, ONCOGENE, V26, P4541, DOI 10.1038/sj.onc.1210236; Pinol V, 2005, JAMA-J AM MED ASSOC, V293, P1986, DOI 10.1001/jama.293.16.1986; Rahner N, 2008, J PATHOL, V214, P10, DOI 10.1002/path.2263; Rodriguez J, 2006, CANCER RES, V66, P8462, DOI 10.1158/0008-5472.CAN-06-0293; Shahrzad S, 2007, EPIGENETICS-US, V2, P119, DOI 10.4161/epi.2.2.4613; Siegel RL, 2009, CANCER EPIDEM BIOMAR, V18, P1695, DOI 10.1158/1055-9965.EPI-09-0186; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wolff EM, PLOS GENET, V6; Yamada Y, 2005, P NATL ACAD SCI USA, V102, P13580, DOI 10.1073/pnas.0506612102; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032	39	131	136	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45357	10.1371/journal.pone.0045357	http://dx.doi.org/10.1371/journal.pone.0045357			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049789	gold, Green Submitted, Green Published			2022-12-27	WOS:000309556100040
J	Behrens, JW; Axelsson, M; Neuenfeldt, S; Seth, H				Behrens, Jane W.; Axelsson, Michael; Neuenfeldt, Stefan; Seth, Henrik			Effects of Hypoxic Exposure during Feeding on SDA and Postprandial Cardiovascular Physiology in the Atlantic Cod, Gadus morhua	PLOS ONE			English	Article							GASTROINTESTINAL BLOOD-FLOW; DYNAMIC ACTION; OXYGEN-CONSUMPTION; PROTEIN-SYNTHESIS; BALTIC SEA; TEMPERATURE; RESPONSES; RECOVERY; LEVEL	Some Atlantic cod in the Bornholm Basin undertake vertical foraging migrations into severely hypoxic bottom water. Hypoxic conditions can reduce the postprandial increase in gastrointestinal blood flow (GBF). This could subsequently postpone or reduce the postprandial increase in oxygen consumption (MO2), i.e. the SDA, leading to a disturbed digestion. Additionally, a restricted oxygen uptake could result in an oxygen debt that needs to be compensated for upon return to normoxic waters and this may also affect the ability to process the food. Long-term cardio-respiratory measurements were made on fed G. morhua in order to understand how the cardio-respiratory system of feeding fish respond to a period of hypoxia and a subsequent return to normoxia. These were exposed to 35% water oxygen saturation for 90 minutes, equivalent to the time and oxygen level cod voluntarily endure when searching for food in the Bornholm Basin. We found that i) gastric and intestinal blood flows, cardiac output and MO2 increased after feeding, ii) gastric and intestinal blood flows were spared in hypoxia, and iii) there were no indications of an oxygen debt at the end of the hypoxic period. The magnitude and time course of the measured variables are similar to values obtained from fish not exposed to the hypoxic period. In conclusion, when cod in the field search for and ingest prey under moderate hypoxic conditions they appear to stay within safe limits of oxygen availability as we saw no indications of an oxygen debt, or negative influence on digestive capacity, when simulating field observations.	[Behrens, Jane W.; Neuenfeldt, Stefan] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Axelsson, Michael; Seth, Henrik] Univ Gothenburg, Dept Biol & Environm Sci, Gothenburg, Sweden; [Seth, Henrik] Univ Gothenburg, Dept Neurosci & Physiol, Gothenburg, Sweden	Technical University of Denmark; University of Gothenburg; University of Gothenburg	Behrens, JW (corresponding author), Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark.	jabeh@aqua.dtu.dk	Axelsson, Michael/D-1412-2009	Axelsson, Michael/0000-0002-7839-3233; Neuenfeldt, Stefan/0000-0001-8574-3257; Behrens, Jane Windfeldt/0000-0002-0136-9681	Carlsberg Foundation [2008_01_0388]	Carlsberg Foundation(Carlsberg Foundation)	The study was financially supported by a post doc stipend [grant number 2008_01_0388] from the Carlsberg Foundation to Jane W. Behrens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen NG, 2001, J FISH BIOL, V59, P1198, DOI 10.1006/jfbi.2001.1731; AXELSSON M, 1991, J EXP BIOL, V158, P181; Axelsson M, 2000, J COMP PHYSIOL B, V170, P145, DOI 10.1007/s003600050269; Axelsson M, 2002, J EXP BIOL, V205, P2891; Behrens JW, 2011, LAB ANIM-UK, V45, P240, DOI 10.1258/la.2011.011013; BROWN CR, 1991, PHYSIOL ZOOL, V64, P276, DOI 10.1086/physzool.64.1.30158524; BROWN CR, 1991, PHYSIOL ZOOL, V64, P298, DOI 10.1086/physzool.64.1.30158525; Carter C.G., 2001, Fish Physiology, V20, P31; Conley DJ, 2002, ENVIRON SCI TECHNOL, V36, P5315, DOI 10.1021/es025763w; Dupont-Prinet A, 2009, COMP BIOCHEM PHYS A, V154, P233, DOI 10.1016/j.cbpa.2009.06.015; Eliason EJ, 2008, COMP BIOCHEM PHYS A, V149, P380, DOI 10.1016/j.cbpa.2008.01.033; Farrell AP, 2001, COMP BIOCHEM PHYS A, V128, P551, DOI 10.1016/S1095-6433(00)00335-4; FRITSCHE R, 1993, RESP PHYSIOL, V94, P173, DOI 10.1016/0034-5687(93)90046-D; Gamperl AK, 2009, FISH PHYSIOL, V27, P301, DOI 10.1016/S1546-5098(08)00007-1; Gnaiger E., 1983, CALCULATION ENERGETI, P337, DOI [10.1007/978-3-642-81863-9_30, DOI 10.1007/978-3-642-81863-9_30]; Grans A, 2009, HYDROBIOLOGIA, V619, P11, DOI 10.1007/s10750-008-9578-7; Grans A, 2010, J EXP BIOL, V213, P3198, DOI 10.1242/jeb.043570; Jordan AD, 2007, PHYSIOL BIOCHEM ZOOL, V80, P178, DOI 10.1086/510565; Lewis JM, 2007, J EXP BIOL, V210, P1935, DOI 10.1242/jeb.005371; McKenzie DJ, 2009, COMP BIOCHEM PHYS A, V153, P332, DOI 10.1016/j.cbpa.2009.03.009; Neuenfeldt S, 2003, J FISH BIOL, V62, P168, DOI 10.1046/j.1095-8649.2003.00013.x; Neuenfeldt S, 2009, J FISH BIOL, V75, P290, DOI 10.1111/j.1095-8649.2009.02281.x; Perez-Casanova JC, 2010, AQUAC RES, V41, P198, DOI 10.1111/j.1365-2109.2009.02318.x; Plante S, 1998, J FISH BIOL, V53, P1342, DOI 10.1006/jfbi.1998.0798; PRIEDE IG, 1977, NATURE, V267, P610, DOI 10.1038/267610a0; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; SCHURMANN H, 1992, J FISH BIOL, V41, P927, DOI 10.1111/j.1095-8649.1992.tb02720.x; Schurmann H, 1997, J FISH BIOL, V50, P1166, DOI 10.1006/jfbi.1997.0387; Secor SM, 2009, J COMP PHYSIOL B, V179, P1, DOI 10.1007/s00360-008-0283-7; Seth H, 2008, AM J PHYSIOL-REG I, V294, pR1648, DOI 10.1152/ajpregu.00900.2007; Seth H, 2011, FISH PHYSIOL, V30, P351, DOI 10.1016/S1546-5098(10)03009-8; Seth H, 2010, J EXP BIOL, V213, P3118, DOI 10.1242/jeb.043612; Seth H, 2010, AM J PHYSIOL-REG I, V298, pR1240, DOI 10.1152/ajpregu.00781.2009; STEFFENSEN JF, 1994, POLAR BIOL, V14, P49; Svendsen JC, 2012, CAN J ZOOL, V90, P1, DOI [10.1139/z11-095, 10.1139/Z11-095]; Thorarensen H, 1994, THESIS S FRASER U BU; Thuy NH, 2010, J FISH BIOL, V76, P1025, DOI 10.1111/j.1095-8649.2009.02533.x	37	12	12	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46227	10.1371/journal.pone.0046227	http://dx.doi.org/10.1371/journal.pone.0046227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049987	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100160
J	Burgess, AP				Burgess, Adrian P.			Towards a Unified Understanding of Event-Related Changes in the EEG: The Firefly Model of Synchronization through Cross-Frequency Phase Modulation	PLOS ONE			English	Article							EVOKED-RESPONSES; RECOGNITION MEMORY; THETA OSCILLATIONS; BRAIN OSCILLATIONS; DYNAMICS; WAVES; GAMMA; DECOMPOSITION; HIPPOCAMPUS; MECHANISM	Although event-related potentials (ERPs) are widely used to study sensory, perceptual and cognitive processes, it remains unknown whether they are phase-locked signals superimposed upon the ongoing electroencephalogram (EEG) or result from phase-alignment of the EEG. Previous attempts to discriminate between these hypotheses have been unsuccessful but here a new test is presented based on the prediction that ERPs generated by phase-alignment will be associated with event-related changes in frequency whereas evoked-ERPs will not. Using empirical mode decomposition (EMD), which allows measurement of narrow-band changes in the EEG without predefining frequency bands, evidence was found for transient frequency slowing in recognition memory ERPs but not in simulated data derived from the evoked model. Furthermore, the timing of phase-alignment was frequency dependent with the earliest alignment occurring at high frequencies. Based on these findings, the Firefly model was developed, which proposes that both evoked and induced power changes derive from frequency-dependent phase-alignment of the ongoing EEG. Simulated data derived from the Firefly model provided a close match with empirical data and the model was able to account for i) the shape and timing of ERPs at different scalp sites, ii) the event-related desynchronization in alpha and synchronization in theta, and iii) changes in the power density spectrum from the pre-stimulus baseline to the post-stimulus period. The Firefly Model, therefore, provides not only a unifying account of event-related changes in the EEG but also a possible mechanism for cross-frequency information processing.	Aston Univ, Aston Brain Ctr, Birmingham B4 7ET, W Midlands, England	Aston University	Burgess, AP (corresponding author), Aston Univ, Aston Brain Ctr, Birmingham B4 7ET, W Midlands, England.	a.p.burgess@aston.ac.uk		Burgess, Adrian P/0000-0002-0977-8105				Basar E, 1980, EEG BRAIN DYNAMICS R, pxxi; Burgess AP, 1997, NEUROREPORT, V8, P1039, DOI 10.1097/00001756-199703030-00044; Burgess AP, 2002, INT J PSYCHOPHYSIOL, V46, P91, DOI 10.1016/S0167-8760(02)00108-3; Burgess AP, 2000, PSYCHOPHYSIOLOGY, V37, P596, DOI 10.1017/S0048577200981356; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cong Fengyu, 2009, Nonlinear Biomed Phys, V3, P1, DOI 10.1186/1753-4631-3-1; Fingelkurts Andrew A, 2008, Open Neuroimag J, V2, P73, DOI 10.2174/1874440000802010073; Flandrin P, 2004, IEEE SIGNAL PROC LET, V11, P112, DOI 10.1109/LSP.2003.821662; Geisler C, 2010, P NATL ACAD SCI USA, V107, P7957, DOI 10.1073/pnas.0912478107; Haken H, 1983, SYNERGETICS INTRO NO, pxiv; Heckenlively JR, 2006, PRINCIPLES PRACTICE, pxxii; Huang NE, 2005, INTERD MATH SCI, V5, P1; HUGHES JR, 1995, CLIN ELECTROENCEPHAL, V26, P1, DOI 10.1177/155005949502600103; KALCHER J, 1995, ELECTROEN CLIN NEURO, V94, P381, DOI 10.1016/0013-4694(95)00040-6; Klimesch W, 2006, NEUROIMAGE, V29, P808, DOI 10.1016/j.neuroimage.2005.08.041; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2007, NEUROSCI BIOBEHAV R, V31, P1003, DOI 10.1016/j.neubiorev.2007.03.005; Klimesch W, 2007, J NEUROPHYSIOL, V97, P1311, DOI 10.1152/jn.00876.2006; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lobaugh NJ, 2001, PSYCHOPHYSIOLOGY, V38, P517, DOI 10.1017/S0048577201991681; Luo JW, 2006, PROG NAT SCI-MATER, V16, P942; Makeig S, 2002, SCIENCE, V295, P690, DOI 10.1126/science.1066168; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Mazaheri A, 2008, J NEUROSCI, V28, P7781, DOI 10.1523/JNEUROSCI.1631-08.2008; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Nikulin VV, 2007, EUR J NEUROSCI, V25, P3146, DOI 10.1111/j.1460-9568.2007.05553.x; Nunez PL, 2000, BEHAV BRAIN SCI, V23, P371, DOI 10.1017/S0140525X00003253; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Pfurtscheller G, 1999, J CLIN NEUROPHYSIOL, V16, P512, DOI 10.1097/00004691-199911000-00003; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pletzer B, 2010, BRAIN RES, V1335, P91, DOI 10.1016/j.brainres.2010.03.074; Ritter P, 2009, NEUROIMAGE, V47, P1, DOI 10.1016/j.neuroimage.2009.04.031; Roopun AK, 2008, FRONT NEUROSCI-SWITZ, V2, P145, DOI 10.3389/neuro.01.034.2008; Sauseng P, 2007, NEUROSCIENCE, V146, P1435, DOI 10.1016/j.neuroscience.2007.03.014; SAYERS BMA, 1974, NATURE, V247, P481, DOI 10.1038/247481a0; Schack B, 2002, INT J PSYCHOPHYSIOL, V44, P143, DOI 10.1016/S0167-8760(01)00199-4; Soltani Maryam, 2000, Critical Reviews in Neurobiology, V14, P199; VAKMAN DE, 1977, USP FIZ NAUK+, V123, P657; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wilding EL, 2006, CLIN EEG NEUROSCI, V37, P315, DOI 10.1177/155005940603700409; Wu ZH, 2004, P ROY SOC A-MATH PHY, V460, P1597, DOI 10.1098/rspa.2003.1221; Yeung N, 2004, PSYCHOPHYSIOLOGY, V41, P822, DOI 10.1111/j.1469-8986.2004.00239.x	46	35	35	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45630	10.1371/journal.pone.0045630	http://dx.doi.org/10.1371/journal.pone.0045630			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049827	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100061
J	Garzon-Ospina, D; Lopez, C; Forero-Rodriguez, J; Patarroyo, MA				Garzon-Ospina, Diego; Lopez, Carolina; Forero-Rodriguez, Johanna; Patarroyo, Manuel A.			Genetic Diversity and Selection in Three Plasmodium vivax Merozoite Surface Protein 7 (Pvmsp-7) Genes in a Colombian Population	PLOS ONE			English	Article							MALARIA PARASITE; POSITIVE SELECTION; INTRAGENIC RECOMBINATION; STATISTICAL TESTS; DEATH EVOLUTION; FAMILY; CONVERSION; ANTIGENS; VACCINE; IDENTIFICATION	A completely effective vaccine for malaria (one of the major infectious diseases worldwide) is not yet available; different membrane proteins involved in parasite-host interactions have been proposed as candidates for designing it. It has been found that proteins encoded by the merozoite surface protein (msp)-7 multigene family are antibody targets in natural infection; the nucleotide diversity of three Pvmsp-7 genes was thus analyzed in a Colombian parasite population. By contrast with P. falciparum msp-7 loci and ancestral P. vivax msp-7 genes, specie-specific duplicates of the latter specie display high genetic variability, generated by single nucleotide polymorphisms, repeat regions, and recombination. At least three major allele types are present in Pvmsp-7C, Pvmsp-7H and Pvmsp-7I and positive selection seems to be operating on the central region of these msp-7 genes. Although this region has high genetic polymorphism, the C-terminus (Pfam domain ID: PF12948) is conserved and could be an important candidate when designing a subunit-based antimalarial vaccine.	[Garzon-Ospina, Diego; Lopez, Carolina; Forero-Rodriguez, Johanna; Patarroyo, Manuel A.] Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia; [Garzon-Ospina, Diego; Lopez, Carolina] Univ Nacl Colombia, Microbiol Postgrad Program, Bogota, Colombia; [Garzon-Ospina, Diego; Lopez, Carolina; Patarroyo, Manuel A.] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia	Universidad Nacional de Colombia; Universidad del Rosario	Patarroyo, MA (corresponding author), Fdn Inst Inmunol Colombia FIDIC, Bogota, Colombia.	mapatarr.fidic@gmail.com	Garzón-Ospina, Diego/L-8585-2016; López-Santana, Carolina/L-8580-2016; Garzón-Ospina, Diego/AFS-7704-2022; Patarroyo, Manuel A/I-8046-2016	Garzón-Ospina, Diego/0000-0003-3829-6719; López-Santana, Carolina/0000-0003-1313-7607; Patarroyo, Manuel A/0000-0002-4751-2500				Andrews TD, 2004, GENETICS, V166, P25, DOI 10.1534/genetics.166.1.25; Anisimova M, 2003, GENETICS, V164, P1229; Betran E, 1997, GENETICS, V146, P89; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carvalho LJM, 2002, SCAND J IMMUNOL, V56, P327, DOI 10.1046/j.1365-3083.2002.01160.x; Chen JH, 2010, J PROTEOME RES, V9, P6479, DOI 10.1021/pr100705g; Cifuentes G, 2008, MED CHEM, V4, P278, DOI 10.2174/157340608784325160; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Figtree M, 2000, MOL BIOCHEM PARASIT, V108, P53, DOI 10.1016/S0166-6851(00)00204-8; Fu YX, 1997, GENETICS, V147, P915; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Garcia Y, 2007, J MED CHEM, V50, P5665, DOI 10.1021/jm070773z; Garzon-Ospina D, 2011, INFECT GENET EVOL, V11, P528, DOI 10.1016/j.meegid.2010.12.002; Garzon-Ospina D, 2010, MOL PHYLOGENET EVOL, V55, P399, DOI 10.1016/j.ympev.2010.02.017; Genton B, 2007, CURR OPIN INFECT DIS, V20, P467, DOI 10.1097/QCO.0b013e3282dd7a29; Gomez A, 2006, PARASITOLOGY, V133, P661, DOI 10.1017/S0031182006001168; Guerra CA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000774; HUDSON RR, 1985, GENETICS, V111, P147; Imwong M, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-20; Jorda J, 2009, BIOINFORMATICS, V25, P2632, DOI 10.1093/bioinformatics/btp482; Kadekoppala M, 2010, INT J PARASITOL, V40, P1155, DOI 10.1016/j.ijpara.2010.04.008; Kadekoppala M, 2008, EUKARYOT CELL, V7, P2123, DOI 10.1128/EC.00274-08; Katju V, 2003, GENETICS, V165, P1793; Kelly JK, 1997, GENETICS, V146, P1197; Kimura M., 1983, NEUTRAL THEORY MOL E; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; Pond SLK, 2006, PLOS COMPUT BIOL, V2, P530, DOI 10.1371/journal.pcbi.0020062; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lysenko AJ, 1968, MED GEOGRAPHY MED GE; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martinez O, 2004, PARASITOLOGY, V128, P353, DOI 10.1017/S0031182003004773; Martinez Pilar, 2005, Infection Genetics and Evolution, V5, P354, DOI 10.1016/j.meegid.2004.12.001; Mascorro CN, 2005, PARASITOLOGY, V131, P25, DOI 10.1017/S0031182005007547; Mello K, 2004, INFECT IMMUN, V72, P1010, DOI 10.1128/IAI.72.2.1010-1018.2004; Mello K, 2002, EUKARYOT CELL, V1, P915, DOI 10.1128/EC.1.6.915-925.2002; Mongui A, 2006, BIOCHEM BIOPH RES CO, V351, P639, DOI 10.1016/j.bbrc.2006.10.082; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nei M, 2000, P NATL ACAD SCI USA, V97, P10866, DOI 10.1073/pnas.97.20.10866; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Orsi RH, 2007, MICROBIOL-SGM, V153, P2666, DOI 10.1099/mic.0.2007/007310-0; Pachebat JA, 2001, MOL BIOCHEM PARASIT, V117, P83, DOI 10.1016/S0166-6851(01)00336-X; Patarroyo ME, 2008, ACCOUNTS CHEM RES, V41, P377, DOI 10.1021/ar700120t; Peek AS, 2001, J MOL EVOL, V52, P193, DOI 10.1007/s002390010148; Poespoprodjo JR, 2009, CLIN INFECT DIS, V48, P1704, DOI 10.1086/599041; Polley SD, 2001, GENETICS, V158, P1505; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Putaporntip C, 2000, MOL BIOCHEM PARASIT, V109, P111, DOI 10.1016/S0166-6851(00)00238-3; Putaporntip C, 2010, GENE, V456, P24, DOI 10.1016/j.gene.2010.02.007; Putaporntip C, 2009, INFECT GENET EVOL, V9, P821, DOI 10.1016/j.meegid.2009.04.017; Richie TL, 2002, NATURE, V415, P694, DOI 10.1038/415694a; Roy SW, 2009, GENE, V443, P12, DOI 10.1016/j.gene.2009.05.007; Rozas J, 2001, GENETICS, V158, P1147; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Semple C, 1999, J MOL EVOL, V48, P555, DOI 10.1007/PL00006498; Suarez CF, 2006, IMMUNOGENETICS, V58, P542, DOI 10.1007/s00251-006-0127-0; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tetteh KKA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005568; Tewari R, 2005, BLOOD, V105, P394, DOI 10.1182/blood-2004-06-2106; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; Trucco C, 2001, MOL BIOCHEM PARASIT, V112, P91, DOI 10.1016/S0166-6851(00)00350-9; Wang L, 2003, PARASITE IMMUNOL, V25, P403, DOI 10.1111/j.1365-3024.2003.00647.x; Woehlbier U, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-77; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708	70	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45962	10.1371/journal.pone.0045962	http://dx.doi.org/10.1371/journal.pone.0045962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049905	gold, Green Published, Green Accepted			2022-12-27	WOS:000309556100109
J	Simone, R; Tenca, C; Fais, F; Luciani, M; De Rossi, G; Pesce, G; Bagnasco, M; Saverino, D				Simone, Rita; Tenca, Claudya; Fais, Franco; Luciani, Matteo; De Rossi, Giulio; Pesce, Giampaola; Bagnasco, Marcello; Saverino, Daniele			A Soluble Form of CTLA-4 Is Present in Paediatric Patients with Acute Lymphoblastic Leukaemia and Correlates with CD1d(+) Expression	PLOS ONE			English	Article							COSTIMULATORY MOLECULES CTLA-4; ACUTE MYELOID-LEUKEMIA; T-CELL-ACTIVATION; CLINICAL-SIGNIFICANCE; NEGATIVE REGULATION; IMMUNE-RESPONSE; ANTIGEN 4; IN-VIVO; CD86; SERUM	CTLA-4 is a key factor in regulating and maintaining self tolerance, providing a negative signal to the T cell and thus limiting immune responses. Several polymorphisms within the CTLA-4 gene have been associated with an increased risk of developing autoimmune diseases and, very recently, with susceptibility to human cancer. Acute lymphoblastic leukemia is a clonal disorder of lymphoid progenitors representing the most frequent malignancy of childhood. Here, we show the presence at significantly elevated levels of a circulating soluble form of CTLA-4 in 70% of B-ALL pediatric patients with active disease, the positive correlation between the percentage of leukemic B lymphocytes and the amount of serum sCTLA-4, and the expression of sCTLA-4 transcript by B cells in patients. Finally, a correlation between CD1d expression (a negative prognostic marker) and the sCTLA-4 in B-ALL patients was observed. This suggests a possible role of this soluble molecule as a marker of progression or severity of the neoplastic disease.	[Simone, Rita; Tenca, Claudya; Fais, Franco; Saverino, Daniele] Univ Genoa, Sect Human Anat, Dept Expt Med, Genoa, Italy; [Simone, Rita] N Shore LIJ Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Luciani, Matteo; De Rossi, Giulio] Bambino Gesu Pediat Hosp, Dept Pediat Haematol & Oncol, Rome, Italy; [Pesce, Giampaola; Bagnasco, Marcello] Univ Genoa, Dept Internal Med, Med & Radiometabol Therapy Unit, I-16126 Genoa, Italy	University of Genoa; Northwell Health; IRCCS Bambino Gesu; University of Genoa	Saverino, D (corresponding author), Univ Genoa, Sect Human Anat, Dept Expt Med, Genoa, Italy.	daniele.saverino@unige.it	Luciani, Matteo/AAB-3162-2020; Fais, Franco/K-1096-2016; Saverino, Daniele/I-4741-2014; FAIS, FRANCO/AAG-3069-2021	Fais, Franco/0000-0002-6643-7083; FAIS, FRANCO/0000-0002-6643-7083; Pesce, Giampaola/0000-0002-6294-9110	Fondazione CARIGE; Associazione "Davide Ciavattini'' Onlus	Fondazione CARIGE(Fondazione Carige); Associazione "Davide Ciavattini'' Onlus	This work was supported by grants from Fondazione CARIGE and from Associazione "Davide Ciavattini'' Onlus. Fondazione CARIGE as well as Associazione "Davide Ciavattini'' Onlus had no involvement in study design, nor in the collection, analysis and interpretation of data, nor in the writing of the report and in the decision to submit the paper for publication.	Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Caligaris-Cappio F, 2003, ATLAS BLOOD CELLS FU, V2, P567; Carroll William L, 2003, Hematology Am Soc Hematol Educ Program, P102; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chikuma S, 2003, J EXP MED, V197, P129, DOI 10.1084/jem.20021646; Contardi E, 2005, INT J CANCER, V117, P538, DOI 10.1002/ijc.21155; Eguchi M, 2003, INT J HEMATOL, V78, P390, DOI 10.1007/BF02983811; Fais F, 2005, LEUKEMIA, V19, P551, DOI 10.1038/sj.leu.2403671; Greenwald RJ, 2002, EUR J IMMUNOL, V32, P366, DOI 10.1002/1521-4141(200202)32:2<366::AID-IMMU366>3.0.CO;2-5; Gu X, 2010, HUM IMMUNOL, V71, P83, DOI 10.1016/j.humimm.2009.09.353; Hock BD, 2006, BRIT J HAEMATOL, V133, P165, DOI 10.1111/j.1365-2141.2006.05983.x; Hock BD, 2004, LEUKEMIA LYMPHOMA, V45, P2111, DOI 10.1080/10428190410001712199; Hock BD, 2003, CANCER, V98, P1681, DOI 10.1002/cncr.11693; Hock BD, 2002, LEUKEMIA, V16, P865, DOI 10.1038/sj.leu.2402466; Hou RP, 2010, MOL BIOL REP, V37, P515, DOI 10.1007/s11033-009-9705-1; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Laurent S, 2010, HUM IMMUNOL, V71, P934, DOI 10.1016/j.humimm.2010.07.007; Levings MK, 2002, J EXP MED, V196, P1335, DOI 10.1084/jem.20021139; Masteller EL, 2000, J IMMUNOL, V164, P5319, DOI 10.4049/jimmunol.164.10.5319; Merlo A, 2005, CLIN DIAGN LAB IMMUN, V12, P705, DOI 10.1128/CDLI.12.6.705-712.2005; Oaks MK, 2000, J IMMUNOL, V164, P5015, DOI 10.4049/jimmunol.164.10.5015; Pawlak E, 2010, HUM IMMUNOL, V71, P195, DOI 10.1016/j.humimm.2009.11.006; Perez-Garcia A, 2009, LEUKEMIA, V23, P486, DOI 10.1038/leu.2008.339; Pistillo MP, 2003, BLOOD, V101, P202, DOI 10.1182/blood-2002-06-1668; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; PUROHIT S, 2005, J AUTOIMMUNE DIS, V31, P2; Qi P, 2010, INT J COLORECTAL DIS, V25, P39, DOI 10.1007/s00384-009-0806-z; Saito T, 1998, CURR OPIN IMMUNOL, V10, P313, DOI 10.1016/S0952-7915(98)80170-2; Sato S, 2004, RHEUMATOLOGY, V43, P1261, DOI 10.1093/rheumatology/keh303; Saverino D, 2009, J ALLERGY CLIN IMMUN, V123, P258, DOI 10.1016/j.jaci.2008.09.023; Saverino D, 2007, CLIN IMMUNOL, V123, P190, DOI 10.1016/j.clim.2007.01.003; Simone R, 2009, INT IMMUNOL, V21, P1037, DOI 10.1093/intimm/dxp069; Simone Rita, 2009, Current Immunology Reviews, V5, P54; Sun T, 2009, CANCER RES, V69, P6011, DOI 10.1158/0008-5472.CAN-09-0176; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; WALUNAS TL, 1994, IMMUNITY, V1, P405, DOI 10.1016/1074-7613(94)90071-X; Wang XB, 2002, J NEUROIMMUNOL, V130, P224, DOI 10.1016/S0165-5728(02)00228-X; Wong CK, 2005, RHEUMATOLOGY, V44, P989, DOI 10.1093/rheumatology/keh663; Wong CK, 2005, CLIN EXP IMMUNOL, V141, P122, DOI 10.1111/j.1365-2249.2005.02815.x	41	27	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44654	10.1371/journal.pone.0044654	http://dx.doi.org/10.1371/journal.pone.0044654			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049754	Green Submitted, gold, Green Published			2022-12-27	WOS:000309556100019
J	Wu, TC; Chao, CY; Lin, SJ; Chen, JW				Wu, Tao-Cheng; Chao, Chih-Yu; Lin, Shing-Jong; Chen, Jaw-Wen			Low-Dose Dextromethorphan, a NADPH Oxidase Inhibitor, Reduces Blood Pressure and Enhances Vascular Protection in Experimental Hypertension	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE DISMUTASE; INJURY FOLLOWING TRANSIENT; OXIDATIVE STRESS; FOCAL ISCHEMIA; NITRIC-OXIDE; ACTIVE TREATMENT; AMLODIPINE; DYSFUNCTION; SENSITIVITY; ACTIVATION	Background: Vascular oxidative stress may be increased with age and aggravate endothelial dysfunction and vascular injury in hypertension. This study aimed to investigate the effects of dextromethorphan (DM), a NADPH oxidase inhibitor, either alone or in combination treatment, on blood pressure (BP) and vascular protection in aged spontaneous hypertensive rats (SHRs). Methodology/Principal Findings: Eighteen-week-old WKY rats and SHRs were housed for 2 weeks. SHRs were randomly assigned to one of the 12 groups: untreated; DM monotherapy with 1, 5 or 25 mg/kg/day; amlodipine (AM, a calcium channel blocker) monotherapy with 1 or 5 mg/kg/day; and combination therapy of DM 1, 5 or 25 mg/kg/day with AM 1 or 5 mg/kg/day individually for 4 weeks. The in vitro effects of DM were also examined. In SHRs, AM monotherapy dose-dependently reduced arterial systolic BP. DM in various doses significantly and similarly reduced arterial systolic BP. Combination of DM with AM gave additive effects on BP reduction. DM, either alone or in combination with AM, improved aortic endothelial function indicated by ex vivo acetylcholine-induced relaxation. The combination of low-dose DM with AM gave most significant inhibition on aortic wall thickness in SHRs. Plasma total antioxidant status was significantly increased by all the therapies except for the combination of high-dose DM with high-dose AM. Serum nitrite and nitrate level was significantly reduced by AM but not by DM or the combination of DM with AM. Furthermore, in vitro treatment with DM reduced angiotensin II-induced reactive oxygen species and NADPH oxidase activation in human aortic endothelial cells. Conclusions/Significance: Treatment of DM reduced BP and enhanced vascular protection probably by inhibiting vascular NADPH oxidase in aged hypertensive animals with or without AM treatment. It provides the potential rationale to a novel combination treatment with low-dose DM and AM in clinical hypertension.	[Wu, Tao-Cheng; Chao, Chih-Yu; Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Wu, Tao-Cheng; Lin, Shing-Jong; Chen, Jaw-Wen] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei 112, Taiwan; [Lin, Shing-Jong] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Lin, Shing-Jong; Chen, Jaw-Wen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Chen, Jaw-Wen] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chen, JW (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan.	jwchen@vghtpe.gov.tw			Cardiovascular Research Center of National Yang-Ming University; Ministry of Education, Aim for the Top University Plan; Taipei Veterans General Hospital, Taiwan, R.O.C. [V99-B2-008]; United University System of Taiwan (UST)- University of California San Diego (UCSD) International Center of Excellence in Advanced Bio-engineering; Taiwan National Science Council International Research-Intensive Centers of Excellence (I-RiCE) in Taiwan Program [NSC-99-2911-I-009-101]	Cardiovascular Research Center of National Yang-Ming University; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); Taipei Veterans General Hospital, Taiwan, R.O.C.(Taipei Veterans General Hospital); United University System of Taiwan (UST)- University of California San Diego (UCSD) International Center of Excellence in Advanced Bio-engineering; Taiwan National Science Council International Research-Intensive Centers of Excellence (I-RiCE) in Taiwan Program	This study was partially supported by a grant from Cardiovascular Research Center of National Yang-Ming University, by a grant from Ministry of Education, Aim for the Top University Plan, by a grant from Taipei Veterans General Hospital, Taiwan, R.O.C. (V99-B2-008 to T-CW), and by the United University System of Taiwan (UST)- University of California San Diego (UCSD) International Center of Excellence in Advanced Bio-engineering sponsored by the Taiwan National Science Council International Research-Intensive Centers of Excellence (I-RiCE) in Taiwan Program under Grant Number: NSC-99-2911-I-009-101. This work was also assisted in part by the Division of Experimental Surgery, the Department of Surgery, Taipei Veterans General Hospital, Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2008, BRIT J PHARMACOL, V153, P926, DOI 10.1038/sj.bjp.0707575; Bhatia K, 2012, AM J PHYSIOL-REG I, V302, pR274, DOI 10.1152/ajpregu.00546.2011; Britton P, 1997, LIFE SCI, V60, P1729, DOI 10.1016/S0024-3205(97)00132-X; Brown MJ, 2000, LANCET, V356, P366, DOI 10.1016/S0140-6736(00)02527-7; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chen JW, 2003, ARTERIOSCL THROM VAS, V23, P1559, DOI 10.1161/01.ATV.0000089012.73180.63; Chen YW, 2011, CAN J ANESTH, V58, P55, DOI 10.1007/s12630-010-9408-z; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Delano FA, 2006, MICROCIRCULATION, V13, P551, DOI 10.1080/10739680600885152; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; FIESE G, 1969, J PHARM SCI, V58, P599, DOI 10.1002/jps.2600580519; Fujiwara N, 2000, CIRCULATION, V101, P856, DOI 10.1161/01.CIR.101.8.856; GEORGE CP, 1988, BRAIN RES, V440, P375, DOI 10.1016/0006-8993(88)91011-6; Gongora MC, 2006, HYPERTENSION, V48, P473, DOI 10.1161/01.HYP.0000235682.47673.ab; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Harrison DG, 2007, J AM SOC HYPERTENS, V1, P30, DOI 10.1016/j.jash.2006.11.006; Hung CL, 2009, ACTA CARDIOL SIN, V25, P7; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kitada M, 2003, DIABETES, V52, P2603, DOI 10.2337/diabetes.52.10.2603; Konda T, 2009, AM J NEPHROL, V30, P155, DOI 10.1159/000210396; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Li Fangxiong, 2010, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V35, P807, DOI 10.3969/j.issn.1672-7347.2010.08.006; Liu LS, 1998, J HYPERTENS, V16, P1823, DOI 10.1097/00004872-199816120-00016; Liu SL, 2009, CARDIOVASC RES, V82, P161, DOI 10.1093/cvr/cvp043; Lob HE, 2011, HYPERTENSION, V58, P232, DOI 10.1161/HYPERTENSIONAHA.111.172718; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; MONYER H, 1988, BRAIN RES, V446, P144, DOI 10.1016/0006-8993(88)91304-2; Mounier-Vehier C, 1998, AM J HYPERTENS, V11, P478, DOI 10.1016/S0895-7061(97)00485-8; Mullan BA, 2002, HYPERTENSION, V40, P804, DOI 10.1161/01.HYP.0000039961.13718.00; Nishino T, 2008, FEBS J, V275, P3278, DOI 10.1111/j.1742-4658.2008.06489.x; O'Connor PJ, 2006, ARCH INTERN MED, V166, P1802, DOI 10.1001/archinte.166.17.1802; Ong KL, 2007, HYPERTENSION, V49, P69, DOI 10.1161/01.HYP.0000252676.46043.18; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; PRINCE DA, 1988, NEUROSCI LETT, V85, P291, DOI 10.1016/0304-3940(88)90581-2; Srivastava P, 1998, PHARMACOL RES, V38, P265, DOI 10.1006/phrs.1998.0357; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; STEINBERG GK, 1988, STROKE, V19, P1112, DOI 10.1161/01.STR.19.9.1112; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Tortella FC, 1999, J PHARMACOL EXP THER, V291, P399; TORTELLA FC, 1989, TRENDS PHARMACOL SCI, V10, P501, DOI 10.1016/0165-6147(89)90050-3; Widder JD, 2007, ARTERIOSCL THROM VAS, V27, P762, DOI 10.1161/01.ATV.0000259298.11129.a2; Zhang W, 2004, FASEB J, V18, P589, DOI 10.1096/fj.03-0983fje	44	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46067	10.1371/journal.pone.0046067	http://dx.doi.org/10.1371/journal.pone.0046067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049937	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100130
J	Guo, F; Mead, J; Aliya, N; Wang, L; Cuconati, A; Wei, L; Li, K; Block, TM; Guo, JT; Chang, J				Guo, Fang; Mead, Jennifer; Aliya, Nishat; Wang, Lijuan; Cuconati, Andrea; Wei, Lai; Li, Kui; Block, Timothy M.; Guo, Ju-Tao; Chang, Jinhong			RO 90-7501 Enhances TLR3 and RLR Agonist Induced Antiviral Response	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTOR-3; 1918 INFLUENZA-VIRUS; I-LIKE RECEPTORS; NF-KAPPA-B; RIG-I; INFLAMMATORY RESPONSES; GENE-EXPRESSION; DENDRITIC CELLS	Recognition of virus infection by innate pattern recognition receptors (PRRs), including membrane-associated toll-like receptors (TLR) and cytoplasmic RIG-I-like receptors (RLR), activates cascades of signal transduction pathways leading to production of type I interferons (IFN) and proinflammatory cytokines that orchestrate the elimination of the viruses. Although it has been demonstrated that PRR-mediated innate immunity plays an essential role in defending virus from infection, it also occasionally results in overwhelming production of proinflammatory cytokines that cause severe inflammation, blood vessel leakage and tissue damage. In our efforts to identify small molecules that selectively enhance PRR-mediated antiviral, but not the detrimental inflammatory response, we discovered a compound, RO 90-7501 ('2'-(4-Aminophenyl)-[2,5'-bi-1H-benzimidazol]-5-amine), that significantly promoted both TLR3 and RLR ligand-induced IFN-beta gene expression and antiviral response, most likely via selective activation of p38 mitogen-activated protein kinase (MAPK) pathway. Our results thus imply that pharmacological modulation of PRR signal transduction pathways in favor of the induction of a beneficial antiviral response can be a novel therapeutic strategy.	[Guo, Fang; Mead, Jennifer; Aliya, Nishat; Wang, Lijuan; Block, Timothy M.; Guo, Ju-Tao; Chang, Jinhong] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Doylestown, PA USA; [Cuconati, Andrea; Block, Timothy M.] Inst Hepatitis Virus Res, Hepatitis B Fdn, Doylestown, PA USA; [Wei, Lai] Peking Univ, Inst Hepatol, Beijing 100871, Peoples R China; [Li, Kui] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	Drexel University; Peking University; University of Tennessee System; University of Tennessee Health Science Center	Guo, JT (corresponding author), Drexel Univ, Coll Med, Dept Microbiol & Immunol, Doylestown, PA USA.	ju-tao.guo@drexelmed.edu; jinhong.chang@drexelmed.edu	Cuconati, Andrea/GWV-4662-2022; Cuconati, Andrea/AAI-7533-2020	Cuconati, Andrea/0000-0001-5123-0381	National Institutes of Health [AI061441, AI069285]; Hepatitis B Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI069285, U01AI061441, R01AI069285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hepatitis B Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (AI061441, AI069285) and the Hepatitis B Foundation through an appropriation of the Commonwealth of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balachandran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002165; Bohrmann B, 2000, J STRUCT BIOL, V130, P232, DOI 10.1006/jsbi.2000.4241; Bray M, 2005, CURR OPIN IMMUNOL, V17, P399, DOI 10.1016/j.coi.2005.05.001; Brennan K, 2010, CURR OPIN MICROBIOL, V13, P503, DOI 10.1016/j.mib.2010.05.007; Chang JH, 2009, ANTIMICROB AGENTS CH, V53, P1501, DOI 10.1128/AAC.01457-08; Chang YC, 2005, SOUTH MED J, V98, P914, DOI 10.1097/01.SMJ.0000176712.01491.98; Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; Conforti R, 2010, CANCER RES, V70, P490, DOI 10.1158/0008-5472.CAN-09-1890; Damm J, 2012, NEUROSCIENCE, V201, P166, DOI 10.1016/j.neuroscience.2011.11.013; Elco CP, 2005, J VIROL, V79, P3920, DOI 10.1128/JVI.79.7.3920-3929.2005; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; Fidock MD, 2011, CLIN PHARMACOL THER, V89, P821, DOI 10.1038/clpt.2011.60; Geiss G, 2001, J BIOL CHEM, V276, P30178, DOI 10.1074/jbc.C100137200; Guo H, 2009, J VIROL, V83, P847, DOI 10.1128/JVI.02008-08; Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005; Horsmans Y, 2005, HEPATOLOGY, V42, P724, DOI 10.1002/hep.20839; Hrincius ER, 2011, CELL MICROBIOL, V13, P1907, DOI 10.1111/j.1462-5822.2011.01680.x; Ireton RC, 2011, VIRUSES-BASEL, V3, P906, DOI 10.3390/v3060906; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Mitchell D, 2010, MOL IMMUNOL, V47, P2065, DOI 10.1016/j.molimm.2010.04.004; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Pockros PJ, 2007, HEPATOLOGY, V45, P569, DOI 10.1002/hep.21561; Salaun B, 2011, CANCER RES, V71, P1607, DOI 10.1158/0008-5472.CAN-10-3490; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Schrofelbauer B, 2009, BIOCHEM J, V421, P473, DOI 10.1042/BJ20082416; Steer SA, 2006, J IMMUNOL, V177, P3413, DOI 10.4049/jimmunol.177.5.3413; Stewart MJ, 2006, J INTERF CYTOK RES, V26, P521, DOI 10.1089/jir.2006.26.521; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thiel V, 2008, CYTOKINE GROWTH F R, V19, P121, DOI 10.1016/j.cytogfr.2008.01.001; Wang N, 2010, J BIOL CHEM, V285, P6080, DOI 10.1074/jbc.M109.054486; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140	43	19	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e42583	10.1371/journal.pone.0042583	http://dx.doi.org/10.1371/journal.pone.0042583			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056170	Green Submitted, Green Published, gold			2022-12-27	WOS:000309454000002
J	Iyer, KV; Maharana, S; Gupta, S; Libchaber, A; Tlusty, T; Shivashankar, GV				Iyer, K. Venkatesan; Maharana, Shovamayee; Gupta, Soumya; Libchaber, Albert; Tlusty, Tsvi; Shivashankar, G. V.			Modeling and Experimental Methods to Probe the Link between Global Transcription and Spatial Organization of Chromosomes	PLOS ONE			English	Article							HUMAN INTERPHASE CHROMOSOMES; GENE-EXPRESSION; CHROMATIN; NUCLEI; CELLS; TERRITORIES; GENOMES; ASSOCIATION; ORDER	Genomes are spatially assembled into chromosome territories (CT) within the nucleus of living cells. Recent evidences have suggested associations between three-dimensional organization of CTs and the active gene clusters within neighboring CTs. These gene clusters are part of signaling networks sharing similar transcription factor or other downstream transcription machineries. Hence, presence of such gene clusters of active signaling networks in a cell type may regulate the spatial organization of chromosomes in the nucleus. However, given the probabilistic nature of chromosome positions and complex transcription factor networks (TFNs), quantitative methods to establish their correlation is lacking. In this paper, we use chromosome positions and gene expression profiles in interphase fibroblasts and describe methods to capture the correspondence between their spatial position and expression. In addition, numerical simulations designed to incorporate the interacting TFNs, reveal that the chromosome positions are also optimized for the activity of these networks. These methods were validated for specific chromosome pairs mapped in two distinct transcriptional states of T-Cells (naive and activated). Taken together, our methods highlight the functional coupling between topology of chromosomes and their respective gene expression patterns.	[Iyer, K. Venkatesan; Maharana, Shovamayee; Gupta, Soumya; Shivashankar, G. V.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Libchaber, Albert] Rockefeller Univ, Lab Expt Condensed Matter Phys, New York, NY 10021 USA; [Tlusty, Tsvi] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Iyer, K. Venkatesan; Maharana, Shovamayee; Gupta, Soumya; Shivashankar, G. V.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Iyer, K. Venkatesan; Maharana, Shovamayee; Gupta, Soumya; Shivashankar, G. V.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Rockefeller University; Weizmann Institute of Science; National University of Singapore; National University of Singapore	Iyer, KV (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	Tsvi.Tlusty@weizmann.ac.il; shiva.gvs@gmail.com	Tlusty, Tsvi/A-9880-2008	Tlusty, Tsvi/0000-0002-9662-3725; Maharana, Shovamayee/0000-0003-3909-9151	Department of Science and Technology, India [SR/S5/NM-36/2005, DST/SJF/GVS/6223]; Israel Science Foundation [1329/08]; Mechanobiology Institute, Singapore; Council of Scientific and Industrial Research doctoral fellowship	Department of Science and Technology, India(Department of Science & Technology (India)); Israel Science Foundation(Israel Science Foundation); Mechanobiology Institute, Singapore; Council of Scientific and Industrial Research doctoral fellowship	The authors thank the Nanoscience Initiative (SR/S5/NM-36/2005) and Swarnajayanti (DST/SJF/GVS/6223) grants from the Department of Science and Technology, India (http://www.dst.gov.in), Israel Science Foundation grant 1329/08 and Mechanobiology Institute, Singapore. KVI and SM were awarded Council of Scientific and Industrial Research doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DC, 1999, J CELL BIOL, V145, P1, DOI 10.1083/jcb.145.1.1; Ameur A, 2011, NAT STRUCT MOL BIOL, V18, P1435, DOI 10.1038/nsmb.2143; Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Bohn M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012218; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Boyle S, 2001, HUM MOL GENET, V10, P211, DOI 10.1093/hmg/10.3.211; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chandley AC, 1996, J CELL SCI, V109, P773; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Cook PR, 2010, J MOL BIOL, V395, P1, DOI 10.1016/j.jmb.2009.10.031; Cornforth MN, 2002, J CELL BIOL, V159, P237, DOI 10.1083/jcb.200206009; Cremer M, 2001, CHROMOSOME RES, V9, P541, DOI 10.1023/A:1012495201697; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Eils R, 1996, J CELL BIOL, V135, P1427, DOI 10.1083/jcb.135.6.1427; Foster HA, 2005, J CELL SCI, V118, P1811, DOI 10.1242/jcs.02301; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; Fritsche M, 2012, NUCLEIC ACIDS RES, V40, P972, DOI 10.1093/nar/gkr779; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Janga SC, 2008, P NATL ACAD SCI USA, V105, P15761, DOI 10.1073/pnas.0806317105; Jerabek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037525; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Khrameeva EE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033947; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Kosak ST, 2007, PLOS BIOL, V5, P2602, DOI 10.1371/journal.pbio.0050309; Kreth G, 2004, BIOPHYS J, V86, P2803, DOI 10.1016/S0006-3495(04)74333-7; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Luger K, 2005, CURR OPIN STRUC BIOL, V15, P188, DOI 10.1016/j.sbi.2005.03.006; Mateos-Langerak J, 2009, P NATL ACAD SCI USA, V106, P3812, DOI 10.1073/pnas.0809501106; Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028; NAGELE R, 1995, SCIENCE, V270, P1831, DOI 10.1126/science.270.5243.1831; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Parada LA, 2002, CURR BIOL, V12, P1692, DOI 10.1016/S0960-9822(02)01166-1; Rajapakse I, 2009, P NATL ACAD SCI USA, V106, P6679, DOI 10.1073/pnas.0900986106; Ramirez MJ, 2008, CYTOGENET GENOME RES, V122, P237, DOI 10.1159/000167809; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Schrock E, 1996, SCIENCE, V273, P494, DOI 10.1126/science.273.5274.494; Shu L, 2006, BLOOD CELL MOL DIS, V37, P64, DOI 10.1016/j.bcmd.2006.04.002; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Stine MJ, 2011, CANCER RES, V71, P2433, DOI 10.1158/0008-5472.CAN-10-1875; Strickfaden H, 2010, NUCLEUS-PHILA, V1, P284, DOI 10.4161/nucl.1.3.11969; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Taddei A, 2009, GENOME RES, V19, P611, DOI 10.1101/gr.083881.108; Walter J, 2003, J CELL BIOL, V160, P685, DOI 10.1083/jcb.200211103; Xu M, 2008, J CELL BIOL, V181, P615, DOI 10.1083/jcb.200710053	58	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46628	10.1371/journal.pone.0046628	http://dx.doi.org/10.1371/journal.pone.0046628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049710	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388500037
J	Shin, MK; Drager, LF; Yao, QL; Bevans-Fonti, S; Yoo, DY; Jun, JC; Aja, S; Bhanot, S; Polotsky, VY				Shin, Mi-Kyung; Drager, Luciano F.; Yao, Qiaoling; Bevans-Fonti, Shannon; Yoo, Doo-Young; Jun, Jonathan C.; Aja, Susan; Bhanot, Sanjay; Polotsky, Vsevolod Y.			Metabolic Consequences of High-Fat Diet Are Attenuated by Suppression of HIF-1 alpha	PLOS ONE			English	Article							INDUCIBLE FACTOR 1-ALPHA; BROWN ADIPOSE-TISSUE; CHRONIC INTERMITTENT HYPOXIA; INSULIN-RESISTANCE; LIPID-METABOLISM; OBESE MICE; ENERGY-EXPENDITURE; LEAN MICE; GLUCOSE; OXYGEN	Obesity is associated with tissue hypoxia and the up-regulation of hypoxia inducible factor 1 alpha (HIF-1 alpha). Prior studies in transgenic mice have shown that HIF-1 alpha plays a role in the metabolic dysfunction associated with obesity. Therefore, we hypothesized that, after the development of diet-induced obesity (DIO), metabolic function could be improved by administration of HIF-1 alpha antisense oligonucleotides (ASO). DIO mice were treated with HIF-1 alpha ASO or with control ASO for 8 weeks and compared with an untreated group. We found that HIF-1 alpha ASO markedly suppressed Hif-1 alpha gene expression in adipose tissue and the liver. HIF-1 alpha ASO administration induced weight loss. Final body weight was 41.6 +/- 1.4 g in the HIF-1 alpha ASO group vs 46.7 +/- 0.9 g in the control ASO group and 47.9 +/- 0.8 g in untreated mice (p<0.001). HIF-1 alpha ASO increased energy expenditure (13.3 +/- 0.6 vs 12 +/- 0.1 and 11.9 +/- 0.4 kcal/kg/hr, respectively, p<0.001) and decreased the respiratory exchange ratio (0.71 +/- 0.01 vs 0.75 +/- 0.01 and 0.76 +/- 0.01, respectively, p<0.001), which suggested switching metabolism to fat oxidation. In contrast, HIF-1a ASO had no effect on food intake or activity. HIF-1 alpha ASO treatment decreased fasting blood glucose (195.5 +/- 8.4 mg/dl vs 239 +/- 7.8 mg/dl in the control ASO group and 222 +/- 8.2 mg/dl in untreated mice, p<0.01), plasma insulin, hepatic glucose output, and liver fat content. These findings demonstrate that the metabolic consequences of DIO are attenuated by HIF-1 alpha ASO treatment.	[Shin, Mi-Kyung; Yao, Qiaoling; Bevans-Fonti, Shannon; Yoo, Doo-Young; Jun, Jonathan C.; Polotsky, Vsevolod Y.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA; [Aja, Susan] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Drager, Luciano F.] Univ Sao Paulo, Sch Med, Hypertens Unit, Inst Heart InCor, Sao Paulo, Brazil; [Bhanot, Sanjay] Isis Pharmaceut Inc, Carlsbad, CA USA	Johns Hopkins University; Johns Hopkins University; Universidade de Sao Paulo; Isis Pharmaceuticals Inc	Polotsky, VY (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD 21205 USA.	vpolots1@jhmi.edu	Drager, Luciano F/A-1535-2014		National Institutes of Health [R01 HL080105, P50 HL084945]; American Heart Association [10GRNT3360001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084945, R01HL080105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by National Institutes of Health R01 HL080105, P50 HL084945; American Heart Association 10GRNT3360001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett CF, 2010, ANNU REV PHARMACOL, V50, P259, DOI 10.1146/annurev.pharmtox.010909.105654; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Burgueno AL, 2012, CLIN SCI LOND; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carabelli J, 2011, J CELL MOL MED, V15, P1329, DOI 10.1111/j.1582-4934.2010.01128.x; Collins S, 2010, INT J OBESITY, V34, pS28, DOI 10.1038/ijo.2010.180; Delarue J, 2007, CURR OPIN CLIN NUTR, V10, P142, DOI 10.1097/MCO.0b013e328042ba90; Drager LF, 2011, OBESITY, V19, P2167, DOI 10.1038/oby.2011.240; Enerback S, 2010, INT J OBESITY, V34, pS43, DOI 10.1038/ijo.2010.183; Fleischmann E, 2005, OBES SURG, V15, P813, DOI 10.1381/0960892054222867; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Fromme T, 2011, AM J PHYSIOL-REG I, V300, pR1, DOI 10.1152/ajpregu.00411.2010; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Iiyori N, 2007, AM J RESP CRIT CARE, V175, P851, DOI 10.1164/rccm.200610-1527OC; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Jiang GQ, 2005, J CLIN INVEST, V115, P1030, DOI 10.1172/JCI200523962; Kaidanovich Oksana, 2002, Expert Opin Ther Targets, V6, P555; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kozak LP, 2008, INT J OBESITY, V32, pS32, DOI 10.1038/ijo.2008.236; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Li JG, 2005, J APPL PHYSIOL, V99, P1643, DOI 10.1152/japplphysiol.00522.2005; Li JG, 2005, CIRC RES, V97, P698, DOI 10.1161/01.RES.0000183879.60089.a9; Li JG, 2007, PHYSIOL GENOMICS, V31, P273, DOI 10.1152/physiolgenomics.00082.2007; Li JG, 2007, J APPL PHYSIOL, V102, P557, DOI 10.1152/japplphysiol.01081.2006; Li JG, 2006, PHYSIOL GENOMICS, V25, P450, DOI 10.1152/physiolgenomics.00293.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lusk G, 1928, ELEMENTS SCI NUTR; McKay RA, 1999, J BIOL CHEM, V274, P1715, DOI 10.1074/jbc.274.3.1715; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Ochiai D, 2011, BIOCHEM BIOPH RES CO, V415, P445, DOI 10.1016/j.bbrc.2011.10.089; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Paton CM, 2009, AM J PHYSIOL-ENDOC M, V297, pE28, DOI 10.1152/ajpendo.90897.2008; Polotsky VY, 2003, J PHYSIOL-LONDON, V552, P253, DOI 10.1113/jphysiol.2003.048173; Reinke C, 2011, J APPL PHYSIOL, V111, P881, DOI 10.1152/japplphysiol.00492.2011; Robson-Doucette CA, 2011, DIABETES, V60, P2710, DOI 10.2337/db11-0132; Satterfield MC, 2011, FRONT BIOSCI-LANDMRK, V16, P1589, DOI 10.2741/3807; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Tajima T, 2009, BIOCHEM BIOPH RES CO, V387, P789, DOI 10.1016/j.bbrc.2009.07.115; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Walston J, 2008, J GERONTOL A-BIOL, V63, P391, DOI 10.1093/gerona/63.4.391; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wood IS, 2009, P NUTR SOC, V68, P370, DOI 10.1017/S0029665109990206; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yin J, 2009, AM J PHYSIOL-ENDOC M, V296, pE333, DOI 10.1152/ajpendo.90760.2008; Zhang XM, 2010, J BIOL CHEM, V285, P32869, DOI 10.1074/jbc.M110.135509	54	50	52	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46562	10.1371/journal.pone.0046562	http://dx.doi.org/10.1371/journal.pone.0046562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049707	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388500034
J	van den Berg, BA; Reinders, MJT; Hulsman, M; Wu, L; Pel, HJ; Roubos, JA; de Ridder, D				van den Berg, Bastiaan A.; Reinders, Marcel J. T.; Hulsman, Marc; Wu, Liang; Pel, Herman J.; Roubos, Johannes A.; de Ridder, Dick			Exploring Sequence Characteristics Related to High-Level Production of Secreted Proteins in Aspergillus niger	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; FILAMENTOUS FUNGI; MOLECULAR-BIOLOGY; ENZYME-PRODUCTION; PREDICTION; STABILITY; SIGNAL; GLYCOSYLATION; EFFICIENCY; EXPRESSION	Protein sequence features are explored in relation to the production of over-expressed extracellular proteins by fungi. Knowledge on features influencing protein production and secretion could be employed to improve enzyme production levels in industrial bioprocesses via protein engineering. A large set, over 600 homologous and nearly 2,000 heterologous fungal genes, were overexpressed in Aspergillus niger using a standardized expression cassette and scored for high versus no production. Subsequently, sequence-based machine learning techniques were applied for identifying relevant DNA and protein sequence features. The amino-acid composition of the protein sequence was found to be most predictive and interpretation revealed that, for both homologous and heterologous gene expression, the same features are important: tyrosine and asparagine composition was found to have a positive correlation with high-level production, whereas for unsuccessful production, contributions were found for methionine and lysine composition. The predictor is available online at http://bioinformatics.tudelft.nl/hipsec. Subsequent work aims at validating these findings by protein engineering as a method for increasing expression levels per gene copy.	[van den Berg, Bastiaan A.; Reinders, Marcel J. T.; Hulsman, Marc; de Ridder, Dick] Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Dept Intelligent Syst, Delft Bioinformat Lab, Delft, Netherlands; [van den Berg, Bastiaan A.; Reinders, Marcel J. T.; Hulsman, Marc; de Ridder, Dick] Netherlands Bioinformat Ctr, Nijmegen, Netherlands; [Wu, Liang; Pel, Herman J.; Roubos, Johannes A.] DSM Biotechnol Ctr, Delft, Netherlands; [van den Berg, Bastiaan A.; Reinders, Marcel J. T.; Hulsman, Marc; de Ridder, Dick] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands	Delft University of Technology; DSM NV	van den Berg, BA (corresponding author), Delft Univ Technol, Fac Elect Engn Math & Comp Sci, Dept Intelligent Syst, Delft Bioinformat Lab, Delft, Netherlands.	b.a.vandenberg@tudelft.nl	de Ridder, Dick/F-3169-2010	de Ridder, Dick/0000-0002-4944-4310	BioRange programme of the Netherlands Bioinformatics Centre (NBIC)	BioRange programme of the Netherlands Bioinformatics Centre (NBIC)	This work was supported by the BioRange programme of the Netherlands Bioinformatics Centre (NBIC) and was part of the Kluyver Centre for Genomics of Industrial Fermentation, subsidiaries of the Netherlands Genomics Initiative (NGI). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The used data set was provided by DSM Biotechnology Center. Study design, data collection and analysis, decision to publish, and preparation of the manuscript has been done in cooperation with the DSM employees who are co-authors.	Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; Archer DB, 1997, CRIT REV BIOTECHNOL, V17, P273, DOI 10.3109/07388559709146616; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blum T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-274; Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; Carvalho NDSP, 2011, APPL MICROBIOL BIOT, V89, P357, DOI 10.1007/s00253-010-2916-5; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Conesa A, 2001, FUNGAL GENET BIOL, V33, P155, DOI 10.1006/fgbi.2001.1276; Dondoshansky I, 2002, BLASTCLUST NCBI SOFT; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Eriksen SH, 1998, CURR MICROBIOL, V37, P117, DOI 10.1007/s002849900348; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fleissner A, 2010, APPL MICROBIOL BIOT, V87, P1255, DOI 10.1007/s00253-010-2672-6; Gouka RJ, 1997, APPL MICROBIOL BIOT, V47, P1, DOI 10.1007/s002530050880; Guillemette T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-158; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Horton P, 2006, SER ADV BIOINFORM, V3, P39, DOI 10.1142/9781860947292_0007; Jacobs DI, 2009, FUNGAL GENET BIOL, V46, pS141, DOI 10.1016/j.fgb.2008.08.012; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones E., 2001, SCIPY OPEN SOURCE SC; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kjeldsen T, 2002, J BIOL CHEM, V277, P18245, DOI 10.1074/jbc.C200137200; Kochetov AV, 2008, BIOESSAYS, V30, P683, DOI 10.1002/bies.20771; Kowalski JM, 1998, BIOCHEMISTRY-US, V37, P1264, DOI 10.1021/bi9722397; Kowalski JM, 1998, J BIOL CHEM, V273, P19453, DOI 10.1074/jbc.273.31.19453; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LESLIE C, 2002, P PSB, V7, P566; Liu Y, 2009, BIOTECHNOL PROGR, V25, P1468, DOI 10.1002/btpr.241; Lubertozzi D, 2009, BIOTECHNOL ADV, V27, P53, DOI 10.1016/j.biotechadv.2008.09.001; Magnan CN, 2009, BIOINFORMATICS, V25, P2200, DOI 10.1093/bioinformatics/btp386; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Neduva V, 2005, FEBS LETT, V579, P3342, DOI 10.1016/j.febslet.2005.04.005; Nevalainen KMH, 2005, TRENDS BIOTECHNOL, V23, P468, DOI 10.1016/j.tibtech.2005.06.002; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Pierleoni A, 2006, BIOINFORMATICS, V22, pE408, DOI 10.1093/bioinformatics/btl222; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Punt PJ, 2002, TRENDS BIOTECHNOL, V20, P200, DOI 10.1016/S0167-7799(02)01933-9; Ratsch G., 2004, KERNEL METHODS COMPU, P277; Sagt CMJ, 2000, APPL ENVIRON MICROB, V66, P4940, DOI 10.1128/AEM.66.11.4940-4944.2000; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Sonnenburg S, 2008, BIOINFORMATICS, V24, pI6, DOI 10.1093/bioinformatics/btn170; Sonnenburg S, 2010, J MACH LEARN RES, V11, P1799; Strickler SS, 2006, BIOCHEMISTRY-US, V45, P2761, DOI 10.1021/bi0600143; TAYLOR WR, 1986, J THEOR BIOL, V119, P205, DOI 10.1016/S0022-5193(86)80075-3; Toussaint NC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S8-S7; van den Berg BA, 2010, LECT N BIOINFORMAT, V6282, P3, DOI 10.1007/978-3-642-16001-1_1; den Brink HM, 2006, J BIOTECHNOL, V125, P304, DOI 10.1016/j.jbiotec.2006.02.024; van Dijck PWM, 2003, REGUL TOXICOL PHARM, V38, P27, DOI 10.1016/S0273-2300(03)00049-7; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Whyteside G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022692	58	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45869	10.1371/journal.pone.0045869	http://dx.doi.org/10.1371/journal.pone.0045869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049690	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388500017
J	Fan, LL; Xu, CR; Wang, CM; Tao, JY; Ho, C; Jiang, LJ; Gui, B; Huang, S; Evert, M; Calvisi, DF; Chen, X				Fan, Lingling; Xu, Chuanrui; Wang, Chunmei; Tao, Junyan; Ho, Coral; Jiang, Lijie; Gui, Bing; Huang, Shiang; Evert, Matthias; Calvisi, Diego F.; Chen, Xin			Bmi1 Is Required for Hepatic Progenitor Cell Expansion and Liver Tumor Development	PLOS ONE			English	Article							HEMATOPOIETIC STEM; SELF-RENEWAL; HEPATOCELLULAR-CARCINOMA; INK4A-ARF LOCUS; OVAL CELLS; PROLIFERATION; TUMORIGENESIS; GROWTH; MICE; RAT	Bmi1 is a polycomb group transcriptional repressor and it has been implicated in regulating self-renewal and proliferation of many types of stem or progenitor cells. In addition, Bmi1 has been shown to function as an oncogene in multiple tumor types. In this study, we investigated the functional significance of Bmi1 in regulating hepatic oval cells, the major type of bipotential progenitor cells in adult liver, as well as the role of Bmi1 during hepatocarcinogenesis using Bmi1 knockout mice. We found that loss of Bmi1 significantly restricted chemically induced oval cell expansion in the mouse liver. Concomitant deletion of Ink4a/Arf in Bmi1 deficient mice completely rescued the oval cell expansion phenotype. Furthermore, ablation of Bmi1 delayed hepatocarcinogenesis induced by AKT and Ras co-expression. This antineoplastic effect was accompanied by the loss of hepatic oval cell marker expression in the liver tumor samples. In summary, our data demonstrated that Bmi1 is required for hepatic oval cell expansion via deregulating the Ink4a/Arf locus in mice. Our study also provides the evidence, for the first time, that Bmi1 expression is required for liver cancer development in vivo, thus representing a promising target for innovative treatments against human liver cancer.	[Fan, Lingling; Wang, Chunmei; Tao, Junyan; Ho, Coral; Jiang, Lijie; Gui, Bing; Chen, Xin] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Chen, Xin] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA; [Fan, Lingling; Huang, Shiang] Huazhong Univ Sci & Technol, Ctr Stem Cell Res & Applicat, Union Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Xu, Chuanrui] Huazhong Univ Sci & Technol, Sch Pharm, Tongji Med Coll, Wuhan 430074, Peoples R China; [Evert, Matthias; Calvisi, Diego F.] Ernst Moritz Arndt Univ Greifswald, Inst Pathol, Greifswald, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Ernst Moritz Arndt Universitat Greifswald	Chen, X (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	xin.chen@ucsf.edu	Wang, Chunmei/J-2423-2013; tao, junyan/C-6919-2015	Wang, Chunmei/0000-0003-4615-0517; 	National Institutes of Health [R01CA136606, P30DK026743]; NATIONAL CANCER INSTITUTE [R01CA136606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by National Institutes of Health grant R01CA136606 to X.C., and P30DK026743 to the University of California San Francisco Liver Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arranz L, 2012, CELL CYCLE, V11, P65, DOI 10.4161/cc.11.1.18097; Becker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004230; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; BRUNK BP, 1991, NATURE, V353, P351, DOI 10.1038/353351a0; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Carlson CM, 2005, P NATL ACAD SCI USA, V102, P17059, DOI 10.1073/pnas.0502974102; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Chiba T, 2010, HEPATOLOGY, V52, P1111, DOI 10.1002/hep.23793; Dorrell C, 2008, HEPATOLOGY, V48, P1282, DOI 10.1002/hep.22468; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737; FAKTOR V M, 1990, Ontogenez, V21, P625; Fan C, 2008, BBA-MOL BASIS DIS, V1782, P642, DOI 10.1016/j.bbadis.2008.08.009; GOLDING M, 1995, HEPATOLOGY, V22, P1243, DOI 10.1002/hep.1840220433; Ho C, 2012, HEPATOLOGY, V55, P833, DOI 10.1002/hep.24736; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Kim H, 2004, J HEPATOL, V40, P298, DOI 10.1016/j.jhep.2003.10.023; Laconi S, 1999, J HEPATOL, V31, P1069, DOI 10.1016/S0168-8278(99)80320-1; Lee KP, 2010, P NATL ACAD SCI USA, V107, P8248, DOI 10.1073/pnas.0912203107; Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Michael LE, 2008, NEOPLASIA, V10, P1343, DOI 10.1593/neo.81078; Mihic-Probst D, 2007, INT J CANCER, V121, P1764, DOI 10.1002/ijc.22891; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Okabe M, 2009, DEVELOPMENT, V136, P1951, DOI 10.1242/dev.031369; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pietersen AM, 2008, CURR BIOL, V18, P1094, DOI 10.1016/j.cub.2008.06.070; Preisegger KH, 1999, LAB INVEST, V79, P103; Pritchard MT, 2010, AM J PATHOL, V176, P2743, DOI 10.2353/ajpath.2010.091186; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; Schuringa JJ, 2010, CURR OPIN HEMATOL, V17, P294, DOI 10.1097/MOH.0b013e328338c439; Sell S, 2001, HEPATOLOGY, V33, P738, DOI 10.1053/jhep.2001.21900; Silva J, 2006, CLIN CANCER RES, V12, P6929, DOI 10.1158/1078-0432.CCR-06-0788; Smith KS, 2003, MOL CELL, V12, P393, DOI 10.1016/S1097-2765(03)00277-6; Tirnitz-Parker JEE, 2007, INT J BIOCHEM CELL B, V39, P2226, DOI 10.1016/j.biocel.2007.06.008; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; VANLOHUIZEN M, 1991, NATURE, V353, P353, DOI 10.1038/353353a0; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Wang X, 2003, P NATL ACAD SCI USA, V100, P11881, DOI 10.1073/pnas.1734199100; Wu XZ, 2006, J GASTROEN HEPATOL, V21, P1093, DOI 10.1111/j.1440-1746.2006.04485.x; Xu CR, 2009, MOL CANCER RES, V7, P1937, DOI 10.1158/1541-7786.MCR-09-0333; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Zheng D, 2006, AM J PATHOL, V169, P2066, DOI 10.2353/ajpath.2006.060211	52	26	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46472	10.1371/journal.pone.0046472	http://dx.doi.org/10.1371/journal.pone.0046472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029524	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900165
J	Makondo, E; Bell, TG; Kramvis, A				Makondo, Euphodia; Bell, Trevor G.; Kramvis, Anna			Genotyping and Molecular Characterization of Hepatitis B Virus from Human Immunodeficiency Virus-Infected Individuals in Southern Africa	PLOS ONE			English	Article							BASIC CORE PROMOTER; PRE-S DELETION; ANTIRETROVIRAL THERAPY; CLINICAL-SIGNIFICANCE; HIV COINFECTION; HEPATOCELLULAR-CARCINOMA; LAMIVUDINE-RESISTANCE; VIRAL REPLICATION; BLOOD-TRANSFUSION; HBV COINFECTION	Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) are hyperendemic in sub-Saharan Africa. The HBV genotypes prevailing in HIV-infected Africans are unknown. Our aim was to determine the HBV genotypes in HIV-infected participants and to identify clinically significant HBV mutations. From 71 HBV DNA(+ve) HIV-infected participants, 49 basic core promoter/precore (BCP/PC) and 29 complete S regions were successfully sequenced. Following phylogenetic analysis of 29 specimens in the complete S region, 28 belonged to subgenotype A1 and one to D3. Mutations affecting HBeAg expression at the transcriptional (1762T1764A), translational (Kozak 1809-1812, initiation 1814-1816, G1896A with C1858T), or post translational levels (G1862T), were responsible for the high HBeAg-negativity observed. The G1862T mutation occurred only in subgenotype A1 isolates, which were found in one third (7/21) of HBsAg(-ve) participants, but in none of the 18 HBsAg(+ve) participants (p<0.05). Pre-S deletion mutants were detected in four HBsAg(+ve) and one HBsAg(-ve) participant/s. The following mutations occurred significantly more frequently in HBV isolated in this study than in strains of the same cluster of the phylogenetic tree: ps1F25L, ps1V88L/A; ps2Q10R, ps2 R48K/T, ps2A53V and sQ129R/H, sQ164A/V/G/D, sV168A and sS174N (p<0.05). ps1I48V/T occurred more frequently in females than males (p<0.05). Isolates with sV168A occurred more frequently in participants with viral loads.200 IU per ml (p<0.05) and only sS174N occurred more frequently in HBsAg(-ve) than in HBsAg(+ve) individuals (p<0.05). Prior to initiation of ART, ten percent, 3 of 29 isolates sequenced, had drug resistance mutations rtV173L, rtL180M+rtM204V and rtV214A, respectively. This study has provided important information on the molecular characteristics of HBV in HIV-infected southern Africans prior to ART initiation, which has important clinical relevance in the management of HBV/HIV co-infection in our unique setting.	[Makondo, Euphodia; Bell, Trevor G.; Kramvis, Anna] Univ Witwatersrand, Hepatitis Virus Div Res Programme, Dept Internal Med, Johannesburg, South Africa	University of Witwatersrand	Kramvis, A (corresponding author), Univ Witwatersrand, Hepatitis Virus Div Res Programme, Dept Internal Med, Johannesburg, South Africa.	Anna.Kramvis@wits.ac.za	Bell, Trevor Graham/B-7388-2016	Bell, Trevor Graham/0000-0003-2630-7513; Kramvis, Anna/0000-0001-6006-3765	South African Medical Research Council; National Research Foundation (NRF) [65530]; National Bioinformatics Network; Poliomyelitis Research Foundation (PRF); NRF; Belgium Technical Cooperation Fellowship; PRF; Deutsch Forschungsgemeinschaft (German Research Foundation); Cancer Association of South Africa	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation (NRF); National Bioinformatics Network; Poliomyelitis Research Foundation (PRF); NRF; Belgium Technical Cooperation Fellowship; PRF; Deutsch Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG)); Cancer Association of South Africa	This study was supported by grants received from the South African Medical Research Council and the National Research Foundation (NRF; GUN#65530) awarded to AK. TGB received bursaries from the National Bioinformatics Network, Poliomyelitis Research Foundation (PRF) and NRF. EM received a Belgium Technical Cooperation Fellowship and bursaries from the NRF and PRF. Research was supported by funding from Deutsch Forschungsgemeinschaft (German Research Foundation) and the Cancer Association of South Africa. The funders had no role in study design, data collection and analysis, decision to publish.	Acar A, 2010, BRAZ J INFECT DIS, V14, P41, DOI 10.1590/S1413-86702010000100009; Ahn SH, 2003, GASTROENTEROLOGY, V125, P1370, DOI 10.1016/j.gastro.2003.07.016; Allain JP, 2009, HEPATOLOGY, V49, P1868, DOI 10.1002/hep.22879; Allen MI, 1998, HEPATOLOGY, V27, P1670, DOI 10.1002/hep.510270628; Arankalle VA, 2010, J VIRAL HEPATITIS, V17, P501, DOI 10.1111/j.1365-2893.2009.01206.x; Arauz-Ruiz P, 2002, J GEN VIROL, V83, P2059, DOI 10.1099/0022-1317-83-8-2059; Audsley J, 2009, HIV MED, V10, P229, DOI 10.1111/j.1468-1293.2008.00675.x; Audsley J, 2010, VIROLOGY, V405, P539, DOI 10.1016/j.virol.2010.06.038; Baptista M, 1999, HEPATOLOGY, V29, P946, DOI 10.1002/hep.510290336; Barth RE, 2011, J MED VIROL, V83, P929, DOI 10.1002/jmv.22026; Bell TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045750; Bock CT, 2002, GASTROENTEROLOGY, V122, P264, DOI 10.1053/gast.2002.31015; BOTHA JF, 1984, LANCET, V1, P1210; Bowyer SM, 1997, J GEN VIROL, V78, P1719, DOI 10.1099/0022-1317-78-7-1719; Boyles TH, 2011, SAMJ S AFR MED J, V101, P470; Buckwold VE, 1997, J GEN VIROL, V78, P2055, DOI 10.1099/0022-1317-78-8-2055; Burnett RJ, 2007, INT J STD AIDS, V18, P152, DOI 10.1258/095646207780132523; Burnett RJ, 2005, LIVER INT, V25, P201, DOI 10.1111/j.1478-3231.2005.01054.x; CARMAN WF, 1989, LANCET, V2, P588; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Chen CY, 2008, HEPATOL RES, V38, P580, DOI 10.1111/j.1872-034X.2007.00315.x; Chen WN, 2000, EUR J CLIN INVEST, V30, P787; Collinson MA, 2007, SCAND J PUBLIC HEALT, V35, P77, DOI 10.1080/14034950701356401; Delaney WE, 2003, J VIROL, V77, P11833, DOI 10.1128/JVI.77.21.11833-11841.2003; DIBISCEGLIE AM, 1985, J MED VIROL, V16, P337, DOI 10.1002/jmv.1890160406; Fares MA, 2002, J MOL EVOL, V54, P807, DOI 10.1007/s00239-001-0084-z; Firnhaber C, 2012, INT J INFECT DIS, V16, pE268, DOI 10.1016/j.ijid.2011.12.007; Firnhaber C, 2008, SAMJ S AFR MED J, V98, P541; Firnhaber C, 2009, INT J INFECT DIS, V13, P488, DOI 10.1016/j.ijid.2008.08.018; Gous N, 2010, ANTIVIR THER, V15, P61, DOI 10.3851/IMP1487; Gunther S, 1998, J CLIN MICROBIOL, V36, P531; Gutierrez C, 2004, J MED VIROL, V73, P200, DOI 10.1002/jmv.20076; Henke-Gendo C, 2008, J INFECT DIS, V198, P1620, DOI 10.1086/592987; Hildt E, 1996, VIROLOGY, V225, P235, DOI 10.1006/viro.1996.0594; Hoffmann CJ, 2008, CLIN INFECT DIS, V47, P1479, DOI 10.1086/593104; Hou JL, 2002, J GEN VIROL, V83, P2291, DOI 10.1099/0022-1317-83-9-2291; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Huy TTT, 2008, J VIROL, V82, P5657, DOI 10.1128/JVI.02556-07; Iacomi F, 2009, J MED VIROL, V81, P1151, DOI 10.1002/jmv.21505; Kew MC, 2005, J MED VIROL, V75, P513, DOI 10.1002/jmv.20311; Kew MC, 1996, GUT, V38, pS31, DOI 10.1136/gut.38.Suppl_2.S31; Kim HS, 1997, J GEN VIROL, V78, P1083, DOI 10.1099/0022-1317-78-5-1083; Kimbi GC, 2004, J GEN VIROL, V85, P1211, DOI 10.1099/vir.0.19749-0; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kottilil S, 2005, INDIAN J MED RES, V121, P424; Kramvis A, 2005, J VIRAL HEPATITIS, V12, P456, DOI 10.1111/j.1365-2893.2005.00624.x; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Kramvis A, 2007, HEPATOL RES, V37, pS27, DOI 10.1111/j.1872-034X.2007.00100.x; Laras A, 1998, J VIRAL HEPATITIS, V5, P241, DOI 10.1046/j.1365-2893.1998.00109.x; Lin CM, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-17; Lukhwareni A, 2009, J MED VIROL, V81, P406, DOI 10.1002/jmv.21418; Matthews GV, 2011, AIDS, V25, P1727, DOI 10.1097/QAD.0b013e328349bbf3; Mphahlele MJ, 2006, J CLIN VIROL, V35, P14, DOI 10.1016/j.jcv.2005.04.003; NAUMANN H, 1993, J GEN VIROL, V74, P1627, DOI 10.1099/0022-1317-74-8-1627; Nicholas K.B., 1997, GENEDOC ANAL VISUALI; NORDER H, 1992, J GEN VIROL, V73, P3141, DOI 10.1099/0022-1317-73-12-3141; NORDER H, 1994, VIROLOGY, V198, P489, DOI 10.1006/viro.1994.1060; OKAMOTO H, 1988, J GEN VIROL, V69, P2575, DOI 10.1099/0022-1317-69-10-2575; Olinger CM, 2008, EMERG INFECT DIS, V14, P1777, DOI 10.3201/eid1411.080437; Orito E, 2001, HEPATOLOGY, V33, P218, DOI 10.1053/jhep.2001.20532; ORITO E, 1989, P NATL ACAD SCI USA, V86, P7059, DOI 10.1073/pnas.86.18.7059; Osiowy C, 2010, J MED VIROL, V82, P942, DOI 10.1002/jmv.21758; PASTORE G, 1988, J HEPATOL, V7, P164, DOI 10.1016/S0168-8278(88)80478-1; Paulij WP, 1999, J GEN VIROL, V80, P2121, DOI 10.1099/0022-1317-80-8-2121; Quarleri J, 2007, AIDS RES HUM RETROV, V23, P525, DOI 10.1089/aid.2006.0172; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salisse J, 2009, J VIROL, V83, P9321, DOI 10.1128/JVI.00678-09; Selabe SG, 2007, J MED VIROL, V79, P1650, DOI 10.1002/jmv.20974; Selabe SG, 2009, J MED VIROL, V81, P996, DOI 10.1002/jmv.21479; Stuyver L, 2000, J GEN VIROL, V81, P67, DOI 10.1099/0022-1317-81-1-67; TAKAHASHI K, 1995, J GEN VIROL, V76, P3159, DOI 10.1099/0022-1317-76-12-3159; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tatematsu K, 2009, J VIROL, V83, P10538, DOI 10.1128/JVI.00462-09; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Torresi J, 2002, VIROLOGY, V299, P88, DOI 10.1006/viro.2002.1448; Torresi J, 2002, VIROLOGY, V293, P305, DOI 10.1006/viro.2001.1246; Torresi J, 2002, J CLIN VIROL, V25, P97, DOI 10.1016/S1386-6532(02)00049-5; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Vardas E, 1999, J MED VIROL, V58, P111, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;111::AID-JMV2&gt;3.0.CO;2-B; VENTO S, 1989, LANCET, V2, P108; Vermeulen M, 2012, TRANSFUSION, V52, P880, DOI 10.1111/j.1537-2995.2011.03355.x; XIA X, 2000, DATA ANAL MOL BIOL E; Yeh CT, 2010, HEPATOLOGY, V52, P1922, DOI 10.1002/hep.23898; Yeung P, 2011, J INFECT DIS, V203, P646, DOI 10.1093/infdis/jiq096; Yu H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009297; Zhang D, 2012, BMC INFECT DIS, V10, P271; Zhou Y, 2007, J MOL EVOL, V65, P197, DOI 10.1007/s00239-007-0054-1	91	34	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46345	10.1371/journal.pone.0046345	http://dx.doi.org/10.1371/journal.pone.0046345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029487	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900140
J	Park, SH; Sim, WY; Min, BH; Yang, SS; Khademhosseini, A; Kaplan, DL				Park, Sang-Hyug; Sim, Woo Young; Min, Byoung-Hyun; Yang, Sang Sik; Khademhosseini, Ali; Kaplan, David L.			Chip-Based Comparison of the Osteogenesis of Human Bone Marrow- and Adipose Tissue-Derived Mesenchymal Stem Cells under Mechanical Stimulation	PLOS ONE			English	Article							HUMAN OSTEOBLAST PROLIFERATION; EXTRACELLULAR-MATRIX; STROMAL CELLS; SHEAR-STRESS; DIFFERENTIATION; EXPRESSION; INTEGRIN; STRAIN; PERFUSION; PROTEIN	Adipose tissue-derived stem cells (ASCs) are considered as an attractive stem cell source for tissue engineering and regenerative medicine. We compared human bone marrow-derived mesenchymal stem cells (hMSCs) and hASCs under dynamic hydraulic compression to evaluate and compare osteogenic abilities. A novel micro cell chip integrated with microvalves and microscale cell culture chambers separated from an air-pressure chamber was developed using microfabrication technology. The microscale chip enables the culture of two types of stem cells concurrently, where each is loaded into cell culture chambers and dynamic compressive stimulation is applied to the cells uniformly. Dynamic hydraulic compression (1 Hz, 1 psi) increased the production of osteogenic matrix components (bone sialoprotein, oateopontin, type I collagen) and integrin (CD11b and CD31) expression from both stem cell sources. Alkaline phosphatase and Alrizarin red staining were evident in the stimulated hMSCs, while the stimulated hASCs did not show significant increases in staining under the same stimulation conditions. Upon application of mechanical stimulus to the two types of stem cells, integrin (beta 1) and osteogenic gene markers were upregulated from both cell types. In conclusion, stimulated hMSCs and hASCs showed increased osteogenic gene expression compared to non-stimulated groups. The hMSCs were more sensitive to mechanical stimulation and more effective towards osteogenic differentiation than the hASCs under these modes of mechanical stimulation.	[Park, Sang-Hyug; Kaplan, David L.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Park, Sang-Hyug] Jungwon Univ, Dept Biomed Engn, Goesan Eup, Chungbuk, South Korea; [Sim, Woo Young; Khademhosseini, Ali] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Biomed Engn,Dept Med, Boston, MA 02115 USA; [Sim, Woo Young; Khademhosseini, Ali] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Min, Byoung-Hyun] Ajou Univ, Dept Orthopead Surg, Sch Med, Suwon 441749, South Korea; [Min, Byoung-Hyun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea; [Yang, Sang Sik] Ajou Univ, Dept Elect & Comp Engn, Suwon 441749, South Korea; [Khademhosseini, Ali] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	Tufts University; Jungwon University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Ajou University; Ajou University; Ajou University; Harvard University	Kaplan, DL (corresponding author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.	david.kaplan@tufts.edu	Khademhosseini, Ali/A-9435-2010	Khademhosseini, Ali/0000-0002-2692-1524; Min, Byoung-Hyun/0000-0001-8928-414X; Khademhosseini, Ali/0000-0001-6322-8852	National Institutes of Health [EB003210, EB002520, EB008392]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003210, R01EB008392, P41EB002520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Support from the National Institutes of Health [EB003210 (DLK), EB002520 (DLK) and EB008392 (AK)] for these studies is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arihiro K, 2001, PATHOL INT, V51, P100, DOI 10.1046/j.1440-1827.2001.01164.x; Baker M, 2011, NATURE, V471, P661, DOI 10.1038/471661a; Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599; CARVALHO RS, 1995, ARCH ORAL BIOL, V40, P257, DOI 10.1016/0003-9969(95)98814-F; CHENG S, 1994, J MED CHEM, V37, P1, DOI 10.1021/jm00027a001; Cregger M, 2006, ARCH PATHOL LAB MED, V130, P1026; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fan M, 2006, J CELL PHYSIOL, V207, P454, DOI 10.1002/jcp.20581; Globus R K, 1995, ASGSB Bull, V8, P19; Hanson AD, 2009, ANN BIOMED ENG, V37, P955, DOI 10.1007/s10439-009-9648-7; Hayashi O, 2008, CALCIFIED TISSUE INT, V82, P238, DOI 10.1007/s00223-008-9112-y; Hebert E, 2000, BIOSCIENCE REP, V20, P213, DOI 10.1023/A:1026484722248; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Hwang CM, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/4/045001; Hwang NS, 2008, ADV DRUG DELIVER REV, V60, P199, DOI 10.1016/j.addr.2007.08.036; Ilan N, 2003, CURR OPIN CELL BIOL, V15, P515, DOI 10.1016/S0955-0674(03)00100-5; Jagodzinski M, 2008, J BIOMECH, V41, P1885, DOI 10.1016/j.jbiomech.2008.04.001; Jagodzinski M, 2004, Eur Cell Mater, V7, P35; Jang K, 2008, ANAL BIOANAL CHEM, V390, P825, DOI 10.1007/s00216-007-1752-7; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Kaspar D, 2000, J BIOMECH, V33, P45, DOI 10.1016/S0021-9290(99)00171-2; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013; Kim K, 2010, BIOCHIP J, V4, P148, DOI 10.1007/s13206-010-4210-0; Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Knippenberg M, 2005, TISSUE ENG, V11, P1780, DOI 10.1089/ten.2005.11.1780; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Liu F, 2003, J CELL SCI, V116, P1787, DOI 10.1242/jcs.00376; Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109; Miura Y, 2005, P NATL ACAD SCI USA, V102, P14022, DOI 10.1073/pnas.0409397102; Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068; Ogawa Rei, 2006, Curr Stem Cell Res Ther, V1, P13, DOI 10.2174/157488806775269043; Park SH, 2006, TISSUE ENG, V12, P3107, DOI 10.1089/ten.2006.12.3107; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pommerenke H, 2002, J BONE MINER RES, V17, P603, DOI 10.1359/jbmr.2002.17.4.603; Prodanov L, 2010, BIOMATERIALS, V31, P7758, DOI 10.1016/j.biomaterials.2010.06.050; Qi MC, 2008, INT J ORAL MAX SURG, V37, P453, DOI 10.1016/j.ijom.2007.12.008; Qi MC, 2009, INT J ORAL SCI, V1, P143, DOI 10.4248/IJOS.09021; RAMBAUT PC, 1985, LANCET, V2, P1050; Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432; Schmidt C, 1998, J BIOL CHEM, V273, P5081, DOI 10.1074/jbc.273.9.5081; Shav D, 2010, ANN NY ACAD SCI, V1188, P25, DOI 10.1111/j.1749-6632.2009.05079.x; Sim WY, 2007, LAB CHIP, V7, P1775, DOI 10.1039/b712361m; SIMKIN A, 1987, CALCIFIED TISSUE INT, V40, P59, DOI 10.1007/BF02555706; Szeszel MK, 2005, J HISTOCHEM CYTOCHEM, V53, P753, DOI 10.1369/jhc.4A6600.2005; Tani-Ishii N, 2002, J PERIODONTAL RES, V37, P184, DOI 10.1034/j.1600-0765.2002.00610.x; Todd RF, 1997, J LAB CLIN MED, V129, P492, DOI 10.1016/S0022-2143(97)90003-2; Ward DF, 2007, STEM CELLS DEV, V16, P467, DOI 10.1089/scd.2007.0034; Wozniak M, 2000, J BONE MINER RES, V15, P1731, DOI 10.1359/jbmr.2000.15.9.1731; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606; Xiong YM, 2003, J IMMUNOL, V171, P1042, DOI 10.4049/jimmunol.171.2.1042; Yoshikawa T, 1997, BIO-MED MATER ENG, V7, P369; Zhu YX, 2008, CELL BIOCHEM FUNCT, V26, P664, DOI 10.1002/cbf.1488; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	58	83	90	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46689	10.1371/journal.pone.0046689	http://dx.doi.org/10.1371/journal.pone.0046689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029565	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900199
J	Perlis, RH; Ruderfer, D; Hamilton, SP; Ernst, C				Perlis, Roy H.; Ruderfer, Douglas; Hamilton, Steven P.; Ernst, Carl			Copy Number Variation in Subjects with Major Depressive Disorder Who Attempted Suicide	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PSYCHIATRIC-DISORDERS; RISK; METAANALYSIS; RECURRENT; BEHAVIOR	Background: Suicide is one of the top ten leading causes of death in North America and represents a major public health burden, partcularly for people with Major Depressive disorder (MD). Many studies have suggested that suicidal behavior runs in families, however, identification of genomic loci that drive this efffect remain to be identified. Methodology/Principal Findings: Using subjects collected as part of STAR*D, we genotyped 189 subjects with MD with history of a suicide attempt and 1073 subjects with Major Depressive disorder that had never attempted suicide. Copy Number Variants (CNVs) were called in Birdsuite and analyzed in PLINK. We found a set of CNVs present in the suicide attempter group that were not present in in the non-attempter group including in SNTG2 and MACROD2 - two brain expressed genes previously linked to psychopathology; however, these results failed to reach genome-wide signifigance. Conclusions: These data suggest potential CNVs to be investigated further in relation to suicide attempts in MD using large sample sizes.	[Ernst, Carl] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Perlis, Roy H.; Ruderfer, Douglas; Ernst, Carl] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA; [Hamilton, Steven P.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA	McGill University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of California System; University of California San Francisco	Ernst, C (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	carl.ernst@mcgill.ca	Ruderfer, Douglas M/M-5795-2016	Ruderfer, Douglas M/0000-0002-2365-386X; Hamilton, Steven/0000-0001-8106-6260	American Foundation for Suicide Prevention; Canada Research Chair in Psychiatric Genetics; Proteus Biomedical	American Foundation for Suicide Prevention; Canada Research Chair in Psychiatric Genetics; Proteus Biomedical	This work was funded by a Young Investigator grant from the American Foundation for Suicide Prevention to CE. CE receives salary support from a Canada Research Chair in Psychiatric Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CE, DR, and SH have declared that no competing interests exist RP has received research support from Proteus Biomedical. RP has consulted or advised for Genomind; Proteus Biomedical; RIDVentures. RP has a financial interest in Concordant Rater Systems. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Brent DA, 2002, ARCH GEN PSYCHIAT, V59, P801, DOI 10.1001/archpsyc.59.9.801; Brent DA, 1996, ARCH GEN PSYCHIAT, V53, P1145; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Dumais A, 2005, AM J PSYCHIAT, V162, P2116, DOI 10.1176/appi.ajp.162.11.2116; Garriock HA, 2010, BIOL PSYCHIAT, V67, P133, DOI 10.1016/j.biopsych.2009.08.029; Kessler RC, 1997, PSYCHOL MED, V27, P861, DOI 10.1017/S0033291797004807; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lee C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001390; Mondimore FM, 2006, AM J PSYCHIAT, V163, P1554, DOI 10.1176/appi.ajp.163.9.1554; Muglia P, 2010, MOL PSYCHIATR, V15, P589, DOI 10.1038/mp.2008.131; Munafo MR, 2006, GENES BRAIN BEHAV, V5, P3, DOI 10.1111/j.1601-183X.2006.00188.x; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Perlis RH, 2010, AM J PSYCHIAT, V167, P1499, DOI 10.1176/appi.ajp.2010.10040541; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Weissman M, 2009, ANN EPIDEMIOL, V19, P264, DOI 10.1016/j.annepidem.2009.01.021	23	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46315	10.1371/journal.pone.0046315	http://dx.doi.org/10.1371/journal.pone.0046315			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029476	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517500088
J	Talmont, F; Mouledous, L; Boue, J; Mollereau, C; Dietrich, G				Talmont, Franck; Mouledous, Lionel; Boue, Jerome; Mollereau, Catherine; Dietrich, Gilles			Denatured G-Protein Coupled Receptors as Immunogens to Generate Highly Specific Antibodies	PLOS ONE			English	Article							MU-OPIOID-RECEPTOR; NEUROBLASTOMA SH-SY5Y CELLS; 3RD EXTRACELLULAR LOOPS; MORPHINE-LIKE ACTIVITY; NATURAL HUMAN-IGG; PICHIA-PASTORIS; FUNCTIONAL EXPRESSION; ADRENERGIC-RECEPTORS; SYSTEM; MICE	G-protein coupled receptors (GPCRs) play a major role in a number of physiological and pathological processes. Thus, GPCRs have become the most frequent targets for development of new therapeutic drugs. In this context, the availability of highly specific antibodies may be decisive to obtain reliable findings on localization, function and medical relevance of GPCRs. However, the rapid and easy generation of highly selective anti-GPCR antibodies is still a challenge. Herein, we report that highly specific antibodies suitable for detection of GPCRs in native and unfolded forms can be elicited by immunizing animals against purified full length denatured recombinant GPCRs. Contrasting with the currently admitted postulate, our study shows that an active and well-folded GPCR is not required for the production of specific anti-GPCR antibodies. This new immunizing strategy validated with three different human GPCR (m-opioid, k-opioid, neuropeptide FF2 receptors) might be generalized to other members of the GPCR family.	[Talmont, Franck; Mouledous, Lionel; Mollereau, Catherine] IPBS, CNRS, Toulouse, France; [Talmont, Franck; Mouledous, Lionel; Boue, Jerome; Mollereau, Catherine; Dietrich, Gilles] Univ Toulouse 3, F-31062 Toulouse, France; [Boue, Jerome; Dietrich, Gilles] Fac Med Toulouse, INSERM, U1043, Ctr Physiopathol Toulouse Purpan, F-31073 Toulouse, France; [Boue, Jerome; Dietrich, Gilles] CNRS, U5282, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS)	Talmont, F (corresponding author), IPBS, CNRS, Toulouse, France.	franck.talmont@ipbs.fr	Dietrich, Gilles/AAC-2119-2020	Dietrich, Gilles/0000-0002-2232-1716; Mollereau, Catherine/0000-0003-1543-5624; Mouledous, Lionel/0000-0002-7675-3493	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite Paul Sabatier, Toulouse III	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paul Sabatier, Toulouse III	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Institut National de la Sante et de la Recherche Medicale (INSERM), and the Universite Paul Sabatier, Toulouse III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agirregoitia E, 2006, J CLIN ENDOCR METAB, V91, P4969, DOI 10.1210/jc.2006-0599; Asada H, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-24; Baneres JL, 2011, TRENDS BIOTECHNOL, V29, P314, DOI 10.1016/j.tibtech.2011.03.002; Beermann S, 2011, N-S ARCH PHARMACOL, V385, P125; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Bockaert J, 2004, CURR OPIN DRUG DISC, V7, P649; Boue J, 2012, PAIN, V153, P485, DOI 10.1016/j.pain.2011.11.013; Boue J, 2011, J IMMUNOL, V186, P5078, DOI 10.4049/jimmunol.1003335; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Day PW, 2007, NAT METHODS, V4, P927, DOI 10.1038/NMETH1112; Dietrich G, 1998, J NEUROCHEM, V70, P2106; Gupta A, 2007, J BIOL CHEM, V282, P5116, DOI 10.1074/jbc.M609254200; Gupta A, 2006, MT SINAI J MED, V73, P673; Hamdani N, 2009, N-S ARCH PHARMACOL, V379, P403, DOI 10.1007/s00210-009-0392-1; Harrison Charlotte, 2006, Journal of Pharmacological and Toxicological Methods, V54, P26, DOI 10.1016/j.vascn.2005.11.001; Hino T, 2012, NATURE, V482, P237, DOI 10.1038/nature10750; Huang LL, 2005, J MOL RECOGNIT, V18, P327, DOI 10.1002/jmr.735; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Jositsch G, 2009, N-S ARCH PHARMACOL, V379, P389, DOI 10.1007/s00210-008-0365-9; KAZMI SMI, 1987, MOL PHARMACOL, V32, P109; Kivell BM, 2004, DEV BRAIN RES, V149, P9, DOI 10.1016/j.devbrainres.2003.11.012; Koutsopoulos S, 2012, CHEM SOC REV, V41, P1721, DOI 10.1039/c1cs15180k; Lu XY, 2009, N-S ARCH PHARMACOL, V379, P417, DOI 10.1007/s00210-009-0394-z; Mace G, 2002, BLOOD, V100, P3261, DOI 10.1182/blood-2002-01-0055; Mace G, 1999, J BIOL CHEM, V274, P20079, DOI 10.1074/jbc.274.29.20079; Mace G, 1999, EUR J IMMUNOL, V29, P997, DOI 10.1002/(SICI)1521-4141(199903)29:03<997::AID-IMMU997>3.0.CO;2-1; Mancia F, 2007, P NATL ACAD SCI USA, V104, P4303, DOI 10.1073/pnas.0700301104; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Mollereau C, 2005, MOL PHARMACOL, V67, P965, DOI 10.1124/mol.104.004614; Mouledous L, 2005, MOL PHARMACOL, V68, P467, DOI 10.1124/mol.105.013391; Muller I, 2008, J MEMBRANE BIOL, V223, P49, DOI 10.1007/s00232-008-9112-x; Muller I, 2010, APPL BIOCHEM BIOTECH, V160, P2175, DOI 10.1007/s12010-009-8715-8; Niwa H, 2012, BRIT J ANAESTH, V108, P530, DOI 10.1093/bja/aes015; Peckys D, 1999, NEUROSCIENCE, V88, P1093, DOI 10.1016/S0306-4522(98)00251-6; Pradidarcheep W, 2009, N-S ARCH PHARMACOL, V379, P397, DOI 10.1007/s00210-009-0393-0; Sarramegna V, 2006, CELL MOL LIFE SCI, V63, P1149, DOI 10.1007/s00018-005-5557-6; Sarramegna V, 2005, PROTEIN EXPRES PURIF, V43, P85, DOI 10.1016/j.pep.2005.05.007; Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7; Scherrer G, 2009, CELL, V137, P1148, DOI 10.1016/j.cell.2009.04.019; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Singh S, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-28; Stein C, 2011, PHARMACOL REV, V63, P860, DOI 10.1124/pr.110.003145; Tansky MF, 2007, P NATL ACAD SCI USA, V104, P10691, DOI 10.1073/pnas.0703394104	44	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46348	10.1371/journal.pone.0046348	http://dx.doi.org/10.1371/journal.pone.0046348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029489	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500092
J	Fang, YP; Middaugh, CR; Fang, JW				Fang, Yaping; Middaugh, C. Russell; Fang, Jianwen			In Silico Classification of Proteins from Acidic and Neutral Cytoplasms	PLOS ONE			English	Article							SOLVENT ACCESSIBILITY; SECONDARY STRUCTURE; THERMAL ADAPTATION; RATIONAL DESIGN; PREDICTION; STABILITY; PH; THERMOSTABILITY; RUSTICYANIN; BACTERIA	Protein acidostability is a common problem in biopharmaceutical and other industries. However, it remains a great challenge to engineer proteins for enhanced acidostability because our knowledge of protein acidostabilization is still very limited. In this paper, we present a comparative study of proteins from bacteria with acidic (AP) and neutral cytoplasms (NP) using an integrated statistical and machine learning approach. We construct a set of 393 non-redundant AP-NP ortholog pairs and calculate a total of 889 sequence based features for these proteins. The pairwise alignments of these ortholog pairs are used to build a residue substitution propensity matrix between APs and NPs. We use Gini importance provided by the Random Forest algorithm to rank the relative importance of these features. A scoring function using the 10 most significant features is developed and optimized using a hill climbing algorithm. The accuracy of the score function is 86.01% in predicting AP-NP ortholog pairs and is 76.65% in predicting non-ortholog AP-NP pairs, suggesting that there are significant differences between APs and NPs which can be used to predict relative acidostability of proteins. The overall trends uncovered in the study can be used as general guidelines for designing acidostable proteins. To best of our knowledge, this work represents the first systematic comparative study of the acidostable proteins and their non-acidostable orthologs.	[Fang, Yaping; Fang, Jianwen] Univ Kansas, Appl Bioinformat Lab, Lawrence, KS 66045 USA; [Middaugh, C. Russell] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66045 USA	University of Kansas; University of Kansas	Fang, JW (corresponding author), Univ Kansas, Appl Bioinformat Lab, Lawrence, KS 66045 USA.	jwfang@ku.edu		Fang, Yaping/0000-0001-6075-0768				Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Allison SD, 2006, BIOGEOCHEMISTRY, V81, P361, DOI 10.1007/s10533-006-9046-2; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker-Austin C, 2007, TRENDS MICROBIOL, V15, P165, DOI 10.1016/j.tim.2007.02.005; Botuyan MV, 1996, J MOL BIOL, V263, P752, DOI 10.1006/jmbi.1996.0613; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Counterman AE, 1999, J AM CHEM SOC, V121, P4031, DOI 10.1021/ja984344p; Das S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-186; Diaz-Uriarte R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-328; DUBCHAK I, 1993, PROTEINS, V16, P79, DOI 10.1002/prot.340160109; EISENHABER F, 1993, J COMPUT CHEM, V14, P1272, DOI 10.1002/jcc.540141103; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelch BA, 2007, J MOL BIOL, V368, P870, DOI 10.1016/j.jmb.2007.02.032; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Krulwich TA, 2011, NAT REV MICROBIOL, V9, P330, DOI 10.1038/nrmicro2549; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-62; Liao J, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-16; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Mahato RI, 2003, CRIT REV THER DRUG, V20, P153, DOI 10.1615/CritRevTherDrugCarrierSyst.v20.i23.30; Mandrich L, 2004, J MOL BIOL, V335, P357, DOI 10.1016/j.jmb.2003.10.038; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; McDonald JH, 2001, MOL BIOL EVOL, V18, P741, DOI 10.1093/oxfordjournals.molbev.a003856; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; MENZEL U, 1985, ARCH MICROBIOL, V143, P47, DOI 10.1007/BF00414767; Vinh NX, 2011, BIOINFORMATICS, V27, P2765, DOI 10.1093/bioinformatics/btr457; Nielsen JE, 2007, J MOL GRAPH MODEL, V25, P691, DOI 10.1016/j.jmgm.2006.05.007; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Sadeghi M, 2006, BIOPHYS CHEM, V119, P256, DOI 10.1016/j.bpc.2005.09.018; Sakurai K, 2011, MICROBIOL-SGM, V157, P899, DOI 10.1099/mic.0.045906-0; Schweiker Katrina L., 2009, V490, P261, DOI 10.1007/978-1-59745-367-7_11; Schweiker KL, 2009, METHOD ENZYMOL, V454, P175, DOI 10.1016/S0076-6879(08)03807-X; Slonczewski JL, 2009, ADV MICROB PHYSIOL, V55, P1, DOI 10.1016/S0065-2911(09)05501-5; Tynan-Connolly BM, 2006, NUCLEIC ACIDS RES, V34, pW48, DOI 10.1093/nar/gkl192; Walter RL, 1996, J MOL BIOL, V263, P730, DOI 10.1006/jmbi.1996.0612; Wilkins MR, 1999, METH MOL B, V112, P531	42	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45585	10.1371/journal.pone.0045585	http://dx.doi.org/10.1371/journal.pone.0045585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049817	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300034
J	Marschinke, F; Hashemian, S; Matozaki, T; Oldenborg, PA; Stromberg, I				Marschinke, Franziska; Hashemian, Sanaz; Matozaki, Takashi; Oldenborg, Per-Arne; Stromberg, Ingrid			The Absence of CD47 Promotes Nerve Fiber Growth from Cultured Ventral Mesencephalic Dopamine Neurons	PLOS ONE			English	Article							INTEGRIN-ASSOCIATED PROTEIN; ORGANOTYPIC TISSUE-CULTURES; CHONDROITIN SULFATE PROTEOGLYCAN; SIGNAL-REGULATORY PROTEIN; NEURITE OUTGROWTH; CORTICAL-NEURONS; CELL-ADHESION; INHIBITION; SHP-2; THROMBOSPONDIN	In ventral mesencephalic organotypic tissue cultures, two timely separated sequences of nerve fiber growth have been observed. The first appearing nerve fiber pattern is a long-distance outgrowth that occurs before astrocytes start to proliferate and migrate to form an astrocytic monolayer that finally surrounds the tissue slice. These long-distance growing nerve fibers are retracted as the astrocytes migrate, and are followed by a secondary outgrowth. The secondary outgrowth is persistent in time but reaches short distances, comparable with outgrowth seen from a dopaminergic graft implanted to the brain. The present study was focused on the interaction between the astrocytes and the long-distance growing non-glial associated nerve fibers. Cross talk between astroglia and neurite formation might occur through the integrin-associated protein CD47. CD47 serves as a ligand for signal regulatory protein (SIRP) alpha and as a receptor for the extracellular matrix protein thrombospondin-1 (TSP-1). Embryonic day 14 ventral mesencephalic tissue from CD47(+/+) and CD47(-/-) mice was used to investigate astrocytic migration and the tyrosine hydroxylase (TH) -positive outgrowth that occurred remote from the astrocytes. TH-immunohistochemistry demonstrated that the non-glial-associated nerve fiber outgrowth in CD47(-/-) cultures reached significantly longer distances and higher density compared to nerve fibers formed in CD47(+/+) cultures at 14 days in vitro. These nerve fibers often had a dotted appearance in CD47(+/+) cultures. No difference in the astrocytic migration was observed. Further investigations revealed that the presence of CD47 in control culture did neither hamper non-glial-associated growth through SIRP alpha nor through TSP-1 since similar outgrowth was found in SIRP alpha mutant cultures and in CD47(+/+) cultures treated with blocking antibodies against the TSP-1, respectively, as in the control cultures. In conclusion, long-distance growing nerve fiber formation is promoted by the absence of CD47, even though the presence of astrocytes is not inhibited.	[Marschinke, Franziska; Hashemian, Sanaz; Oldenborg, Per-Arne; Stromberg, Ingrid] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Matozaki, Takashi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Signaling, Kobe, Hyogo 657, Japan	Umea University; Kobe University	Stromberg, I (corresponding author), Umea Univ, Dept Integrat Med Biol, Umea, Sweden.	ingrid.stromberg@histocel.umu.se			Swedish Research Council [09917]; Umea University Medical Faculty Foundations	Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea University Medical Faculty Foundations	This study was supported by the Swedish Research Council grant # 09917 and Umea University Medical Faculty Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	af Bjerken S, 2008, INT J DEV NEUROSCI, V26, P683, DOI 10.1016/j.ijdevneu.2008.07.014; af Bjerken S, 2007, BRAIN RES, V1133, P10, DOI 10.1016/j.brainres.2006.11.052; Araki T, 2000, J NEUROCHEM, V74, P659, DOI 10.1046/j.1471-4159.2000.740659.x; Barker RA, 1996, EXP NEUROL, V141, P79, DOI 10.1006/exnr.1996.0141; Berglof E, 2008, J NEUROSCI RES, V86, P84, DOI 10.1002/jnr.21465; Berglof E, 2007, J COMP NEUROL, V501, P431, DOI 10.1002/cne.21251; BICKNESE AR, 1994, J NEUROSCI, V14, P3500; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; COLE GJ, 1991, NEURON, V7, P1007, DOI 10.1016/0896-6273(91)90345-Z; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Fujioka Y, 1996, MOL CELL BIOL, V16, P6887; Gross RE, 2007, CELL TRANSPLANT, V16, P245, DOI 10.3727/000000007783464740; Huang AM, 1998, J NEUROSCI, V18, P4305; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Jiang PH, 1999, J BIOL CHEM, V274, P559, DOI 10.1074/jbc.274.2.559; Johansson S, 2003, CELL TRANSPLANT, V12, P243, DOI 10.3727/000000003108746803; Johansson S, 2002, J COMP NEUROL, V443, P237, DOI 10.1002/cne.10119; Kharitonenkov A, 1997, NATURE, V386, P181, DOI 10.1038/386181a0; Latour S, 2001, J IMMUNOL, V167, P2547, DOI 10.4049/jimmunol.167.5.2547; Lindberg FP, 1996, SCIENCE, V274, P795, DOI 10.1126/science.274.5288.795; Marschinke F, 2008, BRAIN RES, V1215, P30, DOI 10.1016/j.brainres.2008.03.070; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Mi ZP, 2000, J COMP NEUROL, V416, P335; Murata T, 2006, J NEUROSCI, V26, P12397, DOI 10.1523/JNEUROSCI.3981-06.2006; Myers SA, 2011, NEUROBIOL DIS, V42, P21, DOI 10.1016/j.nbd.2010.12.010; NEUGEBAUER KM, 1991, NEURON, V6, P345, DOI 10.1016/0896-6273(91)90244-T; NIKKHAH G, 1994, BRAIN RES, V633, P133, DOI 10.1016/0006-8993(94)91532-6; Numakawa T, 2004, J BIOL CHEM, V279, P43245, DOI 10.1074/jbc.M406733200; Ohnishi H, 2005, J NEUROSCI, V25, P2702, DOI 10.1523/JNEUROSCI.5173-04.2005; Ohnishi H, 2004, J BIOL CHEM, V279, P27878, DOI 10.1074/jbc.M313085200; Ohnishi H, 1999, J NEUROCHEM, V72, P1402, DOI 10.1046/j.1471-4159.1999.721402.x; OSHEA KS, 1990, J CELL BIOL, V110, P1275, DOI 10.1083/jcb.110.4.1275; OSTERHOUT DJ, 1992, DEV BIOL, V150, P256, DOI 10.1016/0012-1606(92)90240-H; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Seiffert M, 1999, BLOOD, V94, P3633, DOI 10.1182/blood.V94.11.3633.423k01_3633_3643; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Takai S, 2002, J NEUROCHEM, V82, P353, DOI 10.1046/j.1471-4159.2002.00960.x; TAKESHIMA T, 1994, NEUROSCIENCE, V60, P809, DOI 10.1016/0306-4522(94)90506-1; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200; Wang XXX, 2003, J NEUROCHEM, V86, P55, DOI 10.1046/j.1471-4159.2003.01810.x	42	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45218	10.1371/journal.pone.0045218	http://dx.doi.org/10.1371/journal.pone.0045218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049778	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300019
J	Papi, M; Brunelli, R; Familiari, G; Frassanito, MC; Lamberti, L; Maulucci, G; Monaci, M; Pappalettere, C; Parasassi, T; Relucenti, M; Sylla, L; Ursini, F; De Spirito, M				Papi, Massimiliano; Brunelli, Roberto; Familiari, Giuseppe; Frassanito, Maria Cristina; Lamberti, Luciano; Maulucci, Giuseppe; Monaci, Maurizio; Pappalettere, Carmine; Parasassi, Tiziana; Relucenti, Michela; Sylla, Lakamy; Ursini, Fulvio; De Spirito, Marco			Whole-Depth Change in Bovine Zona Pellucida Biomechanics after Fertilization: How Relevant in Hindering Polyspermy?	PLOS ONE			English	Article							IN-VITRO; RECOGNITION; EGGS	Polyspermy is a common problem in bovine in vitro fertilization (IVF) and has a still unclear etiology. In this specie, after IVF, despite the lack of a biochemical post-fertilization hardening, the stiffness of the outer ZP layer is significantly increased. Therefore, polyspermy might be related to an incomplete or insufficient stiffening of the ZP. We obtained, by using atomic force spectroscopy in physiological conditions, a complete characterization of the biomechanical changes of the inner and outer ZP layers occurring during oocyte maturation/fertilization and correlated them to the ultrastructural changes observed by transmission electron microscopy using ruthenium red and saponin technique. In both the inner and outer ZP layers, stiffness decreased at maturation while, conversely, increased after fertilization. Contextually, at the nanoscale, during maturation both ZP layers displayed a fine filaments network whose length increased while thickness decreased. After fertilization, filaments partially recovered the immature features, appearing again shorter and thicker. Overall, the observed biomechanical modifications were substantiated by ultrastructural findings in the ZP filament mesh. In fertilized ZP, the calculated force necessary to displace ZP filaments resulted quite similar to that previously reported as generated by bovine sperm flagellum. Therefore, in bovine IVF biomechanical modifications of ZP appear ineffective in hindering sperm transit, highlighting the relevance of additional mechanisms operating in vivo.	[Papi, Massimiliano; Maulucci, Giuseppe; De Spirito, Marco] Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy; [Brunelli, Roberto] Univ Roma La Sapienza, Dipartimento Sci Ginecol Ostetr & Sci Urol, Rome, Italy; [Familiari, Giuseppe; Relucenti, Michela] Univ Roma La Sapienza, Dipartimento Sci Anat Istol Med Legali & Apparato, Rome, Italy; [Frassanito, Maria Cristina; Lamberti, Luciano; Pappalettere, Carmine] Politecn Bari, Dipartimento Ingn Meccan & Gestionale, Bari, Italy; [Monaci, Maurizio; Sylla, Lakamy] Univ Perugia, Dipartimento Patol Diagnost & Clin Vet, I-06100 Perugia, Italy; [Parasassi, Tiziana] CNR, Ist Farmacol Traslazionale, Rome, Italy; [De Spirito, Marco] Fdn Ric & Cura Giovanni Paolo II, Campobasso, Italy; [Ursini, Fulvio] Univ Padua, Dipartimento Chim Biol, Padua, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; Sapienza University Rome; Politecnico di Bari; University of Perugia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); IRCCS Istituto Tumori Bari Giovanni Paolo II; University of Padua	De Spirito, M (corresponding author), Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy.	m.despirito@rm.unicatt.it	Maulucci, Giuseppe/C-7400-2009; Relucenti, Michela/I-2377-2012; De Spirito, Marco/U-3817-2019; Sylla, Lakamy/AFP-9574-2022; De Spirito, Marco/C-5386-2008; Papi, Massimiliano/AAC-3657-2022	Maulucci, Giuseppe/0000-0002-2154-319X; Relucenti, Michela/0000-0002-3805-9505; De Spirito, Marco/0000-0003-4260-5107; Sylla, Lakamy/0000-0002-7114-4736; De Spirito, Marco/0000-0003-4260-5107; Papi, Massimiliano/0000-0002-0029-1309; MONACI, MAURIZIO/0000-0002-6506-6794; Parasassi, Tiziana/0000-0002-9795-0568; LAMBERTI, Luciano/0000-0002-9845-8786; Pappalettere, Carmine/0000-0002-6947-2917	Universita Cattolica del S. Cuore	Universita Cattolica del S. Cuore	The research has been partially funded by Universita Cattolica del S. Cuore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Allen MJ, 2010, NANOMED-NANOTECHNOL, V6, P510, DOI 10.1016/j.nano.2009.12.003; Aviles M, 2010, MOL HUM REPROD, V16, P896, DOI 10.1093/molehr/gaq056; Boccaccio A, 2012, J R SOC INTERFACE, P1742, DOI [10.1098/rsif20120269, DOI 10.1098/RSIF20120269]; Brunelli R, 2007, FASEB J, V21, P3872, DOI 10.1096/fj.07-8189com; Coy P, 2008, P NATL ACAD SCI USA, V105, P15809, DOI 10.1073/pnas.0804422105; Coy P, 2008, REPRODUCTION, V135, P19, DOI 10.1530/REP-07-0280; De Spirito M, 2006, BIOPHYS J, V90, P4239, DOI 10.1529/biophysj.105.075788; DEGENNES PG, 1985, SCALING CONCEPTS POL; FAMILIARI G, 1992, MOL REPROD DEV, V32, P51, DOI 10.1002/mrd.1080320109; Familiari G, 2008, FRONT BIOSCI-LANDMRK, V13, P6730, DOI 10.2741/3185; Familiari G, 2006, INT REV CYTOL, V249, P53, DOI 10.1016/S0074-7696(06)49002-1; Familiari G, 2006, MICROSC RES TECHNIQ, V69, P415, DOI 10.1002/jemt.20301; Gahlay G, 2010, SCIENCE, V329, P216, DOI 10.1126/science.1188178; Garg SK, 2006, CLIN IMMUNOL, V121, P23, DOI 10.1016/j.clim.2006.06.003; Green D P, 1997, Rev Reprod, V2, P147, DOI 10.1530/ror.0.0020147; Hoodbhoy T, 2004, REPRODUCTION, V127, P417, DOI 10.1530/rep.1.00181; HYTTEL P, 1989, ANAT EMBRYOL, V179, P435, DOI 10.1007/BF00319585; Iwamoto K, 1999, J REPROD FERTIL, V117, P395, DOI 10.1530/jrf.0.1170395; Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039; Maulucci G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018906; MINHAS BS, 1984, BIOL REPROD, V30, P687, DOI 10.1095/biolreprod30.3.687; NOGUCHI S, 1994, BBA-GEN SUBJECTS, V1201, P7, DOI 10.1016/0304-4165(94)90143-0; Papi M, 2012, APPL PHYS LETT, V88; Papi M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2970963; Papi M, 2010, EUR BIOPHYS J BIOPHY, V39, P987, DOI 10.1007/s00249-009-0468-3; Papi M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3107265; Parasassi T, 2008, FASEB J, V22, P2350, DOI 10.1096/fj.07-097774; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Sun QY, 2003, MICROSC RES TECHNIQ, V61, P342, DOI 10.1002/jemt.10347; Tiribilli B, 2005, ULTRAMICROSCOPY, V102, P227, DOI 10.1016/j.ultramic.2004.10.003	30	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45696	10.1371/journal.pone.0045696	http://dx.doi.org/10.1371/journal.pone.0045696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049839	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300044
J	Perala, MM; Mannisto, S; Kaartinen, NE; Kajantie, E; Osmond, C; Barker, DJP; Valsta, LM; Eriksson, JG				Perala, Mia-Maria; Mannisto, Satu; Kaartinen, Niina E.; Kajantie, Eero; Osmond, Clive; Barker, David J. P.; Valsta, Liisa M.; Eriksson, Johan G.			Body Size at Birth Is Associated with Food and Nutrient Intake in Adulthood	PLOS ONE			English	Article							SWEET TASTE SENSITIVITY; LOW-PROTEIN DIET; PRENATAL EXPOSURE; HEART-DISEASE; FREQUENCY QUESTIONNAIRE; PHYSICAL-ACTIVITY; LEPTIN LEVELS; WEIGHT; RISK; GROWTH	Background: Small body size at birth is associated with an increased risk of cardiovascular disease and type 2 diabetes. Dietary habits are tightly linked with these disorders, but the association between body size at birth and adult diet has been little studied. We examined the association between body size at birth and intake of foods and macronutrients in adulthood. Methodology/Principal Findings: We studied 1797 participants, aged 56 to 70, of the Helsinki Birth Cohort Study, whose birth weight and length were recorded. Preterm births were excluded. During a clinical study, diet was assessed with a validated food-frequency questionnaire. A linear regression model adjusted for potential confounders was used to assess the associations. Intake of fruits and berries was 13.26 g (95% confidence interval [CI]: 0.56, 25.96) higher per 1 kg/m(3) increase in ponderal index (PI) at birth, and 83.16 g (95% CI: 17.76, 148.56) higher per 1 kg higher birth weight. One unit higher PI at birth was associated with 0.14% of energy (E%) lower intake of fat (95% CI: -0.26, -0.03) and 0.18 E% higher intake of carbohydrates (95% CI: 0.04, 0.32) as well as 0.08 E% higher sucrose (95% CI: 0.00, 0.15), 0.05 E% higher fructose (95% CI: 0.01, 0.09), and 0.18 g higher fiber (95% CI: 0.02, 0.34) intake in adulthood. Similar associations were observed between birth weight and macronutrient intake. Conclusions: Prenatal growth may modify later life food and macronutrient intake. Altered dietary habits could potentially explain an increased risk of chronic disease in individuals born with small body size.	[Perala, Mia-Maria; Mannisto, Satu; Kaartinen, Niina E.; Kajantie, Eero; Eriksson, Johan G.] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, Helsinki, Finland; [Osmond, Clive; Barker, David J. P.] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Barker, David J. P.] Oregon Hlth & Sci Univ, Heart Res Ctr, Portland, OR 97201 USA; [Barker, David J. P.] King Saud Univ, Fetal Programming Res Chair, Riyadh, Saudi Arabia; [Valsta, Liisa M.] Natl Inst Hlth & Welf, Dept Lifestyle & Participat, Helsinki, Finland; [Valsta, Liisa M.] European Food Safety Author, Parma, Italy; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Vaasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland	Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Southampton; Oregon Health & Science University; King Saud University; Finland National Institute for Health & Welfare; European Food Safety Authority; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital; Folkhalsan Research Center	Perala, MM (corresponding author), Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland.	mia.perala@thl.fi	Kaartinen, Niina/AAZ-8585-2020	Eriksson, Johan/0000-0002-2516-2060; Mannisto, Satu/0000-0002-8668-3046; Osmond, Clive/0000-0002-9054-4655; Perala, Mia-Maria/0000-0002-6349-6301	Academy of Finland; Emil Aaltonen Foundation; Finnish Foundation for Pediatric Research; Finska Lakaresallskapet; Samfundet Folkhalsan; Juho Vainio Foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Yrjo Jahnsson Foundation; Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Graduate School on Applied Bioscience; Medical Research Council [MC_UP_A620_1017] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC1016374] Funding Source: researchfish; MRC [MC_UP_A620_1017] Funding Source: UKRI	Academy of Finland(Academy of Finland); Emil Aaltonen Foundation; Finnish Foundation for Pediatric Research; Finska Lakaresallskapet; Samfundet Folkhalsan; Juho Vainio Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo Jahnsson Foundation; Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Finnish Graduate School on Applied Bioscience; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from Academy of Finland, Emil Aaltonen Foundation, Finnish Foundation for Pediatric Research, Finska Lakaresallskapet, Samfundet Folkhalsan, Juho Vainio Foundation, Novo Nordisk Foundation, Paivikki and Sakari Sohlberg Foundation, Signe and Ane Gyllenberg Foundation, Sigrid Juselius Foundation, Yrjo Jahnsson Foundation, The Diabetes Research Foundation, Finnish Foundation for Cardiovascular Research, and the Finnish Graduate School on Applied Bioscience. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Ayres C, 2012, INT J PEDIA IN PRESS; Barbieri MA, 2009, PEDIATR RES, V65, P215, DOI 10.1203/PDR.0b013e31818d6850; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bayol SA, 2007, BRIT J NUTR, V98, P843, DOI 10.1017/S0007114507812037; Bellinger L, 2004, BRIT J NUTR, V92, P513, DOI 10.1079/BJN20041224; Bellinger L, 2005, CLIN SCI, V109, P413, DOI 10.1042/CS20050127; Dauchet L, 2009, NAT REV CARDIOL, V6, P599, DOI 10.1038/nrcardio.2009.131; Erhuma A, 2007, BRIT J NUTR, V98, P517, DOI 10.1017/S0007114507721505; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Horton ES, 2009, OBESITY, V17, pS43, DOI 10.1038/oby.2009.388; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Ignarro LJ, 2007, CARDIOVASC RES, V73, P326, DOI 10.1016/j.cardiores.2006.06.030; Jyotaki M, 2010, ENDOCR J, V57, P467, DOI 10.1507/endocrj.K10E-095; Kaartinen NE, 2010, EUR J CLIN NUTR, V64, pS68, DOI 10.1038/ejcn.2010.214; Lissner L, 1999, OBES RES, V7, P150, DOI 10.1002/j.1550-8528.1999.tb00696.x; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lussana F, 2008, AM J CLIN NUTR, V88, P1648, DOI 10.3945/ajcn.2008.26140; Mannisto S, 1996, J CLIN EPIDEMIOL, V49, P401, DOI 10.1016/0895-4356(95)00551-X; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Nakamura Y, 2008, DIABETES, V57, P2661, DOI 10.2337/db07-1103; Paalanen L, 2006, J CLIN EPIDEMIOL, V59, P994, DOI 10.1016/j.jclinepi.2006.01.002; Phillips DIW, 1999, INT J OBESITY, V23, P1025, DOI 10.1038/sj.ijo.0801050; Plagemann A, 2000, J NUTR, V130, P2582, DOI 10.1093/jn/130.10.2582; Portella AK, 2012, J DEV ORIG HLTH DIS, V3, P140, DOI 10.1017/S2040174412000062; Primeaux SD, 2006, PEPTIDES, V27, P1644, DOI 10.1016/j.peptides.2005.12.009; Reinivuo H, 2010, PUBLIC HEALTH NUTR, V13, P915, DOI 10.1017/S1368980010001096; Shigemura N, 2004, ENDOCRINOLOGY, V145, P839, DOI 10.1210/en.2003-0602; Shultis WA, 2005, J EPIDEMIOL COMMUN H, V59, P955, DOI 10.1136/jech.2005.034413; Silveira PP, 2012, PEDIATR RES, V71, P293, DOI 10.1038/pr.2011.39; Stafford M, 1998, BRIT MED J, V316, P1247, DOI 10.1136/bmj.316.7139.1247; Stein AD, 2009, J NUTR, V139, P1555, DOI 10.3945/jn.109.105536; Umabiki M, 2010, TOHOKU J EXP MED, V220, P267, DOI 10.1620/tjem.220.267; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; Yliharsila H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612; Yliharsila H, 2008, AM J CLIN NUTR, V87, P1769, DOI 10.1093/ajcn/87.6.1769	37	51	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46139	10.1371/journal.pone.0046139	http://dx.doi.org/10.1371/journal.pone.0046139			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049962	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000309517300090
J	Ruiz-Lopez, MJ; Monello, RJ; Gompper, ME; Eggert, LS				Ruiz-Lopez, Maria Jose; Monello, Ryan J.; Gompper, Matthew E.; Eggert, Lori S.			The Effect and Relative Importance of Neutral Genetic Diversity for Predicting Parasitism Varies across Parasite Taxa	PLOS ONE			English	Article							HETEROZYGOSITY-FITNESS CORRELATIONS; DERMACENTOR-VARIABILIS; SPECIES RICHNESS; RESISTANCE; SELECTION; MHC; POPULATIONS; PREVALENCE; NEMATODES; RESOURCE	Understanding factors that determine heterogeneity in levels of parasitism across individuals is a major challenge in disease ecology. It is known that genetic makeup plays an important role in infection likelihood, but the mechanism remains unclear as does its relative importance when compared to other factors. We analyzed relationships between genetic diversity and macroparasites in outbred, free-ranging populations of raccoons (Procyon lotor). We measured heterozygosity at 14 microsatellite loci and modeled the effects of both multi-locus and single-locus heterozygosity on parasitism using an information theoretic approach and including non-genetic factors that are known to influence the likelihood of parasitism. The association of genetic diversity and parasitism, as well as the relative importance of genetic diversity, differed by parasitic group. Endoparasite species richness was better predicted by a model that included genetic diversity, with the more heterozygous hosts harboring fewer endoparasite species. Genetic diversity was also important in predicting abundance of replete ticks (Dermacentor variabilis). This association fit a curvilinear trend, with hosts that had either high or low levels of heterozygosity harboring fewer parasites than those with intermediate levels. In contrast, genetic diversity was not important in predicting abundance of non-replete ticks and lice (Trichodectes octomaculatus). No strong single-locus effects were observed for either endoparasites or replete ticks. Our results suggest that in outbred populations multi-locus diversity might be important for coping with parasitism. The differences in the relationships between heterozygosity and parasitism for the different parasites suggest that the role of genetic diversity varies with parasite-mediated selective pressures.	[Ruiz-Lopez, Maria Jose; Monello, Ryan J.; Gompper, Matthew E.] Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65211 USA; [Ruiz-Lopez, Maria Jose; Eggert, Lori S.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Ruiz-Lopez, MJ (corresponding author), Univ Missouri, Dept Fisheries & Wildlife Sci, Columbia, MO 65211 USA.	ruizlopezmj@gmail.com	Ruiz-Lopez, Maria Jose/AAA-8693-2020	Ruiz-Lopez, Maria Jose/0000-0002-6849-644X	National Science Foundation [DEB-0347609, DEB-3170841654]; Division of Biological Sciences	National Science Foundation(National Science Foundation (NSF)); Division of Biological Sciences	This work was supported by National Science Foundation grants DEB-0347609 and DEB-3170841654, and by Division of Biological Sciences new investigator funding to LSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2005, MOL ECOL, V14, P3209, DOI 10.1111/j.1365-294X.2005.02656.x; Acevedo-Whitehouse K, 2003, NATURE, V422, P35, DOI 10.1038/422035a; Acevedo-Whitehouse K, 2006, MOL ECOL, V15, P1973, DOI 10.1111/j.1365-294X.2006.02903.x; Amos W, 2011, P ROY SOC B-BIOL SCI, V278, P1183, DOI 10.1098/rspb.2010.1920; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; ANDERSON RM, 1986, PHILOS T ROY SOC B, V314, P533, DOI 10.1098/rstb.1986.0072; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Balloux F, 2004, EVOLUTION, V58, P1891; Berenos C, 2011, P ROY SOC B-BIOL SCI, V278, P218, DOI 10.1098/rspb.2010.1211; Bierne N, 2000, GENETICS, V155, P1981; Blanchet S, 2009, MOL ECOL, V18, P1112, DOI 10.1111/j.1365-294X.2009.04099.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chapman JR, 2009, MOL ECOL, V18, P2746, DOI 10.1111/j.1365-294X.2009.04247.x; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Cote SD, 2005, MOL ECOL, V14, P4159, DOI 10.1111/j.1365-294X.2005.02733.x; David P, 1998, HEREDITY, V80, P531, DOI 10.1046/j.1365-2540.1998.00393.x; DENHOLLANDER N, 1985, EXP PARASITOL, V59, P118, DOI 10.1016/0014-4894(85)90064-5; Eggert LS, 2005, METHOD ENZYMOL, V395, P73, DOI 10.1016/S0076-6879(05)95006-4; Ellison A, 2011, EVOLUTION, V65, P3021, DOI 10.1111/j.1558-5646.2011.01354.x; Elton C., 1958; Excoffier L, 2006, ARLEQUIN VER 3 1 INT; Finkelman FD, 1997, ANNU REV IMMUNOL, V15, P505, DOI 10.1146/annurev.immunol.15.1.505; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Gompper ME, 2011, P ROY SOC B-BIOL SCI, V278, P204, DOI 10.1098/rspb.2010.1113; Grau GA, 1970, J WILDLIFE MANAGE, V266, P215; Haldane J. B. S., 1949, Ricerca Scientifica Suppl, P68; Hansson B, 2002, MOL ECOL, V11, P2467, DOI 10.1046/j.1365-294X.2002.01644.x; Hawley DM, 2005, BIOL LETTERS, V1, P326, DOI 10.1098/rsbl.2005.0303; Hovius JWR, 2009, J INVEST DERMATOL, V129, P2337, DOI 10.1038/jid.2009.202; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; King KC, 2012, HEREDITY, V109, P199, DOI 10.1038/hdy.2012.33; LEONARD KJ, 1969, PHYTOPATHOLOGY, V59, P1845; Lieutenant-Gosselin M, 2006, EVOLUTION, V60, P1658; Ljungqvist M, 2010, MOL ECOL, V19, P851, DOI 10.1111/j.1365-294X.2010.04522.x; Luikart G, 2008, BIOL LETTERS, V4, P228, DOI 10.1098/rsbl.2007.0633; MacDougall-Shackleton EA, 2005, BIOL LETTERS, V1, P105, DOI 10.1098/rsbl.2004.0264; Marshall AG, 1982, ECOLOGY ECTOPARASITI; Marshall TC, 2000, ANIM CONSERV, V3, P241, DOI 10.1111/j.1469-1795.2000.tb00109.x; Meagher S, 1999, EVOLUTION, V53, P1318, DOI 10.1111/j.1558-5646.1999.tb04547.x; Moller AP, 2005, OECOLOGIA, V142, P169, DOI 10.1007/s00442-004-1735-8; Monello RJ, 2007, PARASITOLOGY, V134, P2053, DOI 10.1017/S0031182007003423; Monello RJ, 2011, OIKOS, V120, P1427, DOI 10.1111/j.1600-0706.2011.19260.x; Monello RJ, 2010, J ANIM ECOL, V79, P602, DOI 10.1111/j.1365-2656.2010.01663.x; Monello RJ, 2009, J PARASITOL, V95, P56, DOI 10.1645/GE-1643.1; Morand S, 2006, MICROMAMMALS MACROPA; Mueller JC, 2011, EVOL ECOL, V25, P1, DOI 10.1007/s10682-010-9377-2; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Neff BD, 2004, P NATL ACAD SCI USA, V101, P2381, DOI 10.1073/pnas.0307522100; Ortego J, 2007, MOL ECOL, V16, P4858, DOI 10.1111/j.1365-294X.2007.03554.x; Ortego J, 2007, MOL ECOL, V16, P3712, DOI 10.1111/j.1365-294X.2007.03406.x; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Pitcher TE, 2006, MOL ECOL, V15, P2357, DOI 10.1111/j.1365-294X.2006.02942.x; Poulin R, 2000, INT J PARASITOL, V30, P697, DOI 10.1016/S0020-7519(00)00047-3; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rijks JM, 2008, HEREDITY, V100, P587, DOI 10.1038/hdy.2008.18; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Schwensow N, 2007, HEREDITY, V99, P265, DOI 10.1038/sj.hdy.6800993; Siripunkaw C, 2008, MOL ECOL RESOUR, V8, P199, DOI 10.1111/j.1471-8286.2007.01922.x; Slate J, 2006, CURR BIOL, V16, pR790, DOI 10.1016/j.cub.2006.08.047; Spielman D, 2004, CONSERV GENET, V5, P439, DOI 10.1023/B:COGE.0000041030.76598.cd; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Szulkin M, 2010, EVOLUTION, V64, P1202, DOI 10.1111/j.1558-5646.2010.00966.x; Thornhill N.W., 1993, NATURAL HIST INBREED; Vali U, 2008, MOL ECOL, V17, P3808, DOI 10.1111/j.1365-294X.2008.03876.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wehtje M, 2011, WILDLIFE BIOL, V17, P25, DOI 10.2981/10-012; WEIR BS, 1973, GENET RES, V21, P247, DOI 10.1017/S0016672300013446; Westerdahl H, 2005, P ROY SOC B-BIOL SCI, V272, P1511, DOI 10.1098/rspb.2005.3113; Whitaker J. O, 1982, ECTOPARASITES MAMMAL; Whiteman NK, 2007, MOL ECOL, V16, P4759, DOI 10.1111/j.1365-294X.2007.03512.x; Wilfert L, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-187; Wilson K., 2002, P6	73	15	15	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45404	10.1371/journal.pone.0045404	http://dx.doi.org/10.1371/journal.pone.0045404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049796	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300025
J	Blechingberg, J; Luo, YL; Bolund, L; Damgaard, CK; Nielsen, AL				Blechingberg, Jenny; Luo, Yonglun; Bolund, Lars; Damgaard, Christian Kroun; Nielsen, Anders Lade			Gene Expression Responses to FUS, EWS, and TAF15 Reduction and Stress Granule Sequestration Analyses Identifies FET-Protein Non-Redundant Functions	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; RNA-BINDING PROTEIN; CYTOCHROME-P450 2E1; DENDRITIC SPINES; POLYMERASE-II; TET FAMILY; TLS; MUTATIONS; DISEASE; TRANSFORMATION	The FET family of proteins is composed of FUS/TLS, EWS/EWSR1, and TAF15 and possesses RNA- and DNA-binding capacities. The FET-proteins are involved in transcriptional regulation and RNA processing, and FET-gene deregulation is associated with development of cancer and protein granule formations in amyotrophic lateral sclerosis, frontotemporal lobar degeneration, and trinucleotide repeat expansion diseases. We here describe a comparative characterization of FET-protein localization and gene regulatory functions. We show that FUS and TAF15 locate to cellular stress granules to a larger extend than EWS. FET-proteins have no major importance for stress granule formation and cellular stress responses, indicating that FET-protein stress granule association most likely is a downstream response to cellular stress. Gene expression analyses showed that the cellular response towards FUS and TAF15 reduction is relatively similar whereas EWS reduction resulted in a more unique response. The presented data support that FUS and TAF15 are more functionally related to each other, and that the FET-proteins have distinct functions in cellular signaling pathways which could have implications for the neurological disease pathogenesis.	[Blechingberg, Jenny; Luo, Yonglun; Bolund, Lars; Nielsen, Anders Lade] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Damgaard, Christian Kroun] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark	Aarhus University; Aarhus University	Nielsen, AL (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	aln@hum-gen.au.dk	Damgaard, Christian/AAR-4075-2020; Damgaard, Christian/AAP-3147-2021; Luo, Yonglun/C-4708-2013; Damgaard, Christian K/G-7360-2015; Luo, Yonglun/AAG-9253-2020; Nielsen, Anders Lade L/Q-9604-2016	Damgaard, Christian/0000-0003-4940-0868; Luo, Yonglun/0000-0002-0007-7759; Nielsen, Anders Lade L/0000-0003-4372-9961	Faculty of Health, Aarhus University; Fonden til Laegevidenskabens fremme; Danish Research Council (FSS); Lundbeck Foundation	Faculty of Health, Aarhus University; Fonden til Laegevidenskabens fremme; Danish Research Council (FSS)(Det Frie Forskningsrad (DFF)Danish Medical Research Council); Lundbeck Foundation(Lundbeckfonden)	This project was supported by a fellowship to JB by the Faculty of Health, Aarhus University, and supported by Fonden til Laegevidenskabens fremme, the Danish Research Council (FSS), and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; [Anonymous], ALS ONL GEN DAT; Bell-Parikh LC, 1999, J BIOL CHEM, V274, P23833, DOI 10.1074/jbc.274.34.23833; Belyanskaya LL, 2001, J BIOL CHEM, V276, P18681, DOI 10.1074/jbc.M011446200; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bertolotti A, 1999, ONCOGENE, V18, P8000, DOI 10.1038/sj.onc.1203207; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; BIEDLER JL, 1978, CANCER RES, V38, P3751; Blechingberg J, 2012, GENE, V493, P27, DOI 10.1016/j.gene.2011.11.038; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Brooke GN, 2011, CANCER RES, V71, P914, DOI 10.1158/0008-5472.CAN-10-0874; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; Deng HX, 2010, ANN NEUROL, V67, P739, DOI 10.1002/ana.22051; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Doi H, 2010, NEUROSCI RES, V66, P131, DOI 10.1016/j.neures.2009.10.004; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fujii R, 2005, J CELL SCI, V118, P5755, DOI 10.1242/jcs.02692; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Gal J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.010; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Jellinger KA, 2009, J NEURAL TRANSM, V116, P1111, DOI 10.1007/s00702-009-0240-y; Jobert L, 2009, EXP CELL RES, V315, P1273, DOI 10.1016/j.yexcr.2008.12.008; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lerga A, 2001, J BIOL CHEM, V276, P6807, DOI 10.1074/jbc.M008304200; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Meissner M, 2003, EXP CELL RES, V283, P184, DOI 10.1016/S0014-4827(02)00046-0; Morohoshi F, 1998, GENE, V221, P191, DOI 10.1016/S0378-1119(98)00463-6; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Nguyen CD, 2011, J MOL BIOL, V407, P273, DOI 10.1016/j.jmb.2010.12.041; OHNO T, 1994, ONCOGENE, V9, P3087; Riggi N, 2007, J PATHOL, V213, P4, DOI 10.1002/path.2209; Sanchez-Ramos C, 2011, ANTIOXID REDOX SIGN, V15, P325, DOI 10.1089/ars.2010.3643; Sayre LM, 2008, CHEM RES TOXICOL, V21, P172, DOI 10.1021/tx700210j; Shahabi HN, 2008, SYNAPSE, V62, P379, DOI 10.1002/syn.20505; Shahabi HN, 2009, J NEURAL TRANSM, V116, P567, DOI 10.1007/s00702-009-0221-1; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Shiohama A, 2007, EXP CELL RES, V313, P4196, DOI 10.1016/j.yexcr.2007.07.020; Spitzer JI, 2011, GENE CHROMOSOME CANC, V50, P338, DOI 10.1002/gcc.20858; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Thomsen Rune, 2010, J Bioinform Comput Biol, V8, P885, DOI 10.1142/S0219720010004963; Ticozzi N., 2011, AM J MED GENET B; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang H, 2011, ARCH NEUROL-CHICAGO, V68, P207, DOI 10.1001/archneurol.2010.367; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Weisskopf MG, 2009, J NEUROL NEUROSUR PS, V80, P558, DOI 10.1136/jnnp.2008.156976; Woulfe J, 2010, BRAIN PATHOL, V20, P589, DOI 10.1111/j.1750-3639.2009.00337.x; Zhou ZL, 2010, BIOCHEM BIOPH RES CO, V398, P565, DOI 10.1016/j.bbrc.2010.06.119; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513; Zinszner H, 1997, J CELL SCI, V110, P1741	60	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46251	10.1371/journal.pone.0046251	http://dx.doi.org/10.1371/journal.pone.0046251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049996	Green Submitted, gold, Green Published			2022-12-27	WOS:000309556100167
J	Han, HJ; Kass, PH; Wilsey, BL; Li, CS				Han, Huijun; Kass, Philip H.; Wilsey, Barth L.; Li, Chin-Shang			Individual and County-Level Factors Associated with Use of Multiple Prescribers and Multiple Pharmacies to Obtain Opioid Prescriptions in California	PLOS ONE			English	Article							NEIGHBORHOOD SOCIOECONOMIC-STATUS; CORONARY-HEART-DISEASE; ILLICIT DRUG-USE; INJECTION CESSATION; ADOLESCENT ALCOHOL; MARIJUANA USE; CHRONIC PAIN; RISK; DISADVANTAGE; ENVIRONMENT	Use of multiple prescribers and pharmacies is a means by which some individuals misuse opioids. Community characteristics may be important determinants of the likelihood of this phenomenon independent of individual-level factors. This was a retrospective cohort study with individual-level data derived from California's statewide prescription drug monitoring program (PDMP) and county-level socioeconomic status (SES) data derived from the United States Census. Zero-truncated negative binomial (ZTNB) regression was used to model the association of individual factors (age, gender, drug schedule and drug dose type) and county SES factors (ethnicity, adult educational attainment, median household income, and physician availability) with the number of prescribers and the number of pharmacies that an individual used during a single year (2006). The incidence rates of new prescriber use and new pharmacy use for opioid prescriptions declined across increasing age groups. Males had a lower incidence rate of new prescriber use and new pharmacy use than females. The total number of licensed physicians and surgeons in a county was positively, linearly, and independently associated with the number of prescribers and pharmacies that individuals used for prescription opioids. In summary, younger age, female gender, and living in counties with more licensed physicians and surgeons were associated with use of more prescribers and/or more pharmacies for obtaining prescription opioids.	[Kass, Philip H.; Li, Chin-Shang] Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA; [Han, Huijun] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Wilsey, Barth L.] Univ Calif Davis, Med Ctr, Dept Phys Med & Rehabil, Davis, CA 95616 USA; [Wilsey, Barth L.] Univ Calif Davis, Med Ctr, VA No Calif Hlth Care Syst, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Kass, PH (corresponding author), Univ Calif Davis, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.	phkass@ucdavis.edu			Robert Wood Johnson Foundation; National Center for Research Resources, a component of the National Institutes of Health (NIH) [UL1 RR024146]; NIH; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024146] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Center for Research Resources, a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding for this project was provided by the Robert Wood Johnson Foundation. Database architect support was derived through Grant Number UL1 RR024146 from the National Center for Research Resources, a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research. This research and its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson T.L., 2001, ENCY CRIMINOLOGY DEV, V4, P286; Boardman JD, 2001, J HEALTH SOC BEHAV, V42, P151, DOI 10.2307/3090175; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Chichlowska KL, 2008, PSYCHOSOM MED, V70, P986, DOI 10.1097/PSY.0b013e318183a491; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Crum RM, 1996, DRUG ALCOHOL DEPEN, V43, P155, DOI 10.1016/S0376-8716(96)01298-7; Curtis LH, 2006, HEALTH SERV RES, V41, P837, DOI 10.1111/j.1475-6773.2006.00511.x; Davis WR, 2008, DRUG ALCOHOL DEPEN, V92, P267, DOI 10.1016/j.drugalcdep.2007.08.008; EPA, 1999, FED REG, V74; Food and Drug Administration, 2009, JOINT M DRUG SAF RIS; Franks P, 2010, ANN FAM MED, V8, P447, DOI 10.1370/afm.1167; Furr-Holden CDM, 2011, J STUD ALCOHOL DRUGS, V72, P371, DOI 10.15288/jsad.2011.72.371; Galea S, 2003, J URBAN HEALTH, V80, P50; Genberg BL, 2011, ADDICTION, V106, P1966, DOI 10.1111/j.1360-0443.2011.03501.x; Green TC, 2009, DRUG ALCOHOL DEPEN, V103, P65, DOI 10.1016/j.drugalcdep.2009.03.014; Grow HMG, 2010, SOC SCI MED, V71, P584, DOI 10.1016/j.socscimed.2010.04.018; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Institute of Medicine, 2011, REL PAIN AM BLUEPR T; Ives TJ, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-46; Kim D, 2010, CANCER-AM CANCER SOC, V116, P4187, DOI 10.1002/cncr.25195; Lineberry TW, 2004, MAYO CLIN PROC, V79, P1031, DOI 10.4065/79.8.1031; Mallinckrodt C H, 2001, J Biopharm Stat, V11, P9, DOI 10.1081/BIP-100104194; Manchikanti Laxmaiah, 2007, J Opioid Manag, V3, P89; Nandi A, 2010, AM J EPIDEMIOL, V171, P391, DOI 10.1093/aje/kwp416; National Center for Health Statistics, 2006, HLTH US 2006 CHARTB, P68; Pradel V, 2009, PHARMACOEPIDEM DR S, V18, P36, DOI 10.1002/pds.1681; RAND California, 2006, PHYS SURG CAL; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Rustoen T, 2005, CLIN J PAIN, V21, P513, DOI 10.1097/01.ajp.0000146217.31780.ef; Schroeder JR, 2001, ANN EPIDEMIOL, V11, P389, DOI 10.1016/S1047-2797(01)00225-3; Sellstrom E, 2011, HEALTH PLACE, V17, P551, DOI 10.1016/j.healthplace.2010.12.013; Simoni-Wastila L, 2004, AM J PUBLIC HEALTH, V94, P266, DOI 10.2105/AJPH.94.2.266; Simoni-Wastila L, 2004, SUBST USE MISUSE, V39, P1, DOI 10.1081/JA-120027764; Streiner DL, 2002, CAN J PSYCHIAT, V47, P68; Substance Abuse and Mental Health Services Administration, 2007, NSDUH SER H; Substance Abuse and Mental Health Services Administration, 2007, NSDUH REP ILL DRUG U; Substance Abuse and Mental Health Services Administration, 2010, NSDUH SER H A, VH-38A; Substance Abuse and Mental Health Services Administration (Office of Applied Studies), 2009, HHS PUBL; Sunder PK, 2007, AM J COMMUN PSYCHOL, V40, P167, DOI 10.1007/s10464-007-9135-y; Sundquist K, 2004, AM J EPIDEMIOL, V159, P655, DOI 10.1093/aje/kwh096; *US CENS BUR, 2006, AM COMM SURV; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b; Weisner CM, 2009, PAIN, V145, P287, DOI 10.1016/j.pain.2009.05.006; White Alan G, 2005, J Manag Care Pharm, V11, P469; White AG, 2009, AM J MANAG CARE, V15, P897; Wilsey BL, 2010, DRUG ALCOHOL DEPEN, V112, P99, DOI 10.1016/j.drugalcdep.2010.05.007; Wilson N, 2005, AM J HEALTH PROMOT, V20, P11, DOI 10.4278/0890-1171-20.1.11; Winstanley EL, 2008, DRUG ALCOHOL DEPEN, V92, P173, DOI 10.1016/j.drugalcdep.2007.07.012	48	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46246	10.1371/journal.pone.0046246	http://dx.doi.org/10.1371/journal.pone.0046246			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049992	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100164
J	Pasini, A; Manenti, R; Rothbacher, U; Lemaire, P				Pasini, Andrea; Manenti, Raoul; Rothbaecher, Ute; Lemaire, Patrick			Antagonizing Retinoic Acid and FGF/MAPK Pathways Control Posterior Body Patterning in the Invertebrate Chordate Ciona intestinalis	PLOS ONE			English	Article							EPIDERMAL SENSORY NEURONS; GENE REGULATORY NETWORKS; FGF SIGNALING CONTROLS; CENTRAL-NERVOUS-SYSTEM; EVOLUTIONARY PLASTICITY; TRANSCRIPTION FACTORS; OPPOSING FGF; EXPRESSION; DIFFERENTIATION; SEGMENTATION	Vertebrate embryos exploit the mutual inhibition between the RA and FGF signalling pathways to coordinate the proliferative elongation of the main body axis with the progressive patterning and differentiation of its neuroectodermal and paraxial mesodermal structures. The evolutionary history of this patterning system is still poorly understood. Here, we investigate the role played by the RA and FGF/MAPK signals during the development of the tail structures in the tunicate Ciona intestinalis, an invertebrate chordate belonging to the sister clade of vertebrates, in which the prototypical chordate body plan is established through very derived morphogenetic processes. Ciona embryos are constituted of few cells and develop according to a fixed lineage; elongation of the tail occurs largely by rearrangement of postmitotic cells; mesoderm segmentation and somitogenesis are absent. We show that in the Ciona embryo, the antagonism of the RA and FGF/MAPK signals is required to control the anteroposterior patterning of the tail epidermis. We also demonstrate that the RA, FGF/MAPK and canonical Wnt pathways control the anteroposterior patterning of the tail peripheral nervous system, and reveal the existence of distinct subpopulations of caudal epidermal neurons with different responsiveness to the RA, FGF/MAPK and canonical Wnt signals. Our data provide the first demonstration that the use of the antagonism between the RA and FGF signals to pattern the main body axis predates the emergence of vertebrates and highlight the evolutionary plasticity of this patterning strategy, showing that in different chordates it can be used to pattern different tissues within the same homologous body region.	[Pasini, Andrea; Rothbaecher, Ute; Lemaire, Patrick] Univ Aix Marseille, IBDML, UMR7288, CNRS, Marseille, France; [Manenti, Raoul] Univ Milan, Dipartimento Biol, Milan, Italy; [Lemaire, Patrick] Univ Montpellier, CRBM, UMR5237, CNRS, F-34059 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Milan; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Pasini, A (corresponding author), Univ Aix Marseille, IBDML, UMR7288, CNRS, Marseille, France.	andrea.pasini@univ-amu.fr	Manenti, Raoul/D-4419-2013; Manenti, Raoul/O-5166-2017; Rothbächer, Ute/G-2688-2013; Rothbächer, Ute/AAB-6901-2022; Lemaire, Patrick/B-5560-2012; Lemaire, Patrick/P-8228-2019	Manenti, Raoul/0000-0001-6071-8194; Rothbächer, Ute/0000-0002-9989-6139; Rothbächer, Ute/0000-0002-9989-6139; Lemaire, Patrick/0000-0003-4925-2009; Lemaire, Patrick/0000-0003-4925-2009	CNRS; Agence Nationale pour la Recherche (Programme Blanc "Chor-Evo-Net"); Erasmus fellowship	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale pour la Recherche (Programme Blanc "Chor-Evo-Net")(French National Research Agency (ANR)); Erasmus fellowship	Work was financed by the CNRS and the Agence Nationale pour la Recherche (Programme Blanc "Chor-Evo-Net"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AP, UR and PL are CNRS staff members. RM was supported by an Erasmus fellowship. Thanks to C. Lamy, S. Fujiwara, H. Saiga and T. Kusakabe for the gift of reagents. Thanks to S. Choksi for help with cluster analysis and to C. Sunyach for help with Fig. S3. Thanks to C. Hudson, H. Yasuo, H. Saiga, R. Pennati, M. Schubert for sharing comments, criticisms, unpublished data etc.	Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Bel-Vialar S, 2002, DEVELOPMENT, V129, P5103; Bertrand N, 2000, DEVELOPMENT, V127, P4837; Bertrand S, 2011, P NATL ACAD SCI USA, V108, P9160, DOI 10.1073/pnas.1014235108; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Canestro C, 2007, DEV BIOL, V305, P522, DOI 10.1016/j.ydbio.2007.02.032; Canestro C, 2006, EVOL DEV, V8, P394, DOI 10.1111/j.1525-142X.2006.00113.x; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Diez del Corral R, 2003, NEURON, V40, P65; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Diez del Corral R, 2002, DEVELOPMENT, V129, P1681; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Escriva H, 2002, DEVELOPMENT, V129, P2905; Holland LZ, 2003, BIOESSAYS, V25, P529, DOI 10.1002/bies.10302; Horie T, 2008, J COMP NEUROL, V508, P249, DOI 10.1002/cne.21678; Hotta K, 2007, DEV DYNAM, V236, P1790, DOI 10.1002/dvdy.21188; Hudson C, 2003, DEVELOPMENT, V130, P147, DOI 10.1242/dev.00200; Hudson C, 2007, DEVELOPMENT, V134, P3527, DOI 10.1242/dev.002352; Ikuta T, 2004, P NATL ACAD SCI USA, V101, P15118, DOI 10.1073/pnas.0401389101; Ikuta T, 2010, DEVELOPMENT, V137, P1505, DOI 10.1242/dev.046938; Imai JH, 2007, J COMP NEUROL, V501, P335, DOI 10.1002/cne.21247; Imai K, 2000, DEVELOPMENT, V127, P3009; Imai KS, 2002, MECH DEVELOP, V119, pS275, DOI 10.1016/S0925-4773(03)00128-X; Imai KS, 2004, DEVELOPMENT, V131, P4047, DOI 10.1242/dev.01270; Kanda M, 2009, DEV BIOL, V335, P454, DOI 10.1016/j.ydbio.2009.09.027; Katsuyama Y, 1999, DEV BIOL, V213, P257, DOI 10.1006/dbio.1999.9403; Krol AJ, 2011, DEVELOPMENT, V138, P2783, DOI 10.1242/dev.063834; Lemaire P, 2009, DEV BIOL, V332, P48, DOI 10.1016/j.ydbio.2009.05.540; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; Meulemans D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000787; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Moreno TA, 2004, DEV CELL, V6, P205, DOI 10.1016/S1534-5807(04)00026-7; Nagatomo K, 2003, GENE EXPR PATTERNS, V3, P273, DOI 10.1016/S1567-133X(03)00051-6; Ohtsuka Y, 2001, DEV GENES EVOL, V211, P252; Olivera-Martinez I, 2007, DEVELOPMENT, V134, P2125, DOI 10.1242/dev.000216; Pasini A, 2006, PLOS BIOL, V4, P1173, DOI 10.1371/journal.pbio.0040225; Passamaneck YJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000714; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Rothbacher U, 2007, DEVELOPMENT, V134, P4023, DOI 10.1242/dev.010850; Sawada A, 2001, DEVELOPMENT, V128, P4873; Schubert M, 2004, P NATL ACAD SCI USA, V101, P10320, DOI 10.1073/pnas.0403216101; Schubert M, 2001, DEV BIOL, V240, P262, DOI 10.1006/dbio.2001.0460; Schubert M, 2006, DEV BIOL, V296, P190, DOI 10.1016/j.ydbio.2006.04.457; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Shi WY, 2009, DEVELOPMENT, V136, P23, DOI 10.1242/dev.029157; Sobral D, 2009, CURR BIOL, V19, P2014, DOI 10.1016/j.cub.2009.10.036; Terakubo HQ, 2010, DEV DYNAM, V239, P2278, DOI 10.1002/dvdy.22361	51	36	36	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46193	10.1371/journal.pone.0046193	http://dx.doi.org/10.1371/journal.pone.0046193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049976	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100151
J	Terahara, N; Sano, M; Ito, M				Terahara, Naoya; Sano, Motohiko; Ito, Masahiro			A Bacillus Flagellar Motor That Can Use Both Na+ and K+ as a Coupling Ion Is Converted by a Single Mutation to Use Only Na+	PLOS ONE			English	Article							ALKALIPHILIC BACILLUS; PH HOMEOSTASIS; FIRMUS OF4; K+/H+ ANTIPORTER; PSEUDOFIRMUS OF4; MOTILITY; TRANSPORT; H+; SUBTILIS; EXPRESSION	In bacteria, the sodium ion (Na+) cycle plays a critical role in negotiating the challenges of an extremely alkaline and sodium-rich environment. Alkaliphilic bacteria that grow optimally at high pH values use Na+ for solute uptake and flagellar rotation because the proton (H+) motive force is insufficient for use at extremely alkaline pH. Only three types of electrically driven rotary motors exist in nature: the F-type ATPase, the V-type ATPase, and the bacterial flagellar motor. Until now, only H+ and Na+ have been reported as coupling ions for these motors. Here, we report that the alkaliphilic bacterium Bacillus alcalophilus Vedder 1934 can grow not only under a Na+-rich and potassium ion (K+)-poor condition but also under the opposite condition in an extremely alkaline environment. In this organism, swimming performance depends on concentrations of Na+, K+ or Rb+. In the absence of Na+, swimming behavior is clearly K+-dependent. This pattern was confirmed in swimming assays of stator-less Bacillus subtilis and Escherichia coli mutants expressing MotPS from B. alcalophilus (BA-MotPS). Furthermore, a single mutation in BA-MotS was identified that converted the naturally bi-functional BA-MotPS to stators that cannot use K+ or Rb+. This is the first report that describes a flagellar motor that can use K+ and Rb+ as coupling ions. The finding will affect the understanding of the operating principles of flagellar motors and the molecular mechanisms of ion selectivity, the field of the evolution of environmental changes and stresses, and areas of nanotechnology.	[Sano, Motohiko; Ito, Masahiro] Toyo Univ, Grad Sch Life Sci, Kawagoe, Saitama, Japan; [Terahara, Naoya] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Ito, Masahiro] Toyo Univ, Bionano Elect Res Ctr, Kawagoe, Saitama, Japan	Toyo University; Osaka University; Toyo University	Ito, M (corresponding author), Toyo Univ, Grad Sch Life Sci, Kawagoe, Saitama, Japan.	masahiro.ito@toyo.jp	ITO, MASAHIRO/H-1960-2013; Terahara, Naoya/AAA-2929-2021	ITO, MASAHIRO/0000-0002-4976-762X; Terahara, Naoya/0000-0002-2849-0756	Ministry of Education, Culture, Sports, Science and Technology of Japan [21370074]; Grants-in-Aid for Scientific Research [10J01439] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The Strategic Research Foundation Grant-aided for Private Universities and Grant-in-Aid for Scientific Research (B) No. 21370074 of the Ministry of Education, Culture, Sports, Science and Technology of Japan was awarded to MI. NT is a Research Fellow of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AONO R, 1992, BIOSCI BIOTECH BIOCH, V56, P48, DOI 10.1271/bbb.56.48; Asai Y, 2000, EMBO J, V19, P3639, DOI 10.1093/emboj/19.14.3639; Atsumi T, 1996, J BACTERIOL, V178, P5024, DOI 10.1128/jb.178.16.5024-5026.1996; BAKKER EP, 1993, ALKALI CATION TRANSP, P00205; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Buurman ET, 2004, J BACTERIOL, V186, P4238, DOI 10.1128/JB.186.13.4238-4245.2004; Castagna M, 1998, P NATL ACAD SCI USA, V95, P5395, DOI 10.1073/pnas.95.9.5395; Che YS, 2008, J BACTERIOL, V190, P6660, DOI 10.1128/JB.00503-08; CLEJAN S, 1989, J BACTERIOL, V171, P1744, DOI 10.1128/jb.171.3.1744-1746.1989; DEMOT R, 1994, MOL MICROBIOL, V12, P333; DOW JAT, 1984, AM J PHYSIOL, V246, pR633, DOI 10.1152/ajpregu.1984.246.4.R633; Doyle TB, 2004, J BACTERIOL, V186, P6341, DOI 10.1128/JB.186.19.6341-6350.2004; Dzioba-Winogrodzki J, 2009, J MOL MICROB BIOTECH, V16, P176, DOI 10.1159/000119547; EPSTEIN W, 1993, BIOCHEM SOC T, V21, P1006, DOI 10.1042/bst0211006; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; Fujinami S, 2007, ARCH MICROBIOL, V187, P239, DOI 10.1007/s00203-006-0192-7; Fujinami S, 2009, FUTURE MICROBIOL, V4, P1137, DOI 10.2217/FMB.09.76; Gilmour R, 2000, J BACTERIOL, V182, P5969, DOI 10.1128/JB.182.21.5969-5981.2000; GRUNDY FJ, 1994, J BACTERIOL, V176, P4527, DOI 10.1128/JB.176.15.4527-4533.1994; GUFFANTI AA, 1979, J BIOL CHEM, V254, P1033; GUFFANTI AA, 1981, P NATL ACAD SCI-BIOL, V78, P1481, DOI 10.1073/pnas.78.3.1481; GUZMAN CA, 1994, GENE, V148, P171, DOI 10.1016/0378-1119(94)90254-2; Harvey WR, 2009, J EXP BIOL, V212, P1620, DOI 10.1242/jeb.031534; HENNIGAN BB, 1993, BIOCHIM BIOPHYS ACTA, V1148, P209, DOI 10.1016/0005-2736(93)90131-I; HIROTA N, 1983, J BIOL CHEM, V258, P577; IRETON K, 1993, GENE DEV, V7, P283, DOI 10.1101/gad.7.2.283; Ito M, 2005, J MOL BIOL, V352, P396, DOI 10.1016/j.jmb.2005.07.030; Ito M, 2004, MOL MICROBIOL, V53, P1035, DOI 10.1111/j.1365-2958.2004.04173.x; Ito M, 2004, P NATL ACAD SCI USA, V101, P10566, DOI 10.1073/pnas.0402692101; Ito M, 1997, EXTREMOPHILES, V1, P22, DOI 10.1007/s007920050011; Kanai Y, 2003, EUR J PHARMACOL, V479, P237, DOI 10.1016/j.ejphar.2003.08.073; Kitada M, 2000, EXTREMOPHILES, V4, P253, DOI 10.1007/s007920070010; KITADA M, 1987, J BACTERIOL, V169, P5761, DOI 10.1128/jb.169.12.5761-5765.1987; Kitada M, 1997, EXTREMOPHILES, V1, P135, DOI 10.1007/s007920050026; Kojima S, 2004, INT REV CYTOL, V233, P93, DOI 10.1016/S0074-7696(04)33003-2; Krulwich T, 2010, ADAPTIVE MECH EXTREM; Krulwich TA, 2007, PHYSIOLOGY AND BIOCHEMISTRY OF EXTREMOPHILES, P311; McCarter LL, 2005, J BACTERIOL, V187, P1207, DOI 10.1128/JB.187.4.1207-1209.2005; Ohkuma Moriya, 2003, Microbes and Environments, V18, P145, DOI 10.1264/jsme2.18.145; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; Putnoky P, 1998, MOL MICROBIOL, V28, P1091, DOI 10.1046/j.1365-2958.1998.00868.x; Radchenko MV, 2006, MOL MICROBIOL, V59, P651, DOI 10.1111/j.1365-2958.2005.04966.x; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Southworth TW, 2001, J BACTERIOL, V183, P5896, DOI 10.1128/JB.183.20.5896-5903.2001; STURR MG, 1994, J BACTERIOL, V176, P3111, DOI 10.1128/jb.176.11.3111-3116.1994; SUGIYAMA S, 1985, FEBS LETT, V182, P265, DOI 10.1016/0014-5793(85)80312-4; Swartz TH, 2007, J BACTERIOL, V189, P3081, DOI 10.1128/JB.00021-07; Terahara N, 2008, P NATL ACAD SCI USA, V105, P14359, DOI 10.1073/pnas.0802106105; Vedder A., 1934, ANTON LEEUW INT J G, V1, P143; Wei Y, 2003, J BACTERIOL, V185, P5133, DOI 10.1128/JB.185.17.5133-5147.2003	52	45	45	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46248	10.1371/journal.pone.0046248	http://dx.doi.org/10.1371/journal.pone.0046248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049994	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100166
J	Scheidegger, M; Walter, M; Lehmann, M; Metzger, C; Grimm, S; Boeker, H; Boesiger, P; Henning, A; Seifritz, E				Scheidegger, Milan; Walter, Martin; Lehmann, Mick; Metzger, Coraline; Grimm, Simone; Boeker, Heinz; Boesiger, Peter; Henning, Anke; Seifritz, Erich			Ketamine Decreases Resting State Functional Network Connectivity in Healthy Subjects: Implications for Antidepressant Drug Action	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; METHYL-D-ASPARTATE; MAJOR-DEPRESSIVE-DISORDER; NEGATIVE BOLD RESPONSES; NMDA RECEPTOR BLOCKADE; DEFAULT-MODE NETWORK; GLUTAMATE; ABNORMALITIES; ANHEDONIA; TASK	Increasing preclinical and clinical evidence underscores the strong and rapid antidepressant properties of the glutamate-modulating NMDA receptor antagonist ketamine. Targeting the glutamatergic system might thus provide a novel molecular strategy for antidepressant treatment. Since glutamate is the most abundant and major excitatory neurotransmitter in the brain, pathophysiological changes in glutamatergic signaling are likely to affect neurobehavioral plasticity, information processing and large-scale changes in functional brain connectivity underlying certain symptoms of major depressive disorder. Using resting state functional magnetic resonance imaging (rsfMRI), the "dorsal nexus "(DN) was recently identified as a bilateral dorsal medial prefrontal cortex region showing dramatically increased depression-associated functional connectivity with large portions of a cognitive control network (CCN), the default mode network (DMN), and a rostral affective network (AN). Hence, Sheline and colleagues (2010) proposed that reducing increased connectivity of the DN might play a critical role in reducing depression symptomatology and thus represent a potential therapy target for affective disorders. Here, using a randomized, placebo-controlled, double-blind, crossover rsfMRI challenge in healthy subjects we demonstrate that ketamine decreases functional connectivity of the DMN to the DN and to the pregenual anterior cingulate (PACC) and medioprefrontal cortex (MPFC) via its representative hub, the posterior cingulate cortex (PCC). These findings in healthy subjects may serve as a model to elucidate potential biomechanisms that are addressed by successful treatment of major depression. This notion is further supported by the temporal overlap of our observation of subacute functional network modulation after 24 hours with the peak of efficacy following an intravenous ketamine administration in treatment-resistant depression.	[Scheidegger, Milan; Lehmann, Mick; Boesiger, Peter; Henning, Anke] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Scheidegger, Milan; Lehmann, Mick; Boesiger, Peter; Henning, Anke; Seifritz, Erich] ETH, Zurich, Switzerland; [Scheidegger, Milan; Grimm, Simone; Boeker, Heinz; Seifritz, Erich] Psychiat Univ Hosp, Clin Affect Disorders & Gen Psychiat, Zurich, Switzerland; [Walter, Martin; Metzger, Coraline] Otto Von Guericke Univ, Dept Psychiat, Magdeburg, Germany; [Walter, Martin] Leibniz Inst Neurobiol, Dept Behav Neurol, Magdeburg, Germany; [Walter, Martin; Metzger, Coraline] CBBS, Ctr Behav & Brain Sci, Clin Affect Neuroimaging Lab CANLAB, Magdeburg, Germany; [Grimm, Simone] Free Univ Berlin, Berlin, Germany; [Grimm, Simone] CBF, Dept Psychiat, Charite, Berlin, Germany; [Henning, Anke; Seifritz, Erich] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Boesiger, Peter; Seifritz, Erich] Univ Zurich, Neurosci Ctr Zurich, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN); Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich	Scheidegger, M (corresponding author), Univ Zurich, Inst Biomed Engn, Zurich, Switzerland.	scheidegger@biomed.ee.ethz.ch; martin.walter@med.ovgu.de	Scheidegger, Milan/S-2358-2017	Scheidegger, Milan/0000-0003-1313-2208; Henning, Anke/0000-0002-2267-4861; Walter, Martin/0000-0001-7857-4483	canton of Zurich	canton of Zurich	Imaging was carried out using an MR scanner financed by the "highly specilized medicine" grant of the canton of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	aan het Rot M, 2010, BIOL PSYCHIAT, V67, P139, DOI 10.1016/j.biopsych.2009.08.038; Abel KM, 2003, NEUROREPORT, V14, P387, DOI 10.1097/01.wnr.0000058031.29600.31; Abel KM, 2003, HUM BRAIN MAPP, V18, P135, DOI 10.1002/hbm.10064; Alt A, 2006, BIOCHEM PHARMACOL, V71, P1273, DOI 10.1016/j.bcp.2005.12.022; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Bechtholt-Gompf AJ, 2010, NEUROPSYCHOPHARMACOL, V35, P2049, DOI 10.1038/npp.2010.74; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Chana G, 2003, BIOL PSYCHIAT, V53, P1086, DOI 10.1016/S0006-3223(03)00114-8; Choudary PV, 2005, P NATL ACAD SCI USA, V102, P15653, DOI 10.1073/pnas.0507901102; Cotter D, 2001, ARCH GEN PSYCHIAT, V58, P545, DOI 10.1001/archpsyc.58.6.545; Dittrich A, 1998, PHARMACOPSYCHIATRY, V31, P80, DOI 10.1055/s-2007-979351; Drevets WC, 2008, CNS SPECTRUMS, V13, P663, DOI 10.1017/S1092852900013754; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Duncan NW, 2011, HUM BRAIN MAPP, V32, P2172, DOI 10.1002/hbm.21179; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Fu CHY, 2005, PSYCHOPHARMACOLOGY, V183, P92, DOI 10.1007/s00213-005-0154-9; Garcia LSB, 2008, PROG NEURO-PSYCHOPH, V32, P140, DOI 10.1016/j.pnpbp.2007.07.027; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Grimm S, 2009, NEUROPSYCHOPHARMACOL, V34, P932, DOI 10.1038/npp.2008.81; Hamilton JP, 2011, BIOL PSYCHIAT, V70, P327, DOI 10.1016/j.biopsych.2011.02.003; Holtzheimer PE, 2011, TRENDS NEUROSCI, V34, P1, DOI 10.1016/j.tins.2010.10.004; Honey RAE, 2004, NEUROPSYCHOPHARMACOL, V29, P1203, DOI 10.1038/sj.npp.1300438; Horn DI, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00033; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Kim SY, 2011, NMR BIOMED, V24, P1235, DOI 10.1002/nbm.1681; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Lorrain DS, 2003, NEUROSCIENCE, V117, P697, DOI 10.1016/S0306-4522(02)00652-8; Machado-Vieira R, 2009, PHARMACOL THERAPEUT, V123, P143, DOI 10.1016/j.pharmthera.2009.02.010; Maeng S, 2008, BIOL PSYCHIAT, V63, P349, DOI 10.1016/j.biopsych.2007.05.028; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; McCabe C, 2011, MOL PSYCHIATR, V16, P592, DOI 10.1038/mp.2010.138; McCabe C, 2011, NEUROIMAGE, V57, P1317, DOI 10.1016/j.neuroimage.2011.05.051; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Musso F, 2011, NEUROIMAGE, V58, P508, DOI 10.1016/j.neuroimage.2011.06.045; Muthukumaraswamy SD, 2009, P NATL ACAD SCI USA, V106, P8356, DOI 10.1073/pnas.0900728106; Nagels A, 2011, NEUROIMAGE, V54, P1307, DOI 10.1016/j.neuroimage.2010.08.021; Northoff G, 2005, SCHIZOPHR RES, V72, P235, DOI 10.1016/j.schres.2004.04.009; Northoff G, 2007, NAT NEUROSCI, V10, P1515, DOI 10.1038/nn2001; Phelps LE, 2009, BIOL PSYCHIAT, V65, P181, DOI 10.1016/j.biopsych.2008.09.029; Portella MJ, 2011, J PSYCHIATR RES, V45, P427, DOI 10.1016/j.jpsychires.2010.08.010; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rowland LM, 2005, AM J PSYCHIAT, V162, P394, DOI 10.1176/appi.ajp.162.2.394; Salvadore G, 2009, BIOL PSYCHIAT, V65, P289, DOI 10.1016/j.biopsych.2008.08.014; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sheline YI, 2009, P NATL ACAD SCI USA, V106, P1942, DOI 10.1073/pnas.0812686106; Sinner B., 2008, V182, P313, DOI 10.1007/978-3-540-74806-9_15; SNAITH RP, 1995, BRIT J PSYCHIAT, V167, P99, DOI 10.1192/bjp.167.1.99; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Spielberger C., 1983, STAI MANUAL; Stone JM, 2012, MOL PSYCHIATR, V17, P664, DOI 10.1038/mp.2011.171; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Valentine GW, 2009, BIOCHEM PHARMACOL, V78, P431, DOI 10.1016/j.bcp.2009.04.008; Vollenweider FX, 2010, NAT REV NEUROSCI, V11, P642, DOI 10.1038/nrn2884; Walter M, 2009, ARCH GEN PSYCHIAT, V66, P478, DOI 10.1001/archgenpsychiatry.2009.39; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yuksel C, 2010, BIOL PSYCHIAT, V68, P785, DOI 10.1016/j.biopsych.2010.06.016; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zhou Y, 2010, J AFFECT DISORDERS, V121, P220, DOI 10.1016/j.jad.2009.05.029	66	169	172	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e44799	10.1371/journal.pone.0044799	http://dx.doi.org/10.1371/journal.pone.0044799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23049758	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000309554700016
J	Mori, S; Bernardi, R; Laurent, A; Resnati, M; Crippa, A; Gabrieli, A; Keough, R; Gonda, TJ; Blasi, F				Mori, Silvia; Bernardi, Rosa; Laurent, Audrey; Resnati, Massimo; Crippa, Ambra; Gabrieli, Arianna; Keough, Rebecca; Gonda, Thomas J.; Blasi, Francesco			Myb-Binding Protein 1A (MYBBP1A) Is Essential for Early Embryonic Development, Controls Cell Cycle and Mitosis, and Acts as a Tumor Suppressor	PLOS ONE			English	Article							FALSE DISCOVERY RATE; PREP1; P53; NUCLEOLUS; NORMALIZATION; ACETYLATION; REPRESSOR; SUMMARIES; P38	MYBBP1A is a predominantly nucleolar transcriptional regulator involved in rDNA synthesis and p53 activation via acetylation. However little further information is available as to its function. Here we report that MYBBP1A is developmentally essential in the mouse prior to blastocyst formation. In cell culture, down-regulation of MYBBP1A decreases the growth rate of wild type mouse embryonic stem cells, mouse embryo fibroblasts (MEFs) and of human HeLa cells, where it also promotes apoptosis. HeLa cells either arrest at G2/M or undergo delayed and anomalous mitosis. At mitosis, MYBBP1A is localized to a parachromosomal region and gene-expression profiling shows that its down-regulation affects genes controlling chromosomal segregation and cell cycle. However, MYBBP1A down-regulation increases the growth rate of the immortalized NIH3T3 cells. Such Mybbp1a down-regulated NIH3T3 cells are more susceptible to Ras-induced transformation and cause more potent Ras-driven tumors. We conclude that MYBBP1A is an essential gene with novel roles at the pre-mitotic level and potential tumor suppressor activity.	[Mori, Silvia; Bernardi, Rosa; Blasi, Francesco] Univ Vita Salute San Raffaele, Milan, Italy; [Bernardi, Rosa; Resnati, Massimo; Crippa, Ambra] Ist Sci San Raffaele, I-20132 Milan, Italy; [Laurent, Audrey; Gabrieli, Arianna; Blasi, Francesco] Fdn Ist FIRC Oncol Mol IFOM, Milan, Italy; [Keough, Rebecca] Flinders Univ S Australia, Adelaide, SA 5001, Australia; [Gonda, Thomas J.] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia; [Keough, Rebecca; Gonda, Thomas J.] Inst Med & Vet Sci, Div Human Immunol, Adelaide, SA 5000, Australia; [Keough, Rebecca; Gonda, Thomas J.] Inst Med & Vet Sci, Hanson Inst, Adelaide, SA 5000, Australia	Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; IFOM - FIRC Institute of Molecular Oncology; IRCCS Istituti Fisioterapici Ospitalieri (IFO); Flinders University South Australia; University of Queensland; Institute Medical & Veterinary Science Australia; Hanson Institute; Institute Medical & Veterinary Science Australia	Blasi, F (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	francesco.blasi@ifom-ieo-campus.it	Massimo, Resnati/AAN-5854-2020; bernardi, rosa/B-1650-2013; Mori, Silvia/K-1454-2016	Massimo, Resnati/0000-0002-4804-4569; bernardi, rosa/0000-0002-3607-6336; Mori, Silvia/0000-0001-5049-756X; Blasi, Francesco/0000-0001-9406-1784; LAURENT, Audrey/0000-0002-7643-6017; Gonda, Thomas/0000-0002-8792-3021; Gabrieli, Arianna/0000-0002-2657-8025	Associazione Italiana Ricerche sul Cancro (AIRC) [8929]; European Community [201681]; Australian National Health and Medical Research Council [ID000115]	Associazione Italiana Ricerche sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Community(European Commission); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Associazione Italiana Ricerche sul Cancro (AIRC) grant 8929 and European Community FP7 201681 "Prepobedia'' to FB, the Australian National Health and Medical Research Council to RK and TJG (project ID000115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Diaz VM, 2007, MOL CELL BIOL, V27, P7981, DOI 10.1128/MCB.01290-07; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Fernandez-Diaz LC, 2010, DEVELOPMENT, V137, P3393, DOI 10.1242/dev.050567; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iotti G, 2011, P NATL ACAD SCI USA, V108, pE314, DOI 10.1073/pnas.1105216108; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jones LC, 2002, J BIOL CHEM, V277, P22515, DOI 10.1074/jbc.M200740200; Keough RA, 2003, EXP CELL RES, V289, P108, DOI 10.1016/S0014-4827(03)00262-3; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Kuroda T, 2011, EMBO J, V30, P1054, DOI 10.1038/emboj.2011.23; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Longobardi E, 2010, MOL ONCOL, V4, P126, DOI 10.1016/j.molonc.2010.01.001; Oriente F, 2008, MOL CELL BIOL, V28, P5634, DOI 10.1128/MCB.00117-08; Owen HR, 2007, J MOL BIOL, V366, P725, DOI 10.1016/j.jmb.2006.11.099; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perrera C, 2010, J BIOL CHEM, V285, P11775, DOI 10.1074/jbc.M109.068312; Qian HR, 2005, GENOMICS, V86, P495, DOI 10.1016/j.ygeno.2005.06.007; ROBB L, 1995, P NATL ACAD SCI USA, V92, P9565, DOI 10.1073/pnas.92.21.9565; Shih RSM, 2008, EXP BIOL MED, V233, P317, DOI 10.3181/0708-RM-220; Shimizu K, 2002, P NATL ACAD SCI USA, V99, P9133, DOI 10.1073/pnas.142277999; Takezawa S, 2007, EMBO J, V26, P764, DOI 10.1038/sj.emboj.7601548; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tavner FJ, 1998, MOL CELL BIOL, V18, P989, DOI 10.1128/MCB.18.2.989; Tolstonog GV, 2009, NAT STRUCT MOL BIOL, V16, P900, DOI 10.1038/nsmb0909-900; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Yamauchi T, 2008, GENES CELLS, V13, P27, DOI 10.1111/j.1365-2443.2007.01148.x	30	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e39723	10.1371/journal.pone.0039723	http://dx.doi.org/10.1371/journal.pone.0039723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056166	Green Published, gold, Green Submitted			2022-12-27	WOS:000309831500002
J	Besirli, CG; Zheng, QD; Reed, DM; Zacks, DN				Besirli, Cagri G.; Zheng, Qiong-Duon; Reed, David M.; Zacks, David N.			ERK-Mediated Activation of Fas Apoptotic Inhibitory Molecule 2 (Faim2) Prevents Apoptosis of 661W Cells in a Model of Detachment-Induced Photoreceptor Cell Death	PLOS ONE			English	Article							PHOSPHORYLATION; EXPRESSION; LIFEGUARD; NEURONS; PATHWAY; TUMORS	In this study, we examined the role of Fas apoptotic inhibitory molecule 2 (Faim2), an inhibitor of the Fas signaling pathway, and its regulation by stress kinase signaling during Fas-mediated apoptosis of 661W cells, an immortalized photoreceptor-like cell line Treatment of 661W cells with a Fas-activating antibody led to increased levels of Faim2. Both ERK and JNK stress kinase pathways were activated in Fas-treated 661W cells, but only the inhibition of the ERK pathway reduced the levels of Faim2. Blocking the ERK pathway using a pharmacological inhibitor increased the susceptibility of 661W cells to Fas-induced caspase activation and apoptosis. When the levels of Faim2 were reduced in 661W cells by siRNA knockdown, Fas activating antibody treatment resulted in earlier and more robust caspase activation, and increased cell death. These results demonstrate that Faim2 acts as a neuroprotectant during Fas-mediated apoptosis of 661W cells. The expression of Faim2 is triggered, at least in part, by Fas-receptor activation and subsequent ERK signaling. Our findings identify a novel protective pathway that auto-regulates Fas-induced photoreceptor apoptosis in vitro. Modulation of this pathway to increase Faim2 expression may be a potential therapeutic option to prevent photoreceptor death.	[Besirli, Cagri G.; Zheng, Qiong-Duon; Reed, David M.; Zacks, David N.] Univ Michigan, Dept Ophthalmol & Visual Sci, WK Kellogg Eye Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Zacks, DN (corresponding author), Univ Michigan, Dept Ophthalmol & Visual Sci, WK Kellogg Eye Ctr, Ann Arbor, MI 48109 USA.	davzacks@umich.edu	Zacks, David/I-4394-2013; Reed, David M/S-7063-2019; Reed, David Millard/AFQ-5520-2022	Reed, David M/0000-0002-4772-6138; Zacks, David/0000-0001-8592-5165; Besirli, Cagri/0000-0001-7154-2024	Michigan Eye Bank and Transplantation Center; NEI [R01-020823]; Departmental Core Center for Vision Research [NEI-EY-07003]; Heed Ophthalmic Foundation; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY020823] Funding Source: NIH RePORTER	Michigan Eye Bank and Transplantation Center; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Departmental Core Center for Vision Research; Heed Ophthalmic Foundation; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the Michigan Eye Bank and Transplantation Center (DNZ); NEI R01-020823 (DNZ); and Departmental Core Center for Vision Research NEI-EY-07003. CGB is supported by The Heed Ophthalmic Foundation Fellowship. DMR is partially supported by an unrestricted grant from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; Beier CP, 2005, J NEUROSCI, V25, P6765, DOI 10.1523/JNEUROSCI.1700-05.2005; Besirli CG, 2011, INVEST OPHTH VIS SCI, V52, P4193, DOI 10.1167/iovs.10-7090; Besirli CG, 2010, INVEST OPHTH VIS SCI, V51, P2177, DOI 10.1167/iovs.09-4439; Burton T C, 1982, Trans Am Ophthalmol Soc, V80, P475; Chong DY, 2008, INVEST OPHTH VIS SCI, V49, P3193, DOI 10.1167/iovs.07-1641; de Mendoza TH, 2011, P NATL ACAD SCI USA, V108, P17189, DOI 10.1073/pnas.1114226108; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; Hu L, 2009, APOPTOSIS, V14, P1255, DOI 10.1007/s10495-009-0402-2; Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8; Nozaki K, 2001, MOL NEUROBIOL, V23, P1, DOI 10.1385/MN:23:1:01; Piccolino FC, 2005, AM J OPHTHALMOL, V139, P87, DOI 10.1016/j.ajo.2004.08.037; Raoul C, 2000, CURR OPIN NEUROBIOL, V10, P111, DOI 10.1016/S0959-4388(99)00055-0; Reich A, 2011, J NEUROSCI, V31, P225, DOI 10.1523/JNEUROSCI.2188-10.2011; Reimers K, 2006, INT J MOL MED, V18, P729; Ross W H, 2000, Curr Opin Ophthalmol, V11, P191, DOI 10.1097/00055735-200006000-00007; Ross WH, 2002, EYE, V16, P440, DOI 10.1038/sj.eye.6700192; Somia NV, 1999, P NATL ACAD SCI USA, V96, P12667, DOI 10.1073/pnas.96.22.12667; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Zacks DN, 2007, ARCH OPHTHALMOL-CHIC, V125, P1389, DOI 10.1001/archopht.125.10.1389; Zacks David N, 2009, Trans Am Ophthalmol Soc, V107, P343; Zacks DN, 2003, INVEST OPHTH VIS SCI, V44, P1262, DOI 10.1167/iovs.02-0492; Zacks DN, 2004, INVEST OPHTH VIS SCI, V45, P4563, DOI 10.1167/iovs.04-0598	26	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46664	10.1371/journal.pone.0046664	http://dx.doi.org/10.1371/journal.pone.0046664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029562	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900196
J	Coutellier, L; Beraki, S; Ardestani, PM; Saw, NL; Shamloo, M				Coutellier, Laurence; Beraki, Simret; Ardestani, Pooneh Memar; Saw, Nay Lui; Shamloo, Mehrdad			Npas4: A Neuronal Transcription Factor with a Key Role in Social and Cognitive Functions Relevant to Developmental Disorders	PLOS ONE			English	Article							MICE LACKING; PREPULSE INHIBITION; SYNAPSE DEVELOPMENT; PERIRHINAL CORTEX; SCHIZOPHRENIA; MEMORY; HIPPOCAMPUS; BEHAVIOR; PROTEIN; PAS	Npas4 is a transcription factor, which is highly expressed in the brain and regulates the formation and maintenance of inhibitory synapses in response to excitatory synaptic activity. A deregulation of the inhibitory-excitatory balance has been associated with a variety of human developmental disorders such as schizophrenia and autism. However, not much is known about the role played by inhibitory synapses and inhibitory pathways in the development of nervous system disorders. We hypothesized that alterations in the inhibitory pathways induced by the absence of Npas4 play a major role in the expression of the symptoms observed in psychiatric disorders. To test this hypothesis we tested mice lacking the transcription factor (Npas4 knock-out mice (Npas4-KO)) in a battery of behavioral assays focusing on general activity, social behaviors, and cognitive functions. Npas4-KO mice are hyperactive in a novel environment, spend less time exploring an unfamiliar ovariectomized female, spend more time avoiding an unfamiliar male during a first encounter, show higher social dominance than their WT littermates, and display pre-pulse inhibition, working memory, long-term memory, and cognitive flexibility deficits. These behavioral deficits may replicate schizophrenia-related symptomatology such as social anxiety, hyperactivity, and cognitive and sensorimotor gating deficits. Immunohistochemistry analyses revealed that Npas4 expression is induced in the hippocampus after a social encounter and that Npas4 regulates the expression of c-Fos in the CA1 and CA3 regions of the hippocampus after a cognitive task. Our results suggest that Npas4 may play a major role in the regulation of cognitive and social functions in the brain with possible implications for developmental disorders such as schizophrenia and autism.	[Coutellier, Laurence; Beraki, Simret; Ardestani, Pooneh Memar; Saw, Nay Lui; Shamloo, Mehrdad] Stanford Univ, Sch Med, Behav & Funct Neurosci Lab, Palo Alto, CA 94304 USA	Stanford University	Shamloo, M (corresponding author), Stanford Univ, Sch Med, Behav & Funct Neurosci Lab, Palo Alto, CA 94304 USA.	mshamloo@stanford.edu	Coutellier, Laurence/AAH-6706-2020	Coutellier, Laurence/0000-0001-9331-8701	National Institute of Neurological Disorders and Stroke P30 center core grant [NS069375-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS069375] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke P30 center core grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institute of Neurological Disorders and Stroke P30 center core grant (NS069375-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belforte JE, 2010, NAT NEUROSCI, V13, P76, DOI 10.1038/nn.2447; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Benes FM, 1998, BIOL PSYCHIAT, V44, P88, DOI 10.1016/S0006-3223(98)00138-3; Blundell J, 2009, GENES BRAIN BEHAV, V8, P114, DOI 10.1111/j.1601-183X.2008.00455.x; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Breuillaud L, 2012, BIOL PSYCHI IN PRESS; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; Eichler SA, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.002.2008; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Enticott PG, 2008, PSYCHIAT RES, V157, P251, DOI 10.1016/j.psychres.2007.04.007; Fendt M, 2011, BEHAV BRAIN RES, V217, P1, DOI 10.1016/j.bbr.2010.09.022; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Gaffan EA, 2000, BEHAV NEUROSCI, V114, P18, DOI 10.1037/0735-7044.114.1.18; Gainetdinov RR, 2001, P NATL ACAD SCI USA, V98, P11047, DOI 10.1073/pnas.191353298; Gaspar PA, 2009, J NEUROCHEM, V111, P891, DOI 10.1111/j.1471-4159.2009.06325.x; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gould GG, 2011, J NEUROCHEM, V116, P291, DOI 10.1111/j.1471-4159.2010.07104.x; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Guidotti G, 2012, NEUROPSYCHOPHARMACOL, V37, P746, DOI 10.1038/npp.2011.252; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Heckers S, 1998, NAT NEUROSCI, V1, P318, DOI 10.1038/1137; Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008; Homberg JR, 2007, PSYCHOPHARMACOLOGY, V195, P175, DOI 10.1007/s00213-007-0895-8; Hussman JP, 2001, J AUTISM DEV DISORD, V31, P247, DOI 10.1023/A:1010715619091; Kalueff AV, 2010, NEUROSCI BIOBEHAV R, V34, P373, DOI 10.1016/j.neubiorev.2009.08.003; KIM JS, 1980, NEUROSCI LETT, V20, P379, DOI 10.1016/0304-3940(80)90178-0; Klar AJS, 2004, GENETICS, V167, P1833, DOI 10.1534/genetics.104.028217; Kubik S, 2007, LEARN MEMORY, V14, P758, DOI 10.1101/lm.698107; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; LINDZEY G, 1961, NATURE, V191, P474, DOI 10.1038/191474a0; Machaalani R, 2002, BRAIN RES, V951, P293, DOI 10.1016/S0006-8993(02)03175-X; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Morellini F, 2010, CEREB CORTEX, V20, P2712, DOI 10.1093/cercor/bhq017; Moser M, 2004, MOL BRAIN RES, V128, P141, DOI 10.1016/j.molbrainres.2004.06.023; O'Tuathaigh CMP, 2007, NEUROSCIENCE, V147, P18, DOI 10.1016/j.neuroscience.2007.03.051; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Raemaekers M, 2002, ARCH GEN PSYCHIAT, V59, P313, DOI 10.1001/archpsyc.59.4.313; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Shamir A, 2012, J NEUROSCI, V32, P2988, DOI 10.1523/JNEUROSCI.1899-11.2012; Shamloo M, 2006, EUR J NEUROSCI, V24, P2705, DOI 10.1111/j.1460-9568.2006.05172.x; SHEPHERD JK, 1994, PSYCHOPHARMACOLOGY, V116, P56, DOI 10.1007/BF02244871; Thaker GK, 2001, NAT MED, V7, P667, DOI 10.1038/89040; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Xiang JZ, 1999, EUR J NEUROSCI, V11, P3715, DOI 10.1046/j.1460-9568.1999.00790.x; Yamada K, 2004, AM J MED GENET B, V127B, P11, DOI 10.1002/ajmg.b.20166; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360	55	84	85	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46604	10.1371/journal.pone.0046604	http://dx.doi.org/10.1371/journal.pone.0046604			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029555	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900189
J	Schallner, N; Fuchs, M; Schwer, CI; Loop, T; Buerkle, H; Lagreze, WA; van Oterendorp, C; Biermann, J; Goebel, U				Schallner, Nils; Fuchs, Matthias; Schwer, Christian I.; Loop, Torsten; Buerkle, Hartmut; Lagreze, Wolf Alexander; van Oterendorp, Christian; Biermann, Julia; Goebel, Ulrich			Postconditioning with Inhaled Carbon Monoxide Counteracts Apoptosis and Neuroinflammation in the Ischemic Rat Retina	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; REPERFUSION LUNG INJURY; HEAT-SHOCK RESPONSE; CARDIOPULMONARY BYPASS; GANGLION-CELLS; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; MULLER CELLS; MICROGLIA; PATHWAY	Purpose: Ischemia and reperfusion injury (I/R) of neuronal structures and organs is associated with increased morbidity and mortality due to neuronal cell death. We hypothesized that inhalation of carbon monoxide (CO) after I/R injury ('postconditioning') would protect retinal ganglion cells (RGC). Methods: Retinal I/R injury was performed in Sprague-Dawley rats (n = 8) by increasing ocular pressure (120 mmHg, 1 h). Rats inhaled room air or CO (250 ppm) for 1 h immediately following ischemia or with 1.5 and 3 h latency. Retinal tissue was harvested to analyze Bcl-2, Bax, Caspase-3, HO-1 expression and phosphorylation of the nuclear transcription factor (NF)-kappa B, p38 and ERK-1/2 MAPK. NF-kappa B activation was determined and inhibition of ERK-1/2 was performed using PD98059 (2 mg/kg). Densities of fluorogold prelabeled RGC were analyzed 7 days after injury. Microglia, macrophage and Muller cell activation and proliferation were evaluated by Iba-1, GFAP and Ki-67 staining. Results: Inhalation of CO after I/R inhibited Bax and Caspase-3 expression (Bax: 1.9 +/- 0.3 vs. 1.4 +/- 0.2, p = 0.028; caspase-3: 2.0 +/- 0.2 vs. 1.5 +/- 0.1, p = 0.007; mean +/- S.D., fold induction at 12 h), while expression of Bcl-2 was induced (1.2 +/- 0.2 vs. 1.6 +/- 0.2, p = 0.001; mean +/- S. D., fold induction at 12 h). CO postconditioning suppressed retinal p38 phosphorylation (p = 0.023 at 24 h) and induced the phosphorylation of ERK-1/2 (p < 0.001 at 24 h). CO postconditioning inhibited the expression of HO-1. The activation of NF-kappa B, microglia and Muller cells was potently inhibited by CO as well as immigration of proliferative microglia and macrophages into the retina. CO protected I/R-injured RGC with a therapeutic window at least up to 3 h (n = 8; RGC/mm(2); mean +/- S.D.: 1255 +/- 327 I/R only vs. 1956 +/- 157 immediate CO treatment, vs. 1830 +/- 109 1.5 h time lag and vs. 1626 +/- 122 3 h time lag; p < 0.001). Inhibition of ERK-1/2 did not counteract the CO effects (RGC/mm(2) : 1956 +/- 157 vs. 1931 +/- 124, mean +/- S.D., p = 0.799). Conclusion: Inhaled CO, administered after retinal ischemic injury, protects RGC through its strong anti-apoptotic and antiinflammatory effects.	[Schallner, Nils; Fuchs, Matthias; Schwer, Christian I.; Loop, Torsten; Buerkle, Hartmut; Goebel, Ulrich] Univ Med Ctr Freiburg Breisgau, Dept Anesthesiol & Crit Care Med, Freiburg, Germany; [Lagreze, Wolf Alexander; van Oterendorp, Christian; Biermann, Julia] Univ Eye Hosp, Univ Med Ctr, Freiburg, Germany	University of Freiburg	Schallner, N (corresponding author), Univ Med Ctr Freiburg Breisgau, Dept Anesthesiol & Crit Care Med, Freiburg, Germany.	nils.schallner@uniklinik-freiburg.de	Buerkle, Hartmut/I-5785-2014; Goebel, Ulrich M./AGG-1495-2022; Göbel, Ulrich/Q-7613-2016	Göbel, Ulrich/0000-0002-9991-3226	departmental funding; German Research Foundation (DFG); Albert Ludwigs University Freiburg in the funding programme "Open Access Publishing''	departmental funding; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg in the funding programme "Open Access Publishing''	This work was supported by departmental funding. The article processing charge was funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme "Open Access Publishing''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEGATE LA, 1991, CANCER RES, V51, P974; Bani-Hani MG, 2006, J PHARMACOL EXP THER, V318, P1315, DOI 10.1124/jpet.106.104729; Biermann J, 2010, INVEST OPHTH VIS SCI, V51, P3784, DOI 10.1167/iovs.09-4894; Danias J, 2002, INVEST OPHTH VIS SCI, V43, P587; De Backer O, 2009, GUT, V58, P347, DOI 10.1136/gut.2008.155481; Dvoriantchikova G, 2009, EUR J NEUROSCI, V30, P175, DOI 10.1111/j.1460-9568.2009.06814.x; Fischer D, 2000, INVEST OPHTH VIS SCI, V41, P3943; Ganesh BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018305; GELLER SF, 1995, INVEST OPHTH VIS SCI, V36, P737; Goebel U, 2009, BRIT J ANAESTH, V103, P173, DOI 10.1093/bja/aep087; Goebel U, 2008, ANESTHESIOLOGY, V108, P1025, DOI 10.1097/ALN.0b013e3181733115; Goebel U, 2011, ANESTH ANALG, V112, P282, DOI 10.1213/ANE.0b013e318203f591; Graham BL, 2002, AM J RESP CRIT CARE, V165, P1504, DOI 10.1164/rccm.2108071; Guo YL, 2001, J CELL BIOCHEM, V82, P556, DOI 10.1002/jcb.1180; Jaissle GB, 2011, GRAEF ARCH CLIN EXP, V249, P183, DOI 10.1007/s00417-010-1470-2; Jehle T, 2008, INVEST OPHTH VIS SCI, V49, P1056, DOI 10.1167/iovs.07-1050; Kamphuis W, 2007, MOL VIS, V13, P1020; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P4162, DOI 10.1167/iovs.08-1738; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Kim HP, 2005, J IMMUNOL, V175, P2622, DOI 10.4049/jimmunol.175.4.2622; Kohno H, 2006, GRAEF ARCH CLIN EXP, V244, P90, DOI 10.1007/s00417-005-0030-7; Lewis G, 1999, AM J OPHTHALMOL, V128, P165, DOI 10.1016/S0002-9394(99)00103-8; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Li SY, 2009, INVEST OPHTH VIS SCI, V50, P836, DOI 10.1167/iovs.08-2310; Marra C, 2011, J NEUROIMMUNOL, V233, P120, DOI 10.1016/j.jneuroim.2010.12.008; Mashour GA, 2011, ANESTHESIOLOGY, V114, P1289, DOI 10.1097/ALN.0b013e318216e7f4; Mayr FB, 2005, AM J RESP CRIT CARE, V171, P354, DOI 10.1164/rccm.200404-446OC; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Nakanishi Y, 2006, EXP EYE RES, V83, P1108, DOI 10.1016/j.exer.2006.05.018; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Otterbein LE, 2000, NAT MED, V6, P422, DOI 10.1038/74680; Otterbein LE, 2003, AM J PATHOL, V163, P2555, DOI 10.1016/S0002-9440(10)63610-3; Schallner N, 2011, EUR J PHARMACOL, V670, P58, DOI 10.1016/j.ejphar.2011.08.028; Takeuchi A, 2000, AM J RESP CRIT CARE, V161, P1816, DOI 10.1164/ajrccm.161.6.9907038; Vieira HLA, 2008, J NEUROCHEM, V107, P375, DOI 10.1111/j.1471-4159.2008.05610.x; VILLEGASPEREZ MP, 1988, J NEUROSCI, V8, P265; Wang LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023194; Weber J, 1998, STROKE, V29, P2076, DOI 10.1161/01.STR.29.10.2076; Williams AJ, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-17; Wohl SG, 2010, INVEST OPHTH VIS SCI, V51, P2686, DOI 10.1167/iovs.09-4537; Wong GY, 2000, ANESTHESIOLOGY, V92, P425, DOI 10.1097/00000542-200002000-00024; Yabluchanskiy A, 2012, CRIT CARE MED, V40, P544, DOI 10.1097/CCM.0b013e31822f0d64; Zeiss CJ, 2004, INVEST OPHTH VIS SCI, V45, P971, DOI 10.1167/iovs.03-0301; Zeynalov E, 2009, NEUROTOX RES, V15, P133, DOI 10.1007/s12640-009-9014-4; Zhang XC, 2003, J BIOL CHEM, V278, P22061, DOI 10.1074/jbc.M301858200; Zhang XC, 2003, J BIOL CHEM, V278, P1248, DOI 10.1074/jbc.M208419200; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	49	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46479	10.1371/journal.pone.0046479	http://dx.doi.org/10.1371/journal.pone.0046479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029526	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900167
J	Solt, LA; Kamenecka, TM; Burris, TP				Solt, Laura A.; Kamenecka, Theodore M.; Burris, Thomas P.			LXR-Mediated Inhibition of CD4(+) T Helper Cells	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; ROR-GAMMA-T; X-RECEPTOR AGONIST; ADOPTIVE TRANSFER; INTERFERON-GAMMA; GENE-EXPRESSION; DIFFERENTIATION; BET; INDUCTION; LINEAGE	T(H)17 cells, which require the expression of both retinoic acid receptor-related orphan receptors alpha and gamma t (ROR alpha and ROR gamma t) for full differentiation and function, have been implicated as major effectors in the pathogenesis of inflammatory and autoimmune diseases. We recently demonstrated that the Liver X Receptor (LXR) agonist, T0901317 (T09), also displays high-affinity ROR alpha and ROR gamma inverse activity, potentially explaining its effectiveness in various T(H)17-mediated autoimmune disease models. However, recent studies suggest that in conjunction with the RORs, LXR mediates a negative regulatory effect on T(H)17 cell differentiation. Since T09 acts on both LXRs and RORs, it presents as a valuable tool to understand how compounds with mixed pharmacology affect potential pathological cell types. Therefore, using T09, we investigated the mechanism by which the LXRs and RORs affect T(H)17 cell differentiation and function. Here we demonstrate that T09 activity at ROR alpha and gamma, not LXR, is facilitating the inhibition of T(H)17 cell differentiation and function. We also demonstrate that LXR activity inhibits the differentiation and function of T(H)1, T(H)2 and iT(reg) cells. Finally, T09 inhibited T cell proliferation and induced cell death. These data help explain much of the efficacy of T09 in inflammatory models and suggest that the generation of synthetic ligands with graded, combined LXR and ROR activity may hold utility in the treatment of inflammatory and autoimmune diseases where targeting both T(H)17 and T(H)1 cells is required.	[Solt, Laura A.; Kamenecka, Theodore M.; Burris, Thomas P.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA	Scripps Research Institute	Burris, TP (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA.	tburris@scripps.edu	Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	National Institutes of Health [R01DK080201]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institutes of Health R01DK080201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO DG, 1989, CELL IMMUNOL, V124, P132, DOI 10.1016/0008-8749(89)90117-2; Armstrong AJ, 2010, J IMMUNOL, V184, P173, DOI 10.4049/jimmunol.0902372; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; CHRIST M, 1993, IMMUNOLOGY, V78, P455; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; Ferber IA, 1996, J IMMUNOL, V156, P5; Gocke AR, 2007, J IMMUNOL, V178, P1341, DOI 10.4049/jimmunol.178.3.1341; Gutcher I, 2007, J CLIN INVEST, V117, P1119, DOI 10.1172/JCI31720; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwakura Y, 2006, J CLIN INVEST, V116, P1218, DOI 10.1172/JCI28508; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Joseph SB, 2004, CELL, V119, P299, DOI 10.1016/j.cell.2004.09.032; Kang HS, 2011, DIABETES, V60, P177, DOI 10.2337/db10-0628; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lovett-Racke AE, 2004, IMMUNITY, V21, P719, DOI 10.1016/j.immuni.2004.09.010; MCDONALD AH, 1988, J IMMUNOL, V140, P1132; Nath N, 2006, IMMUNOLOGY, V118, P384, DOI 10.1111/j.1365-2567.2006.02385.x; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; PETTINELLI CB, 1981, J IMMUNOL, V127, P1420; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Tamauchi H, 2004, INT IMMUNOL, V16, P179, DOI 10.1093/intimm/dxh026; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Valledor AF, 2004, P NATL ACAD SCI USA, V101, P17813, DOI 10.1073/pnas.0407749101; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Waldburger KE, 1996, AM J PATHOL, V148, P375; Willenborg DO, 1996, J IMMUNOL, V157, P3223; Xu JH, 2009, J LEUKOCYTE BIOL, V86, P401, DOI 10.1189/jlb.1008600; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yura M, 2001, J AUTOIMMUN, V17, P17, DOI 10.1006/jaut.2001.0520; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zuercher WJ, 2010, J MED CHEM, V53, P3412, DOI 10.1021/jm901797p	47	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46615	10.1371/journal.pone.0046615	http://dx.doi.org/10.1371/journal.pone.0046615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029557	gold, Green Submitted, Green Published			2022-12-27	WOS:000309973900191
J	Sulaeman, S; Hernould, M; Schaumann, A; Coquet, L; Bolla, JM; De, E; Tresse, O				Sulaeman, Sheiam; Hernould, Mathieu; Schaumann, Annick; Coquet, Laurent; Bolla, Jean-Michel; De, Emmanuelle; Tresse, Odile			Enhanced Adhesion of Campylobacter jejuni to Abiotic Surfaces Is Mediated by Membrane Proteins in Oxygen-Enriched Conditions	PLOS ONE			English	Article							OXIDATIVE STRESS RESISTANCE; ELONGATION-FACTOR TU; BIOFILM FORMATION; ESCHERICHIA-COLI; C-JEJUNI; BINDING PROTEIN; IDENTIFICATION; ADHERENCE; PROTEOMICS; VIRULENCE	Campylobacter jejuni is responsible for the major foodborne bacterial enteritis in humans. In contradiction with its fastidious growth requirements, this microaerobic pathogen can survive in aerobic food environments, suggesting that it must employ a variety of protection mechanisms to resist oxidative stress. For the first time, C. jejuni 81-176 inner and outer membrane subproteomes were analyzed separately using two-dimensional protein electrophoresis (2-DE) of oxygen-acclimated cells and microaerobically grown cells. LC-MS/MS analyses successfully identified 42 and 25 spots which exhibited a significantly altered abundance in the IMP-enriched fraction and in the OMP-enriched fraction, respectively, in response to oxidative conditions. These spots corresponded to 38 membrane proteins that could be grouped into different functional classes: (i) transporters, (ii) chaperones, (iii) fatty acid metabolism, (iv) adhesion/virulence and (v) other metabolisms. Some of these proteins were up-regulated at the transcriptional level in oxygen-acclimated cells as confirmed by qRT-PCR. Downstream analyses revealed that adhesion of C. jejuni to inert surfaces and swarming motility were enhanced in oxygen-acclimated cells or paraquat-stressed cells, which could be explained by the higher abundance of membrane proteins involved in adhesion and biofilm formation. The virulence factor CadF, over-expressed in the outer membrane of oxygen-acclimated cells, contributes to the complex process of C. jejuni adhesion to inert surfaces as revealed by a reduction in the capability of C. jejuni 81-176 DCadF cells compared to the isogenic strain. Taken together, these data demonstrate that oxygen-enriched conditions promote the over-expression of membrane proteins involved in both the biofilm initiation and virulence of C. jejuni.	[Sulaeman, Sheiam; Hernould, Mathieu; Tresse, Odile] INRA, SECALIM, UMR1014, F-44026 Nantes, France; [Sulaeman, Sheiam; Hernould, Mathieu; Tresse, Odile] Univ Nantes, LUNAM Univ, Nantes, France; [Schaumann, Annick; Coquet, Laurent; De, Emmanuelle] CNRS, IFRMP23, FR 3038, Mont St Aignan, France; [Schaumann, Annick; Coquet, Laurent; De, Emmanuelle] Univ Rouen, Lab Polymeres Biopolyme Surfaces, UMR 6270, Mont St Aignan, France; [Bolla, Jean-Michel] Univ Aix Marseille, IRBA, Fac Med & Pharm, UMR MD1, Marseille, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; INRAE; Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rouen Normandie; UDICE-French Research Universities; Aix-Marseille Universite	Tresse, O (corresponding author), INRA, SECALIM, UMR1014, F-44026 Nantes, France.	odile.tresse@oniris-nantes.fr	Bolla, Jean Michel/D-3885-2014	Bolla, Jean Michel/0000-0003-3892-4340; COQUET, Laurent/0000-0001-7778-7321; De, Emmanuelle/0000-0002-9564-1649; Tresse, Odile/0000-0001-9833-2510	Pays de la Loire region (France) through the project GENICAMP; Syrian fellowship	Pays de la Loire region (France) through the project GENICAMP(Region Pays de la Loire); Syrian fellowship	This research was funded by the Pays de la Loire region (France) through the project GENICAMP. Sheiam Sulaeman was the recipient of a Syrian fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheson DWK, 1999, CURR OPIN GASTROEN, V15, P538, DOI 10.1097/00001574-199911000-00015; Asakura H, 2007, FEMS MICROBIOL LETT, V275, P278, DOI 10.1111/j.1574-6968.2007.00893.x; Atack JM, 2008, J BACTERIOL, V190, P5279, DOI 10.1128/JB.00100-08; Atack JM, 2009, FUTURE MICROBIOL, V4, P677, DOI 10.2217/FMB.09.44; Baillon MLA, 1999, J BACTERIOL, V181, P4798, DOI 10.1128/JB.181.16.4798-4804.1999; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Batz B., 2011, RANKING RISKS 10 PAT; Berrier C, 2000, J BACTERIOL, V182, P248, DOI 10.1128/JB.182.1.248-251.2000; Bieche C, 2012, J PROTEOMICS, V75, P1144, DOI 10.1016/j.jprot.2011.10.028; Boyanova L, 2004, DIAGN MICR INFEC DIS, V49, P71, DOI 10.1016/j.diagmicrobio.2003.12.004; Broman T, 2002, J CLIN MICROBIOL, V40, P4594, DOI 10.1128/JCM.40.12.4594-4602.2002; Brown RN, 2010, J PROTEOME RES, V9, P4454, DOI 10.1021/pr100215h; BURUCOA C, 1995, RES MICROBIOL, V146, P467, DOI 10.1016/0923-2508(96)80292-0; Chan KF, 2001, APPL ENVIRON MICROB, V67, P4186, DOI 10.1128/AEM.67.9.4186-4191.2001; Chavant P, 2007, J MICROBIOL METH, V68, P605, DOI 10.1016/j.mimet.2006.11.010; Corcionivoschi Nicolae, 2007, Bacteriol Virusol Parazitol Epidemiol, V52, P51; Cordwell SJ, 2008, PROTEOMICS, V8, P122, DOI 10.1002/pmic.200700561; Cremet L, 2012, J INFECTION, V64, P169, DOI 10.1016/j.jinf.2011.11.010; Elvers KT, 2002, MICROBIOL-SGM, V148, P1475, DOI 10.1099/00221287-148-5-1475; European Food Safety Authority, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1503; FILIP C, 1973, J BACTERIOL, V115, P717, DOI 10.1128/JB.115.3.717-722.1973; FISHER MT, 1992, J BIOL CHEM, V267, P1872; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; Garenaux A, 2009, CURR MICROBIOL, V58, P134, DOI 10.1007/s00284-008-9289-3; Garenaux A, 2008, RES MICROBIOL, V159, P718, DOI 10.1016/j.resmic.2008.08.001; Gil F, 2007, RES MICROBIOL, V158, P529, DOI 10.1016/j.resmic.2007.05.004; GRANT CCR, 1993, INFECT IMMUN, V61, P1764, DOI 10.1128/IAI.61.5.1764-1771.1993; GRANT KA, 1995, MICROBIOL-SGM, V141, P1369, DOI 10.1099/13500872-141-6-1369; Guerry P, 2007, TRENDS MICROBIOL, V15, P456, DOI 10.1016/j.tim.2007.09.006; Gundogdu O, 2011, J BACTERIOLOGY; HASSAN HM, 1979, J BIOL CHEM, V254, P846; Hobb RI, 2009, MICROBIOL-SGM, V155, P979, DOI 10.1099/mic.0.024539-0; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Hwang S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022300; Jeon B, 2011, J ANTIMICROB CHEMOTH, V66, P79, DOI 10.1093/jac/dkq418; John A, 2011, RES MICROBIOL, V162, P410, DOI 10.1016/j.resmic.2011.02.004; Joshua GWP, 2006, MICROBIOL-SGM, V152, P387, DOI 10.1099/mic.0.28358-0; Kaakoush NO, 2007, RES MICROBIOL, V158, P644, DOI 10.1016/j.resmic.2007.07.009; Kim TJ, 2008, APPL ENVIRON MICROB, V74, P5466, DOI 10.1128/AEM.00222-08; Kirov SM, 2004, INFECT IMMUN, V72, P1939, DOI 10.1128/IAI.72.4.1939-1945.2004; Kolberg J, 2008, FEMS IMMUNOL MED MIC, V53, P222, DOI 10.1111/j.1574-695X.2008.00419.x; Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004; Konkel ME, 1997, MOL MICROBIOL, V24, P953, DOI 10.1046/j.1365-2958.1997.4031771.x; Larson CL, 2008, MICROBIOL-SGM, V154, P3835, DOI 10.1099/mic.0.2008/021279-0; Leon-Kempis MD, 2006, MOL MICROBIOL, V60, P1262, DOI 10.1111/j.1365-2958.2006.05168.x; Li JK, 2010, J PROTEOME RES, V9, P6578, DOI 10.1021/pr100768t; Liu XY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002562; Mace C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003897; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Moore JE, 2005, VET RES, V36, P351, DOI 10.1051/vetres:2005012; Nachamkin I, 2002, MICROBES INFECT, V4, P399, DOI 10.1016/S1286-4579(02)01553-8; Nikaido E, 2011, MICROBIOL-SGM, V157, P648, DOI 10.1099/mic.0.045757-0; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Prokhorova TA, 2006, VACCINE, V24, P6446, DOI 10.1016/j.vaccine.2006.05.085; Rathbun KM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-160; Reuter M, 2010, APPL ENVIRON MICROB, V76, P2122, DOI 10.1128/AEM.01878-09; Ritz M, 2009, J MICROBIOL METH, V76, P196, DOI 10.1016/j.mimet.2008.10.014; Santoni V, 2000, ELECTROPHORESIS, V21, P3329, DOI 10.1002/1522-2683(20001001)21:16<3329::AID-ELPS3329>3.0.CO;2-F; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scott AE, 2007, PLOS PATHOG, V3, P1142, DOI 10.1371/journal.ppat.0030119; Scott NE, 2010, PROTEOMICS, V10, P277, DOI 10.1002/pmic.200900440; Seal BS, 2007, J PROTEOME RES, V6, P4582, DOI 10.1021/pr070356a; Sellars MJ, 2002, J BACTERIOL, V184, P4187, DOI 10.1128/JB.184.15.4187-4196.2002; Siroy A, 2006, J PROTEOME RES, V5, P3385, DOI 10.1021/pr060372s; SKIRROW MB, 1990, LANCET, V336, P921, DOI 10.1016/0140-6736(90)92282-M; Solis N, 2011, PROTEOMICS, V11, P3169, DOI 10.1002/pmic.201000808; St Maurice M, 2007, J BACTERIOL, V189, P4764, DOI 10.1128/JB.00287-07; Sulaeman S, 2010, J APPL MICROBIOL, V108, P1303, DOI 10.1111/j.1365-2672.2009.04534.x; van Vliet AHM, 2002, FEMS MICROBIOL REV, V26, P173, DOI 10.1111/j.1574-6976.2002.tb00609.x; van Vliet AHM, 2001, FEMS MICROBIOL LETT, V196, P189, DOI 10.1016/S0378-1097(01)00067-2; Vilain S, 2001, ELECTROPHORESIS, V22, P4368, DOI 10.1002/1522-2683(200112)22:20<4368::AID-ELPS4368>3.0.CO;2-9; WASSENAAR TM, 1991, EMBO J, V10, P2055, DOI 10.1002/j.1460-2075.1991.tb07736.x; Watnick PI, 2001, MOL MICROBIOL, V39, P223, DOI 10.1046/j.1365-2958.2001.02195.x; Yamasaki M, 2004, FEMS MICROBIOL LETT, V235, P57, DOI 10.1016/j.femsle.2004.04.012; Yao RJ, 1997, MOL MICROBIOL, V23, P1021, DOI 10.1046/j.1365-2958.1997.2861650.x; YAO RJ, 1994, MOL MICROBIOL, V14, P883, DOI 10.1111/j.1365-2958.1994.tb01324.x; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	79	38	38	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46402	10.1371/journal.pone.0046402	http://dx.doi.org/10.1371/journal.pone.0046402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029510	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900154
J	Gorman, S; Scott, NM; Tan, DHW; Weeden, CE; Tuckey, RC; Bisley, JL; Grimbaldeston, MA; Hart, PH				Gorman, Shelley; Scott, Naomi M.; Tan, Daryl H. W.; Weeden, Clare E.; Tuckey, Robert C.; Bisley, Jacqueline L.; Grimbaldeston, Michele A.; Hart, Prue H.			Acute Erythemal Ultraviolet Radiation Causes Systemic Immunosuppression in the Absence of Increased 25-Hydroxyvitamin D-3 Levels in Male Mice	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; VITAMIN-D; UV-RADIATION; CONTACT HYPERSENSITIVITY; MURINE SKIN; IN-VITRO; T-CELLS; IRRADIATION; SUPPRESSION; SUSCEPTIBILITY	Vitamin D is synthesised by ultraviolet (UV) irradiation of skin and is hypothesized to be a direct mediator of the immunosuppression that occurs following UV radiation (UVR) exposure. Both UVR and vitamin D drive immune responses towards tolerance by ultimately increasing the suppressive activities of regulatory T cells. To examine a role for UVR-induced vitamin D, vitamin D-3-deficient mice were established by dietary vitamin D-3 restriction. In comparison to vitamin D-3-replete mice, vitamin D-3-deficient mice had significantly reduced serum levels of 25-hydroxyvitamin D-3 (25(OH)D-3, < 20 nmol.L-1) and 1,25-dihydroxyvitamin D-3 (1,25(OH)(2)D-3, < 20 pmol.L-1). Following either acute erythemal UVR, or chronic sub-erythemal UVR (8 exposures over 4 weeks) treatment, serum 25(OH)D-3 levels significantly increased in vitamin D-3-deficient female but not male mice. To determine if UVR-induced vitamin D was a mediator of UVR-induced systemic immunosuppression, responses were measured in mice that were able (female) or unable (male) to increase systemic levels of 25(OH)D-3 after UVR. Erythemal UVR (>= 4 kJ/m(2)) suppressed contact hypersensitivity responses (T helper type-1 or -17), aspects of allergic airway disease (T helper type-2) and also the in vivo priming capacity of bone marrow-derived dendritic cells to a similar degree in female and male vitamin D-3-deficient mice. Thus, in male mice, UVR-induced 25(OH)D-3 is not essential for mediating the immunosuppressive effects of erythemal UVR.	[Gorman, Shelley; Scott, Naomi M.; Tan, Daryl H. W.; Weeden, Clare E.; Bisley, Jacqueline L.; Hart, Prue H.] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Gorman, Shelley; Scott, Naomi M.; Tan, Daryl H. W.; Weeden, Clare E.; Bisley, Jacqueline L.; Hart, Prue H.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Tuckey, Robert C.] Univ Western Australia, Sch Biomed Biomol & Chem Sci, Perth, WA 6009, Australia; [Grimbaldeston, Michele A.] SA Pathol, Div Human Immunol, Ctr Canc Biol, Adelaide, SA, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Western Australia; Centre for Cancer Biology; SA Pathology	Gorman, S (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	shelleyg@ichr.uwa.edu.au	Gorman, Shelley/E-1649-2013; Scott, Naomi/R-9951-2017; Gorman, Shelley/R-9953-2017; Tuckey, Robert/H-5983-2014	Gorman, Shelley/0000-0002-7111-6735; Hart, Prue/0000-0001-7207-6467; Tuckey, Robert/0000-0002-5022-4729; Weeden, Clare/0000-0002-1561-1416	National Health and Medical Research Council of Australia [458612]; Cancer Council of Western Australia [1008985]; Asthma Foundation of Western Australia; Raine Foundation; BrightSpark Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of Western Australia(Cancer Council Western Australia); Asthma Foundation of Western Australia; Raine Foundation; BrightSpark Foundation	This study was supported by grants from the National Health and Medical Research Council of Australia (#458612, PHH), the Cancer Council of Western Australia (#1008985, PHH and SG), the Asthma Foundation of Western Australia (SG and PHH), the Raine Foundation (SG and PHH), and the BrightSpark Foundation (SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becklund BR, 2010, P NATL ACAD SCI USA, V107, P6418, DOI 10.1073/pnas.1001119107; Biggs L, 2010, J EXP MED, V207, P455, DOI 10.1084/jem.20091725; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Cantorna MT, 1999, J NUTR, V129, P1966, DOI 10.1093/jn/129.11.1966; Ellison TI, 2008, J INVEST DERMATOL, V128, P2508, DOI 10.1038/jid.2008.131; Ghoreishi M, 2006, J IMMUNOL, V176, P2635, DOI 10.4049/jimmunol.176.4.2635; Ghoreishi M, 2009, J IMMUNOL, V182, P6071, DOI 10.4049/jimmunol.0804064; Giulietti A, 2004, DIABETOLOGIA, V47, P451, DOI 10.1007/s00125-004-1329-3; Gorman S, 2007, J IMMUNOL, V179, P6273, DOI 10.4049/jimmunol.179.9.6273; Gorman S, 2007, J INVEST DERMATOL, V127, P915, DOI 10.1038/sj.jid.5700600; Gorman S, 2012, PEDIAT ALLERG IMM-UK, V23, P83, DOI 10.1111/j.1399-3038.2011.01146.x; Gorman S, 2010, IMMUNOLOGY, V131, P415, DOI 10.1111/j.1365-2567.2010.03315.x; Gorman S, 2010, J STEROID BIOCHEM, V121, P247, DOI 10.1016/j.jsbmb.2010.02.034; Halliday GM, 2010, J INVEST DERMATOL, V130, P1209, DOI 10.1038/jid.2009.374; Hart PH, 1998, J EXP MED, V187, P2045, DOI 10.1084/jem.187.12.2045; Hart PH, 2011, NAT REV IMMUNOL, V11, P584, DOI 10.1038/nri3045; HAUSER SL, 1984, J IMMUNOL, V132, P1276; HOW KL, 1994, GEN COMP ENDOCR, V96, P12, DOI 10.1006/gcen.1994.1154; Kelly DA, 2000, J EXP MED, V191, P561, DOI 10.1084/jem.191.3.561; Lagishetty V, 2010, ENDOCRINOLOGY, V151, P2423, DOI 10.1210/en.2010-0089; Lehmann B, 2003, ARCH DERMATOL RES, V295, P24, DOI 10.1007/s00403-003-0387-6; Loser K, 2006, NAT MED, V12, P1372, DOI 10.1038/nm1518; MACLAUGHLIN J, 1985, J CLIN INVEST, V76, P1536, DOI 10.1172/JCI112134; Matheu V, 2003, J ALLERGY CLIN IMMUN, V112, P585, DOI [10.1016/S0091-6749(03)01855-4, 10.1037/mai.2003.1703]; McGlade JP, 2007, CLIN EXP ALLERGY, V37, P1267, DOI 10.1111/j.1365-2222.2007.02750.x; McGlade JP, 2007, J IMMUNOL, V178, P2794, DOI 10.4049/jimmunol.178.5.2794; MIYAUCHI H, 1995, J INVEST DERMATOL, V104, P364, DOI 10.1111/1523-1747.ep12665832; Moghaddami M, 2012, IMMUNOL CELL BIOL, V90, P168, DOI 10.1038/icb.2011.22; Ng RLX, 2010, J IMMUNOL, V185, P7207, DOI 10.4049/jimmunol.1001693; Norval M, 2006, PROG BIOPHYS MOL BIO, V92, P108, DOI 10.1016/j.pbiomolbio.2006.02.009; Norval M, 2011, PHOTOCHEM PHOTOBIOL, V87, P965, DOI 10.1111/j.1751-1097.2011.00969.x; Paterson CR, 1997, NUTRITION, V13, P771, DOI 10.1016/S0899-9007(97)00186-X; Reeve VE, 2012, PHOTOCH PHOTOBIO SCI, V11, P173, DOI 10.1039/c1pp05224a; Schwarz A, 2005, J EXP MED, V201, P173, DOI 10.1084/jem.20041212; Song YR, 2003, J NUTR, V133, P374, DOI 10.1093/jn/133.2.374; Soontrapa K, 2011, P NATL ACAD SCI USA, V108, P6668, DOI 10.1073/pnas.1018625108; Spach KM, 2005, J IMMUNOL, V175, P4119, DOI 10.4049/jimmunol.175.6.4119; Taher YA, 2008, J IMMUNOL, V180, P5211, DOI 10.4049/jimmunol.180.8.5211; Topilski I, 2004, EUR J IMMUNOL, V34, P1068, DOI 10.1002/eji.200324532; TUCKEY RC, 1985, EUR J BIOCHEM, V148, P379, DOI 10.1111/j.1432-1033.1985.tb08849.x; Ullrich SE, 2005, MUTAT RES-FUND MOL M, V571, P185, DOI 10.1016/j.mrfmmm.2004.06.059; Vink AA, 1997, P NATL ACAD SCI USA, V94, P5255, DOI 10.1073/pnas.94.10.5255; Wittke A, 2007, ARCH BIOCHEM BIOPHYS, V460, P306, DOI 10.1016/j.abb.2006.12.011; Zhang ZL, 2011, ENDOCR RES, V36, P101, DOI 10.3109/07435800.2010.542415	44	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46006	10.1371/journal.pone.0046006	http://dx.doi.org/10.1371/journal.pone.0046006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049920	Green Accepted, Green Published, gold			2022-12-27	WOS:000309517300074
J	Ratto-Kim, S; Currier, JR; Cox, JH; Excler, JL; Valencia-Micolta, A; Thelian, D; Lo, V; Sayeed, E; Polonis, VR; Earl, PL; Moss, B; Robb, ML; Michael, NL; Kim, JH; Marovich, MA				Ratto-Kim, Silvia; Currier, Jeffrey R.; Cox, Josephine H.; Excler, Jean-Louis; Valencia-Micolta, Anais; Thelian, Doris; Lo, Vicky; Sayeed, Eddy; Polonis, Victoria R.; Earl, Patricia L.; Moss, Bernard; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.; Marovich, Mary A.			Heterologous Prime-Boost Regimens Using rAd35 and rMVA Vectors Elicit Stronger Cellular Immune Responses to HIV Proteins Than Homologous Regimens	PLOS ONE			English	Article							VACCINE VECTORS; IMMUNOGENICITY; DNA; PROTECTION; ANKARA; SIV	We characterized prime-boost vaccine regimens using heterologous and homologous vector and gene inserts. Heterologous regimens offer a promising approach that focuses the cell-mediated immune response on the insert and away from vector-dominated responses. Ad35-GRIN/ENV (Ad35-GE) vaccine is comprised of two vectors containing sequences from HIV-1 subtype A gag, rt, int, nef (Ad35-GRIN) and env (Ad35-ENV). MVA-CMDR (MVA-C), MVA-KEA (MVA-K) and MVA-TZC (MVA-T) vaccines contain gag, env and pol genes from HIV-1 subtypes CRF01_AE, A and C, respectively. Balb/c mice were immunized with different heterologous and homologous vector and insert prime-boost combinations. HIV and vector-specific immune responses were quantified post-boost vaccination. Gag-specific IFN-gamma ELISPOT, intracellular cytokine staining (ICS) (CD107 alpha, IFN-alpha, TNF-alpha and IL-2), pentamer staining and T-cell phenotyping were used to differentiate responses to inserts and vectors. Ad35-GE prime followed by boost with any of the recombinant MVA constructs (rMVA) induced CD8+ Gag-specific responses superior to Ad35-GE-Ad35-GE or rMVA-rMVA prime-boost combinations. Notably, there was a shift toward insert-focus responses using heterologous vector prime-boost regimens. Gag-specific central and effector memory T cells were generated more rapidly and in greater numbers in the heterologous compared to the homologous prime-boost regimens. These results suggest that heterologous prime-boost vaccination regimens enhance immunity by increasing the magnitude, onset and multifunctionality of the insert-specific cell-mediated immune response compared to homologous vaccination regimens. This study supports the rationale for testing heterologous prime-boost regimens in humans.	[Ratto-Kim, Silvia; Currier, Jeffrey R.; Valencia-Micolta, Anais; Thelian, Doris; Lo, Vicky; Polonis, Victoria R.; Robb, Merlin L.; Michael, Nelson L.; Kim, Jerome H.; Marovich, Mary A.] Walter Reed Army Inst Res, US Mil HIV Res Program, Rockville, MD USA; [Cox, Josephine H.; Excler, Jean-Louis; Sayeed, Eddy] Int AIDS Vaccine Initiat, New York, NY USA; [Earl, Patricia L.; Moss, Bernard] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); International AIDS Vaccine Initiative; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ratto-Kim, S (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Rockville, MD USA.	sratto-kim@hivresearch.org		Moss, Bernard/0000-0002-2154-8564; Ratto-Kim, Silvia/0000-0003-2025-6399; Cox, Josephine/0000-0003-1301-7373	United States Army Medical Research and Materiel Command [Y1-AI-2642-12]; National Institute of Allergy and Infectious Diseases; Henry M. Jackson Foundation for the Advancement of Military Medicine [W81XWH-07-2-6700-P00001]; United States Department of Defense; International AIDS Vaccine Initiative; American people through the United States Agency for International Development (USAID) [GPO-A-00-06-00006-00]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000416] Funding Source: NIH RePORTER	United States Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine; United States Department of Defense(United States Department of Defense); International AIDS Vaccine Initiative; American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by an Interagency Agreement (Y1-AI-2642-12) between the United States Army Medical Research and Materiel Command and the National Institute of Allergy and Infectious Diseases and by a cooperative agreement (W81XWH-07-2-6700-P00001) between the Henry M. Jackson Foundation for the Advancement of Military Medicine and the United States Department of Defense. This study was also partially funded by the International AIDS Vaccine Initiative and its donors, including the generous support of the American people through the United States Agency for International Development (USAID; USAID Cooperative Agreement number GPO-A-00-06-00006-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bett AJ, 2010, VACCINE, V28, P7881, DOI 10.1016/j.vaccine.2010.09.079; Bot A, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-132; Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983; Doe B, 1996, AIDS, V10, P793, DOI 10.1097/00002030-199606001-00015; Earl PL, 2009, VACCINE, V27, P5885, DOI 10.1016/j.vaccine.2009.07.039; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Honda M, 2009, J IMMUNOL, V183, P2425, DOI 10.4049/jimmunol.0900581; Keefer M, 2010, AIDS RES HUM RETROV, V26, pA16; Lemckert AAC, 2005, J VIROL, V79, P9694, DOI 10.1128/JVI.79.15.9694-9701.2005; Lu Y, 2009, VACCINE, V27, P5411, DOI 10.1016/j.vaccine.2009.06.089; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Pillai VKB, 2011, VACCINE, V29, P5399, DOI 10.1016/j.vaccine.2011.05.083; Radosevic K, 2010, CLIN VACCINE IMMUNOL, V17, P1687, DOI 10.1128/CVI.00311-10; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Reyes-Sandoval A, 2011, J IMMUNOL, V187, P1347, DOI 10.4049/jimmunol.1100302; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Tscharke DC, 2006, J VIROL, V80, P6318, DOI 10.1128/JVI.00427-06; Vuola JM, 2005, J IMMUNOL, V174, P449, DOI 10.4049/jimmunol.174.1.449; Wang S, 2008, VACCINE, V26, P3626, DOI 10.1016/j.vaccine.2008.04.073; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Xu JQ, 2006, AIDS, V20, P2293, DOI 10.1097/QAD.0b013e328010ad0c	27	32	35	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45840	10.1371/journal.pone.0045840	http://dx.doi.org/10.1371/journal.pone.0045840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049876	Green Submitted, gold, Green Published			2022-12-27	WOS:000309517300058
J	Abouseada, NM; Assafi, MSA; Mahdavi, J; Oldfield, NJ; Wheldon, LM; Wooldridge, KG; Ala'Aldeen, DAA				Abouseada, Noha M.; Assafi, Mahde Saleh A.; Mahdavi, Jafar; Oldfield, Neil J.; Wheldon, Lee M.; Wooldridge, Karl G.; Ala'Aldeen, Dlawer A. A.			Mapping the Laminin Receptor Binding Domains of Neisseria meningitidis PorA and Haemophilus influenzae OmpP2	PLOS ONE			English	Article							CELL-SURFACE RECEPTOR; SYNTHETIC PEPTIDES; PROTEIN P2; VIRUS; IDENTIFICATION; SEQUENCES; ACYLATION; STRAINS; GENE	Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae are major bacterial agents of meningitis. They each bind the 37/67-kDa laminin receptor (LamR) via the surface protein adhesins: meningococcal PilQ and PorA, H. influenzae OmpP2 and pneumococcal CbpA. We have previously reported that a surface-exposed loop of the R2 domain of CbpA mediates LamR-binding. Here we have identified the LamR-binding regions of PorA and OmpP2. Using truncated recombinant proteins we show that binding is dependent on amino acids 171-240 and 91-99 of PorA and OmpP2, respectively, which are predicted to localize to the fourth and second surface-exposed loops, respectively, of these proteins. Synthetic peptides corresponding to the loops bound LamR and could block LamR-binding to bacterial ligands in a dose dependant manner. Meningococci expressing PorA lacking the apex of loop 4 and H. influenzae expressing OmpP2 lacking the apex of loop 2 showed significantly reduced LamR binding. Since both loops are hyper-variable, our data may suggest a molecular basis for the range of LamR-binding capabilities previously reported among different meningococcal and H. influenzae strains.	[Abouseada, Noha M.; Assafi, Mahde Saleh A.; Mahdavi, Jafar; Oldfield, Neil J.; Wheldon, Lee M.; Wooldridge, Karl G.; Ala'Aldeen, Dlawer A. A.] Univ Nottingham, Mol Bacteriol & Immunol Grp, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Nottingham	Ala'Aldeen, DAA (corresponding author), Univ Nottingham, Mol Bacteriol & Immunol Grp, Ctr Biomol Sci, Nottingham NG7 2RD, England.	daa@nottingham.ac.uk	Oldfield, Neil J/C-2599-2009; Abouseada, Noha/H-5017-2016; Assafi, Assist Prof Dr. Mahde Saleh A/AAA-9643-2019	Oldfield, Neil J/0000-0001-7423-8378; Abouseada, Noha/0000-0002-1980-1276; assafi, Mahde/0000-0002-4863-282X; Wooldridge, Karl/0000-0002-7925-9474	Medical Research Council, UK [G0801173]; Medical Research Council [G0801173] Funding Source: researchfish; MRC [G0801173] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Medical Research Council, UK (www.mrc.ac.uk); award number G0801173. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; BELL J, 1994, INFECT IMMUN, V62, P2639, DOI 10.1128/IAI.62.6.2639-2643.1994; Buto S, 1998, J CELL BIOCHEM, V69, P244, DOI 10.1002/(SICI)1097-4644(19980601)69:3<244::AID-JCB2>3.0.CO;2-R; DANNER DB, 1980, GENE, V11, P311, DOI 10.1016/0378-1119(80)90071-2; de Filippis I, 2011, INFECT GENET EVOL, V11, P248, DOI 10.1016/j.meegid.2010.08.011; FRASCH CE, 1985, REV INFECT DIS, V7, P504; Galdiero S, 2006, BIOCHEMISTRY-US, V45, P4491, DOI 10.1021/bi052262p; Galdiero S, 2003, INFECT IMMUN, V71, P2798, DOI 10.1128/IAI.71.5.2798-2809.2003; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Givant-Horwitz V, 2004, CANCER RES, V64, P3572, DOI 10.1158/0008-5472.CAN-03-3424; Granoff DM, 2010, CLIN INFECT DIS, V50, pS54, DOI 10.1086/648966; Hadi HA, 2001, MOL MICROBIOL, V41, P611, DOI 10.1046/j.1365-2958.2001.02516.x; Hakenbeck R, 2009, FEMS MICROBIOL REV, V33, P572, DOI 10.1111/j.1574-6976.2009.00172.x; Hundt C, 2001, EMBO J, V20, P5876, DOI 10.1093/emboj/20.21.5876; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; Kinoshita K, 1998, BIOCHEM BIOPH RES CO, V253, P277, DOI 10.1006/bbrc.1998.9699; LANDOWSKI TH, 1995, BIOCHEMISTRY-US, V34, P11276, DOI 10.1021/bi00035a037; LESOT H, 1983, EMBO J, V2, P861, DOI 10.1002/j.1460-2075.1983.tb01514.x; Ludwig GV, 1996, J VIROL, V70, P5592, DOI 10.1128/JVI.70.8.5592-5599.1996; MAIDEN MCJ, 1991, MOL MICROBIOL, V5, P727, DOI 10.1111/j.1365-2958.1991.tb00743.x; MALINOFF HL, 1983, J CELL BIOL, V96, P1475, DOI 10.1083/jcb.96.5.1475; MCGUINNESS B, 1990, J EXP MED, V171, P1871, DOI 10.1084/jem.171.6.1871; McNichol BA, 2007, INFECT IMMUN, V75, P5095, DOI 10.1128/IAI.00075-07; Menard S, 1997, J CELL BIOCHEM, V67, P155, DOI 10.1002/(SICI)1097-4644(19971101)67:2<155::AID-JCB1>3.3.CO;2-O; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Newcombe J, 1998, MOL MICROBIOL, V30, P453, DOI 10.1046/j.1365-2958.1998.01056.x; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Panatto D, 2011, EXPERT REV VACCINES, V10, P1337, DOI [10.1586/ERV.11.103, 10.1586/erv.11.103]; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Poolman JT, 2000, VACCINE, V19, pS108, DOI 10.1016/S0264-410X(00)00288-7; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Protopopova EV, 1999, ZBL BAKT-INT J MED M, V289, P632; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Scheiman J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.19; Scheiman J, 2010, MOL THER, V18, P63, DOI 10.1038/mt.2009.199; Severino V, 2010, J PROTEOME RES, V9, P1050, DOI 10.1021/pr900931n; SIKKEMA DJ, 1992, INFECT IMMUN, V60, P5204, DOI 10.1128/IAI.60.12.5204-5211.1992; SRIKUMAR R, 1992, J BACTERIOL, V174, P4007, DOI 10.1128/jb.174.12.4007-4016.1992; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Tunio SA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-280; Tunio SA, 2010, MOL MICROBIOL, V76, P605, DOI 10.1111/j.1365-2958.2010.07098.x; Van der Ende A, 1999, INFECT IMMUN, V67, P2928, DOI 10.1128/IAI.67.6.2928-2934.1999; van der Ende A, 2000, INFECT IMMUN, V68, P6685, DOI 10.1128/IAI.68.12.6685-6690.2000; VANDERLEY P, 1991, INFECT IMMUN, V59, P2963, DOI 10.1128/IAI.59.9.2963-2971.1991; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Vitiello M, 2011, MICROBIOL IMMUNOL, V55, P347, DOI 10.1111/j.1348-0421.2011.00318.x; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; Yi KC, 1997, INFECT IMMUN, V65, P150, DOI 10.1128/IAI.65.1.150-155.1997	48	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46233	10.1371/journal.pone.0046233	http://dx.doi.org/10.1371/journal.pone.0046233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049988	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100161
J	Chauvel, M; Nesseir, A; Cabral, V; Znaidi, S; Goyard, S; Bachellier-Bassi, S; Firon, A; Legrand, M; Diogo, D; Naulleau, C; Rossignol, T; d'Enfert, C				Chauvel, Murielle; Nesseir, Audrey; Cabral, Vitor; Znaidi, Sadri; Goyard, Sophie; Bachellier-Bassi, Sophie; Firon, Arnaud; Legrand, Melanie; Diogo, Dorothee; Naulleau, Claire; Rossignol, Tristan; d'Enfert, Christophe			A Versatile Overexpression Strategy in the Pathogenic Yeast Candida albicans: Identification of Regulators of Morphogenesis and Fitness	PLOS ONE			English	Article							INDUCED FILAMENTOUS GROWTH; TRANSCRIPTION FACTOR; HYPHAL DEVELOPMENT; LARGE-SCALE; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; VIRULENCE FACTORS; TRUE HYPHAL; DELETION; ROLES	Candida albicans is the most frequently encountered human fungal pathogen, causing both superficial infections and life-threatening systemic diseases. Functional genomic studies performed in this organism have mainly used knock-out mutants and extensive collections of overexpression mutants are still lacking. Here, we report the development of a first generation C. albicans ORFeome, the improvement of overexpression systems and the construction of two new libraries of C. albicans strains overexpressing genes for components of signaling networks, in particular protein kinases, protein phosphatases and transcription factors. As a proof of concept, we screened these collections for genes whose overexpression impacts morphogenesis or growth rates in C. albicans. Our screens identified genes previously described for their role in these biological processes, demonstrating the functionality of our strategy, as well as genes that have not been previously associated to these processes. This article emphasizes the potential of systematic overexpression strategies to improve our knowledge of regulatory networks in C. albicans. The C. albicans plasmid and strain collections described here are available at the Fungal Genetics Stock Center. Their extension to a genome-wide scale will represent important resources for the C. albicans community.	[Chauvel, Murielle; Nesseir, Audrey; Cabral, Vitor; Znaidi, Sadri; Goyard, Sophie; Bachellier-Bassi, Sophie; Firon, Arnaud; Legrand, Melanie; Diogo, Dorothee; Naulleau, Claire; Rossignol, Tristan; d'Enfert, Christophe] Inst Pasteur, Dept Genomes & Genet, Unite Biol & Pathogenicite Fong, Paris, France; [Chauvel, Murielle; Nesseir, Audrey; Cabral, Vitor; Znaidi, Sadri; Goyard, Sophie; Bachellier-Bassi, Sophie; Firon, Arnaud; Legrand, Melanie; Diogo, Dorothee; Naulleau, Claire; Rossignol, Tristan; d'Enfert, Christophe] INRA, USC2019, Paris, France; [Nesseir, Audrey; Cabral, Vitor; Diogo, Dorothee] Univ Paris Diderot, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; UDICE-French Research Universities; Universite Paris Cite	d'Enfert, C (corresponding author), Inst Pasteur, Dept Genomes & Genet, Unite Biol & Pathogenicite Fong, Paris, France.	christophe.denfert@pasteur.fr	Znaidi, Sadri/W-6952-2019; Bachellier-Bassi, Sophie/AAB-7981-2020; Rossignol, Tristan/B-9398-2008; Cabral, Vitor/G-4460-2015	Znaidi, Sadri/0000-0001-9238-2218; Bachellier-Bassi, Sophie/0000-0003-3970-4825; Rossignol, Tristan/0000-0003-0718-0684; Cabral, Vitor/0000-0002-0367-3521; DIOGO, DOROTHEE/0000-0003-2913-5913; FIRON, Arnaud/0000-0002-5323-5212; Goyard, Sophie/0000-0002-8937-2796; d'Enfert, Christophe/0000-0002-6235-3886	European Commission [LSHM-CT-2005-518199, MRTN-CT-2003-504148, PITN-GA-2008-214004]; Agence Nationale de la Recherche [ANR-08-MIE-033-01]; Wellcome Trust [WT088858MA]; Pasteur-Genopole-Ile-de-France; DIM-Malinf Region Ile-de-France; Institut Pasteur (Bourse Roux); INRA/Institut Pasteur PhD fellowship	European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche(French National Research Agency (ANR)); Wellcome Trust(Wellcome Trust); Pasteur-Genopole-Ile-de-France(Region Ile-de-France); DIM-Malinf Region Ile-de-France(Region Ile-de-France); Institut Pasteur (Bourse Roux); INRA/Institut Pasteur PhD fellowship	This work has been supported by the European Commission (EURESFUN, LSHM-CT-2005-518199; Galar Fungail 2, MRTN-CT-2003-504148; FINSysB, PITN-GA-2008-214004), Agence Nationale de la Recherche (KANJI, ANR-08-MIE-033-01) and the Wellcome Trust (The Candida albicans ORFeome project, WT088858MA). Oligonucleotide synthesis and plasmid sequencing were supported by Pasteur-Genopole-Ile-de-France. AN was the recipient of a PhD fellowship from the DIM-Malinf Region Ile-de-France. VC was the recipient of a PhD fellowship of the European Commission (FINSysB, PITN-GA-2008-214004). SZ was the recipient from post-doctoral fellowships of the European Commission (FINSysB, PITN-GA-2008-214004) and Agence Nationale de la Recherche (KANJI, ANR-08-MIE-033-01). AF and ML were the recipients of post-doctoral fellowships of Institut Pasteur (Bourse Roux). DD was the recipient of a joined INRA/Institut Pasteur PhD fellowship. TR was the recipient of a post-doctoral fellowship from the European Commission (EURESFUN, LSHM-CT-2005-518199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud MB, 2007, NUCLEIC ACIDS RES, V35, pD452, DOI 10.1093/nar/gkl899; Bassilana M, 2005, EUKARYOT CELL, V4, P588, DOI 10.1128/EC.4.3.588-603.2005; Bassilana M, 2003, EUKARYOT CELL, V2, P9, DOI 10.1128/EC.2.1.9-18.2003; Bauer J, 2007, EUKARYOT CELL, V6, P1736, DOI 10.1128/EC.00236-07; Becker JM, 2010, P NATL ACAD SCI USA, V107, P22044, DOI 10.1073/pnas.1009845107; Benson ES, 2002, EUKARYOT CELL, V1, P787, DOI 10.1128/EC.1.5.787-798.2002; Bharucha N, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002058; Blankenship JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000752; Bockmuhl DP, 2001, MOL MICROBIOL, V42, P1243, DOI 10.1046/j.1365-2958.2001.02688.x; Cabral Vitor, 2012, Methods Mol Biol, V845, P227, DOI 10.1007/978-1-61779-539-8_15; Calderone RA, 2002, CANDIDA CANDIDIASIS, P307; Carlisle PL, 2009, P NATL ACAD SCI USA, V106, P599, DOI 10.1073/pnas.0804061106; Chamilos G, 2009, J INFECT DIS, V200, P152, DOI 10.1086/599363; Chua G, 2006, P NATL ACAD SCI USA, V103, P12045, DOI 10.1073/pnas.0605140103; Cleary IA, 2010, EUKARYOT CELL, V9, P1363, DOI 10.1128/EC.00088-10; Cottier F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002485; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Davis DA, 2002, GENETICS, V162, P1573; Delgado ML, 2003, YEAST, V20, P713, DOI 10.1002/yea.993; Doedt T, 2004, MOL BIOL CELL, V15, P3167, DOI 10.1091/mbc.E03-11-0782; Du H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029707; Eason RG, 2004, P NATL ACAD SCI USA, V101, P11046, DOI 10.1073/pnas.0403672101; Enjalbert B, 2009, INFECT IMMUN, V77, P4847, DOI 10.1128/IAI.00223-09; Epp E, 2010, MOL MICROBIOL, V75, P1182, DOI 10.1111/j.1365-2958.2009.07038.x; Feng QH, 1999, J BACTERIOL, V181, P6339, DOI 10.1128/JB.181.20.6339-6346.1999; Firon A, 2007, MOL MICROBIOL, V66, P1256, DOI 10.1111/j.1365-2958.2007.06011.x; Fu Y, 2008, EUKARYOT CELL, V7, P483, DOI 10.1128/EC.00445-07; Ganguly S, 2011, EUKARYOT CELL, V10, P1448, DOI 10.1128/EC.05196-11; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; GOSSEN M, 1993, NUCLEIC ACIDS RES, V21, P4411, DOI 10.1093/nar/21.18.4411; Hernday AD, 2010, METHOD ENZYMOL, V470, P737, DOI 10.1016/S0076-6879(10)70031-8; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Huang H, 2008, MICROBIOL RES, V163, P380, DOI 10.1016/j.micres.2008.03.001; Hurtado CAR, 2002, EUKARYOT CELL, V1, P526, DOI 10.1128/EC.1.4.526-537.2002; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Khalaf RA, 2001, GENETICS, V157, P1503; Kim MJ, 2008, J MICROBIOL BIOTECHN, V18, P242; Kohler JR, 1996, P NATL ACAD SCI USA, V93, P13223, DOI 10.1073/pnas.93.23.13223; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; Lane S, 2001, MOL CELL BIOL, V21, P6418, DOI 10.1128/MCB.21.19.6418-6428.2001; Leberer E, 1997, EMBO J, V16, P83, DOI 10.1093/emboj/16.1.83; Legrand M, 2011, CANDIDA CANDIDIASIS, P505; Leuker CE, 1997, GENE, V192, P235, DOI 10.1016/S0378-1119(97)00069-3; Li Y, 2007, EUKARYOT CELL, V6, P2112, DOI 10.1128/EC.00199-07; LIU HP, 1994, SCIENCE, V266, P1723, DOI 10.1126/science.7992058; Loeb JDJ, 1999, MOL CELL BIOL, V19, P4019; Lorenz MC, 2000, MOL BIOL CELL, V11, P183, DOI 10.1091/mbc.11.1.183; Lu YQ, 2012, PLANT METHODS, V8, DOI [10.1186/1746-4811-8-9, 10.1371/journal.ppat.1002663]; Magtanong L, 2011, NAT BIOTECHNOL, V29, P505, DOI 10.1038/nbt.1855; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Michel S, 2002, MOL MICROBIOL, V46, P269, DOI 10.1046/j.1365-2958.2002.03167.x; Miwa T, 2004, EUKARYOT CELL, V3, P919, DOI 10.1128/EC.3.4.919-931.2004; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Nakayama H, 2000, INFECT IMMUN, V68, P6712, DOI 10.1128/IAI.68.12.6712-6719.2000; Nobile CJ, 2005, CURR BIOL, V15, P1150, DOI 10.1016/j.cub.2005.05.047; Nobile CJ, 2006, CELL MICROBIOL, V8, P1382, DOI 10.1111/j.1462-5822.2006.00761.x; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2012, CELL, V148, P126, DOI 10.1016/j.cell.2011.10.048; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Noble SM, 2007, ANNU REV GENET, V41, P193, DOI 10.1146/annurev.genet.41.042007.170146; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; ODDS FC, 1988, J MED VET MYCOL, V26, P277; Odds FC, 2008, MICROBIOL-SGM, V154, P3245, DOI 10.1099/mic.0.2008/023671-0; Oh J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001140; Park H, 2009, EUKARYOT CELL, V8, P1498, DOI 10.1128/EC.00165-09; Park YN, 2005, EUKARYOT CELL, V4, P1328, DOI 10.1128/EC.4.8.1328-1342.2005; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Prelich G, 2012, GENETICS, V190, P841, DOI 10.1534/genetics.111.136911; Pukkila-Worley R, 2009, EUKARYOT CELL, V8, P1750, DOI 10.1128/EC.00163-09; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roemer T, 2003, MOL MICROBIOL, V50, P167, DOI 10.1046/j.1365-2958.2003.03697.x; Rual JF, 2004, CURR OPIN CHEM BIOL, V8, P20, DOI 10.1016/j.cbpa.2003.12.002; Sahni N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000363; Schaub Y, 2006, J BASIC MICROB, V46, P416, DOI 10.1002/jobm.200510133; Schweizer A, 2000, MOL MICROBIOL, V38, P435, DOI 10.1046/j.1365-2958.2000.02132.x; Shapiro RS, 2012, CURR BIOL, V22, P461, DOI 10.1016/j.cub.2012.01.062; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Shi QM, 2007, MOL BIOL CELL, V18, P815, DOI 10.1091/mbc.E06-05-0442; Singh P, 2004, INFECT IMMUN, V72, P2390, DOI 10.1128/IAI.72.4.2390-2394.2004; Sinha I, 2007, DEV CELL, V13, P421, DOI 10.1016/j.devcel.2007.06.011; Song WJ, 2011, FEMS YEAST RES, V11, P209, DOI 10.1111/j.1567-1364.2010.00710.x; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Spiering MJ, 2010, EUKARYOT CELL, V9, P251, DOI 10.1128/EC.00291-09; Staib P, 2004, INFECT IMMUN, V72, P2386, DOI 10.1128/IAI.72.4.2386-2389.2004; Stevenson LF, 2001, P NATL ACAD SCI USA, V98, P3946, DOI 10.1073/pnas.051013498; Sudbery P, 2004, TRENDS MICROBIOL, V12, P317, DOI 10.1016/j.tim.2004.05.008; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Uhl MA, 2003, EMBO J, V22, P2668, DOI 10.1093/emboj/cdg256; Vandeputte P, 2012, EUKARYOT CELL, V11, P916, DOI 10.1128/EC.00134-12; von der Haar T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001078; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; Walther A, 2003, CURR GENET, V42, P339, DOI 10.1007/s00294-002-0349-0; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Xu DM, 2007, PLOS PATHOG, V3, P835, DOI 10.1371/journal.ppat.0030092; Yoshikawa K, 2011, YEAST, V28, P349, DOI 10.1002/yea.1843; Zeidler U, 2009, FEMS YEAST RES, V9, P126, DOI 10.1111/j.1567-1364.2008.00459.x	102	67	85	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45912	10.1371/journal.pone.0045912	http://dx.doi.org/10.1371/journal.pone.0045912			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049891	gold, Green Submitted, Green Published			2022-12-27	WOS:000309556100099
J	Jonsson, MT; Thor, G				Jonsson, Mari T.; Thor, Goran			Estimating Coextinction Risks from Epidemic Tree Death: Affiliate Lichen Communities among Diseased Host Tree Populations of Fraxinus excelsior	PLOS ONE			English	Article							CHALARA-FRAXINEA; INFECTIOUS-DISEASE; VIABILITY ANALYSIS; BETA REGRESSION; BIODIVERSITY; PERFORMANCE; PATHOGENS; DYNAMICS; PATTERNS; ECOLOGY	At least 10% of the world's tree species are threatened with extinction and pathogens are increasingly implicated in tree threats. Coextinction and threats to affiliates as a consequence of the loss or decline of their host trees is a poorly understood phenomenon. Ash dieback is an emerging infectious disease causing severe dieback of common ash Fraxinus excelsior throughout Europe. We utilized available empirical data on affiliate epiphytic lichen diversity (174 species and 17,800 observations) among 20 ash dieback infected host tree populations of F. excelsior on the island Gotland in the Baltic Sea, Sweden. From this, we used structured scenario projections scaled with empirical data of ash dieback disease to generate probabilistic models for estimating local and regional lichen coextinction risks. Average coextinction probabilities ((A) over bar) were 0.38 (95% CI +/- 0.09) for lichens occurring on F. excelsior and 0.14 (95% CI +/- 0.03) when considering lichen persistence on all tree species. (A) over bar was strongly linked to local disease incidence levels and generally increasing with lichen host specificity to F. excelsior and decreasing population size. Coextinctions reduced affiliate community viability, with significant local reductions in species richness and shifts in lichen species composition. Affiliates were projected to become locally extirpated before their hosts, illuminating the need to also consider host tree declines. Traditionally managed open wooded meadows had the highest incidence of ash dieback disease and significantly higher proportions of affiliate species projected to go extinct, compared with unmanaged closed forests and semi-open grazed sites. Most cothreatened species were not previously red-listed, which suggest that tree epidemics cause many unforeseen threats to species. Our analysis shows that epidemic tree deaths represent an insidious, mostly overlooked, threat to sessile affiliate communities in forested environments. Current conservation and management strategies must account for secondary extinctions associated with epidemic tree death.	[Jonsson, Mari T.; Thor, Goran] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Jonsson, MT (corresponding author), Swedish Univ Agr Sci, Swedish Species Informat Ctr, Uppsala, Sweden.	mari.jonsson@slu.se			WWF; Swedish EPA; Swedish University of Agricultural Sciences; foundation Oscar and Lili Lamms Minne	WWF; Swedish EPA; Swedish University of Agricultural Sciences; foundation Oscar and Lili Lamms Minne	This work was supported by WWF, the Swedish EPA, the Swedish University of Agricultural Sciences and the foundation Oscar and Lili Lamms Minne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplund J, 2010, J ECOL, V98, P218, DOI 10.1111/j.1365-2745.2009.01584.x; Bakys R, 2009, PLANT PATHOL, V58, P284, DOI 10.1111/j.1365-3059.2008.01977.x; Bakys R, 2009, EUR J FOREST RES, V128, P51, DOI 10.1007/s10342-008-0238-2; CASTELLO JD, 1995, BIOSCIENCE, V45, P16, DOI 10.2307/1312531; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Cribari-Neto F, 2010, J STAT SOFTW, V34, P1; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; Ebenman B, 2005, TRENDS ECOL EVOL, V20, P568, DOI 10.1016/j.tree.2005.06.011; Ebenman B, 2004, ECOLOGY, V85, P2591, DOI 10.1890/03-8018; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Eskelson BNI, 2011, FOREST SCI, V57, P212; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Gardenfors U., 2010, RED LIST SWEDISH SPE; Gelman A., 2007, DATA ANAL USING REGR; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Jones JT, 2008, MOL PLANT PATHOL, V9, P357, DOI 10.1111/J.1364-3703.2007.00461.X; Juodvalkis A., 2002, L U MOKSLO DARBAI BI, V56, P17; Kennedy TA, 2002, NATURE, V417, P636, DOI 10.1038/nature00776; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Kowalski T, 2006, FOREST PATHOL, V36, P264, DOI 10.1111/j.1439-0329.2006.00453.x; Kowalski T, 2009, FOREST PATHOL, V39, P304, DOI 10.1111/j.1439-0329.2008.00589.x; KROK TOB, 2001, SVENSK FLORA FANEROG; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; La Porta N, 2008, CAN J PLANT PATHOL, V30, P177, DOI 10.1080/07060661.2008.10540534; Lindenmayer DB, 2010, FRONT ECOL ENVIRON, V8, P527, DOI 10.1890/090184; Lohmus P., 2003, Folia Cryptogamica Estonica, P19; Loo J, 2009, BIOL INVASIONS, V11, P81, DOI 10.1007/s10530-008-9321-3; McKinney LV, 2011, HEREDITY, V106, P788, DOI 10.1038/hdy.2010.119; Moir ML, 2010, CONSERV BIOL, V24, P682, DOI 10.1111/j.1523-1739.2009.01398.x; Oldfield S., 1998, WORLD LIST THREATENE; Pliura A, 2011, BALT FOR, V17, P17; Poulin R, 2011, TRENDS PARASITOL, V27, P355, DOI 10.1016/j.pt.2011.05.003; Poykko H, 2003, J ANIM ECOL, V72, P383, DOI 10.1046/j.1365-2656.2003.00709.x; Roberge JM, 2011, J APPL ECOL, V48, P650, DOI 10.1111/j.1365-2664.2011.01963.x; ROSE F, 1984, Field Studies, V6, P117; Santesson R., 2004, LICHENFORMING LICHEN; Smith C. W., 2009, LICHENS GREAT BRITAI; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Smith KF, 2005, FRONT ECOL ENVIRON, V3, P29, DOI 10.1890/1540-9295(2005)003[0029:ETTEID]2.0.CO;2; Snall T, 2003, OIKOS, V103, P566, DOI 10.1034/j.1600-0706.2003.12551.x; Taguchi Y, 2005, BIOINFORMATICS, V21, P730, DOI 10.1093/bioinformatics/bti067; Thor G, 2010, BIODIVERS CONSERV, V19, P2307, DOI 10.1007/s10531-010-9843-8; Tilman D, 2001, ENCY BIODIVERSITY, V3, P109, DOI [DOI 10.1016/B0-12-226865-2/00132-2, 10.1006/rwbd.1999.0154]	46	49	50	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45701	10.1371/journal.pone.0045701	http://dx.doi.org/10.1371/journal.pone.0045701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049840	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000309556100069
J	Kurdi, M; Cherel, G; Lenting, PJ; Denis, CV; Christophe, OD				Kurdi, Mohamad; Cherel, Ghislaine; Lenting, Peter J.; Denis, Cecile V.; Christophe, Olivier D.			Coagulation Factor X Interaction with Macrophages through Its N-Glycans Protects It from a Rapid Clearance	PLOS ONE			English	Article							IN-VIVO; BLOOD-COAGULATION; ENDOTHELIAL-CELLS; RECEPTOR; LIVER; ADENOVIRUS; HEMOPHILIA; CONTRIBUTE; BINDING; HEXON	Factor X (FX), a plasma glycoprotein playing a central role in coagulation has a long circulatory half-life compared to closely related coagulation factors. The activation peptide of FX has been shown to influence its clearance with two N-glycans as key determinants of FX's relatively long survival. To decipher FX clearance mechanism, organ biodistribution and cellular interactions of human plasma FX (pd-FX), recombinant FX (rFX), N-deglycosylated FX (N-degly-FX) and recombinant FX mutated at both N-glycosylation sites (rFX(N181A-N191A)) were evaluated. Biodistribution analysis of I-125-labelled FX proteins after administration to mice revealed liver as major target organ for all FX variants. Liver tissue sections analysis showed an interaction of pd-FX and N-degly-FX to different cell types. These findings were confirmed in cell binding studies revealing that FX and FX without N-glycans interact with macrophages and hepatocytes, respectively. N-degly-FX appeared to be degraded in hepatocytes while interestingly pd-FX was not by macrophages. Furthermore, the chemical inactivation of macrophages by gadolinium chloride resulted in a significant decrease of circulating pd-FX into mice and not of N-degly-FX. Altogether our data lead to the conclusion that FX interaction with macrophages through its N-glycans protects it from a rapid clearance explaining its relatively long circulatory half-life.	[Kurdi, Mohamad; Cherel, Ghislaine; Lenting, Peter J.; Denis, Cecile V.; Christophe, Olivier D.] INSERM, U770, F-94275 Le Kremlin Bicetre, France; [Cherel, Ghislaine; Lenting, Peter J.; Denis, Cecile V.; Christophe, Olivier D.] Univ Paris Sud, UMR S 770, F-94275 Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Christophe, OD (corresponding author), INSERM, U770, F-94275 Le Kremlin Bicetre, France.	olivier.christophe-kb@inserm.fr	Lenting, Peter/AAH-5663-2019; Lenting, Peter/F-8269-2013; christophe, olivier/W-4268-2017; Denis, Cecile/A-7649-2011	Lenting, Peter/0000-0002-7937-3429; Lenting, Peter/0000-0002-7937-3429; christophe, olivier/0000-0002-9080-6336; Denis, Cecile/0000-0001-5152-9156	Institut National de la Sante et de la Recherche Medicale of France (INSERM); University of Kalamoon, Deirattiah-Syria for Mohamad Kurdi	Institut National de la Sante et de la Recherche Medicale of France (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Kalamoon, Deirattiah-Syria for Mohamad Kurdi	This study was supported in part by Institut National de la Sante et de la Recherche Medicale of France (INSERM), and by University of Kalamoon, Deirattiah-Syria for Mohamad Kurdi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 1999, HEPATOLOGY, V29, P728, DOI 10.1002/hep.510290324; Bae JS, 2010, J BIOL CHEM, V285, P34803, DOI 10.1074/jbc.M110.163642; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Di Paolo NC, 2009, MOL THER, V17, P675, DOI 10.1038/mt.2008.307; Disse J, 2011, J BIOL CHEM, V286, P5756, DOI 10.1074/jbc.M110.201228; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; FUCHS HE, 1983, J CLIN INVEST, V72, P2041, DOI 10.1172/JCI111169; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Gueguen P, 2010, J THROMB HAEMOST, V8, P1651, DOI 10.1111/j.1538-7836.2010.03905.x; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296; Harstad EB, 2002, TOXICOL APPL PHARM, V180, P178, DOI 10.1006/taap.2002.9385; HERTZBERG M, 1994, BLOOD REV, V8, P56, DOI 10.1016/0268-960X(94)90007-8; HJORT PF, 1961, SCAND J CLIN LAB INV, V13, P668, DOI 10.3109/00365516109137342; Ivanciu L, 2011, NAT BIOTECHNOL, V29, P1028, DOI 10.1038/nbt.1995; JACKSON CM, 1980, ANNU REV BIOCHEM, V49, P765, DOI 10.1146/annurev.bi.49.070180.004001; Johansson L, 2011, BLOOD, V117, P3445, DOI 10.1182/blood-2010-06-290098; Junghans RP, 1996, P NATL ACAD SCI USA, V93, P5512, DOI 10.1073/pnas.93.11.5512; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Kask L, 2004, J BIOL CHEM, V279, P23869, DOI 10.1074/jbc.C400159200; Levigne S, 2007, J BIOL CHEM, V282, P31569, DOI 10.1074/jbc.M704837200; LIUCHEN LY, 1993, MOL PHARMACOL, V44, P749; Louvain-Quintard VB, 2005, J BIOL CHEM, V280, P41352, DOI 10.1074/jbc.M507846200; MANN KG, 1990, BLOOD, V76, P1; Narita M, 1998, BLOOD, V91, P555, DOI 10.1182/blood.V91.2.555.555_555_560; NAWROTH PP, 1985, THROMB RES, V40, P677, DOI 10.1016/0049-3848(85)90305-6; OKAJIMA K, 1990, THROMB HAEMOSTASIS, V63, P48; Parker AL, 2006, BLOOD, V108, P2554, DOI 10.1182/blood-2006-04-008532; ROBERTS HR, 1965, THROMB DIATH HAEMOST, V13, P305, DOI 10.1055/s-0038-1656232; SAKAI T, 1990, J BIOL CHEM, V265, P9105; Sen P, 2011, BLOOD, V118, P2635, DOI 10.1182/blood-2011-05-354571; THOMAS P, 1977, BIOCHEM SOC T, V5, P312, DOI 10.1042/bst0050312; van Schooten CJ, 2008, BLOOD, V112, P1704, DOI 10.1182/blood-2008-01-133181; Waddington SN, 2008, CELL, V132, P397, DOI 10.1016/j.cell.2008.01.016	34	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45111	10.1371/journal.pone.0045111	http://dx.doi.org/10.1371/journal.pone.0045111			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049768	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100027
J	Negro, F; Farina, D				Negro, Francesco; Farina, Dario			Factors Influencing the Estimates of Correlation between Motor Unit Activities in Humans	PLOS ONE			English	Article							SHORT-TERM SYNCHRONIZATION; NEURONAL SPIKE TRAINS; MOTONEURON SYNCHRONIZATION; COMMON MODULATION; SPINAL-CORD; MUSCLES; DISCHARGE; COHERENCE; CONTRACTIONS; INTERCOSTAL	Background: Alpha motoneurons receive common synaptic inputs from spinal and supraspinal pathways. As a result, a certain degree of correlation can be observed between motoneuron spike trains during voluntary contractions. This has been studied by using correlation measures in the time and frequency domains. These measures are interpreted as reflecting different types of connectivity in the spinal networks, although the relation between the degree of correlation of the output motoneuron spike trains and of their synaptic inputs is unclear. Methodology/Principal Findings: In this study, we analyze theoretically this relation and we complete this analysis by simulations and experimental data on the abductor digiti minimi muscle. The results demonstrate that correlation measures between motoneuron output spike trains are inherently influenced by the discharge rate and that this influence cannot be compensated by normalization. Because of the influence of discharge rate, frequency domain measures of correlation (coherence) do not identify the full frequency content of the common input signal when computed from pairs of motoneurons. Rather, an increase in sampling rate is needed by using cumulative spike trains of several motoneurons. Moreover, the application of averaging filters to the spike trains influences the magnitude of the estimated correlation levels calculated in the time, but not in the frequency domain (coherence). Conclusions: It is concluded that the analysis of coherence in different frequency bands between cumulative spike trains of a sufficient number of motoneurons provides information on the spectrum of the common synaptic input. Nonetheless, the absolute values of coherent peaks cannot be compared across conditions with different cumulative discharge rates.	[Negro, Francesco; Farina, Dario] Univ Gottingen, Dept Neurorehabil Engn, Bernstein Focus Neurotechnol Gottingen, Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Negro, Francesco] Aalborg Univ, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI, Aalborg, Denmark	University of Gottingen; Aalborg University	Negro, F (corresponding author), Univ Gottingen, Dept Neurorehabil Engn, Bernstein Focus Neurotechnol Gottingen, Bernstein Ctr Computat Neurosci, Gottingen, Germany.	negro.francesco@bccn.uni-goettingen.de	Farina, Dario/AAB-2648-2019; Negro, Francesco/H-4471-2019; Negro, Francesco/K-1345-2013	Negro, Francesco/0000-0002-9094-8932; Negro, Francesco/0000-0002-9094-8932	German Ministry for Education and Research (BMBF) via the Bernstein Focus Neurotechnology (BFNT) Gottingen [1GQ0810]; European Research Council Advanced Grant DEMOVE [267888]	German Ministry for Education and Research (BMBF) via the Bernstein Focus Neurotechnology (BFNT) Gottingen(Federal Ministry of Education & Research (BMBF)); European Research Council Advanced Grant DEMOVE	The authors acknowledge financial support by the German Ministry for Education and Research (BMBF) via the Bernstein Focus Neurotechnology (BFNT) Gottingen under grant number 1GQ0810 and the European Research Council Advanced Grant DEMOVE (contract #267888) (DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedenbaugh P, 1997, NEURAL COMPUT, V9, P1265, DOI 10.1162/neco.1997.9.6.1265; BREMNER FD, 1991, J PHYSIOL-LONDON, V432, P381, DOI 10.1113/jphysiol.1991.sp018390; Christou EA, 2007, EXP BRAIN RES, V178, P285, DOI 10.1007/s00221-006-0739-5; Cisi RRL, 2008, J COMPUT NEUROSCI, V25, P520, DOI 10.1007/s10827-008-0092-8; DATTA AK, 1990, J PHYSIOL-LONDON, V422, P397, DOI 10.1113/jphysiol.1990.sp017991; DAVEY NJ, 1993, EXP PHYSIOL, V78, P649, DOI 10.1113/expphysiol.1993.sp003713; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; De Luca CJ, 2002, J NEUROPHYSIOL, V87, P2200, DOI 10.1152/jn.00793.2001; DE LUCA CJ, 1982, J PHYSIOL-LONDON, V329, P129, DOI 10.1113/jphysiol.1982.sp014294; ELLAWAY PH, 1985, Q J EXP PHYSIOL CMS, V70, P219, DOI 10.1113/expphysiol.1985.sp002905; ELLAWAY PH, 1978, ELECTROEN CLIN NEURO, V45, P302, DOI 10.1016/0013-4694(78)90017-2; FARMER SF, 1993, J PHYSIOL-LONDON, V463, P83, DOI 10.1113/jphysiol.1993.sp019585; FUGLEVAND AJ, 1993, J NEUROPHYSIOL, V70, P2470, DOI 10.1152/jn.1993.70.6.2470; Gerstein GL, 2000, J NEUROSCI METH, V100, P41, DOI 10.1016/S0165-0270(00)00226-0; Heckman C, 2004, HAND CLIN N, V4, P119; ISHIZUKA N, 1979, J COMP NEUROL, V186, P189, DOI 10.1002/cne.901860206; Johnston JA, 2005, J NEUROPHYSIOL, V94, P206, DOI 10.1152/jn.01134.2004; Kakuda N, 1999, J PHYSIOL-LONDON, V520, P929, DOI 10.1111/j.1469-7793.1999.00929.x; KIRKWOOD PA, 1979, J NEUROSCI METH, V1, P107, DOI 10.1016/0165-0270(79)90009-8; KIRKWOOD PA, 1978, J PHYSIOL-LONDON, V275, P103, DOI 10.1113/jphysiol.1978.sp012180; Laine CM, 2011, J NEUROPHYSIOL, V105, P380, DOI 10.1152/jn.00766.2010; LAWRENCE DG, 1985, J COMP NEUROL, V232, P499, DOI 10.1002/cne.902320407; Lazar AA, 2004, IEEE T CIRCUITS-I, V51, P2060, DOI 10.1109/TCSI.2004.835026; Lazar AA, 2008, NEURAL COMPUT, V20, P2715, DOI 10.1162/neco.2008.06-07-559; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Lowery MM, 2007, J NEUROSCI METH, V163, P384, DOI 10.1016/j.jneumeth.2007.03.011; Maltenfort MG, 1998, J NEUROPHYSIOL, V80, P309, DOI 10.1152/jn.1998.80.1.309; Marsden JF, 1999, J PHYSIOL-LONDON, V521, P553, DOI 10.1111/j.1469-7793.1999.00553.x; Mattei B, 2003, J PHYSIOL-LONDON, V548, P615, DOI 10.1113/jphysiol.2002.033126; McGill KC, 2005, J NEUROSCI METH, V149, P121, DOI 10.1016/j.jneumeth.2005.05.015; MILLS KR, 1995, J PHYSIOL-LONDON, V483, P511, DOI 10.1113/jphysiol.1995.sp020602; Mochizuki G, 2007, J NEUROPHYSIOL, V97, P3917, DOI 10.1152/jn.01025.2006; MOORE GP, 1966, ANNU REV PHYSIOL, V28, P493, DOI 10.1146/annurev.ph.28.030166.002425; MORI S, 1975, J NEUROPHYSIOL, V38, P859, DOI 10.1152/jn.1975.38.4.859; Moritz CT, 2005, J NEUROPHYSIOL, V94, P105, DOI 10.1152/jn.01179.2004; Myers Lance J, 2004, J Neuroeng Rehabil, V1, P2, DOI 10.1186/1743-0003-1-2; Nakao M, 1997, IEEE T BIO-MED ENG, V44, P419, DOI 10.1109/10.568918; Negro F, 2011, J NEUROPHYSIOL, V106, P2688, DOI 10.1152/jn.00336.2011; Negro F, 2011, J PHYSIOL-LONDON, V589, P629, DOI 10.1113/jphysiol.2010.202473; Negro F, 2009, J PHYSIOL-LONDON, V587, P5925, DOI 10.1113/jphysiol.2009.178509; NORDSTROM MA, 1992, J PHYSIOL-LONDON, V453, P547, DOI 10.1113/jphysiol.1992.sp019244; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; Rice A, 2011, J NEUROPHYSIOL, V105, P2330, DOI 10.1152/jn.01078.2010; Rosenbaum R, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00058; ROSENBERG JR, 1989, PROG BIOPHYS MOL BIO, V53, P1, DOI 10.1016/0079-6107(89)90004-7; Santo Neto H, ARCH ITALIANO ANATOM, V90, P47; SCHMIED A, 1994, J PHYSIOL-LONDON, V480, P369, DOI 10.1113/jphysiol.1994.sp020367; Schmied A, 2010, CLIN NEUROPHYSIOL, V121, P1624, DOI 10.1016/j.clinph.2010.02.165; SEARS TA, 1976, J PHYSIOL-LONDON, V263, P357, DOI 10.1113/jphysiol.1976.sp011635; Semmler JG, 2002, J PHYSIOL-LONDON, V545, P681, DOI 10.1113/jphysiol.2002.026948; Semmler JG, 1997, BRAIN RES, V767, P314, DOI 10.1016/S0006-8993(97)00621-5; Semmler JG, 2004, J NEUROPHYSIOL, V92, P3320, DOI 10.1152/jn.00316.2004; Shampine LF., 1975, COMPUTER SOLUTION OR; Shea-Brown E, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.108102; Taylor AM, 2004, J NEUROPHYSIOL, V91, P796, DOI 10.1152/jn.00802.2003; Tchumatchenko T, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00068; Tchumatchenko T, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/neuro.10.001.2010; Tetzlaff T, 2008, NEURAL COMPUT, V20, P2133, DOI 10.1162/neco.2008.05-07-525; Traub R. D., 1991, NEURONAL NETWORKS HI, V777; Turker KS, 2001, J NEUROPHYSIOL, V86, P2807, DOI 10.1152/jn.2001.86.6.2807; Vaughan CW, 1997, J PHYSIOL-LONDON, V503, P673, DOI 10.1111/j.1469-7793.1997.673bg.x	61	60	61	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44894	10.1371/journal.pone.0044894	http://dx.doi.org/10.1371/journal.pone.0044894			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049762	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100023
J	Rasmussen, JG; Riis, SE; Frobert, O; Yang, SF; Kastrup, J; Zachar, V; Simonsen, U; Fink, T				Rasmussen, Jeppe Grondahl; Riis, Simone Elkjaer; Frobert, Ole; Yang, Sufang; Kastrup, Jens; Zachar, Vladimir; Simonsen, Ulf; Fink, Trine			Activation of Protease-Activated Receptor 2 Induces VEGF Independently of HIF-1	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN ADIPOSE-TISSUE; GROWTH-FACTOR EXPRESSION; EPITHELIAL-CELLS; MOLECULAR-CLONING; STROMAL CELLS; CANCER CELLS; FACTOR-ALPHA; HYPOXIA; PATHWAYS	Background: Human adipose stem cells (hASCs) can promote angiogenesis through secretion of proangiogenic factors such as vascular endothelial growth factor (VEGF). In other cell types, it has been shown that induction of VEGF is mediated by both protease activated receptor 2 (PAR2) and hypoxia inducible factor 1(HIF-1). The present study hypothesized that PAR2 stimulation through activation of kinase signaling cascades lead to induction of HIF-1 and secretion of VEGF. Methodology/Principal Findings: Immunohistochemistry revealed the expression of PAR2 receptors on the surface of hASCs. Blocking the PAR2 receptors with a specific antibody prior to trypsin treatment showed these receptors are involved in trypsin-evoked increase in VEGF secretion from hASCs. Blocking with specific kinase inhibitors suggested that that activation of MEK/ERK and PI3-kinase/Akt pathways are involved in trypsin-eveoked induction of VEGF. The effect of the trypsin treatment on the transcription of VEGF peaked at 6 hours after the treatment and was comparable to the activation observed after keeping hASCs for 24 hours at 1% oxygen. In contrast to hypoxia, trypsin alone failed to induce HIF-1 measured with ELISA, while the combination of trypsin and hypoxia had an additive effect on both VEGF transcription and secretion, results which were confirmed by Western blot. Conclusion: In hASCs trypsin and hypoxia induce VEGF expression through separate pathways.	[Rasmussen, Jeppe Grondahl; Simonsen, Ulf] Aarhus Univ, Dept Biomed Pulm & Cardiovasc Pharmacol, Aarhus, Denmark; [Rasmussen, Jeppe Grondahl; Riis, Simone Elkjaer; Yang, Sufang; Zachar, Vladimir; Fink, Trine] Aalborg Univ, Lab Stem Cell Res, Aalborg, Denmark; [Frobert, Ole] Orebro Univ Hosp, Dept Cardiol, Orebro, Sweden; [Yang, Sufang] Guangxi Univ, Anim Reprod Inst, Nanning 530004, Peoples R China; [Kastrup, Jens] Copenhagen Univ Hosp, Cardiac Stem Cell Lab, Ctr Heart, Rigshosp, Copenhagen, Denmark	Aarhus University; Aalborg University; Orebro University; Guangxi University; Rigshospitalet; University of Copenhagen	Fink, T (corresponding author), Aarhus Univ, Dept Biomed Pulm & Cardiovasc Pharmacol, Aarhus, Denmark.	trinef@hst.aau.dk	Fink, Trine/H-4434-2012; Fink, Trine/ABC-4003-2020; Porsborg, Simone Riis/AAI-6397-2021	Fink, Trine/0000-0001-7578-1137; Fink, Trine/0000-0001-7578-1137; Porsborg, Simone Riis/0000-0003-0167-5408; Zachar, Vladimir/0000-0002-5279-2690; Frobert, Ole/0000-0002-5846-345X	Danish Heart Foundation [08-4-R64-A2020-B584-22460, 07-4-B584-A1453-22364, 1004-R78-A2925-22599]; Brodrene Hartmanns Foundation; Frimodt-Heineke Foundation; Torben and Alice Frimodt Foundation; Kobmand Sven Hansen and hustru Ina Hansens Foundation; Faculty of Health Science, Aarhus University	Danish Heart Foundation; Brodrene Hartmanns Foundation; Frimodt-Heineke Foundation; Torben and Alice Frimodt Foundation; Kobmand Sven Hansen and hustru Ina Hansens Foundation; Faculty of Health Science, Aarhus University	This work was supported by grants from the Danish Heart Foundation (08-4-R64-A2020-B584-22460 to J.G.R., 07-4-B584-A1453-22364 to J.G.R., and 1004-R78-A2925-22599 to J.G.R.); Brodrene Hartmanns Foundation; Frimodt-Heineke Foundation; Torben and Alice Frimodt Foundation; Kobmand Sven Hansen and hustru Ina Hansens Foundation; and the Faculty of Health Science, Aarhus University (to J.G.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XW, 2010, BIOCHEM BIOPH RES CO, V401, P321, DOI 10.1016/j.bbrc.2010.09.012; Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Dery O, 1999, J BIOL CHEM, V274, P18524, DOI 10.1074/jbc.274.26.18524; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dutra-Oliveira A, 2012, BIOCHEM BIOPH RES CO, V421, P221, DOI 10.1016/j.bbrc.2012.03.140; Fink T, 2011, METHODS MOL BIOL, V698, P243, DOI 10.1007/978-1-60761-999-4_19; Fink Trine, 2011, Front Biosci (Elite Ed), V3, P256, DOI 10.2741/e241; Fink T, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-98; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Greenberg DL, 2003, BIOCHEMISTRY-US, V42, P702, DOI 10.1021/bi027100x; Herrmann JL, 2010, SHOCK, V33, P24, DOI 10.1097/SHK.0b013e3181b7d137; Jing Y, 2012, TOXICOL SCI, V125, P10, DOI 10.1093/toxsci/kfr256; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Leung KW, 2011, ANGIOGENESIS, V14, P515, DOI 10.1007/s10456-011-9235-z; Liu Y, 2006, BIOCHEM BIOPH RES CO, V344, P1263, DOI 10.1016/j.bbrc.2006.04.005; Miranville A, 2004, CIRCULATION, V110, P349, DOI 10.1161/01.CIR.0000135466.16823.D0; NYSTEDT S, 1994, P NATL ACAD SCI USA, V91, P9208, DOI 10.1073/pnas.91.20.9208; Pilgaard L, 2009, REGEN MED, V4, P539, DOI [10.2217/rme.09.28, 10.2217/RME.09.28]; Pilgaard L, 2008, REGEN MED, V3, P705, DOI 10.2217/17460751.3.5.705; Rasmussen JG, 2011, CYTOTHERAPY, V13, P318, DOI 10.3109/14653249.2010.506505; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Sadat S, 2007, BIOCHEM BIOPH RES CO, V363, P674, DOI 10.1016/j.bbrc.2007.09.058; Svensson KJ, 2011, P NATL ACAD SCI USA, V108, P13147, DOI 10.1073/pnas.1104261108; Tanaka Y, 2008, BIOCHEM BIOPH RES CO, V377, P622, DOI 10.1016/j.bbrc.2008.10.018; Uusitalo-Jarvinen H, 2007, ARTERIOSCL THROM VAS, V27, P1456, DOI 10.1161/ATVBAHA.107.142539; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; Wang XH, 2009, STEM CELLS, V27, P3021, DOI 10.1002/stem.230; Yagi Y, 2006, EUR J PHARMACOL, V536, P19, DOI 10.1016/j.ejphar.2006.02.024; Zachar V, 2011, EXPERT OPIN BIOL TH, V11, P775, DOI 10.1517/14712598.2011.570258; Zhong H, 2000, CANCER RES, V60, P1541; Zhu T, 2006, ARTERIOSCL THROM VAS, V26, P744, DOI 10.1161/01.ATV.0000205591.88522.d4; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	34	27	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46087	10.1371/journal.pone.0046087	http://dx.doi.org/10.1371/journal.pone.0046087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049945	Green Submitted, gold, Green Published			2022-12-27	WOS:000309556100134
J	Wu, XH; Fu, Y; Yang, DY; Zhang, RH; Zheng, WP; Nie, HM; Xie, Y; Yan, N; Hao, GY; Gu, XB; Wang, SX; Peng, XR; Yang, GY				Wu, Xuhang; Fu, Yan; Yang, Deying; Zhang, Runhui; Zheng, Wanpeng; Nie, Huaming; Xie, Yue; Yan, Ning; Hao, Guiying; Gu, Xiaobin; Wang, Shuxian; Peng, Xuerong; Yang, Guangyou			Detailed Transcriptome Description of the Neglected Cestode Taenia multiceps	PLOS ONE			English	Article							PARASITIC NEMATODE; HUMAN COENUROSIS; GENE-EXPRESSION; CEREBRALIS CYST; SHEEP; INFECTION; PROTEIN; GENOME; ANNOTATION; SINENSIS	Background: The larval stage of Taenia multiceps, a global cestode, encysts in the central nervous system (CNS) of sheep and other livestock. This frequently leads to their death and huge socioeconomic losses, especially in developing countries. This parasite can also cause zoonotic infections in humans, but has been largely neglected due to a lack of diagnostic techniques and studies. Recent developments in next-generation sequencing provide an opportunity to explore the transcriptome of T. multiceps. Methodology/Principal Findings: We obtained a total of 31,282 unigenes (mean length 920 bp) using Illumina paired-end sequencing technology and a new Trinity de novo assembler without a referenced genome. Individual transcription molecules were determined by sequence-based annotations and/or domain-based annotations against public databases (Nr, UniprotKB/Swiss-Prot, COG, KEGG, UniProtKB/TrEMBL, InterPro and Pfam). We identified 26,110 (83.47%) unigenes and inferred 20,896 (66.8%) coding sequences (CDS). Further comparative transcripts analysis with other cestodes (Taenia pisiformis, Taenia solium, Echincoccus granulosus and Echincoccus multilocularis) and intestinal parasites (Trichinella spiralis, Ancylostoma caninum and Ascaris suum) showed that 5,100 common genes were shared among three Taenia tapeworms, 261 conserved genes were detected among five Taeniidae cestodes, and 109 common genes were found in four zoonotic intestinal parasites. Some of the common genes were genes required for parasite survival, involved in parasite-host interactions. In addition, we amplified two full-length CDS of unigenes from the common genes using RT-PCR. Conclusions/Significance: This study provides an extensive transcriptome of the adult stage of T. multiceps, and demonstrates that comparative transcriptomic investigations deserve to be further studied. This transcriptome dataset forms a substantial public information platform to achieve a fundamental understanding of the biology of T. multiceps, and helps in the identification of drug targets and parasite-host interaction studies.	[Wu, Xuhang; Fu, Yan; Yang, Deying; Zhang, Runhui; Zheng, Wanpeng; Nie, Huaming; Xie, Yue; Yan, Ning; Hao, Guiying; Gu, Xiaobin; Wang, Shuxian; Yang, Guangyou] Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Peoples R China; [Peng, Xuerong] Sichuan Agr Univ, Coll Life & Basic Sci, Dept Chem, Yaan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Yang, GY (corresponding author), Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Peoples R China.	guangyou1963@yahoo.com.cn		Hao, Guiying/0000-0003-0233-4947	Program for Changjiang Scholars and Innovative Research Team in University PCSIRT [IRT0848]	Program for Changjiang Scholars and Innovative Research Team in University PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the "Program for Changjiang Scholars and Innovative Research Team in University" (PCSIRT) (No. IRT0848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo-Shehada MN, 2002, PREV VET MED, V55, P201, DOI 10.1016/S0167-5877(02)00056-9; Achenef M, 1999, TROP ANIM HEALTH PRO, V31, P15, DOI 10.1023/A:1005125316275; Almeida CR, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-35; Almeida GT, 2011, EXPT PARASI IN PRESS; [Anonymous], 2011, MOL PHYLOGENET EVOL, P638; BENGER A, 1981, AM J TROP MED HYG, V30, P638, DOI 10.4269/ajtmh.1981.30.638; Benifla M, 2007, J NEUROSURG, V107, P511, DOI 10.3171/PED-07/12/511; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bonizzoni M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-82; Bussell KM, 1997, VET REC, V140, P560, DOI 10.1136/vr.140.21.560; Cantacessi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023590; Cantacessi C, 2010, INFECT GENET EVOL, V10, P1199, DOI 10.1016/j.meegid.2010.07.024; Cantacessi C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-266; Cantacessi C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000684; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Craig PS, 2007, LANCET INFECT DIS, V7, P385, DOI 10.1016/S1473-3099(07)70134-2; DOHERTY ML, 1989, VET REC, V124, P591, DOI 10.1136/vr.124.22.591; EDWARDS GT, 1982, BRIT VET J, V138, P489, DOI 10.1016/S0007-1935(17)30934-X; El-On Joseph, 2008, Vet Ital, V44, P621; Euzeby J, 1966, MALADIES VERMINEUSES; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gauci C, 2008, INT J PARASITOL, V38, P1041, DOI 10.1016/j.ijpara.2007.11.006; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Harris TD, 2008, SCIENCE, V320, P106, DOI 10.1126/science.1150427; HERBERT IV, 1984, ANN TROP MED PARASIT, V78, P243, DOI 10.1080/00034983.1984.11811809; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ing MB, 1998, CLIN INFECT DIS, V27, P519, DOI 10.1086/514716; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jia WZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-447; Li G, 2007, ADV PARASIT, P109; Lundstrom J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000919; Ma X, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-481; Mahadevan A, 2011, CLIN NEUROPATHOL, V30, P28, DOI 10.5414/NPP30028; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mitreva M, 2011, NAT GENET, V43, P228, DOI 10.1038/ng.769; Moreno Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001370; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Olson PD, 2012, PARASITE IMMUNOL, V34, P130, DOI 10.1111/j.1365-3024.2011.01319.x; Pan Q, 2004, MOLECULAR PARASITOLO, P353; Pandey V, 2008, NEXT GENERATION GENO, P29, DOI DOI 10.1002/9783527625130.CH3; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Riddiford N, 2011, DEV GENES EVOL, P1; Scala A, 2007, VET PARASITOL, V143, P294, DOI 10.1016/j.vetpar.2006.08.020; Sharma DK, 2006, SMALL RUMINANT RES, V64, P197, DOI 10.1016/j.smallrumres.2005.05.021; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Skerritt GC, 1991, COENUROSIS DIS SHEEP; Tendler M, 1996, P NATL ACAD SCI USA, V93, P269, DOI 10.1073/pnas.93.1.269; Varcasia A, 2009, VET PARASITOL, V162, P285, DOI 10.1016/j.vetpar.2009.03.008; Verma A. K., 2012, Journal of Pharmacy Research, V5, P1248; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-307; Wheat CW, 2011, METHODS MOL BIOL, V772, P129, DOI 10.1007/978-1-61779-228-1_7; WILSON VCLC, 1972, T ROY SOC TROP MED H, V66, P611, DOI 10.1016/0035-9203(72)90307-0; Yang DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032283; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; YOSHINO T, 1988, JPN J VET SCI, V50, P433; Young ND, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001004; Young ND, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000719; Young ND, 2010, BIOTECHNOL ADV, V28, P222, DOI 10.1016/j.biotechadv.2009.12.003; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	62	19	19	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45830	10.1371/journal.pone.0045830	http://dx.doi.org/10.1371/journal.pone.0045830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049872	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100086
J	Lenormand, M; Huet, S; Gargiulo, F; Deffuant, G				Lenormand, Maxime; Huet, Sylvie; Gargiulo, Floriana; Deffuant, Guillaume			A Universal Model of Commuting Networks	PLOS ONE			English	Article							DISTANCE-DECAY	We show that a recently proposed model generates accurate commuting networks on 80 case studies from different regions of the world (Europe and United-States) at different scales (e.g. municipalities, counties, regions). The model takes as input the number of commuters coming in and out of each geographic unit and generates the matrix of commuting flows between the units. The single parameter of the model follows a universal law that depends only on the scale of the geographic units. We show that our model significantly outperforms two other approaches proposing a universal commuting model [1,2], particularly when the geographic units are small (e.g. municipalities).	[Lenormand, Maxime; Huet, Sylvie; Deffuant, Guillaume] Irstea, LISC, Clermont Ferrand, France; [Gargiulo, Floriana] CNRS, CAMS, Paris, France	INRAE; Centre National de la Recherche Scientifique (CNRS)	Lenormand, M (corresponding author), Irstea, LISC, Clermont Ferrand, France.	maxime.lenormand@irstea.fr	Huet, Sylvie/AAV-5505-2020; Gargiulo, Floriana/GYJ-8061-2022; Deffuant, Guillaume/GRF-3580-2022	Huet, Sylvie/0000-0003-2973-7738; Deffuant, Guillaume/0000-0001-6265-9300	PRIMA (Prototypical Policy Impacts on Multifunctional Activities in Rural Municipalities) collaborative project; EU [212345]; Auvergne region	PRIMA (Prototypical Policy Impacts on Multifunctional Activities in Rural Municipalities) collaborative project; EU(European Commission); Auvergne region(Region Auvergne-Rhone-Alpes)	This publication has been funded under the PRIMA (Prototypical Policy Impacts on Multifunctional Activities in Rural Municipalities) collaborative project, EU 7th Framework Programme (ENV 2007-1), contract no. 212345 (https://prima.cemagref.fr/). The work of the first author has been funded by the Auvergne region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; CHOUKROUN JM, 1975, REG SCI URBAN ECON, V5, P177, DOI 10.1016/0166-0462(75)90003-4; De Montis A, 2007, ENVIRON PLANN B, V34, P905, DOI 10.1068/b32128; de Vries JJ, 2009, ENVIRON PLANN A, V41, P461, DOI 10.1068/a39369; DeMontis Andrea, 2010, J TRANSP LAND USE, V2, P39, DOI DOI 10.5198/jtlu.v2i3.14; FOTHERINGHAM AS, 1981, ANN ASSOC AM GEOGR, V71, P425; Gargiulo F, 2012, JASSS-J ARTIF SOC S, V15, P13; Lenormand M, 2012, GENERATING FRENCH VI; Ortuzar JD, 2011, MODELLING TRANSPORT, 4TH EDITION; Roth C, 2011, PLOS ONE, V6; Rouwendal J, 2004, GROWTH CHANGE, V35, P287, DOI 10.1111/j.1468-2257.2004.00250.x; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Sorensen T., 1948, K DAN VIDENSK SELSK, V5, P1; Wilson AG, 1998, J TRANSP ECON POLICY, V32, P3	15	54	56	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45985	10.1371/journal.pone.0045985	http://dx.doi.org/10.1371/journal.pone.0045985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014PQ	23049691	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388500018
J	Bazzigaluppi, P; Ruigrok, T; Saisan, P; De Zeeuw, CI; de Jeu, M				Bazzigaluppi, Paolo; Ruigrok, Tom; Saisan, Payam; De Zeeuw, Chris I.; de Jeu, Marcel			Properties of the Nucleo-Olivary Pathway: An In Vivo Whole-Cell Patch Clamp Study	PLOS ONE			English	Article							INFERIOR OLIVARY NEURONS; MEDIAL ACCESSORY OLIVE; MEMBRANE-POTENTIAL OSCILLATIONS; GAP-JUNCTIONS; CEREBELLAR INHIBITION; GABAERGIC INNERVATION; DECEREBRATE FERRET; DENDRITIC SPINES; GABA(B) BINDING; RAT-BRAIN	The inferior olivary nucleus (IO) forms the gateway to the cerebellar cortex and receives feedback information from the cerebellar nuclei (CN), thereby occupying a central position in the olivo-cerebellar loop. Here, we investigated the feedback input from the CN to the IO in vivo in mice using the whole-cell patch-clamp technique. This approach allows us to study how the CN-feedback input is integrated with the activity of olivary neurons, while the olivo-cerebellar system and its connections are intact. Our results show how IO neurons respond to CN stimulation sequentially with: i) a short depolarization (EPSP), ii) a hyperpolarization (IPSP) and iii) a rebound depolarization. The latter two phenomena can also be evoked without the EPSPs. The IPSP is sensitive to a GABA(A) receptor blocker. The IPSP suppresses suprathreshold and subthreshold activity and is generated mainly by activation of the GABA(A) receptors. The rebound depolarization re-initiates and temporarily phase locks the subthreshold oscillations. Lack of electrotonical coupling does not affect the IPSP of individual olivary neurons, nor the sensitivity of its GABA(A) receptors to blockers. The GABAergic feedback input from the CN does not only temporarily block the transmission of signals through the IO, it also isolates neurons from the network by shunting the junction current and re-initiates the temporal pattern after a fixed time point. These data suggest that the IO not only functions as a cerebellar controlled gating device, but also operates as a pattern generator for controlling motor timing and/or learning.	[Bazzigaluppi, Paolo; Ruigrok, Tom; De Zeeuw, Chris I.; de Jeu, Marcel] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Saisan, Payam] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [De Zeeuw, Chris I.] Netherlands Inst Neurosci, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Diego; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	de Jeu, M (corresponding author), Erasmus MC, Dept Neurosci, Rotterdam, Netherlands.	m.dejeu@erasmusmc.nl		Bazzigaluppi, Paolo/0000-0002-0434-2548	ZonMw [917.96.347]	ZonMw(Netherlands Organization for Health Research and Development)	The present work has been funded by ZonMw Grant 917.96.347 (M.d.J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON G, 1988, EXP BRAIN RES, V72, P450; ANGAUT P, 1989, BRAIN RES, V479, P361, DOI 10.1016/0006-8993(89)91641-7; Bal T, 1997, J NEUROPHYSIOL, V77, P3145, DOI 10.1152/jn.1997.77.6.3145; Bengtsson F, 2006, CEREBELLUM, V5, P7, DOI 10.1080/14734220500462757; Bengtsson F, 2004, EUR J NEUROSCI, V20, P2999, DOI 10.1111/j.1460-9568.2004.03789.x; Best AR, 2009, NEURON, V62, P555, DOI 10.1016/j.neuron.2009.04.018; BRIDGES RJ, 1989, AM J PHYSIOL, V256, pC902, DOI 10.1152/ajpcell.1989.256.4.C902; Choi S, 2010, J PHYSIOL-LONDON, V588, P3031, DOI 10.1113/jphysiol.2009.184705; Chorev E, 2007, J NEUROSCI, V27, P5043, DOI 10.1523/JNEUROSCI.5187-06.2007; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; De Zeeuw CI, 2003, J NEUROSCI, V23, P4700; Devor A, 2000, PROG BRAIN RES, V124, P213; Devor A, 2001, J NEUROPHYSIOL, V85, P1686, DOI 10.1152/jn.2001.85.4.1686; DEZEEUW CI, 1989, J COMP NEUROL, V284, P12, DOI 10.1002/cne.902840103; DEZEEUW CI, 1990, J COMP NEUROL, V300, P495, DOI 10.1002/cne.903000405; DEZEEUW CI, 1990, NEUROSCIENCE, V34, P645, DOI 10.1016/0306-4522(90)90171-Y; DEZEEUW CI, 1990, J COMP NEUROL, V300, P478, DOI 10.1002/cne.903000404; Dudek SM, 1996, J NEUROPHYSIOL, V75, P2167, DOI 10.1152/jn.1996.75.5.2167; FREDETTE BJ, 1991, ANAT EMBRYOL, V184, P225, DOI 10.1007/BF01673258; GRUART A, 1994, EXP BRAIN RES, V101, P173; HESSLOW G, 1986, NEUROSCI LETT, V63, P76, DOI 10.1016/0304-3940(86)90016-9; Hesslow G, 1996, EXP BRAIN RES, V110, P36; Hoebeek FE, 2010, P NATL ACAD SCI USA, V107, P8410, DOI 10.1073/pnas.0907118107; Khosrovani S, 2007, P NATL ACAD SCI USA, V104, P15911, DOI 10.1073/pnas.0702727104; KIM JH, 1988, NEUROSCIENCE, V25, P475, DOI 10.1016/0306-4522(88)90252-7; Kistler WM, 2002, ANN NY ACAD SCI, V978, P391, DOI 10.1111/j.1749-6632.2002.tb07582.x; Kistler WM, 2002, NEURAL COMPUT, V14, P2597, DOI 10.1162/089976602760407991; Lang EJ, 1996, J NEUROPHYSIOL, V76, P255, DOI 10.1152/jn.1996.76.1.255; Leznik E, 2005, J NEUROPHYSIOL, V94, P2447, DOI 10.1152/jn.00353.2005; LLINAS R, 1974, J NEUROPHYSIOL, V37, P560, DOI 10.1152/jn.1974.37.3.560; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P549, DOI 10.1113/jphysiol.1981.sp013763; LLINAS R, 1986, J PHYSIOL-LONDON, V376, P163, DOI 10.1113/jphysiol.1986.sp016147; Llinas RR, 2011, J PHYSIOL-LONDON, V589, P3423, DOI 10.1113/jphysiol.2011.207464; Long MA, 2002, J NEUROSCI, V22, P10898; MCCORMICK DA, 1985, BRAIN RES, V359, P120, DOI 10.1016/0006-8993(85)91419-2; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Medina JF, 2001, J NEUROSCI, V21, P4081, DOI 10.1523/JNEUROSCI.21-11-04081.2001; Park YG, 2010, P NATL ACAD SCI USA, V107, P10731, DOI 10.1073/pnas.1002995107; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; Placantonakis DG, 2001, J PHYSIOL-LONDON, V534, P123, DOI 10.1111/j.1469-7793.2001.t01-1-00123.x; Ruigrok TJ, 2010, CEREBELLUM IN PRESS; RUIGROK TJH, 1995, EUR J NEUROSCI, V7, P679, DOI 10.1111/j.1460-9568.1995.tb00672.x; RUIGROK TJH, 1990, J COMP NEUROL, V298, P315, DOI 10.1002/cne.902980305; Sanchez-Campusano R, 2009, J NEUROSCI, V29, P10750, DOI 10.1523/JNEUROSCI.2178-09.2009; Sangrey T, 2010, EUR J NEUROSCI, V32, P1646, DOI 10.1111/j.1460-9568.2010.07408.x; SEARS LL, 1991, BRAIN RES, V545, P114, DOI 10.1016/0006-8993(91)91276-7; SOTELO C, 1974, J NEUROPHYSIOL, V37, P541, DOI 10.1152/jn.1974.37.3.541; SOTELO C, 1986, J COMP NEUROL, V252, P32, DOI 10.1002/cne.902520103; Svensson P, 2006, EXP BRAIN RES, V168, P241, DOI 10.1007/s00221-005-0086-y; TURGEON SM, 1994, NEUROSCIENCE, V62, P601, DOI 10.1016/0306-4522(94)90392-1; TURGEON SM, 1994, NEUROBIOL AGING, V15, P705, DOI 10.1016/0197-4580(94)90052-3; Van Der Giessen RS, 2008, NEURON, V58, P599, DOI 10.1016/j.neuron.2008.03.016; YAROM Y, 1987, J NEUROSCI, V7, P1166; Zeeuw DE CI, 1997, CLIMBING FIBER COLLA	54	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46360	10.1371/journal.pone.0046360	http://dx.doi.org/10.1371/journal.pone.0046360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029495	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500096
J	Kong, C; Samovski, D; Srikanth, P; Wainszelbaum, MJ; Charron, AJ; Liu, JL; Lange, JJ; Chen, PI; Pan, ZQ; Su, X; Stahl, PD				Kong, Chen; Samovski, Dmitri; Srikanth, Priya; Wainszelbaum, Marisa J.; Charron, Audra J.; Liu, Jialiu; Lange, Jeffrey J.; Chen, Pin-I; Pan, Zhen-Qiang; Su, Xiong; Stahl, Philip D.			Ubiquitination and Degradation of the Hominoid-Specific Oncoprotein TBC1D3 Is Mediated by CUL7 E3 Ligase	PLOS ONE			English	Article							COPY NUMBER VARIATION; 3-M SYNDROME; ONCOGENE; PROTEIN; PATHWAY; GROWTH; CANCER; CELLS; MUTATIONS; GENE	Expression of the hominoid-specific TBC1D3 oncoprotein enhances growth factor receptor signaling and subsequently promotes cellular proliferation and survival. Here we report that TBC1D3 is degraded in response to growth factor signaling, suggesting that TBC1D3 expression is regulated by a growth factor-driven negative feedback loop. To gain a better understanding of how TBC1D3 is regulated, we studied the effects of growth factor receptor signaling on TBC1D3 post-translational processing and turnover. Using a yeast two-hybrid screen, we identified CUL7, the scaffolding subunit of the CUL7 E3 ligase complex, as a TBC1D3-interacting protein. We show that CUL7 E3 ligase ubiquitinates TBC1D3 in response to serum stimulation. Moreover, TBC1D3 recruits F-box 8 (Fbw8), the substrate recognition domain of CUL7 E3 ligase, in pull-down experiments and in an in vitro assay. Importantly, alkaline phosphatase treatment of TBC1D3 suppresses its ability to recruit Fbw8, indicating that TBC1D3 phosphorylation is critical for its ubiquitination and degradation. We conclude that serum-and growth factor-stimulated TBC1D3 ubiquitination and degradation are regulated by its interaction with CUL7-Fbw8.	[Kong, Chen; Samovski, Dmitri; Srikanth, Priya; Wainszelbaum, Marisa J.; Charron, Audra J.; Liu, Jialiu; Lange, Jeffrey J.; Chen, Pin-I; Stahl, Philip D.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Pan, Zhen-Qiang] Icahn Med Inst, Dept Oncol Sci, New York, NY USA; [Su, Xiong] Washington Univ, Sch Med, Ctr Human Nutr, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL); Icahn School of Medicine at Mount Sinai; Washington University (WUSTL)	Stahl, PD (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	xsu@wustl.edu; pstahl@wustl.edu	Samovski, Dmitri/AAQ-2014-2020; Samovski, Dmitri/K-3705-2019	Samovski, Dmitri/0000-0002-6860-6688; Srikanth, Priya/0000-0002-9669-0434	National Health Institute [GM086566]; McDonnell Center for Cellular and Molecular Neurobiology and Systems Neuroscience at Washington University in St. Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, R01GM086566] Funding Source: NIH RePORTER	National Health Institute; McDonnell Center for Cellular and Molecular Neurobiology and Systems Neuroscience at Washington University in St. Louis; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Health Institute grant GM086566 and a grant from the McDonnell Center for Cellular and Molecular Neurobiology and Systems Neuroscience at Washington University in St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng JW, 2009, SEMIN CANCER BIOL, V19, P218, DOI 10.1016/j.semcancer.2009.03.002; Duda DM, 2011, CURR OPIN STRUC BIOL, V21, P257, DOI 10.1016/j.sbi.2011.01.003; Frittoli E, 2008, MOL BIOL CELL, V19, P1304, DOI 10.1091/mbc.E07-06-0594; Hahn K, 2010, CELL METAB, V11, P438, DOI 10.1016/j.cmet.2010.03.015; Hanson D, 2011, HORM RES PAEDIAT, V76, P369, DOI 10.1159/000334392; Hanson D, 2011, AM J HUM GENET, V89, P148, DOI 10.1016/j.ajhg.2011.05.028; Hatanaka H, 2010, CANCER SCI, V101, P54, DOI 10.1111/j.1349-7006.2009.01348.x; Hodzic D, 2006, GENOMICS, V88, P731, DOI 10.1016/j.ygeno.2006.05.009; HUEBNER K, 1988, ONCOGENE, V3, P449; Kaustov L, 2007, J BIOL CHEM, V282, P11300, DOI 10.1074/jbc.M611297200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Litterman N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001060; NAKAMURA T, 1992, ONCOGENE, V7, P733; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Pei L, 2002, CANCER RES, V62, P5420; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Starczynowski DT, 2008, BLOOD, V112, P3412, DOI 10.1182/blood-2007-11-122028; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Wainszelbaum MJ, 2008, J BIOL CHEM, V283, P13233, DOI 10.1074/jbc.M800234200; Wainszelbaum MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031225; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Zhao X, 2008, J VIROL, V82, P5316, DOI 10.1128/JVI.02677-07	25	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46485	10.1371/journal.pone.0046485	http://dx.doi.org/10.1371/journal.pone.0046485			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029530	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517500104
J	Asthagiri, AR; Vasquez, RA; Butman, JA; Wu, TX; Morgan, K; Brewer, CC; King, K; Zalewski, C; Kim, HJ; Lonser, RR				Asthagiri, Ashok R.; Vasquez, Raul A.; Butman, John A.; Wu, Tianxia; Morgan, Keaton; Brewer, Carmen C.; King, Kelly; Zalewski, Chris; Kim, H. Jeffrey; Lonser, Russell R.			Mechanisms of Hearing Loss in Neurofibromatosis Type 2	PLOS ONE			English	Article							VESTIBULAR-SCHWANNOMA; NATURAL-HISTORY; FLUID; DETERIORATION; BEVACIZUMAB; PROTEINS	Introduction: Patients with neurofibromatosis type 2 (NF2) develop bilateral cochleovestibular schwannomas (CVSs) that cause binaural deafness in most individuals. Hearing loss occurs in an unpredictable manner and the underlying mechanisms are not known. To gain insight into the pathophysiologic basis for hearing loss in NF2, we performed a prospective cross-sectional study of untreated ears in NF2 patients. Methods: One hundred consecutive NF2 patients in a prospective natural history study were included. Clinical and audiometric data were analyzed for treatment naive ears. In addition to standard MR-imaging sequences, alterations in intralabyrinthine protein content were determined utilizing high resolution FLAIR, the presence of cochlear aperture obstruction was determined by examining 3D T2 sequences, and endolymphatic hydrops was identified on delayed post-contrast FLAIR sequences. Results: Eighty-nine ears harboring 84 untreated CVSs in 56 consecutive NF2 patients (age 30 +/- 16 years) were analyzed. Thirty-four (38%) ears had varying degrees of hearing loss. Elevated intralabyrinthine protein was identified in 70 (75%) ears by FLAIR MR-imaging and was strongly associated with the presence of hearing loss (32/34 hearing loss ears; 94%)(Fisher's exact test; P = .005). Elevated intralabyrinthine protein was associated with the presence of CVS-associated cochlear aperture obstruction (64 of 67 ears with elevated protein; 96%)(Fisher's exact test; P<0.0001) in both normal and hearing loss ears. Elevated intralabyrinthine protein was not identified in ears without CVS (5 ears). While larger tumor size was associated with hearing loss (P = 0.006), 16 hearing loss ears (47%) harbored CVSs less than 0.5 cm(3), including 14 ears (88%) with block of the cochlear aperture and elevated protein. Discussion: These findings are consistent with a model in which hearing loss develops as a result of cochlear aperture obstruction and accumulation of intralabyrinthine protein. MRI based identification of elevated intralabyrinthine protein may help identify the ear at-risk for developing hearing loss.	[Asthagiri, Ashok R.; Vasquez, Raul A.; Morgan, Keaton; Lonser, Russell R.] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Vasquez, Raul A.] Univ Florida, Dept Neurol Surg, Gainesville, FL USA; [Butman, John A.] NIH, Ctr Clin, Bethesda, MD USA; [Wu, Tianxia] NINDS, Clin Neurosci Program, NIH, Bethesda, MD 20892 USA; [Brewer, Carmen C.; King, Kelly; Zalewski, Chris] Natl Inst Deafness & Other Commun Disorders, Audiol Unit, Otolaryngol Branch, NIH, Bethesda, MD USA; [Kim, H. Jeffrey] Natl Inst Deafness & Other Commun Disorders, Off Clin Director, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Asthagiri, AR (corresponding author), NINDS, Surg Neurol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	asthagiria@ninds.nih.gov	Butman, John A/A-2694-2008; Butman, John/J-2780-2013	Butman, John/0000-0002-1547-9195; Morgan, Keaton/0000-0001-9140-4454	National Institute of Neurologic Disorders and Stroke; National Institute on Deafness and Other Communication Disorders; Clinical Center at the National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003132, ZIANS003053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIDDC000075, ZIADC000064] Funding Source: NIH RePORTER	National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Clinical Center at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was supported by the Intramural Research Program of the National Institute of Neurologic Disorders and Stroke, National Institute on Deafness and Other Communication Disorders and the Clinical Center at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza MM, 1996, LARYNGOSCOPE, V106, P694, DOI 10.1097/00005537-199606000-00007; Asthagiri AR, 2009, LANCET, V373, P1974, DOI 10.1016/S0140-6736(09)60259-2; Baser ME, 2002, NEUROLOGY, V59, P1759, DOI 10.1212/01.WNL.0000035638.74084.F4; Butman JA, 2008, JAMA-J AM MED ASSOC, V300, P1334, DOI 10.1001/jama.300.11.1334; Butman JA, 2007, JAMA-J AM MED ASSOC, V298, P41, DOI 10.1001/jama.298.1.41; DIX M R, 1950, J Laryngol Otol, V64, P658; ECKERMEIER L, 1979, ARCH OHREN NASEN KEH, V222, P1, DOI 10.1007/BF00456332; Evans DGR, 2005, OTOL NEUROTOL, V26, P93, DOI 10.1097/00129492-200501000-00016; EVANS DGR, 1992, J MED GENET, V29, P841, DOI 10.1136/jmg.29.12.841; EVANS DGR, 1992, Q J MED, V84, P603; Fisher LM, 2009, OTOL NEUROTOL, V30, P835, DOI 10.1097/MAO.0b013e3181b2364c; Froin G, 1903, GAZ HOP, P76; GARDNER WJ, 1954, NEW ENGL J MED, V250, P932, DOI 10.1056/NEJM195406032502202; Graamans K, 2003, ACTA OTO-LARYNGOL, V123, P51, DOI 10.1080/0036554021000028075; King KA, 2007, EAR HEARING, V28, P831, DOI 10.1097/AUD.0b013e318157677f; LUNDIN P, 1992, J COMPUT ASSIST TOMO, V16, P519, DOI 10.1097/00004728-199207000-00004; Lysaght AC, 2011, J PROTEOME RES, V10, P3845, DOI 10.1021/pr200346q; Masuda A, 2004, OTOL NEUROTOL, V25, P150, DOI 10.1097/00129492-200403000-00012; Melhem ER, 1997, AM J ROENTGENOL, V169, P859, DOI 10.2214/ajr.169.3.9275912; Nakashima T, 2010, ACTA OTO-LARYNGOL, V130, P338, DOI [10.1080/00016480903143986, 10.3109/00016480903143986]; Pennings RJE, 2011, NEUROSURGERY, V68, P68, DOI 10.1227/NEU.0b013e3181fc60cb; Plotkin SR, 2012, OTOL NEUROTOL, V33, P1046, DOI 10.1097/MAO.0b013e31825e73f5; Plotkin SR, 2009, NEW ENGL J MED, V361, P358, DOI 10.1056/NEJMoa0902579; Roosli C, 2012, OTOL NEUROTOL, V33, P473, DOI 10.1097/MAO.0b013e318248ee02; Schuknecht H F, 1966, Nihon Jibiinkoka Gakkai Kaiho, V69, P1825; Shepherd RK, 2004, ARCH OTOLARYNGOL, V130, P518, DOI 10.1001/archotol.130.5.518; Silverstein H, 1973, Otolaryngol Clin North Am, V6, P229; SILVERSTEIN H, 1966, ARCHIV OTOLARYNGOL, V84, P395; Slattery WH, 2005, OTOL NEUROTOL, V26, P733, DOI 10.1097/01.mao.0000169048.15889.80; Tagaya M, 2011, ACTA OTO-LARYNGOL, V131, P474, DOI 10.3109/00016489.2010.534114; THOMSEN J, 1982, ORL J OTO-RHINO-LARY, V44, P61, DOI 10.1159/000275574; Trofatter J A, 1993, Cell, V75, P826; WENTHOLD RJ, 1982, BRAIN RES, V253, P263, DOI 10.1016/0006-8993(82)90693-X; Yamazaki M, 2009, NEURORADIOLOGY, V51, P855, DOI 10.1007/s00234-009-0588-6; Yoshida T, 2008, LARYNGOSCOPE, V118, P1433, DOI 10.1097/MLG.0b013e318172ef85	35	45	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46132	10.1371/journal.pone.0046132	http://dx.doi.org/10.1371/journal.pone.0046132			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049959	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300088
J	Dama, MS				Dama, Madhukar Shivajirao			Parasite Stress Predicts Offspring Sex Ratio	PLOS ONE			English	Article							EVOLUTIONARY ECOLOGY; HEPATITIS-B; CYCLE DAY; BIRTH; MORTALITY; SONS; UNDERNUTRITION; POPULATIONS; TRIMESTER; PATTERNS	In this study, I predict that the global variation of offspring sex ratio might be influenced in part by the level of parasite stress. From an energetic standpoint, higher gestational costs of producing a male offspring could decrease male births in a population with limited resources. This implies that, any factor that limits the parental resources could be expected to favor female offspring production. Human sex ratio at birth (SRB) is believed to be influenced by numerous socioeconomic, biological, and environmental factors. Here, I test a prediction that parasite stress, by virtue of its effects on the general health condition, may limit the parental investment ability and therefore could influence the SRB at the population level. The statistical analysis supports this prediction, and show that the level of parasite stress has a significant inverse relation with population SRB across the world. Further, this relation is many-folds stronger than the association of SRB with other factors, like; polygyny, fertility, latitude, and son-preference. Hence, I propose that condition affecting ability of parasites (but not adaptive significance) could be a likely causal basis for the striking variation of SRB across populations.	Karnataka Vet Anim & Fisheries Sci Univ, Inst Wildlife Vet Res, Somavarpet Taluk, Karnataka, India		Dama, MS (corresponding author), Karnataka Vet Anim & Fisheries Sci Univ, Inst Wildlife Vet Res, Somavarpet Taluk, Karnataka, India.	madhukar262@gmail.com	Dama, Madhukar/H-9945-2012	Dama, Madhukar/0000-0002-8361-1530				[Anonymous], 1989, RACIAL ETHNIC DIFFER; [Anonymous], 2004, WORLD HLTH REP; Barber N, 2004, SOC BIOL, V51, P71; Berrigan D, 2003, PREV MED, V36, P615, DOI 10.1016/S0091-7435(02)00067-1; Betzig L, 2012, EVOL HUM BEHAV, V33, P309, DOI 10.1016/j.evolhumbehav.2011.10.008; Boklage CE, 2005, HUM REPROD, V20, P583, DOI 10.1093/humrep/deh662; Brown GR, 2009, TRENDS ECOL EVOL, V24, P297, DOI 10.1016/j.tree.2009.02.005; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Butts SF, 2010, FERTIL STERIL, V93, P681, DOI 10.1016/j.fertnstert.2009.10.047; BYRNE J, 1987, AM J MED GENET, V26, P605, DOI 10.1002/ajmg.1320260315; CHAHNAZARIAN A, 1988, J BIOSOC SCI, V20, P357, DOI 10.1017/S0021932000006696; Chambliss R, 1949, SOC FORCES, V28, P190, DOI 10.2307/2572646; CHARNOV E L, 1982; Cramer JS, 2010, HUM BIOL, V82, P103, DOI 10.3378/027.082.0106; Dama MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023792; Das Gupta M, 2006, POPUL DEV REV, V32, P328; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DREW JS, 1978, SCIENCE, V201, P687, DOI 10.1126/science.566954; Ember C.R., 2001, CROSS CULTURAL RES M; Florey HW, 1970, GEN PATHOLOGY; Fox J., 1991, SAGE U PAPER SERIES; Fukuda M, 1998, HUM REPROD, V13, P2321, DOI 10.1093/humrep/13.8.2321; Grech V, 2000, J EPIDEMIOL COMMUN H, V54, P244, DOI 10.1136/jech.54.4.244; Grech V, 2002, BRIT MED J, V324, P1010, DOI 10.1136/bmj.324.7344.1010; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Helle S, 2008, BIOL LETTERS, V4, P60, DOI 10.1098/rsbl.2007.0482; Helle S, 2009, J ANIM ECOL, V78, P1226, DOI 10.1111/j.1365-2656.2009.01598.x; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; Hummer RA, 2011, DU BOIS REV, V8, P5, DOI 10.1017/S1742058X11000051; Ian CWH, 2002, HUMAN SEX RATIOS ADA; JAKOBOVITS AA, 1991, EUR J OBSTET GYN R B, V40, P211, DOI 10.1016/0028-2243(91)90119-6; James WH, 2006, ENVIRON RES, V100, P77, DOI 10.1016/j.envres.2005.03.001; JAMES WH, 1971, LANCET, V1, P112; James WH, 2000, HUM REPROD, V15, P1206, DOI 10.1093/humrep/15.5.1206; Kankova S, 2007, NATURWISSENSCHAFTEN, V94, P122, DOI 10.1007/s00114-006-0166-2; Levine RS, 2001, PUBLIC HEALTH REP, V116, P474, DOI 10.1093/phr/116.5.474; Lin MJ, 2012, AM J HUM BIOL, V24, P541, DOI 10.1002/ajhb.22267; Mace R, 2003, COMP BIOCHEM PHYS A, V136, P85, DOI 10.1016/S1095-6433(03)00019-9; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; Martin Joyce A, 2002, Natl Vital Stat Rep, V50, P1; Navara KJ, 2009, BIOL LETTERS, V5, P524, DOI 10.1098/rsbl.2009.0069; PEDERSEN JF, 1980, BRIT MED J, V281, P1253, DOI 10.1136/bmj.281.6250.1253; Piazze J, 1999, EARLY HUM DEV, V54, P137, DOI 10.1016/S0378-3782(98)00088-7; Pollet T, 2010, J EVOLUTIONARY PSYCH, V8, P57; PRICE B, 1977, PSYCHOL BULL, V84, P759, DOI 10.1037/0033-2909.84.4.759; Reed TE, 2008, SCIENCE, V321, P1681, DOI 10.1126/science.1159466; Richardus JH, 2001, AM J PUBLIC HEALTH, V91, P1251, DOI 10.2105/AJPH.91.8.1251; ROJANSKY N, 1992, HUM REPROD, V7, P735, DOI 10.1093/oxfordjournals.humrep.a137729; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shields MD, 2002, BRIT MED J, V325, P335; Sparks PJ, 2009, MATERN CHILD HLTH J, V13, P769, DOI 10.1007/s10995-009-0476-z; Stein AD, 2004, P ROY SOC B-BIOL SCI, V271, pS138, DOI 10.1098/rsbl.2003.0123; Stein AD, 2004, P ROY SOC B-BIOL SCI, V271, pS37, DOI 10.1098/rsbl.2003.0086; Tamimi RM, 2003, BRIT MED J, V326, P1245, DOI 10.1136/bmj.326.7401.1245; Teitelbaum M S, 1970, J Biosoc Sci Suppl, V2, P61; Thornhill R, 2009, BIOL REV, V84, P113, DOI 10.1111/j.1469-185X.2008.00062.x; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; United Nations Development Programme, 2009, HUM DEV REP; US Central Intelligence Agency, 2011, WORLD FACTB; WHITING JWM, 1993, AM ANTHROPOL, V95, P435, DOI 10.1525/aa.1993.95.2.02a00090; WHO, 2004, GLOB BURD DIS 2004; Winkleby MA, 2004, AM J HEALTH PROMOT, V19, P19, DOI 10.4278/0890-1171-19.1.19; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Health Organization, 2011, GLOB HLTH RISKS MORT; Zorn B, 2002, HUM REPROD, V17, P3173, DOI 10.1093/humrep/17.12.3173	65	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46169	10.1371/journal.pone.0046169	http://dx.doi.org/10.1371/journal.pone.0046169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049967	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300093
J	Porco, D; Potapov, M; Bedos, A; Busmachiu, G; Weiner, WM; Hamra-Kroua, S; Deharveng, L				Porco, David; Potapov, Mikhail; Bedos, Anne; Busmachiu, Galina; Weiner, Wanda M.; Hamra-Kroua, Salah; Deharveng, Louis			Cryptic Diversity in the Ubiquist Species Parisotoma notabilis (Collembola, Isotomidae): A Long-Used Chimeric Species?	PLOS ONE			English	Article							GENETIC DIFFERENTIATION; SPRINGTAILS HEXAPODA; SOIL; MITOCHONDRIAL; COMMUNITIES; FOREST; POPULATIONS; DIVERGENCE; EARTHWORM; POLLUTION	Parisotoma notabilis is the most common species of Collembola in Europe and is currently designated as ubiquist. This species has been extensively used in numerous studies and is considered as well characterized on a morphological ground. Despite the homogeneity of its morphology, the sequencing of the barcoding fragment (5' end of COI) for several populations throughout Europe and North America revealed four distinct genetic lineages. The divergence found between these lineages was similar to the genetic distance among other species of the genus Parisotoma included in the analysis. All four lineages have been confirmed by the nuclear gene 28S. This congruence between mitochondrial and nuclear signals, as well as the geographical distribution pattern of lineages observed in Europe, supports the potential specific status of these lineages. Based on specimens from the type locality (Hamburg), the species name was successfully assigned to one of these lineages. This finding raises several problems as Parisotoma notabilis has been widely used in many ecological studies. Accumulation of new data for the different lineages detected, especially ecological information and life history traits, is needed to help resolve this situation.	[Porco, David] Univ Rouen, Ecol Lab, EA ECODIV 1293, FED SCALE, Mont St Aignan, France; [Potapov, Mikhail] Moscow State Pedag Univ, Dept Zool & Ecol, Moscow 119435, Russia; [Bedos, Anne; Deharveng, Louis] Museum Natl Hist Nat, Origine Struct & Evolut Biodiversite UMR7205, F-75231 Paris, France; [Busmachiu, Galina] Moldavian Acad Sci, Inst Zool, Kishinev, Moldova; [Weiner, Wanda M.] Polish Acad Sci, Inst Systemat & Evolut Anim, Krakow, Poland; [Hamra-Kroua, Salah] Univ Mentouri Constantine, Lab Biosystemat & Ecol Arthropodes, Fac SNV, Dept Biol Anim, Constantine, Algeria	Universite de Rouen Normandie; Moscow State University of Education; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Academy of Sciences of Moldova; Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences; Universite Constantine	Porco, D (corresponding author), Univ Rouen, Ecol Lab, EA ECODIV 1293, FED SCALE, Mont St Aignan, France.	david.porco.gm@gmail.com	Weiner, Wanda Maria/AAW-3735-2020; Potapov, Mikhail/AAG-4607-2022; Potapov, Mikhail B./T-7534-2017; Potapov, Mikhail/AFK-6336-2022	Weiner, Wanda Maria/0000-0002-7257-3671; Potapov, Mikhail/0000-0002-6111-3354; Potapov, Mikhail/0000-0002-6111-3354	NSERC (Natural Science and Engineering Research Council of Canada), Genome Canada; Ontario Genomics Institute [2008-OGI-ICI-03]	NSERC (Natural Science and Engineering Research Council of Canada), Genome Canada; Ontario Genomics Institute	This work was funded by NSERC (Natural Science and Engineering Research Council of Canada), Genome Canada and the Ontario Genomics Institute (2008-OGI-ICI-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez T, 1997, PEDOBIOLOGIA, V41, P110; Barraclough TG, 2003, EVOLUTION, V57, P2166; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Birky Jr CW, 2009, ASEXUAL SPECIFICATIO, P201; CARAPELLI A, 1995, EUR J SOIL BIOL, V31, P87; CARAPELLI A, 1995, B ZOOL, V62, P71, DOI 10.1080/11250009509356053; Chahartaghi M, 2006, PEDOBIOLOGIA, V50, P331, DOI 10.1016/j.pedobi.2006.06.001; Chahartaghi-Abnieh M, 2007, THESIS; Cicconardi F, 2010, MOL ECOL, V19, P386, DOI 10.1111/j.1365-294X.2009.04457.x; D'Haese CA, 2002, P ROY SOC B-BIOL SCI, V269, P1143, DOI 10.1098/rspb.2002.1981; Decaens T, 2012, APPL SOIL E IN PRESS; Deharveng L, 2004, PEDOBIOLOGIA, V48, P415, DOI 10.1016/j.pedobi.2004.08.001; Deharveng L, 1996, CONSERV BIOL, V10, P74, DOI 10.1046/j.1523-1739.1996.10010074.x; Deharveng L., 1981, CNFRA (Comite National Francais des Recherches Antarctiques), P33; Fanciulli PP, 2009, PEDOBIOLOGIA, V52, P309, DOI 10.1016/j.pedobi.2008.11.004; Fanciulli PP, 2000, BIOL J LINN SOC, V70, P221, DOI 10.1006/bijl.1999.0369; FANCIULLI PP, 1991, REV ECOL BIOL SOL, V28, P165; FJELLBERG A, 1977, ENTOMOL SCAND, V8, P9, DOI 10.1163/187631277X00026; Fjellberg A, 1980, IDENTIFICATION KEYS; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FRATI F, 1992, J HERED, V83, P275, DOI 10.1093/oxfordjournals.jhered.a111213; Frati Francesco, 1995, Polskie Pismo Entomologiczne, V64, P41; Fromm H, 1997, 26 TU; Haimi J, 1996, FRESEN J ANAL CHEM, V354, P672; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hausmann A, 2009, ZOOTAXA, P1; Havermans C, 2011, DEEP-SEA RES PT II, V58, P230, DOI 10.1016/j.dsr2.2010.09.028; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heethoff M, 2007, J EVOLUTION BIOL, V20, P392, DOI 10.1111/j.1420-9101.2006.01183.x; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; James SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015629; Kaprus IJ, 1999, P SHEVCHENKO SCI SOC, V3, P235; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; King RA, 2008, MOL ECOL, V17, P4684, DOI 10.1111/j.1365-294X.2008.03931.x; Kuznetsova NA, 1997, RUSS J ECOL+, V28, P386; Larink O, 1997, SPRINGTAILS MITES IM, P225; LEE BH, 1977, PAC INSECTS, V17, P155; Lefebure T, 2006, MOL ECOL, V15, P1797, DOI 10.1111/j.1365-294X.2006.02888.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; LOPES CM, 1994, EUR J SOIL BIOL, V30, P133; Martynova EF, 1977, KOMPONENTY BIOCENOZO, P102; Novo M, 2010, MOL PHYLOGENET EVOL, V56, P507, DOI 10.1016/j.ympev.2010.04.010; Perez-Losada M, 2009, MOL PHYLOGENET EVOL, V52, P293, DOI 10.1016/j.ympev.2009.04.003; PETERSEN H, 1971, Revue d'Ecologie et de Biologie du Sol, V8, P133; Petersen H, 1987, SOIL FAUNA SOIL FERT, P217; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Porco D, 2012, INVERTEBRAT IN PRESS; Porco D, 2012, BIOL INVASI IN PRESS; Porco D, 2010, MOL ECOL RESOUR, V10, P942, DOI 10.1111/j.1755-0998.2010.2839.x; Porco David, 2010, Zootaxa, V2639, P59; POTAPOV M B, 1991, Acta Zoologica Cracoviensia, V34, P267; Potapov Mikhail, 2001, Abhandlungen und Berichte des Naturkundemuseums Goerlitz, V73, P1; Radulovici AE, 2009, MOL ECOL RESOUR, V9, P181, DOI 10.1111/j.1755-0998.2009.02643.x; Rougerie R, 2009, PESQUI AGROPECU BRAS, V44, P789, DOI 10.1590/S0100-204X2009000800002; RUSEK J, 1984, ACTA ENTOMOL BOHEMOS, V81, P343; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salmon J. T., 1941, Transactions and Proceedings of the Royal Society of New Zealand, V70, P282; Salmon S, 2010, REV ECOL-TERRE VIE, V65, P45; Simonsen V, 2004, PEDOBIOLOGIA, V48, P297, DOI 10.1016/j.pedobi.2004.03.002; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Soto-Adames FN, 2000, SYST ENTOMOL, V25, P485, DOI 10.1046/j.1365-3113.2000.00127.x; Stevens MI, 2006, MOL BIOL EVOL, V23, P874, DOI 10.1093/molbev/msj073; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torricelli G, 2010, GENE, V449, P30, DOI 10.1016/j.gene.2009.09.006; TRANVIK L, 1993, J APPL ECOL, V30, P43, DOI 10.2307/2404269; Vaglia T, 2008, ZOOTAXA, P18, DOI 10.11646/zootaxa.1923.1.2; Van Straalen NM, 1996, CRITICAL BODY CONCEN, P5; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Zhou X, 2009, FRONTIERS ZOOLOGY, V6, P9	73	48	52	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46056	10.1371/journal.pone.0046056	http://dx.doi.org/10.1371/journal.pone.0046056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049931	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300078
J	Yang, WY; Zhao, WH; Xiao, JZ; Li, R; Zhang, P; Kissimova-Skarbek, K; Schneider, E; Jia, WP; Ji, LN; Guo, XH; Shan, ZY; Liu, J; Tian, HM; Chen, L; Zhou, ZG; Ji, QH; Ge, JP; Chen, G; Brown, J				Yang, Wenying; Zhao, Wenhui; Xiao, Jianzhong; Li, Rui; Zhang, Ping; Kissimova-Skarbek, Katarzyna; Schneider, Erin; Jia, Weiping; Ji, Linong; Guo, Xiaohui; Shan, Zhongyan; Liu, Jie; Tian, Haoming; Chen, Li; Zhou, Zhiguang; Ji, Qiuhe; Ge, Jiapu; Chen, Gang; Brown, Jonathan			Medical Care and Payment for Diabetes in China: Enormous Threat and Great Opportunity	PLOS ONE			English	Article							PRESSURE-LOWERING DRUGS; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; COST-EFFECTIVENESS; LOW-INCOME; FOLLOW-UP; PREVENTION; MELLITUS; PREVALENCE; BURDEN	Background: The Diabetes Impact Study followed up a large national population-based screening study to estimate the use of and expenditures for medical care caused by diabetes in China and to ascertain the use and cost of essential basic medicines and care. Methods: In 2009-10, the study team interviewed 1482 adults with diabetes and 1553 adults with glucose tolerance in the normal range from population-based random samples at 12 sites in China. The response rate was 67%. Findings: After adjusting for age, sex, and urban/rural location, people with diabetes received 1.93 times more days of inpatient treatment, 2.40 times more outpatient visits, and 3.35 times more medications than people with normal glucose tolerance (all p<0.05). Adjusted expenditures for medical care were 3.38 times higher among people with diabetes than among people with normal glucose tolerance (p<0.01, unadjusted 3.97). Persons who were diagnosed with >= 10 years prior to the survey paid 3.75 times as much for medical care as those with <= 5 years of diagnosed diabetes. Among persons with diabetes, 45.2% took medication to control blood sugar, 21.1% took an antihypertensive medicine, 22.4% took daily aspirin, and 1.8% took a statin. Over the three months before the interview, 46.1% of persons with diabetes recalled seeing a doctor, 48.9% recalled a blood pressure measurement, and 54.5% recalled a blood sugar test. Over the year preceding the interview, 32.1% recalled a retinal screening and 17.9% recalled a foot examination. Conclusions: In China, health care use and costs were dramatically higher for people with diabetes than for people with normal glucose tolerance and, in relative terms, much higher than in industrialized countries. Low-cost generic medicines that would reduce diabetes expenditures were not fully used.	[Kissimova-Skarbek, Katarzyna; Schneider, Erin; Brown, Jonathan] Int Diabet Federat, Brussels, Belgium; [Yang, Wenying; Zhao, Wenhui; Xiao, Jianzhong] Chinese Japanese Friendship Hosp, Beijing, Peoples R China; [Zhao, Wenhui] Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China; [Zhao, Wenhui] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Li, Rui; Zhang, Ping] Ctr Dis Control & Prevent, Atlanta, GA USA; [Kissimova-Skarbek, Katarzyna] Jagiellonian Univ, Coll Med, Inst Publ Hlth, Krakow, Poland; [Schneider, Erin] Natl Bur Asian Res, Seattle, WA USA; [Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Ji, Linong] Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China; [Guo, Xiaohui] Peking Univ, Hosp 1, Beijing 100871, Peoples R China; [Shan, Zhongyan] Chinese Med Univ, Affiliated Hosp 1, Shenyang, Liaoling, Peoples R China; [Liu, Jie] Shanxi Prov Peoples Hosp, Taiyuan, Shaanxi, Peoples R China; [Tian, Haoming] Sichuan Univ, W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Chen, Li] Shandong Univ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Zhou, Zhiguang] Xiangya Second Hosp, Changsha, Hunan, Peoples R China; [Ji, Qiuhe] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Ge, Jiapu] Xinjiang Uygur Autonomous Reg Hosp, Urumqi, Xinjiang, Peoples R China; [Chen, Gang] Fujian Prov Hosp, Fuzhou, Fujiang, Peoples R China	China-Japan Friendship Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Centers for Disease Control & Prevention - USA; Jagiellonian University; Collegium Medicum Jagiellonian University; Shanghai Jiao Tong University; Peking University; Peking University; China Medical University; Shanxi People's Hospital; Sichuan University; Shandong University; Central South University; Air Force Military Medical University; Fujian Provincial Hospital	Brown, J (corresponding author), Int Diabet Federat, Brussels, Belgium.	jonabrown@gmail.com	Linong, Ji/AAB-6543-2020	Kissimova-Skarbek, Katarzyna/0000-0003-4624-0918; Zhou, Zhiguang/0000-0002-0374-1838	Economic Study Fund of the International Diabetes Federation (IDF); Chinese Diabetes Society; Merck and Co.; Novo Nordisk; Eli Lilly and Co.; Takeda Pharmaceuticals North America; GSK, Inc.; GSK; Eli Lilly; Merck; Roche and Co.	Economic Study Fund of the International Diabetes Federation (IDF); Chinese Diabetes Society; Merck and Co.(Merck & Company); Novo Nordisk(Novo Nordisk); Eli Lilly and Co.(Eli Lilly); Takeda Pharmaceuticals North America(Takeda Pharmaceutical Company Ltd); GSK, Inc.; GSK(GlaxoSmithKline); Eli Lilly(Eli Lilly); Merck(Merck & Company); Roche and Co.	This study was funded by allocations from the Economic Study Fund of the International Diabetes Federation (IDF), a not-for-profit NGO headquartered in Brussels, Belgium, and from the Chinese Diabetes Society. The IDF's Economic Studies Fund was created from contributions that IDF solicited from Merck and Co., Novo Nordisk, Eli Lilly and Co., Takeda Pharmaceuticals North America, and GSK, Inc. These funders had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript, or selection of countries in which economic impact studies were conducted. Additional resources, in the form of volunteer time, logistical support, and expertise were provided by the 12 study sites in China, by the Chinese Diabetes Society, by the Chinese-Japanese Friendship Hospital, by the Kaiser Permanente Center for Health Research, by the United States Centers for Disease Control and Prevention, by the International Diabetes Federation, and by the authors.; Before retirement in 11/09 J. Brown led or could have led studies funded by research contracts with Novo Nordisk, GSK, Takeda Pharmaceuticals North America, Eli Lilly, and Merck. J. Brown had no consulting or other paid or unpaid arrangements with these or other actual or potential commercial funders. Starting in 2002 J. Brown led the creation of the IDF Economic Studies Fund with funds from Novo Nordisk, GSK, Takeda, Eli Lilly, and Merck. As per the rules of the Fund established before solicitation, the funders did not participate in decisions regarding countries to be studied or in doing, analyzing or writing up any study. Since election in Oct 2009 as unpaid IDF VP, J. Brown has accepted no grants or contracts or gifts or employment from any drug or device firms and has not accepted any positions on their editorial or advisory groups. In 2010, J. Brown accepted travel reimbursement from Novo Nordisk to speak at the 6th International Symposium on Diabetes and Pregnancy. In 2009, at the request of IDF, J. Brown accepted reimbursement from IDF to speak at a satellite meeting of ADA sponsored by Roche and Co. Drs. Ping Zhang and Rui Li worked on this project on their own time while in the employ of the United States Center for Disease Control. Drs. Zhang and Li declare that no potential competing interests exist. During most of this study Dr. Skarbek was an employee of the IDF. IDF is supported financially by many commercial entities. She declares that no competing interests exist. All other authors have no potentially competing interests. The authors declare that none of the competing interests described above will alter the authors' adherence to all the PLOS One policies on sharing data and materials.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Banister J, 2010, 53 HARV PROGR GLOB D; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Brown JB, 1999, DIABETES CARE, V22, P1116, DOI 10.2337/diacare.22.7.1116; Chen XB, 2003, CHIN J DIABETES, V11, P238; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Gong Q, 2011, DIABETOLOGIA, V54, P300, DOI 10.1007/s00125-010-1948-9; Harbage B, 1999, AM J PREV MED, V16, P314, DOI 10.1016/S0749-3797(98)00101-9; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Hu J-P, 2007, CHIN J PREV CHRONIC, V15, P4; Human Development Unit East Asia and Pacific Region World Bank, 2011, 62318CN WORLD BANK; IDF Clinical Guidelines Task Force, 2005, GLOB GUID TYP 2 DIAB; International Diabetes Federation, 2011, IDF DIAB ATL; Jonsson B, 1998, DIABETES CARE, V21, pC7, DOI 10.2337/diacare.21.3.C7; Koster I, 2006, DIABETOLOGIA, V49, P1498, DOI 10.1007/s00125-006-0277-5; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Leeder S, 2004, RACE TIME CHALLENGE; Li R, 2010, DIABETES CARE, V33, P1872, DOI 10.2337/dc10-0843; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Mohan V, 2006, DIABETOLOGIA, V49, P1175, DOI 10.1007/s00125-006-0219-2; Narayan KMV, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P591; Nichols G, 2006, INT DIAB FED TRIENN; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Petrou S, 2002, INT J TECHNOL ASSESS, V18, P705, DOI 10.1017/S026646230200051X; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; Roseboom TJ, 2011, MATURITAS, V70, P141, DOI 10.1016/j.maturitas.2011.06.017; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wang J, 2008, CHIL HLTH QUAL MANAG, V15, P65; Wang WB., 2008, CHIN HLTH RESOUR, V11, P127, DOI DOI 10.3969/J.ISSN.1007-953X.2008.03.013; Wang WB, 2009, AM J MANAG CARE, V15, P593; World Health Organization, 2010, GLOBAL RECOMMENDATIO, P18; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026; Zhang Z, 2007, CHINESE HLTH RESOURC, V10, P162	41	57	61	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e39513	10.1371/journal.pone.0039513	http://dx.doi.org/10.1371/journal.pone.0039513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049727	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300002
J	Aomatsu, N; Yashiro, M; Kashiwagi, S; Takashima, T; Ishikawa, T; Ohsawa, M; Wakasa, K; Hirakawa, K				Aomatsu, Naoki; Yashiro, Masakazu; Kashiwagi, Shinichiro; Takashima, Tsutomu; Ishikawa, Tetsuro; Ohsawa, Masahiko; Wakasa, Kenichi; Hirakawa, Kosei			CD133 Is a Useful Surrogate Marker for Predicting Chemosensitivity to Neoadjuvant Chemotherapy in Breast Cancer	PLOS ONE			English	Article							SURGICAL ADJUVANT BREAST; STEM-CELLS; PROSPECTIVE IDENTIFICATION; PREOPERATIVE DOXORUBICIN; PATHOLOGICAL RESPONSE; GENE-EXPRESSION; PHASE-II; DOCETAXEL; CYCLOPHOSPHAMIDE; THERAPY	Background: Neoadjuvant chemotherapy (NAC) is a standard care regimen for patients with breast cancer. However, the pathologic complete response (pCR) rate remains at 30%. We hypothesized that a cancer stem cell marker may identify NAC-resistant patients, and evaluated CD133 and ALDH1 as a potential surrogate marker for breast cancer. The aim of this study was to find a surrogate maker to predict chemosensitivity of NAC for breast cancer. Methodology/Findings: A total of 102 patients with breast cancer were treated with NAC consisting of epirubicin followed by paclitaxel. Core needle biopsy (CNB) specimens and resected tumors were obtained from all patients before and after NAC, respectively. Chemosensitivity and prognostic potential of CD133 or ALDH1 expression was evaluated by immunohistochemistry. Clinical CR (cCR) and pCR rates were 18% (18/102) and 29% (30/102), respectively. Forty-seven (46%) patients had CD133-positive tumors before NAC, and CD133 expression was significantly associated with a low pCR rate (p = 0.035) and clinical non-responders. Multivariate analysis revealed that CD133 expression was significantly (p = 0.03) related to pCR. Recurrence was more frequent in patients with CD133-positive tumors (21/47, 45%) than that in patients with CD133-negative tumors (7/55, 13%). The number of patients with CD133-positive tumors (62%) after NAC was higher than that (46%) before NAC. Furthermore, most patients with CD133-positive tumors before NAC maintained the same status after NAC. Conclusion/Significance: CD133 before NAC might be a useful marker for predicting the effectiveness of NAC and recurrence of breast cancer after NAC.	[Aomatsu, Naoki; Yashiro, Masakazu; Kashiwagi, Shinichiro; Takashima, Tsutomu; Ishikawa, Tetsuro; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan; [Yashiro, Masakazu] Osaka City Univ, Grad Sch Med, Oncol Inst Geriatr & Med Sci, Osaka 558, Japan; [Ohsawa, Masahiko; Wakasa, Kenichi] Osaka City Univ, Dept Diagnost Pathol, Grad Sch Med, Abeno Ku, Osaka 558, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Yashiro, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Osaka 558, Japan.	m9312510@med.osaka-cu.ac.jp	Kashiwagi, Shinichiro/AAE-5243-2020; Kashiwagi, Shinichiro/AAC-7070-2019	Kashiwagi, Shinichiro/0000-0002-0460-9599; Kashiwagi, Shinichiro/0000-0002-0460-9599	Ministry of Education, Science, Sports, Culture and Technology of Japan [20591573, 22390262, 23390329]	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in Aid for Scientific Research (KAKENHI, nos. 20591573, 22390262, and 23390329) from the Ministry of Education, Science, Sports, Culture and Technology of Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bear HD, 2006, J CLIN ONCOL, V24, P2019, DOI 10.1200/JCO.2005.04.1665; Bear HD, 2003, J CLIN ONCOL, V21, P4165, DOI 10.1200/JCO.2003.12.005; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chollet P, 2002, BRIT J CANCER, V86, P1041, DOI 10.1038/sj/bjc/6600210; Chuthapisith S, 2006, SURG-J R COLL SURG E, V4, P211, DOI 10.1016/S1479-666X(06)80062-4; Colleoni M, 2004, CLIN CANCER RES, V10, P6622, DOI 10.1158/1078-0432.CCR-04-0380; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Deng S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010277; Estevez LG, 2003, CLIN CANCER RES, V9, P686; Evans TRJ, 2005, J CLIN ONCOL, V23, P2988, DOI 10.1200/JCO.2005.06.156; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Fisher B, 1997, J CLIN ONCOL, V15, P2483, DOI 10.1200/JCO.1997.15.7.2483; Fisher CS, 2012, ANN SURG ONCOL, V19, P253, DOI 10.1245/s10434-011-1877-y; Ghods AJ, 2007, STEM CELLS, V25, P1645, DOI 10.1634/stemcells.2006-0624; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Horiguchi Kazumi, 2010, Journal of Medical and Dental Sciences, V57, P165; Jones RL, 2006, LANCET ONCOL, V7, P869, DOI 10.1016/S1470-2045(06)70906-8; Kai K, 2010, BREAST CANCER-TOKYO, V17, P80, DOI 10.1007/s12282-009-0176-y; Kurosumi M, 2008, BREAST CANCER-TOKYO, V15, P5, DOI 10.1007/s12282-007-0016-x; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu Q, 2009, CHINESE MED J-PEKING, V122, P2763, DOI 10.3760/cma.j.issn.0366-6999.2009.22.017; Lorico A, 2011, J ONCOL, V2011, DOI 10.1155/2011/135039; Mayer EL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1755; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Neuzil J, 2007, BIOCHEM BIOPH RES CO, V355, P855, DOI 10.1016/j.bbrc.2007.01.159; Nishimura R, 2010, BREAST CANCER-TOKYO, V17, P269, DOI 10.1007/s12282-009-0161-5; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Resetkova E, 2010, BREAST CANCER RES TR, V123, P97, DOI 10.1007/s10549-009-0619-3; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rody A, 2007, BREAST, V16, P86, DOI 10.1016/j.breast.2006.06.008; Ross JS, 2005, ADV CLIN CHEM, V40, P99, DOI 10.1016/S0065-2423(05)40003-7; Sachelarie I, 2006, ONCOLOGIST, V11, P574, DOI 10.1634/theoncologist.11-6-574; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Singletary S Eva, 2003, Semin Surg Oncol, V21, P53, DOI 10.1002/ssu.10021; Smith IC, 2002, J CLIN ONCOL, V20, P1456, DOI 10.1200/JCO.20.6.1456; Smith LM, 2008, BRIT J CANCER, V99, P100, DOI 10.1038/sj.bjc.6604437; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Tanei T, 2009, CLIN CANCER RES, V15, P4234, DOI 10.1158/1078-0432.CCR-08-1479; Tang C, 2007, FASEB J, V21, P3777, DOI 10.1096/fj.07-8560rev; Toi M, 2008, BREAST CANCER RES TR, V110, P531, DOI 10.1007/s10549-007-9744-z; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wolmark N, 2001, J Natl Cancer Inst Monogr, P96; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Xiao Y, 2008, AM J PATHOL, V173, P561, DOI 10.2353/ajpath.2008.071214; Zhao P, 2011, CANCER SCI, V102, P1107, DOI 10.1111/j.1349-7006.2011.01894.x	52	43	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45865	10.1371/journal.pone.0045865	http://dx.doi.org/10.1371/journal.pone.0045865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049880	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100093
J	D'Amato, NC; Ostrander, JH; Bowie, ML; Sistrunk, C; Borowsky, A; Cardiff, RD; Bell, K; Young, LJT; Simin, K; Bachelder, RE; Delrow, J; Dawson, A; Yee, LD; Mrozek, K; Clay, TM; Osada, T; Seewaldt, VL				D'Amato, Nicholas C.; Ostrander, Julie H.; Bowie, Michelle L.; Sistrunk, Christopher; Borowsky, Alexander; Cardiff, Robert D.; Bell, Katie; Young, Lawrence J. T.; Simin, Karl; Bachelder, Robin E.; Delrow, Jeff; Dawson, Alyssa; Yee, Lisa D.; Mrozek, Krzysztof; Clay, Timothy M.; Osada, Takuya; Seewaldt, Victoria L.			Evidence for Phenotypic Plasticity in Aggressive Triple-Negative Breast Cancer: Human Biology Is Recapitulated by a Novel Model System	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION PATTERNS; E-CADHERIN EXPRESSION; TUMOR PROGRESSION; CELL-LINES; STEM-CELLS; TRANSCRIPTIONAL REPRESSOR; INCREASES SENSITIVITY; STEM/PROGENITOR CELLS; ESTROGEN-RECEPTOR	Breast cancers with a basal-like gene signature are primarily triple-negative, frequently metastatic, and carry a poor prognosis. Basal-like breast cancers are enriched for markers of breast cancer stem cells as well as markers of epithelial-mesenchymal transition (EMT). While EMT is generally thought to be important in the process of metastasis, in vivo evidence of EMT in human disease remains rare. Here we report a novel model of human triple-negative breast cancer, the DKAT cell line, which was isolated from an aggressive, treatment-resistant triple-negative breast cancer that demonstrated morphological and biochemical evidence suggestive of phenotypic plasticity in the patient. The DKAT cell line displays a basal-like phenotype in vitro when cultured in serum-free media, and undergoes phenotypic changes consistent with EMT/MET in response to serum-containing media, a unique property among the breast cancer cell lines we tested. This EMT is marked by increased expression of the transcription factor Zeb1,and Zeb1 is required for the enhanced migratory ability of DKAT cells in the mesenchymal state. DKAT cells also express progenitor-cell markers, and single DKAT cells are able to generate tumorspheres containing both epithelial and mesenchymal cell types. In vivo, as few as ten DKAT cells are capable of forming xenograft tumors which display a range of epithelial and mesenchymal phenotypes. The DKAT model provides a novel model to study the molecular mechanisms regulating phenotypic plasticity and the aggressive biology of triple-negative breast cancers.	[Bowie, Michelle L.; Sistrunk, Christopher; Clay, Timothy M.; Seewaldt, Victoria L.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [D'Amato, Nicholas C.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Ostrander, Julie H.] Univ Minnesota, Dept Med, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Borowsky, Alexander; Cardiff, Robert D.; Bell, Katie; Young, Lawrence J. T.] Univ Calif Davis, Ctr Comparat Med, Davis, CA 95616 USA; [Simin, Karl] Univ Massachusetts, Dept Canc Biol, Sch Med, Worcester, MA USA; [Bachelder, Robin E.] Duke Univ, Dept Pathol, Durham, NC 27706 USA; [Delrow, Jeff; Dawson, Alyssa] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Yee, Lisa D.; Mrozek, Krzysztof] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Osada, Takuya] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Duke University; Duke University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Davis; University of Massachusetts System; University of Massachusetts Worcester; Duke University; Fred Hutchinson Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Duke University	Seewaldt, VL (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	seewa001@mc.duke.edu	Borowsky, Alexander D/S-5404-2017; Mrózek, Krzysztof/A-3142-2008	Sistrunk, Christopher/0000-0002-5951-1361	National Institutes of Health/National Cancer Institute (NIH/NCI) [CA68438-AV13, 2P30CA14236-26, R01CA88799, R01CA98441, R01CA114068]; Susan G. Komen Breast Cancer Award [BCTR061314]; V-Foundation Award; Department of Defense Breast Cancer Pre-doctoral Traineeship Award [W81XWH-08-1-0364]; NIH/NCI [P50-CA068438, U01-CA084294, U42-RR14905, P30-CA093373-01]; Kislak-Fields Family Fund; Simeon J. Fortin Charitable Foundation; CDMRP Breast Cancer Center of Excellence [W81XWH-05-1-0405]; NATIONAL CANCER INSTITUTE [R01CA155664, R01CA098441, P30CA014236, P30CA093373, U01CA084294, R01CA158668, P30CA015704, R01CA088799, P50CA068438, R01CA114068] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR014905] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute (NIH/NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen Breast Cancer Award(Susan G. Komen Breast Cancer Foundation); V-Foundation Award; Department of Defense Breast Cancer Pre-doctoral Traineeship Award(United States Department of Defense); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kislak-Fields Family Fund; Simeon J. Fortin Charitable Foundation; CDMRP Breast Cancer Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by: VLS: National Institutes of Health/National Cancer Institute (NIH/NCI) grants CA68438-AV13 [AVON/NCI Partners in Progress], 2P30CA14236-26, R01CA88799, R01CA98441, and R01CA114068 [http://www.cancer.gov/researchandfunding]; Susan G. Komen Breast Cancer Award BCTR061314 [http://ww5.komen.org/]; and V-Foundation Award [http://www.jimmyv.org/]. NCD: Department of Defense Breast Cancer Pre-doctoral Traineeship Award W81XWH-08-1-0364 [http://cdmrp.army.mil/bcrp/] TMC: NIH/NCI grant P50-CA068438 [http://www.cancer.gov/researchandfunding]; The Kislak-Fields Family Fund [http://www.kislakrealty.com/celebrating.html]. KS: Simeon J. Fortin Charitable Foundation. RDC: NIH/NCI grants U01-CA084294, U42-RR14905, P30-CA093373-01, and CDMRP Breast Cancer Center of Excellence W81XWH-05-1-0405 [http://www.cancer.gov/researchandfunding]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Aghdassi A, 2012, GUT, V61, P439, DOI 10.1136/gutjnl-2011-300060; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Bachman KE, 2004, CANCER BIOL THER, V3, P772, DOI 10.4161/cbt.3.8.994; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; BURDSAL CA, 1993, DEVELOPMENT, V118, P829; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; Chao YL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-179; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dong P, 2007, CLIN EXP METASTAS, V24, P471, DOI 10.1007/s10585-007-9084-8; Dontu G, 2004, TRENDS ENDOCRIN MET, V15, P193, DOI 10.1016/j.tem.2004.05.011; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Long XH, 2006, J BIOL CHEM, V281, P9607, DOI 10.1074/jbc.M510809200; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mrozek K, 2002, GENE CHROMOSOME CANC, V34, P137, DOI 10.1002/gcc.10027; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; SEEWALDT VL, 1995, CELL GROWTH DIFFER, V6, P1077; Seewaldt VL, 2001, J CELL BIOL, V155, P471, DOI 10.1083/jcb.200011001; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Wang CS, 2000, CANCER GENET CYTOGEN, V120, P58, DOI 10.1016/S0165-4608(99)00253-8; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009	47	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45684	10.1371/journal.pone.0045684	http://dx.doi.org/10.1371/journal.pone.0045684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049838	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100068
J	Harkin, B; Miellet, S; Kessler, K				Harkin, Ben; Miellet, Sebastien; Kessler, Klaus			What Checkers Actually Check: An Eye Tracking Study of Inhibitory Control and Working Memory	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; ANTERIOR CINGULATE CORTEX; COGNITIVE DEFICITS; PANIC DISORDER; ATTENTION; CONFLICT; UNCERTAINTY; DYSFUNCTION; ACTIVATION; TESTS	Background: Not only is compulsive checking the most common symptom in Obsessive Compulsive Disorder (OCD) with an estimated prevalence of 50-80% in patients, but approximately similar to 15% of the general population reveal subclinical checking tendencies that impact negatively on their performance in daily activities. Therefore, it is critical to understand how checking affects attention and memory in clinical as well as subclinical checkers. Eye fixations are commonly used as indicators for the distribution of attention but research in OCD has revealed mixed results at best. Methodology/Principal Finding: Here we report atypical eye movement patterns in subclinical checkers during an ecologically valid working memory (WM) manipulation. Our key manipulation was to present an intermediate probe during the delay period of the memory task, explicitly asking for the location of a letter, which, however, had not been part of the encoding set (i.e., misleading participants). Using eye movement measures we now provide evidence that high checkers' inhibitory impairments for misleading information results in them checking the contents of WM in an atypical manner. Checkers fixate more often and for longer when misleading information is presented than non-checkers. Specifically, checkers spend more time checking stimulus locations as well as locations that had actually been empty during encoding. Conclusions/Significance: We conclude that these atypical eye movement patterns directly reflect internal checking of memory contents and we discuss the implications of our findings for the interpretation of behavioural and neuropsychological data. In addition our results highlight the importance of ecologically valid methodology for revealing the impact of detrimental attention and memory checking on eye movement patterns.	[Harkin, Ben; Kessler, Klaus] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Miellet, Sebastien] Univ Fribourg, CH-1700 Fribourg, Switzerland	University of Glasgow; University of Fribourg	Kessler, K (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	k.kessler@psy.gla.ac.uk	Miellet, Sebastien/AFL-6215-2022	Miellet, Sebastien/0000-0002-3519-033X; Harkin, Ben/0000-0002-1446-9673; Kessler, Klaus/0000-0001-7307-9539	University of Glasgow PhD scholarship; Medical Research Council [MR/J001953/1]	University of Glasgow PhD scholarship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	BH was funded by a University of Glasgow PhD scholarship. The research was further supported by the Medical Research Council in the form of a grant to KK (MR/J001953/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolado GM, 2011, BEHAV RES THER, V49, P42, DOI 10.1016/j.brat.2010.10.001; Altmann GTM, 2004, COGNITION, V93, pB79, DOI 10.1016/j.cognition.2004.02.005; Antony MM, 1998, OBSESSIVE-COMPULSIVE DISORDER, P3; Ashbaugh AR, 2007, COGNITIVE THER RES, V31, P291, DOI 10.1007/s10608-006-9087-9; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Boldrini M, 2005, ACTA PSYCHIAT SCAND, V111, P150, DOI 10.1111/j.1600-0447.2004.00247.x; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Ciesielski KT, 2007, HUM BRAIN MAPP, V28, P1401, DOI 10.1002/hbm.20365; Ciesielski KT, 2011, CLIN NEUROPHYSIOL, V122, P107, DOI 10.1016/j.clinph.2010.05.027; Ciesielski KT, 2005, NEUROIMAGE, V24, P1180, DOI 10.1016/j.neuroimage.2004.10.018; Crawford H, 1995, 8 INT S AV PSYCH; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Dek ECP, 2010, BEHAV RES THER, V48, P580, DOI 10.1016/j.brat.2010.03.009; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gooding DC, 2008, BRAIN COGNITION, V68, P371, DOI 10.1016/j.bandc.2008.08.024; Hajcak G, 2002, PSYCHIAT RES, V110, P63, DOI 10.1016/S0165-1781(02)00034-3; Harkin B, 2011, CLIN PSYCHOL REV, V31, P1004, DOI 10.1016/j.cpr.2011.06.004; Harkin B, 2011, FRONT PSYCHOL, V2, DOI [10.3389/fpsyg.2011.00078, 10.3389/fpsyt.2011.00037]; Harkin B, 2011, APPL COGNITIVE PSYCH, V25, P219, DOI 10.1002/acp.1666; Harkin B, 2009, BEHAV RES THER, V47, P504, DOI 10.1016/j.brat.2009.03.002; Harkin BL, 2008, BEHAV RES THER, V46, P861, DOI 10.1016/j.brat.2008.03.009; HENDERSON JG, 1988, J CLIN PSYCHOL, V44, P747, DOI 10.1002/1097-4679(198809)44:5<747::AID-JCLP2270440513>3.0.CO;2-2; Henseler I, 2008, J PSYCHIATR NEUROSCI, V33, P209; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Jaafari N, 2011, ACTA PSYCHIAT SCAND, V124, P87, DOI 10.1111/j.1600-0447.2011.01721.x; Klimesch W, 2001, CLIN NEUROPHYSIOL, V112, P1186, DOI 10.1016/S1388-2457(01)00543-0; Koch K, 2012, NEUROPSYCHOLOGIA, V50, P958, DOI 10.1016/j.neuropsychologia.2012.02.002; KOJIMA T, 1992, SCHIZOPHRENIA BULL, V18, P85, DOI 10.1093/schbul/18.1.85; Kyrios M, 1999, 33 C ASS ADV BEH THE; Lind C, 2009, J ANXIETY DISORD, V23, P1047, DOI 10.1016/j.janxdis.2009.07.005; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; MacLeod C, 2007, INHIBITION COGNITION; Mataix-Cols D, 1999, BIOL PSYCHIAT, V45, P898, DOI 10.1016/S0006-3223(98)00260-1; MataixCols D, 1997, PSYCHIAT RES, V72, P115, DOI 10.1016/S0165-1781(97)00074-7; Morein-Zamir S, 2010, PSYCHOPHARMACOLOGY, V212, P357, DOI 10.1007/s00213-010-1963-z; Moritz Steffen, 2003, Cogn Neuropsychiatry, V8, P261; Muller J, 2005, J ANXIETY DISORD, V19, P1, DOI 10.1016/j.janxdis.2003.12.001; Najmi S, 2010, J ABNORM PSYCHOL, V119, P136, DOI 10.1037/a0017549; Nakao T, 2009, J PSYCHIATR RES, V43, P784, DOI 10.1016/j.jpsychires.2008.10.013; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P1243, DOI 10.1037/0096-1523.32.5.1243; Olley A, 2007, J AFFECT DISORDERS, V104, P15, DOI 10.1016/j.jad.2007.02.023; Omori IM, 2007, J PSYCHIATR RES, V41, P776, DOI 10.1016/j.jpsychires.2006.05.005; Purcell R, 1998, ARCH GEN PSYCHIAT, V55, P415, DOI 10.1001/archpsyc.55.5.415; Purcell R, 1998, BIOL PSYCHIAT, V43, P348, DOI 10.1016/S0006-3223(97)00201-1; Radomsky AS, 2010, J BEHAV THER EXP PSY, V41, P345, DOI 10.1016/j.jbtep.2010.03.005; RASMUSSEN SA, 1988, PSYCHOPHARMACOL BULL, V24, P466; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rotge JY, 2007, EUR NEUROPSYCHOPHARM, V17, pS300, DOI 10.1016/S0924-977X(07)70424-8; Schmidt BK, 2002, PERCEPT PSYCHOPHYS, V64, P754, DOI 10.3758/BF03194742; Stein MB, 1997, AM J PSYCHIAT, V154, P1120; Sweeney JA, 2002, PROG BRAIN RES, V140, P507; Tallis F, 1999, BEHAV RES THER, V37, P161, DOI 10.1016/S0005-7967(98)00075-8; Theeuwes J, 2009, ACTA PSYCHOL, V132, P106, DOI 10.1016/j.actpsy.2009.01.005; Thordarson DS, 2004, BEHAV RES THER, V42, P1289, DOI 10.1016/j.brat.2003.08.007; Tolin DF, 2003, J ANXIETY DISORD, V17, P233, DOI 10.1016/S0887-6185(02)00182-2; Ursu S, 2003, PSYCHOL SCI, V14, P347, DOI 10.1111/1467-9280.24411; van den Hout M, 2004, J BEHAV THER EXP PSY, V35, P165, DOI 10.1016/j.jbtep.2004.04.007; van den Hout M, 2003, BEHAV RES THER, V41, P301, DOI 10.1016/S00005-7967(02)00012-8; van den Hout M, 2003, BEHAV RES THER, V41, P369, DOI 10.1016/S0005-7967(02)00097-9; van den Hout MA, 2009, BEHAV RES THER, V47, P535, DOI 10.1016/j.brat.2009.03.001; van den Hout MA, 2008, BEHAV RES THER, V46, P1300, DOI 10.1016/j.brat.2008.09.002; van der Wee NJA, 2003, NEUROIMAGE, V20, P2271, DOI 10.1016/j.neuroimage.2003.05.001; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Veale DM, 1996, PSYCHOL MED, V26, P1261, DOI 10.1017/S0033291700035984; WELLS A, 1990, BEHAV THER, V21, P273, DOI 10.1016/S0005-7894(05)80330-2; Wells A., 2000, EMOTIONAL DISORDERS, DOI DOI 10.1017/S0033291702225702; Woods CM, 2002, CLIN PSYCHOL-SCI PR, V9, P353, DOI 10.1093/clipsy/9.4.353; Zielinski CM, 1991, NEUROPSY NEUROPSY BE, V4, P110; Zitterl W, 2001, PSYCHOPATHOLOGY, V34, P113, DOI 10.1159/000049292	73	13	13	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44689	10.1371/journal.pone.0044689	http://dx.doi.org/10.1371/journal.pone.0044689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049755	Green Accepted, Green Published, gold			2022-12-27	WOS:000309556100020
J	He, XW; Knepper, M; Ding, C; Li, J; Castro, S; Siddiqui, M; Schachner, M				He, Xiaowen; Knepper, Michael; Ding, Cheng; Li, Jun; Castro, Suita; Siddiqui, Maham; Schachner, Melitta			Promotion of Spinal Cord Regeneration by Neural Stem Cell-Secreted Trimerized Cell Adhesion Molecule L1	PLOS ONE			English	Article							NEURITE OUTGROWTH; FUNCTIONAL RECOVERY; IMMUNOGLOBULIN SUPERFAMILY; RECOGNITION MOLECULES; COMPRESSION INJURY; MICE; EXPRESSION; MIGRATION; NEURONS; BINDING	The L1 cell adhesion molecule promotes neurite outgrowth and neuronal survival in homophilic and heterophilic interactions and enhances neurite outgrowth and neuronal survival homophilically, i.e. by self binding. We investigated whether exploitation of homophilic and possibly also heterophilic mechanisms of neural stem cells overexpressing the full-length transmembrane L1 and a secreted trimer engineered to express its extracellular domain would be more beneficial for functional recovery of the compression injured spinal cord of adult mice than stem cells overexpressing only full-length L1 or the parental, non-engineered cells. Here we report that stem cells expressing trimeric and full-length L1 are indeed more efficient in promoting locomotor recovery when compared to stem cells overexpressing only full-length L1 or the parental stem cells. The trimer expressing stem cells were also more efficient in reducing glial scar volume and expression of chondroitin sulfates and the chondroitin sulfate proteoglycan NG2. They were also more efficient in enhancing regrowth/sprouting and/ or preservation of serotonergic axons, and remyelination and/or myelin sparing. Moreover, degeneration/dying back of corticospinal cord axons was prevented more by the trimer expressing stem cells. These results encourage the view that stem cells engineered to drive the beneficial functions of L1 via homophilic and heterophilic interactions are functionally optimized and may thus be of therapeutic value.	[He, Xiaowen; Ding, Cheng; Li, Jun; Castro, Suita; Siddiqui, Maham; Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, New Brunswick, NJ 08903 USA; [He, Xiaowen; Ding, Cheng; Li, Jun; Castro, Suita; Siddiqui, Maham; Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, New Brunswick, NJ 08903 USA; [Knepper, Michael] Univ Hamburg, Univ Krankenhaus Hamburg Eppendorf, Zentrum Mol Neurobiol, Hamburg, Germany; [Schachner, Melitta] Shantou Univ, Coll Med, Ctr Neurosci, Shantou, Peoples R China	Rutgers State University New Brunswick; Rutgers State University New Brunswick; University of Hamburg; University Medical Center Hamburg-Eppendorf; Shantou University	Schachner, M (corresponding author), Rutgers State Univ, Keck Ctr Collaborat Neurosci, New Brunswick, NJ 08903 USA.	schachner@stu.edu.cn			New Jersey Commission on Spinal Cord Research, "Endowed Chair for Melitta Schachner, New Jersey Professor of Spinal Cord Research"	New Jersey Commission on Spinal Cord Research, "Endowed Chair for Melitta Schachner, New Jersey Professor of Spinal Cord Research"	A grant from the New Jersey Commission on Spinal Cord Research, "Endowed Chair for Melitta Schachner, New Jersey Professor of Spinal Cord Research" (http://www.state.nj.us/health/spinalcord/). The grant covers the cost of the experimental material and animals. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolova I, 2006, J NEUROSCI, V26, P7849, DOI 10.1523/JNEUROSCI.1526-06.2006; APPEL F, 1993, J NEUROSCI, V13, P4764; Barbin G, 2004, NEURON GLIA BIOL, V1, P65, DOI 10.1017/s1740925x04000092; Barritt AW, 2006, J NEUROSCI, V26, P10856, DOI 10.1523/JNEUROSCI.2980-06.2006; Bernreuther C, 2006, J NEUROSCI, V26, P11532, DOI 10.1523/JNEUROSCI.2688-06.2006; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Castellani V, 2002, ADV EXP MED BIOL, V515, P91; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Chen J, 2005, EUR J NEUROSCI, V22, P1895, DOI 10.1111/j.1460-9568.2005.04348.x; Chen J, 2005, J NEUROTRAUM, V22, P896, DOI 10.1089/neu.2005.22.896; Chen J, 2007, BRAIN, V130, P954, DOI 10.1093/brain/awm049; Chen JA, 2010, MOL THER, V18, P1769, DOI 10.1038/mt.2010.133; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Cui YF, 2010, BRAIN, V133, P189, DOI 10.1093/brain/awp290; CURTIS R, 1993, J NEUROCYTOL, V22, P51, DOI 10.1007/BF01183975; Dihne M, 2003, J NEUROSCI, V23, P6638; Dihne M, 2006, STEM CELLS, V24, P1458, DOI 10.1634/stemcells.2005-0413; Engesser-Cesar C, 2005, J NEUROTRAUM, V22, P157, DOI 10.1089/neu.2005.22.157; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Guseva D, 2009, BRAIN, V132, P2180, DOI 10.1093/brain/awp160; Hall H, 2000, J NEUROCHEM, V75, P336, DOI 10.1046/j.1471-4159.2000.0750336.x; Haney CA, 1999, J CELL BIOL, V146, P1173, DOI 10.1083/jcb.146.5.1173; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kleene R, 2001, J BIOL CHEM, V276, P21656, DOI 10.1074/jbc.M101790200; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LEMMON V, 1989, NEURON, V2, P1597, DOI 10.1016/0896-6273(89)90048-2; Loers G, 2005, J NEUROCHEM, V92, P1463, DOI 10.1111/j.1471-4159.2004.02983.x; Loers G, 2007, J NEUROCHEM, V101, P865, DOI 10.1111/j.1471-4159.2006.04409.x; Loers G, 2012, J NEUROSCI, V32, P3917, DOI 10.1523/JNEUROSCI.6165-11.2012; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MORI M, 1990, J COMP NEUROL, V299, P167, DOI 10.1002/cne.902990204; Nagaraj K, 2006, TRENDS BIOCHEM SCI, V31, P544, DOI 10.1016/j.tibs.2006.07.010; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; RATHJEN FG, 1984, EMBO J, V3, P1; Roonprapunt C, 2003, J NEUROTRAUM, V20, P871, DOI 10.1089/089771503322385809; SEILHEIMER B, 1989, J CELL BIOL, V108, P1909, DOI 10.1083/jcb.108.5.1909; Thelen K, 2002, J NEUROSCI, V22, P4918, DOI 10.1523/JNEUROSCI.22-12-04918.2002; WOOD P, 1990, ANN NY ACAD SCI, V605, P1, DOI 10.1111/j.1749-6632.1990.tb42376.x; Xu G, 2004, NEUROREPORT, V15, P2167, DOI 10.1097/00001756-200410050-00004; Zhang Y, 2008, RESTOR NEUROL NEUROS, V26, P81	41	20	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46223	10.1371/journal.pone.0046223	http://dx.doi.org/10.1371/journal.pone.0046223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049984	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100157
J	Orban, JC; Cattet, F; Lefrant, JY; Leone, M; Jaber, S; Constantin, JM; Allaouchiche, B; Ichai, C				Orban, Jean-Christophe; Cattet, Florian; Lefrant, Jean-Yves; Leone, Marc; Jaber, Samir; Constantin, Jean-Michel; Allaouchiche, Bernard; Ichai, Carole		AzuRea Grp	The Practice of Therapeutic Hypothermia after Cardiac Arrest in France: A National Survey	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; CARDIOPULMONARY-RESUSCITATION; COMATOSE SURVIVORS; CLINICAL-PRACTICE; GUIDELINES; IMPLEMENTATION; INTERVENTION; PHYSICIANS; IMPROVE	Aims: Cardiac arrest is a major health concern worldwide accounting for 375,000 cases per year in Europe with a survival rate of <10%. Therapeutic hypothermia has been shown to improve patients' neurological outcome and is recommended by scientific societies. Despite these guidelines, different surveys report a heterogeneous application of this treatment. The aim of the present study was to evaluate the clinical practice of therapeutic hypothermia in cardiac arrest patients. Methods: This self-declarative web based survey was proposed to all registered French adult intensive care units (ICUs) (n = 357). Paediatrics and neurosurgery ICUs were excluded. The different questions addressed the structure, the practical modalities of therapeutic hypothermia and the use of prognostic factors in patients admitted after cardiac arrest. Results: One hundred and thirty-two out of 357 ICUs (37%) answered the questionnaire. Adherence to recommendations regarding the targeted temperature and hypothermia duration were 98% and 94% respectively. Both guidelines were followed in 92% ICUs. During therapeutic hypothermia, sedative drugs were given in 99% ICUs, mostly midazolam (77%) and sufentanil (59%). Neuromuscular blocking agents (NMBA) were used in 97% ICUs, mainly cisatracurium (77%). Numerous prognostic factors were used after cardiac arrest such as clinical factors (95%), biomarkers (53%), electroencephalography (78%) and evoked potentials (35%). Conclusions: In France, adherence to recommendations for therapeutic hypothermia after cardiac arrest is higher than those previously reported in other countries. Numerous prognostic factors are widely used even if their reliability remains controversial.	[Orban, Jean-Christophe; Cattet, Florian; Ichai, Carole] Ctr Hosp Univ Nice, Hop St Roch, Nice, France; [Orban, Jean-Christophe; Ichai, Carole] Univ Nice, Fac Med, IRCAN, Nice, France; [Lefrant, Jean-Yves] Ctr Hosp Univ Nimes, Div Anesthesie Reanimat Douleur Urgences, Nimes, France; [Leone, Marc] Hop Nord Marseille, Serv Anesthesie & Reanimat, Marseille, France; [Jaber, Samir] CHU Montpellier, Dept Anesthesie & Reanimat, Montpellier, France; [Constantin, Jean-Michel] Ctr Hosp Univ Clermont Ferrand, Unite Soins Intensifs, Clermont Ferrand, France; [Allaouchiche, Bernard] Hosp Civils Lyon, Hop Edouard Herriot, Dept Anesthesie Reanimat, Lyon, France	CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Universite de Montpellier; CHU de Nimes; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite de Montpellier; CHU de Montpellier; CHU Clermont Ferrand; CHU Lyon	Orban, JC (corresponding author), Ctr Hosp Univ Nice, Hop St Roch, Nice, France.	orban.jc@chu-nice.fr	Leone, Marc/P-4835-2016	Leone, Marc/0000-0002-3097-758X				Abella BS, 2005, RESUSCITATION, V64, P181, DOI 10.1016/j.resuscitation.2004.09.014; Base S, 2011, PROSTAG LEUKOTR ESS, V84, P123, DOI 10.1016/j.plefa.2010.11.006; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bianchin A, 2009, MINERVA ANESTESIOL, V75, P357; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Chamorro C, 2010, ANESTH ANALG, V110, P1328, DOI 10.1213/ANE.0b013e3181d8cacf; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; Deye N, 2010, RESUSCITATION, V81, pS3; Dumas F, 2011, CIRCULATION, V123, P877, DOI 10.1161/CIRCULATIONAHA.110.987347; Empey PE, 2012, CRIT CARE MED, V40, P1221, DOI 10.1097/CCM.0b013e31823779f9; Fugate JE, 2011, NEUROLOGY, V77, P1346, DOI 10.1212/WNL.0b013e318231527d; Gillies MA, 2010, RESUSCITATION, V81, P1117, DOI 10.1016/j.resuscitation.2010.05.001; Grasner JT, 2011, CRIT CARE, V15, DOI 10.1186/cc10035; Gueugniaud PY, 2008, NEW ENGL J MED, V359, P21, DOI 10.1056/NEJMoa0706873; Hachimi-Idrissi S, 2001, RESUSCITATION, V51, P275, DOI 10.1016/S0300-9572(01)00412-9; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kalhan R, 2006, CRIT CARE MED, V34, P300, DOI 10.1097/01.CCM.0000198328.83571.4A; Kim JJ, 2011, AM J EMERG MED, V29, P148, DOI 10.1016/j.ajem.2009.08.021; Laver SR, 2006, ANAESTHESIA, V61, P873, DOI 10.1111/j.1365-2044.2006.04552.x; Lefrant JY, 2010, ANN FR ANESTH, V29, P621, DOI 10.1016/j.annfar.2010.04.007; Merchant RM, 2006, CRIT CARE MED, V34, P1935, DOI 10.1097/01.CCM.0000220494.90290.92; Nolan JP, 2007, ANAESTHESIA, V62, P1207, DOI 10.1111/j.1365-2044.2007.05232.x; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Oddo M, 2006, CRIT CARE MED, V34, P1865, DOI 10.1097/01.CCM.0000221922.08878.49; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Rossetti AO, 2010, ANN NEUROL, V67, P301, DOI 10.1002/ana.21984; Seguin R, 2004, CAN FAM PHYSICIAN, V50, P414; Tomte O, 2011, CRIT CARE MED, V39, P443, DOI 10.1097/CCM.0b013e318206b80f; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Wolfrum S, 2007, RESUSCITATION, V72, P207, DOI 10.1016/j.resuscitation.2006.06.033	31	21	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45284	10.1371/journal.pone.0045284	http://dx.doi.org/10.1371/journal.pone.0045284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049783	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100037
J	Ramey, AM; Ely, CR; Schmutz, JA; Pearce, JM; Heard, DJ				Ramey, Andrew M.; Ely, Craig R.; Schmutz, Joel A.; Pearce, John M.; Heard, Darryl J.			Molecular Detection of Hematozoa Infections in Tundra Swans Relative to Migration Patterns and Ecological Conditions at Breeding Grounds	PLOS ONE			English	Article							CYGNUS-COLUMBIANUS-COLUMBIANUS; YUKON-KUSKOKWIM DELTA; BLOOD PARASITES; LEUCOCYTOZOON-SIMONDI; BEHAVIOR; MALARIA; ALASKA; ADULT; GEESE; BIRDS	Tundra swans (Cygnus columbianus) are broadly distributed in North America, use a wide variety of habitats, and exhibit diverse migration strategies. We investigated patterns of hematozoa infection in three populations of tundra swans that breed in Alaska using satellite tracking to infer host movement and molecular techniques to assess the prevalence and genetic diversity of parasites. We evaluated whether migratory patterns and environmental conditions at breeding areas explain the prevalence of blood parasites in migratory birds by contrasting the fit of competing models formulated in an occupancy modeling framework and calculating the detection probability of the top model using Akaike Information Criterion (AIC). We described genetic diversity of blood parasites in each population of swans by calculating the number of unique parasite haplotypes observed. Blood parasite infection was significantly different between populations of Alaska tundra swans, with the highest estimated prevalence occurring among birds occupying breeding areas with lower mean daily wind speeds and higher daily summer temperatures. Models including covariates of wind speed and temperature during summer months at breeding grounds better predicted hematozoa prevalence than those that included annual migration distance or duration. Genetic diversity of blood parasites in populations of tundra swans appeared to be relative to hematozoa prevalence. Our results suggest ecological conditions at breeding grounds may explain differences of hematozoa infection among populations of tundra swans that breed in Alaska.	[Ramey, Andrew M.; Ely, Craig R.; Schmutz, Joel A.; Pearce, John M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Heard, Darryl J.] Univ Florida, Coll Vet Med, Gainesville, FL USA	United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida	Ramey, AM (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA.	aramey@usgs.gov		Ramey, Andrew/0000-0002-3601-8400	U.S. Geological Survey through the Alaska Science Center's Changing Arctic Ecosystems Initiative and Avian Disease Research Program; U.S. Fish and Wildlife Service through the Avian Influenza Surveillance Program	U.S. Geological Survey through the Alaska Science Center's Changing Arctic Ecosystems Initiative and Avian Disease Research Program; U.S. Fish and Wildlife Service through the Avian Influenza Surveillance Program	This work was funded by the U.S. Geological Survey through the Alaska Science Center's Changing Arctic Ecosystems Initiative and Avian Disease Research Program, and by the U.S. Fish and Wildlife Service through the Avian Influenza Surveillance Program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Agresti A., 1990, CATEGORICAL DATA ANA; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barnard WH, 2010, CONDOR, V112, P849, DOI 10.1525/cond.2010.100143; Bellrose F, 1980, DUCKS GEESE SWANS N; BENNETT GF, 1982, J WILDLIFE DIS, V18, P287, DOI 10.7589/0090-3558-18.3.287; BENNETT GF, 1972, CAN J ZOOLOG, V50, P1, DOI 10.1139/z72-001; BENNETT GF, 1992, CONDOR, V94, P289, DOI 10.2307/1368821; BENNETT GF, 1981, J WILDLIFE DIS, V17, P213, DOI 10.7589/0090-3558-17.2.213; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CLS (Collecte Localisation Satellites), 2016, ARG US MAN; Cosgrove CL, 2006, J PARASITOL, V92, P1362, DOI 10.1645/GE-879R.1; Dau CP, 2002, WATERBIRDS, V25, P241; Deviche P, 2001, J WILDLIFE DIS, V37, P28, DOI 10.7589/0090-3558-37.1.28; Douglas D., 2006, DOUGLAS ARGOS FILTER; EIDE A, 1972, J PROTOZOOL, V19, P414, DOI 10.1111/j.1550-7408.1972.tb03494.x; Ely CR, 1997, WILSON BULL, V109, P679; Engstrom H, 2000, WATERBIRDS, V23, P486, DOI 10.2307/1522187; Figuerola J, 2000, EVOL ECOL, V14, P143, DOI 10.1023/A:1011009419264; Gjullin CM, 1961, USDA HDB, V182; GREINER EC, 1975, CAN J ZOOL, V53, P1762, DOI 10.1139/z75-211; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hollmen TE, 1998, CONDOR, V100, P402, DOI 10.2307/1370286; Jenkins T, 2012, EVOLUTION, V66, P740, DOI 10.1111/j.1558-5646.2011.01470.x; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; KLEI T R, 1975, Journal of Wildlife Diseases, V11, P130; LAIRD M, 1961, CAN J ZOOLOG, V39, P209, DOI 10.1139/z61-025; Limpert Roland J., 1991, Wildfowl, P78; MacKenzie D. I., 2006, OCCUPANCY ESTIMATION; Moermond Jack E., 1997, Wildfowl, V48, P16; MONDA MJ, 1994, J WILDLIFE MANAGE, V58, P757, DOI 10.2307/3809691; National Oceanic and Atmospheric Administration, NNDC CLIM DAT ONL; NICHOLS JD, 1992, J WILDLIFE MANAGE, V56, P485, DOI 10.2307/3808863; NOBLET R, 1975, J MED ENTOMOL, V12, P111, DOI 10.1093/jmedent/12.1.111; Petrie SA, 2003, CAN J ZOOL, V81, P861, DOI 10.1139/Z03-063; Rambaut A, 2007, FIGTREE V1 0; Richmond OMW, 2010, ECOL APPL, V20, P2036, DOI 10.1890/09-0470.1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SERVICE MW, 1980, INT J BIOMETEOROL, V24, P347, DOI 10.1007/BF02250577; SLADEN W J L, 1973, Wildfowl, V24, P8; Sokal R. R., 1981, BIOMETRY PRINCIPLES; Stickney AA, 2002, WATERBIRDS, V25, P227; SUPER PE, 1995, J WILDLIFE DIS, V31, P447, DOI 10.7589/0090-3558-31.4.447; Szymanski MM, 2005, J PARASITOL, V91, P768, DOI 10.1645/GE-417R1.1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valki<umacron>nas G, 2005, AVIAN MALARIA PARASI; Valkiunas G, 2001, J PARASITOL, V87, P930, DOI 10.1645/0022-3395(2001)087[0930:ACOTBP]2.0.CO;2; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WILK RJ, 1988, ARCTIC, V41, P288; Wilkins Khristi A., 2010, Wildfowl, V60, P20	50	30	32	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45789	10.1371/journal.pone.0045789	http://dx.doi.org/10.1371/journal.pone.0045789			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049862	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100080
J	Trott, AR; Donelson, NC; Griffith, LC; Ejima, A				Trott, Alexander R.; Donelson, Nathan C.; Griffith, Leslie C.; Ejima, Aki			Song Choice Is Modulated by Female Movement in Drosophila Males	PLOS ONE			English	Article							COURTSHIP SONG; NEURAL CIRCUITRY; MELANOGASTER; BEHAVIOR; STIMULI; NEUROBIOLOGY; EVOLUTION; OLFACTION; NEURONS; CUES	Mate selection is critical to ensuring the survival of a species. In the fruit fly, Drosophila melanogaster, genetic and anatomical studies have focused on mate recognition and courtship initiation for decades. This model system has proven to be highly amenable for the study of neural systems controlling the decision making process. However, much less is known about how courtship quality is regulated in a temporally dynamic manner in males and how a female assesses male performance as she makes her decision of whether to accept copulation. Here, we report that the courting male dynamically adjusts the relative proportions of the song components, pulse song or sine song, by assessing female locomotion. Male flies deficient for olfaction failed to perform the locomotion-dependent song modulation, indicating that olfactory cues provide essential information regarding proximity to the target female. Olfactory mutant males also showed lower copulation success when paired with wild-type females, suggesting that the male's ability to temporally control song significantly affects female mating receptivity. These results depict the consecutive inter-sex behavioral decisions, in which a male smells the close proximity of a female as an indication of her increased receptivity and accordingly coordinates his song choice, which then enhances the probability of his successful copulation.	[Ejima, Aki] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Kyoto, Japan; [Trott, Alexander R.; Donelson, Nathan C.; Griffith, Leslie C.] Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02254 USA; [Trott, Alexander R.; Donelson, Nathan C.; Griffith, Leslie C.] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA	Kyoto University; Brandeis University; Brandeis University	Ejima, A (corresponding author), Kyoto Univ, Career Path Promot Unit Young Life Scientists, Kyoto, Japan.	aki@cp.kyoto-u.ac.jp.jp		Griffith, Leslie/0000-0003-3164-9876	Hayashi Memorial Foundation for Female Natural Scientists; NOVARTIS Foundation for the Promotion of Science;  [T32 NS007292];  [R01 NS44232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER	Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists); NOVARTIS Foundation for the Promotion of Science; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	T32 NS007292 to NCD (http://grants.nih.gov/training/T_Table.htm), R01 NS44232 to LCG (http://grants.nih.gov/grants/funding/r01.htm), Grant-in-Aid for Young Scientists (A), Grant-in-Aid for Scientific Research on Innovative Areas, Grant-in-Aid for Exploratory Research to AE (http://www.jsps.go.jp/english/egrants/grants01.html), Hayashi Memorial Foundation for Female Natural Scientists to AE (http://www.smth.jp/en/) and NOVARTIS Foundation for the Promotion of Science to AE (http://novartisfound.or.jp/eng/index-e.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt S, 1998, ANIM BEHAV, V56, P87, DOI 10.1006/anbe.1998.0743; Bavelier D, 2002, NAT REV NEUROSCI, V3, P443, DOI 10.1038/nrn848; BENNETCL.HC, 1967, NATURE, V215, P669, DOI 10.1038/215669a0; Broughton SJ, 2004, CURR BIOL, V14, pR290, DOI 10.1016/j.cub.2004.03.037; Clyne JD, 2008, CELL, V133, P354, DOI 10.1016/j.cell.2008.01.050; CROSSLEY SA, 1995, ANIM BEHAV, V50, P827, DOI 10.1016/0003-3472(95)80142-1; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; EWING AW, 1979, J COMP PHYSIOL, V130, P87, DOI 10.1007/BF02582977; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; GAILEY DA, 1986, BEHAV GENET, V16, P375, DOI 10.1007/BF01071319; GERHARDT HC, 1991, ANIM BEHAV, V42, P615, DOI 10.1016/S0003-3472(05)80245-3; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Griffith LC, 2009, LEARN MEMORY, V16, P743, DOI 10.1101/lm.956309; Griffith LC, 2009, ANN NY ACAD SCI, V1170, P394, DOI 10.1111/j.1749-6632.2009.04367.x; HALL JC, 1979, GENETICS, V92, P437; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hedwig B, 2006, J COMP PHYSIOL A, V192, P677, DOI 10.1007/s00359-006-0115-8; Kelley DB, 2004, CURR OPIN NEUROBIOL, V14, P751, DOI 10.1016/j.conb.2004.10.015; Kowalski S, 2004, CAN J ZOOL, V82, P1258, DOI 10.1139/Z04-102; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lasbleiz C, 2006, ANIM BEHAV, V72, P1001, DOI 10.1016/j.anbehav.2006.01.027; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Liu LZ, 2007, GENETICS, V175, P1197, DOI 10.1534/genetics.106.068411; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Nowicki S, 2004, ANN NY ACAD SCI, V1016, P704, DOI 10.1196/annals.1298.012; ROBERTSON HM, 1983, EXPERIENTIA, V39, P333, DOI 10.1007/BF01955335; Rybak F, 2002, CAN J ZOOL, V80, P987, DOI 10.1139/Z02-082; SCHILCHER FV, 1976, ANIM BEHAV, V24, P18; SHOREY HH, 1962, SCIENCE, V137, P677, DOI 10.1126/science.137.3531.677; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tauber E, 2001, J COMP PHYSIOL A, V187, P341, DOI 10.1007/s003590100206; TRIMARCHI JR, 1994, J COMP NEUROL, V340, P427, DOI 10.1002/cne.903400311; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; VONSCHILCHER F, 1976, ANIM BEHAV, V24, P622, DOI 10.1016/S0003-3472(76)80076-0; WHEELER DA, 1988, BEHAV GENET, V18, P675, DOI 10.1007/BF01066850	38	19	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46025	10.1371/journal.pone.0046025	http://dx.doi.org/10.1371/journal.pone.0046025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049926	Green Submitted, gold, Green Published			2022-12-27	WOS:000309556100122
J	Zanetti-Domingues, LC; Martin-Fernandez, ML; Needham, SR; Rolfe, DJ; Clarke, DT				Zanetti-Domingues, Laura C.; Martin-Fernandez, Marisa L.; Needham, Sarah R.; Rolfe, Daniel J.; Clarke, David T.			A Systematic Investigation of Differential Effects of Cell Culture Substrates on the Extent of Artifacts in Single-Molecule Tracking	PLOS ONE			English	Article							BIOMATERIAL SURFACE-CHEMISTRY; BINDING AFFIBODY MOLECULE; LIPID RAFTS; FLUORESCENCE MICROSCOPY; PARTICLE TRACKING; EGF RECEPTOR; PROTEIN; MEMBRANE; ADHESION; DOMAIN	Single-molecule techniques are being increasingly applied to biomedical investigation, notwithstanding the numerous challenges they pose in terms of signal-to-noise ratio issues. Non-specific binding of probes to glass substrates, in particular, can produce experimental artifacts due to spurious molecules on glass, which can be particularly deleterious in live-cell tracking experiments. In order to resolve the issue of non-specific probe binding to substrates, we performed systematic testing of a range of available surface coatings, using three different proteins, and then extended our assessment to the ability of these coatings to foster cell growth and retain non-adhesive properties. Linear PEG, a passivating agent commonly used both in immobilized-molecule single-molecule techniques and in tissue engineering, is able to both successfully repel non-specific adhesion of fluorescent probes and to foster cell growth when functionalized with appropriate adhesive peptides. Linear PEG treatment results in a significant reduction of tracking artifacts in EGFR tracking with Affibody ligands on a cell line expressing EGFR-eGFP. The findings reported herein could be beneficial to a large number of experimental situations where single-molecule or single-particle precision is required.	[Zanetti-Domingues, Laura C.; Martin-Fernandez, Marisa L.; Needham, Sarah R.; Rolfe, Daniel J.; Clarke, David T.] Rutherford Appleton Lab, Cent Laser Facil, Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England	UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Clarke, DT (corresponding author), Rutherford Appleton Lab, Cent Laser Facil, Sci & Technol Facil Council, Res Complex Harwell, Didcot OX11 0QX, Oxon, England.	dave.clarke@stfc.ac.uk	Zanetti-Domingues, Laura Carolina/AAJ-1387-2021; Zanetti-Domingues, Laura Carolina/GWB-9443-2022	Zanetti-Domingues, Laura Carolina/0000-0003-0514-3185; Zanetti-Domingues, Laura Carolina/0000-0003-0514-3185; Rolfe, Daniel/0000-0002-8394-8395; martin-fernandez, marisa/0000-0001-5496-6300; Needham, Sarah/0000-0002-3311-1036; Clarke, David/0000-0002-8776-1341	Biotechnology and Biological Sciences Research Council [BB/G006911/1]; UK Biotechnology and Biological Sciences Research Council [BB/G006911/1]; Biotechnology and Biological Sciences Research Council [BB/G007160/1] Funding Source: researchfish; BBSRC [BB/G007160/1, BB/G006911/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/), Grant number BB/G006911/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge and thank Dr. Sarah Cartmell (Manchester X-Ray Imaging Facility) and Dr. Paul Roach (Institute for Science and Technology in Medicine, Keele University) for useful advice about biomaterials, Dr. Donna Arndt-Jovin (Max Planck Institute for Biophysical Chemistry) for the kind gift of CHO-EGFR-eGFP cells and Dr. Christopher J Tynan for critical reading of the manuscript and helpful suggestions. The authors gratefully acknowledge funding from the UK Biotechnology and Biological Sciences Research Council (BB/G006911/1).	ATTO-TEC GmbH, 2011, PROD INF ATTO 647N; Balbis A, 2010, J CELL BIOCHEM, V109, P1103, DOI 10.1002/jcb.22505; Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199; Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Clarke DT, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3635536; DENHARTIGH JC, 1992, J CELL BIOL, V119, P349, DOI 10.1083/jcb.119.2.349; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Fordyce P. M, SINGLE MOL TECHNIQUE, P431; Friedman M, 2007, PROTEIN ENG DES SEL, V20, P189, DOI 10.1093/protein/gzm011; Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029; Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785; GRAF J, 1987, BIOCHEMISTRY-US, V26, P6896, DOI 10.1021/bi00396a004; Groll J, 2005, J BIOMED MATER RES A, V74A, P607, DOI 10.1002/jbm.a.30335; Harris J. M., 1997, ACS S SERIES, V680; Heyes CD, 2004, J PHYS CHEM B, V108, P13387, DOI 10.1021/jp049057o; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; Holtzer L, 2009, SINGLE PARTICLE TRAC, P25; Hovius R, 2006, SINGLE MOL DETECTION; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1349, DOI 10.1093/oxfordjournals.jbchem.a133103; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H; Nakao A, 1987, J Biomater Appl, V2, P219, DOI 10.1177/088532828700200203; Neuman KC, 2008, NAT METHODS, V5, P491, DOI 10.1038/NMETH.1218; Nordberg E, 2007, NUCL MED BIOL, V34, P609, DOI 10.1016/j.nucmedbio.2007.05.010; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; Orr G, 2005, BIOPHYS J, V89, P1362, DOI 10.1529/biophysj.104.056192; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Qin M, 2007, COLLOID SURFACE B, V60, P243, DOI 10.1016/j.colsurfb.2007.06.018; Qu XH, 2004, P NATL ACAD SCI USA, V101, P11298, DOI 10.1073/pnas.0402155101; Rolfe DJ, 2011, EUR BIOPHYS J BIOPHY, V40, P1167, DOI 10.1007/s00249-011-0747-7; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selvin P R, 2007, SINGLE MOL TECHNIQUE; Shekaran A, 2011, BBA-GEN SUBJECTS, V1810, P350, DOI 10.1016/j.bbagen.2010.04.006; Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E; Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l; Soung YH, 2010, BMB REP, V43, P311, DOI 10.5483/BMBRep.2010.43.5.311; Taite LJ, 2008, J BIOMED MATER RES B, V84B, P108, DOI 10.1002/jbm.b.30850; Tessler LA, 2011, J R SOC INTERFACE, V8, P1400, DOI 10.1098/rsif.2010.0669; Tessler LA, 2009, ANAL CHEM, V81, P7141, DOI 10.1021/ac901068x; Tessmar JK, 2007, MACROMOL BIOSCI, V7, P23, DOI 10.1002/mabi.200600096; Wattendorf U, 2008, J PHARM SCI-US, V97, P4655, DOI 10.1002/jps.21350; Wikman M, 2004, PROTEIN ENG DES SEL, V17, P455, DOI 10.1093/protein/gzh053; Xiao ZY, 2008, BIOCHEM BIOPH RES CO, V369, P730, DOI 10.1016/j.bbrc.2008.02.084; Yao JZ, 2012, J AM CHEM SOC, V134, P3720, DOI 10.1021/ja208090p; Yildiz A, 2005, ACCOUNTS CHEM RES, V38, P574, DOI 10.1021/ar040136s; Zhong H, 2010, COLD SPRING HARBBOR, V2010; Zhu JM, 2010, BIOMATERIALS, V31, P4639, DOI 10.1016/j.biomaterials.2010.02.044	59	19	20	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45655	10.1371/journal.pone.0045655	http://dx.doi.org/10.1371/journal.pone.0045655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049831	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100064
J	Zheng, L; Liang, P; Li, J; Huang, XB; Liu, SC; Zhao, HZ; Han, KQ; Wang, Z				Zheng, Lu; Liang, Ping; Li, Jing; Huang, Xiao-bing; Liu, Shi-cheng; Zhao, Hong-zhi; Han, Ke-qiang; Wang, Zheng			ShRNA-Targeted COMMD7 Suppresses Hepatocellular Carcinoma Growth	PLOS ONE			English	Article							TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; PROGNOSTIC-FACTORS; EPIDEMIOLOGY; THERAPY; CANCER	Background: COMMD7 is a newly identified gene overexpressed in hepatocellular carcinoma (HCC) and associated with tumor invasion and poor prognosis. We aim to examine the biological function of COMMD7 in HCC by shRNA silencing. Methods: COMMD7 expressions were examined in human HCC cell lines HepG2, Huh7, Hep3B, HLE, HLF, SK-Hep-1 and PLC/PRF/5 cells. Recombinant pGenesil-COMMD7-shRNA was transfected into COMMD7-abundant HepG2 cells to silence COMMD7 expression. The effects of COMMD7 silencing on HepG2 cell proliferation in vitro and xenograft tumor growth in vivo were evaluated. Flow cytometry profiling was used to detect the presence of apoptosis in COMMD7-silenced HepG2 cells and to differentiate cell cycle distribution. Electrophoretic mobility shift assay and luciferase reporter assays to examine the activities of nuclear factor-kappaB (NF-kappa B) signaling pathways in response to tumor necrosis factor (TNF)-alpha in COMMD7-silenced HepG2 cells. Results: COMMD7 expression level was abundance in HepG2 and SK-Hep-1 cells. COMMD7 was aberrantly overexpressed in HepG2 cells, whilst pGenesil-COMMD7-shRNA exhibited a maximal inhibition rate of 75%. COMMD7 silencing significantly reduced HepG2 cell proliferation and colony formation. The knockdown of COMMD7 resulted in an increased apoptosis and cell cycle arrest at S-phase. COMMD7 knockdown also exhibited an antineoplastic effect in vivo, which manifested as tumor xenograft growth retardation. COMMD7 silencing also suppressed the responsiveness of NF-kappa B signaling pathway to the stimulation with TNF-alpha in vitro. Moreover, the similar suppressive effects of COMMD7 silence on SK-Hep-1 cells were also observed. Conclusions: COMMD7 contributes to HCC progression by reducing cell apoptosis and overcoming cell cycle arrest. The proliferative and antiapoptotic effects of COMMD7 may be mediated by NF-kappa B signaling pathway.	[Zheng, Lu; Liang, Ping; Li, Jing; Huang, Xiao-bing; Liu, Shi-cheng; Zhao, Hong-zhi; Han, Ke-qiang; Wang, Zheng] Third Mil Med Univ, Xinqiao Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China	Army Medical University	Liang, P (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Hepatobiliary Surg, Chongqing, Peoples R China.	xqyylp@hotmail.com; xqyylj@hotmail.com	zheng, lu/GXH-7035-2022		Natural Science Foundation of China [81001105, 30570843]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by a grant from Natural Science Foundation of China (# 81001105 and # 30570843). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch FX, 1999, SEMIN LIVER DIS, V19, P271, DOI 10.1055/s-2007-1007117; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Imbeaud S, 2010, SEMIN LIVER DIS, V30, P75, DOI 10.1055/s-0030-1247134; Jakobs TF, 2008, RADIOLOGE, V48, P839, DOI 10.1007/s00117-008-1730-x; Kagawa T, 2010, CANCER-AM CANCER SOC, V116, P3638, DOI 10.1002/cncr.25142; Kew MC, 2002, TOXICOLOGY, V181, P35, DOI 10.1016/S0300-483X(02)00251-2; Kudo M, 2010, ONCOLOGY-BASEL, V78, P154, DOI 10.1159/000315245; Li CX, 2010, EUR J CANCER, V46, P2513, DOI 10.1016/j.ejca.2010.06.015; LI J, 2003, CHINESE J MED GENET, V20, P49; [刘世呈 LIU Shicheng], 2007, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V29, P2207; Mo Qin-Guo, 2003, Ai Zheng, V22, P189; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Sahara S, 2010, JPN J RADIOL, V28, P362, DOI 10.1007/s11604-010-0436-y; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; VAN WC, 2007, CLIN CANCER RES, V13, P1076; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yuan BB, 2004, NUCLEIC ACIDS RES, V32, pW130, DOI 10.1093/nar/gkh366; Zhao HZ, 2004, WORLD CHIN J DIG, V12, P1785; Zheng L, 2010, HEPATO-GASTROENTEROL, V57, P919; [周建波 ZHOU Jianbo], 2006, [中华实验外科杂志, Chinese Journal of Experimental Surgery], V23, P288; Zhou L, 2007, WORLD J SURG, V31, P1782, DOI 10.1007/s00268-007-9029-z	23	19	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45412	10.1371/journal.pone.0045412	http://dx.doi.org/10.1371/journal.pone.0045412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049798	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100046
J	Zuccala, ES; Gout, AM; Dekiwadia, C; Marapana, DS; Angrisano, F; Turnbull, L; Riglar, DT; Rogers, KL; Whitchurch, CB; Ralph, SA; Speed, TP; Baum, J				Zuccala, Elizabeth S.; Gout, Alexander M.; Dekiwadia, Chaitali; Marapana, Danushka S.; Angrisano, Fiona; Turnbull, Lynne; Riglar, David T.; Rogers, Kelly L.; Whitchurch, Cynthia B.; Ralph, Stuart A.; Speed, Terence P.; Baum, Jake			Subcompartmentalisation of Proteins in the Rhoptries Correlates with Ordered Events of Erythrocyte Invasion by the Blood Stage Malaria Parasite	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MEROZOITES; HOST-CELL INVASION; TOXOPLASMA-GONDII INVASION; MEMBRANE ANTIGEN 1; APICOMPLEXAN PARASITES; MOVING JUNCTION; PARASITOPHOROUS VACUOLE; STRUCTURED ILLUMINATION; PROTEOMIC ANALYSIS; XIV MYOSIN	Host cell infection by apicomplexan parasites plays an essential role in lifecycle progression for these obligate intracellular pathogens. For most species, including the etiological agents of malaria and toxoplasmosis, infection requires active host-cell invasion dependent on formation of a tight junction - the organising interface between parasite and host cell during entry. Formation of this structure is not, however, shared across all Apicomplexa or indeed all parasite lifecycle stages. Here, using an in silico integrative genomic search and endogenous gene-tagging strategy, we sought to characterise proteins that function specifically during junction-dependent invasion, a class of proteins we term invasins to distinguish them from adhesins that function in species specific host-cell recognition. High-definition imaging of tagged Plasmodium falciparum invasins localised proteins to multiple cellular compartments of the blood stage merozoite. This includes several that localise to distinct subcompartments within the rhoptries. While originating from the same organelle, however, each has very different dynamics during invasion. Apical Sushi Protein and Rhoptry Neck protein 2 release early, following the junction, whilst a novel rhoptry protein PFF0645c releases only after invasion is complete. This supports the idea that organisation of proteins within a secretory organelle determines the order and destination of protein secretion and provides a localisation-based classification strategy for predicting invasin function during apicomplexan parasite invasion.	[Gout, Alexander M.; Speed, Terence P.; Baum, Jake] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia; [Rogers, Kelly L.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Imaging Facil, Parkville, Vic 3050, Australia; [Zuccala, Elizabeth S.; Gout, Alexander M.; Angrisano, Fiona; Riglar, David T.; Rogers, Kelly L.; Speed, Terence P.; Baum, Jake] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Dekiwadia, Chaitali; Ralph, Stuart A.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Turnbull, Lynne; Whitchurch, Cynthia B.] Univ Technol Sydney, Inst I3, Sydney, NSW 2007, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne; University of Melbourne; University of Technology Sydney	Baum, J (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia.	jake@wehi.edu.au	Zuccala, Elizabeth/HDM-5025-2022; Ralph, Stuart/C-8590-2014; Whitchurch, Cynthia/A-5954-2008; Turnbull, Lynne/A-2605-2012	Angrisano, Fiona/0000-0002-0457-5982; Ralph, Stuart/0000-0003-0114-7808; Zuccala, Elizabeth/0000-0002-9189-9810; Rogers, Kelly L./0000-0002-6755-0221; Whitchurch, Cynthia/0000-0003-2296-3791; Turnbull, Lynne/0000-0002-9255-9033; Riglar, David/0000-0002-5004-4373; Baum, Jake/0000-0002-0275-352X	National Health and Medical Research Council of Australia (NHMRC Project) [637340]; Human Frontier Science Program (HFSP Young Investigator Program) [RGY0071/2011]; Australian Postgraduate Award (APA); University of Melbourne Postgraduate Research Scholarship (MRS); Walter & Eliza Hall Institute Postgraduate Scholarship; Pratt Foundation PhD scholarship through the University of Melbourne; Chancellor's Postdoctoral Fellowship from the University of Technology, Sydney; Senior Research Fellowship from the NHMRC; Australian Research Council (ARC) Future Fellowship [FT0990350]; Australia Fellowship from the NHMRC; ARC Future Fellowship [FT100100112]	National Health and Medical Research Council of Australia (NHMRC Project)(National Health and Medical Research Council (NHMRC) of Australia); Human Frontier Science Program (HFSP Young Investigator Program); Australian Postgraduate Award (APA)(Australian Government); University of Melbourne Postgraduate Research Scholarship (MRS); Walter & Eliza Hall Institute Postgraduate Scholarship; Pratt Foundation PhD scholarship through the University of Melbourne; Chancellor's Postdoctoral Fellowship from the University of Technology, Sydney; Senior Research Fellowship from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Future Fellowship(Australian Research Council); Australia Fellowship from the NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC Future Fellowship(Australian Research Council)	This work was made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIISS. Funding for the research came from the National Health and Medical Research Council of Australia (NHMRC Project Grant 637340 JB and SAR) and the Human Frontier Science Program (HFSP Young Investigator Program Grant RGY0071/2011 JB). ESZ is supported by an Australian Postgraduate Award (APA); AMG was the recipient of a University of Melbourne Postgraduate Research Scholarship (MRS); FA is supported by a Walter & Eliza Hall Institute Postgraduate Scholarship; DTR is supported by a Pratt Foundation PhD scholarship through the University of Melbourne; LT is supported by a Chancellor's Postdoctoral Fellowship from the University of Technology, Sydney; CBW is supported by a Senior Research Fellowship from the NHMRC; SAR is supported by an Australian Research Council (ARC) Future Fellowship (FT0990350); TPS is supported by an Australia Fellowship from the NHMRC. JB is supported by an ARC Future Fellowship (FT100100112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAWA M, 1978, J CELL BIOL, V77, P72, DOI 10.1083/jcb.77.1.72; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Angrisano F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032188; BANNISTER LH, 1975, PARASITOLOGY, V71, P483, DOI 10.1017/S0031182000047247; Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5; BANNISTER LH, 1986, PARASITOLOGY, V92, P291, DOI 10.1017/S0031182000064064; Baum J, 2008, TRENDS PARASITOL, V24, P557, DOI 10.1016/j.pt.2008.08.006; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0; Boothroyd JC, 2008, NAT REV MICROBIOL, V6, P79, DOI 10.1038/nrmicro1800; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; BUSHELL GR, 1988, MOL BIOCHEM PARASIT, V28, P105, DOI 10.1016/0166-6851(88)90057-6; Cao J, 2009, PARASITOL INT, V58, P29, DOI 10.1016/j.parint.2008.09.005; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Charron AJ, 2004, TRAFFIC, V5, P855, DOI 10.1111/j.1600-0854.2004.00228.x; Chen ZQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003611; Collins CR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000273; Crabb BS, 2004, METH MOL B, V270, P263; DESAI SA, 1993, NATURE, V362, P643, DOI 10.1038/362643a0; Dobrowolski JM, 1996, CELL, V84, P933, DOI 10.1016/S0092-8674(00)81071-5; Dubremetz JF, 2007, CELL MICROBIOL, V9, P841, DOI 10.1111/j.1462-5822.2007.00909.x; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Elliott DA, 2001, INFECT IMMUN, V69, P5940, DOI 10.1128/IAI.69.9.5940-5942.2001; Elliott DA, 2000, INFECT IMMUN, V68, P2315, DOI 10.1128/IAI.68.4.2315-2322.2000; Farrow RE, 2011, SEMIN CELL DEV BIOL, V22, P953, DOI 10.1016/j.semcdb.2011.09.022; Frenal K, 2009, CELL HOST MICROBE, V5, P602, DOI 10.1016/j.chom.2009.05.013; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gilson PR, 2006, MOL CELL PROTEOMICS, V5, P1286, DOI 10.1074/mcp.M600035-MCP200; Giovannini D, 2011, CELL HOST MICROBE, V10, P591, DOI 10.1016/j.chom.2011.10.012; Gustafsson MGL, 2008, BIOPHYS J, V94, P4957, DOI 10.1529/biophysj.107.120345; Healer J, 2002, INFECT IMMUN, V70, P5751, DOI 10.1128/IAI.70.10.5751-5758.2002; Hossain ME, 2012, PARASITOL RES, V110, P1711, DOI 10.1007/s00436-011-2690-z; Hu GA, 2010, NAT BIOTECHNOL, V28, P91, DOI 10.1038/nbt.1597; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Huynh MH, 2009, EUKARYOT CELL, V8, P530, DOI 10.1128/EC.00358-08; Ito D, 2011, PARASITOL INT, V60, P132, DOI 10.1016/j.parint.2011.01.001; Johnson TM, 2007, MOL BIOL CELL, V18, P3039, DOI 10.1091/mbc.E07-01-0040; Kaiser K, 2004, MOL BIOCHEM PARASIT, V133, P15, DOI 10.1016/j.molbiopara.2003.08.009; Kawase O, 2010, PARASITOL INT, V59, P211, DOI 10.1016/j.parint.2010.02.001; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Kono M, 2012, MOL BIOL EVOL; Lal K, 2009, PROTEOMICS, V9, P1142, DOI 10.1002/pmic.200800404; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Lingelbach K, 1998, J CELL SCI, V111, P1467; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; LUMB R, 1988, PARASITOL RES, V74, P531, DOI 10.1007/BF00531630; Narum DL, 2008, INFECT IMMUN, V76, P4876, DOI 10.1128/IAI.01717-07; O'Keeffe AH, 2005, MOL BIOCHEM PARASIT, V140, P61, DOI 10.1016/j.molbiopara.2004.12.003; Patra KP, 2008, PROTEOMICS, V8, P2492, DOI 10.1002/pmic.200700727; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Putignani L, 2010, INTERDISCIP PERSPECT; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Richard D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000328; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11; SAFFER LD, 1992, J PROTOZOOL, V39, P526, DOI 10.1111/j.1550-7408.1992.tb04844.x; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; SCHUPP E, 1978, Z PARASITENKD, V55, P189, DOI 10.1007/BF00390369; Shaw MK, 2003, TRENDS PARASITOL, V19, P2, DOI 10.1016/S1471-4922(02)00015-6; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Srivastava A, 2010, MOL BIOCHEM PARASIT, V174, P66, DOI 10.1016/j.molbiopara.2010.06.003; Straub KW, 2009, CELL MICROBIOL, V11, P590, DOI 10.1111/j.1462-5822.2008.01276.x; SussToby E, 1996, P NATL ACAD SCI USA, V93, P8413, DOI 10.1073/pnas.93.16.8413; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; TORII M, 1989, INFECT IMMUN, V57, P3230, DOI 10.1128/IAI.57.10.3230-3233.1989; TORII M, 1992, J PROTOZOOL, V39, P449, DOI 10.1111/j.1550-7408.1992.tb04830.x; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Triglia T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002075; Tufet-Bayona M, 2009, MOL BIOCHEM PARASIT, V166, P22, DOI 10.1016/j.molbiopara.2009.02.009; Tyler JS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001282; VERNON LP, 1985, ARCH BIOCHEM BIOPHYS, V238, P18, DOI 10.1016/0003-9861(85)90136-5; VETTERLING JM, 1971, J PROTOZOOL, V18, P248, DOI 10.1111/j.1550-7408.1971.tb03316.x; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	79	38	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46160	10.1371/journal.pone.0046160	http://dx.doi.org/10.1371/journal.pone.0046160			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049965	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100144
J	Jiang, XP; Langille, MGI; Neches, RY; Elliot, M; Levin, SA; Eisen, JA; Weitz, JS; Dushoff, J				Jiang, Xingpeng; Langille, Morgan G. I.; Neches, Russell Y.; Elliot, Marie; Levin, Simon A.; Eisen, Jonathan A.; Weitz, Joshua S.; Dushoff, Jonathan			Functional Biogeography of Ocean Microbes Revealed through Non-Negative Matrix Factorization	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENOMIC ANALYSIS; METAGENOMICS; NETWORKS; SEQUENCE; ECOLOGY	The direct "metagenomic'' sequencing of genomic material from complex assemblages of bacteria, archaea, viruses and microeukaryotes has yielded new insights into the structure of microbial communities. For example, analysis of metagenomic data has revealed the existence of previously unknown microbial taxa whose spatial distributions are limited by environmental conditions, ecological competition, and dispersal mechanisms. However, differences in genotypes that might lead biologists to designate two microbes as taxonomically distinct need not necessarily imply differences in ecological function. Hence, there is a growing need for large-scale analysis of the distribution of microbial function across habitats. Here, we present a framework for investigating the biogeography of microbial function by analyzing the distribution of protein families inferred from environmental sequence data across a global collection of sites. We map over 6,000,000 protein sequences from unassembled reads from the Global Ocean Survey dataset to 8214 protein families, generating a protein family relative abundance matrix that describes the distribution of each protein family across sites. We then use non-negative matrix factorization (NMF) to approximate these protein family profiles as linear combinations of a small number of ecological components. Each component has a characteristic functional profile and site profile. Our approach identifies common functional signatures within several of the components. We use our method as a filter to estimate functional distance between sites, and find that an NMF-filtered measure of functional distance is more strongly correlated with environmental distance than a comparable PCA-filtered measure. We also find that functional distance is more strongly correlated with environmental distance than with geographic distance, in agreement with prior studies. We identify similar protein functions in several components and suggest that functional co-occurrence across metagenomic samples could lead to future methods for de-novo functional prediction. We conclude by discussing how NMF, and other dimension reduction methods, can help enable a macroscopic functional description of marine ecosystems.	[Weitz, Joshua S.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Weitz, Joshua S.] Georgia Inst Technol, Sch Phys, Atlanta, GA 30332 USA; [Jiang, Xingpeng] Drexel Univ, Coll Informat Sci & Technol, Philadelphia, PA 19104 USA; [Langille, Morgan G. I.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Neches, Russell Y.; Eisen, Jonathan A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Neches, Russell Y.; Eisen, Jonathan A.] Univ Calif Davis, Microbiol Grad Grp, Davis, CA 95616 USA; [Elliot, Marie; Dushoff, Jonathan] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Elliot, Marie; Dushoff, Jonathan] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Levin, Simon A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Ecol & Evolut, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Drexel University; Dalhousie University; University of California System; University of California Davis; University of California System; University of California Davis; McMaster University; McMaster University; Princeton University; University of California System; University of California Davis	Weitz, JS (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	jsweitz@gatech.edu; dushoff@mcmaster.ca	Weitz, Jeffrey/AAD-1929-2019; Levin, Simon A/J-1218-2014; Eisen, Jonathan A./H-2706-2019	Weitz, Jeffrey/0000-0002-1092-7550; Levin, Simon A/0000-0002-8216-5639; Eisen, Jonathan A./0000-0002-0159-2197; Neches, Russell/0000-0002-2055-8381; Langille, Morgan/0000-0002-6604-3009	Defense Advanced Projects Research Agency [HR0011-05-1-0057, HR0011-09-1-0055]; Gordon and Betty Moore Foundation [1660]; National Science Foundation [1046001]; Burroughs Wellcome Fund	Defense Advanced Projects Research Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF)); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by the Defense Advanced Projects Research Agency under grants HR0011-05-1-0057 and HR0011-09-1-0055. Additional support was received from the Gordon and Betty Moore Foundation, Grant 1660, to JE, and from the National Science Foundation Award 1046001 to SL. JW holds a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzate C, 2010, IEEE T PATTERN ANAL, V32, P335, DOI 10.1109/TPAMI.2008.292; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bates ST, 2011, APPL ENVIRON MICROB, V77, P1309, DOI 10.1128/AEM.02257-10; Borcard D, 2012, ECOLOGY, V93, P1473; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Carmona-Saez P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-78; Devarajan K, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000029; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Eisen JA, 2007, PLOS BIOL, V5, P384, DOI 10.1371/journal.pbio.0050082; Fanti C, 2004, ADV NEUR IN, V16, P1603; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; HOLDRIDGE LR, 1947, SCIENCE, V105, P367, DOI 10.1126/science.105.2727.367; Jiang XP, 2012, J MATH BIOL, V64, P697, DOI 10.1007/s00285-011-0428-2; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim H, 2007, BIOINFORMATICS, V23, P1495, DOI 10.1093/bioinformatics/btm134; Kim PM, 2003, GENOME RES, V13, P1706, DOI 10.1101/gr.903503; Kislyuk AO, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-32; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Maetschke SR, 2010, BIOINFORMATICS, V26, P737, DOI 10.1093/bioinformatics/btq042; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Patel PV, 2010, GENOME RES, V20, P960, DOI 10.1101/gr.102814.109; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Raes J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.6; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; WHITTAKER RH, 1962, BOT REV, V28, P1, DOI 10.1007/BF02860872; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	38	25	26	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2012	7	9							e43866	10.1371/journal.pone.0043866	http://dx.doi.org/10.1371/journal.pone.0043866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040HS	23049741	gold, Green Published			2022-12-27	WOS:000311313900010
J	Andersson, AMC; Hakansson, KO; Jensen, BAH; Christensen, D; Andersen, P; Thomsen, AR; Christensen, JP				Andersson, Anne-Marie Carola; Hakansson, Kjell O.; Jensen, Benjamin Anderschou Holbech; Christensen, Dennis; Andersen, Peter; Thomsen, Allan Randrup; Christensen, Jan Pravsgaard			Increased Immunogenicity and Protective Efficacy of Influenza M2e Fused to a Tetramerizing Protein	PLOS ONE			English	Article							ANTIGENIC PEPTIDE VACCINE; EXTRACELLULAR DOMAIN; MONOCLONAL-ANTIBODIES; CATIONIC LIPOSOMES; MATRIX PROTEIN-2; FUSION PROTEIN; VIRUS; MICE; ADJUVANT; IMMUNIZATION	The ectodomain of the matrix 2 protein (M2e) of influenza A virus represents an attractive target for developing a universal influenza A vaccine, with its sequence being highly conserved amongst human variants of this virus. With the aim of targeting conformational epitopes presumably shared by diverse influenza A viruses, a vaccine (M2e-NSP4) was constructed linking M2e (in its consensus sequence) to the rotavirus fragment NSP4(98-135); due to its coiled-coil region this fragment is known to form tetramers in aqueous solution and in this manner we hoped to mimick the natural configuration of M2e as presented in membranes. M2e-NSP4 was then evaluated side-by-side with synthetic M2e peptide for its immunogenicity and protective efficacy in a murine influenza challenge model. Here we demonstrate that M2e fused to the tetramerizing protein induces an accelerated, augmented and more broadly reactive antibody response than does M2e peptide as measured in two different assays. Most importantly, vaccination with M2e-NSP4 caused a significant decrease in lung virus load early after challenge with influenza A virus and maintained its efficacy against a lethal challenge even at very low vaccine doses. Based on the results presented in this study M2e-NSP4 merits further investigation as a candidate for or as a component of a universal influenza A vaccine.	[Andersson, Anne-Marie Carola; Jensen, Benjamin Anderschou Holbech; Thomsen, Allan Randrup; Christensen, Jan Pravsgaard] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Hakansson, Kjell O.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Christensen, Dennis; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Statens Serum Institut	Christensen, JP (corresponding author), Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	JPC@sund.ku.dk	Christensen, Dennis/C-6378-2008; Jensen, Benjamin A. H./M-4661-2014; Christensen, Jan Pravsgaard/I-4782-2017	Christensen, Dennis/0000-0003-2382-8639; Jensen, Benjamin A. H./0000-0001-6991-0828; Christensen, Jan Pravsgaard/0000-0002-4299-9479; Thomsen, Allan Randrup/0000-0002-2392-9803; Andersson, Anne-Marie/0000-0001-5455-4162; Andersen, Peter/0000-0002-5869-2551	Lundbeck Foundation; Danish Council for Strategic Research; Danish Council for Independent Research, Health and Disease; Bertil Anderssons Foundation	Lundbeck Foundation(Lundbeckfonden); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Council for Independent Research, Health and Disease; Bertil Anderssons Foundation	This work was supported by the Lundbeck Foundation, The Danish Council for Strategic Research, The Danish Council for Independent Research, Health and Disease and Bertil Anderssons Foundation. The funding sources had no involvement in any decisions made regarding study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Bowman GD, 2000, J MOL BIOL, V304, P861, DOI 10.1006/jmbi.2000.4250; Christensen D, 2011, EXPERT REV VACCINES, V10, P513, DOI [10.1586/erv.11.17, 10.1586/ERV.11.17]; Christensen D, 2009, J LIPOSOME RES, V19, P2, DOI 10.1080/08982100902726820; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200; De Filette M, 2008, VACCINE, V26, P6503, DOI 10.1016/j.vaccine.2008.09.038; Ellebedy AH, 2009, VACCINE, V27, pD65, DOI 10.1016/j.vaccine.2009.08.038; Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021; Feng JQ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-102; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Fomsgaard A, 2011, VACCINE, V29, P7067, DOI 10.1016/j.vaccine.2011.07.025; Fu TM, 2009, VIROLOGY, V385, P218, DOI 10.1016/j.virol.2008.11.035; Grandea AG, 2010, P NATL ACAD SCI USA, V107, P12658, DOI 10.1073/pnas.0911806107; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; KAWAOKA Y, 1991, J VIROL, V65, P3891, DOI 10.1128/JVI.65.7.3891-3894.1991; Liu WL, 2005, MICROBES INFECT, V7, P171, DOI 10.1016/j.micinf.2004.10.006; Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Okuda K, 2001, VACCINE, V19, P3681, DOI 10.1016/S0264-410X(01)00078-0; Park KS, 2011, VACCINE, V29, P5481, DOI 10.1016/j.vaccine.2011.05.062; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Soboleski MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021937; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Wu F, 2009, VACCINE, V27, P6095, DOI 10.1016/j.vaccine.2008.11.037; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; ZEBEDEE SL, 1989, NUCLEIC ACIDS RES, V17, P2870, DOI 10.1093/nar/17.7.2870; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-9; Zhong WM, 2011, J IMMUNOL METHODS, V369, P115, DOI 10.1016/j.jim.2011.04.010	35	32	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46395	10.1371/journal.pone.0046395	http://dx.doi.org/10.1371/journal.pone.0046395			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049700	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388500027
J	Levy, E; Kennington, WJ; Tomkins, JL; Lebas, NR				Levy, Esther; Kennington, W. Jason; Tomkins, Joseph L.; LeBas, Natasha R.			Phylogeography and Population Genetic Structure of the Ornate Dragon Lizard, Ctenophorus ornatus	PLOS ONE			English	Article							DIRECT-DEVELOPING FROG; AUSTRALIAN LIZARD; LACERTA-AGILIS; F-STATISTICS; SAND LIZARD; DISPERSAL; FLOW; BIOGEOGRAPHY; SOFTWARE; PATTERNS	Species inhabiting ancient, geologically stable landscapes that have been impacted by agriculture and urbanisation are expected to have complex patterns of genetic subdivision due to the influence of both historical and contemporary gene flow. Here, we investigate genetic differences among populations of the granite outcrop-dwelling lizard Ctenophorus ornatus, a phenotypically variable species with a wide geographical distribution across the south-west of Western Australia. Phylogenetic analysis of mitochondrial DNA sequence data revealed two distinct evolutionary lineages that have been isolated for more than four million years within the C. ornatus complex. This evolutionary split is associated with a change in dorsal colouration of the lizards from deep brown or black to reddish-pink. In addition, analysis of microsatellite data revealed high levels of genetic structuring within each lineage, as well as strong isolation by distance at multiple spatial scales. Among the 50 outcrop populations' analysed, non-hierarchical Bayesian clustering analysis revealed the presence of 23 distinct genetic groups, with outcrop populations less than 4 km apart usually forming a single genetic group. When a hierarchical analysis was carried out, almost every outcrop was assigned to a different genetic group. Our results show there are multiple levels of genetic structuring in C. ornatus, reflecting the influence of both historical and contemporary evolutionary processes. They also highlight the need to recognise the presence of two evolutionarily distinct lineages when making conservation management decisions on this species.	[Levy, Esther; Kennington, W. Jason; Tomkins, Joseph L.; LeBas, Natasha R.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Perth, WA 6009, Australia	University of Western Australia	Levy, E (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Perth, WA 6009, Australia.	levye01@student.uwa.edu.au	Kennington, Winn J/H-5182-2014; Tomkins, Joseph L/A-8091-2011; LeBas, Natasha R/E-7339-2015	Kennington, Winn J/0000-0001-6100-6543; Tomkins, Joseph L/0000-0003-1259-7898; LeBas, Natasha R/0000-0003-4706-3909	Holsworth Wildlife Research Endowment; School of Animal Biology at the University of Western Australia; Australian Postgraduate Award; Australian Research Council Fellowships	Holsworth Wildlife Research Endowment; School of Animal Biology at the University of Western Australia; Australian Postgraduate Award(Australian Government); Australian Research Council Fellowships(Australian Research Council)	This research was supported by the Holsworth Wildlife Research Endowment and the School of Animal Biology at the University of Western Australia. EL was funded by an Australian Postgraduate Award. NRL and JLT were funded by Australian Research Council Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F., 2007, CONSERVATION GENETIC; Beard JS, 2000, J BIOGEOGR, V27, P1257, DOI 10.1046/j.1365-2699.2000.00509.x; Berry O, 2005, CONSERV BIOL, V19, P855, DOI 10.1111/j.1523-1739.2005.00161.x; Byrne M, 2000, AUST J BOT, V48, P305, DOI 10.1071/BT99017; Byrne M, 2004, AUST J BOT, V52, P459, DOI 10.1071/BT03117; Byrne M, 2003, THEOR APPL GENET, V107, P1208, DOI 10.1007/s00122-003-1365-2; Byrne M, 2003, HEREDITY, V91, P389, DOI 10.1038/sj.hdy.6800346; Byrne M, 2008, BIOL J LINN SOC, V93, P177, DOI 10.1111/j.1095-8312.2007.00946.x; Capula M, 1996, HEREDITY, V77, P518, DOI 10.1038/hdy.1996.179; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Clark RW, 2008, MOL ECOL, V17, P719; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coates DJ, 2003, AM J BOT, V90, P997, DOI 10.3732/ajb.90.7.997; Coulon A, 2008, MOL ECOL, V17, P1685, DOI 10.1111/j.1365-294X.2008.03705.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dever JA, 2002, COPEIA, P1078; Edward D.H.D., 1989, Acta Biologica Debrecina Supplementum Oecologica Hungarica, V2, P181; Edwards DL, 2008, J BIOGEOGR, V35, P1803, DOI 10.1111/j.1365-2699.2008.01927.x; Edwards DL, 2007, MOL PHYLOGENET EVOL, V45, P494, DOI 10.1016/j.ympev.2007.05.023; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gardner MG, 2007, J ETHOL, V25, P263, DOI 10.1007/s10164-006-0022-z; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Gullberg A, 1998, BIOL J LINN SOC, V65, P257, DOI 10.1006/bijl.1998.0221; Hart MW, 2011, EVOLUTION, V65, P613, DOI 10.1111/j.1558-5646.2010.01202.x; Hey J, 2006, TRENDS ECOL EVOL, V21, P447, DOI 10.1016/j.tree.2006.05.011; Hoehn M, 2007, MOL ECOL, V16, P3299, DOI 10.1111/j.1365-294X.2007.03352.x; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; Jarvis N., 1986, W AUSTR ATLAS HUMAN; King RB, 2001, COPEIA, P602, DOI 10.1643/0045-8511(2001)001[0602:POPSAG]2.0.CO;2; LAMONT BB, 1995, AUST J BOT, V43, P283, DOI 10.1071/BT9950283; Lebas NR, 2000, MOL ECOL, V9, P365, DOI 10.1046/j.1365-294x.2000.00874.x; LeBas NR, 2000, P ROY SOC B-BIOL SCI, V267, P445, DOI 10.1098/rspb.2000.1020; Lebas NR, 2001, MOL ECOL, V10, P193, DOI 10.1046/j.1365-294X.2001.01174.x; Levy E, 2010, CONSERV GENET RESOUR, V2, P313, DOI 10.1007/s12686-010-9216-3; Levy E, 2010, MOL ECOL, V19, P4192, DOI 10.1111/j.1365-294X.2010.04810.x; MAIN BY, 1991, J NAT HIST, V25, P383, DOI 10.1080/00222939100770271; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; Melville J, 2001, J EXP ZOOL, V291, P339, DOI 10.1002/jez.1133; Melville J, 2008, AUST J ZOOL, V56, P159, DOI 10.1071/ZO07069; Moir ML, 2009, J BIOGEOGR, V36, P1958, DOI 10.1111/j.1365-2699.2009.02137.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oksanen J., 2022, VEGAN COMMUNITY ECOL; OLSSON M, 1994, ANIM BEHAV, V48, P607, DOI 10.1006/anbe.1994.1280; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK., 2010, DOCUMENTATION STRUCT; Rix MG, 2010, INVERTEBR SYST, V24, P209, DOI 10.1071/IS09048; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROSEN D E, 1979, Bulletin of the American Museum of Natural History, V162, P267; Rousset F, 1997, GENETICS, V145, P1219; Row JR, 2010, MOL ECOL, V19, P5157, DOI 10.1111/j.1365-294X.2010.04872.x; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; STORR GM, 1983, LIZARDS W AUSTR, V0002; Stow AJ, 2001, MOL ECOL, V10, P867, DOI 10.1046/j.1365-294X.2001.01253.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K., 2011, MOL BIOL EVOLU UNPUB; Twidale CR., 1982, GRANITE LANDFORMS; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Withers P. C., 2000, Journal of the Royal Society of Western Australia, V83, P103; Zofkova M, 2009, HYDROBIOLOGIA, V635, P67, DOI 10.1007/s10750-009-9862-1	68	16	17	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46351	10.1371/journal.pone.0046351	http://dx.doi.org/10.1371/journal.pone.0046351			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049697	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388500024
J	Breinholt, JW; Porter, ML; Crandall, KA				Breinholt, Jesse W.; Porter, Megan L.; Crandall, Keith A.			Testing Phylogenetic Hypotheses of the Subgenera of the Freshwater Crayfish Genus Cambarus (Decapoda: Cambaridae)	PLOS ONE			English	Article							CONVERGENT EVOLUTION; MOLECULAR SYSTEMATICS; ORCONECTES DECAPODA; LARVAL MORPHOLOGY; SPECIES COMPLEX; TREE SELECTION; CAVE CRAYFISH; RIBOSOMAL DNA; MIXED MODELS; RIVER-BASIN	Background: The genus Cambarus is one of three most species rich crayfish genera in the Northern Hemisphere. The genus has its center of diversity in the Southern Appalachians of the United States and has been divided into 12 subgenera. Using Cambarus we test the correspondence of subgeneric designations based on morphology used in traditional crayfish taxonomy to the underlying evolutionary history for these crayfish. We further test for significant correlation and explanatory power of geographic distance, taxonomic model, and a habitat model to estimated phylogenetic distance with multiple variable regression. Methodology/Principal Findings: We use three mitochondrial and one nuclear gene regions to estimate the phylogenetic relationships for species within the genus Cambarus and test evolutionary hypotheses of relationships and associated morphological and biogeographical hypotheses. Our resulting phylogeny indicates that the genus Cambarus is polyphyletic, however we fail to reject the monophyly of Cambarus with a topology test. The majority of the Cambarus subgenera are rejected as monophyletic, suggesting the morphological characters used to define those taxa are subject to convergent evolution. While we found incongruence between taxonomy and estimated phylogenetic relationships, a multiple model regression analysis indicates that taxonomy had more explanatory power of genetic relationships than either habitat or geographic distance. Conclusions: We find convergent evolution has impacted the morphological features used to delimit Cambarus subgenera. Studies of the crayfish genus Orconectes have shown gonopod morphology used to delimit subgenera is also affected by convergent evolution. This suggests that morphological diagnoses based on traditional crayfish taxonomy might be confounded by convergent evolution across the cambarids and has little utility in diagnosing relationships or defining natural groups. We further suggest that convergent morphological evolution appears to be a common occurrence in invertebrates suggesting the need for careful phylogenetically based interpretations of morphological evolution in invertebrate systematics.	[Breinholt, Jesse W.; Crandall, Keith A.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Porter, Megan L.] Univ S Dakota, Dept Biol, Vermillion, SD 57069 USA; [Crandall, Keith A.] George Washington Univ, Computat Biol Inst, Ashburn, VA USA	Brigham Young University; University of South Dakota; George Washington University	Breinholt, JW (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	jessebreinholt@gmail.com	Breinholt, Jesse/K-6252-2019; Breinholt, Jesse/F-4330-2014; Crandall, Keith A./H-2789-2019	Breinholt, Jesse/0000-0002-3867-2430; Breinholt, Jesse/0000-0002-3867-2430; Crandall, Keith A./0000-0002-0836-3389	US NSF [EF-0531762]; Brigham Young University	US NSF(National Science Foundation (NSF)); Brigham Young University	This work was partially funded by a grant from the US NSF EF-0531762 awarded to KAC and Brigham Young University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapow P-M, 2004, Q REV BIOL IN PRESS; Alejandrino A, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-164; [Anonymous], 2014, TRACER V1 6; Bichain JM, 2007, MOL PHYLOGENET EVOL, V45, P927, DOI 10.1016/j.ympev.2007.07.018; Bone Q, 2005, J MAR BIOL ASSOC UK, V85, P641, DOI 10.1017/S0025315405011574; Bouchard R.W., 1976, Smithsonian Contributions to Zoology, VNo. 224, P1; Bouchard R.W., 1972, ASB Bull, V19, P56; Bouchard Raymond W., 1995, Notulae Naturae (Philadelphia), V471, P1; Breinholt J, 2009, CRUSTACEAN ISS, V18, P305; Buhay JE, 2005, MOL ECOL, V14, P4259, DOI 10.1111/j.1365-294X.2005.02755.x; Buhay JE, 2007, MOL PHYLOGENET EVOL, V42, P435, DOI 10.1016/j.ympev.2006.07.014; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P121, DOI 10.1651/08-3089.1; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Byrne M, 2003, BIOL BULL-US, V205, P285, DOI 10.2307/1543292; Cooper JE, 2010, P BIOL SOC WASH, V123, P335, DOI 10.2988/10-20.1; Cooper SJB, 2002, INVERTEBR SYST, V16, P589, DOI 10.1071/IT01039; Crandall KA, 1996, SYST BIOL, V45, P1; Crandall KA, 1998, BIOL CONSERV, V84, P107, DOI 10.1016/S0006-3207(97)00112-2; Crandall KA, 2007, CONSERV GENET, V10, P177; Crandall KA, 1996, COURIER FORSCHUNGSIN; Crandall KA, 2008, HYDROBIOLOGIA, V595, P295, DOI 10.1007/s10750-007-9120-3; Daniels SR, 2006, MOL PHYLOGENET EVOL, V40, P227, DOI 10.1016/j.ympev.2006.02.022; De Grave S, 2009, RAFFLES B ZOOL, P1; Derkarabetian S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010388; Dohrmann M, 2006, MOL PHYLOGENET EVOL, V40, P830, DOI 10.1016/j.ympev.2006.04.016; Erichson W, 1846, ARCH NATURGESCH, V12, P86; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fetzner Jr JW, 2011, GLOBAL CRAYFISH RESO; Fetzner JW, 1996, J CRUSTACEAN BIOL, V16, P111, DOI 10.2307/1548936; Finlay JB, 2006, ANIM CONSERV, V9, P375, DOI 10.1111/j.1469-1795.2006.00046.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Forgie SA, 2006, MOL PHYLOGENET EVOL, V40, P662, DOI 10.1016/j.ympev.2006.04.018; Fukami H, 2004, NATURE, V427, P832, DOI 10.1038/nature02339; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guiasu RC, 2009, CRUSTACEANA, V82, P721, DOI 10.1163/156854009X407722; Hobbs H.H. Jr., 1974, Smithsonian Contributions to Zoology, VNo. 164, P1; HOBBS HH, 1988, P BIOL SOC WASH, V101, P644; HOBBS HH, 1969, RES DIVISION MONOGRA, V1, P93; Hobbs Jr. H.H., 1989, SMITHS CONTRIB ZOOL, V480, P236, DOI [10.5479/si.00810282.480, DOI 10.5479/SI.00810282.480]; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Husemann M, 2012, ZOOL SCR, V41, P515, DOI 10.1111/j.1463-6409.2012.00548.x; JEZERINAC RF, 1993, P BIOL SOC WASH, V106, P532; Kanzaki N., 2006, Journal of the Japanese Forest Society, V88, P392, DOI 10.4005/jjfs.88.392; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2001, J MOL EVOL, V53, P477, DOI 10.1007/s002390010238; Kohler F, 2008, MALACOLOGIA, V50, P331; Leclere L, 2009, SYST BIOL, V58, P509, DOI 10.1093/sysbio/syp044; Loughman ZJ, 2011, P BIOL SOC WASH, V124, P99, DOI 10.2988/10-09.1; Maddison WP, 2019, MESQUITE MODULAR SYS; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Mathews LM, 2008, MOL PHYLOGENET EVOL, V48, P126, DOI 10.1016/j.ympev.2008.02.006; McHenry MJ, 2004, EVOLUTION, V58, P1209; Mokady O, 1999, J MOL EVOL, V49, P367, DOI 10.1007/PL00006560; Moore J, 1997, BIOL REV, V72, P1, DOI 10.1017/S0006323196004926; Murphy NP, 2005, ZOOL SCR, V34, P187, DOI 10.1111/j.1463-6409.2005.00185.x; Perez-Losada M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-15; Podolsky RD, 2005, BIOL BULL-US, V209, P127, DOI 10.2307/3593130; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rhoades Rendell, 1944, AMER MIDLAND NAT, V31, P111, DOI 10.2307/2421386; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; SINCLAIR E. A., 2004, FRESHWATER CRAYFISH, V14, P1; Song H, 2008, P NATL ACAD SC UNPUB; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Struck TH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-57; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taylor CA, 2002, J CRUSTACEAN BIOL, V22, P874, DOI 10.1651/0278-0372(2002)022[0874:POTCSC]2.0.CO;2; Taylor CA, 2007, FISHERIES, V32, P372, DOI 10.1577/1548-8446(2007)32[372:AROTCS]2.0.CO;2; Taylor CA, 2006, BIOL J LINN SOC, V89, P1, DOI 10.1111/j.1095-8312.2006.00637.x; Taylor PD, 2006, J GEOL SOC LONDON, V163, P225, DOI 10.1144/0016-764905-145; Thoma RF, 2011, P BIOL SOC WASH, V124, P318; Toon A, 2009, CRUSTACEAN ISS, V18, P9; Toon A, 2010, J BIOGEOGR, V37, P2275, DOI 10.1111/j.1365-2699.2010.02374.x; Whiting AS, 2000, ANIM CONSERV, V3, P155; Whiting MF, 2003, NATURE, V421, P264, DOI 10.1038/nature01313; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1	79	23	23	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46105	10.1371/journal.pone.0046105	http://dx.doi.org/10.1371/journal.pone.0046105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049950	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300085
J	Miller-Rushing, AJ; Primack, RB; Phillips, N; Kaufmann, RK				Miller-Rushing, Abraham J.; Primack, Richard B.; Phillips, Nathan; Kaufmann, Robert K.			Effects of Warming Temperatures on Winning Times in the Boston Marathon	PLOS ONE			English	Article							RUNNING PERFORMANCE; DISTANCE RUNNERS; WEATHER; WOMEN; MEN	It is not known whether global warming will affect winning times in endurance events, and counterbalance improvements in race performances that have occurred over the past century. We examined a time series (1933-2004) from the Boston Marathon to test for an effect of warming on winning times by men and women. We found that warmer temperatures and headwinds on the day of the race slow winning times. However, 1.6 degrees C warming in annual temperatures in Boston between 1933 and 2004 did not consistently slow winning times because of high variability in temperatures on race day. Starting times for the race changed to earlier in the day beginning in 2006, making it difficult to anticipate effects of future warming on winning times. However, our models indicate that if race starting times had not changed and average race day temperatures had warmed by 0.058 degrees C/yr, a high-end estimate, we would have had a 95% chance of detecting a consistent slowing of winning marathon times by 2100. If average race day temperatures had warmed by 0.028 degrees C/yr, a mid-range estimate, we would have had a 64% chance of detecting a consistent slowing of winning times by 2100.	[Miller-Rushing, Abraham J.; Primack, Richard B.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Phillips, Nathan; Kaufmann, Robert K.] Boston Univ, Dept Geog & Environm, Boston, MA 02215 USA	Boston University; Boston University	Primack, RB (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	primack@bu.edu	Kaufmann, Robert K/I-4962-2017; Miller-Rushing, Abraham/D-5102-2009	Kaufmann, Robert K/0000-0002-5670-7027; Miller-Rushing, Abraham/0000-0003-3203-0143	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	The National Science Foundation provided funding for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheuvront SN, 2005, SPORTS MED, V35, P1017, DOI 10.2165/00007256-200535120-00002; Cheuvront SN, 2001, SPORTS MED, V31, P743, DOI 10.2165/00007256-200131100-00004; CONOVER JH, 1985, B AM METEOROL SOC, V66, P30, DOI 10.1175/1520-0477(1985)066<0030:HOTHOT>2.0.CO;2; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; El Helou N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037407; Ely MR, 2007, MED SCI SPORT EXER, V39, P2029, DOI 10.1249/mss.0b013e318149f2c3; Ely MR, 2007, MED SCI SPORT EXER, V39, P487, DOI 10.1249/mss.0b013e31802d3aba; Hayhoe K, 2007, CLIM DYNAM, V28, P381, DOI 10.1007/s00382-006-0187-8; IPCC, 2007, CONTRIBUTION WORKING; Martin DE, 1999, CHANCE, V12, P20, DOI DOI 10.1080/09332480.1999.10542170; McCann DJ, 1997, MED SCI SPORT EXER, V29, P955, DOI 10.1097/00005768-199707000-00016; New England Regional Assessment Group, 2001, PREP CHANG CLIM POT; NIELSEN B, 1988, EUR J APPL PHYSIOL O, V58, P189, DOI 10.1007/BF00636625; Sparling PB, 1998, MED SCI SPORT EXER, V30, P1725, DOI 10.1097/00005768-199812000-00011; TRAPASSO LM, 1989, INT J BIOMETEOROL, V33, P233, DOI 10.1007/BF01051083; WHIPP BJ, 1992, NATURE, V355, P25, DOI 10.1038/355025a0; YAGLOU C P, 1957, AMA Arch Ind Health, V16, P302; ZHANG SP, 1992, INT J BIOMETEOROL, V36, P63; Zhang XY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020137	19	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e43579	10.1371/journal.pone.0043579	http://dx.doi.org/10.1371/journal.pone.0043579			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049738	Green Published, gold			2022-12-27	WOS:000309517300006
J	Hanggi, D; Perrin, J; Eicker, S; Beseoglu, K; Etminan, N; Kamp, MA; Heiroth, HJ; Bege, N; Macht, S; Frauenknecht, K; Sommer, C; Kissel, T; Steiger, HJ				Haenggi, Daniel; Perrin, Jason; Eicker, Sven; Beseoglu, Kerim; Etminan, Nima; Kamp, Marcel Alexander; Heiroth, Hi-Jae; Bege, Nadia; Macht, Stephan; Frauenknecht, Katrin; Sommer, Clemens; Kissel, Thomas; Steiger, Hans-Jakob			Local Delivery of Nimodipine by Prolonged-Release Microparticles-Feasibility, Effectiveness and Dose-Finding in Experimental Subarachnoid Hemorrhage	PLOS ONE			English	Article							CHRONIC CEREBRAL VASOSPASM; INTRATHECAL NIMODIPINE; IN-VIVO; MODEL; RAT; ANGIOGRAPHY; ARTERIES; THERAPY; NANOPARTICLES; PREVENTION	Background and Purpose: To investigate the effect of locally applied nimodipine prolonged-release microparticles on angiographic vasospasm and secondary brain injury after experimental subarachnoid hemorrhage (SAH). Methods: 70 male Wistar rats were categorized into three groups: 1) sham operated animals (control), 2) animals with SAH only (control) and the 3) treatment group. SAH was induced using the double hemorrhage model. The treatment group received different concentrations (20%, 30% or 40%) of nimodipine microparticles. Angiographic vasospasm was assessed 5 days later using digital subtraction angiography (DSA). Histological analysis of frozen sections was performed using H&E-staining as well as Iba1 and MAP2 immunohistochemistry. Results: DSA images were sufficient for assessment in 42 animals. Severe angiographic vasospasm was present in group 2 (SAH only), as compared to the sham operated group (p<0.001). Only animals within group 3 and the highest nimodipine microparticles concentration (40%) as well as group 1 (sham) demonstrated the largest intracranial artery diameters. Variation in vessel calibers, however, did not result in differences in Iba-1 or MAP2 expression, i.e. in histological findings for secondary brain injury. Conclusions: Local delivery of high-dose nimodipine prolonged-release microparticles at high concentration resulted in significant reduction in angiographic vasospasm after experimental SAH and with no histological signs for matrix toxicity.	[Haenggi, Daniel; Perrin, Jason; Eicker, Sven; Beseoglu, Kerim; Etminan, Nima; Kamp, Marcel Alexander; Heiroth, Hi-Jae; Steiger, Hans-Jakob] Univ Dusseldorf, Dept Neurosurg, D-40225 Dusseldorf, Germany; [Macht, Stephan] Univ Dusseldorf, Inst Neuroradiol, D-40225 Dusseldorf, Germany; [Bege, Nadia; Kissel, Thomas] Univ Marburg, Dept Pharmaceut & Biopharm, Marburg, Germany; [Frauenknecht, Katrin; Sommer, Clemens] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Neuropathol, Mainz, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Philipps University Marburg; Johannes Gutenberg University of Mainz	Hanggi, D (corresponding author), Univ Dusseldorf, Dept Neurosurg, D-40225 Dusseldorf, Germany.	daniel.haenggi@uni-duesseldorf.de	Frauenknecht, Katrin/AAF-1638-2020; Eicker, Sven/B-3341-2015; Steiger, Hans-Jakob/AAN-8307-2021	Frauenknecht, Katrin/0000-0002-1372-3297; Steiger, Hans-Jakob/0000-0002-8249-2998; Kamp, Marcel/0000-0002-1252-2944	Kluh Foundation, Dusseldorf, Germany	Kluh Foundation, Dusseldorf, Germany	The study was supported by a grant of the Kluh Foundation, Dusseldorf, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladag MA, 2003, ACTA NEUROCHIR, V145, P673, DOI 10.1007/s00701-003-0052-z; AUER LM, 1982, ACTA NEUROCHIR, V63, P297, DOI 10.1007/BF01728885; Barth M, 2007, STROKE, V38, P330, DOI 10.1161/01.STR.0000254601.74596.0f; Bederson JB, 1998, NEUROSURGERY, V42, P352, DOI 10.1097/00006123-199802000-00091; BOULLIN DJ, 1981, NEURORADIOLOGY, V21, P245, DOI 10.1007/BF02100154; DELGADO TJ, 1985, STROKE, V16, P595, DOI 10.1161/01.STR.16.4.595; Frauenknecht K, 2010, J NEUROIMMUNOL, V227, P1, DOI 10.1016/j.jneuroim.2010.05.043; GIOIA AE, 1985, J NEUROSURG, V62, P721, DOI 10.3171/jns.1985.62.5.0721; Grasso G, 2004, BRAIN RES REV, V44, P49, DOI 10.1016/j.brainresrev.2003.10.003; Hanggi D, 2008, CLIN NEUROL NEUROSUR, V110, P784, DOI 10.1016/j.clineuro.2008.05.001; Hanggi D, 2009, NEUROSURGERY, V64, P1155, DOI 10.1227/01.NEU.0000340685.06407.FD; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Kasuya H, 2005, NEUROSURGERY, V56, P895; Lee SH, 2011, INT J PHARMACEUT, V403, P192, DOI 10.1016/j.ijpharm.2010.10.012; LEWIS PJ, 1988, NEUROSURGERY, V22, P492; Li XA, 2010, J CONTROL RELEASE, V147, P304, DOI 10.1016/j.jconrel.2010.07.113; Longo M, 2002, NEURORADIOLOGY, V44, P689, DOI 10.1007/s00234-002-0781-3; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Marbacher S, 2008, INTENS CARE MED, V34, P932, DOI 10.1007/s00134-008-0995-x; Megyesi JF, 2000, NEUROSURGERY, V46, P448, DOI 10.1097/00006123-200002000-00035; Ono S, 1997, STROKE, V28, P1631, DOI 10.1161/01.STR.28.8.1631; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Prunell GF, 2004, NEUROSURGERY, V54, P426, DOI 10.1227/01.NEU.0000103670.09687.7A; Satoh M, 2002, STROKE, V33, P775, DOI 10.1161/hs0302.103734; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Tanay E, 2006, BRAIN RES, V1112, P222, DOI 10.1016/j.brainres.2006.07.004; Turowski B, 2007, NEURORADIOLOGY, V49, P129, DOI 10.1007/s00234-006-0168-y; Vatter H, 2006, NEUROSURGERY, V58, P1190, DOI 10.1227/01.NEU.0000199346.74649.66; VERLOOY J, 1992, ACTA NEUROCHIR, V117, P48, DOI 10.1007/BF01400635; VOLDBY B, 1984, ACTA NEUROCHIR, V70, P243, DOI 10.1007/BF01406653; ZABRAMSKI JM, 1986, NEUROSURGERY, V18, P1	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e42597	10.1371/journal.pone.0042597	http://dx.doi.org/10.1371/journal.pone.0042597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049732	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100004
J	Laliberte, E; Adair, EC; Hobbie, SE				Laliberte, Etienne; Adair, E. Carol; Hobbie, Sarah E.			Estimating Litter Decomposition Rate in Single-Pool Models Using Nonlinear Beta Regression	PLOS ONE			English	Article							NITROGEN	Litter decomposition rate (k) is typically estimated from proportional litter mass loss data using models that assume constant, normally distributed errors. However, such data often show non-normal errors with reduced variance near bounds (0 or 1), potentially leading to biased k estimates. We compared the performance of nonlinear regression using the beta distribution, which is well-suited to bounded data and this type of heteroscedasticity, to standard nonlinear regression (normal errors) on simulated and real litter decomposition data. Although the beta model often provided better fits to the simulated data (based on the corrected Akaike Information Criterion, AIC(c)), standard nonlinear regression was robust to violation of homoscedasticity and gave equally or more accurate k estimates as nonlinear beta regression. Our simulation results also suggest that k estimates will be most accurate when study length captures mid to late stage decomposition (50-80% mass loss) and the number of measurements through time is >= 5. Regression method and data transformation choices had the smallest impact on k estimates during mid and late stage decomposition. Estimates of k were more variable among methods and generally less accurate during early and end stage decomposition. With real data, neither model was predominately best; in most cases the models were indistinguishable based on AICc, and gave similar k estimates. However, when decomposition rates were high, normal and beta model k estimates often diverged substantially. Therefore, we recommend a pragmatic approach where both models are compared and the best is selected for a given data set. Alternatively, both models may be used via model averaging to develop weighted parameter estimates. We provide code to perform nonlinear beta regression with freely available software.	[Laliberte, Etienne] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Adair, E. Carol] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93106 USA; [Hobbie, Sarah E.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Western Australia; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of Minnesota System; University of Minnesota Twin Cities	Adair, EC (corresponding author), Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT 05405 USA.	Carol.Adair@uvm.edu	Laliberté, Etienne/B-6855-2008	Laliberté, Etienne/0000-0002-3167-2622; Adair, E. Carol/0000-0002-8567-9045; Hobbie, Sarah/0000-0001-5159-031X	NSF [EF-0553768]; University of California, Santa Barbara; State of California; University of Western Australia; Australian Research Council (ARC); Office Of The Director [1101317] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; University of Western Australia; Australian Research Council (ARC)(Australian Research Council); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was conducted while E.C.A. was a Postdoctoral Associate at the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant # EF-0553768), the University of California, Santa Barbara, and the State of California. E.L. was supported by fellowships from the University of Western Australia and the Australian Research Council (ARC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair EC, 2010, ECOLOGY, V91, P1225, DOI 10.1890/09-0430.1; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolker B.M., 2010, BBMLE TOOLS GEN MAXI; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Hayes JP, 2006, PHYSIOL BIOCHEM ZOOL, V79, P665, DOI 10.1086/502814; Hobbie SE, 2008, ECOLOGY, V89, P2633, DOI 10.1890/07-1119.1; Hobbie SE, 2005, ECOSYSTEMS, V8, P644, DOI 10.1007/s10021-003-0110-7; Hobbie SE, 2004, OECOLOGIA, V140, P113, DOI 10.1007/s00442-004-1556-9; JANSSEN PHM, 1995, ECOL MODEL, V83, P55, DOI 10.1016/0304-3800(95)00084-9; Laliberte E, 2012, ECOLOGY, V93, P145, DOI 10.1890/11-0338.1; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; PAOLINO P, 2001, POLIT ANAL, V0009; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Scott D, 1999, NEW ZEAL J AGR RES, V42, P365, DOI 10.1080/00288233.1999.9513386; SHAVER GR, 2001, NPP TUNDRA TOOLIK LA; Smithson M, 2006, PSYCHOL METHODS, V11, P54, DOI 10.1037/1082-989X.11.1.54; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Xiao X, 2011, ECOLOGY, V92, P1887, DOI 10.1890/11-0538.1; Zuur Alain F., 2009, P1	19	6	7	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45140	10.1371/journal.pone.0045140	http://dx.doi.org/10.1371/journal.pone.0045140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049771	Green Published, gold			2022-12-27	WOS:000309556100029
J	Li, C; Zhang, Q; Hu, WJ; Mu, H; Lin, Z; Ma, L; Park, YD; Zhou, HM				Li, Chang; Zhang, Qian; Hu, Wei-Jiang; Mu, Hang; Lin, Zong; Ma, Long; Park, Yong-Doo; Zhou, Hai-Meng			Effect of SNPs on Creatine Kinase Structure and Function: Identifying Potential Molecular Mechanisms for Possible Creatine Kinase Deficiency Diseases	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; CARBONIC-ANHYDRASE-II; K+-CL-COTRANSPORTER; NEURODEGENERATIVE DISORDERS; BRAIN; MUSCLE; ALZHEIMERS; ISOENZYMES; STABILITY; TISSUES	Single-nucleotide polymorphisms (SNPs) are common genetic material changes that often occur naturally. SNPs can cause amino acid replacements that may lead to severe diseases, such as the well-known sickle-cell anemia. We constructed eight SNP mutants of human brain-type creatine kinase (CKB) based on bioinformatics predictions. The biochemical and biophysical characteristics of these SNP mutants were determined and compared to those of the wild-type creatine kinase to explore the potential molecular mechanisms of possible creatine kinase SNP-induced diseases. While the reactivation of six SNP mutants after heat shock dropped more than 45%, only three of them showed notable increases in ANS fluorescence intensity and decreases in catalytic efficiency. Among them, H26Y and P36T bind substrates as well as the wildtype form does, but the melting temperatures (T-m) dropped below body temperature, while the T59I mutant exhibited decreased catalytic activity that was most likely due to the much reduced binding affinity of this mutant for substrates. These findings indicate that SNPs such as H26Y, P36T and T59I have the potential to induce genetic diseases by different mechanisms.	[Li, Chang; Zhou, Hai-Meng] Tsinghua Univ, Sch Life Sci, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China; [Zhang, Qian; Ma, Long] Beijing Univ Chinese Med, Sch Basic Med Sci, Beijing, Peoples R China; [Hu, Wei-Jiang; Mu, Hang; Lin, Zong; Park, Yong-Doo; Zhou, Hai-Meng] Tsinghua Univ, Yangtze Delta Reg Inst, Zhejiang Prov Key Lab Appl Enzymol, Jiaxing, Peoples R China; [Zhou, Hai-Meng] Tsinghua Univ, Sch Life Sci, Bejing Key Lab Prot Therapeut, Beijing 100084, Peoples R China	Tsinghua University; Beijing University of Chinese Medicine; Tsinghua University; Tsinghua University	Zhou, HM (corresponding author), Tsinghua Univ, Sch Life Sci, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China.	zhm-dbs@mail.tsinghua.edu.cn	Li, Chang/E-6862-2011; Li, Chang/AAC-6770-2021	Li, Chang/0000-0002-7725-8873; 	National Key Basic Research and Development (973) Program of China [2011CB910800, 2012CB917304]; National Natural Science Foundation of China [31170732]; Zhejiang Natural Science Foundation [LR12C05001]; Zhejiang leading team of Science & Technology innovation [2010R50019]	National Key Basic Research and Development (973) Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang leading team of Science & Technology innovation	This study was supported by the National Key Basic Research and Development (973) Program of China (No. 2011CB910800 and No. 2012CB917304, http://www. most. gov. cn/), and the National Natural Science Foundation of China (No. 31170732, http://www. nsfc. gov. cn), Zhejiang Natural Science Foundation (No. LR12C05001, http://www. zjnsf. gov. cn/) and Zhejiang leading team of Science & Technology innovation (Team No. 2010R50019, http://www. zjkjt. gov. cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov M, 2000, J NEUROCHEM, V74, P2520, DOI 10.1046/j.1471-4159.2000.0742520.x; Aksenov MY, 1997, EXP NEUROL, V146, P458, DOI 10.1006/exnr.1997.6550; Aksenova MV, 1999, DEMENT GERIATR COGN, V10, P158, DOI 10.1159/000017098; Almstedt K, 2004, J MOL BIOL, V342, P619, DOI 10.1016/j.jmb.2004.07.024; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bong SM, 2008, FEBS LETT, V582, P3959, DOI 10.1016/j.febslet.2008.10.039; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; CARNEY DN, 1984, CANCER RES, V44, P5399; Cox JM, 2003, BIOCHEMISTRY-US, V42, P1863, DOI 10.1021/bi027083b; Crowther DC, 2002, HUM MUTAT, V20, P1, DOI 10.1002/humu.10100; EPPENBERGER HM, 1967, J BIOL CHEM, V242, P204; Feng S, 2007, INT J BIOCHEM CELL B, V39, P392, DOI 10.1016/j.biocel.2006.09.004; Galen RS, 1976, CLIN CHEM, V22; Gao YS, 2010, INT J BIOL MACROMOL, V47, P27, DOI 10.1016/j.ijbiomac.2010.03.025; He HW, 2005, BIOPHYS J, V89, P2650, DOI 10.1529/biophysj.105.066142; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; Inoue K, 2006, J NEUROCHEM, V96, P598, DOI 10.1111/j.1471-4159.2005.03560.x; Inoue K, 2004, FEBS LETT, V564, P131, DOI 10.1016/S0014-5793(04)00328-X; Jost CR, 2002, EUR J NEUROSCI, V15, P1692, DOI 10.1046/j.1460-9568.2002.02001.x; KASTE M, 1977, ARCH NEUROL-CHICAGO, V34, P142, DOI 10.1001/archneur.1977.00500150028004; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; NOGUCHI CT, 1985, ANNU REV BIOPHYS BIO, V14, P239, DOI 10.1146/annurev.biophys.14.1.239; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PERMYAKOV EA, 1980, EUR J BIOCHEM, V109, P307, DOI 10.1111/j.1432-1033.1980.tb04796.x; Robertson AD, 1997, CHEM REV, V97, P1251, DOI 10.1021/cr960383c; Ruijs MWG, 2007, EUR J HUM GENET, V15, P110, DOI 10.1038/sj.ejhg.5201715; SCHLEGEL J, 1988, J BIOL CHEM, V263, P16963; Streijger F, 2005, BEHAV BRAIN RES, V157, P219, DOI 10.1016/j.bbr.2004.07.002; Streijger F, 2009, PHYSIOL BEHAV, V97, P76, DOI 10.1016/j.physbeh.2009.02.003; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; TSOU CL, 1993, SCIENCE, V262, P380, DOI 10.1126/science.8211158; Uversky VN, 2003, J PHARM SCI, V92, P847, DOI 10.1002/jps.10355; WALLIMANN T, 1994, MOL CELL BIOCHEM, V133, P193, DOI 10.1007/BF01267955; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wang KJ, 2011, HUM MUTAT, V32, pE2050, DOI 10.1002/humu.21436; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024681; WATTS DC, 1973, ENZYMES, V8, P383; Yamamichi H, 2001, CLIN CHEM, V47, P1967; YAO QZ, 1982, SCI SIN B-CHEM B A M, V25, P1296; Zhao TJ, 2005, J BIOL CHEM, V280, P13470, DOI 10.1074/jbc.M413882200	42	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45949	10.1371/journal.pone.0045949	http://dx.doi.org/10.1371/journal.pone.0045949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049898	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100105
J	Martinez-Morillo, E; Diamandis, A; Romaschin, AD; Diamandis, EP				Martinez-Morillo, Eduardo; Diamandis, Anastasia; Romaschin, Alexander D.; Diamandis, Eleftherios P.			Kallikrein 6 as a Serum Prognostic Marker in Patients with Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							PROTEASE M/NEUROSIN; ALZHEIMERS-DISEASE; SPINAL-CORD; INJURY; DEMYELINATION; DIAGNOSIS; BRAIN	Background: Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating condition that frequently causes death or significant disabilities. Blood tests to predict possible early complications could be very useful aids for therapy. The aim of this study was to analyze serum levels of kallikrein 6 (KLK6) in individuals with aSAH to determine the relevance of this protease with the outcome of these patients. Methodology/Principal Findings: A reference interval for KLK6 was established by using serum samples (n = 136) from an adult population. Additionally, serum samples (n = 326) from patients with aSAH (n = 13) were collected for 5 to 14 days, to study the concentration of KLK6 in this disease. The correlation between KLK6 and S100B, an existing brain damage biomarker, was analyzed in 8 of 13 patients. The reference interval for KLK6 was established to be 1.04 to 3.93 ng/mL. The mean levels in patients with aSAH within the first 56 hours ranged from 0.27 to 1.44 ng/mL, with lowest levels found in patients with worse outcome. There were significant differences between patients with good recovery or moderate disability (n = 8) and patients with severe disability or death (n = 5) (mean values of 1.03 ng/mL versus 0.47 ng/mL, respectively) (p<0.01). There was no significant correlation between KLK6 and S100B. Conclusions/Significance: Decreased serum concentrations of KLK6 are found in patients with aSAH, with the lowest levels in patients who died.	[Martinez-Morillo, Eduardo; Diamandis, Eleftherios P.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Joseph & Wolf Lebovic Hlth Ctr, Toronto, ON M5G 1X5, Canada; [Diamandis, Anastasia; Diamandis, Eleftherios P.] Toronto Gen Hosp, Dept Clin Biochem, Univ Hlth Network, Toronto, ON, Canada; [Romaschin, Alexander D.] Univ Toronto, St Michaels Hosp, Dept Lab Med & Pathobiol, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Diamandis, Eleftherios P.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Diamandis, Eleftherios P.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Diamandis, EP (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Joseph & Wolf Lebovic Hlth Ctr, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	ediamandis@mtsinai.on.ca		Diamandis, Eleftherios/0000-0002-1589-820X				Ashby EL, 2010, BRAIN RES, V1363, P1, DOI 10.1016/j.brainres.2010.09.017; Bando Y, 2006, NEUROSCI LETT, V405, P175, DOI 10.1016/j.neulet.2006.06.030; Blaber SI, 2002, BIOCHEMISTRY-US, V41, P1165, DOI 10.1021/bi015781a; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Edlow JA, 2005, NEUROCRIT CARE, V2, P99, DOI 10.1385/NCC:2:2:099; Ferro JM, 2008, J NEUROL, V255, P465, DOI 10.1007/s00415-008-0606-3; Fraser CG, 2001, BIOL VARIATION PRINC; Lovelock CE, 2010, NEUROLOGY, V74, P1494, DOI 10.1212/WNL.0b013e3181dd42b3; Martin Coleman O, 2011, Mo Med, V108, P124; Martinez-Morillo E, 2012, CLIN CHEM LAB MED, V50, P931, DOI 10.1515/cclm-2012-0075; Menendez-Gonzalez M, 2008, J ALZHEIMERS DIS, V14, P59; Menendez-Gonzalez Manuel, 2008, Int Arch Med, V1, P11, DOI 10.1186/1755-7682-1-11; Nieuwkamp DJ, 2009, LANCET NEUROL, V8, P635, DOI 10.1016/S1474-4422(09)70126-7; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Scarisbrick IA, 2006, EUR J NEUROSCI, V24, P1457, DOI 10.1111/j.1460-9568.2006.05021.x; Scarisbrick IA, 2002, BRAIN, V125, P1283, DOI 10.1093/brain/awf142; Shaw JLV, 2007, CLIN CHEM, V53, P1423, DOI 10.1373/clinchem.2007.088104; Strojnik T, 2009, ANTICANCER RES, V29, P3269; Terayama R, 2004, GLIA, V48, P91, DOI 10.1002/glia.20058; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vos PE, 2006, EUR J NEUROL, V13, P632, DOI 10.1111/j.1468-1331.2006.01332.x; Wang Y, 2008, CELL MOL LIFE SCI, V65, P237, DOI 10.1007/s00018-007-7288-3; Zacharia BE, 2010, NEUROSURG CLIN N AM, V21, P221, DOI 10.1016/j.nec.2009.10.002	23	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45676	10.1371/journal.pone.0045676	http://dx.doi.org/10.1371/journal.pone.0045676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049835	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100066
J	Song, S; Nones, K; Miller, D; Harliwong, I; Kassahn, KS; Pinese, M; Pajic, M; Gill, AJ; Johns, AL; Anderson, M; Holmes, O; Leonard, C; Taylor, D; Wood, S; Xu, QY; Newell, F; Cowley, MJ; Wu, JM; Wilson, P; Fink, L; Biankin, AV; Waddell, N; Grimmond, SM; Pearson, JV				Song, Sarah; Nones, Katia; Miller, David; Harliwong, Ivon; Kassahn, Karin S.; Pinese, Mark; Pajic, Marina; Gill, Anthony J.; Johns, Amber L.; Anderson, Matthew; Holmes, Oliver; Leonard, Conrad; Taylor, Darrin; Wood, Scott; Xu, Qinying; Newell, Felicity; Cowley, Mark J.; Wu, Jianmin; Wilson, Peter; Fink, Lynn; Biankin, Andrew V.; Waddell, Nic; Grimmond, Sean M.; Pearson, John V.			qpure: A Tool to Estimate Tumor Cellularity from Genome-Wide Single-Nucleotide Polymorphism Profiles	PLOS ONE			English	Article							MUTATION DETECTION; SAMPLES	Tumour cellularity, the relative proportion of tumour and normal cells in a sample, affects the sensitivity of mutation detection, copy number analysis, cancer gene expression and methylation profiling. Tumour cellularity is traditionally estimated by pathological review of sectioned specimens; however this method is both subjective and prone to error due to heterogeneity within lesions and cellularity differences between the sample viewed during pathological review and tissue used for research purposes. In this paper we describe a statistical model to estimate tumour cellularity from SNP array profiles of paired tumour and normal samples using shifts in SNP allele frequency at regions of loss of heterozygosity (LOH) in the tumour. We also provide qpure, a software implementation of the method. Our experiments showed that there is a medium correlation 0.42 (p-value = 0.0001) between tumor cellularity estimated by qpure and pathology review. Interestingly there is a high correlation 0.87 (p-value < 2.2e-16) between cellularity estimates by qpure and deep Ion Torrent sequencing of known somatic KRAS mutations; and a weaker correlation 0.32 (p-value = 0.004) between IonTorrent sequencing and pathology review. This suggests that qpure may be a more accurate predictor of tumour cellularity than pathology review. qpure can be downloaded from https://sourceforge.net/projects/qpure/.	[Song, Sarah; Nones, Katia; Miller, David; Harliwong, Ivon; Kassahn, Karin S.; Anderson, Matthew; Holmes, Oliver; Leonard, Conrad; Taylor, Darrin; Wood, Scott; Xu, Qinying; Newell, Felicity; Wilson, Peter; Fink, Lynn; Waddell, Nic; Grimmond, Sean M.; Pearson, John V.] Univ Queensland, Queensland Ctr Med Genom, Inst Mol Biosci, Brisbane, Qld, Australia; [Pinese, Mark; Pajic, Marina; Gill, Anthony J.; Johns, Amber L.; Cowley, Mark J.; Wu, Jianmin; Biankin, Andrew V.] Garvan Inst Med Res, Kinghorn Canc Ctr, Canc Res Program, Sydney, NSW, Australia; [Biankin, Andrew V.] Univ New S Wales, Fac Med, S Western Sydney Clin Sch, Liverpool, NSW, Australia; [Biankin, Andrew V.] Bankstown Hosp, Dept Surg, Sydney, NSW, Australia; [Song, Sarah] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Gill, Anthony J.] Univ Sydney, Sydney, NSW 2006, Australia; [Gill, Anthony J.] Royal N Shore Hosp, Canc Diag Grp, No Canc Translat Res Unit, St Leonards, NSW 2065, Australia	University of Queensland; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Queensland; University of Sydney; Royal North Shore Hospital	Song, S (corresponding author), Univ Queensland, Queensland Ctr Med Genom, Inst Mol Biosci, Brisbane, Qld, Australia.	s.song@imb.uq.edu.au; s.grimmond@imb.uq.edu.au	Leonard, Conrad/AAD-2587-2020; Gill, Anthony/D-4215-2015; Pearson, John/AAT-4211-2020; xu, qinying/I-4259-2012; Waddell, Nicola/H-4929-2015; Pearson, John V/F-2249-2011; Fink, Lynn/C-2031-2008; Cowley, Mark/K-8731-2019; Gill, Anthony J./M-5015-2019; Grimmond, Sean/K-3246-2019; Grimmond, Sean M/J-5304-2016; Nones, Katia/AAX-6453-2021; Newell, Felicity/AAN-1253-2020	Leonard, Conrad/0000-0002-4131-2065; Gill, Anthony/0000-0002-9447-1967; xu, qinying/0000-0002-6933-9139; Waddell, Nicola/0000-0002-3950-2476; Pearson, John V/0000-0003-0904-4598; Fink, Lynn/0000-0003-2912-6048; Cowley, Mark/0000-0002-9519-5714; Grimmond, Sean/0000-0002-8102-7998; Grimmond, Sean M/0000-0002-8102-7998; Nones, Katia/0000-0003-1925-5196; Pajic, Marina/0000-0002-3871-3829; Biankin, Andrew/0000-0002-0362-5597; Kassahn, Karin/0000-0002-1662-3355; Pinese, Mark/0000-0001-5078-6687	National Health and Medical Research Council of Australia (NHMRC) [631701, 535903, 427601]; Australian Government: Department of Innovation, Industry, Science and Research; Australian Cancer Research Foundation; Queensland Government (National and International Research Alliances Program); University of Queensland; Cancer Council New South Wales (NSW) [SRP06-01]; Cancer Institute NSW [06/ECF/1-24, 09/CDF/2-40, 07/CDF/1-03, 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26, 10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26]; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Gastroenterological Society of Australia; American Association for Cancer Research Landon Foundation INNOVATOR Award; Royal Australasian College of Surgeons; Royal Australasian College of Physicians; Royal College of Pathologists of Australasia; Petre Foundation	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government: Department of Innovation, Industry, Science and Research(Australian GovernmentDepartment of Industry, Innovation and Science); Australian Cancer Research Foundation; Queensland Government (National and International Research Alliances Program); University of Queensland(University of Queensland); Cancer Council New South Wales (NSW)(Cancer Council New South Wales); Cancer Institute NSW; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Gastroenterological Society of Australia; American Association for Cancer Research Landon Foundation INNOVATOR Award; Royal Australasian College of Surgeons; Royal Australasian College of Physicians(General Electric); Royal College of Pathologists of Australasia; Petre Foundation	This research has been supported by the National Health and Medical Research Council of Australia (NHMRC; 631701, 535903, 427601); the Australian Government: Department of Innovation, Industry, Science and Research; the Australian Cancer Research Foundation; the Queensland Government (National and International Research Alliances Program); the University of Queensland; the Cancer Council New South Wales (NSW): (SRP06-01); the Cancer Institute NSW: (06/ECF/1-24; 09/CDF/2-40; 07/CDF/1-03; 10/CRF/1-01, 08/RSA/1-15, 07/CDF/1-28, 10/CDF/2-26,10/FRL/2-03, 06/RSA/1-05, 09/RIG/1-02, 10/TPG/1-04, 11/REG/1-10, 11/CDF/3-26); the Garvan Institute of Medical Research; the Avner Nahmani Pancreatic Cancer Research Foundation; the R.T. Hall Trust; the Petre Foundation; the Gastroenterological Society of Australia; the American Association for Cancer Research Landon Foundation INNOVATOR Award; the Royal Australasian College of Surgeons; the Royal Australasian College of Physicians; and the Royal College of Pathologists of Australasia. SG is a recipient of a NHMRC Principal Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Assie G, 2008, AM J HUM GENET, V82, P903, DOI 10.1016/j.ajhg.2008.01.012; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Hartigan JA, 1979, J ROYAL STAT SOC C, V28, P100, DOI DOI 10.2307/2346830; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Nancarrow DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001093; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Steen JA, 2011, NAT METHODS, V8, P548, DOI 10.1038/nmeth.1634; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Yau C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r92	15	97	97	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45835	10.1371/journal.pone.0045835	http://dx.doi.org/10.1371/journal.pone.0045835			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049875	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100089
J	Hoyer, S; Nguon, S; Kim, S; Habib, N; Khim, N; Sum, S; Christophel, EM; Bjorge, S; Thomson, A; Kheng, S; Chea, N; Yok, S; Top, S; Ros, S; Sophal, U; Thompson, MM; Mellor, S; Ariey, F; Witkowski, B; Yeang, C; Yeung, S; Duong, S; Newman, RD; Menard, D				Hoyer, Stefan; Nguon, Sokomar; Kim, Saorin; Habib, Najibullah; Khim, Nimol; Sum, Sarorn; Christophel, Eva-Maria; Bjorge, Steven; Thomson, Andrew; Kheng, Sim; Chea, Nguon; Yok, Sovann; Top, Samphornarann; Ros, Seyha; Sophal, Uth; Thompson, Michelle M.; Mellor, Steve; Ariey, Frederic; Witkowski, Benoit; Yeang, Chhiang; Yeung, Shunmay; Duong, Socheat; Newman, Robert D.; Menard, Didier			Focused Screening and Treatment (FSAT): A PCR-Based Strategy to Detect Malaria Parasite Carriers and Contain Drug Resistant P. falciparum, Pailin, Cambodia	PLOS ONE			English	Article							MEFLOQUINE COMBINATION; PLASMODIUM; EFFICACY; PYRIMETHAMINE; EPIDEMIOLOGY; SURVEILLANCE; ELIMINATION; ARTESUNATE; THERAPY	Recent studies have shown that Plasmodium falciparum malaria parasites in Pailin province, along the border between Thailand and Cambodia, have become resistant to artemisinin derivatives. To better define the epidemiology of P. falciparum populations and to assess the risk of the possible spread of these parasites outside Pailin, a new epidemiological tool named "Focused Screening and Treatment" (FSAT), based on active molecular detection of asymptomatic parasite carriers was introduced in 2010. Cross-sectional malariometric surveys using PCR were carried out in 20 out of 109 villages in Pailin province. Individuals detected as P. falciparum carriers were treated with atovaquone-proguanil combination plus a single dose of primaquine if the patient was non-G6PD deficient. Interviews were conducted to elicit history of cross-border travel that might contribute to the spread of artemisinin-resistant parasites. After directly observed treatment, patients were followed up and re-examined on day 7 and day 28. Among 6931 individuals screened, prevalence of P. falciparum carriers was less than 1%, of whom 96% were asymptomatic. Only 1.6% of the individuals had a travel history or plans to go outside Cambodia, with none of those tested being positive for P. falciparum. Retrospective analysis, using 2010 routine surveillance data, showed significant differences in the prevalence of asymptomatic carriers discovered by FSAT between villages classified as "high risk" and "low risk" based on malaria incidence data. All positive individuals treated and followed-up until day 28 were cured. No mutant-type allele related to atovaquone resistance was found. FSAT is a potentially useful tool to detect, treat and track clusters of asymptomatic carriers of P. falciparum along with providing valuable epidemiological information regarding cross-border movements of potential malaria parasite carriers and parasite gene flow.	[Hoyer, Stefan; Newman, Robert D.] WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland; [Nguon, Sokomar; Kheng, Sim; Chea, Nguon; Yok, Sovann; Top, Samphornarann; Ros, Seyha; Yeang, Chhiang; Duong, Socheat] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Kim, Saorin; Khim, Nimol; Sum, Sarorn; Witkowski, Benoit; Menard, Didier] Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Habib, Najibullah; Bjorge, Steven; Thomson, Andrew] WHO, Phnom Penh, Cambodia; [Christophel, Eva-Maria] WHO, Reg Off Western Pacific, Manila, Philippines; [Sophal, Uth; Thompson, Michelle M.; Mellor, Steve] Malaria Consortium, Manila, Philippines; [Ariey, Frederic] Inst Pasteur, Unite Immunol Mol Parasites, Paris, France; [Yeung, Shunmay] London Sch Hyg & Trop Med, Malaria Ctr, London WC1, England	World Health Organization; National Center Parasitology, Entomology & Malaria Control; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; World Health Organization; WHO Western Pacific Regional Office; World Health Organization; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of London; London School of Hygiene & Tropical Medicine	Hoyer, S (corresponding author), WHO, Global Malaria Programme, CH-1211 Geneva, Switzerland.	hoyers@who.int; dmenard@pasteur-kh.org	ariey, frederic/P-1185-2017; Menard, Didier/O-3294-2013; Witkowski, Benoit/T-1118-2019	ariey, frederic/0000-0002-0680-1090; Menard, Didier/0000-0003-1357-4495; Yeung, Shunmay/0000-0002-0997-0850	Bill & Melinda Gates Foundation [48821.01]; WHO under the title: "A strategy for the containment of artemisinin tolerant malaria parasites in SE Asia''; French Ministry of Foreign Affairs	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); WHO under the title: "A strategy for the containment of artemisinin tolerant malaria parasites in SE Asia''; French Ministry of Foreign Affairs	The funding of this operational research was provided by the Bill & Melinda Gates Foundation (Grant No 48821.01) and WHO under the title: "A strategy for the containment of artemisinin tolerant malaria parasites in SE Asia''. Didier Menard was supported by the French Ministry of Foreign Affairs during this work. Shunmay Yeung was the ARC programme was operational research coordinator during the early planning stages of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CONT MAL MULT RES CA; [Anonymous], 2007, METHODS TECHNIQUES C; Atkinson JA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-101; Cattamanchi A, 2003, AM J TROP MED HYG, V68, P133, DOI 10.4269/ajtmh.2003.68.133; CONTACOS PETER G., 1963, TRANS ROY SOC TROP MED HYG, V57, P417, DOI 10.1016/0035-9203(63)90074-9; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; DENIS MB, 1991, FOLIA PARASIT, V38, P187; Denis MB, 2006, TROP MED INT HEALTH, V11, P1800, DOI 10.1111/j.1365-3156.2006.01739.x; Denis MB, 2006, TROP MED INT HEALTH, V11, P1360, DOI 10.1111/j.1365-3156.2006.01690.x; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Goudet J., 2003, FSTAT VERSION 2 9 4; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HOFLER W, 1980, DEUT MED WOCHENSCHR, V105, P350; Khamsiriwatchara A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-120; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028357; Korsinczky M, 2000, ANTIMICROB AGENTS CH, V44, P2100, DOI 10.1128/AAC.44.8.2100-2108.2000; Kuwahata M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-223; Littrell M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-328; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; NEI M, 1978, GENETICS, V89, P583; Phyo AP, 2012, LANCET; Rogers WO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-10; Shewchuk T, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-325; SMITHUIS FM, 1993, ANTIMICROB AGENTS CH, V37, P1977, DOI 10.1128/AAC.37.9.1977; Steenkeste N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-86; VERDRAGER J, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P111; VERDRAGER J, 1986, J TROP MED HYG, V89, P277; Verdrager Jacques, 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P23; Wangroongsarb P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-117; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; World Health Organization, 2009, METH SURV ANT DRUG E; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Yasuoka J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-4; Yeung S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-243; Yeung S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-96	37	55	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45797	10.1371/journal.pone.0045797	http://dx.doi.org/10.1371/journal.pone.0045797			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049687	gold, Green Published, Green Accepted			2022-12-27	WOS:000309388500014
J	Nishimura, M; Song, WJ				Nishimura, Masataka; Song, Wen-Jie			Temporal Sequence of Visuo-Auditory Interaction in Multiple Areas of the Guinea Pig Visual Cortex	PLOS ONE			English	Article							MULTISENSORY INTERACTIONS; NEURONAL OSCILLATIONS; ANATOMICAL EVIDENCE; OBJECT RECOGNITION; SENSORY CORTICES; STRIATE CORTEX; MACAQUE MONKEY; BARREL CORTEX; IN-VIVO; HUMANS	Recent studies in humans and monkeys have reported that acoustic stimulation influences visual responses in the primary visual cortex (V1). Such influences can be generated in V1, either by direct auditory projections or by feedback projections from extrastriate cortices. To test these hypotheses, cortical activities were recorded using optical imaging at a high spatiotemporal resolution from multiple areas of the guinea pig visual cortex, to visual and/or acoustic stimulations. Visuo-auditory interactions were evaluated according to differences between responses evoked by combined auditory and visual stimulation, and the sum of responses evoked by separate visual and auditory stimulations. Simultaneous presentation of visual and acoustic stimulations resulted in significant interactions in V1, which occurred earlier than in other visual areas. When acoustic stimulation preceded visual stimulation, significant visuo-auditory interactions were detected only in V1. These results suggest that V1 is a cortical origin of visuo-auditory interaction.	[Nishimura, Masataka; Song, Wen-Jie] Kumamoto Univ, Dept Sensory & Cognit Physiol, Grad Sch Med Sci, Kumamoto, Japan	Kumamoto University	Song, WJ (corresponding author), Kumamoto Univ, Dept Sensory & Cognit Physiol, Grad Sch Med Sci, Kumamoto, Japan.	song@kumamoto-u.ac.jp		Song, Wen-Jie/0000-0003-2909-3098; Nishimura, Masataka/0000-0002-3309-458X	Ministry of Education, Culture, Sports, Science and Technology of Japan [23115516]; JSPS [20300112, 22220004, 23659797];  [203900]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); 	This work was supported by a Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Fellows #203900, a Grant-in-Aid for Scientific Research on Innovative Areas "Mesoscopic Neurocircuitry'' (#23115516) of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and JSPS grants (#20300112, #22220004, and #23659797). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTH DS, 1995, BRAIN RES, V678, P177, DOI 10.1016/0006-8993(95)00182-P; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Bizley JK, 2009, HEARING RES, V258, P55, DOI 10.1016/j.heares.2009.06.017; Bizley JK, 2008, BRAIN RES, V1242, P24, DOI 10.1016/j.brainres.2008.02.087; Campi KL, 2010, CEREB CORTEX, V20, P89, DOI 10.1093/cercor/bhp082; Cappe C, 2009, HEARING RES, V258, P28, DOI 10.1016/j.heares.2009.04.017; Cappe C, 2010, J NEUROSCI, V30, P12572, DOI 10.1523/JNEUROSCI.1099-10.2010; Clancy B, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.007.2010; COHEN LB, 1978, ANNU REV NEUROSCI, V1, P171, DOI 10.1146/annurev.ne.01.030178.001131; Falchier A, 2002, J NEUROSCI, V22, P5749; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Fujita S, 2010, NEUROSCIENCE, V165, P278, DOI 10.1016/j.neuroscience.2009.09.073; FUKUNISHI K, 1992, BIOL CYBERN, V67, P501, DOI 10.1007/BF00198757; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; GRINVALD A, 1994, J NEUROSCI, V14, P2545; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; Hall AJ, 2008, EXP BRAIN RES, V190, P413, DOI 10.1007/s00221-008-1485-7; Horikawa J, 1996, J PHYSIOL-LONDON, V497, P629, DOI 10.1113/jphysiol.1996.sp021795; Inui K, 2006, J NEUROPHYSIOL, V96, P775, DOI 10.1152/jn.00103.2006; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Kayser C, 2008, CEREB CORTEX, V18, P1560, DOI 10.1093/cercor/bhm187; Kayser C, 2007, BRAIN STRUCT FUNCT, V212, P121, DOI 10.1007/s00429-007-0154-0; Kubota M, 2008, NEUROREPORT, V19, P1691, DOI 10.1097/WNR.0b013e32831579ff; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2007, NEURON, V53, P279, DOI 10.1016/j.neuron.2006.12.011; Lakatos P, 2009, NEURON, V64, P419, DOI 10.1016/j.neuron.2009.10.014; Maeda S, 2001, NEUROSCI LETT, V302, P137, DOI 10.1016/S0304-3940(01)01678-0; Meirovithz E, 2010, CEREB CORTEX, V20, P1293, DOI 10.1093/cercor/bhp191; Molholm S, 2004, CEREB CORTEX, V14, P452, DOI 10.1093/cercor/bhh007; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Nishimura M, 2006, NEUROSCI RES, V54, P230, DOI 10.1016/j.neures.2005.12.002; Nishimura M, 2007, J NEUROPHYSIOL, V97, P927, DOI 10.1152/jn.00689.2006; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2001, J NEUROSCI, V21, P8435, DOI 10.1523/JNEUROSCI.21-21-08435.2001; Raij T, 2010, EUR J NEUROSCI, V31, P1772, DOI 10.1111/j.1460-9568.2010.07213.x; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Saitoh K, 2010, NEUROSCI RES, V68, P107, DOI 10.1016/j.neures.2010.06.009; Schmolesky MT, 1998, J NEUROPHYSIOL, V79, P3272, DOI 10.1152/jn.1998.79.6.3272; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Song WJ, 2006, CEREB CORTEX, V16, P718, DOI 10.1093/cercor/bhj018; SPATZ WB, 1991, EXP BRAIN RES, V84, P495; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Takagaki K, 2008, NEUROSCI LETT, V431, P191, DOI 10.1016/j.neulet.2007.11.069; Teder-Salejarvi WA, 2002, COGNITIVE BRAIN RES, V14, P106, DOI 10.1016/S0926-6410(02)00065-4; Wallace MN, 2000, EXP BRAIN RES, V132, P445, DOI 10.1007/s002210000362; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; Wang Y, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-79; Watkins S, 2006, NEUROIMAGE, V31, P1247, DOI 10.1016/j.neuroimage.2006.01.016; WREE A, 1981, ANAT EMBRYOL, V162, P81, DOI 10.1007/BF00318096; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016	52	7	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46339	10.1371/journal.pone.0046339	http://dx.doi.org/10.1371/journal.pone.0046339			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029483	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900136
J	Rampal, S; Mahadeva, S; Guallar, E; Bulgiba, A; Mohamed, R; Rahmat, R; Arif, MT; Rampal, L				Rampal, Sanjay; Mahadeva, Sanjiv; Guallar, Eliseo; Bulgiba, Awang; Mohamed, Rosmawati; Rahmat, Ramlee; Arif, Mohamad Taha; Rampal, Lekhraj			Ethnic Differences in the Prevalence of Metabolic Syndrome: Results from a Multi-Ethnic Population-Based Survey in Malaysia	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; BODY-COMPOSITION; COMPONENTS; DISEASE; ADULTS	Introduction: The prevalence of metabolic syndrome is increasing disproportionately among the different ethnicities in Asia compared to the rest of the world. This study aims to determine the differences in the prevalence of metabolic syndrome across ethnicities in Malaysia, a multi-ethnic country. Methods: In 2004, we conducted a national cross-sectional population-based study using a stratified two-stage cluster sampling design (N = 17,211). Metabolic syndrome was defined according to the International Diabetes Federation/National Heart, Lung and Blood Institute/American Heart Association (IDF/NHLBI/AHA-2009) criteria. Multivariate models were used to study the independent association between ethnicity and the prevalence of the metabolic syndrome. Results: The overall mean age was 36.9 years, and 50.0% participants were female. The ethnic distribution was 57.0% Malay, 28.5% Chinese, 8.9% Indian and 5.0% Indigenous Sarawakians. The overall prevalence of the metabolic syndrome was 27.5%, with a prevalence of central obesity, raised triglycerides, low high density lipoprotein cholesterol, raised blood pressure and raised fasting glucose of 36.9%, 29.3%, 37.2%, 38.0% and 29.1%, respectively. Among those,40 years, the adjusted prevalence ratios for metabolic syndrome for ethnic Chinese, Indians, and Indigenous Sarawakians compared to ethnic Malay were 0.81 (95% CI 0.67 to 0.96), 1.42 (95% CI 1.19 to 1.69) and 1.37 (95% CI 1.08 to 1.73), respectively. Among those aged >= 40 years, the corresponding prevalence ratios were 0.86 (95% CI 0.79 to 0.92), 1.25 (95% CI 1.15 to 1.36), and 0.94 (95% CI 0.80, 1.11). The P-value for the interaction of ethnicity by age was 0.001. Conclusions: The overall prevalence of metabolic syndrome in Malaysia was high, with marked differences across ethnicities. Ethnic Chinese had the lowest prevalence of metabolic syndrome, while ethnic Indians had the highest. Indigenous Sarawakians showed a marked increase in metabolic syndrome at young ages.	[Rampal, Lekhraj] Univ Putra Malaysia, Fac Med & Hlth Sci, Serdang, Malaysia; [Rampal, Sanjay; Bulgiba, Awang] Univ Malaya, Fac Med, Julius Ctr, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Rampal, Sanjay; Guallar, Eliseo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Rampal, Sanjay; Guallar, Eliseo] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA; [Mahadeva, Sanjiv; Mohamed, Rosmawati] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Guallar, Eliseo] Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; [Guallar, Eliseo] Natl Ctr Cardiovasc Res CNIC, Area Cardiovasc Epidemiol & Populat Genet, Madrid, Spain; [Rahmat, Ramlee] Minist Hlth, Putrajaya, Malaysia; [Arif, Mohamad Taha] Univ Sarawak Malaysia, Fac Med & Hlth Sci, Sarawak, Malaysia	Universiti Putra Malaysia; Universiti Malaya; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universiti Malaya; Johns Hopkins University; Johns Hopkins Medicine; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Kementerian Kesihatan Malaysia; University of Malaysia Sarawak	Rampal, L (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Serdang, Malaysia.	rampal@medic.upm.edu.my	Bulgiba, Awang/B-8271-2010; Guallar, Eliseo/D-3807-2014; Rampal, Lekhraj/G-6117-2010; Rampal, Sanjay/B-9691-2010; Mahadeva, Sanjiv/E-1711-2011	Bulgiba, Awang/0000-0002-5313-0445; Guallar, Eliseo/0000-0002-4471-9565; Rampal, Sanjay/0000-0002-0105-6407; Mahadeva, Sanjiv/0000-0001-5824-0590	Ministry of Science, Technology and Environment (MOSTE) IRPA Project [06-02-04-0000-PR-0041/05-03]	Ministry of Science, Technology and Environment (MOSTE) IRPA Project	The authors are grateful to the Director General of Health, Ministry of Health Malaysia, all the State Directors of Medical and Health Services and their staff for their assistance. This study is part of the National study on Cardio-Vascular Disease Risk Factors and funded by Ministry of Science, Technology and Environment (MOSTE) IRPA Project Grant No. 06-02-04-0000-PR-0041/05-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aekplakorn W, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-854; Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; Bhardwaj S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024362; Borch-Johnsen K, 2007, DAN MED BULL, V54, P157; Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005; Chowdhury B, 1996, METABOLISM, V45, P634, DOI 10.1016/S0026-0495(96)90036-0; Das Mithun, 2010, J Cardiovasc Dis Res, V1, P130, DOI 10.4103/0975-3583.70911; Das Mithun, 2010, J Cardiovasc Dis Res, V1, P86, DOI 10.4103/0975-3583.64442; Department of Statistics Malaysia, 2000, POP DISTR BAS DEM CH; Ghosh Arnab, 2010, J Cardiovasc Dis Res, V1, P81, DOI 10.4103/0975-3583.64441; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Health IoP, 2006, NAT HLTH MORB SURV N; Kuk JL, 2010, DIABETES CARE, V33, P2457, DOI 10.2337/dc10-0942; Lao XQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-64; Lian CW, 2011, MALAYS J MED SCI, V18, P58; Malik A, 2007, J DIG DIS, V8, P58, DOI 10.1111/j.1443-9573.2007.00286.x; Misra A, 2009, BRIT J NUTR, V101, P465, DOI 10.1017/S0007114508073649; Mohamud WNW, 2011, DIABETES RES CLIN PR, V91, P239, DOI 10.1016/j.diabres.2010.11.025; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Narayanan P, 2011, METAB SYNDR RELAT D, V9, P389, DOI 10.1089/met.2011.0014; Nestel P, 2007, ASIA PAC J CLIN NUTR, V16, P362; Nuur Amalina A G, 2012, Med J Malaysia, V67, P31; Pandit Kaushik, 2012, Indian J Endocrinol Metab, V16, P44, DOI 10.4103/2230-8210.91187; Polotsky HN, 2010, SEMIN REPROD MED, V28, P426, DOI 10.1055/s-0030-1262902; Rampal L, 2008, PUBLIC HEALTH, V122, P11, DOI 10.1016/j.puhe.2007.05.008; Rampal L, 2007, ASIA PAC J CLIN NUTR, V16, P561; Rampal S, 2010, ASIA-PAC J PUBLIC HE, V22, P194, DOI 10.1177/1010539509334816; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Tan AKG, 2011, METAB SYNDR RELAT D, V9, P441, DOI 10.1089/met.2011.0031; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Venkataraman R, 2004, AM J CARDIOL, V94, P977, DOI 10.1016/j.amjcard.2004.06.048; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Zainuddin LRM, 2011, INT J PREVENTIVE MED, V2, P229	34	73	75	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46365	10.1371/journal.pone.0046365	http://dx.doi.org/10.1371/journal.pone.0046365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029497	gold, Green Published			2022-12-27	WOS:000309973900144
J	Wu, QF; Sun, CC; Lin, HY; Babitt, JL				Wu, Qifang; Sun, Chia Chi; Lin, Herbert Y.; Babitt, Jodie L.			Repulsive Guidance Molecule (RGM) Family Proteins Exhibit Differential Binding Kinetics for Bone Morphogenetic Proteins (BMPs)	PLOS ONE			English	Article							NEURAL-TUBE CLOSURE; HEPCIDIN EXPRESSION; NEOGENIN INTERACTS; IRON OVERLOAD; HEMOJUVELIN; MEMBRANE; INHIBITION; PROMOTES; DRAGON; RECEPTORS	Bone morphogenetic proteins (BMPs) are members of the transforming growth factor beta superfamily that exert their effects via type I and type II serine threonine kinase receptors and the SMAD intracellular signaling pathway to regulate diverse biologic processes. Recently, we discovered that the repulsive guidance molecule (RGM) family, including RGMA, RGMB, and RGMC/hemojuvelin (HJV), function as co-receptors that enhance cellular responses to BMP ligands. Here, we use surface plasmon resonance to quantitate the binding kinetics of RGM proteins for BMP ligands. We show that among the RGMs, HJV exhibits the highest affinity for BMP6, BMP5, and BMP7 with KD 8.1, 17, and 20 nM respectively, versus 28, 33, and 166 nM for RGMB, and 55, 83, and 63 nM for RGMA. Conversely, RGMB exhibits preferential binding to BMP4 and BMP2 with KD 2.6 and 5.5 nM respectively, versus 4.5 and 9.4 nM for HJV, and 14 and 22 nM for RGMA, while RGMA exhibits the lowest binding affinity for most BMPs tested. Among the BMP ligands, RGMs exhibit the highest relative affinity for BMP4 and the lowest relative affinity for BMP7, while none of the RGMs bind to BMP9. Thus, RGMs exhibit preferential binding for distinct subsets of BMP ligands. The preferential binding of HJV for BMP6 is consistent with the functional role of HJV and BMP6 in regulating systemic iron homeostasis. Our data may help explain the mechanism by which BMPs exert cell-context specific effects via a limited number of type I and type II receptors.	[Babitt, Jodie L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Anemia Signaling Res,Div Nephrol, Boston, MA 02114 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Syst Biol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Babitt, JL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Program Anemia Signaling Res,Div Nephrol, Boston, MA 02114 USA.	babitt.jodie@mgh.harvard.edu			National Institutes of Health [K08-DK075846, RO1-DK087727, RO1 DK-069533, RO1 DK-071837]; Massachusetts General Hospital; National Center for Research Resources; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 RR 025758]; Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069533, K08DK075846, R01DK071837, R01DK087727] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital(General Electric); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Harvard University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the National Institutes of Health [grant numbers K08-DK075846, RO1-DK087727 (to J.L.B.), RO1 DK-069533, and RO1 DK-071837 (to H.Y.L.)] and a Claflin Distinguished Scholar Award from the Massachusetts General Hospital (to J.L.B.). This work was conducted with support from Harvard Catalyst/The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health [Award #UL1 RR 025758] and financial contributions from Harvard University and its affiliated academic health care centers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; Babitt JL, 2007, J CLIN INVEST, V117, P1933, DOI 10.1172/JCI31342; Brasse-Lagnel C, 2010, HAEMATOL-HEMATOL J, V95, P2031, DOI 10.3324/haematol.2010.022129; Brinks H, 2004, J NEUROSCI, V24, P3862, DOI 10.1523/JNEUROSCI.5296-03.2004; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; Celeste AJ, 1994, J BONE MINER RES  S1, V9, pS136; Chen WJ, 2013, HAEMATOLOGICA, V98, P296, DOI 10.3324/haematol.2012.070136; Corradini E, 2010, GASTROENTEROLOGY, V139, P1721, DOI 10.1053/j.gastro.2010.07.044; Corradini E, 2009, CYTOKINE GROWTH F R, V20, P389, DOI 10.1016/j.cytogfr.2009.10.008; Halbrooks Peter J, 2007, J Mol Signal, V2, P4, DOI 10.1186/1750-2187-2-4; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049; Kee N, 2008, J NEUROSCI, V28, P12643, DOI 10.1523/JNEUROSCI.4265-08.2008; Koeberle PD, 2010, NEUROSCIENCE, V169, P495, DOI 10.1016/j.neuroscience.2010.04.079; Kuninger David, 2008, BMC Biochemistry, V9, P9, DOI 10.1186/1471-2091-9-9; Lin L, 2005, BLOOD, V106, P2884, DOI 10.1182/blood-2005-05-1845; Lin L, 2011, BLOOD CELL MOL DIS, V40, P122; Ma CHE, 2011, J NEUROSCI, V31, P18391, DOI 10.1523/JNEUROSCI.4550-11.2011; Maes K, 2010, BLOOD, V116, P3635, DOI 10.1182/blood-2010-03-274571; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Monnier PP, 2002, NATURE, V419, P392, DOI 10.1038/nature01041; Muramatsu R, 2011, NAT MED, V17, P488, DOI 10.1038/nm.2321; Niederkofler V, 2004, J NEUROSCI, V24, P808, DOI 10.1523/JNEUROSCI.4610-03.2004; Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683; Oldekamp J, 2004, GENE EXPR PATTERNS, V4, P283, DOI 10.1016/j.modgep.2003.11.008; Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Samad TA, 2004, J NEUROSCI, V24, P2027, DOI 10.1523/JNEUROSCI.4115-03.2004; Saremba S, 2008, FEBS J, V275, P172, DOI 10.1111/j.1742-4658.2007.06187.x; Schmidtmer J, 2004, GENE EXPR PATTERNS, V4, P105, DOI 10.1016/S1567-133X(03)00144-3; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Tassew NG, 2012, DEV CELL, V22, P391, DOI 10.1016/j.devcel.2011.11.022; Theurl I, 2011, BLOOD, V118, P4977, DOI 10.1182/blood-2011-03-345066; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; Xia Y, 2008, BLOOD, V111, P5195, DOI 10.1182/blood-2007-09-111567; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Xia Y, 2011, J IMMUNOL, V186, P1369, DOI 10.4049/jimmunol.1002047; Xia Y, 2010, J AM SOC NEPHROL, V21, P666, DOI 10.1681/ASN.2009050511; Yang F, 2008, BIOCHEMISTRY-US, V47, P4237, DOI 10.1021/bi800036h; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang AS, 2007, J BIOL CHEM, V282, P12547, DOI 10.1074/jbc.M608788200	52	39	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46307	10.1371/journal.pone.0046307	http://dx.doi.org/10.1371/journal.pone.0046307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029472	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500087
J	Alonso-Perez, E; Suarez-Gestal, M; Calaza, M; Ordi-Ros, J; Balada, E; Bijl, M; Papasteriades, C; Carreira, P; Skopouli, FN; Witte, T; Endreffy, E; Marchini, M; Migliaresi, S; Sebastiani, GD; Santos, MJ; Suarez, A; Blanco, FJ; Barizzone, N; Pullmann, R; Ruzickova, S; Lauwerys, BR; Gomez-Reino, JJ; Gonzalez, A				Alonso-Perez, Elisa; Suarez-Gestal, Marian; Calaza, Manuel; Ordi-Ros, Josep; Balada, Eva; Bijl, Marc; Papasteriades, Chryssa; Carreira, Patricia; Skopouli, Fotini N.; Witte, Torsten; Endreffy, Emoeke; Marchini, Maurizio; Migliaresi, Sergio; Sebastiani, Gian Domenico; Santos, Maria Jose; Suarez, Ana; Blanco, Francisco J.; Barizzone, Nadia; Pullmann, Rudolf; Ruzickova, Sarka; Lauwerys, Bernard R.; Gomez-Reino, Juan J.; Gonzalez, Antonio		European Consortium SLE DNA Collec	Further Evidence of Subphenotype Association with Systemic Lupus Erythematosus Susceptibility Loci: A European Cases Only Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DISEASE SUSCEPTIBILITY; GENETIC SUSCEPTIBILITY; ITGAM; RISK; SLE; NEPHRITIS; VARIANTS; MANIFESTATIONS; POLYMORPHISMS	Introduction: Systemic Lupus Erythematosus (SLE) shows a spectrum of clinical manifestations that complicate its diagnosis, treatment and research. This variability is likely related with environmental exposures and genetic factors among which known SLE susceptibility loci are prime candidates. The first published analyses seem to indicate that this is the case for some of them, but results are still inconclusive and we aimed to further explore this question. Methods: European SLE patients, 1444, recruited at 17 centres from 10 countries were analyzed. Genotypes for 26 SLE associated SNPs were compared between patients with and without each of 11 clinical features: ten of the American College of Rheumatology (ACR) classification criteria (except ANAs) and age of disease onset. These analyses were adjusted for centre of recruitment, top ancestry informative markers, gender and time of follow-up. Overlap of samples with previous studies was excluded for assessing replication. Results: There were three new associations: the SNPs in XKR6 and in FAM167A-BLK were associated with lupus nephritis (OR = 0.76 and 1.30, P-corr = 0.007 and 0.03, respectively) and the SNP of MECP2, which is in chromosome X, with earlier age of disease onset in men. The previously reported association of STAT4 with early age of disease onset was replicated. Some other results were suggestive of the presence of additional associations. Together, the association signals provided support to some previous findings and to the characterization of lupus nephritis, autoantibodies and age of disease onset as the clinical features more associated with SLE loci. Conclusion: Some of the SLE loci shape the disease phenotype in addition to increase susceptibility to SLE. This influence is more prominent for some clinical features than for others. However, results are only partially consistent between studies and subphenotype specific GWAS are needed to unravel their genetic component.	[Alonso-Perez, Elisa; Suarez-Gestal, Marian; Calaza, Manuel; Gomez-Reino, Juan J.; Gonzalez, Antonio] Univ Santiago, Hosp Clin, Inst Invest Sanitaria, Lab Invest 10, Santiago De Compostela, Spain; [Alonso-Perez, Elisa; Suarez-Gestal, Marian; Calaza, Manuel; Gomez-Reino, Juan J.; Gonzalez, Antonio] Univ Santiago, Hosp Clin, Inst Invest Sanitaria, Rheumatol Unit, Santiago De Compostela, Spain; [Ordi-Ros, Josep; Balada, Eva] Hosp Valle De Hebron, Res Lab Autoimmune Dis, Barcelona, Spain; [Bijl, Marc] Martini Hosp, Dept Internal Med & Rheumatol, Groningen, Netherlands; [Papasteriades, Chryssa] Evangelismos Med Ctr, Dept Histocompatibil & Immunol, Athens, Greece; [Carreira, Patricia] Hosp 12 Octubre, Dept Rheumatol, E-28041 Madrid, Spain; [Skopouli, Fotini N.] Univ Athens, Sch Med, Dept Pathophysiol, GR-11527 Athens, Greece; [Witte, Torsten] Hannover Med Sch, Dept Internal Med, Div Clin Immunol, D-3000 Hannover, Germany; [Endreffy, Emoeke] Univ Szeged, Albert Szent Gyorgyi Med Ctr, Dept Paediat, Szeged, Hungary; [Marchini, Maurizio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Referral Ctr Syst Autoimmune Dis, Milan, Italy; [Marchini, Maurizio] Univ Milan, Milan, Italy; [Migliaresi, Sergio] Univ Naples 2, Rheumatol Unit, Naples, Italy; [Sebastiani, Gian Domenico] Azienda Osped San Camillo Forlanini, UOC Reumatol, Rome, Italy; [Santos, Maria Jose] Hosp Garcia de Orta, Dept Rheumatol, Lisbon, Portugal; [Santos, Maria Jose] Inst Mol Med, Rheumatol Res Unit, Lisbon, Portugal; [Suarez, Ana] Univ Oviedo, Hosp Univ Cent Asturias, Dept Funct Biol, Oviedo, Spain; [Blanco, Francisco J.] INIBIC CH Univ A Coruna, La Coruna, Spain; [Barizzone, Nadia] Eastern Piedmont Univ, Dept Med Sci, Novara, Italy; [Barizzone, Nadia] Eastern Piedmont Univ, IRCAD, Novara, Italy; [Pullmann, Rudolf] Martin Fac Hosp, Jessenius Med Fac, Inst Clin Biochem, Martin, Slovakia; [Ruzickova, Sarka] Acad Sci Czech Republic, Inst Biotechnol, Prague, Czech Republic; [Lauwerys, Bernard R.] Clin Univ St Luc, B-1200 Brussels, Belgium; [Lauwerys, Bernard R.] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Gomez-Reino, Juan J.] Univ Santiago de Compostela, Dept Med, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Hospital Universitari Vall d'Hebron; Martini Hospital; Evangelismos Hospital; Hospital Universitario 12 de Octubre; Athens Medical School; National & Kapodistrian University of Athens; Hannover Medical School; Szeged University; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Universita della Campania Vanvitelli; Azienda Ospedaliera San Camillo-Forlanini; Hospital Garcia de Orta; Universidade de Lisboa; Central University Hospital Asturias; University of Oviedo; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Comenius University Bratislava; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Universidade de Santiago de Compostela	Gonzalez, A (corresponding author), Univ Santiago, Hosp Clin, Inst Invest Sanitaria, Lab Invest 10, Santiago De Compostela, Spain.	Antonio.Gonzalez.Martinez-Pedrayo@sergas.es	Gonzalez, Antonio/C-4444-2008; Carreira, Patricia E/D-4429-2018; Santos, Maria Jose/N-6913-2014; Witte, Torsten/B-5783-2016; Suarez, Ana/F-4492-2015; Blanco, Francisco J./C-3192-2014; Gomez-Reino, Juan/ABI-2853-2020; D'Alfonso, Sandra/K-7295-2014	Gonzalez, Antonio/0000-0002-2624-0606; Carreira, Patricia E/0000-0001-8279-3806; Santos, Maria Jose/0000-0002-7946-1365; Suarez, Ana/0000-0002-4452-7539; Blanco, Francisco J./0000-0001-9821-7635; Calaza Cabanas, Manuel/0000-0003-3082-525X; Rapa, Anna/0000-0002-5523-5224; Gomez-Reino, Juan/0000-0001-5229-6294; D'Alfonso, Sandra/0000-0002-3983-9925; Sebastiani, Gian Domenico/0000-0003-2969-6649	Instituto de Salud Carlos III (Spain); Instituto de Salud Carlos III (Spain) [RD08/0075]; European Regional Development Fund of the European Union; Xunta de Galicia; DFG [KFO 250, TP 03];  [08/0744];  [11/01048]	Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); European Regional Development Fund of the European Union; Xunta de Galicia(Xunta de GaliciaEuropean Commission); DFG(German Research Foundation (DFG)); ; 	EA-P is the recipient of a pre-doctoral bursary of the Instituto de Salud Carlos III (Spain). This work was supported by grants 08/0744 and 11/01048 and by RETICS Program, RD08/0075 (RIER) of the Instituto de Salud Carlos III (Spain) that are partially financed by the European Regional Development Fund of the European Union, and by grants from the Xunta de Galicia and by DFG KFO 250, TP 03 to TW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Arfaj AS, 2009, LUPUS, V18, P465, DOI 10.1177/0961203308100660; Alarcon GS, 2002, LUPUS, V11, P95, DOI 10.1191/0961203302lu155oa; Alonso-Perez E, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3818; Alonso-Perez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029033; Budarf ML, 2011, GENES IMMUN, V12, P51, DOI 10.1038/gene.2010.47; Cervera R, 2006, AUTOIMMUN REV, V5, P180, DOI 10.1016/j.autrev.2005.06.004; Chung SA, 2009, ARTHRITIS RHEUM-US, V60, P2448, DOI 10.1002/art.24707; Deng Y, 2010, NAT REV RHEUMATOL, V6, P683, DOI 10.1038/nrrheum.2010.176; Eisenberg R, 2009, J AUTOIMMUN, V32, P223, DOI 10.1016/j.jaut.2009.02.006; Ferreiro-Neira I, 2007, GENES IMMUN, V8, P429, DOI 10.1038/sj.gene.6364407; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Graham DSC, 2008, GENES IMMUN, V9, P93, DOI 10.1038/sj.gene.6364453; Graham DSC, 2008, NAT GENET, V40, P83, DOI 10.1038/ng.2007.47; Gregersen PK, 2006, SEMIN IMMUNOL, V18, P214, DOI 10.1016/j.smim.2006.03.009; Guillemin F, 2007, NAT CLIN PRACT RHEUM, V3, P407, DOI 10.1038/ncprheum0528; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Karassa FB, 2003, KIDNEY INT, V63, P1475, DOI 10.1046/j.1523-1755.2003.00873.x; Kim-Howard X, 2009, ANN RHEUM DIS; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Lauwerys B, 2005, LUPUS, V14, P2, DOI 10.1191/0961203305lu2052oa; Moser KL, 2009, GENES IMMUN, V10, P373, DOI 10.1038/gene.2009.39; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nath SK, 2008, NAT GENET, V40, P152, DOI 10.1038/ng.71; Pons-Estel BA, 2004, MEDICINE, V83, P1, DOI 10.1097/01.md.0000104742.42401.e2; Rhodes B, 2008, RHEUMATOLOGY, V47, P1603, DOI 10.1093/rheumatology/ken247; Richman IB, 2010, GENES IMMUN, V11, P515, DOI 10.1038/gene.2009.80; Sanchez E, 2011, ANN RHEUM DIS, V70, P1752, DOI 10.1136/ard.2011.154104; Sawalha AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001727; Sestak AL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2176; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sigurdsson S, 2008, HUM MOL GENET, V17, P2868, DOI 10.1093/hmg/ddn184; Suarez-Gestal M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2698; Taylor KE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000084; Taylor KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001311; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tsao BP, 2004, CURR OPIN RHEUMATOL, V16, P513, DOI 10.1097/01.bor.0000132648.62680.81; Wallace DJ, 2007, DUBOIS LUPUS ERYTHEM, pxvii; Warchol T, 2011, DNA CELL BIOL, V30, P33, DOI 10.1089/dna.2010.1041; Yang WL, 2009, HUM MOL GENET, V18, P2063, DOI 10.1093/hmg/ddp118	42	27	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45356	10.1371/journal.pone.0045356	http://dx.doi.org/10.1371/journal.pone.0045356			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049788	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300022
J	Field, E; Pande, R; Papp, J; Park, YJ				Field, Erica; Pande, Rohini; Papp, John; Park, Y. Jeanette			Repayment Flexibility Can Reduce Financial Stress: A Randomized Control Trial with Microfinance Clients in India	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; POVERTY; CORTISOL; IMPACT; INCOME	Financial stress is widely believed to cause health problems. However, policies seeking to relieve financial stress by limiting debt levels of poor households may directly worsen their economic well-being. We evaluate an alternative policy increasing the repayment flexibility of debt contracts. A field experiment randomly assigned microfinance clients to a monthly or a traditional weekly installment schedule (N = 200). We used cell phones to gather survey data on income, expenditure, and financial stress every 48 hours over seven weeks. Clients repaying monthly were 51 percent less likely to report feeling "worried, tense, or anxious" about repaying, were 54 percent more likely to report feeling confident about repaying, and reported spending less time thinking about their loan compared to weekly clients. Monthly clients also reported higher business investment and income, suggesting that the flexibility encouraged them to invest their loans more profitably, which ultimately reduced financial stress.	[Pande, Rohini] Harvard Univ, Kennedy Sch, Cambridge, MA 02138 USA; [Field, Erica] Duke Univ, Dept Econ, Durham, NC 27706 USA; [Papp, John] Highbridge Capital Management, New York, NY USA; [Park, Y. Jeanette] Harvard Univ, Sch Business, Boston, MA 02163 USA	Harvard University; Duke University; Harvard University	Pande, R (corresponding author), Harvard Univ, Kennedy Sch, Cambridge, MA 02138 USA.	rohini_pande@harvard.edu	Papp, John/AAA-3073-2019	Papp, John/0000-0002-7495-5454	ICICI Foundation; Exxon-Mobil; International Growth Center; U.S. Department of Labor	ICICI Foundation; Exxon-Mobil; International Growth Center; U.S. Department of Labor	This study was funded by the ICICI Foundation, Exxon-Mobil, International Growth Center, and the U.S. Department of Labor. These sources did not play a role in the data collection, analysis, interpretation, trial design, recruitment or any other aspect pertinent to the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya N, 2011, WALL STREET J; [Anonymous], 2009, PUBL HLTH MED; [Anonymous], 2009, PRINCET U PRESS, DOI DOI 10.1080/09614524.2010.491535; BANERJEE A, 2010, 15973 NBER; Bauer J, 2012, AM EC REV IN PRESS; Beegle K, 2010, WORLD BANK POLICY RE; Biswas Soutik, 2010, BBC; Borders AEB, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.08.002; Chetty R, 2006, J PUBLIC ECON, V90, P2351, DOI 10.1016/j.jpubeco.2006.07.002; Coleman BE, 1999, J DEV ECON, V60, P105, DOI 10.1016/S0304-3878(99)00038-3; Fernald LCH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-409; Hjortskov N, 2004, STRESS HEALTH, V20, P91, DOI 10.1002/smi.1000; Karlan D, 2011, SCIENCE, V332, P1278, DOI 10.1126/science.1200138; Kessler R, 1987, J HLTH SOC BEHAV, V28; Lund C, 2011, LANCET, V378, P1502, DOI 10.1016/S0140-6736(11)60754-X; McIntosh C, 2008, REV ECON STAT, V90, P15, DOI 10.1162/rest.90.1.15; McKenzie D, 2012, J DEV ECON, V99, P210, DOI 10.1016/j.jdeveco.2012.01.002; Microcredit Summit Campaign Website, 2011, STAT MICR SUMM CAMP; MORDUCH J, 1995, J ECON PERSPECT, V9, P103, DOI 10.1257/jep.9.3.103; Morduch J, 2011, SCIENCE, V332, P1271, DOI 10.1126/science.1208113; Nobelprize.org, 2006, NOB PEAC PRIZ; Patel V, 1999, SOC SCI MED, V49, P1461, DOI 10.1016/S0277-9536(99)00208-7; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Price Richard H, 2002, J Occup Health Psychol, V7, P302, DOI 10.1037/1076-8998.7.4.302; Shylendra H. S., 2006, EC POLITICAL WEEKLY; Steenland K, 2000, OCCUP MED-STATE ART, V15, P7; Steptoe A, 2005, PSYCHOSOM MED, V67, P281, DOI 10.1097/01.psy.0000156932.96261.d2; World Health Organization Website, 2001, WORLD HLTH REP FIN S	28	27	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45679	10.1371/journal.pone.0045679	http://dx.doi.org/10.1371/journal.pone.0045679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049836	Green Submitted, gold, Green Published			2022-12-27	WOS:000309517300043
J	Javadi, AH; Wee, N				Javadi, Amir Homayoun; Wee, Natalie			Cross-Category Adaptation: Objects Produce Gender Adaptation in the Perception of Faces	PLOS ONE			English	Article							VISUAL-ADAPTATION; CORTEX; ORIENTATION; NEURONS	Adaptation aftereffects have been found for low-level visual features such as colour, motion and shape perception, as well as higher-level features such as gender, race and identity in domains such as faces and biological motion. It is not yet clear if adaptation effects in humans extend beyond this set of higher order features. The aim of this study was to investigate whether objects highly associated with one gender, e.g. high heels for females or electric shavers for males can modulate gender perception of a face. In two separate experiments, we adapted subjects to a series of objects highly associated with one gender and subsequently asked participants to judge the gender of an ambiguous face. Results showed that participants are more likely to perceive an ambiguous face as male after being exposed to objects highly associated to females and vice versa. A gender adaptation aftereffect was obtained despite the adaptor and test stimuli being from different global categories (objects and faces respectively). These findings show that our perception of gender from faces is highly affected by our environment and recent experience. This suggests two possible mechanisms: (a) that perception of the gender associated with an object shares at least some brain areas with those responsible for gender perception of faces and (b) adaptation to gender, which is a high-level concept, can modulate brain areas that are involved in facial gender perception through top-down processes.	[Javadi, Amir Homayoun] Tech Univ Dresden, Sect Syst Neurosci, D-01062 Dresden, Germany; [Javadi, Amir Homayoun] UCL, Inst Cognit Neurosci, London, England; [Wee, Natalie] Duke NUS Grad Med Sch, Cognit Neurosci Lab, Singapore, Singapore; [Wee, Natalie] UCL, Div Psychol & Language Sci, London, England	Technische Universitat Dresden; University of London; University College London; National University of Singapore; University of London; University College London	Javadi, AH (corresponding author), Tech Univ Dresden, Sect Syst Neurosci, D-01062 Dresden, Germany.	a.h.javadi@gmail.com	Javadi, Amir-Homayoun/G-8547-2013	Javadi, Amir-Homayoun/0000-0003-0569-6441				Anderson ND, 2005, VISION RES, V45, P1815, DOI 10.1016/j.visres.2005.01.012; Bales JF, 1935, J EXP PSYCHOL, V18, P499, DOI 10.1037/h0061259; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V203, P237, DOI 10.1113/jphysiol.1969.sp008862; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carbon CC, 2007, MEM COGNITION, V35, P1966, DOI 10.3758/BF03192929; Carbon CC, 2011, J EXP PSYCHOL HUMAN, V37, P615, DOI 10.1037/a0019949; Deliyski D, 1997, CHARACTERISTICS MOTO, P3600; Fang F, 2005, NEURON, V45, P793, DOI 10.1016/j.neuron.2005.01.037; Frisby J.P., 1979, SEEING ILLUSION BRAI; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gibson JJ, 1933, J EXP PSYCHOL, V16, P1, DOI 10.1037/h0074626; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; HAMMER ER, 1949, AM J PSYCHOL, V62, P337, DOI 10.2307/1418276; Hsu SM, 2004, VIS COGN, V11, P871, DOI 10.1080/13506280444000030; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Hurlbert A, 2001, NAT NEUROSCI, V4, P3, DOI 10.1038/82877; Jenkins R, 2006, PSYCHOL SCI, V17, P506, DOI 10.1111/j.1467-9280.2006.01736.x; Jordan H, 2006, NAT NEUROSCI, V9, P738, DOI 10.1038/nn1710; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kaul C, 2011, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00238; Kloth N, 2010, J COGNITIVE NEUROSCI, V22, P2345, DOI 10.1162/jocn.2009.21329; Kloth N, 2008, J VISION, V8, DOI 10.1167/8.11.4; Kovacs G, 2006, CEREB CORTEX, V16, P742, DOI 10.1093/cercor/bhj020; Kovacs G, 2004, NEUROREPORT, V15, P1275, DOI 10.1097/01.wnr.0000130234.51411.0e; Leopold DA, 2005, P ROY SOC B-BIOL SCI, V272, P897, DOI 10.1098/rspb.2004.3022; Leopold DA, 2001, NAT NEUROSCI, V4, P89, DOI 10.1038/82947; MCCOLLOUGH C, 1965, SCIENCE, V149, P1115, DOI 10.1126/science.149.3688.1115; McKone E., 2005, J VISION, V5, P822, DOI [10.1167/5.8.822, DOI 10.1167/5.8.822]; Menghini F, 2007, NEUROCOMPUTING, V70, P2000, DOI 10.1016/j.neucom.2006.10.081; Neitz J, 2002, NEURON, V35, P783, DOI 10.1016/S0896-6273(02)00818-8; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rhodes G, 2004, CURR BIOL, V14, P2119, DOI 10.1016/j.cub.2004.11.053; Rhodes G, 2007, VISION RES, V47, P2291, DOI 10.1016/j.visres.2007.05.012; Rhodes G, 2011, VISION RES, V51, P1811, DOI 10.1016/j.visres.2011.06.008; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Seyama J, 2006, PSYCHOL RES-PSYCH FO, V70, P59, DOI 10.1007/s00426-004-0188-3; Smith EL, 2007, CURR BIOL, V17, P1680, DOI 10.1016/j.cub.2007.08.043; Troje NF, 2006, J VISION, V6, P850, DOI 10.1167/6.8.7; Vul E, 2008, J VISION, V8, DOI 10.1167/8.12.4; Watson TL, 2003, PERCEPTION, V32, P1109, DOI 10.1068/p5082; Webster MA, 1999, PSYCHON B REV, V6, P647, DOI 10.3758/BF03212974; Webster MA, 2004, NATURE, V428, P557, DOI 10.1038/nature02420; Yamashita JA, 2005, J EXP PSYCHOL HUMAN, V31, P420, DOI 10.1037/0096-1523.31.3.420	44	16	16	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46079	10.1371/journal.pone.0046079	http://dx.doi.org/10.1371/journal.pone.0046079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049942	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300080
J	Li, Q; Lu, FR; Wang, KF				Li, Qiang; Lu, Furong; Wang, Kaifa			Modeling of HIV-1 Infection: Insights to the Role of Monocytes/Macrophages, Latently Infected T4 Cells, and HAART Regimes	PLOS ONE			English	Article							FOLLICULAR DENDRITIC CELLS; ACTIVE ANTIRETROVIRAL THERAPY; IN-VIVO; LYMPHOID ORGANS; IMMUNODEFICIENCY; PATHOGENESIS; MACROPHAGES; LYMPHOCYTES; APOPTOSIS; RESERVOIR	A novel dynamic model covering five types of cells and three connected compartments, peripheral blood (PB), lymph nodes (LNs), and the central nervous system (CNS), is here proposed. It is based on assessment of the biological principles underlying the interactions between the human immunodeficiency virus type I (HIV-1) and the human immune system. The simulated results of this model matched the three well-documented phases of HIV-1 infection very closely and successfully described the three stages of LN destruction that occur during HIV-1 infection. The model also showed that LNs are the major location of viral replication, creating a pool of latently infected T4 cells during the latency period. A detailed discussion of the role of monocytes/macrophages is made, and the results indicated that infected monocytes/macrophages could determine the progression of HIV-1 infection. The effects of typical highly active antiretroviral therapy (HAART) drugs on HIV-1 infection were analyzed and the results showed that efficiency of each drug but not the time of the treatment start contributed to the change of the turnover of the disease greatly. An incremental count of latently infected T4 cells was made under therapeutic simulation, and patients were found to fail to respond to HAART therapy in the presence of certain stimuli, such as opportunistic infections. In general, the dynamics of the model qualitatively matched clinical observations very closely, indicating that the model may have benefits in evaluating the efficacy of different drug therapy regimens and in the discovery of new monitoring markers and therapeutic schemes for the treatment of HIV-1 infection.	[Li, Qiang; Wang, Kaifa] Third Mil Med Univ, Dept Device & Equipment, Sch Biomed Engn & Med Imaging, Chongqing, Peoples R China; [Lu, Furong] Chongqing Univ, Dept Chem, Coll Chem & Chem Engn, Chongqing 630044, Peoples R China	Army Medical University; Chongqing University	Wang, KF (corresponding author), Third Mil Med Univ, Dept Device & Equipment, Sch Biomed Engn & Med Imaging, Chongqing, Peoples R China.	kaifawang@yahoo.com.cn		Wang, Kaifa/0000-0002-6787-5018	National Natural Science Fund of People's Republic of China [11271369, 30770555]; Natural Science Foundation Project of CQ CSTC [2010BB5020]	National Natural Science Fund of People's Republic of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	This work was partially supported by the National Natural Science Fund of People's Republic of China (11271369, 30770555) and the Natural Science Foundation Project of CQ CSTC (2010BB5020). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlkalizeForHealth, LYMPH SYST HLTH DIS; Althaus CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016468; [Anonymous], 1990, Wkly Epidemiol Rec, V65, P221; [Anonymous], 1995, THEORY EPIDEMICS SER; Aquaro S, 1997, J LEUKOCYTE BIOL, V62, P138, DOI 10.1002/jlb.62.1.138; Aquaro S, 2002, ANTIVIR RES, V55, P209, DOI 10.1016/S0166-3542(02)00052-9; ASCHER MS, 1988, CLIN EXP IMMUNOL, V73, P165; Azzoni L, 2007, AIDS, V21, P293, DOI 10.1097/QAD.0b013e328012b85f; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Barsov EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023703; Bonnet F, 2005, HIV MED, V6, P198, DOI 10.1111/j.1468-1293.2005.00290.x; Brodie SJ, 1999, NAT MED, V5, P34, DOI 10.1038/4716; Burkhead E, 2009, B MATH BIOL, V71, P25, DOI 10.1007/s11538-008-9351-0; Burton GF, 2002, SEMIN IMMUNOL, V14, P275, DOI 10.1016/S1044-5323(02)00060-X; Cain LE, 2011, ANN INTERN MED, V154, P509, DOI 10.7326/0003-4819-154-8-201104190-00001; Callaway DS, 2002, B MATH BIOL, V64, P29, DOI 10.1006/bulm.2001.0266; Cameron PU, 2000, HIV MANAGEMENT AUSTR, P19; Caponetti G, 2008, ENT-EAR NOSE THROAT, V87, P374, DOI 10.1177/014556130808700706; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Davenport MP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000728; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; Deeks SG, 2007, CLIN PHARMACOL THER, V82, P248, DOI 10.1038/sj.clpt.6100205; Del Cacho E, 2008, J IMMUNOL METHODS, V334, P59, DOI 10.1016/j.jim.2008.02.001; Dockrell DH, 1998, J CLIN INVEST, V101, P2394, DOI 10.1172/JCI1171; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; Ernst JD, 2006, ADV M C M, P246, DOI 10.1017/CBO9780511541513.008; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Flexner C, 2007, NAT REV DRUG DISCOV, V6, P959, DOI 10.1038/nrd2336; Funk MJ, 2011, ARCH INTERN MED, V171, P1560, DOI 10.1001/archinternmed.2011.401; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gras G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-30; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; GROUARD G, 1995, J IMMUNOL, V155, P3345; GUPTA KK, 1993, NEW ENGL J MED, V328, P288, DOI 10.1056/NEJM199301283280419; HEATH SL, 1995, NATURE, V377, P740, DOI 10.1038/377740a0; Hellerstein M, 1999, NAT MED, V5, P83, DOI 10.1038/4772; HENDERSON JM, 1981, RADIOLOGY, V141, P525, DOI 10.1148/radiology.141.2.6974875; Herbein G, 1998, J VIROL, V72, P660, DOI 10.1128/JVI.72.1.660-670.1998; Ho DD, 1996, SCIENCE, V272, P1124, DOI 10.1126/science.272.5265.1124; Ho J, 2007, J IMMUNOL, V178, P6968, DOI 10.4049/jimmunol.178.11.6968; Hu QX, 2000, J VIROL, V74, P11858, DOI 10.1128/JVI.74.24.11858-11872.2000; JANEWAY CA, 2001, IMMUNOBIOLOGY, V5; Joly M, 2006, AICHE J, V52, P856, DOI 10.1002/aic.10716; Keele BF, 2008, J VIROL, V82, P5548, DOI 10.1128/JVI.00124-08; Kesmir C, 1999, J IMMUNOL, V163, P2463; King JT, 2003, MED DECIS MAKING, V23, P9, DOI 10.1177/0272989X02239652; Kirschner D, 2000, J ACQ IMMUN DEF SYND, V24, P352; Kirschner D., 1996, NOTICES AM MATH SOC, V43, P191; Kirschner DE, 1997, B MATH BIOL, V59, P95; Laforge M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002087; Lawn SD, 2000, J VIROL, V74, P139, DOI 10.1128/JVI.74.1.139-145.2000; Lawyer G, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-26; Levy JA, 1996, IMMUNOL TODAY, V17, P217, DOI 10.1016/0167-5699(96)10011-6; LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993; Lieberman J, 2001, BLOOD, V98, P1667, DOI 10.1182/blood.V98.6.1667; Loftus WK, 1999, J CLIN ULTRASOUND, V27, P71, DOI 10.1002/(SICI)1097-0096(199902)27:2<71::AID-JCU4>3.3.CO;2-L; Mangino G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022982; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; McNeil AC, 2001, P NATL ACAD SCI USA, V98, P13878, DOI 10.1073/pnas.251539598; Murray JM, 1998, MATH BIOSCI, V154, P57, DOI 10.1016/S0025-5564(98)10046-9; Nelson PW, 2000, MATH BIOSCI, V163, P201, DOI 10.1016/S0025-5564(99)00055-3; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PANTALEO G, 1991, P NATL ACAD SCI USA, V88, P9838, DOI 10.1073/pnas.88.21.9838; PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508; PANTALEO G, 1994, IMMUNOL REV, V140, P105, DOI 10.1111/j.1600-065X.1994.tb00867.x; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Pierson T, 2000, J VIROL, V74, P7824, DOI 10.1128/JVI.74.17.7824-7833.2000; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Prosperi MCF, 2010, CLIN INFECT DIS, V50, P1316, DOI 10.1086/651688; Roger W, 1973, ANGIOLOGY, P588; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Rosenberg ES, 1999, IMMUNOL LETT, V66, P89, DOI 10.1016/S0165-2478(98)00165-5; Rosenberg YJ, 1999, SEMIN IMMUNOL, V11, P139, DOI 10.1006/smim.1999.0169; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Schaefer MR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000131; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Sloand EM, 1999, BLOOD, V94, P1021, DOI 10.1182/blood.V94.3.1021.415k29_1021_1027; Stefano GB, 2000, MODERN ASPECTS IMMUN, V1, P63; Thacker TC, 2009, J VIROL, V83, P150, DOI 10.1128/JVI.01652-08; Tsai WP, 1996, VIROLOGY, V226, P205, DOI 10.1006/viro.1996.0648; Tuckwell HC, 1998, J THEOR BIOL, V195, P451, DOI 10.1006/jtbi.1998.0806; Ueno T, 2008, J IMMUNOL, V180, P1107, DOI 10.4049/jimmunol.180.2.1107; VANFURTH R, 1968, J EXP MED, V128, P415, DOI 10.1084/jem.128.3.415; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wahl SM, 1999, J INFECT DIS, V179, pS457, DOI 10.1086/314814; Waki K, 2010, VIRUSES-BASEL, V2, P1603, DOI 10.3390/v2081603; Walport M., 1999, IMMUNOBIOLOGY; Wang LQ, 1999, J IMMUNOL, V162, P268; Wang LQ, 1997, VIROLOGY, V228, P141, DOI 10.1006/viro.1996.8397; Wasserstein-Robbins F, 2010, B MATH BIOL, V72, P1208, DOI 10.1007/s11538-009-9488-5; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wodarz D, 2002, BIOESSAYS, V24, P1178, DOI 10.1002/bies.10196; Wu Y, 2010, United States Patent Application, Patent No. [US20100292181A1, 20100292181]	106	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46026	10.1371/journal.pone.0046026	http://dx.doi.org/10.1371/journal.pone.0046026			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049927	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300076
J	Taira, Y; Hayashida, N; Yamaguchi, H; Yamashita, S; Endo, Y; Takamura, N				Taira, Yasuyuki; Hayashida, Naomi; Yamaguchi, Hitoshi; Yamashita, Shunichi; Endo, Yuukou; Takamura, Noboru			Evaluation of Environmental Contamination and Estimated Radiation Doses for the Return to Residents' Homes in Kawauchi Village, Fukushima Prefecture	PLOS ONE			English	Article								To evaluate the environmental contamination and radiation exposure dose rates due to artificial radionuclides in Kawauchi Village, Fukushima Prefecture, the restricted area within a 30-km radius from the Fukushima Dai-ichi Nuclear Power Plant (FNPP), the concentrations of artificial radionuclides in soil samples, tree needles, and mushrooms were analyzed by gamma spectrometry. Nine months have passed since samples were collected on December 19 and 20, 2011, 9 months after the FNPP accident, and the prevalent dose-forming artificial radionuclides from all samples were Cs-134 and Cs-137. The estimated external effective doses from soil samples were 0.42-7.2 mu Sv/h (3.7-63.0 mSv/y) within the 20-km radius from FNPP and 0.0011-0.38 mu Sv/h (0.010-3.3 mSv/y) within the 20-30 km radius from FNPP. The present study revealed that current levels are sufficiently decreasing in Kawauchi Village, especially in areas within the 20- to 30-km radius from FNPP. Thus, residents may return their homes with long-term follow-up of the environmental monitoring and countermeasures such as decontamination and restrictions of the intake of foods for reducing unnecessary exposure. The case of Kawauchi Village will be the first model for the return to residents' homes after the FNPP accident.	[Taira, Yasuyuki; Hayashida, Naomi; Takamura, Noboru] Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 852, Japan; [Yamashita, Shunichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiat Med Sci, Nagasaki 852, Japan; [Yamaguchi, Hitoshi] Nagasaki Univ, Grad Sch Engn, Dept Ecomat Sci, Nagasaki 852, Japan; [Taira, Yasuyuki; Yamaguchi, Hitoshi] Nagasaki Prefectural Inst Environm Res & Publ Hlt, Omura, Japan; [Endo, Yuukou] Kawauchi Municipal Govt, Fukushima, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Takamura, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 852, Japan.	takamura@nagasaki-u.ac.jp	Yamashita, Shunichi/GVS-9508-2022	Yamashita, Shunichi/0000-0001-6399-6261; Takamura, Noboru/0000-0002-5552-3234				[Anonymous], 2006, HLTH EFF CHERN ACC S, P182; Endo S, 2011, J ENV RADIOACT; ICRU, 1994, 53 ICRU; International Atomic Energy Agency, 2000, IAEATECDOC1162; International Commission on Radiobiological Protection, 2007, ANN ICRP, V37; International Commission on Radiological Protection, 1996, ICRP PUBL 5; International Commission on Radiological Protection, 2007, ICRP PUBL; Kato H, 2011, J ENV RADIOACT; Ministry of Economy Trade and Industry Japan, BAS POL EM RESP DEC; Ministry of Education Culture Sports Science and Technology, ENV RAD RAD JAP; Ministry of Education Culture Sports Science and Technology Japan, 2012, ENV RAD RAD JAP MON; Ministry of Health Labour and Welfare Japan, INF GREAT E JAP EART; Ministry of Health Labour and Welfare of Japan, NAT HLTH NUTR SURV; Ministry of the Environment Japan, DIS WAST MAN; Monzen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027761; Muck K, 2002, HEALTH PHYS, V82, P141, DOI 10.1097/00004032-200202000-00002; Tagami K, 2011, SCI TOTAL ENVIRON, V409, P4885, DOI 10.1016/j.scitotenv.2011.07.067; Taira Y, 2012, RAD PROT DOSIM; Taira Y, 2011, J RADIAT RES, V52, P88, DOI 10.1269/jrr.10104; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, SOURC EFF ION RAD 20; United Nations Scientific Committee on the Effects of Atomic Radiation, 2008, SOURC EFF ION RAD 20, VII	21	22	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45816	10.1371/journal.pone.0045816	http://dx.doi.org/10.1371/journal.pone.0045816			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049869	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300056
J	Yang, PH; Deng, JJ; Li, CG; Zhang, PR; Xing, L; Li, ZW; Wang, W; Zhao, Y; Yan, YW; Gu, HJ; Liu, X; Zhao, ZP; Zhang, SG; Wang, XL; Jiang, CY				Yang, Penghui; Deng, Jiejie; Li, Chenggang; Zhang, Peirui; Xing, Li; Li, Zhiwei; Wang, Wei; Zhao, Yan; Yan, Yiwu; Gu, Hongjing; Liu, Xin; Zhao, Zhongpeng; Zhang, Shaogeng; Wang, Xiliang; Jiang, Chengyu			Characterization of the 2009 Pandemic A/Beijing/501/2009 H1N1 Influenza Strain in Human Airway Epithelial Cells and Ferrets	PLOS ONE			English	Article							VIRUS; PATHOGENESIS; VACCINE; IMMUNOGENICITY; TRANSMISSION; RESPONSES; CHILDREN; SAFETY; MODEL; MICE	Background: A novel 2009 swine-origin influenza A H1N1 virus (S-OIV H1N1) has been transmitted among humans worldwide. However, the pathogenesis of this virus in human airway epithelial cells and mammals is not well understood. Methodology/Principal Finding: In this study, we showed that a 2009 A (H1N1) influenza virus strain, A/Beijing/501/2009, isolated from a human patient, caused typical influenza-like symptoms including weight loss, fluctuations in body temperature, and pulmonary pathological changes in ferrets. We demonstrated that the human lung adenocarcinoma epithelial cell line A549 was susceptible to infection and that the infected cells underwent apoptosis at 24 h post-infection. In contrast to the seasonal H1N1 influenza virus, the 2009 A (H1N1) influenza virus strain A/Beijing/501/2009 induced more cell death involving caspase-3-dependent apoptosis in A549 cells. Additionally, ferrets infected with the A/Beijing/501/2009 H1N1 virus strain exhibited increased body temperature, greater weight loss, and higher viral titers in the lungs. Therefore, the A/Beijing/501/2009 H1N1 isolate successfully infected the lungs of ferrets and caused more pathological lesions than the seasonal influenza virus. Our findings demonstrate that the difference in virulence of the 2009 pandemic H1N1 influenza virus and the seasonal H1N1 influenza virus in vitro and in vivo may have been mediated by different mechanisms. Conclusion/Significance: Our understanding of the pathogenesis of the 2009 A (H1N1) influenza virus infection in both humans and animals is broadened by our findings that apoptotic cell death is involved in the cytopathic effect observed in vitro and that the pathological alterations in the lungs of S-OIV H1N1-infected ferrets are much more severe.	[Yang, Penghui; Zhang, Peirui; Li, Zhiwei; Zhang, Shaogeng] 302 Mil Hosp, Dept Hepatobiliary, Beijing, Peoples R China; [Yang, Penghui; Xing, Li; Gu, Hongjing; Liu, Xin; Zhao, Zhongpeng; Wang, Xiliang] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Deng, Jiejie; Li, Chenggang; Wang, Wei; Zhao, Yan; Yan, Yiwu; Jiang, Chengyu] Tsinghua Univ, State Key Lab Med Mol Biol, Inst Basic Med Sci, Peking Union Med Coll,Chinese Acad Med Sci, Beijing 100084, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Beijing Institute of Microbiology & Epidemiology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Tsinghua University	Zhang, SG (corresponding author), 302 Mil Hosp, Dept Hepatobiliary, Beijing, Peoples R China.	Zhsg302@hotmail.com; xiliangw@126.com; chengyujiang@gmail.com	Yan, Yiwu/P-5499-2017; Wang, Wei/N-9423-2019	Yan, Yiwu/0000-0001-8289-7277; Wang, Wei/0000-0001-9243-8672; zhongpeng, zhao/0000-0002-9147-6252	National Natural Scientific Foundation [30800977, 30972614]; Beijing Natural Science Foundation [7112105]; National Basic Research Program (973) [2009CB522102, 2012CB518905]; National Key Technologies RD Program [2006AA02Z450, SS2012AA020905]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Basic Research Program (973)(National Basic Research Program of China); National Key Technologies RD Program(National Key Technology R&D Program)	The study was supported by the National Natural Scientific Foundation (30800977 and 30972614), the Beijing Natural Science Foundation (7112105), the National Basic Research Program (973) (2009CB522102 and 2012CB518905), and the National Key Technologies R&D Program (2006AA02Z450 and SS2012AA020905). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Carlile GW, 2004, BLOOD, V103, P4310, DOI 10.1182/blood-2003-09-3362; Ekchariyawat P, 2012, INNATE IMMUN-LONDON, V18, P390, DOI 10.1177/1753425911410998; Huang SSH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027512; Isken B, 2012, VACCINE; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kang YM, 2011, ARCH VIROL, V156, P759, DOI 10.1007/s00705-010-0914-7; Kiseleva I, 2010, INFLUENZA OTHER RESP, V4, P1, DOI 10.1111/j.1750-2659.2009.00118.x; Kwon D, 2010, J MICROBIOL, V48, P657, DOI 10.1007/s12275-010-0120-z; Lednicky JA, 2010, COMPARATIVE MED, V60, P364; Li CG, 2012, CELL RES, V22, P528, DOI 10.1038/cr.2011.165; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Lu CY, 2010, VACCINE, V28, P5864, DOI 10.1016/j.vaccine.2010.06.059; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Meunier I, 2012, VIROLOGY, V422, P125, DOI 10.1016/j.virol.2011.10.018; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Neumann G, 2001, VIROLOGY, V287, P243, DOI 10.1006/viro.2001.1008; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Safronetz D, 2011, J VIROL, V85, P1214, DOI 10.1128/JVI.01848-10; Shinya K, 2011, J VIROL, V85, P5202, DOI 10.1128/JVI.00239-11; Sun SH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-52; van Doremalen N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025755; Wu JA, 2010, NEW ENGL J MED, V363, P2416, DOI 10.1056/NEJMoa1006736; Xu CE, 2011, VIRAL IMMUNOL, V24, P369, DOI 10.1089/vim.2011.0003; Yang N, 2011, J MOL CELL BIOL, V3, P221, DOI 10.1093/jmcb/mjr017; Yang PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030252; Yang PH, 2011, VACCINE, V29, P698, DOI 10.1016/j.vaccine.2010.11.026; Yang PH, 2010, CELL MOL IMMUNOL, V7, P116, DOI 10.1038/cmi.2009.116; Zhu HC, 2011, INFLUENZA OTHER RESP, V5, P82	31	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46184	10.1371/journal.pone.0046184	http://dx.doi.org/10.1371/journal.pone.0046184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049974	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300096
J	Bieg, HJ; Bresciani, JP; Bulthoff, HH; Chuang, LL				Bieg, Hans-Joachim; Bresciani, Jean-Pierre; Buelthoff, Heinrich H.; Chuang, Lewis L.			Looking for Discriminating Is Different from Looking for Looking's Sake	PLOS ONE			English	Article							SACCADIC EYE-MOVEMENTS; HAND COORDINATION; REACTION-TIME; MAIN-SEQUENCE; ARM MOVEMENT; REWARD; ATTENTION; FATIGUE; LATENCY; VISION	Recent studies provide evidence for task-specific influences on saccadic eye movements. For instance, saccades exhibit higher peak velocity when the task requires coordinating eye and hand movements. The current study shows that the need to process task-relevant visual information at the saccade endpoint can be, in itself, sufficient to cause such effects. In this study, participants performed a visual discrimination task which required a saccade for successful completion. We compared the characteristics of these task-related saccades to those of classical target-elicited saccades, which required participants to fixate a visual target without performing a discrimination task. The results show that task-related saccades are faster and initiated earlier than target-elicited saccades. Differences between both saccade types are also noted in their saccade reaction time distributions and their main sequences, i.e., the relationship between saccade velocity, duration, and amplitude.	[Bieg, Hans-Joachim; Buelthoff, Heinrich H.; Chuang, Lewis L.] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany; [Bresciani, Jean-Pierre] Univ Pierre Mendes France, Lab Psychol & Neurocognit, CNRS, UMR 5105, Grenoble, France; [Bresciani, Jean-Pierre] Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland; [Buelthoff, Heinrich H.] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; University of Fribourg; Korea University	Bulthoff, HH (corresponding author), Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, Tubingen, Germany.	heinrich.buelthoff@tuebingen.mpg.de	Bülthoff, Heinrich/AAC-8818-2019; Bresciani, Jean-Pierre/H-4340-2012; Chuang, Lewis/U-4430-2017; Bülthoff, Heinrich H/J-6579-2012	Chuang, Lewis/0000-0002-1975-5716; Bülthoff, Heinrich H/0000-0003-2568-0607; Bresciani, Jean-Pierre/0000-0002-7242-5433	Max Planck Society; Information Technology Program through the state of Baden-Wurttemberg, Germany (BW-FIT); Ministry of Education, Science and Technology through the National Research Foundation of Korea [R31-10008]	Max Planck Society(Max Planck Society); Information Technology Program through the state of Baden-Wurttemberg, Germany (BW-FIT); Ministry of Education, Science and Technology through the National Research Foundation of Korea	This research was supported by a PhD stipend from the Max Planck Society (HJB), the Information Technology Program through the state of Baden-Wurttemberg, Germany (BW-FIT) (HJB, LLC), and by the WCU (World Class University) program funded by the Ministry of Education, Science and Technology through the National Research Foundation of Korea (R31-10008) (HHB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS RA, 1990, J EXP PSYCHOL HUMAN, V16, P248, DOI 10.1037/0096-1523.16.2.248; Baguley T, 2011, BEHAV RES METHODS; Bahill T., 1975, MATH BIOSCI, V24, P191; Binsted G, 2001, HUM MOVEMENT SCI, V20, P563, DOI 10.1016/S0167-9457(01)00068-9; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Carpenter RHS, 1988, MOVEMENTS EYES; Cattell JM, 1886, BRAIN, V8, P433; Chen-Harris H, 2008, J NEUROSCI, V28, P2804, DOI 10.1523/JNEUROSCI.5300-07.2008; De Brabander B, 2002, BEHAV NEUROSCI, V116, P397, DOI 10.1037//0735-7044.116.3.397; Deci EL, 2000, PSYCHOL INQ, V11, P227, DOI 10.1207/S15327965PLI1104_01; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; Epelboim J, 1997, VISION RES, V37, P2597, DOI 10.1016/S0042-6989(97)00075-8; Findlay J. M., 2003, ACTIVE VISION PSYCHO; FISCHER B, 1993, EXP BRAIN RES, V92, P528; FISCHER B, 1983, BRAIN RES, V260, P21, DOI 10.1016/0006-8993(83)90760-6; FUCHS AF, 1983, J NEUROPHYSIOL, V49, P28, DOI 10.1152/jn.1983.49.1.28; Garbutt S, 2001, BRIT J OPHTHALMOL, V85, P1477, DOI 10.1136/bjo.85.12.1477; Goossens HHLM, 2006, J NEUROPHYSIOL, V95, P2326, DOI 10.1152/jn.00889.2005; Guyader N, 2010, PSYCHOL RES-PSYCH FO, V74, P12, DOI 10.1007/s00426-008-0218-7; Harris CM, 2006, BIOL CYBERN, V95, P21, DOI 10.1007/s00422-006-0064-x; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Kline RB, 2005, SIGNIFICANCE TESTING; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Land MF, 2009, VISUAL NEUROSCI, V26, P51, DOI 10.1017/S0952523808080899; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Lunenburger L, 2000, EUR J NEUROSCI, V12, P4107, DOI 10.1046/j.1460-9568.2000.00298.x; Lunenburger L, 2003, EUR J NEUROSCI, V17, P2481, DOI 10.1046/j.1460-9568.2003.02653.x; Madelain L, 2011, J NEUROPHYSIOL, V106, P219, DOI 10.1152/jn.01094.2009; Madelain L, 2011, BEHAV PROCESS, V87, P142, DOI 10.1016/j.beproc.2011.02.009; MANSFIELD RJ, 1973, VISION RES, V13, P2219, DOI 10.1016/0042-6989(73)90224-1; Milstein DM, 2007, J NEUROSCI, V27, P4810, DOI 10.1523/JNEUROSCI.0577-07.2007; Montagnini A, 2005, VISION RES, V45, P3391, DOI 10.1016/j.visres.2005.07.013; Navalpakkam V, 2010, P NATL ACAD SCI USA, V107, P5232, DOI 10.1073/pnas.0911972107; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Prsa M, 2010, J NEUROSCI, V30, P15834, DOI 10.1523/JNEUROSCI.3901-10.2010; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reddi BAJ, 2003, J NEUROPHYSIOL, V90, P3538, DOI 10.1152/jn.00689.2002; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; REULEN JPH, 1984, BIOL CYBERN, V50, P263, DOI 10.1007/BF00337076; REUTERLORENZ PA, 1991, PERCEPT PSYCHOPHYS, V49, P167, DOI 10.3758/BF03205036; SALMONI AW, 1984, PSYCHOL BULL, V95, P355, DOI 10.1037/0033-2909.95.3.355; SANDERS A F, 1970, Ergonomics, V13, P101, DOI 10.1080/00140137008931124; SCHMIDT D, 1979, AVIAT SPACE ENVIR MD, V50, P393; Shadmehr R, 2010, J NEUROSCI, V30, P10507, DOI 10.1523/JNEUROSCI.1343-10.2010; Snyder LH, 2002, J NEUROPHYSIOL, V87, P2279, DOI 10.1152/jn.00854.2001; Stark L, 1975, INVEST OPHTHALMOL, V14, P468; Straube A, 1997, J NEUROPHYSIOL, V77, P874, DOI 10.1152/jn.1997.77.2.874; Stritzke M, 2009, J OPT SOC AM A, V26, pB1, DOI 10.1364/JOSAA.26.0000B1; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Trottier L, 2005, VISION RES, V45, P1349, DOI 10.1016/j.visres.2004.12.007; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; WHITE RW, 1959, PSYCHOL REV, V66, P297, DOI 10.1037/h0040934; Yeshurun Y, 1999, VISION RES, V39, P293, DOI 10.1016/S0042-6989(98)00114-X	59	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45445	10.1371/journal.pone.0045445	http://dx.doi.org/10.1371/journal.pone.0045445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049801	Green Published, gold			2022-12-27	WOS:000309556100049
J	Ejaz, A; Steinmann, E; Banki, Z; Anggakusuma; Khalid, S; Lengauer, S; Wilhelm, C; Zoller, H; Schloegl, A; Steinmann, J; Grabski, E; Kleines, M; Pietschmann, T; Stoiber, H				Ejaz, Asim; Steinmann, Eike; Banki, Zoltan; Anggakusuma; Khalid, Sana; Lengauer, Susanne; Wilhelm, Corinne; Zoller, Heinz; Schloegl, Anna; Steinmann, Joerg; Grabski, Elena; Kleines, Michael; Pietschmann, Thomas; Stoiber, Heribert			Specific Acquisition of Functional CD59 but Not CD46 or CD55 by Hepatitis C Virus	PLOS ONE			English	Article							DECAY-ACCELERATING FACTOR; COMPLEMENT ACTIVATION; HUMAN HEPATOCYTES; DENDRITIC CELLS; PROTEIN; REGULATORS; INFECTION; STRATEGIES; MIGRATION; CHIMERAS	Viruses of different families encode for regulators of the complement system (RCAs) or acquire such RCAs from the host to get protection against complement-mediated lysis (CML). As hepatitis C virus (HCV) shares no genetic similarity to any known RCA and is detectable at high titers in sera of infected individuals, we investigated whether HCV has adapted host-derived RCAs to resist CML. Here we report that HCV selectively incorporates CD59 while neither CD55, nor CD46 are associated with the virus. The presence of CD59 was shown by capture assays using patient- and cell culture-derived HCV isolates. Association of CD59 with HCV was further confirmed by Western blot analysis using purified viral supernatants from infected Huh 7.5 cells. HCV captured by antibodies specific for CD59 remained infectious for Huh 7.5 cells. In addition, blocking of CD59 in the presence of active complement reduced the titer of HCV most likely due to CML. HCV produced in CD59 knock-down cells were more significantly susceptible to CML compared to wild type virus, but neither replication, assembly nor infectivity of the virus seemed to be impaired in the absence of CD59. In summary our data indicate that HCV incorporates selectively CD59 in its envelope to gain resistance to CML in serum of infected individuals.	[Ejaz, Asim; Banki, Zoltan; Khalid, Sana; Lengauer, Susanne; Kleines, Michael; Stoiber, Heribert] Innsbruck Med Univ, Inst Virol, Innsbruck, Austria; [Steinmann, Eike; Anggakusuma; Wilhelm, Corinne; Pietschmann, Thomas] Ctr Expt & Clin Infect Res, TWINCORE, Div Expt Virol, Hannover, Germany; [Zoller, Heinz; Schloegl, Anna] Univ Innsbruck Hosp, Dept Med, Clin Div Gastroenterol & Hepatol, A-6020 Innsbruck, Austria; [Steinmann, Joerg] Univ Hosp Essen, Inst Med Microbiol, Essen, Germany; [Grabski, Elena] Ctr Expt & Clin Infect Res, Inst Expt Infect Res, TWINCORE, Hannover, Germany	Medical University of Innsbruck; Helmholtz Association; Helmholtz-Center for Infection Research; Medical University of Innsbruck; University of Duisburg Essen	Stoiber, H (corresponding author), Innsbruck Med Univ, Inst Virol, Innsbruck, Austria.	hygiene@i-med.ac.at	Ejaz, Asim/J-9236-2019; Kleines, Michael/C-8801-2009; Pietschmann, Thomas/E-9241-2015; Zoller, Heinz/AAD-7225-2019	Pietschmann, Thomas/0000-0001-5138-6239; Steinmann, Eike/0000-0002-3654-9965; Banki, Zoltan/0000-0002-3826-5800; Kusuma, Angga/0000-0002-5060-5310	Austrian Research Fund FWF [215080, 17914]; Federal Government of Tyrol (Tiroler Wissenschaftsfonds) [TWF-2008-1-562]; DFG [STE 1954/1-1]; Emmy Noether-fellowship [PI 734/1-1]; Deutsche Forschungsgemeinschaft (DFG) [SFB900]; Initiative and Networking Fund of the Helmholtz association [SO-024]; Austrian Science Fund (FWF) [P 21508] Funding Source: researchfish	Austrian Research Fund FWF(Austrian Science Fund (FWF)); Federal Government of Tyrol (Tiroler Wissenschaftsfonds); DFG(German Research Foundation (DFG)); Emmy Noether-fellowship(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Initiative and Networking Fund of the Helmholtz association; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors are supported by grants of the Austrian Research Fund FWF (215080 to ZB and 17914 to HS) and the Federal Government of Tyrol (Tiroler Wissenschaftsfonds TWF-2008-1-562 to HS). E.S. was supported by the DFG (STE 1954/1-1). T.P. was supported by an Emmy Noether-fellowship (PI 734/1-1) and by the SFB900 (project A6) both provided by the Deutsche Forschungsgemeinschaft (DFG) and also by a grant from the Initiative and Networking Fund of the Helmholtz association SO-024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2007, INDIAN J BIOCHEM BIO, V44, P331; Amet T, 2011, HEPATOLOGY; Ariumi Y, PLOS ONE, V6; Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750; Banerjee A, 2011, J VIROL, V85, P4157, DOI 10.1128/JVI.02449-10; Bankwitz D, 2010, J VIROL, V84, P5751, DOI 10.1128/JVI.02200-09; Bitzegeio J, PLOS PATHOG, V6; Blasiole DA, 2007, MOL BIOSYST, V3, P608, DOI 10.1039/b700706j; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Blom AM, 2004, ARCH IMMUNOL THER EX, V52, P83; Bode JG, 2008, BIOL CHEM, V389, P1283, DOI 10.1515/BC.2008.147; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Boson B, PLOS PATHOG, V7; Brown KS, 2010, PROTEIN CELL, V1, P664, DOI 10.1007/s13238-010-0088-9; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; Chang ML, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-51; Corless L, 2010, J GEN VIROL, V91, P362, DOI 10.1099/vir.0.017285-0; Favoreel HW, 2003, J GEN VIROL, V84, P1, DOI 10.1099/vir.0.18709-0; Frank I, 1996, AIDS, V10, P1611, DOI 10.1097/00002030-199612000-00004; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Halme J, 2009, MOL IMMUNOL, V46, P2284, DOI 10.1016/j.molimm.2009.04.005; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Kanmura S, 2010, J GASTROENTEROL, V45, P459, DOI 10.1007/s00535-009-0160-5; Khan S, BIOCH J; Kim DD, 2006, CLIN IMMUNOL, V118, P127, DOI 10.1016/j.clim.2005.10.014; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Liu J, 2009, CELL MOL IMMUNOL, V6, P235, DOI 10.1038/cmi.2009.32; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; McLauchlan J, 2009, BIOCHEM SOC T, V37, P986, DOI 10.1042/BST0370986; Mollnes Tom E., 2002, Trends in Immunology, V23, P61, DOI 10.1016/S1471-4906(01)02129-9; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Pitha PM, 2007, CURR TOP MICROBIOL, V316, P41; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Scandella E, 2004, BLOOD, V103, P1595, DOI 10.1182/blood-2003-05-1643; Schmidt J, 2011, BIOMARK MED, V5, P155, DOI [10.2217/BMM.11.19, 10.2217/bmm.11.19]; Seeff LB, 2002, HEPATOLOGY, V36, pS1, DOI 10.1053/jhep.2002.36992; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Soederholm A, 2007, EUR J IMMUNOL, V37, P2156, DOI 10.1002/eji.200636820; Stoiber H, 1996, J EXP MED, V183, P307, DOI 10.1084/jem.183.1.307; Stoiber H, 2005, MOL IMMUNOL, V42, P153, DOI 10.1016/j.molimm.2004.06.024; Vasei M, 2008, HEPATO-GASTROENTEROL, V55, P1066; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wilflingseder D, 2004, J IMMUNOL, V173, P7497, DOI 10.4049/jimmunol.173.12.7497; Yanagi M, 1999, VIROLOGY, V262, P250, DOI 10.1006/viro.1999.9889	51	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45770	10.1371/journal.pone.0045770	http://dx.doi.org/10.1371/journal.pone.0045770			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049856	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100076
J	Hu, P; Oomen, C; van Dam, AM; Wester, J; Zhou, JN; Joels, M; Lucassen, PJ				Hu, Pu; Oomen, Charlotte; van Dam, Anne-Marie; Wester, Jordi; Zhou, Jiang-Ning; Joels, Marian; Lucassen, Paul J.			A Single-Day Treatment with Mifepristone Is Sufficient to Normalize Chronic Glucocorticoid Induced Suppression of Hippocampal Cell Proliferation	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; COMBINED DEXAMETHASONE/CRH TEST; CHRONIC PSYCHOSOCIAL STRESS; RAT DENTATE GYRUS; ADULT HIPPOCAMPUS; PSYCHOTIC DEPRESSION; SYNAPTIC PLASTICITY; PROGENITOR CELLS; NUCLEAR ANTIGEN; NERVOUS-SYSTEM	Background: Chronic stress or prolonged administration of glucocorticoids suppresses proliferation and/or survival of newborn cells in adult rat dentate gyrus. Earlier we showed that administration of the glucocorticoid receptor antagonist mifepristone during the final 4 days of a 21 days period of corticosterone treatment fully normalized the number of newborn cells. Here we aimed to better understand how mifepristone achieves this effect and questioned whether an even shorter (single day) mifepristone treatment (instead of 4 days) also suffices to normalize neurogenesis. Methods: We investigated various steps of the neurogenic process, using the immunohistochemical markers BrdU, doublecortin, proliferating cell nuclear antigen as well as glial fibrillary acidic protein, after 17 or 21 days of corticosterone (versus vehicle) treatment. Results: Corticosterone primarily attenuates the proliferation of cells which subsequently develop into neurons; this is fully reversed by mifepristone. Surprisingly, the corticosteroid effects on neurogenesis can even be fully re-set by a single-day treatment with mifepristone (on day 18), despite the continued corticosterone exposure on subsequent days. Conclusions: Our results emphasize that studies into the therapeutical efficacy of new antidepressants, especially those targeting HPA-activity or the glucocorticoid receptor, should explore the possibility to reduce treatment duration.	[Hu, Pu; Oomen, Charlotte; Wester, Jordi; Joels, Marian; Lucassen, Paul J.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Hu, Pu; Zhou, Jiang-Ning] Univ Sci & Technol China, CAS Key Lab Brain Funct & Dis, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [van Dam, Anne-Marie] Vrije Univ Amsterdam, Med Ctr, Dept Anat & Neurosci, Amsterdam, Netherlands; [Joels, Marian] Univ Med Ctr Utrecht, Dept Neurosci & Pharmacol, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands	University of Amsterdam; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center	Lucassen, PJ (corresponding author), Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	p.j.lucassen@uva.nl	Joëls, Marian/P-6415-2016; Lucassen, Paul/ABA-3113-2020; Oomen, Charlotte/K-5259-2014; Zhou, JiangNing/N-3374-2013	Lucassen, Paul/0000-0001-9708-9133; Zhou, Jiang-Ning/0000-0003-1225-2873; Joels, Marian/0000-0002-4826-6209	Netherlands Brain Foundation; European Union; ISAO; NWO; Human Frontiers Science Program; Corcept Inc.; Natural Science Foundation of China [81100811]; Corcept Therapeutics, USA	Netherlands Brain Foundation; European Union(European Commission); ISAO; NWO(Netherlands Organization for Scientific Research (NWO)); Human Frontiers Science Program(Human Frontier Science Program); Corcept Inc.; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Corcept Therapeutics, USA	PJL is supported by the Netherlands Brain Foundation, the European Union and ISAO. MJ is supported by NWO and the Human Frontiers Science Program. MJ, PJL and PH were in part supported by Corcept Inc. PH is further supported in part by the Natural Science Foundation of China (81100811). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and would like to declare that there are no conflicts of interest to report other than that ms Hu, unaware of this source, was in part supported by a student fellowship awarded to Prof. Dr. Joels by Corcept Therapeutics, USA, (http://www.corcept. com/). This does this alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Belanoff JK, 2001, J CLIN PSYCHOPHARM, V21, P516, DOI 10.1097/00004714-200110000-00009; Blasey CM, 2011, J CLIN PSYCHOPHARM, V31, P436, DOI 10.1097/JCP.0b013e3182239191; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Cameron HA, 2001, J COMP NEUROL, V435, P406, DOI 10.1002/cne.1040; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; Cotter DR, 2001, BRAIN RES BULL, V55, P585, DOI 10.1016/S0361-9230(01)00527-5; Coyle JT, 2000, ARCH GEN PSYCHIAT, V57, P90, DOI 10.1001/archpsyc.57.1.90; Czeh B, 2002, BIOL PSYCHIAT, V52, P1057, DOI 10.1016/S0006-3223(02)01457-9; Czeh B, 2006, NEUROPSYCHOPHARMACOL, V31, P1616, DOI 10.1038/sj.npp.1300982; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; DEROCHE V, 1995, J NEUROSCI, V15, P7181; Ehninger D, 2008, CELL TISSUE RES, V331, P243, DOI 10.1007/s00441-007-0478-3; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Fava M, 2000, NEURON, V28, P335, DOI 10.1016/S0896-6273(00)00112-4; Fleseriu M, 2012, J CLIN ENDOCRINOL ME; Flores BH, 2006, NEUROPSYCHOPHARMACOL, V31, P628, DOI 10.1038/sj.npp.1300884; Fuchs E, 2006, FRONT BIOSCI-LANDMRK, V11, P2746, DOI 10.2741/2004; Garza JC, 2012, MOL PSYCHIATR, V17, P790, DOI 10.1038/mp.2011.161; Hanson ND, 2011, PSYCHONEUROENDOCRINO, V36, P1520, DOI 10.1016/j.psyneuen.2011.04.006; HEIKINHEIMO O, 1994, HUM REPROD, V9, P40, DOI 10.1093/humrep/9.suppl_1.40; HEIKINHEIMO O, 1993, ANN MED, V25, P71, DOI 10.3109/07853899309147861; Heine VM, 2005, EUR J NEUROSCI, V21, P1304, DOI 10.1111/j.1460-9568.2005.03951.x; Heine VM, 2004, EUR J NEUROSCI, V19, P131, DOI 10.1046/j.1460-9568.2003.03100.x; Holsboer F, 2010, ANNU REV PSYCHOL, V61, P81, DOI 10.1146/annurev.psych.093008.100321; Ino H, 2000, MOL BRAIN RES, V78, P163, DOI 10.1016/S0169-328X(00)00092-9; Ising M, 2005, PROG NEURO-PSYCHOPH, V29, P1085, DOI 10.1016/j.pnpbp.2005.03.014; Joels M, 2007, FRONT NEUROENDOCRIN, V28, P72, DOI 10.1016/j.yfrne.2007.04.001; Joels M, 2011, PSYCHONEUROENDOCRINO, V36, P406, DOI 10.1016/j.psyneuen.2010.03.004; Karst H, 2007, NEUROPSYCHOPHARMACOL, V32, P1830, DOI 10.1038/sj.npp.1301296; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kim JB, 2004, BRAIN RES, V1027, P1, DOI 10.1016/j.brainres.2004.070.93; Krishnan V, 2010, AM J PSYCHIAT, V167, P1305, DOI 10.1176/appi.ajp.2009.10030434; Krugers HJ, 2006, EUR J NEUROSCI, V23, P3051, DOI 10.1111/j.1460-9568.2006.04842.x; Li H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037030; Limke TL, 2003, DEV NEUROSCI-BASEL, V25, P257, DOI 10.1159/000072273; Llorens-Martin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028376; Lucassen PJ, 2013, MOL PSYCHIATR, V18, P396, DOI 10.1038/mp.2012.39; Lucassen PJ, 2010, EUR NEUROPSYCHOPHARM, V20, P1, DOI 10.1016/j.euroneuro.2009.08.003; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Mayer JL, 2006, J NEUROENDOCRINOL, V18, P629, DOI 10.1111/j.1365-2826.2006.01455.x; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Namba T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025303; Naryzhny SN, 2008, CELL MOL LIFE SCI, V65, P3789, DOI 10.1007/s00018-008-8305-x; NIEMAN LK, 1985, J CLIN ENDOCR METAB, V61, P536, DOI 10.1210/jcem-61-3-536; Nierenberg AA, 2007, J PSYCHIATR RES, V41, P214, DOI 10.1016/j.jpsychires.2006.02.005; Oomen CA, 2007, EUR J NEUROSCI, V26, P3395, DOI 10.1111/j.1460-9568.2007.05972.x; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Pariante CM, 2009, ANN NY ACAD SCI, V1179, P144, DOI 10.1111/j.1749-6632.2009.04978.x; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; RATKA A, 1988, NEUROENDOCRINOLOGY, V48, P439, DOI 10.1159/000125046; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Sandi C, 1999, BRAIN RES, V828, P127, DOI 10.1016/S0006-8993(99)01346-3; Sandi C, 2004, NAT REV NEUROSCI, V5, P917, DOI 10.1038/nrn1555; Schmidt ED, 2003, NEUROSCIENCE, V116, P275, DOI 10.1016/S0306-4522(02)00555-9; Schmitz C, 2005, NEUROSCIENCE, V130, P813, DOI 10.1016/j.neuroscience.2004.08.050; Schoenfeld TJ, 2012, EXP NEUROL, V233, P12, DOI 10.1016/j.expneurol.2011.01.008; Simpson GM, 2005, J CLIN PSYCHIAT, V66, P598, DOI 10.4088/JCP.v66n0509; Steiner B, 2004, GLIA, V46, P41, DOI 10.1002/glia.10337; Stohr T, 1999, BEHAV BRAIN RES, V103, P85, DOI 10.1016/S0166-4328(99)00027-3; Thomas RM, 2007, J NEUROSCI, V27, P2734, DOI 10.1523/JNEUROSCI.3849-06.2007; Vanderschuren LJMJ, 1999, J NEUROSCI, V19, P9579, DOI 10.1523/jneurosci.19-21-09579.1999; VANDIJKEN HH, 1993, NEUROENDOCRINOLOGY, V58, P57, DOI 10.1159/000126512; Walker TL, 2007, J NEUROSCI, V27, P3734, DOI 10.1523/JNEUROSCI.5060-06.2007; Wong EYH, 2006, NEUROSCIENCE, V137, P83, DOI 10.1016/j.neuroscience.2005.08.073; Wong EYH, 2005, EUR J NEUROSCI, V22, P785, DOI 10.1111/j.1460-9568.2005.04277.x; Wong EYH, 2004, EUR J NEUROSCI, V20, P2491, DOI 10.1111/j.1460-9568.2004.03717.x; Wulsin AC, 2010, PSYCHONEUROENDOCRINO, V35, P1100, DOI 10.1016/j.psyneuen.2010.01.011; Young AH, 2004, NEUROPSYCHOPHARMACOL, V29, P1538, DOI 10.1038/sj.npp.1300471; Zobel AW, 2001, J PSYCHIAT RES, V35, P83, DOI 10.1016/S0022-3956(01)00013-9	75	43	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46224	10.1371/journal.pone.0046224	http://dx.doi.org/10.1371/journal.pone.0046224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049985	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100158
J	Marx, FM; Dunbar, R; Enarson, DA; Beyers, N				Marx, Florian M.; Dunbar, Rory; Enarson, Donald A.; Beyers, Nulda			The Rate of Sputum Smear-Positive Tuberculosis after Treatment Default in a High-Burden Setting: A Retrospective Cohort Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; SINGLE NUCLEOTIDE POLYMORPHISMS; COMMON VARIANTS; CHILDHOOD OBESITY; ADULT OBESITY; GENETIC-VARIANTS; CHINESE CHILDREN; FTO GENE; MC4R	Rationale: High rates of recurrent tuberculosis after successful treatment have been reported from different high burden settings in Sub-Saharan Africa. However, little is known about the rate of smear-positive tuberculosis after treatment default. In particular, it is not known whether or not treatment defaulters continue to be or become again smear-positive and thus pose a potential for transmission of infection to others. Objective: To investigate, in a high tuberculosis burden setting, the rate of re-treatment for smear-positive tuberculosis among cases defaulting from standardized treatment compared to successfully treated cases. Methods: Retrospective cohort study among smear-positive tuberculosis cases treated between 1996 and 2008 in two urban communities in Cape Town, South Africa. Episodes of re-treatment for smear-positive tuberculosis were ascertained via probabilistic record linkage. Survival analysis and Poisson regression were used to compare the rate of smear-positive tuberculosis after treatment default to that after successful treatment. Results: A total of 2,136 smear-positive tuberculosis cases were included in the study. After treatment default, the rate of re-treatment for smear-positive tuberculosis was 6.86 (95% confidence interval [CI]: 5.59-8.41) per 100 person-years compared to 2.09 (95% CI: 1.81-2.41) after cure (adjusted Hazard Ratio [aHR]: 3.97; 95% CI: 3.00-5.26). Among defaulters, the rate was inversely associated with treatment duration and sputum conversion prior to defaulting. Smear grade at start of the index treatment episode (Smear3+: aHR 1.61; 95% CI 1.11-2.33) was independently associated with smear-positive tuberculosis re-treatment, regardless of treatment outcome. Conclusions: In this high-burden setting, there is a high rate of subsequent smear-positive tuberculosis after treatment default. Treatment defaulters are therefore likely to contribute to the pool of infectious source cases in the community. Our findings underscore the importance of preventing treatment default, as a means of successful tuberculosis control in high-burden settings.	[Marx, Florian M.] Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany; [Marx, Florian M.; Dunbar, Rory; Enarson, Donald A.; Beyers, Nulda] Univ Stellenbosch, Desmond Tutu TB Ctr, ZA-7505 Tygerberg, South Africa; [Enarson, Donald A.] Int Union TB & Lung Dis, Paris, France	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Stellenbosch University	Marx, FM (corresponding author), Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany.	florian.marx@charite.de	Marx, Florian/AAD-7148-2019	Marx, Florian/0000-0003-4630-4598	TREAT TB	TREAT TB	This study was supported by a grant from TREAT TB, managed by the International Union Against Tuberculosis and Lung Disease and provided by USAID. The contents of this document are the sole responsibility of the authors and can under no circumstances be regarded as reflecting the positions of the International Union Against Tuberculosis and Lung Disease (The Union) or those of the donor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckers S, 2011, MOL GENET METAB, V103, P71, DOI 10.1016/j.ymgme.2011.01.007; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cauchi S, 2009, J MOL MED, V87, P537, DOI 10.1007/s00109-009-0451-6; Chambers JC, 2008, NAT GENET, V40, P716, DOI 10.1038/ng.156; Cheung CYY, 2010, J CLIN ENDOCR METAB, V95, P1395, DOI 10.1210/jc.2009-1465; Clark MF, 2006, INTENS CARE MED, V32, P1706, DOI 10.1007/s00134-006-0327-y; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; Doak CM, 2012, OBES REV, V13, P174, DOI 10.1111/j.1467-789X.2011.00943.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Grant SFA, 2009, OBESITY, V17, P1461, DOI 10.1038/oby.2009.53; Holzapfel C, 2010, INT J OBESITY, V34, P1538, DOI 10.1038/ijo.2010.79; Hong J, 2013, INT J OBESITY, V37, P673, DOI 10.1038/ijo.2012.87; Hotta K, 2009, J HUM GENET, V54, P727, DOI 10.1038/jhg.2009.106; Huang H, 2012, MOL BIOL REP, V39, P1739, DOI 10.1007/s11033-011-0914-z; Huang W, 2011, ENDOCRINE, V39, P69, DOI 10.1007/s12020-010-9413-6; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Li SX, 2010, AM J CLIN NUTR, V91, P184, DOI 10.3945/ajcn.2009.28403; Liem ET, 2010, AM J CLIN NUTR, V91, P321, DOI 10.3945/ajcn.2009.28186; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Loos RJF, 2011, EUR J PHARMACOL, V660, P156, DOI 10.1016/j.ejphar.2011.01.033; MANTEL N, 1959, J NATL CANCER I, V22, P719; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Ng MCY, 2010, J CLIN ENDOCR METAB, V95, P2418, DOI 10.1210/jc.2009-2077; Okada Y, 2012, NAT GENET, V44, P302, DOI 10.1038/ng.1086; Pan ZL, 2005, PLOS MED, V2, P1309, DOI 10.1371/journal.pmed.0020334; Paternoster L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024303; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Razquin C, 2011, MOL NUTR FOOD RES, V55, P136, DOI 10.1002/mnfr.201000445; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Rouskas K, 2012, OBESITY, V20, P389, DOI 10.1038/oby.2011.177; Scherag A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013967; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Shi JJ, 2010, AM J EPIDEMIOL, V172, P244, DOI 10.1093/aje/kwq129; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stutzmann F, 2007, HUM MOL GENET, V16, P1837, DOI 10.1093/hmg/ddm132; Tabara Y, 2009, INT J OBESITY, V33, P1243, DOI 10.1038/ijo.2009.161; Tao LM, 2012, MOL BIOL REP, V39, P6487, DOI 10.1007/s11033-012-1476-4; Thomsen M, 2012, J CLIN ENDOCR METAB, V97, pE1074, DOI 10.1210/jc.2011-3282; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Valladares M, 2010, NUTR NEUROSCI, V13, P71, DOI 10.1179/147683010X12611460763643; Vogel CIG, 2011, OBESITY FACTS, V4, P67, DOI 10.1159/000324557; Wang D, 2010, OBESITY, V18, P573, DOI 10.1038/oby.2009.268; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Wu LJ, 2010, DIABETES, V59, P3085, DOI 10.2337/db10-0273; Xi B, 2011, AM J EPIDEMIOL, V173, P1256, DOI 10.1093/aje/kwr008; Zhao JH, 2011, OBESITY, V19, P2436, DOI 10.1038/oby.2011.237; Zobel DP, 2009, DIABETES, V58, P757, DOI 10.2337/db08-0620	52	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45724	10.1371/journal.pone.0045724	http://dx.doi.org/10.1371/journal.pone.0045724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049846	Green Published, gold			2022-12-27	WOS:000309556100074
J	Roman, EA; Faraj, SE; Gallo, M; Salvay, AG; Ferreiro, DU; Santos, J				Roman, Ernesto A.; Faraj, Santiago E.; Gallo, Mariana; Salvay, Andres G.; Ferreiro, Diego U.; Santos, Javier			Protein Stability and Dynamics Modulation: The Case of Human Frataxin	PLOS ONE			English	Article							FREE-ENERGY CHANGES; LINEAR EXTRAPOLATION METHOD; IRON-BINDING ACTIVITY; FRIEDREICH ATAXIA; TOPOLOGICAL FRUSTRATION; STAPHYLOCOCCAL NUCLEASE; GLOBULAR-PROTEINS; POINT MUTATIONS; YEAST FRATAXIN; ALPHA-HELICES	Frataxin (FXN) is an alpha/beta protein that plays an essential role in iron homeostasis. Apparently, the function of human FXN (hFXN) depends on the cooperative formation of crucial interactions between helix alpha 1, helix alpha 2, and the C-terminal region (CTR) of the protein. In this work we quantitatively explore these relationships using a purified recombinant fragment hFXN90-195. This variant shows the hydrodynamic behavior expected for a monomeric globular domain. Circular dichroism, fluorescence, and NMR spectroscopies show that hFXN90-195 presents native-like secondary and tertiary structure. However, chemical and temperature induced denaturation show that CTR truncation significantly destabilizes the overall hFXN fold. Accordingly, limited proteolysis experiments suggest that the native-state dynamics of hFXN90-195 and hFXN90-210 are indeed different, being the former form much more sensitive to the protease at specific sites. The overall folding dynamics of hFXN fold was further explored with structure-based protein folding simulations. These suggest that the native ensemble of hFXN can be decomposed in at least two substates, one with consolidation of the CTR and the other without consolidation of the CTR. Explicit-solvent all atom simulations identify some of the proteolytic target sites as flexible regions of the protein. We propose that the local unfolding of CTR may be a critical step for the global unfolding of hFXN, and that modulation of the CTR interactions may strongly affect hFXN physiological function.	[Roman, Ernesto A.; Faraj, Santiago E.; Santos, Javier] Univ Buenos Aires, Inst Quim & Fis Quim Biol, Buenos Aires, DF, Argentina; [Gallo, Mariana] Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Gallo, Mariana] IIBBA CONICET, Buenos Aires, DF, Argentina; [Salvay, Andres G.] Univ Nacl La Plata, Inst Fis Liquidos & Sistemas Biol, Fac Ciencias Exactas, La Plata, Argentina; [Salvay, Andres G.] Univ Nacl Quilmes, Dept Ciencia & Tecnol, Bernal, Provincia De Bu, Argentina; [Roman, Ernesto A.; Ferreiro, Diego U.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, Prot Physiol Lab,Dept Quim Biol, Buenos Aires, DF, Argentina	University of Buenos Aires; Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Santos, J (corresponding author), Univ Buenos Aires, Inst Quim & Fis Quim Biol, Buenos Aires, DF, Argentina.	jsantos@qb.ffyb.uba.ar	Salvay, Andrés Gerardo/AAC-8505-2021; Faraj, Santiago E./P-3148-2016	Faraj, Santiago E./0000-0001-6608-4700; Santos, Javier/0000-0002-1140-8234; Gallo, Mariana/0000-0002-0022-4499; Salvay, Andres/0000-0003-4020-1336; Ferreiro, Diego/0000-0002-7869-4247	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de Buenos Aires (UBACyT)	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT)(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires (UBACyT)(University of Buenos Aires)	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) and Universidad de Buenos Aires (UBACyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi S, 2004, BIOCHEMISTRY-US, V43, P6511, DOI 10.1021/bi036049+; Adinolfi S, 2002, HUM MOL GENET, V11, P1865, DOI 10.1093/hmg/11.16.1865; Al-Mahdawi S, 2000, Hum Mutat, V16, P95, DOI 10.1002/1098-1004(200007)16:1<95::AID-HUMU29>3.0.CO;2-E; Baralle M, 2008, AM J HUM GENET, V83, P77, DOI 10.1016/j.ajhg.2008.06.018; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; BOLEN DW, 1988, BIOCHEMISTRY-US, V27, P8069, DOI 10.1021/bi00421a015; Bridwell-Rabb J, 2011, BIOCHEMISTRY-US, V50, P7265, DOI 10.1021/bi200895k; Capraro DT, 2008, P NATL ACAD SCI USA, V105, P14844, DOI 10.1073/pnas.0807812105; Cho SS, 2006, P NATL ACAD SCI USA, V103, P586, DOI 10.1073/pnas.0509768103; Clementi C, 2000, J MOL BIOL, V298, P937, DOI 10.1006/jmbi.2000.3693; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Correia AR, 2008, FEBS J, V275, P3680, DOI 10.1111/j.1742-4658.2008.06512.x; Correia AR, 2006, BIOCHEM J, V398, P605, DOI 10.1042/BJ20060345; Correia AR, 2010, BIOCHEM J, V426, P197, DOI 10.1042/BJ20091612; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Eftink MR, 1997, PROTEINS, V28, P227; Fisinger S, 2001, PROTEIN SCI, V10, P809, DOI 10.1110/ps.34901; Forrest SM, 1998, NEUROGENETICS, V1, P253, DOI 10.1007/s100480050037; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Gellera C, 2007, NEUROGENETICS, V8, P289, DOI 10.1007/s10048-007-0101-5; Gosavi S, 2006, J MOL BIOL, V357, P986, DOI 10.1016/j.jmb.2005.11.074; Gottesfeld JM, 2007, PHARMACOL THERAPEUT, V116, P236, DOI 10.1016/j.pharmthera.2007.06.014; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hills RD, 2008, J MOL BIOL, V382, P485, DOI 10.1016/j.jmb.2008.07.007; Iannuzzi C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021992; Jenik M, 2012, NUCL ACIDS RES; King AC, 2011, PROTEIN SCI, V20, P1546, DOI 10.1002/pro.680; Kondapalli KC, 2010, BIOMOL NMR ASSIGN, V4, P61, DOI 10.1007/s12104-010-9209-x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koutnikova H, 1998, HUM MOL GENET, V7, P1485, DOI 10.1093/hmg/7.9.1485; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Layton CJ, 2011, PROTEIN SCI; Layton CJ, 2010, BIOCHEMISTRY-US, V49, P10831, DOI 10.1021/bi101414z; Leidgens S, 2010, HUM MOL GENET, V19, P276, DOI 10.1093/hmg/ddp495; Long S, 2008, P NATL ACAD SCI USA, V105, P13468, DOI 10.1073/pnas.0806762105; Marczenko Z., 1976, SPECTROPHOTOMETRIC D; Musco G, 2000, STRUCTURE, V8, P695, DOI 10.1016/S0969-2126(00)00158-1; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Nishimura C, 2001, BIOCHEMISTRY-US, V40, P2113, DOI 10.1021/bi000861k; Noel JK, 2010, NUCLEIC ACIDS RES, V38, pW657, DOI 10.1093/nar/gkq498; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Pandolfo M, 2009, J NEUROL, V256, P9, DOI 10.1007/s00415-009-1003-2; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085; Park C, 2007, J MOL BIOL, V368, P1426, DOI 10.1016/j.jmb.2007.02.091; Patel PI, 2001, AM J HUM GENET, V69, P15, DOI 10.1086/321283; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Prischi F, 2009, FEBS J, V276, P6669, DOI 10.1111/j.1742-4658.2009.07381.x; Puccio H, 2007, Handb Exp Pharmacol, P365; Roman EA, 2010, PROTEINS, V78, P2757, DOI 10.1002/prot.22789; SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P4901, DOI 10.1021/bi00135a022; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Seznec H, 2005, HUM MOL GENET, V14, P463, DOI 10.1093/hmg/ddi042; SWENDSEN RH, 1993, PHYSICA A, V194, P53, DOI 10.1016/0378-4371(93)90339-6; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Vertrees J, 2005, BIOINFORMATICS, V21, P3318, DOI 10.1093/bioinformatics/bti520; Wrabl JO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000722; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Yoon H, 2012, BIOCHEM J, V441, P473, DOI 10.1042/BJ20111637; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Yoon T, 2007, J BIOL INORG CHEM, V12, P535, DOI 10.1007/s00775-007-0205-2	68	22	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45743	10.1371/journal.pone.0045743	http://dx.doi.org/10.1371/journal.pone.0045743			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049850	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100075
J	van der Kop, ML; Karanja, S; Thabane, L; Marra, C; Chung, MH; Gelmon, L; Kimani, J; Lester, RT				van der Kop, Mia L.; Karanja, Sarah; Thabane, Lehana; Marra, Carlo; Chung, Michael H.; Gelmon, Lawrence; Kimani, Joshua; Lester, Richard T.			In-Depth Analysis of Patient-Clinician Cell Phone Communication during the WelTel Kenya1 Antiretroviral Adherence Trial	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HIV-1-INFECTED PATIENTS; THERAPY; SYSTEM; SUPPORT	Background: The WelTel Kenya1 trial demonstrated that text message support improved adherence to antiretroviral therapy (ART) and suppression of HIV-1 RNA load. The intervention involved sending weekly messages to patients inquiring how they were doing; participants were required to respond either that they were well or that there was a problem. Objectives: 1) Describe problems participants identified through mobile phone support and reasons why participants did not respond to the messages; 2) investigate factors associated with indicating a problem and not responding; and 3) examine participant perceptions of the intervention. Design: Secondary analysis of WelTel Kenya1 trial data. Methods: Reasons participants indicated a problem or did not respond were extracted from the study log. Negative binomial regression was used to determine participant characteristics associated with indicating a problem and non-response. Data from follow-up questionnaires were used to describe participant perceptions of the intervention. Results: Between 2007 and 2009, 271 participants generated 11,873 responses; 377 of which indicated a problem. Health issues were the primary reason for problem responses (72%). Rural residence (adjusted incidence rate ratio [IRR] 1.96; 95%CI 1.19-3.25; p = 0.009 and age were associated with indicating a problem (adjusted IRR 0.63 per increase in age group category; 95%CI 0.50-0.80; p < 0.001). Higher educational level was associated with a decreased rate of non-response (adjusted IRR 0.81; 95%CI 0.69-0.94; p = 0.005). Of participants interviewed, 62% (n = 129) stated there were no barriers to the intervention; cell phone issues were the most common barrier. Benefits included reminding patients to take medication and promoting a feeling that "someone cares''. Conclusions: The WelTel intervention enabled frequent communication between clinicians and patients during the WelTel Kenya1 trial. Many patients valued the service for the support it provided, with health-related concerns comprising the majority of problems identified by participants. Few sociodemographic characteristics were associated with participant engagement in the intervention.	[van der Kop, Mia L.; Marra, Carlo; Lester, Richard T.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [van der Kop, Mia L.; Lester, Richard T.] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Karanja, Sarah; Gelmon, Lawrence; Lester, Richard T.] Univ Manitoba, Nairobi, Kenya; [Thabane, Lehana] McMaster Univ, Hamilton, ON, Canada; [Chung, Michael H.] Univ Washington, Seattle, WA 98195 USA; [Gelmon, Lawrence; Kimani, Joshua; Lester, Richard T.] Univ Nairobi, Nairobi, Kenya	University of British Columbia; McMaster University; University of Washington; University of Washington Seattle; University of Nairobi	van der Kop, ML (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	miavanderkop@gmail.com	Marra, Carlo/AAE-4904-2021	Marra, Carlo/0000-0002-2625-2121	United States President's Emergency Plan for AIDS Relief (PEPFAR) through the Centre for Disease Control (CDC) [5U62PS024510, PHE:KE07.0045]; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [U62PS024510] Funding Source: NIH RePORTER	United States President's Emergency Plan for AIDS Relief (PEPFAR) through the Centre for Disease Control (CDC); NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The original trial was funded by the United States President's Emergency Plan for AIDS Relief (PEPFAR) through the Centre for Disease Control (CDC) cooperative agreement 5U62PS024510 as a public-health evaluation (PHE:KE07.0045). No additional funding was secured to conduct this investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammassari A, 2011, JAIDS-J ACQ IMM DEF, V58, pE113, DOI 10.1097/QAI.0b013e3182359d2a; Berman P, 1995, KENYA NONGOVERNMENTA; Bowen H, 2010, ANAL MEDIA USE COMMU; Bowen H., 2010, AFRICA DEV RES SERIE; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Curioso WH, 2009, AMIA ANN S P, P129; Dunbar PJ, 2003, J AM MED INFORM ASSN, V10, P11, DOI 10.1197/jamia.M1047; Franklin VL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.962; Hardy H, 2011, AIDS PATIENT CARE ST, V25, P153, DOI 10.1089/apc.2010.0006; Harris LT, 2010, TELEMED J E-HEALTH, V16, P1024, DOI 10.1089/tmj.2010.0050; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lester RT, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-87; Miloh T, 2009, PEDIATRICS, V124, pE844, DOI 10.1542/peds.2009-0415; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Sidney K, 2012, AIDS CARE, V24, P612, DOI 10.1080/09540121.2011.630357; Silverberg MJ, 2007, ARCH INTERN MED, V167, P684, DOI 10.1001/archinte.167.7.684; Simoni JM, 2009, JAIDS-J ACQ IMM DEF, V52, P465, DOI 10.1097/QAI.0b013e3181b9300c; U.S. Department of Health and Human Services Health Resources and Services Administration, MHEALTH; Wesolowski A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035319	19	42	44	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46033	10.1371/journal.pone.0046033	http://dx.doi.org/10.1371/journal.pone.0046033			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049928	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100123
J	Donohoe, DR; Wali, A; Brylawski, BP; Bultman, SJ				Donohoe, Dallas R.; Wali, Aminah; Brylawski, Bruna P.; Bultman, Scott J.			Microbial Regulation of Glucose Metabolism and Cell-Cycle Progression in Mammalian Colonocytes	PLOS ONE			English	Article							GUT MICROBIOME; EPITHELIAL-CELLS; ENERGY-METABOLISM; GERM-FREE; INTESTINE; OBESITY; MOUSE; MUTUALISM; ECOLOGY; COLON	A prodigious number of microbes inhabit the human body, especially in the lumen of the gastrointestinal (GI) tract, yet our knowledge of how they regulate metabolic pathways within our cells is rather limited. To investigate the role of microbiota in host energy metabolism, we analyzed ATP levels and AMPK phosphorylation in tissues isolated from germfree and conventionally-raised C57BL/6 mice. These experiments demonstrated that microbiota are required for energy homeostasis in the proximal colon to a greater extent than other segments of the GI tract that also harbor high densities of bacteria. This tissue-specific effect is consistent with colonocytes utilizing bacterially-produced butyrate as their primary energy source, whereas most other cell types utilize glucose. However, it was surprising that glucose did not compensate for butyrate deficiency. We measured a 3.5-fold increase in glucose uptake in germfree colonocytes. However, C-13-glucose metabolic-flux experiments and biochemical assays demonstrated that they shifted their glucose metabolism away from mitochondrial oxidation/CO2 production and toward increased glycolysis/lactate production, which does not yield enough ATPs to compensate. The mechanism responsible for this metabolic shift is diminished pyruvate dehydrogenase (PDH) levels and activity. Consistent with perturbed PDH function, the addition of butyrate, but not glucose, to germfree colonocytes ex vivo stimulated oxidative metabolism. As a result of this energetic defect, germfree colonocytes exhibited a partial block in the G(1)-to-S-phase transition that was rescued by a butyrate-fortified diet. These data reveal a mechanism by which microbiota regulate glucose utilization to influence energy homeostasis and cell-cycle progression of mammalian host cells.	[Donohoe, Dallas R.; Wali, Aminah; Bultman, Scott J.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Donohoe, Dallas R.; Wali, Aminah; Bultman, Scott J.] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC USA; [Brylawski, Bruna P.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bultman, SJ (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	Scott_Bultman@med.unc.edu	Ariel, Pablo/AGJ-4118-2022		National Institutes of Health [CA125237]; American Institute of Cancer Research; Prevent Cancer Foundation; NIH [P30-ES10126]; NATIONAL CANCER INSTITUTE [R01CA125237, P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute of Cancer Research; Prevent Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (CA125237 to S.J.B.), the American Institute of Cancer Research, and The Prevent Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank V. Madden, S. Ray, and B. Bagnell at the UNC Micrsocopy Services Laboratory for advice with confocal microscopy. We would also like to thank L. Collin at the UNC Biomarker Mass Spectrometry Facility (supported by NIH grant P30-ES10126) for his technical assistance in performing the LC-MS/MS experiments. Finally, we would like to thank the staff of the National Gnotobiotic Resource Center at UNC for maintaining germfree mice.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; GORDON HA, 1971, BACTERIOL REV, V35, P390, DOI 10.1128/MMBR.35.4.390-429.1971; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hooper LV, 2000, CURR OPIN MICROBIOL, V3, P79, DOI 10.1016/S1369-5274(99)00055-7; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; KHOURY KA, 1969, J EXP MED, V130, P659, DOI 10.1084/jem.130.3.659; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; ROEDIGER WEW, 1979, GUT, V20, P484, DOI 10.1136/gut.20.6.484; ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424; ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; SAVAGE DC, 1981, APPL ENVIRON MICROB, V42, P996, DOI 10.1128/AEM.42.6.996-1001.1981; SEWELL DL, 1975, AM J PHYSIOL, V228, P526, DOI 10.1152/ajplegacy.1975.228.2.526; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	31	93	96	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46589	10.1371/journal.pone.0046589	http://dx.doi.org/10.1371/journal.pone.0046589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029553	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900187
J	Moustafa, AA; Hewedi, DH; Eissa, AM; Myers, CE; Sadek, HA				Moustafa, Ahmed A.; Hewedi, Doaa H.; Eissa, Abeer M.; Myers, Catherine E.; Sadek, Hisham A.			The Relationship between Associative Learning, Transfer Generalization, and Homocysteine Levels in Mild Cognitive Impairment	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; PLASMA HOMOCYSTEINE; ALZHEIMERS-DISEASE; ALLOSTERIC MODULATION; TREATMENT STRATEGY; RISK-FACTOR; HIPPOCAMPAL; MEMORY; DEMENTIA; DECLINE	Previous studies have shown that high total homocysteine levels are associated with Alzheimer's disease (AD) and mild cognitive impairment (MCI). In this study, we test the relationship between cognitive function and total homocysteine levels in healthy subjects (Global Dementia Rating, CDR = 0) and individuals with MCI (CDR = 0.5). We have used a cognitive task that tests learning and generalization of rules, processes that have been previously shown to rely on the integrity of the striatal and hippocampal regions, respectively. We found that total homocysteine levels are higher in MCI individuals than in healthy controls. Unlike what we expected, we found no difference between MCI subjects and healthy controls in learning and generalization. We conducted further analysis after diving MCI subjects in two groups, depending on their Global Deterioration Scale (GDS) scores: individuals with very mild cognitive decline (vMCD, GDS = 2) and mild cognitive decline (MCD, GDS = 3). There was no difference among the two MCI and healthy control groups in learning performance. However, we found that individuals with MCD make more generalization errors than healthy controls and individuals with vMCD. We found no difference in the number of generalization errors between healthy controls and MCI individuals with vMCD. In addition, interestingly, we found that total homocysteine levels correlate positively with generalization errors, but not with learning errors. Our results are in agreement with prior results showing a link between hippocampal function, generalization performance, and total homocysteine levels. Importantly, our study is perhaps among the first to test the relationship between learning (and generalization) of rules and homocysteine levels in healthy controls and individuals with MCI.	[Moustafa, Ahmed A.] Univ Western Sydney, Sch Social Sci & Psychol, Sydney, NSW, Australia; [Moustafa, Ahmed A.] Univ Western Sydney, Marcs Inst Brain & Behav, Sydney, NSW, Australia; [Hewedi, Doaa H.; Eissa, Abeer M.; Sadek, Hisham A.] Ain Shams Univ, Sch Med, Psychogeriatr Res Ctr, Dept Psychiat, Cairo, Egypt; [Myers, Catherine E.] Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA; [Myers, Catherine E.] New Jersey Hlth Care Syst, NeuroBehav Res Lab, Dept Vet Affairs, E Orange, NJ USA	Western Sydney University; Western Sydney University; Egyptian Knowledge Bank (EKB); Ain Shams University; Rutgers State University Newark; Rutgers State University New Brunswick; New Jersey Department of Health & Senior Services	Moustafa, AA (corresponding author), Univ Western Sydney, Sch Social Sci & Psychol, Sydney, NSW, Australia.	a.moustafa@uws.edu.au	Myers, Catherine E./AAU-5804-2020; Eissa, Abeer/GZG-9440-2022; Moustafa, Ahmed/AAM-2836-2021	Myers, Catherine E./0000-0002-2776-4823; Moustafa, Ahmed/0000-0001-5971-273X; Eissa, Abeer/0000-0003-1635-6039				Algaidi SA, 2006, EXP NEUROL, V197, P8, DOI 10.1016/j.expneurol.2005.07.003; Annerbo S, 2005, DEMENT GERIATR COGN, V20, P209, DOI 10.1159/000087297; Apostolova LG, 2006, ARCH NEUROL-CHICAGO, V63, P693, DOI 10.1001/archneur.63.5.693; Ayesa-Arriola R, 2012, EUR ARCH PSY CLIN N, V262, P557, DOI 10.1007/s00406-012-0302-2; Baydas G, 2005, BRAIN RES, V1046, P187, DOI 10.1016/j.brainres.2005.04.011; BONARDI C, 1993, ANIM LEARN BEHAV, V21, P369, DOI 10.3758/BF03198003; Bowen J, 1997, LANCET, V349, P763, DOI 10.1016/S0140-6736(96)08256-6; Chen CS, 2011, AM J GERIAT PSYCHIAT, V19, P618, DOI 10.1097/JGP.0b013e318209ddf1; Christie LA, 2005, NEUROSCI LETT, V373, P119, DOI 10.1016/j.neulet.2004.09.072; Collins AGE, 2012, EUR J NEUROSCI, V35, P1024, DOI 10.1111/j.1460-9568.2011.07980.x; de Jager CA, 2012, INT J GERIATR PSYCH, V27, P592, DOI 10.1002/gps.2758; DELEON MJ, 1989, LANCET, V2, P672; den Heijer T, 2003, BRAIN, V126, P170, DOI 10.1093/brain/awg006; Dufouil C, 2003, ANN NEUROL, V53, P214, DOI 10.1002/ana.10440; EICHENBAUM H, 1989, BEHAV NEUROSCI, V103, P1207, DOI 10.1037/0735-7044.103.6.1207; EICHENBAUM H, 1988, BEHAV NEUROSCI, V102, P331, DOI 10.1037/0735-7044.102.3.331; Faux NG, 2011, J ALZHEIMERS DIS, V27, P909, DOI 10.3233/JAD-2011-110752; Feng L, 2006, AM J CLIN NUTR, V84, P1506, DOI 10.1093/ajcn/84.6.1506; FLICKER C, 1991, NEUROLOGY, V41, P1006, DOI 10.1212/WNL.41.7.1006; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fouquet M, 2009, BRAIN, V132, P2058, DOI 10.1093/brain/awp132; Frank MJ, 2006, PSYCHOL SCI, V17, P700, DOI 10.1111/j.1467-9280.2006.01769.x; Frank MJ, 2003, HIPPOCAMPUS, V13, P341, DOI 10.1002/hipo.10084; Frantzen F, 1998, CLIN CHEM, V44, P311; Ganguly PK, 2008, BRAIN RES, V1226, P192, DOI 10.1016/j.brainres.2008.05.090; Gao L, 2012, NEUROL SCI, V33, P39, DOI 10.1007/s10072-011-0645-x; Garcia A, 2004, J GERONTOL A-BIOL, V59, P1323, DOI 10.1093/gerona/59.12.1323; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Genedani S, 2010, CURR ALZHEIMER RES, V7, P150, DOI 10.2174/156720510790691074; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; Grambaite R, 2011, J ALZHEIMERS DIS, V27, P453, DOI 10.3233/JAD-2011-110290; Haan MN, 2007, AM J CLIN NUTR, V85, P511, DOI 10.1093/ajcn/85.2.511; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; Ho RCM, 2011, AM J GERIAT PSYCHIAT, V19, P607, DOI 10.1097/JGP.0b013e3181f17eed; Hooshmand B, 2012, J INTERN MED, V271, P204, DOI 10.1111/j.1365-2796.2011.02484.x; Hooshmand B, 2010, NEUROLOGY, V75, P1408, DOI 10.1212/WNL.0b013e3181f88162; Ikonomovic MD, 2003, J ALZHEIMERS DIS, V5, P39, DOI 10.3233/JAD-2003-5106; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; Jack CR, 2000, NEUROLOGY, V55, P484, DOI 10.1212/WNL.55.4.484; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Jahanshahi M, 2009, NEUROPSYCHOLOGIA; Jog MS, 1999, SCIENCE, V286, P1745, DOI 10.1126/science.286.5445.1745; Johnson SC, 2007, NEUROPSYCHOL DEV C B, P1; KILLIANY RJ, 1993, ARCH NEUROL-CHICAGO, V50, P949, DOI 10.1001/archneur.1993.00540090052010; Kim J, 2007, J NUTR, V137, P2093, DOI 10.1093/jn/137.9.2093; Kluger A, 1999, J GERIATR PSYCH NEUR, V12, P168, DOI 10.1177/089198879901200402; Krishna R, 2012, COGN BEHAV NEUROL, V25, P7, DOI 10.1097/WNN.0b013e318248ff1b; Kumaran D, 2012, PSYCHOL REV, V119, P573, DOI 10.1037/a0028681; Kumaran D, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00157; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; Macpherson H, 2012, PSYCHOPHARMACOLOGY, V220, P351, DOI 10.1007/s00213-011-2481-3; Maelicke A, 2000, EUR J PHARMACOL, V393, P165, DOI 10.1016/S0014-2999(00)00093-5; Maelicke A, 2000, DEMENT GERIATR COGN, V11, P11, DOI 10.1159/000051227; Matte C, 2009, NEUROSCIENCE, V163, P1039, DOI 10.1016/j.neuroscience.2009.07.023; Matthews FE, 2007, PLOS MED, V4, P1615, DOI 10.1371/journal.pmed.0040304; McCaddon A, 2001, DEMENT GERIATR COGN, V12, P309, DOI 10.1159/000051275; Morris JC, 2001, ARCH NEUROL-CHICAGO, V58, P397, DOI 10.1001/archneur.58.3.397; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Moustafa AA, 2010, BRAIN COGNITION, V74, P132, DOI 10.1016/j.bandc.2010.07.013; Myers CE, 2008, NEUROPSYCHOLOGY, V22, P681, DOI 10.1037/0894-4105.22.5.681; MYERS CE, 1994, BEHAV NEUROSCI, V108, P835, DOI 10.1037/0735-7044.108.5.835; Myers CE, 2003, J COGNITIVE NEUROSCI, V15, P185, DOI 10.1162/089892903321208123; Narayan SK, 2011, INT PSYCHOGERIATR, V23, P1607, DOI 10.1017/S1041610211000779; Nurk E, 2005, ANN NEUROL, V58, P847, DOI 10.1002/ana.20645; Oddo S, 2006, J PHYSIOL-PARIS, V99, P172, DOI 10.1016/j.jphysparis.2005.12.080; Oulhaj A, 2010, INT J GERIATR PSYCH, V25, P82, DOI 10.1002/gps.2303; Pan XC, 2012, EUR J NEUROSCI, V35, P1083, DOI 10.1111/j.1460-9568.2011.07981.x; Perneezky R, 2007, J GERIATR PSYCH NEUR, V20, P84, DOI 10.1177/0891988706297093; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pirchl M, 2010, EUR J NEUROSCI, V32, P1516, DOI 10.1111/j.1460-9568.2010.07434.x; Poldrack RA, 2001, NATURE, V414, P546, DOI 10.1038/35107080; Portet F, 2006, J NEUROL NEUROSUR PS, V77, P714, DOI 10.1136/jnnp.2005.085332; Prins ND, 2002, NEUROLOGY, V59, P1375, DOI 10.1212/01.WNL.0000032494.05619.93; Rajagopalan P, 2011, NEUROREPORT, V22, P391, DOI 10.1097/WNR.0b013e328346bf85; Redish AD, 1998, NEURAL COMPUT, V10, P73, DOI 10.1162/089976698300017908; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Reisberg B, 2008, INT PSYCHOGERIATR, V20, P18, DOI 10.1017/S1041610207006394; Reitz C, 2009, DEMENT GERIATR COGN, V27, P11, DOI 10.1159/000182421; Sabri O, 2008, EUR J NUCL MED MOL I, V35, pS30, DOI 10.1007/s00259-007-0701-1; Sachdev PS, 2005, PROG NEURO-PSYCHOPH, V29, P1152, DOI 10.1016/j.pnpbp.2005.06.026; SCHACTER DL, 1985, J CLIN EXP NEUROPSYC, V7, P79, DOI 10.1080/01688638508401243; Seger CA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00066; Seger CA, 2010, ANNU REV NEUROSCI, V33, P203, DOI 10.1146/annurev.neuro.051508.135546; Shohamy D, 2006, NEUROPSYCHOLOGIA, V44, P774, DOI 10.1016/j.neuropsychologia.2005.07.013; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Steinhauser M, 2010, J NEUROSCI, V30, P15643, DOI 10.1523/JNEUROSCI.1899-10.2010; Stoub TR, 2006, P NATL ACAD SCI USA, V103, P10041, DOI 10.1073/pnas.0603414103; Tamminen Jakke, 2012, Cognition, V125, P107, DOI 10.1016/j.cognition.2012.06.014; Teunissen C E, 2003, J Nutr Health Aging, V7, P153; Thompson R.F., 1972, TOPICS LEARNING PERF, P105; van den Kommer TN, 2010, NEUROBIOL AGING, V31, P1700, DOI 10.1016/j.neurobiolaging.2008.09.009; van Rossum IA, 2010, J ALZHEIMERS DIS, V20, P881, DOI 10.3233/JAD-2010-091606; Vandenberghe R, 1999, EUR J NEUROSCI, V11, P4037, DOI 10.1046/j.1460-9568.1999.00813.x; Weiner MF, 2009, CURR ALZHEIMER RES, V6, P52, DOI 10.2174/156720509787313952; Wimmer GE, 2012, EUR J NEUROSCI, V35, P1092, DOI 10.1111/j.1460-9568.2012.08017.x; YOUNG BJ, 1994, J NEUROSCI, V14, P6553; Zhuo JM, 2011, TRENDS PHARMACOL SCI, V32, P562, DOI 10.1016/j.tips.2011.05.003; Zoccolella Stefano, 2006, Current Vascular Pharmacology, V4, P237, DOI 10.2174/157016106777698414	101	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46496	10.1371/journal.pone.0046496	http://dx.doi.org/10.1371/journal.pone.0046496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029537	gold, Green Published			2022-12-27	WOS:000309973900175
J	Vaapil, M; Helczynska, K; Villadsen, R; Petersen, OW; Johansson, E; Beckman, S; Larsson, C; Pahlman, S; Jogi, A				Vaapil, Marica; Helczynska, Karolina; Villadsen, Rene; Petersen, Ole W.; Johansson, Elisabet; Beckman, Siv; Larsson, Christer; Pahlman, Sven; Jogi, Annika			Hypoxic Conditions Induce a Cancer-Like Phenotype in Human Breast Epithelial Cells	PLOS ONE			English	Article							LOOP-HELIX PROTEINS; HUMAN NEUROBLASTOMA-CELLS; EXPRESSION PATTERN; E-CADHERIN; TUMOR CHARACTERISTICS; MOLECULAR-CLONING; GENE-EXPRESSION; STEM-CELLS; MUC1 EMA; ID-1	Introduction: Solid tumors are less oxygenated than their tissue of origin. Low intra-tumor oxygen levels are associated with worse outcome, increased metastatic potential and immature phenotype in breast cancer. We have reported that tumor hypoxia correlates to low differentiation status in breast cancer. Less is known about effects of hypoxia on non-malignant cells. Here we address whether hypoxia influences the differentiation stage of non-malignant breast epithelial cells and potentially have bearing on early stages of tumorigenesis. Methods: Normal human primary breast epithelial cells and immortalized non-malignant mammary epithelial MCF-10A cells were grown in a three-dimensional overlay culture on laminin-rich extracellular matrix for up to 21 days at normoxic or hypoxic conditions. Acinar morphogenesis and expression of markers of epithelial differentiation and cell polarization were analyzed by immunofluorescence, immunohistochemistry, qPCR and immunoblot. Results: In large ductal carcinoma in situ patient-specimens, we find that epithelial cells with high HIF-1 alpha levels and multiple cell layers away from the vasculature are immature compared to well-oxygenated cells. We show that hypoxic conditions impaired acinar morphogenesis of primary and immortalized breast epithelial cells grown ex vivo on laminin-rich matrix. Normoxic cultures formed polarized acini-like spheres with the anticipated distribution of marker proteins associated with mammary epithelial polarization e. g. alpha 6-integrin, laminin 5 and Human Milk Fat Globule/MUC1. At hypoxia, cells were not polarized and the sub-cellular distribution pattern of the marker proteins rather resembled that reported in vivo in breast cancer. The hypoxic cells remained in a mitotic state, whereas proliferation ceased with acinar morphogenesis at normoxia. We found induced expression of the differentiation repressor ID1 in the undifferentiated hypoxic MCF-10A cell structures. Acinar morphogenesis was associated with global histone deacetylation whereas the hypoxic breast epithelial cells showed sustained global histone acetylation, which is generally associated with active transcription and an undifferentiated proliferative state.	[Vaapil, Marica; Helczynska, Karolina; Johansson, Elisabet; Beckman, Siv; Larsson, Christer; Pahlman, Sven; Jogi, Annika] Skane Univ Hosp Malmo, Ctr Mol Pathol, Dept Lab Med, Malmo, Sweden; [Vaapil, Marica; Helczynska, Karolina; Johansson, Elisabet; Beckman, Siv; Pahlman, Sven; Jogi, Annika] Lund Univ, CREATE Hlth, Lund, Sweden; [Helczynska, Karolina] Skane Univ Hosp, Dept Surg, Malmo, Sweden; [Villadsen, Rene; Petersen, Ole W.] Univ Copenhagen, Dept Cellular & Mol Med, Ctr Biol Dis Anal, Copenhagen, Denmark; [Villadsen, Rene; Petersen, Ole W.] Univ Copenhagen, Danish Stem Cell Ctr, Fac Hlth Sci, Copenhagen, Denmark	Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital; University of Copenhagen; University of Copenhagen	Jogi, A (corresponding author), Skane Univ Hosp Malmo, Ctr Mol Pathol, Dept Lab Med, Malmo, Sweden.	annika.jogi@med.lu.se	Vaapil, Marica/R-4420-2019	Villadsen, Rene/0000-0002-5226-381X; Jogi, Annika/0000-0003-1697-8030; Petersen, Ole William/0000-0003-1691-749X	Swedish Cancer Society; Children's Cancer Foundation of Sweden; Swedish Research Council; SSF Strategic Center for Translational Cancer Research - CREATE Health; BioCARE; Strategic Reasearch Program at Lund University; Hans von Kantzows Stiftelse; Gunnar Nilsson's Cancer Foundation; Jeanssons Foundation; Magnus Bergvall's Foundation; Royal Physiographic Society; Gyllenstiernska Krapperup Foundation; Danish Cancer Society [DP07063, R20-A1149-10-S2]; European Comission [LSHC-CT-2006_037632]; Danish Agency for Science and Technology Innovation [2107-05-0006, 10-092798, 08-045450]; Lundbeck Foundation; Novo Nordic Foundation; Fru Astrid Thaysens Legat for Laegevidenskabelig Grundforskning	Swedish Cancer Society(Swedish Cancer Society); Children's Cancer Foundation of Sweden(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); SSF Strategic Center for Translational Cancer Research - CREATE Health; BioCARE; Strategic Reasearch Program at Lund University; Hans von Kantzows Stiftelse; Gunnar Nilsson's Cancer Foundation; Jeanssons Foundation; Magnus Bergvall's Foundation; Royal Physiographic Society; Gyllenstiernska Krapperup Foundation; Danish Cancer Society(Danish Cancer Society); European Comission(European CommissionEuropean Commission Joint Research Centre); Danish Agency for Science and Technology Innovation; Lundbeck Foundation(Lundbeckfonden); Novo Nordic Foundation(Novo Nordisk Foundation); Fru Astrid Thaysens Legat for Laegevidenskabelig Grundforskning	Funding provided by Swedish Cancer Society, the Children's Cancer Foundation of Sweden, the Swedish Research Council, the SSF Strategic Center for Translational Cancer Research - CREATE Health, BioCARE, a Strategic Reasearch Program at Lund University, Hans von Kantzows Stiftelse, Gunnar Nilsson's Cancer Foundation, Jeanssons Foundation, Magnus Bergvall's Foundation, The Royal Physiographic Society, Gyllenstiernska Krapperup Foundation. The work from the laboratory of OWP and RV is supported by grants from the Danish Cancer Society (DP07063 and R20-A1149-10-S2), the European Comission (Contract no. LSHC-CT-2006_037632 to EuroCSC), the Danish Agency for Science and Technology Innovation (2107-05-0006 to DANED, 10-092798 to DANSTEM and 08-045450 to Danish-Japanese Cooperative Research), the Lundbeck Foundation, the Novo Nordic Foundation, and Fru Astrid Thaysens Legat for Laegevidenskabelig Grundforskning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baysal BE, 2004, AM J MED GENET C, V129C, P85, DOI 10.1002/ajmg.c.30018; Bissell MJ, 2003, CURR OPIN CELL BIOL, V15, P753, DOI 10.1016/j.ceb.2003.10.016; BURCHELL J, 1983, J IMMUNOL, V131, P508; Chakrabarti J, 2004, BRIT J CANCER, V91, P954, DOI 10.1038/sj.bjc.6602059; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Davis TL, 2001, PROSTATE, V46, P240; de Roos MAJ, 2007, HISTOPATHOLOGY, V51, P227, DOI 10.1111/j.1365-2559.2007.02754.x; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DELAMONTE SM, 1985, AM J PEDIAT HEMATOL, V7, P109; Desprez PY, 2003, J MAMMARY GLAND BIOL, V8, P225, DOI 10.1023/A:1025957025773; DESPREZ PY, 1995, MOL CELL BIOL, V15, P3398; Erler JT, 2009, CLIN EXP METASTAS, V26, P35, DOI 10.1007/s10585-008-9209-8; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Helczynska K, 2008, CANCER RES, V68, P9212, DOI 10.1158/0008-5472.CAN-08-1135; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Inman Jamie L, 2010, J Biol, V9, P2, DOI 10.1186/jbiol213; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jacobs TW, 1999, NEW ENGL J MED, V340, P430, DOI 10.1056/NEJM199902113400604; Jogi A, 2004, EXP CELL RES, V295, P469, DOI 10.1016/j.yexcr.2004.01.013; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Jogi A, 2002, J BIOL CHEM, V277, P9118, DOI 10.1074/jbc.M107713200; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kronblad A, 2005, ONCOGENE, V24, P6835, DOI 10.1038/sj.onc.1208830; Le Beyec J, 2007, EXP CELL RES, V313, P3066, DOI 10.1016/j.yexcr.2007.04.022; Lelievre SA, 1998, P NATL ACAD SCI USA, V95, P14711, DOI 10.1073/pnas.95.25.14711; Lofstedt T, 2004, J BIOL CHEM, V279, P39223, DOI 10.1074/jbc.M402904200; Manfrin E, 2008, BREAST CANCER RES TR, V107, P371, DOI 10.1007/s10549-007-9569-9; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Nemetski SM, 2007, J BIOL CHEM, V282, P240, DOI 10.1074/jbc.M607275200; Parrinello S, 2001, J BIOL CHEM, V276, P39213, DOI 10.1074/jbc.M104473200; Pietras A, 2010, CURR TOP MICROBIOL I; PYKE C, 1994, AM J PATHOL, V145, P782; Rahn JJ, 2001, CANCER, V91, P1973, DOI 10.1002/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO;2-A; Schietke R, 2010, J BIOL CHEM, V285, P6658, DOI 10.1074/jbc.M109.042424; Schoppmann SF, 2003, INT J CANCER, V104, P677, DOI 10.1002/ijc.11009; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen SM, 2005, J CELL BIOL, V169, P577, DOI 10.1083/jcb.200412101; Shinto E, 2005, LAB INVEST, V85, P257, DOI 10.1038/labinvest.3700199; Singh J, 2001, J BIOL CHEM, V276, P11852, DOI 10.1074/jbc.M006931200; SOULE HD, 1990, CANCER RES, V50, P6075; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1111/j.1432-0436.1998.00201.x; STREULI CH, 1995, J CELL BIOL, V129, P591, DOI 10.1083/jcb.129.3.591; van der Vegt B, 2007, HISTOPATHOLOGY, V51, P322, DOI 10.1111/j.1365-2559.2007.02757.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Wells A, 2008, CLIN EXP METASTAS, V25, P621, DOI 10.1007/s10585-008-9167-1	52	30	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46543	10.1371/journal.pone.0046543	http://dx.doi.org/10.1371/journal.pone.0046543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029547	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900183
J	Heyes, DJ; Hardman, SJO; Mansell, D; Gardiner, JM; Scrutton, NS				Heyes, Derren J.; Hardman, Samantha J. O.; Mansell, David; Gardiner, John M.; Scrutton, Nigel S.			Mechanistic Reappraisal of Early Stage Photochemistry in the Light-Driven Enzyme Protochlorophyllide Oxidoreductase	PLOS ONE			English	Article							TIME-RESOLVED ABSORPTION; EXCITED-STATE PROCESSES; PRODUCT RELEASE STEPS; ENERGY-TRANSFER; TRANSIENT ABSORPTION; ACTIVATED ENZYME; CATALYTIC CYCLE; CHLOROPHYLL; DYNAMICS; INTERMEDIATE	The light-driven enzyme protochlorophyllide oxidoreductase (POR) catalyzes the reduction of protochlorophyllide (Pchlide) to chlorophyllide (Chlide). This reaction is a key step in the biosynthesis of chlorophyll. Ultrafast photochemical processes within the Pchlide molecule are required for catalysis and previous studies have suggested that a short-lived excited-state species, known as I675*, is the first catalytic intermediate in the reaction and is essential for capturing excitation energy to drive subsequent hydride and proton transfers. The chemical nature of the I675* excited state species and its role in catalysis are not known. Here, we report time-resolved pump-probe spectroscopy measurements to study the involvement of the I675* intermediate in POR photochemistry. We show that I675* is not unique to the POR-catalyzed photoreduction of Pchlide as it is also formed in the absence of the POR enzyme. The I675* species is only produced in samples that contain both Pchlide substrate and Chlide product and its formation is dependent on the pump excitation wavelength. The rate of formation and the quantum yield is maximized in 50: 50 mixtures of the two pigments (Pchlide and Chlide) and is caused by direct energy transfer between Pchlide and neighboring Chlide molecules, which is inhibited in the polar solvent methanol. Consequently, we have re-evaluated the mechanism for early stage photochemistry in the light-driven reduction of Pchlide and propose that I675* represents an excited state species formed in Pchlide-Chlide dimers, possibly an excimer. Contrary to previous reports, we conclude that this excited state species has no direct mechanistic relevance to the POR-catalyzed reduction of Pchlide.	[Heyes, Derren J.] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; Univ Manchester, Photon Sci Inst, Manchester, Lancs, England	University of Manchester; University of Manchester	Heyes, DJ (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	derren.heyes@manchester.ac.uk; nigel.scrutton@manchester.ac.uk	Gardiner, John M/Q-7268-2017	Gardiner, John M/0000-0003-1827-6817; Hardman, Samantha/0000-0002-8310-4758; Heyes, Derren/0000-0002-7453-1571	United Kingdom Biotechnology and Biological Sciences Research Council [BB/F000537/1]; Engineering and Physical Sciences Research Council [EP/J020192/1]; Royal Society; EPSRC [EP/J020192/1] Funding Source: UKRI	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The study was funded by the United Kingdom Biotechnology and Biological Sciences Research Council (BB/F000537/1), the Engineering and Physical Sciences Research Council (EP/J020192/1) and the Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Connelly JP, 1997, BIOCHEMISTRY-US, V36, P281, DOI 10.1021/bi962467l; Croce R, 2003, BIOPHYS J, V84, P2508, DOI 10.1016/S0006-3495(03)75056-5; Dietzek B, 2006, J PHYS CHEM B, V110, P4399, DOI 10.1021/jp0556456; Dietzek B, 2004, CHEM PHYS LETT, V397, P110, DOI 10.1016/j.cplett.2004.08.075; Dietzek B, 2006, CHEMPHYSCHEM, V7, P1727, DOI 10.1002/cphc.200600172; Dietzek B, 2010, CHEM PHYS LETT, V492, P157, DOI 10.1016/j.cplett.2010.04.027; Dietzek B, 2009, CHEMPHYSCHEM, V10, P144, DOI 10.1002/cphc.200800536; Durin G, 2009, BIOPHYS J, V96, P1902, DOI [10.1016/j.bpj.2008.10.065, 10.1016/j.bpj.200X.10.065]; Heyes DJ, 2007, J BIOL CHEM, V282, P32015, DOI 10.1074/jbc.M706098200; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2011, J BIOL CHEM, V286, P11849, DOI 10.1074/jbc.M111.219626; Heyes DJ, 2009, ANGEW CHEM INT EDIT, V48, P3850, DOI 10.1002/anie.200900086; Heyes DJ, 2009, J BIOL CHEM, V284, P3762, DOI 10.1074/jbc.M808548200; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2004, BIOCHEMISTRY-US, V43, P8265, DOI 10.1021/bi049576h; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; Hynninen PH, 2002, J ORG CHEM, V67, P4055, DOI 10.1021/jo010673f; Kleima FJ, 1997, BIOCHEMISTRY-US, V36, P15262, DOI 10.1021/bi9716480; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; LINDSEY JS, 1995, INORG CHEM, V34, P1063, DOI 10.1021/ic00109a011; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; MATHIS P, 1972, BIOCHIM BIOPHYS ACTA, V267, P498, DOI 10.1016/0005-2728(72)90178-8; Mathis P, 1972, PLANT PHYSIOL, V51, P115; Muller AH, 2011, ANAL BIOCHEM, V419, P271, DOI 10.1016/j.ab.2011.08.028; Scrutton NS, 2012, PHYS CHEM CHEM PHYS, V14, P8818, DOI 10.1039/c2cp23789j; Snellenburg JJ, 2012, J STAT SOFTW, V49, P1, DOI 10.18637/jss.v049.i03; Sytina OA, 2012, PHYS CHEM CHEM PHYS, V14, P616, DOI 10.1039/c1cp21713e; Sytina OA, 2010, J PHYS CHEM B, V114, P4335, DOI 10.1021/jp9089326; Sytina OA, 2008, NATURE, V456, P1001, DOI 10.1038/nature07354; VAUGHAN GD, 1974, BIOCHIM BIOPHYS ACTA, V347, P383, DOI 10.1016/0005-2728(74)90077-2; WASIELEWSKI MR, 1976, P NATL ACAD SCI USA, V73, P4282, DOI 10.1073/pnas.73.12.4282; Zhao GJ, 2008, BIOPHYS J, V94, P38, DOI 10.1529/biophysj.107.113738	34	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45642	10.1371/journal.pone.0045642	http://dx.doi.org/10.1371/journal.pone.0045642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049830	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300040
J	Jeong, WJ; Rho, JH; Yoon, YG; Yoo, SH; Jeong, NY; Ryu, WY; Ahn, HB; Park, WC; Rho, SH; Yoon, HS; Choi, YH; Yoo, YH				Jeong, Woo Jin; Rho, Jee Hyun; Yoon, Young Geol; Yoo, Seung Hee; Jeong, Na Young; Ryu, Won Yeol; Ahn, Hee Bae; Park, Woo Chan; Rho, Sae Heun; Yoon, Hee Seong; Choi, Yung Hyun; Yoo, Young Hyun			Cytoplasmic and Nuclear Anti-Apoptotic Roles of alpha B-Crystallin in Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							MIMICKING PHOSPHORYLATION; CARDIAC MYOCYTES; MESANGIAL CELLS; SC35 SPECKLES; METHYLGLYOXAL; ACTIVATION; CHAPERONE; CASPASE-2; PIDDOSOME; RPE	In addition to its well-characterized role in the lens, alpha B-crystallin performs other functions. Methylglyoxal (MGO) can alter the function of the basement membrane of retinal pigment epithelial (RPE) cells. Thus, if MGO is not efficiently detoxified, it can induce adverse reactions in RPE cells. In this study, we examined the mechanisms underlying the anti-apoptotic activity of alpha B-crystallin in the human retinal pigment epithelial cell line ARPE-19 following MGO treatment using various assays, including nuclear staining, flow cytometry, DNA electrophoresis, pulse field gel electrophoresis, western blot analysis, confocal microscopy and co-immunoprecipitation assays. To directly assess the role of phosphorylation of alpha B-crystallin, we used site-directed mutagenesis to convert relevant serine residues to alanine residues. Using these techniques, we demonstrated that MGO induces apoptosis in ARPE-19 cells. Silencing alpha B-crystallin sensitized ARPE-19 cells to MGO-induced apoptosis, indicating that alpha B-crystallin protects ARPE-19 cells from MGO-induced apoptosis. Furthermore, we found that alpha B-crystallin interacts with the caspase subtypes, caspase-2L, -2S, -3, -4, -7, -8, -9 and -12 in untreated control ARPE-19 cells and that MGO treatment caused the dissociation of these caspase subtypes from alpha B-crystallin; transfection of S19A, S45A or S59A mutants caused the depletion of alpha B-crystallin from the nuclei of untreated control RPE cells leading to the release of caspase subtypes. Additionally, transfection of these mutants enhanced MGO-induced apoptosis in ARPE-19 cells, indicating that phosphorylation of nuclear alpha B-crystallin on serine residues 19, 45 and 59 plays a pivotal role in preventing apoptosis in ARPE-19 cells. Taken together, these results suggest that alpha B-crystallin prevents caspase activation by physically interacting with caspase subtypes in the cytoplasm and nucleus, thereby protecting RPE cells from MGO-induced apoptosis.	[Yoon, Young Geol; Yoo, Seung Hee; Jeong, Na Young; Yoo, Young Hyun] Dong A Univ, Dept Anat & Cell Biol, Coll Med, Pusan, South Korea; [Yoon, Young Geol; Yoo, Seung Hee; Jeong, Na Young; Yoo, Young Hyun] Mitochondria Hub Regulat Ctr, Pusan, South Korea; [Jeong, Woo Jin; Rho, Jee Hyun; Ryu, Won Yeol; Ahn, Hee Bae; Park, Woo Chan; Rho, Sae Heun] Dong A Univ, Dept Ophthalmol, Coll Med, Pusan, South Korea; [Yoon, Hee Seong] Sungmo Eye Hosp Inc, Pusan, South Korea; [Choi, Yung Hyun] Dong Eui Univ, Coll Oriental Med, Dept Biochem, Pusan, South Korea; [Choi, Yung Hyun] Dong Eui Univ, Coll Oriental Med, Res Inst Oriental Med, Pusan, South Korea	Dong A University; Dong A University; Dong-Eui University; Dong-Eui University; Korea Institute of Oriental Medicine (KIOM)	Yoo, YH (corresponding author), Dong A Univ, Dept Anat & Cell Biol, Coll Med, Pusan, South Korea.	yhyoo@dau.ac.kr	; Ryu, Won Yeol/A-2227-2013	Yoon, Young Geol/0000-0003-4524-9531; Ryu, Won Yeol/0000-0001-5135-718X	Korean government [2011-0001262]; National Research Foundation of Korea	Korean government(Korean Government); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea grant funded by the Korean government (2011-0001262). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alge CS, 2002, INVEST OPHTH VIS SCI, V43, P3575; Amicarelli F, 2003, FREE RADICAL BIO MED, V35, P856, DOI 10.1016/S0891-5849(03)00438-6; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Delori FC, 2001, INVEST OPHTH VIS SCI, V42, P1855; den Engelsman J, 2004, EUR J BIOCHEM, V271, P4195, DOI 10.1111/j.1432-1033.2004.04359.x; den Englesman J, 2005, J BIOL CHEM, V280, P37139, DOI 10.1074/jbc.M504106200; Derham BK, 2002, BIOCHEM J, V364, P711, DOI 10.1042/BJ20011512; Fosmark DS, 2006, METABOLISM, V55, P232, DOI 10.1016/j.metabol.2005.08.017; Glenn JV, 2009, BBA-GEN SUBJECTS, V1790, P1109, DOI 10.1016/j.bbagen.2009.04.016; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Inoue S, 2009, CELL DEATH DIFFER, V16, P1053, DOI 10.1038/cdd.2009.29; Ito H, 1997, J BIOL CHEM, V272, P29934, DOI 10.1074/jbc.272.47.29934; Jan CR, 2005, CELL SIGNAL, V17, P847, DOI 10.1016/j.cellsig.2004.11.007; Jiang ZH, 1998, P NATL ACAD SCI USA, V95, P9155, DOI 10.1073/pnas.95.16.9155; Kimura R, 2009, NEUROSCIENCE, V162, P1212, DOI 10.1016/j.neuroscience.2009.05.025; Kitevska T, 2009, APOPTOSIS, V14, P829, DOI 10.1007/s10495-009-0365-3; Krumschnabel G, 2009, CELL DEATH DIFFER, V16, P195, DOI 10.1038/cdd.2008.170; Kumar MS, 2004, BIOCHEM J, V379, P273, DOI 10.1042/BJ20031633; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lee HK, 2009, J NEUROCHEM, V108, P273, DOI 10.1111/j.1471-4159.2008.05764.x; Li SY, 2007, LIFE SCI, V80, P1051, DOI 10.1016/j.lfs.2006.11.035; Liu BF, 2003, KIDNEY INT, V63, P947, DOI 10.1046/j.1523-1755.2003.00829.x; Logette E, 2003, ONCOGENE, V22, P935, DOI 10.1038/sj.onc.1206172; Manzl C, 2009, J CELL BIOL, V185, P291, DOI 10.1083/jcb.200811105; Mao YW, 2001, J BIOL CHEM, V276, P43435, DOI 10.1074/jbc.M102195200; Morrison LE, 2003, CIRC RES, V92, P203, DOI 10.1161/01.RES.0000052989.83995.A5; Noh SJ, 2008, INVEST OPHTH VIS SCI, V49, P4753, DOI 10.1167/iovs.08-2166; Oya-Ito T, 2006, J CELL BIOCHEM, V99, P279, DOI 10.1002/jcb.20781; Padival AK, 2003, FEBS LETT, V551, P113, DOI 10.1016/S0014-5793(03)00874-3; POMPLIANO DL, 1990, BIOCHEMISTRY-US, V29, P3186, DOI 10.1021/bi00465a005; Shi MG, 2009, CELL, V136, P508, DOI 10.1016/j.cell.2008.12.021; Shin JH, 2009, NEUROSCI RES, V64, P355, DOI 10.1016/j.neures.2009.04.006; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; THORNALLEY PJ, 1993, MOL ASPECTS MED, V14, P287, DOI 10.1016/0098-2997(93)90002-U; Thornalley PJ, 1996, GEN PHARMACOL-VASC S, V27, P565, DOI 10.1016/0306-3623(95)02054-3; Tinel A, 2004, SCIENCE, V304, P843, DOI 10.1126/science.1095432; Vakifahmetoglu-Norberg H, 2010, TRENDS CELL BIOL, V20, P150, DOI 10.1016/j.tcb.2009.12.006; van Rijk AF, 2003, EUR J CELL BIOL, V82, P361, DOI 10.1078/0171-9335-00321; Wu LY, 2006, CAN J PHYSIOL PHARM, V84, P129, DOI 10.1139/Y05-137; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107	40	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45754	10.1371/journal.pone.0045754	http://dx.doi.org/10.1371/journal.pone.0045754			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049853	gold, Green Submitted, Green Published			2022-12-27	WOS:000309517300050
J	Reen, FJ; Woods, DF; Mooij, MJ; Adams, C; O'Gara, F				Reen, F. Jerry; Woods, David F.; Mooij, Marlies J.; Adams, Claire; O'Gara, Fergal			Respiratory Pathogens Adopt a Chronic Lifestyle in Response to Bile	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; PSEUDOMONAS QUINOLONE SIGNAL; GASTROESOPHAGEAL-REFLUX DISEASE; LUNG TRANSPLANTATION; AIRWAY COLONIZATION; BRONCHIOLITIS OBLITERANS; PULMONARY-FUNCTION; ACID ASPIRATION; AERUGINOSA; EXPRESSION	Chronic respiratory infections are a major cause of morbidity and mortality, most particularly in Cystic Fibrosis (CF) patients. The recent finding that gastro-esophageal reflux (GER) frequently occurs in CF patients led us to investigate the impact of bile on the behaviour of Pseudomonas aeruginosa and other CF-associated respiratory pathogens. Bile increased biofilm formation, Type Six Secretion, and quorum sensing in P. aeruginosa, all of which are associated with the switch from acute to persistent infection. Furthermore, bile negatively influenced Type Three Secretion and swarming motility in P. aeruginosa, phenotypes associated with acute infection. Bile also modulated biofilm formation in a range of other CF-associated respiratory pathogens, including Burkholderia cepacia and Staphylococcus aureus. Therefore, our results suggest that GER-derived bile may be a host determinant contributing to chronic respiratory infection.	[Reen, F. Jerry; Woods, David F.; Mooij, Marlies J.; Adams, Claire; O'Gara, Fergal] Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland	University College Cork	O'Gara, F (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Microbiol, BIOMERIT Res Ctr, Cork, Ireland.	f.ogara@ucc.ie	Reen, Jerry/AAG-7155-2019	Woods, David F/0000-0002-5623-6501; O'Gara, Fergal/0000-0002-2659-0673; Reen, F. Jerry/0000-0002-7717-9892	European Commission [MTKD-CT-2006-042062, O36314, 256596]; Science Foundation Ireland [SFI 04/BR/B0597, 07/IN.1/B948, 08/RFP/GEN1295, 08/RFP/GEN1319, 09/RFP/BMT2350]; Department of Agriculture and Food [DAF RSF 06 321, DAF RSF 06 377, FIRM 08/RDC/629]; Irish Research Council for Science, Engineering and Technology [05/EDIV/FP107, PD/2011/2414]; Health Research Board [RP/2006/271, RP/2007/290, HRA/2009/146]; Environmental Protection Agency [EPA2006-PhD-S-21, EPA2008-PhD-S-2]; Marine Institute [C2CRA 2007/082]; Higher Education Authority of Ireland [PRTLI3]; Health Service Executive (HSE) surveillance fund	European Commission(European CommissionEuropean Commission Joint Research Centre); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Department of Agriculture and Food(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and TechnologyCGIAR); Health Research Board; Environmental Protection Agency(United States Environmental Protection Agency); Marine Institute; Higher Education Authority of Ireland; Health Service Executive (HSE) surveillance fund	This work was supported in part by grants awarded by the European Commission (MTKD-CT-2006-042062; O36314; FP7-PEOPLE-2009-RG, EU 256596, 2010-2013), Science Foundation Ireland (SFI 04/BR/B0597; 07/IN.1/B948; 08/RFP/GEN1295; 08/RFP/GEN1319; 09/RFP/BMT2350), the Department of Agriculture and Food (DAF RSF 06 321; DAF RSF 06 377; FIRM 08/RDC/629), the Irish Research Council for Science, Engineering and Technology (05/EDIV/FP107; PD/2011/2414), the Health Research Board (RP/2006/271; RP/2007/290; HRA/2009/146), the Environmental Protection Agency (EPA2006-PhD-S-21; EPA2008-PhD-S-2), the Marine Institute (Beaufort award C2CRA 2007/082), the Higher Education Authority of Ireland (PRTLI3) and the Health Service Executive (HSE) surveillance fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams C, 1998, J INFECTION, V37, P151, DOI 10.1016/S0163-4453(98)80170-9; Aseeri A, 2012, AM J RESP CRIT CARE, V185, P463, DOI 10.1164/ajrccm.185.4.463; Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; Baysse C, 2005, MICROBIOL-SGM, V151, P2529, DOI 10.1099/mic.0.28185-0; Bjarnsholt T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010115; Bleves S, 2005, J BACTERIOL, V187, P3898, DOI 10.1128/JB.187.11.3898-3902.2005; Blondeau K, 2008, GUT, V57, P1049, DOI 10.1136/gut.2007.146134; Blondeau K, 2010, J PEDIATR GASTR NUTR, V50, P161, DOI 10.1097/MPG.0b013e3181acae98; Burrowes E, 2006, MICROBIOL-SGM, V152, P405, DOI 10.1099/mic.0.28324-0; Button BM, 2005, J HEART LUNG TRANSPL, V24, P1522, DOI 10.1016/j.healun.2004.11.312; Button BM, 2004, ARCH DIS CHILD, V89, P435, DOI 10.1136/adc.2003.033100; Carpagnano GE, 2006, J INTERN MED, V259, P323, DOI 10.1111/j.1365-2796.2005.01611.x; Cummins J, 2009, MICROBIOL-SGM, V155, P2826, DOI 10.1099/mic.0.025643-0; D'Argenio DA, 2007, MOL MICROBIOL, V64, P512, DOI 10.1111/j.1365-2958.2007.05678.x; D'Ovidio F, 2005, ANN THORAC SURG, V80, P1254, DOI 10.1016/j.athoracsur.2005.03.106; D'Ovidio F, 2005, J THORAC CARDIOV SUR, V129, P1144, DOI 10.1016/j.jtcvs.2004.10.035; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Fletcher MP, 2007, NAT PROTOC, V2, P1254, DOI 10.1038/nprot.2007.158; Fung C, 2010, J MED MICROBIOL, V59, P1089, DOI 10.1099/jmm.0.019984-0; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Goss CH, 2007, THORAX, V62, P360, DOI 10.1136/thx.2006.060889; GOTLEY DC, 1988, BRIT J SURG, V75, P587, DOI 10.1002/bjs.1800750632; Haussler S, 2010, INT J MED MICROBIOL, V300, P544, DOI 10.1016/j.ijmm.2010.08.006; Hallberg K, 2004, J PEDIATR GASTR NUTR, V38, P312, DOI 10.1097/00005176-200403000-00016; Hassett DJ, 2010, EXPERT OPIN THER TAR, V14, P117, DOI 10.1517/14728220903454988; KORVICK JA, 1991, SURGERY, V109, P62; Koskenniemi K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002741; Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Ledson MJ, 1998, J ROY SOC MED, V91, P10, DOI 10.1177/014107689809100104; Ledson MJ, 1998, J ROY SOC MED, V91, P7, DOI 10.1177/014107689809100103; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Matsumoto K, 2004, BIOL CHEM, V385, P1007, DOI 10.1515/BC.2004.131; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; McGlacken GP, 2010, TETRAHEDRON LETT, V51, P5919, DOI 10.1016/j.tetlet.2010.09.013; McGrath S, 2004, FEMS MICROBIOL LETT, V230, P27, DOI 10.1016/S0378-1097(03)00849-8; Mena A, 2008, J BACTERIOL, V190, P7910, DOI 10.1128/JB.01147-08; Merritt JH, 2010, MBIO, V1, DOI 10.1128/mBio.00183-10; MESHKINPOUR H, 1981, ARCH SURG-CHICAGO, V116, P1148; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Mousa Hayat M, 2012, Curr Gastroenterol Rep, V14, P226, DOI 10.1007/s11894-012-0261-9; Murray TS, 2007, CURR OPIN PEDIATR, V19, P83, DOI 10.1097/MOP.0b013e3280123a5d; Nassr AO, 2011, J GASTROINTEST SURG, V15, P908, DOI 10.1007/s11605-011-1520-z; Navarro J, 2001, EUR RESPIR J, V18, P298, DOI 10.1183/09031936.01.00068901; Nehra D, 2010, J GASTROINTEST SURG, V14, P6, DOI 10.1007/s11605-009-1026-0; O'Callaghan J, 2012, MICROBIOLOGY; O'Callaghan J, 2011, MICROBIOL-SGM, V157, P3417, DOI 10.1099/mic.0.052050-0; Palm K, 2011, PEDIAT PULMONOL; Pauwels A., 2011, CHEST; Perng DW, 2008, RESPIROLOGY, V13, P983, DOI 10.1111/j.1440-1843.2008.01402.x; Perng DW, 2007, CHEST, V132, P1548, DOI 10.1378/chest.07-1373; Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x; Poulter S, 2010, ENV MICROBIOL REP, V2, P322, DOI 10.1111/j.1758-2229.2010.00140.x; Prouty AM, 2000, INFECT IMMUN, V68, P6763, DOI 10.1128/IAI.68.12.6763-6769.2000; Quillin SJ, 2011, MOL MICROBIOL, V81, P129, DOI 10.1111/j.1365-2958.2011.07683.x; Reen FJ, 2011, FEMS MICROBIOL ECOL, V77, P413, DOI 10.1111/j.1574-6941.2011.01121.x; Schobert M, 2010, FUTURE MICROBIOL, V5, P603, DOI 10.2217/FMB.10.16; Scott M, 1999, AM FAM PHYSICIAN, V59, P1161; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Sriramulu DD, 2005, J MED MICROBIOL, V54, P667, DOI 10.1099/jmm.0.45969-0; STRINGER DA, 1988, J CAN ASSOC RADIOL, V39, P100; Sweet MP, 2009, THORAX, V64, P167, DOI 10.1136/thx.2007.082719; Sweet MP, 2007, J THORAC CARDIOV SUR, V133, P1078, DOI 10.1016/j.jtcvs.2006.09.085; van der Doef HPJ, 2009, J PEDIATR-US, V155, P629, DOI 10.1016/j.jpeds.2009.06.040; van Mansfeld R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013482; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Vincent F, 2010, ENVIRON MICROBIOL, V12, P1775, DOI 10.1111/j.1462-2920.2010.02264.x; Vos R, 2008, EUR RESPIR J, V31, P1037, DOI 10.1183/09031936.00128607; Vos R, 2007, AM J TRANSPLANT, V7, P1278, DOI 10.1111/j.1600-6143.2007.01771.x; Vos R, 2008, J HEART LUNG TRANSPL, V27, P843, DOI 10.1016/j.healun.2008.05.022; Wallick Kristin, 2002, J Cyst Fibros, V1, P99, DOI 10.1016/S1569-1993(02)00036-X; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Wileman SM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003243.pub2; Wu JCY, 2008, J GASTROEN HEPATOL, V23, P1785, DOI 10.1111/j.1440-1746.2008.05684.x; Wu YC, 2009, CHEST, V136, P118, DOI 10.1378/chest.08-2668; Yang L, 2009, MOL MICROBIOL, V74, P1380, DOI 10.1111/j.1365-2958.2009.06934.x	78	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45978	10.1371/journal.pone.0045978	http://dx.doi.org/10.1371/journal.pone.0045978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049911	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300070
J	Bhattacharya, A; Ziebarth, JD; Cui, Y				Bhattacharya, Anindya; Ziebarth, Jesse D.; Cui, Yan			Systematic Analysis of microRNA Targeting Impacted by Small Insertions and Deletions in Human Genome	PLOS ONE			English	Article							PROSTATE-CANCER RISK; FUNCTIONAL POLYMORPHISM; LINKING POLYMORPHISMS; WIDE IDENTIFICATION; POLYMIRTS DATABASE; TUMOR-SUPPRESSOR; HUMAN-DISEASES; MIR-146A GENE; CONFERS RISK; BINDING-SITE	MicroRNAs (miRNAs) are small noncoding RNA that play an important role in posttranscriptional regulation of mRNA. Genetic variations in miRNAs or their target sites have been shown to alter miRNA function and have been associated with risk for several diseases. Previous studies have focused on the most abundant type of genetic variations, single nucleotide polymorphisms (SNPs) that affect miRNA-mRNA interactions. Here, we systematically identified small insertions and deletions (indels) in miRNAs and their target sites, and investigated the effects of indels on miRNA targeting. We studied the distribution of indels in miRNAs and their target sites and found that indels in mature miRNAs, experimentally supported miRNA target sites and PAR-CLIP footprints have significantly lower density compared to flanking regions. We identified over 20 indels in the seed regions of miRNAs, which may disrupt the interactions between these miRNAs and their target genes. We also identified hundreds of indels that alter experimentally supported miRNA target sites. We mapped these genes to human disease pathways to identify indels that affect miRNA targeting in these pathways. We also used the results of genome-wide association studies (GWAS) to identify potential links between miRNA-related indels and diseases.	[Bhattacharya, Anindya; Ziebarth, Jesse D.; Cui, Yan] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Bhattacharya, Anindya; Ziebarth, Jesse D.; Cui, Yan] Univ Tennessee, Ctr Hlth Sci, Ctr Integrat & Translat Genom, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Cui, Y (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.	ycui2@uthsc.edu	Bhattacharya, Anindya/K-3740-2016	Cui, Yan/0000-0002-7577-6845	The University of Tennessee Center for Integrative and Translational Genomics; Department of Defense grant [W81XHW-05-01-0227]	The University of Tennessee Center for Integrative and Translational Genomics; Department of Defense grant(United States Department of Defense)	This work was supported by The University of Tennessee Center for Integrative and Translational Genomics and Department of Defense grant W81XHW-05-01-0227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouizerat BE, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-29; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chen H, 2009, BIOCHEM BIOPH RES CO, V385, P596, DOI 10.1016/j.bbrc.2009.05.113; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Dai Yang, 2010, Open Access Bioinformatics, V2, P29; Dawson E, 2001, GENOME RES, V11, P170, DOI 10.1101/gr.156901; Drake KM, 2009, CLIN CANCER RES, V15, P5985, DOI 10.1158/1078-0432.CCR-09-1065; Du Y, 2009, J GASTROENTEROL, V44, P556, DOI 10.1007/s00535-009-0037-7; Duex JE, 2011, J BIOL CHEM, V286, P25377, DOI 10.1074/jbc.M111.222760; Ehrenreich IM, 2008, PLANT PHYSIOL, V146, P1974, DOI 10.1104/pp.108.116582; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Feng NH, 2012, MOL BIOL REP, V39, P369, DOI 10.1007/s11033-011-0747-9; Flies Dallas B., 2011, Yale Journal of Biology and Medicine, V84, P409; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gao YZ, 2009, CARCINOGENESIS, V30, P2064, DOI 10.1093/carcin/bgp283; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gong AY, 2009, J IMMUNOL, V182, P1325, DOI 10.4049/jimmunol.182.3.1325; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hammell M, 2010, SEMIN CELL DEV BIOL, V21, P738, DOI 10.1016/j.semcdb.2010.01.004; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Y, 2011, CELL DEATH DIFFER, V18, P1220, DOI 10.1038/cdd.2010.188; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kikkawa N, 2010, BRIT J CANCER, V103, P877, DOI 10.1038/sj.bjc.6605811; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee KH, 2009, EXP CELL RES, V315, P2529, DOI 10.1016/j.yexcr.2009.06.001; Leivonen SK, 2009, ONCOGENE, V28, P3926, DOI 10.1038/onc.2009.241; Li J, 2012, J CANC RES CLIN ONCO; Li L, 2010, MAMM GENOME, V21, P1, DOI 10.1007/s00335-009-9241-2; Li X, 2011, BIOCHEM PHARMACOL, V81, P783, DOI 10.1016/j.bcp.2010.12.018; Lin SL, 2010, CANCER RES, V70, P9473, DOI 10.1158/0008-5472.CAN-10-2746; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mees ST, 2009, ANN SURG ONCOL, V16, P2339, DOI 10.1245/s10434-009-0531-4; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Morales-Prieto DM, 2011, AM J REPROD IMMUNOL, V66, P57, DOI 10.1111/j.1600-0897.2011.01037.x; Mullaney JM, 2010, HUM MOL GENET, V19, pR131, DOI 10.1093/hmg/ddq400; O'Halloran AM, 2009, J THROMB THROMBOLYS, V27, P175, DOI 10.1007/s11239-008-0196-z; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; Quach H, 2009, AM J HUM GENET, V84, P316, DOI 10.1016/j.ajhg.2009.01.022; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Saetrom P, 2009, CANCER RES, V69, P7459, DOI 10.1158/0008-5472.CAN-09-1201; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Scapoli L, 2010, INT J IMMUNOPATH PH, V23, P1229, DOI 10.1177/039463201002300427; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Shohet JM, 2011, CANCER RES, V71, P3841, DOI 10.1158/0008-5472.CAN-10-4391; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stratmann J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-345; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Vermeer PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030447; Wang F, 2010, BRIT J CANCER, V103, P567, DOI 10.1038/sj.bjc.6605724; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu B, 2010, PROSTATE, V70, P467, DOI 10.1002/pros.21080; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Yu XF, 2010, TOXICOL SCI, V118, P391, DOI 10.1093/toxsci/kfq296; Yue C, 2011, GYNECOL ONCOL, V122, P33, DOI 10.1016/j.ygyno.2011.03.032; Zhang LM, 2010, CARCINOGENESIS, V31, P559, DOI 10.1093/carcin/bgp335; Ziebarth JD, 2012, NUCLEIC ACIDS RES, V40, pD216, DOI 10.1093/nar/gkr1026	77	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46176	10.1371/journal.pone.0046176	http://dx.doi.org/10.1371/journal.pone.0046176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049969	Green Submitted, gold, Green Published			2022-12-27	WOS:000309556100147
J	Chon, YE; Choi, EH; Song, KJ; Park, JY; Kim, DY; Han, KH; Chon, CY; Ahn, SH; Kim, SU				Chon, Young Eun; Choi, Eun Hee; Song, Ki Jun; Park, Jun Yong; Kim, Do Young; Han, Kwang-Hyub; Chon, Chae Yoon; Ahn, Sang Hoon; Kim, Seung Up			Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis	PLOS ONE			English	Article							STIFFNESS MEASUREMENT; NONINVASIVE ASSESSMENT; CIRRHOSIS; DIAGNOSIS; ACCURACY; BIOPSY; VARIABILITY; THERAPY; PREDICT; UPDATE	Background: Transient elastography (TE), a non-invasive tool that measures liver stiffness, has been evaluated in meta-analyses for effectiveness in assessing liver fibrosis in European populations with chronic hepatitis C(CHC). However, these data cannot be extrapolated to populations in Asian countries, where chronic hepatitis B(CHB) is more prevalent. In this study, we performed a meta-analysis to assess the overall performance of TE for assessing liver fibrosis in patients with CHB. Methods: Studies from the literature and international conference abstracts which enrolled only patients with CHB or performed a subgroup analysis of such patients were enrolled. Combined effects were calculated using area under the receiver operating characteristic curves (AUROC) and diagnostic accuracy values of each study. Result: A total of 18 studies comprising 2,772 patients were analyzed. The mean AUROCs for the diagnosis of significant fibrosis (F2), severe fibrosis (F3), and cirrhosis (F4) were 0.859 (95% confidence interval [CI], 0.857-0.860), 0.887 (95% CI, 0.886-0.887), and 0.929 (95% CI, 0.928-0.929), respectively. The estimated cutoff for F2 was 7.9 (range, 6.1-11.8) kPa, with a sensitivity of 74.3% and specificity of 78.3%. For F3, the cutoff value was determined to be 8.8 (range, 8.1-9.7) kPa, with a sensitivity of 74.0% and specificity of 63.8%. The cutoff value for F4 was 11.7 (range, 7.3-17.5) kPa, with a sensitivity of 84.6% and specificity of 81.5%. Conclusion: TE can be performed with good diagnostic accuracy for quantifying liver fibrosis in patients with CHB.	[Chon, Young Eun; Park, Jun Yong; Kim, Do Young; Han, Kwang-Hyub; Chon, Chae Yoon; Ahn, Sang Hoon; Kim, Seung Up] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Chon, Young Eun; Park, Jun Yong; Kim, Do Young; Han, Kwang-Hyub; Chon, Chae Yoon; Ahn, Sang Hoon; Kim, Seung Up] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea; [Park, Jun Yong; Kim, Do Young; Han, Kwang-Hyub; Chon, Chae Yoon; Ahn, Sang Hoon; Kim, Seung Up] Liver Cirrhosis Clin Res Ctr, Seoul, South Korea; [Choi, Eun Hee; Song, Ki Jun] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Ahn, SH (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	ahnsh@yuhs.ac; ksukorea@yuhs.ac	Park, Jun Yong/H-7127-2019	Park, Jun Yong/0000-0001-6324-2224; Ahn, Sang Hoon/0000-0002-3629-4624; Han, Kwang-Hyub/0000-0003-3960-6539; Kim, Seung Up/0000-0002-9658-8050; Song, Ki Jun/0000-0003-2505-4112; Choi, Eunhee/0000-0002-3449-0672	Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea [A102065]	Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare Technology R & D Project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedossa P, 2003, HEPATOLOGY, V38, P1449, DOI 10.1016/j.hep.2003.09.022; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2009, HEPATOLOGY, V50, p978A; Chan HLY, 2009, J VIRAL HEPATITIS, V16, P36, DOI 10.1111/j.1365-2893.2008.01037.x; Chang J, 2006, HEPATOL INT, V1, P785; Chang J, 2009, HEPATOLOGY, V50, p501A; Chen Y, 2011, HEPATOL INT, V54, P304; Chien RN, 2003, J HEPATOL, V38, P322, DOI 10.1016/S0168-8278(02)00419-1; Choi JW, 2008, HEPATOLOGY, V48, p750A; Chon YE, 2012, J CLIN GAST IN PRESS; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Foucher J, 2005, J HEPATOL, V42, P78; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Friedrich-Rust M, 2008, GASTROENTEROLOGY, V134, P960, DOI 10.1053/j.gastro.2008.01.034; Fung J, 2011, AM J GASTROENTEROL, V106, P492, DOI 10.1038/ajg.2010.463; Gaia S, 2011, J HEPATOL, V54, P64, DOI 10.1016/j.jhep.2010.06.022; Ganne-Carrie N, 2006, HEPATOLOGY, V44, P1511, DOI 10.1002/hep.21420; Garg H, 2011, HEPATOLOGY, V53, P774, DOI 10.1002/hep.24109; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Jeon SW, 2006, DIGESTIVE DIS WEEK, pS1610; Jia JD, 2010, HEPATOL INT, V4, P22; Jung KS, 2011, HEPATOLOGY, V53, P885, DOI 10.1002/hep.24121; Kettaneh A, 2007, J HEPATOL, V46, P628, DOI 10.1016/j.jhep.2006.11.010; Kim BK, 2007, LIVER INT, V27, P969, DOI 10.1111/j.1478-3231.2007.01519.x; Kim DY, 2009, DIGEST DIS SCI, V54, P1758, DOI 10.1007/s10620-008-0541-2; Kim SU, 2010, ALIMENT PHARM THER, V32, P498, DOI 10.1111/j.1365-2036.2010.04353.x; Kim SU, 2011, J GASTROEN HEPATOL, V26, P937, DOI 10.1111/j.1440-1746.2011.06741.x; Kim SU, 2010, J GASTROEN HEPATOL, V25, P1472, DOI 10.1111/j.1440-1746.2010.06432.x; Kim SU, 2010, J CLIN GASTROENTEROL, V44, P66, DOI 10.1097/MCG.0b013e3181a95c7f; Kim SU, 2009, J CLIN GASTROENTEROL, V43, P267, DOI 10.1097/MCG.0b013e31816f212e; Kim SU, 2012, PLOS ONE, V7; Lesmana CR, 2010, HEPATOL INT, V4, P21; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Marcellin P, 2009, LIVER INT, V29, P242, DOI 10.1111/j.1478-3231.2008.01802.x; Masuzaki R, 2009, PROSPECTIVE RISK ASS; Nahon P, 2006, AM J GASTROENTEROL, V101, P2744, DOI 10.1111/j.1572-0241.2006.00816.x; Pungpapong S, 2007, MAYO CLIN PROC, V82, P967, DOI 10.4065/82.8.967; Rousselet MC, 2005, HEPATOLOGY, V41, P257, DOI 10.1002/hep.20535; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sheth SG, 1998, AM J GASTROENTEROL, V93, P44, DOI 10.1111/j.1572-0241.1998.044_c.x; Sporea I, 2010, WORLD J GASTROENTERO, V16, P4832, DOI 10.3748/wjg.v16.i38.4832; Stebbing J, 2010, J CLIN GASTROENTEROL, V44, P214, DOI 10.1097/MCG.0b013e3181b4af1f; Sturm N, 2009, J HEPATOLOGY, V50; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Talwalkar JA, 2007, CLIN GASTROENTEROL H, V5, P1214, DOI 10.1016/j.cgh.2007.07.020; Tanwandee T, 2008, HEPATOLOGY, V48, p709A; Tsochatzis EA, 2011, J HEPATOL, V54, P650, DOI 10.1016/j.jhep.2010.07.033; Verveer C, 2011, LIVER INT; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wang JH, 2009, J GASTROENTEROL, V44, P439, DOI 10.1007/s00535-009-0017-y; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wong GLH, 2008, CLIN GASTROENTEROL H, V6, P1027, DOI 10.1016/j.cgh.2008.02.038; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003; Zhu X, 2011, HEPATOL INT, V5, P306; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	56	204	212	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44930	10.1371/journal.pone.0044930	http://dx.doi.org/10.1371/journal.pone.0044930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049764	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100025
J	Dynon, K; Heng, S; Puryer, M; Li, Y; Walton, K; Endo, Y; Nie, GY				Dynon, Kemperly; Heng, Sophea; Puryer, Michelle; Li, Ying; Walton, Kelly; Endo, Yaeta; Nie, Guiying			HtrA3 as an Early Marker for Preeclampsia: Specific Monoclonal Antibodies and Sensitive High-Throughput Assays for Serum Screening	PLOS ONE			English	Article							MATERNAL-FETAL INTERFACE; FACTOR A3 HTRA3; SERINE-PROTEASE; ENDOMETRIAL CANCER; EARLY-PREGNANCY; LUNG-CANCER; PLACENTATION; EXPRESSION; MOUSE; INSULIN	Mammalian HtrA3 (high temperature requirement A3) is a serine protease of the HtrA family. It has two isoforms [long (HtrA3-L) and short (HtrA3-S)] and is important for placental development and cancer progression. Recently, HtrA3 was identified as a potential diagnostic marker for early detection of preeclampsia, a life-threatening pregnancy-specific disorder. Currently there are no high-throughput assays available to detect HtrA3 in human serum. In this study we generated and fully tested a panel of five HtrA3 mouse monoclonal antibodies (mAbs). Three mAbs recognised both HtrA3-L and HtrA3-S and the other two detected HtrA3-L only. All five mAbs were highly specific to HtrA3 and applicable in western blotting and immunohistochemical analysis of endogenous HtrA3 proteins in the mouse and human tissues. Amplified luminescent proximity homogeneous assays-linked immunosorbent assays (AlphaLISAs), were developed to detect HtrA3 isoforms in picomolar levels in serum. The HtrA3 AlphaLISA detected significantly higher serum levels of HtrA3 in women at 13-14 weeks of gestation who subsequently developed preeclampsia compared to gestational-age matched controls. These HtrA3 mAbs are valuable for the development of immunoassays and characterisation of HtrA3 isoform-specific biology. The newly developed HtrA3 AlphaLISA assays are suitable for large scale screening of human serum.	[Dynon, Kemperly; Heng, Sophea; Puryer, Michelle; Li, Ying; Walton, Kelly; Nie, Guiying] Prince Henrys Inst Med Res, Clayton, Vic, Australia; [Endo, Yaeta] Ehime Univ, Cell Free Sci & Technol Res Ctr, Matsuyama, Ehime, Japan; [Nie, Guiying] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Prince Henry's Institute of Medical Research; Ehime University; Monash University	Nie, GY (corresponding author), Prince Henrys Inst Med Res, Clayton, Vic, Australia.	guiying.nie@princehenrys.org	Walton, Kelly/ABF-7282-2020	Walton, Kelly/0000-0003-0627-2958; Nie, Guiying/0000-0001-9641-087X	National Health and Medical Research Council of Australia [494808, 494802]; Australian Academy of Science exchange program; Japan Society for the Promotion of Science; Bill & Melinda Gates Foundation [OPP1025076]; Victorian Government's Operational Infrastructure Support Program	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Academy of Science exchange program; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Victorian Government's Operational Infrastructure Support Program	This work was supported by the National Health and Medical Research Council of Australia [Fellowship #494808 (to GN) and Program grant #494802], Australian Academy of Science exchange program with the Japan Society for the Promotion of Science (to GN), the Bill & Melinda Gates Foundation [OPP1025076 (to GN)] and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Prince Henry's Institute data audit number for this work is 12-04.	Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Beleford D, 2010, CLIN CANCER RES, V16, P398, DOI 10.1158/1078-0432.CCR-09-1677; Beleford D, 2010, J BIOL CHEM, V285, P12011, DOI 10.1074/jbc.M109.097790; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Bowden M, 2009, J EXP ZOOL PART B, V312B, P701, DOI 10.1002/jez.b.21288; Bowden MA, 2010, MOL CELL ENDOCRINOL, V327, P13, DOI 10.1016/j.mce.2010.06.001; Bowden MA, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-22; Bowden MA, 2006, GYNECOL ONCOL, V103, P253, DOI 10.1016/j.ygyno.2006.03.006; Cetin I, 2011, PLACENTA, V32, pS4, DOI 10.1016/j.placenta.2010.11.022; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; DOLEA C, 2003, GLOBAL BURDEN HYPERT; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Golla R, 2004, J BIOMOL SCREEN, V9, P62, DOI 10.1177/1087057103260515; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hadker Nandini, 2010, J Med Econ, V13, P728, DOI 10.3111/13696998.2010.535285; Huang B, 2009, ARCH TOXICOL, V83, P619, DOI 10.1007/s00204-009-0410-6; Kajantie E, 2009, STROKE, V40, P1176, DOI 10.1161/STROKEAHA.108.538025; Kato MV, 2000, MOL MED, V6, P126, DOI 10.1007/BF03401780; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Li Y, 2011, J CLIN ENDOCR METAB, V96, P403, DOI 10.1210/jc.2010-1405; McGiven JA, 2008, J IMMUNOL METHODS, V337, P7, DOI 10.1016/j.jim.2008.05.004; Narkiewicz J, 2009, ONCOL REP, V21, P1529, DOI 10.3892/or_00000385; Narklewicz J, 2008, CLIN BIOCHEM, V41, P561, DOI 10.1016/j.clinbiochem.2008.01.004; Nie G, 2006, PLACENTA, V27, P491, DOI 10.1016/j.placenta.2005.03.009; Nie GY, 2003, MOL HUM REPROD, V9, P279, DOI 10.1093/molehr/gag036; Nie GY, 2006, BIOL REPROD, V74, P366, DOI 10.1095/biolreprod.105.047324; Nie GY, 2003, BIOCHEM J, V371, P39, DOI 10.1042/BJ20021569; Osungbade KO, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/481095; Petersen SB, 2010, J PHARMACEUT BIOMED, V51, P217, DOI 10.1016/j.jpba.2009.08.008; Poulsen F, 2007, J BIOMOL SCREEN, V12, P240, DOI 10.1177/1087057106297566; Roberts JM, 2003, HYPERTENS PREGNANCY, V22, P109, DOI 10.1081/PRG-120016792; Singh H, 2010, PLACENTA, V31, P1085, DOI 10.1016/j.placenta.2010.10.003; Singh H, 2012, BIOTECHNIQUES, V52, P23, DOI 10.2144/000113798; Singh H, 2011, HUM REPROD, V26, P748, DOI 10.1093/humrep/der019; Than NG, 2008, PLACENTA, V29, pS83, DOI 10.1016/j.placenta.2007.10.008; Theoleyre S, 2010, BIOCHEM BIOPH RES CO, V394, P453, DOI 10.1016/j.bbrc.2009.11.163; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Wang LJ, 2012, MOL CELL BIOL; Wu CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.060	41	30	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45956	10.1371/journal.pone.0045956	http://dx.doi.org/10.1371/journal.pone.0045956			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049902	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100107
J	Greenwood, BN; Strong, PV; Loughridge, AB; Day, HEW; Clark, PJ; Mika, A; Hellwinkel, JE; Spence, KG; Fleshner, M				Greenwood, Benjamin N.; Strong, Paul V.; Loughridge, Alice B.; Day, Heidi E. W.; Clark, Peter J.; Mika, Agnieszka; Hellwinkel, Justin E.; Spence, Katie G.; Fleshner, Monika			5-HT2C Receptors in the Basolateral Amygdala and Dorsal Striatum Are a Novel Target for the Anxiolytic and Antidepressant Effects of Exercise	PLOS ONE			English	Article							CHLOROPHENYLPIPERAZINE M-CPP; ANXIETY-LIKE BEHAVIOR; PRE-MESSENGER-RNA; META-CHLOROPHENYLPIPERAZINE; VOLUNTARY EXERCISE; NEUROENDOCRINE RESPONSES; UNCONTROLLABLE STRESS; LEARNED HELPLESSNESS; ACUTE FLUOXETINE; CENTRAL NUCLEUS	Physical activity reduces the incidence and severity of psychiatric disorders such as anxiety and depression. Similarly, voluntary wheel running produces anxiolytic- and antidepressant-like effects in rodent models. The specific neurobiological mechanisms underlying the beneficial properties of exercise, however, remain unclear. One relevant pharmacological target in the treatment of psychiatric disorders is the 5-HT2C receptor (5-HT2CR). Consistent with data demonstrating the anxiogenic consequences of 5-HT2CR activation in humans and rodents, we have previously reported that site-specific administration of the selective 5-HT2CR agonist CP-809101 in the lateral/basolateral amygdala (BLA) increases shock-elicited fear while administration of CP-809101 in the dorsal striatum (DS) interferes with shuttle box escape learning. These findings suggest that activation of 5-HT2CR in discrete brain regions contributes to specific anxiety-and depression-like behaviors and may indicate potential brain sites involved in the anxiolytic and antidepressant effects of exercise. The current studies tested the hypothesis that voluntary wheel running reduces the behavioral consequences of 5-HT2CR activation in the BLA and DS, specifically enhanced shock-elicited fear and interference with shuttle box escape learning. After 6 weeks of voluntary wheel running or sedentary conditions, the selective 5-HT2CR agonist CP-809101 was microinjected into either the BLA or the DS of adult Fischer 344 rats, and shock-elicited fear and shuttle box escape learning was assessed. Additionally, in-situ hybridization was used to determine if 6 weeks of voluntary exercise changed levels of 5-HT2CR mRNA. We found that voluntary wheel running reduced the behavioral effects of CP-809101 and reduced levels of 5-HT2CR mRNA in both the BLA and the DS. The current data indicate that expression of 5-HT2CR mRNA in discrete brain sites is sensitive to physical activity status of the organism, and implicates the 5-HT2CR as a target for the beneficial effects of physical activity on mental health.	[Greenwood, Benjamin N.; Strong, Paul V.; Loughridge, Alice B.; Clark, Peter J.; Mika, Agnieszka; Hellwinkel, Justin E.; Spence, Katie G.; Fleshner, Monika] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Day, Heidi E. W.] Univ Colorado, Dept Psychol & Neurosci, Boulder, CO 80309 USA; [Greenwood, Benjamin N.; Strong, Paul V.; Day, Heidi E. W.; Clark, Peter J.; Mika, Agnieszka; Fleshner, Monika] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Greenwood, BN (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.	ben.greenwood@colorado.edu		DAY, HEIDI/0000-0002-5683-3496; Fleshner, Monika/0000-0002-0470-0827	National Institutes of Health [NIMH 068283, NIMH 050479]; American Foundation for Suicide Prevention	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Foundation for Suicide Prevention	The work in this manuscript was supported by the National Institutes of Health grant: NIMH 068283 (M.F.), NIMH 050479 (B.G.) and the American Foundation for Suicide Prevention (B.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex KD, 2005, SYNAPSE, V55, P242, DOI 10.1002/syn.20109; Anderson IM, 1999, ADV EXP MED BIOL, V467, P43; Atallah HE, 2007, NAT NEUROSCI, V10, P126, DOI 10.1038/nn1817; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; Bagdy G, 2001, INT J NEUROPSYCHOPH, V4, P399, DOI 10.1017/S1461145701002632; Balleine BW, 2009, BEHAV BRAIN RES, V199, P43, DOI 10.1016/j.bbr.2008.10.034; Barbon A, 2011, NEUROPSYCHOBIOLOGY, V63, P160, DOI 10.1159/000321593; Berg KA, 2008, NEUROPHARMACOLOGY, V55, P969, DOI 10.1016/j.neuropharm.2008.06.014; Binder E, 2004, BEHAV BRAIN RES, V155, P197, DOI 10.1016/j.bbr.2004.04.017; Broocks A, 2001, PSYCHOPHARMACOLOGY, V155, P234, DOI 10.1007/s002130100706; Broocks A, 1999, NEUROPSYCHOPHARMACOL, V20, P150, DOI 10.1016/S0893-133X(98)00056-6; Burghardt NS, 2007, BIOL PSYCHIAT, V62, P1111, DOI 10.1016/j.biopsych.2006.11.023; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; Campbell BM, 2003, BRAIN RES, V993, P1, DOI 10.1016/S0006-8993(03)03384-5; CAMPEAU S, 1995, J NEUROSCI, V15, P2301, DOI 10.1523/JNEUROSCI.15-03-02301.1995; CHARNEY DS, 1987, PSYCHOPHARMACOLOGY, V92, P14, DOI 10.1007/BF00215473; Christianson JP, 2010, BIOL PSYCHIAT, V67, P339, DOI 10.1016/j.biopsych.2009.09.011; Cornelio AM, 2007, BEHAV BRAIN RES, V178, P82, DOI 10.1016/j.bbr.2006.12.003; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cruz APM, 2005, PSYCHOPHARMACOLOGY, V182, P345, DOI 10.1007/s00213-005-0108-2; Davis JM, 1997, MED SCI SPORT EXER, V29, P45, DOI 10.1097/00005768-199701000-00008; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; Dishman RK, 1997, BRAIN RES BULL, V42, P399, DOI 10.1016/S0361-9230(96)00329-2; Duman CH, 2008, BRAIN RES; Dwyer D, 2000, ACTA PHYSIOL SCAND, V170, P211, DOI 10.1111/j.1365-201X.2000.00774.x; EberleWang K, 1997, J COMP NEUROL, V384, P233, DOI 10.1002/(SICI)1096-9861(19970728)384:2<233::AID-CNE5>3.0.CO;2-2; Englander MT, 2005, J NEUROSCI, V25, P648, DOI 10.1523/JNEUROSCI.3895-04.2005; Fanselow M., 1988, EVOLUTION LEARNING, P197; Fox JH, 2008, BEHAV NEUROSCI, V122, P943, DOI 10.1037/0735-7044.122.4.943; Gardiner Katheleen, 2006, Briefings in Functional Genomics & Proteomics, V5, P37, DOI 10.1093/bfgp/ell006; Gatch MB, 2003, LIFE SCI, V73, P1347, DOI 10.1016/S0024-3205(03)00422-3; Graeff FG, 1996, PHARMACOL BIOCHEM BE, V54, P129, DOI 10.1016/0091-3057(95)02135-3; Graeff FG, 2004, NEUROSCI BIOBEHAV R, V28, P239, DOI 10.1016/j.neubiorev.2003.12.004; Graeff FG, 1997, NEUROSCI BIOBEHAV R, V21, P791, DOI 10.1016/S0149-7634(96)00059-0; Greenwood BN, 2008, PSYCHOPHARMACOLOGY, V199, P209, DOI 10.1007/s00213-008-1167-y; Greenwood BN, 2012, BEHAV BRAIN RES, V233, P314, DOI 10.1016/j.bbr.2012.05.017; Greenwood BN, 2011, EXERC SPORT SCI REV, V39, P140, DOI 10.1097/JES.0b013e31821f7e45; Greenwood BN, 2011, BEHAV BRAIN RES, V217, P354, DOI 10.1016/j.bbr.2010.11.005; Greenwood BN, 2005, BIOL PSYCHIAT, V57, P559, DOI 10.1016/j.biopsych.2004.11.025; Greenwood BN, 2005, BRAIN RES, V1033, P164, DOI 10.1016/j.brainres.2004.11.037; Greenwood BN, 2003, J NEUROSCI, V23, P2889; Gurevich I, 2002, J NEUROSCI, V22, P10529; Gurevich I, 2002, NEURON, V34, P349, DOI 10.1016/S0896-6273(02)00660-8; Hasler G, 2008, ARCH GEN PSYCHIAT, V65, P521, DOI 10.1001/archpsyc.65.5.521; Herrick-Davis K, 1999, J NEUROCHEM, V73, P1711, DOI 10.1046/j.1471-4159.1999.731711.x; Herring MP, 2010, ARCH INTERN MED, V170, P321, DOI 10.1001/archinternmed.2009.530; Iwamoto K, 2009, RNA BIOL, V6, P248, DOI 10.4161/rna.6.3.8370; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lex B, 2010, CEREB CORTEX, V20, P873, DOI 10.1093/cercor/bhp151; Li Q, 2003, J NEUROCHEM, V84, P1256, DOI 10.1046/j.1471-4159.2003.01607.x; Li Q, 2012, NEUROPHARMACOLOGY, V62, P474, DOI 10.1016/j.neuropharm.2011.09.002; Lovinger DM, 2010, NEUROPHARMACOLOGY, V58, P951, DOI 10.1016/j.neuropharm.2010.01.008; MAIER SF, 1990, J EXP PSYCHOL ANIM B, V16, P137, DOI 10.1037/0097-7403.16.2.137; Maier SF, 1998, COGNITIVE THER RES, V22, P595, DOI 10.1023/A:1018794104325; Millan MJ, 2005, PSYCHOPHARMACOLOGY, V177, P448, DOI 10.1007/s00213-004-1962-z; Millan MJ, 2005, THERAPIE, V60, P441, DOI 10.2515/therapie:2005065; Millan MJ, 2003, PROG NEUROBIOL, V70, P83, DOI 10.1016/s0301-0082(03)00087-X; Moreau JL, 1996, EUR NEUROPSYCHOPHARM, V6, P169, DOI 10.1016/0924-977X(96)00015-6; Moya Pablo R., 2011, BMC Pharmacology, V11, P3, DOI 10.1186/1471-2210-11-3; MURPHY DL, 1989, PSYCHOPHARMACOLOGY, V98, P275, DOI 10.1007/BF00444705; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Ninan PT, 1999, J CLIN PSYCHIAT, V60, P12; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; Olie JP, 2007, INT J NEUROPSYCHOPH, V10, P661, DOI 10.1017/S1461145707007766; Ota KT, 2012, NEUROBIOLOGY DIS; Overstreet DH, 2006, PSYCHOPHARMACOLOGY, V187, P1, DOI 10.1007/s00213-006-0389-0; Owens M J, 1998, Depress Anxiety, V8 Suppl 1, P5, DOI 10.1002/(SICI)1520-6394(1998)8:1+<5::AID-DA2>3.0.CO;2-I; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pjrek E, 2007, PSYCHOPHARMACOLOGY, V190, P575, DOI 10.1007/s00213-006-0645-3; Price RD, 2000, MOL PHARMACOL, V58, P859, DOI 10.1124/mol.58.4.859; Ribases M, 2008, J PSYCHIATR RES, V42, P50, DOI 10.1016/j.jpsychires.2006.09.001; Saeed SA, 2010, AM FAM PHYSICIAN, V81, P981; Salam JN, 2009, BEHAV BRAIN RES, V197, P31, DOI 10.1016/j.bbr.2008.07.036; Serretti A, 2004, EXPERT OPIN THER TAR, V8, P15, DOI 10.1517/eott.8.1.15.26405; Sharp T, 2011, CURR OPIN PHARMACOL, V11, P45, DOI 10.1016/j.coph.2011.02.003; SHERMAN AD, 1982, PHARMACOL BIOCHEM BE, V16, P449, DOI 10.1016/0091-3057(82)90451-8; Solberg LC, 1999, AM J PHYSIOL-REG I, V276, pR152, DOI 10.1152/ajpregu.1999.276.1.R152; Stein DJ, 2008, J CLIN PSYCHOPHARM, V28, P561, DOI 10.1097/JCP.0b013e318184ff5b; Strohle A, 2009, J NEURAL TRANSM, V116, P777, DOI 10.1007/s00702-008-0092-x; Strong PV, 2011, NEUROSCIENCE, V197, P132, DOI 10.1016/j.neuroscience.2011.09.041; Strong PV, 2009, PSYCHOPHARMACOLOGY, V203, P665, DOI 10.1007/s00213-008-1413-3; Strong PV, 2011, NEUROSCIENCE; Van Veen JF, 2007, EUR NEUROPSYCHOPHARM, V17, P637, DOI 10.1016/j.euroneuro.2007.03.005; Vollert C, 2011, BEHAV BRAIN RES, V224, P233, DOI 10.1016/j.bbr.2011.05.010; Wang QD, 2000, J NEUROCHEM, V74, P1290; Wilensky AE, 2006, J NEUROSCI, V26, P12387, DOI 10.1523/JNEUROSCI.4316-06.2006	86	54	54	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46118	10.1371/journal.pone.0046118	http://dx.doi.org/10.1371/journal.pone.0046118			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049953	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100138
J	Rothe, J; Watkins, NE; Nagy, M				Rothe, Jessica; Watkins, Norman E., Jr.; Nagy, Marion			New Prediction Model for Probe Specificity in an Allele-Specific Extension Reaction for Haplotype-Specific Extraction (HSE) of Y Chromosome Mixtures	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; NEAREST-NEIGHBOR THERMODYNAMICS; TAQ DNA-POLYMERASE; DISCRIMINATION; IDENTIFICATION; MISMATCHES; PCR	Allele-specific extension reactions (ASERs) use 3' terminus-specific primers for the selective extension of completely annealed matches by polymerase. The ability of the polymerase to extend non-specific 3' terminal mismatches leads to a failure of the reaction, a process that is only partly understood and predictable, and often requires time-consuming assay design. In our studies we investigated haplotype-specific extraction (HSE) for the separation of male DNA mixtures. HSE is an ASER and provides the ability to distinguish between diploid chromosomes from one or more individuals. Here, we show that the success of HSE and allele- specific extension depend strongly on the concentration difference between complete match and 3' terminal mismatch. Using the oligonucleotide-modeling platform Visual Omp, we demonstrated the dependency of the discrimination power of the polymerase on match- and mismatch-target hybridization between different probe lengths. Therefore, the probe specificity in HSE could be predicted by performing a relative comparison of different probe designs with their simulated differences between the duplex concentration of target-probe match and mismatches. We tested this new model for probe design in more than 300 HSE reactions with 137 different probes and obtained an accordance of 88%.	[Rothe, Jessica; Nagy, Marion] Charite Campus Virchow Klinikum, Dept Forens Genet, Inst Legal Med & Forens Sci, Berlin, Germany; [Watkins, Norman E., Jr.] DNA Software Inc, Ann Arbor, MI USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rothe, J (corresponding author), Charite Campus Virchow Klinikum, Dept Forens Genet, Inst Legal Med & Forens Sci, Berlin, Germany.	jessica.rothe@charite.de		Nagy, Marion/0000-0002-7319-8033				Allawi HT, 1997, BIOCHEMISTRY-US, V36, P10581, DOI 10.1021/bi962590c; Ayyadevara S, 2000, ANAL BIOCHEM, V284, P11, DOI 10.1006/abio.2000.4635; Cai YN, 2010, ANAL BIOCHEM, V406, P29, DOI 10.1016/j.ab.2010.06.043; Chan KM, 2011, CLIN BIOCHEM, V44, P1253, DOI 10.1016/j.clinbiochem.2011.07.014; Dapprich J, 2007, TISSUE ANTIGENS, V69, P282, DOI 10.1111/j.1399-0039.2006.00752.x; Dapprich J, 2001, U.S. Patent Application, Patent No. 20010031467; Dapprich J, 2001, Australian Patent, Patent No. 785211; Dapprich J, 2007, HUM IMMUNOL, V68, P418, DOI 10.1016/j.humimm.2007.01.015; Dapprich J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn345; Endres RO, 2007, TISSUE ANTIGENS, V70, P259, DOI 10.1111/j.1399-0039.2007.00889.x; Gabriel A, 2006, PLOS GENET, V2, P2026, DOI 10.1371/journal.pgen.0020212; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; Lim J, 2009, TISSUE ANTIGENS, V73, P78, DOI 10.1111/j.1399-0039.2008.01177.x; Litos IK, 2011, CLIN CHIM ACTA, V412, P1968, DOI 10.1016/j.cca.2011.07.001; Onodera Kenji, 2007, V402, P61; Rothe J, 2011, FORENSIC SCI INT-GEN, V5, P117, DOI 10.1016/j.fsigen.2010.09.011; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SantaLucia John Jr., 2007, V402, P3; Ulrich S, 2008, TISSUE ANTIGENS, V71, P91, DOI 10.1111/j.1399-0039.2007.00951.x; Watkins NE, 2005, NUCLEIC ACIDS RES, V33, P6258, DOI 10.1093/nar/gki918	22	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45955	10.1371/journal.pone.0045955	http://dx.doi.org/10.1371/journal.pone.0045955			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049901	gold, Green Submitted, Green Published			2022-12-27	WOS:000309556100106
J	Tripathy, SP; Shafiullah, SN; Cox, MJ				Tripathy, Srimant P.; Shafiullah, Syed N.; Cox, Michael J.			Influence of Correspondence Noise and Spatial Scaling on the Upper Limit for Spatial Displacement in Fully-Coherent Random-Dot Kinematogram Stimuli	PLOS ONE			English	Article							TEMPORAL VISUAL AREA; SHORT-RANGE PROCESS; DIRECTION DISCRIMINATION; APPARENT MOTION; FUNCTIONAL-PROPERTIES; RESPONSE PROPERTIES; RECEPTIVE-FIELDS; ELEMENT DENSITY; MACAQUE MT; NEURONS	Correspondence noise is a major factor limiting direction discrimination performance in random-dot kinematograms [1]. In the current study we investigated the influence of correspondence noise on Dmax, which is the upper limit for the spatial displacement of the dots for which coherent motion is still perceived. Human direction discrimination performance was measured, using 2-frame kinematograms having leftward/rightward motion, over a 200-fold range of dot-densities and a four-fold range of dot displacements. From this data Dmax was estimated for the different dot densities tested. A model was proposed to evaluate the correspondence noise in the stimulus. This model summed the outputs of a set of elementary Reichardt-type local detectors that had receptive fields tiling the stimulus and were tuned to the two directions of motion in the stimulus. A key assumption of the model was that the local detectors would have the radius of their catchment areas scaled with the displacement that they were tuned to detect; the scaling factor k linking the radius to the displacement was the only free parameter in the model and a single value of k was used to fit all of the psychophysical data collected. This minimal, correspondence-noise based model was able to account for 91% of the variability in the human performance across all of the conditions tested. The results highlight the importance of correspondence noise in constraining the largest displacement that can be detected.	[Tripathy, Srimant P.; Shafiullah, Syed N.; Cox, Michael J.] Univ Bradford, Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England	University of Bradford	Tripathy, SP (corresponding author), Univ Bradford, Sch Optometry & Vis Sci, Bradford BD7 1DP, W Yorkshire, England.	s.p.tripathy@bradford.ac.uk		Tripathy, Srimant/0000-0002-2988-6840	University of Bradford; School of Optometry Vision Science	University of Bradford; School of Optometry Vision Science	SNS was supported by an Overseas Research Scholarship at University of Bradford. The publication fee is based on funds agreed by the School of Optometry & Vision Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ANSTIS SM, 1970, VISION RES, V10, P1411, DOI 10.1016/0042-6989(70)90092-1; ANSTIS SM, 1980, PHILOS T ROY SOC B, V290, P153, DOI 10.1098/rstb.1980.0088; ATTNEAFE F, 1974, PSYCHOLOGIA, V17, P108; BAKER CL, 1982, VISION RES, V22, P1253, DOI 10.1016/0042-6989(82)90137-7; BAKER CL, 1985, VISION RES, V25, P803, DOI 10.1016/0042-6989(85)90188-9; BAKER CL, 1985, PERCEPTION, V14, P181, DOI 10.1068/p140181; Barlow H, 1997, J NEUROSCI, V17, P7954; BARLOW HB, 1979, VISION RES, V19, P783, DOI 10.1016/0042-6989(79)90154-8; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; Bours RJE, 2007, J VISION, V7, DOI 10.1167/7.11.8; Bours RJE, 2007, J VISION, V7, DOI 10.1167/7.1.2; BRADDICK O, 1974, VISION RES, V14, P519, DOI 10.1016/0042-6989(74)90041-8; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; Cavanagh P, 1991, Spat Vis, V5, P303, DOI 10.1163/156856891X00065; CHANG JJ, 1983, VISION RES, V23, P639, DOI 10.1016/0042-6989(83)90070-6; CHANG JJ, 1983, VISION RES, V23, P1379, DOI 10.1016/0042-6989(83)90149-9; Chung STL, 1996, VISION RES, V36, P2395, DOI 10.1016/0042-6989(95)00342-8; Comtois R., 2003, VISION SHELL PPC SOF; DAWSON MRW, 1991, PSYCHOL REV, V98, P569, DOI 10.1037/0033-295X.98.4.569; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Eagle RA, 1997, VISION RES, V37, P2091, DOI 10.1016/S0042-6989(96)00153-8; Eagle RA, 1996, VISION RES, V36, P545, DOI 10.1016/0042-6989(96)89252-2; FELLEMAN DJ, 1984, J NEUROPHYSIOL, V52, P488, DOI 10.1152/jn.1984.52.3.488; GATTASS R, 1981, J NEUROPHYSIOL, V46, P621, DOI 10.1152/jn.1981.46.3.621; Giaschi DE, 1997, INVEST OPHTH VIS SCI, V38, P358; Glasser DM, 2011, P NATL ACAD SCI USA, V108, pE1080, DOI 10.1073/pnas.1101141108; GREEN M, 1986, VISION RES, V26, P599, DOI 10.1016/0042-6989(86)90008-8; HADANI I, 1980, VISION RES, V20, P947, DOI 10.1016/0042-6989(80)90076-0; Hibbard PB, 2000, P ROY SOC B-BIOL SCI, V267, P1369, DOI 10.1098/rspb.2000.1152; LAPPIN JS, 1976, VISION RES, V16, P161, DOI 10.1016/0042-6989(76)90093-6; Levi DM, 1996, CURR BIOL, V6, P1020, DOI 10.1016/S0960-9822(02)00647-4; LEVINSON E, 1975, NATURE, V254, P692, DOI 10.1038/254692a0; Majaj NJ, 2007, J NEUROSCI, V27, P366, DOI 10.1523/JNEUROSCI.3183-06.2007; Marr D., 1982, VISION COMPUTATIONAL; MATHER G, 1995, VISION RES, V35, P2105, DOI 10.1016/0042-6989(94)00297-5; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MIKAMI A, 1992, EXP BRAIN RES, V90, P40; MORGAN MJ, 1992, NATURE, V355, P344, DOI 10.1038/355344a0; MORGAN MJ, 1980, VISION RES, V20, P431, DOI 10.1016/0042-6989(80)90033-4; MORGAN MJ, 1992, P ROY SOC B-BIOL SCI, V248, P189, DOI 10.1098/rspb.1992.0061; Movshon JA, 1996, J NEUROSCI, V16, P7733; NAKAYAMA K, 1984, VISION RES, V24, P293, DOI 10.1016/0042-6989(84)90054-3; NAKAYAMA K, 1985, VISION RES, V25, P625, DOI 10.1016/0042-6989(85)90171-3; NAKAYAMA K, 1981, VISION RES, V21, P427, DOI 10.1016/0042-6989(81)90089-4; Newsome William T., 1995, P401; NEWSOME WT, 1986, J NEUROPHYSIOL, V55, P1340, DOI 10.1152/jn.1986.55.6.1340; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Priebe NJ, 2003, J NEUROSCI, V23, P5650; Prince S, 2001, PERCEPTION, V30, P367, DOI 10.1068/p3049; RAIGUEL S, 1995, EUR J NEUROSCI, V7, P2064, DOI 10.1111/j.1460-9568.1995.tb00629.x; RAMACHANDRAN VS, 1986, SCI AM, V254, P102, DOI 10.1038/scientificamerican0686-102; Reichardt W., 1961, S PRINC SENS COMM 19, P302; RODMAN HR, 1987, VISION RES, V27, P2035, DOI 10.1016/0042-6989(87)90118-0; SALZMAN CD, 1992, J NEUROSCI, V12, P2331; Sato T, 1990, PERCEPTION, V19, P329; Shafiullah SN, 2008, THESIS U BRADFORD; SNOWDEN RJ, 1991, J NEUROSCI, V11, P2768; TODD JT, 1995, VISION RES, V35, P2287, DOI 10.1016/0042-6989(94)00312-A; Tripathy S. P., 1998, IOVS, V39, pS1074; Ullman S., 1979, PROC R SOC SER B-BIO, DOI 10.7551/mitpress/3877.003.0009; VANDOORN AJ, 1982, BIOL CYBERN, V44, P167, DOI 10.1007/BF00344272; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; Watanabe T., 1998, HIGH LEVEL MOTION PR, P115; WILLIAMS DW, 1984, VISION RES, V24, P55, DOI 10.1016/0042-6989(84)90144-5; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	73	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e42995	10.1371/journal.pone.0042995	http://dx.doi.org/10.1371/journal.pone.0042995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056172	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400001
J	Westerhof, LB; Wilbers, RHP; Roosien, J; van de Velde, J; Goverse, A; Bakker, J; Schots, A				Westerhof, Lotte B.; Wilbers, Ruud H. P.; Roosien, Jan; van de Velde, Jan; Goverse, Aska; Bakker, Jaap; Schots, Arjen			3D Domain Swapping Causes Extensive Multimerisation of Human Interleukin-10 When Expressed In Planta	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; TRANSGENIC TOBACCO; ESCHERICHIA-COLI; INTERFERON-GAMMA; RECEPTOR; REVEALS; IL-10; CSF; DISEASE; CYTOSOL	Heterologous expression platforms of biopharmaceutical proteins have been significantly improved over the last decade. Further improvement can be established by examining the intrinsic properties of proteins. Interleukin-10 (IL-10) is an anti-inflammatory cytokine with a short half-life that plays an important role in re-establishing immune homeostasis. This homodimeric protein of 36 kDa has significant therapeutic potential to treat inflammatory and autoimmune diseases. In this study we show that the major production bottleneck of human IL-10 is not protein instability as previously suggested, but extensive multimerisation due to its intrinsic 3D domain swapping characteristic. Extensive multimerisation of human IL-10 could be visualised as granules in planta. On the other hand, mouse IL-10 hardly multimerised, which could be largely attributed to its glycosylation. By introducing a short glycine-serine-linker between the fourth and fifth alpha helix of human IL-10 a stable monomeric form of IL-10 (hIL-10(mono)) was created that no longer multimerised and increased yield up to 20-fold. However, hIL-10(mono) no longer had the ability to reduce pro-inflammatory cytokine secretion from lipopolysaccharide-stimulated macrophages. Forcing dimerisation restored biological activity. This was achieved by fusing human IL-10(mono) to the C-terminal end of constant domains 2 and 3 of human immunoglobulin A (Fc alpha), a natural dimer. Stable dimeric forms of IL-10, like Fc alpha-IL-10, may not only be a better format for improved production, but also a more suitable format for medical applications.	[Westerhof, Lotte B.; Wilbers, Ruud H. P.; Roosien, Jan; van de Velde, Jan; Goverse, Aska; Bakker, Jaap; Schots, Arjen] Wageningen Univ, Nematol Lab, Wageningen, Netherlands	Wageningen University & Research	Westerhof, LB (corresponding author), Wageningen Univ, Nematol Lab, Wageningen, Netherlands.	lotte.westerhof@wur.nl	Schots, Arjen/ABF-8014-2020; Schots, Arjen/U-1839-2017; Wilbers, Ruud/O-1844-2019; Wilbers, Ruud/S-8796-2017	Schots, Arjen/0000-0002-6036-7088; Schots, Arjen/0000-0002-6036-7088; Wilbers, Ruud/0000-0003-1149-9268; Wilbers, Ruud/0000-0003-1149-9268	Synthon BV, the Netherlands	Synthon BV, the Netherlands	This work was funded by Synthon BV, the Netherlands (http://www.synthon.com/en/contact/netherlands.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Brandizzi F, 2003, PLANT J, V34, P269, DOI 10.1046/j.1365-313X.2003.01728.x; Colombel JF, 2001, GUT, V49, P42, DOI 10.1136/gut.49.1.42; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Fujiwara Y, 2010, PROTEIN EXPRES PURIF, V72, P125, DOI 10.1016/j.pep.2010.02.008; James EA, 2000, PROTEIN EXPRES PURIF, V19, P131, DOI 10.1006/prep.2000.1232; Josephson K, 2000, J BIOL CHEM, V275, P13552, DOI 10.1074/jbc.275.18.13552; Josephson K, 2001, IMMUNITY, V15, P35, DOI 10.1016/S1074-7613(01)00169-8; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Lee JH, 2002, J BIOTECHNOL, V96, P205, DOI 10.1016/S0168-1656(02)00044-5; Li J, 1997, P NATL ACAD SCI USA, V94, P6694, DOI 10.1073/pnas.94.13.6694; Li J, 2007, SCI HORTIC-AMSTERDAM, V112, P258, DOI 10.1016/j.scienta.2006.12.047; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Luo J, 2008, J PROTEOME RES, V8, P829; Menassa R, 2001, MOL BREEDING, V8, P177, DOI 10.1023/A:1013376407362; Menassa R, 2007, PLANT BIOTECHNOL J, V5, P50, DOI 10.1111/j.1467-7652.2006.00214.x; Mocellin S, 2004, CYTOKINE GROWTH F R, V15, P61, DOI 10.1016/j.cytogfr.2003.11.001; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Ning TT, 2008, BIOTECHNOL LETT, V30, P1679, DOI 10.1007/s10529-008-9717-2; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PROUDFOOT AEI, 1990, BIOCHEM J, V270, P357, DOI 10.1042/bj2700357; Rao DVK, 2009, APPL BIOCHEM BIOTECH, V158, P140, DOI 10.1007/s12010-008-8318-9; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Sardana R, 2007, TRANSGENIC RES, V16, P713, DOI 10.1007/s11248-006-9062-y; Schouten A, 1996, PLANT MOL BIOL, V30, P781, DOI 10.1007/BF00019011; Schwager K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2814; Schwanke RC, 2009, INT J BIOL MACROMOL, V45, P97, DOI 10.1016/j.ijbiomac.2009.04.005; Shameer K, 2011, PROTEIN PEPTIDE LETT, V18, P1010, DOI 10.2174/092986611796378729; Steidler L, 2003, NAT BIOTECHNOL, V21, P785, DOI 10.1038/nbt840; Sun Jie, 2007, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V23, P220; VANENGELEN FA, 1994, PLANT MOL BIOL, V26, P1701, DOI 10.1007/BF00019485; WALTER MR, 1995, BIOCHEMISTRY-US, V34, P12118, DOI 10.1021/bi00038a004; Yang SC, 2005, J MOL BIOL, V352, P202, DOI 10.1016/j.jmb.2005.06.062; ZDANOV A, 1995, STRUCTURE, V3, P591, DOI 10.1016/S0969-2126(01)00193-9; ZHENG XX, 1995, J IMMUNOL, V154, P5590	37	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46460	10.1371/journal.pone.0046460	http://dx.doi.org/10.1371/journal.pone.0046460			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049703	Green Published, gold			2022-12-27	WOS:000309388500030
J	Leidner, B; Sheikh, H; Ginges, J				Leidner, Bernhard; Sheikh, Hammad; Ginges, Jeremy			Affective Dimensions of Intergroup Humiliation	PLOS ONE			English	Article							ACTION TENDENCIES; ANGER; SHAME; TERRORISM; REJECTION; VIOLENCE; GUILT; CATEGORIZATION; EMBARRASSMENT; EMOTIONS	Despite the wealth of theoretical claims about the emotion of humiliation and its effect on human relations, there has been a lack of empirical research investigating what it means to experience humiliation. We studied the affective characteristics of humiliation, comparing the emotional experience of intergroup humiliation to two other emotions humiliation is often confused with: anger and shame. The defining characteristics of humiliation were low levels of guilt and high levels of other-directed outrage (like anger and unlike shame), and high levels of powerlessness (like shame and unlike anger). Reasons for the similarities and differences of humiliation with anger and shame are discussed in terms of perceptions of undeserved treatment and injustice. Implications for understanding the behavioral consequences of humiliation and future work investigating the role of humiliation in social life are discussed.	[Leidner, Bernhard] Univ Massachusetts, Dept Psychol, Amherst, MA 01003 USA; [Sheikh, Hammad; Ginges, Jeremy] New Sch Social Res, Dept Psychol, New York, NY 10011 USA	University of Massachusetts System; University of Massachusetts Amherst; The New School	Leidner, B (corresponding author), Univ Massachusetts, Dept Psychol, Tobin Hall, Amherst, MA 01003 USA.	bleidner@psych.umass.edu	Sheikh, Hammad/AAD-5953-2019	Sheikh, Hammad/0000-0002-5472-4309	Gottlieb Daimler- und Karl Benz-Foundation [02-15/06]; Alliance of Civilizations Media Fund; National Science Foundation [BCS-827313]; Department of Defense Multidisciplinary University Research Initiative [AOR-MURI W911NF-08-1-0301]	Gottlieb Daimler- und Karl Benz-Foundation; Alliance of Civilizations Media Fund; National Science Foundation(National Science Foundation (NSF)); Department of Defense Multidisciplinary University Research Initiative(MURI)	Research reported here as well as the writing of this paper was supported by a Fellowship for Young Scientists of the Gottlieb Daimler- und Karl Benz-Foundation (02-15/06), to Bernhard Leidner, and by grants from the Alliance of Civilizations Media Fund, the National Science Foundation (BCS-827313) and the Department of Defense Multidisciplinary University Research Initiative (AOR-MURI W911NF-08-1-0301) to Jeremy Ginges. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Atran S, 2003, SCIENCE, V299, P1534, DOI 10.1126/science.1078854; Atran S, 2005, NATURE, V437, P630, DOI 10.1038/437620a; Batson CD, 2007, EUR J SOC PSYCHOL, V37, P1272, DOI 10.1002/ejsp.434; BAUMEISTER RF, 1990, J SOC CLIN PSYCHOL, V9, P165, DOI 10.1521/jscp.1990.9.2.165; Beck AT, 1985, ANXIETY DISORDERS PH; Bourgeois KS, 2001, MOTIV EMOTION, V25, P101, DOI 10.1023/A:1010661825137; BROWN GW, 1995, PSYCHOL MED, V25, P7, DOI 10.1017/S003329170002804X; BROWNE A, 1993, AM PSYCHOL, V48, P1077, DOI 10.1037/0003-066X.48.10.1077; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Cattell R.B., 1966, HDB MULTIVARIATE EXP; Cohen D, 1996, J PERS SOC PSYCHOL, V70, P945, DOI 10.1037/0022-3514.70.5.945; Coleman P. T., 2007, ANN C INT ASS CONFL; Combs DJY, 2010, BASIC APPL SOC PSYCH, V32, P128, DOI 10.1080/01973531003738379; Duhl L, 1992, J Prim Prev, V12, P243, DOI 10.1007/BF02015517; Ellsworth PC, 2006, EMOTION, V6, P572, DOI 10.1037/1528-3542.6.4.572; Fontan V, 2006, TERROR POLIT VIOLENC, V18, P217, DOI 10.1080/09546550500383266; Gilbert P, 1997, BRIT J MED PSYCHOL, V70, P113, DOI 10.1111/j.2044-8341.1997.tb01893.x; Ginges J, 2008, J COGN CULT, V8, P281, DOI 10.1163/156853708X358182; GREIST JH, 1995, J CLIN PSYCHIAT, V56, P5; Hartling L.M., 1999, J PRIM PREV, V19, P259, DOI [10.1023/A:1022622422521, DOI 10.1023/A:1022622422521]; Hassan N., 2007, ROOTS TERRORISM; Henrich J., BEHAV BRAIN IN PRESS; Hoffman M. L., 2001, EMPATHY MORAL DEV IM; Jackson M, 2000, THESIS; Juergensmeyer M., 2000, TERROR MIND GOD; Keltner D, 1997, PSYCHOL BULL, V122, P250, DOI 10.1037/0033-2909.122.3.250; Klein D C, 1991, J Prim Prev, V12, P93, DOI 10.1007/BF02015214; Leary MR, 2006, PERS SOC PSYCHOL REV, V10, P111, DOI 10.1207/s15327957pspr1002_2; Leary MR, 1998, J PERS SOC PSYCHOL, V74, P1290, DOI 10.1037/0022-3514.74.5.1290; Leary MR, 2003, AGGRESSIVE BEHAV, V29, P202, DOI 10.1002/ab.10061; Lerner JS, 2003, PSYCHOL SCI, V14, P144, DOI 10.1111/1467-9280.01433; Lindner, 2006, MAKING ENEMIES HUMIL; Lindner E. G., 2002, PEACE CONFLICT J PEA, V8, P125, DOI DOI 10.1207/S15327949PAC0802_02; MacDonald G, 2005, PSYCHOL BULL, V131, P202, DOI 10.1037/0033-2909.131.2.202; Mackie D.M., 2015, APA HDB PERSONALITY, P263, DOI [10.1037/14342-010, DOI 10.1037/14342-010]; Mackie D. M., 2009, HDB PREJUDICE STEREO, P285; Mackie DM, 2000, J PERS SOC PSYCHOL, V79, P602, DOI 10.1037//0022-3514.79.4.602; Medin DL, 2004, PSYCHOL REV, V111, P960, DOI 10.1037/0033-295x.111.4.960; Mikula G, 1998, PERS SOC PSYCHOL B, V24, P769, DOI 10.1177/0146167298247009; Miller William Ian, 1993, HUMILIATION OTHER ES; Moghadam A, 2006, STUD CONFL TERROR, V29, P707, DOI 10.1080/10576100600561907; Montada L., 1988, SOC JUSTICE RES, V3, P313, DOI [10.1007/BF01048081, DOI 10.1007/BF01048081]; Mosquera PMR, 2002, J CROSS CULT PSYCHOL, V33, P16, DOI 10.1177/0022022102033001002; Murphy K, 2009, SOC JUSTICE RES, V22, P1, DOI 10.1007/s11211-008-0086-8; Rodriguez Mosquera P, 2008, COGNITION EMOTION, V22, P1471, DOI 10.1080/02699930701822272; Scheff T.J., 1987, ROLE SHAME SYMPTOM F, P109; Scheff Thomas J., 2000, J MUNDANE BEHAV, V1, P303; SHAVER P, 1987, J PERS SOC PSYCHOL, V52, P1061, DOI 10.1037//0022-3514.52.6.1061; SILVER M, 1986, J THEOR SOC BEHAV, V16, P269, DOI 10.1111/j.1468-5914.1986.tb00080.x; Small DA, 2006, POLIT PSYCHOL, V27, P289, DOI 10.1111/j.1467-9221.2006.00007.x; SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813; Stanton J. M., 2006, 13007 SYR U SCH INF; STEINBERG BS, 1991, POLIT PSYCHOL, V12, P653, DOI 10.2307/3791551; Stern J., 2003, TERROR NAME GOD WHY, DOI [10.2307/20033801, DOI 10.2307/20033801]; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Tangney J.P., 1999, HDB COGNITION EMOTIO, P541, DOI DOI 10.1002/0470013494.CH26; Tangney J.P., 2003, SHAME GUILT; Tangney J.P, 2007, SELF CONSCIOUS EMOTI, P310; Tangney JP, 1996, J PERS SOC PSYCHOL, V70, P1256, DOI 10.1037/0022-3514.70.6.1256; TANGNEY JP, 1992, J PERS SOC PSYCHOL, V62, P669, DOI 10.1037/0022-3514.62.4.669; Tracy JL, 2004, PSYCHOL SCI, V15, P194, DOI 10.1111/j.0956-7976.2004.01503008.x; van Zomeren M, 2004, J PERS SOC PSYCHOL, V87, P649, DOI 10.1037/0022-3514.87.5.649; VOGEL W, 1990, CONTEMP FAM THER, V12, P139, DOI 10.1007/BF00892492; Wallace C., 2004, 13006 SYR U SCH INF; Weiss HM, 1999, J APPL PSYCHOL, V84, P786, DOI 10.1037/0021-9010.84.5.786; Yzerbyt V, 2003, BRIT J SOC PSYCHOL, V42, P533, DOI 10.1348/014466603322595266	67	37	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46375	10.1371/journal.pone.0046375	http://dx.doi.org/10.1371/journal.pone.0046375			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029499	Green Submitted, gold, Green Published			2022-12-27	WOS:000309973900146
J	Wong, MCS; Wang, HHX; Wong, SYS; Wei, XL; Yang, N; Zhang, ZZ; Li, HT; Gao, Y; Li, DKT; Tang, JL; Wang, JJ; Griffiths, SM				Wong, Martin C. S.; Wang, Harry H. X.; Wong, Samuel Y. S.; Wei, Xiaolin; Yang, Nan; Zhang, Zhenzhen; Li, Haitao; Gao, Yang; Li, Donald K. T.; Tang, JinLing; Wang, Jiaji; Griffiths, Sian M.			Performance Comparison among the Major Healthcare Financing Systems in Six Cities of the Pearl River Delta Region, Mainland China	PLOS ONE			English	Article							REFORM	Background: The healthcare system of mainland China is undergoing drastic reform and the optimal models for healthcare financing for provision of primary care will need to be identified. This study compared the performance indicators of the community health centres (CHCs) under different healthcare financing systems in the six cities of the Pearl River Delta region. Methods: Approximately 300 hypertensive patients were randomly recruited from the computerized chronic disease management records provided by one CHC in each of the six cities in 2011 using a multi-stage cluster random sampling method. The major outcome measures included the treatment rate of hypertension, defined as prescription of >= one antihypertensive agent; and the control rate of hypertension, defined as systolic blood pressure levels <140 mmHg and diastolic blood pressure levels <90 mmHg in patients without diabetes mellitus, or <130/80 mmHg among patients with concomitant diabetes. Binary logistic regression analyses were conducted with these two measures as outcome variables, respectively, controlling for patients' socio-demographic variables. The financing system (Hospital-vs. Government-vs. private-funded) was the independent variable tested for association with the outcomes. Results: From 1,830 patients with an average age of 65.9 years (SD 12.8), the overall treatment and control rates were 75.4% and 20.2%, respectively. When compared with hospital-funded CHCs, patients seen in the Government-funded (adjusted odds ratio [AOR] 0.462, 95% C.I. 0.325-0.656) and private-funded CHCs (AOR 0.031, 95% C.I. 0.019-0.052) were significantly less likely to be prescribed antihypertensive medication. However, the Government-funded CHC was more likely to have optimal BP control (AOR 1.628, 95% C.I. 1.157-2.291) whilst the privately-funded CHC was less likely to achieve BP control (AOR 0.146, 95% C.I. 0.069-0.310), irrespective of whether antihypertensive drugs were prescribed. Conclusions: Privately-funded CHCs had the lowest rates of BP treatment and control due to a variety of potential factors as discussed.	[Wong, Martin C. S.; Wang, Harry H. X.; Wong, Samuel Y. S.; Wei, Xiaolin; Yang, Nan; Zhang, Zhenzhen; Li, Haitao; Gao, Yang; Tang, JinLing; Griffiths, Sian M.] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Fac Med, Hong Kong, Hong Kong, Peoples R China; [Li, Donald K. T.] Bauhinia Fdn Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Wang, Jiaji] Guangzhou Med Univ, Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China	Chinese University of Hong Kong; Guangzhou Medical University	Griffiths, SM (corresponding author), Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Fac Med, Hong Kong, Hong Kong, Peoples R China.	siangriffiths@cuhk.edu.hk	Yang, Yanae/C-6536-2014; WONG, Samuel Yeung Shan/D-7311-2013; Tang, JL/G-1759-2013; WANG, Jia Ji/E-9059-2015; Wang, Harry H.X./E-9027-2015; Wong, Martin/L-4568-2014; Wei, Xiaolin/H-5364-2013	WONG, Samuel Yeung Shan/0000-0003-0934-6385; Wang, Harry H.X./0000-0002-0361-6527; Wong, Martin/0000-0001-7706-9370; Gao, Yang (Gemma)/0000-0003-0439-4804	Bauhinia Foundation Research Centre, Hong Kong	Bauhinia Foundation Research Centre, Hong Kong	This study was funded by the Bauhinia Foundation Research Centre, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, 2010 MAIN SOC EC IND; [Anonymous], 2007, 14 GUANGD GOV; [Anonymous], 2007, 75 GUANGD GOV; [Anonymous], 2008, 63 GUANGD GOV; [Anonymous], 2008, 11 5 YEAR PLAN 2007, V2; [Anonymous], 2007, 96 DONGG GOV; [Anonymous], 2009, 9 STAT COUNC; [Anonymous], 2012, CHANG LANDSC CHIN PH; [Anonymous], 2010, 71 DONGG GOV; [Anonymous], 2002, 107 ZHUH GOV; [Anonymous], 2010, SCHEM IMPR COMM HEAL; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Commonwealth of Australia, 2011, IMPR PRIM HLTH CAR A; Guthrie B, 2007, BMJ-BRIT MED J, V335, P542, DOI 10.1136/bmj.39259.400069.AD; Hsiao WCL, 1996, NEW ENGL J MED, V335, P430, DOI 10.1056/NEJM199608083350611; Lawrence M., 1997, EUR J GEN PRACT, V3, P103, DOI DOI 10.3109/13814789709160336; Ma WJ, 2012, AM J HYPERTENS, V25, P590, DOI 10.1038/ajh.2012.11; Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149; McGlynn EA, 1998, AM J PREV MED, V14, P14, DOI 10.1016/S0749-3797(97)00032-9; Meads G, 2006, HEALTH SERV MANAG RE, V19, P166, DOI 10.1258/095148406777888125; Prince MJ, 2012, J HYPERTENS, V30, P177, DOI 10.1097/HJH.0b013e32834d9eda; Rasella D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-380; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Starfield B, 2008, NEW ENGL J MED, V359, P2087, DOI 10.1056/NEJMp0805763; WHO, 1988, ALM AT YEAR 2000 REF; WHO, 2008, PHARMAFORUM 0121; Zhao DY, 2011, FUDAN J SOCIAL SCI, V3, P88; Zhao XS, 2012, AM J HYPERTENS, V25, P583, DOI 10.1038/ajh.2012.9	29	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46309	10.1371/journal.pone.0046309	http://dx.doi.org/10.1371/journal.pone.0046309			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029474	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000309973900131
J	Zhang, H; Yu, CH; Jiang, YP; Peng, C; He, K; Tang, JY; Xin, HL				Zhang, Hong; Yu, Cheng-Hao; Jiang, Yi-Ping; Peng, Cheng; He, Kun; Tang, Jian-Yuan; Xin, Hai-Liang			Protective Effects of Polydatin from Polygonum cuspidatum against Carbon Tetrachloride-Induced Liver Injury in Mice	PLOS ONE			English	Article							NF-KAPPA-B; INDUCED OXIDATIVE STRESS; EXTRACT; RATS; ACTIVATION; FIBROSIS; REGENERATION; INFLAMMATION; HEPATITIS; CARCINOMA	Polydatin is one of main compounds in Polygonum cuspidatum, a plant with both medicinal and nutritional value. The possible hepatoprotective effects of polydatin on acute liver injury mice induced by carbon tetrachloride (CCl4) and the mechanisms involved were investigated. Intraperitoneal injection of CCl4 (50 ml/kg) resulted in a significant increase in the levels of serum aspartate aminotransferase (AST), alanine aminotransferase (ALT) and hepatic malondialdehyde (MDA), also a marked enhancement in the expression of hepatic tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS) and nuclearfactor-kappa B (NF-kappa B). On the other hand, decreased glutathione (GSH) content and activities of glutathione transferase (GST), superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) were observed following CCl4 exposure. Nevertheless, all of these phenotypes were evidently reversed by preadministration of polydatin for 5 continuous days. The mRNA and protein expression levels of hepatic growth factor-beta1 (TGF-beta(1)) were enhanced further by polydatin. These results suggest that polydatin protects mice against CCl4-induced liver injury through antioxidant stress and antiinflammatory effects. Polydatin may be an effective hepatoprotective agent and a promising candidate for the treatment of oxidative stress-and inflammation-related diseases.	[Zhang, Hong; Yu, Cheng-Hao; Peng, Cheng] Chengdu Univ Tradit Chinese Med, Key Lab Standardizat Chinese Herbal Med, Minist Educ, Coll Pharm, Chengdu, Peoples R China; [Zhang, Hong; Jiang, Yi-Ping; He, Kun] Second Mil Med Univ, Sch Pharm, Dept Pharmacognosy, Shanghai, Peoples R China; [Tang, Jian-Yuan] State Food & Drug Adm, Ctr Drug Evaluat, Beijing, Peoples R China; [Xin, Hai-Liang] Second Mil Med Univ, Dept Tradit Chinese Med, Changhai Hosp, Shanghai, Peoples R China	Chengdu University of Traditional Chinese Medicine; Naval Medical University; Naval Medical University	Peng, C (corresponding author), Chengdu Univ Tradit Chinese Med, Key Lab Standardizat Chinese Herbal Med, Minist Educ, Coll Pharm, Chengdu, Peoples R China.	pengchengchengdu@126.com; tangjianyuan163@163.com; hailiangxin@163.com		Peng, Cheng/0000-0003-3303-906X; zhang, hong/0000-0002-6191-0046	National Natural Science Foundation of China [81173462]; Open Research Fund of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources [2011012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Research Fund of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources	This work was supported by the National Natural Science Foundation of China (81173462) and the Open Research Fund of State Key Laboratory Breeding Base of Systematic Research, Development and Utilization of Chinese Medicine Resources (2011012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breitkopf K, 2006, Z GASTROENTEROL, V44, P57, DOI 10.1055/s-2005-858989; Campo GM, 2008, BRIT J PHARMACOL, V155, P945, DOI 10.1038/bjp.2008.338; Chang JS, 2005, ANTIVIR RES, V66, P29, DOI 10.1016/j.antiviral.2004.12.006; Du J, 2009, PHYTOMEDICINE, V16, P652, DOI 10.1016/j.phymed.2008.10.001; Fakurazi S, 2008, FOOD CHEM TOXICOL, V46, P2611, DOI 10.1016/j.fct.2008.04.018; Fei HongHua, 2008, Journal of Shandong University (Health Sciences), V46, P43; GOLDBERG DM, 1965, GASTROENTEROLOGY, V49, P256; Gopal N, 2008, FITOTERAPIA, V79, P24, DOI 10.1016/j.fitote.2007.07.006; Gross A, 2009, CHEM-BIOL INTERACT, V178, P56, DOI 10.1016/j.cbi.2008.09.025; He YD, 2012, BRIT J DERMATOL, V167, P941, DOI 10.1111/j.1365-2133.2012.10951.x; Huang B, 2010, FOOD CHEM, V120, P873, DOI 10.1016/j.foodchem.2009.11.020; Huang ZS, 1999, WORLD J GASTROENTERO, V5, P41; Ji H, 2012, BRAIN RES BULL, V87, P50, DOI 10.1016/j.brainresbull.2011.09.021; Jia XY, 2011, FOOD CHEM, V125, P673, DOI 10.1016/j.foodchem.2010.09.062; Kanzler S, 1999, AM J PHYSIOL-GASTR L, V276, pG1059, DOI 10.1152/ajpgi.1999.276.4.G1059; Kim HY, 2011, TOXICOLOGY, V282, P104, DOI 10.1016/j.tox.2011.01.017; Kim KW, 2007, VASC PHARMACOL, V47, P99, DOI 10.1016/j.vph.2007.04.007; Li L, 2013, EXP TOXICOL PATHOL, V65, P73, DOI 10.1016/j.etp.2011.06.003; Li RP, 2012, PHYTOMEDICINE, V19, P677, DOI 10.1016/j.phymed.2012.03.002; Liu HH, 2011, J CELL BIOCHEM, V112, P3695, DOI 10.1002/jcb.23303; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Mehmetcik G, 2008, EXP TOXICOL PATHOL, V60, P475, DOI 10.1016/j.etp.2008.04.014; Miao Q, 2011, PHYTOMEDICINE, V19, P8, DOI 10.1016/j.phymed.2011.06.023; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Pan YM, 2007, FOOD CHEM, V105, P1518, DOI 10.1016/j.foodchem.2007.05.039; Ray Gibanananda, 2002, Indian Journal of Experimental Biology, V40, P1213; Recknagel R.O., 2020, HEPATOTOXICOLOGY, P401; RECKNAGEL RO, 1989, PHARMACOL THERAPEUT, V43, P139, DOI 10.1016/0163-7258(89)90050-8; REJ R, 1978, CLIN CHEM, V24, P1971; Rosillo MA, 2011, BIOCHEM PHARMACOL, V82, P737, DOI 10.1016/j.bcp.2011.06.043; Shan B, 2008, FOOD CHEM, V109, P530, DOI 10.1016/j.foodchem.2007.12.064; Shu SY, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-31; Simpson KJ, 1997, J HEPATOL, V27, P1120, DOI 10.1016/S0168-8278(97)80160-2; Singh N, 2008, ENVIRON TOXICOL PHAR, V26, P241, DOI 10.1016/j.etap.2008.05.006; Srivastava A, 2010, FOOD CHEM, V118, P411, DOI 10.1016/j.foodchem.2009.05.014; Taniguchi M, 2004, LIFE SCI, V75, P1539, DOI 10.1016/j.lfs.2004.02.030; Tipoe GL, 2010, TOXICOLOGY, V273, P45, DOI 10.1016/j.tox.2010.04.014; Tung YT, 2009, FOOD CHEM TOXICOL, V47, P1385, DOI 10.1016/j.fct.2009.03.021; Venukumar M R, 2002, Indian J Clin Biochem, V17, P80, DOI 10.1007/BF02867976; Weerachayaphorn J, 2010, J ETHNOPHARMACOL, V129, P254, DOI 10.1016/j.jep.2010.03.026; WILLIAMS AT, 1990, SEMIN LIVER DIS, V10, P279, DOI 10.1055/s-2008-1040483; Wu JG, 2009, PHYTOMEDICINE, V16, P1033, DOI 10.1016/j.phymed.2009.04.005; Xiao J, 2012, J ETHNOPHARMACOL, V139, P462, DOI 10.1016/j.jep.2011.11.033; Xing WW, 2009, BIOMED PHARMACOTHER, V63, P457, DOI 10.1016/j.biopha.2008.06.035; Yang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021971; Yener Z, 2009, FOOD CHEM TOXICOL, V47, P418, DOI 10.1016/j.fct.2008.11.031; Zhang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031157; Zhang RR, 2009, J ETHNOPHARMACOL, V126, P207, DOI 10.1016/j.jep.2009.08.044	48	78	86	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46574	10.1371/journal.pone.0046574	http://dx.doi.org/10.1371/journal.pone.0046574			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029551	Green Submitted, gold, Green Published			2022-12-27	WOS:000309973900185
J	Zou, HS; Gowda, S; Zhou, LJ; Hajeri, S; Chen, GY; Duan, YP				Zou, Huasong; Gowda, Siddarame; Zhou, Lijuan; Hajeri, Subhas; Chen, Gongyou; Duan, Yongping			The Destructive Citrus Pathogen, 'Candidatus Liberibacter asiaticus' Encodes a Functional Flagellin Characteristic of a Pathogen-Associated Molecular Pattern	PLOS ONE			English	Article							SINORHIZOBIUM-MELILOTI; DEFENSE RESPONSE; GREENING DISEASE; PLANT DEFENSE; PERCEPTION; GENES; IDENTIFICATION; ARABIDOPSIS; FLG22; FLS2	Huanglongbing (HLB) is presently the most devastating citrus disease worldwide. As an intracellular plant pathogen and insect symbiont, the HLB bacterium, 'Candidatus Liberibacter asiaticus' (Las), retains the entire flagellum-encoding gene cluster in its significantly reduced genome. Las encodes a flagellin and hook-associated protein (Fla) of 452 amino acids that contains a conserved 22 amino acid domain (flg22) at positions 29 to 50 in the N-terminus. The phenotypic alteration in motility of a Sinorhizobium meliloti mutant lacking the fla genes was partially restored by constitutive expression of Fla(Las). Agrobacterium-mediated transient expression in planta revealed that Fla(Las) induced cell death and callose deposition in Nicotiana benthamiana, and that the transcription of BAK1 and SGT1, which are associated with plant innate immunity, was upregulated. Amino acid substitution experiments revealed that residues 38 (serine) and 39 (aspartate) of Fla(Las) were essential for callose induction. The synthetic flg22(Las) peptide could not induce plant cell death but retained the ability to induce callose deposition at a concentration of 20 mu M or above. This demonstrated that the pathogen-associated molecular pattern (PAMP) activity of flg22 in Las was weaker than those in other well-studied plant pathogenic bacteria. These results indicate that Fla(Las) acts as a PAMP and may play an important role in triggering host plant resistance to the HLB bacteria.	[Zou, Huasong; Zhou, Lijuan; Duan, Yongping] USDA ARS, US Hort Res Lab, Ft Pierce, FL USA; [Gowda, Siddarame; Hajeri, Subhas] Univ Florida, Citrus Res & Educ Ctr, Inst Food & Agr Sci, Lake Alfred, FL USA; [Zhou, Lijuan] Univ Florida, Indian River Res & Educ Ctr, Ft Pierce, FL USA; [Zou, Huasong; Chen, Gongyou] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China	United States Department of Agriculture (USDA); State University System of Florida; University of Florida; State University System of Florida; University of Florida; Shanghai Jiao Tong University	Duan, YP (corresponding author), USDA ARS, US Hort Res Lab, Ft Pierce, FL USA.	Yongping.Duan@ars.usda.gov	CHEN, Gongyou/AAA-9694-2019; Hajeri, Subhas/E-8180-2018; Zhou, Li/GSE-4531-2022; Zou, Huasong/GLN-3569-2022	CHEN, Gongyou/0000-0003-1979-2880; Hajeri, Subhas/0000-0002-5993-118X; Zou, Huasong/0000-0001-5758-1975	United States Department of Agriculture; Citrus Research and Development Foundation [312, 162]	United States Department of Agriculture(United States Department of Agriculture (USDA)); Citrus Research and Development Foundation	Funding provided by United States Department of Agriculture and Citrus Research and Development Foundation grant #162 and #312. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bove JM, 2006, J PLANT PATHOL, V88, P7; Chakravarthy S, 2010, MOL PLANT MICROBE IN, V23, P715, DOI 10.1094/MPMI-23-6-0715; Che FS, 2000, J BIOL CHEM, V275, P32347, DOI 10.1074/jbc.M004796200; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Cornelis P, 2011, MICROBIOL-SGM, V157, P1251, DOI 10.1099/mic.0.049635-0; DAGRACA JV, 1991, ANNU REV PHYTOPATHOL, V29, P109, DOI 10.1146/annurev.py.29.090191.000545; Denoux C, 2008, MOL PLANT, V1, P423, DOI 10.1093/mp/ssn019; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FINAN TM, 1986, J BACTERIOL, V167, P66, DOI 10.1128/jb.167.1.66-72.1986; Folimonova SY, 2010, PHYTOPATHOLOGY, V100, P949, DOI 10.1094/PHYTO-100-9-0949; Folimonova SY, 2009, PHYTOPATHOLOGY, V99, P1346, DOI 10.1094/PHYTO-99-12-1346; Ginger ML, 2008, NAT REV MICROBIOL, V6, P838, DOI 10.1038/nrmicro2009; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Koh EJ, 2012, PROTOPLASMA, V249, P687, DOI 10.1007/s00709-011-0312-3; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lacomme C, 2008, CURR PROTOC MICROBIO, p16I11; Lin H, 2011, PLOS ONE, V6; Liu Y, 2010, CHINESE SCI BULL, V55, P259, DOI 10.1007/s11434-009-0721-2; Lu HY, 2010, MICROBIOL-SGM, V156, P2092, DOI 10.1099/mic.0.038547-0; Lyle S., 2012, CITRUS DIS HUANGLONG; Naito K, 2008, MOL PLANT MICROBE IN, V21, P1165, DOI 10.1094/MPMI-21-9-1165; Nurnberger T, 2001, TRENDS PLANT SCI, V6, P372, DOI 10.1016/S1360-1385(01)02019-2; Robatzek S, 2007, PLANT MOL BIOL, V64, P539, DOI 10.1007/s11103-007-9173-8; Rybak M, 2009, MOL PLANT PATHOL, V10, P249, DOI 10.1111/j.1364-3703.2008.00528.x; Sambrook J., 2001, MOL CLONING LAB MANU; Scharf B, 2001, J BACTERIOL, V183, P5334, DOI 10.1128/JB.183.18.5334-5342.2001; SCHNEIDER H, 1968, PHYTOPATHOLOGY, V58, P1155; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Taguchi F, 2003, PLANT PHYSIOL BIOCH, V41, P165, DOI 10.1016/S0981-9428(02)00018-9; Takai R, 2008, MOL PLANT MICROBE IN, V21, P1635, DOI 10.1094/MPMI-21-12-1635; Teixeira DD, 2005, MOL CELL PROBE, V19, P173, DOI 10.1016/j.mcp.2004.011.002; Tsai CH, 2008, BOT STUD, V49, P49; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Zhao XY, 1981, P INT SOC CITRICULTU, V1, P466	42	32	36	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46447	10.1371/journal.pone.0046447	http://dx.doi.org/10.1371/journal.pone.0046447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029520	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900161
J	Xie, XJ; Lu, H; Moorleghen, JJ; Howatt, DA; Rateri, DL; Cassis, LA; Daugherty, A				Xie, Xiaojie; Lu, Hong; Moorleghen, Jessica J.; Howatt, Deborah A.; Rateri, Debra L.; Cassis, Lisa A.; Daugherty, Alan			Doxycycline Does Not Influence Established Abdominal Aortic Aneurysms in Angiotensin II-Infused Mice	PLOS ONE			English	Article							E-DEFICIENT MICE; ATHEROSCLEROTIC LESIONS; MATRIX METALLOPROTEINASES; CLINICAL-TRIAL; INHIBITION; GROWTH; MODEL; LOCALIZATION; DEGENERATION; SUPPRESSION	Background: There is no proven medical approach to attenuating expansion and rupture of abdominal aortic aneurysms (AAAs). One approach that is currently being investigated is the use of doxycycline. Despite being primarily used as an antimicrobial drug, doxycycline has been proposed to function in reducing AAA expansion. Doxycycline is effective in reducing the formation in the most commonly used mouse models of AAAs when administered prior to the initiation of the disease. The purpose of the current study was to determine the effects of doxycycline on established AAAs when it was administered at a dose that produces therapeutic serum concentrations. Methods and Results: LDL receptor (-)/(-) male mice fed a saturated-fat supplemented diet were infused with AngII (1,000 ng/kg/min) via mini-osmotic pumps for 28 days. Upon verification of AAA formation by noninvasive high frequency ultrasonography, mice were stratified based on aortic lumen diameters, and continuously infused with AngII while also administered either vehicle or doxycycline (100 mg/kg/day) in drinking water for 56 days. Administration of doxycycline led to serum drug concentrations of 2.3 +/- 0.6 mu g/ml. Doxycycline administration had no effect on serum cholesterol concentrations and systolic blood pressures. Doxycycline administration did not prevent progressive aortic dilation as determined by temporal measurements of lumen dimensions using high frequency ultrasound. This lack of effect on AAA regression and progression was confirmed at the termination of the study by ex vivo measurements of maximal width of suprarenal aortas and AAA volumes. Also, doxycycline did not reduce AAA rupture. Medial and adventitial remodeling was not overtly changed by doxycycline as determined by immunostaining and histological staining. Conclusions: Doxycycline administration did not influence AngII-induced AAA progression and aortic rupture when administered to mice with established AAAs.	[Xie, Xiaojie; Lu, Hong; Moorleghen, Jessica J.; Howatt, Deborah A.; Rateri, Debra L.; Daugherty, Alan] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA; [Xie, Xiaojie] Zhejiang Univ, Coll Med, Dept Cardiol,Affiliated Hosp 2, Key Lab Diag & Treatment Cardiovasc Dis Zhejiang, Hangzhou 310003, Zhejiang, Peoples R China; [Cassis, Lisa A.; Daugherty, Alan] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY USA	University of Kentucky; Zhejiang University; University of Kentucky	Daugherty, A (corresponding author), Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY 40536 USA.	Alan.Daugherty@uky.edu	Daugherty, Alan/C-8282-2009; Lu, Hong S./ABH-3929-2020; Lu, Hong Shen/C-4626-2015	Daugherty, Alan/0000-0003-2093-3775; Lu, Hong Shen/0000-0002-0577-2558; Xie, Xiaojie/0000-0001-8421-2737	National Institutes of Health [HL80100, HL70239]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080100, R01HL070239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research work was supported by grants from the National Institutes of Health (HL80100 and HL70239). The funders had no role in the study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Axisa B, 2000, J CHROMATOGR B, V744, P359, DOI 10.1016/S0378-4347(00)00261-9; Barisione C, 2006, J VASC SURG, V44, P372, DOI 10.1016/j.jvs.2006.04.047; Bartoli MA, 2006, ANN VASC SURG, V20, P228, DOI 10.1007/s10016-006-9017-z; Baxter BT, 2008, CIRCULATION, V117, P1883, DOI 10.1161/CIRCULATIONAHA.107.735274; Baxter BT, 2002, J VASC SURG, V36, P1, DOI 10.1067/mva.2002.125018; Choke E, 2005, EUR J VASC ENDOVASC, V30, P227, DOI 10.1016/j.ejvs.2005.03.009; Curci JA, 1998, J VASC SURG, V28, P1082, DOI 10.1016/S0741-5214(98)70035-7; Curci JA, 1998, J CLIN INVEST, V102, P1900, DOI 10.1172/JCI2182; DAUGHERTY A, 1994, ARTERIOSCLER THROMB, V14, P2017, DOI 10.1161/01.ATV.14.12.2017; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; DAUGHERTY A, 2009, J VIS EXP, V1291; Daugherty A, 2011, J ZHEJIANG UNIV-SC B, V12, P624, DOI 10.1631/jzus.B1101002; Fontaine V, 2002, AM J PATHOL, V161, P1701, DOI 10.1016/S0002-9440(10)64447-1; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Kaito K, 2003, SURG TODAY, V33, P426, DOI 10.1007/s10595-002-2513-0; Lindeman JHN, 2009, CIRCULATION, V119, P2209, DOI 10.1161/CIRCULATIONAHA.108.806505; Longo GM, 2005, SURGERY, V137, P457, DOI 10.1016/j.surg.2004.12.004; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Lu Hong, 2007, V139, P77; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Mao DL, 1999, BIOCHEM BIOPH RES CO, V261, P904, DOI 10.1006/bbrc.1999.1142; Mosorin M, 2001, J VASC SURG, V34, P606, DOI 10.1067/mva.2001.117891; NEWMAN KM, 1994, J VASC SURG, V20, P814, DOI 10.1016/S0741-5214(94)70169-5; Pearce WH, 2006, ANN NY ACAD SCI, V1085, P117, DOI 10.1196/annals.1383.025; Petrinec D, 1996, ANN NY ACAD SCI, V800, P263, DOI 10.1111/j.1749-6632.1996.tb33326.x; Petrinec D, 1996, J VASC SURG, V23, P336, DOI 10.1016/S0741-5214(96)70279-3; Powell JT, 2011, BRIT J SURG, V98, P609, DOI 10.1002/bjs.7465; Prall AK, 2002, J VASC SURG, V35, P923, DOI 10.1067/mva.2002.123757; Pyo R, 2000, J CLIN INVEST, V105, P1641, DOI 10.1172/JCI8931; Rateri DL, 2011, AM J PATHOL, V179, P1542, DOI 10.1016/j.ajpath.2011.05.049; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Sho E, 2004, J VASC SURG, V39, P1312, DOI 10.1016/j.jvs.2004.01.036; Thompson RW, 1999, ANN NY ACAD SCI, V878, P159, DOI 10.1111/j.1749-6632.1999.tb07682.x; Turner GH, 2008, CIRC-CARDIOVASC IMAG, V1, P220, DOI 10.1161/CIRCIMAGING.108.787358; Uchida HA, 2010, ATHEROSCLEROSIS, V211, P399, DOI 10.1016/j.atherosclerosis.2010.02.034; Wang Y. X., 2006, HDB MOUSE MODELS CAR, V125; Wilson WRW, 2006, CIRCULATION, V113, P438, DOI 10.1161/CIRCULATIONAHA.105.551572; Xiong WF, 2009, J BIOL CHEM, V284, P1765, DOI 10.1074/jbc.M806239200; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335	42	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46411	10.1371/journal.pone.0046411	http://dx.doi.org/10.1371/journal.pone.0046411			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029514	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500102
J	Gaskins, AJ; Mumford, SL; Chavarro, JE; Zhang, CL; Pollack, AZ; Wactawski-Wende, J; Perkins, NJ; Schisterman, EF				Gaskins, Audrey J.; Mumford, Sunni L.; Chavarro, Jorge E.; Zhang, Cuilin; Pollack, Anna Z.; Wactawski-Wende, Jean; Perkins, Neil J.; Schisterman, Enrique F.			The Impact of Dietary Folate Intake on Reproductive Function in Premenopausal Women: A Prospective Cohort Study	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; MARGINAL STRUCTURAL MODELS; MENSTRUAL-CYCLE; FOLIC-ACID; FOOD FORTIFICATION; PREVENTION; FERTILITY; SUPPLEMENTATION; BIOAVAILABILITY; BIOCYCLE	Background: Folic acid is recommended to reproductive-aged women to prevent birth defects, though little is known about the effects of dietary intake on other reproductive outcomes. Improved pregnancy rates have been documented after folic acid supplement use, suggesting a possible link with ovulation, however research is limited. Our objective was to evaluate the association between dietary folate intake, hormone levels, and sporadic anovulation in healthy, regularly menstruating women. Methodology/Principal Findings: The BioCycle study (2005-2007) prospectively followed 259 healthy women aged 18-44 years from the western New York region for up to 2 menstrual cycles. Total folate and specific sources of folate were assessed up to 4 times per cycle by 24-hour recall. Estradiol, progesterone, luteinizing hormone, and follicle-stimulating hormone were measured in serum up to 8 times per cycle, timed using fertility monitors. Anovulation was defined as a cycle with peak progesterone concentration <= 5 ng/mL and no LH peak in the mid/late luteal phase. Higher intake of dietary folate (in dietary equivalents) across tertiles had a marginally significant association with greater luteal progesterone levels (P trend 0.08). Higher intake of synthetic folate was significantly associated with higher luteal progesterone levels (P trend 0.05). Specifically, women in the 3rd tertile of synthetic folate intake had, on average, 16.0% (95% CI, 0.5-33.8%) higher luteal progesterone levels compared to women in the 1st tertile. Moreover, consumption of synthetic folate was significantly and inversely associated with anovulation such that women in the 3rd tertile had a 64% (95% CI, 8-86%) decreased odds of anovulation compared to the women in the 1st tertile (P trend 0.03). Conclusions/Significance: These findings suggest that a diet high in synthetic folate may be associated with increased progesterone levels and lower risk of sporadic anovulation. Further study of the effect of dietary folate and folic acid supplement use on reproductive health is warranted.	[Gaskins, Audrey J.; Mumford, Sunni L.; Zhang, Cuilin; Pollack, Anna Z.; Perkins, Neil J.; Schisterman, Enrique F.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Epidemiol Stat & Prevent Res, Rockville, MD USA; [Gaskins, Audrey J.; Chavarro, Jorge E.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Chavarro, Jorge E.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Chavarro, Jorge E.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Chavarro, Jorge E.] Harvard Univ, Sch Med, Boston, MA USA; [Wactawski-Wende, Jean] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Schisterman, EF (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Epidemiol Stat & Prevent Res, Rockville, MD USA.	schistee@mail.nih.gov	Wactawski-Wende, Jean/AGH-5457-2022; Chavarro, Jorge E/AAE-5665-2021; Gaskins, Audrey/K-6246-2019; Pollack, Anna/L-7652-2018	Wactawski-Wende, Jean/0000-0003-3096-9595; Chavarro, Jorge E/0000-0002-4436-9630; Perkins, Neil/0000-0002-6802-4733; Mumford, Sunni/0000-0003-0133-3176; Schisterman, Enrique/0000-0003-3757-641X; Zhang, Cuilin/0000-0002-8014-2708; Pollack, Anna/0000-0002-4313-3298	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health; Harvard Nutrition Department NIH [T32DK007703-16]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007703] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Harvard Nutrition Department NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The BioCycle Study was funded by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. Audrey J. Gaskins is funded by the Harvard Nutrition Department NIH Training Grant T32DK007703-16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baily LB, 1998, NUTR REV, V56, P294, DOI 10.1111/j.1753-4887.1998.tb01662.x; Browne RW, 2009, CLIN CHEM, V55, P1245, DOI 10.1373/clinchem.2008.122101; Chavarro JE, 2008, FERTIL STERIL, V89, P668, DOI 10.1016/j.fertnstert.2007.03.089; Chen LT, 2004, NUTR REV, V62, pS40, DOI 10.1301/nr.2004.jun.S40-S43; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; Czeizel AE, 1996, INT J VITAM NUTR RES, V66, P55; Ebisch IMW, 2007, HUM REPROD UPDATE, V13, P163, DOI 10.1093/humupd/dml054; FLEGAL KM, 1991, AM J EPIDEMIOL, V134, P1233, DOI 10.1093/oxfordjournals.aje.a116026; Food and Drug Administration, 1996, FED REGISTER, V61, P8781; Forges T, 2007, HUM REPROD UPDATE, V13, P225, DOI 10.1093/humupd/dml063; Gaskins AJ, 2009, AM J CLIN NUTR, V90, P1061, DOI 10.3945/ajcn.2009.27990; Haggarty P, 2006, LANCET, V367, P1513, DOI 10.1016/S0140-6736(06)68651-0; Hecht S, 2009, FERTIL STERIL, V91, P56, DOI 10.1016/j.fertnstert.2007.11.011; Hertrampf E, 2004, NUTR REV, V62, pS44, DOI 10.1111/j.1753-4887.2004.tb00074.x; Howards PP, 2009, AM J EPIDEMIOL, V169, P105, DOI 10.1093/aje/kwn287; Lewis CJ, 1999, AM J CLIN NUTR, V70, P198; MATTE JJ, 1984, J ANIM SCI, V59, P1020, DOI 10.2527/jas1984.5941020x; McMahon JM, 2006, COMPUT STAT DATA AN, V50, P3663, DOI 10.1016/j.csda.2005.08.008; McNulty H, 2004, P NUTR SOC, V63, P529, DOI 10.1079/PNS2004383; MOHANTY D, 1982, J NUTR, V112, P1565, DOI 10.1093/jn/112.8.1565; Mohanty D, 1976, 16 INT C HAEM KYOT J, V2, P66; Mumford SL, 2011, PAEDIATR PERINAT EP, V25, P448, DOI 10.1111/j.1365-3016.2011.01204.x; National Research Council, 1998, DIET REF INT THIAM R; Ray JG, 2004, NUTR REV, V62, pS35, DOI 10.1111/j.1753-4887.2004.tb00072.x; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Szymanski Wieslaw, 2003, Ginekol Pol, V74, P1392; Thaler CJ, 2006, AM J REPROD IMMUNOL, V55, P251, DOI 10.1111/j.1600-0897.2005.00357.x; Verkleij-Hagoort AC, 2007, EUR J CLIN NUTR, V61, P610, DOI 10.1038/sj.ejcn.1602581; Wactawski-Wende J, 2009, PAEDIATR PERINAT EP, V23, P171, DOI 10.1111/j.1365-3016.2008.00985.x; WALD N, 1991, LANCET, V338, P131; Weng HY, 2009, AM J EPIDEMIOL, V169, P1182, DOI 10.1093/aje/kwp035; Westphal L M, 2006, Clin Exp Obstet Gynecol, V33, P205; Westphal LM, 2004, J REPROD MED, V49, P289; WILLMOTT M, 1968, J ENDOCRINOL, V41, P439, DOI 10.1677/joe.0.0410439; Yang QH, 2010, AM J CLIN NUTR, V91, P64, DOI 10.3945/ajcn.2009.28401	37	35	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46276	10.1371/journal.pone.0046276	http://dx.doi.org/10.1371/journal.pone.0046276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050004	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300103
J	McDonald, JU; Rosas, M; Brown, GD; Jones, SA; Taylor, PR				McDonald, Jacqueline U.; Rosas, Marcela; Brown, Gordon D.; Jones, Simon A.; Taylor, Philip R.			Differential Dependencies of Monocytes and Neutrophils on Dectin-1, Dectin-2 and Complement for the Recognition of Fungal Particles in Inflammation	PLOS ONE			English	Article							BETA-GLUCAN RECEPTOR; C-TYPE LECTIN; CANDIDA-ALBICANS; HOST-DEFENSE; IN-VIVO; DENDRITIC CELLS; MACROPHAGES; INDUCTION; PATHWAY; HETEROGENEITY	We have re-investigated the role of the complement system and the non-opsonic pattern recognition receptors dectin-1 and dectin-2 in the recognition of fungal particles by inflammatory neutrophils, monocytes and macrophages. We have used in vivo and ex vivo models to study the recognition and response of these cells: i) We confirm previous observations regarding the importance of complement to neutrophil but not monocytic responses; ii) We show that dectin-1 is important for driving inflammatory cell recruitment to fungal stimuli and that it biases the immediate inflammatory response to one that favors neutrophil over monocyte recruitment; iii) We show that dectin-2 contributes to the physical recognition of fungal particles by inflammatory monocytes/macrophages, but is also expressed on neutrophils, where we show it has the potential to contribute to cellular activation; iv) Additionally, we show that serum-opsonization has the potential to interfere with non-opsonic recognition of fungal particles by dectin-1 and dectin-2, presumably through masking of ligands. Collectively these roles are consistent with previously described roles of dectin-1 and dectin-2 in driving inflammatory and adaptive immune responses and complement in containing fungal burdens. This study emphasizes the importance of heterogeneity of receptor expression across myeloid cell subsets in protective immune responses.	[McDonald, Jacqueline U.; Rosas, Marcela; Jones, Simon A.; Taylor, Philip R.] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, Wales; [Brown, Gordon D.] Univ Aberdeen, Inst Med Sci, Sect Infect & Immun, Aberdeen, Scotland	Cardiff University; University of Aberdeen	Taylor, PR (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, Wales.	TaylorPR@cf.ac.uk	Rosas Nexticapa, Marcela/HGU-1088-2022; Jones, Simon Arnett/Q-7017-2018	brown, gordon/0000-0002-0287-5383; Taylor, Philip/0000-0003-0163-1421; Jones, Simon Arnett/0000-0001-7297-9711	UK Medical Research Council [G0601617]; Medical Research Council; Medical Research Council funded Doctoral Training Grant PhD studentship; Wellcome Trust; MRC [G0601617] Funding Source: UKRI; Medical Research Council [G0601617] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council funded Doctoral Training Grant PhD studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the UK Medical Research Council (G0601617). JUM is the recipient of a Medical Research Council funded Doctoral Training Grant PhD studentship. GDB is supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariizumi K, 2000, J BIOL CHEM, V275, P11957, DOI 10.1074/jbc.275.16.11957; Barrett NA, 2009, J IMMUNOL, V182, P1119, DOI 10.4049/jimmunol.182.2.1119; Brereton CF, 2009, J IMMUNOL, V183, P1715, DOI 10.4049/jimmunol.0803851; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; CZOP JK, 1978, J IMMUNOL, V120, P1132; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; Dioszeghy V, 2008, J IMMUNOL, V181, P6514, DOI 10.4049/jimmunol.181.9.6514; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hara H, 2007, NAT IMMUNOL, V8, P619, DOI 10.1038/ni1466; Heinsbroek SEM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000218; Henderson RB, 2003, BLOOD, V102, P328, DOI 10.1182/blood-2002-10-3228; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Levitz SM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000758; Li X, 2011, CELL HOST MICROBE, V10, P603, DOI 10.1016/j.chom.2011.10.009; Liddiard K, 2011, EUR J IMMUNOL, V41, P2503, DOI 10.1002/eji.201141743; McDonald JU, 2011, FASEB J, V25, P1972, DOI 10.1096/fj.10-178517; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Mullaly SC, 2007, EUR J IMMUNOL, V37, P224, DOI 10.1002/eji.200636405; Plantinga TS, 2009, CLIN INFECT DIS, V49, P724, DOI 10.1086/604714; Robinson MJ, 2009, J EXP MED, V206, P2037, DOI 10.1084/jem.20082818; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; ROOS D, 1981, J IMMUNOL, V126, P433; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Rosas M, 2011, EUR J IMMUNOL, V41, P356, DOI 10.1002/eji.201040962; Rosas M, 2010, J LEUKOCYTE BIOL, V88, P169, DOI 10.1189/jlb.0809548; Saijo S, 2007, NAT IMMUNOL, V8, P39, DOI 10.1038/ni1425; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2005, EUR J IMMUNOL, V35, P2163, DOI 10.1002/eji.200425785; Taylor PR, 2004, J IMMUNOL, V172, P1157, DOI 10.4049/jimmunol.172.2.1157; Taylor PR, 2003, EUR J IMMUNOL, V33, P2090, DOI 10.1002/eji.200324003; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Tsoni SV, 2009, INFECT IMMUN, V77, P3679, DOI 10.1128/IAI.00233-09; Wells CA, 2008, J IMMUNOL, V180, P7404, DOI 10.4049/jimmunol.180.11.7404; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106	42	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45781	10.1371/journal.pone.0045781	http://dx.doi.org/10.1371/journal.pone.0045781			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049859	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000309517300053
J	Tolfvenstam, T; Norbeck, O; Ohrmalm, L				Tolfvenstam, Thomas; Norbeck, Oscar; Ohrmalm, Lars			No Evidence of Presence of Parvovirus 4 in a Swedish Cohort of Severely Immunocompromised Children and Adults	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; BLOOD-DONORS; TRANSPLANT PATIENTS; DRUG-USERS; PARV4; INFECTION; PERSISTENCE; B19; EPIDEMIOLOGY; TRANSMISSION	The recently discovered human parvovirus 4 (PARV4) has been associated with seropositivity for human immunodeficiency virus, hepatitis B virus and hepatitis C virus. High prevalence is seen especially in intravenous drug users. The virus has been detected in blood products and persons who have been repeatedly transfused have shown to be a risk-group. Furthermore, reports from different parts of the world suggesting a prevalence ranging from zero to one third of the healthy population and the virus is thought to cause a latent or persistent infection. We investigated the presence of PARV4 DNA and parvovirus B19 (B19) DNA in serum from 231 severely immunocompromised cancer patients that have been exposed for blood products. Compared to B19, which was found in 3.9% of the patients, we found no evidence of PARV4. Our results may indicate a very low prevalence of the virus in Sweden, and it would be useful to measure the real PARV4 exposure of the healthy population as well as individuals with known risk factors by serology.	[Tolfvenstam, Thomas; Norbeck, Oscar; Ohrmalm, Lars] Karolinska Inst, Dept Med, Infect Dis Unit, Ctr Mol Med,Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Ohrmalm, L (corresponding author), Karolinska Inst, Dept Med, Infect Dis Unit, Ctr Mol Med,Karolinska Univ Hosp, Stockholm, Sweden.	lars.ohrmalm@ki.se		Tolfvenstam, Thomas/0000-0003-3549-8083	Stockholm County Council; Karolinska Institutet; Swedish Society of Medicine; Clas Groschinsky foundation; Karolinska Institutet Infection Network; The Swedish Childhood Cancer Foundation	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Society of Medicine; Clas Groschinsky foundation; Karolinska Institutet Infection Network; The Swedish Childhood Cancer Foundation	Grants were received from the Stockholm County Council (www.sll.se)/Karolinska Institutet (www.ki.se), the Swedish Society of Medicine (www.sls.se), the Clas Groschinsky foundation (www.groschinsky.org), Karolinska Institutet Infection Network (www.ki.se) and from The Swedish Childhood Cancer Foundation (www.barncancerfonden.se) for method development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biagini P, 2008, EMERG INFECT DIS, V14, P1811, DOI 10.3201/eid1411.080862; Botto S, 2009, NEW MICROBIOL, V32, P189; Chen MY, 2011, EMERG INFECT DIS, V17, P1954, DOI 10.3201/eid1710.101841; Fryer JF, 2007, VOX SANG, V93, P341, DOI 10.1111/j.1423-0410.2007.00979.x; Fryer JF, 2007, TRANSFUSION, V47, P1054, DOI 10.1111/j.1537-2995.2007.01235.x; Fryer JF, 2007, EMERG INFECT DIS, V13, P175; Fryer JF, 2006, EMERG INFECT DIS, V12, P151, DOI 10.3201/eid1201.050916; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Lahtinen A, 2011, EMERG INFECT DIS, V17, P79, DOI 10.3201/eid1701.100750; Lavoie M, 2012, EMERG INFECT DIS, V18, P680, DOI 10.3201/eid1804.110628; Lindblom A, 2005, CLIN INFECT DIS, V41, P1201, DOI 10.1086/444503; Longhi E, 2007, AIDS, V21, P1481, DOI 10.1097/QAD.0b013e3281e38558; Lurcharchaiwong W, 2008, INFECTION, V36, P488, DOI 10.1007/s15010-008-7336-4; Ma YY, 2012, VOX SANG; Manning A, 2007, J INFECT DIS, V195, P1345, DOI 10.1086/513280; Panning M, 2010, EMERG INFECT DIS, V16, P1143, DOI 10.3201/eid1607.100025; Schneider B, 2008, HAEMOPHILIA, V14, P978, DOI 10.1111/j.1365-2516.2008.01800.x; Schneider B, 2008, J MED VIROL, V80, P345, DOI 10.1002/jmv.21069; Servant-Delmas A, 2009, TRANSFUSION, V49, P1771, DOI 10.1111/j.1537-2995.2009.02286.x; Sharp CP, 2010, EMERG INFECT DIS, V16, P1605, DOI 10.3201/eid1610.101001; Sharp CP, 2009, J INFECT DIS, V200, P1119, DOI 10.1086/605646; Sharp CP, 2011, TRANSFUSION; Simmonds P, 2008, J GEN VIROL, V89, P2299, DOI 10.1099/vir.0.2008/001180-0; Simmonds P, 2007, EMERG INFECT DIS, V13, P1386, DOI 10.3201/eid1309.070428; Simmons R, 2012, J INFECT DIS; Simmons R, 2011, J INFECT DIS, V203, P1378, DOI 10.1093/infdis/jir036; Szelei J, 2010, EMERG INFECT DIS, V16, P561, DOI [10.3210/eid1603.090746, 10.3201/eid1603.090746]; Touinssi M, 2011, J MED VIROL, V83, P717, DOI 10.1002/jmv.22003; Touinssi M, 2010, EMERG INFECT DIS, V16, P165, DOI 10.3201/eid1601.090517; Vallerini D, 2008, EMERG INFECT DIS, V14, P185, DOI 10.3201/eid1401.070610; Yang SJ, 2011, J CLIN VIROL, V51, P64, DOI 10.1016/j.jcv.2011.01.017; Yu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029474	32	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46430	10.1371/journal.pone.0046430	http://dx.doi.org/10.1371/journal.pone.0046430			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050026	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300116
J	Canuet, L; Tellado, I; Couceiro, V; Fraile, C; Fernandez-Novoa, L; Ishii, R; Takeda, M; Cacabelos, R				Canuet, Leonides; Tellado, Ivan; Couceiro, Veronica; Fraile, Carmen; Fernandez-Novoa, Lucia; Ishii, Ryouhei; Takeda, Masatoshi; Cacabelos, Ramon			Resting-State Network Disruption and APOE Genotype in Alzheimer's Disease: A lagged Functional Connectivity Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; RESOLUTION ELECTROMAGNETIC TOMOGRAPHY; EVENT-RELATED SYNCHRONIZATION; APOLIPOPROTEIN-E; BRAIN ACTIVITY; EEG SYNCHRONIZATION; ALPHA-ACTIVITY; ALLELE; FMRI; MEMORY	Background: The apolipoprotein E epsilon 4 (APOE-4) is associated with a genetic vulnerability to Alzheimer's disease (AD) and with AD-related abnormalities in cortical rhythms. However, it is unclear whether APOE-4 is linked to a specific pattern of intrinsic functional disintegration of the brain after the development of the disease or during its different stages. This study aimed at identifying spatial patterns and effects of APOE genotype on resting-state oscillations and functional connectivity in patients with AD, using a physiological connectivity index called "lagged phase synchronization''. Methodology/Principal Findings: Resting EEG was recorded during awake, eyes-closed state in 125 patients with AD and 60 elderly controls. Source current density and functional connectivity were determined using eLORETA. Patients with AD exhibited reduced parieto-occipital alpha oscillations compared with controls, and those carrying the APOE-4 allele had reduced alpha activity in the left inferior parietal and temporo-occipital cortex relative to noncarriers. There was a decreased alpha2 connectivity pattern in AD, involving the left temporal and bilateral parietal cortex. Several brain regions exhibited increased lagged phase synchronization in low frequencies, specifically in the theta band, across and within hemispheres, where temporal lobe connections were particularly compromised. Areas with abnormal theta connectivity correlated with cognitive scores. In patients with early AD, we found an APOE-4-related decrease in interhemispheric alpha connectivity in frontal and parieto-temporal regions. Conclusions/Significance: In addition to regional cortical dysfunction, as indicated by abnormal alpha oscillations, there are patterns of functional network disruption affecting theta and alpha bands in AD that associate with the level of cognitive disturbance or with the APOE genotype. These functional patterns of nonlinear connectivity may potentially represent neurophysiological or phenotypic markers of AD, and aid in early detection of the disorder.	[Canuet, Leonides; Tellado, Ivan; Couceiro, Veronica; Fraile, Carmen; Cacabelos, Ramon] Inst CNS Disorders & Genom Med, EuroEspes Biomed Res Ctr, Corunna, Spain; [Fernandez-Novoa, Lucia; Cacabelos, Ramon] Inst CNS Disorders & Genom Med, EuroEspes Biotechnol Div Ebiotec, Corunna, Spain; [Ishii, Ryouhei; Takeda, Masatoshi] Osaka Univ, Dept Psychiat, Grad Sch Med, Suita, Osaka, Japan	Osaka University	Canuet, L (corresponding author), Inst CNS Disorders & Genom Med, EuroEspes Biomed Res Ctr, Corunna, Spain.	diagnosticodigital2@euroespes.com	Ishii, Ryouhei/A-9929-2008; Canuet, Leonides/B-1655-2008	Ishii, Ryouhei/0000-0002-4245-0953; Canuet, Leonides/0000-0003-1608-4715				Adler G, 2003, J NEURAL TRANSM, V110, P1051, DOI 10.1007/s00702-003-0024-8; Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderer P, 1998, NEUROPSYCHOBIOLOGY, V37, P20, DOI 10.1159/000026472; Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P252, DOI 10.1016/j.clinph.2005.09.019; Babiloni C, 2006, ANN NEUROL, V59, P323, DOI 10.1002/ana.20724; Bajo R, 2010, J ALZHEIMERS DIS, V22, P183, DOI 10.3233/JAD-2010-100177; Bigler ED, 2000, AM J NEURORADIOL, V21, P1857; Bozzali M, 2011, CURR MED CHEM, V18, P2452, DOI 10.2174/092986711795843263; Brown JA, 2011, P NATL ACAD SCI USA, V108, P20760, DOI 10.1073/pnas.1109038108; Cacabelos R, 2003, PHARMACOGENOMICS, V4, P597, DOI 10.1517/phgs.4.5.597.23795; Cacabelos R, 1996, ACTA NEUROL SCAND, V93, P72; Cacabelos R., 2006, DRUG FUTURE, V3, P5, DOI [10.2217/1745509X.1.2.303, DOI 10.2217/1745509X.1.2.303]; Cacabelos Ramon, 2005, Methods Find Exp Clin Pharmacol, V27 Suppl A, P1; Canuet L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027863; Canuet L, 2010, EPILEPSY BEHAV, V17, P109, DOI 10.1016/j.yebeh.2009.11.002; Damoiseaux JS, 2009, HUM BRAIN MAPP, V30, P1051, DOI 10.1002/hbm.20563; de Waal H, 2011, J NEUROL NEUROSUR PS, V82, P67, DOI 10.1136/jnnp.2010.216432; Dierks T, 2000, CLIN NEUROPHYSIOL, V111, P1817, DOI 10.1016/S1388-2457(00)00427-2; Filippini N, 2011, NEUROIMAGE, V54, P602, DOI 10.1016/j.neuroimage.2010.08.009; Filippini N, 2009, J MAGN RESON IMAGING, V29, P1021, DOI 10.1002/jmri.21757; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Alonso JF, 2011, ANN BIOMED ENG, V39, P524, DOI 10.1007/s10439-010-0155-7; Gour N, 2011, NEUROIMAGE, V58, P687, DOI 10.1016/j.neuroimage.2011.05.090; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Heise V, 2011, MOL PSYCHIATR, V16, P908, DOI 10.1038/mp.2010.90; Hlinka J, 2011, NEUROIMAGE, V54, P2218, DOI 10.1016/j.neuroimage.2010.08.042; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Ikezawa K, 2011, NEUROSCI RES, V71, P235, DOI 10.1016/j.neures.2011.07.1819; Ishii R, 1999, NEUROREPORT, V10, P675, DOI 10.1097/00001756-199903170-00003; Ishii R, 2010, PSYCHOGERIATRICS, V10, P138, DOI 10.1111/j.1479-8301.2010.00326.x; Jelic V, 1997, J NEUROL NEUROSUR PS, V63, P59, DOI 10.1136/jnnp.63.1.59; Jelles B, 2008, CLIN NEUROPHYSIOL, V119, P837, DOI 10.1016/j.clinph.2007.12.002; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Jones DT, 2011, NEUROLOGY, V77, P1524, DOI 10.1212/WNL.0b013e318233b33d; Kleen JK, 2011, J NEUROSCI, V31, P15397, DOI 10.1523/JNEUROSCI.2196-11.2011; Kramer G, 2008, CLIN NEUROPHYSIOL, V119, P2727, DOI 10.1016/j.clinph.2008.08.019; Kurimoto R, 2008, NEUROSCI LETT, V443, P86, DOI 10.1016/j.neulet.2008.07.015; Lee SH, 2010, NEUROSCI RES, V66, P333, DOI 10.1016/j.neures.2009.12.004; Li TQ, 2011, ACTA RADIOL, V52, P211, DOI 10.1258/ar.2010.100053; Liu Y, 2008, NEUROPSYCHOLOGIA, V46, P1648, DOI 10.1016/j.neuropsychologia.2008.01.027; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Maestu F, 2011, J CLIN NEUROPHYSIOL, V28, P202, DOI 10.1097/WNP.0b013e3182121743; Matsuda H, 2001, ANN NUCL MED, V15, P85, DOI 10.1007/BF02988596; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meltzer CC, 1996, NEUROLOGY, V47, P454, DOI 10.1212/WNL.47.2.454; Mulert C, 2011, INT J PSYCHOPHYSIOL, V79, P55, DOI 10.1016/j.ijpsycho.2010.08.004; Mulert C, 2004, NEUROIMAGE, V22, P83, DOI 10.1016/j.neuroimage.2003.10.051; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Park YM, 2008, NEUROSCI RES, V62, P112, DOI 10.1016/j.neures.2008.06.009; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; Pascual-Marqui RD, 2007, ARXIV07111455STATME; Pascual-Marqui RD, 2011, PHILOS T R SOC A, V369, P3768, DOI 10.1098/rsta.2011.0081; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Pievani M, 2011, LANCET NEUROL, V10, P829, DOI 10.1016/S1474-4422(11)70158-2; Reisberg B., 2011, PRINCIPLES PRACTICE, V3rd ed., P162, DOI DOI 10.1002/9780470669600; ROSES AD, 1995, JAMA-J AM MED ASSOC, V273, P374, DOI 10.1001/jama.273.5.374; Rytsar R, 2011, NEUROIMAGE, V57, P1131, DOI 10.1016/j.neuroimage.2011.05.029; Sankari Z, 2011, CLIN NEUROPHYSIOL, V122, P897, DOI 10.1016/j.clinph.2010.09.008; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Sorg C, 2009, CURR ALZHEIMER RES, V6, P541, DOI 10.2174/156720509790147106; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P708, DOI 10.1016/j.clinph.2004.09.022; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Takeda M, 2010, PSYCHIAT CLIN NEUROS, V64, P592, DOI 10.1111/j.1440-1819.2010.02148.x; Thatcher RW, 2012, HUM BRAIN MAPP, V33, P1062, DOI 10.1002/hbm.21271; Tiraboschi P, 2004, NEUROLOGY, V62, P1984, DOI 10.1212/01.WNL.0000129697.01779.0A; Trachtenberg AJ, 2012, NEUROIMAGE, V59, P565, DOI 10.1016/j.neuroimage.2011.07.059; Vitacco D, 2002, HUM BRAIN MAPP, V17, P4, DOI 10.1002/hbm.10038; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; Worrell GA, 2000, BRAIN TOPOGR, V12, P273, DOI 10.1023/A:1023407521772; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; Zhang HY, 2009, BEHAV BRAIN RES, V197, P103, DOI 10.1016/j.bbr.2008.08.012; Zumsteg D, 2006, CLIN NEUROPHYSIOL, V117, P2615, DOI 10.1016/j.clinph.2006.07.319	81	104	108	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46289	10.1371/journal.pone.0046289	http://dx.doi.org/10.1371/journal.pone.0046289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050006	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100173
J	Johansson, V; Nybom, R; Wetterberg, L; Hultman, CM; Cannon, TD; Johansson, AGM; Ekman, CJ; Landen, M				Johansson, Viktoria; Nybom, Rolf; Wetterberg, Lennart; Hultman, Christina M.; Cannon, Tyrone D.; Johansson, Anette G. M.; Ekman, Carl Johan; Landen, Mikael			Microscopic Particles in Two Fractions of Fresh Cerebrospinal Fluid in Twins with Schizophrenia or Bipolar Disorder and in Healthy Controls	PLOS ONE			English	Article							MICROMETER-SIZED PARTICLES; CSF; INTERVIEW; BARRIER; SCALE; PATHOPHYSIOLOGY; IDENTIFICATION; CHILDHOOD; RATIONALE; HISTORY	Background: Using scanning electron microscopy, microscopic structures have been identified in fresh cerebrospinal fluid (CSF) in patients with schizophrenia and bipolar disorder, but only rarely in control subjects. However, it has not been determined whether these microscopic particles represent state or trait markers, i.e. if their presence is related to clinical manifestations of the disease or if they also can be found in as yet asymptomatic individuals with a genetic liability. This question can be addressed by studying twins discordant or concordant for schizophrenia or bipolar disorder. Methodology/Principal Findings: We investigated microscopic structures in CSF in 102 individuals: 21 monozygotic and 16 dizygotic twins affected or not affected with schizophrenia, schizoaffective disorder or bipolar disorder and in 65 healthy singleton controls. A first and a second fraction of CSF was freshly applied on filters and examined by scanning electron microscopy technique. Spherical particles with lipid appearance averaging between 0.1 to 8.0 mu m in diameter were detected in the center of the filter as well as located in the margins of larger aggregates binding in a viscous state. Structures were found in 12 of 17 probands, 5 of 12 healthy co-twins and 3 of 73 healthy controls. Thus, a positive microscopic finding significantly increased the likelihood of belonging to the proband group (OR = 48, 95% CL: 8.2-550, p<0.0001) and the co-twin-group (OR = 16, 95% CL: 2.0-218, p = 0.006). Age, sex, history of alcohol abuse or anxiety syndrome, somatic disorder and markers of acute inflammatory activity did not account for group differences; nor did exposure to psychotropic medication. Conclusion: Presence of microscopic particles in CSF may possibly reflect trait dependent genetic or environmental vulnerability in patients with schizophrenia, schizoaffective disorder or bipolar disorder.	[Wetterberg, Lennart; Johansson, Anette G. M.; Ekman, Carl Johan] Karolinska Inst, Dept Clin Neurosci St Goran, Stockholm, Sweden; [Johansson, Viktoria; Hultman, Christina M.; Landen, Mikael] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Nybom, Rolf] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Cannon, Tyrone D.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Cannon, Tyrone D.] Univ Calif Los Angeles, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; [Landen, Mikael] Gothenburg Univ, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Gothenburg	Wetterberg, L (corresponding author), Karolinska Inst, Dept Clin Neurosci St Goran, Stockholm, Sweden.	lennart.wetterberg@ki.se	Johansson, Viktoria/E-7780-2018; Landen, Mikael/AAD-7917-2020; johansson, anette/ABB-8638-2020	Johansson, Viktoria/0000-0003-3775-7245; Johansson, Anette GM/0000-0003-1271-8960; Wetterberg, Lennart/0000-0001-7656-7458	Stockholm County Council [ALF 20100305, ALF 20090183]; NIH [RO1 MH52857]; Swedish Medical Research Council [K2008-62x-14647- 06-3, K2010-61X-21569-01-1, K2010-61P-21568-01-4]; Brain foundation (Hjarnfonden); Karolinska Institutet [ALF 20100305, ALF 20090183]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052857] Funding Source: NIH RePORTER	Stockholm County Council(Stockholm County Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Brain foundation (Hjarnfonden); Karolinska Institutet(Karolinska Institutet); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Financial support was provided through the regional agreement on medical training and clinical research between Stockholm County Council and the Karolinska Institutet (ALF 20100305; ALF 20090183); NIH T.D. Cannon RO1 MH52857; and through grants from the Swedish Medical Research Council (K2008-62x-14647- 06-3, K2010-61X-21569-01-1, and K2010-61P-21568-01-4), and the Brain foundation (Hjarnfonden). There are no financial interests, personal relationships or affiliations, which could have influenced the work. There is no involvement of the sponsors in study design, analysis, and interpretation of the collected data nor in the reporting writing and in the choice of the journal.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; ANDERSSON C, 1995, J INTERN MED, V237, P301, DOI 10.1111/j.1365-2796.1995.tb01179.x; Andreasen N., 1984, SCALE ASSESSMENT POS; Andreasen N. C., 1984, SCALE ASSESSMENT POS; BAUER K, 1987, EUR ARCH PSY CLIN N, V236, P257, DOI 10.1007/BF00380949; Bave U, 2010, BIPOLAR DISORD, V12, P298, DOI 10.1111/j.1399-5618.2010.00805.x; Bechter K, 2011, NEUROL PSYCHIAT BR, V17, P51, DOI 10.1016/j.npbr.2011.06.003; Berman AH, 2005, EUR ADDICT RES, V11, P22, DOI 10.1159/000081413; BLENNOW K, 1993, EUR NEUROL, V33, P129, DOI 10.1159/000116919; Dalman C, 2008, AM J PSYCHIAT, V165, P59, DOI 10.1176/appi.ajp.2007.07050740; Derr RE, 2000, PERFORMING EXACT LOG; Ekelund J, 2003, NEUROSCI LETT, V349, P68, DOI 10.1016/S0304-3940(03)00654-2; First M. B., 1997, STRUCTURED CLIN INTE; Gupta S, 2010, J R SOC INTERFACE, V7, P1195, DOI 10.1098/rsif.2010.0033; Hannelius U, 2007, TWIN RES HUM GENET, V10, P604, DOI 10.1375/twin.10.4.604; KIRCH DG, 1992, J NEURAL TRANSM-GEN, V89, P219, DOI 10.1007/BF01250674; Lawrie SM, 2011, WORLD PSYCHIATRY, V10, P19; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Mattsson N, 2011, CLIN CHEM LAB MED, V49, P345, DOI 10.1515/CCLM.2011.082; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; REIBER H, 1987, CLIN CHIM ACTA, V163, P319, DOI 10.1016/0009-8981(87)90250-6; Ryden E, 2009, ACTA PSYCHIAT SCAND, V120, P239, DOI 10.1111/j.1600-0447.2009.01399.x; Sachs GS, 2003, BIOL PSYCHIAT, V53, P1028, DOI 10.1016/S0006-3223(03)00165-3; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schwarz E, 2008, EXPERT REV MOL DIAGN, V8, P209, DOI 10.1586/14737159.8.2.209; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; TORGERSEN S, 1993, AM J PSYCHIAT, V150, P1661; Wetterberg L, 2002, NEUROSCI LETT, V329, P91, DOI 10.1016/S0304-3940(02)00580-3; WILLIAMS JBW, 1988, ARCH GEN PSYCHIAT, V45, P742; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429; Zachau Anne C, 2012, J Med Case Rep, V6, P274, DOI 10.1186/1752-1947-6-274	33	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45994	10.1371/journal.pone.0045994	http://dx.doi.org/10.1371/journal.pone.0045994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049916	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100115
J	Jorgensen, PB; Livbjerg, AH; Hansen, HJ; Petersen, T; Hollsberg, P				Jorgensen, Pernille B.; Livbjerg, Astrid H.; Hansen, Hans J.; Petersen, Thor; Hollsberg, Per			Epstein-Barr virus Peptide Presented by HLA-E is Predominantly Recognized by CD8(bright) Cells in multiple Sclerosis Patients	PLOS ONE			English	Article							CD8(+) T-CELLS; CLASS IB MOLECULES; MEDIATED RECOGNITION; ANTIBODY-TITERS; INFECTION; ANTIGEN; BRAIN; QA-1; TCR; IMMUNITY	Multiple sclerosis (MS) is associated with Epstein-Barr virus (EBV) infection, but impaired immune suppression may be part of the disease pathogenesis. CD8(+) T cells that are restricted by HLA-E exert an important immunoregulatory mechanism. To explore how EBV might interfere with immune regulation, we examined the expression of HLA-E and the frequency of CD8(+) cells recognizing HLA-E, presenting either an EBV peptide from the BZLF1 protein or a signal sequence peptide from HLA-A2, in relapsing remitting (MS-RR), primary progressive (MS-PP) MS patients, and healthy controls (HC). Treatment with IFN-alpha or EBV increased HLA-E expression on CD4(+) cells. However, only MS-PP had increased expression of HLA-E on resting CD4(+) cells when compared with HC (p<0.005). CD8(+) cells were divided into CD8(bright) and CD8(dim) cells by flow cytometry analyses. MS-RR had significantly fewer CD8(dim) cells than HC (p<0.003). Flow cytometry analyses were performed with HLA-E tetramers folded in the presence of the EBV or HLA-A2 peptide to identify HLA-E-interacting cells. MS-RR had increased frequency of CD8(bright) cells recognizing HLA-E/A2 (p = 0.006) and HLA-E/BZLF1 (p = 0.016). Conversely, MS-RR had fewer CD8(dim) cells that recognized HLA-E/BZLF1 (p = 0.001), but this could be attributed to the overall lower number of CD8(dim) cells in MS-RR. Whereas HLA-E/A2 was predominantly recognized by CD8(dim) cells, HLA-E/BZLF1 was predominantly recognized by CD8(bright) cells in MS-RR and MS-PP, but not in HC. As expected, HLA-E/A2 was also recognized by CD8-negative cells in a CD94-dependent manner, whereas HLA-E/BZLF1 was poorly recognized in all groups by CD8-negative cells. These data demonstrate that MS-RR patients have expanded their CD8(bright) cells recognizing HLA-E/BZLF1. Moreover, HLA-E/BZLF1 appears to be recognized by the immune system in a different manner than HLA-E/A2.	[Jorgensen, Pernille B.; Livbjerg, Astrid H.; Hollsberg, Per] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Hansen, Hans J.; Petersen, Thor] Aarhus Univ Hosp, Dept Neurol, MS Clin, DK-8000 Aarhus, Denmark; [Hollsberg, Per] Aarhus Univ, Danish Neurosci Ctr, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Hollsberg, P (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.	ph@microbiology.au.dk		Petersen, Thor/0000-0001-5633-2600	Danish Multiple Sclerosis Society	Danish Multiple Sclerosis Society	The study was supported by the Danish Multiple Sclerosis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2010, BRAIN, V133, DOI 10.1093/brain/awq223; Alotaibi S, 2004, JAMA-J AM MED ASSOC, V291, P1875, DOI 10.1001/jama.291.15.1875; Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Ascherio A, 2010, J NEUROIMMUNE PHARM, V5, P271, DOI 10.1007/s11481-010-9201-3; Banwell B, 2007, LANCET NEUROL, V6, P773, DOI 10.1016/S1474-4422(07)70196-5; Barun B, 2012, CLIN IMMUNOL, V142, P31, DOI 10.1016/j.clim.2011.04.005; BRAY PF, 1983, ARCH NEUROL-CHICAGO, V40, P406, DOI 10.1001/archneur.1983.04050070036006; Correale J, 2008, J NEUROIMMUNOL, V195, P121, DOI 10.1016/j.jneuroim.2007.12.004; Davies A, 2003, J IMMUNOL, V170, P5027, DOI 10.4049/jimmunol.170.10.5027; Garcia P, 2002, EUR J IMMUNOL, V32, P936, DOI 10.1002/1521-4141(200204)32:4<936::AID-IMMU936>3.3.CO;2-D; Haahr S, 1995, Mult Scler, V1, P73; Haahr S, 2006, REV MED VIROL, V16, P297, DOI 10.1002/rmv.503; Heinzel AS, 2002, J EXP MED, V196, P1473, DOI 10.1084/jem.20020609; HOLLSBERG P, 1994, J IMMUNOL, V153, P566; Hu D, 2004, NAT IMMUNOL, V5, P516, DOI 10.1038/ni1063; IMANI F, 1991, P NATL ACAD SCI USA, V88, P10475, DOI 10.1073/pnas.88.23.10475; Jensen PE, 2004, IMMUNOL RES, V29, P81, DOI 10.1385/IR:29:1-3:081; Jiang H, 2005, J CLIN INVEST, V115, P302, DOI 10.1172/JCI200523879; Jiang H, 2001, P NATL ACAD SCI USA, V98, P6301, DOI 10.1073/pnas.101123098; JIANG H, 1995, IMMUNITY, V2, P185, DOI 10.1016/S1074-7613(95)80079-4; Jiang H, 2010, J CLIN INVEST, V120, P3641, DOI 10.1172/JCI43522; Joosten SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000782; KIKUTA H, 1984, J GEN VIROL, V65, P837, DOI 10.1099/0022-1317-65-4-837; Kumar V, 2004, J CLIN INVEST, V114, P1222, DOI 10.1172/JCI200423166; LARSEN PD, 1985, NEUROLOGY, V35, P435, DOI 10.1212/WNL.35.3.435; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; Li JF, 2001, J IMMUNOL, V167, P3800, DOI 10.4049/jimmunol.167.7.3800; Lo WF, 2000, NAT MED, V6, P215, DOI 10.1038/72329; LOTZ M, 1986, J IMMUNOL, V136, P3636; Michaelsson J, 2002, J EXP MED, V196, P1403, DOI 10.1084/jem.20020797; Munch M, 1998, ACTA NEUROL SCAND, V97, P171; Nielsen TR, 2007, ARCH NEUROL-CHICAGO, V64, P72, DOI 10.1001/archneur.64.1.72; Panoutsakopoulou V, 2004, J CLIN INVEST, V113, P1218, DOI 10.1172/JCI200420772; Pender MP, 2009, AUTOIMMUN REV, V8, P563, DOI 10.1016/j.autrev.2009.01.017; Pietra G, 2001, EUR J IMMUNOL, V31, P3687, DOI 10.1002/1521-4141(200112)31:12<3687::AID-IMMU3687>3.0.CO;2-C; Pohl D, 2006, NEUROLOGY, V67, P2063, DOI 10.1212/01.wnl.0000247665.94088.8d; Ransohoff RM, 2007, NEW ENGL J MED, V356, P2622, DOI 10.1056/NEJMct071462; Romagnani C, 2004, HUM IMMUNOL, V65, P437, DOI 10.1016/j.humimm.2004.02.001; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Serafini B, 2010, J NEUROPATH EXP NEUR, V69, P677, DOI 10.1097/NEN.0b013e3181e332ec; SUMAYA CV, 1980, ARCH NEUROL-CHICAGO, V37, P94, DOI 10.1001/archneur.1980.00500510052009; SUMAYA CV, 1985, ANN NEUROL, V17, P371, DOI 10.1002/ana.410170412; Tennakoon DK, 2006, J IMMUNOL, V176, P7119, DOI 10.4049/jimmunol.176.11.7119; Ulbrecht M, 1998, J IMMUNOL, V160, P4375; ULBRECHT M, 1992, J IMMUNOL, V149, P2945; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; Watanabe N, 1997, BLOOD, V90, P3662, DOI 10.1182/blood.V90.9.3662; Weiss EH, 1998, AM J REPROD IMMUNOL, V40, P177; Willis SN, 2009, BRAIN, V132, P3318, DOI 10.1093/brain/awp200	51	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46120	10.1371/journal.pone.0046120	http://dx.doi.org/10.1371/journal.pone.0046120			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049954	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100139
J	Kim, Y; Sun, H				Kim, Yongsoon; Sun, Hong			ASM-3 Acid Sphingomyelinase Functions as a Positive Regulator of the DAF-2/AGE-1 Signaling Pathway and Serves as a Novel Anti-Aging Target	PLOS ONE			English	Article							OXIDATIVE STRESS RESISTANCE; NEMATODE CAENORHABDITIS-ELEGANS; NUCLEAR DAF-16/FOXO ACTIVITY; LIFE-SPAN; C-ELEGANS; MULTIDRUG-RESISTANCE; ENDOCRINE REGULATION; FAMILY-MEMBER; FAT-BODY; LONGEVITY	In C. elegans, the highly conserved DAF-2/insulin/insulin-like growth factor 1 receptor signaling (IIS) pathway regulates longevity, metabolism, reproduction and development. In mammals, acid sphingomyelinase (ASM) is an enzyme that hydrolyzes sphingomyelin to produce ceramide. ASM has been implicated in CD95 death receptor signaling under certain stress conditions. However, the involvement of ASM in growth factor receptor signaling under physiological conditions is not known. Here, we report that in vivo ASM functions as a positive regulator of the DAF-2/IIS pathway in C. elegans. We have shown that inactivation of asm-3 extends animal lifespan and promotes dauer arrest, an alternative developmental process. A significant cooperative effect on lifespan is observed between asm-3 deficiency and loss-of-function alleles of the age-1/PI 3-kinase, with the asm-3; age-1 double mutant animals having a mean lifespan 259% greater than that of the wildtype animals. The lifespan extension phenotypes caused by the loss of asm-3 are dependent on the functions of daf-16/FOXO and daf-18/PTEN. We have demonstrated that inactivation of asm-3 causes nuclear translocation of DAF-16::GFP protein, up-regulates endogenous DAF-16 protein levels and activates the downstream targeting genes of DAF-16. Together, our findings reveal a novel role of asm-3 in regulation of lifespan and diapause by modulating IIS pathway. Importantly, we have found that two drugs known to inhibit mammalian ASM activities, desipramine and clomipramine, markedly extend the lifespan of wild-type animals, in a manner similar to that achieved by genetic inactivation of the asm genes. Our studies illustrate a novel strategy of anti-aging by targeting ASM, which may potentially be extended to mammals.	[Kim, Yongsoon; Sun, Hong] Nevada Canc Inst, Lab Canc Genom, Las Vegas, NV USA; [Kim, Yongsoon; Sun, Hong] Univ Nevada, Dept Chem, Las Vegas, NV 89154 USA	University of California System; University of California San Diego; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Kim, Y (corresponding author), Nevada Canc Inst, Lab Canc Genom, Las Vegas, NV USA.	ykim@nvcancer.org; hong.sun@unlv.edu			American Cancer Society [RSG-03-246-01-MBC]; Nevada System of Higher Education	American Cancer Society(American Cancer Society); Nevada System of Higher Education	This work was supported in part by the American Cancer Society grant RSG-03-246-01-MBC and Inter-Institutional Biomedical Research Activities Fund from the Nevada System of Higher Education awarded to H.S. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alam H, 2010, CELL METAB, V12, P30, DOI 10.1016/j.cmet.2010.05.004; ALBOUZ S, 1981, BIOMED EXPRESS, V35, P218; Ayyadevara S, 2008, AGING CELL, V7, P13, DOI 10.1111/j.1474-9726.2007.00348.x; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Brenner B, 1998, CELL DEATH DIFFER, V5, P29, DOI 10.1038/sj.cdd.4400307; BRENNER S, 1974, GENETICS, V77, P71; Charruyer A, 2005, J BIOL CHEM, V280, P19196, DOI 10.1074/jbc.M412867200; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Gems D, 1998, GENETICS, V150, P129; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hertweck M, 2004, DEV CELL, V6, P577, DOI 10.1016/S1534-5807(04)00095-4; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; Houthoofd K, 2005, AGING CELL, V4, P87, DOI 10.1111/j.1474-9726.2005.00150.x; Hu PJ, 2006, PLOS GENET, V2, P930, DOI 10.1371/journal.pgen.0020099; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Iser WB, 2007, DEV BIOL, V303, P434, DOI 10.1016/j.ydbio.2006.04.467; JAFFREZOU JP, 1995, BBA-MOL CELL RES, V1266, P1, DOI 10.1016/0167-4889(94)00219-5; JAFFREZOU JP, 1991, J BIOL CHEM, V266, P19858; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim Y, 2007, AGING CELL, V6, P489, DOI 10.1111/j.1474-9726.2007.00302.x; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kwon ES, 2010, NATURE, V466, P498, DOI 10.1038/nature09184; Landis JN, 2010, DEV DYNAM, V239, P1405, DOI 10.1002/dvdy.22244; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Li J, 2007, DEV BIOL, V301, P82, DOI 10.1016/j.ydbio.2006.10.013; Li WS, 2007, DEV CELL, V12, P235, DOI 10.1016/j.devcel.2006.12.002; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin XH, 1998, J BIOL CHEM, V273, P14374, DOI 10.1074/jbc.273.23.14374; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Masse I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003354; Mihaylova VT, 1999, P NATL ACAD SCI USA, V96, P7427, DOI 10.1073/pnas.96.13.7427; Morris JZ, 1996, NATURE, V382, P536, DOI 10.1038/382536a0; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Ren P, 1996, SCIENCE, V274, P1398; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Wolkow CA, 2002, J BIOL CHEM, V277, P49591, DOI 10.1074/jbc.M207866200; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3; Zeidan YH, 2007, TRENDS MOL MED, V13, P327, DOI 10.1016/j.molmed.2007.06.002; Zhang YM, 2008, DEV BIOL, V315, P290, DOI 10.1016/j.ydbio.2007.12.032	58	22	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45890	10.1371/journal.pone.0045890	http://dx.doi.org/10.1371/journal.pone.0045890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049887	Green Submitted, gold, Green Published			2022-12-27	WOS:000309556100097
J	Kraska, A; Santin, MD; Dorieux, O; Joseph-Mathurin, N; Bourrin, E; Petit, F; Jan, C; Chaigneau, M; Hantraye, P; Lestage, P; Dhenain, M				Kraska, Audrey; Santin, Mathieu D.; Dorieux, Olene; Joseph-Mathurin, Nelly; Bourrin, Emmanuel; Petit, Fanny; Jan, Caroline; Chaigneau, Marion; Hantraye, Philippe; Lestage, Pierre; Dhenain, Marc			In Vivo Cross-sectional Characterization of Cerebral Alterations Induced by Intracerebroventricular Administration of Streptozotocin	PLOS ONE			English	Article							INDUCED EXPERIMENTAL DEMENTIA; GROWTH-FACTOR EXPRESSION; ALZHEIMER-LIKE CHANGES; ADULT-RAT BRAIN; OXIDATIVE STRESS; INDUCED MODEL; MEMORY IMPAIRMENT; INSULIN; DISEASE; INJECTION	Cerebral aging is often associated with the occurrence of neurodegenerative diseases leading to dementia. Animal models are critical to elucidate mechanisms associated to dementia and to evaluate neuroprotective drugs. Rats that received intracerebroventricular injection of streptozotocin (icv-STZ) have been reported as a model of dementia. In these animals, this drug induces oxidative stress and brain glucose metabolism impairments associated to insulin signal transduction failure. These mechanisms are reported to be involved in the pathogenesis of Alzheimer's disease and other dementia. Icv-STZ rats also display memory impairments. However, little is known about the precise location of the lesions induced by STZ administration. In this context, the present study characterized the cerebral lesions induced by two-doses of icv-STZ by using high-field magnetic resonance imaging to easily and longitudinally detect cerebral abnormalities and by using immunohistochemistry to evaluate neuronal loss and neuroinflammation (astrocytosis and microgliosis). We showed that, at high doses, icv-STZ induces severe and acute neurodegenerative lesions in the septum and corpus callosum. The lesions are associated with an inflammation process. They are less severe and more progressive at low doses. The relevance of high and low doses of icv-STZ to mimic dementia and evaluate new drugs is discussed in the final part of this article.	[Kraska, Audrey; Santin, Mathieu D.; Dorieux, Olene; Joseph-Mathurin, Nelly; Bourrin, Emmanuel; Petit, Fanny; Jan, Caroline; Chaigneau, Marion; Hantraye, Philippe; Dhenain, Marc] Ctr Natl Rech Sci, URA 2210, Fontenay Aux Roses, France; [Kraska, Audrey; Bourrin, Emmanuel; Lestage, Pierre] Inst Rech Servier, Croissy Sur Seine, France; [Kraska, Audrey; Santin, Mathieu D.; Dorieux, Olene; Joseph-Mathurin, Nelly; Bourrin, Emmanuel; Petit, Fanny; Jan, Caroline; Chaigneau, Marion; Hantraye, Philippe; Dhenain, Marc] Commissariat Energie Atom & Energies Alternat, Direct Sci Vivant, Inst Imagerie Biomed, Mol Imaging Res Ctr, Fontenay Aux Roses, France	Centre National de la Recherche Scientifique (CNRS); Servier; Institut de Recherches Internationales Servier; CEA; UDICE-French Research Universities; Universite Paris Saclay	Dhenain, M (corresponding author), Ctr Natl Rech Sci, URA 2210, Fontenay Aux Roses, France.	Marc.Dhenain@cea.fr	Santin, Mathieu/AAJ-2213-2020; Dhenain, Marc/K-5630-2013	Dhenain, Marc/0000-0001-8804-4101; Joseph-Mathurin, Nelly/0000-0002-9735-5152	France-Alzheimer Association; CNRS (National Center for Scientific Research ("French NIH")); National Foundation for Alzheimer's Disease and Related Disorders; Hoffmann-La Roche	France-Alzheimer Association; CNRS (National Center for Scientific Research ("French NIH")); National Foundation for Alzheimer's Disease and Related Disorders; Hoffmann-La Roche(Hoffmann-La Roche)	This work was supported by the by the France-Alzheimer Association, the longevity program from the CNRS (National Center for Scientific Research ("French NIH")) and the National Foundation for Alzheimer's Disease and Related Disorders. OD was financed by Hoffmann-La Roche but on a project that was unrelated to the current article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Olene Dorieux was financed by Hoffmann-La Roche but on a project that was unrelated to the current article. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Agrawal R, 2011, EUR NEUROPSYCHOPHARM, V21, P261, DOI 10.1016/j.euroneuro.2010.11.009; Arluison M, 2004, J CHEM NEUROANAT, V28, P117, DOI 10.1016/j.jchemneu.2004.05.009; COFFEY PJ, 1990, NEUROSCIENCE, V35, P121, DOI 10.1016/0306-4522(90)90126-O; Correia SC, 2011, AGEING RES REV, V10, P264, DOI 10.1016/j.arr.2011.01.001; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; de la Monte SM, 2006, J ALZHEIMERS DIS, V9, P167; Deshmukh R, 2009, EUR J PHARMACOL, V620, P49, DOI 10.1016/j.ejphar.2009.08.027; Dhull DK, 2012, J MOL NEUROSCI, V46, P223, DOI 10.1007/s12031-011-9583-6; Diguet E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004637; Eriksson SH, 2009, J NEUROSCI METH, V181, P111, DOI 10.1016/j.jneumeth.2009.05.001; Fitz NF, 2006, BRAIN RES BULL, V69, P660, DOI 10.1016/j.brainresbull.2006.03.011; Frederiksen KS, 2011, NEURODEGENER DIS, V8, P476, DOI 10.1159/000327753; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Grunblatt E, 2007, J NEUROCHEM, V101, P757, DOI 10.1111/j.1471-4159.2006.04368.x; Hoyer S, 1998, J NEURAL TRANSM, V105, P415, DOI 10.1007/s007020050067; Hoyer S, 1994, J Neural Transm Suppl, V44, P259; Hung CW, 2010, AGEING RES REV, V9, pS36, DOI 10.1016/j.arr.2010.08.006; Ishrat T, 2006, BEHAV BRAIN RES, V171, P9, DOI 10.1016/j.bbr.2006.03.009; Ishrat T, 2009, BRAIN RES, V1281, P117, DOI 10.1016/j.brainres.2009.04.010; Isik AT, 2009, AGE, V31, P39, DOI 10.1007/s11357-008-9078-8; Janowsky JS, 1996, J AM GERIATR SOC, V44, P798, DOI 10.1111/j.1532-5415.1996.tb03736.x; Javed H, 2011, BRAIN RES, V1389, P133, DOI 10.1016/j.brainres.2011.02.072; KESNER RP, 1988, NEUROBIOL AGING, V9, P609, DOI 10.1016/S0197-4580(88)80122-2; Kirby BP, 2003, BEHAV BRAIN RES, V143, P41, DOI 10.1016/S0166-4328(03)00005-6; Lannert H, 1998, BEHAV NEUROSCI, V112, P1199, DOI 10.1037/0735-7044.112.5.1199; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Lester-Coll N, 2006, J ALZHEIMERS DIS, V9, P13; MCGEER PL, 1986, NEUROLOGY, V36, P1569, DOI 10.1212/WNL.36.12.1569; Niewiadomska G, 2009, PROG NEURO-PSYCHOPH, V33, P791, DOI 10.1016/j.pnpbp.2009.03.039; Pathan AR, 2006, LIFE SCI, V79, P2209, DOI 10.1016/j.lfs.2006.07.018; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pinton S, 2011, BEHAV BRAIN RES, V223, P1, DOI 10.1016/j.bbr.2011.04.014; PLASCHKE K, 1993, INT J DEV NEUROSCI, V11, P477, DOI 10.1016/0736-5748(93)90021-5; Plaschke K, 2010, J ALZHEIMERS DIS, V19, P691, DOI 10.3233/JAD-2010-1270; Prakash AK, 2009, J PHARM PHARMACOL, V61, P1665, DOI 10.1211/jpp/61.12.0012; Salkovic-Petrisic M, 2007, J NEURAL TRANSM-SUPP, P217; Salkovic-Petrisic M, 2006, J NEUROCHEM, V96, P1005, DOI 10.1111/j.1471-4159.2005.03637.x; Salkovic-Petrisic M, 2011, J NEURAL TRANSM, V118, P765, DOI 10.1007/s00702-011-0651-4; Sapcanin A, 2008, NEUROTOX RES, V13, P97, DOI 10.1007/BF03033561; Saxena G, 2008, EUR J PHARMACOL, V581, P283, DOI 10.1016/j.ejphar.2007.12.009; Sharma B, 2008, PHARMACOL BIOCHEM BE, V89, P535, DOI 10.1016/j.pbb.2008.02.012; Sharma B, 2008, J PSYCHOPHARMACOL, V22, P162, DOI 10.1177/0269881107081553; Sharma M, 2001, LIFE SCI, V68, P1021, DOI 10.1016/S0024-3205(00)01005-5; Sharma N, 2011, PHARM BIOCH BEHAV, V96, P386; Shoham S, 2003, EXP NEUROL, V184, P1043, DOI 10.1016/j.expneurol.2003.08.015; Shoham S, 2007, NEUROPHARMACOLOGY, V52, P836, DOI 10.1016/j.neuropharm.2006.10.005; Smith MA, 1996, NATURE, V382, P120, DOI 10.1038/382120b0; Sonkusare S, 2005, LIFE SCI, V77, P1, DOI 10.1016/j.lfs.2004.10.036; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Sultana R, 2011, J ALZHEIMERS DIS, V24, P77, DOI 10.3233/JAD-2011-101425; Szkudelski T, 2001, PHYSIOL RES, V50, P537; TERWEL D, 1995, EUR J PHARMACOL, V287, P65, DOI 10.1016/0014-2999(95)00475-4; Tramontina AC, 2011, J NEURAL TRANSM, V118, P1641, DOI 10.1007/s00702-011-0680-z; WILEY RG, 1991, BRAIN RES, V562, P149, DOI 10.1016/0006-8993(91)91199-B; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8	56	62	62	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46196	10.1371/journal.pone.0046196	http://dx.doi.org/10.1371/journal.pone.0046196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049978	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100153
J	Kumasaka, N; Aoki, M; Okada, Y; Takahashi, A; Ozaki, K; Mushiroda, T; Hirota, T; Tamari, M; Tanaka, T; Nakamura, Y; Kamatani, N; Kubo, M				Kumasaka, Natsuhiko; Aoki, Masayuki; Okada, Yukinori; Takahashi, Atsushi; Ozaki, Kouichi; Mushiroda, Taisei; Hirota, Tomomitsu; Tamari, Mayumi; Tanaka, Toshihiro; Nakamura, Yusuke; Kamatani, Naoyuki; Kubo, Michiaki			Haplotypes with Copy Number and Single Nucleotide Polymorphisms in CYP2A6 Locus Are Associated with Smoking Quantity in a Japanese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; UNRELATED INDIVIDUALS; NICOTINE METABOLISM; COMMON DISEASES; SNP GENOTYPES; ADULT TWINS; BEHAVIOR; METAANALYSIS; IMPUTATION; VARIANTS	Smoking is a major public health problem, but the genetic factors associated with smoking behaviors are not fully elucidated. Here, we have conducted an integrated genome-wide association study to identify common copy number polymorphisms (CNPs) and single nucleotide polymorphisms (SNPs) associated with the number of cigarettes smoked per day (CPD) in Japanese smokers (N = 17,158). Our analysis identified a common CNP with a strong effect on CPD (rs8102683; P = 3.8 x 10(-42)) in the 19q13 region, encompassing the CYP2A6 locus. After adjustment for the associated CNP, we found an additional associated SNP (rs11878604; P = 9.7 x 10(-30)) located 30 kb downstream of the CYP2A6 gene. Imputation of the CYP2A6 locus revealed that haplotypes underlying the CNP and the SNP corresponded to classical, functional alleles of CYP2A6 gene that regulate nicotine metabolism and explained 2% of the phenotypic variance of CPD (ANOVA F-test P = 9.5 x 10(-52)). These haplotypes were also associated with smoking-related diseases, including lung cancer, chronic obstructive pulmonary disease and arteriosclerosis obliterans.	[Aoki, Masayuki; Kubo, Michiaki] RIKEN, Ctr Genom Med, Res Grp Genotyping, Yokohama, Kanagawa, Japan; [Kumasaka, Natsuhiko; Okada, Yukinori; Takahashi, Atsushi] RIKEN, Ctr Genom Med, Res Grp Med Informat, Tokyo, Japan; [Ozaki, Kouichi; Hirota, Tomomitsu; Tamari, Mayumi; Tanaka, Toshihiro] RIKEN, Ctr Genom Med, Res Grp Dis Causing Mech, Yokohama, Kanagawa, Japan; [Mushiroda, Taisei; Kamatani, Naoyuki] RIKEN, Ctr Genom Med, Res Grp Pharmacogen, Yokohama, Kanagawa, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan	RIKEN; RIKEN; RIKEN; RIKEN; University of Tokyo	Kubo, M (corresponding author), RIKEN, Ctr Genom Med, Res Grp Genotyping, Yokohama, Kanagawa, Japan.	mkubo@src.riken.jp	Tanaka, Toshihiro/J-9310-2014; Mushiroda, Taisei/E-3022-2010; Kubo, Michiaki/N-7947-2015; Tamari, Mayumi/N-5378-2015	Tanaka, Toshihiro/0000-0001-6201-9784; Ozaki, Kouichi/0000-0003-0028-1570	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government	Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was conducted as a part of the BioBank Japan Project, which is supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank all technical staff of BioBank Japan Project and Laboratory for Genotyping Development at RIKEN for SNP genotyping. This work was conducted as a part of the BioBank Japan Project, which is supported by the Ministry of Education, Culture, Sports, Sciences and Technology of the Japanese government.	Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Bodin L, 2005, J BIOMED BIOTECHNOL, P248, DOI 10.1155/JBB.2005.248; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; DEMPSTER ER, 1950, GENETICS, V35, P212; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fujieda M, 2004, CARCINOGENESIS, V25, P2451, DOI 10.1093/carcin/bgh258; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Hosono N, 2009, CLIN CHEM, V55, P1546, DOI 10.1373/clinchem.2009.123620; Ikeda F, 2011, TOB CONTROL; Koopmans JR, 1999, BEHAV GENET, V29, P383, DOI 10.1023/A:1021618719735; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kumasaka N, 2011, GENET EPIDEMIOL, V35, P831, DOI 10.1002/gepi.20633; Kumasaka N, 2010, J HUM GENET, V55, P525, DOI 10.1038/jhg.2010.63; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLachlan GJ, 1997, EM ALGORITHM EXTENSI; Morris AP, 2010, GENET EPIDEMIOL, V34, P188, DOI 10.1002/gepi.20450; Nakamura Yusuke, 2007, Clin Adv Hematol Oncol, V5, P696; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; QUESENBERRY CP, 1980, J STAT COMPUT SIM, V11, P41, DOI 10.1080/00949658008810388; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schoedel KA, 2004, PHARMACOGENETICS, V14, P615, DOI 10.1097/00008571-200409000-00006; Stram DO, 2003, HUM HERED, V55, P179, DOI 10.1159/000073202; Swan GE, 2005, PHARMACOGENET GENOM, V15, P115, DOI 10.1097/01213011-200502000-00007; Thorgeirsson TE, 2010, NAT GENET, V42, P448, DOI 10.1038/ng.573; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019	38	39	40	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44507	10.1371/journal.pone.0044507	http://dx.doi.org/10.1371/journal.pone.0044507			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049750	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100015
J	Park, HS; Ni, M; Jeong, KC; Kim, YH; Yu, JH				Park, Hee-Soo; Ni, Min; Jeong, Kwang Cheol; Kim, Young Hwan; Yu, Jae-Hyuk			The Role, Interaction and Regulation of the Velvet Regulator VelB in Aspergillus nidulans	PLOS ONE			English	Article							SECONDARY METABOLISM; TRANSCRIPTION FACTOR; ASEXUAL SPORULATION; SEXUAL DEVELOPMENT; FILAMENTOUS FUNGI; STRESS-RESPONSE; GENE ENCODES; TREHALOSE; FUMIGATUS; ABAA	The multifunctional regulator VelB physically interacts with other velvet regulators and the resulting complexes govern development and secondary metabolism in the filamentous fungus Aspergillus nidulans. Here, we further characterize VelB's role in governing asexual development and conidiogenesis in A. nidulans. In asexual spore formation, velB deletion strains show reduced number of conidia, and decreased and delayed mRNA accumulation of the key asexual regulatory genes brlA, abaA, and vosA. Overexpression of velB induces a two-fold increase of asexual spore production compared to wild type. Furthermore, the velB deletion mutant exhibits increased conidial germination rates in the presence of glucose, and rapid germination of conidia in the absence of external carbon sources. In vivo immuno-pull-down analyses reveal that VelB primarily interacts with VosA in both asexual and sexual spores, and VelB and VosA play an inter-dependent role in spore viability, focal trehalose biogenesis and control of conidial germination. Genetic and in vitro studies reveal that AbaA positively regulates velB and vosA mRNA expression during sporogenesis, and directly binds to the promoters of velB and vosA. In summary, VelB acts as a positive regulator of asexual development and regulates spore maturation, focal trehalose biogenesis and germination by interacting with VosA in A. nidulans.	[Park, Hee-Soo; Ni, Min; Jeong, Kwang Cheol; Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol & Genet, Madison, WI 53706 USA; [Park, Hee-Soo; Yu, Jae-Hyuk] Univ Wisconsin, Dept Mol & Environm Toxicol Ctr, Madison, WI USA; [Kim, Young Hwan] Korea Basic Sci Inst, Mass Spectrometry Team, Mass Spectrometry Res Ctr, Taejon, South Korea	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Korea Basic Science Institute (KBSI)	Yu, JH (corresponding author), Univ Wisconsin, Dept Bacteriol & Genet, Madison, WI 53706 USA.	jyu1@wisc.edu	Kim, Young Hwan/AAA-5484-2022; Park, Hee-Soo/AAC-6422-2019; Yu, Jae-Hyuk/A-2343-2008	Kim, Young Hwan/0000-0003-3478-8839; Yu, Jae-Hyuk/0000-0002-6530-8407	National Science Foundation [IOS-0950850]; USDA CSREES Hatch [WIS01195]; UW Food Research Institute; UW FRI Foster Award; Korea Government (MOEHRD) [KRF-2007-612-E00010]; Korea Basic Science Institute [G30123]; Korea Research Foundation; Division Of Integrative Organismal Sys [0950850] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); USDA CSREES Hatch(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); UW Food Research Institute; UW FRI Foster Award; Korea Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Korea Basic Science Institute; Korea Research Foundation(National Research Foundation of Korea); Division Of Integrative Organismal Sys(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (IOS-0950850), USDA CSREES Hatch (WIS01195) and UW Food Research Institute grants to JHY. HSP was in part supported by the UW FRI Foster Award and Korea Research Foundation Grant funded by the Korea Government (MOEHRD) (KRF-2007-612-E00010). Y. H. Kim was supported by a grant of Korea Basic Science Institute (G30123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TH, 1990, MOL CELL BIOL, V10, P4912, DOI 10.1128/MCB.10.9.4912; ADAMS TH, 1990, P NATL ACAD SCI USA, V87, P5405, DOI 10.1073/pnas.87.14.5405; ADAMS TH, 1988, CELL, V54, P353, DOI 10.1016/0092-8674(88)90198-5; Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; AGUIRRE J, 1993, MOL MICROBIOL, V8, P211, DOI 10.1111/j.1365-2958.1993.tb01565.x; Al-Bader N, 2010, INFECT IMMUN, V78, P3007, DOI 10.1128/IAI.00813-09; ANDRIANOPOULOS A, 1994, MOL CELL BIOL, V14, P2503, DOI 10.1128/MCB.14.4.2503; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bayram OS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001226; BOYLAN MT, 1987, MOL CELL BIOL, V7, P3113, DOI 10.1128/MCB.7.9.3113; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; Casselton L, 2002, NAT REV GENET, V3, P683, DOI 10.1038/nrg889; Chang MH, 2004, GENETICS, V167, P1305, DOI 10.1534/genetics.103.025379; CLUTTERBUCK AJ, 1969, GENETICS, V63, P317; dEnfert C, 1997, MOL MICROBIOL, V24, P203, DOI 10.1046/j.1365-2958.1997.3131693.x; Dutton JR, 1997, EMBO J, V16, P5710, DOI 10.1093/emboj/16.18.5710; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fillinger S, 2001, MICROBIOL-SGM, V147, P1851, DOI 10.1099/00221287-147-7-1851; GWYNNE DI, 1987, GENE, V51, P205, DOI 10.1016/0378-1119(87)90309-X; Han KH, 2001, MOL MICROBIOL, V41, P299, DOI 10.1046/j.1365-2958.2001.02472.x; Han KH, 2004, MOL MICROBIOL, V53, P529, DOI 10.1111/j.1365-2958.2004.04163.x; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974; Kim JY, 2008, MOL CELL PROTEOMICS, V7, P431, DOI 10.1074/mcp.M700194-MCP200; Lafon A, 2005, GENETICS, V171, P71, DOI 10.1534/genetics.105.040584; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee J, 2012, MICROBIOLOGY; Ni M, 2005, EUKARYOT CELL, V4, P1465, DOI 10.1128/EC.4.8.1465-1476.2005; Ni M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000970; Ni M, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P559; Osmani AH, 1999, J BIOL CHEM, V274, P23565, DOI 10.1074/jbc.274.33.23565; Park BC, 2003, FEMS MICROBIOL LETT, V220, P241, DOI 10.1016/S0378-1097(03)00120-4; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Seo JA, 2003, GENETICS, V165, P1083; Seo JA, 2004, MOL MICROBIOL, V53, P1611, DOI 10.1111/j.1365-2958.2004.04232.x; SEWALL TC, 1990, PLANT CELL, V2, P731, DOI 10.1105/tpc.2.8.731; Shin KS, 2009, CURR GENET, V55, P631, DOI 10.1007/s00294-009-0276-4; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Vienken K, 2005, GENETICS, V169, P619, DOI 10.1534/genetics.104.030767; Vienken K, 2006, MOL MICROBIOL, V61, P544, DOI 10.1111/j.1365-2958.2006.05257.x; Webster RH, 2008, P NATL ACAD SCI USA, V105, P14573, DOI 10.1073/pnas.0806221105; Wei HJ, 2001, FUNGAL GENET BIOL, V34, P217, DOI 10.1006/fgbi.2001.1303; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; YELTON MM, 1984, P NATL ACAD SCI-BIOL, V81, P1470, DOI 10.1073/pnas.81.5.1470; Yu Jae-Hyuk, 2010, Mycobiology, V38, P229, DOI 10.4489/MYCO.2010.38.4.229; Yu JH, 2006, J MICROBIOL, V44, P145; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	51	19	28	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45935	10.1371/journal.pone.0045935	http://dx.doi.org/10.1371/journal.pone.0045935			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049895	gold, Green Submitted, Green Published			2022-12-27	WOS:000309556100102
J	Peris, D; Lopes, CA; Arias, A; Barrio, E				Peris, David; Lopes, Christian A.; Arias, Armando; Barrio, Eladio			Reconstruction of the Evolutionary History of Saccharomyces cerevisiae x S-kudriavzevii Hybrids Based on Multilocus Sequence Analysis	PLOS ONE			English	Article							BAYANUS VAR. UVARUM; NATURAL HYBRIDS; WINE YEAST; MOLECULAR CHARACTERIZATION; WILD; STRAINS; IDENTIFICATION; POPULATIONS; EXPRESSION; NETWORKS	In recent years, interspecific hybridization and introgression are increasingly recognized as significant events in the evolution of Saccharomyces yeasts. These mechanisms have probably been involved in the origin of novel yeast genotypes and phenotypes, which in due course were to colonize and predominate in the new fermentative environments created by human manipulation. The particular conditions in which hybrids arose are still unknown, as well as the number of possible hybridization events that generated the whole set of natural hybrids described in the literature during recent years. In this study, we could infer at least six different hybridization events that originated a set of 26 S. cerevisiae x S. kudriavzevii hybrids isolated from both fermentative and non-fermentative environments. Different wine S. cerevisiae strains and European S. kudriavzevii strains were probably involved in the hybridization events according to gene sequence information, as well as from previous data on their genome composition and ploidy. Finally, we postulate that these hybrids may have originated after the introduction of vine growing and winemaking practices by the Romans to the present Northern vine-growing limits and spread during the expansion of improved viticulture and enology practices that occurred during the Late Middle Ages.	[Lopes, Christian A.; Barrio, Eladio] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, E-46010 Valencia, Spain; [Peris, David; Arias, Armando] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain; [Lopes, Christian A.] Univ Nacl Comahue, Fac Ingn & Ciencias Agr, Inst Multidisciplinario Invest & Desarrollo Patag, Grp Biodiversidad & Biotecnol Levaduras, Neuquen, Argentina; [Arias, Armando] Univ Guadalajara, CUCBA, Unidad Bot & Zool, Lab Biotecn, Zapopan, Jalisco, Mexico; [Barrio, Eladio] Univ Valencia, Dept Genet, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Valencia; Universidad Nacional del Comahue; Universidad de Guadalajara; University of Valencia	Barrio, E (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, Jaime Roig 11, E-46010 Valencia, Spain.	eladio.barrio@uv.es	David, Peris/K-8393-2018; Garcia, Armando Arias/AAS-4810-2020; Peris, David/GQB-3861-2022; Barrio, Eladio/G-8969-2015; Arias, Armando/ABH-6081-2020	David, Peris/0000-0001-9912-8802; Barrio, Eladio/0000-0003-1024-954X; Arias, Armando/0000-0002-7474-1878	Spanish Government project [AGL2009-12673-CO2-02]; Generalitat Valenciana grant [PROMETEO/2009/019]; Spanish Government FPI fellowship; Spanish Government postdoctoral contract; Mexican Government PROMEP fellowship	Spanish Government project(Spanish Government); Generalitat Valenciana grant(Center for Forestry Research & Experimentation (CIEF)); Spanish Government FPI fellowship; Spanish Government postdoctoral contract; Mexican Government PROMEP fellowship	This work was supported by Spanish Government project AGL2009-12673-CO2-02 to EB, and Generalitat Valenciana grant PROMETEO/2009/019. DP, CL and AA acknowledge a Spanish Government FPI fellowship, a Spanish Government postdoctoral contract, and a Mexican Government PROMEP fellowship, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aa E, 2006, FEMS YEAST RES, V6, P702, DOI 10.1111/j.1567-1364.2006.00059.x; Arias A, 2008, DIVERSIDAD GENETICA; Arroyo-Garcia R, 2006, MOL ECOL, V15, P3707, DOI 10.1111/j.1365-294X.2006.03049.x; Arroyo-Lopez FN, 2010, YEAST, V27, P1005, DOI 10.1002/yea.1809; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Belloch C, 2008, INT J FOOD MICROBIOL, V122, P188, DOI 10.1016/j.ijfoodmicro.2007.11.083; Belloch C, 2009, APPL ENVIRON MICROB, V75, P2534, DOI 10.1128/AEM.02282-08; Berger KH, 2000, TRENDS MICROBIOL, V8, P508, DOI 10.1016/S0966-842X(00)01862-X; Bradbury JE, 2006, ANTON LEEUW INT J G, V89, P27, DOI 10.1007/s10482-005-9006-1; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; Burton Janet, 2011, CISTERCIANS MIDDLE A; Carreto L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-524; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; CORRAN H. S., 1975, HIST BREWING; de Barros Lopes Miguel, 2002, FEMS Yeast Res, V1, P323, DOI 10.1016/S1567-1356(01)00051-4; Demuyter C, 2004, J APPL MICROBIOL, V97, P1140, DOI 10.1111/j.1365-2672.2004.02394.x; Dunn B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-53; Dunn B, 2008, GENOME RES, V18, P1610, DOI 10.1101/gr.076075.108; Dunn B, 2012, GENOME RES, V22, P908, DOI 10.1101/gr.130310.111; Erny C, 2012, APPL ENV MICROBIOL; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Felsenstein Joe, 2005, PHYLIP PHYLOGENY INF; Gangl H, 2009, NEW BIOTECHNOL, V25, P244, DOI 10.1016/j.nbt.2008.10.001; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Gonzalez SS, 2007, INT J FOOD MICROBIOL, V116, P11, DOI 10.1016/j.ijfoodmicro.2006.10.047; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; Gromicho M, 2006, CHROMOSOME RES, V14, P297, DOI 10.1007/s10577-006-1047-4; Huson DH, 2004, IEEE ACM T COMPUT BI, V1, P151, DOI 10.1109/TCBB.2004.44; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Johnson LJ, 2004, GENETICS, V166, P43, DOI 10.1534/genetics.166.1.43; Joly S, 2004, MOL BIOL EVOL, V21, P1409, DOI 10.1093/molbev/msh140; Kodama Y, 2006, TOP CURR GENET, V15, P145, DOI 10.1007/b106370; Koufopanou V, 2006, PHILOS T R SOC B, V361, P1941, DOI 10.1098/rstb.2006.1922; Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Le Jeune C, 2007, FEMS YEAST RES, V7, P540, DOI 10.1111/j.1567-1364.2007.00207.x; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lopandic K, 2007, FEMS YEAST RES, V7, P953, DOI 10.1111/j.1567-1364.2007.00240.x; Lopes CA, 2010, FEMS YEAST RES, V10, P412, DOI 10.1111/j.1567-1364.2010.00614.x; Masneuf I, 1998, APPL ENVIRON MICROB, V64, P3887; McGovern, 2010, UNCORKING QUEST WINE; McGovern PE, 2004, P NATL ACAD SCI USA, V101, P17593, DOI 10.1073/pnas.0407921102; MCGOVERN PE, 1997, EXPEDITION, V39, P3; MICHEL RH, 1992, NATURE, V360, P24, DOI 10.1038/360024b0; Murphy N, 2008, MOL PHYLOGENET EVOL, V47, P378, DOI 10.1016/j.ympev.2008.01.022; Myers CL, 2004, BIOINFORMATICS, V20, P3533, DOI 10.1093/bioinformatics/bth440; Naumov GI, 2000, RES MICROBIOL, V151, P683, DOI 10.1016/S0923-2508(00)90131-1; Naumov GI, 2002, APPL MICROBIOL BIOT, V59, P727, DOI 10.1007/s00253-002-1077-6; Naumov GI, 2001, INT J FOOD MICROBIOL, V65, P163, DOI 10.1016/S0168-1605(00)00515-8; Arroyo-Lopez FN, 2009, INT J FOOD MICROBIOL, V131, P120, DOI 10.1016/j.ijfoodmicro.2009.01.035; Novo M, 2009, P NATL ACAD SCI USA, V106, P16333, DOI 10.1073/pnas.0904673106; Perez-Traves L, 2012, INT J FOOD MICROBIOL, V156, P102, DOI 10.1016/j.ijfoodmicro.2012.03.008; Peris D, 2012, BMC GENOMIC IN PRESS; Peris D, 2012, YEAST, V29, P81, DOI 10.1002/yea.2891; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; QUEROL A, 1992, APPL ENVIRON MICROB, V58, P2948, DOI 10.1128/AEM.58.9.2948-2953.1992; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Salvado Z, 2011, APPL ENVIRON MICROB, V77, P2292, DOI 10.1128/AEM.01861-10; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Scannell DR, 2011, G3-GENES GENOM GENET, V1, P11, DOI 10.1534/g3.111.000273; Serra A, 2005, INT J FOOD MICROBIOL, V104, P257, DOI 10.1016/j.ijfoodmicro.2005.03.006; Shibata T, 2007, MITOCHONDRION, V7, P17, DOI 10.1016/j.mito.2006.11.024; Sicard D, 2011, CR BIOL, V334, P229, DOI 10.1016/j.crvi.2010.12.016; Staden R, 2000, Methods Mol Biol, V132, P115; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; Whitfield JB, 2008, SYST BIOL, V57, P939, DOI 10.1080/10635150802552849; Zambonelli C, 1997, J SCI FOOD AGR, V74, P7, DOI 10.1002/(SICI)1097-0010(199705)74:1<7::AID-JSFA753>3.3.CO;2-O	75	19	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45527	10.1371/journal.pone.0045527	http://dx.doi.org/10.1371/journal.pone.0045527			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049811	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100054
J	Wu, F; Guclu, H				Wu, Felicia; Guclu, Hasan			Aflatoxin Regulations in a Network of Global Maize Trade	PLOS ONE			English	Article							PUBLIC-HEALTH; EXPOSURE; GROWTH	Worldwide, food supplies often contain unavoidable contaminants, many of which adversely affect health and hence are subject to regulations of maximum tolerable levels in food. These regulations differ from nation to nation, and may affect patterns of food trade. We soughtto determine whether there is an association between nations' food safety regulations and global food trade patterns, with implications for public health and policymaking. We developed a network model of maize trade around the world. From maize import/export data for 217 nations from 2000-2009, we calculated basic statistics on volumes of trade; then examined how regulations of aflatoxin, a common contaminant of maize, are similar or different between pairs of nations engaging in significant amounts of maize trade. Globally, market segregation appears to occur among clusters of nations. The United States is at the center of one cluster; European countries make up another cluster with hardly any maize trade with the US; and Argentina, Brazil, and China export maize all over the world. Pairs of nations trading large amounts of maize have very similar aflatoxin regulations: nations with strict standards tend to trade maize with each other, while nations with more relaxed standards tend to trade maize with each other. Rarely among the top pairs of maize-trading nations do total aflatoxin standards (standards based on the sum of the levels of aflatoxins B-1, B-2, G(1), and G(2)) differ by more than 5 mu g/kg. These results suggest that, globally, separate maize trading communities emerge; and nations tend to trade with other nations that have very similar food safety standards.	[Wu, Felicia] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA; [Guclu, Hasan] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Guclu, Hasan] Univ Pittsburgh, Publ Hlth Dynam Lab, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, F (corresponding author), Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15260 USA.	few8@pitt.edu	Guclu, Hasan/B-7080-2008	Guclu, Hasan/0000-0003-3582-9460	National Cancer Institute (NCI) of the National Institutes of Health (NIH) [5R01CA153073-2.]; NATIONAL CANCER INSTITUTE [R01CA153073] Funding Source: NIH RePORTER	National Cancer Institute (NCI) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Cancer Institute (NCI) of the National Institutes of Health (NIH), Grant No. 5R01CA153073-2. The content is solely the responsibility of the authors and does not necessarily represent the official views of NCI or NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boddiger D, 2007, LANCET, V370, P923, DOI 10.1016/S0140-6736(07)61427-5; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; De Nooy W., 2005, EXPLORATORY SOCIAL N; Epstein JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000401; FAO, 2004, WORLDW REG MYC FOOD; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Gong YY, 2002, BRIT MED J, V325, P20, DOI 10.1136/bmj.325.7354.20; Groopman JD, 2008, ANNU REV PUBL HEALTH, V29, P187, DOI 10.1146/annurev.publhealth.29.020907.090859; Henry SH, 1999, SCIENCE, V286, P2453, DOI 10.1126/science.286.5449.2453; Jaffee S., 2005, FOOD SAFETY AGR HLTH; *JECFA, 1998, WHO FOOD ADD SER, V40; Jolly P. E., 2008, Mycotoxins: detection methods, management, public health and agricultural trade, P41, DOI 10.1079/9781845930820.0041; Khlangwiset P, 2011, CRIT REV TOXICOL, V41, P740, DOI 10.3109/10408444.2011.575766; Kuniholm MH, 2008, ENVIRON HEALTH PERSP, V116, P1553, DOI 10.1289/ehp.11661; Liu Y, 2010, ENVIRON HEALTH PERSP, V118, P818, DOI 10.1289/ehp.0901388; Lyons R, 2011, STAT POLITICS POLICY, V2, pA2; McKenzie FE, 2004, AM J TROP MED HYG, V71, P94, DOI 10.4269/ajtmh.2004.71.94; Otsuki T, 2001, FOOD POLICY, V26, P495, DOI 10.1016/S0306-9192(01)00018-5; Petroczi A, 2011, WORLD MYCOTOXIN J, V4, P329, DOI 10.3920/WMJ2010.1271; Strosnider H, 2006, ENVIRON HEALTH PERSP, V114, P1898, DOI 10.1289/ehp.9302; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; van Egmond HP, 2007, ANAL BIOANAL CHEM, V389, P147, DOI 10.1007/s00216-007-1317-9; Wu F, 2008, WORLD MYCOTOXIN J, V1, P95, DOI 10.3920/WMJ2008.x011; Wu F, 2004, ENVIRON SCI TECHNOL, V38, P4049, DOI 10.1021/es035353n	25	76	78	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45151	10.1371/journal.pone.0045151	http://dx.doi.org/10.1371/journal.pone.0045151			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049773	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000309556100030
J	Yagi-Utsumi, M; Yoshikawa, S; Yamaguchi, Y; Nishi, Y; Kurimoto, E; Ishida, Y; Homma, T; Hoseki, J; Nishikawa, Y; Koide, T; Nagata, K; Kato, K				Yagi-Utsumi, Maho; Yoshikawa, Sumi; Yamaguchi, Yoshiki; Nishi, Yohei; Kurimoto, Eiji; Ishida, Yoshihito; Homma, Takayuki; Hoseki, Jun; Nishikawa, Yoshimi; Koide, Takaki; Nagata, Kazuhiro; Kato, Koichi			NMR and Mutational Identification of the Collagen-Binding Site of the Chaperone Hsp47	PLOS ONE			English	Article							SHOCK-PROTEIN 47; MOLECULAR CHAPERONE; TRIPLE-HELIX; EXPRESSION; LIVER; BIOSYNTHESIS; RECOGNITION	Heat shock protein 47 (Hsp47) acts as a client-specific chaperone for collagen and plays a vital role in collagen maturation and the consequent embryonic development. In addition, this protein can be a potential target for the treatment of fibrosis. Despite its physiological and pathological importance, little is currently known about the collagen-binding mode of Hsp47 from a structural aspect. Here, we describe an NMR study that was conducted to identify the collagen-binding site of Hsp47. We used chicken Hsp47, which has higher solubility than its human counterpart, and applied a selective N-15-labeling method targeting its tryptophan and histidine residues. Spectral assignments were made based on site-directed mutagenesis of the individual residues. By inspecting the spectral changes that were observed upon interaction with a trimeric collagen peptide and the mutational data, we successfully mapped the collagen-binding site in the B/C beta-barrel domain and a nearby loop in a 3D-homology model based upon a serpin fold. This conclusion was confirmed by mutational analysis. Our findings provide a molecular basis for the design of compounds that target the interaction between Hsp47 and procollagen as therapeutics for fibrotic diseases.	[Yagi-Utsumi, Maho; Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448585, Japan; [Yagi-Utsumi, Maho; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448585, Japan; [Yagi-Utsumi, Maho; Yoshikawa, Sumi; Yamaguchi, Yoshiki; Nishi, Yohei; Kurimoto, Eiji; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan; [Yamaguchi, Yoshiki] RIKEN, Syst Glycobiol Res Grp, Dept Biol Chem, Adv Sci Inst, Wako, Saitama, Japan; [Kurimoto, Eiji] Meijo Univ, Fac Pharm, Nagoya, Aichi 468, Japan; [Ishida, Yoshihito; Homma, Takayuki] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan; [Hoseki, Jun; Nagata, Kazuhiro] Kyoto Sangyo Univ, Fac Life Sci, Lab Mol & Cellular Biol, Kyoto 603, Japan; [Nishikawa, Yoshimi; Koide, Takaki] Waseda Univ, Sch Adv Sci & Engn, Tokyo, Japan	National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Nagoya City University; RIKEN; Meijo University; Kyoto University; Kyoto Sangyo University; Waseda University	Kato, K (corresponding author), Natl Inst Nat Sci, Inst Mol Sci, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	kkatonmr@ims.ac.jp	Hoseki, Jun/AAE-6704-2020; Yamaguchi, Yoshiki/N-5246-2015	Yamaguchi, Yoshiki/0000-0003-0100-5439; Yagi-Utsumi, Maho/0000-0001-8144-740X; Kato, Koichi/0000-0001-7187-9612	Nanotechnology Network Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan;  [20059030];  [21370050]	Nanotechnology Network Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan; ; 	This work was supported in part by Grants-in-Aid for Scientific Research (20059030, 21370050) (http://www.jsps.go.jp/english/e-grants/index.html) and the Nanotechnology Network Project of the Ministry of Education, Culture, Sports, Science and Technology of Japan (https://nanonet.nims.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brown KE, 2005, LAB INVEST, V85, P789, DOI 10.1038/labinvest.3700271; Dafforn TR, 2001, J BIOL CHEM, V276, P49310, DOI 10.1074/jbc.M108896200; Dmitriev OY, 2008, BBA-BIOENERGETICS, V1777, P227, DOI 10.1016/j.bbabio.2007.11.011; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Ishida Y, 2006, MOL BIOL CELL, V17, P2346, DOI 10.1091/mbc.E05-11-1065; Ishida Y, 2011, METHOD ENZYMOL, V499, P167, DOI 10.1016/B978-0-12-386471-0.00009-2; Koide T, 2006, J BIOL CHEM, V281, P3432, DOI 10.1074/jbc.M509707200; Koide T, 2006, J BIOL CHEM, V281, P11177, DOI 10.1074/jbc.M601369200; Koide T, 2004, BIOORG MED CHEM LETT, V14, P125, DOI 10.1016/j.bmcl.2003.10.005; Koide T, 2002, J BIOL CHEM, V277, P6178, DOI 10.1074/jbc.M106497200; Mala JGS, 2010, LIFE SCI, V87, P579, DOI 10.1016/j.lfs.2010.09.024; MASUDA H, 1994, J CLIN INVEST, V94, P2481, DOI 10.1172/JCI117617; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Nagata K, 2003, SEMIN CELL DEV BIOL, V14, P275, DOI 10.1016/j.semcdb.2003.09.020; Nishida N, 2006, J BIOCHEM, V140, P591, DOI 10.1093/jb/mvj188; Ragg H, 2007, CELL MOL LIFE SCI, V64, P2763, DOI 10.1007/s00018-007-7157-0; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Sunamoto M, 1998, INT J EXP PATHOL, V79, P133, DOI 10.1046/j.1365-2613.1998.00061.x; Takehara S, 2009, J MOL BIOL, V388, P11, DOI 10.1016/j.jmb.2009.03.007; Takeuchi K, 2007, J BIOMOL NMR, V38, P89, DOI 10.1007/s10858-007-9152-z; Yagi-Utsumi Maho, 2010, Int J Alzheimers Dis, V2011, P925073, DOI 10.4061/2011/925073	22	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45930	10.1371/journal.pone.0045930	http://dx.doi.org/10.1371/journal.pone.0045930			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049894	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100101
J	Rao, M; Song, WQ; Jiang, AX; Shyr, Y; Lev, S; Greenstein, D; Brantley-Sieders, D; Chen, J				Rao, Meghana; Song, Wenqiang; Jiang, Aixiang; Shyr, Yu; Lev, Sima; Greenstein, David; Brantley-Sieders, Dana; Chen, Jin			VAMP-Associated Protein B (VAPB) Promotes Breast Tumor Growth by Modulation of Akt Activity	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; METASTATIC PROGRESSION; FFAT MOTIF; MEMBRANE; CANCER; EXPRESSION; TRANSPORT; ER; IDENTIFICATION; TRAFFICKING	VAPB (VAMP- associated protein B) is an ER protein that regulates multiple biological functions. Although aberrant expression of VAPB is associated with breast cancer, its function in tumor cells is poorly understood. In this report, we provide evidence that VAPB regulates breast tumor cell proliferation and AKT activation. VAPB protein expression is elevated in primary and metastatic tumor specimens, and VAPB mRNA expression levels correlated negatively with patient survival in two large breast tumor datasets. Overexpression of VAPB in mammary epithelial cells increased cell growth, whereas VAPB knockdown in tumor cells inhibited cell proliferation in vitro and suppressed tumor growth in orthotopic mammary gland allografts. The growth regulation of mammary tumor cells controlled by VAPB appears to be mediated, at least in part, by modulation of AKT activity. Overexpression of VAPB in MCF10A-HER2 cells enhances phosphorylation of AKT. In contrast, knockdown of VAPB in MMTV-Neu tumor cells inhibited pAKT levels. Pharmacological inhibition of AKT significantly reduced three-dimensional spheroid growth induced by VAPB. Collectively, the genetic, functional and mechanistic analyses suggest a role of VAPB in tumor promotion in human breast cancer.	[Rao, Meghana; Chen, Jin] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA; [Song, Wenqiang; Brantley-Sieders, Dana; Chen, Jin] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Chen, Jin] Vanderbilt Univ, Sch Med, Dept Cellular & Dev Biol, Nashville, TN 37212 USA; [Jiang, Aixiang; Shyr, Yu] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Jiang, Aixiang; Shyr, Yu; Chen, Jin] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA; [Chen, Jin] Tennessee Valley Healthcare Syst, Vet Affairs Med Ctr, Nashville, TN 37212 USA; [Lev, Sima] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Greenstein, David] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Weizmann Institute of Science; University of Minnesota System; University of Minnesota Twin Cities	Chen, J (corresponding author), Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA.	jin.chen@vanderbilt.edu	Lev, Sima/AAP-7880-2020	Lev, Sima/0000-0002-2108-3330; Chen, Jin/0000-0002-5557-2079; Jiang, Aixiang/0000-0002-6153-7595; Greenstein, David/0000-0001-8189-2087	Department of Veterans Affairs (VA) through a VA Merit Award; National Institutes of Health [CA95004, CA114301, CA1179151, CA68485, DK20593, DK58404, HD15052, DK59637, EY08126]; Department of Defense predoctoral fellowship [W81XWH-10-1-0256]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009592, P30CA068485, R01CA114301, R01CA095004] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, U24DK059637, P30DK020593, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057173, R01GM065115] Funding Source: NIH RePORTER	Department of Veterans Affairs (VA) through a VA Merit Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense predoctoral fellowship(United States Department of Defense); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Department of Veterans Affairs (VA) through a VA Merit Award (JC), National Institutes of Health RO1 grants CA95004 & CA114301 (JC), a KO1 award CA1179151 (DBS), and a Department of Defense predoctoral fellowship W81XWH-10-1-0256 (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the Vanderbilt Mass Spectrometry Research Center and Dr. Hayes McDonald for support on sample analyses and data interpretations and the Vanderbilt Translational Pathology Shared Resource for tumor section immunohistochemistry. Confocal microscopy was performed in part through the use of the VUMC Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, HD15052, DK59637 and EY08126). We also thank Mr. Yoonha Hwang for helping in generating some of the constructs. Temperature-sensitive VSVG-GFP construct was generously provided by Dr. Jennifer Lippencott-Swartz (National Institute of Health).	Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Arriola E, 2008, LAB INVEST, V88, P491, DOI 10.1038/labinvest.2008.19; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; Brantley DM, 2001, MOL BIOL CELL, V12, P1445, DOI 10.1091/mbc.12.5.1445; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Brantley-Sieders DM, 2008, J CLIN INVEST, V118, P64, DOI 10.1172/JCI33154; Chen J, 2012, ADV CANCER RES, V114, P1, DOI 10.1016/B978-0-12-386503-8.00001-6; Chen Jin, 2008, Cancer Res, V68, P10031, DOI 10.1158/0008-5472.CAN-08-3010; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gkogkas C, 2008, HUM MOL GENET, V17, P1517, DOI 10.1093/hmg/ddn040; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jansen M, 2011, TRAFFIC, V12, P218, DOI 10.1111/j.1600-0854.2010.01142.x; Kagiwada S, 2003, J BIOCHEM, V133, P515, DOI 10.1093/jb/mvg068; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Lapierre LA, 1999, J CELL SCI, V112, P3723; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Miller MA, 2003, GENE DEV, V17, P187, DOI 10.1101/gad.1028303; Moumen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026066; Muraoka RS, 2003, MOL CELL BIOL, V23, P8691, DOI 10.1128/MCB.23.23.8691-8703.2003; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; Rizki A, 2008, CANCER RES, V68, P1378, DOI 10.1158/0008-5472.CAN-07-2225; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Spang A, 2002, CURR OPIN CELL BIOL, V14, P423, DOI 10.1016/S0955-0674(02)00346-0; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Suzuki H, 2009, J NEUROCHEM, V108, P973, DOI [10.1111/j.1471-4159.2008.05857.x, 10.1111/j.0022-3042.2008.05857.x]; Tsuda H, 2008, CELL, V133, P963, DOI 10.1016/j.cell.2008.04.039; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vaught D, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2207; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247	45	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46281	10.1371/journal.pone.0046281	http://dx.doi.org/10.1371/journal.pone.0046281			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049696	gold, Green Submitted, Green Published			2022-12-27	WOS:000309388500023
J	Crombach, A; Cicin-Sain, D; Wotton, KR; Jaeger, J				Crombach, Anton; Cicin-Sain, Damjan; Wotton, Karl R.; Jaeger, Johannes			Medium-Throughput Processing of Whole Mount In Situ Hybridisation Experiments into Gene Expression Domains	PLOS ONE			English	Article							3-DIMENSIONAL MORPHOLOGY; DROSOPHILA BLASTODERM; SEGMENTATION GENES; PATTERNS; IMAGE; ATLAS; FLY	Understanding the function and evolution of developmental regulatory networks requires the characterisation and quantification of spatio-temporal gene expression patterns across a range of systems and species. However, most high-throughput methods to measure the dynamics of gene expression do not preserve the detailed spatial information needed in this context. For this reason, quantification methods based on image bioinformatics have become increasingly important over the past few years. Most available approaches in this field either focus on the detailed and accurate quantification of a small set of gene expression patterns, or attempt high-throughput analysis of spatial expression through binary pattern extraction and large-scale analysis of the resulting datasets. Here we present a robust, "medium-throughput" pipeline to process in situ hybridisation patterns from embryos of different species of flies. It bridges the gap between high-resolution, and high-throughput image processing methods, enabling us to quantify graded expression patterns along the anteroposterior axis of the embryo in an efficient and straightforward manner. Our method is based on a robust enzymatic (colorimetric) in situ hybridisation protocol and rapid data acquisition through wide-field microscopy. Data processing consists of image segmentation, profile extraction, and determination of expression domain boundary positions using a spline approximation. It results in sets of measured boundaries sorted by gene and developmental time point, which are analysed in terms of expression variability or spatio-temporal dynamics. Our method yields integrated time series of spatial gene expression, which can be used to reverse-engineer developmental gene regulatory networks across species. It is easily adaptable to other processes and species, enabling the in silico reconstitution of gene regulatory networks in a wide range of developmental contexts.	[Jaeger, Johannes] CRG, EMBL CRG Res Unit Syst Biol, Barcelona, Spain; UPF, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL); Pompeu Fabra University	Jaeger, J (corresponding author), CRG, EMBL CRG Res Unit Syst Biol, Barcelona, Spain.	yogi.jaeger@crg.eu	Crombach, Anton/H-1275-2015	Crombach, Anton/0000-0002-2889-5120; Jaeger, Johannes/0000-0002-2568-2103; Wotton, Karl/0000-0002-8672-9948	MEC-EMBL agreement for the EMBL/CRG Research Unit in Systems Biology; ERANet: ComplexityNET program [153]; Catalan funding agency AGAUR [406]; Spanish Ministry of Science [BFU2009-10184]; European Commission [FP7-KBBE-2011-5/289434]	MEC-EMBL agreement for the EMBL/CRG Research Unit in Systems Biology; ERANet: ComplexityNET program; Catalan funding agency AGAUR; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	The laboratory of Johannes Jaeger and this study in particular was funded by the MEC-EMBL agreement for the EMBL/CRG Research Unit in Systems Biology, by grant 153 (MOPDEV) of the ERANet: ComplexityNET program, by SGR grant 406 from the Catalan funding agency AGAUR, by grant BFU2009-10184 from the Spanish Ministry of Science, and by European Commission grant FP7-KBBE-2011-5/289434 (BioPreDyn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAM M, 1987, DEVELOPMENT, V101, P1; Ay A, 2008, TISSUE ENG PT A, V14, P1517, DOI 10.1089/ten.tea.2008.0202; Crombach A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002589; Foley J.D., 1995, COMPUTER GRAPHICS PR; Fowlkes CC, 2008, CELL, V133, P364, DOI 10.1016/j.cell.2008.01.053; Frise E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2009.102; Furriols M, 2003, EMBO J, V22, P1947, DOI 10.1093/emboj/cdg224; Garcia-Solache M, 2010, DEV BIOL, V344, P306, DOI 10.1016/j.ydbio.2010.04.019; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; Gurunathan R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-202; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; Jaeger J, 2010, LEARNING INFERENCE C, P9; Jaeger J, 2012, ADV EXP MED BIOL, V751, P93, DOI 10.1007/978-1-4614-3567-9_5; Jaeger J, 2011, CELL MOL LIFE SCI, V68, P243, DOI 10.1007/s00018-010-0536-y; Janssens H, 2005, DEV GENES EVOL, V215, P374, DOI 10.1007/s00427-005-0484-y; Keranen SVE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r124; Khairy K, 2011, GENESIS, V49, P488, DOI 10.1002/dvg.20698; Kherlopian AR, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-74; Kumar S, 2002, GENETICS, V162, P2037; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Lemke S, 2009, DEVELOPMENT, V136, P117, DOI 10.1242/dev.030270; Luengo Hendriks CL, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r123; Mace DL, 2010, BIOINFORMATICS, V26, P761, DOI 10.1093/bioinformatics/btp658; Megason SG, 2007, CELL, V130, P784, DOI 10.1016/j.cell.2007.08.031; Myasnikova E, 2005, DEV GENES EVOL, V215, P320, DOI 10.1007/s00427-005-0472-2; Myasnikova E, 2001, BIOINFORMATICS, V17, P3, DOI 10.1093/bioinformatics/17.1.3; Peng HC, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-S1-S7; Pisarev A, 2009, NUCLEIC ACIDS RES, V37, pD560, DOI 10.1093/nar/gkn717; Poustelnikova E, 2004, BIOINFORMATICS, V20, P2212, DOI 10.1093/bioinformatics/bth222; Puniyani K, 2010, BIOINFORMATICS, V26, pi47, DOI 10.1093/bioinformatics/btq172; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shamir L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000974; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; STJOHNSTON D, 1992, CELL, V68, P201; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; Surkova S, 2008, FLY, V2, P58, DOI 10.4161/fly.6060; Tomancak P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r145	37	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46658	10.1371/journal.pone.0046658	http://dx.doi.org/10.1371/journal.pone.0046658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029561	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900195
J	Murphy, SV; Lim, R; Heraud, P; Cholewa, M; Le Gros, M; de Jonge, MD; Howard, DL; Paterson, D; McDonald, C; Atala, A; Jenkin, G; Wallace, EM				Murphy, Sean V.; Lim, Rebecca; Heraud, Philip; Cholewa, Marian; Le Gros, Mark; de Jonge, Martin D.; Howard, Daryl L.; Paterson, David; McDonald, Courtney; Atala, Anthony; Jenkin, Graham; Wallace, Euan M.			Human Amnion Epithelial Cells Induced to Express Functional Cystic Fibrosis Transmembrane Conductance Regulator	PLOS ONE			English	Article							GENE-THERAPY; CHLORIDE CHANNELS; CFTR	Cystic fibrosis, an autosomal recessive disorder caused by a mutation in a gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR), remains a leading cause of childhood respiratory morbidity and mortality. The respiratory consequences of cystic fibrosis include the generation of thick, tenacious mucus that impairs lung clearance, predisposing the individual to repeated and persistent infections, progressive lung damage and shortened lifespan. Currently there is no cure for cystic fibrosis. With this in mind, we investigated the ability of human amnion epithelial cells (hAECs) to express functional CFTR. We found that hAECs formed 3-dimensional structures and expressed the CFTR gene and protein after culture in Small Airway Growth Medium (SAGM). We also observed a polarized CFTR distribution on the membrane of hAECs cultured in SAGM, similar to that observed in polarized airway cells in vivo. Further, hAECs induced to express CFTR possessed functional iodide/chloride (I-/Cl-) ion channels that were inhibited by the CFTR-inhibitor CFTR-172, indicating the presence of functional CFTR ion channels. These data suggest that hAECs may be a promising source for the development of a cellular therapy for cystic fibrosis.	[Murphy, Sean V.; Lim, Rebecca; McDonald, Courtney; Jenkin, Graham; Wallace, Euan M.] Monash Univ, Ritchie Ctr, Monash Inst Med Res, Melbourne, Vic 3004, Australia; [Heraud, Philip] Monash Univ, Ctr Biospect, Sch Chem, Melbourne, Vic 3004, Australia; [Cholewa, Marian] Monash Univ, Monash Ctr Synchrotron Sci, Melbourne, Vic 3004, Australia; [Le Gros, Mark] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [de Jonge, Martin D.; Howard, Daryl L.; Paterson, David] Australian Synchrotron, Xray Fluorescence Microscopy, Melbourne, Vic, Australia; [Lim, Rebecca; Jenkin, Graham; Wallace, Euan M.] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic 3004, Australia; [Atala, Anthony] Wake Forest Univ, Bowman Gray Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC USA	Monash University; Monash University; Monash University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Monash University; Wake Forest University; Wake Forest Baptist Medical Center	Wallace, EM (corresponding author), Monash Univ, Ritchie Ctr, Monash Inst Med Res, Melbourne, Vic 3004, Australia.	euan.wallace@monash.edu	Cholewa, Marian/C-9474-2011; Wallace, Euan M/K-6774-2015; de Jonge, Martin D/C-3400-2011; Lim, Rebecca/K-5175-2019; Howard, Daryl/E-9107-2013	Wallace, Euan M/0000-0002-4506-5233; de Jonge, Martin D/0000-0001-7731-6175; Lim, Rebecca/0000-0002-0410-497X; Heraud, Philip/0000-0003-4377-9184; Howard, Daryl/0000-0001-6071-2382; McDonald, Courtney/0000-0001-8421-461X; Atala, Anthony/0000-0001-8186-2160	Australian Synchrotron International Synchrotron Access Program; NHMRC Project [606483]; Australian Cystic Fibrosis Research Trust; Victorian Government Operational Inftrastructure Support Program; National Center for Research Resources [5 P41 RR019664-08]; National Institute of General Medical Sciences of the National Institutes of Health [8 P41 GM103445-08]; US Department of Energy, Office of Biological and Environmental Research [DE-AC02-05CH11231]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR019664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103445] Funding Source: NIH RePORTER	Australian Synchrotron International Synchrotron Access Program; NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia); Australian Cystic Fibrosis Research Trust; Victorian Government Operational Inftrastructure Support Program; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Australian Synchrotron International Synchrotron Access Program, NHMRC Project Grant 606483, the Australian Cystic Fibrosis Research Trust, the Victorian Government Operational Inftrastructure Support Program, the National Center for Research Resources (5 P41 RR019664-08) and the National Institute of General Medical Sciences (8 P41 GM103445-08) of the National Institutes of Health and the US Department of Energy, Office of Biological and Environmental Research (Contract No. DE-AC02-05CH11231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson TJ, 2008, CURR GENE THER, V8, P201, DOI 10.2174/156652308784746468; Chappe V, 2005, EMBO J, V24, P2730, DOI 10.1038/sj.emboj.7600747; Chen YT, 2007, STEM CELLS, V25, P1995, DOI 10.1634/stemcells.2006-0677; Conese M, 2011, J CYST FIBROS, V10, pS114, DOI 10.1016/S1569-1993(11)60017-9; Erdogan H, 1999, PHYS MED BIOL, V44, P2835, DOI 10.1088/0031-9155/44/11/311; Ferrari S, 2002, ADV DRUG DELIVER REV, V54, P1373, DOI 10.1016/S0169-409X(02)00145-X; Griesenbach U, 2004, GENE THER, V11, pS43, DOI 10.1038/sj.gt.3302368; Griesenbach U, 2004, CURR OPIN PULM MED, V10, P542, DOI 10.1097/01.mcp.0000142102.91202.04; Hida K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019919; Ilancheran S, 2007, BIOL REPROD, V77, P577, DOI 10.1095/biolreprod.106.055244; Ito Y, 2000, BIOCHEM BIOPH RES CO, V274, P230, DOI 10.1006/bbrc.2000.3125; KARTNER N, 1992, NAT GENET, V1, P321, DOI 10.1038/ng0892-321; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Lu M, 2006, J CLIN INVEST, V116, P797, DOI 10.1172/JCI26961; Maduke M, 2000, ANNU REV BIOPH BIOM, V29, P411, DOI 10.1146/annurev.biophys.29.1.411; Moodley Y, 2010, AM J RESP CRIT CARE, V182, P643, DOI 10.1164/rccm.201001-0014OC; Murphy S, 2010, CURR PROTOC STEM CEL, V1, p1E61; Murphy S, 2011, CELL TRANSPLANT, V20, P909, DOI 10.3727/096368910X543385; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Paracchini V, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/575471; Paterson D, 2011, AIP CONF PROC, V1365, P219, DOI 10.1063/1.3625343; Rosenecker J, 2006, CURR OPIN MOL THER, V8, P439; Stayman JW, 2000, IEEE T MED IMAGING, V19, P601, DOI 10.1109/42.870666; Tang WM, 2004, J BIOMOL SCREEN, V9, P607, DOI 10.1177/1087057104266740; Uchida M, 2009, P NATL ACAD SCI USA, V106, P19375, DOI 10.1073/pnas.0906145106; Vankeerberghen Anne, 2002, J Cyst Fibros, V1, P13, DOI 10.1016/S1569-1993(01)00003-0; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; Walsh DE, 2000, J MEMBRANE BIOL, V177, P209, DOI 10.1007/s002320010004	28	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46533	10.1371/journal.pone.0046533	http://dx.doi.org/10.1371/journal.pone.0046533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029546	Green Submitted, gold, Green Published			2022-12-27	WOS:000309973900182
J	Wilson, MJ; Dearden, PK				Wilson, Megan J.; Dearden, Peter K.			Pair-Rule Gene Orthologues Have Unexpected Maternal Roles in the Honeybee (Apis mellifera)	PLOS ONE			English	Article							GROUP-III GENES; SPIDER CUPIENNIUS-SALEI; HOMEODOMAIN PROTEIN FTZ; SHORT-GERM INSECT; FUSHI-TARAZU; EXPRESSION PATTERNS; TRIBOLIUM-CASTANEUM; GAP-LIKE; DROSOPHILA; SEGMENTATION	Pair-rule genes are a class of segmentation genes first identified in Drosophila melanogaster. In Drosophila, these genes act to translate non-periodic information produced by the overlapping patterns of gap gene expression into patterns of gene expression in every other segment. While pair-rule genes are, for the most part, conserved in metazoans, their function in pair-rule patterning is not. Many of these genes do, however, regulate segmentation in arthropods and do so with dual-segment periodicity. Here we examine the expression and function of honeybee orthologues of Drosophila pair-rule genes. Knockdown of the expression of these genes leads to extensive patterning defects, implying that they act in early patterning, as well as segmentation in honeybee embryos. We show that these pair-rule gene orthologues indeed regulate the expression of honeybee maternal and gap genes implying roles in maternal patterning of the honeybee embryo.	[Wilson, Megan J.; Dearden, Peter K.] Univ Otago, Dept Biochem, Lab Evolut & Dev, Natl Res Ctr Growth & Dev & Genet Otago, Dunedin, New Zealand	University of Otago	Dearden, PK (corresponding author), Univ Otago, Dept Biochem, Lab Evolut & Dev, Natl Res Ctr Growth & Dev & Genet Otago, Dunedin, New Zealand.	peter.dearden@otago.ac.nz	Dearden, Peter/B-7607-2008	Dearden, Peter/0000-0001-7790-9675; Wilson, Megan/0000-0003-3425-5071	Royal Society of New Zealand Marsden Grant [UOO0401]	Royal Society of New Zealand Marsden Grant(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by a Royal Society of New Zealand Marsden Grant to P. K. D. (UOO0401). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binner P, 1997, DEV GENES EVOL, V206, P447, DOI 10.1007/s004270050074; BROWN SJ, 1994, P NATL ACAD SCI USA, V91, P12922, DOI 10.1073/pnas.91.26.12922; Chipman AD, 2004, CURR BIOL, V14, P1250, DOI 10.1016/j.cub.2004.07.026; Choe CP, 2007, DEV BIOL, V302, P281, DOI 10.1016/j.ydbio.2006.09.037; Choe CP, 2006, P NATL ACAD SCI USA, V103, P6560, DOI 10.1073/pnas.0510440103; Damen WGM, 2000, P NATL ACAD SCI USA, V97, P4515, DOI 10.1073/pnas.97.9.4515; Daubresse G, 1999, DEVELOPMENT, V126, P1175; Davis GK, 2001, DEVELOPMENT, V128, P3445; DAWES R, 1994, DEVELOPMENT, V120, P1561; Dearden PK, 2006, GENOME RES, V16, P1376, DOI 10.1101/gr.5108606; Dearden PK, 2002, DEVELOPMENT, V129, P5461, DOI 10.1242/dev.00099; Dearden PK, 2009, COLD SPRING HARB PRO; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Duncan EJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-558; DuPraw E., 1967, METHODS DEV BIOL, P183; FINKELSTEIN R, 1990, NATURE, V346, P485, DOI 10.1038/346485a0; Florence B, 1997, DEVELOPMENT, V124, P839; Guichet A, 1997, NATURE, V385, P548, DOI 10.1038/385548a0; Heffer A, 2010, P NATL ACAD SCI USA, V107, P18040, DOI 10.1073/pnas.1010746107; Hughes CL, 2004, EVOL DEV, V6, P393, DOI 10.1111/j.1525-142X.2004.04048.x; Hughes CL, 2002, DEV BIOL, V247, P47, DOI 10.1006/dbio.2002.0683; Liu PZ, 2005, DEVELOPMENT, V132, P2081, DOI 10.1242/dev.01807; Lohr U, 2005, CURR BIOL, V15, P643, DOI 10.1016/j.cub.2005.02.048; Lohr U, 2001, CURR BIOL, V11, P1403, DOI 10.1016/S0960-9822(01)00443-2; MACDONALD PM, 1986, CELL, V47, P721, DOI 10.1016/0092-8674(86)90515-5; Mito T, 2007, DEV BIOL, V303, P202, DOI 10.1016/j.ydbio.2006.11.003; Mouchel-Vielh E, 2002, EVOL DEV, V4, P76, DOI 10.1046/j.1525-142X.2002.01063.x; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Osborne P, 2005, APIDOLOGIE, V36, P113, DOI 10.1051/apido:2004075; Osborne PW, 2005, DEV GENES EVOL, V215, P499, DOI 10.1007/s00427-005-0008-9; PATEL NH, 1992, NATURE, V357, P339, DOI 10.1038/357339a0; Peel AD, 2005, NAT REV GENET, V6, P905, DOI 10.1038/nrg1724; Sander K., 1976, Advances in insect physiology. Volume 12., P125, DOI 10.1016/S0065-2806(08)60255-6; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Schoppmeier M, 2005, EVOL DEV, V7, P160, DOI 10.1111/j.1525-142X.2005.05018.x; Stauber M, 1999, P NATL ACAD SCI USA, V96, P3786, DOI 10.1073/pnas.96.7.3786; Tang AH, 2001, DEVELOPMENT, V128, P801; TSAI CC, 1994, DEVELOPMENT, V120, P1671; WALLDORF U, 1989, P NATL ACAD SCI USA, V86, P9971, DOI 10.1073/pnas.86.24.9971; Wilson MJ, 2011, DEVELOPMENT, V138, P3497, DOI 10.1242/dev.067926; Wilson MJ, 2010, DEV BIOL, V339, P200, DOI 10.1016/j.ydbio.2009.12.015; Wilson MJ, 2009, DEV BIOL, V335, P276, DOI 10.1016/j.ydbio.2009.09.002; Yu Y, 1997, NATURE, V385, P552, DOI 10.1038/385552a0; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004	44	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46490	10.1371/journal.pone.0046490	http://dx.doi.org/10.1371/journal.pone.0046490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029534	Green Submitted, gold, Green Published			2022-12-27	WOS:000309973900173
J	Eyupoglu, IY; Hore, N; Savaskan, NE; Grummich, P; Roessler, K; Buchfelder, M; Ganslandt, O				Eyuepoglu, Ilker Y.; Hore, Nirjhar; Savaskan, Nic E.; Grummich, Peter; Roessler, Karl; Buchfelder, Michael; Ganslandt, Oliver			Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization Approach	PLOS ONE			English	Article							FLUORESCENCE-GUIDED RESECTION; ACID-INDUCED FLUORESCENCE; GLIOBLASTOMA-MULTIFORME; 5-AMINOLEVULINIC ACID; FUNCTIONAL NEURONAVIGATION; ADJUVANT TEMOZOLOMIDE; CLINICAL ARTICLE; GRADE GLIOMAS; BRAIN-TUMORS; PHASE-III	Despite continuing debates around cytoreductive surgery in malignant gliomas, there is broad consensus that increased extent of tumor reduction improves overall survival. However, maximization of the extent of tumor resection is hampered by difficulty in intraoperative discrimination between normal and pathological tissue. In this context, two established methods for tumor visualization, fluorescence guided surgery with 5-ALA and intraoperative MRI (iMRI) with integrated functional neuronavigation were investigated as a dual intraoperative visualization (DIV) approach. Thirty seven patients presumably suffering from malignant gliomas (WHO grade III or IV) according to radiological appearance were included. Twenty-one experimental sequences showing complete resection according to the 5-ALA technique were confirmed by iMRI. Fourteen sequences showing complete resection according to the 5-ALA technique could not be confirmed by iMRI, which detected residual tumor. Further analysis revealed that these sequences could be classified as functional grade II tumors (adjacent to eloquent brain areas). The combination of fluorescence guided resection and intraoperative evaluation by high field MRI significantly increased the extent of tumor resection in this subgroup of malignant gliomas located adjacent to eloquent areas from 61.7% to 100%; 5-ALA alone proved to be insufficient in attaining gross total resection without the danger of incurring postoperative neurological deterioration. Furthermore, in the case of functional grade III gliomas, iMRI in combination with functional neuronavigation was significantly superior to the 5-ALA resection technique. The extent of resection could be increased from 57.1% to 71.2% without incurring postoperative neurological deficits.	[Eyuepoglu, Ilker Y.; Hore, Nirjhar; Savaskan, Nic E.; Grummich, Peter; Roessler, Karl; Buchfelder, Michael; Ganslandt, Oliver] Univ Erlangen Nurnberg, Dept Neurosurg, Erlangen, Germany	University of Erlangen Nuremberg	Eyupoglu, IY (corresponding author), Univ Erlangen Nurnberg, Dept Neurosurg, Erlangen, Germany.	ilker.eyupoglu@uk-erlangen.de	Rössler, Karl/AAN-5096-2021; Savaskan, Nicolai/D-2923-2018	Rössler, Karl/0000-0002-9249-8082; Eyupoglu, Ilker/0000-0002-8185-7764; Savaskan, Nicolai/0000-0003-1348-094X				ALBERT FK, 1994, NEUROSURGERY, V34, P45, DOI 10.1097/00006123-199401000-00008; Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031; Chang EF, 2011, J NEUROSURG, V114, P566, DOI 10.3171/2010.6.JNS091246; De Witt Hamer PC, 2012, J CLIN ONCOL; Valle RD, 2011, J NEURO-ONCOL, V102, P105, DOI 10.1007/s11060-010-0296-4; Feigl GC, 2010, J NEUROSURG, V113, P352, DOI 10.3171/2009.10.JNS09447; Kleihues P., 2000, TUMOURS NERVOUS SYST; Kowalczuk A, 1997, NEUROSURGERY, V41, P1028, DOI 10.1097/00006123-199711000-00004; Kreth FW, 1999, CANCER, V86, P2117, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2117::AID-CNCR33>3.3.CO;2-#; Kubben PL, 2011, LANCET ONCOL, V12, P1062, DOI 10.1016/S1470-2045(11)70130-9; Kuhnt D, 2011, NEURO-ONCOLOGY, V13, P1339, DOI 10.1093/neuonc/nor133; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467; Liao HG, 2008, LECT NOTES COMPUT SC, V5242, P373, DOI 10.1007/978-3-540-85990-1_45; McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9; Nimsky C, 2004, NEUROSURGERY, V55, P358, DOI 10.1227/01.NEU.0000129694.64671.91; Nimsky C, 2004, ADV TECH STAND NEUR, V29, P229; Nimsky C, 2006, NEUROL RES, V28, P482, DOI 10.1179/016164106X115125; ROBERTS DW, 2010, J NEUROSURG; Sanai N, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.12.FOCUS09266; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; Stepp H, 2007, J ENVIRON PATHOL TOX, V26, P157, DOI 10.1615/JEnvironPatholToxicolOncol.v26.i2.110; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 2000, J NEUROSURG, V93, P1003, DOI 10.3171/jns.2000.93.6.1003; STUMMER W, 2010, J NEUROSURG; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tsugu A, 2011, WORLD NEUROSURG, V76, P120, DOI 10.1016/j.wneu.2011.02.005; van den Bent MJ, 2006, EUR J CANCER, V42, P582, DOI 10.1016/j.ejca.2005.06.031; Van Meir EG, 2010, CA-CANCER J CLIN, V60, P166, DOI 10.3322/caac.20069; VECHT CJ, 1990, J NEUROL NEUROSUR PS, V53, P466, DOI 10.1136/jnnp.53.6.466; Vuorinen V, 2003, ACTA NEUROCHIR, V145, P5, DOI 10.1007/s00701-002-1030-6; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wick W, 2004, NEUROLOGY, V62, P2113, DOI 10.1212/01.WNL.0000127617.89363.84; Yung WKA, 2000, BRIT J CANCER, V83, P588, DOI 10.1054/bjoc.2000.1316	36	86	88	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e44885	10.1371/journal.pone.0044885	http://dx.doi.org/10.1371/journal.pone.0044885			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049761	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300013
J	Kriechbaumer, V; Nabok, A; Widdowson, R; Smith, DP; Abell, BM				Kriechbaumer, Verena; Nabok, Alexei; Widdowson, Robert; Smith, David P.; Abell, Ben M.			Quantification of Ligand Binding to G-Protein Coupled Receptors on Cell Membranes by Ellipsometry	PLOS ONE			English	Article							INTERNAL-REFLECTION ELLIPSOMETRY; SURFACE-PLASMON RESONANCE; CHEMOKINE RECEPTORS; CXCR4; RECONSTITUTION; GLYCOSYLATION; INHIBITION; CORECEPTOR; EXPRESSION; RESIDUES	G-protein-coupled receptors (GPCRs) are prime drug targets and targeted by approximately 60% of current therapeutic drugs such as beta-blockers, antipsychotics and analgesics. However, no biophysical methods are available to quantify their interactions with ligand binding in a native environment. Here, we use ellipsometry to quantify specific interactions of receptors within native cell membranes. As a model system, the GPCR-ligand CXCL12 alpha and its receptor CXCR4 are used. Human-derived Ishikawa cells were deposited onto gold coated slides via Langmuir-Schaefer film deposition and interactions between the receptor CXCR4 on these cells and its ligand CXCL12 alpha were detected via total internal reflection ellipsometry (TIRE). This interaction could be inhibited by application of the CXCR4-binding drug AMD3100. Advantages of this approach are that it allows measurement of interactions in a lipid environment without the need for labelling, protein purification or reconstitution of membrane proteins. This technique is potentially applicable to a wide variety of cell types and their membrane receptors, providing a novel method to determine ligand or drug interactions targeting GPCRs and other membrane proteins.	[Kriechbaumer, Verena; Widdowson, Robert; Smith, David P.; Abell, Ben M.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England; [Nabok, Alexei] Sheffield Hallam Univ, Mat & Engn Res Inst, Sheffield S1 1WB, S Yorkshire, England	Sheffield Hallam University; Sheffield Hallam University	Kriechbaumer, V (corresponding author), Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Oxford OX3 0BP, England.	vkriechbaumer@brookes.ac.uk	Nabok, Alexei/AAW-5758-2020; Kriechbaumer, Verena/AAW-9148-2020; Kriechbaumer, Verena/ABF-5534-2020	Kriechbaumer, Verena/0000-0003-3782-5834; Abell, Ben/0000-0002-0953-0046; Smith, David/0000-0001-5177-8574	European Plastic Surgery Research Council (EPSRC) [EP/H000275/1, EP/I016473/1]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E01559X/1]; BBSRC [BB/E01559X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E01559X/1] Funding Source: researchfish	European Plastic Surgery Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the European Plastic Surgery Research Council (EPSRC) Engineering for Life research grant (number EP/H000275/1) and Feasibility Study grant (number EP/I016473/1), and a Biotechnology and Biological Sciences Research Council (BBSRC) research grant (number BB/E01559X/1) awarded to BMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arwin H, 2004, APPL OPTICS, V43, P3028, DOI 10.1364/AO.43.003028; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Berson JF, 1996, J VIROL, V70, P6288, DOI 10.1128/JVI.70.9.6288-6295.1996; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Chabot DJ, 2000, J VIROL, V74, P4404, DOI 10.1128/JVI.74.9.4404-4413.2000; Cooper MA, 2004, J MOL RECOGNIT, V17, P286, DOI 10.1002/jmr.675; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Davies S, 2000, BRIT J CANCER, V83, P1730, DOI 10.1054/bjoc.2000.1507; Emons G, 1997, TRENDS ENDOCRIN MET, V8, P355, DOI 10.1016/S1043-2760(97)00155-0; Filmore D., 2004, MOD DRUG DISCOV, V7, P24; Fuxe K, 2008, PHYSIOLOGY, V23, P322, DOI 10.1152/physiol.00028.2008; Gerlach LO, 2003, BIOCHEMISTRY-US, V42, P710, DOI 10.1021/bi0264770; Gonzalez-Maeso J, 2010, NAT NEUROSCI, V13, P524, DOI 10.1038/nn0510-524; Huang XQ, 2003, BIOPHYS J, V84, P171, DOI 10.1016/S0006-3495(03)74840-1; Jingami H, 2005, J MOL NEUROSCI, V26, P123, DOI 10.1385/JMN:26:2-3:123; Kalatskaya I, 2009, MOL PHARMACOL, V75, P1240, DOI 10.1124/mol.108.053389; Katayama H, 2010, P NATL ACAD SCI USA, V107, P3453, DOI 10.1073/pnas.1000100107; Kriechbaumer V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034455; Kubarek L, 2007, FEBS LETT, V581, P1441, DOI 10.1016/j.febslet.2007.02.070; Liu X, 2003, ANAL BIOCHEM, V314, P301, DOI 10.1016/S0003-2697(02)00696-6; Maynard Jennifer A., 2009, Biotechnology Journal, V4, P1542, DOI 10.1002/biot.200900195; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Monnot C, 1996, J BIOL CHEM, V271, P1507, DOI 10.1074/jbc.271.3.1507; Murdoch C, 2000, BLOOD, V95, P3032; Nabok A, 2011, SENSOR ACTUAT B-CHEM, V154, P232, DOI 10.1016/j.snb.2010.02.005; Nabok A, 2008, THIN SOLID FILMS, V516, P8993, DOI 10.1016/j.tsf.2007.11.077; Naumann U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009175; Paxton WA, 1998, VIROLOGY, V244, P66, DOI 10.1006/viro.1998.9082; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Petty M.C., 1996, LANGMUIR BLODGETT FI, DOI 10.1017/CBO9780511622519; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Ray P, 2011, NEOPLASIA, V13, P1152, DOI 10.1593/neo.111076; Schoneberg T, 2004, PHARMACOL THERAPEUT, V104, P173, DOI 10.1016/j.pharmthera.2004.08.008; Szekacs A, 2009, APPL OPTICS, V48, pB151, DOI 10.1364/AO.48.00B151; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Tsutsumi A, 2011, FERTIL STERIL, V95, P444, DOI 10.1016/j.fertnstert.2010.08.037; Velez-Ruiz GA, 2011, METHODS MOL BIOL, V756, P167, DOI 10.1007/978-1-61779-160-4_8; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Woods AS, 2004, J PROTEOME RES, V3, P478, DOI 10.1021/pr034091l; Woollam J. A., 2002, GUIDE USING WVASE32; Zhou HP, 1999, ARCH BIOCHEM BIOPHYS, V369, P267, DOI 10.1006/abbi.1999.1368; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	47	4	4	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46221	10.1371/journal.pone.0046221	http://dx.doi.org/10.1371/journal.pone.0046221			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049983	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300098
J	Pagani, M; Di Lorenzo, G; Verardo, AR; Nicolais, G; Monaco, L; Lauretti, G; Russo, R; Niolu, C; Ammaniti, M; Fernandez, I; Siracusano, A				Pagani, Marco; Di Lorenzo, Giorgio; Verardo, Anna Rita; Nicolais, Giampaolo; Monaco, Leonardo; Lauretti, Giada; Russo, Rita; Niolu, Cinzia; Ammaniti, Massimo; Fernandez, Isabel; Siracusano, Alberto			Neurobiological Correlates of EMDR Monitoring - An EEG Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SCRIPT-DRIVEN IMAGERY; CEREBRAL-BLOOD-FLOW; EMISSION COMPUTED-TOMOGRAPHY; EYE-MOVEMENT DESENSITIZATION; PREFRONTAL CORTEX; EPISODIC MEMORY; ELECTROMAGNETIC TOMOGRAPHY; THETA OSCILLATIONS; POLICE OFFICERS	Background: Eye Movement Desensitization and Reprocessing (EMDR) is a recognized first-line treatment for psychological trauma. However its neurobiological bases have yet to be fully disclosed. Methods: Electroencephalography (EEG) was used to fully monitor neuronal activation throughout EMDR sessions including the autobiographical script. Ten patients with major psychological trauma were investigated during their first EMDR session (T0) and during the last one performed after processing the index trauma (T1). Neuropsychological tests were administered at the same time. Comparisons were performed between EEGs of patients at T0 and T1 and between EEGs of patients and 10 controls who underwent the same EMDR procedure at T0. Connectivity analyses were carried out by lagged phase synchronization. Results: During bilateral ocular stimulation (BS) of EMDR sessions EEG showed a significantly higher activity on the orbitofrontal, prefrontal and anterior cingulate cortex in patients at T0 shifting towards left temporo-occipital regions at T1. A similar trend was found for autobiographical script with a higher firing in fronto-temporal limbic regions at T0 moving to right temporo-occipital cortex at T1. The comparisons between patients and controls confirmed the maximal activation in the limbic cortex of patients occurring before trauma processing. Connectivity analysis showed decreased pair-wise interactions between prefrontal and cingulate cortex during BS in patients as compared to controls and between fusiform gyrus and visual cortex during script listening in patients at T1 as compared to T0. These changes correlated significantly with those occurring in neuropsychological tests. Conclusions: The ground-breaking methodology enabled our study to image for the first time the specific activations associated with the therapeutic actions typical of EMDR protocol. The findings suggest that traumatic events are processed at cognitive level following successful EMDR therapy, thus supporting the evidence of distinct neurobiological patterns of brain activations during BS associated with a significant relief from negative emotional experiences.	[Pagani, Marco] CNR, Inst Cognit Sci & Technol, Rome, Italy; [Di Lorenzo, Giorgio; Monaco, Leonardo; Niolu, Cinzia; Siracusano, Alberto] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Verardo, Anna Rita; Lauretti, Giada; Russo, Rita; Fernandez, Isabel] EMDR Italy Assoc, Bovisio Masciago, MI, Italy; [Nicolais, Giampaolo] Univ Roma La Sapienza, Dept Dev & Social Psychol, Rome, Italy; [Ammaniti, Massimo] Univ Roma La Sapienza, Int Psychoanalyt Assoc, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Rome Tor Vergata; Sapienza University Rome; Sapienza University Rome	Pagani, M (corresponding author), CNR, Inst Cognit Sci & Technol, Rome, Italy.	marco.pagani@istc.cnr.it	pagani, marco/AAV-9176-2020; Lauretti, Gabriela GR/A-6170-2015; Di Lorenzo, Giorgio/B-1308-2013; Lauretti, Gabriela R/C-8577-2015	Di Lorenzo, Giorgio/0000-0002-0576-4064; NIOLU, CINZIA/0000-0001-6173-2684; Ammaniti, Massimo/0000-0002-2995-3839; SIRACUSANO, ALBERTO/0000-0001-8406-093X				Aftanas LI, 2001, NEUROSCI LETT, V303, P115, DOI 10.1016/S0304-3940(01)01703-7; American Psychiatric Association, 2004, PRACT GUID TREATM PA; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Anderson KL, 2010, CEREB CORTEX, V20, P1604, DOI 10.1093/cercor/bhp223; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Beck A, 1993, MANUAL BECK DEPRESSI; Begic D, 2001, INT J PSYCHOPHYSIOL, V40, P167, DOI 10.1016/S0167-8760(00)00153-7; Bollimunta A, 2008, J NEUROSCI, V28, P9976, DOI 10.1523/JNEUROSCI.2699-08.2008; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Bremner J.D., 2002, DOES STRESS DAMAGE B; Bremner J Douglas, 2007, Expert Rev Neurother, V7, P393, DOI 10.1586/14737175.7.4.393; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Briere J, 2005, J TRAUMA STRESS, V18, P401, DOI 10.1002/jts.20048; Britton JC, 2005, BIOL PSYCHIAT, V57, P832, DOI 10.1016/j.biopsych.2004.12.025; Canuet L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027863; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; Derogatis L.R., 1994, USE PSYCHOL TESTING, P217; Desgranges B, 1998, NEUROIMAGE, V8, P198, DOI 10.1006/nimg.1998.0359; Dutch National Steering Committee Guidelines Mental Health Care, 2003, MULT GUID ANX DIS; Ehlers A, 2010, CLIN PSYCHOL REV, V30, P269, DOI 10.1016/j.cpr.2009.12.001; Francati V, 2007, DEPRESS ANXIETY, V24, P202, DOI 10.1002/da.20208; Frei E, 2001, HUM BRAIN MAPP, V14, P152, DOI 10.1002/hbm.1049; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Hasselmo ME, 2005, HIPPOCAMPUS, V15, P936, DOI 10.1002/hipo.20116; Hirata M, 2007, NEUROIMAGE, V35, P420, DOI 10.1016/j.neuroimage.2006.11.025; Hogberg G, 2008, PSYCHIAT RES, V159, P101, DOI 10.1016/j.psychres.2007.10.019; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; INSERM, 2004, PSYCH EV 3 APPR; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lanius RA, 2002, BIOL PSYCHIAT, V52, P305, DOI 10.1016/S0006-3223(02)01367-7; Lansing K, 2005, J NEUROPSYCH CLIN N, V17, P526, DOI 10.1176/appi.neuropsych.17.4.526; Lin CH, 2003, J NEUROSCI, V23, P8310; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P853, DOI 10.1016/j.biopsych.2004.08.003; Mazard A, 2002, J COGNITIVE NEUROSCI, V14, P172, DOI 10.1162/089892902317236821; MCFARLANE AC, 1992, J NERV MENT DIS, V180, P498, DOI 10.1097/00005053-199208000-00004; Nardo D, 2011, PSYCHOL MED, V15, P1; Nardo D, 2010, J PSYCHIATR RES, V44, P477, DOI 10.1016/j.jpsychires.2009.10.014; Ni TO, 2009, NEUROSCI RES, V65, P375, DOI 10.1016/j.neures.2009.08.014; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niedermeyer E, 2003, CLIN ELECTROENCEPHAL, V34, P5, DOI 10.1177/155005940303400105; North CS, 1999, JAMA-J AM MED ASSOC, V282, P755, DOI 10.1001/jama.282.8.755; Nyhus E, 2010, NEUROSCI BIOBEHAV R, V34, P1023, DOI 10.1016/j.neubiorev.2009.12.014; Pagani M, 2007, NUCL MED COMMUN, V28, P757, DOI 10.1097/MNM.0b013e3282742035; Pagani M, 2011, J EMDR PRACT RES, V5, P42, DOI 10.1891/1933-3196.5.2.42; Pascual-Marqui RD, 2011, PHILOS T R SOC A, V369, P3768, DOI 10.1098/rsta.2011.0081; Peres JFP, 2007, PSYCHOL MED, V37, P1481, DOI 10.1017/S003329170700997X; Phillips JS, 2009, NEUROIMAGE, V46, P1209, DOI 10.1016/j.neuroimage.2009.02.044; Porcaro C, 2009, HUM BRAIN MAPP, V30, P660, DOI 10.1002/hbm.20533; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rutishauser U, 2010, NATURE, V464, P903, DOI 10.1038/nature08860; Sachinvala N, 2000, MIL MED, V165, P473, DOI 10.1093/milmed/165.6.473; Sack M, 2008, J EMDR PRACT RES, V2, P239, DOI 10.1891/1933-3196.2.4.239; Seedat S, 2004, J AFFECT DISORDERS, V80, P45, DOI 10.1016/S0165-0327(03)00047-8; Shapiro F, 1989, J TRAUMA STRESS, P199, DOI DOI 10.1002/JTS.2490020207; Shapiro F., 2001, EYE MOVEMENT DESENSI; Shin LM, 1999, AM J PSYCHIAT, V156, P575; Staniloiu A, 2010, CONSCIOUS COGN, V19, P778, DOI 10.1016/j.concog.2010.06.024; Steele JD, 2004, NEUROIMAGE, V21, P868, DOI 10.1016/j.neuroimage.2003.09.066; Stickgold R, 2008, J EMDR PRACT RES, V2, P289, DOI 10.1891/1933-3196.2.4.289; Toscani M, 2010, EXP BRAIN RES, V207, P213, DOI 10.1007/s00221-010-2444-7; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; United Kingdom Department of Health, 2001, TREATM CHOIC PSYCH T; Wang XJ, 2010, PHYSIOL REV, V90, P1195, DOI 10.1152/physrev.00035.2008	66	89	93	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45753	10.1371/journal.pone.0045753	http://dx.doi.org/10.1371/journal.pone.0045753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049852	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300049
J	Broyles, ST; Staiano, AE; Drazba, KT; Gupta, AK; Sothern, M; Katzmarzyk, PT				Broyles, Stephanie T.; Staiano, Amanda E.; Drazba, Kathryn T.; Gupta, Alok K.; Sothern, Melinda; Katzmarzyk, Peter T.			Elevated C-Reactive Protein in Children from Risky Neighborhoods: Evidence for a Stress Pathway Linking Neighborhoods and Inflammation in Children	PLOS ONE			English	Article							ADULT SOCIOECONOMIC-STATUS; NUTRITION EXAMINATION SURVEY; CORONARY-HEART-DISEASE; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; OLDER-ADULTS; PHYSICAL-ACTIVITY; HEALTH BEHAVIORS; NATIONAL-HEALTH	Background: Childhood socioeconomic status is linked to adult cardiovascular disease and disease risk. One proposed pathway involves inflammation due to exposure to a stress-inducing neighborhood environment. Whether CRP, a marker of systemic inflammation, is associated with stressful neighborhood conditions among children is unknown. Methods and Results: The sample included 385 children 5-18 years of age from 255 households and 101 census tracts. Multilevel logistic regression analyses compared children and adolescents with CRP levels >3 mg/L to those with levels <= 3 mg/L across neighborhood environments. Among children living in neighborhoods (census tracts) in the upper tertile of poverty or crime, 18.6% had elevated CRP levels, in contrast to 7.9% of children living in neighborhoods with lower levels of poverty and crime. Children from neighborhoods with the highest levels of either crime or poverty had 2.7 (95% CI: 1.2-6.2) times the odds of having elevated CRP levels when compared to children from other neighborhoods, independent of adiposity, demographic and behavioral differences. Conclusions: Children living in neighborhoods with high levels of poverty or crime had elevated CRP levels compared to children from other neighborhoods. This result is consistent with a psychosocial pathway favoring early development of cardiovascular risk that involves chronic stress from exposure to socially- and physically-disordered neighborhoods characteristic of poverty.	[Broyles, Stephanie T.; Staiano, Amanda E.; Drazba, Kathryn T.; Gupta, Alok K.; Katzmarzyk, Peter T.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Sothern, Melinda] Louisiana State Univ, Hlth Sci Ctr, Sch Publ Hlth, New Orleans, LA USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Broyles, ST (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA.	stephanie.broyles@pbrc.edu	Katzmarzyk, Peter T/N-1974-2017; Broyles, Stephanie/C-8647-2011; Staiano, Amanda E/H-3956-2017	Katzmarzyk, Peter T/0000-0002-9280-6022; Broyles, Stephanie/0000-0003-3168-0056; Staiano, Amanda E/0000-0001-7846-046X; Gupta, Alok/0000-0002-0102-7155	National Institutes of Health [RC1 DK086881]; American Heart Association [11GRNT7750027]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, RC1DK086881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grant RC1 DK086881 (PTK) and American Heart Association grant 11GRNT7750027 (STB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alley DE, 2006, BRAIN BEHAV IMMUN, V20, P498, DOI 10.1016/j.bbi.2005.10.003; [Anonymous], 2004, LIFE COURSE APPROACH; [Anonymous], 2010, POV THRESH; ATTAR BK, 1994, J CLIN CHILD PSYCHOL, V23, P391, DOI 10.1207/s15374424jccp2304_5; Augustin T, 2008, AM J PUBLIC HEALTH, V98, P1664, DOI 10.2105/AJPH.2007.125138; Balagopal P, 2011, CIRCULATION, V123, P2749, DOI 10.1161/CIR.0b013e31821c7c64; Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; Brunner E, 1997, BMJ-BRIT MED J, V314, P1472, DOI 10.1136/bmj.314.7092.1472; Brunner EJ, 2002, CIRCULATION, V106, P2659, DOI 10.1161/01.CIR.0000038364.26310.BD; Brunner EJ, 1997, DIABETOLOGIA, V40, P1341, DOI 10.1007/s001250050830; Chen E, 2006, HEALTH PSYCHOL, V25, P704, DOI 10.1037/0278-6133.25.6.704; Chichlowska KL, 2009, ANN EPIDEMIOL, V19, P875, DOI 10.1016/j.annepidem.2009.07.094; Chichlowska KL, 2008, PSYCHOSOM MED, V70, P986, DOI 10.1097/PSY.0b013e318183a491; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Clark AM, 2009, NAT REV CARDIOL, V6, P712, DOI 10.1038/nrcardio.2009.163; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen S, 1999, ANN NY ACAD SCI, V896, P246, DOI 10.1111/j.1749-6632.1999.tb08119.x; Cook DG, 2000, ATHEROSCLEROSIS, V149, P139, DOI 10.1016/S0021-9150(99)00312-3; Dallongeville J, 2005, DIABETES CARE, V28, P409, DOI 10.2337/diacare.28.2.409; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Dowd JB, 2010, AM J PREV MED, V39, P314, DOI 10.1016/j.amepre.2010.05.014; Dulin-Keita A, 2012, J EPIDEMIOL COMMUN H, V66, P24, DOI 10.1136/jech.2009.092676; Federico Bruno, 2011, BMC Res Notes, V4, P301, DOI 10.1186/1756-0500-4-301; Ford ES, 2005, DIABETES CARE, V28, P878, DOI 10.2337/diacare.28.4.878; Ford ES, 2003, CIRCULATION, V108, P1053, DOI 10.1161/01.CIR.0000080913.81393.B8; Ford ES, 2001, J PEDIATR-US, V138, P486, DOI 10.1067/mpd.2001.112898; Freedman DS, 2005, INT J OBESITY, V29, P1, DOI 10.1038/sj.ijo.0802735; Fuligni AJ, 2009, PSYCHOSOM MED, V71, P329, DOI 10.1097/PSY.0b013e3181921b1f; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Garrett Bridgette E., 2011, Morbidity and Mortality Weekly Report, V60, P109; Glass TA, 2006, AM J PREV MED, V31, P455, DOI 10.1016/j.amepre.2006.07.028; Goldoftas BF, 2008, EPIDEMIOLOGY, V19, pS268; Goodman E, 2005, PSYCHOSOM MED, V67, P9, DOI 10.1097/01.psy.0000149254.36133.1a; Gouin JP, 2011, HLTH PSYCHOL; Gupta AK, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-36; Hanson MD, 2007, J BEHAV MED, V30, P263, DOI 10.1007/s10865-007-9098-3; Helba M, 2009, PEDIATR RADIOL, V39, P647, DOI 10.1007/s00247-009-1247-0; Hill TD, 2005, J HEALTH SOC BEHAV, V46, P170, DOI 10.1177/002214650504600204; Holmes ME, 2010, OBES REV, V11, P492, DOI 10.1111/j.1467-789X.2009.00680.x; Howe LD, 2010, INT J OBESITY, V34, P1149, DOI 10.1038/ijo.2010.52; Jackson RW, 1999, INT J PSYCHOPHYSIOL, V31, P111, DOI 10.1016/S0167-8760(98)00044-0; Jarvisalo MJ, 2002, ARTERIOSCL THROM VAS, V22, P1323, DOI 10.1161/01.ATV.0000024222.06463.21; Jaye DL, 1997, PEDIATR INFECT DIS J, V16, P735, DOI 10.1097/00006454-199708000-00003; Juonala M, 2006, ARTERIOSCL THROM VAS, V26, P1883, DOI 10.1161/01.ATV.0000228818.11968.7a; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kumari M, 2004, ARCH INTERN MED, V164, P1873, DOI 10.1001/archinte.164.17.1873; Lande MB, 2008, PEDIATRICS, V122, P1252, DOI 10.1542/peds.2007-3162; Lee RE, 2002, AM J PUBLIC HEALTH, V92, P428, DOI 10.2105/AJPH.92.3.428; Lee TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027670; Leventhal T, 2000, PSYCHOL BULL, V126, P309, DOI 10.1037/0033-2909.126.2.309; Lidfeldt J, 2007, AM J EPIDEMIOL, V165, P882, DOI 10.1093/aje/kwk078; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Little R. J. A., 1987, STAT ANAL MISSING DA; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; McDade TW, 2006, PSYCHOSOM MED, V68, P376, DOI 10.1097/01.psy.0000221371.43607.64; McEwen BS, 1999, ANN NY ACAD SCI, V896, P30, DOI 10.1111/j.1749-6632.1999.tb08103.x; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Morley R, 2000, ACTA PAEDIATR, V89, P703, DOI 10.1080/080352500750044043; Muennig P, 2007, PREV MED, V45, P35, DOI 10.1016/j.ypmed.2007.04.005; Murasko JE, 2008, SOC SCI MED, V67, P1889, DOI 10.1016/j.socscimed.2008.09.018; Nazmi A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-212; Owen N, 2003, BRAIN BEHAV IMMUN, V17, P286, DOI 10.1016/S0889-1591(03)00058-8; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Perel P, 2006, DIABETES CARE, V29, P2694, DOI 10.2337/dc06-0022; Petersen KL, 2008, PSYCHOSOM MED, V70, P646, DOI 10.1097/PSY.0b013e31817b8ee4; Pollitt RA, 2008, J EPIDEMIOL COMMUN H, V62, P484, DOI 10.1136/jech.2006.054106; Pollitt RA, 2007, EUR J EPIDEMIOL, V22, P55, DOI 10.1007/s10654-006-9082-1; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Prochaska JJ, 2001, ARCH PEDIAT ADOL MED, V155, P554, DOI 10.1001/archpedi.155.5.554; Robbins JM, 2005, DIABETES RES CLIN PR, V68, P230, DOI 10.1016/j.diabres.2004.09.007; Ross CE, 2001, J HEALTH SOC BEHAV, V42, P258, DOI 10.2307/3090214; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Schafer MH, 2011, J GERONTOL A-BIOL, V66, P667, DOI 10.1093/gerona/glr009; Sesso HD, 2003, JAMA-J AM MED ASSOC, V290, P2945, DOI 10.1001/jama.290.22.2945; Shrewsbury V, 2008, OBESITY, V16, P275, DOI 10.1038/oby.2007.35; Skinner AC, 2010, PEDIATRICS, V125, pE801, DOI 10.1542/peds.2009-2182; Slopen N, 2011, BRAIN BEHAV IMMUN; Steptoe A, 2001, ANN BEHAV MED, V23, P177, DOI 10.1207/S15324796ABM2303_5; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Sundquist J, 1999, INT J EPIDEMIOL, V28, P841, DOI 10.1093/ije/28.5.841; Sundquist K, 2006, SOC SCI MED, V62, P2061, DOI 10.1016/j.socscimed.2005.08.051; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Williams ED, 2010, DIABETOLOGIA, V53, P2538, DOI 10.1007/s00125-010-1888-4; Williams ED, 2012, DIABETES CARE, V35, P1455, DOI 10.2337/dc11-1410	90	56	56	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45419	10.1371/journal.pone.0045419	http://dx.doi.org/10.1371/journal.pone.0045419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049799	Green Published, gold			2022-12-27	WOS:000309556100047
J	Cui, W; Zhang, ZJ; Li, WM; Mak, SH; Hu, SQ; Zhang, H; Yuan, S; Rong, JH; Choi, TC; Lee, SMY; Han, YF				Cui, Wei; Zhang, Zaijun; Li, Wenming; Mak, Shinghung; Hu, Shengquan; Zhang, Huan; Yuan, Shuai; Rong, Jianhui; Choi, Tony Chunglit; Lee, Simon M. Y.; Han, Yifan			Unexpected Neuronal Protection of SU5416 against 1-Methyl-4-Phenylpyridinium Ion-Induced Toxicity via Inhibiting Neuronal Nitric Oxide Synthase	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; PHASE-I; EXPRESSION; GROWTH; NEUROPROTECTION; BIS(7)-TACRINE; PARKINSONISM; ZEBRAFISH; SYSTEM; CELLS	SU5416 was originally designed as a potent and selective inhibitor of vascular endothelial growth factor receptor-2 (VEGFR-2) for cancer therapy. In this study, we have found for the first time that SU5416 unexpectedly prevented 1-methyl-4-phenylpyridinium ion (MPP+)-induced neuronal apoptosis in cerebellar granule neurons, and decreased 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP)-induced loss of dopaminergic neurons and impairment of swimming behavior in zebrafish in a concentration-dependent manner. However, VEGFR-2 kinase inhibitor II, another specific VEGFR-2 inhibitor, failed to reverse neurotoxicity at the concentration exhibiting anti-angiogenic activity, strongly suggesting that the neuroprotective effect of SU5416 is independent from its anti-angiogenic action. SU5416 potently reversed MPP+-increased intracellular nitric oxide level with an efficacy similar to 7-nitroindazole, a specific neuronal nitric oxide synthase (nNOS) inhibitor. Western blotting analysis showed that SU5416 reduced the elevation of nNOS protein expression induced by MPP+. Furthermore, SU5416 directly inhibited the enzyme activity of rat cerebellum nNOS with an IC50 value of 22.7 mu M. In addition, knock-down of nNOS expression using short hairpin RNA (shRNA) abolished the neuroprotective effects of SU5416 against MPP+-induced neuronal loss. Our results strongly demonstrate that SU5416 might exert its unexpected neuroprotective effects by concurrently reducing nNOS protein expression and directly inhibiting nNOS enzyme activity. In view of the capability of SU5416 to cross the blood-brain barrier and the safety for human use, our findings further indicate that SU5416 might be a novel drug candidate for neurodegenerative disorders, particularly those associated with NO-mediated neurotoxicity.	[Cui, Wei; Li, Wenming; Mak, Shinghung; Hu, Shengquan; Zhang, Huan; Choi, Tony Chunglit; Han, Yifan] Hong Kong Polytech Univ, Inst Modern Med, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Zhang, Zaijun; Yuan, Shuai; Lee, Simon M. Y.] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Zhang, Zaijun] Jinan Univ, Coll Pharm, Guangdong Prov Key Lab Pharmacodynam Constituents, Inst New Drug Res, Guang Zhou, Guangdong, Peoples R China; [Rong, Jianhui] Univ Hong Kong, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; University of Macau; Jinan University; University of Hong Kong	Lee, SMY (corresponding author), Hong Kong Polytech Univ, Inst Modern Med, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China.	SimonLee@umac.mo; bcyfhan@polyu.edu.hk	hu, shengquan/S-8266-2019; Rong, Jianhui/C-4385-2009	Zhang, Huan/0000-0002-2771-5036; Han, Yifan/0000-0002-5833-069X; Rong, Jianhui/0000-0002-3545-2811; MAK, Shinghung/0000-0002-9103-4833	Research Grants Council of Hong Kong [PolyU5609/09M, 5610/11M]; Hong Kong Polytechnic University [G-U952]; Shenzhen Shuangbai Funding Scheme; Science and Technology Development Fund (FDCT) of Macao SAR [045/2007/A3]; Research Committee of the University of Macau [UL017/09-Y1]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Hong Kong Polytechnic University(Hong Kong Polytechnic University); Shenzhen Shuangbai Funding Scheme; Science and Technology Development Fund (FDCT) of Macao SAR; Research Committee of the University of Macau	This work was supported by grants from the Research Grants Council of Hong Kong (PolyU5609/09M and 5610/11M), The Hong Kong Polytechnic University (G-U952) and the Shenzhen Shuangbai Funding Scheme 2008; the Science and Technology Development Fund (FDCT) of Macao SAR (045/2007/A3) and the Research Committee of the University of Macau (UL017/09-Y1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Choi DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005482; Cui W, 2011, NEUROCHEM INT, V59, P945, DOI 10.1016/j.neuint.2011.07.005; Flinn L, 2008, J NEUROCHEM, V106, P1991, DOI 10.1111/j.1471-4159.2008.05463.x; Fong TAT, 1999, CANCER RES, V59, P99; Gal S, 2010, NEUROTOX RES, V17, P15, DOI 10.1007/s12640-009-9070-9; Gonzalez-Polo RA, 2004, MOL NEUROBIOL, V30, P253, DOI 10.1385/MN:30:3:253; Grayson M, 2010, NATURE, V466, pS1, DOI 10.1038/466S2a; Hantraye P, 1996, NAT MED, V2, P1017, DOI 10.1038/nm0996-1017; Kavya R, 2006, NITRIC OXIDE-BIOL CH, V15, P280, DOI 10.1016/j.niox.2006.07.003; Kieran MW, 2009, PEDIATR BLOOD CANCER, V52, P169, DOI 10.1002/pbc.21873; Lees AJ, 2009, LANCET, V373, P2055, DOI 10.1016/S0140-6736(09)60492-X; Li WM, 2007, MOL PHARMACOL, V71, P1258, DOI 10.1124/mol.106.029108; Li WM, 2006, NEUROREPORT, V17, P471, DOI 10.1097/01.wnr.0000209014.09094.72; Li WM, 2005, J BIOL CHEM, V280, P18179, DOI 10.1074/jbc.M411085200; Mahairaki V, 2009, J NEUROSCI METH, V179, P292, DOI 10.1016/j.jneumeth.2009.02.006; Muramatsu Y, 2003, J NEURAL TRANSM, V110, P1129, DOI 10.1007/s00702-003-0021-y; Nagl F, 2009, AM J PHYSIOL-CELL PH, V297, pC1146, DOI 10.1152/ajpcell.00034.2009; Przedborski S, 1996, P NATL ACAD SCI USA, V93, P4565, DOI 10.1073/pnas.93.10.4565; Sabaliauskas NA, 2006, METHODS, V39, P246, DOI 10.1016/j.ymeth.2006.03.001; Schweitzer J, 2011, DEV NEUROBIOL; Shawver LK, 2002, CANCER CELL, V1, P117, DOI 10.1016/S1535-6108(02)00039-9; Sheng JZ, 2005, J PHARMACOL EXP THER, V315, P931, DOI 10.1124/jpet.105.087932; Shin JH, 2009, CELL, V139, DOI 10.1016/j.cell.2009.09.026; Stopeck A, 2002, CLIN CANCER RES, V8, P2798; Sun L, 1998, J MED CHEM, V41, P2588, DOI 10.1021/jm980123i; Thomas B, 2008, NEUROCHEM INT, V52, P990, DOI 10.1016/j.neuint.2007.10.012; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Ye C, 2006, TOXICOL IN VITRO, V20, P154, DOI 10.1016/j.tiv.2005.06.047; Zhang ZJ, 2011, INT J MOL MED, V27, P195, DOI 10.3892/ijmm.2010.571; Zhu YH, 2003, FASEB J, V17, P186, DOI 10.1096/fj.02-0515com	31	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46253	10.1371/journal.pone.0046253	http://dx.doi.org/10.1371/journal.pone.0046253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049997	Green Published, gold			2022-12-27	WOS:000309556100168
J	van Gennip, RGP; van de Water, SGP; Maris-Veldhuis, M; van Rijn, PA				van Gennip, Rene G. P.; van de Water, Sandra G. P.; Maris-Veldhuis, Mieke; van Rijn, Piet A.			Bluetongue Viruses Based on Modified-Live Vaccine Serotype 6 with Exchanged Outer Shell Proteins Confer Full Protection in Sheep against Virulent BTV8	PLOS ONE			English	Article							FUNCTIONAL-CHARACTERIZATION; CAPSID PROTEIN; EXPRESSION; PARTICLES; INFECTION; EPIDEMIC	Since 1998, Bluetongue virus (BTV)-serotypes 1, 2, 4, 9, and 16 have invaded European countries around the Mediterranean Basin. In 2006, a huge BT outbreak started after incursion of BTV serotype 8 (BTV8) in North-Western Europe. IN 2008, BTV6 and BTV11 were reported in the Netherlands and Germany, and in Belgium, respectively. In addition, Toggenburg orbivirus (TOV) was detected in 2008 in Swiss goats, which was recognized as a new serotype of BTV (BTV25). The (re-)emergency of BTV serotypes needs a rapid response to supply effective vaccines. Reverse genetics has been developed for BTV1 and more recently also for BTV6. This latter strain, BTV6/net08, is closely related to live-attenuated vaccine for serotype 6 as determined by full genome sequencing. Here, we used this strain as backbone and exchanged segment 2 and 6, respectively Seg-2 (VP2) and Seg-6 (VP5), for those of BTV serotype 1 and 8 using reverse genetics. These so-called 'serotyped' vaccine viruses, as mono-serotype and multi-serotype vaccine, were compared for their protective capacity in sheep. In general, all vaccinated animals developed a neutralizing antibody response against their respective serotype. After challenge at three weeks post vaccination with cell-passaged, virulent BTV8/net07 (BTV8/net07/e1/bhkp3) the vaccinated animals showed nearly no clinical reaction. Even more, challenge virus could not be detected, and seroconversion or boostering after challenge was negligible. These data demonstrate that all sheep were protected from a challenge with BTV8/net07, since sheep of the control group showed viremia, seroconversion and clinical signs that are specific for Bluetongue. The high level of cross-protection is discussed.	[van Gennip, Rene G. P.; van de Water, Sandra G. P.; Maris-Veldhuis, Mieke; van Rijn, Piet A.] Cent Vet Inst Wageningen UR CVI, Dept Virol, Ab Lelystad, Netherlands	Wageningen University & Research	van Gennip, RGP (corresponding author), Cent Vet Inst Wageningen UR CVI, Dept Virol, Ab Lelystad, Netherlands.	rene.vangennip@wur.nl	van Rijn, Piet A/C-1163-2017; van Rijn, Piet A./AAG-7398-2019	van Rijn, Piet A/0000-0002-2594-1232; van Rijn, Piet A./0000-0002-2594-1232; van Gennip, Rene/0000-0002-5450-3493	Dutch Ministry of Economic Affairs, Agriculture, and Innovation	Dutch Ministry of Economic Affairs, Agriculture, and Innovation	This research was funded by the Dutch Ministry of Economic Affairs, Agriculture, and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW M, 1995, VET IMMUNOL IMMUNOP, V47, P311, DOI 10.1016/0165-2427(94)05410-T; Backx A, 2009, VET MICROBIOL, V138, P235, DOI 10.1016/j.vetmic.2009.04.003; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Celma CCP, 2009, J VIROL, V83, P6806, DOI 10.1128/JVI.00263-09; Dal Pozzo F, 2009, VET MICROBIOL, V136, P352, DOI 10.1016/j.vetmic.2008.11.012; Elbers ARW, 2010, VACCINE, V28, P2473, DOI 10.1016/j.vaccine.2010.01.047; Elbers ARW, 2008, PREV VET MED, V87, P21, DOI 10.1016/j.prevetmed.2008.06.004; ELLIS JA, 1990, VET IMMUNOL IMMUNOP, V24, P49, DOI 10.1016/0165-2427(90)90077-6; Eschbaumer M, 2010, VET MICROBIOL, V143, P189, DOI 10.1016/j.vetmic.2009.11.040; Eschbaumer M, 2009, VACCINE, V27, P4169, DOI 10.1016/j.vaccine.2009.04.056; Forzan M, 2004, P NATL ACAD SCI USA, V101, P2100, DOI 10.1073/pnas.0306448101; Gonzalez JM, 2010, VET REC, V166, P757, DOI 10.1136/vr.b4849; HAIG D. A., 1956, ONDER STEPOORT JOUR VET RES, V27, P171; Hassan SH, 2001, J VIROL, V75, P8356, DOI 10.1128/JVI.75.18.8356-8367.2001; Hassan SS, 1999, J VIROL, V73, P9832, DOI 10.1128/JVI.73.12.9832-9842.1999; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HUISMANS H, 1973, VIROLOGY, V52, P81, DOI 10.1016/0042-6822(73)90400-5; HUISMANS H, 1981, ONDERSTEPOORT J VET, V48, P51; HUISMANS H, 1987, VIROLOGY, V157, P172, DOI 10.1016/0042-6822(87)90326-6; HUISMANS H, 1987, VIROLOGY, V157, P180, DOI 10.1016/0042-6822(87)90327-8; JEGGO M H, 1985, P477; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; Matsuo E, 2011, J VIROL, V85, P10213, DOI 10.1128/JVI.05412-11; Matsuo E, 2009, J VIROL, V83, P8842, DOI 10.1128/JVI.00465-09; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Noad R, 2009, VACCINE, V27, pD86, DOI 10.1016/j.vaccine.2009.08.037; OIE, 2022, NUMB NEW H5 OUTBR; OSBURN BI, 1994, COMP IMMUNOL MICROB, V17, P189, DOI 10.1016/0147-9571(94)90042-6; Ratinier M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002477; Roy P, 2005, ADV VIRUS RES, V64, P69, DOI 10.1016/S0065-3527(05)64004-3; Roy P, 2009, NAT REV MICROBIOL, V7, P120, DOI 10.1038/nrmicro2052; Roy P, 2008, CELL BIOCHEM BIOPHYS, V50, P143, DOI 10.1007/s12013-008-9009-4; SATO M, 1977, ARCH VIROL, V54, P333, DOI 10.1007/BF01314778; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; van Gennip RGP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030540; van Gennip RGP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-261; van Rijn PA, 2011, EP 5 ANN M ARNH NETH; van Rijn PA, 2012, J VET DIAGN INVEST, V24, P469, DOI 10.1177/1040638712440986; Veldman D., 2012, VET MICROBIOL; Zhang X, 2010, P NATL ACAD SCI USA, V107, P6292, DOI 10.1073/pnas.0913403107	43	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44619	10.1371/journal.pone.0044619	http://dx.doi.org/10.1371/journal.pone.0044619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049753	Green Published, gold			2022-12-27	WOS:000309556100018
J	Zhou, XL; Xu, J				Zhou, Xiaolin; Xu, Jie			Free Cholesterol Induces Higher beta-Sheet Content in A beta Peptide Oligomers by Aromatic Interaction with Phe19	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; ALZHEIMERS-DISEASE; AMYLOID-BETA; CONFORMATIONAL TRANSITION; FIBRIL FORMATION; GAMMA-SECRETASE; IN-VITRO; AGGREGATION; PROTEIN; RAFTS	Accumulating experimental evidence support an enhancing effect of free cholesterol on amyloid-beta (Ab) aggregation. To probe the mechanisms of cholesterol-mediated Ab aggregation, we applied all-atom molecular dynamic simulations on A beta 42 peptides in presence of free cholesterol. Several control systems were also designed to examine the specificity of cholesterol-residue interactions, including mutation on aromatic residue, substitution of cholesterol with sphingomyelin (SM) and DPPC bilayer, and a mixing SM and cholesterol. Each system was performed 4 independent simulations, with a total time of 560 ns. It was found that cholesterol increased beta-sheet formation by 4 folds, but the Phe19 -> Ser mutation on Ab42 peptide totally eliminated cholesterol's effect. A stable contact was recognized between the steroid group of cholesterol and the Benzyl group of Phe19. Interestingly, our simulation revealed a regular 1 ns time interval between the establishment of cholesterol-phenylalanine contact and consequent beta-sheet formation, suggesting an important role of steroid-benzyl interaction in cholesterol-mediated aggregation. The presence of SM slightly increased beta-sheet formation, but the mixture of cholesterol and SM had a strong induction effect. Also, the measurement of Phe19-lipid distance indicates that aromatic side chains of peptides prone to bind to cholesterol on the surface of the mixed micelle. In the DPPC system, polar chains were attracted to the surface of membrane, yielding moderate increase of beta-sheet formation. These results shed light on the mechanism of cholesterol-mediated fibrillogenesis, and help to differentiate the effects of cholesterol and other lipids on beta-sheet formation process.	[Zhou, Xiaolin] Shanghai Jiao Tong Univ, Dept Neurol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China; [Xu, Jie] Shanghai Jiao Tong Univ, GI Div, Sch Med, Renji Hosp,Shanghai Inst Digest Dis, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhou, XL (corresponding author), Shanghai Jiao Tong Univ, Dept Neurol, Shanghai Peoples Hosp 1, Sch Med, Shanghai 200030, Peoples R China.	zhou_xiaolin@163.com; xujieletter@gmail.com	Xu, Jie/C-4283-2016	Xu, Jie/0000-0001-9163-3898	National Natural Science Foundation of China [81200976, 81000861, 81272383]; Shanghai Natural Science Foundation [12ZR1417900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai)	This research project is supported by National Natural Science Foundation of China to Xiaolin Zhou (Grant No. 81200976), National Natural Science Foundation of China to Jie Xu (Grant No. 81000861 and 81272383), and Shanghai Natural Science Foundation (12ZR1417900) to Jie Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avdulov NA, 1997, J NEUROCHEM, V69, P1746; Baumketner A, 2006, J MOL BIOL, V362, P567, DOI 10.1016/j.jmb.2006.07.032; Berger O, 1997, BIOPHYS J, V72, P2002, DOI 10.1016/S0006-3495(97)78845-3; Burns M, 2003, J NEUROSCI, V23, P5645; Cecchini M, 2006, J MOL BIOL, V357, P1306, DOI 10.1016/j.jmb.2006.01.009; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de la Paz ML, 2005, J MOL BIOL, V349, P583, DOI 10.1016/j.jmb.2005.03.081; Distl R, 2001, ACTA NEUROPATHOL, V101, P547; Esposito L, 2006, P NATL ACAD SCI USA, V103, P11533, DOI 10.1073/pnas.0602345103; Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Gsponer J, 2003, P NATL ACAD SCI USA, V100, P5154, DOI 10.1073/pnas.0835307100; Harris JR, 2008, MICRON, V39, P1192, DOI 10.1016/j.micron.2008.05.001; Harris JR, 2010, SUBCELL BIOCHEM, V51, P47, DOI 10.1007/978-90-481-8622-8_2; Harris JR, 2002, MICRON, V33, P609, DOI 10.1016/S0968-4328(02)00029-X; Hartmann T, 2006, NEURODEGENER DIS, V3, P305, DOI 10.1159/000095271; Heaton NJ, 1998, J AM CHEM SOC, V120, P9632, DOI 10.1021/ja980528s; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hoyer S, 2006, NEUROCHEM RES; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kuzmin PI, 2005, BIOPHYS J, V88, P1120, DOI 10.1529/biophysj.104.048223; Lascombe MB, 2002, ACTA CRYSTALLOGR D, V58, P1442, DOI 10.1107/S0907444902011745; Marrink SJ, 1998, BIOPHYS J, V74, P931, DOI 10.1016/S0006-3495(98)74016-0; Mishchenko E L, 2001, Bioorg Khim, V27, P408; Muller-Plathe F, 1999, PHYS REV E, V59, P4894, DOI 10.1103/PhysRevE.59.4894; Nguyen PH, 2007, P NATL ACAD SCI USA, V104, P111, DOI 10.1073/pnas.0607440104; Nieva J, 2011, CHEM BIOL, V18, P920, DOI 10.1016/j.chembiol.2011.02.018; Panchal M, 2010, J LIPID RES, V51, P598, DOI 10.1194/jlr.M001859; Pastorino L, 2006, EUR J PHARMACOL, V545, P29, DOI 10.1016/j.ejphar.2006.06.078; Sathishkumar K, 2007, J ALZHEIMERS DIS, V11, P261; Shobab LA, 2005, LANCET NEUROL, V4, P841, DOI 10.1016/S1474-4422(05)70248-9; Takano K, 2006, FEBS J, V273, P150, DOI 10.1111/j.1742-4658.2005.05051.x; Tieleman DP, 1996, J CHEM PHYS, V105, P4871, DOI 10.1063/1.472323; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Umeda T, 2012, LIFE SCI; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Wada S, 2003, BIOCHEMISTRY-US, V42, P13977, DOI 10.1021/bi034904j; Wurth C, 2002, J MOL BIOL, V319, P1279, DOI 10.1016/S0022-2836(02)00399-6; Xu YC, 2005, P NATL ACAD SCI USA, V102, P5403, DOI 10.1073/pnas.0501218102	43	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46245	10.1371/journal.pone.0046245	http://dx.doi.org/10.1371/journal.pone.0046245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049991	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100163
J	Orbach, R; Zhao, Z; Wang, YC; O'Neill, G; Cadavid, D				Orbach, Rotem; Zhao, Zhenming; Wang, Yong-Cheng; O'Neill, Gilmore; Cadavid, Diego			Comparison of Disease Activity in SPMS and PPMS in the Context of Multicenter Clinical Trials	PLOS ONE			English	Article							PROGRESSIVE MULTIPLE-SCLEROSIS; STATUS SCALE EDSS; NATURAL-HISTORY; FUNCTIONAL COMPOSITE; PREDICTIVE-VALUE; DOUBLE-BLIND; DISABILITY; MS; RESPONSIVENESS; RELAPSES	Background: Retrospective single center natural history studies have shown that times to reach disability milestones and ages at which they are reached are similar in primary (PPMS) and secondary (SPMS) progressive multiple sclerosis suggesting that they may be phenotypic variations of the same disease. Objective: Here we compared longitudinal disease activity in SPMS and PPMS in the context of international multicenter clinical trials. Methods: We analyzed all objective outcome measures that were systematically collected over 2 years for all subjects randomized to placebo arms in one SPMS and one PPMS clinical trial over the last decade. Conventional and exploratory definitions of clinical disease activity were used. Disease activity was analyzed in 3 different categories intermittent activity, progression, and improvement. Conventional MRI measures and one patient reported outcome measure of quality of life were included when available for comparison. Heat maps were drawn for all results followed by hierarchical clustering. Results: There were 101 outcome variables from 206 SPMS subjects and 79 outcome variables from 135 PPMS subjects. The comparison revealed that SPMS and PPMS subjects exhibited similar disease activity over 2 years in all but two of the variables in common worsening in the EDSS sensory system was more common in PPMS while worsening on the 9 hole PEG was more common in SPMS. Intermittent activity was the most common pattern of disease activity in SPMS and PPMS. Clinical worsening and improvement occurred at similar frequency in both. Conclusion: Longitudinal disease activity was nearly identical in SPMS and PPMS subjects in the context of the two multicenter international clinical trials we examined.	[Orbach, Rotem; Zhao, Zhenming; Wang, Yong-Cheng; O'Neill, Gilmore; Cadavid, Diego] Biogen Idec Inc, MS Clin Dev Grp, Cambridge, MA USA; [Orbach, Rotem] Sheba Med Ctr, Multiple Sclerosis Ctr, Tel Hashomer, Israel	Biogen; Chaim Sheba Medical Center	Cadavid, D (corresponding author), Biogen Idec Inc, MS Clin Dev Grp, Cambridge, MA USA.	diego.cadavid@biogenidec.com			Biogen Idec; Genentech	Biogen Idec(Biogen); Genentech(Roche HoldingGenentech)	This study was partly funded by Biogen Idec. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; GO and DC are full time paid employees and own stock and/or stock options in Biogen Idec. JZ and YCW were full time paid employees of Biogen Idec. RO was a paid Intern at Biogen Idec. Biogen Idec was the sponsor of the IMPACT study and together with Genentech (now a subsidiary of the Roche group) of the OLYMPUS study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Amato MP, 2004, J NEUROL, V251, P1472, DOI 10.1007/s00415-004-0567-0; Cadavid D, 2010, REV NEUROLOGIA, V51, P321, DOI 10.33588/rn.5106.2010390; Cohen JA, 2002, NEUROLOGY, V59, P679, DOI 10.1212/WNL.59.5.679; Confavreux C, 2006, BRAIN, V129, P606, DOI 10.1093/brain/awl007; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Degenhardt A, 2009, NAT REV NEUROL, V5, P672, DOI 10.1038/nrneurol.2009.178; Ebers GC, 2008, NEUROLOGY, V71, P624, DOI 10.1212/01.wnl.0000313034.46883.16; Fischer JS, 1999, MULT SCLER J, V5, P251, DOI 10.1177/135245859900500410; Hawker K, 2009, ANN NEUROL, V66, P460, DOI 10.1002/ana.21867; Kragt JJ, 2008, NEUROLOGY, V70, P1084, DOI 10.1212/01.wnl.0000288179.86056.e1; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; La Mantia L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005181.pub3; Lassmann H, 2007, CURR NEUROL NEUROSCI, V7, P239, DOI 10.1007/s11910-007-0036-0; Lex A, 2010, IEEE T VIS COMPUT GR, V16, P1027, DOI 10.1109/TVCG.2010.138; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Polman CH, 2010, NEUROLOGY, V74, pS8, DOI 10.1212/WNL.0b013e3181dbb571; Quintana FJ, 2008, P NATL ACAD SCI USA, V105, P18889, DOI 10.1073/pnas.0806310105; Rovaris M, 2006, LANCET NEUROL, V5, P343, DOI 10.1016/S1474-4422(06)70410-0; Rudick RA, 2009, MULT SCLER J, V15, P984, DOI 10.1177/1352458509106212; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Siepman TAM, 2010, J NEUROL, V257, P1654, DOI 10.1007/s00415-010-5589-1; Stevenson VL, 2002, J NEUROL, V249, P171, DOI 10.1007/PL00007860; Stevenson VL, 2000, J NEUROL NEUROSUR PS, V68, P713, DOI 10.1136/jnnp.68.6.713; Villar LM, 2009, J NEUROIMMUNOL, V211, P101, DOI 10.1016/j.jneuroim.2009.03.003; WEINSHENKER BG, 1989, BRAIN, V112, P1419, DOI 10.1093/brain/112.6.1419; Wolinsky JS, 2007, ANN NEUROL, V61, P14, DOI 10.1002/ana.21079	27	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45409	10.1371/journal.pone.0045409	http://dx.doi.org/10.1371/journal.pone.0045409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049678	gold, Green Submitted, Green Published			2022-12-27	WOS:000309388500005
J	Harvey, EL; Menden-Deuer, S				Harvey, Elizabeth L.; Menden-Deuer, Susanne			Predator-Induced Fleeing Behaviors in Phytoplankton: A New Mechanism for Harmful Algal Bloom Formation?	PLOS ONE			English	Article							HETEROSIGMA-AKASHIWO RAPHIDOPHYCEAE; DIURNAL VERTICAL MIGRATION; POPULATION-DISTRIBUTIONS; PREY INTERACTIONS; TOXIN PRODUCTION; ECOLOGICAL ROLE; MARINE BIRDS; MICROZOOPLANKTON; GROWTH; EUTROPHICATION	In the plankton, heterotrophic microbes encounter and ingest phytoplankton prey, which effectively removes >50% of daily phytoplankton production in the ocean and influences global primary production and biochemical cycling rates. Factors such as size, shape, nutritional value, and presence of chemical deterrents are known to affect predation pressure. Effects of movement behaviors of either predator or prey on predation pressure, and particularly fleeing behaviors in phytoplankton are thus far unknown. Here, we quantified individual 3D movements, population distributions, and survival rates of the toxic phytoplankton species, Heterosigma akashiwo in response to a ciliate predator and predator-derived cues. We observed predator-induced defense behaviors previously unknown for phytoplankton. Modulation of individual phytoplankton movements during and after predator exposure resulted in an effective separation of predator and prey species. The strongest avoidance behaviors were observed when H. akashiwo co-occurred with an actively grazing predator. Predator-induced changes in phytoplankton movements resulted in a reduction in encounter rate and a 3-fold increase in net algal population growth rate. A spatially explicit population model predicted rapid phytoplankton bloom formation only when fleeing behaviors were incorporated. These model predictions reflected field observations of rapid H. akashiwo harmful algal bloom (HAB) formation in the coastal ocean. Our results document a novel behavior in phytoplankton that can significantly reduce predation pressure and suggests a new mechanism for HAB formation. Phytoplankton behaviors that minimize predatory losses, maximize resource acquisition, and alter community composition and distribution patterns could have major implications for our understanding and predictive capacity of marine primary production and biochemical cycling rates.	[Harvey, Elizabeth L.; Menden-Deuer, Susanne] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	University of Rhode Island	Harvey, EL (corresponding author), Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA.	smenden@gso.uri.edu		Menden-Deuer, Susanne/0000-0002-8434-4251	Rhode Island EPSCoR [1004057]; US Department of Agriculture [2008-38420-18737]; Ecology of Harmful Algal Blooms [NA06NOS4780248]; National Science Foundation [0826205]	Rhode Island EPSCoR; US Department of Agriculture(United States Department of Agriculture (USDA)); Ecology of Harmful Algal Blooms; National Science Foundation(National Science Foundation (NSF))	A portion of this work was conducted at the Rhode Island EPSCoR supported Center for Marine Life Science (NSF EPSCoR Grant #1004057). Funding was provided by a Disease in Marine Organisms Fellowship through the US Department of Agriculture (2008-38420-18737 to M. Gomez-Chiarri), an Ecology of Harmful Algal Blooms grant (NA06NOS4780248 to S. Strom and S. Menden-Deuer), and the National Science Foundation (Biological-Oceanography Award 0826205 to S. Menden-Deuer). This is EcoHAB publication number ECO702. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Bearon RN, 2006, MAR ECOL PROG SER, V306, P153, DOI 10.3354/meps306153; Bearon RN, 2004, LIMNOL OCEANOGR, V49, P607, DOI 10.4319/lo.2004.49.2.0607; BOLLENS SM, 1989, J PLANKTON RES, V11, P1047, DOI 10.1093/plankt/11.5.1047; Calbet A, 2004, LIMNOL OCEANOGR, V49, P51, DOI 10.4319/lo.2004.49.1.0051; CULLEN JJ, 1981, MAR BIOL, V62, P81, DOI 10.1007/BF00388169; DODSON S, 1988, LIMNOL OCEANOGR, V33, P1431, DOI 10.4319/lo.1988.33.6_part_2.1431; Dolan JR, 2001, J PLANKTON RES, V23, P1009, DOI 10.1093/plankt/23.9.1009; Durham WM, 2009, SCIENCE, V323, P1067, DOI 10.1126/science.1167334; Dyhrman ST, 2008, HARMFUL ALGAE, V8, P167, DOI 10.1016/j.hal.2008.08.016; Fredrickson KA, 2011, J PHYCOL, V47, P25, DOI 10.1111/j.1529-8817.2010.00942.x; Fredrickson KA, 2009, J PLANKTON RES, V31, P135, DOI 10.1093/plankt/fbn112; Fu F, 2012, MAR ECOL PR IN PRESS; Glibert Patricia M., 2005, Oceanography, V18, P136; Godhantaraman N, 2003, J PLANKTON RES, V25, P465, DOI 10.1093/plankt/25.5.465; Graham SL, 2010, AQUAT MICROB ECOL, V59, P111, DOI 10.3354/ame01391; Graneli E, 2008, HARMFUL ALGAE, V8, P94, DOI 10.1016/j.hal.2008.08.011; Haque SM, 2002, BOT MAR, V45, P356, DOI 10.1515/BOT.2002.036; Harvey EL, 2011, LIMNOL OCEANOGR, V56, P371, DOI 10.4319/lo.2011.56.1.0371; Hershberger PK, 1997, CAN J FISH AQUAT SCI, V54, P2228, DOI 10.1139/cjfas-54-10-2228; Irigoien X, 2005, J PLANKTON RES, V27, P313, DOI 10.1093/plankt/fbi011; Jakobsen HH, 2006, AQUAT MICROB ECOL, V44, P197, DOI 10.3354/ame044197; Jessup DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004550; KAMYKOWSKI D, 1977, LIMNOL OCEANOGR, V22, P148, DOI 10.4319/lo.1977.22.1.0148; Kiorboe T, 2009, MECHANISTIC APPROACH; LAMPERT W, 1994, LIMNOL OCEANOGR, V39, P1543, DOI 10.4319/lo.1994.39.7.1543; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Lehrter JC, 1999, ESTUARIES, V22, P113, DOI 10.2307/1352932; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; Long DL, 2007, PNAS, V104, P10512, DOI DOI 10.1073/PNAS.0611600104; Mcgillicuddy DJ, 2003, J PLANKTON RES, V25, P1131, DOI 10.1093/plankt/25.9.1131; Menden-Deuer S, 2006, LIMNOL OCEANOGR, V51, P109, DOI 10.4319/lo.2006.51.1.0109; Menden-Deuer S, 2010, HARMFUL ALGAE 2008, P98; Rensel JEJ, 2010, HARMFUL ALGAE, V10, P98, DOI 10.1016/j.hal.2010.07.005; Selander E, 2006, P ROY SOC B-BIOL SCI, V273, P1673, DOI 10.1098/rspb.2006.3502; Selander E, 2011, P NATL ACAD SCI USA, V108, P4030, DOI 10.1073/pnas.1011870108; Shumway SE, 2003, HARMFUL ALGAE, V2, P1, DOI 10.1016/S1568-9883(03)00002-7; Smayda T.J., 1998, PHYSL ECOLOGY HARMFU, P113; Smayda Theodore J., 2002, Harmful Algae, V1, P95, DOI 10.1016/S1568-9883(02)00010-0; SMAYDA TJ, 1990, TOXIC MARINE PHYTOPLANKTON, P29; Smayda TJ, 1997, LIMNOL OCEANOGR, V42, P1137, DOI 10.4319/lo.1997.42.5_part_2.1137; Steinke M, 2002, J PHYCOL, V38, P630, DOI 10.1046/j.1529-8817.2002.02057.x; Strom S, J PHYCOL IN PRESS; Strom SL, 2001, MAR BIOL, V138, P355, DOI 10.1007/s002270000461; TAYLOR FJR, 1993, DEV MAR BIO, V3, P705; Taylor G.I., 1921, P LOND MATH SOC, V20, P196, DOI [DOI 10.1112/PLMS/S2-20.1.196, 10.1112/plms/s2-20.1.196]; Tillmann U, 2004, J EUKARYOT MICROBIOL, V51, P156, DOI 10.1111/j.1550-7408.2004.tb00540.x; Titelman J, 2001, MAR ECOL PROG SER, V213, P203, DOI 10.3354/meps213203; TOMAS CR, 1978, J PHYCOL, V14, P309, DOI 10.1111/j.1529-8817.1978.tb00303.x; Utermohl V. H., 1931, VERH INT VEREIN THEO, V5, P567, DOI DOI 10.1080/03680770.1931.11898492; Van Dolah FM, 2001, HUM ECOL RISK ASSESS, V7, P1329; Van Donk E, 2007, ECOL INFORM, V2, P112, DOI 10.1016/j.ecoinf.2007.03.002; VANDONK E, 1993, OECOLOGIA, V93, P508, DOI 10.1007/BF00328958; Visser AW, 2006, OECOLOGIA, V148, P538, DOI 10.1007/s00442-006-0385-4; Wolfe GV, 2000, BIOL BULL-US, V198, P225, DOI 10.2307/1542526; YIN KD, 1995, ESTUAR COAST SHELF S, V40, P505, DOI 10.1006/ecss.1995.0035; Yin KD, 1997, MAR ECOL PROG SER, V161, P173, DOI 10.3354/meps161173	57	41	41	1	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46438	10.1371/journal.pone.0046438	http://dx.doi.org/10.1371/journal.pone.0046438			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029518	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900159
J	Alfonso, V; Maroniche, GA; Reca, SR; Lopez, MG; del Vas, M; Taboga, O				Alfonso, Victoria; Maroniche, Guillermo A.; Reca, Sol R.; Gabriela Lopez, Maria; del Vas, Mariana; Taboga, Oscar			AcMNPV Core Gene ac109 Is Required for Budded Virion Transport to the Nucleus and for Occlusion of Viral Progeny	PLOS ONE			English	Article							CALIFORNICA MULTIPLE NUCLEOPOLYHEDROVIRUS; ESCHERICHIA-COLI; EFFICIENT GENERATION; STRUCTURAL PROTEINS; POLYHEDROSIS-VIRUS; ODV ENVELOPMENT; BV PRODUCTION; CELLS; BACULOVIRUSES; NUCLEOCAPSIDS	The Autographa californica multiple nucleopolyhedrovirus (AcMNPV) ac109 core gene has been previously characterized as an essential late gene. Our results showed that budded virions could be detected in supernatants of infected Sf-9 cells, even when ac109 knockout viruses displayed a single-cell infection phenotype. Moreover, confocal microscopy analysis revealed that budded virions can enter the cytoplasm but are unable to enter the cell nucleus. This defect could be repaired by complementing ac109 in trans. In addition, polyhedra of normal size could be detected in Sf-9 nuclei infected with ac109 knockout viruses. However, electron microscopy demonstrated that these occlusion bodies were empty. Altogether, these results indicate that ac109 is required for infectivity of both phenotypes of virus.	[Alfonso, Victoria; Reca, Sol R.; Gabriela Lopez, Maria; del Vas, Mariana; Taboga, Oscar] Inst Nacl Tecnol Agr IB INTA, CICVyA, Inst Biotecnol, Buenos Aires, DF, Argentina; [Maroniche, Guillermo A.] Inst Nacl Tecnol Agr IMyZA INTA, Inst Microbiol & Zool Agr, CICVyA, Hurlingham, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Taboga, O (corresponding author), Inst Nacl Tecnol Agr IB INTA, CICVyA, Inst Biotecnol, Buenos Aires, DF, Argentina.	otaboga@cnia.inta.gov.ar		del Vas, Mariana/0000-0002-8365-8582; Alfonso, Victoria/0000-0002-9167-6107; , Oscar/0000-0001-9575-3045; Lopez, Maria Gabriela/0000-0002-0560-7472	Proyecto de Investigacion Plurianual del CONICET (PIP-CONICET) [11420100100101]; Proyecto Especifico del Instituto Nacional de Tecnologia Agropecuaria (PE-INTA) [232161]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Proyecto de Investigacion Plurianual del CONICET (PIP-CONICET); Proyecto Especifico del Instituto Nacional de Tecnologia Agropecuaria (PE-INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by Proyecto de Investigacion Plurianual del CONICET (PIP-CONICET) No11420100100101 and Proyecto Especifico del Instituto Nacional de Tecnologia Agropecuaria (PE-INTA)No232161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; GAM holds a doctoral fellowship from the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). VA, MdV and OT are career members of CONICET. The authors would like to thank Dr. Julia Sabio y Garcia for English language editing.	Au S, 2012, J STRUCT BIOL, V177, P90, DOI 10.1016/j.jsb.2011.11.006; Bideshi DK, 2000, J GEN VIROL, V81, P1593, DOI 10.1099/0022-1317-81-6-1593; Blissard GW, 1996, CYTOTECHNOLOGY, V20, P73, DOI 10.1007/BF00350390; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; BRAUNAGEL SC, 1994, VIROLOGY, V202, P315, DOI 10.1006/viro.1994.1348; Braunagel SC, 2003, P NATL ACAD SCI USA, V100, P9797, DOI 10.1073/pnas.1733972100; Braunagel SC, 2007, CURR DRUG TARGETS, V8, P1084, DOI 10.2174/138945007782151315; CHARLTON CA, 1993, VIROLOGY, V197, P245, DOI 10.1006/viro.1993.1585; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Fang MG, 2009, VIROLOGY, V389, P66, DOI 10.1016/j.virol.2009.04.003; Lopez MG, 2011, ARCH VIROL, V156, P695, DOI 10.1007/s00705-010-0885-8; Lopez MG, 2010, J BIOTECHNOL, V145, P199, DOI 10.1016/j.jbiotec.2009.10.015; Gandhi KM, 2012, J GEN VIROL, V93, P1795, DOI 10.1099/vir.0.041848-0; Giri L, 2010, J GEN VIROL, V91, P3053, DOI 10.1099/vir.0.024430-0; Goley ED, 2006, SCIENCE, V314, P464, DOI 10.1126/science.1133348; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; HOHMANN AW, 1983, VIROLOGY, V125, P432, DOI 10.1016/0042-6822(83)90214-3; Hu ZY, 2010, J VIROL, V84, P7437, DOI 10.1128/JVI.02103-09; Lin L, 2009, VIRUS RES, V144, P130, DOI 10.1016/j.virusres.2009.04.010; Liu C, 2008, VIROLOGY, V382, P59, DOI 10.1016/j.virol.2008.09.003; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Maroniche GA, 2011, INSECT MOL BIOL, V20, P675, DOI 10.1111/j.1365-2583.2011.01100.x; McCarthy CB, 2008, VIROLOGY, V372, P325, DOI 10.1016/j.virol.2007.10.019; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; Ohkawa T, 2010, J CELL BIOL, V190, P187, DOI 10.1083/jcb.201001162; Peng K, J GEN VIROL, V91, P659; Rohrmann G.F., 2019, BACULOVIRUS MOL BIOL; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; van Oers MM, 2007, CURR DRUG TARGETS, V8, P1051, DOI 10.2174/138945007782151333; van Oers MM, 2011, J INVERTEBR PATHOL, V107, pS3, DOI 10.1016/j.jip.2011.05.001; Wang RR, 2010, J VIROL, V84, P7233, DOI 10.1128/JVI.00040-10; Wang Y, 2008, J VIROL, V82, P4554, DOI 10.1128/JVI.02510-07; WHITT MA, 1988, VIROLOGY, V163, P33, DOI 10.1016/0042-6822(88)90231-0; Williams GV, 1997, BACULOVIRUSES, P61, DOI DOI 10.1007/978-1-4899-1834-5_4; Wu WB, 2006, J VIROL, V80, P11475, DOI 10.1128/JVI.01155-06; Wu WB, 2010, J VIROL, V84, P12351, DOI 10.1128/JVI.01598-10; Yuan MJ, 2008, VIROLOGY, V379, P87, DOI 10.1016/j.virol.2008.06.015	37	18	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46146	10.1371/journal.pone.0046146	http://dx.doi.org/10.1371/journal.pone.0046146			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049963	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300091
J	Banerjee, D; Bhat, SN; Bhat, SV; Leporini, D				Banerjee, Debamalya; Bhat, Shrivalli N.; Bhat, Subray V.; Leporini, Dino			Molecular Probe Dynamics Reveals Suppression of Ice-Like Regions in Strongly Confined Supercooled Water	PLOS ONE			English	Article							STOKES-EINSTEIN RELATION; LIQUID WATER; STRUCTURAL RELAXATION; AQUEOUS-SOLUTIONS; THERMAL-BEHAVIOR; PHASE-BEHAVIOR; CAGED DYNAMICS; AMORPHOUS ICE; HIGH-DENSITY; VEIN SYSTEM	The structure of the hydrogen bond network is a key element for understanding water's thermodynamic and kinetic anomalies. While ambient water is strongly believed to be a uniform, continuous hydrogen-bonded liquid, there is growing consensus that supercooled water is better described in terms of distinct domains with either a low-density ice-like structure or a high-density disordered one. We evidenced two distinct rotational mobilities of probe molecules in interstitial supercooled water of polycrystalline ice [Banerjee D, et al. (2009) ESR evidence for 2 coexisting liquid phases in deeply supercooled bulk water. Proc Natl Acad Sci USA 106: 11448-11453]. Here we show that, by increasing the confinement of interstitial water, the mobility of probe molecules, surprisingly, increases. We argue that loose confinement allows the presence of ice-like regions in supercooled water, whereas a tighter confinement yields the suppression of this ordered fraction and leads to higher fluidity. Compelling evidence of the presence of ice-like regions is provided by the probe orientational entropy barrier which is set, through hydrogen bonding, by the configuration of the surrounding water molecules and yields a direct measure of the configurational entropy of the same. We find that, under loose confinement of supercooled water, the entropy barrier surmounted by the slower probe fraction exceeds that of equilibrium water by the melting entropy of ice, whereas no increase of the barrier is observed under stronger confinement. The lower limit of metastability of supercooled water is discussed.	[Banerjee, Debamalya; Bhat, Shrivalli N.; Bhat, Subray V.] Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India; [Leporini, Dino] Univ Pisa, Dipartimento Fis Enrico Fermi, Pisa, Italy; [Leporini, Dino] UoS Pisa, Consiglio Nazl Ric, Inst Proc Chim Fis, Pisa, Italy	Indian Institute of Science (IISC) - Bangalore; University of Pisa; Consiglio Nazionale delle Ricerche (CNR)	Bhat, SV (corresponding author), Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India.	svbhat@physics.iisc.ernet.in; dino.leporini@df.unipi.it	Bhat, Subray V/S-3636-2018; Bhat, S V/AAY-7394-2021	Bhat, Subray V/0000-0003-3430-4734; Bhat, S V/0000-0003-3430-4734; Leporini, Dino/0000-0002-9429-0509	Indian National Science Academy; University of Pisa	Indian National Science Academy; University of Pisa	The work was financially supported by the Indian National Science Academy and the University of Pisa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN MK, 1976, J CHEM PHYS, V64, P134, DOI 10.1063/1.431963; Alavi S, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3124187; Andreozzi L, 1996, J PHYS-CONDENS MAT, V8, P3795, DOI 10.1088/0953-8984/8/21/007; ANDREOZZI L, 1993, APPL MAGN RESON, V4, P279, DOI 10.1007/BF03162503; Angell CA, 2008, SCIENCE, V319, P582, DOI 10.1126/science.1131939; Banerjee D, 2009, P NATL ACAD SCI USA, V106, P11448, DOI 10.1073/pnas.0900734106; Barbieri A, 2004, J CHEM PHYS, V120, P437, DOI 10.1063/1.1630293; Barnes PRF, 2003, MICROSC RES TECHNIQ, V62, P62, DOI 10.1002/jemt.10385; Bernal JD, 1933, J CHEM PHYS, V1, P515, DOI 10.1063/1.1749327; Bhat SN, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.235702; BORICK SS, 1995, J PHYS CHEM-US, V99, P3781, DOI 10.1021/j100011a054; BOSIO L, 1981, PHYS REV LETT, V46, P597, DOI 10.1103/PhysRevLett.46.597; Brice JC., 1973, GROWTH CRYSTALS LIQU; Brovchenko I, 2008, CHEMPHYSCHEM, V9; Capaccioli S, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3633242; Chen SH, 2006, P NATL ACAD SCI USA, V103, P12974, DOI 10.1073/pnas.0603253103; Clark GNI, 2010, P NATL ACAD SCI USA, V107, P14003, DOI 10.1073/pnas.1006599107; Clark GNI, 2010, MOL PHYS, V108, P1415, DOI 10.1080/00268971003762134; de los Santos F, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.010602; De Michele C, 2011, SOFT MATTER, V7, P4025, DOI 10.1039/c0sm00941e; De Michele C, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.036702; Debenedetti PG, 2003, J PHYS-CONDENS MAT, V15, pR1669, DOI 10.1088/0953-8984/15/45/R01; Douglas JF, 1998, J NON-CRYST SOLIDS, V235, P137, DOI 10.1016/S0022-3093(98)00501-8; DOWELL LG, 1960, NATURE, V188, P1144, DOI 10.1038/1881144a0; Eisenberg D. S., 2005, STRUCTURE PROPERTIES; Errington JR, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.215503; Feistel R, 2006, J PHYS CHEM REF DATA, V35, P1021, DOI 10.1063/1.2183324; FRANK FC, 1968, NATURE, V220, P350, DOI 10.1038/220350a0; FRANK HS, 1957, DISCUSS FARADAY SOC, P133, DOI 10.1039/df9572400133; Gallo P, 2010, J PHYS CHEM LETT, V1, P729, DOI 10.1021/jz9003125; GIORDANO M, 1983, PHYS REV A, V28, P2474, DOI 10.1103/PhysRevA.28.2474; Houriez C, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3478999; Huang C, 2009, P NATL ACAD SCI USA, V106, P15214, DOI 10.1073/pnas.0904743106; Ito K, 1999, NATURE, V398, P492, DOI 10.1038/19042; JENNISKENS P, 1994, SCIENCE, V265, P753, DOI 10.1126/science.11539186; Jenniskens P, 1996, ASTROPHYS J, V473, P1104, DOI 10.1086/178220; Jenniskens P, 1997, J CHEM PHYS, V107, P1232, DOI 10.1063/1.474468; Johari GP, 1998, J CHEM PHYS, V109, P1070, DOI 10.1063/1.476649; Johari GP, 1995, THERMOCHIM ACTA, V266, P31, DOI 10.1016/0040-6031(95)02341-0; JOHARI GP, 1994, J CHEM PHYS, V100, P4548, DOI 10.1063/1.466286; Kim CU, 2009, P NATL ACAD SCI USA, V106, P4596, DOI 10.1073/pnas.0812481106; Kumar P, 2009, P NATL ACAD SCI USA, V106, P22130, DOI 10.1073/pnas.0911094106; Laage D, 2006, SCIENCE, V311, P832, DOI 10.1126/science.1122154; Larini L, 2008, NAT PHYS, V4, P42, DOI 10.1038/nphys788; LEIGH JS, 1971, J PHYS CHEM-US, V75, P1202, DOI 10.1021/j100679a003; LEPORINI D, 1994, PHYS REV A, V49, P992, DOI 10.1103/PhysRevA.49.992; MADER HM, 1992, J GLACIOL, V38, P333, DOI 10.3189/S0022143000002227; MADER HM, 1992, J GLACIOL, V38, P359, DOI 10.3189/S0022143000002240; Malani A, 2009, J PHYS CHEM B, V113, P13825, DOI 10.1021/jp902562v; Mallamace F, 2008, P NATL ACAD SCI USA, V105, P12725, DOI 10.1073/pnas.0805032105; Mallamace F, 2007, P NATL ACAD SCI USA, V104, P424, DOI 10.1073/pnas.0607138104; Matsumoto M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.017801; Mazza MG, 2011, P NATL ACAD SCI USA, V108, P19873, DOI 10.1073/pnas.1104299108; Mishima O, 1998, NATURE, V396, P329, DOI 10.1038/24540; Mishima O, 1998, NATURE, V392, P164, DOI 10.1038/32386; MISHIMA O, 1985, NATURE, V314, P76, DOI 10.1038/314076a0; Moore EB, 2011, NATURE, V479, P506, DOI 10.1038/nature10586; Moore EB, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3451112; Moore EB, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3158470; NEMETHY G, 1962, J CHEM PHYS, V36, P3382, DOI 10.1063/1.1732472; Nemilov SV, 2007, J NON-CRYST SOLIDS, V353, P4613, DOI 10.1016/j.jnoncrysol.2007.08.045; NORDIO PL, 1976, SPIN LABELING THEORY, P5; Nye J. F., 1973, S HYDROLOGY GLACIERS, V95, P157; NYE JF, 1991, J GLACIOL, V37, P401, DOI 10.3189/S0022143000005839; Ottochian A, 2011, PHILOS MAG, V91, P1786, DOI 10.1080/14786435.2010.521530; Ottochian A, 2011, J NON-CRYST SOLIDS, V357, P298, DOI 10.1016/j.jnoncrysol.2010.05.094; Ottochian A, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3269041; POOLE PH, 1994, PHYS REV LETT, V73, P1632, DOI 10.1103/PhysRevLett.73.1632; POOLE PH, 1992, NATURE, V360, P324, DOI 10.1038/360324a0; POPLE JA, 1951, PROC R SOC LON SER-A, V205, P163, DOI 10.1098/rspa.1951.0024; PRUPPACHER HR, 1967, PURE APPL GEOPHYS, V68, P186, DOI 10.1007/BF00874894; Puosi F, 2012, J CHEM PHYS, V136, DOI 10.1063/1.4704674; Puosi F, 2011, J PHYS CHEM B, V115, P14046, DOI 10.1021/jp203659r; Raviv U, 2001, NATURE, V413, P51, DOI 10.1038/35092523; Rosenhain W, 1913, J I MET, V10, P119; ROSS RT, 1965, J CHEM PHYS, V42, P3919, DOI 10.1063/1.1695859; SALVETTI G, 1995, J CHEM PHYS, V102, P4987, DOI 10.1063/1.469548; Santangelo MG, 2008, J PHYS CHEM B, V112, P15546, DOI 10.1021/jp805131j; Sastry S, 1996, PHYS REV E, V53, P6144, DOI 10.1103/PhysRevE.53.6144; Shen XS, 2011, ACS NANO, V5, P8426, DOI 10.1021/nn203399z; Smith JD, 2005, P NATL ACAD SCI USA, V102, P14171, DOI 10.1073/pnas.0506899102; Smith RS, 2011, J PHYS CHEM A, V115, P5908, DOI 10.1021/jp110297q; Soper AK, 2008, MOL PHYS, V106, P2053, DOI 10.1080/00268970802116146; Soper AK, 2000, PHYS REV LETT, V84, P2881, DOI 10.1103/PhysRevLett.84.2881; Souda R, 2007, J PHYS CHEM B, V111, P5628, DOI 10.1021/jp0672050; SPEEDY RJ, 1982, J PHYS CHEM-US, V86, P3002, DOI 10.1021/j100212a038; STANLEY HE, 1980, J CHEM PHYS, V73, P3404, DOI 10.1063/1.440538; Starr FW, 2003, PHYSICA A, V323, P51, DOI 10.1016/S0378-4371(03)00012-8; STILLINGER FH, 1980, SCIENCE, V209, P451, DOI 10.1126/science.209.4455.451; Stillinger FH, 1980, WATER POLYM; Stokely K, 2010, P NATL ACAD SCI USA, V107, P1301, DOI 10.1073/pnas.0912756107; Tanaka H, 2000, PHYS REV E, V62, P6968, DOI 10.1103/PhysRevE.62.6968; Tanaka H, 2000, J CHEM PHYS, V112, P799, DOI 10.1063/1.480609; Tulk CA, 2002, SCIENCE, V297, P1320, DOI 10.1126/science.1074178; Weil J. A., 2006, ELECT PARAMAGNETIC R; Wettlaufer JS, 2006, ANNU REV FLUID MECH, V38, P427, DOI 10.1146/annurev.fluid.37.061903.175758; Whiting H, 1884, THEORY COHESION; Wikfeldt KT, 2011, PHYS CHEM CHEM PHYS, V13, P19918, DOI 10.1039/c1cp22076d; Zhang H, 2009, P NATL ACAD SCI USA, V106, P7735, DOI 10.1073/pnas.0900227106; Zhang Y, 2011, P NATL ACAD SCI USA, V108, P12206, DOI 10.1073/pnas.1100238108	100	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e44382	10.1371/journal.pone.0044382	http://dx.doi.org/10.1371/journal.pone.0044382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049747	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300010
J	Wong, YF; Wilson, PD; Unwin, RJ; Norman, JT; Arno, M; Hendry, BM; Xu, QH				Wong, Yuen Fei; Wilson, Patricia D.; Unwin, Robert J.; Norman, Jill T.; Arno, Matthew; Hendry, Bruce M.; Xu, Qihe			Retinoic Acid Receptor-Dependent, Cell-Autonomous, Endogenous Retinoic Acid Signaling and Its Target Genes in Mouse Collecting Duct Cells	PLOS ONE			English	Article							VITAMIN-A-DEFICIENCY; EPITHELIAL-CELLS; MESENCHYMAL TRANSITION; PRINCIPAL CELLS; TYROSINE KINASE; EXPRESSION; PROTEIN; KIDNEY; DIFFERENTIATION; BIOSYNTHESIS	Background: Vitamin A is necessary for kidney development and has also been linked to regulation of solute and water homeostasis and to protection against kidney stone disease, infection, inflammation, and scarring. Most functions of vitamin A are mediated by its main active form, all-trans retinoic acid (tRA), which binds retinoic acid receptors (RARs) to modulate gene expression. We and others have recently reported that renal tRA/RAR activity is confined to the ureteric bud (UB) and collecting duct (CD) cell lineage, suggesting that endogenous tRA/RARs primarily act through regulating gene expression in these cells in embryonic and adult kidney, respectively. Methodology/Principal Findings: To explore target genes of endogenous tRA/RARs, we employed the mIMCD-3 mouse inner medullary CD cell line, which is a model of CD principal cells and exhibits constitutive tRA/RAR activity as CD principal cells do in vivo. Combining antagonism of RARs, inhibition of tRA synthesis, exposure to exogenous tRA, and gene expression profiling techniques, we have identified 125 genes as candidate targets and validated 20 genes that were highly regulated (Dhrs3, Sprr1a, and Ppbp were the top three). Endogenous tRA/RARs were more important in maintaining, rather than suppressing, constitutive gene expression. Although many identified genes were expressed in UBs and/or CDs, their exact functions in this cell lineage are still poorly defined. Nevertheless, gene ontology analysis suggests that these genes are involved in kidney development, renal functioning, and regulation of tRA signaling. Conclusions/Significance: A rigorous approach to defining target genes for endogenous tRA/RARs has been established. At the pan-genomic level, genes regulated by endogenous tRA/RARs in a CD cell line have been catalogued for the first time. Such a catalogue will guide further studies on molecular mediators of endogenous tRA/RARs during kidney development and in relation to renal defects associated with vitamin A deficiency.	[Wong, Yuen Fei; Hendry, Bruce M.; Xu, Qihe] Kings Coll London, Dept Renal Med, London WC2R 2LS, England; [Wilson, Patricia D.; Unwin, Robert J.; Norman, Jill T.] UCL, Ctr Nephrol, London, England; [Arno, Matthew] Kings Coll London, Genom Ctr, London WC2R 2LS, England	University of London; King's College London; University of London; University College London; University of London; King's College London	Xu, QH (corresponding author), Kings Coll London, Dept Renal Med, London WC2R 2LS, England.	qihe.xu@kcl.ac.uk	Wong, Yuen Fei/AAE-2086-2020; Wong, Yuen Fei/N-2615-2017; Wilson, Patricia/AAW-8481-2021	Wong, Yuen Fei/0000-0002-8761-2848; Wilson, Patricia/0000-0003-0902-188X	Kidney Research UK [IN1/2010]; European Union [223154]	Kidney Research UK(Kidney Research UK (KRUK)); European Union(European Commission)	This work was supported by a Kidney Research UK innovation grant (Grant reference: IN1/2010) awarded to QX, BMH, PDW and RJU and a European Union Framework Programme 7 grant awarded to QX and BMH (Grant agreement No. 223154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann PM, 2011, CURR MED CHEM, V18, P1405; Balmer JE, 2005, J STEROID BIOCHEM, V96, P347, DOI 10.1016/j.jsbmb.2005.05.005; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Batourina E, 2001, NAT GENET, V27, P74, DOI 10.1038/83792; Behr R, 2004, J BIOL CHEM, V279, P41936, DOI 10.1074/jbc.M403354200; Bonilla IE, 2002, J NEUROSCI, V22, P1303, DOI 10.1523/JNEUROSCI.22-04-01303.2002; Butt MJ, 2007, KIDNEY INT, V72, P936, DOI 10.1038/sj.ki.5002457; Cai Q, 2005, P NATL ACAD SCI USA, V102, P503, DOI 10.1073/pnas.0408840102; Cerignoli F, 2002, CANCER RES, V62, P1196; Chassin C, 2011, CELL MICROBIOL, V13, P1107, DOI 10.1111/j.1462-5822.2011.01614.x; Chen XR, 2008, J IMMUNOL, V180, P138, DOI 10.4049/jimmunol.180.1.138; Cohen DM, 1996, J CLIN INVEST, V97, P1884, DOI 10.1172/JCI118619; Feng L, 2010, DEV BIOL, V338, P1, DOI 10.1016/j.ydbio.2009.10.029; Froeling FEM, 2011, GASTROENTEROLOGY, V141, P1486, DOI 10.1053/j.gastro.2011.06.047; FUJIMOTO W, 1993, J INVEST DERMATOL, V101, P268, DOI 10.1111/1523-1747.ep12365200; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Goel M, 2010, AM J PHYSIOL-RENAL, V299, pF225, DOI 10.1152/ajprenal.00670.2009; Hoffman LM, 2006, J CELL BIOL, V174, P101, DOI 10.1083/jcb.200604150; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; JOHNSON AT, 1995, J MED CHEM, V38, P4764, DOI 10.1021/jm00024a003; KANCHA RK, 1992, BIOCHEM MED METAB B, V47, P1, DOI 10.1016/0885-4505(92)90002-G; Kavukcu S, 1999, BJU INT, V83, P1055; Kreutz M, 1998, BLOOD, V91, P4796, DOI 10.1182/blood.V91.12.4796.412k39_4796_4802; Lalevee S, 2011, J BIOL CHEM, V286, P33322, DOI 10.1074/jbc.M111.263681; Lee DCW, 2002, ONCOGENE, V21, P5582, DOI 10.1038/sj.onc.1205741; Lelievre-Pegorier M, 1998, KIDNEY INT, V54, P1455, DOI 10.1046/j.1523-1755.1998.00151.x; Levashova ZB, 2007, J AM SOC NEPHROL, V18, P2359, DOI 10.1681/ASN.2006040380; Liu SG, 1997, EXP NEPHROL, V5, P295; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Nelson AM, 2008, J CLIN INVEST, V118, P1468, DOI 10.1172/JCI33869; Nguyen LT, 2011, ANTIMICROB AGENTS CH, V55, P2074, DOI 10.1128/AAC.01351-10; Paralkar VM, 2002, J CELL PHYSIOL, V190, P207, DOI 10.1002/JCP.10048; Piscione TD, 2001, AM J PHYSIOL-RENAL, V280, pF19, DOI 10.1152/ajprenal.2001.280.1.F19; Pradervand S, 2004, EMBO J, V23, P4517, DOI 10.1038/sj.emboj.7600454; RAUCHMAN MI, 1993, AM J PHYSIOL, V265, pF416, DOI 10.1152/ajprenal.1993.265.3.F416; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Rosselot C, 2010, DEVELOPMENT, V137, P283, DOI 10.1242/dev.040287; RUSSO JE, 1988, BIOCHEM PHARMACOL, V37, P1639, DOI 10.1016/0006-2952(88)90030-5; Sproul A, 2011, AM J PHYSIOL-RENAL, V301, pF44, DOI 10.1152/ajprenal.00666.2010; Starkey ML, 2009, J COMP NEUROL, V513, P51, DOI 10.1002/cne.21944; Tesfaigzi Johannes, 1999, Cell Biochemistry and Biophysics, V30, P243, DOI 10.1007/BF02738069; Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z; Uawithya P, 2008, PHYSIOL GENOMICS, V32, P229, DOI 10.1152/physiolgenomics.00201.2007; van Leersum EC, 1927, BRIT MED J, V1927, P873, DOI 10.1136/bmj.2.3488.873; WALZ A, 1989, J EXP MED, V170, P1745, DOI 10.1084/jem.170.5.1745; Wong YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016770; Xu Q, 2004, KIDNEY INT, V66, P2119, DOI 10.1111/j.1523-1755.2004.66002.x; Xu QH, 2012, SEMIN NEPHROL, V32, P287, DOI 10.1016/j.semnephrol.2012.04.008; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhang XM, 2008, J BIOL CHEM, V283, P7994, DOI 10.1074/jbc.M709837200; ZILE M, 1972, J NUTR, V102, P1255, DOI 10.1093/jn/102.10.1255	53	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45725	10.1371/journal.pone.0045725	http://dx.doi.org/10.1371/journal.pone.0045725			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049847	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300046
J	Adu, B; Dodoo, D; Adukpo, S; Hedley, PL; Arthur, FKN; Gerds, TA; Larsen, SO; Christiansen, M; Theisen, M				Adu, Bright; Dodoo, Daniel; Adukpo, Selorme; Hedley, Paula L.; Arthur, Fareed K. N.; Gerds, Thomas A.; Larsen, Severin O.; Christiansen, Michael; Theisen, Michael			Fc Gamma Receptor IIIB (Fc gamma RIIIB) Polymorphisms Are Associated with Clinical Malaria in Ghanaian Children	PLOS ONE			English	Article							GLUTAMATE-RICH PROTEIN; PLASMODIUM-FALCIPARUM; PERIODONTAL-DISEASE; GENE-FREQUENCIES; IMMUNOGLOBULIN-G; PROTECTION; NEUTROPHILS; POPULATION; RESPONSES; ANTIGENS	Plasmodium falciparum malaria kills nearly a million people annually. Over 90% of these deaths occur in children under five years of age in sub- Saharan Africa. A neutrophil mediated mechanism, the antibody dependent respiratory burst (ADRB),was recently shown to correlate with protection from clinical malaria. Human neutrophils constitutively express Fc gamma receptor-Fc gamma RIIA and Fc gamma RIIIB by which they interact with immunoglobulin (Ig) G (IgG)-subclass antibodies. Polymorphisms in exon 4 of FCGR2A and exon 3 of FCGR3B genes encoding Fc gamma RIIA and Fc gamma RIIIB respectively have been described to alter the affinities of both receptors for IgG. Here, associations between specific polymorphisms, encoding Fc gamma RIIA p.H166R and Fc gamma RIIIB-NA1/NA2/SH variants with clinical malaria were investigated in a longitudinal malaria cohort study. Fc gamma RIIA-p.166H/R was genotyped by gene specific polymerase chain reaction followed by allele specific restriction enzyme digestion. FCGR3B-exon 3 was sequenced in 585 children, aged 1 to 12 years living in a malaria endemic region of Ghana. Multivariate logistic regression analysis found no association between Fc gamma RIIA-166H/R polymorphism and clinical malaria. The A-allele of FCGR3B-c.233C>A (rs5030738) was significantly associated with protection from clinical malaria under two out of three genetic models (additive: p = 0.0061; recessive: p = 0.097; dominant: p = 0.0076) of inheritance. The Fc gamma RIIIB-SH allotype (CTGAAA) containing the 233A-allele (in bold) was associated with protection from malaria (p = 0.049). The Fc gamma RIIIB-NA2*03 allotype (CTGCGA), a variant of the classical Fc gamma RIIIB-NA2 (CTGCAA) was associated with susceptibility to clinical malaria (p = 0.0092). The present study is the first to report an association between a variant of Fc gamma RIIIB-NA2 and susceptibility to clinical malaria and provides justification for further functional characterization of variants of the classical Fc gamma RIIIB allotypes. This would be crucial to the improvement of neutrophil mediated functional assays such as the ADRB assay aimed at assessing the functionality of antibodies induced by candidate malaria vaccines.	[Adu, Bright; Adukpo, Selorme; Hedley, Paula L.; Larsen, Severin O.; Christiansen, Michael; Theisen, Michael] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Adu, Bright; Theisen, Michael] Univ Copenhagen, Rigshosp, Ctr Med Parasitol, Dept Int Hlth Immunol & Microbiol, DK-2100 Copenhagen, Denmark; [Adu, Bright; Theisen, Michael] Univ Copenhagen, Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Dodoo, Daniel] Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; [Hedley, Paula L.] Univ Stellenbosch, Dept Biomed Sci, Cape Town, South Africa; [Arthur, Fareed K. N.] Kwame Nkrumah Univ Sci & Technol, Dept Biochem & Biotechnol, Kumasi, Ghana; [Gerds, Thomas A.] Univ Copenhagen, Dept Biostat, Copenhagen, Denmark	Statens Serum Institut; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Ghana; Stellenbosch University; Kwame Nkrumah University Science & Technology; University of Copenhagen	Christiansen, M (corresponding author), Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark.	mic@ssi.dk; mth@ssi.dk	Hedley, Paula L/E-6156-2011; Adu, Bright/ABA-8631-2020; Christiansen, Michael/B-4588-2009	Hedley, Paula L/0000-0001-5801-960X; Adu, Bright/0000-0002-3622-2137; Christiansen, Michael/0000-0003-4713-755X; Theisen, Michael/0000-0003-4412-1392; Gerds, Thomas Alexander/0000-0002-5955-816X; Arthur, Fareed Kow Nanse/0000-0001-7897-2166	European and Developing Countries Clinical Trials Partnership [TA.2007.40200.012]; European Vaccine Initiative; African Malaria Network Trust [008/2008AIA]	European and Developing Countries Clinical Trials Partnership; European Vaccine Initiative; African Malaria Network Trust	The study was funded by grants from the European and Developing Countries Clinical Trials Partnership (www.edctp.org) (TA.2007.40200.012), the European Vaccine Initiative (www.euvaccine.eu) (08-2007) and the African Malaria Network Trust (www.amanet-trust.org) (008/2008AIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029465; ALLISON AC, 1983, ANNU REV IMMUNOL, V1, P361, DOI 10.1146/annurev.iy.01.040183.002045; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bejon P, 2009, INFECT IMMUN, V77, P1917, DOI 10.1128/IAI.01358-08; Blum KS, 2009, VOX SANG, V97, P69, DOI 10.1111/j.1423-0410.2009.01178.x; Boross P, 2008, FC RECEPTORS ENCY LI, P1; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Burkett K, 2006, J STAT SOFTW, V16, P1; BUX J, 1995, TRANSFUSION, V35, P54, DOI 10.1046/j.1537-2995.1995.35195090663.x; Bux J, 1997, BLOOD, V89, P1027, DOI 10.1182/blood.V89.3.1027; Bux J, 1999, BLOOD, V93, P357, DOI 10.1182/blood.V93.1.357.401k39_357_362; CLARK IA, 1983, INFECT IMMUN, V39, P1; DEHAAS M, 1995, BLOOD, V86, P2403, DOI 10.1182/blood.V86.6.2403.bloodjournal8662403; Dimou NL, 2010, J CLIN PERIODONTOL, V37, P255, DOI 10.1111/j.1600-051X.2009.01530.x; Dodoo D, 2000, J INFECT DIS, V181, P1202, DOI 10.1086/315341; FEIZI T, 1987, BIOCHEM J, V245, P1; Greve B, 1999, J INFECT DIS, V179, P1584, DOI 10.1086/314780; Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004; Jiang XM, 1996, J IMMUNOL METHODS, V199, P55, DOI 10.1016/S0022-1759(96)00164-0; Joos C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009871; KIMBERLY RP, 1995, ARTHRITIS RHEUM, V38, P306, DOI 10.1002/art.1780380303; Koene HR, 1998, BLOOD, V91, P673, DOI 10.1182/blood.V91.2.673.673_673_679; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; LECONTE I, 1992, J BIOL CHEM, V267, P17415; Lettre G, 2007, GENET EPIDEMIOL, V31, P358, DOI 10.1002/gepi.20217; Matsuo K, 2000, TRANSFUSION, V40, P645, DOI 10.1046/j.1537-2995.2000.40060645.x; Ministry of Health, 1992, MAL ACT PLAN 1993 19; MITCHELL MA, 1994, BLOOD, V84, P1753; Morgan AW, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1847; NAJERA JA, 1989, B WORLD HEALTH ORGAN, V67, P229; Niu LH, 2000, BLOOD, V95, P3357, DOI 10.1182/blood.V95.11.3357.011k43_3357_3362; Oeuvray C, 2000, INFECT IMMUN, V68, P2617, DOI 10.1128/IAI.68.5.2617-2620.2000; Omi K, 2002, PARASITOL INT, V51, P361, DOI 10.1016/S1383-5769(02)00040-5; ORY PA, 1989, J CLIN INVEST, V84, P1688, DOI 10.1172/JCI114350; Ouma C, 2011, HUM GENET; PARREN PWHI, 1992, J CLIN INVEST, V90, P1537, DOI 10.1172/JCI116022; PERUSSIA B, 1983, J EXP MED, V158, P1092, DOI 10.1084/jem.158.4.1092; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; RAVETCH JV, 2003, FUNDAMENTAL IMMUNOLO, P685; SALMON JE, 1995, J CLIN INVEST, V95, P2877, DOI 10.1172/JCI117994; SALMON JE, 1990, J CLIN INVEST, V85, P1287, DOI 10.1172/JCI114566; SALMON JE, 1992, J CLIN INVEST, V89, P1274, DOI 10.1172/JCI115712; Schuldt K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002066; Schuldt K, 2010, J MED GENET, V47, P471, DOI 10.1136/jmg.2009.073643; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Shub A, 2009, AUST NZ J OBSTET GYN, V49, P130, DOI 10.1111/j.1479-828X.2009.00953.x; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; SZECOWKA J, 1990, ENDOCRINOLOGY, V126, P1834, DOI 10.1210/endo-126-4-1834; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Terzian CC, 2011, TRANSFUSION; Theisen M, 1998, INFECT IMMUN, V66, P11, DOI 10.1128/IAI.66.1.11-17.1998; TIFFT CJ, 1992, J BIOL CHEM, V267, P3268; Tong Y, 2003, ANN HEMATOL, V82, P574, DOI 10.1007/s00277-003-0725-y; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; WARMERDAM PAM, 1990, J EXP MED, V172, P19, DOI 10.1084/jem.172.1.19; WHO, 2010, WORLD MALARIA REPORT 2010, P1	56	40	40	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46197	10.1371/journal.pone.0046197	http://dx.doi.org/10.1371/journal.pone.0046197			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049979	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100154
J	Bal, W; Kurowska, E; Maret, W				Bal, Wojciech; Kurowska, Ewa; Maret, Wolfgang			The Final Frontier of pH and the Undiscovered Country Beyond	PLOS ONE			English	Article							PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE; VOLUME; VALUES	The comparison of volumes of cells and subcellular structures with the pH values reported for them leads to a conflict with the definition of the pH scale. The pH scale is based on the ionic product of water, K-w = [H+]x[OH-]. We used K-w [in a reversed way] to calculate the number of undissociated H2O molecules required by this equilibrium constant to yield at least one of its daughter ions, H+ or OH- at a given pH. In this way we obtained a formula that relates pH to the minimal volume V-pH required to provide a physical meaning to K-w, V-pH = 10(vertical bar pH) - (pKw/2 vertical bar) x 10(pKw/2)/N-A (where N-A is Avogadro's number). For example, at pH 7 (neutral at 25 degrees C) V-pH = 16.6 aL. Any deviation from neutral pH results in a larger V-pH value. Our results indicate that many subcellular structures, including coated vesicles and lysosomes, are too small to contain free H+ ions at equilibrium, thus the definition of pH based on K-w is no longer valid. Larger subcellular structures, such as mitochondria, apparently contain only a few free H+ ions. These results indicate that pH fails to describe intracellular conditions, and that water appears to be dissociated too weakly to provide free H+ ions as a general source for biochemical reactions. Consequences of this finding are discussed.	[Bal, Wojciech; Kurowska, Ewa] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Maret, Wolfgang] Kings Coll London, Diabet & Nutr Sci Div, London WC2R 2LS, England	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of London; King's College London	Bal, W (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	wbal@ibb.waw.pl		Bal, Wojciech/0000-0003-3780-083X	Polish National Centre for Science [2011/01/B/ST4/06144]	Polish National Centre for Science	This work was supported by the Polish National Centre for Science grant number 2011/01/B/ST4/06144. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Bates R.G., 1973, J ELECTROCHEM SOC, V120, p263C, DOI [10.1149/1.2403829, DOI 10.1149/1.2403829]; BURSZTAJN S, 1981, CELL TISSUE RES, V220, P573, DOI 10.1007/BF00216761; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Coleman J, 2009, MICROSC MICROANAL, V15, P948, DOI 10.1017/S1431927609095713; Han JY, 2010, CHEM REV, V110, P2709, DOI 10.1021/cr900249z; Kapus A, 2000, J BIOL CHEM, V275, P32289, DOI 10.1074/jbc.M003172200; KROLL RG, 1983, BIOCHEM J, V216, P709, DOI 10.1042/bj2160709; MARKOWSKA A, 1994, HISTOL HISTOPATHOL, V9, P263; MONCELLI MR, 1994, BIOPHYS J, V66, P1969, DOI 10.1016/S0006-3495(94)80990-7; THURMOND RL, 1991, BIOPHYS J, V59, P108, DOI 10.1016/S0006-3495(91)82203-2; TSUI FC, 1986, BIOPHYS J, V49, P459, DOI 10.1016/S0006-3495(86)83655-4	12	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45832	10.1371/journal.pone.0045832	http://dx.doi.org/10.1371/journal.pone.0045832			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049874	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100088
J	Gaucherel, C; Boudon, F; Houet, T; Castets, M; Godin, C				Gaucherel, Cedric; Boudon, Frederic; Houet, Thomas; Castets, Mathieu; Godin, Christophe			Understanding Patchy Landscape Dynamics: Towards a Landscape Language	PLOS ONE			English	Article							PLANT-GROWTH; MODELS; PATTERN; HETEROGENEITY; BIODIVERSITY; ARCHITECTURE; BRITTANY; NETWORK	Patchy landscapes driven by human decisions and/or natural forces are still a challenge to be understood and modelled. No attempt has been made up to now to describe them by a coherent framework and to formalize landscape changing rules. Overcoming this lacuna was our first objective here, and this was largely based on the notion of Rewriting Systems, also called Formal Grammars. We used complicated scenarios of agricultural dynamics to model landscapes and to write their corresponding driving rule equations. Our second objective was to illustrate the relevance of this landscape language concept for landscape modelling through various grassland managements, with the final aim to assess their respective impacts on biological conservation. For this purpose, we made the assumptions that a higher grassland appearance frequency and higher land cover connectivity are favourable to species conservation. Ecological results revealed that dairy and beef livestock production systems are more favourable to wild species than is hog farming, although in different ways. Methodological results allowed us to efficiently model and formalize these landscape dynamics. This study demonstrates the applicability of the Rewriting System framework to the modelling of agricultural landscapes and, hopefully, to other patchy landscapes. The newly defined grammar is able to explain changes that are neither necessarily local nor Markovian, and opens a way to analytical modelling of landscape dynamics.	[Gaucherel, Cedric] INRA, UMR, AMAP, F-34060 Montpellier, France; [Gaucherel, Cedric; Castets, Mathieu] CNRS, IFP, Pondicherry, India; [Boudon, Frederic; Godin, Christophe] CIRAD, INRIA, DAP, Montpellier, France; [Houet, Thomas] Univ Toulouse 2, CNRS, GEODE, UMR 5602, Toulouse, France	INRAE; Universite de Montpellier; CIRAD; Inria; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite de Toulouse - Jean Jaures	Gaucherel, C (corresponding author), INRA, UMR, AMAP, F-34060 Montpellier, France.	cedric.gaucherel@ifpindia.org	Boudon, Frédéric/E-6812-2015; Godin, Christophe/C-1218-2008	Godin, Christophe/0000-0002-1202-8460; Houet, Thomas/0000-0001-5890-6145; Boudon, Frederic/0000-0001-9636-3102	Agence Nationale de la Recherche (project "BiodivAgriM''); Agence Nationale de la Recherche (project "INC''); Agence Nationale de la Recherche (project ANR-biodiversite)	Agence Nationale de la Recherche (project "BiodivAgriM'')(French National Research Agency (ANR)); Agence Nationale de la Recherche (project "INC'')(French National Research Agency (ANR)); Agence Nationale de la Recherche (project ANR-biodiversite)(French National Research Agency (ANR))	This research has been funded by the Agence Nationale de la Recherche (projects "BiodivAgriM'' and "INC'', ANR-biodiversite 2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVEDO MF, 1995, ECOL APPL, V5, P1040, DOI 10.2307/2269353; Becker E., 2011, ECOLOGY REVISITED RE, P385; Butler SJ, 2007, SCIENCE, V315, P381, DOI 10.1126/science.1136607; Costanza R, 2004, LANDSCAPE SIMULATION; de Reuille PB, 2006, P NATL ACAD SCI USA, V103, P1627, DOI 10.1073/pnas.0510130103; Dershowitz N, 1990, REWRITE SYSTEMS; Forman R.T.T., 1986, LANDSCAPE ECOL; Gardner R. H., 1991, QUANTITATIVE METHODS; Gardner RH, 1987, LANDSCAPE ECOL, V1, P19, DOI 10.1007/BF02275262; Gaucherel C, 2007, LANDSCAPE URBAN PLAN, V82, P95, DOI 10.1016/j.landurbplan.2007.01.022; Gaucherel C, 2006, ECOL MODEL, V194, P233, DOI 10.1016/j.ecolmodel.2005.10.026; Gaucherel C, 2011, ACTA BIOTHEOR, V59, P67, DOI 10.1007/s10441-010-9119-4; Gaucherel C, 2009, ECOL MODEL, V220, P3477, DOI 10.1016/j.ecolmodel.2009.06.025; Gaucherel C, 2010, LANDSCAPE ECOLOGY, V25, P300; Giavitto JL, 2003, BIOSYSTEMS, V70, P149, DOI 10.1016/S0303-2647(03)00037-6; Godin C, 2000, ANN FOREST SCI, V57, P413; Gustafson EJ, 1998, ECOSYSTEMS, V1, P143, DOI 10.1007/s100219900011; Harte John, 2004, Nature, V430, P33; Hemmerling R, 2008, FUNCT PLANT BIOL, V35, P739, DOI 10.1071/FP08052; Houet T, 2007, REV INT GEOMATIQUE, V3-4, P489; Houet T, 2010, LANDSCAPE ECOL, V25, P249, DOI 10.1007/s10980-009-9362-8; Kotliar NB, 1990, OIKOS, V59, P523; KURTH W, 1994, ECOL MODEL, V75, P299, DOI 10.1016/0304-3800(94)90027-2; Kurth W, 2000, ANN FOR SCI, V57, P543; Le Ber F, 2002, J UNIVERS COMPUT SCI, V8, P751; LI HB, 1994, ECOLOGY, V75, P2446, DOI 10.2307/1940898; LINDENMAYER A, 1968, J THEOR BIOL, V18, P280, DOI 10.1016/0022-5193(68)90079-9; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Nosberger J, 1998, ANN ZOOTECH, V47, P383, DOI 10.1051/animres:19980506; Okubo A., 1980, DIFFUSION ECOLOGICAL; Pradal C, 2008, FUNCT PLANT BIOL, V35, P751, DOI 10.1071/FP08084; Prusinkiewicz P, 2004, CURR OPIN PLANT BIOL, V7, P79, DOI 10.1016/j.pbi.2003.11.007; Prusinkiewicz P, 2004, ALGORITHMIC BEAUTY P; PRUSINKIEWICZ PW, 1994, CAN J BOT, V72, P701, DOI 10.1139/b94-091; Thenail C, 2004, AGR ECOSYST ENVIRON, V101, P53, DOI 10.1016/S0167-8809(03)00199-3; Veldkamp A, 2004, J ENVIRON MANAGE, V72, P1, DOI 10.1016/j.jenvman.2004.04.004	36	19	19	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46064	10.1371/journal.pone.0046064	http://dx.doi.org/10.1371/journal.pone.0046064			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049935	Green Published, gold			2022-12-27	WOS:000309556100128
J	Gromova, I; Gromov, P; Kroman, N; Wielenga, VT; Simon, R; Sauter, G; Moreira, JMA				Gromova, Irina; Gromov, Pavel; Kroman, Niels; Wielenga, Vera Timmermans; Simon, Ronald; Sauter, Guido; Moreira, Jose M. A.			Immunoexpression Analysis and Prognostic Value of BLCAP in Breast Cancer	PLOS ONE			English	Article							TRANSITIONAL-CELL CARCINOMAS; HUMAN BLADDER-CANCER; PROTEOMIC STRATEGIES; GENE-EXPRESSION; FOLLOW-UP; PROTEIN; BIOMARKER; DISCOVERY; IDENTIFICATION; CHALLENGES	Bladder Cancer Associated Protein (BLCAP, formerly Bc10), was identified by our laboratory as being down-regulated in bladder cancer with progression. BLCAP is ubiquitously expressed in different tissues, and several studies have found differential expression of BLCAP in various cancer types, such as cervical and renal cancer, as well as human tongue carcinoma and osteosarcoma. Here we report the first study of the expression patterns of BLCAP in breast tissue. We analyzed by immunohistochemistry tissue sections of normal and malignant specimens collected from 123 clinical high-risk breast cancer patients within the Danish Center for Translational Breast Cancer Research (DCTB) prospective study dataset. The staining pattern, the distribution of the immunostaining, and its intensity were studied in detail. We observed weak immunoreactivity for BLCAP in mammary epithelial cells, almost exclusively localizing to the cytoplasm and found that levels of expression of BLCAP were generally higher in malignant cells as compared to normal cells. Quantitative IHC analysis of BLCAP expression in breast tissues confirmed this differential BLCAP expression in tumor cells, and we could establish, in a 62-patient sample matched cohort, that immunostaining intensity for BLCAP was increased in tumors relative to normal tissue, in more than 45% of the cases examined, indicating that BLCAP may be of value as a marker for breast cancer. We also analyzed BLCAP expression and prognostic value using a set of tissue microarrays comprising an independent cohort of 2,197 breast cancer patients for which we had follow-up clinical information.	[Gromova, Irina; Gromov, Pavel; Moreira, Jose M. A.] Danish Canc Soc Res Ctr, Genome Integr Unit, Copenhagen, Denmark; [Gromova, Irina; Gromov, Pavel; Wielenga, Vera Timmermans; Moreira, Jose M. A.] Danish Ctr Translat Breast Canc Res DCTB, Copenhagen, Denmark; [Kroman, Niels] Copenhagen Univ Hosp, Dept Breast Surg, Copenhagen, Denmark; [Wielenga, Vera Timmermans] Copenhagen Univ Hosp, Dept Pathol, Ctr Diagnost Invest, Copenhagen, Denmark; [Simon, Ronald; Sauter, Guido] Univ Med Ctr Hamburg Eppendorf, Dept Pathol, Ctr Diagnost, Hamburg, Germany; [Moreira, Jose M. A.] Univ Copenhagen, Sect Pathobiol, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Moreira, Jose M. A.] Univ Copenhagen, Sino Danish Breast Canc Res Ctr, Dept Vet Dis Biol, Fac Hlth & Med Sci, Copenhagen, Denmark	Danish Cancer Society; University of Copenhagen; University of Copenhagen; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Copenhagen; University of Copenhagen	Gromova, I (corresponding author), Danish Canc Soc Res Ctr, Genome Integr Unit, Copenhagen, Denmark.	iig@cancer.dk; jom@cancer.dk		Gromova, Irina/0000-0003-4357-5958; Moreira, Jose/0000-0002-9944-1214; Simon, Ronald/0000-0003-0158-4258	Danish Cancer Society; John and Birthe Meyer Foundation; "Race against Breast Cancer'' foundation	Danish Cancer Society(Danish Cancer Society); John and Birthe Meyer Foundation; "Race against Breast Cancer'' foundation	This work was supported by the Danish Cancer Society through the budget of the Research Center, and by grants from the John and Birthe Meyer Foundation, and the "Race against Breast Cancer'' foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BL, 2002, CANCER RES, V62, P3609; Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; Allred DC, 2011, CANCER PREV RES, V4, P1947, DOI 10.1158/1940-6207.CAPR-11-0478; Bichsel VE, 2001, CANCER J, V7, P69; Birkhahn M, 2007, EXPERT REV ANTICANC, V7, P1717, DOI 10.1586/14737140.7.12.1717; Celis JE, 2004, MOL CELL PROTEOMICS, V3, P327, DOI 10.1074/mcp.M400009-MCP200; Celis JE, 2003, CANCER CELL, V3, P9, DOI 10.1016/S1535-6108(02)00242-8; Celis JE, 2005, FEBS J, V272, P2, DOI 10.1111/j.1432-1033.2004.04418.x; Celis JE, 2004, PHARMACOGENOMICS, V5, P381, DOI 10.1517/14622416.5.4.381; Celis JE, 2003, MOL CELL PROTEOMICS, V2, P369, DOI 10.1074/mcp.R300007-MCP200; Celis JE, 2002, MOL CELL PROTEOMICS, V1, P269, DOI 10.1074/mcp.M100031-MCP200; Celis JE, 2009, MOL ONCOL, V3, P220, DOI 10.1016/j.molonc.2009.01.005; Celis JE, 2007, MOL ONCOL, V1, P1, DOI 10.1016/j.molonc.2007.02.003; Clutterbuck DR, 2005, BIOINFORMATICS, V21, P2590, DOI 10.1093/bioinformatics/bti411; Cole K, 2011, CANCER BIOMARK, V9, P177, DOI 10.3233/CBM-2011-0187; Daino K, 2009, INT J CANCER, V125, P612, DOI 10.1002/ijc.24392; Edgell T, 2010, J CANCER RES CLIN, V136, P1079, DOI 10.1007/s00432-009-0755-5; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fan DG, 2011, EXP BIOL MED, V236, P1030, DOI 10.1258/ebm.2011.010315; Galeano F, 2010, INT J CANCER, V127, P127, DOI 10.1002/ijc.25022; Gromov P, 2008, PROTEOM CLIN APPL, V2, P974, DOI 10.1002/prca.200780163; Gromov P, 2010, J PROTEOME RES, V9, P3941, DOI 10.1021/pr100160u; Gromov P, 2010, MOL ONCOL, V4, P65, DOI 10.1016/j.molonc.2009.11.003; Gromova I, 2002, INT J CANCER, V98, P539, DOI 10.1002/ijc.10244; Gromova I, 1998, INT J ONCOL, V13, P379; Jain KK, 2008, MOL ONCOL, V2, P153, DOI 10.1016/j.molonc.2008.05.003; Kashani-Sabet M, 2009, CLIN CANCER RES, V15, P6987, DOI 10.1158/1078-0432.CCR-09-1777; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Misek D. E., 2011, INT J PROTEOMICS, DOI 10.1155/2011/343582; Moreira JMA, 2004, MOL CELL PROTEOMICS, V3, P410, DOI 10.1074/mcp.M300134-MCP200; Moreira JMA, 2010, MOL ONCOL, V4, P539, DOI 10.1016/j.molonc.2010.09.005; Moreira JMA, 2010, MOL CELL PROTEOMICS, V9, P161, DOI 10.1074/mcp.M900294-MCP200; Ohlsson G, 2005, MOL CELL PROTEOMICS, V4, P570, DOI 10.1074/mcp.M500017-MCP200; Ostergaard M, 1999, ELECTROPHORESIS, V20, P349; Ostergaard M, 1997, CANCER RES, V57, P4111; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Rae FK, 2000, INT J CANCER, V88, P726, DOI 10.1002/1097-0215(20001201)88:5<726::AID-IJC7>3.0.CO;2-H; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Su Hai-chuan, 2003, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V19, P465; Whiteley GR, 2006, MOL BIOSYST, V2, P358, DOI 10.1039/b607260g; Yao J, 2007, MOL CELL BIOCHEM, V297, P81, DOI 10.1007/s11010-006-9332-2; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064; Zuo Ze-Hua, 2006, Ai Zheng, V25, P811; Zuo ZH, 2006, TUMOR BIOL, V27, P221, DOI 10.1159/000093057	45	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45967	10.1371/journal.pone.0045967	http://dx.doi.org/10.1371/journal.pone.0045967			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049907	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100110
J	Gui, YS; Wang, LM; Tian, XL; Feng, RE; Ma, AP; Cai, BQ; Zhang, HB; Xu, KF				Gui, Yao-Song; Wang, Lianmei; Tian, Xinlun; Feng, Ruie; Ma, Aiping; Cai, Baiqiang; Zhang, Hongbing; Xu, Kai-Feng			SPC-Cre-ERT2 Transgenic Mouse for Temporal Gene Deletion in Alveolar Epithelial Cells	PLOS ONE			English	Article							CRE RECOMBINASE; MUTAGENESIS; MODEL	Although several Cre-loxP-based gene knockout mouse models have been generated for the study of gene function in alveolar epithelia in the lung, their applications are still limited. In this study, we developed a SPC-Cre-ERT2 mouse model, in which a tamoxifen-inducible Cre recombinase (Cre-ERT2) is under the control of the human surfactant protein C (SPC) promoter. The specificity and efficiency of Cre-ERT2 activity was first evaluated by crossing SPC-Cre-ERT2 mouse with ROSA26R mouse, alpha beta-galactosidase reporter strain. We found that Cre-ERT2 was expressed in 30.7% type II alveolar epithelial cells of SPC-Cre-ERT2/ROSA26R mouse lung tissues in the presence of tamoxifen. We then tested the tamoxifen-inducible recombinase activity of Cre-ERT2 in a mouse strain bearing TSC1 conditional knockout alleles (TSC1(fx/fx)). TSC1 deletion was detected in the lungs of tamoxifen treated SPC-Cre-ERT2/TSC1(fx/fx) mice. Therefore this SPC-Cre-ERT2 mouse model may be a valuable tool to investigate functions of genes in lung development, physiology and disease.	[Gui, Yao-Song; Wang, Lianmei; Tian, Xinlun; Ma, Aiping; Cai, Baiqiang; Xu, Kai-Feng] Peking Union Med Coll, Dept Resp Med, Peking Union Med Coll Hosp, Beijing 100021, Peoples R China; [Gui, Yao-Song; Wang, Lianmei; Tian, Xinlun; Feng, Ruie; Ma, Aiping; Cai, Baiqiang; Zhang, Hongbing; Xu, Kai-Feng] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Wang, Lianmei; Zhang, Hongbing] Peking Union Med Coll, State Key Lab Med Mol Biol, Dept Physiol & Pathophysiol, Inst Basic Med Sci, Beijing 100021, Peoples R China; [Feng, Ruie] Peking Union Med Coll, Dept Pathol, Peking Union Med Coll Hosp, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Xu, KF (corresponding author), Peking Union Med Coll, Dept Resp Med, Peking Union Med Coll Hosp, Beijing 100021, Peoples R China.	kaifeng.xu@gmail.com	Xu, Kai-Feng/AAO-2445-2020; Tian, Xinlun/AAF-5444-2019	Tian, Xinlun/0000-0003-4307-6665	973 Program of China [2009CB522106]	973 Program of China(National Basic Research Program of China)	The work was supported by the 973 Program of China (2009CB522106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lantinga-van Leeuwen IS, 2006, GENESIS, V44, P225, DOI 10.1002/dvg.20207; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Morimoto M, 2009, DEV BIOL, V325, P171, DOI 10.1016/j.ydbio.2008.10.013; Mura M, 2010, AM J PATHOL, V176, P1725, DOI 10.2353/ajpath.2010.090209; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Santagati F, 2005, DEVELOPMENT, V132, P4927, DOI 10.1242/dev.02078; Sun JP, 2008, AM J PATHOL, V172, P571, DOI 10.2353/ajpath.2008.070286; Tafel Oliver, 2008, BMC Pulm Med, V8, P6, DOI 10.1186/1471-2466-8-6; Whitsett JA, 2006, AM J RESP CELL MOL, V34, P519, DOI 10.1165/rcmb.F310	16	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46076	10.1371/journal.pone.0046076	http://dx.doi.org/10.1371/journal.pone.0046076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049940	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100132
J	Hutchinson, PL; Meekers, D				Hutchinson, Paul L.; Meekers, Dominique			Estimating Causal Effects from Family Planning Health Communication Campaigns Using Panel Data: The "Your Health, Your Wealth'' Campaign in Egypt	PLOS ONE			English	Article							PROPENSITY SCORE; INSTRUMENTAL VARIABLES; COST-EFFECTIVENESS; IMPACT; PROGRAMS; TANZANIA; KNOWLEDGE; UGANDA; IDENTIFICATION; DETERMINANTS	Background: Health communication campaigns - involving mass media and interpersonal communication - have long been utilized by national family planning programs to create awareness about contraceptive methods, to shift social norms related to fertility control, and to promote specific behaviors, such as the use of condoms, injectable methods or permanent sterilization. However, demonstrating the effectiveness of these campaigns is often complicated because the infeasibility of experimental designs generally yields statistically non-equivalent samples of campaign-exposed and unexposed individuals. Methods: Using data from a panel survey of reproductive age women in Egypt, we estimate the effects of the multimedia health communication campaign "Your Health, Your Wealth'' ("Sahatek Sarwetek'') on precursors to contraceptive use (e.g., spousal communication, birth spacing attitudes) and on modern contraceptive use. Difference-in-differences and fixed effects estimators that exploit the panel nature of the data are employed to control for both observed and unobserved heterogeneity in the sample of women who self-report recall of the messages, thereby potentially improving upon methods that make no such controls or that rely solely on cross-sectional data. Findings: All of the estimators find positive effects of the "Your Health, Your Wealth'' campaign on reproductive health outcomes, though the "Your of those effects diverge, often considerably. Difference-in-differences estimators find that exposure to the campaign increases the likelihood of spousal discussions by 14.4 percentage points (pp.) (SE = .039, p<0.001) but has no effect on contraceptive use. In contrast, the fixed effects, instrumental variables estimator, controlling for unobserved heterogeneity, finds a large, statistically significant effect on modern contraceptive use (27.4 pp., SE = 0.135, p = 0.043). Conclusions: The difficulties of evaluating family planning communication programs may be surmountable using panel data and analytic methods that address both observed and unobserved heterogeneity in exposure. Not controlling for such effects may lead to substantial underestimates of the effectiveness of such campaigns.	[Hutchinson, Paul L.; Meekers, Dominique] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA	Tulane University	Hutchinson, PL (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Hlth Syst & Dev, New Orleans, LA 70118 USA.	phutchin@tulane.edu			United States Agency for International Development (USAID) through the Health Communication Partnership [GHP-A-00-2-00008-00]	United States Agency for International Development (USAID) through the Health Communication Partnership(United States Agency for International Development (USAID))	This study was funded through the United States Agency for International Development (USAID) through the Health Communication Partnership and under the terms of Cooperative Agreement No. GHP-A-00-2-00008-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2002, ECONOMETRICA, V70, P91, DOI 10.1111/1468-0262.00270; Agha S, 2002, INT FAM PLAN PERSPEC, V28, P151, DOI 10.2307/3088258; Agha S, 2002, INT FAMILY PLANNING, V28, P67; Agha S, 2012, J HEALTH COMMUN, V17, P601, DOI 10.1080/10810730.2011.635768; Angeles G, 1998, J AM STAT ASSOC, V93, P884, DOI 10.2307/2669827; Angeles G, 2005, J POPUL ECON, V18, P367, DOI 10.1007/s00148-005-0226-5; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; Angrist JD, 2001, J BUS ECON STAT, V19, P2, DOI 10.1198/07350010152472571; Arellano M., 2001, HDB ECONOMETRICS, V5, P3229; Babalola S, 2005, J FAM PLAN REPROD H, V31, P207, DOI 10.1783/1471189054484022; Baum CF, 2007, STATA J, V7, P465, DOI 10.1177/1536867X0800700402; Becker SO, 2002, STATA J, V2, P358, DOI 10.1177/1536867X0200200403; Bertrand JT, 1996, WGIEC03; Bertrand JT, 2012, HDB GLOBAL HLTH COMM; Bessinger R, 2004, EVAL PROGRAM PLANN, V27, P397, DOI 10.1016/j.evalprogplan.2004.07.003; Buis ML, 2011, STATA J, V11, P315, DOI 10.1177/1536867X1101100211; CHAMBERLAIN G, 1980, REV ECON STUD, V47, P225, DOI 10.2307/2297110; Do MP, 2006, J HEALTH COMMUN, V11, P301, DOI 10.1080/10810730600614045; El-Zanaty F, 2004, MENYA VILLAGES HLTH; El-Zanaty F, 2005, FOLLOW UP DEMOGRAPHI; Guilkey DK, 2006, J HEALTH COMMUN, V11, P47, DOI 10.1080/10810730600973987; Guilkey DK, 2011, STUD FAMILY PLANN, V42, P93, DOI 10.1111/j.1728-4465.2011.00269.x; Gupta N, 2004, J HEALTH POPUL NUTR, V22, P429; Gupta N, 2003, STUD FAMILY PLANN, V34, P19, DOI 10.1111/j.1728-4465.2003.00019.x; Hess R, 2012, HDB GLOBAL HLTH COMM, P374; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; HOLLAND PW, 1986, J AM STAT ASSOC, V81, P945, DOI 10.2307/2289064; Hutchinson P, 2006, STUD FAMILY PLANN, V37, P169, DOI 10.1111/j.1728-4465.2006.00096.x; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Jato MN, 1999, INT FAM PLAN PERSPEC, V25, P60, DOI 10.2307/2991943; Johns Hopkins University/Center for Communication Programs, 2006, COMM HLTH LIV HLTH C; Kincaid D. L., 1993, ORG ASPECTS HLTH COM; Kincaid DL, 2006, J HEALTH COMMUN, V11, P69, DOI 10.1080/10810730600974522; Kincaid DL, 1996, INT FAM PLAN PERSPEC, V22, P169, DOI 10.2307/2950815; Leuven Edwin., 2003, PSMATCH2 STATA MODUL; Molyneaux JW, 2000, POPUL DEV REV, V26, P61; MONTGOMERY MR, 1993, POP STUD-J DEMOG, V47, P457, DOI 10.1080/0032472031000147246; Mwaikambo L, 2011, STUD FAMILY PLANN, V42, P67, DOI 10.1111/j.1728-4465.2011.00267.x; Noar MD, 2009, GASTROINTEST ENDOSC, V70, P454, DOI 10.1016/j.gie.2009.03.026; Noar SM, 2009, J HEALTH COMMUN, V14, P15, DOI 10.1080/10810730802592239; Piotrow P. T., 1997, HLTH COMMUNICATION L; PITT MM, 1993, WORLD BANK ECON REV, V7, P319, DOI 10.1093/wber/7.3.319; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Rogers Everett, 1973, COMMUNICATION STRATE; Roodman D., 2009, ESTIMATING FULLY OBS ESTIMATING FULLY OBS; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Staiger H, 1997, ECONOMETRICA, V65; Stock, 2005, IDENTIFICATION INFER; Stock JH, 2002, J BUS ECON STAT, V20, P518, DOI 10.1198/073500102288618658; Van Rossem R, 2000, AIDS EDUC PREV, V12, P383; Wooldridge J., 2002, ECONOMETRIC ANAL CRO	54	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46138	10.1371/journal.pone.0046138	http://dx.doi.org/10.1371/journal.pone.0046138			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049961	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100143
J	Jha, A; Chauhan, R; Mehra, M; Singh, HR; Shankar, R				Jha, Ashwani; Chauhan, Rohit; Mehra, Mrigaya; Singh, Heikham Russiachand; Shankar, Ravi			miR-BAG: Bagging Based Identification of MicroRNA Precursors	PLOS ONE			English	Article							DEEP SEQUENCING DATA; HUMAN GENOME; COMPUTATIONAL IDENTIFICATION; GENE-EXPRESSION; PREDICTION; CLASSIFICATION; TOOL; SOFTWARE; PROTEINS; HUNDREDS	Non-coding elements such as miRNAs play key regulatory roles in living systems. These ultra-short, similar to 21 bp long, RNA molecules are derived from their hairpin precursors and usually participate in negative gene regulation by binding the target mRNAs. Discovering miRNA candidate regions across the genome has been a challenging problem. Most of the existing tools work reliably only for limited datasets. Here, we have presented a novel reliable approach, miR-BAG, developed to identify miRNA candidate regions in genomes by scanning sequences as well as by using next generation sequencing (NGS) data. miR-BAG utilizes a bootstrap aggregation based machine learning approach, successfully creating an ensemble of complementary learners to attain high accuracy while balancing sensitivity and specificity. miR-BAG was developed for wide range of species and tested extensively for performance over a wide range of experimentally validated data. Consideration of position-specific variation of triplet structural profiles and mature miRNA anchored structural profiles had a positive impact on performance. miR-BAG's performance was found consistent and the accuracy level was observed to be >90% for most of the species considered in the present study. In a detailed comparative analysis, miR-BAG performed better than six existing tools. Using miR-BAG NGS module, we identified a total of 22 novel miRNA candidate regions in cow genome in addition to a total of 42 cow specific miRNA regions. In practice, discovery of miRNA regions in a genome demands high-throughput data analysis, requiring large amount of processing. Considering this, miR-BAG has been developed in multi-threaded parallel architecture as a web server as well as a user friendly GUI standalone version.	[Jha, Ashwani; Chauhan, Rohit; Mehra, Mrigaya; Singh, Heikham Russiachand; Shankar, Ravi] CSIR IHBT, Studio Computat Biol & Bioinformat Biotechnol Div, Palampur, Himachal Prades, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Shankar, R (corresponding author), CSIR IHBT, Studio Computat Biol & Bioinformat Biotechnol Div, Palampur, Himachal Prades, India.	ravish9@gmail.com		jha, Ashwani/0000-0001-8752-3477	CSIR-EMPOWER [OLP-37]; Department of Biotechnology(DBT), Govt of India [BTPR/11098/BID/07/261/2008]	CSIR-EMPOWER; Department of Biotechnology(DBT), Govt of India(Department of Biotechnology (DBT) India)	The study has been funded by CSIR-EMPOWER grant OLP-37 and Department of Biotechnology(DBT), Govt of India, grant# BTPR/11098/BID/07/261/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeel T, 2009, J MACH LEARN RES, V10, P931; Agarwal S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S29; Batuwita R, 2009, BIOINFORMATICS, V25, P989, DOI 10.1093/bioinformatics/btp107; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Brownawell AM, 2002, J CELL BIOL, V156, P53, DOI 10.1083/jcb.200110082; Cooper SJ, 2006, GENOME RES, V16, P1, DOI 10.1101/gr.4222606; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Gardner PP, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-140; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Harhay GP, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r102; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Jha A, 2011, J BIOSCIENCES, V36, P621, DOI 10.1007/s12038-011-9109-y; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Mathelier A, 2010, BIOINFORMATICS, V26, P2226, DOI 10.1093/bioinformatics/btq329; Ng KLS, 2007, BIOINFORMATICS, V23, P1321, DOI 10.1093/bioinformatics/btm026; Niemann H, 2003, ANIM REPROD SCI, V79, P291, DOI 10.1016/S0378-4320(03)00169-6; Ritchie W, 2008, BIOINFORMATICS, V24, P1394, DOI 10.1093/bioinformatics/btn137; Ronen R, 2010, BIOINFORMATICS, V26, P2615, DOI 10.1093/bioinformatics/btq493; Saetrom P, 2006, OLIGONUCLEOTIDES, V16, P115, DOI 10.1089/oli.2006.16.115; Smalheiser NR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-403; Soler E, 2006, REPROD NUTR DEV, V46, P579, DOI 10.1051/rnd:2006029; Tanzer Andrea, 2006, V342, P335; Wang XW, 2006, NUCLEIC ACIDS RES, V34, P1646, DOI 10.1093/nar/gkl068; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yousef M, 2006, BIOINFORMATICS, V22, P1325, DOI 10.1093/bioinformatics/btl094; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	49	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45782	10.1371/journal.pone.0045782	http://dx.doi.org/10.1371/journal.pone.0045782			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049860	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100078
J	Nie, ZY; Fryer, AD; Jacoby, DB				Nie, Zhenying; Fryer, Allison D.; Jacoby, David B.			beta(2)-Agonists Inhibit TNF-alpha-Induced ICAM-1 Expression in Human Airway Parasympathetic Neurons	PLOS ONE			English	Article							CHALLENGED GUINEA-PIGS; INTERCELLULAR-ADHESION MOLECULE-1; MUSCARINIC RECEPTOR FUNCTION; BETA-ADRENERGIC AGONISTS; B-MEDIATED TRANSCRIPTION; MAJOR BASIC-PROTEIN; ACETYLCHOLINE-RELEASE; EOSINOPHIL ADHESION; CHOLINERGIC NERVES; RACEMIC ALBUTEROL	Background: Major basic protein released from eosinophils to airway parasympathetic nerves blocks inhibitory M-2 muscarinic receptors on the parasympathetic nerves, increasing acetylcholine release and potentiating reflex bronchoconstriction. Recruitment of eosinophils to airway parasympathetic neurons requires neural expression of both intercellular adhesion molecular-1 (ICAM-1) and eotaxin. We have shown that inflammatory cytokines induce eotaxin and ICAM-1 expression in parasympathetic neurons. Objective: To test whether the beta(2) agonist albuterol, which is used to treat asthma, changes TNF-alpha-induced eotaxin and ICAM-1 expression in human parasympathetic neurons. Methods: Parasympathetic neurons were isolated from human tracheas and grown in serum-free medium for one week. Cells were incubated with either (R)-albuterol (the active isomer), (S)-albuterol (the inactive isomer) or (R, S)-albuterol for 90 minutes before adding 2 ng/ml TNF-alpha for another 4 hours (for mRNA) or 24 hours (for protein). Results and Conclusions: Baseline expression of eotaxin and ICAM-1 were not changed by any isomer of albuterol as measured by real time RT-PCR. TNF-alpha induced ICAM-1 expression was significantly inhibited by (R)-albuterol in a dose dependent manner, but not by (S) or (R, S)-albuterol. Eotaxin expression was not changed by TNF-alpha or by any isomer of albuterol. The beta-receptor antagonist propranolol blocked the inhibitory effect of (R)-albuterol on TNF-alpha-induced ICAM-1 expression. Clinical Implication: The suppressive effect of (R)-albuterol on neural ICAM-1 expression may be an additional mechanism for decreasing bronchoconstriction, since it would decrease eosinophil recruitment to the airway nerves.	[Nie, Zhenying; Fryer, Allison D.; Jacoby, David B.] Oregon Hlth & Sci Univ, Sch Med, Div Pulm & Crit Care Med, Portland, OR 97201 USA	Oregon Health & Science University	Nie, ZY (corresponding author), Oregon Hlth & Sci Univ, Sch Med, Div Pulm & Crit Care Med, Portland, OR 97201 USA.	niez@ohsu.edu	Fryer, Allison/F-2420-2014	Fryer, Allison/0000-0003-1712-9831; Jacoby, David/0000-0003-2195-9512	National Institutes of Health [HL55543, HL54659, HL071795, ES014601]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054659, R01HL055543, R01HL071795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014601, R01ES017592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The funders (grants from National Institutes of Health: HL55543 (ADF), HL54659 (DBJ), HL071795 (DBJ), ES014601 (DBJ)) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Sepracor Inc provided albuterol and funding to support part of experiment supplies in this study. But Sepracor Inc also had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameredes BT, 2005, J ALLERGY CLIN IMMUN, V116, P65, DOI 10.1016/j.jaci.2005.03.007; Baramki D, 2002, J ALLERGY CLIN IMMUN, V109, P449, DOI 10.1067/mai.2002.122159; Belvisi MG, 1996, BRIT J PHARMACOL, V117, P1413, DOI 10.1111/j.1476-5381.1996.tb15300.x; Costello RW, 1997, AM J PHYSIOL-LUNG C, V273, pL93, DOI 10.1152/ajplung.1997.273.1.L93; ELBON CL, 1995, AM J RESP CELL MOL, V12, P320, DOI 10.1165/ajrcmb.12.3.7873198; Evans CM, 1997, J CLIN INVEST, V100, P2254, DOI 10.1172/JCI119763; Farmer P, 2000, AM J PHYSIOL-LUNG C, V279, pL675, DOI 10.1152/ajplung.2000.279.4.L675; Fryer AD, 2006, J CLIN INVEST, V116, P228, DOI 10.1172/JCI25423; Hakonarson H, 1998, J CLIN INVEST, V102, P1732, DOI 10.1172/JCI4141; Handley DA, 2000, J ASTHMA, V37, P319, DOI 10.3109/02770900009055455; JACOBY DB, 1993, J CLIN INVEST, V91, P1314, DOI 10.1172/JCI116331; Kikuchi I, 2006, AM J RESP CELL MOL, V34, P760, DOI 10.1165/rcmb.2005-0303OC; Krunkosky TM, 2000, AM J RESP CELL MOL, V22, P685, DOI 10.1165/ajrcmb.22.6.3925; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Minguet S, 2005, EUR J IMMUNOL, V35, P31, DOI 10.1002/eji.200425524; Nelson HS, 1998, J ALLERGY CLIN IMMUN, V102, P943, DOI 10.1016/S0091-6749(98)70332-X; Nie Z, 2007, J ALLERGY CLIN IMMUN; Nie ZY, 2009, BRIT J PHARMACOL, V156, P201, DOI 10.1111/j.1476-5381.2008.00045.x; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; Parry GCN, 1997, J IMMUNOL, V159, P5450; Penn RB, 1996, CLIN REV ALLERG IMMU, V14, P37, DOI 10.1007/BF02772201; Reid DW, 2003, EUR RESPIR J, V21, P994, DOI 10.1183/09031936.03.00109702; Sawatzky DA, 2002, AM J PHYSIOL-LUNG C, V282, pL1279, DOI 10.1152/ajplung.00279.2001; Stanciu LA, 1998, EUR RESPIR J, V11, P949, DOI 10.1183/09031936.98.11040949; vandeStolpe A, 1996, J MOL MED, V74, P13, DOI 10.1007/BF00202069; Volcheck GW, 2005, CLIN EXP ALLERGY, V35, P1341, DOI 10.1111/j.1365-2222.2005.02347.x; Walsh MT, 2004, AM J RESP CELL MOL, V30, P333, DOI 10.1165/rcmb.2003-0188OC; Walter MJ, 2002, J CLIN INVEST, V110, P165, DOI 10.1172/JCI200214345; WEGNER CD, 1991, AGENT ACTION SUPPL, V34, P529; Zhang XY, 1996, RESP PHYSIOL, V106, P81, DOI 10.1016/0034-5687(96)00062-X; ZHANG XY, 1995, AM J PHYSIOL-LUNG C, V268, pL950, DOI 10.1152/ajplung.1995.268.6.L950	31	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44780	10.1371/journal.pone.0044780	http://dx.doi.org/10.1371/journal.pone.0044780			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049757	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100021
J	Zhou, FA; Davis, G				Zhou, Fanzhi Anita; Davis, Greg			Momentary Conscious Pairing Eliminates Unconscious-Stimulus Influences on Task Selection	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; REACTION-TIME; ACTIVATION; CHOICE; WILL	Task selection, previously thought to operate only under conscious, voluntary control, can be activated by unconsciouslyperceived stimuli. In most cases, such activation is observed for unconscious stimuli that closely resemble other conscious, task-relevant stimuli and hence may simply reflect perceptual activation of consciously established stimulus-task associations. However, other studies have reported 'direct' unconscious-stimulus influences on task selection in the absence of any conscious, voluntary association between that stimulus and task (e.g., Zhou and Davis, 2012). In new experiments, described here, these latter influences on cued- and free-choice task selection appear robust and long-lived, yet, paradoxically, are suppressed to undetectable levels following momentary conscious prime-task pairing. Assessing, and rejecting, three intuitive explanations for such suppressive effects, we conclude that conscious prime-task pairing minimizes non-strategic influences of unconscious stimuli on task selection, insulating endogenous choice mechanisms from maladaptive external control.	[Zhou, Fanzhi Anita; Davis, Greg] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Zhou, FA (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.	fz223@cam.ac.uk	Davis, Gregory/G-9954-2012		John Templeton Foundation; Murray Edwards College, Cambridge	John Templeton Foundation; Murray Edwards College, Cambridge	This project was funded in part by grants from the John Templeton Foundation and from Murray Edwards College, Cambridge. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of either institution.	Allport A, 1999, ATTENTION SPACE ACTI, P273; AMMON K, 1990, J NEUROL NEUROSUR PS, V53, P705, DOI 10.1136/jnnp.53.8.705; BRASILNETO JP, 1992, J NEUROL NEUROSUR PS, V55, P964, DOI 10.1136/jnnp.55.10.964; Brass M, 2008, NEUROSCIENTIST, V14, P319, DOI 10.1177/1073858408317417; Custers R, 2010, SCIENCE, V329, P47, DOI 10.1126/science.1188595; DiGirolamo GJ, 2001, NEUROREPORT, V12, P2065, DOI 10.1097/00001756-200107030-00054; GREEN DM, 1991, PERCEPT PSYCHOPHYS, V49, P100, DOI 10.3758/BF03211621; Haggard P, 1999, EXP BRAIN RES, V126, P128, DOI 10.1007/s002210050722; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Kiesel A, 2006, CONSCIOUS COGN, V15, P397, DOI 10.1016/j.concog.2005.10.002; Klapp S, 2005, J EXP PSYCHOL HUMAN, V33, P1366; Klapp ST, 2002, J EXP PSYCHOL GEN, V131, P255, DOI 10.1037//0096-3445.131.2.255; Kunde W, 2003, COGNITION, V88, P223, DOI 10.1016/S0010-0277(03)00023-4; Lau HC, 2007, J NEUROSCI, V27, P5805, DOI 10.1523/JNEUROSCI.4335-06.2007; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Leonard CJ, 2007, J NEUROSCI, V27, P11170, DOI 10.1523/JNEUROSCI.3394-07.2007; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; Macmillan N. A., 1991, DETECTION THEORY USE; Mele A., 2009, EFFECTIVE INTENTIONS, DOI 10.1093/acprof:oso/9780195384260.001.0001; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; REINGOLD EM, 1988, PERCEPT PSYCHOPHYS, V44, P563, DOI 10.3758/BF03207490; Reuss H, 2011, CONSCIOUS COGN, V20, P556, DOI 10.1016/j.concog.2011.02.014; Schurger A, P NATL ACAD IN PRESS; Song S, 2008, EXP BRAIN RES, V189, P145, DOI 10.1007/s00221-008-1411-z; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; TIPPER SP, 1985, Q J EXP PSYCHOL-A, V37, P571, DOI 10.1080/14640748508400920; Tsushima Y, 2008, CURR BIOL, V18, pR516, DOI 10.1016/j.cub.2008.04.029; Veltkamp M, 2011, J CONSUM PSYCHOL, V21, P49, DOI 10.1016/j.jcps.2010.09.011; Wegner DM, 2003, TRENDS COGN SCI, V7, P65, DOI 10.1016/S1364-6613(03)00002-0; Wilson MD, 1988, MRC PSYCHOLINGUISTIC, P6; Wylie GR, 2006, CEREB CORTEX, V16, P394, DOI 10.1093/cercor/bhi118; Zajonc RB, 2001, CURR DIR PSYCHOL SCI, V10, P224, DOI 10.1111/1467-8721.00154; Zhou FA, 2012, ATTEN PERCEPT PSYCHO, V74, P105, DOI 10.3758/s13414-011-0221-8	34	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46320	10.1371/journal.pone.0046320	http://dx.doi.org/10.1371/journal.pone.0046320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23050012	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100177
J	Albarrak, SM; Brown, WC; Noh, SM; Reif, KE; Scoles, GA; Turse, JE; Norimine, J; Ueti, MW; Palmer, GH				Albarrak, Saleh M.; Brown, Wendy C.; Noh, Susan M.; Reif, Kathryn E.; Scoles, Glen A.; Turse, Joshua E.; Norimine, Junzo; Ueti, Massaro W.; Palmer, Guy H.			Subdominant Antigens in Bacterial Vaccines: AM779 Is Subdominant in the Anaplasma marginale Outer Membrane Vaccine but Does Not Associate with Protective Immunity	PLOS ONE			English	Article							MAJOR SURFACE PROTEIN-2; T-LYMPHOCYTE EPITOPES; IDENTIFICATION; RESPONSES; GENOME; RICKETTSIALES; TRANSMISSION; EXPRESSION; EFFICIENCY; VARIANTS	Identification of specific antigens responsible for the ability of complex immunogens to induce protection is a major goal in development of bacterial vaccines. Much of the investigation has focused on highly abundant and highly immunodominant outer membrane proteins. Recently however, genomic and proteomic approaches have facilitated identification of minor components of the bacterial outer membrane that have previously been missed or ignored in immunological analyses. Immunization with Anaplasma marginale outer membranes or a cross-linked surface complex induces protection against bacteremia, however the components responsible for protection within these complex immunogens are unknown. Using outer membrane protein AM779 as a model, we demonstrated that this highly conserved but minor component of the A. marginale surface was immunologically sub-dominant in the context of the outer membrane or surface complex vaccines. Immunologic sub-dominance could be overcome by targeted vaccination with AM779 for T lymphocyte responses but not for antibody responses, suggesting that both abundance and intrinsic immunogenicity determine relative dominance. Importantly, immunization with AM779 supports that once priming is achieved by specific targeting, recall upon infectious challenge is achieved. While immunization with AM779 alone was not sufficient to induce protection, the ability of targeted immunization to prime the immune response to highly conserved but low abundance proteins supports continued investigation into the role of sub-dominant antigens, individually and collectively, in vaccine development for A. marginale and related bacterial pathogens.	[Albarrak, Saleh M.; Reif, Kathryn E.; Palmer, Guy H.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; [Brown, Wendy C.; Reif, Kathryn E.; Turse, Joshua E.; Norimine, Junzo; Palmer, Guy H.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Noh, Susan M.; Scoles, Glen A.; Ueti, Massaro W.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA	Washington State University; Washington State University; United States Department of Agriculture (USDA)	Palmer, GH (corresponding author), Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.	gpalmer@vetmed.wsu.edu	, 0000-0001-7041-1823/B-9144-2014; Albarrak, Saleh/GRO-3447-2022	, 0000-0001-7041-1823/0000-0001-7041-1823; Albarrak, Saleh/0000-0003-4965-6142	National Institutes of Health [AI44005, AIO53692]; Wellcome Trust [GR075800M]; U.S. Department of Agriculture [ARS 5348-32000-033-00D, CSREES 35604-15440]; Saudi Ministry of Higher Education; Infectious Diseases and Microbial Immunology Training Program NIH [T32AI07025]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044005, T32AI007025, R01AI044005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Saudi Ministry of Higher Education; Infectious Diseases and Microbial Immunology Training Program NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI44005 and AIO53692, Wellcome Trust GR075800M, and U.S. Department of Agriculture Grants ARS 5348-32000-033-00D and CSREES 35604-15440. Saleh M. Albarrak was supported by a fellowship from the Saudi Ministry of Higher Education; Joshua E. Turse and Kathryn E. Reif were supported by the Infectious Diseases and Microbial Immunology Training Program NIH T32AI07025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnes JT, 2011, INFECT IMMUN, V79, P1311, DOI 10.1128/IAI.01174-10; Brayton KA, 2005, P NATL ACAD SCI USA, V102, P844, DOI 10.1073/pnas.0406656102; Brayton KA, 2001, P NATL ACAD SCI USA, V98, P4130, DOI 10.1073/pnas.071056298; Brown WC, 2003, J IMMUNOL, V170, P3790, DOI 10.4049/jimmunol.170.7.3790; Brown WC, 1998, INFECT IMMUN, V66, P5406, DOI 10.1128/IAI.66.11.5406-5413.1998; Brown WC, 2001, J IMMUNOL, V166, P1114, DOI 10.4049/jimmunol.166.2.1114; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P234; de Echaide ST, 1998, J CLIN MICROBIOL, V36, P777, DOI 10.1128/JCM.36.3.777-782.1998; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; French DM, 1999, INFECT IMMUN, V67, P5834, DOI 10.1128/IAI.67.11.5834-5840.1999; French DM, 1998, INFECT IMMUN, V66, P1200, DOI 10.1128/IAI.66.3.1200-1207.1998; Gallimore A, 1998, J EXP MED, V187, P1647; Herndon DR, 2010, J BACTERIOL, V192, P379, DOI 10.1128/JB.01330-09; Lopez JE, 2005, INFECT IMMUN, V73, P8109, DOI 10.1128/IAI.73.12.8109-8118.2005; Lopez JE, 2008, J IMMUNOL METHODS, V332, P129, DOI 10.1016/j.jim.2007.12.018; MCGUIRE TC, 1984, INFECT IMMUN, V45, P697, DOI 10.1128/IAI.45.3.697-700.1984; MCGUIRE TC, 1991, J CLIN MICROBIOL, V29, P788, DOI 10.1128/JCM.29.4.788-793.1991; Noh SM, 2008, INFECT IMMUN, V76, P2219, DOI 10.1128/IAI.00008-08; Noh SM, 2006, INFECT IMMUN, V74, P3471, DOI 10.1128/IAI.01843-05; Noh SM, 2010, VACCINE, V28, P3741, DOI 10.1016/j.vaccine.2010.02.067; Norimine J, 2005, IMMUNOGENETICS, V57, P750, DOI 10.1007/s00251-005-0045-6; Oukka M, 1996, J IMMUNOL, V157, P3039; Palmer GH, 1999, PARASITOL TODAY, V15, P281, DOI 10.1016/S0169-4758(99)01469-6; Palmer GH, 2012, FEMS IMMUNOL MED MIC, V64, P115, DOI 10.1111/j.1574-695X.2011.00878.x; Palmer GH, 2009, CELL MICROBIOL, V11, P1697, DOI 10.1111/j.1462-5822.2009.01366.x; Richards S, 2008, IMMUNOL REV, V224, P183, DOI 10.1111/j.1600-065X.2008.00652.x; Rodriguez JL, 2005, GENE, V361, P127, DOI 10.1016/j.gene.2005.06.038; Scoles GA, 2005, J MED ENTOMOL, V42, P668, DOI 10.1603/0022-2585(2005)042[0668:REOBTO]2.0.CO;2; Sette A, 2010, IMMUNITY, V33, P530, DOI 10.1016/j.immuni.2010.09.017; TEBELE N, 1991, INFECT IMMUN, V59, P3199, DOI 10.1128/IAI.59.9.3199-3204.1991; Ueti MW, 2009, INFECT IMMUN, V77, P70, DOI 10.1128/IAI.01164-08	31	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46372	10.1371/journal.pone.0046372	http://dx.doi.org/10.1371/journal.pone.0046372			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029498	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900145
J	Lohavanichbutr, P; Houck, J; Doody, DR; Wang, P; Mendez, E; Futran, N; Upton, MP; Holsinger, FC; Schwartz, SM; Chen, C				Lohavanichbutr, Pawadee; Houck, John; Doody, David R.; Wang, Pei; Mendez, Eduardo; Futran, Neal; Upton, Melissa P.; Holsinger, F. Christopher; Schwartz, Stephen M.; Chen, Chu			Gene Expression in Uninvolved Oral Mucosa of OSCC Patients Facilitates Identification of Markers Predictive of OSCC Outcomes	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NECK-CANCER PATIENTS; CLINICAL-IMPLICATIONS; HUMAN-PAPILLOMAVIRUS; FIELD CANCERIZATION; PROTEOMIC ANALYSIS; RISK-ASSESSMENT; HEAD; HETEROZYGOSITY; SURVIVAL	Oral and oropharyngeal squamous cell carcinomas (OSCC) are among the most common cancers worldwide, with approximately 60% 5-yr survival rate. To identify potential markers for disease progression, we used Affymetrix U133 plus 2.0 arrays to examine the gene expression profiles of 167 primary tumor samples from OSCC patients, 58 uninvolved oral mucosae from OSCC patients and 45 normal oral mucosae from patients without oral cancer, all enrolled at one of the three University of Washington-affiliated medical centers between 2003 to 2008. We found 2,596 probe sets differentially expressed between 167 tumor samples and 45 normal samples. Among 2,596 probe sets, 71 were significantly and consistently up-or down-regulated in the comparison between normal samples and uninvolved oral samples and between uninvolved oral samples and tumor samples. Cox regression analyses showed that 20 of the 71 probe sets were significantly associated with progression-free survival. The risk score for each patient was calculated from coefficients of a Cox model incorporating these 20 probe sets. The hazard ratio (HR) associated with each unit change in the risk score adjusting for age, gender, tumor stage, and high-risk HPV status was 2.7 (95% CI: 2.0-3.8, p = 8.8E-10). The risk scores in an independent dataset of 74 OSCC patients from the MD Anderson Cancer Center was also significantly associated with progression-free survival independent of age, gender, and tumor stage (HR 1.6, 95% CI: 1.1-2.2, p = 0.008). Gene Set Enrichment Analysis showed that the most prominent biological pathway represented by the 71 probe sets was the Integrin cell surface interactions pathway. In conclusion, we identified 71 probe sets in which dysregulation occurred in both uninvolved oral mucosal and cancer samples. Dysregulation of 20 of the 71 probe sets was associated with progression-free survival and was validated in an independent dataset.	[Lohavanichbutr, Pawadee; Houck, John; Doody, David R.; Schwartz, Stephen M.; Chen, Chu] Fred Hutchinson Canc Res Ctr, Program Epidemiol, Seattle, WA 98104 USA; [Wang, Pei] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Seattle, WA 98104 USA; [Mendez, Eduardo; Futran, Neal; Chen, Chu] Univ Washington, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98195 USA; [Mendez, Eduardo] VA Puget Sound Hlth Care Syst, Surg & Perioperat Care Serv, Seattle, WA USA; [Mendez, Eduardo] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Upton, Melissa P.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Holsinger, F. Christopher] Univ Texas MD Anderson Canc Ctr, Dept Otolaryngol Head & Neck Surg, Houston, TX 77030 USA; [Schwartz, Stephen M.; Chen, Chu] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Texas System; UTMD Anderson Cancer Center; University of Washington; University of Washington Seattle	Chen, C (corresponding author), Fred Hutchinson Canc Res Ctr, Program Epidemiol, Seattle, WA 98104 USA.	cchen@fhcrc.org		Doody, David/0000-0003-2291-6493; Schwartz, Stephen/0000-0001-7499-8502; Wang, Pei/0000-0002-6890-6453	National Institutes of Health, National Cancer Institute [NIH/NCI 5R01 CA095419]; Fred Hutchinson Cancer Research Center; Cancer Center Support Core Grant [CA16672]; National Cancer Institute [P50 CA97007]; "Clinician Investigator Program in Translational Research" [K12 CA88084]; NIH Loan Repayment Program; Clinical Research Program [2 L30 CA117652-02A1]; THANC Foundation Young Investigator Award in Head and Neck Cancer; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA095419, P30CA015704, P50CA097007] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fred Hutchinson Cancer Research Center; Cancer Center Support Core Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); "Clinician Investigator Program in Translational Research"; NIH Loan Repayment Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical Research Program; THANC Foundation Young Investigator Award in Head and Neck Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was supported by grants from the National Institutes of Health, National Cancer Institute (NIH/NCI 5R01 CA095419), and by institutional funds from the Fred Hutchinson Cancer Research Center. The study at the MD Anderson Cancer Center was supported by Cancer Center Support Core Grant CA16672 (Affymetrix Microarray Core Facility; the Bioinformatics Core), Specialized Program of Research Excellence in Head and Neck Cancer Grant P50 CA97007 from the National Cancer Institute, "Clinician Investigator Program in Translational Research" K12 CA88084, NIH Loan Repayment Program, Clinical Research Program 2 L30 CA117652-02A1, and THANC Foundation Young Investigator Award in Head and Neck Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON R, 1994, ONCOGENE, V9, P2077; Araki D, 2002, INT J ONCOL, V20, P355; Baldwin C, 2005, CANCER RES, V65, P7561, DOI 10.1158/0008-5472.CAN-05-1513; Belbin TJ, 2005, ARCH OTOLARYNGOL, V131, P10, DOI 10.1001/archotol.131.1.10; BERGLER W, 1989, ARCH OTO-RHINO-LARYN, V246, P121, DOI 10.1007/BF00456651; Bloching MM, 2008, ONCOL REP, V19, P1373; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Brandwein-Gensler A, 2005, AM J SURG PATHOL, V29, P167; Cardoso F, 2008, J CLIN ONCOL, V26, P729, DOI 10.1200/JCO.2007.14.3222; Chang KP, 2011, J PROTEOME RES, V10, P4935, DOI 10.1021/pr200311p; Chen C, 2008, CANCER EPIDEM BIOMAR, V17, P2152, DOI 10.1158/1055-9965.EPI-07-2893; Chen L, 2005, CANCER GENET CYTOGEN, V159, P37, DOI 10.1016/j.cancergencyto.2004.09.011; Cheong SC, 2009, ORAL ONCOL, V45, P712, DOI 10.1016/j.oraloncology.2008.11.002; Chiang WF, 2011, ORAL ONCOL, V47, P452, DOI 10.1016/j.oraloncology.2011.03.025; El-Naggar AK, 1998, ONCOGENE, V16, P2983, DOI 10.1038/sj.onc.1201808; Freier K, 2010, GENE CHROMOSOME CANC, V49, P9, DOI 10.1002/gcc.20714; Giaretti W, 2012, CELL ONCOL, V35, P43, DOI 10.1007/s13402-011-0064-2; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Gonzalez-Garcia R, 2009, HEAD NECK-J SCI SPEC, V31, P1168, DOI 10.1002/hed.21088; Hockel A, 2005, CANCER RES, V65, P2997; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Imai FL, 2001, INT J MOL MED, V7, P43; Jou YJ, 2010, ANAL CHIM ACTA, V681, P41, DOI 10.1016/j.aca.2010.09.030; Kale Alka D, 2012, J Oral Maxillofac Pathol, V16, P10, DOI 10.4103/0973-029X.92966; Kannan S, 1996, BRIT J ORAL MAX SURG, V34, P51, DOI 10.1016/S0266-4356(96)90136-9; Kayahara H, 2001, J HUM GENET, V46, P335, DOI 10.1007/s100380170069; Kooren Joel A, 2011, Clin Proteomics, V8, P13, DOI 10.1186/1559-0275-8-13; Kuriakose MA, 2004, CELL MOL LIFE SCI, V61, P1372, DOI 10.1007/s00018-004-4069-0; Larsen SR, 2009, J ORAL PATHOL MED, V38, P657, DOI 10.1111/j.1600-0714.2009.00797.x; Lazar AD, 1998, CLIN CANCER RES, V4, P2787; Lee CY, 2011, J CELL BIOCHEM, V112, P2549, DOI 10.1002/jcb.23179; Lee DJ, 1997, CLIN CANCER RES, V3, P501; Liao KA, 2011, J PROTEOME RES, V10, P2347, DOI 10.1021/pr101146w; Lo Muzio L, 2006, INT J IMMUNOPATH PH, V19, P675, DOI 10.1177/039463200601900323; Lo WY, 2007, CLIN CHIM ACTA, V376, P101, DOI 10.1016/j.cca.2006.06.030; Lohavanichbutr P, 2009, ARCH OTOLARYNGOL, V135, P180, DOI 10.1001/archoto.2008.540; Mao EJ, 1998, J ORAL PATHOL MED, V27, P297; Mao L, 1996, NAT MED, V2, P682, DOI 10.1038/nm0696-682; Mendez E, 2009, CLIN CANCER RES, V15, P1353, DOI 10.1158/1078-0432.CCR-08-1816; Mishra RC, 1999, EUR J SURG ONCOL, V25, P186, DOI 10.1053/ejso.1998.0624; Mizukoshi E, 2011, HEPATOLOGY, V53, P1206, DOI 10.1002/hep.24149; Morgan MR, 2011, ONCOGENE, V30, P1422, DOI 10.1038/onc.2010.535; Mucke T, 2009, ORAL ONCOL, V45, P687, DOI 10.1016/j.oraloncology.2008.10.011; Nakao M, 2000, J IMMUNOL, V164, P2565, DOI 10.4049/jimmunol.164.5.2565; NEES M, 1993, CANCER RES, V53, P4189; Remmerbach TW, 2011, ORAL ONCOL, V47, P278, DOI 10.1016/j.oraloncology.2011.02.005; Schwartz SR, 2001, OTOLARYNG HEAD NECK, V125, P1, DOI 10.1067/mhn.2001.116979; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Subbaram S, 2011, EXPERT OPIN THER TAR, V15, P1197, DOI 10.1517/14728222.2011.609557; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun G, 2009, ARTIF CELL BLOOD SUB, V37, P125, DOI 10.1080/10731190902913759; Tabor MP, 2001, CLIN CANCER RES, V7, P1523; Thomson PJ, 2002, INT J ORAL MAX SURG, V31, P262, DOI 10.1054/ijom.2002.0220; Uchida K, 2011, ONCOL REP, V26, P463, DOI 10.3892/or.2011.1327; Wang XL, 1999, ONCOGENE, V18, P823, DOI 10.1038/sj.onc.1202318; Wang Y, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-624; Wang Z, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-383; Waridel F, 1997, ONCOGENE, V14, P163, DOI 10.1038/sj.onc.1200812; Woolgar JA, 1999, ORAL ONCOL, V35, P257, DOI 10.1016/S1368-8375(98)00113-4; Yamamoto N, 2001, BRIT J CANCER, V84, P754, DOI 10.1054/bjoc.2000.1656; Yamashita Y, 2002, INT J ONCOL, V20, P595; Ziober AF, 2006, CLIN CANCER RES, V12, P5960, DOI 10.1158/1078-0432.CCR-06-0535	63	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46575	10.1371/journal.pone.0046575	http://dx.doi.org/10.1371/journal.pone.0046575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029552	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900186
J	Monadjem, A; Kane, A; Botha, A; Dalton, D; Kotze, A				Monadjem, Ara; Kane, Adam; Botha, Andre; Dalton, Desire; Kotze, Antoinette			Survival and Population Dynamics of the Marabou Stork in an Isolated Population, Swaziland	PLOS ONE			English	Article							LEPTOPTILOS-CRUMENIFERUS; MODELING SURVIVAL; TAG LOSS; RATES; CICONIA; BIOLOGY; MORTALITY; VULTURES; CLIMATE; IMPACT	Investigating the ecology of long lived birds is particularly challenging owing to the time scales involved. Here an analysis is presented of a long term study of the survival and population dynamics of the marabou stork (Leptoptilos crumeniferus), a wide ranging scavenging bird from Sub-Saharan Africa. Using resightings data of tagged nestlings and free flying birds we show that the stork population can be divided into three general life stages with unique survival probabilities and fecundities. Fecundity of the storks is inversely related to rainfall during their breeding season. Corroborative evidence for a metapopulation structure is discussed highlighting the impact of the Swaziland birds on the ecology of the species in the broader region. The importance of tag loss or illegibility over time is highlighted. Clearly, any attempt at conserving a species will require a detailed understanding of its population structure, of the sort examined here.	[Monadjem, Ara] Univ Swaziland, Dept Biol Sci, All Out Africa Res Unit, Kwaluseni, Eswatini; [Kane, Adam] Univ Dublin Trinity Coll, Sch Nat Sci, Dept Zool, Dublin 2, Ireland; [Botha, Andre] Endangered Wildlife Trust, Birds Prey Programme, Modderfontein, South Africa; [Dalton, Desire; Kotze, Antoinette] Natl Zool Gardens South Africa, Pretoria, South Africa; [Dalton, Desire; Kotze, Antoinette] Univ Free State, Dept Genet, Bloemfontein, South Africa	Trinity College Dublin; National Research Foundation - South Africa; National Zoological Gardens of South Africa; University of the Free State	Monadjem, A (corresponding author), Univ Swaziland, Dept Biol Sci, All Out Africa Res Unit, Kwaluseni, Eswatini.	ara@uniswa.sz	Monadjem, Ara/K-7279-2014; Botha, Andre/Y-2304-2019; Kane, Adam/H-6449-2013	Monadjem, Ara/0000-0003-1906-4023; Kane, Adam/0000-0002-2830-5338; Botha, Andre/0000-0003-1077-1215; Dalton, Desire Lee/0000-0001-5975-6425				Bamford AJ, 2009, S AFR J WILDL RES, V39, P202, DOI 10.3957/056.039.0201; Barnes K. N., 1998, IMPORTANT BIRD AREAS; Borkhataria RR, 2008, WATERBIRDS, V31, P42, DOI 10.1675/1524-4695(2008)31[42:APMOWS]2.0.CO;2; Botha Andre, 2007, Vulture News, V56, P52; Brown L.H., 1984, P97; Brown LH, 1982, BIRDS AFRICA, VI; Burhnam KP, 1987, AM FISH SOC MONOGR, P5; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAMPBELL B, 1974, DICT BIRDS COLOR; Carroll C, 2006, J APPL ECOL, V43, P1056, DOI 10.1111/j.1365-2664.2006.01237.x; CLUTTONBROCK TH, 1985, NATURE, V313, P131, DOI 10.1038/313131a0; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; CROWDER LB, 1994, ECOL APPL, V4, P437, DOI 10.2307/1941948; Diekmann M., 2004, VULTURE NEWS, V51, P34; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Heppell SS, 1998, COPEIA, P367, DOI 10.2307/1447430; Hylton RA, 2006, CONDOR, V108, P97, DOI 10.1650/0010-5422(2006)108[0097:EONHOP]2.0.CO;2; Jovani R, 2004, ECOGRAPHY, V27, P611, DOI 10.1111/j.0906-7590.2004.03925.x; KAHL MP, 1966, J ZOOL, V148, P289; KANYAMIBWA S, 1990, IBIS, V132, P27, DOI 10.1111/j.1474-919X.1990.tb01013.x; KANYAMIBWA S, 1993, ORNIS SCAND, V24, P297, DOI 10.2307/3676791; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; LESLIE PH, 1945, BIOMETRIKA, V33, P183, DOI 10.2307/2332297; Monadjem A, 2005, BIODIVERS CONSERV, V14, P2079, DOI 10.1007/s10531-004-4358-9; Monadjem A, 2005, OSTRICH, V76, P45, DOI 10.2989/00306520509485472; Monadjem A, 2013, AFR J ECOL, V51, P87, DOI 10.1111/aje.12009; Monadjem A, 2010, OSTRICH, V81, P85, DOI 10.2989/00306525.2010.488411; Monadjem A, 2008, OSTRICH, V79, P187, DOI 10.2989/OSTRICH.2008.79.2.8.582; Monadjem A, 2009, IBIS, V151, P344, DOI 10.1111/j.1474-919X.2009.00912.x; Mundy PJ., 2003, HONEYGUIDE, V49; Mundy PJ, 1992, VULTURES AFRICA ACOR; Nevoux M, 2008, J ANIM ECOL, V77, P1143, DOI 10.1111/j.1365-2656.2008.01435.x; Pastor J., 2008, MATH ECOLOGY POPULAT, P344; Piper SE, 1999, BIRD STUDY, V46, P230; POMEROY DE, 1977, ARDEA, V65, P1; POMEROY DE, 1978, ARDEA, V66, P1; Postupalsky S., 1973, MANAGEMENT RAPTORS, P21; Reilly T, 1965, OSTRICH, V36, P96; Rotella JJ, 2005, ECOLOGY, V86, P821, DOI 10.1890/04-1193; Ryan, 2005, ROBERTS BIRDS SO AFR, P626; Saether BE, 2006, J ANIM ECOL, V75, P80, DOI 10.1111/j.1365-2656.2005.01023.x; SARRAZIN F, 1994, AUK, V111, P853; Schaub M, 2005, J ANIM ECOL, V74, P656, DOI 10.1111/j.1365-2656.2005.00961.x; SEBER GAF, 1981, BIOMETRIKA, V68, P211, DOI 10.2307/2335821; Spangenberg JA, 2005, LESLIE LEFKOVITCH MA; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Tarboton WR., 2001, GUIDE NESTS EGGS SO; Tucker AD, 2001, CAN J ZOOL, V79, P2199, DOI 10.1139/cjz-79-12-2199; White GC, 2008, ENVIRON ECOL STAT, V15, P89, DOI 10.1007/s10651-007-0030-3; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; WHYTE IJ, 1993, OSTRICH, V64, P186	52	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46434	10.1371/journal.pone.0046434	http://dx.doi.org/10.1371/journal.pone.0046434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029517	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900158
J	Saito, Y; Ishii, K; Sakuma, N; Kawasaki, K; Oda, K; Mizusawa, H				Saito, Yoko; Ishii, Kenji; Sakuma, Naoko; Kawasaki, Keiichi; Oda, Keiichi; Mizusawa, Hidehiro			Neural Substrates for Semantic Memory of Familiar Songs: Is There an Interface between Lyrics and Melodies?	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; WORD FORM AREA; SPEECH-PERCEPTION; CORTICAL ORGANIZATION; EXPRESSIVE APHASIA; FUNCTIONAL-ANATOMY; CEREBRAL NETWORKS; MUSIC PERCEPTION; TEMPORAL-LOBES; VOCAL-MUSIC	Findings on song perception and song production have increasingly suggested that common but partially distinct neural networks exist for processing lyrics and melody. However, the neural substrates of song recognition remain to be investigated. The purpose of this study was to examine the neural substrates involved in the accessing "song lexicon'' as corresponding to a representational system that might provide links between the musical and phonological lexicons using positron emission tomography (PET). We exposed participants to auditory stimuli consisting of familiar and unfamiliar songs presented in three ways: sung lyrics (song), sung lyrics on a single pitch (lyrics), and the sung syllable 'la' on original pitches (melody). The auditory stimuli were designed to have equivalent familiarity to participants, and they were recorded at exactly the same tempo. Eleven right-handed nonmusicians participated in four conditions: three familiarity decision tasks using song, lyrics, and melody and a sound type decision task (control) that was designed to engage perceptual and prelexical processing but not lexical processing. The contrasts (familiarity decision tasks versus control) showed no common areas of activation between lyrics and melody. This result indicates that essentially separate neural networks exist in semantic memory for the verbal and melodic processing of familiar songs. Verbal lexical processing recruited the left fusiform gyrus and the left inferior occipital gyrus, whereas melodic lexical processing engaged the right middle temporal sulcus and the bilateral temporo-occipital cortices. Moreover, we found that song specifically activated the left posterior inferior temporal cortex, which may serve as an interface between verbal and musical representations in order to facilitate song recognition.	[Saito, Yoko; Ishii, Kenji; Kawasaki, Keiichi; Oda, Keiichi] Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Itabashi Ku, Tokyo, Japan; [Sakuma, Naoko] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Itabashi Ku, Tokyo, Japan; [Mizusawa, Hidehiro] Tokyo Med Dent Univ, Dept Neurol Neurol Sci, Grad Sch Med Dent Sci, Bunkyo Ku, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology; Tokyo Medical & Dental University (TMDU)	Ishii, K (corresponding author), Tokyo Metropolitan Inst Gerontol, Positron Med Ctr, Itabashi Ku, Tokyo, Japan.	ishii@pet.tmig.or.jp			Japan Society for the Promotion of Science [1952353]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by Grant-in-Aid for JSPS Fellows from the Japan Society for the Promotion of Science (1952353). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailes F, 2010, MEM COGNITION, V38, P641, DOI 10.3758/MC.38.5.641; Besson M, 1998, PSYCHOL SCI, V9, P494, DOI 10.1111/1467-9280.00091; Bigand E, 2001, COGNITION, V81, pB11, DOI 10.1016/S0010-0277(01)00117-2; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Blumstein SE, 2009, LANG LINGUIST COMPAS, V3, DOI 10.1111/j.1749-818x.2009.00136.x; Bonnel AM, 2001, PERCEPT PSYCHOPHYS, V63, P1201, DOI 10.3758/BF03194534; Bozic M, 2010, P NATL ACAD SCI USA, V107, P17439, DOI 10.1073/pnas.1000531107; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Buchel C, 1998, NATURE, V394, P274, DOI 10.1038/28389; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Callan DE, 2006, NEUROIMAGE, V31, P1327, DOI 10.1016/j.neuroimage.2006.01.036; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cloutman L, 2009, CORTEX, V45, P641, DOI 10.1016/j.cortex.2008.05.013; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; CROWDER RG, 1990, MEM COGNITION, V18, P469, DOI 10.3758/BF03198480; Dalla Bella S, 2003, PERCEPT PSYCHOPHYS, V65, P1019; Devlin JT, 2006, J COGNITIVE NEUROSCI, V18, P911, DOI 10.1162/jocn.2006.18.6.911; Giraud AL, 2002, NEUROPSYCHOLOGIA, V40, P1562, DOI 10.1016/S0028-3932(02)00023-4; Giraud AL, 2001, J COGNITIVE NEUROSCI, V13, P754, DOI 10.1162/08989290152541421; Gobbini MI, 2007, NEUROPSYCHOLOGIA, V45, P32, DOI 10.1016/j.neuropsychologia.2006.04.015; Gordon RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009889; Groussard M, 2010, NEUROIMAGE, V53, P1301, DOI 10.1016/j.neuroimage.2010.07.013; Groussard M, 2010, NEUROIMAGE, V49, P2764, DOI 10.1016/j.neuroimage.2009.10.039; Halpern AR, 2004, NEUROPSYCHOLOGIA, V42, P1281, DOI 10.1016/j.neuropsychologia.2003.12.017; Halpern AR, 2001, ANN NY ACAD SCI, V930, P179, DOI 10.1111/j.1749-6632.2001.tb05733.x; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Hebert S, 2003, BRAIN, V126, P1838, DOI 10.1093/brain/awg186; Hebert S, 2001, BRAIN COGNITION, V46, P169, DOI 10.1016/S0278-2626(01)80058-0; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hillis AE, 2006, J NEUROSCI, V26, P8069, DOI 10.1523/JNEUROSCI.2088-06.2006; Jeffries KJ, 2003, NEUROREPORT, V14, P749, DOI 10.1097/00001756-200304150-00018; Kassuba T, 2011, NEUROIMAGE, V56, P1566, DOI 10.1016/j.neuroimage.2011.02.032; Koelsch S, 2005, CURR OPIN NEUROBIOL, V15, P207, DOI 10.1016/j.conb.2005.03.005; Langheim FJP, 2002, NEUROIMAGE, V16, P901, DOI 10.1006/nimg.2002.1144; Levitin DJ, 2009, ANN NY ACAD SCI, V1156, P211, DOI 10.1111/j.1749-6632.2009.04417.x; Lewis JW, 2004, CEREB CORTEX, V14, P1008, DOI 10.1093/cercor/bhh061; Ligeois-Chauvel C, 1998, BRAIN, V121, P1853, DOI 10.1093/brain/121.10.1853; MARSLENWILSON WD, 1987, COGNITION, V25, P71, DOI 10.1016/0010-0277(87)90005-9; Nakamura K, 2000, BRAIN, V123, P954, DOI 10.1093/brain/123.5.954; Obleser J, 2007, J NEUROSCI, V27, P2283, DOI 10.1523/JNEUROSCI.4663-06.2007; Obleser J, 2010, CEREB CORTEX, V20, P633, DOI 10.1093/cercor/bhp128; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozdemir E, 2006, NEUROIMAGE, V33, P628, DOI 10.1016/j.neuroimage.2006.07.013; Peretz I, 2004, MEM COGNITION, V32, P142, DOI 10.3758/BF03195827; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; Peretz I, 2005, ANNU REV PSYCHOL, V56, P89, DOI 10.1146/annurev.psych.56.091103.070225; Peretz I, 2009, ANN NY ACAD SCI, V1169, P256, DOI 10.1111/j.1749-6632.2009.04557.x; Plailly J, 2007, CEREB CORTEX, V17, P2650, DOI 10.1093/cercor/bhl173; Platel H, 2003, NEUROIMAGE, V20, P244, DOI 10.1016/S1053-8119(03)00287-8; Platel H, 1997, BRAIN, V120, P229, DOI 10.1093/brain/120.2.229; Poeppel D, 2008, PHILOS T R SOC B, V363, P1071, DOI 10.1098/rstb.2007.2160; Poulin-Charronnat B, 2005, COGNITION, V94, pB67, DOI 10.1016/j.cognition.2004.05.003; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Purnell-Webb P, 2008, PERCEPT MOTOR SKILL, V106, P927, DOI 10.2466/PMS.106.3.927-957; Racette A, 2006, BRAIN, V129, P2571, DOI 10.1093/brain/awl250; Raymer AM, 1997, BRAIN LANG, V58, P137, DOI 10.1006/brln.1997.1786; Saito Y, 2009, JAPANESE J PSYCHOL, V80, P405; Saito Y, 2006, NEUROREPORT, V17, P1893, DOI 10.1097/WNR.0b013e328011519c; Sammler D, 2010, J NEUROSCI, V30, P3572, DOI 10.1523/JNEUROSCI.2751-09.2010; Satoh M, 2006, AM J NEURORADIOL, V27, P1101; Satoh M, 2003, AM J NEURORADIOL, V24, P1843; Schon D, 2010, NEUROIMAGE, V51, P450, DOI 10.1016/j.neuroimage.2010.02.023; Schulkind MD, 2004, PERCEPT PSYCHOPHYS, V66, P1351, DOI 10.3758/BF03195003; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; Steinbeis N, 2008, CEREB CORTEX, V18, P1169, DOI 10.1093/cercor/bhm149; Stevenson RA, 2009, NEUROIMAGE, V44, P1210, DOI 10.1016/j.neuroimage.2008.09.034; Straube T, 2008, NEUROPSYCHOLOGIA, V46, P1505, DOI 10.1016/j.neuropsychologia.2008.01.008; Tranel D, 2005, J COGNITIVE NEUROSCI, V17, P1293, DOI 10.1162/0898929055002508; von Kriegstein K, 2005, J COGNITIVE NEUROSCI, V17, P367, DOI 10.1162/0898929053279577; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Wise RJS, 2001, BRAIN, V124, P83, DOI 10.1093/brain/124.1.83; Wise RJS, 2000, NEUROPSYCHOLOGIA, V38, P985, DOI 10.1016/S0028-3932(99)00152-9; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	80	12	12	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46354	10.1371/journal.pone.0046354	http://dx.doi.org/10.1371/journal.pone.0046354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029492	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900141
J	Vankemmelbeke, M; O'Shea, P; James, R; Penfold, CN				Vankemmelbeke, Mireille; O'Shea, Paul; James, Richard; Penfold, Christopher N.			Interaction of Nuclease Colicins with Membranes: Insertion Depth Correlates with Bilayer Perturbation	PLOS ONE			English	Article							IMMUNITY PROTEIN RELEASE; OUTER-MEMBRANE; CYTOTOXIC DOMAIN; PHOSPHOLIPID-MEMBRANES; ANTIMICROBIAL PEPTIDES; ENDOPLASMIC-RETICULUM; ENDONUCLEASE TOXIN; ESCHERICHIA-COLI; ALPHA-SARCIN; OMPF PORIN	Background: Protein transport across cellular membranes is an important aspect of toxin biology. Escherichia coli cell killing by nuclease colicins occurs through DNA (DNases) or RNA (RNases) hydrolysis and to this end their cytotoxic domains require transportation across two sets of membranes. In order to begin to unravel the molecular mechanisms underlying the membrane translocation of colicin nuclease domains, we have analysed the membrane association of four DNase domains (E9, a charge reduction E9 mutant, E8, and E7) and one ribosomal RNase domain (E3) using a biomembrane model system. Principal Results: We demonstrate, through the use of large unilamellar vesicles composed of synthetic and E. coli lipids and a membrane surface potential sensor, that the colicin nuclease domains bind anionic membranes only, with micromolar affinity and via a cooperative binding mechanism. The evaluation of the nuclease bilayer insertion depth, through a fluorescence quenching analysis using brominated lipids, indicates that the nucleases locate to differential regions in the bilayer. Colicin DNases target the interfacial region of the lipid bilayer, with the DNase E7 showing the deepest insertion, whereas the ribosomal RNase E3 penetrates into the hydrophobic core region of the bilayer. Furthermore, the membrane association of the DNase E7 and the ribosomal RNase E3 induces vesicle aggregation, lipid mixing and content leakage to a much larger extent than that of the other DNases analysed. Conclusions/Significance: Our results show, for the first time, that after the initial electrostatically driven membrane association, the pleiotropic membrane effects induced by colicin nuclease domains relate to their bilayer insertion depth and may be linked to their in vivo membrane translocation.	[Vankemmelbeke, Mireille; James, Richard; Penfold, Christopher N.] Univ Nottingham, Sch Mol Med Sci, Ctr Biomol Sci, Nottingham NG7 2RD, England; [O'Shea, Paul] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Vankemmelbeke, M (corresponding author), Univ Nottingham, Sch Mol Med Sci, Ctr Biomol Sci, Nottingham NG7 2RD, England.	mireille.vankemmelbeke@nottingham.ac.uk	James, Richard/B-2252-2009	O'Shea, paul/0000-0001-9313-8313; James, Richard/0000-0002-5086-788X; Penfold, Christopher/0000-0003-3251-5650; Vankemmelbeke, Mireille/0000-0002-8100-813X	Wellcome Trust [082045/B/07/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Programme grant (082045/B/07/Z) from the Wellcome Trust (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins I, 2012, CURR PHARM BIOTECHNO, V13, P1446, DOI 10.2174/138920112800784835; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Alvarez-Garcia E, 2009, ARCH BIOCHEM BIOPHYS, V481, P37, DOI 10.1016/j.abb.2008.10.012; Amiche M, 2011, CURR PHARM BIOTECHNO, V12, P1184, DOI 10.2174/138920111796117319; Antignani A, 2008, P NATL ACAD SCI USA, V105, P8020, DOI 10.1073/pnas.0711707105; Baboolal TG, 2008, STRUCTURE, V16, P371, DOI 10.1016/j.str.2007.12.023; BOLEN EJ, 1990, BIOCHEMISTRY-US, V29, P9638, DOI 10.1021/bi00493a019; Bonsor DA, 2009, EMBO J, V28, P2846, DOI 10.1038/emboj.2009.224; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chak KF, 1998, PROTEINS, V32, P17, DOI 10.1002/(SICI)1097-0134(19980701)32:1<17::AID-PROT4>3.0.CO;2-B; Chauleau M, 2011, J BIOL CHEM, V286, P29397, DOI 10.1074/jbc.M111.242354; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Clark KS, 2011, BIOCHEMISTRY-US, V50, P7919, DOI 10.1021/bi200873u; Clifton LA, 2012, J BIOL CHEM, V287, P337, DOI 10.1074/jbc.M111.302901; de Zamaroczy M, 2001, MOL CELL, V8, P159, DOI 10.1016/S1097-2765(01)00276-3; Domingues MM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008385; Dowhan W, 2009, J LIPID RES, V50, pS305, DOI 10.1194/jlr.R800041-JLR200; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Duche D, 2006, J BACTERIOL, V188, P8593, DOI 10.1128/JB.00941-06; Edgar R, 2008, MOL MICROBIOL, V68, P1107, DOI 10.1111/j.1365-2958.2008.06205.x; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Fernandez-Vidall M, 2007, J MOL BIOL, V370, P459, DOI 10.1016/j.jmb.2007.05.016; GarinotSchneider C, 1997, MICROBIOL-SGM, V143, P2931, DOI 10.1099/00221287-143-9-2931; GASSET M, 1995, BBA-PROTEIN STRUCT M, V1252, P43, DOI 10.1016/0167-4838(95)00106-5; GASSET M, 1990, BIOCHEM J, V265, P815, DOI 10.1042/bj2650815; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gillor O, 2008, APPL MICROBIOL BIOT, V81, P591, DOI 10.1007/s00253-008-1726-5; Golding C, 1996, BIOCHEMISTRY-US, V35, P10931, DOI 10.1021/bi960905i; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Housden NG, 2010, P NATL ACAD SCI USA, V107, P21412, DOI 10.1073/pnas.1010780107; Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840; Inoue T, 2011, ANNU REV MICROBIOL, V65, P287, DOI 10.1146/annurev-micro-090110-102855; Karst JC, 2012, J BIOL CHEM, V287, P9200, DOI 10.1074/jbc.M111.316166; Kleanthous C, 2010, NAT REV MICROBIOL, V8, P843, DOI 10.1038/nrmicro2454; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lacadena J, 2007, FEMS MICROBIOL REV, V31, P212, DOI 10.1111/j.1574-6976.2006.00063.x; Ladokhin AS, 2001, J MOL BIOL, V309, P543, DOI 10.1006/jmbi.2001.4684; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Leonenko ZV, 2004, BIOPHYS J, V86, P3783, DOI 10.1529/biophysj.103.036681; Liao CC, 2001, BIOCHEM BIOPH RES CO, V284, P556, DOI 10.1006/bbrc.2001.5016; Lopez D, 2010, GENE DEV, V24, P1893, DOI 10.1101/gad.1945010; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Matsuzaki K, 2000, BBA-BIOMEMBRANES, V1467, P219, DOI 10.1016/S0005-2736(00)00223-6; Montalban-Lopez M, 2011, CURR PHARM BIOTECHNO, V12, P1205, DOI 10.2174/138920111796117364; Moreno MR, 2007, BIOCHEMISTRY-US, V46, P10572, DOI 10.1021/bi700911g; Mosbahi K, 2006, PROTEIN SCI, V15, P620, DOI 10.1110/ps.051890306; Mosbahi K, 2004, J BIOL CHEM, V279, P22145, DOI 10.1074/jbc.M400402200; Mosbahi K, 2002, NAT STRUCT BIOL, V9, P476, DOI 10.1038/nsb797; Ng CL, 2010, NAT STRUCT MOL BIOL, V17, P1241, DOI 10.1038/nsmb.1896; Papadakos G, 2012, Q REV BIOPHYS, V45, P57, DOI 10.1017/S0033583511000114; Ramamurthi KS, 2010, CURR OPIN MICROBIOL, V13, P753, DOI 10.1016/j.mib.2010.09.014; Saeki D, 2008, J COLLOID INTERF SCI, V320, P611, DOI 10.1016/j.jcis.2007.12.002; Sandvig K, 2010, FEBS LETT, V584, P2626, DOI 10.1016/j.febslet.2010.04.008; Shi ZH, 2005, J BIOL CHEM, V280, P24663, DOI 10.1074/jbc.M501216200; Sun J, 2004, EUR BIOPHYS J BIOPHY, V33, P572, DOI 10.1007/s00249-004-0400-9; Teixeira V, 2012, PROG LIPID RES, V51, P149, DOI 10.1016/j.plipres.2011.12.005; Top D, 2012, J BIOL CHEM, V287, P3403, DOI 10.1074/jbc.M111.305268; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; van Dalen A, 2004, BBA-MOL CELL RES, V1694, P97, DOI 10.1016/j.bbamcr.2004.03.007; van den Bremer ETJ, 2004, PROTEIN SCI, V13, P1391, DOI 10.1110/ps.03508204; Vankemmelbeke M, 2009, J BIOL CHEM, V284, P18932, DOI 10.1074/jbc.M806149200; Walker D, 2007, J BIOL CHEM, V282, P31389, DOI 10.1074/jbc.M705883200; WALL J, 1995, MOL MEMBR BIOL, V12, P183, DOI 10.3109/09687689509027506; WALLIS R, 1992, EUR J BIOCHEM, V210, P923, DOI 10.1111/j.1432-1033.1992.tb17496.x; Whittaker SBM, 1998, J BIOMOL NMR, V12, P145, DOI 10.1023/A:1008272928173; Whitty A, 2008, NAT CHEM BIOL, V4, P435, DOI 10.1038/nchembio0808-435; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yamashita E, 2008, EMBO J, V27, P2171, DOI 10.1038/emboj.2008.137; Zakharov SD, 2004, BIOPHYS J, V87, P3901, DOI 10.1529/biophysj.104.046151; Zakharov SD, 2006, BIOCHEMISTRY-US, V45, P10199, DOI 10.1021/bi060694+	74	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46656	10.1371/journal.pone.0046656	http://dx.doi.org/10.1371/journal.pone.0046656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029560	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900194
J	Medeiros, RJ; King, RA; Symondson, WOC; Cadiou, B; Zonfrillo, B; Bolton, M; Morton, R; Howell, S; Clinton, A; Felgueiras, M; Thomas, RJ				Medeiros, Renata J.; King, R. Andrew; Symondson, William O. C.; Cadiou, Bernard; Zonfrillo, Bernard; Bolton, Mark; Morton, Rab; Howell, Stephen; Clinton, Anthony; Felgueiras, Marcial; Thomas, Robert J.			Molecular Evidence for Gender Differences in the Migratory Behaviour of a Small Seabird	PLOS ONE			English	Article							SEX IDENTIFICATION; DNA; BIRDS; BONFERRONI; DIMORPHISM; FEATHERS; SAMPLES; TOOLS; SIZE	Molecular sexing revealed an unexpectedly strong female bias in the sex ratio of pre-breeding European Storm Petrels (Hydrobates pelagicus), attracted to playback of conspecific calls during their northwards migration past SW Europe. This bias was consistent across seven years, ranging from 80.8% to 89.7% female (mean annual sex ratio +/- SD = 85.5% female +/- 4.1%). The sex ratio did not differ significantly from unity (i.e., 50% female) among (i) Storm Petrel chicks at a breeding colony in NW France, (ii) adults found dead on beaches in Southern Portugal, (iii) breeding birds attending nest burrows in the UK, captured by hand, and (iv) adults captured near a breeding colony in the UK using copies of the same sound recordings as used in Southern Europe, indicating that females are not inherently more strongly attracted to playback calls than males. A morphological discriminant function analysis failed to provide a good separation of the sexes, showing the importance of molecular sexing for this species. We found no sex difference in the seasonal or nocturnal timing of migration past Southern Europe, but there was a significant tendency for birds to be caught in sex-specific aggregations. The preponderance of females captured in Southern Europe suggests that the sexes may differ in migration route or in their colony-prospecting behaviour during migration, at sites far away from their natal colonies. Such differences in migration behaviour between males and females are poorly understood but have implications for the vulnerability of seabirds to pollution and environmental change at sea during the non-breeding season.	[Medeiros, Renata J.; King, R. Andrew; Symondson, William O. C.; Howell, Stephen; Clinton, Anthony; Thomas, Robert J.] Cardiff Univ, Cardiff Business Sch, Cardiff, S Glam, Wales; [Cadiou, Bernard] Bretagne Vivante Soc Etude & Protect Nat Bretagne, Brest, Brittany, France; [Zonfrillo, Bernard] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Bolton, Mark] RSPB Royal Soc Protect Birds, Sandy, Beds, England; [Felgueiras, Marcial] A Rocha Assoc Crista Estudo & Def Ambient, Mexilhoeira, Algarve, Portugal	Cardiff University; University of Glasgow; Royal Society for Protection of Birds	Medeiros, RJ (corresponding author), Cardiff Univ, Cardiff Business Sch, Cardiff, S Glam, Wales.	medeirosmirrarj@cardiff.ac.uk	Thomas, Robert J/A-6612-2010; Medeiros, Renata/M-8616-2015	Thomas, Robert J/0000-0001-5256-3313; King, Andrew/0000-0001-9737-214X; Bolton, Mark/0000-0001-5605-687X; Symondson, William/0000-0002-3343-4679; Medeiros, Renata/0000-0002-5833-309X	FCT - Portuguese Foundation for Science and Technology	FCT - Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was funded by a fellowship for doctorate research by the FCT - Portuguese Foundation for Science and Technology (http://www.fct.pt/index.phtml.en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albores-Barajas YV, 2010, ARDEOLA, V57, P333; Bantock TM, 2008, MOL ECOL RESOUR, V8, P519, DOI 10.1111/j.1471-8286.2007.01999.x; Bertellotti M, 2002, WATERBIRDS, V25, P479, DOI 10.1675/1524-4695(2002)025[0479:DSOMPU]2.0.CO;2; Bogdanova MI, 2011, P ROY SOC B-BIOL SCI, V278, P2412, DOI 10.1098/rspb.2010.2601; Bolton M., 2001, Ringing and Migration, V20, P193; British Trust for Ornithology, 2012, LONG REC BRIT IR 201; Brooke M, 2004, ALBATROSSES PETRELS; Casey AE, 2009, MOL ECOL RESOUR, V9, P61, DOI 10.1111/j.1755-0998.2008.02307.x; Catry P, 2005, J AVIAN BIOL, V36, P184, DOI 10.1111/j.0908-8857.2005.03445.x; Catry P, 2005, SEXUAL SEGREGATION V; COPESTAKE PG, 1988, POLAR BIOL, V8, P271, DOI 10.1007/BF00263175; Cramp S., 1980, HDB BIRDS EUROPE MID, V1st; Crawley M.J., 2007, R BOOK; Cristol Daniel A., 1999, Current Ornithology, V15, P33; DAVIS P., 1957, BR BIRDS, V50, P371; Davis P., 1957, BR BIRDS, V50, P85; Dawson DA, 2001, MOL ECOL NOTES, V1, P201, DOI 10.1046/j.1471-8278.2001.00060.x; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Ellegren H, 1997, TRENDS ECOL EVOL, V12, P255, DOI 10.1016/S0169-5347(97)01061-6; Fowler J. A., 1986, SEABIRD, V9, P15; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Gladbach A, 2009, POLAR BIOL, V32, P1315, DOI 10.1007/s00300-009-0628-z; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Guilford T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033753; Harris P., 1993, Ringing & Migration, V14, P133; Harvey MG, 2006, J FIELD ORNITHOL, V77, P136, DOI 10.1111/j.1557-9263.2006.00033.x; Hedd A, 2006, MAR ECOL PROG SER, V322, P291, DOI 10.3354/meps322291; JAMES P C, 1983, Ringing and Migration, V4, P249; JAMES PC, 1984, IBIS, V126, P89, DOI 10.1111/j.1474-919X.1984.tb03671.x; Kahn NW, 1998, AUK, V115, P1074; Kokko H, 2006, J ANIM ECOL, V75, P1293, DOI 10.1111/j.1365-2656.2006.01151.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Maguire E.J., 1980, Scottish Birds, V11, P51; Mayr E, 1939, AM NAT, V73, P156, DOI 10.1086/280824; McDonald PG, 2011, J AVIAN BIOL, V42, P197, DOI 10.1111/j.1600-048X.2011.05365.x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; NORMAN FI, 1987, EMU, V87, P179, DOI 10.1071/MU9870179; Norris DR, 2006, BIOL LETTERS, V2, P148, DOI 10.1098/rsbl.2005.0397; O'Dwyer TW, 2006, EMU, V106, P245, DOI 10.1071/MU05058; Okill J. David, 2005, Ringing & Migration, V22, P205; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Phillips RA, 2009, OECOLOGIA, V160, P795, DOI 10.1007/s00442-009-1342-9; R Core Team, 2020, R LANG ENV STAT COMP; Regnaut S, 2006, CONSERV GENET, V7, P449, DOI 10.1007/s10592-005-9023-7; Reudink MW, 2009, P ROY SOC B-BIOL SCI, V276, P1619, DOI 10.1098/rspb.2008.1452; Robb M, 2008, PETRELS NIGHT DAY SO; Robertson BC, 2006, CONSERV GENET, V7, P267, DOI 10.1007/s10592-005-9105-6; Roche JC, 1997, ALL BIRD SONGS BRITA; Rubolini D, 2004, BEHAV ECOL, V15, P592, DOI 10.1093/beheco/arh048; Russello MA, 2001, ZOO BIOL, V20, P41, DOI 10.1002/zoo.1004; Scott DA, 1970, THESIS OXFORD U; Sheldon BC, 1998, HEREDITY, V80, P397, DOI 10.1046/j.1365-2540.1998.00374.x; Shizuka D, 2008, MOL ECOL RESOUR, V8, P1249, DOI 10.1111/j.1755-0998.2008.02342.x; Thomas Robert J., 2006, Atlantic Seabirds, V8, P87; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Warham J., 1996, BEHAV POPULATION BIO; Wernham C., 2002, MIGRATION ATLAS MOVE	58	14	16	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46330	10.1371/journal.pone.0046330	http://dx.doi.org/10.1371/journal.pone.0046330			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029481	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000309517500089
J	Du, Y; An, SO; Liu, L; Li, L; Zhou, XJ; Mason, RP; Mohan, C				Du, Yong; An, Shion; Liu, Li; Li, Li; Zhou, Xin J.; Mason, Ralph P.; Mohan, Chandra			Serial Non-Invasive Monitoring of Renal Disease Following Immune-Mediated Injury Using Near-Infrared Optical Imaging	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; IRON-OXIDE; IN-VIVO; ADHESION; ALPHA-V-BETA-3-INTEGRIN; INFLAMMATION; BIOMARKERS; MORTALITY; NEPHRITIS; SURGERY	Background: Non-invasive monitoring of disease progression in kidney disease is still a major challenge in clinical practice. In vivo near-infrared (NIR) imaging provides a new tool for studying disease mechanisms and non-invasive monitoring of disease development, even in deep organs. The LI-COR IRDye (R) 800CW RGD optical probe (RGD probe) is a NIR fluorophore, that can target integrin alpha v beta 3 (alpha(v)beta(3)) in tissues. Objective: This study aims to monitor renal disease progression in an anti-glomerular basement membrane (GBM) nephritis mouse model. Methods: Anti-GBM nephritis was induced in 129x1/svJ mice by anti-GBM serum challenge. The expression of integrin alpha(v)beta(3) in the diseased kidney was examined by immunohistochemistry and quantitative polymerase chain reaction. The RGD probe and control fluorophores, the 800CW dye, and the BSA-conjugated 800CW dye, were administered into anti-GBM nephritic mice. LI-COR Pearl (R) Impulse imaging system was used for in vivo imaging; while ex vivo organ imaging was acquired using the Maestro (TM) imaging system. Results: Kidney tissue from anti-GBM nephritic mice showed higher levels of integrin alpha(v)beta(3) expression at both the protein and the mRNA level compared to normal mice. The RGD probe allowed in vivo renal imaging and the fluorescent signal could be specifically captured in the diseased kidneys up to 14 days, reflecting longitudinal changes in renal function. Conclusion: The infrared RGD molecular probe that tracks integrin expression can be successfully used to monitor renal disease progression following immune-mediated nephritis.	[Du, Yong; An, Shion; Liu, Li; Li, Li; Zhou, Xin J.; Mason, Ralph P.; Mohan, Chandra] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Mason, RP (corresponding author), Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA.	Ralph.mason@utsouthwestern.edu; chandra.mohan@utsouthwestern.edu	Mohan, Chandra/GPX-8233-2022; Mason, Ralph/C-8472-2012; Liu, LI/B-6912-2013; DU, YONG/B-9964-2011	Mason, Ralph/0000-0001-7517-3721; Liu, LI/0000-0002-9731-6145; DU, YONG/0000-0003-1687-9024	National Institutes of Health [AR050812, DK 081872]; NATIONAL CANCER INSTITUTE [U24CA126608, P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by National Institutes of Health funding AR050812 and DK 081872. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	BARALDI A, 1995, NEPHROL DIAL TRANSPL, V10, P1155, DOI 10.1093/ndt/10.7.1155; Chen XY, 2004, CANCER RES, V64, P8009, DOI 10.1158/0008-5472.CAN-04-1956; Coca SG, 2008, CLIN J AM SOC NEPHRO, V3, P481, DOI 10.2215/CJN.03520807; Crane LM, 2010, JOVE-J VIS EXP, V44, P2225; Dent CL, 2007, CRIT CARE, V11, DOI 10.1186/cc6192; Escobedo JO, 2010, CURR OPIN CHEM BIOL, V14, P64, DOI 10.1016/j.cbpa.2009.10.022; Fischer EG, 2004, BIOCHEM CELL BIOL, V82, P597, DOI 10.1139/O04-051; Fu YY, 2007, CLIN IMMUNOL, V124, P109, DOI 10.1016/j.clim.2007.05.007; Gioux S, 2010, MOL IMAGING, V9, P237, DOI 10.2310/7290.2010.00034; Hauger O, 2000, RADIOLOGY, V217, P819, DOI 10.1148/radiology.217.3.r00dc04819; Hayashida T, 2010, J BIOL CHEM, V285, P30741, DOI 10.1074/jbc.M110.105700; Herborn CU, 2002, INVEST RADIOL, V37, P464, DOI 10.1097/00004424-200208000-00008; Jin DK, 1996, J AM SOC NEPHROL, V7, P2636; KANAHARA K, 1994, NEPHRON, V66, P29, DOI 10.1159/000187762; Karadeli E, 2010, RHEUMATOL INT, V30, P1177, DOI 10.1007/s00296-009-1124-z; Kossodo S, 2010, MOL IMAGING BIOL, V12, P488, DOI 10.1007/s11307-009-0279-z; Lahita RG, 2010, SYSTEMIC LUPUS ERYTH, P453; Lee DK, 2010, J CLIN NEUROL, V6, P10, DOI 10.3988/jcn.2010.6.1.10; Mankoff DA, 2007, J NUCL MED, V48, p18N; Marshall MV, 2010, MOL IMAGING BIOL, V12, P583, DOI 10.1007/s11307-010-0317-x; Mulder WJM, 2009, ANGIOGENESIS, V12, P17, DOI 10.1007/s10456-008-9124-2; Nakamura K, 2010, J CONTROL RELEASE, V148, P351, DOI 10.1016/j.jconrel.2010.09.005; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Parikh CR, 2006, KIDNEY INT, V70, P199, DOI 10.1038/sj.ki.5001527; Parikh CR, 2008, CRIT CARE MED, V36, pS159, DOI 10.1097/CCM.0b013e318168c652; Patey N, 1996, J PATHOL, V179, P414; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; Rao JH, 2007, CURR OPIN BIOTECH, V18, P17, DOI 10.1016/j.copbio.2007.01.003; RoyChaudhury P, 1997, KIDNEY INT, V52, P103, DOI 10.1038/ki.1997.309; Sadick M, 2011, NEPHROL DIAL TRANSPL, V26, P3101, DOI 10.1093/ndt/gfr148; Serkova NJ, 2010, RADIOLOGY, V255, P517, DOI 10.1148/radiol.09091134; Sevick-Muraca EM, 2008, RADIOLOGY, V246, P734, DOI 10.1148/radiol.2463070962; SHIKATA K, 1995, AM J KIDNEY DIS, V25, P680, DOI 10.1016/0272-6386(95)90542-1; Wilder RL, 2002, ANN RHEUM DIS, V61, P96, DOI 10.1136/ard.61.suppl_2.ii96; Xie C, 2004, J IMMUNOL, V172, P5047, DOI 10.4049/jimmunol.172.8.5047; Xie P, 2011, J BIOL CHEM, V286, P34131, DOI 10.1074/jbc.M111.241778; Ympa YP, 2005, AM J MED, V118, P827, DOI 10.1016/j.amjmed.2005.01.069; Zhou HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008051	38	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e43941	10.1371/journal.pone.0043941	http://dx.doi.org/10.1371/journal.pone.0043941			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049742	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300008
J	Juyal, RC; Negi, S; Wakhode, P; Bhat, S; Bhat, B; Thelma, BK				Juyal, Ramesh C.; Negi, Sapna; Wakhode, Preeti; Bhat, Sulekha; Bhat, Bheema; Thelma, B. K.			Potential of Ayurgenomics Approach in Complex Trait Research: Leads from a Pilot Study on Rheumatoid Arthritis	PLOS ONE			English	Article							LIPID-PEROXIDATION; DISEASE SEVERITY; REACTIVE OXYGEN; ASSOCIATION; GENE; POLYMORPHISMS; CLASSIFICATION; VARIABILITY; AYURVEDA; REGION	Background: Inconsistent results across association studies including Genome-wide association, have posed a major challenge in complex disease genetics. Of the several factors which contribute to this, phenotypic heterogeneity is a serious limitation encountered in modern medicine. On the other hand, Ayurveda, a holistic Indian traditional system of medicine, enables subgrouping of individuals into three major categories namely Vata, Pitta and Kapha, based on their physical and mental constitution, referred to as Prakriti. We hypothesised that conditioning association studies on prior risk, predictable in Ayurveda, will uncover much more variance and potentially open up more predictive health. Objectives and Methods: Identification of genetic susceptibility markers by combining the prakriti based subgrouping of individuals with genetic analysis tools was attempted in a Rheumatoid arthritis (RA) cohort. Association of 21 markers from commonly implicated inflammatory and oxidative stress pathways was tested using a case-control approach in a total cohort comprising 325 cases and 356 controls and in the three subgroups separately. We also tested few postulates of Ayurveda on the disease characteristics in different prakriti groups using clinico-genetic data. Results: Inflammatory genes like IL1 beta (C-C-C haplotype, p = 0.0005, OR = 3.09) and CD40 (rs4810485 allelic, p = 0.04, OR = 2.27) seem to be the determinants in Vata subgroup whereas oxidative stress pathway genes are observed in Pitta (SOD3 rs699473, p = 0.004, OR = 1.83; rs2536512 p = 0.005; OR = 1.88 and PON1 rs662, p = 0.04, OR = 1.53) and Kapha (SOD3 rs2536512, genotypic, p = 0.02, OR = 2.39) subgroups. Fixed effect analysis of the associated markers from CD40, SOD3 and TNF alpha with genotype X prakriti interaction terms suggests heterogeneity of effects within the subgroups. Further, disease characteristics such as severity was most pronounced in Vata group. Conclusions: This exploratory study suggests discrete causal pathways for RA etiology in prakriti based subgroups, thereby, validating concepts of prakriti and personalized medicine in Ayurveda. Ayurgenomics approach holds promise for biomarker discovery in complex diseases.	[Thelma, B. K.] Univ Delhi, Dept Genet, New Delhi, India; [Juyal, Ramesh C.; Negi, Sapna] Natl Inst Immunol, Expt Anim Facil, New Delhi 110067, India; [Wakhode, Preeti; Bhat, Sulekha; Bhat, Bheema] Holy Family Hosp, Dept Ayurveda, New Delhi, India	University of Delhi; Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Thelma, BK (corresponding author), Univ Delhi, Dept Genet, South Campus, New Delhi, India.	thelmabk@gmail.com	Negi, Sapna/HGA-5265-2022	Thelma, B.K/0000-0002-2154-5443	Central Council for Research in Ayurveda and Siddha, Department of AYUSH, Ministry of Health and Family Welfare, Government of India, New Delhi [Z.31018/18/2006-RP]	Central Council for Research in Ayurveda and Siddha, Department of AYUSH, Ministry of Health and Family Welfare, Government of India, New Delhi	The financial assistance for this work was provided by Central Council for Research in Ayurveda and Siddha, Department of AYUSH, Ministry of Health and Family Welfare, Government of India, New Delhi, vide F.No. Z.31018/18/2006-R&P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso V, 2007, JOINT BONE SPINE, V74, P324, DOI 10.1016/j.jbspin.2007.02.002; Aggarwal S, 2010, P NATL ACAD SCI USA, V107, P18961, DOI 10.1073/pnas.1006108107; [Anonymous], 2000, SUSRUTA SAMHITA; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baskol G, 2005, CLIN BIOCHEM, V38, P951, DOI 10.1016/j.clinbiochem.2005.06.010; Bauerova K, 1999, GEN PHYSIOL BIOPHYS, V18, P15; Bhushan P, 2005, J ALTERN COMPLEM MED, V11, P349, DOI 10.1089/acm.2005.11.349; Buchs N, 2001, GENES IMMUN, V2, P222, DOI 10.1038/sj.gene.6363766; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dahabreh IJ, 2010, GENET MED, V12, P606, DOI 10.1097/GIM.0b013e3181ee81c6; Dasgupta S, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-7; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Fonseca JE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2173; Grabar PB, 2009, DIS MARKERS, V26, P41, DOI 10.3233/DMA-2009-0603; Harris ML, 2008, ARTHRITIS RHEUM-US, V58, P1958, DOI 10.1002/art.23596; Hee CS, 2007, MOD RHEUMATOL, V5, P429; Ichikawa N, 2009, MOD RHEUMATOL, V19, P134, DOI 10.1007/s10165-008-0134-0; Lee YH, 2012, INFLAMM RES, V61, P665, DOI 10.1007/s00011-012-0459-1; Martinez A, 2003, GENES IMMUN, V4, P117, DOI 10.1038/sj.gene.6363931; Mulcahy B, 1996, AM J HUM GENET, V59, P676; Naganuma T, 2008, HEREDITAS, V145, P283, DOI 10.1111/j.1601-5223.2008.02086.x; Patwardhan B, 2012, CURRENT SCI, V10, P1406; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Prasher B, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-48; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Rodriguez-Rodriguez L, 2011, ARTHRITIS RHEUM-US, V63, P365, DOI 10.1002/art.30145; Sarban S, 2005, CLIN BIOCHEM, V38, P981, DOI 10.1016/j.clinbiochem.2005.08.003; Sethi TP, 2011, ACS CHEM BIOL, V6, P875, DOI 10.1021/cb2003016; Sharma P., 2003, CHARAKA SAMHITA; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Srikanthamurthy KR, 2001, MADHAVA NIDANAM MADH; Srikanthamurthy KR, 2003, ASHTANGA HRIDAYAM; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tamiya G, 2005, HUM MOL GENET, V14, P2305, DOI 10.1093/hmg/ddi234; Taysi S, 2002, RHEUMATOL INT, V21, P200, DOI 10.1007/s00296-001-0163-x; Thelma B. K., 2008, PHISPC SERIES HIST S; Totaro MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024292; Turesson C, 2006, MAYO CLIN PROC, V81, P94, DOI 10.4065/81.1.94; van der Linden MPM, 2009, ARTHRITIS RHEUM, V60, P2242, DOI 10.1002/art.24721; Wang MS, 2011, ATHEROSCLEROSIS, V214, P377, DOI 10.1016/j.atherosclerosis.2010.11.028; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720	41	31	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45752	10.1371/journal.pone.0045752	http://dx.doi.org/10.1371/journal.pone.0045752			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049851	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300048
J	Wang, CL; Su, YJ; Zhang, LM; Wang, M; You, J; Zhao, XL; Zhang, ZF; Liu, J; Hao, XS				Wang, Changli; Su, Yanjun; Zhang, Lianmin; Wang, Meng; You, Jian; Zhao, Xiaoliang; Zhang, Zhenfa; Liu, Jun; Hao, Xishan			The Function of SARI in Modulating Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Metastasis	PLOS ONE			English	Article							E-CADHERIN EXPRESSION; BETA-CATENIN; CANCER PROGRESSION; BREAST-CANCER; EMT; PATIENT; PHOSPHORYLATION; GROWTH; CELLS; ACTIVATION	The SARI (suppressor of AP-1, regulated by IFN) gene, which is also called BATF2, is associated with the risk of several kinds of cancer, and loss of SARI expression is frequently detected in aggressive and metastatic cancer. However, the functional role of SARI in lung adenocarcinoma remains unknown. We have shown that loss of SARI expression initiates epithelial-mesenchymal transition (EMT), which is visualized by repression of E-cadherin and up-regulation of vimentin in lung adenocarcinoma cell lines and in clinical lung adenocarcinoma specimens. Using a human lung xenograft-mouse model, we observed that knocking down endogenous SARI in human carcinoma cells leads to the development of multiple lymph node metastases. Moreover, we showed that SARI functions as a critical protein in regulating EMT by modulating the (GSK)-3 beta-beta-catenin signaling pathway. These results demonstrate the mechanism of SARI function in EMT and suggest that assessment of SARI may serve as a prognostic biomarker and potential therapeutic target for lung adenocarcinoma metastasis.	[Wang, Changli; Su, Yanjun; Zhang, Lianmin; Wang, Meng; You, Jian; Zhao, Xiaoliang; Zhang, Zhenfa; Liu, Jun; Hao, Xishan] Tianjin Med Univ, Dept Lung Canc, Canc Inst & Hosp, Tianjin, Peoples R China	Tianjin Medical University	Liu, J (corresponding author), Tianjin Med Univ, Dept Lung Canc, Canc Inst & Hosp, Tianjin, Peoples R China.	liujun0129@gmail.com; xishanhao_1@163.com	Rui, Zhenhua/J-8195-2019	Rui, Zhenhua/0000-0001-6088-0845	National Natural Science Foundation of China [81101776]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China, 81101776. The funders had role in study design.	Asnaghi L, 2010, ONCOGENE, V29, P2760, DOI 10.1038/onc.2010.39; Braun J, 2010, ONCOGENE, V29, P4237, DOI 10.1038/onc.2010.169; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; Dash R, 2010, ONCOGENE, V29, P4412, DOI 10.1038/onc.2010.194; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Hata A, 2011, LUNG CANC; Hiscox S, 2006, INT J CANCER, V118, P290, DOI 10.1002/ijc.21355; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Kim AN, 2011, BIOCHEM BIOPH RES CO, V407, P181, DOI 10.1016/j.bbrc.2011.02.134; Kook EH, 2010, ONCOL RES, V18, P445, DOI 10.3727/096504010X12671222663674; Kupferman ME, 2010, ONCOGENE, V29, P2047, DOI 10.1038/onc.2009.486; Kyprianou N, 2010, P NATL ACAD SCI USA, V107, P2731, DOI 10.1073/pnas.0914721107; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Lemjabbar-Alaoui H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000093; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Longo F, 2011, ONKOLOGIE, V34, P326, DOI 10.1159/000328788; Maschler S, 2010, EMBO MOL MED, V2, P401, DOI 10.1002/emmm.201000095; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Nozawa N, 2006, PATHOL RES PRACT, V202, P639, DOI 10.1016/j.prp.2006.03.007; Osada H, 2008, CANCER RES, V68, P1647, DOI 10.1158/0008-5472.CAN-07-5039; Rich AL, 2011, BRIT J CANCER, V105, P746, DOI 10.1038/bjc.2011.310; Strand A, 2000, BIOCHEM SYST ECOL, V28, P443, DOI 10.1016/S0305-1978(99)00078-2; Su ZZ, 2008, P NATL ACAD SCI USA, V105, P20906, DOI 10.1073/pnas.0807975106; Teng Y, 2010, BIOCHEM BIOPH RES CO, V392, P373, DOI 10.1016/j.bbrc.2010.01.028; Tseng RC, 2010, CANCER RES, V70, P543, DOI 10.1158/0008-5472.CAN-09-2084; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; WELSH GI, 1993, BIOCHEM J, V294, P625, DOI 10.1042/bj2940625; Weng JH, 2011, CLIN NUCL MED, V36, P731, DOI 10.1097/RLU.0b013e31821a26bf; Zhang HJ, 2011, MOL CELL BIOCHEM, V355, P309, DOI 10.1007/s11010-011-0869-3	33	38	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e38046	10.1371/journal.pone.0038046	http://dx.doi.org/10.1371/journal.pone.0038046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049725	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300001
J	Edmond, V; Ghali, B; Penna, A; Taupin, JL; Daburon, S; Moreau, JF; Legembre, P				Edmond, Valerie; Ghali, Benoist; Penna, Aubin; Taupin, Jean-Luc; Daburon, Sophie; Moreau, Jean-Francois; Legembre, Patrick			Precise Mapping of the CD95 Pre-Ligand Assembly Domain	PLOS ONE			English	Article							AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; LOW-AFFINITY RECEPTOR; FAS GENE-MUTATIONS; APOPTOSIS; ACTIVATION; SIGNAL; DEATH; SIALYLATION; BINDING	Pre-association of CD95 at the plasma membrane is mandatory for efficient death receptor signaling. This homotrimerization occurs through self-association of an extracellular domain called the pre-ligand assembly domain (PLAD). Using novel molecular and cellular tools, we confirmed that CD95-PLAD is necessary to promote CD95 multimerization and plays a pivotal role in the transmission of apoptotic signals. However, while a human CD95 mutant deleted of the previously described PLAD domain (amino acids 1 to 66) fails to interact with its wild-type counterpart and trigger autonomous cell death, deletion of amino acids 1 to 42 does not prevent homo- or hetero (human/mouse)oligomerization of CD95, and thus does not alter transmission of the apoptotic signal. Overall, these findings indicate that the region between amino acids 43 to 66 corresponds to the minimal motif involved in CD95 homotypic interaction and is necessary to convey an efficient apoptotic signal. Interfering with this PLAD may represent a new therapeutic strategy for altering CD95-induced apoptotic and non-apoptotic signals.	[Edmond, Valerie; Penna, Aubin; Legembre, Patrick] Univ Rennes 1, Rennes, France; [Edmond, Valerie; Penna, Aubin; Legembre, Patrick] INSERM, U1085, IRSET, Rennes, France; [Ghali, Benoist; Taupin, Jean-Luc; Daburon, Sophie; Moreau, Jean-Francois] Univ Bordeaux 2, F-33076 Bordeaux, France; [Ghali, Benoist; Taupin, Jean-Luc; Daburon, Sophie; Moreau, Jean-Francois] CNRS, UMR 5164, Bordeaux, France; [Taupin, Jean-Luc; Moreau, Jean-Francois] CHU Bordeaux, Bordeaux, France	Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Legembre, P (corresponding author), Univ Rennes 1, Rennes, France.	patrick.legembre@inserm.fr	Legembre, Patrick/U-1882-2019; legembre, patrick/L-3475-2016; penna, aubin/AAD-2550-2019; PENNA, aubin/E-2208-2018	Legembre, Patrick/0000-0001-6649-8049; legembre, patrick/0000-0001-6649-8049; penna, aubin/0000-0002-1070-5990; PENNA, aubin/0000-0002-1070-5990	Agence Nationale de la Recherche [ANR JC07_183182]; Institut National du Cancer INCa (projets libres recherche biomedicale); Canceropole GO; Fondation pour la Recherche Medicale; Region Bretagne; Rennes Metropole; Ligue Contre le Cancer (Comites d'Ille- et- Vilaine/du Morbihan/des Cotes d'Armor et du Maine)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut National du Cancer INCa (projets libres recherche biomedicale); Canceropole GO; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Region Bretagne(Region Bretagne); Rennes Metropole(Region Bretagne); Ligue Contre le Cancer (Comites d'Ille- et- Vilaine/du Morbihan/des Cotes d'Armor et du Maine)	This work was supported by Agence Nationale de la Recherche (ANR JC07_183182), Institut National du Cancer INCa (projets libres recherche biomedicale), Canceropole GO, Fondation pour la Recherche Medicale, Region Bretagne, Rennes Metropole, Ligue Contre le Cancer (Comites d'Ille- et- Vilaine/du Morbihan/des Cotes d'Armor et du Maine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beneteau M, 2008, MOL CANCER RES, V6, P604, DOI 10.1158/1541-7786.MCR-07-0331; Bodmer JL, 2002, TRENDS BIOCHEM SCI, V27, P19, DOI 10.1016/S0968-0004(01)01995-8; BOLDIN MP, 1995, J BIOL CHEM, V270, P7795, DOI 10.1074/jbc.270.14.7795; Chaigne-Delalande B, 2008, J IMMUNOL, V181, P7630, DOI 10.4049/jimmunol.181.11.7630; Drappa J, 1996, NEW ENGL J MED, V335, P1643, DOI 10.1056/NEJM199611283352204; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Garcia-Fuster MJ, 2004, EUR J PHARMACOL, V496, P63, DOI 10.1016/j.ejphar.2004.06.018; Hoogwater FJH, 2010, GASTROENTEROLOGY, V138, P2357, DOI 10.1053/j.gastro.2010.02.046; Jackson CE, 1999, AM J HUM GENET, V64, P1002, DOI 10.1086/302333; Keppler OT, 1999, GLYCOBIOLOGY, V9, P557, DOI 10.1093/glycob/9.6.557; KISHIMOTO T, 1994, STEM CELLS, V12, P37; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Legembre P, 2003, J IMMUNOL, V171, P5659, DOI 10.4049/jimmunol.171.11.5659; Legembre P, 2002, CELL DEATH DIFFER, V9, P329, DOI 10.1038/sj.cdd.4400960; Letellier E, 2010, IMMUNITY, V32, P240, DOI 10.1016/j.immuni.2010.01.011; Li Y, 2007, INT J BIOCHEM CELL B, V39, P1625, DOI 10.1016/j.biocel.2007.04.002; Papoff G, 1999, J BIOL CHEM, V274, P38241, DOI 10.1074/jbc.274.53.38241; Pensati L, 1997, GASTROENTEROLOGY, V113, P1384, DOI 10.1053/gast.1997.v113.pm9322534; PETER ME, 1995, CELL DEATH DIFFER, V2, P163; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; STAHL N, 1994, SCIENCE, V263, P92, DOI 10.1126/science.8272873; Taupin JL, 1999, J BIOL CHEM, V274, P14482, DOI 10.1074/jbc.274.20.14482; Tauzin S, 2011, CD95 MEDIATED CELL S; Tauzin S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001090; Vaishnaw AK, 1999, J CLIN INVEST, V103, P355, DOI 10.1172/JCI5121; Voisin MB, 2002, J BIOL CHEM, V277, P13682, DOI 10.1074/jbc.M111624200	28	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46236	10.1371/journal.pone.0046236	http://dx.doi.org/10.1371/journal.pone.0046236			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049989	Green Published, gold			2022-12-27	WOS:000309556100162
J	Genini, D; Garcia-Escudero, R; Carbone, GM; Catapano, CV				Genini, Davide; Garcia-Escudero, Ramon; Carbone, Giuseppina M.; Catapano, Carlo V.			Transcriptional and Non-Transcriptional Functions of PPAR beta/delta in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-DELTA; COLORECTAL-CANCER; NUCLEAR RECEPTORS; ADENOMA GROWTH; KAPPA-B; CARCINOGENESIS; EXPRESSION; GAMMA; INHIBITION; COLON	Peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) is a nuclear receptor involved in regulation of lipid and glucose metabolism, wound healing and inflammation. PPAR beta/delta has been associated also with cancer. Here we investigated the expression of PPAR beta/delta and components of the prostaglandin biosynthetic pathway in non-small cell lung cancer (NSCLC). We found increased expression of PPAR beta/delta, Cox-2, cPLA(2), PGES and VEGF in human NSCLC compared to normal lung. In NSCLC cell lines PPAR beta/delta activation increased proliferation and survival, while PPAR beta/delta knock-down reduced viability and increased apoptosis. PPAR beta/delta agonists induced Cox-2 and VEGF transcription, suggesting the existence of feed-forward loops promoting cell survival, inflammation and angiogenesis. These effects were seen only in high PPAR beta/delta expressing cells, while low expressing cells were less or not affected. The effects were also abolished by PPAR beta/delta knock-down or incubation with a PPAR beta/delta antagonist. Induction of VEGF was due to both binding of PPAR beta/delta to the VEGF promoter and PI3K activation through a non-genomic mechanism. We found that PPAR beta/delta interacted with the PI3K regulatory subunit p85a leading to PI3K activation and Akt phosphorylation. Collectively, these data indicate that PPAR beta/delta might be a central element in lung carcinogenesis controlling multiple pathways and representing a potential target for NSCLC treatment.	[Genini, Davide; Carbone, Giuseppina M.; Catapano, Carlo V.] Inst Oncol Res IOR, Bellinzona, Switzerland; [Genini, Davide; Carbone, Giuseppina M.; Catapano, Carlo V.] Oncol Inst So Switzerland IOSI, Bellinzona, Switzerland; [Garcia-Escudero, Ramon] Ctr Invest Energet Medioambientales & Tecnol CIEM, Mol Oncol Unit, Madrid, Spain	Institute of Oncology Research (IOR); Universita della Svizzera Italiana; Institute of Oncology Research (IOR); Centro de Investigaciones Energeticas, Medioambientales Tecnologicas	Catapano, CV (corresponding author), Inst Oncol Res IOR, Bellinzona, Switzerland.	carlo.catapano@ior.iosi.ch	Garcia-Escudero, Ramon/A-2735-2012	Garcia-Escudero, Ramon/0000-0001-5640-6542; Catapano, Carlo V./0000-0002-7079-557X	Fondazione Ticinese per la ricerca sul cancro	Fondazione Ticinese per la ricerca sul cancro	This was supported by "Fondazione Ticinese per la ricerca sul cancro.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2007, P NATL ACAD SCI USA, V104, P12890, DOI 10.1073/pnas.0705505104; Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299; Bren-Mattison Y, 2008, MOL PHARMACOL, V73, P709, DOI 10.1124/mol.107.042002; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Ermert L, 2003, CLIN CANCER RES, V9, P1604; Fauconnet S, 2002, J BIOL CHEM, V277, P23534, DOI 10.1074/jbc.M200172200; Genini D, 2007, J BIOL CHEM, V282, P11776, DOI 10.1074/jbc.M609149200; Genini D, 2008, PPAR RES, V2008, DOI 10.1155/2008/195065; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Glinghammar B, 2003, BIOCHEM BIOPH RES CO, V308, P361, DOI 10.1016/S0006-291X(03)01384-6; Gupta RA, 2000, P NATL ACAD SCI USA, V97, P13275, DOI 10.1073/pnas.97.24.13275; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Gupta RA, 2004, NAT MED, V10, P245, DOI 10.1038/nm993; Han JK, 2008, CIRCULATION, V118, P1021, DOI 10.1161/CIRCULATIONAHA.108.777169; Han SW, 2008, AM J PHYSIOL-LUNG C, V294, pL1238, DOI 10.1152/ajplung.00017.2008; Han SW, 2009, AM J RESP CELL MOL, V40, P325, DOI 10.1165/rcmb.2008-0197OC; Harman FS, 2004, NAT MED, V10, P481, DOI 10.1038/nm1026; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Keith RL, 2004, CANCER RES, V64, P5897, DOI 10.1158/0008-5472.CAN-04-1070; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Napoli S, 2009, EMBO J, V28, P1708, DOI 10.1038/emboj.2009.139; Nemenoff R, 2008, CANCER PREV RES, V1, P349, DOI 10.1158/1940-6207.CAPR-08-0145; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Pedchenko TV, 2008, AM J RESP CELL MOL, V39, P689, DOI 10.1165/rcmb.2007-0426OC; Peeters Louis L. H., 2005, Angiogenesis, V8, P373; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Peters JM, 2011, CANCER METAST REV, V30, P619, DOI 10.1007/s10555-011-9320-1; Reed KR, 2004, ONCOGENE, V23, P8992, DOI 10.1038/sj.onc.1208143; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Shearer BG, 2008, MOL ENDOCRINOL, V22, P523, DOI 10.1210/me.2007-0190; Simoncini T, 2000, NATURE, V407, P538, DOI 10.1038/35035131; Stephen RL, 2004, CANCER RES, V64, P3162, DOI 10.1158/0008-5472.CAN-03-2760; Sun M, 2003, J BIOL CHEM, V278, P42992, DOI 10.1074/jbc.M306295200; Sun S, 2007, J CLIN INVEST, V117, P2740, DOI 10.1172/JCI31809; Vignati S, 2006, NEOPLASIA, V8, P851, DOI 10.1593/neo.06433; Wang DZ, 2006, P NATL ACAD SCI USA, V103, P19069, DOI 10.1073/pnas.0607948103; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Yin YZ, 2005, CANCER RES, V65, P3950, DOI 10.1158/0008-5472.CAN-04-3990; Yoshinaga M, 2011, DIGEST DIS SCI, V56, P1194, DOI 10.1007/s10620-010-1389-9; Zhou H, 2010, CANCER CELL, V17, P560, DOI 10.1016/j.ccr.2010.04.023	42	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46009	10.1371/journal.pone.0046009	http://dx.doi.org/10.1371/journal.pone.0046009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049921	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100118
J	Li, J; Lau, G; Chen, LL; Yuan, YF; Huang, J; Luk, JM; Xie, D; Guan, XY				Li, Jian; Lau, George; Chen, Leilei; Yuan, Yun-Fei; Huang, Jun; Luk, John M.; Xie, Dan; Guan, Xin-Yuan			Interleukin 23 Promotes Hepatocellular Carcinoma Metastasis via NF-Kappa B Induced Matrix Metalloproteinase 9 Expression	PLOS ONE			English	Article							TUMOR-METASTASIS; IL-23; IL-12; CARCINOGENESIS; INFLAMMATION; DISTINCT; GROWTH; INNATE	Background: Hepatocellular carcinoma (HCC) is one of the most popular cancers in the world with poor prognosis, which often develops from chronic liver inflammatory diseases. Interleukin 23 (IL-23) is an inflammatory cytokine which is reported to play an important role in tumor development in animal model. While the function of IL-23 in HCC development remains unknown, so we investigate the role of IL-23 in HCC progression in this study. Methodology and Principal Finding: Transcript level of IL-23, interleukin 17A (IL-17A) and matrix metalloproteinases 9 (MMP9) in clinical HCC samples (n = 81) was determined by qPCR. Protein expression pattern of IL-23 in primary and metastatic HCC tissues pairs (n = 49 pairs) was determined by immunohistochemistry staining. Cell migration, invasion, RNA interfering and immune blotting were used to characterize the functional and signaling mechanisms in IL-23-treated HCC. Compared with paired non-tumor tissue, higher IL-23 expression was detected in HCC tumor tissues with metastasis. Immunohistochemistry staining confirmed the high expression of IL-23 in metastasis HCC. Immune blotting demonstrated that IL-23 was highly expressed in HCC cell lines with metastasis. Functional study found that IL-23 could promote HCC cell migration and invasion. Molecular analysis revealed that IL-23 could upregulate MMP9 expression via NF-kappa B/p65 signaling activation and IL-17A could improve IL-23 expression in tumor cells directly via activating NF-kappa B/p65 signaling pathway. Conclusions: IL-23 could promote HCC metastasis by the upregulation of MMP9 expression via activating NF-kappa B/p65 signaling pathway. At the same time, IL-17A could further promote IL-23 expression in HCC tumor cells.	[Li, Jian; Yuan, Yun-Fei; Huang, Jun; Xie, Dan; Guan, Xin-Yuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Li, Jian; Chen, Leilei; Guan, Xin-Yuan] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Li, Jian; Chen, Leilei; Guan, Xin-Yuan] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Lau, George] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Luk, John M.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Guan, XY (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China.	xyguan@hku.hk	Huang, Jun/J-7002-2015; Luk, John/A-4085-2008; /A-3639-2009	Huang, Jun/0000-0002-1891-8237; Luk, John/0000-0002-6323-7940; /0000-0003-1874-9805; Chen, Polly Leilei/0000-0002-1987-3878; Yuan, Yunfei/0000-0003-2467-3683	National Basic Research Program of China [2012CB967000]; National Natural Science Foundation of China [30971606, 30772475]; Hong Kong Research Grant Council Collaborative Research Fund [HKBU5/CRG/10]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Research Grant Council Collaborative Research Fund	This work was supported by the National Basic Research Program of China (2012CB967000), grants from National Natural Science Foundation of China (30971606 and 30772475) and Hong Kong Research Grant Council Collaborative Research Fund (HKBU5/CRG/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Fu JL, 2007, GASTROENTEROLOGY, V132, P2328, DOI 10.1053/j.gastro.2007.03.102; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kortylewski M, 2009, CANCER CELL, V15, P114, DOI 10.1016/j.ccr.2008.12.018; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Langrish CL, 2004, IMMUNOL REV, V202, P96, DOI 10.1111/j.0105-2896.2004.00214.x; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021816; Littlepage LE, 2010, CANCER RES, V70, P2224, DOI 10.1158/0008-5472.CAN-09-3515; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Tang DJ, 2010, HEPATOLOGY, V51, P1255, DOI 10.1002/hep.23451; Teng MWL, 2010, P NATL ACAD SCI USA, V107, P8328, DOI 10.1073/pnas.1003251107; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang P, 2009, HEPATOL RES, V39, P1169, DOI 10.1111/j.1872-034X.2009.00563.x	16	30	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46264	10.1371/journal.pone.0046264	http://dx.doi.org/10.1371/journal.pone.0046264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050001	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100172
J	Zhang, ZZ; Xu, GL; Liu, DZ; Fan, XY; Zhu, WS; Liu, XF				Zhang, Zhizhong; Xu, Gelin; Liu, Dezhi; Fan, Xinying; Zhu, Wusheng; Liu, Xinfeng			Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism Contributes to Ischemic Stroke Risk: A Meta-Analysis of 50 Case-Control Studies	PLOS ONE			English	Article							ACE I/D POLYMORPHISM; SILENT BRAIN INFARCTION; GENE POLYMORPHISM; DELETION POLYMORPHISM; CEREBROVASCULAR-DISEASE; CEREBRAL INFARCTION; ALDOSTERONE SYSTEM; VESSEL DISEASE; IN-VIVO; ASSOCIATION	Background: Many studies have investigated the association between the angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism and risk of ischemic stroke. However, the evidence is inadequate to draw robust conclusions because most studies were generally small and conducted in heterogeneous populations. To shed light on these inconclusive findings, we conducted a large meta-analysis of studies relating the ACE I/D polymorphism to the risk of ischemic stroke. Methods: Relevant studies were identified by searching PubMed and Embase through February 2012 and by reviewing the references of retrieved articles. We included studies that reported odds ratio (OR) with 95% confidence interval (CI) for the association between this polymorphism and ischemic stroke risk. Results: Fifty independent publications, with 10 070 stroke cases and 22 103 controls, were included. The results indicated that the DD homozygote carriers had a 37% higher risk of ischemic stroke when compared with the homozygotes II and heterozygote ID [odds ratio (OR) = 1.37, 95% confidence interval (CI): 1.22-1.53]. Subgroup analyses indicated that this higher risk was more pronounced among Asians, hospital-based studies, and small vessel disease (SVD). Potential publication bias may exist, but correction for this bias using a formal statistical method did not materially alter the combined risk estimate. Conclusion: The results of our meta-analysis indicate that the D allele of ACE I/D polymorphism is a low-penetrance susceptibility marker of ischemic stroke.	[Zhang, Zhizhong; Xu, Gelin; Liu, Dezhi; Fan, Xinying; Zhu, Wusheng; Liu, Xinfeng] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China	Nanjing University	Liu, XF (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurol, Nanjing, Jiangsu, Peoples R China.	xfliu2@yahoo.com.cn		Xu, Gelin/0000-0002-6194-0341	National Natural Science Foundation of China [31200938, 31171016, 81070922, 81171099]; Natural Science Foundation of Jiangsu Province [BK2011021]; Natural Science Foundation of Jinling Hospital [2012009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Jinling Hospital	This study was supported by National Natural Science Foundation of China (31200938, 31171016, 81070922, 81171099), Natural Science Foundation of Jiangsu Province (BK2011021), and Natural Science Foundation of Jinling Hospital (2012009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AgerholmLarsen B, 1997, ANN INTERN MED, V127, P346, DOI 10.7326/0003-4819-127-5-199709010-00002; Ariyaratnam R, 2007, PLOS MED, V4, P728, DOI 10.1371/journal.pmed.0040131; Banerjee I, 2007, J HUM GENET, V52, P205, DOI 10.1007/s10038-006-0098-x; Bentley P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009136; Bonita R, 2004, LANCET NEUROL, V3, P391, DOI 10.1016/S1474-4422(04)00800-2; Brenner D, 2005, ANN NEUROL, V58, P131, DOI 10.1002/ana.20537; Casas JP, 2004, ARCH NEUROL-CHICAGO, V61, P1652, DOI 10.1001/archneur.61.11.1652; Catto A, 1996, STROKE, V27, P435, DOI 10.1161/01.STR.27.3.435; Celiker G, 2009, CLIN APPL THROMB-HEM, V15, P415, DOI 10.1177/1076029608315163; Chutinet A, 2011, J STROKE CEREBROVASC; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; DANSER AHJ, 1995, CIRCULATION, V92, P1387, DOI 10.1161/01.CIR.92.6.1387; Dikmen M, 2006, ARQ NEURO-PSIQUIAT, V64, P211; Doi Y, 1997, ATHEROSCLEROSIS, V132, P145, DOI 10.1016/S0021-9150(97)00080-4; Domingues-Montanari S, 2010, EUR J NEUROL, V17, P1390, DOI 10.1111/j.1468-1331.2010.03022.x; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Gao XG, 2006, NEUROSCI LETT, V398, P172, DOI 10.1016/j.neulet.2005.12.078; Gawel B, 2007, UDAR MOZGU PROBLEMY, V9, P8; Gormley K, 2007, CEREBROVASC DIS, V23, P148, DOI 10.1159/000097052; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hong SH, 2008, ACTA NEUROL SCAND, V117, P244, DOI 10.1111/j.1600-0404.2007.00932.x; Indrajaya Taufik, 2011, Acta Med Indones, V43, P152; Ioannidis JPA, 2001, P NATL ACAD SCI USA, V98, P831, DOI 10.1073/pnas.021529998; Jiang X, 2009, J HUM HYPERTENS, V23, P176, DOI 10.1038/jhh.2008.123; Juo SHH, 2009, FRONT BIOSCI-LANDMRK, V14, P4525, DOI 10.2741/3545; Kalita J, 2011, CLIN CHIM ACTA, V412, P642, DOI 10.1016/j.cca.2010.12.022; Karagiannis A, 2004, EUR NEUROL, V51, P148, DOI 10.1159/000077203; Kario K, 1996, CIRCULATION, V93, P1630, DOI 10.1161/01.CIR.93.9.1630; Kim S, 2000, PHARMACOL REV, V52, P11; Kostulas K, 1999, EUR J CLIN INVEST, V29, P478, DOI 10.1046/j.1365-2362.1999.00476.x; Lalouschek W, 2007, CLIN CHEM, V53, P600, DOI 10.1373/clinchem.2006.073494; LAU J, 1992, NEW ENGL J MED, V327, P248, DOI 10.1056/NEJM199207233270406; Li Cai-ming, 2007, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V29, P359; Li Y, 2010, PHARMACOGENET GENOM, V20, P298, DOI 10.1097/FPC.0b013e328338f54f; Lin JJ, 2000, J FORMOS MED ASSOC, V99, P895; Margaglione M, 1996, ARTERIOSCL THROM VAS, V16, P304, DOI 10.1161/01.ATV.16.2.304; Markoula S, 2011, J RENIN-ANGIO-ALDO S, V12, P510, DOI 10.1177/1470320310391333; Moellsten A, 2008, J HYPERTENS, V26, P1367, DOI 10.1097/HJH.0b013e3282fe1d55; MORISHITA R, 1994, J CLIN INVEST, V94, P978, DOI 10.1172/JCI117464; Munshi A, 2008, J NEUROL SCI, V272, P132, DOI 10.1016/j.jns.2008.05.017; Nakata Y, 1997, AM J HYPERTENS, V10, P1391, DOI 10.1016/S0895-7061(97)00315-4; Notsu Y, 1999, STROKE, V30, P1881, DOI 10.1161/01.STR.30.9.1881; Ohkubo R, 2002, J NEUROL SCI, V198, P31, DOI 10.1016/S0022-510X(02)00055-2; Pera J, 2006, ACTA NEUROL SCAND, V114, P320, DOI 10.1111/j.1600-0404.2006.00672.x; Pfohl M, 1998, ATHEROSCLEROSIS, V140, P161, DOI 10.1016/S0021-9150(98)00100-2; PITT B, 1994, AM HEART J, V128, P1328, DOI 10.1016/0002-8703(94)90255-0; Polupanov A, 2007, TURK KARDIYOL DERN A, V35, P347; Rao R, 2009, EUR NEUROL, V61, P76, DOI 10.1159/000177939; RAYNOLDS MV, 1993, LANCET, V342, P1073, DOI 10.1016/0140-6736(93)92061-W; RIDKER PM, 1993, CIRCULATION, V87, P1969, DOI 10.1161/01.CIR.87.6.1969; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Rubattu S, 2004, J HYPERTENS, V22, P2129, DOI 10.1097/00004872-200411000-00015; Saidi S, 2009, J THROMB THROMBOLYS, V27, P68, DOI 10.1007/s11239-007-0165-y; Seino Y, 1998, J THROMB THROMBOLYS, V5, P263, DOI 10.1023/A:1008804211738; Sharma P, 1996, J HYPERTENS, V14, P277, DOI 10.1097/00004872-199603000-00002; SHARMA P, 1994, J HUM HYPERTENS, V8, P645; Sharma P, 1998, J NEUROL NEUROSUR PS, V64, P227, DOI 10.1136/jnnp.64.2.227; Shen D, 1998, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V15, P136; Szolnoki Z, 2003, J NEUROL NEUROSUR PS, V74, P1615, DOI 10.1136/jnnp.74.12.1615; Tascilar N, 2009, J NEUROL SCI, V285, P137, DOI 10.1016/j.jns.2009.06.016; Tseng CH, 2007, EUR J CLIN INVEST, V37, P483, DOI 10.1111/j.1365-2362.2007.01813.x; Tuncer N, 2006, J CLIN NEUROSCI, V13, P224, DOI 10.1016/j.jocn.2005.08.005; Ueda S, 1995, J HYPERTENS, V13, P1597; Um JY, 2003, HEREDITAS, V138, P166, DOI 10.1034/j.1601-5223.2003.01605.x; Wang Yi-ming, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P156; Wei X, 2000, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V17, P256; Xu XW, 2008, CEREBROVASC DIS, V26, P48, DOI 10.1159/000135653; XU Y, 1998, CHIN J NEUROL, V31, P152; Yuan Xiao-dong, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P822; Zee RYL, 1999, CIRCULATION, V99, P340, DOI 10.1161/01.CIR.99.3.340; Zhang JH, 2004, CEREBROVASC DIS, V17, P273, DOI 10.1159/000077337; Zhang X, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P462; Zhang X, 2001, Zhonghua Liu Xing Bing Xue Za Zhi, V22, P435	73	46	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46495	10.1371/journal.pone.0046495	http://dx.doi.org/10.1371/journal.pone.0046495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049705	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388500032
J	Harper, EM; Clark, MS; Hoffman, JI; Philipp, EER; Peck, LS; Morley, SA				Harper, Elizabeth M.; Clark, Melody S.; Hoffman, Joseph I.; Philipp, Eva E. R.; Peck, Lloyd S.; Morley, Simon A.			Iceberg Scour and Shell Damage in the Antarctic Bivalve Laternula elliptica	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; BLUE MUSSEL; OCEAN; CLAM; KING; TEMPERATURE; GROWTH; CALCIFICATION; DISSOLUTION; DIVERSITY	We document differences in shell damage and shell thickness in a bivalve mollusc (Laternula elliptica) from seven sites around Antarctica with differing exposures to ice movement. These range from 60% of the sea bed impacted by ice per year (Hangar Cove, Antarctic Peninsula) to those protected by virtually permanent sea ice cover (McMurdo Sound). Patterns of shell damage consistent with blunt force trauma were observed in populations where ice scour frequently occurs; damage repair frequencies and the thickness of shells correlated positively with the frequency of iceberg scour at the different sites with the highest repair rates and thicker shells at Hangar Cove (74.2% of animals damaged) compared to the other less impacted sites (less than 10% at McMurdo Sound). Genetic analysis of population structure using Amplified Fragment Length Polymorphisms (AFLPs) revealed no genetic differences between the two sites showing the greatest difference in shell morphology and repair rates. Taken together, our results suggest that L. elliptica exhibits considerable phenotypic plasticity in response to geographic variation in physical disturbance.	[Harper, Elizabeth M.] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Clark, Melody S.; Peck, Lloyd S.; Morley, Simon A.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Hoffman, Joseph I.] Univ Cambridge, Dept Zool, Cambridge CB2 3EQ, England; [Philipp, Eva E. R.] Univ Kiel, Inst Clin Mol Biol, Kiel, Germany	University of Cambridge; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Cambridge; University of Kiel	Harper, EM (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	emh21@cam.ac.uk	Harper, Elizabeth M/B-3890-2008; Clark, Melody S/D-7371-2014; Hoffman, Joseph i/K-7725-2012	Harper, Elizabeth M/0000-0002-1092-3867; Clark, Melody S/0000-0002-3442-3824; Hoffman, Joseph i/0000-0001-5895-8949	British Antarctic Survey Polar Science for Planet Earth Progamme, Adaptation and Physiology Work Package; Natural Environment Research Council (NERC) British Antarctic Survey (BAS) Strategic Alliance Fellowship; University of Bremen; Natural Environment Research Council [bas0100025, dml011000] Funding Source: researchfish; NERC [bas0100025, dml011000] Funding Source: UKRI	British Antarctic Survey Polar Science for Planet Earth Progamme, Adaptation and Physiology Work Package; Natural Environment Research Council (NERC) British Antarctic Survey (BAS) Strategic Alliance Fellowship; University of Bremen; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was not part of any specific grant but as part of a general research programme between the University of Cambridge and the British Antarctic Survey. SAM, LSP and MSC were supported by the British Antarctic Survey Polar Science for Planet Earth Progamme, Adaptation and Physiology Work Package. JH was supported by a Natural Environment Research Council (NERC) British Antarctic Survey (BAS) Strategic Alliance Fellowship. During the sampling period of the Jubany specimens EP was supported by a PhD scholarship from the University of Bremen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn IY, 1996, MAR POLLUT BULL, V32, P592, DOI 10.1016/0025-326X(95)00247-K; AHN IY, 1993, J EXP MAR BIOL ECOL, V171, P75, DOI 10.1016/0022-0981(93)90141-A; Ansell AD, 1997, J MOLLUS STUD, V63, P285, DOI 10.1093/mollus/63.2.285; APPLETON RD, 1988, P NATL ACAD SCI USA, V85, P4387, DOI 10.1073/pnas.85.12.4387; ARNAUD P M, 1973, Tethys, V5, P549; ARNTZ WE, 1994, OCEANOGR MAR BIOL, V32, P241; Aronson RB, 2007, ANNU REV ECOL EVOL S, V38, P129, DOI 10.1146/annurev.ecolsys.38.091206.095525; Barnes DKA, 2011, NAT CLIM CHANGE, V1, P365, DOI 10.1038/NCLIMATE1232; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; BOND G, 1992, NATURE, V360, P245, DOI 10.1038/360245a0; Brandvik PJ, 2009, COLD REG SCI TECHNOL, V55, P160, DOI 10.1016/j.coldregions.2008.06.006; Brey T, 1997, POLAR BIOL, V17, P465, DOI 10.1007/s003000050143; Brown KM, 2004, OECOLOGIA, V141, P121, DOI 10.1007/s00442-004-1648-6; Cadee GC, 1999, J SEA RES, V41, P149, DOI 10.1016/S1385-1101(98)00042-2; CHECA A, 1993, PALAEOGEOGR PALAEOCL, V100, P309, DOI 10.1016/0031-0182(93)90061-M; Cintra-Buenrostro CE, 2007, J SHELLFISH RES, V26, P221, DOI 10.2983/0730-8000(2007)26[221:TPANMA]2.0.CO;2; Clark MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-362; Clarke A., 1990, P9; Clarke A, 2004, ANTARCT SCI, V16, P559, DOI 10.1017/S0954102004002329; Conlan KE, 1998, MAR ECOL PROG SER, V166, P1, DOI 10.3354/meps166001; CROWL TA, 1990, SCIENCE, V247, P949, DOI 10.1126/science.247.4945.949; Cummings V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016069; Day EG, 2000, J EXP MAR BIOL ECOL, V243, P185, DOI 10.1016/S0022-0981(99)00120-3; De Wolf H, 1998, MAR ECOL PROG SER, V163, P155, DOI 10.3354/meps163155; Denny MW, 2010, ANNU REV MAR SCI, V2, P89, DOI 10.1146/annurev-marine-120308-081011; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; GASPAR MB, 1994, J MAR BIOL ASSOC UK, V74, P927, DOI 10.1017/S0025315400090159; GRAUS RR, 1974, LETHAIA, V7, P303, DOI 10.1111/j.1502-3931.1974.tb00906.x; Guerra C, 2012, AQUAC RES, V43, P756, DOI 10.1111/j.1365-2109.2011.02885.x; Harley CDG, 2009, FUNCT ECOL, V23, P292, DOI 10.1111/j.1365-2435.2008.01496.x; Hoffman JI, 2012, POLAR BIOL, V35, P919, DOI 10.1007/s00300-011-1139-2; Hoffman JI, 2011, MAR BIOL, V158, P287, DOI 10.1007/s00227-010-1558-6; Hoffman JI, 2010, MAR BIOL, V157, P765, DOI 10.1007/s00227-009-1360-5; Hoffman JI, 2011, J HERED, V102, P55, DOI 10.1093/jhered/esq094; Holsinger KE, 2002, MOL ECOL, V11, P1157, DOI 10.1046/j.1365-294X.2002.01512.x; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kaehler S, 1999, MAR BIOL, V135, P497, DOI 10.1007/s002270050650; Kowalewski M., 2002, PALEONTOLOGICAL SOC, V8, P1; Leonard GH, 1999, ECOLOGY, V80, P1; Lesser MP, 2010, COMP BIOCHEM PHYS A, V156, P541, DOI 10.1016/j.cbpa.2010.04.012; Lomovasky BJ, 2005, J SEA RES, V54, P163, DOI 10.1016/j.seares.2005.01.004; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Marshall DJ, 2008, MAR ENVIRON RES, V66, P422, DOI 10.1016/j.marenvres.2008.07.003; Maughan PJ, 1996, THEOR APPL GENET, V93, P392, DOI 10.1007/BF00223181; McClintock JB, 2009, ANTARCT SCI, V21, P449, DOI 10.1017/S0954102009990198; McNeil BI, 2008, P NATL ACAD SCI USA, V105, P18860, DOI 10.1073/pnas.0806318105; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; PALMER AR, 1992, P NATL ACAD SCI USA, V89, P1379, DOI 10.1073/pnas.89.4.1379; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Peck LS, 2007, OECOLOGIA, V154, P479, DOI 10.1007/s00442-007-0858-0; Peck LS, 2004, POLAR BIOL, V27, P357, DOI 10.1007/s00300-003-0588-7; Philipp E, 2005, MECH AGEING DEV, V126, P598, DOI 10.1016/j.mad.2004.12.003; Philipp EER, 2011, ANTARCT SCI, V23, P127, DOI 10.1017/S0954102010000970; RALPH R, 1977, MAR BIOL, V42, P171, DOI 10.1007/BF00391569; Rodrigues Edson, 2007, Oecologia Brasiliensis, V11, P37; SHANKS AL, 1986, OECOLOGIA, V69, P420, DOI 10.1007/BF00377065; Teske PR, 2007, J MOLLUS STUD, V73, P223, DOI 10.1093/mollus/eym012; Trussell GC, 2002, ECOLOGY, V83, P1635, DOI 10.2307/3071984; VEKEMANS X, 2002, AFLP SURV VERSION 1; Vermeij G.J., 1978, BIOGEOGRAPHY ADAPTAT; Vermeij G.J, 1987, EVOLUTION ESCALATION; Watson S., 2009, THESIS U SOUTHAMPTON; Watson SA, 2012, GLOBAL CHANGE BIOL, V18, P3026, DOI 10.1111/j.1365-2486.2012.02755.x; Whitlow WL, 2010, MAR ECOL-EVOL PERSP, V31, P418, DOI 10.1111/j.1439-0485.2009.00350.x; Wilk J, 2009, MAR BIOL RES, V5, P155, DOI 10.1080/17451000802279644; ZAMORANO JH, 1986, POLAR BIOL, V6, P139, DOI 10.1007/BF00274876; Zieritz A, 2010, EVOL ECOL, V24, P923, DOI 10.1007/s10682-009-9350-0	67	43	44	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46341	10.1371/journal.pone.0046341	http://dx.doi.org/10.1371/journal.pone.0046341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029484	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000309973900137
J	Liu, DS; Shi, LD; Han, CG; Yu, JL; Li, DW; Zhang, YL				Liu, Deshui; Shi, Lindan; Han, Chenggui; Yu, Jialin; Li, Dawei; Zhang, Yongliang			Validation of Reference Genes for Gene Expression Studies in Virus-Infected Nicotiana benthamiana Using Quantitative Real-Time PCR	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; DEPENDENT RNA-POLYMERASE; RETRACTED ARTICLE. SEE; TOBACCO RATTLE VIRUS; COWPEA-MOSAIC-VIRUS; RT-PCR; PROTEIN INTERACTIONS; HOUSEKEEPING GENES; INTERNAL CONTROL; VIRAL-INFECTION	Nicotiana benthamiana is the most widely-used experimental host in plant virology. The recent release of the draft genome sequence for N. benthamiana consolidates its role as a model for plant-pathogen interactions. Quantitative real-time PCR (qPCR) is commonly employed for quantitative gene expression analysis. For valid qPCR analysis, accurate normalisation of gene expression against an appropriate internal control is required. Yet there has been little systematic investigation of reference gene stability in N. benthamiana under conditions of viral infections. In this study, the expression profiles of 16 commonly used housekeeping genes (GAPDH, 18S, EF1 alpha, SAMD, L23, UK, PP2A, APR, UBI3, SAND, ACT, TUB, GBP, F-BOX, PPR and TIP41) were determined in N. benthamiana and those with acceptable expression levels were further selected for transcript stability analysis by qPCR of complementary DNA prepared from N. benthamiana leaf tissue infected with one of five RNA plant viruses (Tobacco necrosis virus A, Beet black scorch virus, Beet necrotic yellow vein virus, Barley stripe mosaic virus and Potato virus X). Gene stability was analysed in parallel by three commonly-used dedicated algorithms: geNorm, NormFinder and BestKeeper. Statistical analysis revealed that the PP2A, F-BOX and L23 genes were the most stable overall, and that the combination of these three genes was sufficient for accurate normalisation. In addition, the suitability of PP2A, F-BOX and L23 as reference genes was illustrated by expression-level analysis of AGO2 and RdR6 in virus-infected N. benthamiana leaves. This is the first study to systematically examine and evaluate the stability of different reference genes in N. benthamiana. Our results not only provide researchers studying these viruses a shortlist of potential housekeeping genes to use as normalisers for qPCR experiments, but should also guide the selection of appropriate reference genes for gene expression studies of N. benthamiana under other biotic and abiotic stress conditions.	[Liu, Deshui; Shi, Lindan; Han, Chenggui; Yu, Jialin; Li, Dawei; Zhang, Yongliang] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China	China Agricultural University	Zhang, YL (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, Beijing 100094, Peoples R China.	cauzhangyl@cau.edu.cn	Li, Dawei/CAJ-5076-2022; Li, Dawei/I-8751-2016; Zhang, Yongliang/AAE-7639-2021	Li, Dawei/0000-0003-4133-1263; Zhang, Yongliang/0000-0002-6790-1044	National Natural Science Foundation of China [31100115, 30730006]; Fundamental Research Funds for the Central Universities of China [2010JS074]; earmarked Fund for China Agricultural Research System [CARS-210202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); earmarked Fund for China Agricultural Research System	This work was supported partly by the National Natural Science Foundation of China (Grant No. 31100115 and 30730006), the Fundamental Research Funds for the Central Universities of China (Grant No. 2010JS074) and an earmarked Fund for China Agricultural Research System (CARS-210202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2007, MOL PLANT MICROBE IN, V20, P41, DOI 10.1094/MPMI-20-0041; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aranda MA, 1996, P NATL ACAD SCI USA, V93, P15289, DOI 10.1073/pnas.93.26.15289; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Beauchemin C, 2007, J VIROL, V81, P775, DOI 10.1128/JVI.01277-06; Becker A, 2010, TRENDS PLANT SCI, V15, P1, DOI 10.1016/j.tplants.2009.09.002; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Castro P, 2012, MOL BREEDING, V29, P261, DOI 10.1007/s11032-010-9544-8; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Dean JD, 2002, PLANT MOL BIOL REP, V20, P347, DOI 10.1007/BF02772122; Demidenko NV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019434; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Dong Y, 2007, PLANT PHYSIOL, V145, P1161, DOI 10.1104/pp.107.107391; Godge MR, 2008, PLANT CELL REP, V27, P209, DOI 10.1007/s00299-007-0460-2; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; GRIMSLEY N, 1986, P NATL ACAD SCI USA, V83, P3282, DOI 10.1073/pnas.83.10.3282; Guenin S, 2009, J EXP BOT, V60, P487, DOI 10.1093/jxb/ern305; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Harvey JJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014639; Hefferon K. L., 2011, Current Topics in Virology, Volume 9, P61; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jarosova J, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-146; Jaubert M, 2011, PLANT PHYSIOL, V156, P1556, DOI 10.1104/pp.111.178012; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Kumar V, 2011, AUST J CROP SCI, V5, P1455; Lee JM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-8; LEISER RM, 1992, P NATL ACAD SCI USA, V89, P9136, DOI 10.1073/pnas.89.19.9136; Li HP, 2011, PLANT SCI, V181, P132, DOI 10.1016/j.plantsci.2011.04.014; Li J, 2008, CHINESE SCI BULL, V53, P1682, DOI 10.1007/s11434-008-0204-x; Lico C, 2008, J CELL PHYSIOL, V216, P366, DOI 10.1002/jcp.21423; Lilly ST, 2011, MOL PLANT MICROBE IN, V24, P294, DOI 10.1094/MPMI-10-10-0236; Liu EW, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-5; Liu L, 2002, J VIROL METHODS, V105, P343, DOI 10.1016/S0166-0934(02)00121-0; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Lu R, 2003, EMBO J, V22, P5690, DOI 10.1093/emboj/cdg546; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Mascia T, 2010, MOL PLANT PATHOL, V11, P805, DOI [10.1111/j.1364-3703.2010.00646.x, 10.1111/j.1365-3059.2009.02239.x]; Miranda GJ, 2000, VIROLOGY, V266, P26, DOI 10.1006/viro.1999.0068; Moissiard G, 2004, MOL PLANT PATHOL, V5, P71, DOI 10.1111/j.1364-3703.2004.00207.x; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Nomura K, 2006, SCIENCE, V313, P220, DOI 10.1126/science.1129523; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pineda M, 2010, PHOTOSYNTH RES, V103, P31, DOI 10.1007/s11120-009-9499-y; Purkayastha A, 2009, PLANT PHYSIOL BIOCH, V47, P967, DOI 10.1016/j.plaphy.2009.09.001; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Ren B, 2010, J VIROL, V84, P12914, DOI 10.1128/JVI.00864-10; Robertson D, 2004, ANNU REV PLANT BIOL, V55, P495, DOI 10.1146/annurev.arplant.55.031903.141803; Rotenberg D, 2006, J VIROL METHODS, V138, P49, DOI 10.1016/j.jviromet.2006.07.017; Sainsbury F, 2010, ANNU REV PHYTOPATHOL, V48, P437, DOI 10.1146/annurev-phyto-073009-114242; Sambrook J., 2001, MOL CLONING LAB MANU; Scholthof HB, 2011, PLANT PHYSIOL, V156, P1548, DOI 10.1104/pp.111.178764; Senthil G, 2005, J GEN VIROL, V86, P2615, DOI 10.1099/vir.0.81043-0; Senthil-Kumar M, 2007, NEW PHYTOL, V176, P782, DOI 10.1111/j.1469-8137.2007.02225.x; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; Takahashi Y, 2007, PLANT J, V49, P1030, DOI 10.1111/j.1365-313X.2006.03022.x; Tu LL, 2007, CHINESE SCI BULL, V52, P3110, DOI 10.1007/s11434-007-0461-0; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vaghchhipawala Z, 2011, METHODS MOL BIOL, V678, P65, DOI 10.1007/978-1-60761-682-5_6; Vaistij FE, 2009, PLANT PHYSIOL, V149, P1399, DOI 10.1104/pp.108.132688; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Walter M, 2004, PLANT J, V40, P428, DOI 10.1111/j.1365-313X.2004.02219.x; Wan HJ, 2010, ANAL BIOCHEM, V399, P257, DOI 10.1016/j.ab.2009.12.008; Wang AM, 2012, MOLECULAR FARMING IN PLANTS: RECENT ADVANCES AND FUTURE PROSPECTS, P199, DOI 10.1007/978-94-007-2217-0_10; Wang Y, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-335; Wang ZH, 2003, VIRUS GENES, V27, P163, DOI 10.1023/A:1025776527286; Watson S, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-130; Wood AJ, 2000, J EXP BOT, V51, P1655, DOI 10.1093/jexbot/51.351.1655; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101; Ying XB, 2010, PLANT CELL, V22, P1358, DOI 10.1105/tpc.109.072058; Yuan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026468; Yuan XF, 2006, J GEN VIROL, V87, P3077, DOI 10.1099/vir.0.81928-0; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zhang YJ, 2011, VIRUS RES, V155, P307, DOI 10.1016/j.virusres.2010.10.029; Zhou B, 2010, VACCINE, V28, P6021, DOI 10.1016/j.vaccine.2010.06.094	93	223	229	4	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46451	10.1371/journal.pone.0046451	http://dx.doi.org/10.1371/journal.pone.0046451			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029521	gold, Green Submitted, Green Published			2022-12-27	WOS:000309973900162
J	Mallegol, J; Duncan, C; Prashar, A; So, J; Low, DE; Terebeznik, M; Guyard, C				Mallegol, Julia; Duncan, Carla; Prashar, Akriti; So, Jannice; Low, Donald E.; Terebeznik, Mauricio; Guyard, Cyril			Essential Roles and Regulation of the Legionella pneumophila Collagen-Like Adhesin during Biofilm Formation	PLOS ONE			English	Article							AUTOINDUCER SYNTHASE LQSA; GRAM-NEGATIVE BACTERIA; PSEUDOMONAS-AERUGINOSA; LEGIONNAIRES-DISEASE; ESCHERICHIA-COLI; FLOATING BIOFILMS; CYSTIC-FIBROSIS; VIBRIO-CHOLERAE; WATER; REPLICATION	Legionellosis is mostly caused by Legionella pneumophila (Lp) and is defined by a severe respiratory illness with a case fatality rate ranging from 5 to 80%. In a previous study, we showed that a glycosaminoglycan (GAG)-binding adhesin of Lp, named Lcl, is produced during legionellosis and is unique to the L. pneumophila species. Importantly, a mutant depleted in Lcl (Delta lpg2644) is impaired in adhesion to GAGs and epithelial cells and in biofilm formation. Here, we examine the molecular function(s) of Lcl and the transcriptional regulation of its encoding gene during different stages of the biofilm development. We show that the collagen repeats and the C-terminal domains of Lcl are crucial for the production of biofilm. We present evidence that Lcl is involved in the early step of surface attachment but also in intercellular interactions. Furthermore, we address the relationship between Lcl gene regulation during biofilm formation and quorum sensing (QS). In a static biofilm assay, we show that Lcl is differentially regulated during growth phases and biofilm formation. Moreover, we show that the transcriptional regulation of lpg2644, mediated by a prototype of QS signaling homoserine lactone (3OC12-HSL), may play a role during the biofilm development. Thus, transcriptional down-regulation of lpg2644 may facilitate the dispersion of Lp to reinitiate biofilm colonization on a distal surface.	[Mallegol, Julia; Duncan, Carla; So, Jannice; Low, Donald E.; Guyard, Cyril] OAHPP, Toronto, ON, Canada; [Mallegol, Julia; So, Jannice; Low, Donald E.; Guyard, Cyril] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mallegol, Julia; Low, Donald E.; Guyard, Cyril] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Prashar, Akriti; Terebeznik, Mauricio] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Scarborough	Guyard, C (corresponding author), OAHPP, Toronto, ON, Canada.	cyril.guyard@oahpp.ca		, cyril/0000-0002-2721-0097; Prashar, Akriti/0000-0002-1320-362X	Ontario Agency for Health protection and Promotion; Canadian Institutes of Health Research [MOP-102514]; Natural Sciences and Engineering Research Council of Canada; Ontario Association of Medical Laboratories grants	Ontario Agency for Health protection and Promotion; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Association of Medical Laboratories grants	This work was supported by the Ontario Agency for Health protection and Promotion (http://www.oahpp.ca/) and the Canadian Institutes of Health Research (MOP-102514) (http://www.cihr-irsc.gc.ca/). AP and MT are supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) and the Ontario Association of Medical Laboratories grants (http://www.oaml.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002210; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Bartram Jamie, 2007, P1; Bassler BL, 2002, CELL, V109, P421, DOI 10.1016/S0092-8674(02)00749-3; Benin AL, 2002, CLIN INFECT DIS, V35, P1039, DOI 10.1086/342903; BERGER KH, 1993, MOL MICROBIOL, V7, P7, DOI 10.1111/j.1365-2958.1993.tb01092.x; Bijtenhoorn P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026278; Byrne B, 1998, INFECT IMMUN, V66, P3029, DOI 10.1128/IAI.66.7.3029-3034.1998; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Carlson HK, 2010, MOL MICROBIOL; Cooper IR, 2010, J HOSP INFECT, V74, P152, DOI 10.1016/j.jhin.2009.07.005; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; De Buck E, 2005, BIOCHEM BIOPH RES CO, V331, P1413, DOI 10.1016/j.bbrc.2005.04.060; DebRoy S, 2006, P NATL ACAD SCI USA, V103, P19146, DOI 10.1073/pnas.0608279103; Declerck P, 2007, CURR MICROBIOL, V55, P435, DOI 10.1007/s00284-007-9006-7; Declerck P, 2007, WATER RES, V41, P3159, DOI 10.1016/j.watres.2007.04.011; Declerck P, 2009, MICROBIOL RES, V164, P593, DOI 10.1016/j.micres.2007.06.001; Duncan C, 2011, INFECT IMMUN, V79, P2168, DOI 10.1128/IAI.01304-10; Dunne WM, 2002, J CLIN MICROBIOL, V40, P3889, DOI 10.1128/JCM.40.11.3889-3893.2002; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Fishov I, 1999, MOL MICROBIOL, V32, P1166, DOI 10.1046/j.1365-2958.1999.01425.x; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; FLIERMANS CB, 1981, APPL ENVIRON MICROB, V41, P9, DOI 10.1128/AEM.41.1.9-16.1981; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Heilmann C, 2004, J INFECT DIS, V190, P321, DOI 10.1086/421914; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Hentzer M, 2003, BIODRUGS, V17, P241, DOI 10.2165/00063030-200317040-00003; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; Hilbi H, 2010, MOL MICROBIOL, V76, P1, DOI 10.1111/j.1365-2958.2010.07086.x; Hindre T, 2008, MICROBIOL-SGM, V154, P30, DOI 10.1099/mic.0.2007/008698-0; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Juhas M, 2005, ENVIRON MICROBIOL, V7, P459, DOI 10.1111/j.1462-2920.2005.00769.x; Kimura S, 2009, MICROBIOL-SGM, V155, P1934, DOI 10.1099/mic.0.026641-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau HY, 2009, J APPL MICROBIOL, V107, P368, DOI 10.1111/j.1365-2672.2009.04208.x; LUCK CP, 2009, INT J SYST EVOL MICR; Mampel J, 2006, APPL ENVIRON MICROB, V72, P2885, DOI 10.1128/AEM.72.4.2885-2895.2006; Miller MB, 2002, CELL, V110, P303, DOI 10.1016/S0092-8674(02)00829-2; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Molofsky AB, 2003, MOL MICROBIOL, V50, P445, DOI 10.1046/j.1365-2958.2003.03706.x; Murga R, 2001, MICROBIOL-SGM, V147, P3121, DOI 10.1099/00221287-147-11-3121; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; Piao ZY, 2006, APPL ENVIRON MICROB, V72, P1613, DOI 10.1128/AEM.72.2.1613-1622.2006; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Richards JJ, 2009, CHEMBIOCHEM, V10, P2287, DOI 10.1002/cbic.200900317; Shiner EK, 2005, FEMS MICROBIOL REV, V29, P935, DOI 10.1016/j.femsre.2005.03.001; Shrout JD, 2012, ENVIRON SCI TECHNOL, V46, P1995, DOI 10.1021/es203933h; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Spirig T, 2008, J BIOL CHEM, V283, P18113, DOI 10.1074/jbc.M801929200; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Stoodley P, 2002, J IND MICROBIOL BIOT, V29, P361, DOI 10.1038/sj.jim.7000282; Stout JE, 1997, JAMA-J AM MED ASSOC, V278, P1404, DOI 10.1001/jama.278.17.1404; Tchesnokova V, 2010, MOL MICROBIOL, V76, P489, DOI 10.1111/j.1365-2958.2010.07116.x; Tiaden A, 2008, J BACTERIOL, V190, P7532, DOI 10.1128/JB.01002-08; Tiaden A, 2007, CELL MICROBIOL, V9, P2903, DOI 10.1111/j.1462-5822.2007.01005.x; Tiaden A, 2010, ENVIRON MICROBIOL, V12, P1243, DOI 10.1111/j.1462-2920.2010.02167.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ueda A, 2009, MICROB BIOTECHNOL, V2, P62, DOI 10.1111/j.1751-7915.2008.00060.x; Vandersmissen L, 2010, FEMS MICROBIOL LETT, V306, P168, DOI 10.1111/j.1574-6968.2010.01951.x; Vervaeren H, 2006, FEMS MICROBIOL ECOL, V58, P583, DOI 10.1111/j.1574-6941.2006.00181.x; Wood TK, 2009, ENVIRON MICROBIOL, V11, P1, DOI 10.1111/j.1462-2920.2008.01768.x; Yu VL, 2002, J INFECT DIS, V186, P127, DOI 10.1086/341087	65	19	20	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46462	10.1371/journal.pone.0046462	http://dx.doi.org/10.1371/journal.pone.0046462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029523	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900164
J	Kaakinen, M; Ducci, F; Sillanpaa, MJ; Laara, E; Jarvelin, MR				Kaakinen, Marika; Ducci, Francesca; Sillanpaa, Mikko J.; Laara, Esa; Jarvelin, Marjo-Riitta			Associations between Variation in CHRNA5-CHRNA3-CHRNB4, Body Mass Index and Blood Pressure in the Northern Finland Birth Cohort 1966	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NICOTINE DEPENDENCE; LUNG-CANCER; ENVIRONMENT INTERACTIONS; SUSCEPTIBILITY LOCUS; EUROPEAN-AMERICANS; PERMUTATION TESTS; GENE-ENVIRONMENT; HEAVY SMOKING; WHOLE-GENOME	Background: The CHRNA5-CHRNA3-CHRNB4 gene cluster on 15q25 has consistently been associated with smoking quantity, nicotine dependence and lung cancer. Recent research also points towards its involvement in cardiovascular homeostasis, but studies in large human samples are lacking, especially on the role of the gene cluster in blood pressure regulation. Methodology/Principal Findings: We studied the associations between 18 single nucleotide polymorphisms (SNPs) in CHRNA5-CHRNA3-CHRNB4 and systolic blood pressure (SBP), diastolic blood pressure (DBP), and body mass index (BMI) in 5402 young adults from the Northern Finland Birth Cohort 1966. We observed some evidence for associations between two SNPs and SBP and between six SNPs and BMI; the evidence for associations with DBP was weaker. The associations with the three phenotypes were driven by different loci with low linkage disequilibrium with each other. The associations appeared more pronounced in smokers, such that the smoking-increasing alleles would predict lower SBP and BMI. Each additional copy of the rs1948 G-allele and the rs950776 A-allele reduced SBP on average by -1.21 (95% CI -2.01, -0.40) mmHg in smokers. The variants associated with BMI included rs2036534, rs6495309, rs1996371, rs6495314, rs4887077 and rs11638372 and had an average effect size of -0.38 (-0.68, -0.08) kg/m(2) per an additional copy of the risk allele in smokers. Formal assessments of interactions provided weaker support for these findings, especially after adjustment for multiple testing. Conclusions: Variation at 15q25 appears to interact with smoking status in influencing SBP and BMI. The genetic loci associated with SBP were in low linkage disequilibrium with those associated with BMI suggesting that the gene cluster might regulate SBP through biological mechanisms that partly differ from those regulating BMI. Further studies in larger samples are needed for more precise evaluation of the possible interactions, and to understand the mechanisms behind.	[Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Ducci, Francesca] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Kaakinen, Marika; Sillanpaa, Mikko J.; Jarvelin, Marjo-Riitta] Bioctr Oulu, Oulu, Finland; [Ducci, Francesca] St Georges Univ London, Div Mental Hlth, London, England; [Sillanpaa, Mikko J.; Laara, Esa] Univ Oulu, Dept Math Sci, Oulu, Finland; [Sillanpaa, Mikko J.] Univ Oulu, Dept Biol, Oulu, Finland; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Life Course & Serv, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London, England	University of Oulu; University of London; King's College London; University of Oulu; St Georges University London; University of Oulu; University of Oulu; Finland National Institute for Health & Welfare; Imperial College London	Kaakinen, M (corresponding author), Univ Oulu, Inst Hlth Sci, Oulu, Finland.	marika.kaakinen@oulu.fi		Kaakinen, Marika/0000-0002-9228-0462; Sillanpaa, Mikko J./0000-0003-2808-2768; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	Academy of Finland {Center of Excellence in Complex Disease Genetics and Public Health Challenges Research Program (SALVE)] [104781, 120315, 129418]; University Hospital Oulu, Biocenter, University of Oulu, Finland [75617]; European Commission [QLG1-CT-2000-01643]; The National Heart, Lung and Blood Institute [5R01HL087679-02, 1RL1MH083268-01]; The National Institute of Health/The National Institute of Mental Health [5R01MH63706:02]; European Network of Genomic and Genetic Epidemiology (ENGAGE) project [HEALTH-F4-2007-201413]; Medical Research Council, UK [G0500539, G0600705]; Medical Research Council [G0600705, G0801056B] Funding Source: researchfish; MRC [G0600705] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RL1MH083268] Funding Source: NIH RePORTER	Academy of Finland {Center of Excellence in Complex Disease Genetics and Public Health Challenges Research Program (SALVE)]; University Hospital Oulu, Biocenter, University of Oulu, Finland; European Commission(European CommissionEuropean Commission Joint Research Centre); The National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); The National Institute of Health/The National Institute of Mental Health; European Network of Genomic and Genetic Epidemiology (ENGAGE) project; Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Academy of Finland [project grants 104781, 120315, 129418, Center of Excellence in Complex Disease Genetics and Public Health Challenges Research Program (SALVE)], University Hospital Oulu, Biocenter, University of Oulu, Finland (75617), the European Commission [EURO-BLCS, Framework 5 award QLG1-CT-2000-01643], The National Heart, Lung and Blood Institute [5R01HL087679-02] through the SNP Typing for Association with Multiple Phenotypes from Existing Epidemiologic Data (STAMPEED) program [1RL1MH083268-01], The National Institute of Health/The National Institute of Mental Health [5R01MH63706:02], European Network of Genomic and Genetic Epidemiology (ENGAGE) project and grant agreement [HEALTH-F4-2007-201413], and the Medical Research Council, UK [G0500539, G0600705, PrevMetSyn/Public Health Challenges Research Program (SALVE)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Audrain-McGovern J, 2011, CLIN PHARMACOL THER, V90, P164, DOI 10.1038/clpt.2011.105; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; Broms U, 2012, NICOTINE TOB RES, V14, P720, DOI 10.1093/ntr/ntr283; Buzkova P, 2011, ANN HUM GENET, V75, P36, DOI 10.1111/j.1469-1809.2010.00572.x; Chen XN, 2009, AM J MED GENET B, V150B, P926, DOI 10.1002/ajmg.b.30919; Cheng PW, 2011, BRIT J PHARMACOL, V163, P1203, DOI 10.1111/j.1476-5381.2010.01124.x; Ducci F, 2011, BIOL PSYCHIAT, V69, P650, DOI 10.1016/j.biopsych.2010.09.055; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Figueiredo JC, 2011, CANCER EPIDEM BIOMAR, V20, P758, DOI 10.1158/1055-9965.EPI-10-0675; Freathy RM, 2011, INT J EPIDEMIOL, V40, P1617, DOI 10.1093/ije/dyr077; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Grucza RA, 2006, ALCOHOL RES HEALTH, V29, P172; Hindorff L, 2012, CATALOG PUBLISHED GE; Hong LE, 2010, P NATL ACAD SCI USA, V107, P13509, DOI 10.1073/pnas.1004745107; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Kim J, 2008, CLIN CHEM LAB MED, V46, P1085, DOI 10.1515/CCLM.2008.230; Landgren S, 2009, BRAIN RES, V1305, pS72, DOI 10.1016/j.brainres.2009.08.026; Lasky-Su J, 2008, AM J HUM GENET, V82, P849, DOI 10.1016/j.ajhg.2008.01.018; Leone A, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/264894; Li YF, 2009, NEUROSCI LETT, V462, P20, DOI 10.1016/j.neulet.2009.06.081; Lindstrom JM, 2003, ANN NY ACAD SCI, V998, P41, DOI 10.1196/annals.1254.007; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Liu NJ, 2008, ADV GENET, V60, P335, DOI 10.1016/S0065-2660(07)00414-2; Liu PY, 2008, JNCI-J NATL CANCER I, V100, P1326, DOI 10.1093/jnci/djn268; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Moore C, 2011, EUR J PHARMACOL, V668, P177, DOI 10.1016/j.ejphar.2011.06.055; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Petry NM, 2008, PSYCHOSOM MED, V70, P288, DOI 10.1097/PSY.0b013e3181651651; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; Purcell S, PLINK 1 06; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2020, R LANG ENV STAT COMP; Rana BK, 2009, J PHARMACOL EXP THER, V331, P419, DOI 10.1124/jpet.109.157271; RANTAKALLIO P, 1969, ACTA PAEDIATR SC S, V0193; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Saccone NL, 2010, GENES BRAIN BEHAV, V9, P741, DOI 10.1111/j.1601-183X.2010.00608.x; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Saccone NL, 2009, AM J MED GENET B, V150B, P453, DOI 10.1002/ajmg.b.30828; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Sherva R, 2008, ADDICTION, V103, P1544, DOI 10.1111/j.1360-0443.2008.02279.x; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Thomas DC, 2012, AM J EPIDEMIOL, V175, P203, DOI 10.1093/aje/kwr365; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986	56	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46557	10.1371/journal.pone.0046557	http://dx.doi.org/10.1371/journal.pone.0046557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029550	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500109
J	Lambertucci, SA; Carrete, M; Donazar, JA; Hiraldo, F				Lambertucci, Sergio A.; Carrete, Martina; Antonio Donazar, Jose; Hiraldo, Fernando			Large-Scale Age-Dependent Skewed Sex Ratio in a Sexually Dimorphic Avian Scavenger	PLOS ONE			English	Article							ANDEAN CONDORS; COMMUNAL ROOSTS; VULTUR-GRYPHUS; HABITAT USE; POPULATION; SIZE; SEGREGATION; COMPETITION; ARGENTINA; PATAGONIA	Age-dependent skewed sex ratios have been observed in bird populations, with adult males generally outnumbering females. This trend is mainly driven by higher female mortality, sometimes associated with anthropogenic factors. Despite the large amount of work on bird sex ratios, research examining the spatial stability of adult sex ratios is extremely scarce. The Andean condor (Vultur gryphus) is the only bird of prey with strong sexual dimorphism favouring males (males are 30% heavier than females). By examining data from most of its South-American range, we show that while the juvenile sex ratio is balanced, or even female-skewed, the sex ratio becomes increasing male-skewed with age, with adult males outnumbering females by >20%, and, in some cases by four times more. This result is consistent across regions and independent of the nature of field data. Reasons for this are unknown but it can be hypothesized that the progressive disappearance of females may be associated with mortality caused by anthropogenic factors. This idea is supported by the asymmetric habitat use by the two sexes, with females scavenging in more humanized areas. Whatever the cause, male-skewed adult sex ratios imply that populations of this endangered scavenger face higher risks of extinction than previously believed.	[Lambertucci, Sergio A.] Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina; [Carrete, Martina] Univ Pablo Olavide, Dept Phys Chem & Nat Syst, Seville, Spain; [Carrete, Martina; Antonio Donazar, Jose; Hiraldo, Fernando] CSIC, Estac Biol Donana, Dept Biol Conservac, E-41080 Seville, Spain	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Universidad Pablo de Olavide; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Lambertucci, SA (corresponding author), Univ Nacl Comahue, CONICET, INIBIOMA, Lab Ecotono, San Carlos De Bariloche, Rio Negro, Argentina.	slambertucci@comahue-conicet.gob.ar	Carrete, Martina/A-6376-2009; Hiraldo, Fernando/AAA-8314-2019; Carrete, Martina/D-2618-2017	Carrete, Martina/0000-0002-0491-2950; LAMBERTUCCI, SERGIO/0000-0002-2624-2185; Donazar, Jose Antonio/0000-0002-9433-9755	Project BIOCON from Fundacion BBVA (Fundacion Banco Bilbao Vizcaya Argentaria) [08 126]	Project BIOCON from Fundacion BBVA (Fundacion Banco Bilbao Vizcaya Argentaria)	Funding was provided through the Project BIOCON 08 126, from Fundacion BBVA (Fundacion Banco Bilbao Vizcaya Argentaria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2010, CONDOR, V112, P470, DOI 10.1525/cond.2010.090203; Aresco MJ, 2005, BIOL CONSERV, V123, P37, DOI 10.1016/j.biocon.2004.10.006; Brooke MD, 2012, ANIM CONSERV, V15, P466, DOI 10.1111/j.1469-1795.2012.00535.x; Carrete M, 2010, ANIM CONSERV, V13, P390, DOI 10.1111/j.1469-1795.2010.00352.x; Christe P, 2006, OIKOS, V114, P381, DOI 10.1111/j.2006.0030-1299.15130.x; Darden SK, 2008, BIOL LETTERS, V4, P449, DOI 10.1098/rsbl.2008.0308; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Donazar JA, 1999, BEHAV ECOL SOCIOBIOL, V45, P55, DOI 10.1007/s002650050539; Donazar JA, 2002, CONDOR, V104, P832, DOI 10.1650/0010-5422(2002)104[0832:SSOACR]2.0.CO;2; Feijoo J., 1999, REGISTRO NACL CONDOR, V7, P18; FERRER M, 1992, BIOL CONSERV, V60, P57, DOI 10.1016/0006-3207(92)90799-S; Hardy I.C.W, 2002, SEX RATIOS CONCEPTS; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; Lambertucci SA, 2008, J FIELD ORNITHOL, V79, P147, DOI 10.1111/j.1557-9263.2008.00156.x; Lambertucci SA, 2008, J FIELD ORNITHOL, V79, P138, DOI 10.1111/j.1557-9263.2008.00155.x; Lambertucci SA, 2011, BIOL CONSERV, V144, P1464, DOI 10.1016/j.biocon.2011.01.015; Lambertucci SA, 2010, ORYX, V44, P441, DOI 10.1017/S0030605310000451; Lambertucci SA, 2009, J RAPTOR RES, V43, P245, DOI 10.3356/JRR-08-108.1; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; Manly B.F.J, 2007, RANDOMIZATION BOOTST, DOI DOI 10.1201/9780429329203; McGahan J, 1972, THESIS U WISCONSIN U; Ministerio de Ambiente Vivienda y Desarrollo Territorial, 2006, PROGR NAC CONS COND; Mucientes GR, 2009, BIOL LETTERS, V5, P156, DOI 10.1098/rsbl.2008.0761; Onichimowska Anna., 2012, KONIEC GRY; Orzack SH, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P383, DOI 10.1017/CBO9780511542053.020; Rios-Uzeda B, 2007, J FIELD ORNITHOL, V78, P170, DOI 10.1111/j.1557-9263.2007.00100.x; Ruckstuhl K.E., 2005, SEXUAL SEGREGATION V; Sarno RJ, 2000, REV CHIL HIST NAT, V73, P3; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Speakman JR, 2005, J EXP BIOL, V208, P1717, DOI 10.1242/jeb.01556; Speziale KL, 2008, BIOL CONSERV, V141, P1765, DOI 10.1016/j.biocon.2008.04.017; Stoks R, 2001, ECOL ENTOMOL, V26, P188, DOI 10.1046/j.1365-2311.2001.00303.x; Wehi PM, 2011, J EVOLUTION BIOL, V24, P2321, DOI 10.1111/j.1420-9101.2011.02366.x; White C.M., 1994, NEW WORLD VULTURES G; Wilson K, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P48, DOI 10.1017/CBO9780511542053.004	35	36	42	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46347	10.1371/journal.pone.0046347	http://dx.doi.org/10.1371/journal.pone.0046347			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029488	Green Submitted, gold, Green Published			2022-12-27	WOS:000309517500091
J	Li, J; Wu, RG; Meng, FY; Wang, Z; Wang, CM; Wang, YY; Zhang, ZJ				Li, Jian; Wu, Run-guo; Meng, Fan-yun; Wang, Zhong; Wang, Chang-ming; Wang, Yong-yan; Zhang, Zhan-jun			Synergism and Rules from Combination of Baicalin, Jasminoidin and Desoxycholic acid in Refined Qing Kai Ling for Treat Ischemic Stroke Mice Model	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; TRADITIONAL CHINESE MEDICINE; MIDDLE CEREBRAL-ARTERY; NITRIC-OXIDE SYNTHASE; INJURY IN-VIVO; GENE-EXPRESSION; REPERFUSION INJURY; FOCAL ISCHEMIA; GROWTH-FACTOR; CELL-DEATH	Refined Qing-Kai-Ling (QKL), a modified Chinese medicine, consists of three main ingredients (Baicalin, Jasminoidin and Desoxycholic acid), plays a synergistic effect on the treatment of the acute stage of ischemic stroke. However, the rules of the combination and synergism are still unknown. Based on the ischemic stroke mice model, all different kinds of combination of Baicalin, Jasminoidin, and Desoxycholic acid were investigated by the methods of neurological examination, microarray, and genomics analysis. As a result, it confirmed that the combination of three drugs offered a better therapeutical effect on ischemic stroke than monotherapy of each drug. Additionally, we used Ingenuity pathway Analysis (IPA) and principal component analysis (PCA) to extract the dominant information of expression changes in 373 ischemia-related genes. The results suggested that 5 principal components (PC1-5) could account for more than 95% energy in the gene data. Moreover, 3 clusters (PC1, PC2+PC5, and PC3+PC4) were addressed with cluster analysis. Furthermore, we matched PCs on the drug-target networks, the findings demonstrated that Baicalin related with PC1 that played the leading role in the combination; Jasminoidin related with PC2+PC5 that played a compensatory role; while Desoxycholic acid had the least performance alone which could relate with PC3+PC4 that played a compatible role. These manifestations were accorded with the principle of herbal formulae of Traditional Chinese Medicine (TCM), emperor-minister-adjuvant-courier. In conclusion, we firstly provided scientific evidence to the classic theory of TCM formulae, an initiating holistic viewpoint of combination therapy of TCM. This study also illustrated that PCA might be an applicable method to analyze the complicated data of drug combination.	[Wu, Run-guo; Wang, Chang-ming; Zhang, Zhan-jun] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Li, Jian] Beijing Univ Chinese Med, Sch Basic Med Sci, Beijing, Peoples R China; [Meng, Fan-yun] Beijing Normal Univ, Sch Resources Sci & Technol, Beijing 100875, Peoples R China; [Wang, Zhong; Wang, Yong-yan] China Acad Tradit Chinese Med, Inst Basic Res Clin Med, Beijing, Peoples R China	Beijing Normal University; Beijing University of Chinese Medicine; Beijing Normal University; China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS	Zhang, ZJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	zhang_rzs@bnu.edu.cn		Wu, Runguo/0000-0002-6523-5754	program for new century excellent talents in University [NCET-10-0249]; Program for excellent doctoral dissertation foundation [2007B7]; project of institute of basic research in clinical medicine [Z0175]	program for new century excellent talents in University(Program for New Century Excellent Talents in University (NCET)); Program for excellent doctoral dissertation foundation; project of institute of basic research in clinical medicine	This work was funded by the program for new century excellent talents in University (No. NCET-10-0249), the Program for excellent doctoral dissertation foundation (No. 2007B7) and by the project of institute of basic research in clinical medicine (No. Z0175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarenco Pierre, 2006, Cerebrovasc Dis, V21 Suppl 1, P35, DOI 10.1159/000090360; Ballif BA, 2004, CURR BIOL, V14, P606, DOI 10.1016/j.cub.2004.03.038; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Berezovskaya O, 1996, ACTA NEUROPATHOL, V92, P479, DOI 10.1007/s004010050550; Cao Chunyu, 2009, Zhongguo Zhong Yao Za Zhi, V34, P1549; Carey KM, 2012, ANN PHARMACOTHER, V46, P688, DOI 10.1345/aph.1Q621; Carlson NG, 1999, J IMMUNOL, V163, P3963; Carpi A, 2009, BBA-BIOENERGETICS, V1787, P774, DOI 10.1016/j.bbabio.2009.04.001; Chen YC, 2006, TOXICOL APPL PHARM, V216, P263, DOI 10.1016/j.taap.2006.05.008; Cheng FF, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/567872; CLARK RK, 1993, BRAIN RES BULL, V31, P565, DOI 10.1016/0361-9230(93)90124-T; de Lecinana MA, 2006, J NEUROL SCI, V247, P121, DOI 10.1016/j.jns.2006.03.022; Docagne F, 2002, MOL CELL NEUROSCI, V21, P634, DOI 10.1006/mcne.2002.1206; Dufourcq P, 2008, AM J PATHOL, V172, P37, DOI 10.2353/ajpath.2008.070130; Efferth T, 2007, CURR MED CHEM, V14, P2024; Fisher M, 2008, STROKE, V39, P250, DOI 10.1161/STROKEAHA.107.512244; Fujimoto H, 2004, ARTERIOSCL THROM VAS, V24, P1848, DOI 10.1161/01.ATV.0000142364.85911.0e; Gao Yong-Hong, 2009, Zhong Xi Yi Jie He Xue Bao, V7, P135, DOI 10.3736/jcim20090208; Gorelick PB, 2002, STROKE, V33, P862, DOI 10.1161/hs0302.103657; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; HSU CY, 1993, STROKE, V24, pI78; Hua Q, 2008, BIOL PHARM BULL, V31, P633, DOI 10.1248/bpb.31.633; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kernan WN, 2010, STROKE, V41, pS35, DOI 10.1161/STROKEAHA.110.592022; Koizumi S, 2002, J BIOL CHEM, V277, P30315, DOI 10.1074/jbc.M201132200; Li C, 1999, Zhongguo Zhong Xi Yi Jie He Za Zhi, V19, P212; Li H, 2003, J CHROMATOGR B, V788, P93, DOI 10.1016/S1570-0232(02)01032-2; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Liu Qingyun SJ, 2000, CHIN J IINTEGRATED T, V20, P4; Liu R, 2000, Zhonghua Kou Qiang Yi Xue Za Zhi, V35, P327; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Luo CX, 2007, J NEUROCHEM, V103, P1872, DOI 10.1111/j.1471-4159.2007.04915.x; Mao HP, 2004, J BIOL CHEM, V279, P15472, DOI 10.1074/jbc.M313484200; Marini AM, 2004, RESTOR NEUROL NEUROS, V22, P121; Mastroiacovo F, 2009, J CEREBR BLOOD F MET, V29, P264, DOI 10.1038/jcbfm.2008.111; Nguyen DV, 2002, BIOINFORMATICS, V18, P39, DOI 10.1093/bioinformatics/18.1.39; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Read SJ, 2001, J CEREBR BLOOD F MET, V21, P755, DOI 10.1097/00004647-200107000-00001; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Saito A, 2004, J NEUROSCI, V24, P1584, DOI 10.1523/JNEUROSCI.5209-03.2004; Shi QD, 2009, NEUROSCI LETT, V465, P220, DOI 10.1016/j.neulet.2009.08.049; Shinozaki Y, 2007, NEUROSCIENCE, V147, P153, DOI 10.1016/j.neuroscience.2007.04.032; Simpson JE, 2009, STROKE, V40, P369, DOI 10.1161/STROKEAHA.108.529214; Szewka Aimee Joy, 2009, Comprehensive Therapy, V35, P72; Tureyen K, 2008, J NEUROCHEM, V105, P1313, DOI 10.1111/j.1471-4159.2008.05233.x; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; van der Greef J, 2004, CURR OPIN CHEM BIOL, V8, P559, DOI 10.1016/j.cbpa.2004.08.013; Vikman P, 2006, EUR J NEUROL, V13, P1324, DOI 10.1111/j.1468-1331.2006.01496.x; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang Q, 2002, J BIOL CHEM, V277, P24949, DOI 10.1074/jbc.M203802200; Watanabe S, 2009, J ETHNOPHARMACOL, V125, P203, DOI 10.1016/j.jep.2009.07.014; Woo KJ, 2006, IMMUNOBIOLOGY, V211, P359, DOI 10.1016/j.imbio.2006.02.002; Wu B, 2007, STROKE, V38, P1973, DOI 10.1161/STROKEAHA.106.473165; Xu Lirong, 2004, Zhong Yao Cai, V27, P348; Yang Yan, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P908; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zhang Chun-ying, 2005, Zhongguo Zhongyao Zazhi, V30, P686; Zhang RL, 2007, CURR MOL MED, V7, P459; Zhang Z.J., 2005, ACTA PHARM SIN, V26, P8; Zhang ZJ, 2006, BRAIN RES, V1123, P188, DOI 10.1016/j.brainres.2006.09.063; Zhang ZJ, 2005, ACTA PHARMACOL SIN, V26, P307, DOI 10.1111/j.1745-7254.2005.00051.x; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	63	14	16	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45811	10.1371/journal.pone.0045811	http://dx.doi.org/10.1371/journal.pone.0045811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049867	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300055
J	Lyu, ZX; Shao, Q; Gao, YQ; Zhao, XS				Lyu, Zhi-Xin; Shao, Qiang; Gao, Yi Qin; Zhao, Xin Sheng			Direct Observation of the Uptake of Outer Membrane Proteins by the Periplasmic Chaperone Skp	PLOS ONE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BIOGENESIS; DYNAMICS; AGGREGATION; COMPLEXES; MOLECULES; MECHANISM; EVOLUTION	The transportation of membrane proteins through the aqueous subcellular space is an important and challenging process. Its molecular mechanism and the associated structural change are poorly understood. Periplasmic chaperones, such as Skp in Escherichia coli, play key roles in the transportation and protection of outer membrane proteins (OMPs) in Gram-negative bacteria. The molecular mechanism through which Skp interacts with and protects OMPs remains mysterious. Here, a combined experimental and molecular dynamics simulation study was performed to gain the structural and dynamical information in the process of OMPs and Skp binding. Stopped-flow experiments on site specific mutated and labeled Skp and several OMPs, namely OmpC, the transmembrane domain of OmpA, and OmpF, allowed us to obtain the mechanism of OMP entering the Skp cavity, and molecular dynamics simulations yielded detailed molecular interactions responsible for this process. Both experiment and simulation show that the entrance of OMP into Skp is a highly directional process, which is initiated by the interaction between the N-terminus of OMP and the bottom "tentacle" domain of Skp. The opening of the more flexible tentacle of Skp, the non-specific electrostatic interactions between OMP and Skp, and the constant formation and breaking of salt bridges between Skp and its substrate together allow OMP to enter Skp and gradually "climb" into the Skp cavity in the absence of an external energy supply.	[Lyu, Zhi-Xin; Shao, Qiang; Gao, Yi Qin; Zhao, Xin Sheng] Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Lyu, Zhi-Xin; Zhao, Xin Sheng] Peking Univ, State Key Lab Struct Chem Unstable & Stable Speci, Dept Biol Chem, Biodynam Opt Imaging Ctr,Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Shao, Qiang; Gao, Yi Qin] Peking Univ, Inst Theoret & Computat Chem, Coll Chem & Mol Engn, Beijing 100871, Peoples R China	Chinese Academy of Sciences; Peking University; Chinese Academy of Sciences; Peking University; Peking University	Gao, YQ (corresponding author), Peking Univ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China.	gaoyq@pku.edu.cn; zhaoxs@pku.edu.cn	Shao, Qiang/O-4528-2019; gao, yi/HCI-8298-2022	Shao, Qiang/0000-0001-6460-3095; 	National Key Basic Research Foundation of China [2010CB912302, 2012CB917304]; National Natural Science Foundation of China [21233002, 20973015, 91027044, 21125311, 21003003]	National Key Basic Research Foundation of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by research grants from the National Key Basic Research Foundation of China (2010CB912302 to XSZ and 2012CB917304 to XSZ and YQG) and the National Natural Science Foundation of China (21233002 to XSZ and YQG, 20973015 to XSZ, 91027044 and 21125311 to YQG, and 21003003 to QS). YQG is a 2008 Changjiang Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Bos MP, 2004, CURR OPIN MICROBIOL, V7, P610, DOI 10.1016/j.mib.2004.10.011; Bulieris PV, 2003, J BIOL CHEM, V278, P9092, DOI 10.1074/jbc.M211177200; Case D, 2006, AMBER 9; Chattopadhyay K, 2005, P NATL ACAD SCI USA, V102, P2385, DOI 10.1073/pnas.0500127102; Chen XD, 2008, J AM CHEM SOC, V130, P16947, DOI 10.1021/ja804628x; Cierpicki T, 2006, J AM CHEM SOC, V128, P6947, DOI 10.1021/ja0608343; Clancy BE, 2011, NAT STRUCT MOL BIOL, V18, P1020, DOI 10.1038/nsmb.2104; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P1; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Korndorfer IP, 2004, NAT STRUCT MOL BIOL, V11, P1015, DOI 10.1038/nsmb828; Lin J, 2002, MICROBES INFECT, V4, P325, DOI 10.1016/S1286-4579(02)01545-9; Luo R, 2002, J COMPUT CHEM, V23, P1244, DOI 10.1002/jcc.10120; MEADOWS DL, 1991, J IMMUNOL METHODS, V143, P263, DOI 10.1016/0022-1759(91)90051-G; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Pack CG, 1999, CYTOMETRY, V36, P247, DOI 10.1002/(SICI)1097-0320(19990701)36:3<247::AID-CYTO15>3.0.CO;2-#; Packard BZ, 1996, P NATL ACAD SCI USA, V93, P11640, DOI 10.1073/pnas.93.21.11640; Qu J, 2007, J MOL BIOL, V374, P91, DOI 10.1016/j.jmb.2007.09.020; Qu J, 2009, BIOCHEMISTRY-US, V48, P4926, DOI 10.1021/bi9004039; Remaut H, 2004, CURR OPIN STRUC BIOL, V14, P161, DOI 10.1016/j.sbi.2004.03.004; Ruiz N, 2006, NAT REV MICROBIOL, V4, P57, DOI 10.1038/nrmicro1322; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563; Sugiura M, 1998, ANNU REV GENET, V32, P437, DOI 10.1146/annurev.genet.32.1.437; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Walton TA, 2004, MOL CELL, V15, P367, DOI 10.1016/j.molcel.2004.07.023; Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WEST W, 1965, J PHYS CHEM-US, V69, P1894, DOI 10.1021/j100890a019; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wu S, 2011, BIOCHEM J, V438, P505, DOI 10.1042/BJ20110264; Zhou RB, 2011, NANO LETT, V11, P5482, DOI 10.1021/nl2032876; Zhuang XW, 2000, P NATL ACAD SCI USA, V97, P14241, DOI 10.1073/pnas.97.26.14241	42	16	17	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46068	10.1371/journal.pone.0046068	http://dx.doi.org/10.1371/journal.pone.0046068			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049938	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300079
J	Takeuchi, F; Isono, M; Katsuya, T; Yokota, M; Yamamoto, K; Nabika, T; Shimokawa, K; Nakashima, E; Sugiyama, T; Rakugi, H; Yamaguchi, S; Ogihara, T; Yamori, Y; Kato, N				Takeuchi, Fumihiko; Isono, Masato; Katsuya, Tomohiro; Yokota, Mitsuhiro; Yamamoto, Ken; Nabika, Toru; Shimokawa, Kazuro; Nakashima, Eitaro; Sugiyama, Takao; Rakugi, Hiromi; Yamaguchi, Shuhei; Ogihara, Toshio; Yamori, Yukio; Kato, Norihiro			Association of Genetic Variants Influencing Lipid Levels with Coronary Artery Disease in Japanese Individuals	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; HEART-DISEASE; METABOLIC TRAITS; BLOOD-LIPIDS; RISK; LOCI; POPULATION; TRIGLYCERIDES; DYSLIPIDEMIA	Background/Objective: In Japanese populations, we performed a replication study of genetic loci previously identified in European-descent populations as being associated with lipid levels and risk of coronary artery disease (CAD). Methods: We genotyped 48 single nucleotide polymorphisms (SNPs) from 22 candidate loci that had previously been identified by genome-wide association (GWA) meta-analyses for low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and/or triglycerides in Europeans. We selected 22 loci with 2 parallel tracks from 95 reported loci: 16 significant loci (p<1x10(-30) in Europeans) and 6 other loci including those with suggestive evidence of lipid associations in 1292 GWA-scanned Japanese samples. Genotyping was done in 4990 general population samples, and 1347 CAD cases and 1337 controls. For 9 SNPs, we further examined CAD associations in an additional panel of 3052 CAD cases and 6335 controls. Principal Findings: Significant lipid associations (one-tailed p<0.05) were replicated for 18 of 22 loci in Japanese samples, with significant inter-ethnic heterogeneity at 4 loci-APOB, APOE-C1, CETP, and APOA5-and allelic heterogeneity. The strongest association was detected at APOE rs7412 for LDL-C (p = 1.3x10(-41)), CETP rs3764261 for HDL-C (p = 5.2x10(-24)), and APOA5 rs662799 for triglycerides (p = 5.8x10(-54)). CAD association was replicated and/or verified for 4 loci: SORT1 rs611917 (p = 1.7x10(-8)), APOA5 rs662799 (p = 0.0014), LDLR rs1433099 (p = 2.1x10(-7)), and APOE rs7412 (p = 6.1x10(-13)). Conclusions: Our results confirm that most of the tested lipid loci are associated with lipid traits in the Japanese, further indicating that in genetic susceptibility to lipid levels and CAD, the related metabolic pathways are largely common across the populations, while causal variants at individual loci can be population-specific.	[Takeuchi, Fumihiko; Isono, Masato; Shimokawa, Kazuro; Kato, Norihiro] Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan; [Katsuya, Tomohiro] Osaka Univ, Grad Sch Med, Dept Clin Gene Therapy, Suita, Osaka, Japan; [Katsuya, Tomohiro; Rakugi, Hiromi; Ogihara, Toshio] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka, Japan; [Yokota, Mitsuhiro] Aichi Gakuin Univ, Sch Dent, Dept Genome Sci, Nagoya, Aichi 464, Japan; [Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Fukuoka 812, Japan; [Nabika, Toru] Shimane Univ, Sch Med, Dept Funct Pathol, Izumo, Shimane, Japan; [Nakashima, Eitaro] Nagoya Univ, Grad Sch Med, Dept Internal Med, Div Endocrinol & Diabet, Nagoya, Aichi 4648601, Japan; [Nakashima, Eitaro] Chubu Rosai Hosp, Dept Endocrinol & Diabet, Nagoya, Aichi, Japan; [Sugiyama, Takao] Asahi Life Fdn, Inst Adult Dis, Tokyo, Japan; [Yamaguchi, Shuhei] Shimane Univ, Sch Med, Dept Internal Med 3, Izumo, Shimane, Japan; [Ogihara, Toshio] Morinomiya Univ Med Sci, Osaka, Japan; [Yamori, Yukio] Mukogawa Womens Univ, Inst World Hlth Dev, Nishinomiya, Hyogo, Japan	National Center for Global Health & Medicine - Japan; Osaka University; Osaka University; Aichi Gakuin University; Kyushu University; Shimane University; Nagoya University; Asahi Life Foundation; Shimane University; Mukogawa Women's University	Kato, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Res Inst, Tokyo, Japan.	nokato@ri.ncgm.go.jp		Rakugi, Hiromi/0000-0001-6508-4338	National Center for Global Health and Medicine; Ministry of Health Labour and Welfare	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Ministry of Health Labour and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Grant of National Center for Global Health and Medicine and the Ministry of Health Labour and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SS, 2009, CIRC-CARDIOVASC GENE, V2, P16, DOI 10.1161/CIRCGENETICS.108.813709; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Benn M, 2009, ATHEROSCLEROSIS, V206, P17, DOI 10.1016/j.atherosclerosis.2009.01.004; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Boes E, 2009, EXP GERONTOL, V44, P136, DOI 10.1016/j.exger.2008.11.003; Chang MH, 2011, CIRC-CARDIOVASC GENE, V4, P523, DOI 10.1161/CIRCGENETICS.111.959577; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chasman DI, 2008, CIRC-CARDIOVASC GENE, V1, P21, DOI 10.1161/CIRCGENETICS.108.773168; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Drenos F, 2009, HUM MOL GENET, V18, P2305, DOI 10.1093/hmg/ddp159; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; Erdmann J, 2009, NAT GENET, V41, P280, DOI 10.1038/ng.307; Heid IM, 2008, CIRC-CARDIOVASC GENE, V1, P10, DOI 10.1161/CIRCGENETICS.108.776708; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Khera AV, 2009, TRENDS CARDIOVAS MED, V19, P195, DOI 10.1016/j.tcm.2009.12.003; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; NAMBOODIRI K K, 1985, Genetic Epidemiology, V2, P227, DOI 10.1002/gepi.1370020302; Ordovas JM, 2011, CURR OPIN LIPIDOL, V22, P129, DOI 10.1097/MOL.0b013e32834477a9; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Soutar AK, 2010, IUBMB LIFE, V62, P125, DOI 10.1002/iub.299; Takeuchi F, 2012, EUR J HUM GENET, V20, P333, DOI 10.1038/ejhg.2011.184; Takeuchi F, 2011, GENOME RES, V21, P1122, DOI 10.1101/gr.115832.110; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Talmud PJ, 2009, AM J HUM GENET, V85, P628, DOI 10.1016/j.ajhg.2009.10.014; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tsuchihashi-Makaya M, 2009, HYPERTENS RES, V32, P207, DOI 10.1038/hr.2009.3; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Willer CJ, 2012, CURR OPIN LIPIDOL, V23, P98, DOI 10.1097/MOL.0b013e328350fad2; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751; Zhou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027481	41	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46385	10.1371/journal.pone.0046385	http://dx.doi.org/10.1371/journal.pone.0046385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050023	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300113
J	Vervoort, J; Baraniak, A; Gazin, M; Sabirova, J; Lammens, C; Kazma, M; Grabowska, A; Izdebski, R; Carmeli, Y; Kumar-Singh, S; Gniadkowski, M; Goossens, H; Malhotra-Kumar, S				Vervoort, Jascha; Baraniak, Anna; Gazin, Muriel; Sabirova, Julia; Lammens, Christine; Kazma, Meital; Grabowska, Anna; Izdebski, Radoslaw; Carmeli, Yehuda; Kumar-Singh, Samir; Gniadkowski, Marek; Goossens, Herman; Malhotra-Kumar, Surbhi		MOSAR WP2 Study Grp; SATURN WP1 Study Grp	Characterization of Two New CTX-M-25-Group Extended-Spectrum beta-Lactamase Variants Identified in Escherichia coli Isolates from Israel	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; CLINICAL ISOLATE; PREVALENCE; ENTEROBACTERIACEAE; CTX-M-15; SPREAD; ENZYME; GENES	Objectives: We characterized two new CTX-M-type extended-spectrum beta-lactamase (ESBL) variants in Escherichia coli isolates from stool samples of two elderly patients admitted at the Tel Aviv Sourasky Medical Center, Israel. Both patients underwent treatment with cephalosporins prior to isolation of the E. coli strains. Methods: ESBLs were detected by the double-disk synergy test and PCR-sequencing of beta-lactamase genes. The bla(CTX-M) genes were cloned into the pCR-BluntII-TOPO vector in E. coli TOP10. The role of amino-acid substitutions V77A and D240G was analyzed by site-directed mutagenesis of the bla(CTX-M-94) and bla(CTX-M-100) genes and comparative characterization of the resulting E. coli recombinants. MICs of beta-lactams were determined by Etest. Plasmid profiling, mating experiments, replicon typing and sequencing of bla(CTX-M) flanking regions were performed to identify the genetic background of the new CTX-M variants. Results: The novel CTX-M beta-lactamases, CTX-M-94 and -100, belonged to the CTX-M-25-group. Both variants differed from CTX-M-25 by the substitution V77A, and from CTX-M-39 by D240G. CTX-M-94 differed from all CTX-M-25-group enzymes by the substitution F119L. Glycine-240 was associated with reduced susceptibility to ceftazidime and leucine-119 with increased resistance to ceftriaxone. bla(CTX-M-94) and bla(CTX-M-100) were located within ISEcp1 transposition units inserted into similar to 93 kb non-conjugative IncFI and similar to 130 kb conjugative IncA/C plasmids, respectively. The plasmids carried also different class 1 integrons. Conclusions: This is the first report on CTX-M-94 and -100 ESBLs, novel members of the CTX-M-25-group.	[Vervoort, Jascha; Gazin, Muriel; Sabirova, Julia; Lammens, Christine; Goossens, Herman; Malhotra-Kumar, Surbhi] Univ Antwerp, Dept Med Microbiol, B-2020 Antwerp, Belgium; [Vervoort, Jascha; Gazin, Muriel; Sabirova, Julia; Lammens, Christine; Kumar-Singh, Samir; Goossens, Herman; Malhotra-Kumar, Surbhi] Univ Antwerp, Vaccine & Infect Dis Inst, B-2020 Antwerp, Belgium; [Baraniak, Anna; Grabowska, Anna; Izdebski, Radoslaw; Gniadkowski, Marek] Natl Med Inst, Dept Mol Microbiol, Warsaw, Poland; [Kazma, Meital; Carmeli, Yehuda] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Div Epidemiol, IL-69978 Tel Aviv, Israel; [Kazma, Meital; Carmeli, Yehuda] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Lab Mol Epidemiol & Antibiot Res, IL-69978 Tel Aviv, Israel; [Kumar-Singh, Samir] Univ Antwerp, Mol Pathol Grp, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp; National Medicines Institute Lekow (NIL); Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of Antwerp	Malhotra-Kumar, S (corresponding author), Univ Antwerp, Dept Med Microbiol, B-2020 Antwerp, Belgium.	surbhi.malhotra@ua.ac.be	Kumar-Singh, Samir/G-6280-2012; Baraniak, Anna/U-9015-2018	Kumar-Singh, Samir/0000-0001-9466-6732; Baraniak, Anna/0000-0001-9996-8553; , Anna D./0000-0003-1633-6345	European Community [LSHP-CT-2007-037941, 241796]; Polish Ministry of Science and Higher Education [934/6. PR UE/2009/7]	European Community(European Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	JV and M. Gazin are supported by funding from the European Community (MOSAR network contract LSHP-CT-2007-037941; SATURN network contract FP7-HEALTH-2009-SINGLE STAGE-No241796). AB, AG, RI and M. Gniadkowski were also financed by the MOSAR-complementary grant No. 934/6. PR UE/2009/7 from the Polish Ministry of Science and Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow M, 2008, EMERG INFECT DIS, V14, P423, DOI 10.3201/eid1403.070405; BAUERNFEIND A, 1990, INFECTION, V18, P294, DOI 10.1007/BF01647010; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Canton R, 2008, CLIN MICROBIOL INFEC, V14, P144, DOI 10.1111/j.1469-0691.2007.01850.x; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Chen Y, 2005, J MOL BIOL, V348, P349, DOI 10.1016/j.jmb.2005.02.010; Chmelnitsky I, 2005, ANTIMICROB AGENTS CH, V49, P4745, DOI 10.1128/AAC.49.11.4745-4750.2005; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; CLSI, 2012, M02A11 CLSI; Delmas J, 2008, J MOL BIOL, V375, P192, DOI 10.1016/j.jmb.2007.10.026; Drieux L, 2008, CLIN MICROBIOL INFEC, V14, P90, DOI 10.1111/j.1469-0691.2007.01846.x; Ewers C, 2010, J ANTIMICROB CHEMOTH, V65, P651, DOI 10.1093/jac/dkq004; Gniadkowski M, 2008, CLIN MICROBIOL INFEC, V14, P11, DOI 10.1111/j.1469-0691.2007.01854.x; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Malhotra-Kumar S, 2003, J CLIN MICROBIOL, V41, P5282, DOI 10.1128/JCM.41.11.5282-5284.2003; Mammeri H, 2006, ANTIMICROB AGENTS CH, V50, P2573, DOI 10.1128/AAC.01633-05; Rodriguez MM, 2010, ANTIMICROB AGENTS CH, V54, P3070, DOI 10.1128/AAC.01615-09; McGettigan SE, 2009, J CLIN MICROBIOL, V47, P2970, DOI 10.1128/JCM.00319-09; Monstein HJ, 2007, APMIS, V115, P1400, DOI 10.1111/j.1600-0463.2007.00722.x; Munday CJ, 2004, ANTIMICROB AGENTS CH, V48, P4829, DOI 10.1128/AAC.48.12.4829-4834.2004; Navon-Venezia S, 2008, J ANTIMICROB CHEMOTH, V62, P289, DOI 10.1093/jac/dkn182; Novais A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000735; Paterson DL, 2003, ANTIMICROB AGENTS CH, V47, P3554, DOI 10.1128/AAC.47.11.3554-3560.2003; Peirano G, 2010, ANTIMICROB AGENTS CH, V54, P1327, DOI 10.1128/AAC.01338-09; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; Zhang ZJ, 2009, J CLIN LAB ANAL, V23, P404, DOI 10.1002/jcla.20351	31	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46329	10.1371/journal.pone.0046329	http://dx.doi.org/10.1371/journal.pone.0046329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050014	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000309517300107
J	Ramamoorthy, S; Nuttall, AL				Ramamoorthy, Sripriya; Nuttall, Alfred L.			Half-Octave Shift in Mammalian Hearing Is an Epiphenomenon of the Cochlear Amplifier	PLOS ONE			English	Article							MECHANICAL WAVE-FORM; BASILAR-MEMBRANE; TECTORIAL MEMBRANE; RESPONSES; MODEL; MOTION; EAR	The cochlear amplifier is a hypothesized positive feedback process responsible for our exquisite hearing sensitivity. Experimental evidence for or against the positive feedback hypothesis is still lacking. Here we apply linear control theory to determine the open-loop gain and the closed-loop sensitivity of the cochlear amplifier from available measurements of basilar membrane vibration in sensitive mammalian cochleae. We show that the frequency of peak closed-loop sensitivity is independent of the stimulus level and close to the characteristic frequency. This implies that the half-octave shift in mammalian hearing is an epiphenomenon of the cochlear amplifier. The open-loop gain is consistent with positive feedback and suggests that the high-frequency cut-off of the outer hair cell transmembrane potential in vivo may be necessary for cochlear amplification.	[Ramamoorthy, Sripriya; Nuttall, Alfred L.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol, Portland, OR 97201 USA; [Nuttall, Alfred L.] Univ Michigan, Kresge Hearing Res Inst, Ann Arbor, MI 48109 USA	Oregon Health & Science University; University of Michigan System; University of Michigan	Ramamoorthy, S (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Dept Otolaryngol, Portland, OR 97201 USA.	ramamoor@ohsu.edu		Ramamoorthy, Sripriya/0000-0002-0782-1229	National Institute on Deafness and Other Communication Disorder [R01 DC 000141]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000141, P30DC005983] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorder(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Research was supported by National Institute on Deafness and Other Communication Disorder grants R01 DC 000141 (ALN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DJ, 1971, J ACOUST SOC AM, V49, P1131, DOI 10.1121/1.1912474; Ashmore J, 2010, HEARING RES, V266, P1, DOI 10.1016/j.heares.2010.05.001; Astrom K.J., 2009, FEEDBACK SYSTEMS INT; Chen FY, 2011, NAT NEUROSCI, V14, P770, DOI 10.1038/nn.2827; CODY AR, 1992, HEARING RES, V62, P166, DOI 10.1016/0378-5955(92)90182-M; CODY AR, 1981, J ACOUST SOC AM, V70, P707, DOI 10.1121/1.386906; Cooper NP, 1997, J NEUROPHYSIOL, V78, P261, DOI 10.1152/jn.1997.78.1.261; DAVIS H, 1983, HEARING RES, V9, P79, DOI 10.1016/0378-5955(83)90136-3; de Boer E, 2000, J ACOUST SOC AM, V107, P1497, DOI 10.1121/1.428436; deBoer E, 1997, J ACOUST SOC AM, V101, P3583, DOI 10.1121/1.418319; Elliott SJ, 2007, J ACOUST SOC AM, V122, P2759, DOI 10.1121/1.2783125; Grosh K, 2004, J ACOUST SOC AM, V115, P2178, DOI 10.1121/1.1695431; Gummer AW, 1996, P NATL ACAD SCI USA, V93, P8727, DOI 10.1073/pnas.93.16.8727; Lu TK, 2006, HEARING RES, V214, P45, DOI 10.1016/j.heares.2006.01.018; MAMMANO F, 1993, NATURE, V365, P838, DOI 10.1038/365838a0; MAMMANO F, 1993, J ACOUST SOC AM, V93, P3320, DOI 10.1121/1.405716; Mountain D. C., 1983, MECH HEARING, P119; MOUNTAIN DC, 1989, HEARING RES, V42, P195, DOI 10.1016/0378-5955(89)90144-5; Nakajima HH, 2000, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON RECENT DEVELOPMENTS IN AUDITORY MECHANICS, P202; Narayan SS, 2000, PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON RECENT DEVELOPMENTS IN AUDITORY MECHANICS, P95; NEELY ST, 1993, J ACOUST SOC AM, V94, P137, DOI 10.1121/1.407091; Nuttall AL, 1996, J ACOUST SOC AM, V99, P1556, DOI 10.1121/1.414732; Ogata K., 2010, MODERN CONTROL ENG; PATUZZI RB, 1989, HEARING RES, V42, P47, DOI 10.1016/0378-5955(89)90117-2; Ramamoorthy S, 2004, THESIS U MICHIGAN AN; Ramamoorthy S, 2007, J ACOUST SOC AM, V121, P2758, DOI 10.1121/1.2713725; Ramamoorthy S, 2012, BIOPHYS J, V102, P388, DOI 10.1016/j.bpj.2011.12.040; Ren TY, 2002, P NATL ACAD SCI USA, V99, P17101, DOI 10.1073/pnas.262663699; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; ZWISLOCKI JJ, 1979, SCIENCE, V204, P639, DOI 10.1126/science.432671	31	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45640	10.1371/journal.pone.0045640	http://dx.doi.org/10.1371/journal.pone.0045640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049829	Green Submitted, gold, Green Published			2022-12-27	WOS:000309556100063
J	Stranzl, T; Larsen, MV; Lund, O; Nielsen, M; Brunak, S				Stranzl, Thomas; Larsen, Mette V.; Lund, Ole; Nielsen, Morten; Brunak, Soren			The Cancer Exome Generated by Alternative mRNA Splicing Dilutes Predicted HLA Class I Epitope Density	PLOS ONE			English	Article							MHC CLASS-I; MISSENSE MUTATIONS; PANCREATIC-CANCER; GENE-EXPRESSION; DOWN-REGULATION; AMINO-ACIDS; PROTEIN; SEQUENCE; BINDING; LYMPHOCYTES	Several studies have shown that cancers actively regulate alternative splicing. Altered splicing mechanisms in cancer lead to cancer-specific transcripts different from the pool of transcripts occurring only in healthy tissue. At the same time, altered presentation of HLA class I epitopes is frequently observed in various types of cancer. Down-regulation of genes related to HLA class I antigen processing has been observed in several cancer types, leading to fewer HLA class I antigens on the cell surface. Here, we use a peptidome wide analysis of predicted alternative splice forms, based on a publicly available database, to show that peptides over-represented in cancer splice variants comprise significantly fewer predicted HLA class I epitopes compared to peptides from normal transcripts. Peptides over-represented in cancer transcripts are in the case of the three most common HLA class I supertype representatives consistently found to contain fewer predicted epitopes compared to normal tissue. We observed a significant difference in amino acid composition between protein sequences associated with normal versus cancer tissue, as transcripts found in cancer are enriched with hydrophilic amino acids. This variation contributes to the observed significant lower likelihood of cancer-specific peptides to be predicted epitopes compared to peptides found in normal	[Stranzl, Thomas; Larsen, Mette V.; Lund, Ole; Nielsen, Morten; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark	Technical University of Denmark	Brunak, S (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark.	brunak@cbs.dtu.dk	Nielsen, Morten/AAL-8700-2020; Lund, Ole/F-4437-2014; Nielsen, Morten/E-7754-2011; Brunak, Soren/O-6621-2016	Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Nielsen, Morten/0000-0001-7885-4311; Brunak, Soren/0000-0003-0316-5866	Danish Research Council for Technology and Production Sciences (Project "Disease Gene Finding, Somatic Mutations, and Vaccine Design"); National Institutes of Health [HHSN26620040006C]	Danish Research Council for Technology and Production Sciences (Project "Disease Gene Finding, Somatic Mutations, and Vaccine Design"); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the Danish Research Council for Technology and Production Sciences (Project "Disease Gene Finding, Somatic Mutations, and Vaccine Design"; principal funding recipient, Soren Brunak) and was supported by the National Institutes of Health (contract HHSN26620040006C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMANN G, 1989, PROTEIN ENG, V2, P329, DOI 10.1093/protein/2.5.329; Darby N.J., 1993, PROTEIN STRUCTURE; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Fang F, 2007, CANCER SCI, V98, P1678, DOI 10.1111/j.1349-7006.2007.00589.x; Ferris RL, 2006, CLIN CANCER RES, V12, P3890, DOI 10.1158/1078-0432.CCR-05-2750; Figge MA, 2004, CANCER EPIDEM BIOMAR, V13, P1037; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Ge B, 2005, GENOME RES, V15, P1584, DOI 10.1101/gr.4023805; He C, 2007, CARCINOGENESIS, V28, P2484, DOI 10.1093/carcin/bgm194; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kelso J, 2003, GENOME RES, V13, P1222, DOI 10.1101/gr.985203; Koscielny G, 2009, GENOMICS, V93, P213, DOI 10.1016/j.ygeno.2008.11.003; Larsen ME, 2011, IMMUNOGENETICS, V63, P43, DOI 10.1007/s00251-010-0493-5; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Miranda NFCCD, 2009, J PATHOL, P69, DOI [10.1002/path, DOI 10.1002/PATH]; NA F TA C, 2003, GENE DEV, V17, P419; Nielsen M, 2004, BIOINFORMATICS, V20, P1388, DOI 10.1093/bioinformatics/bth100; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Norell H, 2006, CANCER RES, V66, P6387, DOI 10.1158/0008-5472.CAN-06-0029; Ohnuma S, 2009, SURGERY, V145, P57, DOI 10.1016/j.surg.2008.08.010; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Romero JM, 2005, INT J CANCER, V113, P605, DOI 10.1002/ijc.20499; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Seliger B, 2008, J IMMUNOTOXICOL, V5, P361, DOI 10.1080/15476910802482870; SIMPSON RJ, 2002, PROTEINS PROTEOMICS; Skotheim RI, 2007, INT J BIOCHEM CELL B, V39, P1432, DOI 10.1016/j.biocel.2007.02.016; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Trinquier G, 1998, PROTEIN ENG, V11, P153, DOI 10.1093/protein/11.3.153; Urayama S, 2010, RAPID COMMUN MASS SP, V24, P613, DOI 10.1002/rcm.4420; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Watson NFS, 2006, INT J CANCER, V118, P6, DOI 10.1002/ijc.21303; Wernersson R, 2006, NUCLEIC ACIDS RES, V34, pW385, DOI 10.1093/nar/gkl252; WIEDENFELD EA, 1994, CANCER RES, V54, P1175; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Zhang H, 2009, BIOINFORMATICS, V25, P83, DOI 10.1093/bioinformatics/btn579	44	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e38670	10.1371/journal.pone.0038670	http://dx.doi.org/10.1371/journal.pone.0038670			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049726	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100001
J	Valli, A; Busnadiego, I; Maliogka, V; Ferrero, D; Caston, JR; Rodriguez, JF; Garcia, JA				Valli, Adrian; Busnadiego, Idoia; Maliogka, Varvara; Ferrero, Diego; Caston, Jose R.; Francisco Rodriguez, Jose; Antonio Garcia, Juan			The VP3 Factor from Viruses of Birnaviridae Family Suppresses RNA Silencing by Binding Both Long and Small RNA Duplexes	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; SMALL INTERFERING RNA; BURSAL-DISEASE-VIRUS; HEPATITIS-C VIRUS; VEIN-YELLOWING-IPOMOVIRUS; INFLUENZA-A VIRUS; ANTIVIRAL IMMUNITY; VIRAL SUPPRESSORS; CELLULAR MICRORNAS; STRUCTURAL POLYMORPHISM	RNA silencing is directly involved in antiviral defense in a wide variety of eukaryotic organisms, including plants, fungi, invertebrates, and presumably vertebrate animals. The study of RNA silencing-mediated antiviral defences in vertebrates is hampered by the overlap with other antiviral mechanisms; thus, heterologous systems are often used to study the interplay between RNA silencing and vertebrate-infecting viruses. In this report we show that the VP3 protein of the avian birnavirus Infectious bursal disease virus (IBDV) displays, in addition to its capacity to bind long double-stranded RNA, the ability to interact with double-stranded small RNA molecules. We also demonstrate that IBDV VP3 prevents the silencing mediated degradation of a reporter mRNA, and that this silencing suppression activity depends on its RNA binding ability. Furthermore, we find that the anti-silencing activity of IBDV VP3 is shared with the homologous proteins expressed by both insect- and fish-infecting birnaviruses. Finally, we show that IBDV VP3 can functionally replace the well-characterized HCPro silencing suppressor of Plum pox virus, a potyvirus that is unable to infect plants in the absence of an active silencing suppressor. Altogether, our results support the idea that VP3 protects the viral genome from host sentinels, including those of the RNA silencing machinery.	[Valli, Adrian; Busnadiego, Idoia; Maliogka, Varvara; Ferrero, Diego; Caston, Jose R.; Francisco Rodriguez, Jose; Antonio Garcia, Juan] CSIC, Ctr Nacl Biotecnol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Rodriguez, JF (corresponding author), CSIC, Ctr Nacl Biotecnol, Madrid, Spain.	jfrodrig@cnb.csic.es; jagarcia@cnb.uam.es	Ferrero, Diego Sebastian/ABI-6041-2020; Caston, Jose/AAB-8825-2021; Valli, Adrian/H-6738-2012; Busnadiego, Idoia/O-8641-2016; Maliogka, Varvara/ABC-6161-2020; Garcia, Juan Antonio/N-3723-2014; Rodríguez, José F/T-8500-2017; Caston, Jose R/L-5896-2014	Ferrero, Diego Sebastian/0000-0001-6848-9939; Caston, Jose/0000-0003-2350-9048; Valli, Adrian/0000-0002-3266-7200; Busnadiego, Idoia/0000-0002-8781-9099; Maliogka, Varvara/0000-0001-5714-2710; Garcia, Juan Antonio/0000-0002-4861-9609; Rodríguez, José F/0000-0001-7944-5341; Caston, Jose R/0000-0003-2350-9048	Spanish MICINN [BIO2010-18541, BIO2009-12443, BFU2011-25902]; European Union [KBBE-204429]	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission)	This work was supported by grants BIO2010-18541, BIO2009-12443 and BFU2011-25902 from the Spanish MICINN and KBBE-204429 from European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2010, FEBS LETT, V584, P4313, DOI 10.1016/j.febslet.2010.09.031; Aliyari R, 2009, IMMUNOL REV, V227, P176, DOI 10.1111/j.1600-065X.2008.00722.x; Baulcombe D, 2005, TRENDS BIOCHEM SCI, V30, P290, DOI 10.1016/j.tibs.2005.04.012; Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Bivalkar-Mehla S, 2011, VIRUS RES, V155, P1, DOI 10.1016/j.virusres.2010.10.003; Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Bucher E, 2004, J GEN VIROL, V85, P983, DOI 10.1099/vir.0.19734-0; Burgyan J, 2011, TRENDS PLANT SCI, V16, P265, DOI 10.1016/j.tplants.2011.02.010; Carbonell A, 2012, MOL PLANT MICROBE IN, V25, P151, DOI 10.1094/MPMI-08-11-0216; CARRINGTON JC, 1989, EMBO J, V8, P365, DOI 10.1002/j.1460-2075.1989.tb03386.x; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Casanas A, 2008, STRUCTURE, V16, P29, DOI 10.1016/j.str.2007.10.023; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005; Chen WX, 2008, VIRUS RES, V133, P250, DOI 10.1016/j.virusres.2008.01.011; Coulibaly F, 2005, CELL, V120, P761, DOI 10.1016/j.cell.2005.01.009; Csorba T, 2009, ADV VIRUS RES, V75, P35, DOI 10.1016/S0065-3527(09)07502-2; Cullen BR, 2006, NAT IMMUNOL, V7, P563, DOI 10.1038/ni1352; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; de Vries W, 2008, INT J BIOCHEM CELL B, V40, P2007, DOI 10.1016/j.biocel.2008.04.015; Delgadillo MO, 2004, J GEN VIROL, V85, P993, DOI 10.1099/vir.0.19735-0; Delmas B, 2004, VIRUS TAXONOMY, P561; Diaz-Pendon JA, 2008, ANNU REV PHYTOPATHOL, V46, P303, DOI 10.1146/annurev.phyto.46.081407.104746; Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Ding SW, 2004, VIRUS RES, V102, P109, DOI 10.1016/j.virusres.2004.01.021; Fabozzi G, 2011, J VIROL, V85, P2512, DOI 10.1128/JVI.01160-10; Fenner BJ, 2006, J VIROL, V80, P6822, DOI 10.1128/JVI.00079-06; Fenner BJ, 2006, J VIROL, V80, P85, DOI 10.1128/JVI.80.1.85-94.2006; FernandezArias A, 1997, J VIROL, V71, P8014; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Garriga D, 2007, P NATL ACAD SCI USA, V104, P20540, DOI 10.1073/pnas.0704447104; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gomez-Casado E, 2011, VACCINE, V29, P2657, DOI 10.1016/j.vaccine.2011.01.097; Gottwein E, 2007, NATURE, V450, P1096, DOI 10.1038/nature05992; Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Haasnoot J, 2007, PLOS PATHOG, V3, P794, DOI 10.1371/journal.ppat.0030086; Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975; Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11; Harrison SC, 2007, FIELDS VIROLOGY, P59; Haseloff J, 1997, P NATL ACAD SCI USA, V94, P2122, DOI 10.1073/pnas.94.6.2122; Hemmes H, 2007, RNA, V13, P1079, DOI 10.1261/rna.444007; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Iwamoto T, 2005, J GEN VIROL, V86, P2807, DOI 10.1099/vir.0.80902-0; Ji J, 2008, J GEN VIROL, V89, P2761, DOI 10.1099/vir.0.2008/002923-0; Jing XL, 2011, J VIROL, V85, P12792, DOI 10.1128/JVI.05565-11; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Karjee S, 2010, J VIROL, V84, P10395, DOI 10.1128/JVI.00748-10; Kochan G, 2003, ARCH VIROL, V148, P723, DOI 10.1007/s00705-002-0949-5; Lakatos L, 2006, EMBO J, V25, P2768, DOI 10.1038/sj.emboj.7601164; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Li HW, 2005, FEBS LETT, V579, P5965, DOI 10.1016/j.febslet.2005.08.034; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Lichner Z, 2003, J GEN VIROL, V84, P975, DOI 10.1099/vir.0.18987-0; Lingel A, 2005, EMBO REP, V6, P1149, DOI 10.1038/sj.embor.7400583; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; Luque D, 2009, P NATL ACAD SCI USA, V106, P2148, DOI 10.1073/pnas.0808498106; Maliogka VI, 2012, J GEN VIROL, V93, P1601, DOI 10.1099/vir.0.042168-0; Maraver A, 2003, J VIROL, V77, P6438, DOI 10.1128/JVI.77.11.6438-6449.2003; Merai Z, 2006, J VIROL, V80, P5747, DOI 10.1128/JVI.01963-05; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pedersen T, 2007, J VIROL, V81, P6652, DOI 10.1128/JVI.02831-06; Qian S, 2009, P NATL ACAD SCI USA, V106, P605, DOI 10.1073/pnas.0806822106; Qiu WP, 2002, MOL PLANT MICROBE IN, V15, P269, DOI 10.1094/MPMI.2002.15.3.269; Reinisch KM, 2002, NAT STRUCT BIOL, V9, P714, DOI 10.1038/nsb1002-714; Rohila JS, 2004, PLANT J, V38, P172, DOI 10.1111/j.1365-313X.2004.02031.x; Saugar I, 2005, STRUCTURE, V13, P1007, DOI 10.1016/j.str.2005.04.012; Saugar I, 2010, J BIOL CHEM, V285, P3643, DOI 10.1074/jbc.M109.075994; Schnettler E, 2010, J VIROL, V84, P11542, DOI 10.1128/JVI.00595-10; Schopman NCT, 2012, NUCLEIC ACIDS RES, V40, P414, DOI 10.1093/nar/gkr719; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Shabalina SA, 2008, TRENDS ECOL EVOL, V23, P578, DOI 10.1016/j.tree.2008.06.005; Shimura H, 2011, BBA-GENE REGUL MECH, V1809, P601, DOI 10.1016/j.bbagrm.2011.04.005; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Soldan SS, 2005, J VIROL, V79, P234, DOI 10.1128/JVI.79.1.234-244.2005; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Szittya G, 2002, PLANT CELL, V14, P359, DOI 10.1105/tpc.010366; Tacken MGJ, 2002, J VIROL, V76, P11301, DOI 10.1128/JVI.76.22.11301-11311.2002; Valli A, 2009, ENCY LIFE SCI, DOI [10.1002/9780470015902.a9780470021261, DOI 10.1002/9780470015902.A9780470021261]; Valli A, 2008, J VIROL, V82, P974, DOI 10.1128/JVI.01664-07; Valli A, 2006, J VIROL, V80, P10055, DOI 10.1128/JVI.00985-06; Valli A, 2011, RNA, V17, P1148, DOI 10.1261/rna.2510611; van den Berg TP, 2000, REV SCI TECH OIE, V19, P527; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Van Stry M, 2012, J VIROL; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Wang Y, 2006, GASTROENTEROLOGY, V130, P883, DOI 10.1053/j.gastro.2005.12.028; Wu QF, 2010, CELL HOST MICROBE, V8, P12, DOI 10.1016/j.chom.2010.06.009; Xie Z, 2008, BIOCH BIOPHYS ACTA; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zhu YL, 2012, J VIROL, V86, P3038, DOI 10.1128/JVI.05741-11; Ziebell H, 2007, J GEN VIROL, V88, P2862, DOI 10.1099/vir.0.83138-0	104	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45957	10.1371/journal.pone.0045957	http://dx.doi.org/10.1371/journal.pone.0045957			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049903	gold, Green Submitted, Green Published			2022-12-27	WOS:000309556100108
J	Chen, HJ; Ye, JQ; Xu, KM; Angel, M; Shao, HX; Ferrero, A; Sutton, T; Perez, DR				Chen, Hongjun; Ye, Jianqiang; Xu, Kemin; Angel, Matthew; Shao, Hongxia; Ferrero, Andrea; Sutton, Troy; Perez, Daniel R.			Partial and Full PCR-Based Reverse Genetics Strategy for Influenza Viruses	PLOS ONE			English	Article							POLYMERASE-I PROMOTER; A VIRUS; RNA-POLYMERASE; TRANSFECTION SYSTEM; MOLECULAR ANATOMY; MESSENGER-RNA; 8 PLASMIDS; VIRAL-RNA; REPLICATION; GENERATION	Since 1999, plasmid-based reverse genetics (RG) systems have revolutionized the way influenza viruses are studied. However, it is not unusual to encounter cloning difficulties for one or more influenza genes while attempting to recover virus de novo. To overcome some of these shortcomings we sought to develop partial or full plasmid-free RG systems. The influenza gene of choice is assembled into a RG competent unit by virtue of overlapping PCR reactions containing a cDNA copy of the viral gene segment under the control of RNA polymerase I promoter (pol1) and termination (t1) signals - herein referred to as Flu PCR amplicons. Transfection of tissue culture cells with either HA or NA Flu PCR amplicons and 7 plasmids encoding the remaining influenza RG units, resulted in efficient virus rescue. Likewise, transfections including both HA and NA Flu PCR amplicons and 6 RG plasmids also resulted in efficient virus rescue. In addition, influenza viruses were recovered from a full set of Flu PCR amplicons without the use of plasmids.	[Chen, Hongjun; Ye, Jianqiang; Xu, Kemin; Angel, Matthew; Shao, Hongxia; Ferrero, Andrea; Sutton, Troy; Perez, Daniel R.] Univ Maryland, Virginia Maryland Reg Coll Vet Med, Dept Vet Med, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Perez, DR (corresponding author), Univ Maryland, Virginia Maryland Reg Coll Vet Med, Dept Vet Med, College Pk, MD 20742 USA.	dperez1@umd.edu	ye, jianqiang/ABH-8988-2020; Perez, Daniel R./D-5044-2016	Perez, Daniel R./0000-0002-6569-5689	National Institute of Allergy and Infectious Diseases, National Institutes of Health [HHSN266200700010C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was funded by contract No HHSN266200700010C from the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CF, 2009, ARCH MED RES, V40, P643, DOI 10.1016/j.arcmed.2009.10.007; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Feng LQ, 2009, ARCH VIROL, V154, P1151, DOI 10.1007/s00705-009-0422-9; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Hoffmann E, 2000, J GEN VIROL, V81, P2843, DOI 10.1099/0022-1317-81-12-2843; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2000, VIROLOGY, V267, P310, DOI 10.1006/viro.1999.0140; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Honda A, 1997, BIOL CHEM, V378, P483; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jin H, 2003, VIROLOGY, V306, P18, DOI 10.1016/S0042-6822(02)00035-1; Kawaguchi A, 2007, EMBO J, V26, P4566, DOI 10.1038/sj.emboj.7601881; LOPEZTURISO JA, 1990, VIRUS RES, V16, P325, DOI 10.1016/0168-1702(90)90056-H; Massin P, 2005, J VIROL, V79, P13811, DOI 10.1128/JVI.79.21.13811-13816.2005; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Perales B, 1997, J VIROL, V71, P1381, DOI 10.1128/JVI.71.2.1381-1385.1997; Perez DR, 1998, VIROLOGY, V249, P52, DOI 10.1006/viro.1998.9318; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Perez DR, 2001, J VIROL, V75, P8127, DOI 10.1128/JVI.75.17.8127-8136.2001; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shao H, 2011, VIROLOGY; Song H, 2007, J VIROL, V81, P9238, DOI 10.1128/JVI.00893-07; Suphaphiphat P, 2010, J VIROL, V84, P3721, DOI 10.1128/JVI.01925-09; Vreede FT, 2007, J VIROL, V81, P2196, DOI 10.1128/JVI.02187-06; Wan HQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002923; Wang ZT, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-102; Watanabe Y, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002068; Webby RJ, 2007, CURR TOP MICROBIOL, V315, P67; YAMANAKA K, 1991, P NATL ACAD SCI USA, V88, P5369, DOI 10.1073/pnas.88.12.5369; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145; Ye JQ, 2010, CLIN VACCINE IMMUNOL, V17, P1363, DOI 10.1128/CVI.00002-10; Yewdell JW, 2012, SCIENCE, V337, P164, DOI 10.1126/science.1225539; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Zell R, 2006, EMERG INFECT DIS, V12, P1607, DOI 10.3201/eid1210.060511	36	16	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46378	10.1371/journal.pone.0046378	http://dx.doi.org/10.1371/journal.pone.0046378			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029501	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900148
J	Davanian, H; Stranneheim, H; Bage, T; Lagervall, M; Jansson, L; Lundeberg, J; Yucel-Lindberg, T				Davanian, Haleh; Stranneheim, Henrik; Bage, Tove; Lagervall, Maria; Jansson, Leif; Lundeberg, Joakim; Yucel-Lindberg, Tulay			Gene Expression Profiles in Paired Gingival Biopsies from Periodontitis-Affected and Healthy Tissues Revealed by Massively Parallel Sequencing	PLOS ONE			English	Article							TNF-ALPHA; AGGRESSIVE PERIODONTITIS; CREVICULAR FLUID; SYNOVIAL TISSUE; OSTEOARTHRITIS; SARCOIDOSIS; PREDICTION; CARTILAGE; CCL18; CELLS	Periodontitis is a chronic inflammatory disease affecting the soft tissue and bone that surrounds the teeth. Despite extensive research, distinctive genes responsible for the disease have not been identified. The objective of this study was to elucidate transcriptome changes in periodontitis, by investigating gene expression profiles in gingival tissue obtained from periodontitis-affected and healthy gingiva from the same patient, using RNA-sequencing. Gingival biopsies were obtained from a disease-affected and a healthy site from each of 10 individuals diagnosed with periodontitis. Enrichment analysis performed among uniquely expressed genes for the periodontitis-affected and healthy tissues revealed several regulated pathways indicative of inflammation for the periodontitis-affected condition. Hierarchical clustering of the sequenced biopsies demonstrated clustering according to the degree of inflammation, as observed histologically in the biopsies, rather than clustering at the individual level. Among the top 50 upregulated genes in periodontitis-affected tissues, we investigated two genes which have not previously been demonstrated to be involved in periodontitis. These included interferon regulatory factor 4 and chemokine (C-C motif) ligand 18, which were also expressed at the protein level in gingival biopsies from patients with periodontitis. In conclusion, this study provides a first step towards a quantitative comprehensive insight into the transcriptome changes in periodontitis. We demonstrate for the first time site-specific local variation in gene expression profiles of periodontitis-affected and healthy tissues obtained from patients with periodontitis, using RNA-seq. Further, we have identified novel genes expressed in periodontitis tissues, which may constitute potential therapeutic targets for future treatment strategies of periodontitis.	[Davanian, Haleh; Bage, Tove; Yucel-Lindberg, Tulay] Karolinska Inst, Dept Dent Med, Div Periodontol, Huddinge, Sweden; [Stranneheim, Henrik; Lundeberg, Joakim] Royal Inst Technol KTH, Sch Biotechnol, Div Gen Technol, Sci Life Lab, Solna, Sweden; [Lagervall, Maria; Jansson, Leif] Stockholm Cty Council, Dept Periodontol Skanstull, Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology; Stockholm County Council	Davanian, H (corresponding author), Karolinska Inst, Dept Dent Med, Div Periodontol, Huddinge, Sweden.	haleh.davanian@ki.se		Yucel-Lindberg, Tulay/0000-0003-0129-8809	Swedish National Graduate School in Odontological Science, Swedish Research Council [73XD-15005]; Swedish Patent Revenue Fund, Stockholm County Council and Karolinska Institutet	Swedish National Graduate School in Odontological Science, Swedish Research Council; Swedish Patent Revenue Fund, Stockholm County Council and Karolinska Institutet	This study was supported by funds from the Swedish National Graduate School in Odontological Science, Swedish Research Council, project number 73XD-15005, the Swedish Patent Revenue Fund, Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Armitage G C, 1996, Ann Periodontol, V1, P37, DOI 10.1902/annals.1996.1.1.37; Auer J, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2294; Bage T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-241; Beikler T, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-30; COHEN C, 1981, J ORAL SURG, V39, P613; Covani U, 2008, J PERIODONTOL, V79, P1974, DOI [10.1902/jop.2008.080062, 10.1902/jop.2008.080062 ]; Dasanayake Ananda P, 2010, J Evid Based Dent Pract, V10, P246, DOI 10.1016/j.jebdp.2010.09.006; Davanian H, 2012, CYTOKINE, V57, P406, DOI 10.1016/j.cyto.2011.12.008; Demmer RT, 2008, J PERIODONTOL, V79, P2112, DOI [10.1902/jop.2008.080139, 10.1902/jop.2008.080139 ]; Feng ZM, 2006, PERIODONTOL 2000, V40, P50, DOI 10.1111/j.1600-0757.2005.00148.x; Gamonal J, 2000, J PERIODONTOL, V71, P1535, DOI 10.1902/jop.2000.71.10.1535; Hanada T, 2002, CYTOKINE GROWTH F R, V13, P413, DOI 10.1016/S1359-6101(02)00026-6; Haringman JJ, 2006, ANN RHEUM DIS, V65, P294, DOI 10.1136/ard.2005.037176; Kim DM, 2006, J PERIODONTOL, V77, P1043, DOI 10.1902/jop.2006.050254; Kurashige Y, 2008, ARCH ORAL BIOL, V53, P437, DOI 10.1016/j.archoralbio.2007.12.005; LANG NP, 1986, J CLIN PERIODONTOL, V13, P590, DOI 10.1111/j.1600-051X.1986.tb00852.x; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mahanonda R, 2007, PERIODONTOL 2000, V43, P41, DOI 10.1111/j.1600-0757.2006.00179.x; Momohara S, 2007, J RHEUMATOL, V34, P266; Moretti AJ, 2007, J PERIODONTOL, V78, P2209, DOI 10.1902/jop.2007.070117; Mudter J, 2011, INFLAMM BOWEL DIS, V17, P1343, DOI 10.1002/ibd.21476; Papapanou PN, 2004, EUR J ORAL SCI, V112, P216, DOI 10.1111/j.1600-0722.2004.00124.x; Passoja A, 2010, J CLIN PERIODONTOL, V37, P881, DOI 10.1111/j.1600-051X.2010.01602.x; Pradeep AR, 2009, J PERIODONTOL, V80, P1454, DOI 10.1902/jop.2009.090117; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Schaefer AS, 2010, HUM MOL GENET, V19, P553, DOI 10.1093/hmg/ddp508; Sorsa T, 2006, ANN MED, V38, P306, DOI 10.1080/07853890600800103; Stannus O, 2010, OSTEOARTHR CARTILAGE, V18, P1441, DOI 10.1016/j.joca.2010.08.016; Steinberg T, 2006, J PERIODONTAL RES, V41, P426, DOI 10.1111/j.1600-0765.2006.00884.x; Stranneheim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021910; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Suresh L, 2004, J PERIODONTOL, V75, P478, DOI 10.1902/jop.2004.75.3.478; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tu YK, 2004, J PERIODONTOL, V75, P127, DOI 10.1902/jop.2004.75.1.127; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Wang PL, 2003, BIOCHEM BIOPH RES CO, V305, P970, DOI 10.1016/S0006-291X(03)00821-0; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	39	39	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46440	10.1371/journal.pone.0046440	http://dx.doi.org/10.1371/journal.pone.0046440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029519	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900160
J	Wang, N; Zhu, MF; Tsao, SW; Man, K; Zhang, ZJ; Feng, YB				Wang, Ning; Zhu, Meifen; Tsao, Sai-Wah; Man, Kwan; Zhang, Zhangjin; Feng, Yibin			Up-Regulation of TIMP-1 by Genipin Inhibits MMP-2 Activities and Suppresses the Metastatic Potential of Human Hepatocellular Carcinoma	PLOS ONE			English	Article							JUN NH2-TERMINAL KINASE; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES-1; INDUCED APOPTOSIS; ACTIVATION; PROTEIN; INVASION; MIGRATION; GENIPOSIDE; AGENT	Aim of the Study: The aim of this study is to investigate the anti-metastatic effect of genipin and its underlying mechanism. Experimental Approach: healing and invasion chamber assays were introduced to examine the anti-migration and anti-invasion action of genipin in human hepatocellular carcinoma cell HepG2 and MHCC97L; orthotopical implantation model was used for in vivo evaluation. Gelatin Zymography, Immunoblotting, quantitative real-time polymerase chain reaction and ELISA assays were used to study the mechanisms underlying genipin's anti-metastatic effect. Key Results: Genipin suppresses the motility and invasiveness of HepG2 and MHCC97L at non-toxic doses, which may be correlated to the inhibition of genipin on MMP-2 activities in the cells. No significant reduced expression of MMP-2 was observed either at mRNA or at protein level. Furthermore, genipin could specifically up-regulate the expression of TIMP-1, the endogenous inhibitor of MMP-2 activities. Silencing of TIMP-1 by RNA interference abolishes genipin's anti-metastaic effect. Activation of p38 MAPK signaling was observed in genipin-treated cells, which is responsible for the TIMP-1 overexpression and MMP-2 inhibition. Presence of SB202190, the p38 MAPK inhibitor, attenuates the anti-metastatic potential of genipin in hepatocellular carcinoma. Orthotopical implantation model showed that genipin could suppress the intrahepatic metastatic as well as tumor expansion in liver without exhibiting potent toxicity. Conclusion: Our findings demonstrated the potential of genipin in suppressing hepatocellular carcinoma metastasis, and p38/TIMP-1/MMP-2 pathway may be involved as the key mechanism of its anti-metastasis effect. Hepatocellular carcinoma is one of the most malignant human cancers with high metastatic potential. The anti-metastatic potential of genipin was evaluated by both cell and animal model. Wound	[Wang, Ning; Zhu, Meifen; Zhang, Zhangjin; Feng, Yibin] Univ Hong Kong, Li Ka Shing Fac Med, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Tsao, Sai-Wah; Man, Kwan] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Tsao, Sai-Wah; Man, Kwan] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Feng, YB (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China.	yfeng@hku.hk	zhang, zhang/GQZ-6804-2022; zhang, zheng/HCH-9684-2022		research council of University of Hong Kong [10401764]; The Research Grant Committee (RGC) of Hong Kong SAR of China [10500362]	research council of University of Hong Kong; The Research Grant Committee (RGC) of Hong Kong SAR of China	The study was financially supported by grants from the research council of the University of Hong Kong (Project Code: 10401764), The Research Grant Committee (RGC) of Hong Kong SAR of China (RGC General Research Fund, Project Code: 10500362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Bernardo MM, 2003, BIOCHEM J, V374, P739, DOI 10.1042/BJ20030557; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Bradham C, 2006, CELL CYCLE, V5, P824, DOI 10.4161/cc.5.8.2685; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Cao HL, 2010, BIOL PHARM BULL, V33, P1343, DOI 10.1248/bpb.33.1343; Chen YS, 2007, ALLERGY, V62, P66, DOI 10.1111/j.1398-9995.2006.01255.x; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Ferlay J., 2001, INT J CANCER, V94, P153; Ho YL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/965846; Hong HY, 2007, BIOCHEM BIOPH RES CO, V362, P307, DOI 10.1016/j.bbrc.2007.07.165; Iyoda K, 2003, CANCER-AM CANCER SOC, V97, P3017, DOI 10.1002/cncr.11425; Jayasankar V, 2004, CIRCULATION, V110, pII180, DOI 10.1161/01.CIR.0000138946.29375.49; Kai HST, 2002, J BIOL CHEM, V277, P48696, DOI 10.1074/jbc.M209177200; KANAI T, 1987, CANCER, V60, P810, DOI 10.1002/1097-0142(19870815)60:4<810::AID-CNCR2820600417>3.0.CO;2-1; Kim BC, 2005, BIOCHEM PHARMACOL, V70, P1398, DOI 10.1016/j.bcp.2005.07.025; Kim ES, 2012, ONCOL REP, V27, P567, DOI 10.3892/or.2011.1508; Kitano A, 2006, OPHTHAL RES, V38, P355, DOI 10.1159/000096231; Kitano A, 2006, J CATARACT REFR SURG, V32, P1727, DOI 10.1016/j.jcrs.2006.05.015; Lee TK, 2005, CLIN CANCER RES, V11, P8458, DOI 10.1158/1078-0432.CCR-05-0447; Li FN, 2012, TOXICOL APPL PHARM, V261, P217, DOI 10.1016/j.taap.2012.04.011; Nam KN, 2010, INT IMMUNOPHARMACOL, V10, P493, DOI 10.1016/j.intimp.2010.01.011; Oh J, 2001, CELL, V107, P789, DOI 10.1016/S0092-8674(01)00597-9; Pratheeshkumar P, 2011, EUR J PHARMACOL, V668, P450, DOI 10.1016/j.ejphar.2011.07.029; Ramer R, 2007, ONCOGENE, V26, P5822, DOI 10.1038/sj.onc.1210358; Ramer R, 2010, BIOCHEM PHARMACOL, V79, P955, DOI 10.1016/j.bcp.2009.11.007; Senthilkumar K, 2011, CELL BIOCHEM FUNCT, V29, P87, DOI 10.1002/cbf.1725; Shen Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013086; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Suzuki Y, 2001, PLANTA MED, V67, P807, DOI 10.1055/s-2001-18842; Tanaka M, 2009, BIOL PHARM BULL, V32, P1220, DOI 10.1248/bpb.32.1220; Wang GF, 2009, ACTA PHARMACOL SIN, V30, P589, DOI 10.1038/aps.2009.31; Wang N, 2010, INTEGR CANCER THER, V9, P354, DOI 10.1177/1534735410379121; Wang SC, 2008, J CHROMATOGR A, V1212, P68, DOI 10.1016/j.chroma.2008.10.035; Zhu H, 2010, J PHARMACOL EXP THER, V334, P489, DOI 10.1124/jpet.110.165654	37	58	62	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46318	10.1371/journal.pone.0046318	http://dx.doi.org/10.1371/journal.pone.0046318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029478	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900133
J	Blasic, JR; Brown, RL; Robinson, PR				Blasic, Joseph R., Jr.; Brown, R. Lane; Robinson, Phyllis R.			Phosphorylation of Mouse Melanopsin by Protein Kinase A	PLOS ONE			English	Article							GANGLION-CELL PHOTORECEPTORS; DOPAMINE; LIGHT; EXPRESSION; INDUCTION; SLEEP	The visual pigment melanopsin is expressed in intrinsically photosensitive retinal ganglion cells (ipRGCs) in the mammalian retina, where it is involved in non-image forming light responses including circadian photoentrainment, pupil constriction, suppression of pineal melatonin synthesis, and direct photic regulation of sleep. It has recently been shown that the melanopsin-based light response in ipRGCs is attenuated by the neurotransmitter dopamine. Here, we use a heterologous expression system to demonstrate that mouse melanopsin can be phosphorylated by protein kinase A, and that phosphorylation can inhibit melanopsin signaling in HEK cells. Site-directed mutagenesis experiments revealed that this inhibitory effect is primarily mediated by phosphorylation of sites T186 and S287 located in the second and third intracellular loops of melanopsin, respectively. Furthermore, we show that this phosphorylation can occur in vivo using an in situ proximity-dependent ligation assay (PLA). Based on these data, we suggest that the attenuation of the melanopsin-based light response by dopamine is mediated by direct PKA phosphorylation of melanopsin, rather than phosphorylation of a downstream component of the signaling cascade.	[Blasic, Joseph R., Jr.; Robinson, Phyllis R.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA; [Brown, R. Lane] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA	University System of Maryland; University of Maryland Baltimore County; Washington State University	Robinson, PR (corresponding author), Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21228 USA.	probinso@umbc.edu			National Science Foundation [IOS0721608]; National Eye Institute [R01EY019053]; National Institutes of Health [T32 GM066706]; NATIONAL EYE INSTITUTE [R01EY019053] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by grants from the National Science Foundation to P. R. R (IOS0721608) and from the National Eye Institute to P. R. R. (R01EY019053). J.B. was supported by a National Institutes of Health training grant (T32 GM066706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Blasic JR, 2012, CELL MOL LIFE SCI, V69, P1551, DOI 10.1007/s00018-011-0891-3; Brown TM, 2011, J PHYSIOL-LONDON, V589, P1173, DOI 10.1113/jphysiol.2010.199877; CABELL L, 1993, INT J DEV NEUROSCI, V11, P357, DOI 10.1016/0736-5748(93)90007-Z; Cameron MA, 2009, EUR J NEUROSCI, V29, P761, DOI 10.1111/j.1460-9568.2009.06631.x; Doyle SE, 2002, J NEUROCHEM, V83, P211, DOI 10.1046/j.1471-4159.2002.01149.x; Gooley JJ, 2003, J NEUROSCI, V23, P7093, DOI 10.1523/JNEUROSCI.23-18-07093.2003; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; KRAMER SG, 1971, INVEST OPHTH VISUAL, V10, P438; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Peirson SN, 2004, MOL BRAIN RES, V123, P132, DOI 10.1016/j.molbrainres.2004.01.007; Porter ML, 2012, P ROY SOC B-BIOL SCI, V279, P3, DOI 10.1098/rspb.2011.1819; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Sakamoto K, 2005, EUR J NEUROSCI, V22, P3129, DOI 10.1111/j.1460-9568.2005.04512.x; SANDBERG M, 1991, BIOCHEM J, V279, P521, DOI 10.1042/bj2790521; Soderberg Ola, 2007, Genet Eng (N Y), V28, P85, DOI 10.1007/978-0-387-34504-8_5; Van Hook MJ, 2012, EUR J NEUROSCI, V35, P507, DOI 10.1111/j.1460-9568.2011.07975.x; Vugler AA, 2007, EXP NEUROL, V205, P26, DOI 10.1016/j.expneurol.2007.01.032; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Xue T, 2011, NATURE, V479, P67, DOI 10.1038/nature10567; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	29	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45387	10.1371/journal.pone.0045387	http://dx.doi.org/10.1371/journal.pone.0045387			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049792	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300023
J	Salnikov, AV; Liu, L; Platen, M; Gladkich, J; Salnikova, O; Ryschich, E; Mattern, J; Moldenhauer, G; Werner, J; Schemmer, P; Buchler, MW; Herr, I				Salnikov, Alexei V.; Liu, Li; Platen, Mitja; Gladkich, Jury; Salnikova, Olga; Ryschich, Eduard; Mattern, Juergen; Moldenhauer, Gerhard; Werner, Jens; Schemmer, Peter; Buechler, Markus W.; Herr, Ingrid			Hypoxia Induces EMT in Low and Highly Aggressive Pancreatic Tumor Cells but Only Cells with Cancer Stem Cell Characteristics Acquire Pronounced Migratory Potential	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; INITIATING CELLS; DRUG-RESISTANCE; SOLID TUMORS; PROGRESSION; EXPRESSION; IDENTIFICATION; CONTRIBUTES; METASTASIS; INVASION	Tumor hypoxia induces epithelial-mesenchymal transition (EMT), which induces invasion and metastasis, and is linked to cancer stem cells (CSCs). Whether EMT generates CSCs de novo, enhances migration of existing CSCs or both is unclear. We examined patient tissue of pancreatic ductal adenocarcinoma (PDA) along with carcinomas of breast, lung, kidney, prostate and ovary. For in vitro studies, five established PDA cell lines classified as less (CSClow) and highly aggressive CSC-like cells (CSChigh) were examined by single and double immunofluorescence microscopy, wound-, transwell-, and time-lapse microscopy. HIF-1 alpha and Slug, as well as HIF-2 alpha and CD133 were co-expressed pointing to a putative co-existence of hypoxia, EMT and CSCs in vivo. CSChigh cells exhibited high basal expression of the mesenchymal Vimentin protein but low or absent expression of the epithelial marker E-cadherin, with the opposite result in CSClow cells. Hypoxia triggered altering of cell morphology from an epithelial to a mesenchymal phenotype, which was more pronounced in CSChigh cells. Concomitantly, E-cadherin expression was reduced and expression of Vimentin, Slug, Twist2 and Zeb1 enhanced. While hypoxia caused migration in all cell lines, velocity along with the percentage of migrating, polarized and pseudopodia-forming cells was significantly higher in CSChigh cells. These data indicate that hypoxia-induced EMT occurs in PDA and several other tumor entities. However although hypoxia-induced EMT signaling occurs in all tumor cell populations, only the stem-like cells acquire high migratory potential and thus may be responsible for invasion and metastasis.	[Salnikov, Alexei V.; Liu, Li; Platen, Mitja; Gladkich, Jury; Herr, Ingrid] Heidelberg Univ, Dept Gen Surg, Mol OncoSurg Grp, Heidelberg, Germany; [Salnikov, Alexei V.; Moldenhauer, Gerhard] German Canc Res Ctr, Dept Translat Immunol, D-6900 Heidelberg, Germany; [Salnikov, Alexei V.; Moldenhauer, Gerhard] Natl Ctr Tumor Dis, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Herr, I (corresponding author), Heidelberg Univ, Dept Gen Surg, Mol OncoSurg Grp, Heidelberg, Germany.	i.herr@dkfz.de	Liu, Li/AEU-6051-2022; Herr, Ingrid/AAA-2276-2022		German Cancer Aid (Deutsche Krebshilfe) [109362]; German Research Community [DFG HE 3186/11-1]; German-Israeli Foundation for Scientific Research and Development [GIF 1058-7.11/2008]	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe); German Research Community(German Research Foundation (DFG)); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development)	This study was supported by grants from the German Cancer Aid (Deutsche Krebshilfe 109362), German Research Community (DFG HE 3186/11-1) and German-Israeli Foundation for Scientific Research and Development (GIF 1058-7.11/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bhaskara VK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030905; Brown JM, 1998, CANCER RES, V58, P1408; Celia-Terrassa T, 2012, J CLIN INVEST, V122, P1849, DOI 10.1172/JCI59218; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chang Q, 2011, CANCER RES, V71, P3110, DOI 10.1158/0008-5472.CAN-10-4049; Cheng JC, 2011, ONCOGENE, V30, P3930, DOI 10.1038/onc.2011.117; Chia SK, 2001, J CLIN ONCOL, V19, P3660, DOI 10.1200/JCO.2001.19.16.3660; Durand RE, 2001, CANCER METAST REV, V20, P57, DOI 10.1023/A:1013181107707; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Fang X, 2011, ONCOGENE, V30, P4707, DOI 10.1038/onc.2011.181; Gukovskaya AS, 2004, PANCREATOLOGY, V4, P567, DOI 10.1159/000082182; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Hoffmann AC, 2008, NEOPLASIA, V10, P674, DOI 10.1593/neo.08292; Hotz B, 2007, CLIN CANCER RES, V13, P4769, DOI 10.1158/1078-0432.CCR-06-2926; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Kabashima A, 2009, INT J CANCER, V124, P2771, DOI 10.1002/ijc.24349; Kallifatidis G, 2009, GUT, V58, P949, DOI 10.1136/gut.2008.149039; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Maier HJ, 2010, CANCER LETT, V295, P214, DOI 10.1016/j.canlet.2010.03.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Ohuchida K, 2007, INT J CANCER, V120, P1634, DOI 10.1002/ijc.22295; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Salnikov AV, 2010, INT J CANCER, V126, P950, DOI 10.1002/ijc.24822; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2000, ADV EXP MED BIOL, V475, P123; Simeone DM, 2008, CLIN CANCER RES, V14, P5646, DOI 10.1158/1078-0432.CCR-08-0584; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sipos B, 2003, VIRCHOWS ARCH, V442, P444, DOI 10.1007/s00428-003-0784-4; Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Vaupel P, 2002, Wien Med Wochenschr, V152, P334; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; Zhang Y, 2012, ONCOL REP, V27, P1599, DOI 10.3892/or.2012.1681; Zhou W, 2010, INT J ONCOL, V37, P551, DOI 10.3892/ijo_00000704	45	106	115	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46391	10.1371/journal.pone.0046391	http://dx.doi.org/10.1371/journal.pone.0046391			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050024	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300114
J	Sancho, P; Mainez, J; Crosas-Molist, E; Roncero, C; Fernandez-Rodriguez, CM; Pinedo, F; Huber, H; Eferl, R; Mikulits, W; Fabregat, I				Sancho, Patricia; Mainez, Jessica; Crosas-Molist, Eva; Roncero, Cesar; Fernandez-Rodriguez, Conrado M.; Pinedo, Fernando; Huber, Heidemarie; Eferl, Robert; Mikulits, Wolfgang; Fabregat, Isabel			NADPH Oxidase NOX4 Mediates Stellate Cell Activation and Hepatocyte Cell Death during Liver Fibrosis Development	PLOS ONE			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; GROWTH-FACTOR-BETA; TGF-BETA; MESENCHYMAL TRANSITION; INDUCED APOPTOSIS; OXIDATIVE STRESS; UP-REGULATION; DIFFERENTIATION; FIBROGENESIS	A role for the NADPH oxidases NOX1 and NOX2 in liver fibrosis has been proposed, but the implication of NOX4 is poorly understood yet. The aim of this work was to study the functional role of NOX4 in different cell populations implicated in liver fibrosis: hepatic stellate cells (HSC), myofibroblats (MFBs) and hepatocytes. Two different mice models that develop spontaneous fibrosis (Mdr2(-/-)/p19ARF(-/-), Stat3(Delta hc)/Mdr2(-/-)) and a model of experimental induced fibrosis (CCl4) were used. In addition, gene expression in biopsies from chronic hepatitis C virus (HCV) patients or non-fibrotic liver samples was analyzed. Results have indicated that NOX4 expression was increased in the livers of all animal models, concomitantly with fibrosis development and TGF-beta pathway activation. In vitro TGF-beta-treated HSC increased NOX4 expression correlating with transdifferentiation to MFBs. Knockdown experiments revealed that NOX4 downstream TGF-beta is necessary for HSC activation as well as for the maintenance of the MFB phenotype. NOX4 was not necessary for TGF-beta-induced epithelial-mesenchymal transition (EMT), but was required for TGF-beta-induced apoptosis in hepatocytes. Finally, NOX4 expression was elevated in patients with hepatitis C virus (HCV)-derived fibrosis, increasing along the fibrosis degree. In summary, fibrosis progression both in vitro and in vivo (animal models and patients) is accompanied by increased NOX4 expression, which mediates acquisition and maintenance of the MFB phenotype, as well as TGF-beta-induced death of hepatocytes.	[Sancho, Patricia; Mainez, Jessica; Crosas-Molist, Eva; Fabregat, Isabel] Bellvitge Biomed Res Inst IDIBELL, Biol Clues Invas & Metastat Phenotype Grp, Barcelona, Spain; [Roncero, Cesar] Univ Complutense, Fac Farm, Dept Bioquim & Biol Mol 2, E-28040 Madrid, Spain; [Roncero, Cesar] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Madrid, Spain; [Fernandez-Rodriguez, Conrado M.] Hosp Univ Fdn Alcorcon, Serv Gastroenterol, Madrid, Spain; [Fernandez-Rodriguez, Conrado M.] Univ Rey Juan Carlos, Madrid, Spain; [Pinedo, Fernando] Hosp Univ Fdn Alcorcon, Unit Pathol, Madrid, Spain; [Huber, Heidemarie; Eferl, Robert; Mikulits, Wolfgang] Med Univ Vienna, Div Inst Canc Res, Dept Med 1, Vienna, Austria; [Eferl, Robert] Ludwig Boltzmann Inst Canc Res LBI CR, Vienna, Austria; [Fabregat, Isabel] Univ Barcelona, Dept Physiol Sci 2, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Complutense University of Madrid; Hospital Clinico San Carlos; Alcorcon Foundation University Hospital; Universidad Rey Juan Carlos; Alcorcon Foundation University Hospital; Medical University of Vienna; Ludwig Boltzmann Institute; University of Barcelona	Fabregat, I (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Biol Clues Invas & Metastat Phenotype Grp, Barcelona, Spain.	ifabregat@idibell.cat	Roncero, Cesáreo/H-9039-2015; Sancho, Patricia/ABH-5258-2020; Mikulits, Wolfgang/AAH-4043-2021; Fabregat, Isabel/H-7038-2015	Roncero, Cesáreo/0000-0001-7608-8553; Sancho, Patricia/0000-0002-1092-5395; Pinedo Moraleda, Fernando/0000-0001-7470-093X; Fabregat, Isabel/0000-0003-0136-8440; Mikulits, Wolfgang/0000-0003-4612-7106; Eferl, Robert/0000-0002-6074-7144; Crosas Molist, Eva/0000-0002-2408-0071; Fernandez Rodriguez, Conrado M/0000-0002-1915-2157	Ministerio de Ciencia e Innovacion (MICINN), Spain [BFU2009-07219, ISCIII-RTICC RD06/0020]; AGAUR-Generalitat de Catalunya [2009SGR-312]; European Union [HEALTH-F4-2008-202047]; FPI; FPU; MICINN, Spain	Ministerio de Ciencia e Innovacion (MICINN), Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); AGAUR-Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); European Union(European Commission); FPI(Spanish Government); FPU(Spanish Government); MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants to IF from the Ministerio de Ciencia e Innovacion (MICINN), Spain (BFU2009-07219 and ISCIII-RTICC RD06/0020) and AGAUR-Generalitat de Catalunya (2009SGR-312). The work of WM was supported by the European Union, FP7 Health Research project number HEALTH-F4-2008-202047. JM and EC-M were recipients of pre-doctoral fellowships from the FPI and FPU programs, respectively, MICINN, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhilash PA, 2012, FREE RADICAL RES, V46, P204, DOI 10.3109/10715762.2011.647691; Amara N, 2010, THORAX, V65, P733, DOI 10.1136/thx.2009.113456; Aram G, 2009, HEPATOLOGY, V49, P911, DOI 10.1002/hep.22708; Baghdasaryan A, 2010, GUT, V59, P521, DOI 10.1136/gut.2009.186528; Barikbin R, 2012, HEPATOLOGY, V55, P553, DOI 10.1002/hep.24711; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Boudreau HE, 2009, J VIROL, V83, P12934, DOI 10.1128/JVI.01059-09; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Caja L, 2007, CELL SIGNAL, V19, P683, DOI 10.1016/j.cellsig.2006.09.002; Caja L, 2011, J CELL PHYSIOL, V226, P1214, DOI 10.1002/jcp.22439; Carmona-Cuenca I, 2008, J HEPATOL, V49, P965, DOI 10.1016/j.jhep.2008.07.021; Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Cui WH, 2011, HEPATOLOGY, V54, P949, DOI 10.1002/hep.24465; de Andrade JA, 2009, CURR OPIN RHEUMATOL, V21, P649, DOI 10.1097/BOR.0b013e328330da9b; De Minicis S, 2010, HEPATOLOGY, V52, P1420, DOI 10.1002/hep.23804; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009; Foo NP, 2011, TOXICOLOGY, V282, P39, DOI 10.1016/j.tox.2011.01.009; Franco DL, 2010, J CELL SCI, V123, P3467, DOI 10.1242/jcs.068692; Gonzalez-Rodriguez A, 2007, ENDOCRINOLOGY, V148, P594, DOI 10.1210/en.2006-0644; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Ikeda R, 2011, INFLAMM RES, V60, P597, DOI 10.1007/s00011-011-0309-6; Jiang JX, 2012, FREE RADICAL BIO MED, V53, P289, DOI 10.1016/j.freeradbiomed.2012.05.007; Jiang JX, 2010, GASTROENTEROLOGY, V139, P1375, DOI 10.1053/j.gastro.2010.05.074; Laleu B, 2010, J MED CHEM, V53, P7715, DOI 10.1021/jm100773e; Mair M, 2010, GASTROENTEROLOGY, V138, P2499, DOI 10.1053/j.gastro.2010.02.049; Martin-Garrido A, FREE RADIC BIOL MED, V50, P354; Matsuzaki K, 2009, FRONT BIOSCI-LANDMRK, V14, P2923, DOI 10.2741/3423; Mitchell C, 2009, AM J PATHOL, V175, P1929, DOI 10.2353/ajpath.2009.090332; Murillo MM, 2007, BIOCHEM J, V405, P251, DOI 10.1042/BJ20061846; Paik YH, 2011, HEPATOLOGY, V53, P1730, DOI 10.1002/hep.24281; Povero D, 2010, HISTOL HISTOPATHOL, V25, P1075, DOI 10.14670/HH-25.1075; Proell V, 2005, BBA-MOL CELL RES, V1744, P76, DOI 10.1016/j.bbamcr.2004.12.009; Proell Verena, 2007, Comp Hepatol, V6, P1, DOI 10.1186/1476-5926-6-1; Rowe RG, 2011, MOL CELL BIOL, V31, P2392, DOI 10.1128/MCB.01218-10; Sampson N, 2011, MOL ENDOCRINOL, V25, P503, DOI 10.1210/me.2010-0340; Sanchez A, 1996, J BIOL CHEM, V271, P7416, DOI 10.1074/jbc.271.13.7416; Sancho P, 2011, FREE RADICAL BIO MED, V51, P1789, DOI 10.1016/j.freeradbiomed.2011.08.011; Sancho P, 2009, BBA-MOL CELL RES, V1793, P253, DOI 10.1016/j.bbamcr.2008.09.003; Valdes F, 2002, MOL CANCER RES, V1, P68; van Zijl F, 2009, ONCOGENE, V28, P4022, DOI 10.1038/onc.2009.253; Wells RG, 2010, HEPATOLOGY, V51, P737, DOI 10.1002/hep.23529	45	110	117	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45285	10.1371/journal.pone.0045285	http://dx.doi.org/10.1371/journal.pone.0045285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049784	Green Published, gold			2022-12-27	WOS:000309517300020
J	Wang, ZT; Hu, JJ; Fan, R; Zhou, J; Zhong, J				Wang, Zhengting; Hu, Jiajia; Fan, Rong; Zhou, Jie; Zhong, Jie			Association between CD14 Gene C-260T Polymorphism and Inflammatory Bowel Disease: A Meta-Analysis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; CROHNS-DISEASE; PROMOTER POLYMORPHISM; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; NOD2/CARD15 GENE; SOLUBLE CD14; TLR4; CARD15/NOD2; RECOGNITION	Background: The gene encoding CD14 has been proposed as an IBD-susceptibility gene with its polymorphism C-260T being widely evaluated, yet with conflicting results. The aim of this study was to investigate the association between this polymorphism and IBD by conducting a meta-analysis. Methodology/Principal Findings: Seventeen articles met the inclusion criteria, which included a total of 18 case-control studies, including 1900 ulcerative colitis (UC) cases, 2535 Crohn's disease (CD) cases, and 4004 controls. Data were analyzed using STATA software. Overall, association between C-260T polymorphism and increased UC risk was significant in allelic comparison (odds ratio [OR] = 1.21, 95% confidence interval [CI]: 1.02-1.43; P = 0.027), homozygote model (OR = 1.44, 95% CI: 1.03-2.01; P = 0.033), as well as dominant model (OR = 1.36, 95% CI: 1.06-1.75; P = 0.016). However, there was negative association between this polymorphism and CD risk across all genetic models. Subgroup analyses by ethnicity suggested the risk-conferring profiles of -260T allele and -260 TT genotype with UC in Asians, but not in Caucasians. There was a low probability of publication bias. Conclusions/Significance: Expanding previous results of individual studies, our findings demonstrated that CD14 gene C-260T polymorphism might be a promising candidate marker in susceptibility to UC, especially in Asians.	[Wang, Zhengting; Fan, Rong; Zhou, Jie; Zhong, Jie] Shanghai Jiao Tong Univ, Dept Gastroenterol, Sch Med, Ruijin Hosp, Shanghai 200030, Peoples R China; [Hu, Jiajia] Shanghai Jiao Tong Univ, Dept Nucl Med, Sch Med, Ruijin Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhong, J (corresponding author), Shanghai Jiao Tong Univ, Dept Gastroenterol, Sch Med, Ruijin Hosp, Shanghai 200030, Peoples R China.	Jimmyzj64@medmail.com.cn						Arnott IDR, 2004, GENES IMMUN, V5, P417, DOI 10.1038/sj.gene.6364111; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Baumgart DC, 2007, DIGESTION, V76, P196, DOI 10.1159/000112646; Cho JH, 2011, GASTROENTEROLOGY, V140, P1704, DOI 10.1053/j.gastro.2011.02.046; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fukata M, 2007, BIOCHEM SOC T, V35, P1473, DOI 10.1042/BST0351473; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Gazouli M, 2005, WORLD J GASTROENTERO, V11, P681, DOI 10.3748/wjg.v11.i5.681; Griga T, 2005, EUR J MED RES, V10, P183; Guo QS, 2005, POSTGRAD MED J, V81, P526, DOI 10.1136/pgmj.2004.030825; Han DM, 2010, AM J RHINOL ALLERGY, V24, pE1, DOI 10.2500/ajra.2010.24.3411; Hemminki K, 2006, NAT REV GENET, V7, P958, DOI 10.1038/nrg2009; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kim EJ, 2012, J KOREAN MED SCI, V27, P72, DOI [10.3346/jkms.2011.27.1.72, 10.3346/jkms.2012.27.1.72]; Klausz G, 2005, SCAND J GASTROENTERO, V40, P1197, DOI 10.1080/00365520510023350; Klein W, 2002, SCAND J GASTROENTERO, V37, P189, DOI 10.1080/003655202753416867; Klein W, 2003, SCAND J GASTROENTERO, V38, P834, DOI 10.1080/00365520310003147; Lakatos PL, 2011, INFLAMM BOWEL DIS, V17, P767, DOI 10.1002/ibd.21402; Lee JC, 2011, BRIEF FUNCT GENOMICS, V10, P71, DOI 10.1093/bfgp/elr009; Leong RWL, 2003, ALIMENT PHARM THER, V17, P1465, DOI 10.1046/j.1365-2036.2003.01607.x; Leung E, 2005, IMMUNOL CELL BIOL, V83, P498, DOI 10.1111/j.1440-1711.2005.01362.x; Ma YH, 1999, INFLAMM BOWEL DIS, V5, P271, DOI 10.1097/00054725-199911000-00005; Marks DJB, 2011, CURR OPIN GASTROEN, V27, P328, DOI 10.1097/MOG.0b013e3283463b45; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Nagya Z, 2005, ANN NY ACAD SCI, V1051, P45, DOI 10.1196/annals.1361.045; Obana N, 2002, SCAND J GASTROENTERO, V37, P699, DOI 10.1080/00365520212504; Ouburg S, 2005, GUT, V54, P439; Petermann I, 2009, HUM IMMUNOL, V70, P440, DOI 10.1016/j.humimm.2009.03.002; Peters KE, 2005, SCAND J GASTROENTERO, V40, P194, DOI 10.1080/00365520510011506; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Sivaram G, 2012, HUM IMMUNOL, V73, P201, DOI 10.1016/j.humimm.2011.12.006; Thompson AI, 2011, INFLAMM BOWEL DIS, V17, P831, DOI 10.1002/ibd.21375; Torok HP, 2004, CLIN IMMUNOL, V112, P85, DOI 10.1016/j.clim.2004.03.002; van Heel DA, 2004, HUM MOL GENET, V13, P763, DOI 10.1093/hmg/ddh090; Vermeire S, 2005, GENES IMMUN, V6, P637, DOI 10.1038/sj.gene.6364257; Wang FY, 2007, J GASTROEN HEPATOL, V22, P925, DOI 10.1111/j.1440-1746.2007.04909.x; Waterman M, 2011, INFLAMM BOWEL DIS, V17, P1936, DOI 10.1002/ibd.21579; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Wu XH, 2010, J ASTHMA, V47, P238, DOI 10.3109/02770900903509099; [薛惠平 XUE Huiping], 2007, [上海交通大学学报. 医学版, Journal of Shanghai Jiaotong University. Medical Science], V27, P1127; Yamazaki K, 2002, J HUM GENET, V47, P469, DOI 10.1007/s100380200067; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zeng HS, 2009, J RHEUMATOL, V36, P2025, DOI 10.3899/jrheum.081093; Zhang YG, 2011, IMMUNOGENETICS, V63, P23, DOI 10.1007/s00251-010-0489-1	48	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45144	10.1371/journal.pone.0045144	http://dx.doi.org/10.1371/journal.pone.0045144			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049772	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300017
J	Dechavanne, C; Guillonneau, F; Chiappetta, G; Sago, L; Levy, P; Salnot, V; Guitard, E; Ehrenmann, F; Broussard, C; Chafey, P; Le Port, A; Vinh, J; Mayeux, P; Dugoujon, JM; Lefranc, MP; Migot-Nabias, F				Dechavanne, Celia; Guillonneau, Francois; Chiappetta, Giovanni; Sago, Laila; Levy, Prisca; Salnot, Virginie; Guitard, Evelyne; Ehrenmann, Francois; Broussard, Cedric; Chafey, Philippe; Le Port, Agnes; Vinh, Joelle; Mayeux, Patrick; Dugoujon, Jean-Michel; Lefranc, Marie-Paule; Migot-Nabias, Florence			Mass Spectrometry Detection of G3m and IGHG3 Alleles and Follow-Up of Differential Mother and Neonate IgG3	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; IMMUNOGLOBULIN; SEQUENCE; ANTIBODIES; GM; TRANSMISSION; RECEPTORS; ALLOTYPES; NEWBORNS; MALARIA	Mass spectrometry (MS) analysis for detection of immunoglobulins (IG) of the human IgG3 subclass is described that relies on polymorphic amino acids of the heavy gamma3 chains. IgG3 is the most polymorphic human IgG subclass with thirteen G3m allotypes located on the constant CH2 and CH3 domains of the gamma3 chain, the combination of which leads to six major G3m alleles. Amino acid changes resulting of extensive sequencing previously led to the definition of 19 IGHG3 alleles that have been correlated to the G3m alleles. As a proof of concept, MS proteotypic peptides were defined which encompass discriminatory amino acids for the identification of the G3m and IGHG3 alleles. Plasma samples originating from ten individuals either homozygous or heterozygous for different G3m alleles, and including one mother and her baby (drawn sequentially from birth to 9 months of age), were analyzed. Total IgG3 were purified using affinity chromatography and then digested by a combination of AspN and trypsin proteases, and peptides of interest were detected by mass spectrometry. The sensitivity of the method was assessed by mixing variable amounts of two plasma samples bearing distinct G3m allotypes. A label-free approach using the high-performance liquid chromatography (HPLC) retention time of peptides and their MS mass analyzer peak intensity gave semi-quantitative information. Quantification was realized by selected reaction monitoring (SRM) using synthetic peptides as internal standards. The possibility offered by this new methodology to detect and quantify neo-synthesized IgG in newborns will improve knowledge on the first acquisition of antibodies in infants and constitutes a promising diagnostic tool for vertically-transmitted diseases.	[Dechavanne, Celia; Levy, Prisca; Le Port, Agnes; Migot-Nabias, Florence] IRD, Unite Mixte Rech UMR Mere & Enfant Face Infect Tr, Paris, France; [Dechavanne, Celia; Levy, Prisca; Le Port, Agnes; Migot-Nabias, Florence] Univ Paris 05, Fac Pharm, Paris, France; [Chiappetta, Giovanni; Vinh, Joelle] ESPCI ParisTech, Unite Spectrometrie Masse Biol & Proteom SMBP, Unite Serv & Rech USR CNRS 3149, Paris, France; [Guitard, Evelyne; Dugoujon, Jean-Michel] Univ Toulouse 3, Lab Anthropol Mol & Imagerie Synth, Unite Mixte Rech UMR 5288, CNRS, F-31062 Toulouse, France; [Ehrenmann, Francois; Lefranc, Marie-Paule] Univ Montpellier 2, Int ImMunoGeneT Informat Syst IMGT, Lab ImmunoGenet Mol LIGM, Unite Propre Rech UPR CNRS 1142,IGH, Montpellier, France; [Chafey, Philippe] INSERM, Plate Forme Electophorese Bidimens Inst Cochin Pe, U1016, Paris, France; [Mayeux, Patrick] Univ Paris 05, INSERM, U1016, Dept Hematol,Inst Cochin,CNRS, Paris, France; [Lefranc, Marie-Paule] Inst Univ France, Paris, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut Universitaire de France	Dechavanne, C (corresponding author), IRD, Unite Mixte Rech UMR Mere & Enfant Face Infect Tr, Paris, France.	celia.dechavanne@gmail.com	Vinh, Joelle/K-1347-2015	Vinh, Joelle/0000-0001-7184-2668; Guillonneau, Francois/0000-0003-1484-4696; Broussard, Cedric/0000-0001-9508-2341; Ehrenmann, Francois/0000-0003-2727-0070; Dechavanne, Celia/0000-0001-8439-9976; Le Port, Agnes/0000-0002-8337-6569; Salnot, Virginie/0000-0002-7530-4493; Migot-Nabias, Florence/0000-0001-9982-594X				BRUSCO A, 1995, IMMUNOGENETICS, V42, P414, DOI 10.1007/BF00179404; Chippaux JP, 2010, TROP MED INT HEALTH, V15, P87, DOI 10.1111/j.1365-3156.2009.02431.x; Dard P, 2001, EUR J HUM GENET, V9, P765, DOI 10.1038/sj.ejhg.5200700; Dugoujon JM, 2004, AM J PHYS ANTHROPOL, V125, P175, DOI 10.1002/ajpa.10405; Ehrenmann F, 2010, NUCLEIC ACIDS RES, V38, pD301, DOI 10.1093/nar/gkp946; FIELD LL, 1989, GENET EPIDEMIOL, V6, P31, DOI 10.1002/gepi.1370060108; Giudicelli W, 2005, NUCLEIC ACIDS RES, V33, pD256, DOI 10.1093/nar/gki010; Goetze AM, 2011, MOL IMMUNOL, V49, P338, DOI 10.1016/j.molimm.2011.09.002; HUCK S, 1986, NUCLEIC ACIDS RES, V14, P1779, DOI 10.1093/nar/14.4.1779; HUCK S, 1989, IMMUNOGENETICS, V30, P250, DOI 10.1007/BF02421328; JEFFERIS R, 1992, IMMUNOL LETT, V31, P143, DOI 10.1016/0165-2478(92)90141-A; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; Lefranc G., 1976, ACTA ANTHR, V1, P34; Lefranc M.P., 1990, HUMAN IGG SUBCLASSES, P43; Lefranc M-P., 2001, IMMUNOGLOBULIN FACTS; Lefranc Marie-Paule, 2012, Methods Mol Biol, V882, P635, DOI 10.1007/978-1-61779-842-9_34; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lefranc MP, 2005, DEV COMP IMMUNOL, V29, P185, DOI 10.1016/j.dci.2004.07.003; LeHesran JY, 1997, AM J EPIDEMIOL, V146, P826, DOI 10.1093/oxfordjournals.aje.a009200; Lindner AK, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000783; Migot-Nabias F, 2008, J INFECT DIS, V198, P1892, DOI 10.1086/593210; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pinon JM, 2001, J CLIN MICROBIOL, V39, P2267, DOI 10.1128/JCM.39.6.2267-2271.2001; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Schijman AG, 2003, J ANTIMICROB CHEMOTH, V52, P441, DOI 10.1093/jac/dkg338; Simister NE, 1997, J REPROD IMMUNOL, V37, P1, DOI 10.1016/S0165-0378(97)00068-5; VANLOGHEM E, 1982, VOX SANG, V43, P301; WILLIAMS AI, 1969, ARCH DIS CHILD, V44, P511, DOI 10.1136/adc.44.236.511	28	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46097	10.1371/journal.pone.0046097	http://dx.doi.org/10.1371/journal.pone.0046097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049948	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100135
J	Erkens, PMG; ten Cate, H; Buller, HR; Prins, MH				Erkens, Petra M. G.; ten Cate, Hugo; Buller, Harry R.; Prins, Martin H.			Benchmark for Time in Therapeutic Range in Venous Thromboembolism: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; ORAL ANTICOAGULANT-THERAPY; LONG-TERM TREATMENT; NONRHEUMATIC ATRIAL-FIBRILLATION; VITAMIN-K ANTAGONISTS; INTRAVENOUS UNFRACTIONATED HEPARIN; SYMPTOMATIC PULMONARY-EMBOLISM; XA INHIBITOR RIVAROXABAN; NON-INFERIORITY TRIAL	Introduction: The percentage of time within the target INR range 2.0 to 3.0 (TTR) in patients treated with vitamin K antagonists varies considerably among efficacy-studies of novel anticoagulants. In order to properly asses the quality of anticoagulant control in upcoming cost-effectiveness studies and real life registries this systematic review reports a benchmark of TTR for different treatment durations in patients with venous thromboembolism and discusses ways to calculate TTR. Methods: Medline and Embase were searched for studies published between January 1990 and May 2012. Randomized controlled trials and cohort studies reporting the TTR in patients with objectively confirmed venous thromboembolism treated with vitamin K antagonists (VKA) were eligible. Duplicate reports, studies only reporting INR during initial treatment or with VKA treatment less than 3 months were excluded. Three authors assessed trials for inclusion and extracted data independently. Discrepancies were resolved by discussion between the reviewers. A meta-analysis was performed by calculating a weighted mean, based on the number of participants in each included study, for each time-period in which the TTR was measured since the confirmation of the diagnosis of VTE. Results: Forty studies were included ( 26064 patients). The weighted means of TTR were 54.0% in the first month since the start of treatment, 55.6% in months 1 to 3, 60.0% in months 2 to 3, 60.0% in the months1 to 6+ and 75.2% in months 4 to 12+. Five studies reported TTR in classes. The INR in these studies was >= 67% of time in therapeutic range in 72.0% of the patients. Conclusion: Reported quality of VKA treatment is highly dependent on the time-period since the start of treatment, with TTR ranging from approximately 56% in studies including the 1st month to 75% in studies excluding the first 3 months.	[Erkens, Petra M. G.] Maastricht Univ Med Ctr, Sch Publ Hlth & Primary Care, Dept Family Med, Maastricht, Netherlands; [Erkens, Petra M. G.; ten Cate, Hugo] Maastricht Univ Med Ctr, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands; [ten Cate, Hugo] Maastricht Univ Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Buller, Harry R.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands; [Prins, Martin H.] Maastricht Univ Med Ctr, Dept Clin Epidemiol & Med Technol Assessment, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Maastricht University Medical Centre (MUMC)	Erkens, PMG (corresponding author), Maastricht Univ Med Ctr, Sch Publ Hlth & Primary Care, Dept Family Med, Maastricht, Netherlands.	petra.erkens@maastrichtuniversity.nl	Cate, Hugo ten/AAM-4000-2021	ten Cate, Hugo/0000-0001-7796-4463				Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Agnelli G, 2007, CIRCULATION, V116, P180, DOI 10.1161/CIRCULATIONAHA.106.668020; [Anonymous], 1983, WHO TECH REP SER, V687, P1; Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Aujesky D, 2011, LANCET, V378, P41, DOI 10.1016/S0140-6736(11)60824-6; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Bona RD, 2000, AM J CLIN ONCOL-CANC, V23, P71, DOI 10.1097/00000421-200002000-00020; Buller H, 2008, J THROMB HAEMOST, V6, P1313, DOI 10.1111/j.1538-7836.2008.03054.x; Buller HR, 2008, BLOOD, V112, P2242, DOI 10.1182/blood-2008-05-160143; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Buller HR, 2012, LANCET, V379, P123, DOI 10.1016/S0140-6736(11)61505-5; Buller HR, 2004, CHEST, V126, p401S, DOI 10.1378/chest.126.3_suppl.401S; Buller HR, 2003, NEW ENGL J MED, V349, P1695; Caprini JA, 1999, J VASC SURG, V30, P805, DOI 10.1016/S0741-5214(99)70004-2; Cohen AT, 1996, WORLD J SURG, V20, P526; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Currie CJ, 2006, HEART, V92, P196, DOI 10.1136/hrt.2004.058339; Das SK, 1996, WORLD J SURG, V20, P521, DOI 10.1007/s002689900081; Daskalopoulos ME, 2005, EUR J VASC ENDOVASC, V29, P638, DOI 10.1016/j.ejvs.2004.02.029; DUXBURY BM, 1982, BRIT MED J, V284, P702, DOI 10.1136/bmj.284.6317.702; Eriksson BI, 2009, CLIN PHARMACOKINET, V48, P1, DOI 10.2165/0003088-200948010-00001; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; Fiessinger JN, 2005, JAMA-J AM MED ASSOC, V293, P681, DOI 10.1001/jama.293.6.681; Girolami A, 2004, ARCH INTERN MED, V164, P1077; Gonzalez-Fajardo JA, 1999, J VASC SURG, V30, P283, DOI 10.1016/S0741-5214(99)70139-4; Heidinger KS, 2000, THROMB RES, V98, P287, DOI 10.1016/S0049-3848(00)00181-X; HIRSH J, 1994, CIRCULATION, V89, P1469, DOI 10.1161/01.CIR.89.3.1469; HULL R, 1979, NEW ENGL J MED, V301, P855, DOI 10.1056/NEJM197910183011602; HULL R, 1982, NEW ENGL J MED, V306, P189, DOI 10.1056/NEJM198201283060401; HULL R, 1982, NEW ENGL J MED, V307, P1676, DOI 10.1056/NEJM198212303072704; Hutten BA, 1999, THROMB HAEMOSTASIS, V82, P1260; Hutten BA, 2000, THESIS U AMSTERDAM A, P29; Kearon C, 2004, J THROMB HAEMOST, V2, P743, DOI 10.1046/j.1538-7836.2004.00698.x; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Kearon C, 2006, JAMA-J AM MED ASSOC, V296, P935, DOI 10.1001/jama.296.8.935; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; LEVINE MN, 1995, THROMB HAEMOSTASIS, V74, P606; LOELIGER EA, 1985, ACTA HAEMATOL-BASEL, V74, P125, DOI 10.1159/000206187; Lopez-Beret P, 2001, J VASC SURG, V33, P77, DOI 10.1067/mva.2001.109336; Meyer G, 2002, ARCH INTERN MED, V162, P1729, DOI 10.1001/archinte.162.15.1729; Monreal M, 1998, HAEMOSTASIS, V28, P236; NIELSEN HK, 1994, THROMB RES, V73, P215, DOI 10.1016/0049-3848(94)90100-7; Palareti G, 2000, THROMB HAEMOSTASIS, V84, P805; Perez-de-Llano LA, 2010, BLOOD COAGUL FIBRIN, V21, P744, DOI 10.1097/MBC.0b013e3283401406; PETERSEN P, 1989, LANCET, V1, P175; Phillips Katherine W, 2008, Expert Rev Cardiovasc Ther, V6, P57, DOI 10.1586/14779072.6.1.57; PINI M, 1994, THROMB HAEMOSTASIS, V72, P191; Poli D, 2007, THROMB HAEMOSTASIS, V98, P1148, DOI 10.1160/TH07-050348; Poller L, 2008, J THROMB HAEMOST, V6, P935, DOI 10.1111/j.1538-7836.2008.02959.x; Prandoni P, 2004, ANN INTERN MED, V141, P249, DOI 10.7326/0003-4819-141-4-200408170-00004; ROCKET AF Study Investiagators, 2010, AM HEART J, V159, p[e341, 340]; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Santamaria A, 2006, INT J CLIN PRACT, V60, P518, DOI 10.1111/j.1368-5031.2006.00947.x; SCHULMAN S, 1994, J INTERN MED, V236, P143, DOI 10.1111/j.1365-2796.1994.tb01276.x; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; SUDLOW MF, 1992, LANCET, V340, P873; tenCate JW, 1997, NEW ENGL J MED, V337, P657; van Bladel ER, 2010, THROMB RES, V126, P481, DOI 10.1016/j.thromres.2010.08.019; Veeger NJGM, 2005, BRIT J HAEMATOL, V128, P513, DOI 10.1111/j.1365-2141.2004.05348.x; 1991, CIRCULATION, V84, P527	66	65	71	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e42269	10.1371/journal.pone.0042269	http://dx.doi.org/10.1371/journal.pone.0042269			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049730	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100002
J	Lee, JH; Kim, EJ; Kim, DK; Lee, JM; Park, SB; Lee, IK; Harris, RA; Lee, MO; Choi, HS				Lee, Ja Hee; Kim, Eun-Jin; Kim, Don-Kyu; Lee, Ji-Min; Park, Seung Bum; Lee, In-Kyu; Harris, Robert A.; Lee, Mi-Ock; Choi, Hueng-Sik			Hypoxia Induces PDK4 Gene Expression through Induction of the Orphan Nuclear Receptor ERR gamma	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE KINASE; ESTROGEN-RELATED RECEPTORS; INDUCIBLE FACTOR-1; OXYGEN HOMEOSTASIS; ADIPOSE-TISSUE; KEY REGULATOR; COACTIVATOR; ALPHA; ADAPTATION; METABOLISM	Multiple cellular signaling pathways that control metabolism and survival are activated when cell are incubated under hypoxic conditions. Activation of the hypoxia inducible factor (HIF)-1 promotes expression of genes that increase the capacity to cope with the stress imposed by a reduced oxygen environment. Here we show that the orphan nuclear receptor estrogen related receptor gamma (ERR gamma) plays a critical role in hypoxia-mediated activation of pyruvate dehydrogenase kinase 4 (PDK4) gene expression. ERR gamma mRNA and protein levels were increased by hypoxia or desferrioxamine (DFO) treatment in hepatoma cell lines. Co-expression of HIF-1 alpha and beta increased ERRc promoter activity as well as mRNA expression, while knockdown of endogenous HIF-1 alpha reduced the hypoxia-mediated induction of ERR gamma. In addition, hypoxia also increased the promoter activity and mRNA level of PDK4 in HepG2 cells. Adenovirus mediated-overexpression of ERR gamma specifically increased PDK4 gene expression, while ablation of endogenous ERR gamma significantly decreased hypoxia-mediated induction of PDK4 gene expression. Finally, GSK5182, an inverse agonist of ERR gamma, strongly inhibited the hypoxia-mediated induction of PDK4 protein and promoter activity. Regulation of the transcriptional activity of ERR gamma may provide a therapeutic approach for the regulation of PDK4 gene expression under hypoxia.	[Kim, Eun-Jin; Lee, Mi-Ock] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Lee, Ja Hee; Kim, Don-Kyu; Lee, Ji-Min; Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Sch Biol Sci & Technol, Kwangju, South Korea; [Lee, Ja Hee; Kim, Don-Kyu; Lee, Ji-Min; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju, South Korea; [Park, Seung Bum] Seoul Natl Univ, Coll Nat Sci, Dept Chem, Seoul 151742, South Korea; [Park, Seung Bum] Seoul Natl Univ, Coll Nat Sci, Dept Biophys & Chem Biol, Seoul 151742, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, World Class Univ Program, Res Inst Aging & Metab, Taegu, South Korea; [Lee, In-Kyu] Kyungpook Natl Univ Hosp, Dept Endocrinol & Metab, Taegu, South Korea; [Harris, Robert A.] Roudebush VA Med Ctr, Indianapolis, IN USA; [Harris, Robert A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, World Class Univ Program, Indianapolis, IN USA; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Dept Biomed Sci, Res Inst Med Sci, Kwangju, South Korea	Seoul National University (SNU); Chonnam National University; Chonnam National University; Seoul National University (SNU); Seoul National University (SNU); Kyungpook National University; Kyungpook National University; Kyungpook National University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University Bloomington; Chonnam National University	Lee, MO (corresponding author), Seoul Natl Univ, Coll Pharm, Seoul, South Korea.	molee@snu.ac.kr; hsc@chonnam.ac.kr	Lee, In-Kyu/AAR-6374-2021; Park, Seung Bum/N-1901-2014	Park, Seung Bum/0000-0003-1753-1433	National Creative Research Initiatives Grant from the Korean Ministry of Education, Science and Technology [20110018305]; NRF [2009-0080757]; SRC/ERC [R11-2007-107-01001-0]; World Class University Program through the National Research Foundation of Korea (NRF) [R32-10064]; Ministry of Education, Science, and Technology	National Creative Research Initiatives Grant from the Korean Ministry of Education, Science and Technology; NRF; SRC/ERC(European Research Council (ERC)); World Class University Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a National Creative Research Initiatives Grant (20110018305) from the Korean Ministry of Education, Science and Technology. And M.-O Lee was supported by grants from the NRF(2009-0080757), and the SRC/ERC(R11-2007-107-01001-0). I.-K Lee was supported by World Class University Program (R32-10064) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ao A, 2008, P NATL ACAD SCI USA, V105, P7821, DOI 10.1073/pnas.0711677105; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Chao EYH, 2006, BIOORG MED CHEM LETT, V16, P821, DOI 10.1016/j.bmcl.2005.11.030; Coward P, 2001, P NATL ACAD SCI USA, V98, P8880, DOI 10.1073/pnas.151244398; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Formenti F, 2010, P NATL ACAD SCI USA, V107, P12722, DOI 10.1073/pnas.1002339107; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; GUDI R, 1995, J BIOL CHEM, V270, P28989, DOI 10.1074/jbc.270.48.28989; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Kim DK, 2012, J BIOL CHEM, V287, P21628, DOI 10.1074/jbc.M111.315168; Kim DK, 2011, J BIOL CHEM, V286, P38035, DOI 10.1074/jbc.M111.250613; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200; Kwon HS, 2004, DIABETES, V53, P899, DOI 10.2337/diabetes.53.4.899; Nakayama K, 2009, J BIOCHEM, V146, P757, DOI 10.1093/jb/mvp167; Nath B, 2011, HEPATOLOGY, V53, P1526, DOI 10.1002/hep.24256; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Razzaque MA, 2004, GENE, V340, P275, DOI 10.1016/j.gene.2004.07.010; Sanyal S, 2002, J BIOL CHEM, V277, P1739, DOI 10.1074/jbc.M106140200; Semenza GL, 1998, J LAB CLIN MED, V131, P207, DOI 10.1016/S0022-2143(98)90091-9; Semenza GL, 2007, BIOCHEM J, V405, P1, DOI 10.1042/BJ20070389; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Tremblay GB, 2001, ENDOCRINOLOGY, V142, P4572, DOI 10.1210/en.142.10.4572; WANG GL, 1993, J BIOL CHEM, V268, P21513; Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855; Zhang XM, 2010, J BIOL CHEM, V285, P32869, DOI 10.1074/jbc.M110.135509; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	34	46	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46324	10.1371/journal.pone.0046324	http://dx.doi.org/10.1371/journal.pone.0046324			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050013	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100178
J	Lodola, F; Laforenza, U; Bonetti, E; Lim, D; Dragoni, S; Bottino, C; Ong, HL; Guerra, G; Ganini, C; Massa, M; Manzoni, M; Ambudkar, IS; Genazzani, AA; Rosti, V; Pedrazzoli, P; Tanzi, F; Moccia, F; Porta, C				Lodola, Francesco; Laforenza, Umberto; Bonetti, Elisa; Lim, Dmitry; Dragoni, Silvia; Bottino, Cinzia; Ong, Hwei Ling; Guerra, Germano; Ganini, Carlo; Massa, Margherita; Manzoni, Mariangela; Ambudkar, Indu S.; Genazzani, Armando A.; Rosti, Vittorio; Pedrazzoli, Paolo; Tanzi, Franco; Moccia, Francesco; Porta, Camillo			Store-Operated Ca2+ Entry Is Remodelled and Controls In Vitro Angiogenesis in Endothelial Progenitor Cells Isolated from Tumoral Patients	PLOS ONE			English	Article							STROMAL INTERACTION MOLECULE-1; CAPACITATIVE CALCIUM-ENTRY; STEM-CELLS; STIM1; PROLIFERATION; CHANNELS; GROWTH; CARCINOMA; RECEPTOR; INFLUX	Background: Endothelial progenitor cells (EPCs) may be recruited from bone marrow to sustain tumor vascularisation and promote the metastatic switch. Understanding the molecular mechanisms driving EPC proliferation and tubulogenesis could outline novel targets for alternative anti-angiogenic treatments. Store-operated Ca2+ entry (SOCE), which is activated by a depletion of the intracellular Ca2+ pool, regulates the growth of human EPCs, where is mediated by the interaction between the endoplasmic reticulum Ca2+-sensor, Stim1, and the plasmalemmal Ca2+ channel, Orai1. As oncogenesis may be associated to the capability of tumor cells to grow independently on Ca2+ influx, it is important to assess whether SOCE regulates EPC-dependent angiogenesis also in tumor patients. Methodology/Principal Findings: The present study employed Ca2+ imaging, recombinant sub-membranal and mitochondrial aequorin, real-time polymerase chain reaction, gene silencing techniques and western blot analysis to investigate the expression and the role of SOCE in EPCs isolated from peripheral blood of patients affected by renal cellular carcinoma (RCC; RCC-EPCs) as compared to control EPCs (N-EPCs). SOCE, activated by either pharmacological (i.e. cyclopiazonic acid) or physiological (i.e. ATP) stimulation, was significantly higher in RCC-EPCs and was selectively sensitive to BTP-2, and to the trivalent cations, La3+ and Gd3+. Furthermore, 2-APB enhanced thapsigargin-evoked SOCE at low concentrations, whereas higher doses caused SOCE inhibition. Conversely, the anti-angiogenic drug, carboxyamidotriazole (CAI), blocked both SOCE and the intracellular Ca2+ release. SOCE was associated to the over-expression of Orai1, Stim1, and transient receptor potential channel 1 (TRPC1) at both mRNA and protein level The intracellular Ca2+ buffer, BAPTA, BTP-2, and CAI inhibited RCC-EPC proliferation and tubulogenesis. The genetic suppression of Stim1, Orai1, and TRPC1 blocked CPA-evoked SOCE in RCC-EPCs. Conclusions: SOCE is remodelled in EPCs from RCC patients and stands out as a novel molecular target to interfere with RCC vascularisation due to its ability to control proliferation and tubulogenesis.	[Lodola, Francesco; Dragoni, Silvia; Tanzi, Franco; Moccia, Francesco] Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, I-27100 Pavia, Italy; [Laforenza, Umberto; Bottino, Cinzia] Univ Pavia, Sect Human Physiol, Dept Mol Med, I-27100 Pavia, Italy; [Bonetti, Elisa; Rosti, Vittorio] Clin Epidemiol Lab Fdn IRCCS Policlin San Matteo, Pavia, Italy; [Lim, Dmitry; Genazzani, Armando A.] Univ Eastern Piedmont Amedeo Avogadro, Dept Pharmaceut Sci, Novara, Italy; [Ong, Hwei Ling; Ambudkar, Indu S.] Natl Inst Dent & Craniofacial Res, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Guerra, Germano] Univ Molise, Dept Hlth Sci, Campobasso, Italy; [Ganini, Carlo; Manzoni, Mariangela; Pedrazzoli, Paolo; Porta, Camillo] Med Oncol IRCCS Policlin San Matteo, Pavia, Italy; [Massa, Margherita] Fdn IRCCS Policlin San Matteo, Biotechnol Lab, Pavia, Italy	University of Pavia; University of Pavia; IRCCS Fondazione San Matteo; University of Eastern Piedmont Amedeo Avogadro; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Molise; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo	Moccia, F (corresponding author), Univ Pavia, Dept Biol & Biotechnol Lazzaro Spallanzani, Via Palestro 3, I-27100 Pavia, Italy.	francesco.moccia@unipv.it	Porta, Camillo/AAB-9482-2020; Moccia, Francesco/AAX-6447-2020; Lim, Dmitry/H-9101-2012; Lodola, Francesco/J-8129-2018; Massa, Margherita/K-4682-2016; Genazzani, Armando/AAI-8280-2020; Rosti, Vittorio/K-1743-2018; Ganini, Carlo/V-6297-2017; Bonetti, Elisa/D-4478-2016; Pedrazzoli, Paolo/AAB-8690-2019	Moccia, Francesco/0000-0003-0010-0098; Lodola, Francesco/0000-0002-3506-5619; Massa, Margherita/0000-0001-8037-0439; Rosti, Vittorio/0000-0003-4195-2289; Ganini, Carlo/0000-0002-5839-3965; Bonetti, Elisa/0000-0002-8406-5252; Pedrazzoli, Paolo/0000-0002-9419-7160; Porta, Camillo/0000-0003-2412-1563; Dragoni, Silvia/0000-0002-9107-6291; Genazzani, Armando/0000-0003-1923-7430; Ong, Hwei Ling/0000-0002-7551-6883; Laforenza, Umberto/0000-0003-2951-5983	Ricerca Corrente, IRCCS Policlinico San Matteo Foundation, Pavia [674]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000438] Funding Source: NIH RePORTER	Ricerca Corrente, IRCCS Policlinico San Matteo Foundation, Pavia; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by a grant from Ricerca Corrente, #674, IRCCS Policlinico San Matteo Foundation, Pavia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Antigny F, 2012, J BIOL CHEM, V287, P5917, DOI 10.1074/jbc.M111.295733; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bhatt RS, 2011, BRIT J CANCER, V105, P112, DOI 10.1038/bjc.2011.186; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Bomben VC, 2011, J CELL PHYSIOL, V226, P1879, DOI 10.1002/jcp.22518; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Bussolati B, 2003, FASEB J, V17, P1159, DOI 10.1096/fj.02-0557fje; Bussolati B, 2010, CURR VASC PHARMACOL, V8, P220, DOI 10.2174/157016110790887036; Calzi SL, 2010, MICROVASC RES, V79, P207, DOI 10.1016/j.mvr.2010.02.011; Carrichon L, 2011, BBA-BIOMEMBRANES, V1808, P78, DOI 10.1016/j.bbamem.2010.08.002; Cheng KT, 2011, ADV EXP MED BIOL, V704, P435, DOI 10.1007/978-94-007-0265-3_24; Ciarcia R, 2010, J CELL PHYSIOL, V224, P443, DOI 10.1002/jcp.22140; Cioffi DL, 2012, CIRC RES, V110, P1435, DOI 10.1161/CIRCRESAHA.112.269506; Collado B, 2007, BIOCHIM BIOPHYS ACTA, V744, P224; D'Amato M, 2003, BIOCHEM BIOPH RES CO, V301, P907, DOI 10.1016/S0006-291X(03)00062-7; Dhennin-Duthille I, 2011, CELL PHYSIOL BIOCHEM, V28, P813, DOI 10.1159/000335795; Dragoni S, 2011, STEM CELLS, V29, P1898, DOI 10.1002/stem.734; Dutcher JP, 2005, CANCER, V104, P2392, DOI 10.1002/cncr.21473; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Faehling M, 2002, FASEB J, V16, P1805, DOI 10.1096/fj.01-0938fje; Feldman B, 2010, CELL CALCIUM, V47, P525, DOI 10.1016/j.ceca.2010.05.002; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gao DC, 2009, BBA-REV CANCER, V1796, P33, DOI 10.1016/j.bbcan.2009.05.001; Harper MT, 2011, CELL CALCIUM, V50, P351, DOI 10.1016/j.ceca.2011.06.005; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Hill PA, 2010, PATHOLOGY, V42, P479, DOI 10.3109/00313025.2010.494284; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Huang JB, 2004, CANCER RES, V64, P2482, DOI 10.1158/0008-5472.CAN-03-3501; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Iwata S, 2009, EUR J PHARMACOL, V605, P15, DOI 10.1016/j.ejphar.2008.12.045; Jaffe LF, 2005, ADV CANCER RES, V94, P231, DOI 10.1016/S0065-230X(05)94006-2; Johnstone LS, 2010, J CELL MOL MED, V14, P1890, DOI 10.1111/j.1582-4934.2010.01097.x; Korkiamaki T, 2002, AM J PATHOL, V160, P1981, DOI 10.1016/S0002-9440(10)61148-0; Kuang CY, 2012, STEM CELLS DEV, V21, P487, DOI 10.1089/scd.2011.0027; Kuang CY, 2010, BIOCHEM BIOPH RES CO, V398, P315, DOI 10.1016/j.bbrc.2010.06.088; Lazzari C, 2011, J NEUROCHEM, V116, P881, DOI 10.1111/j.1471-4159.2010.07015.x; Lee JM, 2011, AM J PHYSIOL-CELL PH, V301, pC969, DOI 10.1152/ajpcell.00136.2011; Leung PC, 2006, J VASC RES, V43, P367, DOI 10.1159/000094096; Levi F, 2008, BJU INT, V101, P949, DOI 10.1111/j.1464-410X.2008.07451.x; Li J, 2011, CIRC RES, V108, P1190, DOI 10.1161/CIRCRESAHA.111.243352; Lim D, 2008, J BIOL CHEM, V283, P5780, DOI 10.1074/jbc.M704704200; Manji SSM, 2000, BBA-PROTEIN STRUCT M, V1481, P147, DOI 10.1016/S0167-4838(00)00105-9; McAndrew D, 2011, MOL CANCER THER, V10, P448, DOI 10.1158/1535-7163.MCT-10-0923; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Mignen O, 2005, J CELL SCI, V118, P5615, DOI 10.1242/jcs.02663; Moccia F, 2003, J CELL PHYSIOL, V194, P139, DOI 10.1002/jcp.10198; Moccia F, 2012, CURR SIGNAL TRANSD T, V7, P161, DOI 10.2174/157436212800376672; Moccia F, 2010, CURR DRUG THER, V5, P277, DOI 10.2174/157488510792927483; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Munaron L, 2009, CURR MED CHEM, V16, P4691, DOI 10.2174/092986709789878210; Munaron L, 2008, TECHNOL CANCER RES T, V7, P335, DOI 10.1177/153303460800700408; Namdarian B, 2010, BJU INT, V106, P1081, DOI 10.1111/j.1464-410X.2010.09245.x; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Nunez L, 2006, J PHYSIOL-LONDON, V571, P57, DOI 10.1113/jphysiol.2005.100586; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park JH, 2008, CELL PROLIFERAT, V41, P786, DOI 10.1111/j.1365-2184.2008.00552.x; Patenaude A, 2010, MICROVASC RES, V79, P217, DOI 10.1016/j.mvr.2010.01.007; Patton AM, 2003, CURR PHARM DESIGN, V9, P543, DOI 10.2174/1381612033391559; Piaggio G, 2009, BLOOD, V114, P3127, DOI 10.1182/blood-2008-12-190991; Pla AF, 2008, MOL CANCER RES, V6, P535, DOI 10.1158/1541-7786.MCR-07-0271; Pla AF, 2010, MOL CANCER RES, V8, P1466, DOI 10.1158/1541-7786.MCR-10-0002; Porta C, 2012, CRIT REV ONCOL HEMAT, V82, P323, DOI 10.1016/j.critrevonc.2011.06.001; Porta C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-105; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Putney JW, 2010, MOL INTERV, V10, P209, DOI 10.1124/mi.10.4.4; Ranzato E, 2010, J CELL BIOCHEM, V110, P783, DOI 10.1002/jcb.22591; Ranzato E, 2009, J CELL MOL MED, V13, P2030, DOI 10.1111/j.1582-4934.2008.00467.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rini BI, 2010, CLIN CANCER RES, V16, P1348, DOI 10.1158/1078-0432.CCR-09-2273; Ritchie MF, 2010, J BIOL CHEM, V285, P10591, DOI 10.1074/jbc.M109.083493; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Sanchez-Hernandez Y, 2010, STEM CELLS DEV, V19, P1967, DOI 10.1089/scd.2010.0047; Shang J, 2004, BIOCHEMISTRY-US, V43, P9576, DOI 10.1021/bi049358o; Shi YK, 2010, EXP BIOL MED, V235, P317, DOI 10.1258/ebm.2009.009237; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Soboloff J, 2002, EXP HEMATOL, V30, P1219, DOI 10.1016/S0301-472X(02)00893-7; Soliman EM, 2009, CELL CALCIUM, V45, P284, DOI 10.1016/j.ceca.2008.11.006; Stadler WM, 2005, J CLIN ONCOL, V23, P3726, DOI 10.1200/JCO.2005.44.150; Sundivakkam PC, 2012, MOL PHARMACOL, V81, P510, DOI 10.1124/mol.111.074658; Takezawa R, 2006, MOL PHARMACOL, V69, P1413, DOI 10.1124/mol.105.021154; Touchberry CD, 2011, BIOCHEM BIOPH RES CO, V416, P45, DOI 10.1016/j.bbrc.2011.10.133; Whitfield JF, 2009, CANCER LETT, V275, P9, DOI 10.1016/j.canlet.2008.07.001; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu YG, 1997, CLIN CANCER RES, V3, P1915; Yamazaki D, 2007, J PHARMACOL SCI, V104, P103, DOI 10.1254/jphs.SC0070080; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yeung YG, 2009, ANAL BIOCHEM, V389, P89, DOI 10.1016/j.ab.2009.03.017; Yoon CM, 2008, BLOOD, V112, P1129, DOI 10.1182/blood-2007-11-125203; Yu F, 2010, J CELL BIOL, V191, P523, DOI 10.1083/jcb.201006022; Yuan JP, 2007, NAT CELL BIOL, V9, P636, DOI 10.1038/ncb1590	99	122	124	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e42541	10.1371/journal.pone.0042541	http://dx.doi.org/10.1371/journal.pone.0042541			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049731	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100003
J	Tigerholm, J; Borjesson, SI; Lundberg, L; Elinder, F; Fransen, E				Tigerholm, Jenny; Borjesson, Sara I.; Lundberg, Linnea; Elinder, Fredrik; Fransen, Erik			Dampening of Hyperexcitability in CA1 Pyramidal Neurons by Polyunsaturated Fatty Acids Acting on Voltage-Gated Ion Channels	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; POTASSIUM CHANNELS; CORTICAL-NEURONS; KETOGENIC DIET; ELECTRICAL SYNAPSES; SODIUM CURRENTS; NA+ CHANNELS; IN-VIVO; EXCITABILITY; GENE	A ketogenic diet is an alternative treatment of epilepsy in infants. The diet, rich in fat and low in carbohydrates, elevates the level of polyunsaturated fatty acids (PUFAs) in plasma. These substances have therefore been suggested to contribute to the anticonvulsive effect of the diet. PUFAs modulate the properties of a range of ion channels, including K and Na channels, and it has been hypothesized that these changes may be part of a mechanistic explanation of the ketogenic diet. Using computational modelling, we here study how experimentally observed PUFA-induced changes of ion channel activity affect neuronal excitability in CA1, in particular responses to synaptic input of high synchronicity. The PUFA effects were studied in two pathological models of cellular hyperexcitability associated with epileptogenesis. We found that experimentally derived PUFA modulation of the A-type K (K-A) channel, but not the delayed-rectifier K channel, restored healthy excitability by selectively reducing the response to inputs of high synchronicity. We also found that PUFA modulation of the transient Na channel was effective in this respect if the channel's steady-state inactivation was selectively affected. Furthermore, PUFA-induced hyperpolarization of the resting membrane potential was an effective approach to prevent hyperexcitability. When the combined effect of PUFA on the K-A channel, the Na channel, and the resting membrane potential, was simulated, a lower concentration of PUFA was needed to restore healthy excitability. We therefore propose that one explanation of the beneficial effect of PUFAs lies in its simultaneous action on a range of ion-channel targets. Furthermore, this work suggests that a pharmacological cocktail acting on the voltage dependence of the Na-channel inactivation, the voltage dependences of K-A channels, and the resting potential can be an effective treatment of epilepsy.	[Tigerholm, Jenny; Lundberg, Linnea; Fransen, Erik] KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Computat Biol, Stockholm, Sweden; [Tigerholm, Jenny; Fransen, Erik] KTH Royal Inst Technol, Stockholm Brain Inst, Stockholm, Sweden; [Borjesson, Sara I.; Elinder, Fredrik] Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Linkoping, Sweden	Royal Institute of Technology; Royal Institute of Technology; Linkoping University	Tigerholm, J (corresponding author), KTH Royal Inst Technol, Sch Comp Sci & Commun, Dept Computat Biol, Stockholm, Sweden.	tige@kth.se	Liin, Sara/I-2941-2012	Liin, Sara/0000-0001-8493-0114; Elinder, Fredrik/0000-0001-9125-5583; Lundberg, Linnea/0000-0001-8508-6402	Swedish Research Council [621-2007-4223, 13043]; USA NIH [MH061492-06A2]; Swedish Heart-Lung Foundation; Swedish Brain Foundation; County Council of Ostergotland; King Gustaf V and Queen Victorias Freemasons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061492] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); USA NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Brain Foundation; County Council of Ostergotland; King Gustaf V and Queen Victorias Freemasons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Swedish Research Council (grant numbers 621-2007-4223 and 13043, the USA NIH (grant number MH061492-06A2), the Swedish Heart-Lung Foundation, the Swedish Brain Foundation, the County Council of Ostergotland, and King Gustaf V and Queen Victorias Freemasons Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Azouz R, 1999, J NEUROSCI, V19, P2209; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Blom SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008251; Boland LM, 2008, CELL BIOCHEM BIOPHYS, V52, P59, DOI 10.1007/s12013-008-9027-2; Borjesson SI, 2008, BIOPHYS J, V95, P2242, DOI 10.1529/biophysj.108.130757; Borjesson SI, 2011, J GEN PHYSIOL, V137, P563, DOI 10.1085/jgp.201110599; Borjesson SI, 2010, BIOPHYS J, V98, P396, DOI 10.1016/j.bpj.2009.10.026; Bough KJ, 2007, EPILEPSIA, V48, P43, DOI 10.1111/j.1528-1167.2007.00915.x; Bragin A, 2005, EPILEPSIA, V46, P1592, DOI 10.1111/j.1528-1167.2005.00268.x; Bragin A, 2002, J NEUROSCI, V22, P2012, DOI 10.1523/JNEUROSCI.22-05-02012.2002; Bragin A, 2000, EPILEPSIA, V41, pS144, DOI 10.1111/j.1528-1157.2000.tb01573.x; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Castro PA, 2001, J NEUROSCI, V21, P6626, DOI 10.1523/JNEUROSCI.21-17-06626.2001; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; CYMBALYUK GS, 1994, BIOL CYBERN, V71, P153, DOI 10.1007/BF00197318; Francis J, 1997, NEUROSCI LETT, V232, P91, DOI 10.1016/S0304-3940(97)00593-4; Fransen E, 2010, HIPPOCAMPUS, V20, P877, DOI 10.1002/hipo.20694; Fraser DD, 2003, NEUROLOGY, V60, P1026, DOI 10.1212/01.WNL.0000049974.74242.C6; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Hahn A, 2009, BRAIN DEV-JPN, V31, P515, DOI 10.1016/j.braindev.2009.04.012; HILLE B, 1977, J GEN PHYSIOL, V69, P497, DOI 10.1085/jgp.69.4.497; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hong MP, 2004, BRAIN RES, V1008, P81, DOI 10.1016/j.brainres.2004.02.033; KANG JX, 1995, P NATL ACAD SCI USA, V92, P3997, DOI 10.1073/pnas.92.9.3997; Lasztoczi B, 2004, EUR J NEUROSCI, V19, P1361, DOI 10.1111/j.1460-9568.2004.03231.x; Lauritzen I, 2000, EMBO J, V19, P1784, DOI 10.1093/emboj/19.8.1784; Leaf A, 2003, PHARMACOL THERAPEUT, V98, P355, DOI 10.1016/S0163-7258(03)00039-1; Leaf A, 2005, J MEMBRANE BIOL, V206, P129, DOI 10.1007/s00232-005-0789-9; Loring DW, 2007, NEUROPSYCHOL REV, V17, P413, DOI 10.1007/s11065-007-9043-9; Losonczy A, 2008, NATURE, V452, P436, DOI 10.1038/nature06725; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Migliore M, 2008, HIPPOCAMPUS, V18, P1122, DOI 10.1002/hipo.20480; Peretz A, 2010, P NATL ACAD SCI USA, V107, P15637, DOI 10.1073/pnas.0911294107; Pettit DL, 2000, J NEUROPHYSIOL, V84, P28, DOI 10.1152/jn.2000.84.1.28; Pfeuty B, 2005, NEURAL COMPUT, V17, P633, DOI 10.1162/0899766053019917; Pfeuty B, 2003, J NEUROSCI, V23, P6280; Ragsdale DS, 1996, P NATL ACAD SCI USA, V93, P9270, DOI 10.1073/pnas.93.17.9270; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Rolf S, 2000, N-S ARCH PHARMACOL, V362, P22, DOI 10.1007/s002100000257; Sankar Raman, 2004, J Child Neurol, V19 Suppl 1, pS6, DOI 10.1177/08830738040190010201; Schuele SU, 2008, LANCET NEUROL, V7, P514, DOI 10.1016/S1474-4422(08)70108-X; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; SHERMAN A, 1992, P NATL ACAD SCI USA, V89, P2471, DOI 10.1073/pnas.89.6.2471; Singh B, 2006, NEUROBIOL DIS, V24, P245, DOI 10.1016/j.nbd.2006.07.001; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Smeal RM, 2010, PHILOS T R SOC B, V365, P2407, DOI 10.1098/rstb.2009.0292; Taha AY, 2010, EPILEPSIA, V51, P1348, DOI 10.1111/j.1528-1167.2010.02654.x; Takekawa T, 2007, J COMPUT NEUROSCI, V23, P189, DOI 10.1007/s10827-007-0027-9; Tanner GR, 2011, J NEUROSCI, V31, P8689, DOI 10.1523/JNEUROSCI.5951-10.2011; Tigerholm J, 2011, BIOPHYS J, V101, P1871, DOI 10.1016/j.bpj.2011.08.055; Vreugdenhil M, 1996, P NATL ACAD SCI USA, V93, P12559, DOI 10.1073/pnas.93.22.12559; Vreugdenhil M, 1998, NEUROSCIENCE, V86, P99, DOI 10.1016/S0306-4522(98)00041-4; Wuttke TV, 2005, MOL PHARMACOL, V67, P1009, DOI 10.1124/mol.104.010793; Xiao YF, 1999, BRAIN RES, V846, P112, DOI 10.1016/S0006-8993(99)01997-6; XIAO YF, 1995, P NATL ACAD SCI USA, V92, P11000, DOI 10.1073/pnas.92.24.11000; Xiao YF, 1998, P NATL ACAD SCI USA, V95, P2680, DOI 10.1073/pnas.95.5.2680; Xiong QJ, 2007, NAT CHEM BIOL, V3, P287, DOI 10.1038/nchembio874; Xu XP, 2008, EPILEPSY RES, V80, P57, DOI 10.1016/j.eplepsyres.2008.03.013; ZAGOTTA WN, 1990, J GEN PHYSIOL, V95, P29, DOI 10.1085/jgp.95.1.29	65	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44388	10.1371/journal.pone.0044388	http://dx.doi.org/10.1371/journal.pone.0044388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049748	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100013
J	Vlijm, R; Smitshuijzen, JSJ; Lusser, A; Dekker, C				Vlijm, Rifka; Smitshuijzen, Jeremy S. J.; Lusser, Alexandra; Dekker, Cees			NAP1-Assisted Nucleosome Assembly on DNA Measured in Real Time by Single-Molecule Magnetic Tweezers	PLOS ONE			English	Article							HISTONE (H3-H4)(2) TETRAMER; LINKING NUMBER CHANGE; CORE PARTICLE; REPLICATION INVITRO; CHROMATIN; RESOLUTION; DYNAMICS; OCTAMER; FORCE; ACF	While many proteins are involved in the assembly and (re) positioning of nucleosomes, the dynamics of protein-assisted nucleosome formation are not well understood. We study NAP1 (nucleosome assembly protein 1) assisted nucleosome formation at the single-molecule level using magnetic tweezers. This method allows to apply a well-defined stretching force and supercoiling density to a single DNA molecule, and to study in real time the change in linking number, stiffness and length of the DNA during nucleosome formation. We observe a decrease in end-to-end length when NAP1 and core histones (CH) are added to the dsDNA. We characterize the formation of complete nucleosomes by measuring the change in linking number of DNA, which is induced by the NAP1-assisted nucleosome assembly, and which does not occur for nonnucleosomal bound histones H3 and H4. By rotating the magnets, the supercoils formed upon nucleosome assembly are removed and the number of assembled nucleosomes can be counted. We find that the compaction of DNA at low force is about 56 nm per assembled nucleosome. The number of compaction steps and associated change in linking number indicate that NAP1-assisted nucleosome assembly is a two-step process.	[Vlijm, Rifka; Smitshuijzen, Jeremy S. J.; Dekker, Cees] Delft Univ Technol, Dept Bionanosci, Kavli Inst Nanosci, Delft, Netherlands; [Lusser, Alexandra] Innsbruck Med Univ, Div Mol Biol, Innsbruck, Austria	Delft University of Technology; Medical University of Innsbruck	Dekker, C (corresponding author), Delft Univ Technol, Dept Bionanosci, Kavli Inst Nanosci, Delft, Netherlands.		Vlijm, Rifka/ABB-9663-2020	Vlijm, Rifka/0000-0001-8909-9518; Dekker, Cees/0000-0001-6273-071X; Lusser, Alexandra/0000-0002-2226-9081	Foundation for Fundamental Research on Matter (FOM) [103]; Austrian Science Fund (FWF) [Y 275] Funding Source: researchfish	Foundation for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Foundation for Fundamental Research on Matter (FOM) [Project 103, DNA in action: Physics of the genome]. Funding for open access charge: Foundation for Fundamental Research on Matter (FOM), www.fom.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENTS G, 1991, P NATL ACAD SCI USA, V88, P10148, DOI 10.1073/pnas.88.22.10148; Bancaud A, 2006, NAT STRUCT MOL BIOL, V13, P444, DOI 10.1038/nsmb1087; Bennink ML, 2001, SINGLE MOL, V2, P91, DOI 10.1002/1438-5171(200107)2:2<91::AID-SIMO91>3.0.CO;2-S; Bowman A, 2011, MOL CELL, V41, P398, DOI 10.1016/j.molcel.2011.01.025; Bowman A, 2010, NUCLEIC ACIDS RES, V38, P695, DOI 10.1093/nar/gkp1003; Brower-Toland BD, 2002, P NATL ACAD SCI USA, V99, P1960, DOI 10.1073/pnas.022638399; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Chien FT, 2009, CURR PHARM BIOTECHNO, V10, P474, DOI 10.2174/138920109788922128; Claudet C, 2005, J BIOL CHEM, V280, P19958, DOI 10.1074/jbc.M500121200; DABAN JR, 1982, J MOL BIOL, V156, P771, DOI 10.1016/0022-2836(82)90141-3; De Lucia F, 1999, J MOL BIOL, V285, P1101, DOI 10.1006/jmbi.1998.2382; Drabik CE, 1997, J MOL BIOL, V267, P794, DOI 10.1006/jmbi.1997.0917; Gemmen GJ, 2005, J MOL BIOL, V351, P89, DOI 10.1016/j.jmb.2005.05.058; GERMOND JE, 1975, P NATL ACAD SCI USA, V72, P1843, DOI 10.1073/pnas.72.5.1843; Gupta P, 2009, BIOPHYS J, V97, P3150, DOI 10.1016/j.bpj.2009.09.032; Hamiche A, 1998, J BIOL CHEM, V273, P9261, DOI 10.1074/jbc.273.15.9261; Hamiche A, 1996, P NATL ACAD SCI USA, V93, P7588, DOI 10.1073/pnas.93.15.7588; Ito T, 1996, MOL CELL BIOL, V16, P3112; JORCANO JL, 1979, BIOCHEMISTRY-US, V18, P768, DOI 10.1021/bi00572a005; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Ladoux B, 2000, P NATL ACAD SCI USA, V97, P14251, DOI 10.1073/pnas.250471597; Leuba SH, 2003, P NATL ACAD SCI USA, V100, P495, DOI 10.1073/pnas.0136890100; Levenstein ME, 2002, J BIOL CHEM, V277, P8749, DOI 10.1074/jbc.M111212200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Mazurkiewicz J, 2006, J BIOL CHEM, V281, P16462, DOI 10.1074/jbc.M511619200; Mihardja S, 2006, P NATL ACAD SCI USA, V103, P15871, DOI 10.1073/pnas.0607526103; Nakagawa T, 2001, J BIOL CHEM, V276, P27384, DOI 10.1074/jbc.M101331200; NORTON VG, 1989, CELL, V57, P449, DOI 10.1016/0092-8674(89)90920-3; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; RUIZCARRILLO A, 1979, P NATL ACAD SCI USA, V76, P3284, DOI 10.1073/pnas.76.7.3284; SIMPSON RT, 1985, CELL, V42, P799, DOI 10.1016/0092-8674(85)90276-4; Sivolob A, 2009, FLEXIBILITY NUCLEOSO, P251; SMITH S, 1991, EMBO J, V10, P971, DOI 10.1002/j.1460-2075.1991.tb08031.x; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Strick TR, 2003, REP PROG PHYS, V66, P1, DOI 10.1088/0034-4885/66/1/201; Torigoe SE, 2011, MOL CELL, V43, P638, DOI 10.1016/j.molcel.2011.07.017; TRIFONOV EN, 1985, CRC CR REV BIOCH MOL, V19, P89, DOI 10.3109/10409238509082540; Vilfan ID, 2009, HANDBOOK OF SINGLE-MOLECULE BIOPHYSICS, P371, DOI 10.1007/978-0-387-76497-9_13; ZIVANOVIC Y, 1988, J MOL BIOL, V200, P267, DOI 10.1016/0022-2836(88)90239-2	41	26	26	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46306	10.1371/journal.pone.0046306	http://dx.doi.org/10.1371/journal.pone.0046306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050009	gold, Green Published			2022-12-27	WOS:000309556100174
J	Zhao, G; Gu, XB; Lu, XL; Pan, JJ; Duan, ZQ; Zhao, KK; Gu, M; Liu, QT; He, L; Chen, J; Ge, SQ; Wang, YH; Chen, SJ; Wang, XQ; Peng, DX; Wan, HQ; Liu, XF				Zhao, Guo; Gu, Xiaobing; Lu, Xinlun; Pan, Jinjin; Duan, Zhiqiang; Zhao, Kunkun; Gu, Min; Liu, Qingtao; He, Liang; Chen, Jian; Ge, Shengqiang; Wang, Yanhong; Chen, Sujuan; Wang, Xiaoquan; Peng, Daxin; Wan, Hongquan; Liu, Xiufan			Novel Reassortant Highly Pathogenic H5N2 Avian Influenza Viruses in Poultry in China	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; HEMAGGLUTININ MOLECULE; A VIRUSES; EVOLUTION; EMERGENCE; DUCKS; IDENTIFICATION; VIRULENCE	There has been multiple evidence that domestic poultry may act as a vessel for the generation of novel influenza A viruses. In this study, we have analyzed the evolution and pathogenicity of 4 H5N2 avian influenza viruses isolated from apparently healthy poultry from H5N1 virus endemic areas in China. Phylogenetic analysis revealed that two of these viruses, A/duck/Eastern China/1111/2011 (DK/EC/1111/11) and A/goose/Eastern China/1112/2011 (GS/EC/1112/11) were derived from reassortment events in which clade 2.3.4 highly pathogenic avian influenza (HPAI) H5N1 viruses acquired novel neuraminidase and nonstructural protein genes. Another two isolates, A/chicken/Hebei/1102/2010 (CK/HB/1102/10) and A/duck/Hebei/0908/2009 (DK/HB/0908/09), possess hemagglutinin (HA) gene belong to clade 7 H5 viruses and other genes from endemic H9N2 viruses, or from viruses of various subtypes of the natural gene pool. All of these H5N2 isolates bear characteristic sequences of HPAI virus at the cleavage site of HA, and animal experiments indicated that all of these viruses but DK/HB/0908/09 is highly pathogenic to chickens. In particular, DK/EC/1111/11 and GS/EC/1112/11 are also highly pathogenic to ducks and moderately pathogenic to mice. All of these 4 viruses were able to replicate in domestic ducks and mice without prior adaptation. The emergence of these novel H5N2 viruses adds more evidence for the active evolution of H5 viruses in Asia. The maintenance of the highly pathogenic phenotype of some of these viruses even after reassortment with a new NA subtypes, their ability to replicate and transmit in domestic poultry, and the pathogenicity in the mammalian mouse model, highlight the potential threat posed by these viruses to both veterinary and public health.	[Zhao, Guo; Gu, Xiaobing; Lu, Xinlun; Pan, Jinjin; Duan, Zhiqiang; Zhao, Kunkun; Gu, Min; Liu, Qingtao; He, Liang; Chen, Jian; Ge, Shengqiang; Wang, Yanhong; Chen, Sujuan; Wang, Xiaoquan; Peng, Daxin; Wan, Hongquan; Liu, Xiufan] Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China; [Zhao, Guo; Liu, Xiufan] Yangzhou Univ, Minist Educ, Key Lab Avian Prevent Med, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Liu, XF (corresponding author), Yangzhou Univ, Coll Vet Med, Yangzhou, Jiangsu, Peoples R China.	xfliu@yzu.edu.cn	Peng, Daxin/AAJ-3476-2021	Wan, Hongquan/0000-0002-6374-0343	Major National Basic Research Development Program (973 Program) [2011CB505003]; National Key Technologies R&D Program of China [2010BAD04B01]; Important National Science & Technology Specific Projects [2008ZX10004-013, 2009ZX10004-214]; Jiangsu Natural Science Foundation for Universities and Colleges [10KJA230055]; Special Fund for Agro-scientific Research in the Public Interest [201003012]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University [IRT0978]	Major National Basic Research Development Program (973 Program)(National Basic Research Program of China); National Key Technologies R&D Program of China(National Key Technology R&D Program); Important National Science & Technology Specific Projects; Jiangsu Natural Science Foundation for Universities and Colleges; Special Fund for Agro-scientific Research in the Public Interest; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Major National Basic Research Development Program (973 Program) (grant number 2011CB505003), the National Key Technologies R&D Program of China (grant number 2010BAD04B01), the Important National Science & Technology Specific Projects (No. 2008ZX10004-013 and 2009ZX10004-214), the Jiangsu Natural Science Foundation for Universities and Colleges (grant number 10KJA230055), the Special Fund for Agro-scientific Research in the Public Interest (201003012), the Priority Academic Program Development of Jiangsu Higher Education Institutions, and the Program for Changjiang Scholars and Innovative Research Team in University (IRT0978). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen H, 2004, P NATL ACAD SCI USA, V101, P10452, DOI 10.1073/pnas.0403212101; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen H, 2009, REV SCI TECH OIE, V28, P267, DOI 10.20506/rst.28.1.1860; Cheng MC, 2010, AVIAN DIS, V54, P885, DOI 10.1637/9208-120609-Reg.1; Cong YL, 2007, J GEN VIROL, V88, P2035, DOI 10.1099/vir.0.82783-0; Eagles D, 2009, REV SCI TECH OIE, V28, P341, DOI 10.20506/rst.28.1.1864; Gaidet N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000127; Garcia M, 1996, J GEN VIROL, V77, P1493, DOI 10.1099/0022-1317-77-7-1493; Gu M, 2011, EMERG INFECT DIS, V17, P1060, DOI [10.3201/eid1706.101406, 10.3201/eid/1706.101406]; Guan Y, 2002, P NATL ACAD SCI USA, V99, P8950, DOI 10.1073/pnas.132268999; Guan Y, 2004, P NATL ACAD SCI USA, V101, P8156, DOI 10.1073/pnas.0402443101; Guan Y, 2000, J VIROL, V74, P9372, DOI 10.1128/JVI.74.20.9372-9380.2000; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Guang-Jian Z, 2011, VET MICROBIOL, V155, P409; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Katz JM, 2000, J VIROL, V74, P10807, DOI 10.1128/JVI.74.22.10807-10810.2000; Kaverin NV, 2007, J VIROL, V81, P12911, DOI 10.1128/JVI.01522-07; Kaverin NV, 2002, J GEN VIROL, V83, P2497, DOI 10.1099/0022-1317-83-10-2497; Kim HR, 2010, J GEN VIROL, V91, P1978, DOI 10.1099/vir.0.021238-0; Lee JH, 2009, J VIROL, V83, P4205, DOI [10.1128/JVI.02403-08, 10.1128/JVI.02403-09]; Lee MS, 2001, J VIROL METHODS, V97, P13, DOI 10.1016/S0166-0934(01)00301-9; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Li YB, 2010, J VIROL, V84, P8389, DOI 10.1128/JVI.00413-10; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Londt BZ, 2007, AVIAN PATHOL, V36, P347, DOI 10.1080/03079450701589134; Lu XH, 1999, J VIROL, V73, P5903, DOI 10.1128/JVI.73.7.5903-5911.1999; Ogata T, 2008, J EPIDEMIOL, V18, P160, DOI 10.2188/jea.JE2007446; Perkins LEL, 2002, AVIAN DIS, V46, P53, DOI 10.1637/0005-2086(2002)046[0053:POAHKO]2.0.CO;2; PHILPOTT M, 1990, J VIROL, V64, P2941, DOI 10.1128/JVI.64.6.2941-2947.1990; PHILPOTT M, 1989, J VIROL, V63, P3453, DOI 10.1128/JVI.63.8.3453-3458.1989; Qiu BF, 2009, J VIROL METHODS, V155, P193, DOI 10.1016/j.jviromet.2008.10.001; REED L. J., 1938, AMER JOUR HYG, V27, P493; Scholtissek C, 1998, ANTIVIR RES, V37, P83, DOI 10.1016/S0166-3542(97)00061-2; Snoeck CJ, 2011, J GEN VIROL, V92, P1172, DOI 10.1099/vir.0.029728-0; STIENEKEGROBER A, 1992, EMBO J, V11, P2407, DOI 10.1002/j.1460-2075.1992.tb05305.x; Sun LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005476; Sun YP, 2010, VET MICROBIOL, V146, P215, DOI 10.1016/j.vetmic.2010.05.010; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Xu CT, 2004, MICROBES INFECT, V6, P919, DOI 10.1016/j.micinf.2004.04.015; Xu KM, 2007, J VIROL, V81, P2635, DOI 10.1128/JVI.02316-06	41	102	108	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46183	10.1371/journal.pone.0046183	http://dx.doi.org/10.1371/journal.pone.0046183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049973	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100149
J	Chao, X; Zhang, ZL; Guo, LL; Zhu, JJ; Peng, ML; Vermorken, AJM; Van de Ven, WJM; Chen, C; Cui, YL				Chao, Xu; Zhang, Zhuoli; Guo, Lili; Zhu, Jingjing; Peng, Mingli; Vermorken, Alphonsus J. M.; Van de Ven, Wim J. M.; Chen, Chao; Cui, Yali			A Novel Magnetic Nanoparticle Drug Carrier for Enhanced Cancer Chemotherapy	PLOS ONE			English	Article							GOLD; CYTOTOXICITY; PARTICLES; FIELD	Background: Magnetic nanoparticles (NPs) loaded with antitumor drugs in combination with an external magnetic field (EMF)-guided delivery can improve the efficacy of treatment and may decrease serious side effects. The purpose of this study was 1) to investigate application of PEG modified GMNPs (PGMNPs) as a drug carrier of the chemotherapy compound doxorubicin (DOX) in vitro; 2) to evaluate the therapeutic efficiency of DOX-conjugated PGMNPs (DOX-PGMNPs) using an EMF-guided delivery in vivo. Methods: First, DOX-PGMNPs were synthesized and the cytotoxicity of DOX-PGMNPs was assessed in vitro. Second, upon intravenous administration of DOX-PMGPNs to H22 hepatoma cell tumor-bearing mice, the DOX biodistribution in different organs (tissues) was measured. The antitumor activity was evaluated using different treatment strategies such as DOX-PMGPNs or DOX-PMGPNs with an EMF-guided delivery (DOX-PGMNPs-M). Results: The relative tumor volumes in DOX-PGMNPs-M, DOX-PGMNPs, and DOX groups were 5.46 +/- 1.48, 9.22 +/- 1.51, and 14.8 +/- 1.64, respectively (each p < 0.05), following treatment for 33 days. The life span of tumor-bearing mice treated with DOX-PGMNPs-M, DOX-PGMNPs, and DOX were 74.8 +/- 9.95, 66.1 +/- 13.5 +/- 13.5, and 31.3 +/- 3.31 days, respectively (each p < 0.05). Conclusion: This simple and adaptive nanoparticle design may accommodate chemotherapy for drug delivery optimization and in vivo drug-target definition in system biology profiling, increasing the margin of safety in treatment of cancers in the near future.	[Chao, Xu; Chen, Chao; Cui, Yali] NW Univ Xian, Coll Life Sci, Xian 710069, Peoples R China; [Guo, Lili; Peng, Mingli; Chen, Chao; Cui, Yali] Natl Engn Res Ctr Miniaturized Detect Syst, Xian, Peoples R China; [Zhang, Zhuoli] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA; [Zhu, Jingjing; Vermorken, Alphonsus J. M.; Van de Ven, Wim J. M.] Katholieke Univ Leuven, Mol Oncol Lab, Dept Human Genet, Louvain, Belgium; [Chao, Xu] Shaanxi Univ Chinese Med, Coll Basic Med Sci, Xianyang, Peoples R China	Northwest University Xi'an; Northwestern University; KU Leuven; Shaanxi University of Chinese Medicine	Cui, YL (corresponding author), NW Univ Xian, Coll Life Sci, Xian 710069, Peoples R China.	yali_cui@mail.com	Zhu, Jingjing/R-3277-2017	Zhu, Jingjing/0000-0003-0993-4849; Vermorken, Alphons/0000-0003-2918-298X	National High Technology Research and Development (863) Program of China [2006AA020705]	National High Technology Research and Development (863) Program of China(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development (863) Program of China (2006AA020705). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj G, 2010, PHARM RES-DORDR, V27, P735, DOI 10.1007/s11095-009-0031-z; Carr BI, 2004, GASTROENTEROLOGY, V127, pS218, DOI 10.1053/j.gastro.2004.09.036; Chao X, 2011, J DRUG TARGET, V19, P161, DOI 10.3109/10611861003801842; Chao X, 2010, PHARMAZIE, V65, P500, DOI 10.1691/ph.2010.9362; Cho WS, 2010, TOXICOL APPL PHARM, V245, P116, DOI 10.1016/j.taap.2010.02.013; Cho WS, 2009, TOXICOL APPL PHARM, V236, P16, DOI 10.1016/j.taap.2008.12.023; Cui YL, 2005, BIOMED MICRODEVICES, V7, P153, DOI 10.1007/s10544-005-1596-x; Gibson JD, 2007, J AM CHEM SOC, V129, P11653, DOI 10.1021/ja075181k; Gupta AK, 2005, BIOMATERIALS, V26, P1565, DOI 10.1016/j.biomaterials.2004.05.022; Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012; Huang X, 2011, NANOSCALE, V3, P1600, DOI 10.1039/c0nr00835d; Huynh NT, 2010, NANOMEDICINE-UK, V5, P1415, DOI [10.2217/nnm.10.113, 10.2217/NNM.10.113]; Jain KK, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-83; Kim D, 2007, J AM CHEM SOC, V129, P7661, DOI 10.1021/ja071471p; Kim J, 2006, ANGEW CHEM INT EDIT, V45, P7754, DOI 10.1002/anie.200602471; Kuruppuarachchi M, 2011, MOL PHARMACEUT, V8, P920, DOI 10.1021/mp200023y; Lee W, 2010, P NATL ACAD SCI USA, V107, P20709, DOI 10.1073/pnas.1005211107; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Li ZF, 2007, FOOD ADDIT CONTAM A, V24, P21, DOI 10.1080/02652030600949592; Lin J, 2001, J SOLID STATE CHEM, V159, P26, DOI 10.1006/jssc.2001.9117; Mejias R, 2011, BIOMATERIALS, V32, P2938, DOI 10.1016/j.biomaterials.2011.01.008; Meng YD, 2010, NANOMEDICINE-UK, V5, P1559, DOI [10.2217/nnm.10.91, 10.2217/NNM.10.91]; Paciotti GF, 2004, DRUG DELIV, V11, P169, DOI 10.1080/10717540490433895; Qian XM, 2008, NAT BIOTECHNOL, V26, P83, DOI 10.1038/nbt1377; Sanson C, 2011, ACS NANO, V5, P1122, DOI 10.1021/nn102762f; Shubayev VI, 2009, ADV DRUG DELIVER REV, V61, P467, DOI 10.1016/j.addr.2009.03.007; Shukla S, 2003, BIOCONJUGATE CHEM, V14, P158, DOI 10.1021/bc025586o; Singh A, 2011, ACS APPL MATER INTER, V3, P842, DOI 10.1021/am101196v; Yang XQ, 2011, BIOMATERIALS, V32, P4151, DOI 10.1016/j.biomaterials.2011.02.006; Zamboni WC, 2008, ONCOLOGIST, V13, P248, DOI 10.1634/theoncologist.2007-0180; Zhao XL, 2008, ANAL CHEM, V80, P9091, DOI 10.1021/ac801581m; Zharov VP, 2005, J PHYS D APPL PHYS, V38, P2571, DOI 10.1088/0022-3727/38/15/007	32	31	32	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e40388	10.1371/journal.pone.0040388	http://dx.doi.org/10.1371/journal.pone.0040388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056167	gold, Green Published, Green Submitted			2022-12-27	WOS:000309831500003
J	Le, DT; Aldrich, DL; Valliyodan, B; Watanabe, Y; Van Ha, C; Nishiyama, R; Guttikonda, SK; Quach, TN; Gutierrez-Gonzalez, JJ; Tran, LSP; Nguyen, HT				Le, Dung Tien; Aldrich, Donavan L.; Valliyodan, Babu; Watanabe, Yasuko; Van Ha, Chien; Nishiyama, Rie; Guttikonda, Satish K.; Quach, Truyen N.; Gutierrez-Gonzalez, Juan J.; Lam-Son Phan Tran; Nguyen, Henry T.			Evaluation of Candidate Reference Genes for Normalization of Quantitative RT-PCR in Soybean Tissues under Various Abiotic Stress Conditions	PLOS ONE			English	Article							NAC TRANSCRIPTION FACTORS; FUNCTIONAL-ANALYSIS; EXPRESSION ANALYSIS; ABSCISIC-ACID; MOLECULAR CHARACTERIZATION; REGULATORY NETWORKS; HIGH-SALINITY; ARABIDOPSIS; DROUGHT; TOLERANCE	Quantitative RT-PCR can be a very sensitive and powerful technique for measuring differential gene expression. Changes in gene expression induced by abiotic stresses are complex and multifaceted, which make determining stably expressed genes for data normalization difficult. To identify the most suitable reference genes for abiotic stress studies in soybean, 13 candidate genes collected from literature were evaluated for stability of expression under dehydration, high salinity, cold and ABA (abscisic acid) treatments using delta CT and geNorm approaches. Validation of reference genes indicated that the best reference genes are tissue-and stress-dependent. With respect to dehydration treatment, the Fbox/ABC, Fbox/60s gene pairs were found to have the highest expression stability in the root and shoot tissues of soybean seedlings, respectively. Fbox and 60s genes are the most suitable reference genes across dehydrated root and shoot tissues. Under salt stress the ELF1b/IDE and Fbox/ELF1b are the most stably expressed gene pairs in roots and shoots, respectively, while 60s/Fbox is the best gene pair in both tissues. For studying cold stress in roots or shoots, IDE/60s and Fbox/Act27 are good reference gene pairs, respectively. With regard to gene expression analysis under ABA treatment in either roots, shoots or across these tissues, 60s/ELF1b, ELF1b/Fbox and 60s/ELF1b are the most suitable reference genes, respectively. The expression of ELF1b/60s, 60s/Fbox and 60s/Fbox genes was most stable in roots, shoots and both tissues, respectively, under various stresses studied. Among the genes tested, 60s was found to be the best reference gene in different tissues and under various stress conditions. The highly ranked reference genes identified from this study were proved to be capable of detecting subtle differences in expression rates that otherwise would be missed if a less stable reference gene was used.	[Le, Dung Tien; Watanabe, Yasuko; Van Ha, Chien; Nishiyama, Rie; Lam-Son Phan Tran] RIKEN Plant Sci Ctr, Signaling Pathway Res Unit, Yokohama, Kanagawa, Japan; [Aldrich, Donavan L.; Valliyodan, Babu; Guttikonda, Satish K.; Quach, Truyen N.; Gutierrez-Gonzalez, Juan J.; Nguyen, Henry T.] Univ Missouri, Natl Ctr Soybean Biotechnol, Columbia, MO USA; [Aldrich, Donavan L.; Valliyodan, Babu; Guttikonda, Satish K.; Quach, Truyen N.; Gutierrez-Gonzalez, Juan J.; Nguyen, Henry T.] Univ Missouri, Div Plant Sci, Columbia, MO USA	RIKEN; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Tran, LSP (corresponding author), RIKEN Plant Sci Ctr, Signaling Pathway Res Unit, Yokohama, Kanagawa, Japan.	tran@psc.riken.jp; nguyenhenry@missouri.edu	Gutierrez-Gonzalez, Juan J/B-1387-2018; Tran, Lam-Son P/A-1346-2009; Le, Dung Tien/A-7276-2008	Gutierrez-Gonzalez, Juan J/0000-0002-6795-6192; Tran, Lam-Son P/0000-0001-9883-9768; Le, Dung Tien/0000-0002-5117-3476; Valliyodan, Babu/0000-0001-9457-9508	National Center for Soybean Biotechnology; Missouri Soybean Merchandising Council	National Center for Soybean Biotechnology; Missouri Soybean Merchandising Council	This project was supported by the National Center for Soybean Biotechnology and the Missouri Soybean Merchandising Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALWINE JC, 1977, P NATL ACAD SCI USA, V74, P5350, DOI 10.1073/pnas.74.12.5350; Aslam M, 2012, MOL BIOL REP, V39, P9629, DOI 10.1007/s11033-012-1828-0; Ballman KV, 2008, CIRCULATION, V118, P1593, DOI 10.1161/CIRCULATIONAHA.107.714600; Choudhary SP, 2012, TRENDS PLANT SCI, V17, P594, DOI 10.1016/j.tplants.2012.05.012; Choudhary SP, 2012, J EXP BOT, V63, P5659, DOI 10.1093/jxb/ers219; Czechowski T, 2004, PLANT J, V38, P366, DOI 10.1111/j.1365-313X.2004.02051.x; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Gao SQ, 2011, PLANT MOL BIOL, V75, P537, DOI 10.1007/s11103-011-9738-4; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Gutierrez-Gonzalez JJ, 2010, PLANT CELL PHYSIOL, V51, P936, DOI 10.1093/pcp/pcq065; Ha S, 2012, TRENDS PLANT SCI, V17, P172, DOI 10.1016/j.tplants.2011.12.005; Hadiarto T, 2011, PLANT CELL REP, V30, P297, DOI 10.1007/s00299-010-0956-z; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Irsigler AS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-431; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Jogaiah S, 2012, CRIT REV BIOTECHNOL, DOI [10.3109/07388551.2012.659174, DOI 10.3109/07388551.2012.659174]; Khanlou KM, 2012, PLANTA, V236, P1381, DOI 10.1007/s00425-012-1682-2; Kodaira KS, 2011, PLANT PHYSIOL, V157, P742, DOI 10.1104/pp.111.182683; Kortner TM, 2011, AQUACULTURE, V318, P355, DOI 10.1016/j.aquaculture.2011.05.038; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Le Dung Tien, 2010, GM Crops, V1, P62, DOI 10.4161/gmcr.1.2.10856; Le DT, 2011, DNA RES, V18, P17, DOI 10.1093/dnares/dsq032; Libault M, 2008, PLANT GENOME-US, V1, P44, DOI 10.3835/plantgenome2008.02.0091; Ma Y, 2012, MOL PLANT, V5, P1176, DOI 10.1093/mp/sss085; Manavalan LP, 2009, PLANT CELL PHYSIOL, V50, P1260, DOI 10.1093/pcp/pcp082; Maruyama K, 2012, DNA RES, V19, P37, DOI 10.1093/dnares/dsr040; Matsui A, 2008, PLANT CELL PHYSIOL, V49, P1135, DOI 10.1093/pcp/pcn101; Matsui A, 2010, METHODS MOL BIOL, V639, P141, DOI 10.1007/978-1-60761-702-0_8; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P2017, DOI 10.1093/pcp/pcr153; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Neelakandan AK, 2010, PLANT MOL BIOL, V74, P503, DOI 10.1007/s11103-010-9692-6; Thao NP, 2012, CRIT REV BIOTECHNOL, V32, P349, DOI 10.3109/07388551.2011.643463; Nishiyama R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032124; Nishiyama R, 2011, PLANT CELL, V23, P2169, DOI 10.1105/tpc.111.087395; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Nouri MZ, 2012, PHYTOCHEMISTRY, V74, P20, DOI 10.1016/j.phytochem.2011.11.005; Pereira SS, 2011, GENET MOL RES, V10, DOI [10.4238/2011.October.4221.4235, DOI 10.4238/2011.OCTOBER.4221.4235]; Qin F, 2011, PLANT PHYSIOL, V157, P1900, DOI 10.1104/pp.111.187302; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Stolf-Moreira R, 2010, GENET MOL RES, V9, P858, DOI 10.4238/vol9-2gmr701; Stolf-Moreira R, 2011, PESQUI AGROPECU BRAS, V46, P58, DOI 10.1590/S0100-204X2011000100008; Stolf-Moreira R, 2011, PLANT MOL BIOL REP, V29, P19, DOI 10.1007/s11105-010-0203-3; Tang T, 2007, BIOINFORMATICS, V23, P2686, DOI 10.1093/bioinformatics/btm399; To TK, 2011, BIOCHEM BIOPH RES CO, V406, P414, DOI 10.1016/j.bbrc.2011.02.058; Toda K, 2011, J PLANT RES, V124, P173, DOI 10.1007/s10265-010-0345-2; Tran LSP, 2007, P NATL ACAD SCI USA, V104, P20623, DOI 10.1073/pnas.0706547105; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; Tran LSP, 2007, PLANT J, V49, P46, DOI 10.1111/j.1365-313X.2006.02932.x; Tran Lam-Son Phan, 2010, GM Crops, V1, P32, DOI 10.4161/gmcr.1.1.10569; Tran LSP, 2010, FUNCT INTEGR GENOMIC, V10, P447, DOI 10.1007/s10142-010-0178-z; Tran LSP, 2009, MOL GENET GENOMICS, V281, P647, DOI 10.1007/s00438-009-0436-8; Tran LS, 2009, NITROGEN FIXATION CR, P265; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wei W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007209; Xie ZM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006898; Xin H., 2012, ENV ADAPTATIONS STRE, V13, P279, DOI [10.1007/978-1-4614-0815-4-13, DOI 10.1007/978-1-4614-0815-4-13]	64	110	116	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46487	10.1371/journal.pone.0046487	http://dx.doi.org/10.1371/journal.pone.0046487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029532	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900171
J	Yang, SM; Chen, W; Guo, WW; Jia, SP; Sun, JH; Liu, HZ; Young, WY; He, DZZ				Yang, Shi-Ming; Chen, Wei; Guo, Wei-Wei; Jia, Shuping; Sun, Jian-He; Liu, Hui-Zhan; Young, Wie-Yen; He, David Z. Z.			Regeneration of Stereocilia of Hair Cells by Forced Atoh1 Expression in the Adult Mammalian Cochlea	PLOS ONE			English	Article							INDUCED HEARING-LOSS; IMPULSE NOISE; MECHANICAL DAMAGE; NERVOUS-SYSTEM; PRONEURAL GENE; GUINEA-PIG; MYOSIN-XVA; IN-VIVO; MATH1; RECOVERY	The hallmark of mechanosensory hair cells is the stereocilia, where mechanical stimuli are converted into electrical signals. These delicate stereocilia are susceptible to acoustic trauma and ototoxic drugs. While hair cells in lower vertebrates and the mammalian vestibular system can spontaneously regenerate lost stereocilia, mammalian cochlear hair cells no longer retain this capability. We explored the possibility of regenerating stereocilia in the noise-deafened guinea pig cochlea by cochlear inoculation of a viral vector carrying Atoh1, a gene critical for hair cell differentiation. Exposure to simulated gunfire resulted in a 60-70 dB hearing loss and extensive damage and loss of stereocilia bundles of both inner and outer hair cells along the entire cochlear length. However, most injured hair cells remained in the organ of Corti for up to 10 days after the trauma. A viral vector carrying an EGFP-labeled Atoh1 gene was inoculated into the cochlea through the round window on the seventh day after noise exposure. Auditory brainstem response measured one month after inoculation showed that hearing thresholds were substantially improved. Scanning electron microscopy revealed that the damaged/lost stereocilia bundles were repaired or regenerated after Atoh1 treatment, suggesting that Atoh1 was able to induce repair/regeneration of the damaged or lost stereocilia. Therefore, our studies revealed a new role of Atoh1 as a gene critical for promoting repair/regeneration of stereocilia and maintaining injured hair cells in the adult mammal cochlea. Atoh1-based gene therapy, therefore, has the potential to treat noise-induced hearing loss if the treatment is carried out before hair cells die.	[Yang, Shi-Ming; Guo, Wei-Wei; Sun, Jian-He; Young, Wie-Yen] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Inst Otolaryngol, Beijing, Peoples R China; [Chen, Wei] PLA AF Gen Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Jia, Shuping; Liu, Hui-Zhan; He, David Z. Z.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA	Chinese People's Liberation Army General Hospital; Creighton University	Yang, SM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Inst Otolaryngol, Beijing, Peoples R China.	yangsm301@263.net; hed@creighton.edu	, sunjhe/S-5843-2019	He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	Major State Basic Research Development Program of China (973 Program) [2011CBA01000]; National Basic Research Program of China (973 Program) [2012CB967900]; National Hi-Tech Research and Development Program of China (863 Program) [2007AA02Z150]; National Natural Science Foundation of China [30871398, 30730040]; National Institutes of Health (NIH), National Institute on Deafness and Other Communication Disorders (NIDCD) [R21 DC 009908, R01 DC 004696]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC009908, R01DC004696] Funding Source: NIH RePORTER	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Hi-Tech Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH), National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the Major State Basic Research Development Program of China (973 Program #2011CBA01000), the National Basic Research Program of China (973 Program #2012CB967900), National Hi-Tech Research and Development Program of China (863 Program #2007AA02Z150), the National Natural Science Foundation of China (#30871398, 30730040) to SMY, and by National Institutes of Health (NIH) grants R21 DC 009908 and R01 DC 004696 to DH from the National Institute on Deafness and Other Communication Disorders (NIDCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Baird RA, 2000, P NATL ACAD SCI USA, V97, P11722, DOI 10.1073/pnas.97.22.11722; Belyantseva IA, 2000, J NEUROSCI, V20, part. no.; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; CHEATHAM MA, 1993, HEARING RES, V68, P107, DOI 10.1016/0378-5955(93)90069-D; CHEATHAM MA, 1993, PROG BRAIN RES, V97, P13; Chen P, 2002, DEVELOPMENT, V129, P2495; DALLOS P, 1992, J NEUROSCI, V12, P4575; Delprat B, 2005, HUM MOL GENET, V14, P401, DOI 10.1093/hmg/ddi036; Fettiplace R, 2006, NAT REV NEUROSCI, V7, P19, DOI 10.1038/nrn1828; Gale JE, 2002, J NEUROBIOL, V50, P81, DOI 10.1002/neu.10002; Gorelik J, 2003, P NATL ACAD SCI USA, V100, P5819, DOI 10.1073/pnas.1030502100; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; HAMERNIK RP, 1988, J ACOUST SOC AM, V84, P941, DOI 10.1121/1.396663; HAMERNIK RP, 1984, HEARING RES, V13, P229, DOI 10.1016/0378-5955(84)90077-7; HAMERNIK RP, 1987, J ACOUST SOC AM, V81, P1118, DOI 10.1121/1.394632; Harding GW, 2004, J ACOUST SOC AM, V115, P2207, DOI 10.1121/1.1689961; Helms AW, 1998, DEVELOPMENT, V125, P919; HENDERSON D, 1986, J ACOUST SOC AM, V80, P569, DOI 10.1121/1.394052; Hu BH, 2006, HEARING RES, V211, P16, DOI 10.1016/j.heares.2005.08.006; Hu BH, 2008, HEARING RES, V236, P11, DOI 10.1016/j.heares.2007.11.002; HUDSPETH AJ, 1977, P NATL ACAD SCI USA, V74, P2407, DOI 10.1073/pnas.74.6.2407; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Jia SP, 2009, J NEUROSCI, V29, P15277, DOI 10.1523/JNEUROSCI.3231-09.2009; Kawamoto K, 2003, J NEUROSCI, V23, P4395; Kelly MC, 2012, J NEUROSCI, V32, P6699, DOI 10.1523/JNEUROSCI.5420-11.2012; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Liang Z, 1992, NOISE INDUCED HEARIN, P325; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Manuela M, 2008, J NEUROSCI, V28, P4918; Matsui JI, 2004, J NEUROBIOL, V61, P250, DOI 10.1002/neu.20054; Pan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030358; PICKLES JO, 1987, HEARING RES, V25, P173, DOI 10.1016/0378-5955(87)90089-X; Price GR, 2007, HEARING RES, V226, P5, DOI 10.1016/j.heares.2006.08.005; Salles FT, 2009, NAT CELL BIOL, V11, P443, DOI 10.1038/ncb1851; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Van Keymeulen A, 2009, J CELL BIOL, V187, P91, DOI 10.1083/jcb.200907080; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zheng JL, 1999, J NEUROSCI, V19, P2161	49	20	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46355	10.1371/journal.pone.0046355	http://dx.doi.org/10.1371/journal.pone.0046355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029493	Green Submitted, gold, Green Published			2022-12-27	WOS:000309517500095
J	Chan, WFN; Gurnot, C; Montine, TJ; Sonnen, JA; Guthrie, KA; Nelson, JL				Chan, William F. N.; Gurnot, Cecile; Montine, Thomas J.; Sonnen, Joshua A.; Guthrie, Katherine A.; Nelson, J. Lee			Male Microchimerism in the Human Female Brain	PLOS ONE			English	Article							FETAL CELL MICROCHIMERISM; MATERNAL MICROCHIMERISM; ALZHEIMERS-DISEASE; HEALTHY WOMEN; BONE-MARROW; PURKINJE NEURONS; QUANTITATIVE-ANALYSIS; REPRODUCTIVE FACTORS; HEMATOPOIETIC-CELLS; PERIPHERAL-BLOOD	In humans, naturally acquired microchimerism has been observed in many tissues and organs. Fetal microchimerism, however, has not been investigated in the human brain. Microchimerism of fetal as well as maternal origin has recently been reported in the mouse brain. In this study, we quantified male DNA in the human female brain as a marker for microchimerism of fetal origin (i.e. acquisition of male DNA by a woman while bearing a male fetus). Targeting the Y-chromosome-specific DYS14 gene, we performed real-time quantitative PCR in autopsied brain from women without clinical or pathologic evidence of neurologic disease (n = 26), or women who had Alzheimer's disease (n = 33). We report that 63% of the females (37 of 59) tested harbored male microchimerism in the brain. Male microchimerism was present in multiple brain regions. Results also suggested lower prevalence (p = 0.03) and concentration (p = 0.06) of male microchimerism in the brains of women with Alzheimer's disease than the brains of women without neurologic disease. In conclusion, male microchimerism is frequent and widely distributed in the human female brain.	[Chan, William F. N.; Gurnot, Cecile; Guthrie, Katherine A.; Nelson, J. Lee] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Montine, Thomas J.; Sonnen, Joshua A.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Nelson, J. Lee] Univ Washington, Div Rheumatol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Chan, WFN (corresponding author), Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB, Canada.	fchan@ualberta.ca	Sonnen, Joshua/AAT-5788-2021; Sonnen, Joshua Aaron/H-3738-2016	Sonnen, Joshua Aaron/0000-0001-9267-8705	National Institutes of Health [NS 071418, AI-41721]; Canadian Institutes of Health Research [SIB-95173]; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS071418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health (NS 071418 and AI-41721 to JLN). WFNC was supported by a Canadian Institutes of Health Research Fellowship Award (SIB-95173). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aging NIo, 1997, NEUROBIOL AGING, V18, pS1; Angert RM, 2004, AM J OBSTET GYNECOL, V190, P1087, DOI 10.1016/j.ajog.2003.10.562; ARNEMANN J, 1987, NUCLEIC ACIDS RES, V15, P8713, DOI 10.1093/nar/15.21.8713; Bayes-Genis A, 2005, J HEART LUNG TRANSPL, V24, P2179, DOI 10.1016/j.healun.2005.06.003; Bianchi DW, 2001, AM J OBSTET GYNECOL, V184, P703, DOI 10.1067/mob.2001.111072; Bianchi DW, 1996, P NATL ACAD SCI USA, V93, P705, DOI 10.1073/pnas.93.2.705; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; CANTOR KP, 1993, CANCER CAUSE CONTROL, V4, P505, DOI 10.1007/BF00052425; Chan WFN, 2012, ARTHRITIS RHEUM-US, V64, P380, DOI 10.1002/art.33358; Cipolla MJ, 2011, J APPL PHYSIOL, V110, P329, DOI 10.1152/japplphysiol.01159.2010; Cogle CR, 2004, LANCET, V363, P1432, DOI 10.1016/S0140-6736(04)16102-3; Colucci M, 2006, EUR J NEUROL, V13, P1374, DOI 10.1111/j.1468-1331.2006.01520.x; de Bellefon Laurent Meric, 2010, Chimerism, V1, P56, DOI 10.4161/chim.1.2.14294; DEMOOR G, 1988, ACTA CLIN BELG, V43, P231; Evans PC, 1999, BLOOD, V93, P2033, DOI 10.1182/blood.V93.6.2033.406k18_2033_2037; Fugazzola L, 2011, NAT REV ENDOCRINOL, V7, P89, DOI 10.1038/nrendo.2010.216; Fujiki Y, 2008, BIOL REPROD, V79, P841, DOI 10.1095/biolreprod.108.068973; Fujiki Y, 2009, BIOL REPROD, V81, P26, DOI 10.1095/biolreprod.108.074468; Gammill HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024101; Gammill HS, 2010, INT J DEV BIOL, V54, P531, DOI 10.1387/ijdb.082767hg; GEARING M, 1995, NEUROLOGY, V45, P461, DOI 10.1212/WNL.45.3.461; Gotherstrom C, 2005, FETAL DIAGN THER, V20, P355, DOI 10.1159/000086812; Hatch EE, 2005, INT J CANCER, V114, P797, DOI 10.1002/ijc.20776; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Jonsson AM, 2010, PEDIATR RES, V68, P199, DOI 10.1203/00006450-201011001-00387; Jonsson AM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.047; Kaplan J, 2005, J IMMUNOL, V174, P7123, DOI 10.4049/jimmunol.174.11.7123; Khosrotehrani K, 2005, J REPROD IMMUNOL, V66, P1, DOI 10.1016/j.jri.2005.02.001; Khosrotehrani K, 2004, JAMA-J AM MED ASSOC, V292, P75, DOI 10.1001/jama.292.1.75; Koopmans M, 2005, AM J TRANSPLANT, V5, P1495, DOI 10.1111/j.1600-6143.2005.00858.x; Koopmans M, 2008, J REPROD IMMUNOL, V78, P68, DOI 10.1016/j.jri.2008.01.002; Lambe M, 1997, INT J CANCER, V72, P389; Lambert NC, 2005, ANN RHEUM DIS, V64, P845, DOI 10.1136/ard.2004.029314; Lambert NC, 2004, ARTHRITIS RHEUM-US, V50, P906, DOI 10.1002/art.20200; Lambert NC, 2002, BLOOD, V100, P2845, DOI 10.1182/blood-2002-01-0295; Lee TH, 1999, BLOOD, V93, P3127; Lo YMD, 2000, CLIN CHEM, V46, P1301; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Maloney S, 1999, J CLIN INVEST, V104, P41, DOI 10.1172/JCI6611; Nelson JL, 2007, P NATL ACAD SCI USA, V104, P1637, DOI 10.1073/pnas.0606169104; Nelson JL, 2012, TRENDS IMMUNOL, V33, P421, DOI 10.1016/j.it.2012.03.002; O'Donoghue K, 2004, LANCET, V364, P179, DOI 10.1016/S0140-6736(04)16631-2; Ptok U, 2002, Arch Womens Ment Health, V5, P83, DOI 10.1007/s00737-002-0142-6; Sato T, 2008, OBSTET GYNECOL, V112, P593, DOI 10.1097/AOG.0b013e31818345da; SOBOW TM, 2003, GER J PSYCHIATRY, V6, P49; Stevens AM, 2005, RHEUMATOLOGY, V44, P187, DOI 10.1093/rheumatology/keh453; Stevens AM, 2004, LAB INVEST, V84, P1603, DOI 10.1038/labinvest.3700193; Stevens AM, 2009, PEDIATR DEVEL PATHOL, V12, P337, DOI 10.2350/08-07-0499.1; Tan XW, 2005, STEM CELLS, V23, P1443, DOI 10.1634/stemcells.2004-0169; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Weimann JM, 2003, NAT CELL BIOL, V5, P959, DOI 10.1038/ncb1053; Wenk GL, 2003, J CLIN PSYCHIAT, V64, P7; Yan Z, 2005, AM J MED, V118, P899, DOI 10.1016/j.amjmed.2005.03.037; Zeng XX, 2010, STEM CELLS DEV, V19, P1819, DOI 10.1089/scd.2010.0046; Zota V, 2009, J IMMUNOL, V183, P3522, DOI 10.4049/jimmunol.0900620	56	64	66	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45592	10.1371/journal.pone.0045592	http://dx.doi.org/10.1371/journal.pone.0045592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049819	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300035
J	Clay, JR; Forger, DB; Paydarfar, D				Clay, John R.; Forger, Daniel B.; Paydarfar, David			Ionic Mechanism Underlying Optimal Stimuli for Neuronal Excitation: Role of Na+ Channel Inactivation	PLOS ONE			English	Article							LACUNOSUM-MOLECULARE INTERNEURONS; HIPPOCAMPAL CA1-REGION; EXCITABILITY; SPIKING; MODELS; INPUTS; AXONS	The ionic mechanism underlying optimal stimulus shapes that induce a neuron to fire an action potential, or spike, is relevant to understanding optimal information transmission and therapeutic stimulation in the nervous system. Here we analyze for the first time the ionic basis for stimulus optimality in the Hodgkin and Huxley model and for eliciting a spike in squid giant axons, the preparation for which the model was devised. The experimentally determined stimulus is a smoothly varying biphasic current waveform having a relatively long and shallow hyperpolarizing phase followed by a depolarizing phase of briefer duration. The hyperpolarizing phase removes a small degree of the resting level of Na+ channel inactivation. This result together with the subsequent depolarizing phase provides a signal that is energetically more efficient for eliciting spikes than rectangular current pulses. Sodium channel inactivation is the only variable that is changed during the stimulus waveform, other than the membrane potential, V. The activation variables for Na+ and K+ channels are unchanged throughout the stimulus. This result demonstrates how an optimal stimulus waveform relates to ionic dynamics and may have implications for energy efficiency of neural excitation in many systems including the mammalian brain.	[Clay, John R.] NINDS, NIH, Bethesda, MD 20892 USA; [Forger, Daniel B.] Univ Michigan, Dept Math, Ann Arbor, MI 48109 USA; [Forger, Daniel B.] Univ Michigan, Ctr Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Paydarfar, David] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Paydarfar, David] Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA USA; [Paydarfar, David] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University	Clay, JR (corresponding author), NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	jrclay@ninds.nih.gov; forger@umich.edu; david.paydarfar@umassmed.edu	Forger, Daniel/C-5552-2015	Forger, Daniel/0000-0001-7581-4031	National Institute of Neurological Disorders and Stroke, United States National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002608] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, United States National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by the National Institute of Neurological Disorders and Stroke, United States National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian Y, 2011, J NEUROPHYSIOL, V106, P1038, DOI 10.1152/jn.00427.2010; BRYANT HL, 1976, J PHYSIOL-LONDON, V260, P279, DOI 10.1113/jphysiol.1976.sp011516; Clay JR, 2008, J R SOC INTERFACE, V5, P1421, DOI 10.1098/rsif.2008.0166; CLAY JR, 1983, BIOPHYS J, V42, P151, DOI 10.1016/S0006-3495(83)84381-1; Coffey RJ, 2009, ARTIF ORGANS, V33, P208, DOI 10.1111/j.1525-1594.2008.00620.x; Dodla R, 2006, J NEUROPHYSIOL, V95, P2664, DOI 10.1152/jn.00752.2005; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Forger DB, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002089; Forger DB, 2004, J THEOR BIOL, V230, P521, DOI 10.1016/j.jtbi.2004.04.043; FRASER DD, 1991, J NEUROSCI, V11, P2812; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hofmann Lorenz, 2011, Front Neuroeng, V4, P9, DOI 10.3389/fneng.2011.00009; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; LACAILLE JC, 1988, J NEUROSCI, V8, P1411; LACAILLE JC, 1988, J NEUROSCI, V8, P1400; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Manola L, 2007, CLIN NEUROPHYSIOL, V118, P464, DOI 10.1016/j.clinph.2006.09.012; McIntyre CC, 1999, BIOPHYS J, V76, P878, DOI 10.1016/S0006-3495(99)77251-6; McIntyre CC, 2002, J NEUROPHYSIOL, V88, P1592, DOI 10.1152/jn.2002.88.4.1592; Moehlis J, 2006, J COMPUT NONLIN DYN, V1, P358, DOI 10.1115/1.2338654; Padmanabhan K, 2010, NAT NEUROSCI, V13, P1276, DOI 10.1038/nn.2630; Paydarfar D, 2006, J NEUROPHYSIOL, V96, P3338, DOI 10.1152/jn.00486.2006; RATTAY F, 1986, IEEE T BIO-MED ENG, V33, P974, DOI 10.1109/TBME.1986.325670; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Segev R, 2006, J NEUROPHYSIOL, V95, P2277, DOI 10.1152/jn.00928.2005; Svirskis G, 2004, J NEUROPHYSIOL, V91, P2465, DOI 10.1152/jn.00717.2003; Wongsarnpigoon A, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046009	27	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45983	10.1371/journal.pone.0045983	http://dx.doi.org/10.1371/journal.pone.0045983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049913	Green Submitted, gold, Green Published			2022-12-27	WOS:000309517300071
J	Mane-Padros, D; Cruz, J; Cheng, A; Raikhel, AS				Mane-Padros, Daniel; Cruz, Josefa; Cheng, Andrew; Raikhel, Alexander S.			A Critical Role of the Nuclear Receptor HR3 in Regulation of Gonadotrophic Cycles of the Mosquito Aedes aegypti	PLOS ONE			English	Article							COMPETENCE FACTOR BETA-FTZ-F1; STARVATION-INDUCED AUTOPHAGY; ECDYSONE RECEPTOR; FAT-BODY; DROSOPHILA METAMORPHOSIS; VITELLOGENIC RESPONSE; ECDYSTEROID RECEPTOR; DISTINCT ROLES; GENE; 20-HYDROXYECDYSONE	The orphan nuclear receptor HR3 is essential for developmental switches during insect development and metamorphosis regulated by 20-hydroxyecdysone (20E). Reproduction of female mosquitoes of the major vector of Dengue fever, Aedes aegypti, is cyclic because of its dependence on blood feeding. 20E is an important hormone regulating vitellogenic events in this mosquito; however, any role for HR3 in 20E-driven reproductive events has not been known. Using RNA interference (RNAi) approach, we demonstrated that Aedes HR3 plays a critical role in a timely termination of expression of the vitellogenin (Vg) gene encoding the major yolk protein precursor. It is also important for downregulation of the Target-of-Rapamycin pathway and activation of programmed autophagy in the Aedes fat body at the end of vitellogenesis. HR3 is critical in activating betaFTZ-F1, EcRB and USPA, the expressions of which are highly elevated at the end of vitellogenesis. RNAi depletion of HR3 (iHR3) prior to the first gonadotrophic cycle affects a normal progression of the second gonadotrophic cycle. Most of ovaries 24 h post second blood meal from iHR3 females in the second cycle were small with follicles that were only slightly different in length from of those of resting stage. In addition, these iHR3 females laid a significantly reduced number of eggs per mosquito as compared to those of iMal and the wild type. Our results indicate an important role of HR3 in regulation of 20E-regulated developmental switches during reproductive cycles of A. aegypti females.	[Raikhel, Alexander S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Raikhel, AS (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	araikhel@ucr.edu		Cruz, Josefa/0000-0003-3490-6591	National Institutes of Health [2R01AI036959]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the award 2R01AI036959 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arquier N, 2005, CURR BIOL, V15, P19, DOI 10.1016/j.cub.2004.12.037; Beckstead RB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r99; Broadus J, 1999, MOL CELL, V3, P143, DOI 10.1016/S1097-2765(00)80305-6; Brown MR, 2008, P NATL ACAD SCI USA, V105, P5716, DOI 10.1073/pnas.0800478105; Bryant B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025502; Chen L, 2004, J MOL ENDOCRINOL, V33, P743, DOI 10.1677/jme.1.01531; Cruz J, 2009, FEBS J, V276, P1233, DOI 10.1111/j.1742-4658.2008.06860.x; Cruz J, 2012, MOL CELL ENDOCRINOL, V349, P262, DOI 10.1016/j.mce.2011.11.006; Gulia-Nuss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020401; Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200; Hansen IA, 2004, P NATL ACAD SCI USA, V101, P10626, DOI 10.1073/pnas.0403460101; Hiruma K, 2004, DEV BIOL, V272, P510, DOI 10.1016/j.ydbio.2004.04.028; HORNER MA, 1995, DEV BIOL, V168, P490, DOI 10.1006/dbio.1995.1097; Hou YCC, 2008, J CELL BIOL, V182, P1127, DOI 10.1083/jcb.200712091; Kapitskaya MZ, 2000, MOL CELL ENDOCRINOL, V160, P25, DOI 10.1016/S0303-7207(99)00253-1; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Kokoza VA, 2001, GENE, V274, P47, DOI 10.1016/S0378-1119(01)00602-3; Lam G, 1999, DEV BIOL, V212, P204, DOI 10.1006/dbio.1999.9343; Lam GT, 1997, DEVELOPMENT, V124, P1757; Lee CY, 2001, DEVELOPMENT, V128, P1443; Lee SB, 2007, EMBO REP, V8, P360, DOI 10.1038/sj.embor.7400917; Li C, 2000, DEV BIOL, V224, P96, DOI 10.1006/dbio.2000.9792; Martin D, 2001, MOL CELL ENDOCRINOL, V173, P75, DOI 10.1016/S0303-7207(00)00413-5; McPhee CK, 2009, BBA-MOL CELL RES, V1793, P1452, DOI 10.1016/j.bbamcr.2009.02.009; Melendez A, 2008, DEVELOPMENT, V135, P2347, DOI 10.1242/dev.016105; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; Pierceall WE, 1999, MOL CELL ENDOCRINOL, V150, P73, DOI 10.1016/S0303-7207(99)00022-2; Raikhel A. S., 2005, COMPREHENSIVE MOL IN; RAIKHEL AS, 1986, J INSECT PHYSIOL, V32, P879, DOI 10.1016/0022-1910(86)90103-4; Raikhel AS, 2004, BIOL DIS VECTORS, P329; Roy SG, 2007, INSECT BIOCHEM MOLEC, V37, P1317, DOI 10.1016/j.ibmb.2007.08.004; Roy SG, 2012, FASEB J, V26, P1334, DOI 10.1096/fj.11-189969; Ruaud AF, 2010, DEVELOPMENT, V137, P123, DOI 10.1242/dev.042036; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; Sun GQ, 2005, P NATL ACAD SCI USA, V102, P15506, DOI 10.1073/pnas.0503501102; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Wang SF, 2002, MOL CELL ENDOCRINOL, V196, P29, DOI 10.1016/S0303-7207(02)00225-3; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Zhu JS, 2007, MOL CELL ENDOCRINOL, V267, P97, DOI 10.1016/j.mce.2007.01.006; Zhu JS, 2006, MOL CELL BIOL, V26, P9402, DOI 10.1128/MCB.01318-06; Zhu JS, 2003, P NATL ACAD SCI USA, V100, P13338, DOI 10.1073/pnas.2234416100	46	25	28	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45019	10.1371/journal.pone.0045019	http://dx.doi.org/10.1371/journal.pone.0045019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049766	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300015
J	Schmidt, J; Opgenoorth, L; Holl, S; Bastrop, R				Schmidt, Joachim; Opgenoorth, Lars; Hoell, Steffen; Bastrop, Ralf			Into the Himalayan Exile: The Phylogeography of the Ground Beetle Ethira clade Supports the Tibetan Origin of Forest-Dwelling Himalayan Species Groups	PLOS ONE			English	Article							GENUS PTEROSTICHUS; COLEOPTERA; PHYLOGENY; EVOLUTION; CARABIDAE; MITOCHONDRIAL; PLATEAU; GROWTH; RISE	The Himalayan mountain arc is one of the hotspots of biodiversity on earth, and species diversity is expected to be especially high among insects in this region. Little is known about the origin of the Himalayan insect fauna. With respect to the fauna of high altitude cloud forests, it has generally been accepted that Himalayan lineages are derived from ancestors that immigrated from Western Asia and from adjacent mountainous regions of East and Southeast Asia (immigration hypothesis). In this study, we sought to test a Tibetan Origin as an alternative hypothesis for groups with a poor dispersal ability through a phylogeographic analysis of the Ethira clade of the genus Pterostichus. We sequenced COI mtDNA and the 18S and 28S rDNA genes in 168 Pterostichini specimens, including 46 species and subspecies of the Ethira clade. In our analysis, we were able to show that the Ethira clade is monophyletic and, thus, represents a Himalayan endemic clade, supporting endemism of two of the basal lineages to the Central Himalaya and documenting large distributional gaps within the phylogeographic structure of the Ethira clade. Furthermore, the molecular data strongly indicate very limited dispersal abilities of species and subspecies of these primary wingless ground beetles. These results are consistent with the hypothesis of a Tibetan Origin, which explains the evolution, diversity and distribution of the Himalayan ground beetle Ethira clade much more parsimoniously than the original immigration hypothesis.	[Schmidt, Joachim] Univ Marburg, Fac Geog, Marburg, Germany; [Opgenoorth, Lars] Univ Marburg, Dept Ecol, Marburg, Germany; [Schmidt, Joachim; Hoell, Steffen; Bastrop, Ralf] Univ Rostock, Inst Biol Sci, Rostock, Germany	Philipps University Marburg; Philipps University Marburg; University of Rostock	Schmidt, J (corresponding author), Univ Marburg, Fac Geog, Marburg, Germany.	schmidt@agonum.de; Opgenoorth@uni-marburg.de	Opgenoorth, Lars/C-9624-2018	Opgenoorth, Lars/0000-0003-0737-047X	German Reserach Council; DFG [MI 271/20]	German Reserach Council; DFG(German Research Foundation (DFG))	German Reserach Council. DFG grant MI 271/20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens D, 2004, PHYLOGENY ZOOGEOGRAP; Allegro Gianni, 2010, Bollettino del Museo Civico di Storia Naturale di Verona Botanica Zoologia, V34, P3; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; BARTHLOTT W, 1996, ERDKUNDE, V50, P327; Bousquet Yves, 1999, Fabreries Supplement, V9, P1; Contreras-Diaz HG, 2007, MOL PHYLOGENET EVOL, V42, P687, DOI 10.1016/j.ympev.2006.10.007; DeCelles PG, 2007, EARTH PLANET SC LETT, V253, P389, DOI 10.1016/j.epsl.2006.11.001; Deuve T., 1988, Entomologica Basiliensia, V12, P115; DEUVE T, 1983, Revue Francaise d'Entomologie (Nouvelle Serie), V5, P1; Deuve Thierry, 2007, Bulletin de la Societe Entomologique de France, V112, P53; Dostal A., 1984, Entomologische Zeitschrift, V94, P134; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Facchini S., 2000, Koleopterologische Rundschau, V70, P1; Faille A, 2011, ZOOL SCR, V40, P282, DOI 10.1111/j.1463-6409.2010.00467.x; Gomez-Zurita J, 2000, MOL PHYLOGENET EVOL, V14, P304, DOI 10.1006/mpev.1999.0712; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hieke Fritz, 2003, P107; Hodges KV, 2001, TECTONICS, V20, P799, DOI 10.1029/2001TC001281; Holloway J.D., 1974, ECOLOGY BIOGEOGRAPHY, P473; Johansson US, 2007, EVOLUTION, V61, P324, DOI 10.1111/j.1558-5646.2007.00024.x; Klebs R., 1910, SCHRIFTEN PHYSIKALIS, V51, P217; Lobl I., 2003, CATALOGUE PALAEARCTI; Lorenz W, 2005, SYSTEMATIC LIST EXTE; Mai DH., 1995, TERTI RE VEGETATIONS; Mani M. S., 1986, BUTTERFLIES HIMALAYA; Mani MS., 1974, ECOLOGY BIOGEOGRAPHY, P698, DOI DOI 10.1007/978-94-010-2331-3_24; Martens J, 1993, NEUE FORSCHUNGEN HIM, P231; Martens Jochen, 2011, Ornithological Monographs, V70, P64; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; Morvan P, 1997, LOENED AZIAD AMPREVA, V1, P1; Morvan P, 1984, CHAETOBROSCUS COLEOP; Mulch A, 2006, NATURE, V439, P670, DOI 10.1038/439670a; Muller-Motzfeld G, 2006, KAFER MITTELEUROPAS, DOI [10.1101/603217, DOI 10.1101/603217]; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Perkovsky EE, 2007, AFR INVERTEBR, V48, P229; Pruser F, 1998, INSECT MOL BIOL, V7, P121, DOI 10.1046/j.1365-2583.1998.72056.x; Ruiz C, 2009, MOL PHYLOGENET EVOL, V50, P44, DOI 10.1016/j.ympev.2008.09.023; Sasakawa K, 2005, ENTOMOL SCI, V8, P389, DOI 10.1111/j.1479-8298.2005.00139.x; Sasakawa K, 2007, ANN ENTOMOL SOC AM, V100, P100, DOI 10.1603/0013-8746(2007)100[100:PAGEOC]2.0.CO;2; Schimmel R., 1996, POLLICHIA-BUCH, V33, P1; Schmidt J, 2007, VEROFFENTLICHUNGEN N, V26, P13; Schmidt J, 2012, BIODIVERSITY NATURAL; Schmidt J, 2000, ENTOMOLOGISCHE ABHAN, V58, P5; Schmidt J, 2011, VERNATE, V30, P169; Schmidt J, 2009, NOTES TAXONOMY DISTR, V2009, P131; Schmidt J, 1999, ADV CARABIDOLOGY, P299; Schmidt J, 2012, VEROFFENTLICHUNGEN N, V25, P197; Schmidt Joachim, 2009, Vernate, V28, P183; Schmidt Joachim, 2009, Zootaxa, V2009, P1; Schmidt Joachim, 2006, P179; Schmidt Joachim, 2003, P85; Schoniger M, 1999, J MOL EVOL, V49, P691, DOI 10.1007/PL00006590; Sciaky R, 2003, B MUS REG SCI NAT TO, V20, P401; Stocsits RR, 2009, NUCLEIC ACIDS RES, V37, P6184, DOI 10.1093/nar/gkp600; Stork Nigel E., 1997, P41; Straneo S.L., 1985, Entomologica Basiliensia, V10, P67; STRANEO S L, 1984, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V125, P11; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; Umea University, 2010, 6 TIM MOR INS SPEC T; Wang Y, 2008, EARTH PLANET SC LETT, V270, P73, DOI 10.1016/j.epsl.2008.03.006; Weigold H., 2005, MITTEILUNGEN VEREINS, V3, P1; Weitschat W., 1998, ATLAS PFLANZEN TIERE; Will KW, 2008, ANN CARNEGIE MUS, V77, P93, DOI 10.2992/0097-4463-77.1.93; Xu R., 1982, MONOGRAPH MOUNT XIXI, P356; Xu R., 1981, GEOLOGICAL ECOLOGICA, P139; Yin A, 2000, ANNU REV EARTH PL SC, V28, P211, DOI 10.1146/annurev.earth.28.1.211	70	30	32	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45482	10.1371/journal.pone.0045482	http://dx.doi.org/10.1371/journal.pone.0045482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049805	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300028
J	Bashinskaya, B; Nahed, BV; Walcott, BP; Coumans, JVCE; Onuma, OK				Bashinskaya, Bronislava; Nahed, Brian V.; Walcott, Brian P.; Coumans, Jean-Valery C. E.; Onuma, Oyere K.			Socioeconomic Status Correlates with the Prevalence of Advanced Coronary Artery Disease in the United States	PLOS ONE			English	Article							HEART-DISEASE; CARDIOVASCULAR-DISEASE; PRIMARY PREVENTION; RISK-FACTORS; US ADULTS; CHOLESTEROL LEVELS; FORMAL EDUCATION; POPULATION; AMERICAN; HEALTH	Background: Increasingly studies have identified socioeconomic factors adversely affecting healthcare outcomes for a multitude of diseases. To date, however, there has not been a study correlating socioeconomic details from nationwide databases on the prevalence of advanced coronary artery disease. We seek to identify whether socioeconomic factors contribute to advanced coronary artery disease prevalence in the United States. Methods and Findings: State specific prevalence data was queried form the United States Nationwide Inpatient Sample for 2009. Patients undergoing percutaneous coronary angioplasty and coronary artery bypass graft were identified as principal procedures. Non-cardiac related procedures, lung lobectomy and hip replacement (partial and total) were identified and used as control groups. Information regarding prevalence was then merged with data from the Behavioral Risk Factor Surveillance System, the largest, on-going telephone health survey system tracking health conditions and risk behaviors in the United States. Pearson's correlation coefficient was calculated for individual socioeconomic variables including employment status, level of education, and household income. Household income and education level were inversely correlated with the prevalence of percutaneous coronary angioplasty (-0.717; -0.787) and coronary artery bypass graft surgery (-0.541; -0.618). This phenomenon was not seen in the non-cardiac procedure control groups. In multiple linear regression analysis, socioeconomic factors were significant predictors of coronary artery bypass graft and percutaneous transluminal coronary angioplasty (p < 0.001 and p=0.005, respectively). Conclusions: Socioeconomic status is related to the prevalence of advanced coronary artery disease as measured by the prevalence of percutaneous coronary angioplasty and coronary artery bypass graft surgery.	[Bashinskaya, Bronislava; Nahed, Brian V.; Walcott, Brian P.; Coumans, Jean-Valery C. E.; Onuma, Oyere K.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA; [Nahed, Brian V.; Walcott, Brian P.; Coumans, Jean-Valery C. E.] Harvard Univ, Sch Med, Dept Surg, Div Neurosurg, Boston, MA 02115 USA; [Bashinskaya, Bronislava; Onuma, Oyere K.] Harvard Univ, Sch Med, Dept Med, Div Cardiol, Boston, MA USA; [Bashinskaya, Bronislava] Boston Univ, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University	Walcott, BP (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02115 USA.	walcott.brian@mgh.harvard.edu	; Nahed, Brian/E-4239-2014	Onuma, Oyere/0000-0003-1186-7104; Nahed, Brian/0000-0001-8537-106X				Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; Barbeau EM, 2004, AM J PUBLIC HEALTH, V94, P269, DOI 10.2105/AJPH.94.2.269; Bashinskaya B, 2011, J GLOB INFECT DIS, V3, P366, DOI 10.4103/0974-777X.91061; CALLAHAN LF, 1988, ARTHRITIS RHEUM-US, V31, P1346, DOI 10.1002/art.1780311102; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Connolly V, 2000, J EPIDEMIOL COMMUN H, V54, P173, DOI 10.1136/jech.54.3.173; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Curry WT, 2009, J NEURO-ONCOL, V93, P25, DOI 10.1007/s11060-009-9840-5; Dionne CE, 2001, J EPIDEMIOL COMMUN H, V55, P455, DOI 10.1136/jech.55.7.455; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Eagle Kim A, 2004, Circulation, V110, pe340; Elixhauser A, 1996, MOST FREQUENT DIAGNO, piii; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Gillum RF, 2003, J CLIN EPIDEMIOL, V56, P188, DOI 10.1016/S0895-4356(02)00535-8; Hadley J, 2003, MED CARE RES REV, V60, p3S, DOI 10.1177/1077558703254101; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; LINN S, 1989, AM J EPIDEMIOL, V129, P281, DOI 10.1093/oxfordjournals.aje.a115133; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Morland K, 2002, AM J PREV MED, V22, P23, DOI 10.1016/S0749-3797(01)00403-2; Paeratakul S, 2002, INT J OBESITY, V26, P1205, DOI 10.1038/sj.ijo.0802026; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; RYAN TJ, 1988, CIRCULATION, V78, P486, DOI 10.1161/01.CIR.78.2.486; Saleh SS, 2005, AM J CARDIOL, V96, P1190, DOI 10.1016/j.amjcard.2005.06.054; Satia JA, 2004, PUBLIC HEALTH NUTR, V7, P1089, DOI 10.1079/PHN2004662; SHEA S, 1992, NEW ENGL J MED, V327, P776, DOI 10.1056/NEJM199209103271107; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Unger JB, 2004, J COMMUN HEALTH, V29, P467, DOI 10.1007/s10900-004-3395-3; Walcott BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029193; Walcott BP, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS1124; Wamala SP, 1999, DIABETES CARE, V22, P1999, DOI 10.2337/diacare.22.12.1999; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202	35	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46314	10.1371/journal.pone.0046314	http://dx.doi.org/10.1371/journal.pone.0046314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23050011	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100176
J	Caputo, I; Secondo, A; Lepretti, M; Paolella, G; Auricchio, S; Barone, MV; Esposito, C				Caputo, Ivana; Secondo, Agnese; Lepretti, Marilena; Paolella, Gaetana; Auricchio, Salvatore; Barone, Maria Vittoria; Esposito, Carla			Gliadin Peptides Induce Tissue Transglutaminase Activation and ER-Stress through Ca2+ Mobilization in Caco-2 Cells	PLOS ONE			English	Article							FACTOR-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; CELIAC-DISEASE; ENDOPLASMIC-RETICULUM; INTESTINAL INFLAMMATION; HUNTINGTONS-DISEASE; OXIDATIVE STRESS; EPITHELIAL-CELLS; CROSS-LINKING; PROTEIN	Background: Celiac disease (CD) is an intestinal inflammatory condition that develops in genetically susceptible individuals after exposure to dietary wheat gliadin. The role of post-translational modifications of gliadin catalyzed by tissue transglutaminase (tTG) seems to play a crucial role in CD. However, it remains to be established how and where tTG is activated in vivo. We have investigated whether gliadin peptides modulate intracellular Ca2+ homeostasis and tTG activity. Methods/Principal Findings: We studied Ca2+ homeostasis in Caco-2 cells by single cell microfluorimetry. Under our conditions, A-gliadin peptides 31-43 and 57-68 rapidly mobilized Ca2+ from intracellular stores. Specifically, peptide 31-43 mobilized Ca2+ from the endoplasmic reticulum (ER) and mitochondria, whereas peptide 57-68 mobilized Ca2+ only from mitochondria. We also found that gliadin peptide-induced Ca2+ mobilization activates the enzymatic function of intracellular tTG as revealed by in situ tTG activity using the tTG substrate pentylamine-biotin. Moreover, we demonstrate that peptide 31-43, but not peptide 57-68, induces an increase of tTG expression. Finally, we monitored the expression of glucose-regulated protein-78 and of CCAAT/enhancer binding protein-homologous protein, which are two biochemical markers of ER-stress, by real-time RT-PCR and western blot. We found that chronic administration of peptide 31-43, but not of peptide 57-68, induces the expression of both genes. Conclusions: By inducing Ca2+ mobilization from the ER, peptide 31-43 could promote an ER-stress pathway that may be relevant in CD pathogenesis. Furthermore, peptides 31-43 and 57-68, by activating intracellular tTG, could alter inflammatory key regulators, and induce deamidation of immunogenic peptides and gliadin-tTG crosslinking in enterocytes and specialized antigen-presenting cells.	[Caputo, Ivana; Lepretti, Marilena; Paolella, Gaetana; Esposito, Carla] Univ Salerno, Dept Biol & Chem, I-84100 Salerno, Italy; [Caputo, Ivana; Auricchio, Salvatore; Barone, Maria Vittoria; Esposito, Carla] Univ Naples Federico II, European Lab Invest Food Induced Dis ELFID, Naples, Italy; [Secondo, Agnese] Univ Naples Federico II, Dept Neurosci, Naples, Italy; [Barone, Maria Vittoria] Univ Naples Federico II, Dept Pediat, Naples, Italy	University of Salerno; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Caputo, I (corresponding author), Univ Salerno, Dept Biol & Chem, I-84100 Salerno, Italy.	icaputo@unisa.it	Secondo, Agnese/AAA-3407-2022	PAOLELLA, Gaetana/0000-0003-2188-3829; BARONE, Maria Vittoria/0000-0001-6190-4917; Marilena, Lepretti/0000-0003-4441-7214; Secondo, Agnese/0000-0001-5054-4098; Caputo, Ivana/0000-0003-2825-9711	Fondi di Ateneo per la Ricerca di Base (FARB) [ORSA090313]	Fondi di Ateneo per la Ricerca di Base (FARB)	This work was supported by a grant from "Fondi di Ateneo per la Ricerca di Base (FARB)" 2009, ORSA090313. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen L, 2005, GUT, V54, P503, DOI 10.1136/gut.2003.034165; Bailey CDC, 2005, J NEUROCHEM, V92, P83, DOI 10.1111/j.1471-4159.2004.02839.x; Barone MV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012246; Bodger K, 2006, GUT, V55, P973, DOI 10.1136/gut.2005.086413; Caputo I, 2011, AMINO ACIDS, DOI [10.1007/s00726-011-1120-yOnline First&TRADE, DOI 10.1007/S00726-011-1120-YONLINE]; Caputo I, 2010, BBA-MOL BASIS DIS, V1802, P717, DOI 10.1016/j.bbadis.2010.05.010; Chhabra A, 2009, ANTICANCER RES, V29, P1909; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Esposito C, 2003, AM J GASTROENTEROL, V98, P1813, DOI [10.1016/S0002-9270(03)00431-3, 10.1111/j.1572-0241.2003.07582.x]; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Im MJ, 1997, CELL SIGNAL, V9, P477, DOI 10.1016/S0898-6568(97)00049-1; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Junn E, 2003, P NATL ACAD SCI USA, V100, P2047, DOI 10.1073/pnas.0438021100; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kuo TF, 2011, FEBS J, V278, P4756, DOI 10.1111/j.1742-4658.2011.08409.x; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lesort M, 1998, J BIOL CHEM, V273, P11991, DOI 10.1074/jbc.273.20.11991; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Maiuri L, 2010, GUT, V59, P311, DOI 10.1136/gut.2009.183608; Maiuri MC, 2003, J MOL MED-JMM, V81, P373, DOI 10.1007/s00109-003-0440-0; McConoughey SJ, 2010, EMBO MOL MED, V2, P349, DOI 10.1002/emmm.201000084; McGuckin MA, 2010, AM J PHYSIOL-GASTR L, V298, pG820, DOI 10.1152/ajpgi.00063.2010; Myrsky E, 2009, CELL MOL LIFE SCI, V66, P3375, DOI 10.1007/s00018-009-0116-1; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Nicholas B, 2003, BIOCHEM J, V371, P413, DOI 10.1042/BJ20021949; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Orru S, 2003, J BIOL CHEM, V278, P31766, DOI 10.1074/jbc.M305080200; Park SH, 2010, J BIOL CHEM, V285, P35330, DOI 10.1074/jbc.M110.136259; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; Schuppan D, 1998, NAT MED, V4, P666, DOI 10.1038/nm0698-666; Secondo A, 2007, CELL CALCIUM, V42, P521, DOI 10.1016/j.ceca.2007.01.006; Shin DM, 2004, J BIOL CHEM, V279, P15032, DOI 10.1074/jbc.M308734200; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Silano M, 2007, PEDIATR RES, V61, P67, DOI 10.1203/01.pdr.0000250173.88049.79; Simula MP, 2010, MOL MED, V16, P199, DOI 10.2119/molmed.2009.00173; Singh US, 2001, EMBO J, V20, P2413, DOI 10.1093/emboj/20.10.2413; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Sollid LM, 1997, GUT, V41, P851, DOI 10.1136/gut.41.6.851; Sollid LM, 2011, CURR OPIN IMMUNOL, V23, P732, DOI 10.1016/j.coi.2011.08.006; Tatsukawa H, 2009, GASTROENTEROLOGY, V136, P1783, DOI 10.1053/j.gastro.2009.01.007; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; Verma A, 2007, CURR CANCER DRUG TAR, V7, P559, DOI 10.2174/156800907781662275; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Zemskov EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019414; Zhang JW, 1998, J BIOL CHEM, V273, P2288, DOI 10.1074/jbc.273.4.2288; Zimmer KP, 2010, GUT, V59, P300, DOI 10.1136/gut.2008.169656; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	49	36	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45209	10.1371/journal.pone.0045209	http://dx.doi.org/10.1371/journal.pone.0045209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049776	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100032
J	He, HCH; Kashat, L; Kak, I; Kunavisarut, T; Gundelach, R; Kim, D; So, AKC; MacMillan, C; Freeman, JL; Ralhan, R; Walfish, PG				He, Helen C. -H.; Kashat, Lawrence; Kak, Ipshita; Kunavisarut, Tada; Gundelach, Raefe; Kim, Dae; So, Anthony K. -C.; MacMillan, Christina; Freeman, Jeremy L.; Ralhan, Ranju; Walfish, Paul G.			An Ep-ICD Based Index Is a Marker of Aggressiveness and Poor Prognosis in Thyroid Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CYTOLOGICAL SPECIMENS; DIAGNOSTIC-ACCURACY; CANCER; EPCAM; EXPRESSION; CELLS; NEOPLASMS; MUTATION; IMPROVES	Background: Nuclear accumulation of the intracellular domain of epithelial cell adhesion molecule (Ep-ICD) in tumor cells was demonstrated to predict poor prognosis in thyroid carcinoma patients in our earlier study. Here, we investigated the clinical significance of Ep-ICD subcellular localization index (ESLI) in distinguishing aggressive papillary thyroid carcinoma (PTC) from non-aggressive cases. Methods: Using domain specific antibodies against the intracellular (Ep-ICD) and extracellular (EpEx) domains of epithelial cell adhesion molecule, 200 archived tissues from a new cohort of patients with benign thyroid disease as well as malignant aggressive and non aggressive PTC were analyzed by immunohistochemistry (IHC). ESLI was defined as sum of the IHC scores for accumulation of nuclear and cytoplasmic Ep-ICD and loss of membranous EpEx; ESLI = [Ep-ICDnuc + Ep-ICDcyt + loss of membranous EpEx]. Results: For the benign thyroid tissues, non-aggressive PTC and aggressive PTC, the mean ESLI scores were 4.5, 6.7 and 11 respectively. Immunofluorescence double staining confirmed increased nuclear Ep-ICD accumulation and decreased membrane EpEx expression in aggressive PTC. Receiver-operating characteristic (ROC) curve analysis showed an area under the curve (AUC) of 0.841, 70.2% sensitivity and 83.9% specificity for nuclear Ep-ICD for differentiating aggressive PTC from non-aggressive PTC. ESLI distinguished aggressive PTC from non-aggressive cases with improved AUC of 0.924, 88.4% sensitivity and 85.5% specificity. Our study confirms nuclear accumulation of Ep-ICD and loss of membranous EpEx occurs in aggressive PTC underscoring the potential of Ep-ICD and ESLI to serve as diagnostic markers for aggressive PTC. Kaplan Meier survival analysis revealed significantly reduced disease free survival (DFS) for ESLI positive (cutoff >10) PTC (p<0.05), mean DFS = 133 months as compared to 210 months for patients who did not show positive ESLI. Conclusion: ESLI scoring improves the identification of aggressive PTC and thereby may serve as a useful index for defining aggressiveness and poor prognosis among PTC patients.	[He, Helen C. -H.; Kashat, Lawrence; Kak, Ipshita; Kunavisarut, Tada; So, Anthony K. -C.; Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Pathol & Lab Med, Alex & Simona Shnaider Lab Mol Oncol, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju; Walfish, Paul G.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada; [Gundelach, Raefe; Kim, Dae; Freeman, Jeremy L.; Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Joseph & Mildred Sonshine Family Ctr Head & Neck, Dept Otolaryngol, Head & Neck Surg Program, Toronto, ON M5G 1X5, Canada; [Gundelach, Raefe; Kim, Dae; Freeman, Jeremy L.; Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Med, Div Endocrine, Toronto, ON M5G 1X5, Canada; [Gundelach, Raefe; Kim, Dae; Freeman, Jeremy L.; Ralhan, Ranju; Walfish, Paul G.] Univ Toronto, Sch Med, Toronto, ON, Canada; [MacMillan, Christina; Ralhan, Ranju; Walfish, Paul G.] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Ralhan, Ranju; Walfish, Paul G.] Univ Toronto, Dept Otolaryngol Head & Neck Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Ralhan, R (corresponding author), Mt Sinai Hosp, Dept Pathol & Lab Med, Alex & Simona Shnaider Lab Mol Oncol, Toronto, ON M5G 1X5, Canada.	rralhan@mtsinai.on.ca; pwalfish@mtsinai.on.ca	Kak, Ipshita/AAK-8658-2021		Mount Sinai Foundation of Toronto; Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Cancer; Canadian Institutes of Health Research (CIHR); The Temmy Latner/Dynacare Foundation; George Knudson Oakdale Golf Fund Raiser; Mount Sinai Hospital Department of Medicine Research Fund	Mount Sinai Foundation of Toronto; Da Vinci Gala Fundraiser; Alex and Simona Shnaider Chair in Thyroid Cancer; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); The Temmy Latner/Dynacare Foundation; George Knudson Oakdale Golf Fund Raiser; Mount Sinai Hospital Department of Medicine Research Fund	The financial support of this work from Mount Sinai Foundation of Toronto, Da Vinci Gala Fundraiser, Alex and Simona Shnaider Chair in Thyroid Cancer, Canadian Institutes of Health Research (CIHR) for CIHR Chair in Advanced Cancer Diagnostics, The Temmy Latner/Dynacare Foundation, George Knudson Oakdale Golf Fund Raiser, and the Mount Sinai Hospital Department of Medicine Research Fund is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Cantara S, 2010, J CLIN ENDOCR METAB, V95, P1365, DOI 10.1210/jc.2009-2103; Chaudry MA, 2007, BRIT J CANCER, V96, P1013, DOI 10.1038/sj.bjc.6603505; Chaves-Perez A, 2012, ONCOGENE; Ciampi R, 2005, ENDOCR PATHOL, V16, P163, DOI 10.1385/EP:16:3:163; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Cimino A, 2009, BREAST CANC RES TREA; Cochand-Priollet B, 2011, THYROID, V21, P1067, DOI 10.1089/thy.2011.0014; El-Sahwi K, 2010, MOL CANCER THER, V9, P57, DOI 10.1158/1535-7163.MCT-09-0675; Fadda G, 2011, EUR J ENDOCRINOL, V165, P447, DOI 10.1530/EJE-11-0181; Ghossein R, 2009, ARCH PATHOL LAB MED, V133, P683, DOI 10.1043/1543-2165-133.5.683; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jo YS, 2006, J CLIN ENDOCR METAB, V91, P3667, DOI 10.1210/jc.2005-2836; Knauf JA, 2011, ONCOGENE, V30, P3153, DOI 10.1038/onc.2011.44; Lennard CM, 2001, SURGERY, V129, P552, DOI 10.1067/msy.2001.112592; Lin JD, 2009, THYROID, V19, P1053, DOI 10.1089/thy.2009.0133; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Moses W, 2010, WORLD J SURG, V34, P2589, DOI 10.1007/s00268-010-0720-0; Nikiforov YE, 2011, NAT REV ENDOCRINOL, V7, P569, DOI 10.1038/nrendo.2011.142; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohori NP, 2010, CANCER CYTOPATHOL, V118, P17, DOI 10.1002/cncy.20063; Patriarca C, 2011, CANC TREAT REV; Raffel A, 2010, EUR J ENDOCRINOL, V162, P391, DOI 10.1530/EJE-08-0916; Ralhan R, 2008, MOL CELL PROTEOMICS, V7, P1162, DOI 10.1074/mcp.M700500-MCP200; Ralhan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-331; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Saggiorato E, 2005, ENDOCR-RELAT CANCER, V12, P305, DOI 10.1677/erc.1.00944; Shan YF, 2010, MED ONCOL; Sipos JA, 2010, CLIN ONCOL-UK, V22, P395, DOI 10.1016/j.clon.2010.05.004; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Trzpis M, 2008, FRONT BIOSCI-LANDMRK, V13, P5050, DOI 10.2741/3063; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Weismann P, 2009, NEOPLASMA, V56, P230	33	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e42893	10.1371/journal.pone.0042893	http://dx.doi.org/10.1371/journal.pone.0042893			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049733	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100005
J	Kriszt, R; Krifaton, C; Szoboszlay, S; Cserhati, M; Kriszt, B; Kukolya, J; Czeh, A; Feher-Toth, S; Torok, L; Szoke, Z; Kovacs, KJ; Barna, T; Ferenczi, S				Kriszt, Rokus; Krifaton, Csilla; Szoboszlay, Sandor; Cserhati, Matyas; Kriszt, Balazs; Kukolya, Jozsef; Czeh, Arpad; Feher-Toth, Szilvia; Toeroek, Livia; Szoke, Zsuzsanna; Kovacs, Krisztina J.; Barna, Terez; Ferenczi, Szilamer			A New Zearalenone Biodegradation Strategy Using Non-Pathogenic Rhodococcus pyridinivorans K408 Strain	PLOS ONE			English	Article							MYCOTOXIN ZEARALENONE; ESTROGENIC ACTIVITY; TRICHOSPORON-MYCOTOXINIVORANS; BIOLOGICAL DETOXIFICATION; AFLATOXIN B-1; SP-NOV.; DEGRADATION; TOXICITY; BETA; BIOTRANSFORMATION	Zearalenone (hereafter referred to as ZEA) is a nonsteroidal estrogenic mycotoxin produced by several Fusarium spp. on cereal grains. ZEA is one of the most hazardous natural endocrine disrupting chemicals (EDC) which induces hyper estrogenic responses in mammals. This can result in reproductive disorders in farm animals as well as in humans. Consequently, detoxification strategies for contaminated crops are crucial for food safety. In this study we have developed a bacterial based detoxification system using a non-pathogen Rhodococcus pyridinivorans K408 strain. Following 5 days treatment of ZEA with R. pyridinivorans K408 strain HPLC analyses showed an 87.21% ZEA-degradation efficiency of the bacterial enzyme systems. In another approach, the strain biotransformation ability has also been confirmed by a bioluminescent version of the yeast estrogen screening system (BLYES), which detected an 81.75% of biodegradability of ZEA, in a good agreement with the chemical analyses. Furthermore, the capacity of R. pyridinivorans to eliminate the estrogenic effects of ZEA was tested by using an immature uterotrophic assay. Prepubertal female rats were treated with vehicle (olive oil), 17 beta-estradiol, ZEA (0.1-1-5-10 mg/kg body weight) and LB broth containing 500 mg/l ZEA that has already been incubated with or without Rhodococcus pyridinivorans K408 strain. Uterine weights were measured and the mRNA level changes relating to apelin, aquaporin 5, complement component 2, and calbindin-3 genes were measured by qRT-PCR. These genes represent the major pathways that are affected by estromimetic compounds. Zearalenone feeding significantly increased the uterus weight in a dose dependent manner and at the same time upregulated complement component 2 and calbindin-3 expression as well as decreased apelin and aquaporin 5 mRNA levels comparable to that seen in 17 beta-estradiol exposed rats. In contrast, LB broth in which ZEA was incubated with Rhodococcus pyridinivorans K408 prior to the feeding did not display any estrogenic effect neither on uterine weight nor on the expression of estrogen-regulated genes. Consequently, the identification of Rhodococcus pyridinivorans K408 strain in ZEA biodegradation proved to be a very efficient biological tool that is able to eliminate the complete estrogenic effects of ZEA. It is also remarkable that this biotransformation pathway of ZEA did not result in any residual estrogenic effects.	[Kriszt, Rokus; Kovacs, Krisztina J.; Ferenczi, Szilamer] Hungarian Acad Sci, Inst Expt Med, Lab Mol Neuroendocrinol, Budapest, Hungary; [Krifaton, Csilla; Szoboszlay, Sandor; Cserhati, Matyas; Kriszt, Balazs; Kukolya, Jozsef] Szent Istvan Univ, Dept Environm Protect & Safety, Budapest, Hungary; [Czeh, Arpad; Feher-Toth, Szilvia; Toeroek, Livia; Szoke, Zsuzsanna] Soft Flow Hungary R&D Ltd, Pecs, Hungary; [Czeh, Arpad; Feher-Toth, Szilvia] Univ Pecs, Fac Med, Dept Biophys, Pecs, Hungary; [Barna, Terez] Univ Debrecen, Dept Genet & Appl Microbiol, Debrecen, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Hungarian University of Agriculture & Life Sciences; University of Pecs; University of Debrecen	Ferenczi, S (corresponding author), Hungarian Acad Sci, Inst Expt Med, Lab Mol Neuroendocrinol, Budapest, Hungary.	ferenczi@koki.hu	barna, terez/R-1357-2018	Kriszt, Balazs/0000-0002-9236-2820; Szoboszlay, Sandor/0000-0002-0479-6726; Szoke, Zsuzsanna/0000-0001-9302-1115	Nemzeti Kutatasi es Technologiai Hivatal (National Innovation Office) [NKTHTECH_08-A3/2-2008-0385 (OM-00234/2008)]	Nemzeti Kutatasi es Technologiai Hivatal (National Innovation Office)	This study was supported by the Nemzeti Kutatasi es Technologiai Hivatal (National Innovation Office) (NKTHTECH_08-A3/2-2008-0385 (OM-00234/2008) MYCOSTOP grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS HK, 1984, APPL ENVIRON MICROB, V48, P654, DOI 10.1128/AEM.48.3.654-661.1984; Alberts JF, 2006, INT J FOOD MICROBIOL, V109, P121, DOI 10.1016/j.ijfoodmicro.2006.01.019; Altalhi AD, 2009, J HAZARD MATER, V161, P1166, DOI 10.1016/j.jhazmat.2008.04.068; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aziz NH, 1997, NAHRUNG, V41, P34, DOI 10.1002/food.19970410109; Becci PJ, 1982, J APPL TOXICOL, V2, P201, DOI 10.1002/jat.2550020406; BIEHL ML, 1993, TOXICOL APPL PHARM, V121, P152, DOI 10.1006/taap.1993.1140; Chang HJ, 2008, BIOTECHNOL LETT, V30, P1801, DOI 10.1007/s10529-008-9770-x; Devulder G, 2003, J CLIN MICROBIOL, V41, P1785, DOI 10.1128/JCM.41.4.1785-1787.2003; Dong M, 2010, TOXICON, V55, P523, DOI 10.1016/j.toxicon.2009.10.004; ELSHARKAWY S, 1988, XENOBIOTICA, V18, P365, DOI 10.3109/00498258809041672; FARNWORTH ER, 1981, J ENVIRON SCI HEAL B, V16, P239, DOI 10.1080/03601238109372255; FITZPATRICK DW, 1989, COMP BIOCHEM PHYS C, V94, P691, DOI 10.1016/0742-8413(89)90133-3; Haroune N, 2002, APPL ENVIRON MICROB, V68, P6114, DOI 10.1128/AEM.68.12.6114-6120.2002; Heneweer M, 2007, TOXICOL SCI, V99, P303, DOI 10.1093/toxsci/kfm151; Igawa T, 2007, APPL ENVIRON MICROB, V73, P1622, DOI 10.1128/AEM.01077-06; ITO Y, 1994, J VET MED SCI, V56, P1155, DOI 10.1292/jvms.56.1155; Jung IG, 2005, CHEMOSPHERE, V61, P451, DOI 10.1016/j.chemosphere.2005.03.007; Jung IG, 2004, J BIOSCI BIOENG, V97, P429, DOI 10.1016/S1389-1723(04)70232-7; Kakeya H, 2002, BIOSCI BIOTECH BIOCH, V66, P2723, DOI 10.1271/bbb.66.2723; Karlovsky P, 1999, NAT TOXINS, V7, P1, DOI 10.1002/(SICI)1522-7189(199902)7:1<1::AID-NT37>3.0.CO;2-9; KATZENELLENBOGEN BS, 1979, ENDOCRINOLOGY, V105, P33, DOI 10.1210/endo-105-1-33; Krifaton C, 2011, MUTAT RES-GEN TOX EN, V726, P1, DOI 10.1016/j.mrgentox.2011.07.011; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; KUIPERGOODMAN T, 1987, REGUL TOXICOL PHARM, V7, P253, DOI 10.1016/0273-2300(87)90037-7; Malekinejad H, 2006, VET J, V172, P96, DOI 10.1016/j.tvjl.2005.03.004; Massart F, 2010, INT J ANDROL, V33, P369, DOI 10.1111/j.1365-2605.2009.01009.x; McKenzie KS, 1997, FOOD CHEM TOXICOL, V35, P807, DOI 10.1016/S0278-6915(97)00052-5; Minervini F, 2005, TOXICOL LETT, V159, P272, DOI 10.1016/j.toxlet.2005.05.017; Mitterbauer R, 2003, APPL ENVIRON MICROB, V69, P805, DOI 10.1128/AEM.69.2.805-811.2003; Molnar O, 2004, SYST APPL MICROBIOL, V27, P661, DOI 10.1078/0723202042369947; Moreau M, 2011, J APPL TOXICOL; Precigou S, 2004, BIOTECHNOL LETT, V26, P1379, DOI 10.1023/B:BILE.0000045636.47527.99; Routledge EJ, 1996, ENVIRON TOXICOL CHEM, V15, P241, DOI 10.1002/etc.5620150303; Sabater-Vilar M, 2007, MYCOPATHOLOGIA, V163, P81, DOI 10.1007/s11046-007-0093-6; Sanseverino J, 2005, APPL ENVIRON MICROB, V71, P4455, DOI 10.1128/AEM.71.8.4455-4460.2005; Sanseverino J, 2009, TOXICOL SCI, V107, P122, DOI 10.1093/toxsci/kfn229; Shier WT, 2001, TOXICON, V39, P1435, DOI 10.1016/S0041-0101(00)00259-2; Shin BS, 2009, J TOXICOL ENV HEAL A, V72, P1395, DOI 10.1080/15287390903212741; Takahashi-Ando N, 2004, APPL ENVIRON MICROB, V70, P3239, DOI 10.1128/AEM.70.6.3239-3245.2004; Teniola OD, 2005, INT J FOOD MICROBIOL, V105, P111, DOI 10.1016/j.ijfoodmicro.2005.05.004; Vekiru E, 2010, APPL ENVIRON MICROB, V76, P2353, DOI 10.1128/AEM.01438-09; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wu F, 2008, J AGR FOOD CHEM, V56, P3900, DOI 10.1021/jf072697e; Yoon JH, 2000, INT J SYST EVOL MICR, V50, P2173, DOI 10.1099/00207713-50-6-2173; Yu YS, 2011, BIODEGRADATION, V22, P613, DOI 10.1007/s10532-010-9435-z; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030	47	42	45	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e43608	10.1371/journal.pone.0043608	http://dx.doi.org/10.1371/journal.pone.0043608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049739	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100009
J	Kuchenreuther, JM; Britt, RD; Swartz, JR				Kuchenreuther, Jon M.; Britt, R. David; Swartz, James R.			New Insights into [FeFe] Hydrogenase Activation and Maturase Function	PLOS ONE			English	Article							IRON-MOLYBDENUM COFACTOR; IN-VITRO SYNTHESIS; H-CLUSTER; LYSINE 2,3-AMINOMUTASE; AZOTOBACTER-VINELANDII; PROTEIN; SULFUR; ISCU; HYDG; ADENOSYLMETHIONINE	[FeFe] hydrogenases catalyze H-2 production using the H-cluster, an iron-sulfur cofactor that contains carbon monoxide (CO), cyanide (CN-), and a dithiolate bridging ligand. The HydE, HydF, and HydG maturases assist in assembling the H-cluster and maturing hydrogenases into their catalytically active form. Characterization of these maturases and in vitro hydrogenase activation methods have helped elucidate steps in the H-cluster biosynthetic pathway such as the HydG-catalyzed generation of the CO and CN- ligands from free tyrosine. We have refined our cell-free approach for H-cluster synthesis and hydrogenase maturation by using separately expressed and purified HydE, HydF, and HydG. In this report, we illustrate how substrates and protein constituents influence hydrogenase activation, and for the first time, we show that each maturase can function catalytically during the maturation process. With precise control over the biomolecular components, we also provide evidence for H-cluster synthesis in the absence of either HydE or HydF, and we further show that hydrogenase activation can occur without exogenous tyrosine. Given these findings, we suggest a new reaction sequence for the [FeFe] hydrogenase maturation pathway. In our model, HydG independently synthesizes an iron-based compound with CO and CN- ligands that is a precursor to the H-cluster [2Fe](H) subunit, and which we have termed HydG-co. We further propose that HydF is a transferase that stabilizes HydG-co and also shuttles the complete [2Fe](H) subcluster to the hydrogenase, a translocation process that may be catalyzed by HydE. In summary, this report describes the first example of reconstructing the [FeFe] hydrogenase maturation pathway using purified maturases and subsequently utilizing this in vitro system to better understand the roles of HydE, HydF, and HydG.	[Kuchenreuther, Jon M.; Swartz, James R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Kuchenreuther, Jon M.; Britt, R. David] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Swartz, James R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; University of California System; University of California Davis; Stanford University	Swartz, JR (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	jswartz@stanford.edu			United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-FG02-09ER46632]; United States Department of Energy, Office of Sciences [DE-SC0004334]	United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); United States Department of Energy, Office of Sciences(United States Department of Energy (DOE))	This work was supported by the United States Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under award #DE-FG02-09ER46632 (cell-free studies) and the United States Department of Energy, Office of Sciences under award #DE-SC0004334 (spectroscopic studies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RM, 1996, J BIOL CHEM, V271, P4256; Behshad E, 2004, BIOCHEMISTRY-US, V43, P12220, DOI 10.1021/bi049143e; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Chandramouli K, 2006, BIOCHEMISTRY-US, V45, P11087, DOI 10.1021/bi061237w; Chen DW, 2001, BIOCHEMISTRY-US, V40, P596, DOI 10.1021/bi002265w; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Flint DH, 1996, J BIOL CHEM, V271, P16068; FREY PA, 1993, FASEB J, V7, P662, DOI 10.1096/fasebj.7.8.8500691; Kuchenreuther JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020346; Kuchenreuther JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015491; Kuchenreuther JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007565; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; MORGAN TV, 1984, P NATL ACAD SCI-BIOL, V81, P1931, DOI 10.1073/pnas.81.7.1931; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2010, FEBS LETT, V584, P4197, DOI 10.1016/j.febslet.2010.09.008; Pandey AS, 2008, J AM CHEM SOC, V130, P4533, DOI 10.1021/ja711187e; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Ryde U, 2010, J AM CHEM SOC, V132, P4512, DOI 10.1021/ja909194f; Shepard EM, 2011, CURR OPIN CHEM BIOL; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Shepard EM, 2010, P NATL ACAD SCI USA, V107, P10448, DOI 10.1073/pnas.1001937107; Tron C, 2011, EUR J INORG CHEM, P1121, DOI 10.1002/ejic.201001101; VanderSpek TM, 1996, EUR J BIOCHEM, V237, P629; Wecksler SR, 2009, BIOCHEMISTRY-US, V48, P10151, DOI 10.1021/bi900918b; Yang JJ, 2006, J BIOL CHEM, V281, P27956, DOI 10.1074/jbc.M601356200	35	55	55	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45850	10.1371/journal.pone.0045850	http://dx.doi.org/10.1371/journal.pone.0045850			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049878	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100091
J	Mittendorfer-Rutz, E; Kjeldgard, L; Runeson, B; Perski, A; Melchior, M; Head, J; Alexanderson, K				Mittendorfer-Rutz, Ellenor; Kjeldgard, Linnea; Runeson, Bo; Perski, Aleksander; Melchior, Maria; Head, Jenny; Alexanderson, Kristina			Sickness Absence Due to Specific Mental Diagnoses and All-Cause and Cause-Specific Mortality: A Cohort Study of 4.9 Million Inhabitants of Sweden	PLOS ONE			English	Article							HEALTH-CARE; FOLLOW-UP; PEOPLE; DISORDERS; ILLNESS; POPULATION; DEPRESSION; SUICIDE; DISEASE; CANCER	Background: Despite the magnitude and increase of sickness absence due to mental diagnoses, little is known regarding long-term health outcomes. The aim of this nationwide population-based, prospective cohort study was to investigate the association between sickness absence due to specific mental diagnoses and the risk of all-cause and cause-specific mortality. Methods: A cohort of all 4 857 943 individuals living in Sweden on 31.12.2004 (aged 16-64 years, not sickness absent, or on retirement or disability pension), was followed from 01.01.2005 through 31.12.2008 for all-cause and cause-specific mortality (suicide, cancer, circulatory disease) through linkage of individual register data. Individuals with at least one new sick-leave spell with a mental diagnosis in 2005 were compared to individuals with no sickness absence. Hazard ratios (HR) and 95% confidence intervals (CI) were estimated by Cox regression, adjusting for age, sex, education, country of birth, family situation, area of residence, and pre-existing morbidity (diagnosis-specific hospital inpatient (2000-2005) and outpatient (2001-2005) care). Results: In the multivariate analyses, mental sickness absence in 2005 was associated with an increased risk for all-cause mortality: HR: 1.65, 95% CI: 1.47-1.86 in women and in men: 1.73, 1.57-1.91; for suicide, cancer (both smoking and nonsmoking related) as well as mortality due to circulatory disease only in men. Estimates for cause-specific mortality ranged from 1.48 to 3.37. Associations with all-cause mortality were found for all mental sickness absence diagnostic groups studied. Conclusions: Knowledge about the prognosis of patients sickness absent with specific mental diagnoses is of crucial clinical importance in health care. Sickness absence due to specific mental diagnoses may here be used as a risk indictor for subsequent mortality.	[Mittendorfer-Rutz, Ellenor; Kjeldgard, Linnea; Alexanderson, Kristina] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden; [Runeson, Bo] Karolinska Inst, Dept Clin Neurosci, Ctr Psychiat Res, Stockholm, Sweden; [Perski, Aleksander] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Head, Jenny] UCL, Dept Epidemiol & Publ Hlth, London, England; [Melchior, Maria] INSERM, Villejuif, France	Karolinska Institutet; Karolinska Institutet; Stockholm University; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm)	Mittendorfer-Rutz, E (corresponding author), Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden.	Ellenor.mittendorfer-rutz@ki.se	Alexanderson, Kristina A/J-3429-2013; Head, Jenny/GYA-2625-2022; Melchior, Maria/E-3992-2017	Kjeldgard, Linnea/0000-0002-4575-7483; Alexanderson, Kristina/0000-0002-9313-3413; Runeson, Bo/0000-0003-4122-4636; Head, Jennifer/0000-0002-6054-0872	Swedish Council for Working Life and Social Sciences; Swedish Research Council [522-2010-2683]; National Institute on Aging in Great Britain [R01AG013196]; French National Research Agency; French Institute for Public Health Research; NATIONAL INSTITUTE ON AGING [R01AG013196] Funding Source: NIH RePORTER	Swedish Council for Working Life and Social Sciences(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institute on Aging in Great Britain; French National Research Agency(French National Research Agency (ANR)); French Institute for Public Health Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was financed by the Swedish Council for Working Life and Social Sciences, the Swedish Research Council (Nr 522-2010-2683), the National Institute on Aging in Great Britain (R01AG013196), the French National Research Agency, and the French Institute for Public Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorkenstam E, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000778; Brown S, 1999, PSYCHOL MED, V29, P697, DOI 10.1017/S0033291798008186; Casey P, 2011, WORLD PSYCHIATRY, V10, P11; De Hert M, 2011, WORLD PSYCHIATRY, V10, P138; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Ferrie JE, 2009, J EPIDEMIOL COMMUN H, V63, P50, DOI 10.1136/jech.2008.074369; Forsakringskassan, 2010, 201016 FORS SOC INS, P16; Forsakringskassan, 2011, SOC INS FIG 2011; Gjesdal S, 2009, SCAND J PUBLIC HLTH; Gjesdal S, 2008, EUR J PUBLIC HEALTH, V18, P517, DOI 10.1093/eurpub/ckn010; Godard C, 2006, EUR PSYCHIAT, V21, P451, DOI 10.1016/j.eurpsy.2006.03.001; Goldberg M, 2006, J CLIN EPIDEMIOL, V59, P1213, DOI 10.1016/j.jclinepi.2006.02.020; Haukkala A, 2009, ANN EPIDEMIOL, V19, P623, DOI 10.1016/j.annepidem.2009.01.010; Head J, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1469; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; Hiroeh U, 2001, LANCET, V358, P2110, DOI 10.1016/S0140-6736(01)07216-6; Hiroeh U, 2008, J PSYCHOSOM RES, V64, P275, DOI 10.1016/j.jpsychores.2007.09.008; Hoyer EH, 2000, BRIT J PSYCHIAT, V176, P76, DOI 10.1192/bjp.176.1.76; JARVISALO J., 2005, MENTAL DISORDERS MAJ; Jones S, 2008, ACTA PSYCHIAT SCAND, V118, P169, DOI 10.1111/j.1600-0447.2008.01211.x; Joukamaa M, 2001, BRIT J PSYCHIAT, V179, P498, DOI 10.1192/bjp.179.6.498; Juul SH, 2012, HAND CLINIC, V106, P167, DOI 10.1016/B978-0-444-52002-9.00010-3; Lauber C, 2008, EPIDEMIOL PSICHIAT S, V17, P10, DOI 10.1017/S1121189X0000261X; Lawrence D, 2010, CAN J PSYCHIAT, V55, P752, DOI 10.1177/070674371005501202; Lawrence D, 2010, J PSYCHOPHARMACOL, V24, P61, DOI 10.1177/1359786810382058; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; LJUNGDAHL LO, 1991, SCAND J SOC MED, V19, P148, DOI 10.1177/140349489101900302; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; MCDANIEL JS, 1995, ARCH GEN PSYCHIAT, V52, P89; Melchior M, 2010, AM J EPIDEMIOL, V172, P700, DOI 10.1093/aje/kwq186; Rihmer Zoltan, 2012, Psychiatr Hung, V27, P72; RUTZ W, 1989, ACTA PSYCHIAT SCAND, V80, P151, DOI 10.1111/j.1600-0447.1989.tb01318.x; SCB, 2003, REG IND SVER JAN 200; Schneider B, 2001, J AFFECT DISORDERS, V65, P263, DOI 10.1016/S0165-0327(00)00290-1; Shrivastava Amresh, 2012, Mens Sana Monogr, V10, P70, DOI 10.4103/0973-1229.90181; Socialstyrelsen, 2009, CAUS DEATH REG; Socialstyrelsen, 2008, BESKRIVNING VARDUTNY; Spiegel D, 2003, BIOL PSYCHIAT, V54, P269, DOI 10.1016/S0006-3223(03)00566-3; van der Feltz-Cornelis CM, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-29	40	41	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45788	10.1371/journal.pone.0045788	http://dx.doi.org/10.1371/journal.pone.0045788			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049861	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100079
J	Stein, GY; Yosef, N; Reichman, H; Horev, J; Laser-Azogui, A; Berens, A; Resau, J; Ruppin, E; Sharan, R; Tsarfaty, I				Stein, Gideon Y.; Yosef, Nir; Reichman, Hadar; Horev, Judith; Laser-Azogui, Adi; Berens, Angelique; Resau, James; Ruppin, Eytan; Sharan, Roded; Tsarfaty, Ilan			Met Kinetic Signature Derived from the Response to HGF/SF in a Cellular Model Predicts Breast Cancer Patient Survival	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; GENE-EXPRESSION SIGNATURE; C-MET; TRASTUZUMAB RESISTANCE; COLORECTAL-CANCER; ESTROGEN-RECEPTOR; PROGNOSTIC-FACTOR; IN-VITRO; PROTEIN; NODE	To determine the signaling pathways leading from Met activation to metastasis and poor prognosis, we measured the kinetic gene alterations in breast cancer cell lines in response to HGF/SF. Using a network inference tool we analyzed the putative protein-protein interaction pathways leading from Met to these genes and studied their specificity to Met and prognostic potential. We identified a Met kinetic signature consisting of 131 genes. The signature correlates with Met activation and with response to anti-Met therapy (p<0.005) in in-vitro models. It also identifies breast cancer patients who are at high risk to develop an aggressive disease in six large published breast cancer patient cohorts (p<0.01, N>1000). Moreover, we have identified novel putative Met pathways, which correlate with Met activity and patient prognosis. This signature may facilitate personalized therapy by identifying patients who will respond to anti-Met therapy. Moreover, this novel approach may be applied for other tyrosine kinases and other malignancies.	[Stein, Gideon Y.; Reichman, Hadar; Horev, Judith; Laser-Azogui, Adi; Tsarfaty, Ilan] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Stein, Gideon Y.] Beilinson Med Ctr, Dept Internal Med B, Rabin Med Ctr, Petah Tiqwa, Israel; [Yosef, Nir; Ruppin, Eytan; Sharan, Roded] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Berens, Angelique; Resau, James] Van Andel Res Inst, Grand Rapids, MI USA	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Tel Aviv University; Van Andel Institute	Tsarfaty, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel.	ilants@post.tau.ac.il	Ruppin, Eytan/R-9698-2017	Ruppin, Eytan/0000-0002-7862-3940; Tsarfaty, Ilan/0000-0002-5230-7093	Bikura Converging Technologies grants from the Israel Science Foundation; Breast Cancer Research Foundation; Binational Scientific Foundation; Federico Foundation	Bikura Converging Technologies grants from the Israel Science Foundation; Breast Cancer Research Foundation; Binational Scientific Foundation; Federico Foundation	The Breast Cancer Research Foundation, Binational Scientific Foundation, Federico Foundation and the Bikura Converging Technologies grants from the Israel Science Foundation funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altstock RT, 2000, CYTOMETRY, V41, P155, DOI 10.1002/1097-0320(20001101)41:3<155::AID-CYTO1>3.0.CO;2-4; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balliet RM, 2011, CELL CYCLE, V10, P4065, DOI 10.4161/cc.10.23.18254; Basha R, 2011, GYNECOL ONCOL, V122, P163, DOI 10.1016/j.ygyno.2011.03.014; Bertotti A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000643; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Braun R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-488; Camp RL, 1999, CANCER, V86, P2259, DOI 10.1002/(SICI)1097-0142(19991201)86:11<2259::AID-CNCR13>3.0.CO;2-2; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chen HHW, 2007, BREAST CANCER RES TR, V103, P167, DOI 10.1007/s10549-006-9360-3; Cronin M, 2007, CLIN CHEM, V53, P1084, DOI 10.1373/clinchem.2006.076497; Dulak AM, 2011, ONCOGENE; Frasor J, 2006, CANCER RES, V66, P7334, DOI 10.1158/0008-5472.CAN-05-4269; Fukukawa C, 2010, GENE CHROMOSOME CANC, V49, P861, DOI 10.1002/gcc.20795; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; Garcia S, 2007, INT J ONCOL, V31, P49; Gastaldi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2617; Gerritsen ME, 2003, BRIT J PHARMACOL, V140, P595, DOI 10.1038/sj.bjp.0705494; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Ghoussoub RAD, 1998, CANCER, V82, P1513, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1513::AID-CNCR13>3.0.CO;2-7; Goormachtigh G, 2011, BIOCHEM BIOPH RES CO, V411, P780, DOI 10.1016/j.bbrc.2011.07.024; Graveel CR, 2009, P NATL ACAD SCI USA, V106, P12909, DOI 10.1073/pnas.0810403106; Hanissian SH, 2005, BRAIN RES, V1047, P56, DOI 10.1016/j.brainres.2005.04.017; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Huhn S, 2011, INT J MOL EPIDEMIOL, V2, P36; Hwang CI, 2011, P NATL ACAD SCI USA, V108, P14240, DOI 10.1073/pnas.1017536108; Jansen MP, 2012, BREAST CANC RES TREA; Kamalati T, 1999, J MAMMARY GLAND BIOL, V4, P69, DOI 10.1023/A:1018756620265; Kaposi-Novak P, 2006, J CLIN INVEST, V116, P1582, DOI 10.1172/JCI27236; Keyhanian K, 2007, MOL CELL BIOCHEM, V304, P199, DOI 10.1007/s11010-007-9500-z; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Logullo AF, 2010, ONCOL REP, V23, P313, DOI 10.3892/or_00000638; Ma WW, 2009, CA-CANCER J CLIN, V59, P111, DOI 10.3322/caac.20003; Mbalaviele G, 1996, CANCER RES, V56, P4063; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Nandi AK, 2007, BIOCHEM BIOPH RES CO, V358, P181, DOI 10.1016/j.bbrc.2007.04.125; Ocal IT, 2003, CANCER-AM CANCER SOC, V97, P1841, DOI 10.1002/cncr.11335; Ou WB, 2011, NEOPLASIA, V13, P12, DOI 10.1593/neo.101156; Pauley R J, 1993, Eur J Cancer Prev, V2 Suppl 3, P67; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pise-Masison CA, 2009, BLOOD, V113, P4016, DOI 10.1182/blood-2008-08-175901; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Reshetnikova G, 2007, CELL BIOL INT, V31, P366, DOI 10.1016/j.cellbi.2007.01.022; RONG S, 1993, CANCER RES, V53, P5355; Row PE, 2005, BIOCHEM J, V389, P629, DOI 10.1042/BJ20050067; RUBIN JS, 1993, BIOCHIM BIOPHYS ACTA, V1155, P357, DOI 10.1016/0304-419X(93)90015-5; Salgia R, 2009, SEMIN ONCOL, V36, pS52, DOI 10.1053/j.seminoncol.2009.02.008; Scaltriti M, 2011, P NATL ACAD SCI USA, V108, P3761, DOI 10.1073/pnas.1014835108; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Schroder K, 2011, ANTIOXID REDOX SIGN, V15, P915, DOI 10.1089/ars.2010.3533; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Subik K, 2010, BREAST CANCER-BASIC, V4, P35; Taher TEI, 2002, J IMMUNOL, V169, P3793, DOI 10.4049/jimmunol.169.7.3793; Tong D, 1999, BREAST CANCER RES TR, V56, P91, DOI 10.1023/A:1006262501062; Truitt L, 2010, CANCER RES, V70, P1141, DOI 10.1158/0008-5472.CAN-09-1710; Tsarfaty I, 1999, ANAL QUANT CYTOL, V21, P397; TSARFATY I, 1992, SCIENCE, V257, P1258, DOI 10.1126/science.1387731; Tsutamoto T, 2000, J AM COLL CARDIOL, V35, P714, DOI 10.1016/S0735-1097(99)00594-X; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Ueki T, 2008, ONCOGENE, V27, P5672, DOI 10.1038/onc.2008.186; Uluer ET, 2011, ACTA HISTOCHEM; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; YAMASHITA J, 1994, CANCER RES, V54, P1630; Yamashita SI, 2007, ANTICANCER RES, V27, P2803; Yosef N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001935; Yosef N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.3; Yoshida Y, 2011, ANTICANCER RES, V31, P2535; Zhang YW, 2004, CANCER CELL, V6, P5, DOI 10.1016/j.ccr.2004.07.003	76	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45969	10.1371/journal.pone.0045969	http://dx.doi.org/10.1371/journal.pone.0045969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049908	Green Submitted, gold, Green Published			2022-12-27	WOS:000309556100111
J	Zhang, Y; Liu, CM; Peng, HP; Zhang, JZ; Feng, QL				Zhang, Ying; Liu, Changming; Peng, Huiping; Zhang, Jianzhi; Feng, Quanlin			IL1 Receptor Antagonist Gene IL1-RN Variable Number of Tandem Repeats Polymorphism and Cancer Risk: A Literature Review and Meta-Analysis	PLOS ONE			English	Article							GASTRIC-CANCER; BREAST-CANCER; HELICOBACTER-PYLORI; INTERLEUKIN-1-BETA GENE; LUNG-CANCER; IL-1RN POLYMORPHISMS; CHINESE POPULATION; CERVICAL-CANCER; HEPATITIS-C; CARCINOMA	IL1 receptor antagonist (IL1RA) and IL1beta (IL1 beta), members of the pro-inflammatory cytokine interleukin-1 (IL1) family, play a potential role against infection and in the pathogenesis of cancers. The variable number of tandem repeats (VNTR) polymorphism in the second intron of the IL1 receptor antagonist gene (IL1-RN) and a polymorphism in exon 5 of IL1B (IL1B+3954C>T, rs1143634) have been suggested in predisposition to cancer risk. However, studies have shown inconsistent results. To validate any association, a meta-analysis was performed with 14,854 cases and 19,337 controls from 71 published case-control studies for IL1-RN VNTR and 33 eligible studies contained 7,847 cases and 8917 controls for IL1B +3954. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated from comparisons to assess the strength of the association. There was significant association between the IL1-RN VNTR polymorphism and the risk of cancer for any overall comparison. Furthermore, cancer type stratification analysis revealed that there were significantly increased risks of gastric cancer, bladder cancer and other cancer groups. Infection status analysis indicated that the H. pylori or HBV/HCV infection and IL1-RN VNTR genotypes were independent factors for developing gastric or hepatocellular cancers. In addition, a borderline significant association was observed between IL1B+3954 polymorphism and the increased cancer risk. Although some modest bias could not be eliminated, this meta-analysis suggested that the IL1-RN VNTR polymorphisms may contribute to genetic susceptibility to gastric cancer. More studies are needed to further evaluate the role of the IL1B+3954 polymorphism in the etiology of cancer.	[Feng, Quanlin] Nanjing Univ Chinese Med, Dept Surg Oncol, Kunshan Hosp, Kunshan, Jiangsu, Peoples R China; [Zhang, Ying; Liu, Changming; Zhang, Jianzhi] Nanjing Univ Chinese Med, Inspect Div, Kunshan Hosp, Kunshan, Jiangsu, Peoples R China; [Peng, Huiping] Nanjing Univ Chinese Med, Dept Gastroenterol, Kunshan Hosp, Kunshan, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine	Feng, QL (corresponding author), Nanjing Univ Chinese Med, Dept Surg Oncol, Kunshan Hosp, Kunshan, Jiangsu, Peoples R China.	ksfql@126.com			Social Development Technology Projects of Kunshan City, China [KS1145, KS1248, KS1259]	Social Development Technology Projects of Kunshan City, China	This study was funded by the grants from the Social Development Technology Projects of Kunshan City, China (KS1145, KS1248, KS1259). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abazis-Stamboulieh D, 2007, LEUKEMIA LYMPHOMA, V48, P2196, DOI 10.1080/10428190701615892; Ahirwar DK, 2009, BIOMARKERS, V14, P213, DOI 10.1080/13547500902818246; Atherton JC, 1997, GUT, V40, P701, DOI 10.1136/gut.40.6.701; Chen A, 2004, ALIMENT PHARM THER, V20, P203, DOI 10.1111/j.1365-2036.2004.01826.x; Con SA, 2009, WORLD J GASTROENTERO, V15, P211, DOI 10.3748/wjg.15.211; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Engels EA, 2007, CANCER RES, V67, P6520, DOI 10.1158/0008-5472.CAN-07-0370; Erzin Y, 2008, J GASTROENTEROL, V43, P705, DOI 10.1007/s00535-008-2220-7; Figueiredo C, 2002, J NATL CANCER I, V94, P1680, DOI 10.1093/jnci/94.22.1680; Glas J, 2004, J CLIN ONCOL, V22, P4746, DOI 10.1200/JCO.2004.03.034; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; He BS, 2011, DIGEST DIS SCI, V56, P2017, DOI 10.1007/s10620-010-1557-y; He BS, 2011, MUTAGENESIS, V26, P637, DOI 10.1093/mutage/ger025; Hefler LA, 2005, CLIN CANCER RES, V11, P5718, DOI 10.1158/1078-0432.CCR-05-0001; Heneghan Michael A, 2003, Int J Gastrointest Cancer, V34, P19; Hu X, 2002, J NATL CANCER I, V94, P1704, DOI 10.1093/jnci/94.22.1704; Kiyohara C, 2010, J THORAC ONCOL, V5, P299, DOI 10.1097/JTO.0b013e3181c8cae3; Lee KM, 2006, BREAST CANCER RES TR, V96, P197, DOI 10.1007/s10549-005-9079-6; Leung Nancy, 2005, Med J Malaysia, V60 Suppl B, P63; Lim WY, 2011, CARCINOGENESIS, V32, P522, DOI 10.1093/carcin/bgr006; Liu XA, 2010, BREAST CANCER RES TR, V124, P821, DOI 10.1007/s10549-010-0910-3; Lu WL, 2005, CARCINOGENESIS, V26, P631, DOI 10.1093/carcin/bgh349; Barbosa HPM, 2009, WORLD J GASTROENTERO, V15, P1465, DOI 10.3748/wjg.15.1465; MIDGETTE AS, 1994, MED DECIS MAKING, V14, P108, DOI 10.1177/0272989X9401400203; Palli D, 2005, AM J GASTROENTEROL, V100, P1941, DOI 10.1111/j.1572-0241.2005.50084.x; PATTERSON D, 1993, GENOMICS, V15, P173, DOI 10.1006/geno.1993.1025; Perri F, 2005, CYTOKINE, V30, P293, DOI 10.1016/j.cyto.2005.01.011; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; Powell EE, 2000, HEPATOLOGY, V31, P828, DOI 10.1053/he.2000.6253; Press DJ, 2010, EPIDEMIOLOGY, V21, P566, DOI 10.1097/EDE.0b013e3181e08eb3; Reichlin S, 2000, ENDOCRINOLOGY, V141, P1951, DOI 10.1210/en.141.6.1951; Rocha GA, 2005, INT J CANCER, V115, P678, DOI 10.1002/ijc.20935; Rose D P, 2004, Obes Rev, V5, P153, DOI 10.1111/j.1467-789X.2004.00142.x; Ruzzo A, 2005, ANN ONCOL, V16, P887, DOI 10.1093/annonc/mdi184; Santtila S, 1998, SCAND J IMMUNOL, V47, P195; Sehouli J, 2003, ANN ONCOL, V14, P1501, DOI 10.1093/annonc/mdg413; Shirodaria S, 2000, J DENT RES, V79, P1864, DOI 10.1177/00220345000790110801; Singh H, 2008, BJOG-INT J OBSTET GY, V115, P633, DOI 10.1111/j.1471-0528.2007.01655.x; Smith DE, 2000, J BIOL CHEM, V275, P1169, DOI 10.1074/jbc.275.2.1169; Sobti RC, 2008, INT J GYNECOL OBSTET, V101, P47, DOI 10.1016/j.ijgo.2007.10.014; Speirs V, 1999, INT J ONCOL, V15, P1251; TARLOW JK, 1993, HUM GENET, V91, P403; Tirona MT, 2010, CANCER INVEST, V28, P743, DOI 10.3109/07357907.2010.494321; Wang P, 2007, INT J CANCER, V120, P552, DOI 10.1002/ijc.22353; WILLETT W, 1989, NATURE, V338, P389, DOI 10.1038/338389a0; Witkin SS, 2002, CLIN INFECT DIS, V34, P204, DOI 10.1086/338261; Xue HP, 2010, J GASTROEN HEPATOL, V25, P1604, DOI 10.1111/j.1440-1746.2010.06428.x; Yin N, 2004, CANCER RES, V64, P5870, DOI 10.1158/0008-5472.CAN-04-0655; YU MW, 1994, CRIT REV ONCOL HEMAT, V17, P71, DOI 10.1016/1040-8428(94)90020-5; Zhang WH, 2005, CYTOKINE, V30, P378, DOI 10.1016/j.cyto.2005.02.002	51	23	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46017	10.1371/journal.pone.0046017	http://dx.doi.org/10.1371/journal.pone.0046017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049925	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100121
J	Robinet, C; Kehlenbeck, H; Kriticos, DJ; Baker, RHA; Battisti, A; Brunel, S; Dupin, M; Eyre, D; Faccoli, M; Ilieva, Z; Kenis, M; Knight, J; Reynaud, P; Yart, A; van der Werf, W				Robinet, Christelle; Kehlenbeck, Hella; Kriticos, Darren J.; Baker, Richard H. A.; Battisti, Andrea; Brunel, Sarah; Dupin, Maxime; Eyre, Dominic; Faccoli, Massimo; Ilieva, Zhenya; Kenis, Marc; Knight, Jon; Reynaud, Philippe; Yart, Annie; van der Werf, Wopke			A Suite of Models to Support the Quantitative Assessment of Spread in Pest Risk Analysis	PLOS ONE			English	Article							WESTERN CORN-ROOTWORM; LONG-DISTANCE DISPERSAL; POPULATION EXPANSION; ECONOMIC-IMPACT; PITCH CANKER; INVASION; CLIMATE; EUROPE; TRADE; SIMULATION	Pest Risk Analyses (PRAs) are conducted worldwide to decide whether and how exotic plant pests should be regulated to prevent invasion. There is an increasing demand for science-based risk mapping in PRA. Spread plays a key role in determining the potential distribution of pests, but there is no suitable spread modelling tool available for pest risk analysts. Existing models are species specific, biologically and technically complex, and data hungry. Here we present a set of four simple and generic spread models that can be parameterised with limited data. Simulations with these models generate maps of the potential expansion of an invasive species at continental scale. The models have one to three biological parameters. They differ in whether they treat spatial processes implicitly or explicitly, and in whether they consider pest density or pest presence/absence only. The four models represent four complementary perspectives on the process of invasion and, because they have different initial conditions, they can be considered as alternative scenarios. All models take into account habitat distribution and climate. We present an application of each of the four models to the western corn rootworm, Diabrotica virgifera virgifera, using historic data on its spread in Europe. Further tests as proof of concept were conducted with a broad range of taxa (insects, nematodes, plants, and plant pathogens). Pest risk analysts, the intended model users, found the model outputs to be generally credible and useful. The estimation of parameters from data requires insights into population dynamics theory, and this requires guidance. If used appropriately, these generic spread models provide a transparent and objective tool for evaluating the potential spread of pests in PRAs. Further work is needed to validate models, build familiarity in the user community and create a database of species parameters to help realize their potential in PRA practice.	[van der Werf, Wopke] Wageningen Univ, Ctr Crop Syst Anal, Wageningen, Netherlands; [Robinet, Christelle; Dupin, Maxime; Yart, Annie] INRA, UR Zool Forestiere 633, Orleans, France; [Kehlenbeck, Hella] Julius Kuhn Inst, Inst Natl & Int Plant Hlth, Kleinmachnow, Germany; [Kriticos, Darren J.] CSIRO Ecosyst Sci, Canberra, ACT, Australia; [Kriticos, Darren J.] Cooperat Res Ctr Natl Plant Biosecur, Bruce, Australia; [Baker, Richard H. A.; Eyre, Dominic] Food & Environm Res Agcy, York, N Yorkshire, England; [Battisti, Andrea; Faccoli, Massimo] Univ Padua, Dept Agron Food Nat Resources Anim & Environm DAF, Legnaro, Italy; [Brunel, Sarah] European & Mediterranean Plant Protect Org, Paris, France; [Ilieva, Zhenya] Inst Plant Protect, Kostinbrod, Bulgaria; [Knight, Jon] Univ London Imperial Coll Sci Technol & Med, Ascot, Berks, England; [Kenis, Marc] CABI Europe Switzerland, Delemont, Switzerland; [Knight, Jon] HDC, Agr & Hort Dev Board, Kenilworth, Warwick, England; [Reynaud, Philippe] Anses Lab Sante Vegetaux, Montferrier Sur Lez, France	Wageningen University & Research; INRAE; Julius Kuhn-Institut; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Food & Environment Research Agency; University of Padua; Agricultural Academy - Bulgaria; Imperial College London; Agriculture & Horticulture Development Board (AHDB); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux	van der Werf, W (corresponding author), Wageningen Univ, Ctr Crop Syst Anal, Wageningen, Netherlands.	Wopke.vanderWerf@wur.nl	Faccoli, Massimo/AAC-8141-2020; Ilieva, Zhenya/AAB-8513-2019; Kriticos, Darren J/A-4170-2008; Battisti, Andrea/F-6243-2015; Van Der Werf, Wopke/A-2557-2009	Ilieva, Zhenya/0000-0002-9937-2749; Kriticos, Darren J/0000-0003-2599-8105; Battisti, Andrea/0000-0002-2497-3064; Van Der Werf, Wopke/0000-0002-5506-4699; FACCOLI, MASSIMO/0000-0002-9355-0516; Kehlenbeck, Hella/0000-0002-5568-4070; Robinet, Christelle/0000-0002-4933-4656	EU [RATIQUE KBBE-2007-212459, ISEFOR KBBE-2009-245268]; Netherlands Agricultural Economics Institute, LEI-DLO	EU(European Commission); Netherlands Agricultural Economics Institute, LEI-DLO	The authors gratefully acknowledge support for this work from the EU project PRATIQUE KBBE-2007-212459 (FP7 Project, Enhancements of pest risk analysis techniques; [32]). WvdW acknowledges financial support from the Netherlands Agricultural Economics Institute, LEI-DLO. Publication costs were shared equally between Wageningen University Library and the EU project ISEFOR KBBE-2009-245268 (FP7 Project, Increasing Sustainability of European Forests). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baca F, 1993, 21 YUG ENT C BELGR; Baker R. H. A., 2012, Bulletin OEPP, V42, P65, DOI [10.1111/j.1365-2338.2012.02545.x, 10.1111/epp.2545]; Baker R. H. A., 2009, Bulletin OEPP, V39, P87, DOI 10.1111/j.1365-2338.2009.02246.x; Baufeld P., 2005, BCPC Symposium Proceedings, V81, P149; Baufeld P, 2001, 8 M IWGO DIABR SUBGR; Bianchi FJJA, 2009, BIOL CONTROL, V50, P267, DOI 10.1016/j.biocontrol.2009.04.014; Biosecurity Australia, 2007, IMP RISK AN 2007; Bolker B, 2008, ECOLOGICAL MODELS DA; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; Carrasco LR, 2010, ECOL MODEL, V221, P2068, DOI 10.1016/j.ecolmodel.2010.05.012; Carrasco LR, 2010, ECOL ECON, V69, P1303, DOI 10.1016/j.ecolecon.2010.02.001; Carrasco LR, 2009, ANN APPL BIOL, V155, P1; Carrasco LR, 2009, THESIS, P230; Ciosi M, 2011, EVOL APPL, V4, P54, DOI 10.1111/j.1752-4571.2010.00133.x; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.1890/0012-9658(1999)080[1475:SDNAFP]2.0.CO;2; Cook DC, 2008, AUST FORESTRY, V71, P107, DOI 10.1080/00049158.2008.10676277; Cook DC, 2007, ECOL APPL, V17, P1832, DOI 10.1890/06-1632.1; De Boer D, 2004, DISTRIBUTION POTENTI; Desprez-Loustau ML, 2007, TRENDS ECOL EVOL, V22, P472, DOI 10.1016/j.tree.2007.04.005; Desprez-Loustau Marie-Laure, 2009, V3, P15; Edelstein-Keshet L., 1988, MATH MODELS BIOL; Epanchin-Niell RS, 2010, ECOL LETT, V13, P528, DOI 10.1111/j.1461-0248.2010.01440.x; EPPO, 2011, EPPO PEST RISK AN; EPPO, 1994, EPPO REP SERV 94 001; EPPO (European and Mediterranean Plant Protection Organization), 2011, GUID PEST RISK AN DE; FAO, 2007, FRAM PEST RISK AN IS; FAO, 2004, FAO PUBL, V11; Ganley RJ, 2009, CAN J FOREST RES, V39, P2246, DOI 10.1139/X09-131; Gilbert M, 2004, J ANIM ECOL, V73, P459, DOI 10.1111/j.0021-8790.2004.00820.x; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hemerik L, 2004, ENTOMOL EXP APPL, V111, P59, DOI 10.1111/j.0013-8703.2004.00150.x; Higgins SI, 1996, ECOL MODEL, V87, P249, DOI 10.1016/0304-3800(95)00022-4; Hilborn Ray, 1997, V28; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kehlenbeck H., 2012, Bulletin OEPP, V42, P74, DOI [10.1111/epp.2550, 10.1111/j.1365-2338.2012.02550.x]; Kenis M, 2007, B ENTOMOL RES, V97, P489, DOI 10.1017/S0007485307005184; Kenis M, 2010, BIORISK, V4, P51; Koch FH, 2009, RISK ANAL, V29, P1227, DOI 10.1111/j.1539-6924.2009.01251.x; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Kot M., 2001, ELEMENTS MATH BIOL; Kriticos D, 2008, CLIMATIC PREDICTION; Kriticos D. J., 2012, Bulletin OEPP, V42, P56, DOI [10.1111/j.1365-2338.2012.02540.x, 10.1111/epp.2540]; Krugener S., 2011, Journal fur Kulturpflanzen, V63, P69; Liebhold Andrew M., 2006, American Entomologist, V52, P48; LUDWIG D, 1985, CAN J FISH AQUAT SCI, V42, P1066, DOI 10.1139/f85-132; MacLeod A., 2005, Plant protection and plant health in Europe: introduction and spread of invasive species, held at Humboldt University, Berlin, Germany, 9-11 June 2005, P167; Magarey RD, 2007, PLANT DIS, V91, P336, DOI 10.1094/PDIS-91-4-0336; McGill University, 2011, 175 CROPS DAT AR YIE; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Muirhead JR, 2006, DIVERS DISTRIB, V12, P71, DOI 10.1111/j.1366-9516.2006.00218.x; Murray J.D., 2002, INTERDISCIPLINARY AP, V17; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; OKUBO A, 2001, DIFFUSION ECOLOGICAL; Pitt JPW, 2011, ECOL MODEL, V222, P1880, DOI 10.1016/j.ecolmodel.2011.03.023; Pitt JPW, 2009, ECOL APPL, V19, P1176, DOI 10.1890/08-1777.1; Pitt JPW, 2008, THESIS, P228; Purdue University, 2011, W CORN ROOTW; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robinet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004646; Roques Alain, 2010, New Zealand Journal of Forestry Science, V40, pS77; Roques Alain, 2009, V3, P63; Sharov AA, 1998, ECOL APPL, V8, P1170, DOI 10.1890/1051-0761(1998)008[1170:MOSTSO]2.0.CO;2; SHAW MW, 1995, P ROY SOC B-BIOL SCI, V259, P243, DOI 10.1098/rspb.1995.0036; Shigesada N., 1997, BIOL INVASIONS THEOR; Sivcev I, 2000, 7 M IWGO DIABR SUBGR; Soetaert K., 2009, PRACTICAL GUIDE ECOL; Sutherst R. W., 2007, CLIMEX VERSION 3 USE, P131; Sutherst RW, 2003, J BIOGEOGR, V30, P805, DOI 10.1046/j.1365-2699.2003.00861.x; SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7; Szalai M, 2011, J PEST SCI, V84, P133, DOI 10.1007/s10340-010-0336-z; Turchin Peter, 1998; USDA-APHIS, 2000, GUID PATHW IN PEST R; Waage JK, 2005, NEW AGENDA BIOSECURI, P190; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wesseler J, 2010, J APPL ENTOMOL, V134, P385, DOI 10.1111/j.1439-0418.2010.01510.x; Williamson M., 1996, BIOL INVASIONS; Zseller IH, 2000, 7 M IWGO DIABR SUBGR; Zseller IH, 2001, 8 M IWGO DIABR SUBGR	79	54	57	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e43366	10.1371/journal.pone.0043366	http://dx.doi.org/10.1371/journal.pone.0043366			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056174	Green Submitted, Green Published, gold			2022-12-27	WOS:000309889400003
J	de Jager, CPC; Wever, PC; Gemen, EFA; Kusters, R; van Gageldonk-Lafeber, AB; van der Poll, T; Laheij, RJF				de Jager, Cornelis P. C.; Wever, Peter C.; Gemen, Eugenie F. A.; Kusters, Ron; van Gageldonk-Lafeber, Arianne B.; van der Poll, Tom; Laheij, Robert J. F.			The Neutrophil-Lymphocyte Count Ratio in Patients with Community-Acquired Pneumonia	PLOS ONE			English	Article							SEPTIC SHOCK; PREOPERATIVE NEUTROPHIL; PROGNOSTIC ACCURACY; BIOMARKERS; LYMPHOPENIA; BACTEREMIA; APOPTOSIS; SEVERITY; MARKERS; SEPSIS	Study Objective: The neutrophil-lymphocyte count ratio (NLCR) has been identified as a predictor of bacteremia in medical emergencies. The aim of this study was to investigate the value of the NLCR in patients with community-acquired pneumonia (CAP). Methods and Results: Consecutive adult patients were prospectively studied. Pneumonia severity (CURB-65 score), clinical characteristics, complications and outcomes were related to the NLCR and compared with C-reactive protein (CRP), neutrophil count, white blood cell (WBC) count. The study cohort consisted of 395 patients diagnosed with CAP. The mean age of the patients was 63.4 +/- 16.0 years. 87.6% (346/395) of the patients required hospital admission, 7.8% (31/395) patients were admitted to the Intensive Care Unit (ICU) and 5.8% (23/395) patients of the study cohort died. The NLCR was increased in all patients, predicted adverse medical outcome and consistently increased as the CURB-65 score advanced. NLCR levels (mean +/- SD) were significantly higher in non-survivors (23.3 +/- 16.8) than in survivors (13.0 +/- 11.4). The receiver-operating characteristic (ROC) curve for NLCR predicting mortality showed an area under the curve (AUC) of 0.701. This was better than the AUC for the neutrophil count, WBC count, lymphocyte count and CRP level (0.681, 0.672, 0.630 and 0.565, respectively). Conclusion: Admission NLCR at the emergency department predicts severity and outcome of CAP with a higher prognostic accuracy as compared with traditional infection markers.	[de Jager, Cornelis P. C.; Laheij, Robert J. F.] Jeroen Bosch Ziekenhuis, Dept Emergency Med & Intens Care, sHertogenbosch, Netherlands; [Wever, Peter C.] Jeroen Bosch Ziekenhuis, Dept Med Microbiol & Infect Control, sHertogenbosch, Netherlands; [Gemen, Eugenie F. A.; Kusters, Ron] Jeroen Bosch Ziekenhuis, Dept Clin Chem & Hematol, sHertogenbosch, Netherlands; [van Gageldonk-Lafeber, Arianne B.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1012 WX Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1012 WX Amsterdam, Netherlands; [Laheij, Robert J. F.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands	Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis; Netherlands National Institute for Public Health & the Environment; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center	de Jager, CPC (corresponding author), Jeroen Bosch Ziekenhuis, Dept Emergency Med & Intens Care, sHertogenbosch, Netherlands.	p.de.jager@jbz.nl						Acanfora D, 2001, AM HEART J, V142, P167, DOI 10.1067/mhj.2001.115792; Adams Nicholas G, 2005, Emerg Med Australas, V17, P371, DOI 10.1111/j.1742-6723.2005.00759.x; Ayala A, 1996, BLOOD, V87, P4261, DOI 10.1182/blood.V87.10.4261.bloodjournal87104261; Blasi F, 2012, EUR J INTERN MED, V23, P429, DOI 10.1016/j.ejim.2012.05.002; Buising KL, 2006, THORAX, V61, P419, DOI 10.1136/thx.2005.051326; Chalupa P, 2011, INFECTION, V39, P411, DOI 10.1007/s15010-011-0126-4; Christ-Crain M, 2007, EUR RESPIR J, V30, P556, DOI 10.1183/09031936.00166106; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; de Wit NCJ, 2009, CLIN CHEM LAB MED, V47, P1407, DOI 10.1515/CCLM.2009.307; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Fantin B, 1996, CLIN INFECT DIS, V22, P1096, DOI 10.1093/clinids/22.6.1096; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; Garau J, 2008, CLIN MICROBIOL INFEC, V14, P322, DOI 10.1111/j.1469-0691.2007.01915.x; Gibson PH, 2007, AM HEART J, V154, P995, DOI 10.1016/j.ahj.2007.06.043; GOODMAN DA, 1995, AM SURGEON, V61, P257; Halazun KJ, 2008, EJSO-EUR J SURG ONC, V34, P55, DOI 10.1016/j.ejso.2007.02.014; Halazun KJ, 2009, ANN SURG, V250, P141, DOI 10.1097/SLA.0b013e3181a77e59; Hawkins CA, 2006, INTERN MED J, V36, P385, DOI 10.1111/j.1445-5994.2006.01076.x; Heyland DK, 2011, CRIT CARE MED, V39, P1792, DOI 10.1097/CCM.0b013e31821201a5; Huehnergarth KV, 2005, AM J CARDIOL, V95, P1492, DOI 10.1016/j.amjcard.2005.02.022; Jilma B, 1999, AM J RESP CRIT CARE, V159, P857, DOI 10.1164/ajrccm.159.3.9805087; Joshi VD, 2003, FEBS LETT, V555, P180, DOI 10.1016/S0014-5793(03)01271-7; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kopterides P, 2010, CRIT CARE MED, V38, P2229, DOI 10.1097/CCM.0b013e3181f17bf9; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; LAURENCE J, 1993, ANN INTERN MED, V119, P55, DOI 10.7326/0003-4819-119-1-199307010-00010; Le Tulzo Y, 2002, SHOCK, V18, P487, DOI 10.1097/00024382-200212000-00001; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Martinez R, 2011, EUR RESPIR J, V37, P393, DOI 10.1183/09031936.00040710; Muller B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-10; Ommen SR, 1998, CIRCULATION, V97, P19, DOI 10.1161/01.CIR.97.1.19; Polverino E, 2011, MINERVA ANESTESIOL, V77, P196; Sarraf KM, 2009, J THORAC CARDIOV SUR, V137, P425, DOI 10.1016/j.jtcvs.2008.05.046; Schuetz P, 2007, CURR OPIN CRIT CARE, V13, P578, DOI 10.1097/MCC.0b013e3282c9ac2a; Schuetz P, 2010, CRIT CARE, V14, DOI 10.1186/cc9055; Tamhane UU, 2008, AM J CARDIOL, V102, P653, DOI 10.1016/j.amjcard.2008.05.006; Unsinger J, 2009, J LEUKOCYTE BIOL, V85, P382, DOI 10.1189/jlb.0808491; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Walsh Sr, 2005, J SURG ONCOL, V91, P181, DOI 10.1002/jso.20329; WILLIAMS RC, 1983, AM J MED, V75, P807, DOI 10.1016/0002-9343(83)90412-6; Wyllie DH, 2005, J CLIN PATHOL, V58, P352, DOI 10.1136/jcp.2004.022293; Wyllie DH, 2004, J CLIN PATHOL, V57, P950, DOI 10.1136/jcp.2004.017335; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	44	183	187	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46561	10.1371/journal.pone.0046561	http://dx.doi.org/10.1371/journal.pone.0046561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049706	gold, Green Published			2022-12-27	WOS:000309388500033
J	Huse, K; Bakkebo, M; Walchli, S; Oksvold, MP; Hilden, VI; Forfang, L; Bredahl, ML; Liestol, K; Alizadeh, AA; Smeland, EB; Myklebust, JH				Huse, Kanutte; Bakkebo, Maren; Walchli, Sebastien; Oksvold, Morten P.; Hilden, Vera I.; Forfang, Lise; Bredahl, May L.; Liestol, Knut; Alizadeh, Ash A.; Smeland, Erlend B.; Myklebust, June H.			Role of Smad Proteins in Resistance to BMP-Induced Growth Inhibition in B-Cell Lymphoma	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; RECEPTOR-TYPE-II; UP-REGULATION; EXPRESSION; APOPTOSIS; CANCER; PATHWAY; PROLIFERATION; MICRORNA-155; NETWORKS	Bone morphogenetic protein (BMP) expression and signaling are altered in a variety of cancers, but the functional impact of these alterations is uncertain. In this study we investigated the impact of expression of multiple BMPs and their signaling pathway components in human B-cell lymphoma. BMP messages, in particular BMP7, were detected in normal and malignant B cells. Addition of exogenous BMPs inhibited DNA synthesis in most lymphoma cell lines examined, but some cell lines were resistant. Tumor specimens from three out of five lymphoma patients were also resistant to BMPs, as determined by no activation of the BMP effectors Smad1/5/8. We have previously shown that BMP-7 potently induced apoptosis in normal B cells, which was in contrast to no or little inhibitory effect of this BMP in the lymphoma cells tested. BMP-resistance mechanisms were investigated by comparing sensitive and resistant cell lines. While BMP receptors are downregulated in many cancers, we documented similar receptor levels in resistant and sensitive lymphoma cells. We found a positive correlation between activation of Smad1/5/8 and inhibition of DNA synthesis. Gene expression analysis of two independent data sets showed that the levels of inhibitory Smads varied across different B-cell lymphoma. Furthermore, stable overexpression of Smad7 in two different BMP-sensitive cell lines with low endogenous levels of SMAD7, rendered them completely resistant to BMPs. This work highlights the role of Smads in determining the sensitivity to BMPs and shows that upregulation of Smad7 in cancer cells is sufficient to escape the negative effects of BMPs.	[Huse, Kanutte; Bakkebo, Maren; Walchli, Sebastien; Oksvold, Morten P.; Hilden, Vera I.; Forfang, Lise; Bredahl, May L.; Smeland, Erlend B.; Myklebust, June H.] Oslo Univ Hosp, Immunol Sect, Oslo, Norway; [Huse, Kanutte; Bakkebo, Maren; Oksvold, Morten P.; Hilden, Vera I.; Forfang, Lise; Bredahl, May L.; Liestol, Knut; Smeland, Erlend B.; Myklebust, June H.] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Liestol, Knut] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Alizadeh, Ash A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	University of Oslo; University of Oslo; University of Oslo; Stanford University	Huse, K (corresponding author), Oslo Univ Hosp, Immunol Sect, Oslo, Norway.	kanutte.huse@rr-research.no	Alizadeh, Ash A/C-5594-2009; Myklebust, June Helen/ABH-6494-2020; Smeland, Erlend/AAO-3214-2020	Alizadeh, Ash A/0000-0002-5153-5625; Myklebust, June Helen/0000-0003-0394-9986; Walchli, Sebastien/0000-0001-5869-1746; Huse, Kanutte/0000-0001-9128-670X	The Norwegian Cancer Society; The Research Council of Norway; South-Eastern Norway Regional Health Authority	The Norwegian Cancer Society(Norwegian Cancer SocietyEuropean Commission); The Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority	KH and JHM were supported by fellowships from The Norwegian Cancer Society, and this work has been supported by The Research Council of Norway and South-Eastern Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bakkebo M, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-57; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bernabeu C, 2009, BBA-MOL BASIS DIS, V1792, P954, DOI 10.1016/j.bbadis.2009.07.003; Bhatia M, 1999, J EXP MED, V189, P1139, DOI 10.1084/jem.189.7.1139; Bragdon B, 2011, CELL SIGNAL, V23, P609, DOI 10.1016/j.cellsig.2010.10.003; Cejalvo T, 2007, IMMUNOLOGY, V121, P94, DOI 10.1111/j.1365-2567.2007.02541.x; Chen G, 2007, BLOOD, V109, P5301, DOI 10.1182/blood-2006-06-032128; Choi YS, 1997, IMMUNOL RES, V16, P161, DOI 10.1007/BF02786360; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Daibata M, 2007, CLIN CANCER RES, V13, P3528, DOI 10.1158/1078-0432.CCR-06-2766; Gentles AJ, 2009, BLOOD, V114, P3158, DOI 10.1182/blood-2009-02-202465; Grcevic D, 2010, LEUKEMIA RES, V34, P742, DOI 10.1016/j.leukres.2009.10.016; Hjertner O, 2001, BLOOD, V97, P516, DOI 10.1182/blood.V97.2.516; Holien T, 2012, LEUKEMIA, V26, P1073, DOI 10.1038/leu.2011.263; Hsu MY, 2008, LAB INVEST, V88, P842, DOI 10.1038/labinvest.2008.55; Huang M, 2002, J CLIN INVEST, V109, P931, DOI 10.1172/JCI200214685; Huse K, 2011, EUR J IMMUNOL, V41, P3135, DOI 10.1002/eji.201141558; Ide H, 1997, CANCER RES, V57, P5022; Irish JM, 2010, P NATL ACAD SCI USA, V107, P12747, DOI 10.1073/pnas.1002057107; Jeon HS, 2008, CANCER RES, V68, P9686, DOI 10.1158/0008-5472.CAN-08-1083; Kawamura C, 2002, LEUKEMIA LYMPHOMA, V43, P635, DOI 10.1080/10428190290012182; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kersten C, 2006, EXP HEMATOL, V34, P72, DOI 10.1016/j.exphem.2005.09.010; Kim IY, 2006, CANCER LETT, V241, P118, DOI 10.1016/j.canlet.2005.10.009; Kim IY, 2004, ONCOGENE, V23, P7651, DOI 10.1038/sj.onc.1207924; Kim IY, 2004, CANCER RES, V64, P7355, DOI 10.1158/0008-5472.CAN-04-0154; Kim IY, 2003, CLIN CANCER RES, V9, P6046; Kim SJ, 2003, LEUKEMIA, V17, P1731, DOI 10.1038/sj.leu.2403069; Kim YH, 2004, ANN ONCOL, V15, P574, DOI 10.1093/annonc/mdh131; Kleeff J, 1999, ONCOGENE, V18, P5363, DOI 10.1038/sj.onc.1202909; Kleeff J, 1999, BIOCHEM BIOPH RES CO, V255, P268, DOI 10.1006/bbrc.1999.0171; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; Kodach LL, 2008, GASTROENTEROLOGY, V134, P1332, DOI 10.1053/j.gastro.2008.02.059; Langenfeld EM, 2006, ONCOGENE, V25, P685, DOI 10.1038/sj.onc.1209110; Levy L, 2002, CYTOKINE GROWTH F R, V17, P41; Pangas SA, 2008, MOL CELL BIOL, V28, P248, DOI 10.1128/MCB.01404-07; Patil S, 2000, J BIOL CHEM, V275, P38363, DOI 10.1074/jbc.M004861200; Rai D, 2008, CANCER GENET CYTOGEN, V181, P8, DOI 10.1016/j.cancergencyto.2007.10.008; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Ro TB, 2004, ONCOGENE, V23, P3024, DOI 10.1038/sj.onc.1207386; Roehle A, 2008, BRIT J HAEMATOL, V142, P732, DOI 10.1111/j.1365-2141.2008.07237.x; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; Seckinger A, 2009, ONCOGENE, V28, P3866, DOI 10.1038/onc.2009.257; Seoane J, 2006, CARCINOGENESIS, V27, P2148, DOI 10.1093/carcin/bgl068; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Thawani JP, 2010, NEUROSURGERY, V66, P233, DOI 10.1227/01.NEU.0000363722.42097.C2; Torlakovic E, 2005, J PATHOL, V206, P312, DOI 10.1002/path.1777; Tsalavos S, 2011, J IMMUNOL, V186, P6860, DOI 10.4049/jimmunol.1001833; VARAS A, 2009, INMUNOLOGIA, V28, P125; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06	55	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46117	10.1371/journal.pone.0046117	http://dx.doi.org/10.1371/journal.pone.0046117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049692	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388500019
J	Chang, KH; Chen, YC; Wu, YR; Lee, WF; Chen, CM				Chang, Kuo-Hsuan; Chen, Yi-Chun; Wu, Yih-Ru; Lee, Wan-Fen; Chen, Chiung-Mei			Downregulation of Genes Involved in Metabolism and Oxidative Stress in the Peripheral Leukocytes of Huntington's Disease Patients	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; UNCOUPLING PROTEIN-2; GLUCOSE-METABOLISM; BLOOD; EXPRESSION; ABNORMALITIES; DYSFUNCTION; ACTIVATION; BIOMARKER; DAMAGE	Background: Huntington's disease (HD) is caused by expanded CAG repeats encoding a polyglutamine tract in the huntingtin (HTT) protein. A number of differentially-expressed protein molecules have been identified in striatum of HD animal models. Here we examined if the expression changes could be visualized in the peripheral leukocytes of HD patients and pre-symptomatic HD (PreHD) carriers. Methods and findings: The expression levels of 17 candidate genes that differentially expressed in striatum between transgenic HD and wild-type mice in literature were measured in the peripheral leukocytes of 4 PreHD carriers, 16 HD patients and 20 healthy controls. Four genes majorly involved in metabolism and oxidative stress response, including AHCY1, ACO2, OXCT1 and CAP1, demonstrated consistent downregulation in peripheral leukocytes of both PreHD carriers and HD patients, while UCP2 was only down-regulated in HD patients. Conclusion: These results provide potential peripheral biomarkers to indicate disease onset in preclinical stage, and to monitor the efficacy of early treatment. Further studies of a large series of preHD carriers and symptomatic HD patients will be warranted to verify the findings and examine if these markers correlate with clinical features.	[Chang, Kuo-Hsuan; Chen, Yi-Chun; Wu, Yih-Ru; Lee, Wan-Fen; Chen, Chiung-Mei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Chen, CM (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Neurol, Taipei, Taiwan.	cmchen@adm.cgmh.org.tw	Chen, Chiung-Mei/AAL-6260-2020		Academia Sinica, Taiwan [AS-100-TP2-B02-4]; Chang Gung Memorial Hospital, Taipei, Taiwan [CMRPG3B1381]	Academia Sinica, Taiwan(Academia Sinica - Taiwan); Chang Gung Memorial Hospital, Taipei, Taiwan(Chang Gung Memorial Hospital)	This work was supported by Academia Sinica, Taiwan (AS-100-TP2-B02-4) and from Chang Gung Memorial Hospital, Taipei, Taiwan (CMRPG3B1381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AN, 2008, BRAIN, V131, P381, DOI 10.1093/brain/awm312; Antonini A, 1996, BRAIN, V119, P2085, DOI 10.1093/brain/119.6.2085; Baric I, 2004, P NATL ACAD SCI USA, V101, P4234, DOI 10.1073/pnas.0400658101; Bjorkqvist M, 2008, J EXP MED, V205, P1869, DOI 10.1084/jem.20080178; Bogdanov MB, 2001, J NEUROCHEM, V79, P1246, DOI 10.1046/j.1471-4159.2001.00689.x; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Cha JHJ, 2007, PROG NEUROBIOL, V83, P228, DOI 10.1016/j.pneurobio.2007.03.004; Chaturvedi RK, 2010, HUM MOL GENET, V19, P3190, DOI 10.1093/hmg/ddq229; Chen CM, 2007, BIOCHEM BIOPH RES CO, V359, P335, DOI 10.1016/j.bbrc.2007.05.093; Chiang MC, 2007, MOL CELL PROTEOMICS, V6, P781, DOI 10.1074/mcp.M600356-MCP200; Chiang MC, 2010, HUM MOL GENET, V19, P4043, DOI 10.1093/hmg/ddq322; Colin E, 2005, EUR J NEUROSCI, V21, P1478, DOI 10.1111/j.1460-9568.2005.03985.x; Dalrymple A, 2007, J PROTEOME RES, V6, P2833, DOI 10.1021/pr0700753; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Feng QP, 2009, J NEUROCHEM, V110, P1806, DOI 10.1111/j.1471-4159.2009.06276.x; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; GRAFTON ST, 1992, ARCH NEUROL-CHICAGO, V49, P1161, DOI 10.1001/archneur.1992.00530350075022; Guzman M, 2004, PROSTAG LEUKOTR ESS, V70, P287, DOI 10.1016/j.plefa.2003.05.001; Hu Y, 2011, P NATL ACAD SCI USA, V108, P17141, DOI 10.1073/pnas.1104409108; Hubberstey AV, 2002, FASEB J, V16, P487, DOI 10.1096/fj.01-0659rev; Kieburtz K, 1996, MOVEMENT DISORD, V11, P136, DOI 10.1002/mds.870110204; Kim J, 2010, BBA-MOL BASIS DIS, V1802, P673, DOI 10.1016/j.bbadis.2010.05.001; Klingenberg M, 2001, BBA-BIOENERGETICS, V1504, P128, DOI 10.1016/S0005-2728(00)00242-5; KUWERT T, 1993, J NEUROL, V241, P31, DOI 10.1007/BF00870669; La Spada AR, 2011, NEUROBIOLOGY HUNTING; Leoni V, 2008, BRAIN, V131, P2851, DOI 10.1093/brain/awn212; Lovrecic L, 2009, MOVEMENT DISORD, V24, P2277, DOI 10.1002/mds.22477; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maglione V, 2005, AM J MED GENET B, V139B, P101, DOI 10.1002/ajmg.b.30223; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Mehta SL, 2009, J CEREBR BLOOD F MET, V29, P1069, DOI 10.1038/jcbfm.2009.4; MILLER MW, 1994, EMBO J, V13, P1806, DOI 10.1002/j.1460-2075.1994.tb06449.x; MITCHELL GA, 1995, CLIN INVEST MED, V18, P193; Nagata E, 2004, NEUROREPORT, V15, P1325, DOI 10.1097/01.wnr.0000127073.66692.8f; Naia L, 2012, REV NEUROSCIENCE, V23, P13, DOI 10.1515/RNS.2011.060; Nicholls DG, 1999, J BIOENERG BIOMEMBR, V31, P399, DOI 10.1023/A:1005436121005; Runne H, 2007, P NATL ACAD SCI USA, V104, P14424, DOI 10.1073/pnas.0703652104; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014; Tabchy A, 2006, EUR J HUM GENET, V14, P649, DOI 10.1038/sj.ejhg.5201562; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Underwood BR, 2006, BRAIN, V129, P877, DOI 10.1093/brain/awl027; Wang CH, 2008, J CELL SCI, V121, P2913, DOI 10.1242/jcs.023911; Zuccato C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022966	49	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46492	10.1371/journal.pone.0046492	http://dx.doi.org/10.1371/journal.pone.0046492			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029535	gold, Green Submitted, Green Published			2022-12-27	WOS:000309517500105
J	Sadaf, S; Birman, S; Hasan, G				Sadaf, Sufia; Birman, Serge; Hasan, Gaiti			Synaptic Activity in Serotonergic Neurons Is Required for Air-Puff Stimulated Flight in Drosophila melanogaster	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; NEUROMODULATOR OCTOPAMINE; TARGETED EXPRESSION; LOCUST FLIGHT; BEHAVIOR; CALCIUM; MODULATION; GROWTH; METAMORPHOSIS; SPECIFICATION	Background: Flight is an integral component of many complex behavioral patterns in insects. The giant fiber circuit has been well studied in several insects including Drosophila. However, components of the insect flight circuit that respond to an air-puff stimulus and comprise the flight central pattern generator are poorly defined. Aminergic neurons have been implicated in locust, moth and Drosophila flight. Here we have investigated the requirement of neuronal activity in serotonergic neurons, during development and in adults, on air-puff induced flight in Drosophila. Methodology/Principal Findings: To target serotonergic neurons specifically, a Drosophila strain that contains regulatory regions from the TRH (Tryptophan Hydroxylase) gene linked to the yeast transcription factor GAL4 was used. By blocking synaptic transmission from serotonergic neurons with a tetanus toxin transgene or by hyperpolarisation with Kir2.1, close to 50% adults became flightless. Temporal expression of a temperature sensitive Dynamin mutant transgene (Shi(ts)) suggests that synaptic function in serotonergic neurons is required both during development and in adults. Depletion of IP3R in serotonergic neurons via RNAi did not affect flight. Interestingly, at all stages a partial requirement for synaptic activity in serotonergic neurons was observed. The status of serotonergic neurons was investigated in the central nervous system of larvae and adults expressing tetanus toxin. A small but significant reduction was observed in serotonergic cell number in adult second thoracic segments from flightless tetanus toxin expressing animals. Conclusions: These studies show that loss of synaptic activity in serotonergic neurons causes a flight deficit. The temporal focus of the flight deficit is during pupal development and in adults. The cause of the flight deficit is likely to be loss of neurons and reduced synaptic function. Based on the partial phenotypes, serotonergic neurons appear to be modulatory, rather than an intrinsic part of the flight circuit.	[Sadaf, Sufia; Hasan, Gaiti] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Birman, Serge] ParisTech, Ecole Super Phys & Chim Ind, Ctr Natl Rech Sci, Neurobiol Lab, Paris, France	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Hasan, G (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India.	gaiti@ncbs.res.in	Hasan, Gaiti/P-4107-2019; Hasan, Gaiti/I-5851-2015	Hasan, Gaiti/0000-0001-7194-383X; Hasan, Gaiti/0000-0001-7194-383X; Sadaf, Sufia/0000-0002-0404-7151	Council of Scientific and Industrial research; Department of Biotechnology; Department of Science and Technology; National Centre for Biological Sciences, Tata Institute of Fundamental Research	Council of Scientific and Industrial research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); National Centre for Biological Sciences, Tata Institute of Fundamental Research	This work was supported by research fellowships from the Council of Scientific and Industrial research (http://rdpp.csir.res.in/csir_acsir/Home.aspx) to Sufia Sadaf. The project was supported financially by grants from the Department of Biotechnology (http://dbtindia.nic.in/index.asp), the Department of Science and Technology (http://www.dst.gov.in/), and the National Centre for Biological Sciences, Tata Institute of Fundamental Research (http://www.ncbs.res.in) to GH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2010, J NEUROSCI, V30, P1301, DOI 10.1523/JNEUROSCI.3668-09.2010; Alekseyenko OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010806; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Banerjee S, 2004, J NEUROSCI, V24, P7869, DOI 10.1523/JNEUROSCI.0656-04.2004; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Buhl E, 2008, J EXP BIOL, V211, P2346, DOI 10.1242/jeb.017384; Card G, 2008, CURR BIOL, V18, P1300, DOI 10.1016/j.cub.2008.07.094; Consoulas C, 2005, J COMP NEUROL, V485, P321, DOI 10.1002/cne.20499; Consoulas C, 2002, J NEUROSCI, V22, P4906, DOI 10.1523/JNEUROSCI.22-12-04906.2002; Demarque M, 2010, NEURON, V67, P321, DOI 10.1016/j.neuron.2010.06.006; Dickinson MH, 1997, COMP BIOCHEM PHYS A, V116, P223, DOI 10.1016/S0300-9629(96)00162-4; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Edwards JS, 2006, J EXP BIOL, V209, P4411, DOI 10.1242/jeb.02592; Engel JE, 1996, J NEUROSCI, V16, P3486; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Fenelon VS, 1998, CURR OPIN NEUROBIOL, V8, P705, DOI 10.1016/S0959-4388(98)80111-6; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; Hasan G, 2010, FRONT NEURAL CIRCUIT, V4, DOI 10.3389/fncir.2010.00010; KAMMER AE, 1976, J EXP BIOL, V65, P65; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; PARKER D, 1995, J NEUROPHYSIOL, V73, P923, DOI 10.1152/jn.1995.73.3.923; RAMIREZ JM, 1991, J NEUROPHYSIOL, V66, P1522, DOI 10.1152/jn.1991.66.5.1522; SOMBATI S, 1984, J NEUROBIOL, V15, P481, DOI 10.1002/neu.480150607; SOMBATI S, 1984, J NEUROBIOL, V15, P455, DOI 10.1002/neu.480150606; Spitzer NC, 2002, J PHYSIOLOGY-PARIS, V96, P73, DOI 10.1016/S0928-4257(01)00082-1; Spitzer NC, 2012, NAT REV NEUROSCI, V13, P94, DOI 10.1038/nrn3154; Stevenson PA, 1997, J EXP BIOL, V200, P633; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Sykes PA, 2004, CELL TISSUE RES, V317, P327, DOI 10.1007/s00441-004-0940-4; TANOUYE MA, 1983, J EXP BIOL, V105, P241; VALLES AM, 1988, J COMP NEUROL, V268, P414, DOI 10.1002/cne.902680310; Velazquez-Ulloa NA, 2011, J NEUROSCI, V31, P78, DOI 10.1523/JNEUROSCI.3542-10.2011; Venkiteswaran G, 2009, P NATL ACAD SCI USA, V106, P10326, DOI 10.1073/pnas.0902982106; Vierk R, 2010, J COMP PHYSIOL A, V196, P37, DOI 10.1007/s00359-009-0490-z; White BH, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.020.2009	38	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46405	10.1371/journal.pone.0046405	http://dx.doi.org/10.1371/journal.pone.0046405			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029511	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517500100
J	Garrido, I; Garcia-Sanchez, M; Casimiro, I; Casero, PJ; Garcia-Romera, I; Ocampo, JA; Espinosa, F				Garrido, Inmaculada; Garcia-Sanchez, Mercedes; Casimiro, Ilda; Joaquin Casero, Pedro; Garcia-Romera, Inmaculada; Antonio Ocampo, Juan; Espinosa, Francisco			Oxidative Stress Induced in Sunflower Seedling Roots by Aqueous Dry Olive-Mill Residues	PLOS ONE			English	Article							PROTEIN OXIDATION; PROLINE ACCUMULATION; SUPEROXIDE DISMUTASE; ANTIOXIDANT CAPACITY; LIPID-PEROXIDATION; GROWTH-INHIBITION; WASTE-WATER; OXYGEN; CUCUMBER; PLANTS	The contamination of soils with dry olive-mill residue can represent a serious problem as being an environmental stressor in plants. It has been demonstrated that inoculation of aqueous extract of olive oil-mill residue (ADOR) with saprobe fungi removes some phenolic compounds. In this paper we studied the effect of ADOR uninoculated or inoculated with saprobe fungi in sunflower seedling roots. The germination and root growth, O2 center dot(-) generation, superoxide dismutase (SOD) and extracellular peroxidases (EC-POXs) activities, and the content of some metabolites involved in the tolerance of stress were tested. The roots germinated in ADOR uninoculated show a decrease in meristem size, resulting in a reduction of the root length and fresh weight, and in the number of layers forming the cortex, but did not alter the dry weight, protein and soluble amino acid content. ADOR caused the decreases in O2 center dot(-) generation and EC-POX's activities and protein oxidation, but enhanced SOD activity, lipid peroxidation and proline content. Fluorescence imaging showed that ADOR induced O2 center dot(-) and H2O2 accumulation in the roots. The increase in SOD and the decrease in EC-POX's activities might be involved in the enhancement of H2O2 content and lipid peroxidation. Control roots treated with ADOR for 10 min show an oxidative burst. Roots germinated in ADOR inoculated with saprobe fungi partially recovered normal levels of ROS, morphological characteristics and antioxidant activities. These results suggested that treatment with ADOR caused a phytotoxic effect during germination inducing an oxidative stress. The inoculation of ADOR with saprobe fungi limited the stress.	[Garrido, Inmaculada; Espinosa, Francisco] Univ Extremadura, Dept Biol Vegetal Ecol & Ciencias Tierra, Badajoz, Spain; [Garcia-Sanchez, Mercedes; Garcia-Romera, Inmaculada; Antonio Ocampo, Juan] CSIC, Dept Microorganismos Rizosfer Promotores Crecimie, Estac Expt Zaidin, Granada, Spain; [Casimiro, Ilda; Joaquin Casero, Pedro] Univ Extremadura, Dept Anat Biol Celular & Zool, Badajoz, Spain	Universidad de Extremadura; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Universidad de Extremadura	Garrido, I (corresponding author), Univ Extremadura, Dept Biol Vegetal Ecol & Ciencias Tierra, Badajoz, Spain.	igarridoc@unex.es	García Sánchez, Mercedes/AAA-2411-2022; Romera, Inmaculada García/L-1204-2014; Espinosa, Francisco/I-8205-2018; Casimiro, Ilda/R-3506-2019; Mercedes, Garcia Sanchez/AAA-9813-2021; Ocampo, Juan Antonio/K-7565-2014	García Sánchez, Mercedes/0000-0001-5967-4091; Romera, Inmaculada García/0000-0001-6351-1885; Espinosa, Francisco/0000-0002-6467-0359; GARRIDO CARBALLO, INMACULADA/0000-0002-2367-0985	regional government of Extremadura [GR10084]	regional government of Extremadura	This research was supported by the regional government of Extremadura (GR10084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda E, 2006, INT BIODETER BIODEGR, V58, P176, DOI 10.1016/j.ibiod.2006.06.006; Aranda E, 2007, CHEMOSPHERE, V66, P67, DOI 10.1016/j.chemosphere.2006.05.021; Aranda E, 2004, APPL MICROBIOL BIOT, V64, P132, DOI 10.1007/s00253-003-1368-6; Arbona V, 2008, PHYSIOL PLANTARUM, V132, P452, DOI 10.1111/j.1399-3054.2007.01029.x; AUH CK, 1995, PLANT PHYSIOL, V107, P1241, DOI 10.1104/pp.107.4.1241; Baluska F, 2010, TRENDS PLANT SCI, V15, P402, DOI 10.1016/j.tplants.2010.04.007; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Beemster GTS, 1998, PLANT PHYSIOL, V116, P1515, DOI 10.1104/pp.116.4.1515; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Blum U, 2005, J CHEM ECOL, V31, P1907, DOI 10.1007/s10886-005-5934-5; Bolwell GP, 2002, J EXP BOT, V53, P1367, DOI 10.1093/jexbot/53.372.1367; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buer CS, 2006, PLANT PHYSIOL, V140, P1384, DOI 10.1104/pp.105.075671; Burgos NR, 2004, J CHEM ECOL, V30, P671, DOI 10.1023/B:JOEC.0000018637.94002.ba; Christensen JH, 1998, PLANT PHYSIOL, V118, P125, DOI 10.1104/pp.118.1.125; D'Annibale A, 2004, CHEMOSPHERE, V54, P887, DOI 10.1016/j.chemosphere.2003.10.010; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Denisov E.T., 2005, OXIDATION ANTIOXIDAN, DOI 10.1021/ja059854f; Diaz R, 2010, APPL MICROBIOL BIOT, V88, P133, DOI 10.1007/s00253-010-2723-z; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Doblinski PMF, 2003, BRAZ ARCH BIOL TECHN, V46, P193, DOI 10.1590/S1516-89132003000200009; Fabro G, 2004, MOL PLANT MICROBE IN, V17, P343, DOI 10.1094/MPMI.2004.17.4.343; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Galvez M, 2005, J AGR FOOD CHEM, V53, P1927, DOI 10.1021/jf048076s; Garrido I, 1998, PROTOPLASMA, V205, P141, DOI 10.1007/BF01279304; Hajdari A, 2010, ACTA HORTIC, V860, P75; Haudecoeur E, 2009, P NATL ACAD SCI USA, V106, P14587, DOI 10.1073/pnas.0808005106; Hernandez JA, 2002, PHYSIOL PLANTARUM, V115, P251, DOI 10.1034/j.1399-3054.2002.1150211.x; Hernandez-Mata G, 2010, J PLANT GROWTH REGUL, V29, P441, DOI 10.1007/s00344-010-9156-x; Hossain Z, 2006, FUNCT PLANT BIOL, V33, P91, DOI 10.1071/FP05149; Hossain Z, 2009, J PLANT PHYSIOL, V166, P1391, DOI 10.1016/j.jplph.2009.02.012; Hsu CL, 2003, FOOD CHEM, V83, P85, DOI 10.1016/S0308-8146(03)00053-0; IRIGOYEN JJ, 1992, PHYSIOL PLANTARUM, V84, P55, DOI 10.1111/j.1399-3054.1992.tb08764.x; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Johansson E, 2004, J BIOL CHEM, V279, P22204, DOI 10.1074/jbc.M402652200; Kim DO, 2003, FOOD CHEM, V81, P321, DOI 10.1016/S0308-8146(02)00423-5; Korkina LG, 2007, CELL MOL BIOL, V53, P15, DOI 10.1170/T772; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Zanardo DIL, 2009, ENVIRON EXP BOT, V66, P25, DOI 10.1016/j.envexpbot.2008.12.014; Ma BH, 2007, PLANT GROWTH REGUL, V52, P91, DOI 10.1007/s10725-007-9183-1; Martin J, 2002, SOIL BIOL BIOCHEM, V34, P1769, DOI 10.1016/S0038-0717(02)00164-5; Mata Georgina Hernández, 2006, Braz. J. Plant Physiol., V18, P351, DOI 10.1590/S1677-04202006000200012; Matthaus B, 2002, J AGR FOOD CHEM, V50, P3444, DOI 10.1021/jf011440s; Matysik J, 2002, CURR SCI INDIA, V82, P525; Mehta SK, 1999, NEW PHYTOL, V143, P253, DOI 10.1046/j.1469-8137.1999.00447.x; Mika Angela, 2004, Phytochemistry Reviews, V3, P173, DOI 10.1023/B:PHYT.0000047806.21626.49; MISRA HP, 1972, J BIOL CHEM, V247, P188; Mithofer A, 2004, FEBS LETT, V566, P1, DOI 10.1016/j.febslet.2004.04.011; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; NGO TT, 1980, ANAL BIOCHEM, V105, P389, DOI 10.1016/0003-2697(80)90475-3; Paredes C, 2001, BIODEGRADATION, V12, P225, DOI 10.1023/A:1017374421565; Politycka B, 1996, ACTA PHYSIOL PLANT, V18, P365; Rao KVM, 2000, PLANT SCI, V157, P113, DOI 10.1016/S0168-9452(00)00273-9; Rios JJ, 2008, SCI HORTIC-AMSTERDAM, V116, P248, DOI 10.1016/j.scienta.2008.01.008; Rodriguez-Serrano M, 2006, PLANT CELL ENVIRON, V29, P1532, DOI 10.1111/j.1365-3040.2006.01531.x; Ruiz JM, 2003, INT J PHYTOREMEDIAT, V5, P203, DOI 10.1080/713779220; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Sampedro I, 2004, APPL SOIL ECOL, V26, P149, DOI 10.1016/j.apsoil.2003.10.011; Schinkel H, 1998, J EXP BOT, V49, P931, DOI 10.1093/jexbot/49.323.931; Sgherri C, 2007, J PLANT PHYSIOL, V164, P1152, DOI 10.1016/j.jplph.2006.05.020; Sgobba A, 2011, 10 INT C REACT OX NI, P134; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Tripathi BN, 2004, PLANTA, V219, P397, DOI 10.1007/s00425-004-1237-2; Ubeda-Tomas S, 2009, CURR BIOL, V19, P1194, DOI 10.1016/j.cub.2009.06.023; Wang FJ, 2009, ARCH ENVIRON CON TOX, V56, P723, DOI 10.1007/s00244-008-9226-2; Yang SL, 2009, J PLANT PHYSIOL, V166, P1694, DOI 10.1016/j.jplph.2009.04.006; Yoshiba Y, 1997, PLANT CELL PHYSIOL, V38, P1095, DOI 10.1093/oxfordjournals.pcp.a029093; Yu JQ, 2003, BIOCHEM SYST ECOL, V31, P129, DOI 10.1016/S0305-1978(02)00150-3; Zeng Bin, 2008, Acta Agronomica Sinica, V34, P823, DOI 10.3724/SP.J.1006.2008.00823	75	14	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46137	10.1371/journal.pone.0046137	http://dx.doi.org/10.1371/journal.pone.0046137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049960	Green Submitted, gold, Green Published			2022-12-27	WOS:000309517300089
J	Hussain, RS; McGarvey, ST; Shahab, T; Fruzzetti, LM				Hussain, Rashid S.; McGarvey, Stephen T.; Shahab, Tabassam; Fruzzetti, Lina M.			Fatigue and Fear with Shifting Polio Eradication Strategies in India: A Study of Social Resistance to Vaccination	PLOS ONE			English	Article							HIGH-RISK DISTRICTS; PARALYTIC POLIO; ENDGAME	Shifting polio eradication strategies may have generated fear and "resistance" to the eradication program in Aligarh, India during the summer of 2009. Participant observation and formal interviews with 107 people from May to August 2009 indicated that the intensified frequency of vaccination was correlated with patients' doubt in the efficacy of the vaccine. This doubt was exacerbated in a few cases as families were uninformed of the use of monovalent mOPV1, while P3 cases continued to occur. Many families had also come to believe that their children had been adversely affected by OPV after being told the vaccine carried no risk. Though polio is now largely eradicated in India, with only a single case in 2011, greater transparency about changes with vaccination policy may need to be considered to build trust with the public in future eradication programs.	[Hussain, Rashid S.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [McGarvey, Stephen T.] Brown Univ, Dept Epidemiol, Int Hlth Inst, Providence, RI 02912 USA; [Shahab, Tabassam] Jawaharlal Nehru Med Coll, Dept Paediat, Aligarh, Uttar Pradesh, India; [Fruzzetti, Lina M.] Brown Univ, Dept Anthropol, Providence, RI 02912 USA	Brown University; Brown University; Aligarh Muslim University; Brown University	Hussain, RS (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.	Rashid_Hussain@brown.edu	McGarvey, Stephen T/I-1788-2014	McGarvey, Stephen T/0000-0003-1233-6970	Watson Institute for International Studies' Brown International Scholars Program	Watson Institute for International Studies' Brown International Scholars Program	This project was made possible by funding from the Watson Institute for International Studies' Brown International Scholars Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aligarh Muslim University, 2004, POL ER PROGR COLL EF; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P357; [Anonymous], 1996, MMWR, V6, P1; [Anonymous], 2003, TIMES INDIA; Ansari MA, 2007, J R SOC PROMO HEALTH, V127, P276, DOI 10.1177/1466424007083705; Bodenheimer T, 2008, UNDERSTANDING HLTH P; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; C Chaturvedi G., 2008, VITAL DROP COMMUNICA; Chaturvedi G, 2006, BUILDING COMMUNICATI; Chaturvedi S, 2009, INDIAN PEDIATR, V46, P963; Das J, 2003, SOC SCI MED, V57, P97, DOI 10.1016/S0277-9536(02)00302-7; Dasgupta R, 2008, INDIAN PEDIATR, V45, P357; Friedman AL, 2007, HEALTH EDUC BEHAV, V34, P471, DOI 10.1177/1090198106292022; Global Polio Eradication Initiative, 2010, GPEI PROGR WORK 2010; Grassly NC, 2007, LANCET, V369, P1356, DOI 10.1016/S0140-6736(07)60531-5; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Harris KJ, 1997, HUM ORGAN, V56, P375, DOI 10.17730/humo.56.3.w525025611458003; John TJ, 2000, NEW ENGL J MED, V343, P806, DOI 10.1056/NEJM200009143431111; John TJ, 2002, B WORLD HEALTH ORGAN, V80, P917; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Kishore J, 2003, NATL MED J INDIA, V16, P131; Kohler KA, 2002, B WORLD HEALTH ORGAN, V80, P987; Mittal SK, 2007, INDIAN J PEDIATR, V74, P153, DOI 10.1007/s12098-007-0009-y; Mukherji S, 2005, Med J Armed Forces India, V61, P364, DOI 10.1016/S0377-1237(05)80069-3; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Obregon R, 2010, J HEALTH COMMUN, V15, P25, DOI 10.1080/10810731003695367; Paul Y, 2005, BIOETHICS, V19, P393, DOI 10.1111/j.1467-8519.2005.00451.x; Paul Yash, 2005, Indian J Med Ethics, V2, P115; Roberts L, 2007, SCIENCE, V316, P362, DOI 10.1126/science.316.5823.362; Sathyamala C, 2005, INT J HEALTH SERV, V35, P361, DOI 10.2190/K882-9792-3QYX-JKTD; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Streefland P, 1999, SOC SCI MED, V49, P1705, DOI 10.1016/S0277-9536(99)00239-7; Streefland PH, 2001, HEALTH POLICY, V55, P159, DOI 10.1016/S0168-8510(00)00132-9; Sutter RW, 2010, LANCET, V376, P1682, DOI 10.1016/S0140-6736(10)61230-5; Taylor S, 2010, J HEALTH COMMUN, V15, P48, DOI 10.1080/10810731003698585; Thacker Naveen, 2004, Indian Journal of Pediatrics, V71, P241, DOI 10.1007/BF02724277; The World Health Organization and the Government of India, 2011, NAT POL SURV PROJ	37	11	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46274	10.1371/journal.pone.0046274	http://dx.doi.org/10.1371/journal.pone.0046274			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23050003	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300102
J	Jenkins, R; Cooper, R				Jenkins, Rowena; Cooper, Rose			Improving Antibiotic Activity against Wound Pathogens with Manuka Honey In Vitro	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL ACTIVITY; BACTERIAL-RESISTANCE; COMBINATIONS; INFECTIONS; INHIBITION; DRUGS; ACID	Following the discovery of synergistic action between oxacillin and manuka honey against methicillin-resistant Staphylococcus aureus, this study was undertaken to search for further synergistic combinations of antibiotics and honey that might have potential in treating wounds. Fifteen antibiotics were tested with and without sublethal concentrations of manuka honey against each of MRSA and Pseudomonas aeruginosa using disc diffusion, broth dilution, E strip, chequerboard titration and growth curves. Five novel antibiotic and manuka honey combinations were found that improved antibacterial effectiveness in vitro and these offer a new avenue of future topical treatments for wound infections caused by these two important pathogens.	[Jenkins, Rowena; Cooper, Rose] Cardiff Metropolitan Univ, Cardiff Sch Hlth Sci, Ctr Biomed Sci, Cardiff, S Glam, Wales	Cardiff Metropolitan University; Cardiff University	Jenkins, R (corresponding author), Cardiff Metropolitan Univ, Cardiff Sch Hlth Sci, Ctr Biomed Sci, Cardiff, S Glam, Wales.	rojenkins@cardiffmet.ac.uk		Jenkins, Rowena/0000-0001-6664-6099	Waterloo Foundation [1117535]; Sir Halley Stewart trust [208491]	Waterloo Foundation; Sir Halley Stewart trust	Funding was provided by the Waterloo Foundation (Charity number 1117535) (http://www.waterloofoundation.org.uk/) and the Sir Halley Stewart trust (Charity number 208491) (http://www.sirhalleystewart.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jabri AA, 2005, SAUDI MED J, V26, P767; Andrews JM, 2009, J ANTIMICROB CHEMOTH, V64, P454, DOI 10.1093/jac/dkp244; Blair SE, 2009, EUR J CLIN MICROBIOL, V28, P1199, DOI 10.1007/s10096-009-0763-z; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Cooper RA, 2010, EUR J CLIN MICROBIOL, V29, P1237, DOI 10.1007/s10096-010-0992-1; Cooper RA, 2002, J APPL MICROBIOL, V93, P857, DOI 10.1046/j.1365-2672.2002.01761.x; Cooper RA, 2002, J BURN CARE REHABIL, V23, P366, DOI 10.1097/00004630-200211000-00002; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Gibbons S, 2008, PLANTA MED, V74, P594, DOI 10.1055/s-2008-1074518; Henriques AF, 2011, EUR J CLIN MICROBIOL, V30, P167, DOI 10.1007/s10096-010-1065-1; Henriques AF, 2010, EUR J CLIN MICROBIOL, V29, P45, DOI 10.1007/s10096-009-0817-2; Hiramatsu K, 2002, CURR OPIN INFECT DIS, V15, P407, DOI 10.1097/00001432-200208000-00009; HUGHES J, 1978, BIOCHEM J, V176, P305, DOI 10.1042/bj1760305; Jayaraman P, 2010, INT J BIOL SCI, V6, P556; Jenkins R, 2011, INT J ANTIMICROB AG, V37, P373, DOI 10.1016/j.ijantimicag.2010.11.036; Jenkins RE, 2012, J ANTIMICROB CHEMOTH, V67, P1405, DOI 10.1093/jac/dks071; Karayil S, 1998, J Postgrad Med, V44, P93; Kwakman PHS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017709; Lee JW, 2007, J MICROBIOL, V45, P350; Mendoza N, 2010, EXPERT OPIN EMERG DR, V15, P509, DOI 10.1517/14728214.2010.497486; Mukherjee S, 2011, INDIAN J EXP BIOL, V49, P547; Natarajan S, 2001, J DERMATOL TREAT, V12, P33, DOI 10.1080/095466301750163563; Page MGP, 2009, CURR OPIN PHARMACOL, V9, P558, DOI 10.1016/j.coph.2009.08.006; Rahal JJ, 2006, CLIN INFECT DIS, V43, pS95, DOI 10.1086/504486; SUZUKI T, 1963, J BIOCHEM-TOKYO, V54, P25, DOI 10.1093/oxfordjournals.jbchem.a127742; Tiwari RP, 2005, INDIAN J MED RES, V122, P80; Wagner H, 2011, FITOTERAPIA, V82, P34, DOI 10.1016/j.fitote.2010.11.016	30	55	56	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45600	10.1371/journal.pone.0045600	http://dx.doi.org/10.1371/journal.pone.0045600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049822	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300038
J	Yamaguchi, T; Sugawara, K; Tanaka, S; Yoshida, N; Saito, K; Tanabe, S; Muraoka, Y; Liu, MG				Yamaguchi, Tomofumi; Sugawara, Kenichi; Tanaka, Satoshi; Yoshida, Naoshin; Saito, Kei; Tanabe, Shigeo; Muraoka, Yoshihiro; Liu, Meigen			Real-Time Changes in Corticospinal Excitability during Voluntary Contraction with Concurrent Electrical Stimulation	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MOTOR-EVOKED POTENTIALS; CORTICOMOTOR EXCITABILITY; RANDOMIZED CROSSOVER; NERVE-STIMULATION; UPPER EXTREMITY; STROKE PATIENTS; UPPER-LIMB; MOVEMENT; CORTEX	While previous studies have assessed changes in corticospinal excitability following voluntary contraction coupled with electrical stimulation (ES), we sought to examine, for the first time in the field, real-time changes in corticospinal excitability. We monitored motor evoked potentials (MEPs) elicited by transcranial magnetic stimulation and recorded the MEPs using a mechanomyogram, which is less susceptible to electrical artifacts. We assessed the MEPs at each level of muscle contraction of wrist flexion (0%, 5%, or 20% of maximum voluntary contraction) during voluntary wrist flexion (flexor carpi radialis (FCR) voluntary contraction), either with or without simultaneous low-frequency (10 Hz) ES of the median nerve that innervates the FCR. The stimulus intensity corresponded to 1.2xperception threshold. In the FCR, voluntary contraction with median nerve stimulation significantly increased corticospinal excitability compared with FCR voluntary contraction without median nerve stimulation (p<0.01). In addition, corticospinal excitability was significantly modulated by the level of FCR voluntary contraction. In contrast, in the extensor carpi radialis (ECR), FCR voluntary contraction with median nerve stimulation significantly decreased corticospinal excitability compared with FCR voluntary contraction without median nerve stimulation (p<0.05). Thus, median nerve stimulation during FCR voluntary contraction induces reciprocal changes in cortical excitability in agonist and antagonist muscles. Finally we also showed that even mental imagery of FCR voluntary contraction with median nerve stimulation induced the same reciprocal changes in cortical excitability in agonist and antagonist muscles. Our results support the use of voluntary contraction coupled with ES in neurorehabilitation therapy for patients.	[Yamaguchi, Tomofumi; Liu, Meigen] Keio Univ, Sch Med, Dept Rehabil Med, Tokyo, Japan; [Yamaguchi, Tomofumi] Japan Soc Promot Sci, Tokyo, Japan; [Sugawara, Kenichi] Kanagawa Univ, Human Serv, Div Phys Therapy, Fac Hlth & Social Work, Kanagawa, Japan; [Tanaka, Satoshi] Nagoya Inst Technol, Ctr Fostering Young & Innovat Res, Aichi, Japan; [Yoshida, Naoshin] Yokosuka Kyosai Hosp, Kanagawa, Japan; [Saito, Kei] Tokyo Bay Rehabil Hosp, Chiba, Japan; [Tanabe, Shigeo] Fujita Hlth Univ, Fac Rehabil, Sch Hlth Sci, Aichi, Japan; [Muraoka, Yoshihiro] Waseda Univ, Fac Human Sci, Saitama, Japan	Keio University; Japan Society for the Promotion of Science; Kanagawa University; Nagoya Institute of Technology; Fujita Health University; Waseda University	Yamaguchi, T (corresponding author), Keio Univ, Sch Med, Dept Rehabil Med, Tokyo, Japan.	yama_to_izu_tukigase@hotmail.com	Liu, Meigen/J-6883-2013	Yamaguchi, Tomofumi/0000-0003-2206-8586	Japan Society for the Promotion of Science [22-1697]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was partially supported by the Japan Society for the Promotion of Science (Grant-in-Aid for JSPS fellows, 22-1697). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsi GI, 2008, EXP BRAIN RES, V191, P57, DOI 10.1007/s00221-008-1495-5; Bertolasi L, 1998, J PHYSIOL-LONDON, V511, P947, DOI 10.1111/j.1469-7793.1998.947bg.x; Bhatt E, 2007, EXP BRAIN RES, V182, P435, DOI 10.1007/s00221-007-1001-5; Blickenstorfer A, 2009, HUM BRAIN MAPP, V30, P963, DOI 10.1002/hbm.20559; Bolton DAE, 2004, J NEUROL SCI, V223, P121, DOI 10.1016/j.jns.2004.05.005; Butefisch CM, 2000, P NATL ACAD SCI USA, V97, P3661, DOI 10.1073/pnas.050350297; CAVALLARI P, 1984, EXP BRAIN RES, V56, P574; Chipchase LS, 2011, CLIN NEUROPHYSIOL, V122, P456, DOI 10.1016/j.clinph.2010.07.025; de Kroon JR, 2005, J REHABIL MED, V37, P65, DOI 10.1080/16501970410024190; Fujiwara T, 2003, AM J PHYS MED REHAB, V82, P357, DOI 10.1097/01.PHM.0000064722.01940.E4; Fujiwara T, 2009, NEUROREHAB NEURAL RE, V23, P125, DOI 10.1177/1545968308321777; Hallett M, 1998, ARCH NEUROL-CHICAGO, V55, P601, DOI 10.1001/archneur.55.5.601; Hamdy S, 1998, NAT NEUROSCI, V1, P64, DOI 10.1038/264; Hebb Donald O., 1949, ORG BEHAV; Hsieh TH, 2012, J NEUROPHYSIOL, V107, P966, DOI 10.1152/jn.00690.2011; Iftime-Nielsen SD, 2012, HUM BRAIN MAPP, V33, P40, DOI 10.1002/hbm.21191; Kaelin-Lang A, 2005, J NEUROPHYSIOL, V93, P1099, DOI 10.1152/jn.00143.2004; Khaslavskaia S, 2005, EXP BRAIN RES, V162, P497, DOI 10.1007/s00221-004-2153-1; Knash ME, 2003, EXP BRAIN RES, V153, P366, DOI 10.1007/s00221-003-1628-9; Lewis GN, 2002, BRAIN RES, V943, P263, DOI 10.1016/S0006-8993(02)02699-9; Lewis GN, 2001, BRAIN RES, V900, P282, DOI 10.1016/S0006-8993(01)02369-1; Lotze M, 2003, BRAIN, V126, P866, DOI 10.1093/brain/awg079; Mayr A, 2007, NEUROREHAB NEURAL RE, V21, P307, DOI 10.1177/1545968307300697; McDonnell MN, 2007, NEUROREHAB NEURAL RE, V21, P435, DOI 10.1177/1545968307300437; Mink J W, 1993, Curr Opin Neurobiol, V3, P950, DOI 10.1016/0959-4388(93)90167-W; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Ni Z, 2006, EUR J NEUROSCI, V23, P3399, DOI 10.1111/j.1460-9568.2006.04852.x; Reza MF, 2005, J NEUROSCI METH, V149, P164, DOI 10.1016/j.jneumeth.2005.05.013; Ridding MC, 2000, EXP BRAIN RES, V131, P135, DOI 10.1007/s002219900269; Rosenkranz K, 2000, CLIN NEUROPHYSIOL, V111, P2040, DOI 10.1016/S1388-2457(00)00460-0; Tarkka IM, 2011, TOHOKU J EXP MED, V225, P71, DOI 10.1620/tjem.225.71; Thompson AK, 2004, EXP BRAIN RES, V159, P491, DOI 10.1007/s00221-004-1972-4; Werner C, 2002, STROKE, V33, P2895, DOI 10.1161/01.STR.0000035734.61539.f6; Wu CWH, 2005, NEUROIMAGE, V27, P872, DOI 10.1016/j.neuroimage.2005.05.055; Yamaguchi Tomofumi, 2011, Keio Journal of Medicine, V60, P90; Zehr EP, 1997, J NEUROPHYSIOL, V77, P3311, DOI 10.1152/jn.1997.77.6.3311	36	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46122	10.1371/journal.pone.0046122	http://dx.doi.org/10.1371/journal.pone.0046122			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049955	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300087
J	Akdogan, Y; Reichenwallner, J; Hinderberger, D				Akdogan, Yasar; Reichenwallner, Joerg; Hinderberger, Dariush			Evidence for Water-Tuned Structural Differences in Proteins: An Approach Emphasizing Variations in Local Hydrophilicity	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; FATTY-ACIDS; CONFORMATIONAL-CHANGES; MEMBRANE-PROTEINS; LIGAND-BINDING; HYDROPHOBICITY; SEQUENCE; CRYSTAL; NMR; CALMODULIN	We present experimental evidence for the significant effect that water can have on the functional structure of proteins in solution. Human (HSA) and Bovine Serum Albumin (BSA) have an amino acid sequence identity of 75.52% and are chosen as model proteins. We employ EPR-based nanoscale distance measurements using double electron-electron resonance (DEER) spectroscopy and both albumins loaded with long chain fatty acids (FAs) in solution to globally (yet indirectly) characterize the tertiary protein structures from the bound ligands' points of view. The complete primary structures and crystal structures of HSA and as of recently also BSA are available. We complement the picture as we have recently determined the DEER-derived solution structure of HSA and here present the corresponding BSA solution structure. The characteristic asymmetric FA distribution in the crystal structure of HSA can surprisingly be observed by DEER in BSA in solution. This indicates that the BSA conformational ensemble in solution seems to be narrow and close to the crystal structure of HSA. In contrast, for HSA in solution a much more symmetric FA distribution was found. Thus, conformational adaptability and flexibility dominate in the HSA solution structure while BSA seems to lack these properties. We further show that differences in amino acid hydropathies of specific structural regions in both proteins can be used to correlate the observed difference in the global (tertiary) solution structures with the differences on the primary structure level.	[Akdogan, Yasar; Reichenwallner, Joerg; Hinderberger, Dariush] Max Planck Inst Polymer Res, Mainz, Germany; [Reichenwallner, Joerg] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, Mainz, Germany	Max Planck Society; Johannes Gutenberg University of Mainz	Hinderberger, D (corresponding author), Max Planck Inst Polymer Res, Mainz, Germany.	dariush.hinderberger@mpip-mainz.mpg.de	Hinderberger, Dariush/B-7865-2008	Reichenwallner, Jorg/0000-0002-6862-1802; Akdogan, Yasar/0000-0002-2465-8873	Max Planck Society; Max Planck Graduate Center; University of Mainz (MPGC)	Max Planck Society(Max Planck Society); Max Planck Graduate Center(Max Planck Society); University of Mainz (MPGC)	This work was funded by the Max Planck Society (www.mpg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Christian Bauer for technical support, Prof. Hans W. Spiess for continuing support, and Prof. Wolfgang E. Trommer for helpful discussions and comments. D.H. acknowledges support by the Max Planck Graduate Center with the University of Mainz (MPGC).	Akdogan Y, 2011, J PHYS CHEM B, V115, P15422, DOI 10.1021/jp209646f; Akdogan Y, 2011, BIOMACROMOLECULES, V12, P1072, DOI 10.1021/bm1014156; ATKINS P, 2001, PHYS CHEM; Ben-Naim A, 2008, PHYS CHEM CHEM PHYS, V10, P2451, DOI 10.1039/b716116f; Ben-Naim A, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2205860; Ben-Naim A, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2976442; BENNAIM A, 1994, CURR OPIN STRUC BIOL, V4, P264, DOI 10.1016/S0959-440X(94)90318-2; Berg J.M., 2011, BIOCHEMIE; Bhattacharya AA, 2000, J MOL BIOL, V303, P721, DOI 10.1006/jmbi.2000.4158; Billeter M, 1997, P NATL ACAD SCI USA, V94, P7281, DOI 10.1073/pnas.94.14.7281; Bird GH, 2008, ACS NANO, V2, P1857, DOI 10.1021/nn800327g; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; CARTER DC, 1990, SCIENCE, V249, P302, DOI 10.1126/science.2374930; Chen H, 2000, J BIOL CHEM, V275, P26538, DOI 10.1074/jbc.M909780199; COOPER A, 1976, P NATL ACAD SCI USA, V73, P2740, DOI 10.1073/pnas.73.8.2740; Cooper A, 2005, BIOPHYS CHEM, V115, P89, DOI 10.1016/j.bpc.2004.12.011; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Efremov RG, 2007, CURR MED CHEM, V14, P393, DOI 10.2174/092986707779941050; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Ferrer ML, 2001, BIOPHYS J, V80, P2422, DOI 10.1016/S0006-3495(01)76211-X; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Hanelt I, 2010, J BIOL CHEM, V285, P28210, DOI 10.1074/jbc.M110.139311; HEIDORN DB, 1988, BIOCHEMISTRY-US, V27, P909, DOI 10.1021/bi00403a011; Heller J, 2010, J PHYS CHEM B, V114, P7429, DOI 10.1021/jp910335t; Huang DM, 2000, P NATL ACAD SCI USA, V97, P8324, DOI 10.1073/pnas.120176397; HUBBELL WL, 1994, CURR OPIN STRUC BIOL, V4, P566, DOI 10.1016/S0959-440X(94)90219-4; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Inouye H, 2000, J MOL BIOL, V300, P1283, DOI 10.1006/jmbi.2000.3926; Jeschke G, 2006, APPL MAGN RESON, V30, P473, DOI 10.1007/BF03166213; Jeschke G, 2009, PHYS CHEM CHEM PHYS, V11, P6580, DOI 10.1039/b905724b; Junk MJN, 2011, BIOPHYS J, V100, P2293, DOI 10.1016/j.bpj.2011.03.050; Junk MJN, 2011, J MAGN RESON, V210, P210, DOI 10.1016/j.jmr.2011.03.003; Junk MJN, 2010, ANGEW CHEM INT EDIT, V49, P8755, DOI 10.1002/anie.201003495; KABSCH W, 1984, P NATL ACAD SCI-BIOL, V81, P1075, DOI 10.1073/pnas.81.4.1075; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kim M, 2008, BIOCHEMISTRY-US, V47, P670, DOI 10.1021/bi7016415; KIRKWOOD JG, 1954, J POLYM SCI, V12, P1, DOI 10.1002/pol.1954.120120102; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Majorek KA, 2012, MOL IMMUNOL, V52, P174, DOI 10.1016/j.molimm.2012.05.011; Marlow MS, 2010, NAT CHEM BIOL, V6, P352, DOI 10.1038/nchembio.347; Naderi-Manesh H, 2001, PROTEINS, V42, P452, DOI 10.1002/1097-0134(20010301)42:4<452::AID-PROT40>3.0.CO;2-Q; Nelson D, 2009, BIOCHEMIE; Nucci NV, 2011, NAT STRUCT MOL BIOL, V18, P245, DOI 10.1038/nsmb.1955; Patel AJ, 2012, J PHYS CHEM B, V116, P2498, DOI 10.1021/jp2107523; Peters Jr. T., 1995, ALL ALBUMIN BIOCH GE; Polyansky AA, 2012, J PHYS CHEM LETT, V3, P973, DOI 10.1021/jz300103p; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Simard JR, 2005, P NATL ACAD SCI USA, V102, P17958, DOI 10.1073/pnas.0506440102; Sugio S, 1999, PROTEIN ENG, V12, P439, DOI 10.1093/protein/12.6.439; TANFORD C, 1956, J PHYS CHEM-US, V60, P225, DOI 10.1021/j150536a020; Trivedi VD, 1997, BIOCHEM MOL BIOL INT, V43, P1; WATKINS S, 1993, P NATL ACAD SCI USA, V90, P2409, DOI 10.1073/pnas.90.6.2409	56	59	59	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45681	10.1371/journal.pone.0045681	http://dx.doi.org/10.1371/journal.pone.0045681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049837	Green Submitted, gold, Green Published			2022-12-27	WOS:000309556100067
J	Fox, KCR; Zakarauskas, P; Dixon, M; Ellamil, M; Thompson, E; Christoff, K				Fox, Kieran C. R.; Zakarauskas, Pierre; Dixon, Matt; Ellamil, Melissa; Thompson, Evan; Christoff, Kalina			Meditation Experience Predicts Introspective Accuracy	PLOS ONE			English	Article							EVOKED-POTENTIALS; CEREBRAL-CORTEX; BRAIN DYNAMICS; REPRESENTATION; PRACTITIONERS; ORGANIZATION; AWARENESS; ACUITY; MOTOR	The accuracy of subjective reports, especially those involving introspection of one's own internal processes, remains unclear, and research has demonstrated large individual differences in introspective accuracy. It has been hypothesized that introspective accuracy may be heightened in persons who engage in meditation practices, due to the highly introspective nature of such practices. We undertook a preliminary exploration of this hypothesis, examining introspective accuracy in a cross-section of meditation practitioners (1-15,000 hrs experience). Introspective accuracy was assessed by comparing subjective reports of tactile sensitivity for each of 20 body regions during a 'body-scanning' meditation with averaged, objective measures of tactile sensitivity (mean size of body representation area in primary somatosensory cortex; two-point discrimination threshold) as reported in prior research. Expert meditators showed significantly better introspective accuracy than novices; overall meditation experience also significantly predicted individual introspective accuracy. These results suggest that long-term meditators provide more accurate introspective reports than novices.	[Fox, Kieran C. R.; Dixon, Matt; Ellamil, Melissa; Christoff, Kalina] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada; [Zakarauskas, Pierre; Christoff, Kalina] Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Thompson, Evan] Univ Toronto, Dept Philosophy, Toronto, ON M5S 1A1, Canada	University of British Columbia; University of British Columbia; University of Toronto	Fox, KCR (corresponding author), Univ British Columbia, Dept Psychol, Vancouver, BC, Canada.	kfox@psych.ubc.ca		Thompson, Evan/0000-0003-0084-8477; Dixon, Matthew/0000-0001-8033-8113	Hampton Research Endowment Fund [F08-05696]; UBC	Hampton Research Endowment Fund; UBC	This research was supported in part by Hampton Research Endowment Fund grant F08-05696 to Kalina Christoff and a UBC First-Year Fellowship to Kieran Fox. No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analayo B., 2003, SATIPATTHANA DIRECT; CELESIA GG, 1979, ARCH NEUROL-CHICAGO, V36, P399, DOI 10.1001/archneur.1979.00500430029003; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Corallo G, 2008, PSYCHOL SCI, V19, P1110, DOI 10.1111/j.1467-9280.2008.02211.x; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Disbrow EA, 2000, P NATL ACAD SCI USA, V97, P9718, DOI 10.1073/pnas.170205497; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Farb NAS, 2007, SOC COGN AFFECT NEUR, V2, P313, DOI 10.1093/scan/nsm030; Fisher RA, 1914, BIOMETRIKA, V10, P507; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Fleming SM, 2010, SCIENCE, V329, P1541, DOI 10.1126/science.1191883; FREDRICK WC, 1980, J EDUC RES, V73, P183, DOI 10.1080/00220671.1980.10885233; Goenka S.N., 2000, DISCOURSE SUMMARIES; Grant JA, 2010, EMOTION, V10, P43, DOI 10.1037/a0018334; HAMMEKE TA, 1994, NEUROSURGERY, V35, P677, DOI 10.1227/00006123-199410000-00014; HARI R, 1993, EUR J NEUROSCI, V5, P724, DOI 10.1111/j.1460-9568.1993.tb00536.x; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Jack AI, 2002, TRENDS COGN SCI, V6, P333, DOI 10.1016/S1364-6613(02)01941-1; James W, 1890, PRINCIPLES PSYCHOL, V1; Jha AP, 2010, EMOTION, V10, P54, DOI 10.1037/a0018438; Kabat-Zinn J., 1994, MINDFULNESS MEDITATI; Kerr CE, 2008, EXP BRAIN RES, V188, P317, DOI 10.1007/s00221-008-1409-6; Khalsa SS, 2008, PSYCHOPHYSIOLOGY, V45, P671, DOI 10.1111/j.1469-8986.2008.00666.x; KNIBESTOL M, 1980, J PHYSIOL-LONDON, V300, P251, DOI 10.1113/jphysiol.1980.sp013160; Kozhevnikov M, 2009, PSYCHOL SCI, V20, P645, DOI 10.1111/j.1467-9280.2009.02345.x; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Lutz A, 2003, J CONSCIOUSNESS STUD, V10, P31; Lutz A, 2002, P NATL ACAD SCI USA, V99, P1586, DOI 10.1073/pnas.032658199; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; MacLean KA, 2010, PSYCHOL SCI, V21, P829, DOI 10.1177/0956797610371339; McCaig RG, 2011, NEUROIMAGE, V55, P1298, DOI 10.1016/j.neuroimage.2010.12.016; Michael GA, 2011, CONSCIOUS COGN, V20, P603, DOI 10.1016/j.concog.2010.11.013; Nielsen L, 2006, EMOTION, V6, P392, DOI 10.1037/1528-3542.6.3.392; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Pantev C, 2001, ANN NY ACAD SCI, V930, P300, DOI 10.1111/j.1749-6632.2001.tb05740.x; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Penfield W, 1950, CEREBRAL CORTEX MAN; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Slagter HA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00017; Song C, 2011, CONSCIOUS COGN, V20, P1787, DOI 10.1016/j.concog.2010.12.011; Stevens JC, 1996, SOMATOSENS MOT RES, V13, P153, DOI 10.3109/08990229609051403; Sze JA, 2010, EMOTION, V10, P803, DOI 10.1037/a0020146; Vestergaard-Poulsen P, 2009, NEUROREPORT, V20, P170, DOI 10.1097/WNR.0b013e328320012a; Weber EH., 1978, EH WEBER SENSE TOUCH; WEINSTEIN SIDNEY, 1968, P195; WOOLSEY CN, 1979, J NEUROSURG, V51, P476, DOI 10.3171/jns.1979.51.4.0476	47	103	103	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45370	10.1371/journal.pone.0045370	http://dx.doi.org/10.1371/journal.pone.0045370			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049790	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100041
J	Gienapp, P; Bregnballe, T				Gienapp, Phillip; Bregnballe, Thomas			Fitness Consequences of Timing of Migration and Breeding in Cormorants	PLOS ONE			English	Article							PHALACROCORAX-CARBO-SINENSIS; TIT PARUS-MAJOR; GREAT TIT; REPRODUCTIVE SUCCESS; CLIMATE-CHANGE; CLUTCH-SIZE; TROPHIC INTERACTIONS; CAUSAL RELATIONSHIP; NATURAL-SELECTION; SEASONAL DECLINE	In most bird species timing of breeding affects reproductive success whereby early breeding is favoured. In migratory species migration time, especially arrival at the breeding grounds, and breeding time are expected to be correlated. Consequently, migration time should also have fitness consequences. However, in contrast to breeding time, evidence for fitness consequences of migration time is much more limited. Climate change has been shown to negatively affect the synchrony between trophic levels thereby leading to directional selection on timing but again direct evidence in avian migration time is scarce. We here analysed fitness consequences of migration and breeding time in great cormorants and tested whether climate change has led to increased selection on timing using a long-term data set from a breeding colony on the island of Vorso (Denmark). Reproductive success, measured as number of fledglings, correlated with breeding time and arrival time at the colony and declined during the season. This seasonal decline became steeper during the study period for both migration and breeding time and was positively correlated to winter/spring climate, i.e. selection was stronger after warmer winters/springs. However, the increasing selection pressure on timing seems to be unrelated to climate change as the climatic variables that were related to selection strength did not increase during the study period. There is indirect evidence that phenology or abundances of preferred prey species have changed which could have altered selection on timing of migration and breeding.	[Gienapp, Phillip] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Bregnballe, Thomas] Aarhus Univ, Dept Biosci, Ronde, Denmark	University of Helsinki; Aarhus University	Gienapp, P (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands.	p.gienapp@nioo.knaw.nl	Bregnballe, Thomas/L-1890-2013; Gienapp, Phillip/A-2261-2014	Bregnballe, Thomas/0000-0003-2867-478X; Gienapp, Phillip/0000-0002-9368-8769	Ministry of Environment and Aarhus University; Academy of Finland	Ministry of Environment and Aarhus University; Academy of Finland(Academy of Finland)	The long-term study was financed by grants from the Ministry of Environment and Aarhus University. PG was supported by a grant from the Academy of Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; BERG R, 1985, J FISH BIOL, V26, P537, DOI 10.1111/j.1095-8649.1985.tb04294.x; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Bety J, 2004, BEHAV ECOL SOCIOBIOL, V57, P1, DOI 10.1007/s00265-004-0840-3; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Bregnballe T, 1997, BIRD STUDY, V44, P257, DOI 10.1080/00063659709461062; Bregnballe T, 1996, REPROD PERFORMANCE G; Bregnballe T, 2011, 7 INT C CORM, P8; Bregnballe Thomas, 1996, Dansk Ornitologisk Forenings Tidsskrift, V90, P15; Bregnballe T, 2006, ARDEA, V94, P619; BRINKHOF MWG, 1993, J ANIM ECOL, V62, P577, DOI 10.2307/5206; Brown CR, 1998, EVOLUTION, V52, P1461, DOI 10.1111/j.1558-5646.1998.tb02027.x; CAIRNS D K, 1987, Biological Oceanography, V5, P261; Caro SP, 2009, FUNCT ECOL, V23, P172, DOI 10.1111/j.1365-2435.2008.01486.x; Carscadden J, 1997, CAN J FISH AQUAT SCI, V54, P781, DOI 10.1139/cjfas-54-4-781; CRISTOL DA, 1995, BEHAV ECOL, V6, P87, DOI 10.1093/beheco/6.1.87; DIRKSEN S, 1995, ARDEA, V83, P167; Durant JM, 2003, P ROY SOC B-BIOL SCI, V270, P1461, DOI 10.1098/rspb.2003.2397; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Frederiksen M, 2002, WILDLIFE BIOL, V8, P241, DOI 10.2981/wlb.2002.021; Frederiksen M, 2001, P ROY SOC B-BIOL SCI, V268, P1519, DOI 10.1098/rspb.2001.1701; Frederiksen M, 2011, MAR ECOL PROG SER, V432, P137, DOI 10.3354/meps09177; Furness RW, 2000, MAR ECOL PROG SER, V202, P253, DOI 10.3354/meps202253; Gienapp P, 2006, EVOLUTION, V60, P2381; Harkonen T.J., 1986, GUIDE OTOLITHS BONY, P256; Hurrell JW, 2009, J MARINE SYST, V78, P28, DOI 10.1016/j.jmarsys.2008.11.026; Jansen T, 2011, CONT SHELF RES, V31, P64, DOI 10.1016/j.csr.2010.11.003; Jones T, 2010, J ANIM ECOL, V79, P98, DOI 10.1111/j.1365-2656.2009.01610.x; Kalmbach E, 2001, WATERBIRDS, V24, P345, DOI 10.2307/1522064; Kato A, 2001, ECOL RES, V16, P745, DOI 10.1046/j.1440-1703.2001.00441.x; KLOMP H, 1970, ARDEA, V58, P1; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; McCleery RH, 2004, AM NAT, V164, pE62, DOI 10.1086/422660; Moller AP, 2009, BEHAV ECOL, V20, P433, DOI 10.1093/beheco/arn142; Nehls George, 1997, Vogelwelt, V118, P33; Nur N, 1999, BIRD STUDY, V46, P92; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Philippart CJM, 2003, LIMNOL OCEANOGR, V48, P2171, DOI 10.4319/lo.2003.48.6.2171; Piatt JF, 2007, MAR ECOL PROG SER, V352, P221, DOI 10.3354/meps07078; Pinheiro J, 2001, MIXED EFFECTS MODELS; PLATTEEUW M, 1995, ARDEA, V83, P223; PLATTEEUW M, 1995, ARDEA, V83, P235; PRICE T, 1988, SCIENCE, V240, P798, DOI 10.1126/science.3363360; Prop J, 2003, OIKOS, V103, P403, DOI 10.1034/j.1600-0706.2003.12042.x; Pulido F, 2003, AVIAN MIGRATION, P53; Pulido F, 2007, CLIM RES, V35, P5, DOI 10.3354/cr00711; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.1111/j.1558-5646.1992.tb02070.x; ROWE L, 1994, AM NAT, V143, P698, DOI 10.1086/285627; Saino N, 2010, P ROYAL S B IN PRESS; Sergio F, 2007, BEHAV ECOL, V18, P811, DOI 10.1093/beheco/arm052; Sheldon BC, 2003, EVOLUTION, V57, P406; Sims DW, 2004, J ANIM ECOL, V73, P333, DOI 10.1111/j.0021-8790.2004.00810.x; Smith RJ, 2005, BEHAV ECOL SOCIOBIOL, V57, P231, DOI 10.1007/s00265-004-0855-9; Suter W, 1997, ARDEA, V85, P9; van Rijn S., 2003, VOGELWELT, V124, P15; VANNOORDWIJK AJ, 1981, OECOLOGIA, V49, P158, DOI 10.1007/BF00349183; Verboven N, 2001, ARDEA, V89, P387; VERHULST S, 1995, ECOLOGY, V76, P2392, DOI 10.2307/2265815; VERHULST S, 1991, J ANIM ECOL, V60, P269, DOI 10.2307/5459; Verhulst S, 2008, PHILOS T R SOC B, V363, P399, DOI 10.1098/rstb.2007.2146; Visser ME, 2006, OECOLOGIA, V147, P164, DOI 10.1007/s00442-005-0299-6; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151	66	42	42	3	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46165	10.1371/journal.pone.0046165	http://dx.doi.org/10.1371/journal.pone.0046165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049966	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000309556100145
J	Kim, DS; Stanaway, IB; Rajagopalan, R; Bernbaum, JC; Solot, CB; Burnham, N; Zackai, EH; Clancy, RR; Nicolson, SC; Gerdes, M; Nickerson, DA; Hakonarson, H; Gaynor, JW; Jarvik, GP				Kim, Daniel S.; Stanaway, Ian B.; Rajagopalan, Ramakrishnan; Bernbaum, Judy C.; Solot, Cynthia B.; Burnham, Nancy; Zackai, Elaine H.; Clancy, Robert R.; Nicolson, Susan C.; Gerdes, Marsha; Nickerson, Deborah A.; Hakonarson, Hakon; Gaynor, J. William; Jarvik, Gail P.			Results of Genome-Wide Analyses on Neurodevelopmental Phenotypes at Four- Year Follow-Up following Cardiac Surgery in Infancy	PLOS ONE			English	Article							HYPOTHERMIC CIRCULATORY ARREST; APOLIPOPROTEIN-E GENOTYPE; DEFICIT HYPERACTIVITY DISORDER; DOPAMINE TRANSPORTER GENE; HEART-SURGERY; IMPORTANT DETERMINANTS; PARKINSONS-DISEASE; MOLECULAR-GENETICS; ASSOCIATION SCAN; CANDIDATE GENE	Background: Adverse neurodevelopmental sequelae are reported among children who undergo early cardiac surgery to repair congenital heart defects (CHD). APOE genotype has previously been determined to contribute to the prediction of these outcomes. Understanding further genetic causes for the development of poor neurobehavioral outcomes should enhance patient risk stratification and improve both prevention and treatment strategies. Methods: We performed a prospective observational study of children who underwent cardiac surgery before six months of age; this included a neurodevelopmental evaluation between their fourth and fifth birthdays. Attention and behavioral skills were assessed through parental report utilizing the Attention Deficit-Hyperactivity Disorder-IV scale preschool edition (ADHD-IV), and Child Behavior Checklist (CBCL/1.5-5), respectively. Of the seven investigated, three neurodevelopmental phenotypes met genomic quality control criteria. Linear regression was performed to determine the effect of genome-wide genetic variation on these three neurodevelopmental measures in 316 subjects. Results: This genome-wide association study identified single nucleotide polymorphisms (SNPs) associated with three neurobehavioral phenotypes in the postoperative children ADHD-IV Impulsivity/Hyperactivity, CBCL/1.5-5 PDPs, and CBCL/1.5-5 Total Problems. The most predictive SNPs for each phenotype were: a LGALS8 intronic SNP, rs4659682, associated with ADHD-IV Impulsivity (P = 1.03x10(-6)); a PCSK5 intronic SNP, rs2261722, associated with CBCL/1.5-5 PDPs (P = 1.11X10(-6)); and an intergenic SNP, rs11617488, 50 kb from FGF9, associated with CBCL/1.5-5 Total Problems (P = 3.47X10(-7)). 10 SNPs (3 for ADHD-IV Impulsivity, 5 for CBCL/1.5-5 PDPs, and 2 for CBCL/1.5-5 Total Problems) had p < 10(-5). Conclusions: No SNPs met genome-wide significance for our three neurobehavioral phenotypes; however, 10 SNPs reached a threshold for suggestive significance (p < 10(-5)). Given the unique nature of this cohort, larger studies and/or replication are not possible. Studies to further investigate the mechanisms through which these newly identified genes may influence neurodevelopment dysfunction are warranted.	[Kim, Daniel S.; Rajagopalan, Ramakrishnan; Jarvik, Gail P.] Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Kim, Daniel S.; Stanaway, Ian B.; Nickerson, Deborah A.; Jarvik, Gail P.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Bernbaum, Judy C.] Childrens Hosp Philadelphia, Div Gen Pediat, Philadelphia, PA 19104 USA; [Solot, Cynthia B.] Childrens Hosp Philadelphia, Ctr Childhood Commun, Philadelphia, PA 19104 USA; [Burnham, Nancy; Gaynor, J. William] Childrens Hosp Philadelphia, Div Cardiothorac Surg, Philadelphia, PA 19104 USA; [Zackai, Elaine H.] Childrens Hosp Philadelphia, Div Genet, Philadelphia, PA 19104 USA; [Clancy, Robert R.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Nicolson, Susan C.] Childrens Hosp Philadelphia, Div Cardiothorac Anesthesiol, Philadelphia, PA 19104 USA; [Gerdes, Marsha] Childrens Hosp Philadelphia, Div Psychol, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Jarvik, GP (corresponding author), Univ Washington, Sch Med, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	pair@u.washington.edu	Rajagopalan, Ramakrishnan/I-4349-2019; Jarvik, Gail P/N-6476-2014; gaynor, J william/E-5194-2013; Rajagopalan, Ramakrishnan/Q-9018-2016	Jarvik, Gail P/0000-0002-6710-8708; Kim, Daniel Seung/0000-0003-2971-1909; gaynor, J william/0000-0001-7955-5604; Rajagopalan, Ramakrishnan/0000-0002-5751-9239	Fannie E. Rippel Foundation; American Heart Association National [9950480N]; National Institutes of Health [HL071834]; Washington State Life Sciences Discovery Award; Northwest Institute for Genetic Medicine; Sarnoff Cardiovascular Research Fellowship for Medical Students; Center for Applied Genomics at the Children's Hospital of Philadelphia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071834] Funding Source: NIH RePORTER	Fannie E. Rippel Foundation; American Heart Association National(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington State Life Sciences Discovery Award; Northwest Institute for Genetic Medicine; Sarnoff Cardiovascular Research Fellowship for Medical Students; Center for Applied Genomics at the Children's Hospital of Philadelphia; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the Fannie E. Rippel Foundation, an American Heart Association National Grant-in-Aid (9950480N), HL071834 from the National Institutes of Health, and a Washington State Life Sciences Discovery Award to the Northwest Institute for Genetic Medicine. DSK was supported in part by the Sarnoff Cardiovascular Research Fellowship for Medical Students. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all subjects and families for their participation. Genotyping was performed at and supported by the Center for Applied Genomics at the Children's Hospital of Philadelphia. DSK was supported by the Sarnoff Cardiovascular Research Fellowship for Medical Students.	Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; Andropoulos DB, 2010, J THORAC CARDIOV SUR, V139, P543, DOI 10.1016/j.jtcvs.2009.08.022; Arai Y, 1996, ACTA NEUROPATHOL, V91, P396, DOI 10.1007/s004010050441; Bellinger DC, 1999, CIRCULATION, V100, P526, DOI 10.1161/01.CIR.100.5.526; Bellinger DC, 2003, J THORAC CARDIOV SUR, V126, P1385, DOI 10.1016/S0022-5223(03)00711-6; BELLINGER DC, 1995, NEW ENGL J MED, V332, P549, DOI 10.1056/NEJM199503023320901; Bidon N, 2001, INT J MOL MED, V8, P245; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Fuller S, 2009, EUR J CARDIO-THORAC, V36, P40, DOI 10.1016/j.ejcts.2009.02.047; Furney SJ, 2011, MOL PSYCHIATR, V16, P1130, DOI 10.1038/mp.2010.123; Gaynor JW, 2007, J THORAC CARDIOV SUR, V133, P1344, DOI 10.1016/j.jtcvs.2006.10.087; Gaynor JW, 2010, J THORAC CARDIOV SUR, V140, P1230, DOI 10.1016/j.jtcvs.2010.07.069; Gaynor JW, 2009, PEDIATRICS, V124, P241, DOI 10.1542/peds.2008-2281; Gaynor JW, 2005, J THORAC CARDIOV SUR, V130, P1278, DOI 10.1016/j.jtcvs.2005.02.065; Gaynor JW, 2003, J THORAC CARDIOV SUR, V126, P1736, DOI 10.1016/S0022-5223(03)01188-7; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Hadari YR, 2000, J CELL SCI, V113, P2385; Hellingman CA, 2010, TISSUE ENG PT A, V16, P545, DOI [10.1089/ten.tea.2008.0551, 10.1089/ten.TEA.2008.0551]; Hinney A, 2011, AM J MED GENET B, V156B, P888, DOI 10.1002/ajmg.b.31246; Hovels-Gurich HH, 2002, ARCH DIS CHILD, V87, P506, DOI 10.1136/adc.87.6.506; Kolundzic N, 2011, PLACENTA, V32, P909, DOI 10.1016/j.placenta.2011.07.087; Kuroda MM, 2007, PEDIATRICS, V119, P306, DOI 10.1542/peds.2006-1083; Lasky-Su J, 2008, AM J MED GENET B, V147B, P1345, DOI 10.1002/ajmg.b.30867; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; Licht DJ, 2009, J THORAC CARDIOV SUR, V137, P529, DOI 10.1016/j.jtcvs.2008.10.025; Limperopoulos C, 2001, PEDIATRICS, V108, P1325, DOI 10.1542/peds.108.6.1325; Lowe N, 2004, AM J HUM GENET, V74, P348, DOI 10.1086/381561; Maher BS, 2002, PSYCHIATR GENET, V12, P207, DOI 10.1097/00041444-200212000-00003; Mahle WT, 2002, CIRCULATION, V106, pI109, DOI 10.1161/01.cir.0000032908.33237.b1; Markowitz SD, 2007, SEMIN CARDIOTHORAC V, V11, P59, DOI 10.1177/1089253206297481; McAdoo JD, 2005, NEUROSCI LETT, V381, P305, DOI 10.1016/j.neulet.2005.02.036; Merrell K.W., 2003, PRESCHOOL KINDERGART; Miatton M, 2007, J PEDIATR-US, V151, P73, DOI 10.1016/j.jpeds.2007.02.020; Msall M E, 1998, Semin Pediatr Neurol, V5, P52, DOI 10.1016/S1071-9091(98)80019-3; Muratori F, 2011, EPIDEMIOL PSYCH SCI, V20, P329, DOI 10.1017/S204579601100045X; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Neale BM, 2008, AM J MED GENET B, V147B, P1337, DOI 10.1002/ajmg.b.30866; NEWBURGER JW, 1993, NEW ENGL J MED, V329, P1057, DOI 10.1056/NEJM199310073291501; Oria RB, 2007, MED HYPOTHESES, V68, P1099, DOI 10.1016/j.mehy.2006.09.036; Puk O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023678; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purper-Ouakil D, 2005, PSYCHIAT GENET, V15, P53, DOI 10.1097/00041444-200503000-00009; Rask-Nissila L, 2002, J PEDIATR-US, V140, P328, DOI 10.1067/mpd.2002.122393; Saad M, 2011, HUM MOL GENET, V20, P615, DOI 10.1093/hmg/ddq497; Seidah NG, 1996, BIOCHEM J, V314, P951, DOI 10.1042/bj3140951; Shillingford AJ, 2008, PEDIATRICS, V121, pE759, DOI 10.1542/peds.2007-1066; Shillingford AJ, 2007, CARDIOL YOUNG, V17, P189, DOI 10.1017/S1047951107000248; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Tardiff BE, 1997, ANN THORAC SURG, V64, P715, DOI 10.1016/S0003-4975(97)00757-1; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Visconti KJ, 1999, CIRCULATION, V100, P145; Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW; Wernovsky G, 2005, CURR OPIN CARDIOL, V20, P94, DOI 10.1097/01.hco.0000153451.68212.68; Wickremasinghe AC, 2011, CHILD CARE HLTH DEV; Wright RO, 2003, PEDIATR RES, V54, P819, DOI 10.1203/01.PDR.0000090927.53818.DE; Wypij D, 2003, J THORAC CARDIOV SUR, V126, P1397, DOI 10.1016/S0022-5223(03)00940-1; Yang BR, 2007, AM J MED GENET B, V144B, P541, DOI 10.1002/ajmg.b.30453; Yin YJ, 2011, DEVELOPMENT, V138, P3169, DOI 10.1242/dev.065110; Zeltser I, 2008, J THORAC CARDIOV SUR, V135, P91, DOI 10.1016/j.jtcvs.2007.04.074	61	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45936	10.1371/journal.pone.0045936	http://dx.doi.org/10.1371/journal.pone.0045936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049896	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100103
J	MacManes, MD; Lacey, EA				MacManes, Matthew D.; Lacey, Eileen A.			The Social Brain: Transcriptome Assembly and Characterization of the Hippocampus from a Social Subterranean Rodent, the Colonial Tuco-Tuco (Ctenomys sociabilis)	PLOS ONE			English	Article							GENE-EXPRESSION; SONG SPARROW; ALIGNMENT; BEHAVIOR; RECEPTOR; MICROSATELLITES; VOCALIZATIONS; CALCINEURIN; DIVERSITY; EVOLUTION	Elucidating the genetic mechanisms that underlie complex adaptive phenotypes is a central problem in evolutionary biology. For behavioral biologists, the ability to link variation in gene expression to the occurrence of specific behavioral traits has long been a largely unobtainable goal. Social interactions with conspecifics represent a fundamental component of the behavior of most animal species. Although several studies of mammals have attempted to uncover the genetic bases for social relationships using a candidate gene approach, none have attempted more comprehensive, transcriptome-based analyses using high throughout sequencing. As a first step toward improved understanding of the genetic underpinnings of mammalian sociality, we generated a reference transcriptome for the colonial tuco-tuco (Ctenomys sociabilis), a social species of subterranean rodent that is endemic to southwestern Argentina. Specifically, we analyzed over 500 million Illumina sequencing reads derived from the hippocampi of 10 colonial tuco-tucos housed in captivity under a variety of social conditions. The resulting reference transcriptome provides a critical tool for future studies aimed at exploring relationships between social environment and gene expression in this non-model species of social mammal.	[MacManes, Matthew D.] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Lacey, Eileen A.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Lacey, Eileen A.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	MacManes, MD (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA.	macmanes@gmail.com	MacManes, Matthew/B-8303-2011	MacManes, Matthew/0000-0002-2368-6960	Museum of Vertebrate Zoology Directors Fund; National Institutes of Health NRSA Post-Doctoral fellowship; Extreme Science and Engineering Discovery Environment (XSEDE) PSC-Blacklight; National Science Foundation [OCI-1053575]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK093227] Funding Source: NIH RePORTER	Museum of Vertebrate Zoology Directors Fund; National Institutes of Health NRSA Post-Doctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Extreme Science and Engineering Discovery Environment (XSEDE) PSC-Blacklight; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Museum of Vertebrate Zoology Directors Fund. During all phases of the research, MDM was supported by a National Institutes of Health NRSA Post-Doctoral fellowship. Computational resources were supported by the Extreme Science and Engineering Discovery Environment (XSEDE) PSC-Blacklight, which is supported by National Science Foundation grant number OCI-1053575. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Allaine D, 2000, BEHAV PROCESS, V51, P21, DOI 10.1016/S0376-6357(00)00116-9; Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Beery AK, 2008, J COMP NEUROL, V507, P1847, DOI 10.1002/cne.21638; Bell AM, 2011, SCIENCE, V332, P1161, DOI 10.1126/science.1203295; Blumstein DT, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00034; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chan YL, 2005, BIOL LETT-UK, V1, P423, DOI 10.1098/rsbl.2005.0354; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crestani F, 1999, NAT NEUROSCI, V2, P833, DOI 10.1038/12207; Dottorini T, 2007, P NATL ACAD SCI USA, V104, P16215, DOI 10.1073/pnas.0703904104; Drnevich JM, 2004, P ROY SOC B-BIOL SCI, V271, P2267, DOI 10.1098/rspb.2004.2880; Durbin R, 2009, BIOINFORMATICS; Ebensperger LA, 2008, BEHAV PROCESS, V79, P85, DOI 10.1016/j.beproc.2008.05.006; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Fink S, 2006, P NATL ACAD SCI USA, V103, P10956, DOI 10.1073/pnas.0602380103; Fitzpatrick MJ, 2005, TRENDS ECOL EVOL, V20, P96, DOI 10.1016/j.tree.2004.11.017; Fjerdingstad EJ, 2006, AM NAT, V167, P390, DOI 10.1086/499545; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Gaub S, 2010, GENES BRAIN BEHAV, V9, P390, DOI 10.1111/j.1601-183X.2010.00570.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haesler S, 2004, J NEUROSCI, V24, P3164, DOI 10.1523/JNEUROSCI.4369-03.2004; Heckel G, 2008, PROG BRAIN RES, V170, P321, DOI 10.1016/S0079-6123(08)00426-3; Johnston M, 1998, CURR BIOL, V8, pR171, DOI 10.1016/S0960-9822(98)70103-4; Lacey EA, 1997, J MAMMAL, V78, P556, DOI 10.2307/1382907; Lacey EA, 2004, BEHAV ECOL, V15, P988, DOI 10.1093/beheco/arh104; Lacey EA, 2004, BEHAV ECOL SOCIOBIOL, V56, P449, DOI 10.1007/s00265-004-0805-6; Lacey EA, 2003, J MAMMAL, V84, P1198, DOI 10.1644/BLe-014; Lacey EA, 1999, MOL ECOL, V8, P1754, DOI 10.1046/j.1365-294x.1999.00723-1.x; Lacey EA, 2001, HEREDITY, V86, P628, DOI 10.1046/j.1365-2540.2001.00881.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JI, 2004, MOL CELLS, V17, P390; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Lovell PV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003440; Mack PD, 2006, P NATL ACAD SCI USA, V103, P10358, DOI 10.1073/pnas.0604046103; McGraw LA, 2004, CURR BIOL, V14, P1509, DOI 10.1016/j.cub.2004.08.028; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; MICZEK KA, 1995, PSYCHOPHARMACOLOGY, V121, P38, DOI 10.1007/BF02245590; Miller Jim Wayne, 2010, GENOMICS, P1; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mukai M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008182; Myles S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008219; Nonacs P, 2000, AM NAT, V156, P577, DOI 10.1086/316995; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sustkova-Fiserova M, 2009, NEUROENDOCRINOL LETT, V30, P79; Suzuki G, 2009, HUM MOL GENET, V18, P1652, DOI 10.1093/hmg/ddp086; Takahashi K, 2003, J NEUROSCI RES, V73, P61, DOI 10.1002/jnr.10638; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; Vega-Arreguin JC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-299; Wacker DW, 2010, J COMP NEUROL, V518, P3819, DOI 10.1002/cne.22426; WESTNEAT DF, 1993, BEHAV ECOL, V4, P49, DOI 10.1093/beheco/4.1.49; Whittington CM, 2009, J PROTEOMICS, V72, P155, DOI 10.1016/j.jprot.2008.12.004; Woodruff JA, 2010, J EXP ZOOL PART A, V313A, P498, DOI 10.1002/jez.621; Young LJ, 2007, TRENDS GENET, V23, P209, DOI 10.1016/j.tig.2007.02.010	59	10	10	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45524	10.1371/journal.pone.0045524	http://dx.doi.org/10.1371/journal.pone.0045524			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049809	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100053
J	Remelli, W; Guerrieri, N; Klodmann, J; Papenbrock, J; Pagani, S; Forlani, F				Remelli, William; Guerrieri, Nicoletta; Klodmann, Jennifer; Papenbrock, Jutta; Pagani, Silvia; Forlani, Fabio			Involvement of the Azotobacter vinelandii Rhodanese-Like Protein RhdA in the Glutathione Regeneration Pathway	PLOS ONE			English	Article							OXIDATIVE STRESS; 3-MERCAPTOPYRUVATE SULFURTRANSFERASE; ESCHERICHIA-COLI; THIYL RADICALS; THIOREDOXIN; CYSTEINE; SULFUR; IDENTIFICATION; METABOLISM; ANTIOXIDANT	The phenotypic features of the Azotobacter vinelandii RhdA mutant MV474 (in which the rhdA gene was deleted) indicated that defects in antioxidant systems in this organism were related to the expression of the tandem-domain rhodanese RhdA. In this work, further insights on the effects of the oxidative imbalance generated by the absence of RhdA (e.g. increased levels of lipid hydroperoxides) are provided. Starting from the evidence that glutathione was depleted in MV474, and using both in silico and in vitro approaches, here we studied the interaction of wild-type RhdA and Cys(230) Ala site-directed RhdA mutant with glutathione species. We found that RhdA was able to bind in vitro reduced glutathione (GSH) and that RhdA-Cys(230) residue was mandatory for the complex formation. RhdA catalyzed glutathione-disulfide formation in the presence of a system generating the glutathione thiyl radical (GS(.), an oxidized form of GSH), thereby facilitating GSH regeneration. This reaction was negligible when the Cys230 Ala RhdA mutant was used. The efficiency of RhdA as catalyst in GS(.)-scavenging activity is discussed on the basis of the measured parameters of both interaction with glutathione species and kinetic studies.	[Remelli, William; Guerrieri, Nicoletta; Pagani, Silvia; Forlani, Fabio] Univ Milan, Dipartimento Sci Alimenti Nutr & Ambiente, Milan, Italy; [Klodmann, Jennifer] Leibniz Univ Hannover, Inst Pflanzengenet, Hannover, Germany; [Papenbrock, Jutta] Leibniz Univ Hannover, Inst Bot, Hannover, Germany	University of Milan; Leibniz University Hannover; Leibniz University Hannover	Forlani, F (corresponding author), Univ Milan, Dipartimento Sci Alimenti Nutr & Ambiente, Milan, Italy.	fabio.forlani@unimi.it	Forlani, Fabio/Y-4265-2019; Guerrieri, Nicoletta/B-1241-2012; Braun, Hans-Peter/E-7149-2011; Klodmann, Jennifer/B-2131-2013	Forlani, Fabio/0000-0001-9405-973X; Guerrieri, Nicoletta/0000-0003-3536-4886; Braun, Hans-Peter/0000-0002-4459-9727; Remelli, William/0000-0003-4992-0855; Senkler, Jennifer/0000-0002-1377-3841	Vigoni project [0815171]; Fondo interno ricerca scientifica e tecnologica	Vigoni project; Fondo interno ricerca scientifica e tecnologica	Mobility of researchers between Italy and Germany was sponsored by Vigoni project number 0815171 (2009-2010; and Ateneo Italo-Tedesco, Deutscher Akademischer Austausch Dienst) to FF and JP. SP was partially funded by "Fondo interno ricerca scientifica e tecnologica" (2007; Universita degli Studi di Milano). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigoni O, 2002, BBA-GEN SUBJECTS, V1569, P1, DOI 10.1016/S0304-4165(01)00235-5; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bordo D, 2000, J MOL BIOL, V298, P691, DOI 10.1006/jmbi.2000.3651; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; Bordo' D, 2001, BIOL CHEM, V382, P1245, DOI 10.1515/BC.2001.155; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRADSHAW TP, 1995, FREE RADICAL BIO MED, V18, P279, DOI 10.1016/0891-5849(94)E0136-7; Cartini F, 2011, AMINO ACIDS, V41, P141, DOI 10.1007/s00726-010-0529-z; Cereda A, 2007, FEBS LETT, V581, P1625, DOI 10.1016/j.febslet.2007.03.028; Cereda A, 2009, BIOCHEM J, V418, P135, DOI 10.1042/BJ20081218; Colnaghi R, 1996, EUR J BIOCHEM, V236, P240, DOI 10.1111/j.1432-1033.1996.00240.x; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; Florczyk MA, 2001, INFECT IMMUN, V69, P5777, DOI 10.1128/IAI.69.9.5777-5785.2001; Forlani F, 2005, FEBS LETT, V579, P6786, DOI 10.1016/j.febslet.2005.11.013; Gallogly MM, 2008, BIOCHEMISTRY-US, V47, P11144, DOI 10.1021/bi800966v; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Griffiths G, 2000, J EXP BOT, V51, P1363, DOI 10.1093/jexbot/51.349.1363; Kiley PJ, 2004, PLOS BIOL, V2, P1714, DOI 10.1371/journal.pbio.0020400; Krivobok S, 2003, J BACTERIOL, V185, P3828, DOI 10.1128/JB.185.13.3828-3841.2003; KWAK HS, 1995, P NATL ACAD SCI USA, V92, P4582, DOI 10.1073/pnas.92.10.4582; Mikami Y, 2011, BIOCHEM J, V439, P479, DOI 10.1042/BJ20110841; Nagahara N, 2011, AMINO ACIDS, V41, P59, DOI 10.1007/s00726-010-0508-4; Nandi DL, 2000, INT J BIOCHEM CELL B, V32, P465, DOI 10.1016/S1357-2725(99)00035-7; Nandi DL, 1998, INT J BIOCHEM CELL B, V30, P973, DOI 10.1016/S1357-2725(98)00050-8; NEWTON JW, 1953, J BIOL CHEM, V204, P445; Noguera V, 2005, J MOL BIOL, V353, P629, DOI 10.1016/j.jmb.2005.08.035; PAGANI S, 1984, EUR J BIOCHEM, V142, P361, DOI 10.1111/j.1432-1033.1984.tb08295.x; Pagani S, 2000, FEBS LETT, V472, P307, DOI 10.1016/S0014-5793(00)01477-0; Papenbrock J, 2011, AMINO ACIDS, V41, P43, DOI 10.1007/s00726-010-0478-6; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; QUINTILIANI M, 1977, INT J RADIAT BIOL, V32, P195, DOI 10.1080/09553007714550891; Ray WK, 2000, J BACTERIOL, V182, P2277, DOI 10.1128/JB.182.8.2277-2284.2000; Remelli W, 2010, BIOL CHEM, V391, P777, DOI 10.1515/BC.2010.073; Riemenschneider A, 2005, PLANT PHYSIOL BIOCH, V43, P473, DOI 10.1016/j.plaphy.2005.04.001; Santos PM, 2004, PROTEOMICS, V4, P2640, DOI 10.1002/pmic.200300793; SCHREIBER J, 1989, J BIOL CHEM, V264, P7936; SEVILLA MD, 1990, INT J RADIAT BIOL, V57, P65, DOI 10.1080/09553009014550351; Sipe HJ, 1997, DRUG METAB DISPOS, V25, P468; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; Venkatraman A, 2004, J BIOL CHEM, V279, P22092, DOI 10.1074/jbc.M402245200; Ward Paul, 1995, P1; WESTLEY J, 1983, FUND APPL TOXICOL, V3, P377, DOI 10.1016/S0272-0590(83)80008-6; Westrop GD, 2009, J BIOL CHEM, V284, P33485, DOI 10.1074/jbc.M109.054320; Williams RAM, 2003, J BIOL CHEM, V278, P1480, DOI 10.1074/jbc.M209395200; WINTERBOURN CC, 1993, FREE RADICAL BIO MED, V14, P85, DOI 10.1016/0891-5849(93)90512-S; Yoon SJ, 2002, J BIOCHEM MOL BIOL, V35, P297; Zhao R, 1997, J CHEM SOC PERK T 2, P569, DOI 10.1039/a605727f	47	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45193	10.1371/journal.pone.0045193	http://dx.doi.org/10.1371/journal.pone.0045193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049775	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100031
J	Turner, CE; Sommerlad, M; McGregor, K; Davies, FJ; Pichon, B; Chong, DLW; Farzaneh, L; Holden, MTG; Spratt, BG; Efstratiou, A; Sriskandan, S				Turner, Claire E.; Sommerlad, Mary; McGregor, Karen; Davies, Frances J.; Pichon, Bruno; Chong, Deborah L. W.; Farzaneh, Leili; Holden, Matthew T. G.; Spratt, Brian G.; Efstratiou, Androulla; Sriskandan, Shiranee			Superantigenic Activity of emm3 Streptococcus pyogenes Is Abrogated by a Conserved, Naturally Occurring smeZ Mutation	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; MITOGENIC EXOTOXIN-Z; TOXIC-SHOCK-SYNDROME; PYROGENIC EXOTOXIN; CYNOMOLGUS MACAQUES; CYSTEINE PROTEASE; GENOME SEQUENCE; UNITED-STATES; M3 STRAIN; INFECTION	Streptococcus pyogenes M/emm3 strains have been epidemiologically linked with enhanced infection severity and risk of streptococcal toxic shock syndrome (STSS), a syndrome triggered by superantigenic stimulation of T cells. Comparison of S. pyogenes strains causing STSS demonstrated that emm3 strains were surprisingly less mitogenic than other emm-types (emm1, emm12, emm18, emm28, emm87, emm89) both in vitro and in vivo, indicating poor superantigenic activity. We identified a 13 bp deletion in the superantigen smeZ gene of all emm3 strains tested. The deletion led to a premature stop codon in smeZ, and was not present in other major emm-types tested. Expression of a functional non-M3-smeZ gene successfully enhanced mitogenic activity in emm3 S. pyogenes and also restored mitogenic activity to emm1 and emm89 S. pyogenes strains where the smeZ gene had been disrupted. In contrast, the M3-smeZ gene with the 13 bp deletion could not enhance or restore mitogenicity in any of these S. pyogenes strains, confirming that M3-smeZ is non-functional regardless of strain background. The mutation in M3-smeZ reduced the potential for M3 S. pyogenes to induce cytokines in human tonsil, but not during invasive infection of superantigen-sensitive mice. Notwithstanding epidemiological associations with STSS and disease severity, emm3 strains have inherently poor superantigenicity that is explained by a conserved mutation in smeZ.	[Turner, Claire E.; Sommerlad, Mary; Davies, Frances J.; Chong, Deborah L. W.; Farzaneh, Leili; Sriskandan, Shiranee] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England; [McGregor, Karen; Spratt, Brian G.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Pichon, Bruno; Efstratiou, Androulla] Hlth Protect Agcy Ctr Infect, Resp & Syst Infect Lab, London, England; [Holden, Matthew T. G.] Wellcome Trust Sanger Inst, Cambridge, England	Imperial College London; Imperial College London; Health Protection Agency; Wellcome Trust Sanger Institute	Sriskandan, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England.	s.sriskandan@imperial.ac.uk	Staves, Peter/C-8219-2014; Turner, Claire/H-8142-2019; Holden, Matthew TG/K-6449-2014	Turner, Claire/0000-0002-4458-9748; Holden, Matthew TG/0000-0002-4958-2166; Sriskandan, Shiranee/0000-0002-5214-4941; Chong, Deborah L W/0000-0001-8785-8541	CET; UKCRC (National Centre for Infection Prevention and Management); National Institute for Health Research Biomedical Research Centre Funding scheme; Lee Spark Foundation; Conor Kerin Foundation; Medical Research Council [G0800777] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10336] Funding Source: researchfish; MRC [G0601399, G0800777] Funding Source: UKRI	CET; UKCRC (National Centre for Infection Prevention and Management); National Institute for Health Research Biomedical Research Centre Funding scheme(National Institute for Health Research (NIHR)); Lee Spark Foundation; Conor Kerin Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	CET, UKCRC (National Centre for Infection Prevention and Management); SS acknowledges the National Institute for Health Research Biomedical Research Centre Funding scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Lee Spark and Conor Kerin Foundations for additional support, Professor Daniel Altmann for provision of the HLA-DQ8 mice and helpful comments on the manuscript, and the Imperial College Healthcare Trust Tissue Bank staff for assistance in tonsil acquisition.	Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Beres SB, 2010, P NATL ACAD SCI USA, V107, P4371, DOI 10.1073/pnas.0911295107; BREIMAN RF, 1993, JAMA-J AM MED ASSOC, V269, P390, DOI 10.1001/jama.1993.03500030088038; Curtis SJ, 2007, J INFECTION, V54, P422, DOI 10.1016/j.jinf.2006.10.004; Freshney R.I., 2005, CULTURE ANIMAL CELLS, DOI [10.1002/0471747599.CAC022, DOI 10.1002/0471747599.CAC022]; Hopkins PA, 2005, BLOOD, V105, P3655, DOI 10.1182/blood-2004-07-2523; Kansal RG, 2003, J INFECT DIS, V187, P398, DOI 10.1086/368022; Kazmi SU, 2001, INFECT IMMUN, V69, P4988, DOI 10.1128/IAI.69.8.4988-4995.2001; Lamagni TL, 2008, EMERG INFECT DIS, V14, P202, DOI 10.3201/eid1402.070888; Lerat E, 2005, NUCLEIC ACIDS RES, V33, P3125, DOI 10.1093/nar/gki631; Linch SN, 2009, INFECT IMMUN, V77, P4976, DOI 10.1128/IAI.00306-09; Lintges M, 2007, INT J MED MICROBIOL, V297, P471, DOI 10.1016/j.ijmm.2007.03.015; Llewelyn M, 2002, LANCET INFECT DIS, V2, P156, DOI 10.1016/S1473-3099(02)00222-0; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Maripuu L, 2008, FEMS IMMUNOL MED MIC, V54, P236, DOI 10.1111/j.1574-695X.2008.00469.x; McGregor K, 2005, LANC INT S STREPT ST; Muller-Alouf H, 2001, INFECT IMMUN, V69, P4141, DOI 10.1128/IAI.69.6.4141-4145.2001; Muller-Alouf H, 1997, MICROB PATHOGENESIS, V23, P265, DOI 10.1006/mpat.1997.0155; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nooh MM, 2006, J BIOL CHEM, V281, P35281, DOI 10.1074/jbc.M605544200; O'Brien KL, 2002, CLIN INFECT DIS, V35, P268, DOI 10.1086/341409; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Proft T, 2003, EMERG INFECT DIS, V9, P1211; Proft T, 2000, J EXP MED, V191, P1765, DOI 10.1084/jem.191.10.1765; Proft T, 1999, J EXP MED, V189, P89, DOI 10.1084/jem.189.1.89; Proft T, 2001, J IMMUNOL, V166, P6711, DOI 10.4049/jimmunol.166.11.6711; Russell HH, 2008, MICROB PATHOGENESIS, V44, P537, DOI 10.1016/j.micpath.2007.06.010; Saunders NA, 1997, J CLIN MICROBIOL, V35, P2689, DOI 10.1128/JCM.35.10.2689-2691.1997; Sharkawy A, 2002, CLIN INFECT DIS, V34, P454, DOI 10.1086/338466; Sitkiewicz I, 2006, P NATL ACAD SCI USA, V103, P16009, DOI 10.1073/pnas.0607669103; Sriskandan S, 1999, MOL MICROBIOL, V33, P778, DOI 10.1046/j.1365-2958.1999.01525.x; Sriskandan S, 1996, J INFECT DIS, V173, P1399, DOI 10.1093/infdis/173.6.1399; Sriskandan S, 2006, J ANTIMICROB CHEMOTH, V58, P117, DOI 10.1093/jac/dkl173; Sriskandan S, 2007, INT J BIOCHEM CELL B, V39, P12, DOI 10.1016/j.biocel.2006.08.009; Svensson L, 2005, MICROBES INFECT, V7, P720, DOI 10.1016/j.micinf.2005.01.010; Turner CE, 2009, J INFECT DIS, V200, P555, DOI 10.1086/603541; Unnikrishnan M, 2002, J IMMUNOL, V169, P2561, DOI 10.4049/jimmunol.169.5.2561; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; Virtaneva K, 2003, INFECT IMMUN, V71, P2199, DOI 10.1128/IAI.71.4.2199-2207.2003; Yang L, 2005, J CLIN MICROBIOL, V43, P3570, DOI 10.1128/JCM.43.7.3570-3573.2005	40	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46376	10.1371/journal.pone.0046376	http://dx.doi.org/10.1371/journal.pone.0046376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049698	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000309388500025
J	Zhao, HY; Avenarius, MR; Gillespie, PG				Zhao, Hongyu; Avenarius, Matthew R.; Gillespie, Peter G.			Improved Biolistic Transfection of Hair Cells	PLOS ONE			English	Article							IN-VIVO; GENE-TRANSFER; MYOSIN VIIA; HARMONIN; COCHLEA; TRANSDUCTION; CADHERIN-23; COMPLEXES; DELIVERY; STEREOCILIA	Transient transfection of hair cells has proven challenging. Here we describe modifications to the Bio-Rad Helios Gene Gun that, along with an optimized protocol, improve transfection of bullfrog, chick, and mouse hair cells. The increased penetrating power afforded by our method allowed us to transfect mouse hair cells from the basal side, through the basilar membrane; this configuration protects hair bundles from damage during the procedure. We characterized the efficiency of transfection of mouse hair cells with fluorescently-tagged actin fusion protein using both the optimized procedure and a published procedure; while the efficiency of the two methods was similar, the morphology of transfected hair cells was improved with the new procedure. In addition, using the improved method, we were able to transfect hair cells in the bullfrog sacculus and chick cochlea for the first time. We used fluorescent-protein fusions of harmonin b (USH1C) and PMCA2 (ATP2B2; plasma-membrane Ca2+-ATPase isoform 2) to examine protein distribution in hair cells. While PMCA2-EGFP localization was similar to endogenous PMCA2 detected with antibodies, high levels of harmonin-EGFP were found at stereocilia tapers in bullfrog and chick, but not mouse; by contrast, harmonin-EGFP was concentrated in stereocilia tips in mouse hair cells.	[Zhao, Hongyu] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Zhao, HY (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.	gillespp@ohsu.edu		Avenarius, Matthew/0000-0001-9516-5163; Barr-Gillespie, Peter/0000-0002-9787-5860	National Institutes of Health (NIH) [R01 DC002368, P30 DC005983]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002368, P30DC005983] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The work was supported by National Institutes of Health (NIH) (www.nih.gov) grants R01 DC002368 and P30 DC005983. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahloul A, 2010, HUM MOL GENET, V19, P3557, DOI 10.1093/hmg/ddq271; Bedrosian JC, 2006, MOL THER, V14, P328, DOI 10.1016/j.ymthe.2006.04.003; Belyantseva IA, 2003, P NATL ACAD SCI USA, V100, P13958, DOI 10.1073/pnas.2334417100; Belyantseva Inna A., 2009, V493, P103, DOI 10.1007/978-1-59745-523-7_7; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Dalluge R, 2002, BBA-GENE STRUCT EXPR, V1576, P45, DOI 10.1016/S0167-4781(02)00291-9; Dazert S, 2001, HEARING RES, V151, P30, DOI 10.1016/S0378-5955(00)00189-1; Diebold SS, 2001, GENE THER, V8, P487, DOI 10.1038/sj.gt.3301433; Driver EC, 2010, CURR PROTOC NEUROSCI, P1; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Finsinger D, 2000, GENE THER, V7, P1183, DOI 10.1038/sj.gt.3301227; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Gubbels SP, 2008, NATURE, V455, P537, DOI 10.1038/nature07265; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Hill JK, 2006, J NEUROSCI, V26, P6172, DOI 10.1523/JNEUROSCI.0447-06.2006; Holt JR, 2002, AUDIOL NEURO-OTOL, V7, P157, DOI 10.1159/000058302; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Ishimoto S, 2002, HEARING RES, V173, P187, DOI 10.1016/S0378-5955(02)00579-8; Kachar B, 1997, HEARING RES, V107, P102, DOI 10.1016/S0378-5955(97)00027-0; Karra D, 2010, J NEUROSCI, V30, P6171, DOI 10.1523/JNEUROSCI.0183-10.2010; Klimaschewski L, 2002, J NEUROSCI METH, V113, P63, DOI 10.1016/S0165-0270(01)00473-3; Liu YH, 2005, MOL THER, V12, P725, DOI 10.1016/j.ymthe.2005.03.021; Luebke AE, 2001, HUM GENE THER, V12, P773, DOI 10.1089/104303401750148702; Ma BC, 2007, J CONTROL RELEASE, V123, P184, DOI 10.1016/j.jconrel.2007.08.022; O'Brien JA, 2001, J NEUROSCI METH, V112, P57, DOI 10.1016/S0165-0270(01)00457-5; Ogris M, 1998, GENE THER, V5, P1425, DOI 10.1038/sj.gt.3300745; Raju PA, 2006, VACCINE, V24, P4644, DOI 10.1016/j.vaccine.2005.08.067; Reiners J, 2003, INVEST OPHTH VIS SCI, V44, P5006, DOI 10.1167/iovs.03-0483; Ross PC, 1999, GENE THER, V6, P651, DOI 10.1038/sj.gt.3300863; Rzadzinska AK, 2004, J CELL BIOL, V164, P887, DOI 10.1083/jcb.200310055; Shin JB, 2007, NEURON, V53, P371, DOI 10.1016/j.neuron.2006.12.021; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; THOMAS JL, 2001, J INSECT SCI, V1, P9; Wang H, 2012, GENE THER, V19, P255, DOI 10.1038/gt.2011.91; Yamoah EN, 1998, J NEUROSCI, V18, P610; Zhang DS, 2012, NATURE, V481, P520, DOI 10.1038/nature10745; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zuidam NJ, 1999, INT J PHARM, V183, P43, DOI 10.1016/S0378-5173(99)00041-1	39	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46765	10.1371/journal.pone.0046765	http://dx.doi.org/10.1371/journal.pone.0046765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049715	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388500042
J	Friedrich, DC; Santos, SEB; Ribeiro-dos-Santos, AKC; Hutz, MH				Friedrich, Deise C.; Santos, Sidney E. B.; Ribeiro-dos-Santos, Andrea K. C.; Hutz, Mara H.			Several Different Lactase Persistence Associated Alleles and High Diversity of the Lactase Gene in the Admixed Brazilian Population	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISM; PHLORHIZIN HYDROLASE GENE; ADULT-TYPE HYPOLACTASIA; HAPLOTYPE RECONSTRUCTION; LINKAGE DISEQUILIBRIUM; VARIANT; EVOLUTION; C/T-13910; UPSTREAM; AFRICA	Adult-type hypolactasia is a common phenotype caused by the lactase enzyme deficiency. The -13910 C>T polymorphism, located 14 Kb upstream of the lactase gene (LCT) in the MCM6 gene was associated with lactase persistence (LP) in Europeans. This polymorphism is rare in Africa but several other variants associated with lactase persistence were observed in Africans. The aims of this study were to identify polymorphisms in the MCM6 region associated with the lactase persistence phenotype and to determine the distribution of LCT gene haplotypes in 981 individuals from North, Northeast and South Brazil. These polymorphisms were genotyped by PCR based methods and sequencing. The -13779*C, -13910*T, -13937*A, -14010*C, -14011*T LP alleles previously described in the MCM6 gene region that acts as an enhancer for the LCT gene were identified in Brazilians. The most common LP allele was -13910*T. Its frequency was highly correlated with European ancestry in the Brazilian populations investigated. The -13910*T was higher (0.295) in southern Brazilians of European ancestry and lower (0.175) in the Northern admixed population. LCT haplotypes were derived from the 10 LCT SNPs genotyped. Overall twenty six haplotypes previously described were identified in the four Brazilian populations studied. The Multidimensional Scaling analysis showed that Belem, in the north, was closer to Amerindians. Northeastern and southern Afro-descendants were more related with Bantu-speaking South Africans whereas the Southern population with European ancestry grouped with Southern and Northern Europeans. This study shows a high variability considering the number of LCT haplotypes observed. Due to the highly admixed nature of the Brazilian populations, the diagnosis of hypolactasia in Brazil, based only in the investigation of the -13910*T allele is an oversimplification.	[Friedrich, Deise C.; Hutz, Mara H.] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [Santos, Sidney E. B.; Ribeiro-dos-Santos, Andrea K. C.] Fed Univ Para, Lab Genet Humana & Med, BR-66059 Belem, Para, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Para	Hutz, MH (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil.	mara.hutz@ufrgs.br	Santos, Ândrea Ribeiro dos/B-6061-2013; Hutz, Mara H/I-4070-2012; Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Friedrich, Deise/F-5790-2017	Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Friedrich, Deise/0000-0002-4613-5301; Hutz, Mara/0000-0002-9146-1229	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil) [470937/2010-6]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support was provided by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil; grant # 470937/2010-6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson Joseph H, 2004, Epidemiol Perspect Innov, V1, P6, DOI 10.1186/1742-5573-1-6; BOLL W, 1991, AM J HUM GENET, V48, P889; Bulhoes AC, 2007, BRAZ J MED BIOL RES, V40, P1441, DOI 10.1590/S0100-879X2007001100004; Callegari-Jacques SM, 2003, AM J HUM BIOL, V15, P824, DOI 10.1002/ajhb.10217; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; Coelho M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-80; De Andrade FM, 2011, NUTR METAB CARDIOVAS, V21, P584, DOI 10.1016/j.numecd.2009.12.013; De Franca E, 2004, HUM BIOL, V76, P267, DOI 10.1353/hub.2004.0030; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Enattah NS, 2007, AM J HUM GENET, V81, P615, DOI 10.1086/520705; Enattah NS, 2007, WORLD J GASTROENTERO, V13, P3508, DOI 10.3748/wjg.v13.i25.3508; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Everitt B.S., 1992, ANAL CONTINGENCY TAB; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fiegenbaum M, 2007, CLIN CHIM ACTA, V380, P175, DOI 10.1016/j.cca.2007.02.007; Friedrich DC, 2012, AM J PHYS ANTHROPOL, V147, P427, DOI 10.1002/ajpa.22010; Harvey CB, 1998, ANN HUM GENET, V62, P215, DOI 10.1046/j.1469-1809.1998.6230215.x; HARVEY CB, 1995, EUR J HUM GENET, V3, P27; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; Ingram CJE, 2007, HUM GENET, V120, P779, DOI 10.1007/s00439-006-0291-1; Ingram CJE, 2009, J MOL EVOL, V69, P579, DOI 10.1007/s00239-009-9301-y; Jensen TGK, 2011, HUM GENET, V130, P483, DOI 10.1007/s00439-011-0966-0; KRUSE TA, 1988, FEBS LETT, V240, P123, DOI 10.1016/0014-5793(88)80352-1; Kuokkanen M, 2003, GUT, V52, P647, DOI 10.1136/gut.52.5.647; Lee MF, 1998, NUTR REV, V56, P1; Lember M, 2006, WORLD J GASTROENTERO, V12, P7329, DOI 10.3748/wjg.v12.i45.7329; Lewinsky RH, 2005, HUM MOL GENET, V14, P3945, DOI 10.1093/hmg/ddi418; MANTEI N, 1988, EMBO J, V7, P2705, DOI 10.1002/j.1460-2075.1988.tb03124.x; Mattar R, 2008, CLIN BIOCHEM, V41, P628, DOI 10.1016/j.clinbiochem.2008.01.006; Mattar R, 2010, CLINICS, V65, P1399, DOI 10.1590/S1807-59322010001200030; Mattevi VS, 2002, INT J OBESITY, V26, P1179, DOI 10.1038/sj.ijo.0802067; MONTGOMERY RK, 1991, FASEB J, V5, P2824, DOI 10.1096/fasebj.5.13.1916106; Mulcare CA, 2004, AM J HUM GENET, V74, P1102, DOI 10.1086/421050; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Olds LC, 2003, HUM MOL GENET, V12, P2333, DOI 10.1093/hmg/ddg244; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Poulter M, 2003, ANN HUM GENET, V67, P298, DOI 10.1046/j.1469-1809.2003.00048.x; Romero IG, 2012, MOL BIOL EVOL, V29, P248, DOI 10.1093/molbev/msr190; Salzano FM, 2002, EVOLUTION GENETICS L; Santos NPC, 2010, HUM MUTAT, V31, P184, DOI 10.1002/humu.21159; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Tomas G, 2002, HUM BIOL, V74, P397, DOI 10.1353/hub.2002.0036; Torniainen S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-31; Troelsen JT, 2003, GASTROENTEROLOGY, V125, P1686, DOI 10.1053/j.gastro.2003.09.031; Wang YX, 1998, GASTROENTEROLOGY, V114, P1230, DOI 10.1016/S0016-5085(98)70429-9; Wright S., 1969, EVOLUTION GENETICS P; Wright S., 1978, EVOLUTION GENETICS P	50	22	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46520	10.1371/journal.pone.0046520	http://dx.doi.org/10.1371/journal.pone.0046520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029545	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900181
J	Sakaguchi, H; Takami, T; Yasutani, Y; Maeda, T; Morino, M; Ishii, T; Shiomi, Y; Nishitani, H				Sakaguchi, Hiroki; Takami, Toshihiro; Yasutani, Yoshinori; Maeda, Takeshi; Morino, Masayuki; Ishii, Takashi; Shiomi, Yasushi; Nishitani, Hideo			Checkpoint Kinase ATR Phosphorylates Cdt2, a Substrate Receptor of CRL4 Ubiquitin Ligase, and Promotes the Degradation of Cdt1 following UV Irradiation	PLOS ONE			English	Article							CELL-CYCLE CONTROL; DNA-DAMAGE; S-PHASE; EXCISION-REPAIR; ATAXIA-TELANGIECTASIA; EUKARYOTIC CELLS; LICENSING FACTOR; RE-REPLICATION; PIP BOX; PCNA	The DNA replication-licensing factor Cdt1 is present during the G1 phase of the cell cycle. When cells initiate S phase or are UV-irradiated, Cdt1 is recruited to chromatin-bound PCNA and ubiquitinated by CRL4(Cdt2) for degradation. In both situations, the substrate-recognizing subunit Cdt2 is detected as a highly phosphorylated form. Here, we show that both caffeine-sensitive kinase and MAP kinases are responsible for Cdt2 phosphorylation following UV irradiation. We found that Cdt1 degradation was attenuated in the presence of caffeine. This attenuation was also observed in cells depleted of ATR, but not ATM. Following UV irradiation, Cdt2 was phosphorylated at the S/TQ sites. ATR phosphorylated Cdt2 in vitro, mostly in the C-terminal region. Cdt1 degradation was also induced by DNA damaging chemicals such as methyl methanesulfonate (MMS) or zeocin, depending on PCNA and CRL4-Cdt2, though it was less caffeine-sensitive. These findings suggest that ATR, activated after DNA damage, phosphorylates Cdt2 and promotes the rapid degradation of Cdt1 after UV irradiation in the G1 phase of the cell cycle.	[Sakaguchi, Hiroki; Takami, Toshihiro; Yasutani, Yoshinori; Maeda, Takeshi; Morino, Masayuki; Ishii, Takashi; Shiomi, Yasushi; Nishitani, Hideo] Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo, Japan	University of Hyogo	Nishitani, H (corresponding author), Univ Hyogo, Grad Sch Life Sci, Kamigori, Hyogo, Japan.	hideon@sci.u-hyogo.ac.jp		Nishitani, Hideo/0000-0001-5907-9380	Ministry of Education, Culture, Sport, Science, and Technology of Japan; Naito Foundation; Hyogo Science and Technology Association; Uehara Memorial Foundation	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Hyogo Science and Technology Association; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by Grants in Aid for Scientific Research, Scientific Research in a Priority Area, and the Global Center of Excellence Program from the Ministry of Education, Culture, Sport, Science, and Technology of Japan; and the Naito Foundation; Hyogo Science and Technology Association; and The Uehara Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Acquaviva C, 2006, J CELL SCI, V119, P2401, DOI 10.1242/jcs.02937; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Giannattasio M, 2010, MOL CELL, V40, P50, DOI 10.1016/j.molcel.2010.09.004; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Havens CG, 2009, MOL CELL, V35, P93, DOI 10.1016/j.molcel.2009.05.012; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Ishii T, 2010, J BIOL CHEM, V285, P41993, DOI 10.1074/jbc.M110.161661; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jorgensen S, 2011, J CELL BIOL, V192, P43, DOI 10.1083/jcb.201009076; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Marini F, 2006, P NATL ACAD SCI USA, V103, P17325, DOI 10.1073/pnas.0605446103; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Michishita M, 2011, GENES CELLS, V16, P12, DOI 10.1111/j.1365-2443.2010.01464.x; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; NISHITANI H, 1991, EMBO J, V10, P1555, DOI 10.1002/j.1460-2075.1991.tb07675.x; Nishitani H, 2004, FRONT BIOSCI-LANDMRK, V9, P2115; Nishitani H, 2001, J BIOL CHEM, V276, P44905, DOI 10.1074/jbc.M105406200; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Ravi D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000527; Roukos V, 2011, J CELL SCI, V124, P422, DOI 10.1242/jcs.074229; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Sertic S, 2011, P NATL ACAD SCI USA, V108, P13647, DOI 10.1073/pnas.1108547108; Shiomi Y, 2012, MOL CELL BIOL; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Silvers AL, 2003, NEOPLASIA, V5, P319, DOI 10.1016/S1476-5586(03)80025-8; Stathopoulou A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034621; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Tardat M, 2010, NAT CELL BIOL, V12, P1086, DOI 10.1038/ncb2113; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Warmerdam DO, 2009, CELL CYCLE, V8, P1765, DOI 10.4161/cc.8.11.8721	56	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46480	10.1371/journal.pone.0046480	http://dx.doi.org/10.1371/journal.pone.0046480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029527	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900168
J	Wielstra, B; Beukema, W; Arntzen, JW; Skidmore, AK; Toxopeus, AG; Raes, N				Wielstra, Ben; Beukema, Wouter; Arntzen, Jan W.; Skidmore, Andrew K.; Toxopeus, Albertus G.; Raes, Niels			Corresponding Mitochondrial DNA and Niche Divergence for Crested Newt Candidate Species	PLOS ONE			English	Article							ABSENCE DATA; MODELS; PHYLOGEOGRAPHY; DELIMITATION; SPECIATION; ECOLOGY; AREAS	Genetic divergence of mitochondrial DNA does not necessarily correspond to reproductive isolation. However, if mitochondrial DNA lineages occupy separate segments of environmental space, this supports the notion of their evolutionary independence. We explore niche differentiation among three candidate species of crested newt (characterized by distinct mitochondrial DNA lineages) and interpret the results in the light of differences observed for recognized crested newt species. We quantify niche differences among all crested newt (candidate) species and test hypotheses regarding niche evolution, employing two ordination techniques (PCA-env and ENFA). Niche equivalency is rejected: all (candidate) species are found to occupy significantly different segments of environmental space. Furthermore, niche overlap values for the three candidate species are not significantly higher than those for the recognized species. As the three candidate crested newt species are, not only in terms of mitochondrial DNA genetic divergence, but also ecologically speaking, as diverged as the recognized crested newt species, our findings are in line with the hypothesis that they represent cryptic species. We address potential pitfalls of our methodology.	[Wielstra, Ben; Arntzen, Jan W.; Raes, Niels] Naturalis Biodivers Ctr, Leiden, Netherlands; [Wielstra, Ben; Beukema, Wouter; Skidmore, Andrew K.; Toxopeus, Albertus G.] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, NL-7500 AE Enschede, Netherlands	Naturalis Biodiversity Center; University of Twente	Wielstra, B (corresponding author), Naturalis Biodivers Ctr, Leiden, Netherlands.	ben.wielstra@naturalis.nl	Raes, Niels/A-9645-2011; Toxopeus, Albertus/A-3650-2010; Arntzen, Jan/E-7108-2016; Wielstra, Ben/G-3773-2015; Beukema, Wouter/D-6365-2014; Skidmore, Andrew K/C-7441-2011	Raes, Niels/0000-0002-4329-4892; Arntzen, Jan/0000-0003-3229-5993; Wielstra, Ben/0000-0002-7112-5965; Beukema, Wouter/0000-0002-5839-7683; Skidmore, Andrew K/0000-0002-7446-8429				Arntzen JW, 2010, AMPHIBIA-REPTILIA, V31, P311; Arntzen JW, 2003, HDB REPTILIEN AMPHIB, VIIA, P421, DOI DOI 10.2307/1565573; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; BUCCIINNOCENTI S, 1983, COPEIA, P662; Coyne J.A., 2004, SPECIATION; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Ivanovic A, ZOOL ANZ IN PRESS; Kidd DM, 2008, MOL ECOL RESOUR, V8, P88, DOI 10.1111/j.1471-8286.2007.01925.x; Raxworthy CJ, 2007, SYST BIOL, V56, P907, DOI 10.1080/10635150701775111; Riddle BR, 2008, PROG PHYS GEOG, V32, P173, DOI 10.1177/0309133308093822; Rissler LJ, 2007, SYST BIOL, V56, P924, DOI 10.1080/10635150701703063; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Sobel JM, 2010, EVOLUTION, V64, P295, DOI 10.1111/j.1558-5646.2009.00877.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Team RDC, 2010, R LANG ENV STAT COMP; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Wielstra B, 2010, MOL PHYLOGENET EVOL, V56, P888, DOI 10.1016/j.ympev.2010.04.030; Wielstra B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-162; Wolterstorff W., 1923, BLATTER AQUARIEN TER, V34, P120	31	23	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46671	10.1371/journal.pone.0046671	http://dx.doi.org/10.1371/journal.pone.0046671			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029564	Green Published, Green Accepted, gold			2022-12-27	WOS:000309973900198
J	Ogawa, A; Hayashi, A; Kishihara, E; Yoshino, S; Takeuchi, A; Shichiri, M				Ogawa, Akifumi; Hayashi, Akinori; Kishihara, Eriko; Yoshino, Sonomi; Takeuchi, Akihiro; Shichiri, Masayoshi			New Indices for Predicting Glycaemic Variability	PLOS ONE			English	Article							TYPE-2 DIABETIC-PATIENTS; GLYCATED ALBUMIN; PLASMA-GLUCOSE; CARDIOVASCULAR MORTALITY; HEMOGLOBIN; COMPLICATIONS; HYPERGLYCEMIA; MELLITUS; HBA1C	Blood glucose variability is known to be associated with increased risk of long-term complications. Reliable indices for predicting hyperglycaemic and hypoglycaemic fluctuations are therefore needed. Glycaemic standard deviation (SD) obtained by continuous glucose monitoring correlates closely with nine previously described glycaemic variability formulas. Here, new indices predictive of glycaemic variability were developed, which can be calculated from laboratory measures based on a single blood draw. The indices included the glycated albumin (GA) to HbA1c ratio (GA/A1c ratio) and the fasting C-peptide immunoreactivity (FCPR) to fasting plasma glucose (FPG) ratio (FCPR index). Predictive values of these indices were assessed in 100 adults with diabetes. GA/A1c ratio and FCPR index showed close associations with glycaemic SD in addition to the nine existing glucose variability formulas. Subjects with a GA/A1c ratio >= 2.8 and FCPR index <3.0 showed the greatest SD and longest durations of hypoglycaemia, while those with a GA/A1c ratio <2.8 and FCPR index >= 3.0 had smaller SDs and little sign of hypoglycaemia. In adults with diabetes, a high GA/A1c ratio and low FCPR index value reflect higher glycaemic excursions, irrespective of diabetes type. Simultaneous measurements of GA, HbA1c, FPG and FCPR may help to identify a group of patients who warrant closer monitoring in relation to glycaemic variability and hypoglycaemia.	[Ogawa, Akifumi; Hayashi, Akinori; Kishihara, Eriko; Yoshino, Sonomi; Shichiri, Masayoshi] Kitasato Univ, Dept Endocrinol Diabet & Metab, Sch Med, Kanagawa, Japan; [Takeuchi, Akihiro] Kitasato Univ, Dept Med Informat, Sch Allied Hlth Sci, Kanagawa, Japan	Kitasato University; Kitasato University	Shichiri, M (corresponding author), Kitasato Univ, Dept Endocrinol Diabet & Metab, Sch Med, Kanagawa, Japan.	shichiri@kitasato-u.ac.jp	Hayashi, Akinori/AAD-2469-2020	Hayashi, Akinori/0000-0002-9946-1004; Shichiri, Masayoshi/0000-0002-5704-1378				Borch-Johnsen K, 2001, ARCH INTERN MED, V161, P397, DOI 10.1001/archinte.161.3.397; Buscemi S, 2010, DIABETIC MED, V27, P872, DOI 10.1111/j.1464-5491.2010.03059.x; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; DAY JF, 1979, J BIOL CHEM, V254, P9394; Goto A, 2010, ENDOCR J, V57, P237, DOI 10.1507/endocrj.K09E-279; Kisugi R, 2007, CLIN CHIM ACTA, V382, P59, DOI 10.1016/j.cca.2007.04.001; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Koga M, 2010, ANN CLIN BIOCHEM, V47, P313, DOI 10.1258/acb.2010.009234; Koga M, 2010, DIABETES CARE, V33, P270, DOI 10.2337/dc09-1002; Kohnert KD, 2007, DIABETES RES CLIN PR, V77, P420, DOI 10.1016/j.diabres.2007.01.021; Kohnert KD, 2009, DIABETES CARE, V32, P1058, DOI 10.2337/dc08-1956; McDonnell C M, 2005, Diabetes Technol Ther, V7, P253, DOI 10.1089/dia.2005.7.253; Nakagami T, 2006, EUR J CARDIOV PREV R, V13, P555, DOI 10.1097/01.hjr.0000183916.28354.69; Rodbard D, 2009, DIABETES TECHNOL THE, V11, P551, DOI 10.1089/dia.2009.0015; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; Saisho Y, 2011, ENDOCR J, V58, P315, DOI 10.1507/endocrj.K10E-399; SCHLICHTKRULL J, 1965, ACTA MED SCAND, V177, P95; Seino Y, 2010, DIABETOL INT, V1, P2, DOI 10.1007/s13340-010-0006-7; SERVICE FJ, 1980, DIABETES CARE, V3, P58, DOI 10.2337/diacare.3.1.58; SERVICE FJ, 1970, DIABETES, V19, P644, DOI 10.2337/diab.19.9.644; Suwa T, 2010, ENDOCR J, V57, P135, DOI 10.1507/endocrj.K09E-234; TAHARA Y, 1995, DIABETES CARE, V18, P440, DOI 10.2337/diacare.18.4.440; Weykamp Cas, 2009, J Diabetes Sci Technol, V3, P439; WOJCICKI JM, 1995, HORM METAB RES, V27, P41, DOI 10.1055/s-2007-979906	24	64	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46517	10.1371/journal.pone.0046517	http://dx.doi.org/10.1371/journal.pone.0046517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029543	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500107
J	Kim, S; Chang, KA; Kim, JA; Park, HG; Ra, JC; Kim, HS; Suh, YH				Kim, Saeromi; Chang, Keun-A; Kim, Jeong A.; Park, Hyeong-Geun; Ra, Jeong Chan; Kim, Hye-Sun; Suh, Yoo-Hun			The Preventive and Therapeutic Effects of Intravenous Human Adipose-Derived Stem Cells in Alzheimer's Disease Mice	PLOS ONE			English	Article							STROMAL CELLS; NEURONAL DIFFERENTIATION; NEUROTROPHIC FACTORS; TRANSGENIC MODEL; AMYLOID-PROTEIN; NERVOUS-SYSTEM; GROWTH-FACTOR; MOUSE MODEL; IN-VITRO; TRANSPLANTATION	Alzheimer's disease (AD) is characterized by the accumulation of amyloid plaques and neurofibrillary tangles accompanied by cognitive dysfunction. The aim of the present study was to elucidate preventive and therapeutic potential of stem cells for AD. Among stem cells, autologous human adipose-derived stem cells (hASCs) elicit no immune rejection responses, tumorigenesis, or ethical problems. We found that intravenously transplanted hASCs passed through the BBB and migrated into the brain. The learning, memory and pathology in an AD mouse model (Tg2576) mice greatly improved for at least 4 months after intravenous injection of hASC. The number of amyloid plaques and A beta levels decreased significantly in the brains of hASC-injected Tg mice compared to those of Tg-sham mice. Here, we first report that intravenously or intracerebrally transplanted hASCs significantly rescues memory deficit and neuropathology, in the brains of Tg mice by upregulating IL-10 and VEGF and be a possible use for the prevention and treatment of AD.	[Kim, Saeromi; Chang, Keun-A; Kim, Jeong A.; Kim, Hye-Sun; Suh, Yoo-Hun] Seoul Natl Univ, Coll Med, Neurosci Res Inst, MRC,Dept Pharmacol, Seoul, South Korea; [Park, Hyeong-Geun; Ra, Jeong Chan] RNL Bio Co Ltd, Stem Cell Res Ctr, Seoul, South Korea; [Suh, Yoo-Hun] Korea Brain Res Inst, Taegu, South Korea; [Chang, Keun-A] Gachon Univ Med & Sci, Dept Pharmacol, Inchon, South Korea	Seoul National University (SNU); Korea Brain Research Institute (KBRI); Gachon University	Suh, YH (corresponding author), Seoul Natl Univ, Coll Med, Neurosci Res Inst, MRC,Dept Pharmacol, Seoul, South Korea.	yhsuh@snu.ac.kr	Suh, Yoo-Hun/J-2761-2012		Conversing Research Center Program through the National Research Foundation of Korea (NRF) [2011K000678]; Mid-career Researcher Program through NRF grant; MEST [20110027566]; Brain Research Center of the 21st Century Frontier Research Program, Science and Technology, the Republic of Korea [2011K000270]	Conversing Research Center Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Mid-career Researcher Program through NRF grant(National Research Foundation of Korea); MEST(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Research Center of the 21st Century Frontier Research Program, Science and Technology, the Republic of Korea	This research was supported by the Conversing Research Center Program through the National Research Foundation of Korea (NRF) (2011K000678), Mid-career Researcher Program through NRF grant funded by the MEST (20110027566), and a grant (2011K000270) from Brain Research Center of the 21st Century Frontier Research Program, Science and Technology, the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 2010, Alzheimers Dement, V6, P158, DOI 10.1016/j.jalz.2010.01.009; Anghileri E, 2008, STEM CELLS DEV, V17, P909, DOI 10.1089/scd.2007.0197; Bao XJ, 2011, BRAIN RES, V1367, P103, DOI 10.1016/j.brainres.2010.10.063; Bhang SH, 2009, STEM CELLS, V27, P1976, DOI 10.1002/stem.115; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Carpentier PA, 2009, NEURON, V64, P79, DOI 10.1016/j.neuron.2009.08.038; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Dezawa M, 2001, EUR J NEUROSCI, V14, P1771, DOI 10.1046/j.0953-816x.2001.01814.x; Ebert AD, 2008, EXP NEUROL, V209, P213, DOI 10.1016/j.expneurol.2007.09.022; Enzmann GU, 2006, J NEUROTRAUM, V23, P479, DOI 10.1089/neu.2006.23.479; Gimble JM, 2003, EXPERT OPIN BIOL TH, V3, P705, DOI 10.1517/14712598.3.5.705; Ha TY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008840; Heese K, 2006, NEUROSIGNALS, V15, P1, DOI 10.1159/000094383; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Huang TT, 2007, J SPINAL CORD MED, V30, pS35, DOI 10.1080/10790268.2007.11753967; Ikegaya Y, 2001, J CELL SCI, V114, P4083; Jeynes B, 2011, J NEUROSCI RES, V89, P22, DOI 10.1002/jnr.22527; Kalbermatten DF, 2011, CELL TISSUE RES, V344, P251, DOI 10.1007/s00441-011-1142-5; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Lee E, 2009, BMB REP, V42, P239, DOI 10.5483/BMBRep.2009.42.5.239; Lee HJ, 2010, NEUROSCI LETT, V481, P30, DOI 10.1016/j.neulet.2010.06.045; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lee ST, 2009, ANN NEUROL, V66, P671, DOI 10.1002/ana.21788; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lesne S, 2005, J NEUROSCI, V25, P9367, DOI 10.1523/JNEUROSCI.0849-05.2005; Liu N, 2009, CELL MOL IMMUNOL, V6, P207, DOI 10.1038/cmi.2009.28; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Mathieu P, 2010, J NEUROCHEM, V112, P1368, DOI 10.1111/j.1471-4159.2009.06548.x; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Park KI, 2006, EXP NEUROL, V199, P179, DOI 10.1016/j.expneurol.2006.03.016; Ra JC, 2011, SAFETY INTRAVENOUS I; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Yamasaki TR, 2007, J NEUROSCI, V27, P11925, DOI 10.1523/JNEUROSCI.1627-07.2007; Yang SH, 2009, EXP MOL MED, V41, P315, DOI 10.3858/emm.2009.41.5.035; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	41	97	105	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45757	10.1371/journal.pone.0045757	http://dx.doi.org/10.1371/journal.pone.0045757			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049854	gold, Green Submitted, Green Published			2022-12-27	WOS:000309517300051
J	McNulty, SN; Abubucker, S; Simon, GM; Mitreva, M; McNulty, NP; Fischer, K; Curtis, KC; Brattig, NW; Weil, GJ; Fischer, PU				McNulty, Samantha N.; Abubucker, Sahar; Simon, Gabriel M.; Mitreva, Makedonka; McNulty, Nathan P.; Fischer, Kerstin; Curtis, Kurt C.; Brattig, Norbert W.; Weil, Gary J.; Fischer, Peter U.			Transcriptomic and Proteomic Analyses of a Wolbachia-Free Filarial Parasite Provide Evidence of Trans-Kingdom Horizontal Gene Transfer	PLOS ONE			English	Article							LITOMOSOIDES-SIGMODONTIS; PROTEIN IDENTIFICATIONS; INTRACELLULAR BACTERIA; ABC TRANSPORTERS; GENOME; ENDOSYMBIONTS; PHYLOGENY; STRATEGY; SPECTRA; TOOLS	Most filarial parasites in the subfamilies Onchocercinae and Dirofilariinae depend on Wolbachia endobacteria to successfully carry out their life cycle. Recently published data indicate that the few Wolbachia-free species in these subfamilies were infected in the distant past and have subsequently shed their endosymbionts. We used an integrated transcriptomic and proteomic analysis of Onchocerca flexuosa to explore the molecular mechanisms that allow worms of this species to survive without a bacterial partner. Roche/454 sequencing of the adult transcriptome produced 16,814 isogroup and 47,252 singleton sequences that are estimated to represent approximately 41% of the complete gene set. Sequences similar to 97 Wolbachia genes were identified from the transcriptome, some of which appear on the same transcripts as sequences similar to nematode genes. Computationally predicted peptides, including those with similarity to Wolbachia proteins, were classified at the domain and pathway levels in order to assess the metabolic capabilities of O. flexuosa and compare against the Wolbachia-dependent model filaria, Brugia malayi. Transcript data further facilitated a shotgun proteomic analysis of O. flexuosa adult worm lysate, resulting in the identification of 1,803 proteins. Three of the peptides detected by mass spectroscopy map to two ABC transport-related proteins from Wolbachia. Antibodies raised to one of the Wolbachia-like peptides labeled a single 38 kDa band on Western blots of O. flexuosa lysate and stained specific worm tissues by immunohistology. Future studies will be required to determine the exact functions of Wolbachia-like peptides and proteins in O. flexuosa and to assess their roles in worm biology.	[McNulty, Samantha N.; Fischer, Kerstin; Curtis, Kurt C.; Weil, Gary J.; Fischer, Peter U.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA; [Abubucker, Sahar; Mitreva, Makedonka] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63110 USA; [Simon, Gabriel M.; McNulty, Nathan P.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63110 USA; [Mitreva, Makedonka] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Brattig, Norbert W.] Bernhard Nocht Inst Trop Med, Hamburg, Germany	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Bernhard Nocht Institut fur Tropenmedizin	McNulty, SN (corresponding author), Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA.	smcnulty@wustl.edu		Fischer, Peter/0000-0003-4558-3417; Mitreva, Makedonka/0000-0001-9572-3436	Barnes-Jewish Hospital Foundation; National Institutes of Health Grant [T32-AI007172]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172, R01AI081803] Funding Source: NIH RePORTER	Barnes-Jewish Hospital Foundation; National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Barnes-Jewish Hospital Foundation and by National Institutes of Health Grant T32-AI007172 to SNM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson R.C., 1976, CIH Keys Nematode Parasites Vert, VNo. 3, P59; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P377; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P541; [Anonymous], 2000, NEMATODE PARASITES V; Ardelli BF, 2007, T ROY SOC TROP MED H, V101, P1223, DOI 10.1016/j.trstmh.2005.03.019; Ardelli BF, 2004, ANN TROP MED PARASIT, V98, P371, DOI 10.1179/000349804225003415; ASH LR, 1970, J PARASITOL, V56, P969, DOI 10.2307/3277515; Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591; Bourguinat C, 2008, MOL BIOCHEM PARASIT, V158, P101, DOI 10.1016/j.molbiopara.2007.11.017; Buggiotti L, 2008, PROTEOMICS, V8, P2150, DOI 10.1002/pmic.200701006; Carpentier SC, 2008, MASS SPECTROM REV, V27, P354, DOI 10.1002/mas.20170; Casiraghi M, 2004, INT J PARASITOL, V34, P191, DOI 10.1016/j.ijpara.2003.10.004; Chan CX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004524; Choi YJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001409; Dafa'alla TH, 2000, MOL BIOCHEM PARASIT, V106, P37, DOI 10.1016/S0166-6851(99)00198-X; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; FATH MJ, 1993, MICROBIOL REV, V57, P995, DOI 10.1128/MMBR.57.4.995-1017.1993; Ferri E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020843; Fischer K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001174; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Hoerauf A, 1999, J CLIN INVEST, V103, P11, DOI 10.1172/JCI4768; Hoerauf A, 2003, MED MICROBIOL IMMUN, V192, P211, DOI 10.1007/s00430-002-0174-6; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Jiang DJ, 2008, INT J PARASITOL, V38, P503, DOI 10.1016/j.ijpara.2007.09.010; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin J, 2012, NUCLEIC ACIDS RES, V40, pD720, DOI 10.1093/nar/gkr1194; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; McNulty SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011029; Moreno Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001370; Nikoh N, 2008, GENOME RES, V18, P272, DOI 10.1101/gr.7144908; Noutsos C, 2007, TRENDS GENET, V23, P597, DOI 10.1016/j.tig.2007.08.016; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; PLENGEBONIG A, 1995, PARASITOL RES, V81, P66, DOI 10.1007/BF00932419; Ramani AK, 2011, GENOME RES; Slatko BE, 2010, SYMBIOSIS, V51, P55, DOI 10.1007/s13199-010-0067-1; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Tompkins JB, 2011, PARASITOL RES, V109, P1311, DOI 10.1007/s00436-011-2378-4; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wasmuth James, 2009, V533, P221, DOI 10.1007/978-1-60327-136-3_10; Wasmuth JD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-187; Xu T, 2006, MOL CELL PROTEOMICS, V5, pS174; Yakushi T, 2000, NAT CELL BIOL, V2, P212, DOI 10.1038/35008635; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	49	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45777	10.1371/journal.pone.0045777	http://dx.doi.org/10.1371/journal.pone.0045777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049857	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000309517300052
J	Bifulco, K; Longanesi-Cattani, I; Franco, P; Pavone, V; Mugione, P; Di Carluccio, G; Masucci, MT; Arra, C; Pirozzi, G; Stoppelli, MP; Carriero, MV				Bifulco, Katia; Longanesi-Cattani, Immacolata; Franco, Paola; Pavone, Vincenzo; Mugione, Pietro; Di Carluccio, Gioconda; Masucci, Maria Teresa; Arra, Claudio; Pirozzi, Giuseppe; Stoppelli, Maria Patrizia; Carriero, Maria Vincenza			Single Amino Acid Substitutions in the Chemotactic Sequence of Urokinase Receptor Modulate Cell Migration and Invasion	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; FORMYL PEPTIDE RECEPTOR; VITRONECTIN RECEPTOR; CRYSTAL-STRUCTURE; DEFICIENT MICE; BREAST-CANCER; UPAR; ADHESION; BINDING; LIGAND	The receptor for urokinase-type plasminogen activator (uPAR) plays an important role in controlling cell migration. uPAR binds urokinase and vitronectin extracellular ligands, and signals in complex with transmembrane receptors such as Formylpeptide Receptors (FPR)s and integrins. Previous work from this laboratory has shown that synthetic peptides, corresponding to the uPAR(88-92) chemotactic sequence, when carrying the S90P or S90E substitutions, up-or down-regulate cell migration, respectively. To gain mechanistic insights into these opposite cell responses, the functional consequences of S90P and S90E mutations in full-length uPAR were evaluated. First, (HEK)-293 embryonic kidney cells expressing uPAR S90P exhibit enhanced FPR activation, increased random and directional cell migration, long-lasting Akt phosphorylation, and increased adhesion to vitronectin, as well as uPAR/vitronectin receptor association. In contrast, the S90E substitution prevents agonist-triggered FPR activation and internalization, decreases binding and adhesion to vitronectin, and inhibits uPAR/vitronectin receptor association. Also, 293/uPAR(S90P) cells appear quite elongated and their cytoskeleton well organized, whereas 293/uPARS(90E) cells assume a large flattened morphology, with random orientation of actin filaments. Interestingly, when HT1080 cells co-express wild type uPAR with uPAR S90E, the latter behaves as a dominant-negative, impairing uPAR-mediated signaling and reducing cell wound repair as well as lung metastasis in nude mice. In contrast, signaling, wound repair and in vivo lung metastasis of HT1080 cells bearing wild type uPAR are enhanced when they co-express uPAR(S90P). In conclusion, our findings indicate that Ser(90) is a critical residue for uPAR signaling and that the S90P and S90E exert opposite effects on uPAR activities. These findings may be accommodated in a molecular model, in which uPAR(S90E) and uPAR(S90P) are forced into inactive and active forms, respectively, suggesting important implications for the development of novel drugs targeting uPAR function.	[Bifulco, Katia; Longanesi-Cattani, Immacolata; Mugione, Pietro; Di Carluccio, Gioconda; Masucci, Maria Teresa; Arra, Claudio; Pirozzi, Giuseppe; Carriero, Maria Vincenza] Natl Canc Inst Naples, Dept Expt Oncol, Naples, Italy; [Franco, Paola; Stoppelli, Maria Patrizia] CNR, Inst Genet & Biophys Adriano Buzzati Traverso, Naples, Italy; [Pavone, Vincenzo] Univ Naples Federico II, Dept Chem Sci, Naples, Italy	IRCCS Fondazione Pascale; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Naples Federico II	Carriero, MV (corresponding author), Natl Canc Inst Naples, Dept Expt Oncol, Naples, Italy.	mariolinacarriero@yahoo.it	Franco, Paola/O-5897-2015; Pavone, Vincenzo/D-1688-2011; Carriero, Maria Vincenza/K-1240-2018	Franco, Paola/0000-0002-3289-7284; Pavone, Vincenzo/0000-0001-6432-0802; Carriero, Maria Vincenza/0000-0002-9768-2997; Arra, Claudio/0000-0003-3162-2091; MASUCCI, Maria Teresa/0000-0001-5213-6557; Di Carluccio, Gioconda/0000-0002-3571-9889	AIRC (Associazione Italiana per la Ricerca sul Cancro) [10251]; ESF (European Science Foundation) [M.L.SHC-CT-2003-503237]; MERIT (MEdical Research in ITaly) [RBNE08YFN3]	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); ESF (European Science Foundation)(European Science Foundation (ESF)); MERIT (MEdical Research in ITaly)	This work was supported by AIRC (Associazione Italiana per la Ricerca sul Cancro) 2010, project 10251, ESF (European Science Foundation), Eurocore Project contact M.L.SHC-CT-2003-503237 and MERIT (MEdical Research in ITaly) n. RBNE08YFN3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bifulco K, 2010, J THROMB HAEMOST, V8, P2789, DOI 10.1111/j.1538-7836.2010.04075.x; Bifulco K, 2008, FEBS LETT, V582, P1141, DOI 10.1016/j.febslet.2008.03.001; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Carriero MV, 2011, CURR PHARM DESIGN, V17, P1944; Carriero MV, 2009, MOL CANCER THER, V8, P2708, DOI 10.1158/1535-7163.MCT-09-0174; Carriero MV, 1999, CANCER RES, V59, P5307; Carriero MV, 1997, CLIN CANCER RES, V3, P1299; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Deng G, 1996, J CELL BIOL, V134, P1563, DOI 10.1083/jcb.134.6.1563; Eden G, 2011, CURR PHARM DESIGN, V17, P1874, DOI 10.2174/138161211796718215; ELLIS V, 1989, J BIOL CHEM, V264, P2185; Fazioli F, 1997, EMBO J, V16, P7279, DOI 10.1093/emboj/16.24.7279; Flores SC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-167; Franco P, 2006, J CELL SCI, V119, P3424, DOI 10.1242/jcs.03067; Furlan F, 2004, J CELL SCI, V117, P2909, DOI 10.1242/jcs.01149; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Gardsvoll H, 2011, J BIOL CHEM, V286, P43515, DOI 10.1074/jbc.M111.300020; Gardsvoll H, 2011, J BIOL CHEM, V286, P33544, DOI 10.1074/jbc.M111.220087; Gargiulo L, 2005, J BIOL CHEM, V280, P25225, DOI 10.1074/jbc.M412605200; Gavins FNE, 2010, TRENDS PHARMACOL SCI, V31, P266, DOI 10.1016/j.tips.2010.04.001; Gyetko MR, 2004, J LEUKOCYTE BIOL, V76, P648, DOI 10.1189/jlb.0104023; Hellriegel C, 2011, FASEB J, V25, P2883, DOI 10.1096/fj.11-181537; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; Huang J, 2010, BRIT J CANCER, V102, P1052, DOI 10.1038/sj.bjc.6605591; Kim MK, 2007, FEBS LETT, V581, P1917, DOI 10.1016/j.febslet.2007.03.078; Kjaergaard M, 2008, FRONT BIOSCI-LANDMRK, V13, P5441, DOI 10.2741/3092; Kjoller L, 2001, J CELL BIOL, V152, P1145, DOI 10.1083/jcb.152.6.1145; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; Mazar AP, 2011, CURR PHARM DESIGN, V17, P1970; MCCOY R, 1995, J EXP MED, V182, P207, DOI 10.1084/jem.182.1.207; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; Montuori N, 2011, CELL MOL LIFE SCI, V68, P2453, DOI 10.1007/s00018-010-0564-7; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Rescher U, 2002, J IMMUNOL, V169, P1500, DOI 10.4049/jimmunol.169.3.1500; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Selleri C, 2005, BLOOD, V105, P2198, DOI 10.1182/blood-2004-06-2424; Selleri C, 2006, CANCER RES, V66, P10885, DOI 10.1158/0008-5472.CAN-06-1311; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Silvestri I, 2002, INT J CANCER, V102, P562, DOI 10.1002/ijc.10744; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Xu X, 2012, J MOL BIOL, V416, P629, DOI 10.1016/j.jmb.2011.12.058; Yuan C, 2007, CELL MOL LIFE SCI, V64, P1033, DOI 10.1007/s00018-007-6498-z	50	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44806	10.1371/journal.pone.0044806	http://dx.doi.org/10.1371/journal.pone.0044806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049759	gold, Green Submitted, Green Published			2022-12-27	WOS:000309556100022
J	Di Nunzio, F; Danckaert, A; Fricke, T; Perez, P; Fernandez, J; Perret, E; Roux, P; Shorte, S; Charneau, P; Diaz-Griffero, F; Arhel, NJ				Di Nunzio, Francesca; Danckaert, Anne; Fricke, Thomas; Perez, Patricio; Fernandez, Juliette; Perret, Emmanuelle; Roux, Pascal; Shorte, Spencer; Charneau, Pierre; Diaz-Griffero, Felipe; Arhel, Nathalie J.			Human Nucleoporins Promote HIV-1 Docking at the Nuclear Pore, Nuclear Import and Integration	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MESSENGER-RNA EXPORT; CENTRAL DNA FLAP; NUCLEOCYTOPLASMIC TRANSPORT; IN-VIVO; PREINTEGRATION COMPLEX; REVERSE TRANSCRIPTION; NONDIVIDING CELLS; GENE-EXPRESSION; PROTEIN EXPORT	The nuclear pore complex (NPC) mediates nucleo-cytoplasmic transport of macromolecules and is an obligatory point of passage and functional bottleneck in the replication of some viruses. The Human Immunodeficiency Virus (HIV) has evolved the required mechanisms for active nuclear import of its genome through the NPC. However the mechanisms by which the NPC allows or even assists HIV translocation are still unknown. We investigated the involvement of four key nucleoporins in HIV-1 docking, translocation, and integration: Nup358/RanBP2, Nup214/CAN, Nup98 and Nup153. Although all induce defects in infectivity when depleted, only Nup153 actually showed any evidence of participating in HIV-1 translocation through the nuclear pore. We show that Nup358/RanBP2 mediates docking of HIV-1 cores on NPC cytoplasmic filaments by interacting with the cores and that the C-terminus of Nup358/RanBP2 comprising a cyclophilin-homology domain contributes to binding. We also show that Nup214/CAN and Nup98 play no role in HIV-1 nuclear import per se: Nup214/CAN plays an indirect role in infectivity read-outs through its effect on mRNA export, while the reduction of expression of Nup98 shows a slight reduction in proviral integration. Our work shows the involvement of nucleoporins in diverse and functionally separable steps of HIV infection and nuclear import.	[Di Nunzio, Francesca; Fernandez, Juliette; Charneau, Pierre; Arhel, Nathalie J.] Inst Pasteur, Mol Virol & Vaccinol Unit, CNRS, URA 3015,Dept Virol, Paris, France; [Danckaert, Anne; Perret, Emmanuelle; Roux, Pascal; Shorte, Spencer] Inst Pasteur, Imagopole, Paris, France; [Fricke, Thomas; Perez, Patricio; Diaz-Griffero, Felipe] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Yeshiva University; Albert Einstein College of Medicine	Arhel, NJ (corresponding author), Hop St Louis, INSERM, UMR S 941, Paris, France.	nathalie.arhel@inserm.fr	Fricke, Thomas/B-6885-2013; CHARNEAU, Pierre/M-1565-2017; fernandez, juliette/D-4600-2016; Di Nunzio, Francesca/A-6153-2014	CHARNEAU, Pierre/0000-0003-1184-5773; fernandez, juliette/0000-0003-2969-8150; Di Nunzio, Francesca/0000-0003-2879-3164; Shorte, Spencer/0000-0002-2125-8663; Arhel, Nathalie/0000-0001-5309-1725	CNRS (Centre National de Recherche Scientifique); ANRS (Agence Nationale de Recherche sur le SIDA); FRM (Fondation pour la Recherche Medicale); Sidaction; Pasteur Institute; European Union; National Institutes of Health [R01 AI087390, 4R00MH086162-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R00MH086162] Funding Source: NIH RePORTER	CNRS (Centre National de Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); ANRS (Agence Nationale de Recherche sur le SIDA)(ANRSFrench National Research Agency (ANR)); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); Sidaction; Pasteur Institute; European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by the CNRS (Centre National de Recherche Scientifique), the ANRS (Agence Nationale de Recherche sur le SIDA), the FRM (Fondation pour la Recherche Medicale), the Sidaction, the Pasteur Institute and the European Union. ML, PP and FDG were supported by an National Institutes of Health R01 AI087390 grant and a pathway to independence award 4R00MH086162-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TD, 2000, J CELL SCI, V113, P1651; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Arhel N, 2006, NAT METHODS, V3, P817, DOI 10.1038/nmeth928; Arhel N, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-96; Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; Arhel NJ, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-38; Bastos R, 1996, J CELL BIOL, V134, P1141, DOI 10.1083/jcb.134.5.1141; Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004; BORMAN AM, 1995, J VIROL, V69, P2058, DOI 10.1128/JVI.69.4.2058-2067.1995; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Cohen S, 2011, BBA-MOL CELL RES, V1813, P1634, DOI 10.1016/j.bbamcr.2010.12.009; Copeland AM, 2009, J VIROL, V83, P1660, DOI 10.1128/JVI.01139-08; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; Ebina H, 2004, MICROBES INFECT, V6, P715, DOI 10.1016/j.micinf.2004.04.002; Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861; Fassati A, 2003, EMBO J, V22, P3675, DOI 10.1093/emboj/cdg357; Fassati A, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-74; Fontoura BMA, 1999, J CELL BIOL, V144, P1097, DOI 10.1083/jcb.144.6.1097; Galat A, 2010, CELL MOL LIFE SCI, V67, P3467, DOI 10.1007/s00018-010-0437-0; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Greber UF, 2003, TRAFFIC, V4, P136, DOI 10.1034/j.1600-0854.2003.00114.x; Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kalverda B, 2010, CELL, V140, P360, DOI 10.1016/j.cell.2010.01.011; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Liang Y, 2011, CURR OPIN CELL BIOL, V23, P65, DOI 10.1016/j.ceb.2010.09.008; Lienlaf M, 2011, J VIROL, V85, P8725, DOI 10.1128/JVI.00497-11; Lowe AR, 2010, NATURE, V467, P600, DOI 10.1038/nature09285; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Marechal V, 1998, J VIROL, V72, P2208; Matreyek KA, 2011, J VIROL, V85, P7818, DOI 10.1128/JVI.00325-11; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Ojala PM, 2000, MOL CELL BIOL, V20, P4922, DOI 10.1128/MCB.20.13.4922-4931.2000; Pasdeloup D, 2009, J VIROL, V83, P6610, DOI 10.1128/JVI.02655-08; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Rode K, 2011, J VIROL, V85, P4271, DOI 10.1128/JVI.02067-10; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Trotman LC, 2001, NAT CELL BIOL, V3, P1092, DOI 10.1038/ncb1201-1092; Ullman KS, 1999, MOL BIOL CELL, V10, P649, DOI 10.1091/mbc.10.3.649; vanDeursen J, 1996, EMBO J, V15, P5574, DOI 10.1002/j.1460-2075.1996.tb00942.x; Vaquerizas JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000846; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088; Warrilow D, 2009, REV MED VIROL, V19, P324, DOI 10.1002/rmv.627; Woodward CL, 2009, J VIROL, V83, P6522, DOI 10.1128/JVI.02061-08; Wozniak R, 2010, CELL MOL LIFE SCI, V67, P2215, DOI 10.1007/s00018-010-0325-7; WU J, 1995, J BIOL CHEM, V270, P14209, DOI 10.1074/jbc.270.23.14209; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Zaitseva L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-11; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhang RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015620; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004; Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642	80	112	113	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46037	10.1371/journal.pone.0046037	http://dx.doi.org/10.1371/journal.pone.0046037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049930	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100124
J	Frynta, D; Baudysova, J; Hradcova, P; Faltusova, K; Kratochvil, L				Frynta, Daniel; Baudysova, Jana; Hradcova, Petra; Faltusova, Katerina; Kratochvil, Lukas			Allometry of Sexual Size Dimorphism in Domestic Dog	PLOS ONE			English	Article							RENSCHS RULE; BODY-SIZE; EVOLUTION; SELECTION; HAPLOTYPE; ORIGIN; CHROMOSOME; CANIDAE; PATTERN	Background: The tendency for male-larger sexual size dimorphism (SSD) to scale with body size - a pattern termed Rensch's rule - has been empirically supported in many animal lineages. Nevertheless, its theoretical elucidation is a subject of debate. Here, we exploited the extreme morphological variability of domestic dog (Canis familiaris) to gain insights into evolutionary causes of this rule. Methodology/Principal Findings: We studied SSD and its allometry among 74 breeds ranging in height from less than 19 cm in Chihuahua to about 84 cm in Irish wolfhound. In total, the dataset included 6,221 individuals. We demonstrate that most dog breeds are male-larger, and SSD in large breeds is comparable to SSD of their wolf ancestor. Among breeds, SSD becomes smaller with decreasing body size. The smallest breeds are nearly monomorphic. Conclusions/Significance: SSD among dog breeds follows the pattern consistent with Rensch's rule. The variability of body size and corresponding changes in SSD among breeds of a domestic animal shaped by artificial selection can help to better understand processes leading to emergence of Rensch's rule.	[Kratochvil, Lukas] Charles Univ Prague, Dept Ecol, Fac Sci, Prague, Czech Republic; [Frynta, Daniel; Baudysova, Jana; Hradcova, Petra; Faltusova, Katerina] Charles Univ Prague, Dept Zool, Fac Sci, Prague, Czech Republic	Charles University Prague; Charles University Prague	Kratochvil, L (corresponding author), Charles Univ Prague, Dept Ecol, Fac Sci, Prague, Czech Republic.	lukas.kratochvil@natur.cuni.cz	Kratochvil, Lukas/M-2134-2019; Faltusova, Katerina/AAI-2315-2021; Frynta, Daniel/L-7350-2016; Kratochvíl, Lukáš/A-1997-2008; Faltusova, Katerina/M-5303-2017	Faltusova, Katerina/0000-0003-4260-8797; Frynta, Daniel/0000-0002-1375-7972; Kratochvíl, Lukáš/0000-0002-3515-729X; Faltusova, Katerina/0000-0003-4260-8797	Grant Agency of the Czech Academy of Sciences [IAA6111410]; Czech Science Foundation [206-05-H012, 206/09/0895]	Grant Agency of the Czech Academy of Sciences(Grant Agency of the Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	The project was supported by the Grant Agency of the Czech Academy of Sciences (project No. IAA6111410). The personal costs of K.F. were provided by the Czech Science Foundation (project No. 206-05-H012). L.K. was supported by the Czech Science Foundation (project No. 206/09/0895). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouheif E, 1997, AM NAT, V149, P540, DOI 10.1086/286004; Andersson Malte, 1994; Bannasch DL, 2005, MAMM GENOME, V16, P273, DOI 10.1007/s00335-004-2435-8; Bardeleben C, 2005, MOL PHYLOGENET EVOL, V37, P815, DOI 10.1016/j.ympev.2005.07.019; Blanckenhorn WU, 2006, EVOLUTION, V60, P2004, DOI 10.1111/j.0014-3820.2006.tb01838.x; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Chase K, 2005, GENOME RES, V15, P1820, DOI 10.1101/gr.3712705; Colwell RK, 2000, AM NAT, V156, P495, DOI 10.1086/303406; Cox Robert M., 2007, P38; Dale J, 2007, P ROY SOC B-BIOL SCI, V274, P2971, DOI 10.1098/rspb.2007.1043; Darwin C., 1871, P423; Darwin C, 1859, ORIGIN SPECIES MEANS; Darwin CR., 1868, VARIATION ANIMALS PL, DOI DOI 10.1371/journal.pbio.0040088; Drake AG, 2010, AM NAT, V175, P289, DOI 10.1086/650372; FAIRBAIRN DJ, 1994, AM NAT, V144, P101, DOI 10.1086/285663; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Federation Cynologique Internationale, 2008, NOM STAND; Geffen E, 1996, AM NAT, V147, P140, DOI 10.1086/285844; Gray MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-16; Gundry RL, 2007, J FORENSIC SCI, V52, P562, DOI 10.1111/j.1556-4029.2007.00425.x; Herre W, 1980, NOVA ACTA LEOPOLDINA, V241, P1; Irion DN, 2003, J HERED, V94, P81, DOI 10.1093/jhered/esg004; Isaac JL, 2005, MAMMAL REV, V35, P101, DOI 10.1111/j.1365-2907.2005.00045.x; Kratochvil L, 2002, BIOL J LINN SOC, V76, P303, DOI 10.1046/j.1095-8312.2002.00064.x; Kratochvil Lukas, 2007, P154; Kutzler MA, 2003, THERIOGENOLOGY, V60, P1309, DOI 10.1016/S0093-691X(03)00146-8; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Leonard JA, 2002, SCIENCE, V298, P1613, DOI 10.1126/science.1076980; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lindenfors Patrik, 2007, P16; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Macdonald D.W., 2004, CANIDS FOXES WOLVES; MCARDLE BH, 1988, CAN J ZOOL, V66, P2329, DOI 10.1139/z88-348; Moehlman Patricia D., 1997, P76; MOREY DF, 1994, AM SCI, V82, P336; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Pionnier-Capitan M, 2011, J ARCHAEOL SCI, V38, P2123, DOI 10.1016/j.jas.2011.02.028; Polak J, 2010, EVOL ECOL, V24, P1255, DOI 10.1007/s10682-010-9354-9; Polak J, 2009, BIOL J LINN SOC, V98, P872, DOI 10.1111/j.1095-8312.2009.01294.x; Remes V, 2010, J EVOLUTION BIOL, V23, P2754, DOI 10.1111/j.1420-9101.2010.02126.x; Rensch B., 1950, Bonner Zoologische Beitraege, V1, P58; Rensch B., 1959, EVOLUTION SPECIES LE; Ricankova V, 2004, ZOOL SCRI, V33, P311; Savolainen P, 2004, P NATL ACAD SCI USA, V101, P12387, DOI 10.1073/pnas.0401814101; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Shearin AL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000310; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; Sol D, 2008, BIOL J LINN SOC, V93, P657, DOI 10.1111/j.1095-8312.2008.00957.x; Starostova Z, 2010, J EVOLUTION BIOL, V23, P670, DOI 10.1111/j.1420-9101.2010.01933.x; StatSoft Inc, STATISTICA VERS 6 0; Stephens PR, 2009, EVOLUTION, V63, P910, DOI 10.1111/j.1558-5646.2008.00597.x; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Sundqvist AK, 2006, GENETICS, V172, P1121, DOI 10.1534/genetics.105.042358; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Sutter NB, 2008, MAMM GENOME, V19, P713, DOI 10.1007/s00335-008-9153-6; Szekely Tamas, 2007, P27; Trut LN, 1999, AM SCI, V87, P160, DOI 10.1511/1999.20.813; Vila C, 1999, J HERED, V90, P71, DOI 10.1093/jhered/90.1.71; Vila C, 1997, SCIENCE, V276, P1687, DOI 10.1126/science.276.5319.1687; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Walker SPW, 2009, P ROY SOC B-BIOL SCI, V276, P3335, DOI 10.1098/rspb.2009.0767; Wang W, 2005, GENOME RES, V15, P1798, DOI 10.1101/gr.3765505; WAYNE RK, 1986, EVOLUTION, V40, P243, DOI 10.1111/j.1558-5646.1986.tb00467.x; Webb TJ, 2007, PLOS ONE, V2007, P1	65	28	29	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46125	10.1371/journal.pone.0046125	http://dx.doi.org/10.1371/journal.pone.0046125			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049956	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100140
J	van Alphen, LB; Burt, SA; Veenendaal, AKJ; Bleumink-Pluym, NMC; van Putten, JPM				van Alphen, Lieke B.; Burt, Sara A.; Veenendaal, Andreas K. J.; Bleumink-Pluym, Nancy M. C.; van Putten, Jos P. M.			The Natural Antimicrobial Carvacrol Inhibits Campylobacter jejuni Motility and Infection of Epithelial Cells	PLOS ONE			English	Article							PATHOGEN BACILLUS-CEREUS; PLANT OIL AROMATICS; ESCHERICHIA-COLI; LISTERIA-MONOCYTOGENES; MAMMALIAN-CELLS; INVASION; PROTEIN; ADHERENCE; MEMBRANES; IDENTIFICATION	Background: Natural compounds with anti-microbial properties are attractive reagents to reduce the use of conventional antibiotics. Carvacrol, the main constituent of oregano oil, inhibits the growth of a variety of bacterial foodborne pathogens. As concentrations of carvacrol may vary in vivo or when used in animal feed, we here investigated the effect of subinhibitory concentrations of the compound on major virulence traits of the principal bacterial foodborne pathogen Campylobacter jejuni. Methods/Principal Findings: Motility assays revealed that subinhibitory concentrations of carvacrol inhibited the motility of C. jejuni without affecting bacterial growth. Immunoblotting and electron microscopy showed that carvacrol-treated C. jejuni still expressed flagella. The loss of motility was not caused by reduced intracellular ATP levels. In vitro infection assays demonstrated that subinhibitory concentrations of carvacrol also abolished C. jejuni invasion of human epithelial cells. Bacterial uptake of invasive Escherichia coli was not blocked by carvacrol. Exposure of C. jejuni to carvacrol prior to infection also inhibited cellular infection, indicating that the inhibition of invasion was likely caused by an effect on the bacteria rather than inhibition of epithelial cell function. Conclusions/Significance: Bacterial motility and invasion of eukaryotic cells are considered key steps in C. jejuni infection. Our results indicate that subinhibitory concentrations of carvacrol effectively block these virulence traits by interfering with flagella function without disturbing intracellular ATP levels. These results broaden the spectrum of anti-microbial activity of carvacrol and support the potential of the compound for use in novel infection prevention strategies.	[van Alphen, Lieke B.; Veenendaal, Andreas K. J.; Bleumink-Pluym, Nancy M. C.; van Putten, Jos P. M.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Burt, Sara A.] Univ Utrecht, Fac Vet Med, Inst Risk Assessment Sci, Utrecht, Netherlands	Utrecht University; Utrecht University	van Putten, JPM (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	j.vanputten@uu.nl		van Putten, Jos/0000-0002-4126-8172	Utrecht University, the Netherlands; European Union [PERG02-GA-2007-224937]	Utrecht University, the Netherlands(Netherlands Government); European Union(European Commission)	This research received financial support from Utrecht University, the Netherlands and the European Union to A.K.J.V. (Grant: PERG02-GA-2007-224937). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Bachtiar BM, 2007, FEMS IMMUNOL MED MIC, V49, P149, DOI 10.1111/j.1574-695X.2006.00182.x; Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Burt SA, 2007, APPL ENVIRON MICROB, V73, P4484, DOI 10.1128/AEM.00340-07; BUTZLER JP, 1991, INT J FOOD MICROBIOL, V12, P1, DOI 10.1016/0168-1605(91)90043-O; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; Di Pasqua R, 2006, J AGR FOOD CHEM, V54, P2745, DOI 10.1021/jf052722l; Di Pasqua R, 2007, J AGR FOOD CHEM, V55, P4863, DOI 10.1021/jf0636465; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; ENDTZ HP, 1993, RES MICROBIOL, V144, P703, DOI 10.1016/0923-2508(93)90034-Y; Fabian D, 2006, TOXICOL IN VITRO, V20, P1435, DOI 10.1016/j.tiv.2006.06.012; Fernando U, 2007, INT J FOOD MICROBIOL, V118, P194, DOI 10.1016/j.ijfoodmicro.2007.07.038; Friedman M, 2002, J FOOD PROTECT, V65, P1545, DOI 10.4315/0362-028X-65.10.1545; Gascon J, 2006, DIGESTION, V73, P102, DOI 10.1159/000089785; Gill AO, 2006, INT J FOOD MICROBIOL, V111, P170, DOI 10.1016/j.ijfoodmicro.2006.04.046; Gill AO, 2006, INT J FOOD MICROBIOL, V108, P1, DOI 10.1016/j.ijfoodmicro.2005.10.009; GRANT CCR, 1993, INFECT IMMUN, V61, P1764, DOI 10.1128/IAI.61.5.1764-1771.1993; Griggs DJ, 2009, ANTIMICROB AGENTS CH, V53, P3357, DOI 10.1128/AAC.01655-08; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Hagmuller W, 2006, BERL MUNCH TIERARZTL, V119, P50; Hannu T, 2002, RHEUMATOLOGY, V41, P312, DOI 10.1093/rheumatology/41.3.312; Havelaar AH, 2009, CRIT REV MICROBIOL, V35, P1, DOI 10.1080/10408410802636017; Helander IM, 1998, J AGR FOOD CHEM, V46, P3590, DOI 10.1021/jf980154m; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; ISBERG RR, 1987, CELL, V50, P769, DOI 10.1016/0092-8674(87)90335-7; ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z; Jin SM, 2001, MOL MICROBIOL, V39, P1225, DOI 10.1046/j.1365-2958.2001.02294.x; Louwen R, 2008, INFECT IMMUN, V76, P4431, DOI 10.1128/IAI.00321-08; Manzanilla EG, 2006, J ANIM SCI, V84, P2743, DOI 10.2527/jas.2005-509; MCSWEEGAN E, 1986, INFECT IMMUN, V53, P141, DOI 10.1128/IAI.53.1.141-148.1986; Monteville MR, 2003, MICROBIOL-SGM, V149, P153, DOI 10.1099/mic.0.25820-0; Moser I, 1997, FEMS MICROBIOL LETT, V157, P233, DOI 10.1016/S0378-1097(97)00480-1; Oussalah M, 2006, J FOOD PROTECT, V69, P1046, DOI 10.4315/0362-028X-69.5.1046; PALMER SR, 1983, LANCET, V1, P287, DOI 10.1016/S0140-6736(83)91698-7; Pei ZH, 1998, INFECT IMMUN, V66, P938, DOI 10.1128/IAI.66.3.938-943.1998; Ravishankar S, 2008, J FOOD PROTECT, V71, P1145, DOI 10.4315/0362-028X-71.6.1145; Szymanski CM, 2002, INFECT IMMUN, V70, P2242, DOI 10.1128/IAI.70.4.2242-2244.2002; SZYMANSKI CM, 1995, INFECT IMMUN, V63, P4295, DOI 10.1128/IAI.63.11.4295-4300.1995; Till D, 2008, J WATER HEALTH, V6, P443, DOI 10.2166/wh.2008.071; Ultee A, 1999, APPL ENVIRON MICROB, V65, P4606; Ultee A, 2002, APPL ENVIRON MICROB, V68, P1561, DOI 10.1128/AEM.68.4.1561-1568.2002; Ultee A, 2001, INT J FOOD MICROBIOL, V64, P373, DOI 10.1016/S0168-1605(00)00480-3; van Alphen LB, 2008, CELL MICROBIOL, V10, P53, DOI 10.1111/j.1462-5822.2007.01014.x; van Putten JPM, 2009, CURR TOP MICROBIOL, V337, P197, DOI 10.1007/978-3-642-01846-6_7; WASSENAAR TM, 1991, EMBO J, V10, P2055, DOI 10.1002/j.1460-2075.1991.tb07736.x; Wosten MMSM, 2010, MOL MICROBIOL, V75, P1577, DOI 10.1111/j.1365-2958.2010.07079.x; Wosten MMSM, 2004, J BIOL CHEM, V279, P16214, DOI 10.1074/jbc.M400357200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; YAO RJ, 1994, MOL MICROBIOL, V14, P883, DOI 10.1111/j.1365-2958.1994.tb01324.x	50	50	50	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45343	10.1371/journal.pone.0045343	http://dx.doi.org/10.1371/journal.pone.0045343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049787	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100039
J	Zhu, J; Shao, CY; Yang, W; Zhang, XM; Wu, ZY; Zhou, L; Wang, XX; Li, YH; Xia, J; Luo, JH; Shen, Y				Zhu, Jia; Shao, Chong-Yu; Yang, Wei; Zhang, Xiao-Min; Wu, Zhen-Yong; Zhou, Liang; Wang, Xin-Xin; Li, Yun-Hong; Xia, Jun; Luo, Jian-Hong; Shen, Ying			Chronic Zinc Exposure Decreases the Surface Expression of NR2A-Containing NMDA Receptors in Cultured Hippocampal Neurons	PLOS ONE			English	Article							METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; HISTOCHEMICALLY-REACTIVE ZINC; ALZHEIMERS-DISEASED BRAINS; PROTEIN-TYROSINE KINASES; AIRWAY EPITHELIAL-CELLS; CEREBRAL-ISCHEMIA; CORTICAL-NEURONS; MOLECULAR-ORGANIZATION; EXCITATORY SYNAPSES	Background: Zinc distributes widely in the central nervous system, especially in the hippocampus, amygdala and cortex. The dynamic balance of zinc is critical for neuronal functions. Zinc modulates the activity of N-methyl-D-aspartate receptors (NMDARs) through the direct inhibition and various intracellular signaling pathways. Abnormal NMDAR activities have been implicated in the aetiology of many brain diseases. Sustained zinc accumulation in the extracellular fluid is known to link to pathological conditions. However, the mechanism linking this chronic zinc exposure and NMDAR dysfunction is poorly understood. Methodology/Principal Findings: We reported that chronic zinc exposure reduced the numbers of NR1 and NR2A clusters in cultured hippocampal pyramidal neurons. Whole-cell and synaptic NR2A-mediated currents also decreased. By contrast, zinc did not affect NR2B, suggesting that chronic zinc exposure specifically influences NR2A-containg NMDARs. Surface biotinylation indicated that zinc exposure attenuated the membrane expression of NR1 and NR2A, which might arise from to the dissociation of the NR2A-PSD-95-Src complex. Conclusions: Chronic zinc exposure perturbs the interaction of NR2A to PSD-95 and causes the disorder of NMDARs in hippocampal neurons, suggesting a novel action of zinc distinct from its acute effects on NMDAR activity.	[Zhu, Jia; Shao, Chong-Yu; Yang, Wei; Zhang, Xiao-Min; Wu, Zhen-Yong; Zhou, Liang; Wang, Xin-Xin; Luo, Jian-Hong; Shen, Ying] Zhejiang Univ, Sch Med, Dept Neurobiol, Key Lab Med Neurobiol,Minist Hlth,Zhejiang Prov K, Hangzhou 310003, Zhejiang, Peoples R China; [Xia, Jun] Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; [Li, Yun-Hong] Ningxia Med Univ, Dept Neurobiol, Ctr Sci Technol, Cranial Cerebral Dis Lab, Yinchuan, Peoples R China	Zhejiang University; Hong Kong University of Science & Technology; Ningxia Medical University	Shen, Y (corresponding author), Zhejiang Univ, Sch Med, Dept Neurobiol, Key Lab Med Neurobiol,Minist Hlth,Zhejiang Prov K, Hangzhou 310003, Zhejiang, Peoples R China.	yshen@zju.edu.cn	Luo, jian/HGE-7331-2022; Yang, Wei/HIA-0360-2022; Yang, Wei/GWV-4107-2022; shen, ying/HHS-5635-2022; wang, xinxin/HIR-2598-2022; Xia, Jun/C-7234-2009	Xia, Jun/0000-0001-9308-2188; Zhang, Xiaomin/0000-0002-1179-979X	National Basic Research Program (973) of Ministry of Science and Technology of China [2009CB94140, 2011CB5044000]; National Foundation of Natural Science of China [30600168, 31070945, 30960108, 31060140]; National Foundation of Natural Science [30731160616, N_HKUST605/07]; Research Grants Council of Hong Kong, China [30731160616, N_HKUST605/07]; New Century Talent Award of Ministry of Education of China [NCET-07-0751]; Zhejiang Provincial Foundation of Natural Science of China [R206018]	National Basic Research Program (973) of Ministry of Science and Technology of China(National Basic Research Program of China); National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); National Foundation of Natural Science(National Natural Science Foundation of China (NSFC)); Research Grants Council of Hong Kong, China(Hong Kong Research Grants Council); New Century Talent Award of Ministry of Education of China; Zhejiang Provincial Foundation of Natural Science of China	This work was supported by grants from National Basic Research Program (973) of Ministry of Science and Technology of China (2009CB94140 and 2011CB5044000), National Foundation of Natural Science of China (30600168, 31070945, 30960108 and 31060140), joint grant from the National Foundation of Natural Science and the Research Grants Council of Hong Kong, China (30731160616 and N_HKUST605/07), New Century Talent Award of Ministry of Education of China (NCET-07-0751), and Zhejiang Provincial Foundation of Natural Science of China (R206018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aras MA, 2009, EUR J NEUROSCI, V30, P2250, DOI 10.1111/j.1460-9568.2009.07026.x; Bellinger FP, 2002, SYNAPSE, V43, P95, DOI 10.1002/syn.10020; Bernabeu R, 2000, J CEREBR BLOOD F MET, V20, P1669, DOI 10.1097/00004647-200012000-00006; Capasso M, 2005, J ALZHEIMERS DIS, V8, P93; Carriedo SG, 1998, J NEUROSCI, V18, P7727; Chen K, 2009, BRAIN RES, V1279, P131, DOI 10.1016/j.brainres.2009.04.054; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Cote A, 2005, J PHYSIOL-LONDON, V566, P821, DOI 10.1113/jphysiol.2005.089458; Cuajungco MP, 1997, NEUROBIOL DIS, V4, P137, DOI 10.1006/nbdi.1997.0163; Danscher G, 1997, J NEUROSCI METH, V76, P53, DOI 10.1016/S0165-0270(97)00079-4; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Erreger K, 2008, J PHYSIOL-LONDON, V586, P763, DOI 10.1113/jphysiol.2007.143941; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; FREDERICKSON CJ, 1989, INT REV NEUROBIOL, V31, P145; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Ghelli A, 2003, J BIOL CHEM, V278, P4145, DOI 10.1074/jbc.M210285200; Hidalgo J, 2001, BRAIN RES BULL, V55, P133, DOI 10.1016/S0361-9230(01)00452-X; Hozumi I, 2011, J NEUROL SCI, V303, P95, DOI 10.1016/j.jns.2011.01.003; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Ji YF, 2011, BIOCHEM BIOPH RES CO, V405, P691, DOI 10.1016/j.bbrc.2011.01.105; Jiang XN, 2008, ANN NEUROL, V63, P632, DOI 10.1002/ana.21365; Kalia LV, 2003, NEUROPHARMACOLOGY, V45, P720, DOI 10.1016/S0028-3908(03)00313-7; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Klimaviciusa L, 2008, NEUROTOXICOLOGY, V29, P101, DOI 10.1016/j.neuro.2007.09.006; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Kruczek C, 2009, GLIA, V57, P79, DOI 10.1002/glia.20737; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lee JY, 1999, J NEUROSCI, V19, DOI 10.1523/jneurosci.19-11-j0002.1999; Lei G, 2002, EMBO J, V21, P2977, DOI 10.1093/emboj/cdf292; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; Liao GY, 2000, J NEUROCHEM, V75, P282, DOI 10.1046/j.1471-4159.2000.0750282.x; Liu Y, 2001, BRAIN RES, V909, P51, DOI 10.1016/S0006-8993(01)02619-1; Losi G, 2003, J PHYSIOL-LONDON, V548, P21, DOI 10.1113/jphysiol.2002.034918; Lu YM, 2000, SYNAPSE, V38, P187, DOI 10.1002/1098-2396(200011)38:2<187::AID-SYN10>3.0.CO;2-R; Malaiyandi LM, 2005, J NEUROCHEM, V93, P1242, DOI 10.1111/j.1471-4159.2005.03116.x; Molnar P, 2001, BRAIN RES, V910, P205, DOI 10.1016/S0006-8993(01)02720-2; Nakashima AS, 2009, BRAIN RES REV, V59, P347, DOI 10.1016/j.brainresrev.2008.10.003; Nam HT, 2010, J BIOCHEM, V148, P573, DOI 10.1093/jb/mvq089; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Niethammer M, 1996, J NEUROSCI, V16, P2157; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; PELLEGRINIGIAMPIETRO DE, 1994, J NEUROCHEM, V62, P1067; PETERS S, 1987, SCIENCE, V236, P589, DOI 10.1126/science.2883728; Porter NM, 1997, J NEUROSCI, V17, P5629; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Rowley M, 2001, J MED CHEM, V44, P477, DOI 10.1021/jm0002432; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Samet JM, 1999, AM J RESP CELL MOL, V21, P357, DOI 10.1165/ajrcmb.21.3.3656; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Sensi SL, 1997, J NEUROSCI, V17, P9554; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Sensi SL, 2011, J NEUROSCI, V31, P16076, DOI 10.1523/JNEUROSCI.3454-11.2011; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Shen Y, 1999, EUR J NEUROSCI, V11, P4233, DOI 10.1046/j.1460-9568.1999.00851.x; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Sheng M, 1999, ANN NY ACAD SCI, V868, P483, DOI 10.1111/j.1749-6632.1999.tb11317.x; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; Sun CL, 2011, CEREBELLUM, V10, P88, DOI 10.1007/s12311-010-0233-2; Suvarna N, 2005, J BIOL CHEM, V280, P31450, DOI 10.1074/jbc.M504120200; Takagi N, 1999, J CEREBR BLOOD F MET, V19, P880, DOI 10.1097/00004647-199908000-00007; Takeda A, 2009, NEUROSCIENCE, V158, P585, DOI 10.1016/j.neuroscience.2008.10.009; Tal TL, 2006, TOXICOL APPL PHARM, V214, P16, DOI 10.1016/j.taap.2005.11.011; Traynelis SF, 1998, J NEUROSCI, V18, P6163; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wang WW, 2010, BRAIN RES, V1328, P162, DOI 10.1016/j.brainres.2010.02.055; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Williams K, 1996, NEUROSCI LETT, V215, P9, DOI 10.1016/S0304-3940(96)12924-4; Williams K, 2001, CURR DRUG TARGETS, V2, P285, DOI 10.2174/1389450013348489; XIE XM, 1991, NATURE, V349, P521, DOI 10.1038/349521a0; Yang W, 2007, J BIOL CHEM, V282, P9269, DOI 10.1074/jbc.M700050200; Yu XM, 1998, NATURE, V396, P469, DOI 10.1038/24877; Zhang F, 2007, NEUROSCIENCE, V150, P938, DOI 10.1016/j.neuroscience.2007.09.070	81	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46012	10.1371/journal.pone.0046012	http://dx.doi.org/10.1371/journal.pone.0046012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049922	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100119
J	Shakarian, P; Wickiser, JK				Shakarian, Paulo; Wickiser, J. Kenneth			Similar Pathogen Targets in Arabidopsis thaliana and Homo sapiens Protein Networks	PLOS ONE			English	Article							TRANSMISSION; CENTRALITY; VIRULENCE	We study the behavior of pathogens on host protein networks for humans and Arabidopsis - noting striking similarities. Specifically, we preform k-shell decomposition analysis on these networks - which groups the proteins into various "shells" based on network structure. We observe that shells with a higher average degree are more highly targeted (with a power-law relationship) and that highly targeted nodes lie in shells closer to the inner-core of the network. Additionally, we also note that the inner core of the network is significantly under-targeted. We show that these core proteins may have a role in intra-cellular communication and hypothesize that they are less attacked to ensure survival of the host. This may explain why certain high-degree proteins are not significantly attacked.	[Shakarian, Paulo] United States Mil Acad, Paulo Shakarian Dept Elect Engn & Comp Sci, West Point, NY USA; [Wickiser, J. Kenneth] United States Mil Acad, J Kenneth Wickiser Dept Life Sci, West Point, NY USA	United States Department of Defense; United States Army; United States Department of Defense; United States Army	Shakarian, P (corresponding author), United States Mil Acad, Paulo Shakarian Dept Elect Engn & Comp Sci, West Point, NY USA.	paulo@shakarian.net	Shakarian, Paulo/GPK-6176-2022	Shakarian, Paulo/0000-0002-3159-4660	ARO [611102B74F]	ARO	P.S. and J.K.W. are supported by ARO grant 611102B74F, the opinions in this paper are those of the authors and do not necessarily reflect the opinions of the funders, the U. S. Military Academy, or the U. S. Army. http://www.arl.army.mil/www/default.cfm?page = 29 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berenos C, 2011, J EVOLUTIONARY BIOL, V24; Best A, 2009, AM NAT, V173, P779, DOI 10.1086/598494; Brandes U, 2005, LECT NOTES COMPUT SC, V3404, P533; Brandes U, 2001, J MATH SOCIOL, P25; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Carmi S, 2007, P NATL ACAD SCI USA, V104, P11150, DOI 10.1073/pnas.0701175104; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Jensen K, 2006, PLOS BIOL, V4; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kover PX, 1998, AM NAT, V152, P165, DOI 10.1086/286159; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Navratil V, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-13; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; Reshef D., 2011, SCIENCE, V334; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X; Smith J, 2007, AM NAT, V170, P542, DOI 10.1086/521236; STEPHENSON K, 1989, SOC NETWORKS, V11, P1, DOI 10.1016/0378-8733(89)90016-6	17	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2012	7	9							e45154	10.1371/journal.pone.0045154	http://dx.doi.org/10.1371/journal.pone.0045154			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	014RG	23049774	Green Published, gold			2022-12-27	WOS:000309392800029
J	Jiang, HM; An, LL; Lin, SM; Feng, G; Qiu, YQ				Jiang, Hongmei; An, Lingling; Lin, Simon M.; Feng, Gang; Qiu, Yuqing			A Statistical Framework for Accurate Taxonomic Assignment of Metagenomic Sequencing Reads	PLOS ONE			English	Article							GENERATION; BLAST	The advent of next-generation sequencing technologies has greatly promoted the field of metagenomics which studies genetic material recovered directly from an environment. Characterization of genomic composition of a metagenomic sample is essential for understanding the structure of the microbial community. Multiple genomes contained in a metagenomic sample can be identified and quantitated through homology searches of sequence reads with known sequences catalogued in reference databases. Traditionally, reads with multiple genomic hits are assigned to non-specific or high ranks of the taxonomy tree, thereby impacting on accurate estimates of relative abundance of multiple genomes present in a sample. Instead of assigning reads one by one to the taxonomy tree as many existing methods do, we propose a statistical framework to model the identified candidate genomes to which sequence reads have hits. After obtaining the estimated proportion of reads generated by each genome, sequence reads are assigned to the candidate genomes and the taxonomy tree based on the estimated probability by taking into account both sequence alignment scores and estimated genome abundance. The proposed method is comprehensively tested on both simulated datasets and two real datasets. It assigns reads to the low taxonomic ranks very accurately. Our statistical approach of taxonomic assignment of metagenomic reads, TAMER, is implemented in R and available at http://faculty.wcas.northwestern.edu/similar to hji403/MetaR.htm.	[Jiang, Hongmei; Qiu, Yuqing] Northwestern Univ, Dept Stat, Evanston, IL 60208 USA; [An, Lingling] Univ Arizona, Dept Agr & Biosyst Engn, Tucson, AZ USA; [An, Lingling] Univ Arizona, Interdisciplinary Program Stat, Tucson, AZ USA; [Lin, Simon M.] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Lin, Simon M.] Univ Wisconsin, Inst Clin & Translat Res, Madison, WI USA; [Feng, Gang] Northwestern Univ, Biomed Informat Ctr, Chicago, IL 60611 USA	Northwestern University; University of Arizona; University of Arizona; University of Wisconsin System; University of Wisconsin Madison; Northwestern University	Jiang, HM (corresponding author), Northwestern Univ, Dept Stat, Evanston, IL 60208 USA.	hongmei@northwestern.edu	Jiang, Hongmei/AAU-2911-2021	An, Lingling/0000-0001-8273-0776	National Science Foundation [DMS 1043080, DMS 1222592]; National Institutes of Health [1UL1RR025011, UL1RR025741]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Science Foundation (DMS 1043080 to HJ, LA, and SL, and DMS 1222592 to LA and HJ) and partially by National Institutes of Health (1UL1RR025011 to SL and UL1RR025741 to GF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; [Anonymous], 1982, JACKKNIFE BOOTSTRAP; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Belda-Ferre P, 2011, ISME J; Brennerova MV, 2009, ENVIRON MICROBIOL, V11, P2216, DOI 10.1111/j.1462-2920.2009.01943.x; Clemente JC, 2010, BIOCOMPUT-PAC SYM, P3; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Gerlach W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr225; Gori F, 2011, BIOINFORMATICS, V27, P196, DOI 10.1093/bioinformatics/btq649; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/jour-nal.pone.0037919; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; Meinicke P, 2011, BIOINFORMATICS, V27, P1618, DOI 10.1093/bioinformatics/btr266; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Richter DC, 2008, PLOS ONE, V3; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Sharma VK, 2012, PLOS ONE, V7; Team RDC, 2010, R LANG ENV STAT COMP; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667; Xia LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027992; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	33	21	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46450	10.1371/journal.pone.0046450	http://dx.doi.org/10.1371/journal.pone.0046450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049702	Green Published, gold			2022-12-27	WOS:000309388500029
J	Elgaaen, BV; Olstad, OK; Sandvik, L; Odegaard, E; Sauer, T; Staff, AC; Gautvik, KM				Elgaaen, Bente Vilming; Olstad, Ole Kristoffer; Sandvik, Leiv; Odegaard, Elin; Sauer, Torill; Staff, Anne Cathrine; Gautvik, Kaare M.			ZNF385B and VEGFA Are Strongly Differentially Expressed in Serous Ovarian Carcinomas and Correlate with Survival	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION; LOW-GRADE; CANCER; TUMORS; FOXM1; IDENTIFICATION; ANGIOGENESIS; BEVACIZUMAB; ACTIVATION	Background: The oncogenesis of ovarian cancer is poorly understood. The aim of this study was to identify mRNAs differentially expressed between moderately and poorly differentiated (MD/PD) serous ovarian carcinomas (SC), serous ovarian borderline tumours (SBOT) and superficial scrapings from normal ovaries (SNO), and to correlate these mRNAs with clinical parameters including survival. Methods: Differences in mRNA expression between MD/PD SC, SBOT and SNO were analyzed by global gene expression profiling (n = 23), validated by RT-qPCR (n = 41) and correlated with clinical parameters. Results: Thirty mRNAs differentially expressed between MD/PD SC, SBOT and SNO were selected from the global gene expression analyses, and 21 were verified (p < 0.01) by RT-qPCR. Of these, 13 mRNAs were differentially expressed in MD/PD SC compared with SNO (p, 0.01) and were correlated with clinical parameters. ZNF385B was downregulated (FC = -130.5, p = 1.2 x 10(-7)) and correlated with overall survival (p = 0.03). VEGFA was upregulated (FC = 6.1, p = 6.0 x 10(-6)) and correlated with progression-free survival (p = 0.037). Increased levels of TPX2 and FOXM1 mRNAs (FC = 28.5, p = 2.7 x 10(-10) and FC = 46.2, p = 5.6 x 10(-4), respectively) correlated with normalization of CA125 (p = 0.03 and p = 0.044, respectively). Furthermore, we present a molecular pathway for MD/PD SC, including VEGFA, FOXM1, TPX2, BIRC5 and TOP2A, all significantly upregulated and directly interacting with TP53. Conclusions: We have identified 21 mRNAs differentially expressed (p<0.01) between MD/PD SC, SBOT and SNO. Thirteen were differentially expressed in MD/PD SC, including ZNF385B and VEGFA correlating with survival, and FOXM1 and TPX2 with normalization of CA125. We also present a molecular pathway for MD/PD SC.	[Elgaaen, Bente Vilming; Odegaard, Elin] Oslo Univ Hosp, Dept Gynaecol Oncol, Oslo, Norway; [Elgaaen, Bente Vilming; Sandvik, Leiv; Sauer, Torill; Staff, Anne Cathrine; Gautvik, Kaare M.] Univ Oslo, Fac Med, Oslo, Norway; [Olstad, Ole Kristoffer; Gautvik, Kaare M.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Sandvik, Leiv] Oslo Univ Hosp, Unit Biostat & Epidemiol, Oslo, Norway; [Sauer, Torill] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Staff, Anne Cathrine] Oslo Univ Hosp, Dept Gynaecol, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Elgaaen, BV (corresponding author), Oslo Univ Hosp, Dept Gynaecol Oncol, Oslo, Norway.	bente.vilming.elgaaen@medisin.uio.no	Sauer, Torill/H-7041-2019		The Women and Children's Division, Oslo University Hospital; The Inger and John Fredriksen Foundation for Ovarian Cancer Research	The Women and Children's Division, Oslo University Hospital; The Inger and John Fredriksen Foundation for Ovarian Cancer Research	This study was funded by The Women and Children's Division, Oslo University Hospital, and The Inger and John Fredriksen Foundation for Ovarian Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwahed A, 2007, CHEM-BIOL INTERACT, V165, P1, DOI 10.1016/j.cbi.2006.10.003; Altieri DC, 2008, NAT REV CANCER, V8, P61, DOI 10.1038/nrc2293; Anglesio MS, 2008, MOL CANCER RES, V6, P1678, DOI 10.1158/1541-7786.MCR-08-0193; Asteriti IA, 2010, BBA-REV CANCER, V1806, P230, DOI 10.1016/j.bbcan.2010.08.001; Barsotti AM, 2009, ONCOGENE, V28, P4295, DOI 10.1038/onc.2009.282; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bonome T, 2005, CANCER RES, V65, P10602, DOI 10.1158/0008-5472.CAN-05-2240; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Cancer in Norway, 2011, CANC THER NORW CANC; Chien J, 2009, GYNECOL ONCOL, V114, P3, DOI 10.1016/j.ygyno.2009.04.002; Chon HS, 2011, CANCER CONTROL, V18, P8, DOI 10.1177/107327481101800102; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elgaaen BV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013837; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Emmanuel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017617; Gomez-Raposo C, 2010, GYNECOL ONCOL, V118, P88, DOI 10.1016/j.ygyno.2010.03.012; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Hata K, 2011, ANTICANCER RES, V31, P731; Ishigami SI, 1998, BRIT J CANCER, V78, P1379, DOI 10.1038/bjc.1998.688; Kleinberg L, 2007, CANCER, V109, P228, DOI 10.1002/cncr.22426; Kommoss S, 2009, VIRCHOWS ARCH, V454, P249, DOI 10.1007/s00428-009-0725-y; Li FZ, 2003, J CELL PHYSIOL, V197, P8, DOI 10.1002/jcp.10327; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu KH, 2004, CLIN CANCER RES, V10, P3291, DOI 10.1158/1078-0432.CCR-03-0409; Meinhold-Heerlein I, 2005, ONCOGENE, V24, P1053, DOI 10.1038/sj.onc.1208298; O'Geen H, 2007, PLOS GENET, V3, P916, DOI 10.1371/journal.pgen.0030089; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Pilarsky C, 2004, NEOPLASIA, V6, P744, DOI 10.1593/neo.04277; Pujade-Lauraine E, 2013, J CLIN ONCOL, V31; Qian XY, 2011, APPL IMMUNOHISTO M M, V19, P126, DOI 10.1097/PAI.0b013e3181e30dcd; Ramakrishna M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009983; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Ryan BM, 2009, CANCER TREAT REV, V35, P553, DOI 10.1016/j.ctrv.2009.05.003; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Seidman JD, 2004, INT J GYNECOL PATHOL, V23, P41, DOI 10.1097/01.pgp.0000101080.35393.16; Shigeishi H, 2009, ONCOL REP, V21, P341, DOI 10.3892/or_00000227; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Siddiqui GK, 2010, EUR J GYNAECOL ONCOL, V31, P156; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Vang R, 2009, ADV ANAT PATHOL, V16, P267, DOI 10.1097/PAP.0b013e3181b4fffa; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Zorn KK, 2003, CLIN CANCER RES, V9, P4811	46	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46317	10.1371/journal.pone.0046317	http://dx.doi.org/10.1371/journal.pone.0046317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029477	gold, Green Published			2022-12-27	WOS:000309973900132
J	Song, B; Smink, AM; Jones, CV; Callaghan, JM; Firth, SD; Bernard, CA; Laslett, AL; Kerr, PG; Ricardo, SD				Song, Bi; Smink, Alexandra M.; Jones, Christina V.; Callaghan, Judy M.; Firth, Stephen D.; Bernard, Claude A.; Laslett, Andrew L.; Kerr, Peter G.; Ricardo, Sharon D.			The Directed Differentiation of Human iPS Cells into Kidney Podocytes	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; GLOMERULAR PODOCYTES; DNA METHYLATION; SOMATIC-CELLS; FIBROBLASTS; EXPRESSION; PROLIFERATION; PARIETAL; BETA	The loss of glomerular podocytes is a key event in the progression of chronic kidney disease resulting in proteinuria and declining function. Podocytes are slow cycling cells that are considered terminally differentiated. Here we provide the first report of the directed differentiation of induced pluripotent stem (iPS) cells to generate kidney cells with podocyte features. The iPS-derived podocytes share a morphological phenotype analogous with cultured human podocytes. Following 10 days of directed differentiation, iPS podocytes had an up-regulated expression of mRNA and protein localization for podocyte markers including synaptopodin, nephrin and Wilm's tumour protein (WT1), combined with a down-regulation of the stem cell marker OCT3/4. In contrast to human podocytes that become quiescent in culture, iPS-derived cells maintain a proliferative capacity suggestive of a more immature phenotype. The transduction of iPS podocytes with fluorescent labeled-talin that were immunostained with podocin showed a cytoplasmic contractile response to angiotensin II (AII). A permeability assay provided functional evidence of albumin uptake in the cytoplasm of iPS podocytes comparable to human podocytes. Moreover, labeled iPS-derived podocytes were found to integrate into reaggregated metanephric kidney explants where they incorporated into developing glomeruli and co-expressed WT1. This study establishes the differentiation of iPS cells to kidney podocytes that will be useful for screening new treatments, understanding podocyte pathogenesis, and offering possibilities for regenerative medicine.	[Song, Bi; Smink, Alexandra M.; Jones, Christina V.; Bernard, Claude A.; Ricardo, Sharon D.] Monash Univ, MISCL, Clayton, Vic, Australia; [Laslett, Andrew L.] CSIRO Mat Sci & Engn, Clayton, Vic, Australia; [Laslett, Andrew L.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Kerr, Peter G.] Monash Univ, Dept Med, Monash Med Ctr, Clayton, Vic, Australia	Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University; Monash University	Ricardo, SD (corresponding author), Monash Univ, MISCL, Clayton, Vic, Australia.	Sharon.Ricardo@monash.edu	Laslett, Andrew L/A-9760-2011; Smink, Alexandra/AAP-5285-2021; Kerr, Peter G/I-1461-2013	Laslett, Andrew L/0000-0003-4729-8193; Smink, Alexandra/0000-0002-9714-1779; Ricardo, Sharon/0000-0003-1724-3669; Bernard, Claude Charles Andre/0000-0003-2816-5328	Alport Foundation of Australia; Monash University Strategic Grant; Erdi Fellowship in Neurological Diseases; Baker Foundation	Alport Foundation of Australia; Monash University Strategic Grant(Monash University); Erdi Fellowship in Neurological Diseases; Baker Foundation	This work was supported by the Alport Foundation of Australia and a Monash University Strategic Grant. CA Bernard is a recipient of an Erdi Fellowship in Neurological Diseases and funding from the Baker Foundation. Microscopy was performed with technical expertise from Monash Micro Imaging, Monash University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Appel D, 2009, J AM SOC NEPHROL, V20, P333, DOI 10.1681/ASN.2008070795; Bariety J, 2006, J AM SOC NEPHROL, V17, P2770, DOI 10.1681/ASN.2006040325; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Economou CG, 2004, J CELL SCI, V117, P3281, DOI 10.1242/jcs.01163; Eyre J, 2007, AM J PHYSIOL-RENAL, V292, pF674, DOI 10.1152/ajprenal.00272.2006; Han DW, 2012, CELL STEM CELL, V10, P465, DOI 10.1016/j.stem.2012.02.021; He JCJ, 2004, J CLIN INVEST, V114, P643, DOI 10.1172/JCI200421004; Herman-Edelstein M, 2011, DIABETES, V60, P1779, DOI 10.2337/db10-1110; Humphreys BD, 2007, NEPHROL THER, V3, P3, DOI 10.1016/j.nephro.2006.12.002; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim D, 2005, J AM SOC NEPHROL, V16, P3527, DOI 10.1681/ASN.2005050544; Kobayashi T, 2005, BIOCHEM BIOPH RES CO, V336, P585, DOI 10.1016/j.bbrc.2005.08.136; Kriz W, 2003, PEDIATR NEPHROL, V18, P617, DOI 10.1007/s00467-003-1172-7; Lasagni L, 2010, STEM CELLS, V28, P1673, DOI 10.1002/stem.492; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; LIN SA, 2010, STEM CELLS DEV; Lusis M, 2010, STEM CELL RES, V5, P23, DOI 10.1016/j.scr.2010.03.003; Mae SI, 2010, BIOCHEM BIOPH RES CO, V393, P877, DOI 10.1016/j.bbrc.2010.02.111; MALLIPATTU SK, 2012, J BIOL CHEM; Mene Paolo, 2009, V466, P3, DOI 10.1007/978-1-59745-352-3_1; Morizane R, 2009, BIOCHEM BIOPH RES CO, V390, P1334, DOI 10.1016/j.bbrc.2009.10.148; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Mundel P, 1997, J AM SOC NEPHROL, V8, P697; Nazor KL, 2012, CELL STEM CELL, V10, P620, DOI 10.1016/j.stem.2012.02.013; NORGAARD JOR, 1987, LAB INVEST, V57, P277; Ohi Y, 2011, NAT CELL BIOL, V13, P541, DOI 10.1038/ncb2239; Ohtaka A, 2002, NEPHROL DIAL TRANSPL, V17, P11, DOI 10.1093/ndt/17.suppl_9.11; Palmer RE, 2001, CURR BIOL, V11, P1805, DOI 10.1016/S0960-9822(01)00560-7; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Ruster C, 2009, AM J NEPHROL, V29, P538, DOI 10.1159/000191467; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Saleem MA, 2008, AM J PHYSIOL-RENAL, V295, pF959, DOI 10.1152/ajprenal.00559.2007; Sato Y, 2009, J AM SOC NEPHROL, V20, P1041, DOI 10.1681/ASN.2007121328; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Shkreli M, 2012, NAT MED, V18, P111, DOI 10.1038/nm.2550; Song B, 2011, J AM SOC NEPHROL, V22, P1213, DOI 10.1681/ASN.2010101022; Steenhard BM, 2005, J AM SOC NEPHROL, V16, P1623, DOI 10.1681/ASN.2004070584; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vaughan MR, 2005, KIDNEY INT, V68, P133, DOI 10.1111/j.1523-1755.2005.00387.x; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou T, 2011, J AM SOC NEPHROL, V22, P1221, DOI 10.1681/ASN.2011010106	50	121	133	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46453	10.1371/journal.pone.0046453	http://dx.doi.org/10.1371/journal.pone.0046453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029522	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900163
J	Lee, AJH; Awano, T; Park, GH; Monani, UR				Lee, Andrew J-H; Awano, Tomoyuki; Park, Gyu-Hwan; Monani, Umrao R.			Limited Phenotypic Effects of Selectively Augmenting the SMN Protein in the Neurons of a Mouse Model of Severe Spinal Muscular Atrophy	PLOS ONE			English	Article							MOTOR-NEURONS; NEUROMUSCULAR-JUNCTIONS; SINGLE NUCLEOTIDE; SKELETAL-MUSCLE; CARDIAC DEFECTS; SURVIVAL; GENE; RESCUE; MICE; IDENTIFICATION	The selective vulnerability of motor neurons to paucity of Survival Motor Neuron (SMN) protein is a defining feature of human spinal muscular atrophy (SMA) and indicative of a unique requirement for adequate levels of the protein in these cells. However, the relative contribution of SMN-depleted motor neurons to the disease process is uncertain and it is possible that their characteristic loss and the overall SMA phenotype is a consequence of low protein in multiple cell types including neighboring spinal neurons and non-neuronal tissue. To explore the tissue-specific requirements for SMN and, especially, the salutary effects of restoring normal levels of the protein to neuronal tissue of affected individuals, we have selectively expressed the protein in neurons of mice that model severe SMA. Expressing SMN pan-neuronally in mutant mice mitigated specific aspects of the disease phenotype. Motor performance of the mice improved and the loss of spinal motor neurons that characterizes the disease was arrested. Proprioceptive synapses on the motor neurons were restored and defects of the neuromuscular junctions mitigated. The improvements at the cellular level were reflected in a four-fold increase in survival. Nevertheless, mutants expressing neuronal SMN did not live beyond three weeks of birth, a relatively poor outcome compared to the effects of ubiquitously restoring SMN. This suggests that although neurons and, in particular, spinal motor neurons constitute critical cellular sites of action of the SMN protein, a truly effective treatment of severe SMA will require restoring the protein to multiple cell types including non-neuronal tissue.	[Lee, Andrew J-H; Awano, Tomoyuki; Monani, Umrao R.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA; [Monani, Umrao R.] Columbia Univ, Dept Neurol, New York, NY USA; [Park, Gyu-Hwan] Kyungpook Natl Univ, Dept Neuropharmacol, Taegu, South Korea; [Lee, Andrew J-H; Awano, Tomoyuki; Monani, Umrao R.] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY USA	Columbia University; Columbia University; Kyungpook National University; Columbia University	Monani, UR (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10027 USA.	um2105@columbia.edu	Lee, Andrew/GVU-2817-2022		National Institutes of Health [NS057482]; Muscular Dystrophy Association of America; Families of SMA; SMA Foundation; Department of Defense [W81XWH-08-1-0009 SC3, W81XWH-09-1-0245]; AFMFrance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association of America(Muscular Dystrophy Association); Families of SMA; SMA Foundation; Department of Defense(United States Department of Defense); AFMFrance; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work described in this article was supported by grants from the National Institutes of Health (NS057482), Muscular Dystrophy Association of America, Families of SMA, SMA Foundation, Department of Defense (W81XWH-08-1-0009 SC3 and W81XWH-09-1-0245) and AFMFrance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; BERTINI E, 1989, AM J MED GENET, V33, P328, DOI 10.1002/ajmg.1320330309; Bevan AK, 2010, HUM MOL GENET, V19, P3895, DOI 10.1093/hmg/ddq300; Boon KL, 2009, HUM MOL GENET, V18, P3615, DOI 10.1093/hmg/ddp310; Bosch-Marce M, 2011, HUM MOL GENET, V20, P1844, DOI 10.1093/hmg/ddr067; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2009, CURR TREAT OPTION NE, V11, P90, DOI 10.1007/s11940-009-0012-x; Butchbach MER, 2007, NEUROBIOL DIS, V27, P207, DOI 10.1016/j.nbd.2007.04.009; Chan YB, 2003, HUM MOL GENET, V12, P1367, DOI 10.1093/hmg/ddg157; Chang HCH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003209; Cifuentes-Diaz C, 2001, J CELL BIOL, V152, P1107, DOI 10.1083/jcb.152.5.1107; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; El-Khodor BF, 2008, EXP NEUROL, V212, P29, DOI 10.1016/j.expneurol.2008.02.025; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Foust KD, 2010, NAT BIOTECHNOL, V28, P271, DOI 10.1038/nbt.1610; Frugier T, 2000, HUM MOL GENET, V9, P849, DOI 10.1093/hmg/9.5.849; Gavrilina TO, 2008, HUM MOL GENET, V17, P1063, DOI 10.1093/hmg/ddm379; Gogliotti RG, 2012, J NEUROSCI, V32, P3818, DOI 10.1523/JNEUROSCI.5775-11.2012; Gogliotti RG, 2011, NEUROBIOL DIS, V43, P142, DOI 10.1016/j.nbd.2011.03.002; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Guettier-Sigrist S, 2001, FUND CLIN PHARMACOL, V15, P31, DOI 10.1046/j.1472-8206.2001.00006.x; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Heier CR, 2010, HUM MOL GENET, V19, P3906, DOI 10.1093/hmg/ddq330; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lutz CM, 2011, J CLIN INVEST, V121, P3029, DOI 10.1172/JCI57291; Maddatu TP, 2005, HUM MOL GENET, V14, P3179, DOI 10.1093/hmg/ddi349; Martinez TL, 2012, J NEUROSCI, V32, P8703, DOI 10.1523/JNEUROSCI.0204-12.2012; McAndrew PE, 1997, AM J HUM GENET, V60, P1411, DOI 10.1086/515465; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; MELLINS RB, 1974, PEDIATRICS, V53, P33; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Mutsaers CA, 2011, HUM MOL GENET, V20, P4334, DOI 10.1093/hmg/ddr360; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Park GH, 2010, CURR NEUROL NEUROSCI, V10, P108, DOI 10.1007/s11910-010-0095-5; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Passini MA, 2010, J CLIN INVEST, V120, P1253, DOI 10.1172/JCI41615; PIERCE JP, 1993, J NEUROSCI, V13, P4748; Porensky PN, 2012, HUM MOL GENET, V21, P1625, DOI 10.1093/hmg/ddr600; Satz JS, 2010, J NEUROSCI, V30, P14560, DOI 10.1523/JNEUROSCI.3247-10.2010; Satz JS, 2009, J NEUROSCI, V29, P13136, DOI 10.1523/JNEUROSCI.0474-09.2009; Shababi M, 2010, HUM MOL GENET, V19, P4059, DOI 10.1093/hmg/ddq329; Shafey D, 2005, EXP CELL RES, V311, P49, DOI 10.1016/j.yexcr.2005.08.019; Somers E, 2012, NEUROMUSCULAR DISORD, V22, P435, DOI 10.1016/j.nmd.2011.10.021; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Wishart TM, 2010, HUM MOL GENET, V19, P4216, DOI 10.1093/hmg/ddq340	61	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46353	10.1371/journal.pone.0046353	http://dx.doi.org/10.1371/journal.pone.0046353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029491	gold, Green Submitted, Green Published			2022-12-27	WOS:000309517500094
J	Wang, JT; Chen, YY; Tew, KS; Meng, PJ; Chen, CA				Wang, Jih-Terng; Chen, Yi-Yun; Tew, Kwee Siong; Meng, Pei-Jei; Chen, Chaolun A.			Physiological and Biochemical Performances of Menthol-Induced Aposymbiotic Corals	PLOS ONE			English	Article							ALGA-INVERTEBRATE SYMBIOSIS; CLIMATE-CHANGE; THERMAL TOLERANCE; SEA-ANEMONE; ANTHOPLEURA-ELEGANTISSIMA; SENSORY NEURONS; PHASE-SHIFTS; CELL BIOLOGY; STRESS; ZOOXANTHELLAE	The unique mutualism between corals and their photosynthetic zooxanthellae (Symbiodinium spp.) is the driving force behind functional assemblages of coral reefs. However, the respective roles of hosts and Symbiodinium in this endosymbiotic association, particularly in response to environmental challenges (e.g., high sea surface temperatures), remain unsettled. One of the key obstacles is to produce and maintain aposymbiotic coral hosts for experimental purposes. In this study, a simple and gentle protocol to generate aposymbiotic coral hosts (Isopora palifera and Stylophora pistillata) was developed using repeated incubation in menthol/artificial seawater (ASW) medium under light and in ASW in darkness, which depleted more than 99% of Symbiodinium from the host within 4,8 days. As indicated by the respiration rate, energy metabolism (by malate dehydrogenase activity), and nitrogen metabolism (by glutamate dehydrogenase activity and profiles of free amino acids), the physiological and biochemical performances of the menthol-induced aposymbiotic corals were comparable to their symbiotic counterparts without nutrient supplementation (e.g., for Stylophora) or with a nutrient supplement containing glycerol, vitamins, and a host mimic of free amino acid mixture (e.g., for Isopora). Differences in biochemical responses to menthol-induced bleaching between Stylophora and Isopora were attributed to the former digesting Symbiodinium rather than expelling the algae live as found in the latter species. Our studies showed that menthol could successfully bleach corals and provided aposymbiotic corals for further exploration of coral-alga symbioses.	[Wang, Jih-Terng; Chen, Yi-Yun] Tajen Univ, Grad Inst Biotechnol, Pingtung, Taiwan; [Tew, Kwee Siong; Meng, Pei-Jei] Natl Museum Marine Biol & Aquarium, Pingtung, Taiwan; [Tew, Kwee Siong; Meng, Pei-Jei] Natl Dong Hwa Univ, Inst Marine Biodivers & Evolut, Pingtung, Taiwan; [Chen, Chaolun A.] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Chen, Chaolun A.] Acad Sinica, Taiwan Int Grad Program TIGP Biodivers, Taipei 115, Taiwan; [Chen, Chaolun A.] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan	National Museum of Marine Biology & Aquarium; National Dong Hwa University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Wang, JT (corresponding author), Tajen Univ, Grad Inst Biotechnol, Pingtung, Taiwan.	jtw@mail.tajen.edu.tw; acropora.chen@gmail.com	Meng, PJ/AAC-3677-2021		Academic Sinica Thematic grant; National Science Council [NSC-96-2628-B-001-004-MY3]	Academic Sinica Thematic grant; National Science Council(Ministry of Science and Technology, Taiwan)	Academic Sinica Thematic grant (2008-2010) to JTW and CAC, and National Science Council (NSC-96-2628-B-001-004-MY3) to CAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, CHANGES MARINE COMMU; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Bhagooli R, 2003, J EXP MAR BIOL ECOL, V291, P181, DOI 10.1016/S0022-0981(03)00121-7; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; BROWN JT, 1987, PLANT SCI, V48, P195, DOI 10.1016/0168-9452(87)90090-2; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Chen CA, 2004, CORAL REEFS, V23, P508, DOI 10.1007/s00338-004-0423-9; Coffroth MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013258; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; FITT WK, 1981, MAR BIOL, V61, P199, DOI 10.1007/BF00386660; Gonzalez-Teuber M, 2009, J CHEM ECOL, V35, P459, DOI 10.1007/s10886-009-9618-4; Haeseler G, 2002, EUR J ANAESTH, V19, P571, DOI 10.1017/S0265021502000923; Hans M, 2012, CHEM SENSES, V37, P463, DOI 10.1093/chemse/bjr128; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; JONES BN, 1981, J LIQ CHROMATOGR, V4, P565, DOI 10.1080/01483918108059956; Jones RJ, 2004, MAR ECOL PROG SER, V284, P133, DOI 10.3354/meps284133; Kruskal J, 1978, MULTIDIMENSIONAL SCA; Kuo J, 2010, J EXP MAR BIOL ECOL, V388, P11, DOI 10.1016/j.jembe.2010.03.011; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; MACDONALD MJ, 1982, ARCH BIOCHEM BIOPHYS, V213, P643, DOI 10.1016/0003-9861(82)90594-X; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Mieog JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006364; MOORE SJ, 1989, J MAR BIOL ASSOC UK, V69, P803, DOI 10.1017/S0025315400032173; OECD SIDS, 2003, MENTH, P5; Okazawa M, 2000, NEUROREPORT, V11, P2151, DOI 10.1097/00001756-200007140-00018; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; PORTER JW, 1989, P NATL ACAD SCI USA, V86, P9342, DOI 10.1073/pnas.86.23.9342; RAHAV O, 1989, PROC R SOC SER B-BIO, V236, P325, DOI 10.1098/rspb.1989.0026; REES TAV, 1986, PROC R SOC SER B-BIO, V229, P299, DOI 10.1098/rspb.1986.0087; Reid G, 2002, J PHYSIOL-LONDON, V545, P595, DOI 10.1113/jphysiol.2002.024331; Robison JD, 2006, J PHYCOL, V42, P568, DOI 10.1111/j.1529-8817.2006.00232.x; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; STEEN RG, 1987, BIOL BULL, V172, P246, DOI 10.2307/1541797; SZMANTFROELICH A, 1984, MAR BIOL, V81, P153, DOI 10.1007/BF00393114; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Wang JT, 2011, MAR ECOL PROG SER, V422, P51, DOI 10.3354/meps08913; Wang JT, 2012, ZOOL STUD, V51, P137; Wang JT, 1997, PLANT PHYSIOL, V114, P631, DOI 10.1104/pp.114.2.631; Wang JT, 1998, J EXP BIOL, V201, P2445; Wang JT, 1999, MAR BIOL, V135, P219, DOI 10.1007/s002270050619; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Weis VM, 2008, TRENDS ECOL EVOL, V23, P369, DOI 10.1016/j.tree.2008.03.004; Weis VM, 1996, J EXP BIOL, V199, P883	50	16	16	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46406	10.1371/journal.pone.0046406	http://dx.doi.org/10.1371/journal.pone.0046406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029512	gold, Green Submitted, Green Published			2022-12-27	WOS:000309517500101
J	de Oliveira, EAG; Romeiro, NC; Ribeiro, ED; Santa-Catarina, C; Oliveira, AEA; Silveira, V; de Souza, GA; Venancio, TM; Cruz, MAL				Gamosa de Oliveira, Eduardo Alves; Romeiro, Nelilma Correia; Ribeiro, Elane da Silva; Santa-Catarina, Claudete; Amancio Oliveira, Antonia Elenir; Silveira, Vanildo; de Souza Filho, Goncalo Apolinario; Venancio, Thiago Motta; Lopes Cruz, Marco Antonio			Structural and Functional Characterization of the Protein Kinase Mps1 in Arabidopsis thaliana	PLOS ONE			English	Article							POLE BODY DUPLICATION; CYCLIN-DEPENDENT KINASES; PLANT-CELL CYCLE; SPINDLE-ASSEMBLY CHECKPOINT; LATERAL ROOT INITIATION; MITOTIC CHECKPOINT; PHOSPHORYLATION SITES; GENE-EXPRESSION; SUBCELLULAR-LOCALIZATION; KINETOCHORE LOCALIZATION	In eukaryotes, protein kinases catalyze the transfer of a gamma-phosphate from ATP (or GTP) to specific amino acids in protein targets. In plants, protein kinases have been shown to participate in signaling cascades driving responses to environmental stimuli and developmental processes. Plant meristems are undifferentiated tissues that provide the major source of cells that will form organs throughout development. However, non-dividing specialized cells can also dedifferentiate and re-initiate cell division if exposed to appropriate conditions. Mps1 (Monopolar spindle) is a dual-specificity protein kinase that plays a critical role in monitoring the accuracy of chromosome segregation in the mitotic checkpoint mechanism. Although Mps1 functions have been clearly demonstrated in animals and fungi, its role in plants is so far unclear. Here, using structural and biochemical analyses here we show that Mps1 has highly similar homologs in many plant genomes across distinct lineages (e. g. AtMps1 in Arabidopsis thaliana). Several structural features (i.e. catalytic site, DFG motif and threonine triad) are clearly conserved in plant Mps1 kinases. Structural and sequence analysis also suggest that AtMps1 interact with other cell cycle proteins, such as Mad2 and MAPK1. By using a very specific Mps1 inhibitor (SP600125) we show that compromised AtMps1 activity hampers the development of A. thaliana seedlings in a dose-dependent manner, especially in secondary roots. Moreover, concomitant administration of the auxin IAA neutralizes the AtMps1 inhibition phenotype, allowing secondary root development. These observations let us to hypothesize that AtMps1 might be a downstream regulator of IAA signaling in the formation of secondary roots. Our results indicate that Mps1 might be a universal component of the Spindle Assembly Checkpoint machinery across very distant lineages of eukaryotes.	[Ribeiro, Elane da Silva; Amancio Oliveira, Antonia Elenir; Venancio, Thiago Motta] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Rio De Janeiro, Brazil; [Gamosa de Oliveira, Eduardo Alves; Lopes Cruz, Marco Antonio] Univ Fed Rio de Janeiro, Lab Biotecnol Vegetal, Nucleo Ecol & Desenvolvimento Socioambiental Maca, Rio De Janeiro, Brazil; [Gamosa de Oliveira, Eduardo Alves; Romeiro, Nelilma Correia] Univ Fed Rio de Janeiro, Lab Integrado Computacao Cient, Nucleo Ecol & Desenvolvimento Socioambiental Maca, Rio De Janeiro, Brazil; [Silveira, Vanildo; de Souza Filho, Goncalo Apolinario] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biotecnol, Rio De Janeiro, Brazil; [Santa-Catarina, Claudete] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Biol Celular & Tecidual, Rio De Janeiro, Brazil	Universidade Estadual do Norte Fluminense; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense	Venancio, TM (corresponding author), Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Lab Quim & Funcao Prot & Peptideos, Rio De Janeiro, Brazil.	thiago.venancio@gmail.com; marco.cruz@macae.ufrj.br	Venancio, Thiago M/B-5003-2011; Romeiro, Nelilma/H-8719-2013; Oliveira, Antonia Elenir Amancio/AAS-3885-2021; Santa-Catarina, Claudete/L-5531-2014; Ribeiro, Elane da Silva/Q-8192-2017; Silveira, Vanildo/E-8887-2011; de Souza Filho, Goncalo/S-7251-2017	Venancio, Thiago M/0000-0002-2215-8082; Oliveira, Antonia Elenir Amancio/0000-0002-2618-8916; Santa-Catarina, Claudete/0000-0002-1669-660X; Ribeiro, Elane da Silva/0000-0001-9315-3038; Silveira, Vanildo/0000-0001-5697-6932; Cruz, Marco Antonio Lopes/0000-0002-3013-657X; de Souza Filho, Goncalo/0000-0003-1028-4425	Universidade Estadual do Norte Fluminense Darcy Ribeiro; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Universidade Estadual do Norte Fluminense Darcy Ribeiro; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors acknowledge Universidade Estadual do Norte Fluminense Darcy Ribeiro and the following Brazilian funding agencies for supporting our research: Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anantharaman V, 2007, ANNU REV MICROBIOL, V61, P453, DOI 10.1146/annurev.micro.61.080706.093309; Aravind L, 2009, BIRTH DEFECTS RES C, V87, P143, DOI 10.1002/bdrc.20153; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Caillaud MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006757; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Chu MLH, 2008, J BIOL CHEM, V283, P21495, DOI 10.1074/jbc.M803026200; Chu MLH, 2010, BIOCHEMISTRY-US, V49, P1689, DOI 10.1021/bi901970c; de Jager SM, 2005, SEMIN CELL DEV BIOL, V16, P385, DOI 10.1016/j.semcdb.2005.02.004; De Veylder L, 2007, NAT REV MOL CELL BIO, V8, P655, DOI 10.1038/nrm2227; den Boer BGW, 2000, TRENDS CELL BIOL, V10, P245, DOI 10.1016/S0962-8924(00)01765-7; Denes D, 2011, ANN BOT-LONDON, V107, P1193, DOI 10.1093/aob/mcr038; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Dewitte W, 2003, ANNU REV PLANT BIOL, V54, P235, DOI 10.1146/annurev.arplant.54.031902.134836; Ding DF, 2012, PLANT MOL BIOL, V79, P203, DOI 10.1007/s11103-012-9903-4; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dou Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018793; Enserink JM, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-11; Fischer MS, 2004, J ZOOL SYST EVOL RES, V42, P1; Fisk HA, 2004, CURR BIOL, V14, pR1058, DOI 10.1016/j.cub.2004.11.047; Gao JJ, 2010, MOL CELL PROTEOMICS, V9, P2586, DOI 10.1074/mcp.M110.001388; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haerizadeh F, 2009, PLANT MOL BIOL, V69, P711, DOI 10.1007/s11103-008-9450-1; Hardie DG, 1999, ANNU REV PLANT PHYS, V50, P97, DOI 10.1146/annurev.arplant.50.1.97; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Hicks GR, 2009, NAT CHEM BIOL, V5, P268, DOI 10.1038/nchembio0509-268; Himanen K, 2002, PLANT CELL, V14, P2339, DOI 10.1105/tpc.004960; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Inze D, 2005, EMBO J, V24, P657, DOI 10.1038/sj.emboj.7600561; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Jaspersen SL, 2004, DEV CELL, V7, P263, DOI 10.1016/j.devcel.2004.07.006; Jelluma N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002415; Jiang K, 2005, ANNU REV CELL DEV BI, V21, P485, DOI 10.1146/annurev.cellbio.21.122303.114753; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kang JS, 2007, P NATL ACAD SCI USA, V104, P20232, DOI 10.1073/pnas.0710519105; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kasbek C, 2007, MOL BIOL CELL, V18, P4457, DOI 10.1091/mbc.E07-03-0283; Kieffer M, 2010, CURR OPIN PLANT BIOL, V13, P12, DOI 10.1016/j.pbi.2009.10.006; Lan WJ, 2010, J CELL BIOL, V190, P21, DOI 10.1083/jcb.201006080; LAUZE E, 1995, EMBO J, V14, P1655, DOI 10.1002/j.1460-2075.1995.tb07154.x; Lee TY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-261; Leyser O, 2010, PLANT PHYSIOL, V154, P501, DOI 10.1104/pp.110.161323; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Liu XD, 2012, ANNU REV BIOCHEM, V81, P561, DOI 10.1146/annurev-biochem-061611-090435; Luan S, 2003, ANNU REV PLANT BIOL, V54, P63, DOI 10.1146/annurev.arplant.54.031902.134743; Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050; Malamy JE, 1997, DEVELOPMENT, V124, P33; Malamy JE, 2001, PLANT PHYSIOL, V127, P899, DOI 10.1104/pp.010406; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Menges M, 2002, J BIOL CHEM, V277, P41987, DOI 10.1074/jbc.M207570200; MILLS GB, 1992, J BIOL CHEM, V267, P16000; Mironov V, 1999, PLANT CELL, V11, P509; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nemoto K, 2011, PHYTOCHEMISTRY, V72, P1136, DOI 10.1016/j.phytochem.2011.02.029; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Osmont KS, 2007, ANNU REV PLANT BIOL, V58, P93, DOI 10.1146/annurev.arplant.58.032806.104006; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Perez J, 2008, P NATL ACAD SCI USA, V105, P15950, DOI 10.1073/pnas.0806851105; Pike AN, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-9; Planchais S, 2000, FEBS LETT, V476, P78, DOI 10.1016/S0014-5793(00)01675-6; Poss KD, 2002, DEVELOPMENT, V129, P5141; Robert Stephanie, 2009, Arabidopsis Book, V7, pe0109, DOI 10.1199/tab.0109; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Sasabe M, 2011, P NATL ACAD SCI USA, V108, P17844, DOI 10.1073/pnas.1110174108; Skibbens RV, 1998, ANNU REV GENET, V32, P307, DOI 10.1146/annurev.genet.32.1.307; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suijkerbuijk SJE, 2008, BBA-REV CANCER, V1786, P24, DOI 10.1016/j.bbcan.2008.04.001; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Tyler RK, 2009, BIOCHEM J, V417, P173, DOI 10.1042/BJ20081310; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Umeda M, 2005, PLANT CELL PHYSIOL, V46, P1437, DOI 10.1093/pcp/pci170; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vandepoele K, 2002, PLANT CELL, V14, P903, DOI 10.1105/tpc.010445; Verma DPS, 2001, ANNU REV PLANT PHYS, V52, P751, DOI 10.1146/annurev.arplant.52.1.751; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Wang Huachun, 2007, Arabidopsis Book, V5, pe0106, DOI 10.1199/tab.0106; Wang W, 2009, J CELL MOL MED, V13, P1679, DOI 10.1111/j.1582-4934.2008.00605.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745; Winey M, 2002, ONCOGENE, V21, P6161, DOI 10.1038/sj.onc.1205712; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Yadav RK, 2009, P NATL ACAD SCI USA, V106, P4941, DOI 10.1073/pnas.0900843106; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	101	14	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45707	10.1371/journal.pone.0045707	http://dx.doi.org/10.1371/journal.pone.0045707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049844	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300045
J	Hoque, ME; Ghuman, S				Hoque, Muhammad Ehsanul; Ghuman, Shanaz			Knowledge, Practices, and Attitudes of Emergency Contraception among Female University Students in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							LEVONORGESTREL; GHANA	Objective: The purpose of this study is to investigate the knowledge, practices, and attitudes among female university students in South Africa regarding emergency contraceptives (EC). Methods: A cross-sectional study was conducted among 582 female university students who were selected using multi-stage sampling techniques. Multivariate logistic regression analysis was used to find significant predictors for EC awareness. Results: The average age of the female students was 20.9 years (SD = 3.0) and 57.2% were presently sexually active. Overall, 49.8% of the participants reported having heard about EC prior to the study. Regarding sexual activities among the female students, 53.2% reported to have sex, and 21.2% of the sexually experienced students used EC prior to the study. Regarding the effectiveness of EC, 29.5% students said it could be used up to 72 hours after unprotected sexual intercourse, and 8% said it could be used just before sex. About two-thirds (61.8%) would recommend the use of EC and 63.2% would use it if they needed. The multivariate analysis indicated that students who were older (>20 years), presently sexually active, and living with their parents were more likely to be aware of EC (p<0.05). Conclusion: The students' knowledge and utilization of EC were low. Health education and promotion should be targeted towards these students, and the EC services should be offered on campus.	[Hoque, Muhammad Ehsanul] Univ Limpopo, Sch Hlth Care Sci, Dept Publ Hlth, Pretoria, South Africa; [Ghuman, Shanaz] Mangosuthu Univ Technol, Dept Environm Hlth, Durban, South Africa	University of Limpopo; Mangosuthu University of Technology	Hoque, ME (corresponding author), Univ Limpopo, Sch Hlth Care Sci, Dept Publ Hlth, Medunsa Campus, Pretoria, South Africa.	muhammad.ehsanul@gmail.com			Academic Board & Research & Ethics Committee of Mangosuthu University of Technology	Academic Board & Research & Ethics Committee of Mangosuthu University of Technology	The authors wish to acknowledge the Academic Board & Research & Ethics Committee of Mangosuthu University of Technology for supporting the study. Also acknowledge Mrs. Chetty for editing the manuscript.	Abasiattai A M, 2007, Niger J Clin Pract, V10, P30; Addo VN, 2009, INT J GYNECOL OBSTET, V105, P206, DOI 10.1016/j.ijgo.2009.01.008; Adhikari Ramesh, 2009, BMC Womens Health, V9, P27, DOI 10.1186/1472-6874-9-27; Akani Ci, 2008, Ghana Med J, V42, P68; Baiden F, 2002, CONTRACEPTION, V66, P23, DOI 10.1016/S0010-7824(02)00315-3; CHENG L, 2004, COCHRANE DB SYST REV, V3; Croxatto HB, 2004, CONTRACEPTION, V70, P442, DOI 10.1016/j.contraception.2004.05.007; Department of Health Republic of South Africa, 2001, S AFR DEM HLTH SURV; Ebuehi O M, 2006, East Afr Med J, V83, P90; Ellertson C, 2003, OBSTET GYNECOL, V101, P1168, DOI 10.1016/S0029-7844(03)00352-1; Gemzell-Danielsson K, 2004, HUM REPROD UPDATE, V10, P341, DOI 10.1093/humupd/dmh027; Grimes DA, 2002, ANN INTERN MED, V137, P180, DOI 10.7326/0003-4819-137-3-200208060-00010; Hariparsad N, 2001, EUR J CONTRACEP REPR, V6, P21; Hoque ME, 2011, GENDER BEHAV, V9, P3710; International Consortium for Emergency Contraception, 2004, EM CONTR PILLS; Jewkes R, 2002, SOC SCI MED, V55, P1231, DOI 10.1016/S0277-9536(01)00242-8; Kistnasamy EJ, 2009, S AFR FAM PRACT, V51, P423, DOI 10.1080/20786204.2009.10873896; Kongnyuy EJ, 2007, BMC EMERG MED, V7, DOI 10.1186/1471-227X-7-7; Makiwane M, 2010, DEV SO AFR, V27, P193, DOI 10.1080/03768351003740498; Morroni Chelsea, 2006, BMC Pregnancy Childbirth, V6, P26, DOI 10.1186/1471-2393-6-26; Morroni C, 2006, SAMJ S AFR MED J, V96, P620; Mqhayi Mmabatho Margaret, 2004, Afr J Reprod Health, V8, P137, DOI 10.2307/3583187; Myer Landon, 2007, BMC Womens Health, V7, P14, DOI 10.1186/1472-6874-7-14; Nworah JAO, 2010, INT J MED SCI, V2, P001; Roberts Candice, 2004, J Obstet Gynaecol, V24, P441, DOI 10.1080/01443610410001685619; Rodrigues I, 2001, AM J OBSTET GYNECOL, V184, P531, DOI 10.1067/mob.2001.111102; Tamire W., 2007, Ethiopian Journal of Health Development, V21, P111; Tapia-Curiel Amparo, 2008, Rev Med Inst Mex Seguro Soc, V46, P33; Vahratian A, 2008, J WOMENS HEALTH, V17, P103, DOI 10.1089/jwh.2007.0391	29	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46346	10.1371/journal.pone.0046346	http://dx.doi.org/10.1371/journal.pone.0046346			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050018	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300108
J	Narayan, SM; Krummen, DE; Enyeart, MW; Rappel, WJ				Narayan, Sanjiv M.; Krummen, David E.; Enyeart, Michael W.; Rappel, Wouter-Jan			Computational Mapping Identifies Localized Mechanisms for Ablation of Atrial Fibrillation	PLOS ONE			English	Article							HEART RHYTHM ASSOCIATION; CATHETER ABLATION; PULMONARY-VEIN; MULTIPLE MECHANISMS; AMERICAN-COLLEGE; EUROPEAN-SOCIETY; TASK-FORCE; ACTIVATION; EXCITATION; MANAGEMENT	Atrial fibrillation (AF) is the most common heart rhythm disorder in the Western world and a common cause of hospitalization and death. Pharmacologic and non-pharmacologic therapies have met with limited success, in part due to an incomplete understanding of the underlying mechanisms for AF. AF is traditionally characterized by spatiotemporally disorganized electrical activation and, although initiating triggers for AF are described, it is unclear whether AF is sustained by spatially meandering continuous excitation (re-entrant waves), localized electrical sources within the atria, or some other mechanism. This has limited therapeutic options for this condition. Here we show that human AF is predominantly caused by a small number (1.8 +/- 0.9) of localized re-entrant waves or repetitive focal beats, that remain stable with limited spatial migration over prolonged periods of time. Radiofrequency ablation that selectively targeted the sites of these sources was able to immediately terminate fibrillation and eliminate the arrhythmia with high success. Our results show that human AF, despite apparent spatiotemporal disorganization, is often perpetuated by a few spatially-constrained and temporally conserved sources whose targeted ablation can eliminate this complex rhythm disorder.	[Rappel, Wouter-Jan] Univ Calif San Diego, Dept Phys, San Diego, CA 92103 USA; [Rappel, Wouter-Jan] Univ Calif San Diego, Ctr Theoret Biol Phys, San Diego, CA 92103 USA; [Narayan, Sanjiv M.; Krummen, David E.; Enyeart, Michael W.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Narayan, Sanjiv M.; Krummen, David E.; Enyeart, Michael W.] Univ Calif San Diego, Vet Affairs Med Ctr, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Rappel, WJ (corresponding author), Univ Calif San Diego, Dept Phys, San Diego, CA 92103 USA.	rappel@physics.ucsd.edu			National Heart Lung and Blood Institute [HL70529, HL83359, HL103800]; Doris Duke Charitable foundation; Direct For Mathematical & Physical Scien [1308264] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL070529, R01HL083359, K24HL103800] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Doris Duke Charitable foundation(Doris Duke Charitable Foundation (DDCF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was funded by grants to SMN and WJR from the National Heart Lung and Blood Institute (HL70529, HL83359, HL103800) and Doris Duke Charitable foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allessie MA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P606, DOI 10.1161/CIRCEP.109.910125; [Anonymous], 2006, CIRCULATION, V114, P700; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; Bray MA, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051902; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Chen PS, 2003, CIRCULATION, V108, P2298, DOI 10.1161/01.CIR.0000094404.26004.07; Chou CC, 2011, J AM COLL CARDIOL, V58, P158, DOI 10.1016/j.jacc.2011.02.045; Cox JL, 2004, J CARDIOVASC ELECTR, V15, P250, DOI 10.1046/j.1540-8167.2004.03656.x; Cuculich PS, 2010, CIRCULATION, V122, P1364, DOI 10.1161/CIRCULATIONAHA.110.945709; DAVIDENKO JM, 1992, NATURE, V355, P349, DOI 10.1038/355349a0; de Groot NMS, 2010, CIRCULATION, V122, P1674, DOI 10.1161/CIRCULATIONAHA.109.910901; DURRER D, 1967, CIRCULATION, V35, P15, DOI 10.1161/01.CIR.35.1.15; Ellinor PT, 2010, NAT GENET, V42, P240, DOI 10.1038/ng.537; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Garfinkel A, 2000, P NATL ACAD SCI USA, V97, P6061, DOI 10.1073/pnas.090492697; Gray RA, 1998, NATURE, V392, P75, DOI 10.1038/32164; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Haissaguerre M, 2005, J CARDIOVASC ELECTR, V16, P1125, DOI 10.1111/j.1540-8167.2005.00307.x; Haissaguerre M, 2006, CIRCULATION, V113, P616, DOI 10.1161/CIRCULATIONAHA.105.546648; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hindricks G, 2001, CIRCULATION, V104, P297, DOI 10.1161/01.CIR.104.3.297; Ideker RE, 2009, HEART RHYTHM, V6, P1666, DOI 10.1016/j.hrthm.2009.07.012; JACKMAN WM, 1992, NEW ENGL J MED, V327, P313, DOI 10.1056/NEJM199207303270504; Kalifa JM, 2006, CIRCULATION, V113, P626, DOI 10.1161/CIRCULATIONAHA.105.575340; Kirchhof P, 2012, LANCET; Kirchhof P, 2007, EUR HEART J, V28, P2803, DOI 10.1093/eurheartj/ehm358; Kirchhof P, 2011, THROMB HAEMOSTASIS, V105, P1010, DOI 10.1160/TH11-02-0070; Luther S, 2011, NATURE, V475, P235, DOI 10.1038/nature10216; Mangrum JM, 2000, J CARDIOVASC ELECTR, V11, P1159, DOI 10.1111/j.1540-8167.2000.tb01763.x; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; MOE GK, 1964, AM HEART J, V67, P200, DOI 10.1016/0002-8703(64)90371-0; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Narayan SM, 2008, J AM COLL CARDIOL, V52, P1222, DOI 10.1016/j.jacc.2008.07.012; Nash MP, 2006, CIRCULATION, V114, P536, DOI 10.1161/CIRCULATIONAHA.105.602870; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Nitta T, 2004, J THORAC CARDIOV SUR, V127, P770, DOI 10.1016/j.jtcvs.2003.05.001; Oral H, 2006, NEW ENGL J MED, V354, P934, DOI 10.1056/NEJMoa050955; Ramanathan C, 2004, NAT MED, V10, P422, DOI 10.1038/nm1011; RENSMA PL, 1988, CIRC RES, V62, P395, DOI 10.1161/01.RES.62.2.395; Ryu K, 2005, J CARDIOVASC ELECTR, V16, P1348, DOI 10.1111/j.1540-8167.2005.00266.x; Schilling RJ, 2000, EUR HEART J, V21, P550, DOI 10.1053/euhj.1999.1851; Schotten U, 2011, PHYSIOL REV, V91, P265, DOI 10.1152/physrev.00031.2009; Skanes AC, 1998, CIRCULATION, V98, P1236, DOI 10.1161/01.CIR.98.12.1236; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Waldo AL, 2008, J AM COLL CARDIOL, V51, P779, DOI 10.1016/j.jacc.2007.08.066; Weerasooriya R, 2011, J AM COLL CARDIOL, V57, P160, DOI 10.1016/j.jacc.2010.05.061; WIJFFELS MCEF, 1995, CIRCULATION, V92, P1954, DOI 10.1161/01.CIR.92.7.1954; Winkle RA, 2012, J INTERV CARD ELECTR; Witkowski FX, 1998, NATURE, V392, P78, DOI 10.1038/32170; Yamazaki M, 2009, HEART RHYTHM, V6, P1009, DOI 10.1016/j.hrthm.2009.03.029; Ziegler PD, 2006, HEART RHYTHM, V3, P1445, DOI 10.1016/j.hrthm.2006.07.030; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	52	62	69	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46034	10.1371/journal.pone.0046034	http://dx.doi.org/10.1371/journal.pone.0046034			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049929	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300077
J	Prasad, R; Katiyar, SK				Prasad, Ram; Katiyar, Santosh K.			Bioactive Phytochemical Proanthocyanidins Inhibit Growth of Head and Neck Squamous Cell Carcinoma Cells by Targeting Multiple Signaling Molecules	PLOS ONE			English	Article							DEPENDENT KINASES; INDUCE APOPTOSIS; FACTOR RECEPTOR; CYCLE CONTROL; BCL-2 FAMILY; IN-VIVO; CANCER; THERAPY; PROTEIN; CASPASE-3	Despite advances in surgical and medical therapies, approximate 50% survival rate of head and neck squamous cell carcinoma (HNSCC) has had marginal improvement in the last 30 years. Therefore, alternative strategies are required for the management of HNSCC. Here, we report the chemotherapeutic effect of proanthocyanidins on HNSCC cells using in vitro and in vivo models. Treatment of human HNSCC cell lines from different sub-sites, such as oral cavity (SCC1), larynx (SCC5), tongue (OSC19) and pharynx (FaDu), with grape seed proanthocyanidins (GSPs) reduced their cell viability and induced cell death in a dose-and time-dependent manner. GSPs induced inhibition of cell viability was associated with: (i) G1-phase arrest, (ii) inhibition of expressions of cyclins (cyclin D1 and Cyclin D2) and cyclin-dependent kinases (Cdk), (iii) increased expression of the Cdk inhibitory proteins (Cip1/p21, Kip1/p27), enhanced binding of Cdk inhibitors to Cdks, and downregulation of E2F transcription factor. GSPs significantly (P<0.05-0.001) increased apoptosis of SCC1 and OSC19 cells with induction of Bax, reduced expression of Bcl-2, and activation of caspase-3. GSPs also reduced the expression of epidermal growth factor receptor (EGFR), and treatment of SCC1 cells with erlotinib, an EGFR-targeting small molecule tyrosine kinase inhibitor, significantly (P<0.05-0.001) reduced cell viability and increased cell death. Dietary administration of GSPs (0.5%, w/w) in supplementation with AIN76A control diet inhibited the growth of SCC1 tumor xenografts in athymic nude mice, which was associated with: (i) inhibition of cell proliferation, (ii) induction of apoptosis of tumor xenograft cells, (iii) decreased expression of cyclins and Cdks, (iv) decreased expression of EGFR, and (v) increased expression of Cip1/p21 and Kip1/p27 proteins and their increased binding to Cdks in tumor xenograft samples. Together, these results suggest that GSPs may be a promising candidate for head and neck squamous cell carcinoma therapy.	[Katiyar, Santosh K.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Prasad, Ram; Katiyar, Santosh K.] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Katiyar, Santosh K.] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL 35294 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Katiyar, SK (corresponding author), Birmingham Vet Affairs Med Ctr, Birmingham, AL USA.	skatiyar@uab.edu			Veterans Administration; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by funds from the Veterans Administration Merit Review Award (SKK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Akhtar S, 2009, CLIN CANCER RES, V15, P821, DOI 10.1158/1078-0432.CCR-08-1901; Arbes SJ, 1999, CANCER CAUSE CONTROL, V10, P513, DOI 10.1023/A:1008911300100; Bock JM, 2007, MOL CARCINOGEN, V46, P857, DOI 10.1002/mc.20318; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; DAY GL, 1992, CANCER, V70, P14, DOI 10.1002/1097-0142(19920701)70:1<14::AID-CNCR2820700103>3.0.CO;2-S; Epstein JB, 2001, HEAD NECK-J SCI SPEC, V23, P389, DOI 10.1002/hed.1049; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Friedlander P, 2002, HEAD NECK-J SCI SPEC, V24, P111, DOI 10.1002/hed.10015.abs; Gellrich NC, 2002, J ORAL MAXIL SURG, V60, P772, DOI 10.1053/joms.2002.33244; GRANA X, 1995, ONCOGENE, V11, P211; Grandis JR, 1996, CANCER-AM CANCER SOC, V78, P1284, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1284::AID-CNCR17>3.0.CO;2-X; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; He YK, 1998, JNCI-J NATL CANCER I, V90, P1080, DOI 10.1093/jnci/90.14.1080; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HICKMAN JA, 1992, CANCER METAST REV, V11, P121, DOI 10.1007/BF00048059; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; KASTAN MB, 1995, CANCER METAST REV, V14, P3, DOI 10.1007/BF00690207; Leeman-Neill RJ, 2010, CLIN CANCER RES, V16, P2571, DOI 10.1158/1078-0432.CCR-10-0333; Leon X, 2001, Expert Rev Anticancer Ther, V1, P125, DOI 10.1586/14737140.1.1.125; Loeffler-Ragg J, 2008, EXPERT OPIN INV DRUG, V17, P1517, DOI 10.1517/13543784.17.10.1517 ; Mantena SK, 2005, J NUTR, V135, P2871, DOI 10.1093/jn/135.12.2871; Mantena SK, 2006, CARCINOGENESIS, V27, P1682, DOI 10.1093/carcin/bgl030; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Masuda M, 2011, J ONCOL, V2011, DOI 10.1155/2011/540148; Meeran SM, 2009, CARCINOGENESIS, V30, P520, DOI 10.1093/carcin/bgp019; Mittal A, 2003, CARCINOGENESIS, V24, P1379, DOI 10.1093/carcin/bgg095; Molinari M, 2000, CELL PROLIFERAT, V33, P261, DOI 10.1046/j.1365-2184.2000.00191.x; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Ortega S, 2002, BBA-REV CANCER, V1602, P73, DOI 10.1016/S0304-419X(02)00037-9; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Perlmutter MA, 2002, ARCH OTOLARYNGOL, V128, P887, DOI 10.1001/archotol.128.8.887; PRIEUR C, 1994, PHYTOCHEMISTRY, V36, P781, DOI 10.1016/S0031-9422(00)89817-9; Raina K, 2007, CANCER RES, V67, P5976, DOI 10.1158/0008-5472.CAN-07-0295; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; RICARDO-DA-SILVA JM, 1991, PHYTOCHEMISTRY, V30, P1259, DOI 10.1016/S0031-9422(00)95213-0; Roy AM, 2005, NEOPLASIA, V7, P24, DOI 10.1593/neo.04412; Sharma SD, 2010, MOL CANCER THER, V9, P569, DOI 10.1158/1535-7163.MCT-09-0638; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027444; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Sweeny L, 2012, LARYNGOSCOPE, V122, P1539, DOI 10.1002/lary.23266; Ye X, 1999, MOL CELL BIOCHEM, V196, P99, DOI 10.1023/A:1006926414683	45	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46404	10.1371/journal.pone.0046404	http://dx.doi.org/10.1371/journal.pone.0046404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050025	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300115
J	Strand, AE; Williams, LM; Oleksiak, MF; Sotka, EE				Strand, Allan E.; Williams, Larissa M.; Oleksiak, Marjorie F.; Sotka, Erik E.			Can Diversifying Selection Be Distinguished from History in Geographic Clines? A Population Genomic Study of Killifish (Fundulus heteroclitus)	PLOS ONE			English	Article							BIOCHEMICAL GENETICS; LDH-B; PHYLOGEOGRAPHY; POLYMORPHISMS; ADAPTATIONS; FREQUENCIES; DIVERGENCE; EXPRESSION; PROMISE; MODEL	A common geographical pattern of genetic variation is the one-dimensional cline. Clines may be maintained by diversifying selection across a geographical gradient but can also reflect historical processes such as allopatry followed by secondary contact. To identify loci that may be undergoing diversifying selection, we examined the distribution of geographical variation patterns across the range of the killifish (Fundulus heteroclitus) in 310 loci, including microsatellites, allozymes, and single nucleotide polymorphisms. We employed two approaches to detect loci under strong diversifying selection. First, we developed an automated method to identify clinal variation on a per-locus basis and examined the distribution of clines to detect those that exhibited signifcantly steeper slopes. Second, we employed a classic F-ST-outlier method as a complementary approach. We also assessed performance of these techniques using simulations. Overall, latitudinal clines were detected in nearly half of all loci genotyped (i.e., all eight microsatellite loci, 12 of 16 allozyme loci and 44% of the 285 SNPs). With the exception of few outlier loci (notably mtDNA and malate dehydrogenase), the positions and slopes of Fundulus clines were statistically indistinguishable. The high frequency of latitudinal clines across the genome indicates that secondary contact plays a central role in the historical demography of this species. Our simulation results indicate that accurately detecting diversifying selection using genome scans is extremely difficult in species with a strong signal of secondary contact; neutral evolution under this history produces clines as steep as those expected under selection. Based on these results, we propose that demographic history can explain all clinal patterns observed in F. heteroclitus without invoking natural selection to either establish or maintain the pattern we observe today.	[Strand, Allan E.; Sotka, Erik E.] Coll Charleston, Dept Biol, Grice Marine Lab, Charleston, SC 29424 USA; [Williams, Larissa M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Oleksiak, Marjorie F.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	College of Charleston; Woods Hole Oceanographic Institution; University of Miami	Strand, AE (corresponding author), Coll Charleston, Dept Biol, Grice Marine Lab, Charleston, SC 29424 USA.			Williams, Larissa/0000-0001-8972-9735	National Science Foundation [DEB-0919064, IOS-1052262]; Direct For Biological Sciences [1158241] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation (DEB-0919064 and IOS-1052262; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe TA, 2005, CAN J ZOOL, V83, P13; Adams SM, 2006, MOL ECOL, V15, P1109, DOI 10.1111/j.1365-294X.2006.02859.x; ARNOLD J, 1993, ANNU REV ECOL SYST, V24, P521, DOI 10.1146/annurev.es.24.110193.002513; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; ATZ JW, 1986, AM ZOOL, V26, P111; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1993, HYBRID ZONES EVOLUTI; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; Burnett KG, 2007, COMP BIOCHEM PHYS D, V2, P257, DOI 10.1016/j.cbd.2007.09.001; CASHON RE, 1981, BIOCHEM GENET, V19, P715, DOI 10.1007/BF00484004; Dalziel AC, 2009, MOL ECOL, V18, P4997, DOI 10.1111/j.1365-294X.2009.04427.x; Duvernell DD, 2008, MOL ECOL, V17, P1344, DOI 10.1111/j.1365-294X.2007.03648.x; Eanes WF, 1999, ANNU REV ECOL SYST, V30, P301, DOI 10.1146/annurev.ecolsys.30.1.301; Endler J.A., 1977, Monographs in Population Biology, pi; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Flight PA, 2011, MOL ECOL, V20, P4503, DOI 10.1111/j.1365-294X.2011.05290.x; Gardner JPA, 1997, ADV MAR BIOL, V31, P1, DOI 10.1016/S0065-2881(08)60221-7; Gay L, 2008, EVOLUTION, V62, P2789, DOI 10.1111/j.1558-5646.2008.00491.x; Gompert Z, 2009, MOL ECOL, V18, P1207, DOI 10.1111/j.1365-294X.2009.04098.x; GONZALEZVILLASENOR LI, 1990, EVOLUTION, V44, P27, DOI 10.1111/j.1558-5646.1990.tb04277.x; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; HALDANE JBS, 1948, J GENET, V48, P277, DOI 10.1007/BF02986626; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Haney RA, 2009, J HERED, V100, P284, DOI 10.1093/jhered/esn107; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Kircheis Frederick W., 1998, North American Journal of Fisheries Management, V18, P175, DOI 10.1577/1548-8675(1998)018&lt;0175:SCAEVO&gt;2.0.CO;2; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; MANTEL N, 1967, CANCER RES, V27, P209; MITTON JB, 1975, GENETICS, V79, P97; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; Powell Mark A., 1992, Molecular Marine Biology and Biotechnology, V1, P391; Powers DA, 1998, J EXP ZOOL, V282, P71; POWERS DA, 1978, BIOCHEM GENET, V16, P593, DOI 10.1007/BF00484222; ROPSON IJ, 1990, EVOLUTION, V44, P16, DOI 10.1111/j.1558-5646.1990.tb04276.x; Schmidt PS, 2008, ECOLOGY, V89, pS91, DOI 10.1890/07-1162.1; Schulte PM, 2001, COMP BIOCHEM PHYS B, V128, P597, DOI 10.1016/S1096-4959(00)00357-2; Schulte PM, 1997, GENETICS, V145, P759; SLATKIN M, 1973, GENETICS, V75, P733; Smith MW, 1998, MOL MAR BIOL BIOTECH, V7, P79; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Sotka EE, 2006, ECOLOGY, V87, P1094, DOI 10.1890/0012-9658(2006)87[1094:TUOGCT]2.0.CO;2; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; SZYMURA JM, 1986, EVOLUTION, V40, P1141, DOI 10.1111/j.1558-5646.1986.tb05740.x; Vasemagi A, 2005, MOL ECOL, V14, P3623, DOI 10.1111/j.1365-294X.2005.02690.x; Vasemagi A, 2006, GENETICS, V173, P2411, DOI 10.1534/genetics.106.059881; Whitehead A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-11; Williams LM, 2011, MOL BIOL EVOL, V28, P1817, DOI 10.1093/molbev/msr004; Williams Larissa M, 2010, BMC Genet, V11, P32, DOI 10.1186/1471-2156-11-32; Willing EM, 2010, MOL ECOL, V19, P968, DOI 10.1111/j.1365-294X.2010.04528.x; Woodruff D S, 1978, Science, V199, P1329, DOI 10.1126/science.199.4335.1329	55	26	27	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45138	10.1371/journal.pone.0045138	http://dx.doi.org/10.1371/journal.pone.0045138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049770	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300016
J	Guzzo, C; Hopman, WM; Mat, NFC; Wobeser, W; Gee, K				Guzzo, Christina; Hopman, Wilma M.; Mat, Nor Fazila Che; Wobeser, Wendy; Gee, Katrina			IL-27-Induced Gene Expression Is Downregulated in HIV-Infected Subjects	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; NECROSIS-FACTOR-ALPHA; I CYTOKINE RECEPTOR; CD4(+) T-CELLS; HUMAN MONOCYTES; UP-REGULATION; IL-27; INTERLEUKIN-27; MACROPHAGES; INTERFERON	Objective: To characterize the effect of HIV infection on IL-27-induced gene expression. Design: During HIV infection, cytokine expression and function become deregulated. IL-27 is an important modulator of inflammatory responses. Interestingly, IL-27 can inhibit HIV replication in T cells and monocytes, implicating IL-27 as a potential adjunct to anti-viral treatment. Our previous work demonstrated that circulating HIV may suppress IL-27 expression, therefore, this study, in continuation of our previous work, aimed to understand how HIV affects expression levels of the IL-27 receptor and downstream functions of IL-27. Methods: Peripheral blood mononuclear cells (PBMC) were isolated from whole blood of HIV negative and HIV positive (viremic) individuals to assess IL-27-induced gene expression by flow cytometry and ELISA. PBMC were also processed for monocyte enrichment to assess IL-27 receptor expression by flow cytometry and real-time PCR. Results: Expression of the IL-27 receptor subunit, gp130, was upregulated in response to IL-27 in HIV negative individuals, however, in HIV positive individuals, this IL-27 response was diminished. Furthermore, we observed downregulation of IL-27-induced IL-6, TNF-alpha, and IL-10 expression in HIV positive subjects. Conclusion: In HIV infection, IL-27-induced gene expression was impaired, indicating HIV-mediated dysregulation of IL-27 functions occurs during HIV infection. This study provides evidence for new viral pathogenic mechanisms contributing to the widespread impairment of immune responses observed in HIV pathogenesis.	[Guzzo, Christina; Mat, Nor Fazila Che; Wobeser, Wendy; Gee, Katrina] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Hopman, Wilma M.] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada; [Wobeser, Wendy] Queens Univ, Dept Med, Div Infect Dis, Kingston, ON K7L 3N6, Canada; [Mat, Nor Fazila Che] Univ Sains Malaysia, Sch Hlth Sci, Kelantan, Malaysia	Queens University - Canada; Queens University - Canada; Queens University - Canada; Universiti Sains Malaysia	Gee, K (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada.	kgee@queensu.ca	MAT, NOR FAZILA CHE/M-3349-2015; Gee, Katrina/H-3093-2016	MAT, NOR FAZILA CHE/0000-0002-1698-3633; Gee, Katrina/0000-0002-7535-2882; Guzzo, Christina/0000-0002-3042-0976	Queen's University; National Sciences and Engineering Council of Canada (NSERC) [342168-07]; Ontario HIV Treatment Network (OHTN); Canadian Institutes of Health Research (CIHR) Vanier Scholarship	Queen's University; National Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario HIV Treatment Network (OHTN); Canadian Institutes of Health Research (CIHR) Vanier Scholarship(Canadian Institutes of Health Research (CIHR))	This research was supported by grants from Queen's University (www.queensu.ca,grant number: N/A) and the National Sciences and Engineering Council of Canada (NSERC) (www.nserc-crsng.gc.ca/index_eng.as, grant number: 342168-07). CG has been supported by a studentship from the Ontario HIV Treatment Network (OHTN; www.ohtn.on.ca) and the Canadian Institutes of Health Research (CIHR) Vanier Scholarship (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhetheel A, 2008, AIDS, V22, P1137, DOI 10.1097/QAD.0b013e3283013d42; Baqui AAMA, 2000, IMMUNOPHARM IMMUNOT, V22, P401, DOI 10.3109/08923970009026002; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; BIRX DL, 1990, BLOOD, V76, P2303; Canque B, 1996, BLOOD, V87, P2011; Chen Q, 2000, NATURE, V407, P916, DOI 10.1038/35038103; de Arquer GR, 2007, J LEUKOCYTE BIOL, V82, P72, DOI 10.1189/jlb.1106698; Demyanets S, 2012, VASC PHARMACOL, V56, P34, DOI 10.1016/j.vph.2011.12.004; Feng XM, 2008, BIOCHEMBIOPHYSRESCOM; Gee Katrina, 2009, Inflammation & Allergy Drug Targets, V8, P40; Greenwell-Wild T, 2009, BLOOD, V114, P1864, DOI 10.1182/blood-2009-03-211540; Guzzo C, 2012, J IMMUNOL, V188, P864, DOI 10.4049/jimmunol.1101912; Guzzo C, 2010, J BIOL CHEM, V285, P24404, DOI 10.1074/jbc.M110.112599; Guzzo C, 2010, AIDS, V24, P1371, DOI 10.1097/QAD.0b013e3283391d2b; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Jones ML, 2003, AIDS RES HUM RETROV, V19, P283, DOI 10.1089/088922203764969483; Larousserie F, 2006, J IMMUNOL, V176, P5890, DOI 10.4049/jimmunol.176.10.5890; Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100; McQuaid A, 2003, CLIN EXP IMMUNOL, V134, P321, DOI 10.1046/j.1365-2249.2003.02271.x; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Ruckerl D, 2006, IMMUNOBIOLOGY, V211, P427, DOI 10.1016/j.imbio.2006.05.008; SADEGHI HM, 1995, J INFECT DIS, V172, P547, DOI 10.1093/infdis/172.2.547; Schneider R, 2011, EUR J IMMUNOL, V41, P47, DOI 10.1002/eji.201040804; Sprecher CA, 1998, BIOCHEM BIOPH RES CO, V246, P82, DOI 10.1006/bbrc.1998.8576; Tilton JC, 2006, J VIROL, V80, P11486, DOI 10.1128/JVI.00324-06; Tjernlund A, 2003, AIDS, V17, P1303, DOI 10.1097/00002030-200306130-00004; VONSYDOW M, 1991, AIDS RES HUM RETROV, V7, P375, DOI 10.1089/aid.1991.7.375; Wirtz S, 2006, J EXP MED, V203, P1875, DOI 10.1084/jem.20060471; Wong CK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3067	30	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45706	10.1371/journal.pone.0045706	http://dx.doi.org/10.1371/journal.pone.0045706			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049843	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100072
J	Lekas, M; Lekas, P; Mei, SHJ; Deng, YP; Dumont, DJ; Stewart, DJ				Lekas, Michael; Lekas, Poli; Mei, Shirley H. J.; Deng, Yupu; Dumont, Daniel J.; Stewart, Duncan J.			Tie2-Dependent Neovascularization of the Ischemic Hindlimb Is Mediated by Angiopoietin-2	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BLOOD-VESSEL FORMATION; NITRIC-OXIDE; INTRAMUSCULAR INJECTION; TYROSINE KINASE; CELL SURVIVAL; TIE2 RECEPTOR; GENE-TRANSFER; IN-VIVO; ANGIOGENESIS	The angiopoietins (ANGPT) are ligands for the endothelial cell (EC) receptor tyrosine kinase, Tie2. Angpt-1 is a Tie2 agonist that promotes vascular maturation and stabilization, whereas Angpt-2 is a partial agonist/antagonist involved in the initiation of postnatal angiogenesis. Therefore, we hypothesized that overexpression of Angpt-2 would be more effective than Angpt-1 for enhancing the perfusion recovery in the ischemic hindlimb. Perfusion recovery was markedly impaired in Tie2-deficient animals at day 35 in a model of chronic hindlimb ischemia. Injections of Angpt-2 or VEGFA plasmid at 7 days post femoral artery resection enhanced recovery and improved arteriogenesis as assessed by angiographic scores, whereas Angpt-1 or null plasmid had no effect. In addition, Angpt-2 together with VEGF resulted in greater improvement in perfusion and collateral vessel formation than VEGF alone. Similarly, conditional overexpression of Angpt-2 in mice improved ischemic limb blood flow recovery, while Angpt-1 overexpression was ineffective. These data from Tie2 heterozygote deficient mice demonstrate, for the first time, the importance of the Tie2 pathway in spontaneous neovascularization in response to chronic hindlimb ischemia. Moreover, they show that overexpression of the partial agonist, Angpt-2, but not Angpt-1, enhanced ischemic hind limb perfusion recovery and collateralization, suggesting that a coordinated sequence antagonist and agonist activity is required for effective therapeutic revascularization.	[Lekas, Michael; Lekas, Poli; Mei, Shirley H. J.; Deng, Yupu; Stewart, Duncan J.] Univ Toronto, St Michaels Hosp, Div Cardiol, Terrence Donnelly Res Labs, Toronto, ON M5S 1A1, Canada; [Lekas, Michael; Lekas, Poli; Mei, Shirley H. J.; Deng, Yupu; Stewart, Duncan J.] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Dumont, Daniel J.; Stewart, Duncan J.] Univ Toronto, Fac Med, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5S 1A1, Canada; [Dumont, Daniel J.] Sunnybrook Res Inst, Toronto, ON, Canada; [Mei, Shirley H. J.; Stewart, Duncan J.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Mei, Shirley H. J.; Stewart, Duncan J.] Univ Ottawa, Ottawa, ON K1N 6N5, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Stewart, DJ (corresponding author), Univ Toronto, St Michaels Hosp, Div Cardiol, Terrence Donnelly Res Labs, Toronto, ON M5S 1A1, Canada.	djstewart@ohri.ca		Mei, Shirley/0000-0003-4727-1177	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Canada (HSFC); Physician Services Incorporated Foundation (PSI); Heart & Stroke Richard Lewar TACTICS Research Fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada); Physician Services Incorporated Foundation (PSI); Heart & Stroke Richard Lewar TACTICS Research Fellowship	Financial support for this research work is provided by the Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation of Canada (HSFC) and Physician Services Incorporated Foundation(PSI) funding grant. ML held a Heart & Stroke Richard Lewar TACTICS Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2009, CIRC RES, V104, P1333, DOI 10.1161/CIRCRESAHA.109.196154; Arsic N, 2003, MOL THER, V7, P450, DOI 10.1016/S1525-0016(03)00034-0; Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Comerota AJ, 2002, J VASC SURG, V35, P930, DOI 10.1067/mva.2002.123677; Coxon A, 2010, MOL CANCER THER, V9, P2641, DOI 10.1158/1535-7163.MCT-10-0213; DUMONT DJ, 1992, ONCOGENE, V7, P1471; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Goede V, 1998, LAB INVEST, V78, P1385; Hackett SF, 2000, J CELL PHYSIOL, V184, P275, DOI 10.1002/1097-4652(200009)184:3<275::AID-JCP1>3.3.CO;2-Z; Haninec AL, 2006, BIOCHEM BIOPH RES CO, V345, P1299, DOI 10.1016/j.bbrc.2006.04.149; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Peters KG, 1998, CIRC RES, V83, P342, DOI 10.1161/01.RES.83.3.342; Rabbany SY, 2003, TRENDS MOL MED, V9, P109, DOI 10.1016/S1471-4914(03)00021-2; Reiss Y, 2007, CIRC RES, V101, P88, DOI 10.1161/CIRCRESAHA.106.143594; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schaper W, 2003, ARTERIOSCL THROM VAS, V23, P1143, DOI 10.1161/01.ATV.0000069625.11230.96; Shyu KG, 1998, CIRCULATION, V98, P2081, DOI 10.1161/01.CIR.98.19.2081; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Tanaka S, 1999, J CLIN INVEST, V103, P341, DOI 10.1172/JCI4891; Teichert-Kuliszewska K, 2001, CARDIOVASC RES, V49, P659, DOI 10.1016/S0008-6363(00)00231-5; Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Tressel SL, 2008, ARTERIOSCL THROM VAS, V28, P1989, DOI 10.1161/ATVBAHA.108.175463; Tripathy SK, 1996, P NATL ACAD SCI USA, V93, P10876, DOI 10.1073/pnas.93.20.10876; Visconti RP, 2002, P NATL ACAD SCI USA, V99, P8219, DOI 10.1073/pnas.122109599; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; Yamauchi A, 2003, J GENE MED, V5, P994, DOI 10.1002/jgm.439; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Zhao YDD, 2005, CIRC RES, V96, P442, DOI 10.1161/01.RES.0000157672.70560.7b	40	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e43568	10.1371/journal.pone.0043568	http://dx.doi.org/10.1371/journal.pone.0043568			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049737	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100008
J	Nacif-Pimenta, R; de Mattos, ACA; Orfano, AD; Barbosa, L; Pimenta, PFP; Coelho, PMZ				Nacif-Pimenta, Rafael; Alves de Mattos, Ana Carolina; Orfano, Alessandra da Silva; Barbosa, Luciene; Paolucci Pimenta, Paulo Filemon; Zech Coelho, Paulo Marcos			Schistosoma mansoni in Susceptible and Resistant Snail Strains Biomphalaria tenagophila: In Vivo Tissue Response and In Vitro Hemocyte Interactions	PLOS ONE			English	Article							DOMINANT CHARACTER; GLABRATA; COMPATIBILITY; SPOROCYSTS; PLASMA; PARTICIPATION; INFECTION; HEMOLYMPH; PROTEINS	Schistosomiasis is a parasitic disease that is highly prevalent, especially in developing countries. Biomphalaria tenagophila is an important invertebrate host of Schistosoma mansoni in Brazil, with some strains (e. g. Cabo Frio) being highly susceptible to the parasite, whereas others (e.g. Taim) are completely resistant to infection. Therefore, B. tenagophila is an important research model for studying immune defense mechanisms against S. mansoni. The internal defense system (IDS) of the snail comprises hemocytes and hemolymph factors acting together to recognize self from non-self molecular patterns to eliminate the threat of infection. We performed experiments to understand the cellular defenses related to the resistance and/or susceptibility of B. tenagophila to S. mansoni. During the early stages of infection, fibrous host cells of both snail strains were arranged as a thin layer surrounding the sporocysts. However, at later stages of infection, the cellular reactions in resistant snails were increasingly more intense, with thicker layers surrounding the parasites, in contrast to susceptible strains. All parasites were damaged or destroyed inside resistant snails after 10 h of infection. By contrast, parasites inside susceptible snails appeared to be morphologically healthy. We also performed experiments using isolated hemocytes from the two strains interacting with sporocysts. Hemocyte attachment started as early as 1 h after initial infection in both strains, but the killing of sporocysts was exclusive to hemocytes from the resistant strain and was time course dependent. The resistant strain was able to kill all sporocysts. In conclusion, our study revealed important aspects of the initial process of infection related to immune defense responses of strains of B. tenagophila that were resistant to S. mansoni compared with strains that were susceptible. Such information is relevant for the survival or death of the parasites and so is important in the development of control measures against this parasite.	[Alves de Mattos, Ana Carolina; Zech Coelho, Paulo Marcos] Ctr Pesquisas Rene Rachou Fiocruz, Lab Esquistossomose, Belo Horizonte, MG, Brazil; [Nacif-Pimenta, Rafael; Orfano, Alessandra da Silva; Paolucci Pimenta, Paulo Filemon] Ctr Pesquisas Rene Rachou Fiocruz, Lab Entomol Med, Belo Horizonte, MG, Brazil; [Barbosa, Luciene] Univ Fed Sergipe, Lab Entomol & Parasitol Trop, Aracaju, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Sergipe	Coelho, PMZ (corresponding author), Ctr Pesquisas Rene Rachou Fiocruz, Lab Esquistossomose, Belo Horizonte, MG, Brazil.	coelhopm@cpqrr.fiocruz.br	Pimenta, Paulo/AAH-1502-2020; Coelho, Paulo Marcos Zech/ABE-6169-2021	Coelho, Paulo Marcos Zech/0000-0002-2443-8897	Fundacao Oswaldo Cruz	Fundacao Oswaldo Cruz	This work was supported by Fundacao Oswaldo Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Mattos ACA, 2011, MEM I OSWALDO CRUZ, V106, P424, DOI 10.1590/S0074-02762011000400007; Azevedo CM, 2006, MEM I OSWALDO CRUZ, V101, P199, DOI 10.1590/S0074-02762006000900031; Barbosa L, 2006, MEM I OSWALDO CRUZ, V101, P639, DOI 10.1590/S0074-02762006000600010; Barbosa L, 2006, PARASITE IMMUNOL, V28, P209, DOI 10.1111/j.1365-3024.2006.00827.x; BASCH PF, 1976, EXP PARASITOL, V39, P150, DOI 10.1016/0014-4894(76)90022-9; BAYNE CJ, 1980, EXP PARASITOL, V50, P409, DOI 10.1016/0014-4894(80)90043-0; Bezerra F. S. D. M., 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P197, DOI 10.1590/S0036-46651997000400003; Bezerra FSD, 2003, MEM I OSWALDO CRUZ, V98, P73, DOI 10.1590/S0074-02762003000100010; BOSWELL CA, 1986, IMMUNOLOGY, V57, P261; Chaia G, 1968, REV BRAS MALAR DOENC, V8, P355; CHENG TC, 1968, PAC SCI, V22, P141; Coelho JR, 2006, MEM I OSWALDO CRUZ, V101, P111, DOI 10.1590/S0074-02762006000100022; Coelho PMZ, 2004, MEM I OSWALDO CRUZ, V99, P109, DOI 10.1590/S0074-02762004000900020; Cousin C, 1995, J PARASITOL, V81, P905, DOI 10.2307/3284038; COUSTAU C, 1994, J INVERTEBR PATHOL, V63, P82, DOI 10.1006/jipa.1994.1013; Fester T, 2008, J MICROSC-OXFORD, V231, P342, DOI 10.1111/j.1365-2818.2008.01999.x; GRANATH WO, 1984, EXP PARASITOL, V58, P188, DOI 10.1016/0014-4894(84)90034-1; Hahn UK, 2001, J PARASITOL, V87, P778, DOI 10.1645/0022-3395(2001)087[0778:IONOIK]2.0.CO;2; JOKY A, 1983, DEV COMP IMMUNOL, V7, P669, DOI 10.1016/0145-305X(83)90090-3; KRUPA PL, 1977, J INVERTEBR PATHOL, V30, P35, DOI 10.1016/0022-2011(77)90034-9; Lemos Queli Teixeira, 1999, Revista da Sociedade Brasileira de Medicina Tropical, V32, P343, DOI 10.1590/S0037-86821999000400002; Lie KJ, 1979, IMMUNE RESPONSES PAR, P211; LoVerde P.T., 1984, Progress in Clinical and Biological Research, V157, P17; Martins-Souza RL, 2006, MEM I OSWALDO CRUZ, V101, P185, DOI 10.1590/S0074-02762006000900029; Martins-Souza RL, 2011, MEM I OSWALDO CRUZ, V106, P884, DOI 10.1590/S0074-02762011000700015; Mattos ACA, 2006, MEM I OSWALDO CRUZ, V101, P283, DOI 10.1590/S0074-02762006000900044; Meuleman EA, 1987, DEV COMP IMMUNOL, P116; Negrao-Correa D, 2007, ISJ-INVERT SURVIV J, V4, P101; Pan C, 1965, AM J TROP MED HYG, V14, P6; PARAENSE W. L., 1970, ESQUISTOSSOMOSE MANS, P13; PARAENSE WL, 1978, J PARASITOL, V64, P822, DOI 10.2307/3279509; Pellegrino J, 1968, Adv Parasitology, V6, P233, DOI 10.1016/S0065-308X(08)60475-3; Pereira CAJ, 2008, PARASITE IMMUNOL, V30, P610, DOI 10.1111/j.1365-3024.2008.01062.x; Richards C.S., 1976, Symposia Br Soc Parasit, V14, P45; RICHARDS CS, 1987, J PARASITOL, V73, P1146, DOI 10.2307/3282295; RICHARDS EH, 1991, J COMP PHYSIOL B, V161, P43, DOI 10.1007/BF00258745; Rosa FM, 2005, MEM I OSWALDO CRUZ, V100, P19, DOI 10.1590/S0074-02762005000100004; Rosa FM, 2004, MEM I OSWALDO CRUZ, V99, P85, DOI 10.1590/S0074-02762004000100015; SANTOS M. B. L., 1979, Revista do Instituto de Medicina Tropical de Sao Paulo, V21, P281; Silva LM, 2008, TOXICON, V51, P693, DOI 10.1016/j.toxicon.2007.12.009; Souza CP, 1993, THESIS ICB UFMG BELO; Souza SD, 2006, MEM I OSWALDO CRUZ, V101, P213, DOI 10.1590/S0074-02762006000900033; SPRAY FJ, 1988, COMP BIOCHEM PHYS B, V91, P619, DOI 10.1016/0305-0491(88)90182-4; Sullivan JT, 1990, T AM MICROSC SOC, V111, P1; Teodoro TM, 2010, MOL PHYLOGENET EVOL, V57, P144, DOI 10.1016/j.ympev.2010.05.019; VANDERKNAAP WPW, 1990, PARASITOL TODAY, V6, P175, DOI 10.1016/0169-4758(90)90349-9; YOSHINO TP, 1976, J MORPHOL, V150, P485; ZELCK UE, 1995, DEV COMP IMMUNOL, V19, P181, DOI 10.1016/0145-305X(95)00012-I	48	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45637	10.1371/journal.pone.0045637	http://dx.doi.org/10.1371/journal.pone.0045637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049828	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100062
J	Paulitschke, V; Gruber, S; Hofstatter, E; Haudek-Prinz, V; Klepeisz, P; Schicher, N; Jonak, C; Petzelbauer, P; Pehamberger, H; Gerner, C; Kunstfeld, R				Paulitschke, Verena; Gruber, Silke; Hofstaetter, Elisabeth; Haudek-Prinz, Verena; Klepeisz, Philipp; Schicher, Nikolaus; Jonak, Constanze; Petzelbauer, Peter; Pehamberger, Hubert; Gerner, Christopher; Kunstfeld, Rainer			Proteome Analysis Identified the PPAR gamma Ligand 15d-PGJ2 as a Novel Drug Inhibiting Melanoma Progression and Interfering with Tumor-Stroma Interaction	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; IN-VITRO; MOLECULAR CHAPERONE; SIGNALING PATHWAYS; CANCER; EXPRESSION; GROWTH; AGONISTS; METASTASIS; APOPTOSIS	Peroxisome proliferator-activated receptors (PPARs) have been originally thought to be restricted to lipid metabolism or glucose homeostasis. Recently, evidence is growing that PPAR gamma ligands have inhibitory effects on tumor growth. To shed light on the potential therapeutic effects on melanoma we tested a panel of PPAR agonists on their ability to block tumor proliferation in vitro. Whereas ciglitazone, troglitazone and WY14643 showed moderate effects on proliferation, 15d-PGJ2 displayed profound anti-tumor activity on four different melanoma cell lines tested. Additionally, 15d-PGJ2 inhibited proliferation of tumor-associated fibroblasts and tube formation of endothelial cells. 15d-PGJ2 induced the tumor suppressor gene p21, a G(2)/M arrest and inhibited tumor cell migration. Shot gun proteome analysis in addition to 2D-gel electrophoresis and immunoprecipitation of A375 melanoma cells suggested that 15d-PGJ2 might exert its effects via modification and/or downregulation of Hsp-90 (heat shock protein 90) and several chaperones. Applying the recently established CPL/MUW database with a panel of defined classification signatures, we demonstrated a regulation of proteins involved in metastasis, transport or protein synthesis including paxillin, angio-associated migratory cell protein or matrix metalloproteinase-2 as confirmed by zymography. Our data revealed for the first time a profound effect of the single compound 15d-PGJ2 on melanoma cells in addition to the tumor-associated microenvironment suggesting synergistic therapeutic efficiency.	[Paulitschke, Verena; Gruber, Silke; Hofstaetter, Elisabeth; Schicher, Nikolaus; Jonak, Constanze; Petzelbauer, Peter; Pehamberger, Hubert; Kunstfeld, Rainer] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Haudek-Prinz, Verena; Klepeisz, Philipp; Gerner, Christopher] Med Univ Vienna, Dept Med 1, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Kunstfeld, R (corresponding author), Med Univ Vienna, Dept Dermatol, Vienna, Austria.	rainer.kunstfeld@meduniwien.ac.at	petzelbauer, peter/GLU-3941-2022	Gerner, Christopher/0000-0003-4964-0642; Petzelbauer, Peter/0000-0001-7080-5259	Austrian Federal Reserve Bank [12215, 11425]; Interdisziplinarer Krebsforschungsfond; Hans und Blanca Moser Stipendium; Burgermeisterfond der Stadt Wien	Austrian Federal Reserve Bank; Interdisziplinarer Krebsforschungsfond; Hans und Blanca Moser Stipendium; Burgermeisterfond der Stadt Wien	This study was supported by the following grants of the Austrian Federal Reserve Bank: Project No. 12215 (VP) and No. 11425 (RK), the "Interdisziplinarer Krebsforschungsfond" (VP), "Hans und Blanca Moser Stipendium" (VP) and "Burgermeisterfond der Stadt Wien", (VP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerji U, 2009, CLIN CANCER RES, V15, P9, DOI 10.1158/1078-0432.CCR-08-0132; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Bundscherer A, 2009, ANTI-CANCER AGENT ME, V9, P816, DOI 10.2174/187152009789056912; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Ferruzzi P, 2005, J CLIN ENDOCR METAB, V90, P1332, DOI 10.1210/jc.2004-0978; Fievet C, 2009, CURR ATHEROSCLER REP, V11, P281, DOI 10.1007/s11883-009-0043-5; Funovics P, 2006, PROSTAG OTH LIPID M, V79, P230, DOI 10.1016/j.prostaglandins.2006.02.002; Galli A, 2004, GUT, V53, P1688, DOI 10.1136/gut.2003.031997; Gerner C, 2010, ELECTROPHORESIS, V31, P1822, DOI 10.1002/elps.200900753; Ortiz AG, 2010, CLIN TRANSL ONCOL, V12, P166, DOI 10.1007/s12094-010-0486-8; Goetze S, 2002, BIOCHEM BIOPH RES CO, V293, P1431, DOI 10.1016/S0006-291X(02)00385-6; Grabacka M, 2006, CLIN CANCER RES, V12, P3028, DOI 10.1158/1078-0432.CCR-05-2556; Griss J, 2010, PROTEOMICS; Groger M, 2007, J INVEST DERMATOL, V127, P2893, DOI 10.1038/sj.jid.5701031; Grommes C, 2006, MOL PHARMACOL, V70, P1524, DOI 10.1124/mol.106.022194; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARPER JW, 1993, CELL, V75, P805; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Hoeller C, 2005, J INVEST DERMATOL, V124, P1300, DOI 10.1111/j.0022-202X.2005.23720.x; Hoeller C, 2005, J INVEST DERMATOL, V124, P1293, DOI 10.1111/j.0022-202X.2005.23685.x; Hoeth M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030982; Hofmeister V, 2008, CANCER IMMUNOL IMMUN, V57, P1, DOI 10.1007/s00262-007-0365-5; Kihara S, 1998, ATHEROSCLEROSIS, V136, P163, DOI 10.1016/S0021-9150(97)00207-4; Kubota T, 1998, CANCER RES, V58, P3344; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Lee TS, 2003, J BIOL CHEM, V278, P19325, DOI 10.1074/jbc.M300498200; Li Y, 2006, MED ONCOL, V23, P393, DOI 10.1385/MO:23:3:393; Meyer S, 2010, PPAR RES, V2010, DOI 10.1155/2010/848645; Miyata Y, 1997, P NATL ACAD SCI USA, V94, P14500, DOI 10.1073/pnas.94.26.14500; Mossner R, 2002, J INVEST DERMATOL, V119, P576, DOI 10.1046/j.1523-1747.2002.01861.x; MUELLER BM, 1991, CANCER RES, V51, P2193; Nunez NP, 2006, CANCER LETT, V236, P133, DOI 10.1016/j.canlet.2005.05.009; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Paulitschke V, 2009, J INVEST DERMATOL; Paulitschke V, 2010, MOL MODULAR TUMOR TH; Paulitschke V, 2009, J PROTEOME RES, V8, P2501, DOI 10.1021/pr8010827; PETZELBAUER P, 1993, J IMMUNOL, V151, P5062; Placha W, 2003, MELANOMA RES, V13, P447, DOI 10.1097/00008390-200310000-00003; Powers MV, 2006, ENDOCR-RELAT CANCER, V13, pS125, DOI 10.1677/erc.1.01324; Prakash J, 2009, NEOPLASIA, V11, P1348, DOI 10.1593/neo.91188; Ristow M, 1998, NEW ENGL J MED, V339, P953, DOI 10.1056/NEJM199810013391403; Schadendorf D, 2009, J INVEST DERMATOL, V129, P1061, DOI 10.1038/jid.2009.56; Schicher N, 2009, CLIN CANCER RES, V15, P3495, DOI 10.1158/1078-0432.CCR-08-2407; Schoonjans K, 1997, CURR OPIN LIPIDOL, V8, P159, DOI 10.1097/00041433-199706000-00006; Shen D, 2007, POSTGRAD MED J, V83, P414, DOI 10.1136/pmj.2006.052761; Shields JD, 2004, BRIT J CANCER, V90, P693, DOI 10.1038/sj.bjc.6601571; Smalley KSM, 2005, ANN NY ACAD SCI, V1059, P16, DOI 10.1196/annals.1339.005; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; Smith AG, 2009, INT J BIOCHEM CELL B, V41, P844, DOI 10.1016/j.biocel.2008.08.037; Torra IP, 2001, CURR OPIN LIPIDOL, V12, P245, DOI 10.1097/00041433-200106000-00002; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Tsuzuki T, 2008, CARCINOGENESIS; Vandoros GP, 2006, J CANCER RES CLIN, V132, P76, DOI 10.1007/s00432-005-0042-z; Wimmer H, 2009, ELECTROPHORESIS, V30, P2076, DOI 10.1002/elps.200900072; Xin XH, 1999, J BIOL CHEM, V274, P9116, DOI 10.1074/jbc.274.13.9116; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0	57	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46103	10.1371/journal.pone.0046103	http://dx.doi.org/10.1371/journal.pone.0046103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049949	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100136
J	Vanoverberghe, K; Lehen'kyi, V; Thebault, S; Raphael, M; Vanden Abeele, F; Slomianny, C; Mariot, P; Prevarskaya, N				Vanoverberghe, Karine; Lehen'kyi, V'yacheslav; Thebault, Stephanie; Raphael, Maylis; Vanden Abeele, Fabien; Slomianny, Christian; Mariot, Pascal; Prevarskaya, Natalia			Cytoskeleton Reorganization as an Alternative Mechanism of Store-Operated Calcium Entry Control in Neuroendocrine-Differentiated Cells	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; PLASMA-MEMBRANE; CA2+ INFLUX; IN-VITRO; INTRACELLULAR CA2+; ENDOTHELIAL-CELLS; HUMAN NEUTROPHILS; EPITHELIAL-CELLS; TRP CHANNELS; LNCAP CELLS	Neuroendocrine differentiation (NED) is a hallmark of advanced androgen-independent prostate cancer, for which no successful therapy exists. NED tumour cells escape apoptotic cell death by alterations of Ca2+ homeostasis where the store-operated Ca2+ entry (SOCE) is known to be a key event. We have previously shown that the downregulation of Orai1 protein representing the major molecular component of endogenous SOCE in human prostate cancer cells, and constituting the principal source of Ca2+ influx used by the cell to trigger apoptosis, contributes to the establishment of an apoptosis-resistant phenotype (Cell Death Dis. 2010 Sep 16;1:e75.). Here, we report for the first time that the decrease of SOCE during NED may be caused by alternative NED-induced mechanism involving cytoskeleton reorganisation. NED induced by androgen deprivation resulted in a decrease of SOCE due to cortical F-actin over-polymerization which inhibits thapsigargin-induced SOCE. The disruption of F-actin polymerization by Cytochalasin D in NED cells restored SOCE, while the induction of F-actin polymerization by jasplakinolide or calyculin A diminished SOCE without changing the expression of key SOCE players: Orai1, STIM1, and TRPC1. Our data suggest that targeting cytoskeleton-induced pathways of malignant cells together with SOCE-involved channels may prove a useful strategy in the treatment of advanced prostate cancer.	[Vanoverberghe, Karine; Lehen'kyi, V'yacheslav; Thebault, Stephanie; Raphael, Maylis; Vanden Abeele, Fabien; Slomianny, Christian; Mariot, Pascal; Prevarskaya, Natalia] INSERM, Equipe Labellisee Ligue Natl Canc, U1003, Villeneuve Dascq, France; [Vanoverberghe, Karine; Lehen'kyi, V'yacheslav; Thebault, Stephanie; Raphael, Maylis; Vanden Abeele, Fabien; Slomianny, Christian; Mariot, Pascal; Prevarskaya, Natalia] USTL, Lab Excellence Ion Channels Sci & Therapeut, Villeneuve Dascq, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille	Prevarskaya, N (corresponding author), INSERM, Equipe Labellisee Ligue Natl Canc, U1003, Villeneuve Dascq, France.	natacha.prevarskaya@univ-lille1.fr	Slomianny, Christian/L-8285-2018; Thébault, Stéphanie/AAD-8350-2019; Vanden Abeele, Fabien/O-6012-2017; LEHEN'KYI, V'yacheslav/AAJ-6008-2020	LEHEN'KYI, V'yacheslav/0000-0003-0806-8766; Mariot, Pascal/0000-0001-7226-9162; Vanden Abeele, Fabien/0000-0001-7111-7220; Prevarskaya, natacha/0000-0003-0316-197X; Thebault, Stephanie/0000-0003-3233-282X	Institut National de la Sante et de la Recherche Medicale (INSERM); Association pour la Recherche contre le Cancer (ARC); Ligue Nationale contre le Cancer; Fondation pour la Recherche Medicale (FRM)	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), the Association pour la Recherche contre le Cancer (ARC), the Ligue Nationale contre le Cancer and the Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson PA, 1999, ENDOCR-RELAT CANCER, V6, P503, DOI 10.1677/erc.0.0060503; Ambudkar Indu S, 2004, Novartis Found Symp, V258, P63; AMBUDKAR IS, 2004, SCI STKE, pPE32; AMBUDKAR IS, 2004, NOVART FDN SYMP, V258, P263; AMBUDKAR IS, 2004, NOVART FDN SYMP, V258, P70; AMBUDKAR IS, 2004, NOVART FDN SYMP, V258, P98; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Bonkhoff H, 2001, ANN ONCOL, V12, pS141, DOI 10.1093/annonc/12.suppl_2.S141; Boulay G, 2002, CELL CALCIUM, V32, P201, DOI 10.1016/S0143416002001550; Brazer SCW, 2003, J BIOL CHEM, V278, P27208, DOI 10.1074/jbc.M301118200; Burchardt T, 1999, J UROLOGY, V162, P1800, DOI 10.1016/S0022-5347(05)68241-9; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; COHEN RJ, 1991, BRIT J UROL, V68, P258, DOI 10.1111/j.1464-410X.1991.tb15318.x; Di Sant'Agnese PA, 1998, UROLOGY, V51, P121, DOI 10.1016/S0090-4295(98)00064-8; diSantAgnese PA, 1996, CANCER, V78, P357, DOI 10.1002/(SICI)1097-0142(19960715)78:2<357::AID-CNCR27>3.0.CO;2-U; DISANTAGNESE PA, 1992, HUM PATHOL, V23, P287; Donald CD, 2001, CELL MOL BIOL, V47, P1033; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fixemer T, 2002, PROSTATE, V53, P118, DOI 10.1002/pros.10133; Flourakis M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.52; Grimaldi M, 1999, J BIOL CHEM, V274, P33557, DOI 10.1074/jbc.274.47.33557; HIRANO K, 1992, J MUSCLE RES CELL M, V13, P341, DOI 10.1007/BF01766462; Holda JR, 1997, FEBS LETT, V403, P191, DOI 10.1016/S0014-5793(97)00051-3; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; HSIEH TC, 1995, EXP CELL RES, V218, P137, DOI 10.1006/excr.1995.1140; Itagaki K, 2004, J IMMUNOL, V172, P601, DOI 10.4049/jimmunol.172.1.601; July LV, 2002, PROSTATE, V50, P179, DOI 10.1002/pros.10047; KREIENBUHL P, 1992, BLOOD, V80, P2911; Lockwich T, 2001, J BIOL CHEM, V276, P42401, DOI 10.1074/jbc.M106956200; Mariot P, 2002, J BIOL CHEM, V277, P10824, DOI 10.1074/jbc.M108754200; Montell C, 2004, NAT CELL BIOL, V6, P690, DOI 10.1038/ncb0804-690; Montell C, 2004, NOVART FDN SYMP, V258, P263; Montell C, 2004, NOVART FDN SYMP, V258, P12; Montell C, 2004, NOVART FDN SYMP, V258, P98; Montell Craig, 2004, Novartis Found Symp, V258, P3; Nilius B, 2001, CELL CALCIUM, V29, P417, DOI 10.1054/ceca.2001.0201; Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7; Peng JB, 2003, J PHYSIOL-LONDON, V551, P729, DOI 10.1113/jphysiol.2003.043349; PRENTKI M, 1979, J CELL BIOL, V81, P592, DOI 10.1083/jcb.81.3.592; Putney James W Jr, 2004, Novartis Found Symp, V258, P123; Putney Jr JW, 2004, NOVART FDN SYMP, V258, P155; Putney Jr JW, 2004, NOVART FDN SYMP, V258, P133; Putney Jr JW, 2004, NOVART FDN SYMP, V258, P263; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Putney JW, 1999, CELL, V99, P5, DOI 10.1016/S0092-8674(00)80056-2; RAFFO AJ, 1995, CANCER RES, V55, P4438; Rosado JA, 2000, BIOCHEM J, V350, P631, DOI 10.1042/0264-6021:3500631; Rosado JA, 2004, J BIOL CHEM, V279, P29231, DOI 10.1074/jbc.M403509200; Rumpold H, 2002, PROSTATE, V53, P101, DOI 10.1002/pros.10129; Sanada M, 2004, NEUROREPORT, V15, P197, DOI 10.1097/00001756-200401190-00038; SHINOKI N, 1995, J CELL BIOCHEM, V59, P368, DOI 10.1002/jcb.240590308; Singh BB, 2002, MOL CELL, V9, P739, DOI 10.1016/S1097-2765(02)00506-3; Skryma R, 2000, J PHYSIOL-LONDON, V527, P71, DOI 10.1111/j.1469-7793.2000.00071.x; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; TARLE M, 1994, PROSTATE, V24, P143, DOI 10.1002/pros.2990240308; Vanden Abeele F, 2004, J BIOL CHEM, V279, P30326, DOI 10.1074/jbc.M400106200; Vanden Abeele F, 2002, CANCER CELL, V1, P169; Vanden Abeele F, 2004, J BIOL CHEM; Vanoverberghe K, 2004, CELL DEATH DIFFER, V11, P321, DOI 10.1038/sj.cdd.4401375; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Wang Y, 2002, J NEUROCHEM, V82, P945, DOI 10.1046/j.1471-4159.2002.01059.x; Wu SW, 2001, J CELL BIOL, V154, P1225, DOI 10.1083/jcb.200106156; Xing NZ, 2001, PROSTATE, V48, P7, DOI 10.1002/pros.1076; Xue Y, 1997, AM J PATHOL, V151, P1759; Zelivianski S, 2001, BBA-MOL CELL RES, V1539, P28, DOI 10.1016/S0167-4889(01)00087-8	70	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45615	10.1371/journal.pone.0045615	http://dx.doi.org/10.1371/journal.pone.0045615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049826	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100060
J	Yakala, GK; van der Heijden, R; Molema, G; Schipper, M; Wielinga, PY; Kleemann, R; Kooistra, T; Heeringa, P				Yakala, Gopala K.; van der Heijden, Roel; Molema, Grietje; Schipper, Martin; Wielinga, Peter Y.; Kleemann, Robert; Kooistra, Teake; Heeringa, Peter			Beneficial Effects of an Alternating High- Fat Dietary Regimen on Systemic Insulin Resistance, Hepatic and Renal Inflammation and Renal Function	PLOS ONE			English	Article							DIABETES-MELLITUS; WEIGHT-GAIN; OBESITY; MICE; EXPRESSION; PREVENTION; DISEASE; RATS	Background: An Alternating high-cholesterol dietary regimen has proven to be beneficial when compared to daily high-cholesterol feeding. In the current study we explored whether the same strategy is applicable to a high-fat dietary regimen. Objective: To investigate whether an alternating high-fat dietary regimen can effectively diminish insulin resistance, hepatic and renal inflammation and renal dysfunction as compared to a continuous high-fat diet. Design: Four groups of male ApoE*3Leiden mice (n = 15) were exposed to different diet regimens for 20 weeks as follows: Group 1: low-fat diet (10 kcal% fat); Group 2: intermediate-fat diet (25 kcal% fat); Group 3: high-fat diet (45 kcal% fat) and Group 4: alternating-fat diet (10 kcal% fat for 4 days and 45 kcal% fat for 3 days in a week). Results: Compared to high fat diet feeding, the alternating and intermediate-fat diet groups had reduced body weight gain and did not develop insulin resistance or albuminuria. In addition, in the alternating and intermediate-fat diet groups, parameters of tissue inflammation were markedly reduced compared to high fat diet fed mice. Conclusion: Both alternating and intermediate-fat feeding were beneficial in terms of reducing body weight gain, insulin resistance, hepatic and renal inflammation and renal dysfunction. Thus beneficial effects of alternating feeding regimens on cardiometabolic risk factors are not only applicable for cholesterol containing diets but can be extended to diets high in fat content.	[Yakala, Gopala K.; van der Heijden, Roel; Molema, Grietje; Schipper, Martin; Heeringa, Peter] Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands; [Wielinga, Peter Y.; Kleemann, Robert; Kooistra, Teake] TNO Metab Hlth Res, Leiden, Netherlands; [Yakala, Gopala K.; van der Heijden, Roel; Wielinga, Peter Y.; Kleemann, Robert; Kooistra, Teake; Heeringa, Peter] Top Inst Food & Nutr, Wageningen, Netherlands	University of Groningen; Netherlands Organization Applied Science Research; Top Institute Food & Nutrition	Yakala, GK (corresponding author), Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands.	g.k.yakala@umcg.nl	Heeringa, Peter/A-6008-2009	Heeringa, Peter/0000-0001-8684-763X; Molema, Grietje/0000-0002-4147-6676				Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; de Wit NJW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019145; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Fu WJ, 2012, DIABETES RES CLIN PR, V95, P105, DOI 10.1016/j.diabres.2011.09.031; Gao Q, 2010, NEPHROL DIAL TRANSPL, V25, P3539, DOI 10.1093/ndt/gfq245; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hattori M, 1999, KIDNEY INT, V56, pS47, DOI 10.1046/j.1523-1755.1999.07112.x; Jiang T, 2005, J AM SOC NEPHROL, V16, P2385, DOI 10.1681/ASN.2004080701; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kodama N, 1999, KIDNEY INT, V56, pS174, DOI 10.1016/S0085-2538(15)46633-5; Navarro JF, 2005, NEPHROL DIAL TRANSPL, V20, P2601, DOI 10.1093/ndt/gfi155; Park SY, 2005, ARCH BIOCHEM BIOPHYS, V436, P276, DOI 10.1016/j.abb.2005.01.010; Seidell JC, 2000, BRIT J NUTR, V83, pS5, DOI 10.1017/S000711450000088X; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Tervaert TWC, 2010, J AM SOC NEPHROL, V21, P556, DOI 10.1681/ASN.2010010010; Tsilibary EC, 2003, J PATHOL, V200, P537, DOI 10.1002/path.1439; Varady KA, 2007, AM J CLIN NUTR, V86, P7, DOI 10.1093/ajcn/86.1.7; Weiss EP, 2006, AM J CLIN NUTR, V84, P1033; Wen M, 2002, LAB INVEST, V82, P999, DOI 10.1097/01.LAB.0000022222.03120.D4; Wielinga PY, 2012, MOL NUTR FOOD RES, V56, P1081, DOI 10.1002/mnfr.201100762; Wielinga PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018432; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867	22	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45866	10.1371/journal.pone.0045866	http://dx.doi.org/10.1371/journal.pone.0045866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049881	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100094
J	Yano, J; Kolls, JK; Happel, KI; Wormley, F; Wozniak, KL; Fidel, PL				Yano, Junko; Kolls, Jay K.; Happel, Kyle I.; Wormley, Floyd; Wozniak, Karen L.; Fidel, Paul L., Jr.			The Acute Neutrophil Response Mediated by S100 Alarmins during Vaginal Candida Infections Is Independent of the Th17-Pathway	PLOS ONE			English	Article							TH17 CELLS; T-CELLS; IMMUNITY; IL-17; EXPRESSION; INNATE; RESISTANCE; IL-22; IMMUNOPATHOGENESIS; INTERLEUKIN-1	Vulvovaginal candidiasis (VVC) caused by Candida albicans affects a significant number of women during their reproductive ages. Clinical observations revealed that a robust vaginal polymorphonuclear neutrophil (PMN) migration occurs in susceptible women, promoting pathological inflammation without affecting fungal burden. Evidence to date in the mouse model suggests that a similar acute PMN migration into the vagina is mediated by chemotactic S100A8 and S100A9 alarmins produced by vaginal epithelial cells in response to Candida. Based on the putative role for the Th17 response in mucosal candidiasis as well as S100 alarmin induction, this study aimed to determine whether the Th17 pathway plays a role in the S100 alarmin-mediated acute inflammation during VVC using the experimental mouse model. For this, IL-23p19(-/-), IL-17RA(-/-) and IL-22(-/-) mice were intravaginally inoculated with Candida, and vaginal lavage fluids were evaluated for fungal burden, PMN infiltration, the presence of S100 alarmins and inflammatory cytokines and chemokines. Compared to wild-type mice, the cytokine-deficient mice showed comparative levels of vaginal fungal burden and PMN infiltration following inoculation. Likewise, inoculated mice of all strains with substantial PMN infiltration exhibited elevated levels of vaginal S100 alarmins in both vaginal epithelia and secretions in the vaginal lumen. Finally, cytokine analyses of vaginal lavage fluid from inoculated mice revealed equivalent expression profiles irrespective of the Th17 cytokine status or PMN response. These data suggest that the vaginal S100 alarmin response to Candida does not require the cells or cytokines of the Th17 lineage, and therefore, the immunopathogenic inflammatory response during VVC occurs independently of the Th17-pathway.	[Yano, Junko; Fidel, Paul L., Jr.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Kolls, Jay K.] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Happel, Kyle I.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, Sect Pulm Crit Care Med, New Orleans, LA USA; [Wormley, Floyd; Wozniak, Karen L.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of Texas System; University of Texas at San Antonio (UTSA)	Fidel, PL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA.	pfidel@lsuhsc.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304; Wozniak, Karen/0000-0003-1798-2146	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institute of Health [R01 AI32556]; Louisiana Vaccine Center; Louisiana Board of Regents; South Louisiana Institute for Infectious Disease Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL079142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032556] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID) of the National Institute of Health; Louisiana Vaccine Center; Louisiana Board of Regents; South Louisiana Institute for Infectious Disease Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by research grant R01 AI32556 (PLF Jr.) from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institute of Health (NIH) http://www.niaid.nih.gov, and in part by Louisiana Vaccine Center http://www.louisianavc.org and South Louisiana Institute for Infectious Disease Research sponsored by the Louisiana Board of Regents http://regents.state.la.us. This content is solely the responsibility of the authors and does not reflect the official views of the NIAID or the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barousse MM, 2004, SEX TRANSM INFECT, V80, P48, DOI 10.1136/sti.2002.003855; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; De Luca A, 2010, MUCOSAL IMMUNOL, V3, P361, DOI 10.1038/mi.2010.22; Dongari-Bagtzoglou A, 2005, J DENT RES, V84, P966, DOI 10.1177/154405910508401101; ELLER MS, 1995, J CELL SCI, V108, P2741; Eyerich K, 2008, J INVEST DERMATOL, V128, P2640, DOI 10.1038/jid.2008.139; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Fidel PL, 2004, INFECT IMMUN, V72, P2939, DOI 10.1128/IAI.72.5.2939-2946.2004; Fidel PL, 2003, MED MYCOL, V41, P97, DOI 10.1080/714043904; Fidel PL, 1996, CLIN MICROBIOL REV, V9, P335, DOI 10.1128/CMR.9.3.335; FIDEL PL, 1993, INFECT IMMUN, V61, P1990, DOI 10.1128/IAI.61.5.1990-1995.1993; Fidel PL, 2001, AM J REPROD IMMUNOL, V45, P200, DOI 10.1111/j.8755-8920.2001.450402.x; Fidel PL, 1999, HDB ANIMAL MODELS IN, P741; Godinez I, 2008, INFECT IMMUN, V76, P2008, DOI 10.1128/IAI.01691-07; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; LeBlanc DM, 2006, INFECT IMMUN, V74, P3213, DOI 10.1128/IAI.01824-05; Lev-Sagie A, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.010; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Murphy JE, 2000, J INVEST DERMATOL, V114, P602, DOI 10.1046/j.1523-1747.2000.00917.x; Ness-Schwickerath KJ, 2011, CELL MOL LIFE SCI, V68, P2371, DOI 10.1007/s00018-011-0700-z; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Pietrella D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022770; Rubino SJ, 2012, TRENDS IMMUNOL, V33, P112, DOI 10.1016/j.it.2012.01.003; Saavedra M, 1999, INFECT IMMUN, V67, P5820, DOI 10.1128/IAI.67.11.5820-5826.1999; Sanos SL, 2011, IMMUNOLOGY, V132, P453, DOI 10.1111/j.1365-2567.2011.03410.x; Sobel JD, 1998, AM J OBSTET GYNECOL, V178, P203, DOI 10.1016/S0002-9378(98)80001-X; Sorenson BS, 2012, MUCOSAL IMMUNOL, V5, P66, DOI 10.1038/mi.2011.48; Taylor BN, 2000, MED MYCOL, V38, P419, DOI 10.1080/714030969; Wagner RD, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-58; Yano J, 2010, INFECT IMMUN, V78, P5126, DOI 10.1128/IAI.00388-10; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409	32	74	78	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46311	10.1371/journal.pone.0046311	http://dx.doi.org/10.1371/journal.pone.0046311			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050010	gold, Green Published			2022-12-27	WOS:000309556100175
J	Lildballe, DL; Mutti, E; Birn, H; Nexo, E				Lildballe, Dorte L.; Mutti, Elena; Birn, Henrik; Nexo, Ebba			Maximal Load of the Vitamin B12 Transport System: A Study on Mice Treated for Four Weeks with High-Dose Vitamin B12 or Cobinamide	PLOS ONE			English	Article							COBALAMIN ANALOGS; INTRINSIC-FACTOR; HUMAN-PLASMA; HAPTOCORRIN; BINDING; INSULIN; B12	Several studies suggest that the vitamin B12 (B12) transport system can be used for the cellular delivery of B12-conjugated drugs, also in long-term treatment Whether this strategy will affect the endogenous metabolism of B12 is not known. To study the effect of treatment with excess B12 or an inert derivative, we established a mouse model using implanted osmotic minipumps to deliver saline, cobinamide (Cbi) (4.25 nmol/h), or B12 (1.75 nmol/h) for 27 days (n = 7 in each group). B12 content and markers of B12 metabolism were analysed in plasma, urine, kidney, liver, and salivary glands. Both Cbi and B12 treatment saturated the transcobalamin protein in mouse plasma. Cbi decreased the content of B12 in tissues to 33-50% of the level in control animals but did not influence any of the markers examined. B12 treatment increased the tissue B12 level up to 350%. In addition, the transcript levels for methylenetetrahydrofolate reductase in kidneys and for transcobalamin and transcobalamin receptor in the salivary glands were reduced. Our study confirms the feasibility of delivering drugs through the B12 transport system but emphasises that B12 status should be monitored because there is a risk of decreasing the transport of endogenous B12. This risk may lead to B12 deficiency during prolonged treatment.	[Lildballe, Dorte L.; Mutti, Elena; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark; [Lildballe, Dorte L.] Aarhus Univ Hosp, Dept Clin Genet, DK-8000 Aarhus, Denmark; [Birn, Henrik] Aarhus Univ Hosp, Dept Nephrol, DK-8000 Aarhus, Denmark; [Birn, Henrik] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Lildballe, DL (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark.	dolild@rm.dk	Mutti, Elena/M-8056-2016; Birn, Henrik/C-3931-2009	Mutti, Elena/0000-0001-5621-4786; Birn, Henrik/0000-0003-3715-7266; Nexo, Ebba/0000-0001-9406-9081	Danish Medical Research Council; Lundbeck Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	The study was funded by the Danish Medical Research Council and the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beedholm-Ebsen R, 2010, BLOOD, V115, P1632, DOI 10.1182/blood-2009-07-232587; Birn H, 2003, NEPHROL DIAL TRANSPL, V18, P1095, DOI 10.1093/ndt/gfg089; Briggs C, 2000, CLIN LAB HAEMATOL, V22, P345, DOI 10.1046/j.1365-2257.2000.00330.x; Chalasani KB, 2007, J CONTROL RELEASE, V122, P141, DOI 10.1016/j.jconrel.2007.05.019; GOTTLIEB C, 1965, BLOOD-J HEMATOL, V25, P875, DOI 10.1182/blood.V25.6.875.875; Hardlei TF, 2009, CLIN CHEM, V55, P1002, DOI 10.1373/clinchem.2008.114132; Heimann M, 2009, LAB ANIM-UK, V43, P255, DOI 10.1258/la.2008.007073; Hygum K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020638; KOLHOUSE JF, 1978, NEW ENGL J MED, V299, P785, DOI 10.1056/NEJM197810122991501; Lakso HA, 2008, CLIN CHEM, V54, P2028, DOI 10.1373/clinchem.2007.101253; Morkbak AL, 2007, CLIN CHEM LAB MED, V45, P1751, DOI 10.1515/CCLM.2007.343; Nexo E, 2011, AM J CLIN NUTR, V94, DOI 10.3945/ajcn.111.013458; Nielsen MJ, 2012, NAT REV GASTROENTERO; Petrus AK, 2009, CHEMMEDCHEM, V4, P421, DOI 10.1002/cmdc.200800346; Roche, 2012, VIT B12 AN US EL COB; ROSENTHAL WS, 1967, BLOOD-J HEMATOL, V30, P198, DOI 10.1182/blood.V30.2.198.198; RUSSELLJONES GJ, 1995, BIOCONJUGATE CHEM, V6, P34, DOI 10.1021/bc00031a600; STUPPERICH E, 1991, EUR J BIOCHEM, V199, P299, DOI 10.1111/j.1432-1033.1991.tb16124.x; Tamura J, 1999, CLIN EXP IMMUNOL, V116, P28; Uthus EO, 2006, MECH AGEING DEV, V127, P444, DOI 10.1016/j.mad.2006.01.001; Waibel R, 2008, CANCER RES, V68, P2904, DOI 10.1158/0008-5472.CAN-07-6771; Wang XY, 2007, BIOORGAN MED CHEM, V15, P1780, DOI 10.1016/j.bmc.2006.11.036; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85	23	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46657	10.1371/journal.pone.0046657	http://dx.doi.org/10.1371/journal.pone.0046657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049711	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388500038
J	Shi, JJ; Petrie, HT				Shi, Jianjun; Petrie, Howard T.			Activation Kinetics and Off-Target Effects of Thymus-Initiated Cre Transgenes	PLOS ONE			English	Article							T-CELL DEVELOPMENT; IMMATURE THYMOCYTES; EXPRESSION; RECOMBINASE; RECEPTOR; MICE; CD4; MICROENVIRONMENTS; TOXICITY; PROTEIN	The bacteriophage enzyme Cre is a site-specific recombinase widely used to delete loxP-flanked DNA sequences in lineage-specific fashion. Several mouse lines that direct Cre expression to lymphoid progenitors in the thymus have been established, but a side-by-side comparison of when they first become active, and/or their relative efficiency at various developmental stages, has been lacking. In this study, we evaluated these in four common Cre transgenic strains with thymus-initiated promoters (Lck, Cd2, or Cd4). We found that while all of them eventually labeled nearly all thymocytes, their kinetics were dramatically different, and other than Cd4[Cre], did not faithfully recapitulate the expression pattern of the corresponding endogenous gene. Perhaps even more importantly, while thymuses from some strains compared favorably to thymuses from control (Cre-negative) mice, we found that Cre expression could also result in off-target effects, including moderate to severe decreases in thymic cellularity. These effects occurred in the absence of loxP-flanked DNA target genes, and were dose and copy number dependent. Loss of cellularity was attributable to a specific decrease in CD4(+)8(+) immature cells, and corresponds to an increased rate of programmed cell death. In addition to a comprehensive analysis of activation kinetics in thymus-initiated Cre transgenes, our data show that Cre is toxic to CD4(+)8(+) cells in a dose-dependent fashion, and emphasize that the choice of thymus-initiated Cre strain is critically important for minimizing off-target effects of Cre.	[Shi, Jianjun; Petrie, Howard T.] Scripps Res Inst, Jupiter, FL USA	Scripps Research Institute	Shi, JJ (corresponding author), Scripps Res Inst, Jupiter, FL USA.	hpetrie@scripps.edu	shi, Jianjun/A-3351-2011	shi, Jianjun/0000-0002-5856-1025	Public Health Service [R01AG034876]; The Frenchman's Creek Women for Cancer Research; NATIONAL INSTITUTE ON AGING [R01AG034876] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); The Frenchman's Creek Women for Cancer Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by Public Health Service grant R01AG034876. JS is supported by a fellowship from The Frenchman's Creek Women for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckland J, 2000, EUR J IMMUNOL, V30, P8, DOI 10.1002/1521-4141(200001)30:1<8::AID-IMMU8>3.3.CO;2-#; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Griffith AV, 2009, IMMUNITY, V31, P999, DOI 10.1016/j.immuni.2009.09.024; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Jeannotte L, 2011, GENESIS, V49, P152, DOI 10.1002/dvg.20720; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Naiche LA, 2007, GENESIS, V45, P768, DOI 10.1002/dvg.20353; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; PETRIE HT, 1990, EUR J IMMUNOL, V20, P2813, DOI 10.1002/eji.1830201243; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; REYNOLDS PJ, 1990, MOL CELL BIOL, V10, P4266, DOI 10.1128/MCB.10.8.4266; Rijhsinghani AG, 1996, AM J REPROD IMMUNOL, V36, P269; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Shi JJ, 2011, BLOOD, V118, P2511, DOI 10.1182/blood-2011-04-346726; Shimizu C, 2001, INT IMMUNOL, V13, P105, DOI 10.1093/intimm/13.1.105; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Thanos A, 2012, AM J PATHOL, V180, P1917, DOI 10.1016/j.ajpath.2012.01.017; Thyagarajan B, 2000, GENE, V244, P47, DOI 10.1016/S0378-1119(00)00008-1; Wolfer A, 2001, NAT IMMUNOL, V2, P235, DOI 10.1038/85294; Yuan JS, 2011, BLOOD, V117, P1184, DOI 10.1182/blood-2010-07-296616	25	50	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46590	10.1371/journal.pone.0046590	http://dx.doi.org/10.1371/journal.pone.0046590			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049709	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388500036
J	Ito, H; Takano, H; Arakawa, R; Takahashi, H; Kodaka, F; Takahata, K; Nogami, T; Suzuki, M; Suhara, T				Ito, Hiroshi; Takano, Harumasa; Arakawa, Ryosuke; Takahashi, Hidehiko; Kodaka, Fumitoshi; Takahata, Keisuke; Nogami, Tsuyoshi; Suzuki, Masayuki; Suhara, Tetsuya			Effects of Dopamine D-2 Receptor Partial Agonist Antipsychotic Aripiprazole on Dopamine Synthesis in Human Brain Measured by PET with L-[beta-C-11]DOPA	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; HALOPERIDOL; OCCUPANCY; SCHIZOPHRENIA; DECARBOXYLASE; KINETICS; RELEASE; DRUG; PERFORMANCE; RISPERIDONE	Dopamine D-2 receptor partial agonist antipsychotic drugs can modulate dopaminergic neurotransmission as functional agonists or functional antagonists. The effects of antipsychotics on presynaptic dopaminergic functions, such as dopamine synthesis capacity, might also be related to their therapeutic efficacy. Positron emission tomography (PET) was used to examine the effects of the partial agonist antipsychotic drug aripiprazole on presynaptic dopamine synthesis in relation to dopamine D-2 receptor occupancy and the resulting changes in dopamine synthesis capacity in healthy men. On separate days, PET studies with [C-11] raclopride and L-[beta-C-11]DOPA were performed under resting condition and with single doses of aripiprazole given orally. Occupancy of dopamine D-2 receptors corresponded to the doses of aripiprazole, but the changes in dopamine synthesis capacity were not significant, nor was the relation between dopamine D-2 receptor occupancy and these changes. A significant negative correlation was observed between baseline dopamine synthesis capacity and changes in dopamine synthesis capacity by aripiprazole, indicating that this antipsychotic appears to stabilize dopamine synthesis capacity. The therapeutic effects of aripiprazole in schizophrenia might be related to such stabilizing effects on dopaminergic neurotransmission responsivity.	[Ito, Hiroshi; Takano, Harumasa; Arakawa, Ryosuke; Takahashi, Hidehiko; Kodaka, Fumitoshi; Takahata, Keisuke; Nogami, Tsuyoshi; Suzuki, Masayuki; Suhara, Tetsuya] Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan	National Institutes for Quantum Science & Technology	Ito, H (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 260, Japan.	hito@nirs.go.jp		Takahashi, Hidehiko/0000-0002-5102-1982; Takahata, Keisuke/0000-0002-0884-4924; Ito, Hiroshi/0000-0002-3581-4798	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japanese Government; Japan Society for the Promotion of Science [21591587]; National Institute of Radiological Sciences	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Radiological Sciences	This study was supported in part by a Grant-in-Aid for Molecular Imaging Program from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japanese Government, a Grant-in-Aid for Scientific Research (C) (No. 21591587) from the Japan Society for the Promotion of Science, and a grant from the National Institute of Radiological Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALSARA JJ, 1979, PSYCHOPHARMACOLOGY, V62, P67, DOI 10.1007/BF00426037; BARON JC, 1989, PSYCHOPHARMACOLOGY, V99, P463, DOI 10.1007/BF00589893; Brix G, 1997, J NUCL MED, V38, P1614; BROWN RM, 1979, BRAIN RES, V168, P133, DOI 10.1016/0006-8993(79)90132-X; CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140; Cumming P, 1997, J CEREBR BLOOD F MET, V17, P1254, DOI 10.1097/00004647-199711000-00014; Danielsen EH, 2001, SYNAPSE, V41, P172, DOI 10.1002/syn.1071; Der-Ghazarian T, 2010, J NEURAL TRANSM, V117, P573, DOI 10.1007/s00702-010-0396-5; FARDE L, 1988, ARCH GEN PSYCHIAT, V45, P71; FRISTON KJ, 1990, J CEREBR BLOOD F MET, V10, P458, DOI 10.1038/jcbfm.1990.88; GJEDDE A, 1988, PEPTIDE AND AMINO ACID TRANSPORT MECHANISMS IN THE CENTRAL NERVOUS SYSTEM, P209; GJEDDE A, 1991, P NATL ACAD SCI USA, V88, P2721, DOI 10.1073/pnas.88.7.2721; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Grunder G, 2008, AM J PSYCHIAT, V165, P988, DOI 10.1176/appi.ajp.2008.07101574; Grunder G, 2003, NEUROPSYCHOPHARMACOL, V28, P787, DOI 10.1038/sj.npp.1300103; HARTVIG P, 1991, J NEURAL TRANSM-GEN, V86, P25, DOI 10.1007/BF01250373; HICKS PB, 1990, LIFE SCI, V47, P1609, DOI 10.1016/0024-3205(90)90365-X; Ito H, 2007, ANN NUCL MED, V21, P355, DOI 10.1007/s12149-007-0033-z; Ito H, 2006, NUCL MED COMMUN, V27, P723, DOI 10.1097/01.mnm.0000230069.08576.6d; Ito H, 2009, J NEUROSCI, V29, P13730, DOI 10.1523/JNEUROSCI.4172-09.2009; Kegeles LS, 2008, NEUROPSYCHOPHARMACOL, V33, P3111, DOI 10.1038/npp.2008.33; KIKUCHI T, 1995, J PHARMACOL EXP THER, V274, P329; KORSGAARD S, 1985, EUR J PHARMACOL, V118, P245, DOI 10.1016/0014-2999(85)90135-9; Lammertsma AA, 1996, J CEREBR BLOOD F MET, V16, P42, DOI 10.1097/00004647-199601000-00005; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lieberman JA, 2004, CNS DRUGS, V18, P251, DOI 10.2165/00023210-200418040-00005; LLOYD KG, 1972, J NEUROCHEM, V19, P1549, DOI 10.1111/j.1471-4159.1972.tb05099.x; Mamo D, 2007, AM J PSYCHIAT, V164, P1411, DOI 10.1176/appi.ajp.2007.06091479; Molden E, 2006, THER DRUG MONIT, V28, P744, DOI 10.1097/01.ftd.0000249944.42859.bf; NYBERG S, 1993, PSYCHOPHARMACOLOGY, V110, P265, DOI 10.1007/BF02251280; Oshibuchi H, 2009, EUR J PHARMACOL, V615, P83, DOI 10.1016/j.ejphar.2009.05.006; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Pehek EA, 2001, BRAIN RES, V888, P51, DOI 10.1016/S0006-8993(00)03004-3; Potkin SG, 2003, ARCH GEN PSYCHIAT, V60, P681, DOI 10.1001/archpsyc.60.7.681; Sparshatt A, 2010, J CLIN PSYCHIAT, V71, P1447, DOI 10.4088/JCP.09r05060gre; Sugaya Y, 2001, NEUROSCIENCE, V104, P1, DOI 10.1016/S0306-4522(01)00008-2; Takahata K, 2012, PSYCHOPHARM IN PRESS; Torstenson R, 1998, NEUROPHARMACOLOGY, V37, P989, DOI 10.1016/S0028-3908(98)00085-9; Vernaleken I, 2006, NEUROIMAGE, V30, P1332, DOI 10.1016/j.neuroimage.2005.11.014; Vernaleken I, 2008, NEUROIMAGE, V40, P1222, DOI 10.1016/j.neuroimage.2007.12.045; Watson CC, 1996, COMP IMAG VIS, V4, P255; Wood MD, 2006, EUR J PHARMACOL, V546, P88, DOI 10.1016/j.ejphar.2006.07.008; Yokoi F, 2002, NEUROPSYCHOPHARMACOL, V27, P248, DOI 10.1016/S0893-133X(02)00304-4	43	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46488	10.1371/journal.pone.0046488	http://dx.doi.org/10.1371/journal.pone.0046488			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029533	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900172
J	Karavitis, J; Hix, LM; Shi, YHH; Schultz, RF; Khazaie, K; Zhang, M				Karavitis, John; Hix, Laura M.; Shi, Yihui H.; Schultz, Rachael F.; Khazaie, Khashayarsha; Zhang, Ming			Regulation of COX2 Expression in Mouse Mammary Tumor Cells Controls Bone Metastasis and PGE2-Induction of Regulatory T Cell Migration	PLOS ONE			English	Article							BREAST-CANCER; IN-VIVO; LUNG-CANCER; IFN-GAMMA; CD8(+); MICROENVIRONMENT; CYTOTOXICITY; SURVEILLANCE; SUPPRESSION; PROGRESSION	Background: The targeting of the immune system through immunotherapies to prevent tumor tolerance and immune suppression are at the front lines of breast cancer treatment and research. Human and laboratory studies have attributed breast cancer progression and metastasis to secondary organs such as the bone, to a number of factors, including elevated levels of prostaglandin E2 (PGE2) and the enzyme responsible for its production, cyclooxygenase 2 (COX2). Due to the strong connection of COX2 with immune function, we focused on understanding how variance in COX2 expression manipulates the immune profile in a syngeneic, and immune-competent, mouse model of breast cancer. Though there have been correlative findings linking elevated levels of COX2 and Tregs in other cancer models, we sought to elucidate the mechanisms by which these immuno-suppressive cells are recruited to breast tumor and the means by which they promote tumor tolerance. Methodology/Principal Findings: To elucidate the mechanisms by which exacerbated COX2 expression potentiates metastasis we genetically manipulated non-metastatic mammary tumor cells (TM40D) to over-express COX2 (TM40D-COX2). Over-expression of COX2 in this mouse breast cancer model resulted in an increase in bone metastasis (an observation that was ablated following suppression of COX2 expression) in addition to an exacerbated Treg recruitment in the primary tumor. Interestingly, other immune-suppressive leukocytes, such as myeloid derived suppressor cells, were not altered in the primary tumor or the circulation. Elevated levels of PGE2 by tumor cells can directly recruit CD4+CD25+ cells through interactions with their EP2 and/or EP4 receptors, an effect that was blocked using anti-PGE2 antibody. Furthermore, increased Treg recruitment to the primary tumor contributed to the greater levels of apoptotic CD8+T cells in the TM40D-COX2 tumors. Conclusion/Significance: Due to the systemic effects of COX2 inhibitors, we propose targeting specific EP receptors as therapeutic interventions to breast cancer progression.	[Karavitis, John; Hix, Laura M.; Shi, Yihui H.; Zhang, Ming] Northwestern Univ, Dept Mol Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA; [Karavitis, John; Hix, Laura M.; Shi, Yihui H.; Zhang, Ming] Northwestern Univ, Dept Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA; [Karavitis, John; Hix, Laura M.; Shi, Yihui H.; Schultz, Rachael F.; Khazaie, Khashayarsha; Zhang, Ming] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Zhang, M (corresponding author), Northwestern Univ, Dept Mol Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA.	m-zhang@northwestern.edu			Department of Defense (DOD) [W81XWH-10-1-0685]; Lynn Sage Foundation	Department of Defense (DOD)(United States Department of Defense); Lynn Sage Foundation	This work was supported by the Department of Defense (DOD) W81XWH-10-1-0685, Avon breast cancer award, and Lynn Sage Foundation awarded to M.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi M, 2008, CANCER RES, V68, P7520, DOI 10.1158/0008-5472.CAN-08-1060; American Cancer Society Inc, 2011, BREAST CANC FACTS FI; Baratelli F, 2010, AM J TRANSL RES, V2, P356; Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Bergmann C, 2007, CANCER RES, V67, P8865, DOI 10.1158/0008-5472.CAN-07-0767; Chang SH, 2004, P NATL ACAD SCI USA, V101, P591, DOI 10.1073/pnas.2535911100; Chen ML, 2005, P NATL ACAD SCI USA, V102, P419, DOI 10.1073/pnas.0408197102; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Ehrlich P., 1909, NED TIJDSCHR GENEES, V5, P273; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Fetalvero KM, 2007, PROSTAG OTH LIPID M, V82, P109, DOI 10.1016/j.prostaglandins.2006.05.011; Fujita M, 2011, CANCER RES, V71, P2664, DOI 10.1158/0008-5472.CAN-10-3055; Grossman WJ, 2004, BLOOD, V104, P2840, DOI 10.1182/blood-2004-03-0859; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Hix LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020702; Hoffmann P, 2006, BIOL BLOOD MARROW TR, V12, P267, DOI 10.1016/j.bbmt.2006.01.005; Howe LR, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1678; Huang M, 1998, CANCER RES, V58, P1208; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Khazaie K, 2006, SEMIN CANCER BIOL, V16, P124, DOI 10.1016/j.semcancer.2005.11.006; KITTRELL FS, 1992, CANCER RES, V52, P1924; Klein G, 2005, IMMUNOL LETT, V100, P29, DOI 10.1016/j.imlet.2005.06.024; Knutson KL, 2007, CANCER IMMUNOL IMMUN, V56, P271, DOI 10.1007/s00262-006-0194-y; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Li YS, 2001, CANCER RES, V61, P6906; Li ZG, 2008, CLIN EXP METASTAS, V25, P389, DOI 10.1007/s10585-007-9117-3; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; Ma XR, 2006, CANCER RES, V66, P2923, DOI 10.1158/0008-5472.CAN-05-4348; Menetrier-Caux C, 2009, CANCER RES, V69, P7895, DOI 10.1158/0008-5472.CAN-09-1642; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Obermajer N, 2011, CANCER RES, V71, P7463, DOI 10.1158/0008-5472.CAN-11-2449; Onizuka S, 1999, CANCER RES, V59, P3128; Pockaj BA, 2004, ANN SURG ONCOL, V11, P328, DOI 10.1245/ASO.2004.05.027; Rech AJ, 2010, CANCER IMMUNOL IMMUN, V59, P599, DOI 10.1007/s00262-009-0780-x; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; Stanic AK, 2003, P NATL ACAD SCI USA, V100, P1849, DOI 10.1073/pnas.0430327100; Strauss L, 2009, J IMMUNOL, V182, P1469, DOI 10.4049/jimmunol.182.3.1469; Street SEA, 2004, J EXP MED, V199, P879, DOI 10.1084/jem.20031981; Sugihara AQ, 2009, INT J ONCOL, V34, P1533, DOI 10.3892/ijo_00000282; Sutmuller RPM, 2001, J EXP MED, V194, P823, DOI 10.1084/jem.194.6.823; Thorat MA, 2008, MODERN PATHOL, V21, P15, DOI 10.1038/modpathol.3800970; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Vermi W, 2003, J PATHOL, V200, P255, DOI 10.1002/path.1344; Yaqub S, 2008, CANCER IMMUNOL IMMUN, V57, P813, DOI 10.1007/s00262-007-0417-x; Yuan XL, 2010, CLIN IMMUNOL, V134, P277, DOI 10.1016/j.clim.2009.10.005; Zitvogel L, 2006, CURR TOP MICROBIOL, V298, P157; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	49	66	67	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46342	10.1371/journal.pone.0046342	http://dx.doi.org/10.1371/journal.pone.0046342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029485	Green Submitted, gold, Green Published			2022-12-27	WOS:000309973900138
J	Lintner, M; Weissenbacher, A; Heiss, E				Lintner, Monika; Weissenbacher, Anton; Heiss, Egon			The Oropharyngeal Morphology in the Semiaquatic Giant Asian Pond Turtle, Heosemys grandis, and Its Evolutionary Implications	PLOS ONE			English	Article							DORSAL LINGUAL EPITHELIUM; STERNOTHERUS-ODORATUS CHELONIA; PELUSIOS-CASTANEUS CHELONIA; FEEDING APPARATUS; PREY CAPTURE; TERRAPENE-CAROLINA; CUORA-AMBOINENSIS; FOOD TRANSPORT; FINE-STRUCTURE; BOX-TURTLE	The oropharynx as a functional entity plays a fundamental role in feeding. Transitions from aquatic to terrestrial lifestyles in vertebrates demanded major changes of the oropharynx for the required adaptations to a different feeding environment. Extant turtles evolved terrestrial feeding modes in three families (testudinids, emydids, geoemydids)-independently from other amniotes- and are therefore important model organisms to reconstruct morpho-functional changes behind aquatic-terrestrial transitions. In this study we hypothesized that the oropharyngeal morphology in semiaquatic turtles of the geoemydid family shows parallels to testudinids, the only purely terrestrial extant lineage. We provide an in-depth description of the oropharynx in the semiaquatic geoemydid Heosemys grandis by using a combination of micro computed tomography (micro-CT) and subsequent digital in situ 3-D reconstruction, scanning electron microscopy (SEM), and histology. We show that H. grandis has a large tongue with rough papillose surface and well-developed lingual muscles. The attachment sites of the lingual muscles on the hyolingual skeleton and their courses within the tongue are nearly identical with testudinids. The hyolingual skeleton itself is mainly cartilaginous and shows distinct-but compared to testudinids rather small-anterior extensions of the hyoid body and hypoglossum. Oral glands are well developed in H. grandis but are smaller and simpler than in testudinids. Similarly, oropharyngeal keratinization was minimal and found only in the anterior palate, regions close to the beak, and tongue tip. We conclude that H. grandis shows distinct oropharyngeal morphofunctional adaptations for a terrestrial lifestyle but still retains characters typical for aquatic forms. This makes this species an important example showing the oropharyngeal adaptations behind aquatic-terrestrial transitions in turtles.	[Lintner, Monika; Heiss, Egon] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Weissenbacher, Anton] Zoo Vienna, Vienna, Austria; [Heiss, Egon] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium	University of Vienna; University of Antwerp	Heiss, E (corresponding author), Univ Vienna, Dept Integrat Zool, Vienna, Austria.	Egon.Heiss@ua.ac.be		Heiss, Egon/0000-0002-5257-8889	Austrian Science fund FWF [J3186-B17, P20094-B17]	Austrian Science fund FWF(Austrian Science Fund (FWF))	This study was financially supported by the Austrian Science fund FWF (project numbers: J3186-B17 and P20094-B17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts P, 2001, AM ZOOL, V41, P1299, DOI 10.1668/0003-1569(2001)041[1299:IMACOF]2.0.CO;2; Anquetin J, 2009, P ROY SOC B-BIOL SCI, V276, P879, DOI 10.1098/rspb.2008.1429; Beisser CJ, 2004, ANAT REC PART A, V277A, P227, DOI 10.1002/ar.a.20008; Beisser CJ, 2001, TISSUE CELL, V33, P63, DOI 10.1054/tice.2000.0156; BEISSER CJ, 1995, J MORPHOL, V226, P267, DOI 10.1002/jmor.1052260303; Beisser CJ, 1998, ANAT REC, V250, P127, DOI 10.1002/(SICI)1097-0185(199802)250:2<127::AID-AR1>3.0.CO;2-0; Bels Vincent, 2008, P187; Bels VL, 1997, J EXP ZOOL, V277, P198, DOI 10.1002/(SICI)1097-010X(19970215)277:3<198::AID-JEZ2>3.0.CO;2-J; Bonin F, 2006, TURTLES WORLD; Bramble D.M., 1985, P230; Deban SM, 2003, EXPTL BIOL REV, P161; Deban SM, 2002, ZOOL J LINN SOC-LOND, V134, P375, DOI 10.1046/j.1096-3642.2002.00004.x; Druzisky KA, 2001, ZOOL-ANAL COMPLEX SY, V104, P143, DOI 10.1078/0944-2006-00015; Fahrenholz C., 1937, P115; Gray JE, 1860, ANN MAG NAT HIST 3, V6, P217; Heiss E, 2008, ANAT REC, V291, P876, DOI 10.1002/ar.20695; Heiss E, 2011, J MORPHOL, V272, P1217, DOI 10.1002/jmor.10978; Heiss E, 2010, ANAT REC, V293, P1416, DOI 10.1002/ar.21185; Heiss E, 2009, J MORPHOL, V270, P892, DOI 10.1002/jmor.10728; Iwasaki S, 2002, J ANAT, V201, P1, DOI 10.1046/j.1469-7580.2002.00073.x; Iwasaki SI, 1996, ANAT REC, V246, P305, DOI 10.1002/(SICI)1097-0185(199611)246:3<305::AID-AR1>3.0.CO;2-X; IWASAKI SI, 1992, J MORPHOL, V211, P125, DOI 10.1002/jmor.1052110202; Joyce WG, 2004, P ROY SOC B-BIOL SCI, V271, P1, DOI 10.1098/rspb.2003.2523; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Kiernan JA., 2003, HISTOLOGICAL HISTOCH; Kochva E., 1978, P43; LAUDER GV, 1992, J EXP BIOL, V164, P55; Lemell P, 1997, NETH J ZOOL, V47, P429, DOI 10.1163/156854297X00102; Lemell P, 2000, J MORPHOL, V244, P127, DOI 10.1002/(SICI)1097-4687(200005)244:2<127::AID-JMOR3>3.0.CO;2-U; Lemell P, 2010, AMPHIBIA-REPTILIA, V31, P97, DOI 10.1163/156853810790457803; Li C, 2008, NATURE, V456, P497, DOI 10.1038/nature07533; Lintner M., 2010, THESIS; NALAVADE MN, 1976, FOL HISTOCH CYTOCHEM, V14, P123; Natchev N, 2011, CONTRIB ZOOL, V80, P143, DOI 10.1163/18759866-08002004; Natchev N, 2010, ZOOMORPHOLOGY, V129, P111, DOI 10.1007/s00435-010-0104-x; Natchev N, 2009, ZOOLOGY, V112, P113, DOI 10.1016/j.zool.2008.05.002; PRITCHARD PCH, 1979, ENCY TURTLES; Reisz RR, 2008, NATURE, V456, P450, DOI 10.1038/456450a; Richter S, 2007, AMPHIBIA-REPTILIA, V28, P148, DOI 10.1163/156853807779798983; Romeis B., 1989, MIKROSKOPISCHE TECHN; Schumacher G. H., 1973, P101; Schwenk Kurt, 2001, Bulletin of the Museum of Comparative Zoology, V156, P219; Schwenk Kurt, 2000, P21, DOI 10.1016/B978-012632590-4/50003-4; Stayton CT, 2011, J EXP BIOL, V214, P4083, DOI 10.1242/jeb.060574; Summers AP, 1998, J EXP ZOOL, V281, P280, DOI 10.1002/(SICI)1097-010X(19980701)281:4<280::AID-JEZ4>3.0.CO;2-K; Weisgram J, 1989, PLZEN LEK SBORN S, V59, P117; Werneburg I, 2011, PALAEONTOL ELECTRON, V14; WINOKUR RM, 1988, J MORPHOL, V196, P33, DOI 10.1002/jmor.1051960105; Wocheslander R, 2000, NETH J ZOOL, V50, P445, DOI 10.1163/156854200506080; Wocheslander R, 1999, NETH J ZOOL, V49, P1, DOI 10.1163/156854299X00010	50	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46344	10.1371/journal.pone.0046344	http://dx.doi.org/10.1371/journal.pone.0046344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029486	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900139
J	Hurtado, MD; Acosta, A; Riveros, PP; Baum, BJ; Ukhanov, K; Brown, AR; Dotson, CD; Herzog, H; Zolotukhin, S				Hurtado, Maria D.; Acosta, Andres; Riveros, Paola P.; Baum, Bruce J.; Ukhanov, Kirill; Brown, Alicia R.; Dotson, Cedrick D.; Herzog, Herbert; Zolotukhin, Sergei			Distribution of Y-Receptors in Murine Lingual Epithelia	PLOS ONE			English	Article							NEUROPEPTIDE YY1 RECEPTOR; PANCREATIC-POLYPEPTIDE; PROTEIN EXPRESSION; MICE LACKING; PEPTIDE YY; RAT-BRAIN; CELLS; PROLIFERATION; INTERNALIZATION; MIGRATION	Peptide hormones and their cognate receptors belonging to neuropeptide Y (NPY) family mediate diverse biological functions in a number of tissues. Recently, we discovered the presence of the gut satiation peptide YY (PYY) in saliva of mice and humans and defined its role in the regulation of food intake and body weight maintenance. Here we report the systematic analysis of expression patterns of all NPY receptors (Rs), Y1R, Y2R, Y4R, and Y5R in lingual epithelia in mice. Using four independent assays, immunohistochemistry, in situ hybridization, immunocytochemistry and RT PCR, we show that the morphologically different layers of the keratinized stratified epithelium of the dorsal layer of the tongue express Y receptors in a very distinctive yet overlapping pattern. In particular, the monolayer of basal progenitor cells expresses both Y1 and Y2 receptors. Y1Rs are present in the parabasal prickle cell layer and the granular layer, while differentiated keratinocytes display abundant Y5Rs. Y4Rs are expressed substantially in the neuronal fibers innervating the lamina propria and mechanoreceptors. Basal epithelial cells positive for Y2Rs respond robustly to PYY3-36 by increasing intracellular Ca2+ suggesting their possible functional interaction with salivary PYY. In taste buds of the circumvallate papillae, some taste receptor cells (TRCs) express YRs localized primarily at the apical domain, indicative of their potential role in taste perception. Some of the YR-positive TRCs are co-localized with neuronal cell adhesion molecule (NCAM), suggesting that these TRCs may have synaptic contacts with nerve terminals. In summary, we show that all YRs are abundantly expressed in multiple lingual cell types, including epithelial progenitors, keratinocytes, neuronal dendrites and TRCs. These results suggest that these receptors may be involved in the mediation of a wide variety of functions, including proliferation, differentiation, motility, taste perception and satiation.	[Hurtado, Maria D.; Zolotukhin, Sergei] Univ Florida, Dept Pediat, Gainesville, FL 32611 USA; [Acosta, Andres] Univ Florida, Dept Med, Gainesville, FL USA; [Riveros, Paola P.; Baum, Bruce J.] NIDCR, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Ukhanov, Kirill; Brown, Alicia R.; Dotson, Cedrick D.] Univ Florida, Dept Neurosci, Ctr Smell & Taste, Gainesville, FL 32610 USA; [Ukhanov, Kirill; Brown, Alicia R.; Dotson, Cedrick D.] Univ Florida, Dept Psychiat, Ctr Smell & Taste, Gainesville, FL 32610 USA; [Herzog, Herbert] Garvan Inst Med Res, Neurosci Program, Sydney, NSW, Australia	State University System of Florida; University of Florida; State University System of Florida; University of Florida; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); State University System of Florida; University of Florida; State University System of Florida; University of Florida; Garvan Institute of Medical Research	Zolotukhin, S (corresponding author), Univ Florida, Dept Pediat, Gainesville, FL 32611 USA.	szlt@ufl.edu	Riveros, Paola/AAL-4161-2021; Brown, Alicia/C-6478-2008	Brown, Alicia/0000-0001-6602-7917; , Herbert/0000-0002-1713-1029; Hurtado, Maria Daniela/0000-0002-2322-7334	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK62302-01]; Division of Intramural Research of the National Institute of Dental and Craniofacial Research; NHMRC of Australia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062302] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Division of Intramural Research of the National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by 1R01DK62302-01 (National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases) to SZ; the Division of Intramural Research of the National Institute of Dental and Craniofacial Research in part supported this research (BB). HH is funded by an NHMRC of Australia Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026137; BARD JA, 1995, J BIOL CHEM, V270, P26762, DOI 10.1074/jbc.270.45.26762; Dawidson I, 1996, LIFE SCI, V60, P269, DOI 10.1016/S0024-3205(96)00627-3; Dumont Y, 2002, NEUROPEPTIDE RECEPTO; Fabry M, 2000, EUR J BIOCHEM, V267, P5631, DOI 10.1046/j.1432-1327.2000.01631.x; Fetissov SO, 2004, J COMP NEUROL, V470, P256, DOI 10.1002/cne.11047; GERALD C, 1995, J BIOL CHEM, V270, P26758, DOI 10.1074/jbc.270.45.26758; Ghersi G, 2001, PEPTIDES, V22, P453, DOI 10.1016/S0196-9781(01)00340-0; Gicquiaux H, 2002, J BIOL CHEM, V277, P6645, DOI 10.1074/jbc.M107224200; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; HERZOG H, 1992, P NATL ACAD SCI USA, V89, P5794, DOI 10.1073/pnas.89.13.5794; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Kaya N, 2004, AM J PHYSIOL-REG I, V286, pR649, DOI 10.1152/ajpregu.00572.2003; Kopp J, 2002, NEUROSCIENCE, V111, P443, DOI 10.1016/S0306-4522(01)00463-8; Mahomed F, 2010, J ORAL PATHOL MED, V39, P121, DOI 10.1111/j.1600-0714.2009.00834.x; Mannon PJ, 2000, BIOCHEM J, V350, P655, DOI 10.1042/0264-6021:3500655; Michel MC, 2009, N-S ARCH PHARMACOL, V379, P385, DOI 10.1007/s00210-009-0395-y; Movafagh S, 2006, FASEB J, V20, P1924, DOI 10.1096/fj.05-4770fje; Ohmoto M, 2008, MOL CELL NEUROSCI, V38, P505, DOI 10.1016/j.mcn.2008.04.011; Parker RMC, 1999, EUR J NEUROSCI, V11, P1431, DOI 10.1046/j.1460-9568.1999.00553.x; Parker SL, 2001, EUR J BIOCHEM, V268, P877, DOI 10.1046/j.1432-1327.2001.01966.x; Pedrazzini T, 1998, NAT MED, V4, P722, DOI 10.1038/nm0698-722; Ralevic V, 1998, PHARMACOL REV, V50, P413; Saper CB, 2005, J COMP NEUROL, V493, P477, DOI 10.1002/cne.20839; Squier C A, 2001, J Natl Cancer Inst Monogr, P7; Stanic D, 2008, P NATL ACAD SCI USA, V105, P3610, DOI 10.1073/pnas.0712303105; Stanic D, 2006, J COMP NEUROL, V499, P357, DOI 10.1002/cne.21046; Stanic D, 2011, J COMP NEUROL, V519, P1219, DOI 10.1002/cne.22608; Tipoe GL, 1996, ORAL ONCOL, V32B, P24, DOI 10.1016/0964-1955(95)00049-6; Tschenett A, 2003, EUR J NEUROSCI, V18, P143, DOI 10.1046/j.1460-9568.2003.02725.x; Wolak ML, 2003, J COMP NEUROL, V464, P285, DOI 10.1002/cne.10823; Yoshida R, 2010, INT REV CEL MOL BIO, V279, P101, DOI 10.1016/S1937-6448(10)79004-3; Zhang L, 2011, PHARMACOL THERAPEUT, V131, P91, DOI 10.1016/j.pharmthera.2011.03.011; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102	34	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46358	10.1371/journal.pone.0046358	http://dx.doi.org/10.1371/journal.pone.0046358			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050020	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300110
J	Mahfouz, H; Ragnini-Wilson, A; Venditti, R; De Matteis, MA; Wilson, C				Mahfouz, Hichem; Ragnini-Wilson, Antonella; Venditti, Rossella; De Matteis, Maria Antonietta; Wilson, Cathal			Mutational Analysis of the Yeast TRAPP Subunit Trs20p Identifies Roles in Endocytic Recycling and Sporulation	PLOS ONE			English	Article							AMINO-ACID PERMEASE; SACCHAROMYCES-CEREVISIAE; PROTEIN-TRANSPORT; CRYSTAL-STRUCTURE; GOLGI-APPARATUS; MEMBRANE; COMPLEX; ER; RETRIEVAL; ENCODES	Trs20p is a subunit of the evolutionarily conserved TRAPP (TRAnsport Protein Particle) complex that mediates various aspects of membrane trafficking. Three TRAPP complexes have been identified in yeast with roles in ER-to-Golgi trafficking, post-Golgi and endosomal-to-Golgi transport and in autophagy. The role of Trs20p, which is essential for viability and a component of all three complexes, and how it might function within each TRAPP complex, has not been clarified to date. To begin to address the role of Trs20p we generated different mutants by random mutagenesis but, surprisingly, no defects were observed in diverse anterograde transport pathways or general secretion in Trs20 temperature-sensitive mutants. Instead, mutation of Trs20 led to defects in endocytic recycling and a block in sporulation/meiosis. The phenotypes of different mutants appear to be separable suggesting that the mutations affect the function of Trs20 in different TRAPP complexes.	[Venditti, Rossella; De Matteis, Maria Antonietta; Wilson, Cathal] Telethon Inst Genet & Med, Naples, Italy; [Ragnini-Wilson, Antonella] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Mahfouz, Hichem; Ragnini-Wilson, Antonella] Consorzio Mario Negri Sud, Chieti, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Rome Tor Vergata; Consorzio Mario Negri Sud	Wilson, C (corresponding author), Telethon Inst Genet & Med, Naples, Italy.	wilson@tigem.it	De Matteis, Maria Antonietta/AHE-5161-2022; Ragnini, Antonella/A-8089-2014; Venditti, Rossella/AAT-4281-2020	De Matteis, Maria Antonietta/0000-0003-0053-3061; Ragnini, Antonella/0000-0001-7963-7554; Venditti, Rossella/0000-0002-1884-6501; Wilson, Cathal/0000-0002-0637-8608	Telethon [GGP07075, GGP08183, GGP06166]; AIRC [IG 8623]	Telethon(Fondazione Telethon); AIRC(Fondazione AIRC per la ricerca sul cancro)	This study was supported by the Telethon grants GGP07075 to CW, GGP08183 to ARW, GGP06166 to MADM and the AIRC grant IG 8623 to MADM (http://www.telethon.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMERER G, 1986, MOL CELL BIOL, V6, P2490, DOI 10.1128/MCB.6.7.2490; Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862; Belgareh-Touze N, 2003, TRAFFIC, V4, P607, DOI 10.1034/j.1600-0854.2003.00116.x; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Cai HQ, 2005, J CELL BIOL, V171, P823, DOI 10.1083/jcb.200505145; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Casavola EC, 2008, MOL MICROBIOL, V67, P1051, DOI 10.1111/j.1365-2958.2008.06106.x; Chen EJ, 2002, P NATL ACAD SCI USA, V99, P14837, DOI 10.1073/pnas.232591899; Choi C, 2011, TRAFFIC, V12, P715, DOI 10.1111/j.1600-0854.2011.01181.x; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Derby MC, 2007, TRAFFIC, V8, P758, DOI 10.1111/j.1600-0854.2007.00563.x; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Gaynor EC, 1997, J CELL BIOL, V136, P789, DOI 10.1083/jcb.136.4.789; Gecz J, 2003, GENE, V320, P137, DOI 10.1016/S0378-1119(03)00819-9; Gedeon AK, 1999, NAT GENET, V22, P400, DOI 10.1038/11976; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jang SB, 2002, J BIOL CHEM, V277, P49863, DOI 10.1074/jbc.M207436200; KAYTOR MD, 1995, YEAST, V11, P1147, DOI 10.1002/yea.320111205; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Kim YG, 2005, NAT STRUCT MOL BIOL, V12, P38, DOI 10.1038/nsmb871; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; Lafourcade C, 2004, MOL CELL BIOL, V24, P3815, DOI 10.1128/MCB.24.9.3815-3826.2004; Lesage G, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-8; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Montpetit B, 2009, TRAFFIC, V10, P713, DOI 10.1111/j.1600-0854.2009.00895.x; Morishita M, 2007, TRAFFIC, V8, P1231, DOI 10.1111/j.1600-0854.2007.00606.x; Morozova N, 2006, NAT CELL BIOL, V8, P1263, DOI 10.1038/ncb1489; Munro S, 2005, BIOCHEM SOC T, V33, P601, DOI 10.1042/BST0330601; Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; ROSSI G, 1995, MOL BIOL CELL, V6, P1769, DOI 10.1091/mbc.6.12.1769; Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494; Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sciorra VA, 2005, MOL BIOL CELL, V16, P776, DOI 10.1091/mbc.e04-08-0700; Scrivens PJ, 2011, MOL BIOL CELL, V22, P2083, DOI 10.1091/mbc.E10-11-0873; Scrivens PJ, 2009, TRAFFIC, V10, P724, DOI 10.1111/j.1600-0854.2009.00906.x; Seron K, 1998, MOL BIOL CELL, V9, P2873, DOI 10.1091/mbc.9.10.2873; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Sztul E, 2006, AM J PHYSIOL-CELL PH, V290, pC11, DOI 10.1152/ajpcell.00293.2005; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Turnbull AP, 2005, EMBO J, V24, P875, DOI 10.1038/sj.emboj.7600565; Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2; Wagner W, 2002, EMBO J, V21, P6397, DOI 10.1093/emboj/cdf650; Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289; Wooding S, 1998, MOL BIOL CELL, V9, P2667, DOI 10.1091/mbc.9.9.2667; Yamamoto K, 2002, CURR GENET, V42, P85, DOI 10.1007/s00294-002-0336-5; Yip CK, 2010, NAT STRUCT MOL BIOL, V17, P1298, DOI 10.1038/nsmb.1914; Zhang CJ, 2002, YEAST, V19, P1075, DOI 10.1002/yea.903; Zong M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023350	59	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e41408	10.1371/journal.pone.0041408	http://dx.doi.org/10.1371/journal.pone.0041408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049729	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300004
J	Ostapenko, D; Burton, JL; Solomon, MJ				Ostapenko, Denis; Burton, Janet L.; Solomon, Mark J.			Identification of Anaphase Promoting Complex Substrates in S-cerevisiae	PLOS ONE			English	Article							SPINDLE CHECKPOINT; PSEUDOSUBSTRATE INHIBITION; DEPENDENT DEGRADATION; MEDIATED PROTEOLYSIS; MITOTIC SPINDLE; KEN BOX; YEAST; APC; UBIQUITIN; KINASE	The Anaphase-Promoting Complex/Cyclosome (APC/C) is an essential ubiquitin ligase that targets numerous proteins for proteasome-mediated degradation in mitosis and G1. To gain further insight into cellular pathways controlled by APC/C-Cdh1, we developed two complementary approaches to identify additional APC/C-Cdh1 substrates in budding yeast. First, we analyzed the stabilities of proteins that were expressed at the same time in the cell cycle as known APC/C substrates. Second, we screened for proteins capable of interacting with the Cdh1 substrate-binding protein in a yeast two-hybrid system. Here we characterize five potential APC/C substrates identified using these approaches: the transcription factors Tos4 and Pdr3; the mRNA processing factor Fir1; the spindle checkpoint protein kinase Mps1; and a protein of unknown function, Ybr138C. Analysis of the degradation motifs within these proteins revealed that the carboxyl-terminal KEN box and D-boxes of Tos4 are important for its interaction with Cdh1, whereas the N-terminal domain of Ybr138C is required for its instability. Functionally, we found that a stabilized form of Mps1 delayed cell division upon mild spindle disruption, and that elevated levels of Ybr138C reduced cell fitness. Interestingly, both Tos4 and Pdr3 have been implicated in the DNA damage response, whereas Mps1 regulates the spindle assembly checkpoint. Thus, the APC/C-Cdh1-mediated degradation of these proteins may help to coordinate re-entry into the cell cycle following environmental stresses.	[Ostapenko, Denis; Burton, Janet L.; Solomon, Mark J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Solomon, MJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	Mark.Solomon@yale.edu			National Institutes of Health [GM76200, GM88272]; American Heart Association Founders Affiliate [12GRNT12060663]; March of Dimes Foundation [1-FY05-114]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076200, R01GM088272] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Founders Affiliate(American Heart Association); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants GM76200 and GM88272 from the National Institutes of Health, grant 12GRNT12060663 from the American Heart Association Founders Affiliate, and grant 1-FY05-114 from the March of Dimes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlskog JK, 2010, MOL CELL BIOL, V30, P5608, DOI 10.1128/MCB.01506-09; Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Benanti JA, 2009, MOL CELL, V33, P581, DOI 10.1016/j.molcel.2009.01.032; Burton JL, 2011, EMBO J, V30, P1818, DOI 10.1038/emboj.2011.90; Burton JL, 2000, MOL CELL BIOL, V20, P4614, DOI 10.1128/MCB.20.13.4614-4625.2000; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; D'Aquino KE, 2005, MOL CELL, V19, P223, DOI 10.1016/j.molcel.2005.06.005; de Oliveira FMB, 2012, EMBO J, V31, P1798, DOI 10.1038/emboj.2012.27; Enquist-Newman M, 2008, MOL CELL, V30, P437, DOI 10.1016/j.molcel.2008.04.004; Fang GW, 1998, GENE DEV, V12, P1871, DOI 10.1101/gad.12.12.1871; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Hershkovits G, 2006, P NATL ACAD SCI USA, V103, P9808, DOI 10.1073/pnas.0602014103; Hildebrandt ER, 2001, MOL BIOL CELL, V12, P3402, DOI 10.1091/mbc.12.11.3402; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; James P, 1996, GENETICS, V144, P1425; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kimata Y, 2008, DEV CELL, V14, P446, DOI 10.1016/j.devcel.2007.12.010; Klitzing Cv, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOUMAL.PONE.0028998; Ko N, 2007, MOL BIOL CELL, V18, P5139, DOI 10.1091/mbc.E07-05-0509; Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023; Kucharczyk R, 1999, YEAST, V15, P987, DOI 10.1002/(SICI)1097-0061(199907)15:10B<987::AID-YEA403>3.0.CO;2-5; Liu C, 2011, J BIOL CHEM, V286, P43660, DOI 10.1074/jbc.M111.286229; Mangus DA, 2004, MOL CELL BIOL, V24, P4196, DOI 10.1128/MCB.24.10.4196-4206.2004; Moore DD, 1995, GLOB MOB SURV; Ostapenko D, 2008, MOL CELL BIOL, V28, P4653, DOI 10.1128/MCB.00055-08; Ostapenko D, 2011, MOL BIOL CELL, V22, P2175, DOI 10.1091/mbc.E11-01-0031; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pfleger CM, 2000, GENE DEV, V14, P655; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Woodbury EL, 2007, NAT CELL BIOL, V9, P106, DOI 10.1038/ncb1523; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721; Zhang LY, 2010, EMBO J, V29, P1726, DOI 10.1038/emboj.2010.55; Zhu Y, 2004, NUCLEIC ACIDS RES, V32, P5066, DOI 10.1093/nar/gkh838	54	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45895	10.1371/journal.pone.0045895	http://dx.doi.org/10.1371/journal.pone.0045895			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049888	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300062
J	Ersoz, ES; Wright, MH; Pangilinan, JL; Sheehan, MJ; Tobias, C; Casler, MD; Buckler, ES; Costich, DE				Ersoz, Elhan S.; Wright, Mark H.; Pangilinan, Jasmyn L.; Sheehan, Moira J.; Tobias, Christian; Casler, Michael D.; Buckler, Edward S.; Costich, Denise E.			SNP Discovery with EST and NextGen Sequencing in Switchgrass (Panicum virgatum L.)	PLOS ONE			English	Article							IDENTIFICATION; DIVERSITY	Although yield trials for switchgrass (Panicum virgatum L.), a potentially high value biofuel feedstock crop, are currently underway throughout North America, the genetic tools for crop improvement in this species are still in the early stages of development. Identification of high-density molecular markers, such as single nucleotide polymorphisms (SNPs), that are amenable to high-throughput genotyping approaches, is the first step in a quantitative genetics study of this model biofuel crop species. We generated and sequenced expressed sequence tag (EST) libraries from thirteen diverse switchgrass cultivars representing both upland and lowland ecotypes, as well as tetraploid and octoploid genomes. We followed this with reduced genomic library preparation and massively parallel sequencing of the same samples using the Illumina Genome Analyzer technology platform. EST libraries were used to generate unigene clusters and establish a gene-space reference sequence, thus providing a framework for assembly of the short sequence reads. SNPs were identified utilizing these scaffolds. We used a custom software program for alignment and SNP detection and identified over 149,000 SNPs across the 13 short-read sequencing libraries (SRSLs). Approximately 25,000 additional SNPs were identified from the entire EST collection available for the species. This sequencing effort generated data that are suitable for marker development and for estimation of population genetic parameters, such as nucleotide diversity and linkage disequilibrium. Based on these data, we assessed the feasibility of genome wide association mapping and genomic selection applications in switchgrass. Overall, the SNP markers discovered in this study will help facilitate quantitative genetics experiments and greatly enhance breeding efforts that target improvement of key biofuel traits and development of new switchgrass cultivars.	[Ersoz, Elhan S.; Sheehan, Moira J.; Buckler, Edward S.; Costich, Denise E.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Pangilinan, Jasmyn L.] Joint Genome Inst, Dept Energy, Walnut Creek, CA USA; [Tobias, Christian] ARS, USDA, Western Reg Res Ctr, Albany, CA USA; [Casler, Michael D.] ARS, USDA, US Dairy Forage Res Ctr, Madison, WI USA; [Buckler, Edward S.; Costich, Denise E.] ARS, USDA, Robert Holley Ctr, Ithaca, NY USA	Cornell University; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Ersoz, ES (corresponding author), Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA.	elhan.ersoz@syngenta.com; dc58@cornell.edu	Tobias, Christian/B-6602-2009; Buckler, Edward/GPS-4932-2022; Buckler, Edward/L-7651-2019	Tobias, Christian/0000-0002-7881-750X; Buckler, Edward/0000-0002-3100-371X; Wright, Mark/0000-0001-8036-1161	United States Department of Energy-USDA Plant Feedstock Genomics for Bioenergy Program named "Developing Association Mapping in Polyploid Perennial Biofuel Grasses'' [DE-A102-07ER64454]	United States Department of Energy-USDA Plant Feedstock Genomics for Bioenergy Program named "Developing Association Mapping in Polyploid Perennial Biofuel Grasses''	This study was funded by United States Department of Energy-USDA Plant Feedstock Genomics for Bioenergy Program grant DE-A102-07ER64454 named "Developing Association Mapping in Polyploid Perennial Biofuel Grasses''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BIOEN DOE MISS FOC; [Anonymous], PLANT FEEDST GEN BIO; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barnes RF, 2003, FORAGES, V1; BARNETT FL, 1967, CROP SCI, V7, P301, DOI 10.2135/cropsci1967.0011183X000700040005x; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Brunken JN, 1975, NATURE, V4, P379; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Christian D. G, 1998, ENERGY PLANT SPECIES; Costich DE, 2010, PLANT GENOME-US, V3, P130, DOI 10.3835/plantgenome2010.04.0010; Cushman JH, 1987, OAK RIDGE NATL LAB H; Gasler MD, 2006, SWITCHGRASS GENE POO; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Gore MA, 2009, PLANT GENOME-US, V2, P121, DOI 10.3835/plantgenome2009.01.0002; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Gunter LE, 1996, CROP SCI, V36, P1017, DOI 10.2135/cropsci1996.0011183X003600040034x; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hultquist SJ, 1996, CROP SCI, V36, P1049, DOI 10.2135/cropsci1996.0011183X003600040039x; Jackson BG, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S14; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; MCMILLAN C, 1959, AM J BOT, V46, P590, DOI 10.2307/2439303; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Nielson EL, 1944, J AGRIC RES, V69, P0327; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; PORTER CL, 1966, ECOLOGY, V47, P980, DOI 10.2307/1935646; Riley RD, 1982, CROP SCEINCE, V22, P1022; Samson RA, 1992, SWITCHGRASS POTENTIA; Sanderson MA, 1996, BIORESOURCE TECHNOL, V56, P83, DOI 10.1016/0960-8524(95)00176-X; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Tobias CM, 2008, PLANT GENOME-US, V1, P111, DOI 10.3835/plantgenome2008.08.0003; Tobias CM, 2005, THEOR APPL GENET, V111, P956, DOI 10.1007/s00122-005-0030-3; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; WHEELER WC, 1994, J HERED, V85, P417, DOI 10.1093/oxfordjournals.jhered.a111492; Zalapa JE, 2011, THEOR APPL GENET, V122, P805, DOI 10.1007/s00122-010-1488-1	37	16	16	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44112	10.1371/journal.pone.0044112	http://dx.doi.org/10.1371/journal.pone.0044112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049744	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100011
J	Heffernan, C; Sumer, H; Guillemin, GJ; Manuelpillai, U; Verma, PJ				Heffernan, Corey; Sumer, Huseyin; Guillemin, Gilles J.; Manuelpillai, Ursula; Verma, Paul J.			Design and Screening of a Glial Cell-Specific, Cell Penetrating Peptide for Therapeutic Applications in Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; ANTENNAPEDIA HOMEODOMAIN; RECOMBINANT PROTEINS; IMPROVES DELIVERY; FUSION PROTEIN; TAT PROTEIN; SPINAL-CORD; 3RD HELIX	Multiple Sclerosis (MS) is an autoimmune, neurodegenerative disease of the central nervous system (CNS) characterized by demyelination through glial cell loss. Current and proposed therapeutic strategies to arrest demyelination and/or promote further remyelination include: (i) modulation of the host immune system; and/or (ii) transplantation of myelinating/stem or progenitor cells to the circulation or sites of injury. However, significant drawbacks are inherent with both approaches. Cell penetrating peptides (CPP) are short amino acid sequences with an intrinsic ability to translocate across plasma membranes, and theoretically represent an attractive vector for delivery of therapeutic peptides or nanoparticles to glia to promote cell survival or remyelination. The CPPs described to date are commonly non-selective in the cell types they transduce, limiting their therapeutic application in vivo. Here, we describe a theoretical framework for design of a novel CPP sequence that selectively transduces human glial cells (excluding non-glial cell types), and conduct preliminary screens of purified, recombinant CPPs with immature and matured human oligodendrocytes and astrocytes, and two non-glial cell types. A candidate peptide, termed TD2.2, consistently transduced glial cells, was significantly more effective at transducing immature oligodendrocytes than matured progeny, and was virtually incapable of transducing two non-glial cell types: (i) human neural cells and (ii) human dermal fibroblasts. Time-lapse confocal microscopy confirms trafficking of TD2.2 (fused to EGFP) to mature oligodendrocytes 3-6 hours after protein application in vitro. We propose selectivity of TD2.2 for glial cells represents a new therapeutic strategy for the treatment of glial-related disease, such as MS.	[Heffernan, Corey; Sumer, Huseyin; Verma, Paul J.] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Reprogramming & Stem Cell Lab, Clayton, Vic, Australia; [Manuelpillai, Ursula] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Placental Stem Cell Lab, Clayton, Vic, Australia; [Guillemin, Gilles J.] Univ New S Wales, Dept Pharmacol, Sydney, NSW, Australia; [Verma, Paul J.] S Australian Res & Dev Ind, Turretfield Res Ctr, Rosedale, SA, Australia	Monash University; Monash University; University of New South Wales Sydney	Verma, PJ (corresponding author), Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Reprogramming & Stem Cell Lab, Clayton, Vic, Australia.	Paul.Verma@monash.edu	Verma, Paul/AAQ-4657-2021; Guillemin, Gilles J/C-3878-2015	Guillemin, Gilles J/0000-0001-8105-4470; Sumer, Huseyin/0000-0001-9413-5579	Victorian Government's Operational Infrastructure Support Program; Australian Stem Cell Centre iPS Program Grant; Harold Mitchell Foundation; Australian National Health & Medical Research Council (NHMRC); NHMRC Grant [606473]	Victorian Government's Operational Infrastructure Support Program; Australian Stem Cell Centre iPS Program Grant; Harold Mitchell Foundation; Australian National Health & Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Grant(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported by the Victorian Government's Operational Infrastructure Support Program, and funded by Australian Stem Cell Centre iPS Program Grant and Harold Mitchell Foundation. Personal postgraduate funding for CH and research support for GJG was provided by Australian National Health & Medical Research Council (NH&MRC). UM supported by NH&MRC Grant #606473. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas Y, 2005, BIOCONJUGATE CHEM, V16, P1503, DOI 10.1021/bc050217o; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Back SA, 2005, NAT MED, V11, P966, DOI 10.1038/nm1279; Benn SC, 2005, J NEUROCHEM, V95, P1118, DOI 10.1111/j.1471-4159.2005.03459.x; BORROW P, 1992, J VIROL, V66, P7270, DOI 10.1128/JVI.66.12.7270-7281.1992; BOWIE JU, 1989, J BIOL CHEM, V264, P7596; Buntinx M, 2003, J NEUROCYTOL, V32, P25, DOI 10.1023/A:1027324230923; Chian RJ, 2009, BRAIN RES, V1287, P1, DOI 10.1016/j.brainres.2009.06.066; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188; Efthymiadis A, 1998, J BIOL CHEM, V273, P1623, DOI 10.1074/jbc.273.3.1623; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; Goyal A, 2000, BIOCHEM J, V345, P247, DOI 10.1042/0264-6021:3450247; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Heffernan C, 2012, STEM CELLS IN PRESS; Heffernan C, 2010, REPROD FERT DEVELOP, V22, P1022, DOI 10.1071/RD09265; Huang JK, 2011, NAT NEUROSCI, V14, P45, DOI 10.1038/nn.2702; Ichimura K, 2009, NEURO-ONCOLOGY, V11, P341, DOI 10.1215/15228517-2009-025; Johansson HJ, 2011, METHODS MOL BIOL, V683, P233, DOI 10.1007/978-1-60761-919-2_17; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; Larsen KE, 2006, BRAIN RES, V1120, P1, DOI 10.1016/j.brainres.2006.08.079; Lim C. K., 2007, INT C SER, V1304, P213, DOI [10.1016/j.ics.2007.07.011, DOI 10.1016/J.ICS.2007.07.011]; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Maginnis MS, 2009, SEMIN CANCER BIOL, V19, P261, DOI 10.1016/j.semcancer.2009.02.013; McCandless EE, 2009, J IMMUNOL, V183, P613, DOI 10.4049/jimmunol.0802258; MCLAURIN J, 1995, J NEUROBIOL, V26, P283, DOI 10.1002/neu.480260212; Milward E, 2008, J NEUROIMMUNOL, V193, P140, DOI 10.1016/j.jneuroim.2007.11.001; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Pan CY, 2010, MOL BIOL REP, V37, P2117, DOI 10.1007/s11033-009-9680-6; Rambukkana A, 2003, P NATL ACAD SCI USA, V100, P16071, DOI 10.1073/pnas.2232366100; Ravichandran V, 2006, PROTEOMICS, V6, P5628, DOI 10.1002/pmic.200600261; Ren ZH, 2011, J NEUROSCI, V31, P8329, DOI 10.1523/JNEUROSCI.1028-11.2011; Rusnati M, 1999, J BIOL CHEM, V274, P28198, DOI 10.1074/jbc.274.40.28198; Sawant R, 2010, MOL BIOSYST, V6, P628, DOI 10.1039/b916297f; Sgambato A, 2003, AM J PATHOL, V162, P849, DOI 10.1016/S0002-9440(10)63881-3; Song JH, 2006, J NEUROSCI, V26, P3299, DOI 10.1523/JNEUROSCI.5572-05.2006; Stork R, 2007, PROTEIN ENG DES SEL, V20, P569, DOI 10.1093/protein/gzm061; Sullivan BM, 2011, P NATL ACAD SCI USA, V108, P2969, DOI 10.1073/pnas.1019304108; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Yamada H, 1996, J BIOL CHEM, V271, P23418, DOI 10.1074/jbc.271.38.23418; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	44	11	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45501	10.1371/journal.pone.0045501	http://dx.doi.org/10.1371/journal.pone.0045501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049807	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100052
J	Jangpatarapongsa, K; Xia, H; Fang, Q; Hu, KM; Yuan, YY; Peng, MY; Gao, Q; Sattabongkot, J; Cui, LW; Li, BQ; Udomsangpetch, R				Jangpatarapongsa, Kulachart; Xia, Hui; Fang, Qiang; Hu, Kaiming; Yuan, Yuanying; Peng, Meiyu; Gao, Qi; Sattabongkot, Jetsumon; Cui, Liwang; Li, Baiqing; Udomsangpetch, Rachanee			Immunity to Malaria in Plasmodium vivax Infection: A Study in Central China	PLOS ONE			English	Article							REGULATORY T-CELLS; ASEXUAL BLOOD STAGES; IN-VITRO GROWTH; FALCIPARUM MALARIA; ACQUIRED-IMMUNITY; DENDRITIC CELLS; B-CELLS; GAMMA; ANTIGENS; LYMPHOCYTES	Background: P. vivax infection is characterised by relapsing fever, indicating reinfection by previously hidden parasites in the host. Relapsed infection can lead to the activation of the memory T cell pool, which may lead to protective immunity. This study aims to characterise immune responses in acute P. vivax-infected patients living in an area of central China characterised by only P. vivax infection. Methodology/Principal Findings: We conducted a cross-sectional immune-phenotypic analysis of adults using the following inclusion criteria: acute P. vivax infection (N = 37), a history of P. vivax infection (N = 17), and no known history of P. vivax infection (N = 21). We also conducted a 2-week longitudinal analysis following acute P. vivax infection, in which PBMC proliferation was measured in response to P. vivax and P. falciparum blood stage lysates. Using flow cytometry, we showed elevated memory T cells in the blood during acute P. vivax infection. The levels of gamma delta T cells were two-fold higher than those measured in naive controls. This result suggested that in the two populations, memory and gamma delta T cells promptly responded to P. vivax parasites. Interestingly, P. falciparum antigens stimulated T cells obtained from P. vivax-infected patients during a day 14-convalescence, whereas lymphocytes from the naive control group responded to a lower degree of convalescence. Conclusions/Significance: Cell-mediated immunity during the convalescent period of the P. vivax-infected hosts was comprised of T cells that were specifically able to recognise P. falciparum antigens. Although the magnitude of the response was only half that measured after stimulation with P. vivax antigens, the matter of cross-antigenic stimulation is of great interest.	[Xia, Hui; Fang, Qiang; Li, Baiqing] Bengbu Med Coll, Anhui Key Lab Infect & Immun, Bengbu, Anhui, Peoples R China; [Jangpatarapongsa, Kulachart] Mahidol Univ, Ctr Innovat Dev & Technol Transfer, Fac Med Technol, Bangkok 10700, Thailand; [Jangpatarapongsa, Kulachart] Mahidol Univ, Dept Clin Microbiol & Appl Technol, Fac Med Technol, Bangkok 10700, Thailand; [Xia, Hui; Fang, Qiang; Hu, Kaiming; Yuan, Yuanying] Bengbu Med Coll, Dept Parasitol, Bengbu, Anhui, Peoples R China; [Peng, Meiyu; Li, Baiqing] Bengbu Med Coll, Dept Immunol, Bengbu, Anhui, Peoples R China; [Gao, Qi] Jiangsu Inst Parasit Dis, Wuxi, Peoples R China; [Sattabongkot, Jetsumon] Mahidol Univ, Fac Trop Med, Mahidol Vivax Res Ctr, Bangkok, Thailand; [Cui, Liwang] Penn State Univ, Dept Entomol, State Coll, PA USA; [Udomsangpetch, Rachanee] Mahidol Univ, Fac Sci, Dept Pathobiol, Bangkok 10400, Thailand; [Udomsangpetch, Rachanee] Mahidol Univ, Ctr Neglected Infect Dis, Bangkok 10700, Thailand	Bengbu Medical College; Mahidol University; Mahidol University; Bengbu Medical College; Bengbu Medical College; Mahidol University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Mahidol University; Mahidol University	Li, BQ (corresponding author), Bengbu Med Coll, Anhui Key Lab Infect & Immun, Bengbu, Anhui, Peoples R China.	bb_bqli@yahoo.com; rachanee.udo@mahidol.ac.th	Prachumsri, Jetsumon/AAZ-7732-2021	Jangpatarapongsa, Kulachart/0000-0002-4181-3425; Sattabongkot, Jetsumon/0000-0002-3938-4588	Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; Fogarty International Center, NIH [D43TW006571]; Commission on Higher Education; Thailand Research Fund [BRG498009]; Key Program of Natural Science Foundation of the Anhui Higher Education Institutions [KJ2012A200]; Anhui Provincial Education Department [2004sys008]; FOGARTY INTERNATIONAL CENTER [D43TW006571] Funding Source: NIH RePORTER	Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Commission on Higher Education; Thailand Research Fund(Thailand Research Fund (TRF)); Key Program of Natural Science Foundation of the Anhui Higher Education Institutions; Anhui Provincial Education Department; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; a grant [D43TW006571] funded by the Fogarty International Center, NIH; the Commission on Higher Education to KJ [CHE-RES-PD]; the Thailand Research Fund to RU [BRG498009]; The Key Program of Natural Science Foundation of the Anhui Higher Education Institutions (no. KJ2012A200) to HX; and the key research programme [2004sys008] for Key Lab of Provincial University from Anhui Provincial Education Department to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHIDI EA, 1995, ACTA TROP, V59, P173, DOI 10.1016/0001-706X(95)00076-Q; Artavanis-Tsakonas K, 2002, J IMMUNOL, V169, P2956, DOI 10.4049/jimmunol.169.6.2956; Asito AS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-238; BEHR C, 1992, INT IMMUNOL, V4, P361, DOI 10.1093/intimm/4.3.361; Bergmann ES, 1997, CELL IMMUNOL, V180, P143, DOI 10.1006/cimm.1997.1186; BORDESSOULE D, 1990, J CLIN PATHOL, V43, P461, DOI 10.1136/jcp.43.6.461; Bueno LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009623; Chuangchaiya S, 2010, CLIN EXP IMMUNOL, V160, P233, DOI 10.1111/j.1365-2249.2009.04075.x; Daniel Ribeiro C, 1988, Mem Inst Oswaldo Cruz, V83 Suppl 1, P633, DOI 10.1590/S0074-02761988000500076; DIGGS CL, 1965, EXP PARASITOL, V16, P217, DOI 10.1016/0014-4894(65)90046-9; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Douglas NM, 2011, CLIN INFECT DIS, V52, P612, DOI 10.1093/cid/ciq249; Farouk SE, 2004, EUR J IMMUNOL, V34, P2248, DOI 10.1002/eji.200424861; Goncalves RM, 2010, INFECT IMMUN, V78, P4763, DOI 10.1128/IAI.00578-10; GOODIER M, 1992, INT IMMUNOL, V4, P33, DOI 10.1093/intimm/4.1.33; Hviid L, 2000, INFECT IMMUN, V68, P6087, DOI 10.1128/IAI.68.10.6087-6089.2000; Hviid L, 2005, ACTA TROP, V95, P270, DOI 10.1016/j.actatropica.2005.06.012; Hviid L, 1998, Expert Rev Mol Med, V1998, P1, DOI 10.1017/S1462399498000179; Iriemenam NC, 2009, AFR HEALTH SCI, V9, P66; Jangpatarapongsa K, 2008, EUR J IMMUNOL, V38, P2697, DOI 10.1002/eji.200838186; Jangpatarapongsa K, 2006, MICROBES INFECT, V8, P680, DOI 10.1016/j.micinf.2005.09.003; Kassa D, 2006, CLIN VACCINE IMMUNOL, V13, P376, DOI 10.1128/CVI.13.3.376-379.2006; Kochar DK, 2010, AM J TROP MED HYG, V83, P981, DOI 10.4269/ajtmh.2010.09-0633; KROTOSKI WA, 1980, BMJ-BRIT MED J, V280, P153, DOI 10.1136/bmj.280.6208.153-a; LANDEWE RBM, 1995, CLIN EXP IMMUNOL, V102, P144; Lee HK, 2001, ANN TROP MED PARASIT, V95, P31, DOI 10.1080/00034980020035898; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Lin JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018716; Mavoungou E, 2003, EUR CYTOKINE NETW, V14, P134; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Nogaro SI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025582; Osier FHA, 2007, PARASITE IMMUNOL, V29, P387, DOI 10.1111/j.1365-3024.2007.00951.x; Palmer DR, 2002, EUR J IMMUNOL, V32, P652, DOI 10.1002/1521-4141(200203)32:3<652::AID-IMMU652>3.0.CO;2-9; PERERA MK, 1994, J EXP MED, V179, P311, DOI 10.1084/jem.179.1.311; Qingjun L, 1998, Bull World Health Organ, V76 Suppl 1, P21; Richards MW, 1998, AM J TROP MED HYG, V59, P859, DOI 10.4269/ajtmh.1998.59.859; RILEY EM, 1992, PARASITE IMMUNOL, V14, P321, DOI 10.1111/j.1365-3024.1992.tb00471.x; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Salwati E, 2011, J INFECT DIS, V203, P1192, DOI 10.1093/infdis/jiq166; Sattabongkot J, 2004, TRENDS PARASITOL, V20, P192, DOI 10.1016/j.pt.2004.02.001; SCHULTZ KR, 1995, BLOOD, V86, P4344, DOI 10.1182/blood.V86.11.4344.bloodjournal86114344; Seixas EMG, 1999, J IMMUNOL, V162, P2837; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Snounou G, 2004, TRENDS PARASITOL, V20, P333, DOI 10.1016/j.pt.2004.05.004; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; Srisurapanon S., 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P310; Tasanee P, 2007, INT J PARASITOL, V37, P1551, DOI 10.1016/j.ijpara.2007.05.009; Trager W, 1997, INT J PARASITOL, V27, P989, DOI 10.1016/S0020-7519(97)00080-5; Troye-Blomberg M, 1999, SCAND J IMMUNOL, V50, P642, DOI 10.1046/j.1365-3083.1999.00647.x; Tsuji M, 2010, EXP PARASITOL, V126, P421, DOI 10.1016/j.exppara.2009.11.009; Udomsangpetch R, 2008, TRENDS PARASITOL, V24, P85, DOI 10.1016/j.pt.2007.09.010; Vieira PL, 2004, J IMMUNOL, V172, P5986, DOI 10.4049/jimmunol.172.10.5986; Walther M, 2005, IMMUNITY, V23, P287, DOI 10.1016/j.immuni.2005.08.006; Weiss GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015983; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Wipasa J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001281; Woodberry T, 2008, J INFECT DIS, V198, P134, DOI 10.1086/588711; Zhang WY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-206	59	42	43	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45971	10.1371/journal.pone.0045971	http://dx.doi.org/10.1371/journal.pone.0045971			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049909	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100112
J	La Fleur, L; Johansson, AC; Roberg, K				La Fleur, Linnea; Johansson, Ann-Charlotte; Roberg, Karin			A CD44(high)/EGFR(low) Subpopulation within Head and Neck Cancer Cell Lines Shows an Epithelial-Mesenchymal Transition Phenotype and Resistance to Treatment	PLOS ONE			English	Article							STEM-CELLS; SQUAMOUS CARCINOMA; PANCREATIC-CANCER; INITIATING CELLS; DRUG-RESISTANCE; TUMOR-CELLS; IN-VITRO; IDENTIFICATION; GROWTH; EMT	Mortality in head and neck squamous cell carcinoma (HNSCC) is high due to emergence of therapy resistance which results in local and regional recurrences that may have their origin in resistant cancer stem cells (CSCs) or cells with an epithelial-mesenchymal transition (EMT) phenotype. In the present study, we investigate the possibility of using the cell surface expression of CD44 and epidermal growth factor receptor (EGFR), both of which have been used as stem cell markers, to identify subpopulations within HNSCC cell lines that differ with respect to phenotype and treatment sensitivity. Three subpopulations, consisting of CD44(high)/EGFR(low), CD44(high)/EGFR(high) and CD44(low) cells, respectively, were collected by fluorescence-activated cell sorting. The CD44(high)/EGFR(low) population showed a spindle-shaped EMT-like morphology, while the CD44(low) population was dominated by cobblestone-shaped cells. The CD44(high)/EGFR(low) population was enriched with cells in G0/G1 and showed a relatively low proliferation rate and a high plating efficiency. Using a real time PCR array, 27 genes, of which 14 were related to an EMT phenotype and two with stemness, were found to be differentially expressed in CD44(high)/EGFR(low) cells in comparison to CD44(low) cells. Moreover, CD44(high)/EGFR(low) cells showed a low sensitivity to radiation, cisplatin, cetuximab and gefitinib, and a high sensitivity to dasatinib relative to its CD44(high)/EGFR(high) and CD44(low) counterparts. In conclusion, our results show that the combination of CD44 (high) and EGFR (low) cell surface expression can be used to identify a treatment resistant subpopulation with an EMT phenotype in HNSCC cell lines.	[La Fleur, Linnea; Johansson, Ann-Charlotte; Roberg, Karin] Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Otorhinolaryngol & Head & Neck Surg, Linkoping, Sweden; [Roberg, Karin] Cty Council Ostergotland, UHL, Dept ENT Head & Neck Surg, Linkoping, Sweden	Linkoping University; City Council Ostergotland	Roberg, K (corresponding author), Linkoping Univ, Fac Hlth Sci, Dept Clin & Expt Med, Div Otorhinolaryngol & Head & Neck Surg, Linkoping, Sweden.	karin.roberg@liu.se		Johansson, Ann-Charlotte/0000-0002-5191-8204	Swedish Laryng Foundation; Foundation of Signhild Engkvist; Foundation of Ake Wiberg; Swedish Cancer Society [2008/552, 2010/545]; County Council of Ostergotland; Linkoping University Hospital	Swedish Laryng Foundation; Foundation of Signhild Engkvist; Foundation of Ake Wiberg; Swedish Cancer Society(Swedish Cancer Society); County Council of Ostergotland; Linkoping University Hospital	This study was supported by the Swedish Laryng Foundation, the Foundation of Signhild Engkvist, the Foundation of Ake Wiberg, the Swedish Cancer Society (2008/552, 2010/545), the County Council of Ostergotland and the Research Funds of Linkoping University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; [Anonymous], J NATL CANC I, V98, P1777; Ansell A, 2009, ORAL ONCOL, V45, P866, DOI 10.1016/j.oraloncology.2009.02.008; Arumugam T, 2009, CANCER RES, V69, P5820, DOI 10.1158/0008-5472.CAN-08-2819; Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Biddle A, 2011, CANCER RES, V71, P5317, DOI 10.1158/0008-5472.CAN-11-1059; Chen CYC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015939; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Costello RT, 2000, CANCER RES, V60, P4403; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Farnebo L, 2008, ONCOL REP, V20, P453, DOI 10.3892/or_00000028; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Finn RS, 2007, BREAST CANCER RES TR, V105, P319, DOI 10.1007/s10549-006-9463-x; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Heppner G, 1986, Prog Clin Biol Res, V212, P45; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Holz C, 2011, RADIOTHER ONCOL, V101, P158, DOI 10.1016/j.radonc.2011.05.042; Hsu DSS, 2010, CLIN CANCER RES, V16, P4561, DOI 10.1158/1078-0432.CCR-10-0593; Iwai S, 2010, INT J ONCOL, V37, P1095, DOI 10.3892/ijo_00000761; Jedlinski A, 2012, J ORAL PATHOL MED; Jerhammar F, 2010, CANCER BIOL THER, V10, P1244, DOI 10.4161/cbt.10.12.13432; Jin C, 2002, CANCER GENET CYTOGEN, V132, P85, DOI 10.1016/S0165-4608(01)00535-0; Le Roy H, 2010, STEM CELLS DEV, V19, P209, DOI 10.1089/scd.2009.0150; Leutenegger CM, 1999, VET IMMUNOL IMMUNOP, V71, P291, DOI 10.1016/S0165-2427(99)00100-2; Locke M, 2005, CANCER RES, V65, P8944, DOI 10.1158/0008-5472.CAN-05-0931; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Okamoto A, 2009, ORAL ONCOL, V45, P633, DOI 10.1016/j.oraloncology.2008.10.003; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Prince MEP, 2008, J CLIN ONCOL, V26, P2871, DOI 10.1200/JCO.2007.15.1613; Roberg K, 2008, DIFFERENTIATION, V76, P868, DOI 10.1111/j.1432-0436.2008.00267.x; Shibata SI, 2009, INT J ONCOL, V34, P1433, DOI 10.3892/ijo_00000272; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Skvortsova I, 2010, RADIOTHER ONCOL, V96, P108, DOI 10.1016/j.radonc.2010.04.017; Theys J, 2011, RADIOTHER ONCOL, V99, P392, DOI 10.1016/j.radonc.2011.05.044; Wang XH, 2006, ORAL ONCOL, V42, P740, DOI 10.1016/j.oraloncology.2005.11.018	42	43	46	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44071	10.1371/journal.pone.0044071	http://dx.doi.org/10.1371/journal.pone.0044071			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049743	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100010
J	Tsai, YL; Wang, HTT; Chang, HFG; Tsai, CF; Lin, CK; Teng, PH; Su, C; Jeng, CC; Lee, PY				Tsai, Yun-Long; Wang, Hwa-Tang Thomas; Chang, Hsiao-Fen Grace; Tsai, Chuan-Fu; Lin, Ching-Ko; Teng, Ping-Hua; Su, Chen; Jeng, Chien-Chung; Lee, Pei-Yu			Development of TaqMan Probe-Based Insulated Isothermal PCR (iiPCR) for Sensitive and Specific On-Site Pathogen Detection	PLOS ONE			English	Article							SPOT SYNDROME VIRUS; NUCLEIC-ACID AMPLIFICATION; TIME QUANTITATIVE PCR; DNA; POLYMERASE; CONVECTION; DIAGNOSIS; BACTERIA; MINUTES; PRODUCT	Insulated isothermal PCR (iiPCR), established on the basis of Ralyeigh-Benard convection, is a rapid and low-cost platform for nucleic acid amplification. However, the method used for signal detection, namely gel electrophoresis, has limited the application of iiPCR. In this study, TaqMan probe-based iiPCR system was developed to obviate the need of post-amplification processing. This system includes an optical detection module, which was designed and integrated into the iiPCR device to detect fluorescent signals generated by the probe. TaqMan probe-iiPCR assays targeting white spot syndrome virus (WSSV) and infectious myonecrosis virus were developed for preliminary evaluation of this system. Significant elevation of fluorescent signals was detected consistently among positive iiPCR reactions in both assays, correlating with amplicon detection by gel electrophoresis analysis. After condition optimization, a threshold value of S/N (fluorescent intensity(after)/fluorescent intensity(before)) for positive reactions was defined for WSSV TaqMan probe-iiPCR on the basis of 20 blank reactions. WSSV TaqMan probe-iiPCR generated positive S/Ns from as low as 10 1 copies of standard DNA and lightly infected Litopenaeus vannamei. Compared with an OIE-certified nested PCR, WSSV TaqMan probe-iiPCR showed a sensitivity of 100% and a specificity of 96.67% in 120 WSSV-free or lightly infected shrimp samples. Generating positive signals specifically and sensitively, TaqMan probe-iiPCR system has a potential as a low-cost and rapid on-site diagnostics method.	[Lee, Pei-Yu] Cent Taiwan Univ Sci & Technol, Inst Med Biotechnol, Taichung, Taiwan; [Tsai, Yun-Long; Wang, Hwa-Tang Thomas; Chang, Hsiao-Fen Grace; Tsai, Chuan-Fu; Lin, Ching-Ko; Teng, Ping-Hua; Su, Chen] GeneReach Biotechnol Corp, Dept Res & Dev, Taichung, Taiwan; [Jeng, Chien-Chung] Natl Chung Hsing Univ, Inst Nanosci, Taichung 40227, Taiwan; [Jeng, Chien-Chung] Natl Chung Hsing Univ, Dept Phys, Taichung 40227, Taiwan	Central Taiwan University Science & Technology; National Chung Hsing University; National Chung Hsing University	Lee, PY (corresponding author), Cent Taiwan Univ Sci & Technol, Inst Med Biotechnol, Taichung, Taiwan.	pylee@ctust.edu.tw			Taiwan National Science Council (NSC) grant [NSC 99-2112-M-005-006-MY3]; NSC-Central Taiwan Science Park grant [NSC-CTSP 302403501]	Taiwan National Science Council (NSC) grant; NSC-Central Taiwan Science Park grant	This study was supported by the Taiwan National Science Council (NSC) grant NSC 99-2112-M-005-006-MY3 to CCJ, and NSC-Central Taiwan Science Park grant NSC-CTSP 302403501 to GeneReach Biotechnology Corporation (http://web1.nsc.gov.tw/mp.aspx?mp=1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AM, 2004, ANNU REV PHYTOPATHOL, V42, P339, DOI 10.1146/annurev.phyto.42.040803.140329; Arya M, 2005, EXPERT REV MOL DIAGN, V5, P209, DOI 10.1586/14737159.5.2.209; Belgrader P, 1999, SCIENCE, V284, P449, DOI 10.1126/science.284.5413.449; Briese T, 2005, EMERG INFECT DIS, V11, P310, DOI 10.3201/eid1102.040492; Chang HFG, 2012, BIOTECHNOL J, V7, P662, DOI 10.1002/biot.201100453; Chou WP, 2011, BIOTECHNIQUES, V50, P52, DOI 10.2144/000113589; Dwivedi HP, 2011, CRIT REV MICROBIOL, V37, P40, DOI 10.3109/1040841X.2010.506430; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Hameed ASS, 2003, DIS AQUAT ORGAN, V57, P157, DOI 10.3354/dao057157; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Krishnan M, 2002, SCIENCE, V298, P793, DOI 10.1126/science.298.5594.793; Krishnan N, 2004, ANAL CHEM, V76, P6254, DOI 10.1021/ac049323u; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Lo CF, 1996, DIS AQUAT ORGAN, V27, P215, DOI 10.3354/dao027215; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Mahony JB, 2010, EXPERT REV ANTI-INFE, V8, P1273, DOI [10.1586/eri.10.121, 10.1586/ERI.10.121]; Musthaq SS, 2006, J INVERTEBR PATHOL, V93, P75, DOI 10.1016/j.jip.2006.06.006; Neuzil P, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl416; Stone HA, 2004, ANNU REV FLUID MECH, V36, P381, DOI 10.1146/annurev.fluid.36.050802.122124; Tsai YL, 2012, J VIROL METHODS, V181, P134, DOI 10.1016/j.jviromet.2012.01.017; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Wang X, 2006, HIGH THROUGHPUT PRIM; Zhang CS, 2007, NUCLEIC ACIDS RES, V35, P4223, DOI 10.1093/nar/gkm389	25	68	78	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45278	10.1371/journal.pone.0045278	http://dx.doi.org/10.1371/journal.pone.0045278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049781	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100035
J	Yan, H; Tian, L; Yan, J; Sun, W; Liu, Q; Zhang, YB; Li, XM; Zang, YF; Zhang, D				Yan, Hao; Tian, Lin; Yan, Jun; Sun, Wei; Liu, Qi; Zhang, Yan-Bo; Li, Xin-Ming; Zang, Yu-Feng; Zhang, Dai			Functional and Anatomical Connectivity Abnormalities in Cognitive Division of Anterior Cingulate Cortex in Schizophrenia	PLOS ONE			English	Article							EARLY-ONSET SCHIZOPHRENIA; DIFFUSION-TENSOR MRI; IN-VIVO MORPHOMETRY; RESTING-STATE FMRI; HUMAN BRAIN; 1ST-EPISODE SCHIZOPHRENIA; 1ST-DEGREE RELATIVES; CEREBRAL ASYMMETRY; BASAL GANGLIA; DEFAULT MODE	Introduction: Current pathophysiological theories of schizophrenia highlight the role of altered brain functional and anatomical connectivity. The cognitive division of anterior cingulate cortex (ACC-cd) is a commonly reported abnormal brain region in schizophrenia for its importance in cognitive control process. The aim of this study was to investigate the functional and anatomical connectivity of ACC-cd and its cognitive and clinical manifestation significance in schizophrenia by using the resting-state functional magnetic resonance imaging (fMRI) and the diffusion tensor imaging (DTI). Methods: Thirty-three medicated schizophrenics and 30 well-matched health controls were recruited. Region-of-interest (ROI)-based resting-state functional connectivity analysis and Tract-Based Spatial Statistics (TBSS) were performed on 30 patients and 30 controls, and 24 patients and 29 controls, respectively. The Pearson correlation was performed between the imaging measures and the Stroop performance and scores of the Positive and Negative Syndrome Scale (PANSS), respectively. Results: Patients with schizophrenia showed significantly abnormal in the functional connectivity and its hemispheric asymmetry of the ACC-cd with multiple brain areas, e. g., decreased positive connectivity with the bilateral putamen and caudate, increased negative connectivity with the left posterior cingulated cortex (PCC), increased asymmetry of connectivity strength with the contralateral inferior frontal gyrus (IFG). The FA of the right anterior cingulum was significantly decreased in patients group (p = 0.014). The abnormal functional and structural connectivity of ACC-cd were correlated with Stroop performance and the severity of the symptoms in patients. Conclusions: Our results suggested that the abnormal connectivity of the ACC-cd might play a role in the cognitive impairment and clinical symptoms in schizophrenia.	[Yan, Hao; Tian, Lin; Yan, Jun; Sun, Wei; Liu, Qi; Zhang, Dai] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Yan, Hao; Tian, Lin; Yan, Jun; Sun, Wei; Liu, Qi; Zhang, Dai] Minist Hlth, Key Lab Mental Hlth, Beijing, Peoples R China; [Zhang, Yan-Bo; Li, Xin-Ming] Univ Saskatchewan, Dept Psychiat, Saskatoon, SK S7N 0W0, Canada; [Zhang, Yan-Bo; Li, Xin-Ming] Univ Manitoba, Dept Psychiat, Winnipeg, MB R3T 2N2, Canada; [Zang, Yu-Feng] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Zang, Yu-Feng] Hangzhou Normal Univ, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Zang, Yu-Feng] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Dai] Tsinghua Univ, Peking Tsinghua Ctr Life Sci, Beijing 100084, Peoples R China	Peking University; University of Saskatchewan; University of Manitoba; Hangzhou Normal University; Hangzhou Normal University; Beijing Normal University; Tsinghua University	Zhang, D (corresponding author), Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China.	daizhang@bjmu.edu.cn	ZANG, Yu-Feng/J-1558-2012; Yan, Hao/U-1330-2017	ZANG, Yu-Feng/0000-0003-1833-8010; Yan, Hao/0000-0003-0376-9037	International Science & Technology Cooperation Program of China [2010DFB30820]; National Basic Research Program of China [2011CB707805]; National Natural Science Foundation of China [81000580, 81071088]; Specialized Research Fund for the Doctoral Program of Higher Education [20100001120120]	International Science & Technology Cooperation Program of China; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the International Science & Technology Cooperation Program of China (2010DFB30820 to D.Z.), the National Basic Research Program of China (2011CB707805 to J.Y.), the National Natural Science Foundation of China (81000580 to H.Y., 81071088 to D.Z.), and Specialized Research Fund for the Doctoral Program of Higher Education (20100001120120 to H.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams Rick, 2007, Neuropsychiatr Dis Treat, V3, P87, DOI 10.2147/nedt.2007.3.1.87; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Artiges E, 2000, SCHIZOPHRENIA BULL, V26, P709, DOI 10.1093/oxfordjournals.schbul.a033488; Baiano M, 2007, SCHIZOPHR RES, V93, P1, DOI 10.1016/j.schres.2007.02.012; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brune M, 2005, SCHIZOPHRENIA BULL, V31, P21, DOI 10.1093/schbul/sbi002; BUCHSBAUM MS, 1990, SCHIZOPHRENIA BULL, V16, P377, DOI 10.1093/schbul/16.3.377; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Camchong J, 2011, SCHIZOPHRENIA BULL, V37, P640, DOI 10.1093/schbul/sbp131; Carter CS, 2001, AM J PSYCHIAT, V158, P1423, DOI 10.1176/appi.ajp.158.9.1423; COMALLI PE, 1962, J GENET PSYCHOL, V100, P47, DOI 10.1080/00221325.1962.10533572; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Eisenberg DP, 2010, NEUROPSYCHOPHARMACOL, V35, P258, DOI 10.1038/npp.2009.111; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; FORNITO A, 2008, SCHIZOPHR B; Fox M, 2009, J NEUROPHYSIOL; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; Hadjulis M, 2004, BIOL PSYCHIAT, V55, P148, DOI 10.1016/S0006-3223(02)01905-4; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Huster RJ, 2007, NEUROIMAGE, V34, P888, DOI 10.1016/j.neuroimage.2006.10.023; Kawasaki Y, 2008, BIOL PSYCHIAT, V63, P793, DOI 10.1016/j.biopsych.2007.08.008; Kubicki M, 2003, BIOL PSYCHIAT, V54, P1171, DOI 10.1016/S0006-3223(03)00419-0; Lang DJ, 2006, SCHIZOPHR RES, V87, P89, DOI 10.1016/j.schres.2006.05.002; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Liang M, 2006, NEUROREPORT, V17, P209, DOI 10.1097/01.wnr.0000198434.06518.b8; Lombardo MV, 2010, J COGNITIVE NEUROSCI, V22, P1623, DOI 10.1162/jocn.2009.21287; Lui S, 2009, AM J PSYCHIAT, V166, P196, DOI 10.1176/appi.ajp.2008.08020183; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Margulies DS, 2007, NEUROIMAGE, V37, P579, DOI 10.1016/j.neuroimage.2007.05.019; Matsui M, 2008, PROG NEURO-PSYCHOPH, V32, P280, DOI 10.1016/j.pnpbp.2007.08.019; Meda SA, 2012, BIOL PSYCHIAT, V71, P881, DOI 10.1016/j.biopsych.2012.01.025; Milham MP, 2005, HUM BRAIN MAPP, V25, P328, DOI 10.1002/hbm.20110; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Park HJ, 2004, NEUROIMAGE, V23, P213, DOI 10.1016/j.neuroimage.2004.04.036; Paus T, 1996, J COMP NEUROL, V376, P664, DOI 10.1002/(SICI)1096-9861(19961223)376:4<664::AID-CNE12>3.0.CO;2-M; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sallet PC, 2003, PSYCHIAT RES-NEUROIM, V123, P65, DOI 10.1016/S0925-4927(03)00020-9; Seeley WW, 2009, NEURON, V62, P42, DOI 10.1016/j.neuron.2009.03.024; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Skudlarski P, 2010, BIOL PSYCHIAT, V68, P61, DOI 10.1016/j.biopsych.2010.03.035; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Steinmetz H, 1996, NEUROSCI BIOBEHAV R, V20, P587, DOI 10.1016/0149-7634(95)00071-2; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Stricker NH, 2009, NEUROIMAGE, V45, P10, DOI 10.1016/j.neuroimage.2008.11.027; Sun ZG, 2003, NEUROREPORT, V14, P1833, DOI 10.1097/00001756-200310060-00015; Tang JS, 2010, BRAIN RES, V1343, P199, DOI 10.1016/j.brainres.2010.04.083; Tian L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028794; Wang F, 2004, AM J PSYCHIAT, V161, P573, DOI 10.1176/appi.ajp.161.3.573; Wang F, 2009, J PSYCHIATR NEUROSCI, V34, P181; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Yucel M, 2002, BIOL PSYCHIAT, V52, P15, DOI 10.1016/S0006-3223(02)01312-4; Yucel M, 2003, BRIT J PSYCHIAT, V182, P518, DOI 10.1192/bjp.182.6.518; Zetzsche T, 2007, SCHIZOPHR RES, V96, P34, DOI 10.1016/j.schres.2007.07.027; Zhou Y, 2007, SCHIZOPHR RES; Zhou Y, 2007, NEUROSCI LETT, V417, P297, DOI 10.1016/j.neulet.2007.02.081; Zou LQ, 2008, ACAD RADIOL, V15, P285, DOI 10.1016/j.acra.2007.09.026	70	66	67	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45659	10.1371/journal.pone.0045659	http://dx.doi.org/10.1371/journal.pone.0045659			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049832	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100065
J	You, G; Yan, W; Zhang, W; Wang, YZ; Bao, ZS; Li, SW; Li, SW; Li, GL; Song, YJ; Kang, CS; Jiang, T				You, Gan; Yan, Wei; Zhang, Wei; Wang, Yongzhi; Bao, Zhaoshi; Li, Shouwei; Li, Shaowu; Li, Guilin; Song, Yijun; Kang, Chunsheng; Jiang, Tao			Significance of miR-196b in Tumor-Related Epilepsy of Patients with Gliomas	PLOS ONE			English	Article							EXPRESSION LEVELS; IMMUNE-RESPONSE; MICRORNAS; SEIZURES; GLIOBLASTOMA; CANCER; INFLAMMATION; SURVIVAL; DISEASE; MIRNAS	Objectives: Seizure is a common presenting symptom of primary brain tumors. There are no published studies regarding the roles of MicroRNA (miRNA) in tumor-related epilepsy. The authors set out to correlate miR-196b expression in low-grade glioma patients with pre-operative seizures and post-operative seizure control. Methods: Twenty-three patients with WHO grade II astrocytomas and 83 similar patients for independent validation were included. Follow-up visits regarding seizure prognosis were scheduled at 6 months. MiRNA profiling was used to identify differentially expressed miRNAs. The most important miRNA was determined by quantitative reverse-transcriptase polymerase chain reaction (q-PCR) in the validation cohort. Gene ontology (GO) analysis and whole genome mRNA profiling was performed to investigate the underlying biological processes. Results: Array results showed that 30 miRNAs were overexpressed and 10 miRNAs were underexpressed (with more than 2 fold change) in patients with pre-operative seizures. MiR-196b was validated in the independent validation cohort. Patients with good seizure prognosis exhibited low levels of miR-196b expression compared with those who had poor seizure prognosis in the group without pre-operative seizures. Biological processes that relate to transcription and cell cycles were over-represented in the miR-196b-associated gene expression signature. MiR-196b-associated gene expression profiling was characterized by enrichment of genes usually involved in cell proliferation. Conclusions: We have provided the first evidence that expression of miR-196b was associated with the occurrence of pre-operative seizures in low-grade gliomas, and may predict seizure prognosis in patients without pre-operative seizures. Targeted treatments that decrease endogenous levels of miR-196b might represent novel therapeutic strategies.	[You, Gan; Yan, Wei; Zhang, Wei; Wang, Yongzhi; Bao, Zhaoshi; Jiang, Tao] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Song, Yijun; Kang, Chunsheng] Tianjin Med Univ, Gen Hosp, Lab Neurooncol, Dept Neurosurg,Tianjin Neurol Inst, Tianjin, Peoples R China; [Li, Shouwei; Jiang, Tao] Capital Med Univ, Beijing Sanbo Brain Hosp, Dept Neurosurg, Beijing, Peoples R China; [Li, Shaowu] Capital Med Univ, Beijing Tiantan Hosp, Dept Neuroradiol, Beijing, Peoples R China; [Li, Guilin] Beijing Neurosurg Inst, Dept Neuropathol, Beijing, Peoples R China	Capital Medical University; Tianjin Medical University; Capital Medical University; Capital Medical University; Beijing Neurosurgical Institute	Jiang, T (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China.	taojiang1964@yahoo.com.cn	jiang, tao/GWC-7108-2022; Kang, Chunsheng/AAM-5979-2021; Jiang, Tao/N-8142-2014	Kang, Chunsheng/0000-0002-3255-3369; Li, Shouwei/0000-0003-3320-2517	National High Technology Research and Development Program of China [2012AA02A508]; International Cooperation Program [2012DFA30470]; National Basic Research Program of China [2010CB529406]; National Natural Science Foundation of China [81201993]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); International Cooperation Program; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National High Technology Research and Development Program of China (No. 2012AA02A508), the International Cooperation Program (No. 2012DFA30470), the National Basic Research Program of China (No. 2010CB529406), and the National Natural Science Foundation of China (No. 81201993). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica E, 2010, EUR J NEUROSCI, V31, P1100, DOI 10.1111/j.1460-9568.2010.07122.x; Baraniskin A, 2012, NEURO-ONCOLOGY, V14, P29, DOI 10.1093/neuonc/nor169; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Braig S, 2010, CELL MOL LIFE SCI, V67, P3535, DOI 10.1007/s00018-010-0394-7; Chaichana KL, 2009, J NEUROSURG, V111, P282, DOI 10.3171/2009.2.JNS081132; Chang EF, 2008, J NEUROSURG, V108, P227, DOI 10.3171/JNS/2008/108/2/0227; Danfors T, 2009, EUR J NEUROL, V16, P823, DOI 10.1111/j.1468-1331.2009.02599.x; Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x; Eyal S, 2004, EPILEPSIA, V45, P737, DOI 10.1111/j.0013-9580.2004.00104.x; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Guan YL, 2010, CLIN CANCER RES, V16, P4289, DOI 10.1158/1078-0432.CCR-10-0207; Hebert SS, 2007, SCIENCE, V317, P1179, DOI 10.1126/science.1148530; Hu K, 2011, NEUROSCI LETT, V488, P252, DOI 10.1016/j.neulet.2010.11.040; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Lakomy R, 2011, CANCER SCI, V102, P2186, DOI 10.1111/j.1349-7006.2011.02092.x; Lee JW, 2010, ARCH NEUROL-CHICAGO, V67, P336, DOI 10.1001/archneurol.2010.2; Leighton C, 1997, J CLIN ONCOL, V15, P1294, DOI 10.1200/JCO.1997.15.4.1294; Li XN, 2005, MOL CANCER THER, V4, P1912, DOI 10.1158/1535-7163.MCT-05-0184; Li Y, 2010, CANCER RES, V70, P7894, DOI 10.1158/0008-5472.CAN-10-1675; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Ma RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038096; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Pauley KM, 2009, J AUTOIMMUN, V32, P189, DOI 10.1016/j.jaut.2009.02.012; Pedersen I, 2008, CYTOKINE, V43, P391, DOI 10.1016/j.cyto.2008.07.016; Schaller B, 2003, EPILEPSIA, V44, P1223, DOI 10.1046/j.1528-1157.2003.05203.x; Song YJ, 2011, BRAIN RES, V1387, P134, DOI 10.1016/j.brainres.2011.02.073; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Weller M, 2011, NEUROLOGY, V77, P1156, DOI 10.1212/WNL.0b013e31822f02e1; Williams AE, 2008, BIOCHEM SOC T, V36, P1211, DOI 10.1042/BST0361211; Xia HP, 2009, BIOCHEM BIOPH RES CO, V380, P205, DOI 10.1016/j.bbrc.2008.12.169	32	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46218	10.1371/journal.pone.0046218	http://dx.doi.org/10.1371/journal.pone.0046218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049982	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100156
J	Stubendorff, K; Aarsland, D; Minthon, L; Londos, E				Stubendorff, Kajsa; Aarsland, Dag; Minthon, Lennart; Londos, Elisabet			The Impact of Autonomic Dysfunction on Survival in Patients with Dementia with Lewy Bodies and Parkinson's Disease with Dementia	PLOS ONE			English	Article							QUALITY-OF-LIFE; ORTHOSTATIC HYPOTENSION; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; NONMOTOR SYMPTOMS; ORGANIC DEMENTIA; BLOOD-PRESSURE; PROGRESSION; DIAGNOSIS; PREDICTORS	Introduction: Autonomic dysfunction is a well-known feature in neurodegenerative dementias, especially common in alpha-synucleinopathies like dementia with Lewy bodies and Parkinson's disease with dementia. The most common symptoms are orthostatic hypotension, incontinence and constipation, but its relevance in clinical practice is poorly understood. There are no earlier studies addressing the influence of autonomic dysfunction on clinical course and survival. The aim of this study was to investigate the frequency of the three most common features of autonomic dysfunction and analyze how it affects survival. Methods: Thirty patients with dementia with Lewy bodies and Parkinson's disease with dementia were included in this prospective, longitudinal follow-up study. Presence of incontinence and constipation was recorded at baseline. Blood pressure was measured at baseline, after 3 months and after 6 months according to standardized procedures, with 5 measurements during 10 minutes after rising. Orthostatic hypotension was defined using consensus definitions and persistent orthostatic hypotension was defined as 5 or more measurements with orthostatic hypotension. Difference in survival was analyzed 36 months after baseline. Results: There was a high frequency of persistent orthostatic blood pressure (50%), constipation (30%) and incontinence (30%). Patients with persistent orthostatic hypotension had a significantly shorter survival compared to those with no or non-persistent orthostatic hypotension (Log rank x(2) = 4.47, p = 0.034). Patients with constipation and/or urinary incontinence, in addition to persistent orthostatic hypotension, had a poorer prognosis compared to those with isolated persistent orthostatic hypotension or no orthostatic hypotension (Log rank x(2) = 6.370, p = 0.041). Discussion: According to our findings, the identification of autonomic dysfunction seems to be of great importance in clinical practice, not only to avoid falls and other complications, but also as a possible predictor of survival.	[Stubendorff, Kajsa; Minthon, Lennart; Londos, Elisabet] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Malmo, Sweden; [Aarsland, Dag] Stavanger Univ Hosp, Ctr Age Related Med, Stavanger, Norway; [Aarsland, Dag] Karolinska Inst, Alzheimers Dis Res Ctr, Dept Neurobiol Ward & Soc, Stockholm, Sweden	Lund University; Stavanger University Hospital; Karolinska Institutet	Stubendorff, K (corresponding author), Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Malmo, Sweden.	Kajsa.Stubendorff@med.lu.se		Aarsland, Dag/0000-0001-6314-216X	Swedish Research Council [523-2010-520]; Swedish Parkinson Foundation; H. Lundbeck A/S; Novartis; GE Healthcare; Merck-Serono	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Parkinson Foundation; H. Lundbeck A/S; Novartis(Novartis); GE Healthcare(General ElectricGE Healthcare); Merck-Serono(Merck & Company)	Swedish Research Council (nr 523-2010-520) and the Swedish Parkinson Foundation gave financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare the following interests: D.A. has received honoraria and research support from H. Lundbeck A/S, Novartis, GE Healthcare and Merck-Serono. E.L. has received honoraria from H. Lundbeck A/S and Novartis for lectures. K.S. and L.M. have no conflicts of interest to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, and the authors have declared that no other competing interests exist.	Aarsland D, 2009, LANCET NEUROL, V8, P613, DOI 10.1016/S1474-4422(09)70146-2; Allan LM, 2007, J NEUROL NEUROSUR PS, V78, P671, DOI 10.1136/jnnp.2006.102343; Andersson M, 2008, INT J GERIATR PSYCH, V23, P192, DOI 10.1002/gps.1861; Arbogast SD, 2009, AM J MED, V122, P574, DOI 10.1016/j.amjmed.2008.10.040; Ballard C, 2001, INT J GERIATR PSYCH, V16, P499, DOI 10.1002/gps.381; Bostrom F, 2007, ALZ DIS ASSOC DIS, V21, P150, DOI 10.1097/WAD.0b013e318065c4a9; Bostrom F, 2009, DEMENT GERIATR COGN, V28, P314, DOI 10.1159/000249145; Campbell S, 2001, DRUG AGING, V18, P397, DOI 10.2165/00002512-200118060-00002; Chaudhuri KR, 2006, MOVEMENT DISORD, V21, P916, DOI 10.1002/mds.20844; Chaudhuri KR, 2006, LANCET NEUROL, V5, P235, DOI 10.1016/S1474-4422(06)70373-8; El Assaad MA, 2003, BLOOD PRESS MONIT, V8, P127, DOI 10.1097/00126097-200306000-00006; Findley L, 2002, MOVEMENT DISORD, V17, P60; Gelinas I, 1999, AM J OCCUP THER, V53, P471, DOI 10.5014/ajot.53.5.471; Gray WK, 2009, MOVEMENT DISORD, V24, P2432, DOI 10.1002/mds.22834; Hanyu H, 2009, EUR J NEUROL, V16, P212, DOI 10.1111/j.1468-1331.2008.02388.x; Heims HC, 2006, CLIN AUTON RES, V16, P113, DOI 10.1007/s10286-006-0318-7; Helmes E, 2003, DEMENT GERIATR COGN, V15, P67, DOI 10.1159/000067969; Horimoto Y, 2003, J NEUROL, V250, P530, DOI 10.1007/s00415-003-1029-9; Jellinger KA, 2007, NEURODEGENER DIS, V4, P428, DOI 10.1159/000107703; Kenny RAM, 2002, ANN NY ACAD SCI, V977, P183, DOI 10.1111/j.1749-6632.2002.tb04816.x; Kovari E, 2009, BRAIN RES BULL, V80, P203, DOI 10.1016/j.brainresbull.2009.06.018; Lippa CF, 2007, NEUROLOGY, V68, P812, DOI 10.1212/01.wnl.0000256715.13907.d3; Lopez OL, 2000, NEUROLOGY, V54, P1774, DOI 10.1212/WNL.54.9.1774; LOW PA, 1993, MAYO CLIN PROC, V68, P748, DOI 10.1016/S0025-6196(12)60631-4; Magierski R, 2010, NEUROL NEUROCHIR POL, V44, P139; Marti MJ, 2003, MOVEMENT DISORD, V18, pS21, DOI 10.1002/mds.10560; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; McKeith IG, 2000, NEUROL CLIN, V18, P865, DOI 10.1016/S0733-8619(05)70230-9; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Passant U, 1996, CLIN AUTON RES, V6, P29, DOI 10.1007/BF02291403; Passant U, 1997, INT J GERIATR PSYCH, V12, P395, DOI 10.1002/(SICI)1099-1166(199703)12:3<395::AID-GPS527>3.3.CO;2-R; Poewe W, 2009, MOVEMENT DISORD, V24, pS671, DOI 10.1002/mds.22600; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P308, DOI 10.1136/jnnp.69.3.308; Steenland K, 2010, NEUROEPIDEMIOLOGY, V35, P28, DOI 10.1159/000306055; Suarez GA, 1999, NEUROLOGY, V52, P523, DOI 10.1212/WNL.52.3.523; Tada M, 2007, ARCH NEUROL-CHICAGO, V64, P256, DOI 10.1001/archneur.64.2.256; Thaisetthawatkul P, 2004, NEUROLOGY, V62, P1804, DOI 10.1212/01.WNL.0000125192.69777.6D; Wenning GK, 1999, J NEUROL NEUROSUR PS, V67, P620, DOI 10.1136/jnnp.67.5.620; Williams MM, 2006, NEUROLOGY, V67, P1935, DOI 10.1212/01.wnl.0000247041.63081.98	39	74	76	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45451	10.1371/journal.pone.0045451	http://dx.doi.org/10.1371/journal.pone.0045451			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049679	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388500006
J	Silva, MA; Lucas, TG; Salgueiro, CA; Gomes, CM				Silva, Marta A.; Lucas, Tania G.; Salgueiro, Carlos A.; Gomes, Claudio M.			Protein Folding Modulates the Swapped Dimerization Mechanism of Methyl-Accepting Chemotaxis Heme Sensors	PLOS ONE			English	Article							C-TYPE HEME; SIGNAL-TRANSDUCTION; GEOBACTER-SULFURREDUCENS; BIOPHYSICAL PROPERTIES; BACTERIAL CHEMOTAXIS; STABILITY; DOMAIN; LACTOPEROXIDASE; FERREDOXIN; PLASTICITY	The periplasmic sensor domains GSU0582 and GSU0935 are part of methyl accepting chemotaxis proteins in the bacterium Geobacter sulfurreducens. Both contain one c-type heme group and their crystal structures revealed that these domains form swapped dimers with a PAS fold formed from the two protein chains. The swapped dimerization of these sensors is related to the mechanism of signal transduction and the formation of the swapped dimer involves significant folding changes and conformational rearrangements within each monomeric component. However, the structural changes occurring during this process are poorly understood and lack a mechanistic framework. To address this issue, we have studied the folding and stability properties of two distinct heme-sensor PAS domains, using biophysical spectroscopies. We observed substantial differences in the thermodynamic stability (Delta G = 14.6 kJ. mol(-1) for GSU0935 and Delta G = 26.3 kJ. mol(-1) for GSU0582), and demonstrated that the heme moiety undergoes conformational changes that match those occurring at the global protein structure. This indicates that sensing by the heme cofactor induces conformational changes that rapidly propagate to the protein structure, an effect which is directly linked to the signal transduction mechanism. Interestingly, the two analyzed proteins have distinct levels of intrinsic disorder (25% for GSU0935 and 13% for GSU0582), which correlate with conformational stability differences. This provides evidence that the sensing threshold and intensity of the propagated allosteric effect is linked to the stability of the PAS-fold, as this property modulates domain swapping and dimerization. Analysis of the PAS-domain shows that disorder segments are found either at the hinge region that controls helix motions or in connecting segments of the beta-sheet interface. The latter is known to be widely involved in both intra-and intermolecular interactions, supporting the view that it's folding and stability are at the basis of the specificity and regulation of many types of PAS-containing signaling proteins.	[Lucas, Tania G.; Gomes, Claudio M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Silva, Marta A.; Salgueiro, Carlos A.] UNL, FCT, Dept Quim, CQFB, Caparica, Portugal	Universidade Nova de Lisboa; Universidade Nova de Lisboa	Gomes, CM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	gomes@itqb.unl.pt	Silva, Marta A./P-2221-2019; Gomes, Cláudio M./A-8152-2008; Lucas, Tânia/B-6144-2018; Salgueiro, Carlos/A-4522-2013	Silva, Marta A./0000-0002-4994-5473; Gomes, Cláudio M./0000-0003-4662-6933; Lucas, Tânia/0000-0002-3967-6476; Salgueiro, Carlos/0000-0003-1136-809X	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) [PEst-OE/EQB/LA0004/2011, SFRH/BD/61952/2009];  [PTDC/BIA-PRO/74498/2006];  [PTDC/QUI/70101/2006]	Fundacao para a Ciencia e a Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); ; 	This work was supported by project grants PTDC/BIA-PRO/74498/2006 (to CAS), PTDC/QUI/70101/2006 (to CMG) and by the strategic grant PEst-OE/EQB/LA0004/2011 (to the ITQB Laboratorio Associado) from Fundacao para a Ciencia e a Tecnologia (FCT, Portugal). MAS acknowledges Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) for the doctoral grant SFRH/BD/61952/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aono S, 2003, ACCOUNTS CHEM RES, V36, P825, DOI 10.1021/ar020097p; Boscolo B, 2007, BBA-PROTEINS PROTEOM, V1774, P1164, DOI 10.1016/j.bbapap.2007.07.003; Boscolo B, 2009, BBA-PROTEINS PROTEOM, V1794, P1041, DOI 10.1016/j.bbapap.2009.03.003; Brunori M, 2003, BIOPHYS CHEM, V100, P409, DOI 10.1016/S0301-4622(02)00295-8; Catarino T, 2010, J PHYS CHEM B, V114, P11251, DOI 10.1021/jp1029882; Chan MK, 2001, CURR OPIN CHEM BIOL, V5, P216, DOI 10.1016/S1367-5931(00)00193-9; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Etzkorn M, 2008, NAT STRUCT MOL BIOL, V15, P1031, DOI 10.1038/nsmb.1493; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; Ferguson PL, 2002, BIOCHEMISTRY-US, V41, P3637, DOI 10.1021/bi0118052; FU RD, 1994, J BACTERIOL, V176, P344, DOI 10.1128/JB.176.2.344-350.1994; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Gomes CM, 1998, J BIOL INORG CHEM, V3, P499, DOI 10.1007/s007750050260; GRANT SK, 1992, BIOCHEMISTRY-US, V31, P9491, DOI 10.1021/bi00154a023; Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179; Leal SS, 2004, J BIOL INORG CHEM, V9, P987, DOI 10.1007/s00775-004-0599-z; Leal SS., 2010, PROTEIN FOLDING META, P81; Londer YY, 2006, FEMS MICROBIOL LETT, V258, P173, DOI 10.1111/j.1574-6968.2006.00220.x; Methe BA, 2003, SCIENCE, V302, P1967, DOI 10.1126/science.1088727; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Pace C N, 1986, Methods Enzymol, V131, P266; Pfeil W, 1997, J MOL BIOL, V272, P591, DOI 10.1006/jmbi.1997.1278; Pokkuluri PR, 2008, J MOL BIOL, V377, P1498, DOI 10.1016/j.jmb.2008.01.087; Roberts GP, 2001, PROG NUCLEIC ACID RE, V67, P35, DOI 10.1016/S0079-6603(01)67024-7; Rodgers KR, 1999, CURR OPIN CHEM BIOL, V3, P158, DOI 10.1016/S1367-5931(99)80028-3; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Tompa P., 2010, STRUCTURE FUNCTION I; Tsaprailis G, 1998, BIOCHEMISTRY-US, V37, P2004, DOI 10.1021/bi971032a; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Yoshioka S, 2005, BIOCHEMISTRY-US, V44, P15406, DOI 10.1021/bi0513352	32	10	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46328	10.1371/journal.pone.0046328	http://dx.doi.org/10.1371/journal.pone.0046328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029480	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900135
J	Vimont, S; Boyd, A; Bleibtreu, A; Bens, M; Goujon, JM; Garry, L; Clermont, O; Denamur, E; Arlet, G; Vandewalle, A				Vimont, Sophie; Boyd, Anders; Bleibtreu, Alexandre; Bens, Marcelle; Goujon, Jean-Michel; Garry, Louis; Clermont, Olivier; Denamur, Erick; Arlet, Guillaume; Vandewalle, Alain			The CTX-M-15-Producing Escherichia coli Clone O25b: H4-ST131 Has High Intestine Colonization and Urinary Tract Infection Abilities	PLOS ONE			English	Article							SEQUENCE TYPE ST131; SPECTRUM BETA-LACTAMASES; COMPLETE GENOME SEQUENCE; UNITED-STATES; PHYLOGENETIC GROUP; E. COLI; VIRULENCE; STRAINS; COMMUNITY; CTX-M-15	Increasing numbers of pyelonephritis-associated uropathogenic Escherichia coli (UPEC) are exhibiting high resistance to antibiotic therapy. They include a particular clonal group, the CTX-M-15-producing O25b:H4-ST131 clone, which has been shown to have a high dissemination potential. Here we show that a representative isolate of this E. coli clone, referred to as TN03, has enhanced metabolic capacities, acts as a potent intestine-colonizing strain, and displays the typical features of UPEC strains. In a modified streptomycin-treated mouse model of intestinal colonization where streptomycin was stopped 5 days before inoculation, we show that TN03 outcompetes the commensal E. coli strains K-12 MG1655, IAI1, and ED1a at days 1 and 7. Using an experimental model of ascending UTI in C3H/HeN mice, we then show that TN03 colonized the urinary tract. One week after the transurethral inoculation of the TN03 isolates, the bacterial loads in the bladder and kidneys were significantly greater than those of two other UPEC strains (CFT073 and HT7) belonging to the same B2 phylogenetic group. The differences in bacterial loads did not seem to be directly linked to differences in the inflammatory response, since the intrarenal expression of chemokines and cytokines and the number of polymorphonuclear neutrophils attracted to the site of inflammation was the same in kidneys colonized by TN03, CFT073, or HT7. Lastly, we show that in vitro TN03 has a high maximum growth rate in both complex (Luria-Bertani and human urine) and minimum media. In conclusion, our findings indicate that TN03 is a potent UPEC strain that colonizes the intestinal tract and may persist in the kidneys of infected hosts.	[Vimont, Sophie; Arlet, Guillaume] Hop Univ Est Parisien Site Tenon, AP HP, Serv Bacteriol, Paris, France; [Vimont, Sophie; Boyd, Anders; Arlet, Guillaume] Univ Paris 06, Paris, France; [Boyd, Anders] INSERM, U707, Paris, France; [Bleibtreu, Alexandre; Bens, Marcelle; Garry, Louis; Clermont, Olivier; Denamur, Erick; Vandewalle, Alain] Univ Paris Diderot, Paris, France; [Bleibtreu, Alexandre; Garry, Louis; Clermont, Olivier; Denamur, Erick] INSERM, U722, Paris, France; [Bens, Marcelle; Vandewalle, Alain] INSERM, U773, Paris, France; [Goujon, Jean-Michel] Univ Poitiers, Unite Pathol Ultrastruct & Expt, Ctr Hosp & Univ Poitiers, Poitiers, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Poitiers; Universite de Poitiers	Vimont, S (corresponding author), Hop Univ Est Parisien Site Tenon, AP HP, Serv Bacteriol, Paris, France.	sophie.vimont@tnn.aphp.fr	Arlet, Guillaume/AAW-4918-2020; Arlet, Guillaume/P-2990-2017; Boyd, Anders/GLQ-8906-2022; alexandre, bleibtreu/I-6214-2019	Boyd, Anders/0000-0001-9512-8928; alexandre, bleibtreu/0000-0001-5145-4174	French National Research Agency [ANR-08-MIE-030]; Contrat Hospitalier de Recherche Translationnelle; "Bourse Medico-Scientifique" from the "Fondation pour la Recherche Medicale"	French National Research Agency(French National Research Agency (ANR)); Contrat Hospitalier de Recherche Translationnelle; "Bourse Medico-Scientifique" from the "Fondation pour la Recherche Medicale"	This work was funded in part by a grant from the French National Research Agency under reference ANR-08-MIE-030 (to GA, and AV). AV was in receipt of a "Contrat Hospitalier de Recherche Translationnelle" (CHRP, INSERM-APHP, 2010). A. B. was supported by a "Bourse Medico-Scientifique" from the "Fondation pour la Recherche Medicale". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chassin C, 2007, J EXP MED, V204, P2837, DOI 10.1084/jem.20071032; Chassin C, 2006, J IMMUNOL, V177, P4773, DOI 10.4049/jimmunol.177.7.4773; Chassin C, 2008, J AM SOC NEPHROL, V19, P2364, DOI 10.1681/ASN.2007121273; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2008, J ANTIMICROB CHEMOTH, V61, P1024, DOI 10.1093/jac/dkn084; Clermont O, 2011, INFECT GENET EVOL, V11, P654, DOI 10.1016/j.meegid.2011.02.005; Clermont O, 2009, J ANTIMICROB CHEMOTH, V64, P274, DOI 10.1093/jac/dkp194; Coelho A, 2011, J ANTIMICROB CHEMOTH, V66, P517, DOI 10.1093/jac/dkq491; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Diard M, 2010, J BACTERIOL, V192, P4885, DOI 10.1128/JB.00804-10; Eckert C, 2004, ANTIMICROB AGENTS CH, V48, P1249, DOI 10.1128/AAC.48.4.1249-1255.2004; Ejrnaes K, 2011, VIRULENCE, V2, P528, DOI 10.4161/viru.2.6.18189; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Gupta K, 1999, JAMA-J AM MED ASSOC, V281, P736, DOI 10.1001/jama.281.8.736; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; Hang L, 1999, J IMMUNOL, V162, P3037; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; Hopkins WJ, 1998, INFECT IMMUN, V66, P2798, DOI 10.1128/IAI.66.6.2798-2802.1998; Hung CS, 2009, NAT PROTOC, V4, P1230, DOI 10.1038/nprot.2009.116; Jaureguy F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-560; Johnson JR, 2012, ANTIMICROB AGENTS CH, V56, P2364, DOI 10.1128/AAC.05824-11; Johnson JR, 2012, EMERG INFECT DIS, V18, P598, DOI 10.3201/eid1804.111627; Johnson JR, 2012, INFECT IMMUN, V80, P1554, DOI 10.1128/IAI.06388-11; Johnson JR, 2010, CLIN INFECT DIS, V51, P286, DOI 10.1086/653932; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Lane MC, 2007, KIDNEY INT, V72, P19, DOI 10.1038/sj.ki.5002230; Lane MC, 2007, P NATL ACAD SCI USA, V104, P16669, DOI 10.1073/pnas.0607898104; Lavollay M, 2006, ANTIMICROB AGENTS CH, V50, P2433, DOI 10.1128/AAC.00150-06; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Leflon-Guibout V, 2008, J CLIN MICROBIOL, V46, P3900, DOI 10.1128/JCM.00734-08; Lefort A, 2011, J CLIN MICROBIOL, V49, P777, DOI 10.1128/JCM.01902-10; Lescat M, 2012, COMMENSAL ESCHERICHI; Moreno E, 2008, J CLIN MICROBIOL, V46, P2529, DOI 10.1128/JCM.00813-08; Myhal M L, 1982, Eur J Clin Microbiol, V1, P186, DOI 10.1007/BF02019621; Nicolas-Chanoine MH, 2008, J ANTIMICROB CHEMOTH, V61, P273, DOI 10.1093/jac/dkm464; Owens RC, 2011, J CLIN MICROBIOL, V49, P3406, DOI 10.1128/JCM.00993-11; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Peirano G, 2010, INT J ANTIMICROB AG, V35, P316, DOI 10.1016/j.ijantimicag.2009.11.003; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Pitout JDD, 2009, ANTIMICROB AGENTS CH, V53, P2846, DOI 10.1128/AAC.00247-09; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Rodriguez-Bano J, 2006, CLIN INFECT DIS, V42, P935; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Schilling JD, 2003, P NATL ACAD SCI USA, V100, P4203, DOI 10.1073/pnas.0736473100; Schilling JD, 2002, INFECT IMMUN, V70, P7042, DOI 10.1128/IAI.70.12.7042-7049.2002; Song J, 2008, EUR J CLIN INVEST, V38, P21, DOI 10.1111/j.1365-2362.2008.02005.x; Song JM, 2007, PLOS PATHOG, V3, P541, DOI 10.1371/journal.ppat.0030060; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; WATERS VL, 1991, MICROBIOL REV, V55, P437, DOI 10.1128/MMBR.55.3.437-450.1991; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x	56	70	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46547	10.1371/journal.pone.0046547	http://dx.doi.org/10.1371/journal.pone.0046547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029548	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900184
J	Garcia-Quispes, WA; Pastor, S; Galofre, P; Biarnes, J; Castell, J; Velazquez, A; Marcos, R				Andres Garcia-Quispes, Wilser; Pastor, Susana; Galofre, Pere; Biarnes, Josefina; Castell, Joan; Velazquez, Antonia; Marcos, Ricard			Possible Role of the WDR3 Gene on Genome Stability in Thyroid Cancer Patients	PLOS ONE			English	Article							REPEAT PROTEINS; LYMPHOCYTES; INDIVIDUALS; ASSOCIATION; FREQUENCY; HAPLOTYPE; REGIONS; ASSAY; RISK; SNPS	The role of the WDR3 gene on genomic instability has been evaluated in a group of 115 differentiated thyroid cancer (DTC) patients. Genomic instability has been measured according to the response of peripheral blood lymphocytes to ionizing radiation (0.5 Gy). The response has been measured with the micronucleus (MN) test evaluating the frequency of binucleated cells with MN (BNMN), both before and after the irradiation. No differences between genotypes, for the BNMN frequencies previous the irradiation, were observed. Nevertheless significant decreases in DNA damage after irradiation were observed in individuals carrying the variant alleles for each of the three genotyped SNPs: rs3754127 [-8.85 (-15.01 to -2.70), P<0.01]; rs3765501 [-8.98 (-15.61 to -2.36), P<0.01]; rs4658973 [-8.70 (-14.94 to -2.46), P<0.01]. These values correspond to those obtained assuming a dominant model. This study shows for the first time that WDR3 can modulate genome stability.	[Andres Garcia-Quispes, Wilser; Pastor, Susana; Velazquez, Antonia; Marcos, Ricard] Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Mutagenesi, Bellaterra, Spain; [Pastor, Susana; Velazquez, Antonia; Marcos, Ricard] Inst Salud Carlos III, CIBER Epidemiol & Salud Publ, Madrid, Spain; [Galofre, Pere; Castell, Joan] Hosp Univ Vall dHebron, Nucl Med Serv, Barcelona, Spain; [Biarnes, Josefina] Hosp Josep Trueta, Unitat Endocrinol, Girona, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; Hospital Universitari Vall d'Hebron; Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Marcos, R (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Grp Mutagenesi, Bellaterra, Spain.	ricard.marcos@uab.es	Marcos, Ricard/G-9671-2015; Pastor, Susana/H-7545-2015	Marcos, Ricard/0000-0001-7891-357X; Pastor, Susana/0000-0003-2454-5163; Garcia Quispes, Wilser Andres/0000-0001-6628-2985	Spanish Ministry of Education and Science [SAF2007-6338]; Generalitat de Catalunya (CIRIT) [2009SGR-725]; Universitat Autonoma de Barcelona (PIF)	Spanish Ministry of Education and Science(Spanish Government); Generalitat de Catalunya (CIRIT)(Generalitat de Catalunya); Universitat Autonoma de Barcelona (PIF)	Spanish Ministry of Education and Science (SAF2007-6338) and the Generalitat de Catalunya (CIRIT; 2009SGR-725). W. A. Garcia-Quispes was supported by a predoctoral fellowship from the Universitat Autonoma de Barcelona (PIF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdi A, 2010, THYROID, V20, P803, DOI 10.1089/thy.2010.0072; [Anonymous], 2010, R LANG ENV STAT COMP; Baeyens A, 2010, INT J RADIAT BIOL, V86, P584, DOI 10.3109/09553001003734576; Baida A, 2008, CANCER EPIDEM BIOMAR, V17, P1499, DOI 10.1158/1055-9965.EPI-07-0235; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bonassi S, 2011, MUTAGENESIS, V26, P93, DOI 10.1093/mutage/geq075; Claudio JO, 1999, GENOMICS, V59, P85, DOI 10.1006/geno.1999.5858; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Guo YJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-140; Hudson TJ, 2003, NAT GENET, V33, P439, DOI 10.1038/ng0403-439; Jeggo P, 2010, RADIAT RES, V174, P825, DOI 10.1667/RR1844.1; Jin F, 2004, BIOCHEM GENET, V42, P419, DOI 10.1023/B:BIGI.0000043954.64202.61; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; McMahon M, 2010, J BIOL CHEM, V285, P18309, DOI 10.1074/jbc.M110.108555; Moore HM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009241; Scott D, 1998, BRIT J CANCER, V77, P614, DOI 10.1038/bjc.1998.98; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sprung CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025758; Surralles J, 1997, MUTAT RES-GEN TOX EN, V392, P165, DOI 10.1016/S0165-1218(97)00054-2; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; Zhang J, 1999, CANCER GENET CYTOGEN, V111, P119, DOI 10.1016/S0165-4608(98)00196-4	24	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e44288	10.1371/journal.pone.0044288	http://dx.doi.org/10.1371/journal.pone.0044288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049746	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300009
J	Krasnow, MM; Cosmides, L; Pedersen, EJ; Tooby, J				Krasnow, Max M.; Cosmides, Leda; Pedersen, Eric J.; Tooby, John			What Are Punishment and Reputation for?	PLOS ONE			English	Article							STRONG RECIPROCITY; SOCIAL-EXCHANGE; EVOLUTION; COOPERATION; FOUNDATIONS; BEHAVIOR	Why did punishment and the use of reputation evolve in humans? According to one family of theories, they evolved to support the maintenance of cooperative group norms; according to another, they evolved to enhance personal gains from cooperation. Current behavioral data are consistent with both hypotheses (and both selection pressures could have shaped human cooperative psychology). However, these hypotheses lead to sharply divergent behavioral predictions in circumstances that have not yet been tested. Here we report results testing these rival predictions. In every test where social exchange theory and group norm maintenance theory made different predictions, subject behavior violated the predictions of group norm maintenance theory and matched those of social exchange theory. Subjects do not direct punishment toward those with reputations for norm violation per se; instead, they use reputation self-beneficially, as a cue to lower the risk that they personally will experience losses from defection. More tellingly, subjects direct their cooperative efforts preferentially towards defectors they have punished and away from those they haven't punished; they avoid expending punitive effort on reforming defectors who only pose a risk to others. These results are not consistent with the hypothesis that the psychology of punishment evolved to uphold group norms. The circumstances in which punishment is deployed and withheld-its circuit logic-support the hypothesis that it is generated by psychological mechanisms that evolved to benefit the punisher, by allowing him to bargain for better treatment.	[Krasnow, Max M.; Cosmides, Leda; Pedersen, Eric J.; Tooby, John] Univ Calif Santa Barbara, Ctr Evolutionary Psychol, Santa Barbara, CA 93106 USA; [Krasnow, Max M.; Cosmides, Leda; Pedersen, Eric J.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Tooby, John] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Krasnow, MM (corresponding author), Univ Calif Santa Barbara, Ctr Evolutionary Psychol, Santa Barbara, CA 93106 USA.	max.krasnow@gmail.com		Pedersen, Eric/0000-0003-4692-0577	Academic Senate of the University of California, Santa Barbara; National Institutes of Health [DPI OD000516]; Global Center of Excellence Program "Center for the Sociality of Mind"of Hokkaido University	Academic Senate of the University of California, Santa Barbara; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Center of Excellence Program "Center for the Sociality of Mind"of Hokkaido University	Research funded by a grant from the Academic Senate of the University of California, Santa Barbara (https://senate.ucsb.edu/) to L. C., the National Institutes of Health Director's Pioneer Award (# DPI OD000516 (http://commonfund.nih.gov/pioneer/) to L. C., and the Global Center of Excellence Program "Center for the Sociality of Mind"of Hokkaido University (http://lynx.let.hokudai.ac.jp/CSM/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Burnham TC., 2005, ANAL KRITIK, V27, P113, DOI [10.1515/auk-2005-0107, DOI 10.1515/AUK-2005-0107]; Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Cook KS, 2008, SOC PSYCHOL QUART, V71, P215, DOI 10.1177/019027250807100303; COSMIDES L, 1989, ETHOL SOCIOBIOL, V10, P51, DOI 10.1016/0162-3095(89)90013-7; Cosmides L., 2005, HDB EVOLUTIONARY PSY, P584; Cosmides L, 2010, P NATL ACAD SCI USA, V107, P9007, DOI 10.1073/pnas.0914623107; DAWES RM, 1988, J ECON PERSPECT, V2, P187, DOI 10.1257/jep.2.3.187; Delton AW, 2010, SCIENCE, V329, P389, DOI 10.1126/science.329.5990.389-a; Delton AW, 2011, P NATL ACAD SCI US; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2003, DAHL WS ENV, P55; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Hagen EH, 2006, THEOR POPUL BIOL, V69, P339, DOI 10.1016/j.tpb.2005.09.005; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hammerstein P., 2003, GENETIC CULTURAL EVO; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Hoffman E, 1998, ECON INQ, V36, P335, DOI 10.1111/j.1465-7295.1998.tb01719.x; HOFFMAN E, 1994, GAME ECON BEHAV, V7, P346, DOI 10.1006/game.1994.1056; Kameda T, 2005, CURR DIR PSYCHOL SCI, V14, P331, DOI 10.1111/j.0963-7214.2005.00392.x; Kiyonari T, 2000, EVOL HUM BEHAV, V21, P411, DOI 10.1016/S1090-5138(00)00055-6; Kurzban R, 2001, P NATL ACAD SCI USA, V98, P15387, DOI 10.1073/pnas.251541498; Kurzban R., 2005, HDB EVOLUTIONARY PSY, P653; Lieberman D, 2007, NATURE, V445, P727, DOI 10.1038/nature05510; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; McCullough M., 2008, REVENGE EVOLUTION FO; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Reis DL, 2007, NEUROIMAGE, V35, P1385, DOI 10.1016/j.neuroimage.2006.12.045; Sell A, 2009, P NATL ACAD SCI USA, V106, P15073, DOI 10.1073/pnas.0904312106; Stone VE, 2002, P NATL ACAD SCI USA, V99, P11531, DOI 10.1073/pnas.122352699; Todd PM, 2007, CURR DIR PSYCHOL SCI, V16, P167, DOI 10.1111/j.1467-8721.2007.00497.x; Tooby J., 1996, P BRIT ACAD, P119, DOI DOI 10.1002/(SICI)1520-6300(1998)10:5<681::AID-; Tooby J, 2006, MANAG DECIS ECON, V27, P103, DOI 10.1002/mde.1287; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; West SA, 2007, J EVOLUTION BIOL, V20, P415, DOI 10.1111/j.1420-9101.2006.01258.x; Williams G. C., 1966, P307; WILSON DS, 1994, BEHAV BRAIN SCI, V17, P585, DOI 10.1017/S0140525X00036104; Yamagishi T, 2000, SOC PSYCHOL QUART, V63, P116, DOI 10.2307/2695887; [No title captured]	46	72	73	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45662	10.1371/journal.pone.0045662	http://dx.doi.org/10.1371/journal.pone.0045662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049833	gold, Green Published			2022-12-27	WOS:000309517300041
J	Marhefka, JN; Abbud-Antaki, RA				Marhefka, Joie N.; Abbud-Antaki, Rula A.			Validation of the Cancer BioChip System as a 3D siRNA Screening Tool for Breast Cancer Targets	PLOS ONE			English	Article							CATHEPSIN-L; CELL-TRANSFORMATION; GENE-EXPRESSION; PI3K PATHWAY; IN-VITRO; INHIBITION; PROLIFERATION; RNAI; GROWTH; MIGRATION	Genomic studies have revealed that breast cancer consists of a complex biological process with patient-specific genetic variations, revealing the need for individualized cancer diagnostic testing and selection of patient-specific optimal therapies. One of the bottlenecks in translation of genomic breakthroughs to the clinic is the lack of functional genomic assays that have high clinical translatability. Anchorage-independent three-dimensional (3D) growth assays are considered to be the gold-standard for chemosensitivity testing, and leads identified with these assays have high probability of clinical success. The Cancer BioChip System (CBCS) allows for the simultaneous, quantitative, and real time evaluation of multitudes of anchorage-independent breast cancer cell growth inhibitors. We employed a Test Cancer BioChip that contains silencing RNAs (siRNAs) targeting cancer-related genes to identify 3D-specific effectors of breast cancer cell growth. We compared the effect of these siRNAs on colony growth of the hormone receptor positive (MCF7) and Human Epidermal Growth Factor Receptor 2/c-Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2/c-erb-b2) positive (SK-BR-3) cells on the Test Cancer BioChip. Our results confirmed cell-specific inhibition of MCF7 and SK-BR-3 colony formation by estrogen receptor a (ESR1) and (ERBB2) siRNA, respectively. Both cell lines were also suppressed by Phosphoinositide-3-kinase Catalytic, alpha Polypeptide (PIK3CA) siRNA. Interestingly, we have observed responses to siRNA that are unique to this 3D setting. For example, beta-actin (ACTB) siRNA suppressed colony growth in both cell types while Cathepsin L2 (CTSL2) siRNA caused opposite effects. These results further validate the importance of the CBCS as a tool for the identification of clinically relevant breast cancer targets.	[Marhefka, Joie N.; Abbud-Antaki, Rula A.] Falcon Genom Inc, Pittsburgh, PA USA		Abbud-Antaki, RA (corresponding author), Falcon Genom Inc, Pittsburgh, PA USA.	rabbud@falcongenomics.com		ABBUD-ANTAKI, RULA/0000-0002-0211-3645	National Cancer Institute [1 R43 CA141962-01A2]; NATIONAL CANCER INSTITUTE [R43CA141962] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported through a Phase 1 SBIR grant from the National Cancer Institute: 1 R43 CA141962-01A2, PI: Dr. Rula A. Abbud-Antaki.	Abbud-Antaki RA, 2012, HORM CANC; Bauer JA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2595; Bell-McGuinn KM, 2007, CANCER RES, V67, P7378, DOI 10.1158/0008-5472.CAN-07-0602; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; BERWALD Y, 1963, NATURE, V200, P1182, DOI 10.1038/2001182a0; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Blumenthal RD, 2005, METH MOLEC MED, V110, P3; Boudreau F, 2007, FASEB J, V21, P3853, DOI 10.1096/fj.07-8113com; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Chik F, 2011, CARCINOGENESIS, V32, P224, DOI 10.1093/carcin/bgq221; Clarke M, 1998, LANCET, V351, P1451; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dennemarker J, 2010, ONCOGENE, V29, P1611, DOI 10.1038/onc.2009.466; Faltus T, 2004, NEOPLASIA, V6, P786, DOI 10.1593/neo.04313; Fedorov Y, 2005, NAT METHODS, V2, P241, DOI 10.1038/nmeth0405-241; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; Fu HJ, 2006, CANCER BIOL THER, V5, P842, DOI 10.4161/cbt.5.7.2840; Gocheva V, 2006, GENE DEV, V20, P543, DOI 10.1101/gad.1407406; Gonzalez L, 2006, J BIOL CHEM, V281, P20851, DOI 10.1074/jbc.M601570200; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Gril B, 2011, CLIN CANCER RES, V17, P142, DOI 10.1158/1078-0432.CCR-10-1603; Iorns E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005120; Iorns E, 2009, BIOCHEM J, V417, P361, DOI 10.1042/BJ20081682; Isaacs C, 2011, BREAST CANCER RES TR, V125, P137, DOI 10.1007/s10549-010-1226-z; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; KOPEMAIER P, 1992, CHEM-BIOL INTERACT, V82, P295; Kraning-Rush CM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015009; Lee AV, 2011, ONCOLOGY-NY, V25, P535; Mayer EL, 2010, CLIN CANCER RES, V16, P3526, DOI 10.1158/1078-0432.CCR-09-1834; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Mukohara T, 2011, CHEMOTHER RES PRACT; Mukohara T, 2009, CANCER LETT, V282, P14, DOI 10.1016/j.canlet.2009.02.056; Munster PN, 2009, BRIT J CANCER, V101, P1044, DOI 10.1038/sj.bjc.6605293; Navab R, 2001, J BIOL CHEM, V276, P13644, DOI 10.1074/jbc.M100019200; Nencioni A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009024; Ngan VK, 2001, MOL PHARMACOL, V60, P225, DOI 10.1124/mol.60.1.225; Ocana A, 2008, CLIN CANCER RES, V14, P961, DOI 10.1158/1078-0432.CCR-07-1630; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Rountree MR, 2000, NAT GENET, V25, P269, DOI 10.1038/77023; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Shin IJ, 2011, ONCOL REP, V25, P1313, DOI 10.3892/or.2011.1214; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Sparano JA, 2009, CLIN CANCER RES, V15, P7693, DOI 10.1158/1078-0432.CCR-09-1450; Tran LM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-121; Wang C, 2007, MOL CANCER RES, V5, P1031, DOI 10.1158/1541-7786.MCR-06-0391; Warnberg F, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1395; Xing RY, 1998, CANCER RES, V58, P904; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Zang XP, 2008, ANTICANCER RES, V28, P2733; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zheng X, 2009, AM J PHYSIOL-CELL PH, V296, pC65, DOI 10.1152/ajpcell.00082.2008	56	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46086	10.1371/journal.pone.0046086	http://dx.doi.org/10.1371/journal.pone.0046086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049944	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300082
J	Mole, TB; Kennedy, N; Ndoya, N; Emond, A				Mole, Thomas B.; Kennedy, Neil; Ndoya, Noel; Emond, Alan			ThermoSpots to Detect Hypothermia in Children with Severe Acute Malnutrition	PLOS ONE			English	Article							NEONATAL HYPOTHERMIA; TEMPERATURE	Introduction: Hypothermia is a risk factor for increased mortality in children with severe acute malnutrition (SAM). Yet frequent temperature measurement remains unfeasible in under-resourced units in developing countries. ThermoSpot is a continuous temperature monitoring sticker designed originally for neonates. When applied to skin, its liquid crystals are designed to turn black with hypothermia and remain green with normothermia. Aims: To (i) estimate the diagnostic accuracy of ThermoSpots for detecting WHO-defined hypothermia (core temperature, <35.5 degrees C or peripheral temperature, <35.0 degrees C) in children with SAM and (ii) determine their acceptability amongst mothers. Methods: Children with SAM in a malnutrition unit in Malawi were enrolled during March-July 2010. The sensitivity and specificity of ThermoSpots were calculated by comparing the device colour against 'gold standard' rectal temperatures taken on admission and follow up peripheral temperatures taken until discharge. Guardians completed a questionnaire to assess acceptability. Results: Hypothermia was uncommon amongst the 162 children enrolled. ThermoSpot successfully detected the one rectal temperature and two peripheral temperatures recorded that met the WHO definition of hypothermia. Overall, 3/846 (0.35%) temperature measurements were in the WHO-defined hypothermia range. Interpreting the brown transition colour (between black and green) as hypothermia improved sensitivities. For milder hypothermia definitions, sensitivities declined (<35.4 degrees C, 50.0%; <35.9 degrees C, 39.2%). Specificity was consistently above 94%. From questionnaires, 40/43 (93%) mothers reported they were 90-100% happy with the device overall. Free-text answers revealed themes of "Skin Rashes'', "User-satisfaction'' and "Empowerment". Conclusion: Although hypothermia was uncommon in this study, ThermoSpots successfully detected these episodes in malnourished children and were acceptable to mothers. Research in settings where hypothermia is common is needed to determine performance with certainty. Instructing users to act when the device's transition colour appears could improve accuracy. If reliable, ThermoSpots may offer simple, acceptable and continuous temperature measurement for high-burden areas and reduce the workload of over-stretched staff.	[Mole, Thomas B.; Emond, Alan] Univ Bristol, Ctr Child & Adolescent Hlth, Bristol, Avon, England; [Kennedy, Neil] Univ Malawi, Dept Pediat & Child Hlth, Blantyre, Malawi; [Ndoya, Noel] Univ Malawi, Kamuzu Coll Nursing, Blantyre, Malawi	University of Bristol; University of Malawi; University of Malawi	Mole, TB (corresponding author), Univ Bristol, Ctr Child & Adolescent Hlth, Bristol, Avon, England.	t.b.mole@doctors.org.uk	Mole, Tom/P-7588-2015	Mole, Tom/0000-0001-8732-8188; Kennedy, Neil/0000-0002-6262-2679				Ashworth A, 2001, J PEDIATR GASTR NUTR, V32, P516, DOI 10.1097/00005176-200105000-00003; BROOKE OG, 1972, BMJ-BRIT MED J, V1, P331, DOI 10.1136/bmj.1.5796.331; Green DA, 2006, ARCH DIS CHILD-FETAL, V91, pF96, DOI 10.1136/adc.2005.078410; Kambarami R, 2002, ANN TROP PAEDIATR, V22, P219, DOI 10.1179/027249302125001516; Kennedy N, 2000, LANCET, V355, P1364, DOI 10.1016/S0140-6736(05)72592-7; Kumar V, 2009, J PERINATOL, V29, P401, DOI 10.1038/jp.2008.233; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; Mallet ML, 2002, QJM-INT J MED, V95, P775, DOI 10.1093/qjmed/95.12.775; Manary MJ, 2008, BRIT MED J, V13, p[337, a2180]; Morley D, 2002, TROP DOCT, V32, P22, DOI 10.1177/004947550203200111; Pejaver Ranjan Kumar, 2004, Indian Journal of Pediatrics, V71, P795, DOI 10.1007/BF02730715; Talbert A, 2009, J TROP PEDIATRICS, V55, P413, DOI 10.1093/tropej/fmp038; Teaching Aids at Low Cost (TALC), 2012, J ZEAL THERMOSPOT NO; Wariki WM, 2010, INTERVENTIONS PREVEN; World Health Organisation, 2011, PREV TREAT HYP SEV M; World Health Organization , 2007, COMM BAS MAN SEV AC; World Health Organization, 1999, MAN SEV MALN MAN PHY	17	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45823	10.1371/journal.pone.0045823	http://dx.doi.org/10.1371/journal.pone.0045823			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049871	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300057
J	Terasawa, M; Uruno, T; Mori, S; Kukimoto-Niino, M; Nishikimi, A; Sanematsu, F; Tanaka, Y; Yokoyama, S; Fukui, Y				Terasawa, Masao; Uruno, Takehito; Mori, Sayako; Kukimoto-Niino, Mutsuko; Nishikimi, Akihiko; Sanematsu, Fumiyuki; Tanaka, Yoshihiko; Yokoyama, Shigeyuki; Fukui, Yoshinori			Dimerization of DOCK2 Is Essential for DOCK2-Mediated Rac Activation and Lymphocyte Migration	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTORS; CELL-MIGRATION; CDC42 ACTIVATOR; PROTEIN DOCK2; RHO-GTPASES; DOMAIN; OLIGOMERIZATION; RESPONSES; ZIZIMIN1; MOTILITY	The migratory properties of lymphocytes depend on DOCK2, an atypical Rac activator predominantly expressed in hematopoietic cells. Although DOCK2 does not contain the Dbl homology domain typically found in guanine nucleotide exchange factors (GEFs), DOCK2 mediates the GTP-GDP exchange reaction for Rac via its DOCK homology region (DHR)-2 (also known as CZH2 or Docker) domain. DOCK2 DHR-2 domain is composed of three lobes, and Rac binding site and catalytic center are generated entirely from lobes B and C. On the other hand, lobe A has been implicated in dimer formation, yet its physiological significance remains unknown. Here, we report that lobe A-mediated DOCK2 dimerization is crucial for Rac activation and lymphocyte migration. We found that unlike wild-type DOCK2, DOCK2 mutant lacking lobe A failed to restore motility and polarity when expressed in thymoma cells and primary T cells lacking endogenous expression of DOCK2. Similar results were obtained with the DOCK2 point mutant having a defect in dimerization. Deletion of lobe A from the DHR-2 domain did not affect Rac GEF activity in vitro. However, fluorescence resonance energy transfer analyses revealed that lobe A is required for DOCK2 to activate Rac effectively during cell migration. Our results thus indicate that DOCK2 dimerization is functionally important under the physiological condition where only limited amounts of DOCK2 and Rac are localized to the plasma membrane.	[Terasawa, Masao; Uruno, Takehito; Mori, Sayako; Nishikimi, Akihiko; Sanematsu, Fumiyuki; Tanaka, Yoshihiko; Fukui, Yoshinori] Kyushu Univ, Div Immunogenet, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Fukuoka 812, Japan; [Nishikimi, Akihiko; Sanematsu, Fumiyuki; Tanaka, Yoshihiko; Fukui, Yoshinori] Kyushu Univ, Res Ctr Adv Immunol, Fukuoka 812, Japan; [Terasawa, Masao; Uruno, Takehito; Kukimoto-Niino, Mutsuko; Nishikimi, Akihiko; Sanematsu, Fumiyuki; Tanaka, Yoshihiko; Yokoyama, Shigeyuki; Fukui, Yoshinori] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan; [Kukimoto-Niino, Mutsuko; Yokoyama, Shigeyuki] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 113, Japan	Kyushu University; Kyushu University; Japan Science & Technology Agency (JST); RIKEN; University of Tokyo	Fukui, Y (corresponding author), Kyushu Univ, Div Immunogenet, Dept Immunobiol & Neurosci, Med Inst Bioregulat, Fukuoka 812, Japan.	fukui@bioreg.kyushu-u.ac.jp	Uruno, Takehito/AAF-7998-2019; Kukimoto-Niino, Mutsuko/C-6704-2017; Nishikimi, Akihiko/I-4692-2018; Yokoyama, Shigeyuki/N-6911-2015	Uruno, Takehito/0000-0002-2812-9645; Kukimoto-Niino, Mutsuko/0000-0002-4178-1611; Nishikimi, Akihiko/0000-0001-9497-7557; Yokoyama, Shigeyuki/0000-0003-3133-7338; Fukui, Yoshinori/0000-0003-2335-8745	CREST program of Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science [22247017]; Strategic Japanese-Swiss Cooperative Program of Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [24590586] Funding Source: KAKEN	CREST program of Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Strategic Japanese-Swiss Cooperative Program of Japan Science and Technology Agency; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by CREST program (YF and SY) (http://www.immunesystem.jst.go.jp/en/researcher/index.html) and Strategic Japanese-Swiss Cooperative Program (YF) (http://www.jst.go.jp/inter/english/project/country/switzerland.html) of Japan Science and Technology Agency; Targeted Proteins Research Project (http://www.tanpaku.org/e_research/mp.php) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (YF; 22247017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anborgh PH, 1999, MOL CELL BIOL, V19, P4611; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Hanawa-Suetsugu K, 2012, P NATL ACAD SCI USA, V109, P3305, DOI 10.1073/pnas.1113512109; Harada Y, 2012, BLOOD, V119, P4451, DOI 10.1182/blood-2012-01-407098; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kulkarni K, 2011, J BIOL CHEM, V286, P25341, DOI 10.1074/jbc.M111.236455; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; LETOURNEUR F, 1989, EUR J IMMUNOL, V19, P2269, DOI 10.1002/eji.1830191214; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Meller N, 2004, J BIOL CHEM, V279, P37470, DOI 10.1074/jbc.M404535200; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nishikimi A, 2012, CHEM BIOL, V19, P488, DOI 10.1016/j.chembiol.2012.03.008; Nombela-Arrieta C, 2004, IMMUNITY, V21, P429, DOI 10.1016/j.immuni.2004.07.012; Nombela-Arrieta C, 2007, J EXP MED, V204, P497, DOI 10.1084/jem.20061780; Reif K, 2002, TRENDS CELL BIOL, V12, P368, DOI 10.1016/S0962-8924(02)02330-9; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shulman Z, 2006, BLOOD, V108, P2150, DOI 10.1182/blood-2006-04-017608; Wan YY, 2000, P NATL ACAD SCI USA, V97, P13784, DOI 10.1073/pnas.250356297; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Zhu KJ, 2001, MOL CELL BIOL, V21, P425, DOI 10.1128/MCB.21.2.425-437.2001	27	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46277	10.1371/journal.pone.0046277	http://dx.doi.org/10.1371/journal.pone.0046277			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050005	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300104
J	Garfield, AS; Chan, WS; Dennis, RJ; Ito, D; Heisler, LK; Rochford, JJ				Garfield, Alastair S.; Chan, Wai S.; Dennis, Rowena J.; Ito, Daisuke; Heisler, Lora K.; Rochford, Justin J.			Neuroanatomical Characterisation of the Expression of the Lipodystrophy and Motor-Neuropathy Gene Bscl2 in Adult Mouse Brain	PLOS ONE			English	Article							PARAVENTRICULAR NUCLEUS; ADIPOSE-TISSUE; CATECHOLAMINE NEURONS; SEIPIN; LEPTIN; MUTATIONS; GAMMA; HETEROGENEITY; METABOLISM; DISEASE	The endoplasmic reticulum localised protein seipin, encoded by the gene Berardinelli-Seip congenital lipodystrophy type 2 (BSCL2), serves a critical but poorly defined function in the physiology of both adipose and neural tissue. In humans, BSCL2 loss-of-function mutations cause a severe form of lipodystrophy, whilst a distinct set of gain-of-toxic-function mutations are associated with a heterogeneous group of neuropathies. However, despite the importance of seipin dysfunction to the pathophysiology of these conditions, little is known about its physiological role in adipocytes or neurons. BSCL2 mRNA has previously been identified in human and mouse brain, yet no definitive assessment of its expression has been undertaken. Here we comprehensively characterised the neuroanatomical distribution of mouse Bscl2 using complementary in situ hybridisation histochemistry and immunohistochemistry techniques. Whilst Bscl2 was broadly expressed throughout the rostral-caudal extent of the mouse brain, it exhibited a discrete neuroanatomical profile. Bscl2 was most abundantly expressed in the hypothalamus and in particular regions associated with the regulation of energy balance including, the paraventricular, ventromedial, arcuate and dorsomedial nuclei. Bscl2 expression was also identified within the brainstem dorsal vagal complex, which together with the paraventricular nucleus of the hypothalamus represented the site of highest expression. Further neurochemical profiling of these two nuclei revealed Bscl2/seipin expression within energy balance related neuronal populations. Specifically, seipin was detected in oxytocin neurons of the paraventricular nucleus of the hypothalamus and in catecholamine neurons of the dorsal vagal complex. These data raise the possibility that in addition to its role in adipose tissue development, seipin may also be involved in the central regulation of energy balance.	[Garfield, Alastair S.; Chan, Wai S.; Heisler, Lora K.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England; [Dennis, Rowena J.; Rochford, Justin J.] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England; [Ito, Daisuke] Keio Univ, Sch Med, Dept Neurol, Shinjuku Ku, Tokyo, Japan	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Keio University	Heisler, LK (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	lkh30@cam.ac.uk	Ito, Daisuke/GXF-1648-2022; Ito, Daisuke/M-3608-2013	Ito, Daisuke/0000-0002-4740-1675; Rochford, Justin/0000-0002-5020-4939; Garfield, Alastair/0000-0002-9628-6140	Medical Research Council [GO800203]; Wellcome Trust [WT081713, WT09801]; National Institute for Health Research Comprehensive Biomedical Research Centre [CG50826]; Cambridge MRC Centre for Study of Obesity and Related Disorders (MRC-CORD); Medical Research Council [G0800203, G0600717B] Funding Source: researchfish; MRC [G0800203] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute for Health Research Comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge MRC Centre for Study of Obesity and Related Disorders (MRC-CORD)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (GO800203 to JJR), the Wellcome Trust (WT081713 and WT09801 to LKH), the National Institute for Health Research Comprehensive Biomedical Research Centre (CG50826 to RJD), and by the Cambridge MRC Centre for Study of Obesity and Related Disorders (MRC-CORD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2003, J CLIN ENDOCR METAB, V88, P4840, DOI 10.1210/jc.2003-030855; Agostini M, 2006, CELL METAB, V4, P303, DOI 10.1016/j.cmet.2006.09.003; Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Appleyard SM, 2007, J NEUROSCI, V27, P13292, DOI 10.1523/JNEUROSCI.3502-07.2007; Atasoy D, 2012, NATURE; Bartness TJ, 2010, MOL CELL ENDOCRINOL, V318, P34, DOI 10.1016/j.mce.2009.08.031; Biag J, 2012, J COMP NEUROL, V520, P6, DOI 10.1002/cne.22698; Blevins JE, 2004, AM J PHYSIOL-REG I, V287, pR87, DOI 10.1152/ajpregu.00604.2003; Boutet E, 2009, BIOCHIMIE, V91, P796, DOI 10.1016/j.biochi.2009.01.011; Cartwright BR, 2012, J LIPID RES, V53, P1042, DOI 10.1194/jlr.R023754; Chen WQ, 2009, ENDOCRINOLOGY, V150, P4552, DOI 10.1210/en.2009-0236; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cui RJ, 2011, J NEUROSCI, V31, P3484, DOI 10.1523/JNEUROSCI.3187-10.2011; Cui X, 2011, HUM MOL GENET, V20, P3022, DOI 10.1093/hmg/ddr205; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2011, TRENDS ENDOCRIN MET, V22, P204, DOI 10.1016/j.tem.2011.02.004; Garg A, 2000, AM J MED, V108, P143, DOI 10.1016/S0002-9343(99)00414-3; Gautron L, 2011, J CLIN INVEST, V121, P2087, DOI 10.1172/JCI45888; Ito D, 2008, NEUROBIOL DIS, V31, P266, DOI 10.1016/j.nbd.2008.05.004; Ito D, 2007, ANN NEUROL, V61, P237, DOI 10.1002/ana.21070; Ito D, 2009, BRAIN, V132, P8, DOI 10.1093/brain/awn216; Lu M, 2011, NAT MED, V17, P618, DOI 10.1038/nm.2332; Maejima Y, 2009, CELL METAB, V10, P355, DOI 10.1016/j.cmet.2009.09.002; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Payne VA, 2008, DIABETES, V57, P2055, DOI 10.2337/db08-0184; PETROV T, 1993, BRAIN RES, V609, P81, DOI 10.1016/0006-8993(93)90858-K; Potes CS, 2010, AM J PHYSIOL-REG I, V299, pR623, DOI 10.1152/ajpregu.00791.2009; Rochford JJ, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001547; Sanchez-Lasheras C, 2010, FRONT NEUROENDOCRIN, V31, P4, DOI 10.1016/j.yfrne.2009.08.002; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; SILVER JR, 1966, ANN HUM GENET, V30, P69, DOI 10.1111/j.1469-1809.1966.tb00007.x; Simha V, 2003, J CLIN ENDOCR METAB, V88, P5433, DOI 10.1210/jc.2003-030835; Simmons DM, 2009, J COMP NEUROL, V516, P423, DOI 10.1002/cne.22126; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Tian Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001364; Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722; Wang LX, 2000, REGUL PEPTIDES, V92, P79, DOI 10.1016/S0167-0115(00)00153-1; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Wolinski H, 2011, J CELL SCI, V124, P3894, DOI 10.1242/jcs.091454; Yagi T, 2011, HUM MOL GENET, V20, P3831, DOI 10.1093/hmg/ddr304	40	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45790	10.1371/journal.pone.0045790	http://dx.doi.org/10.1371/journal.pone.0045790			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049863	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100081
J	Hill, DJ; Whittles, C; Virji, M				Hill, Darryl J.; Whittles, Cheryl; Virji, Mumtaz			A Novel Group of Moraxella catarrhalis UspA Proteins Mediates Cellular Adhesion via CEACAMs and Vitronectin	PLOS ONE			English	Article							CARCINOEMBRYONIC ANTIGEN CEA; OUTER-MEMBRANE PROTEIN; HAEMOPHILUS-INFLUENZAE; NEISSERIA-MENINGITIDIS; EPITHELIAL-CELLS; N-DOMAIN; IFN-GAMMA; SURFACE; EXPRESSION; PATHOGEN	Moraxella catarrhalis (Mx) is a common cause of otitis media and exacerbation of chronic obstructive pulmonary disease, an increasing worldwide problem. Surface proteins UspA1 and UspA2 of Mx bind to a number of human receptors and may function in pathogenesis. Genetic recombination events in the pathogen can generate hybrid proteins termed UspA2H. However, whether certain key functions (e.g. UspA1-specific CEACAM binding) can be exchanged between these adhesin families remains unknown. In this study, we have shown that Mx can incorporate the UspA1 CEACAM1-binding region not only into rare UspA1 proteins devoid of CEACAM-binding ability, but also into UspA2 which normally lack this capacity. Further, a screen of Mx isolates revealed the presence of novel UspA2 Variant proteins (UspA2V) in similar to 14% of the CEACAM-binding population. We demonstrate that the expression of UspA2/2V with the CEACAM-binding domain enable Mx to bind both to cell surface CEACAMs and to integrins, the latter via vitronectin. Such properties of UspA2/2V have not been reported to date. The studies demonstrate that the UspA family is much more heterogeneous than previously believed and illustrate the in vivo potential for exchange of functional regions between UspA proteins which could convey novel adhesive functions whilst enhancing immune evasion.	[Hill, Darryl J.; Whittles, Cheryl; Virji, Mumtaz] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England	University of Bristol	Hill, DJ (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England.	Darryl.J.Hill@bristol.ac.uk; m.virji@bristol.ac.uk			Wellcome Trust [077461]	Wellcome Trust(Wellcome TrustEuropean Commission)	The study was supported by a grant from the Wellcome Trust (Ref: 077461). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi C, 1997, INFECT IMMUN, V65, P4367, DOI 10.1128/IAI.65.11.4367-4377.1997; Aebi C, 1998, INFECT IMMUN, V66, P3113, DOI 10.1128/IAI.66.7.3113-3119.1998; Attia AS, 2006, INFECT IMMUN, V74, P1597, DOI 10.1128/IAI.74.3.1597-1611.2006; Bootsma HJ, 2000, J INFECT DIS, V181, P1376, DOI 10.1086/315374; Brooks MJ, 2008, INFECT IMMUN, V76, P5330, DOI 10.1128/IAI.00573-08; Brooks MJ, 2008, INFECT IMMUN, V76, P5322, DOI 10.1128/IAI.00572-08; Brozyna S, 2009, COPD, V6, P4, DOI 10.1080/15412550902724164; Casutt-Meyer S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015159; Cherry JD, 1998, VACCINE, V16, P1901, DOI 10.1016/S0264-410X(98)00226-6; Conners R, 2008, EMBO J, V27, P1779, DOI 10.1038/emboj.2008.101; Cope LD, 1999, J BACTERIOL, V181, P4026, DOI 10.1128/JB.181.13.4026-4034.1999; Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004; Cripps AW, 2005, VACCINE, V23, P2304, DOI 10.1016/j.vaccine.2005.01.023; Cunha CSE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000911; DANSKYULLMANN C, 1995, CYTOKINE, V7, P118, DOI 10.1006/cyto.1995.1016; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; de Vries SPW, 2009, MICROBIOL MOL BIOL R, V73, P389, DOI 10.1128/MMBR.00007-09; Di Stefano A, 2004, EUR RESPIR J, V24, P78, DOI 10.1183/09031936.04.00080303; Diavatopoulos DA, 2006, J EVOLUTION BIOL, V19, P1931, DOI 10.1111/j.1420-9101.2006.01154.x; Duim B, 1997, INFECT IMMUN, V65, P1351, DOI 10.1128/IAI.65.4.1351-1356.1997; FADEN H, 1994, J INFECT DIS, V169, P1312, DOI 10.1093/infdis/169.6.1312; Fahlgren A, 2003, SCAND J IMMUNOL, V58, P628, DOI 10.1111/j.1365-3083.2003.01342.x; Griffiths NJ, 2007, CELL MICROBIOL, V9, P2968, DOI 10.1111/j.1462-5822.2007.01038.x; Griffiths NJ, 2011, MOL MICROBIOL, V82, P1129, DOI 10.1111/j.1365-2958.2011.07876.x; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Heiniger N, 2005, INFECT IMMUN, V73, P8247, DOI 10.1128/IAI.73.12.8247-8255.2005; HELMINEN ME, 1994, J INFECT DIS, V170, P867, DOI 10.1093/infdis/170.4.867; Hendley JO, 2005, APMIS, V113, P213, DOI 10.1111/j.1600-0463.2005.apm1130310.x; Hill DJ, 2005, MOL MICROBIOL, V55, P1515, DOI 10.1111/j.1365-2958.2005.04487.x; Hill DJ, 2003, MOL MICROBIOL, V48, P117, DOI 10.1046/j.1365-2958.2003.03433.x; Hill DJ, 2001, MOL MICROBIOL, V39, P850, DOI 10.1046/j.1365-2958.2001.02233.x; IZUMI M, 1989, BIOCHIM BIOPHYS ACTA, V990, P101, DOI 10.1016/S0304-4165(89)80019-4; KLINGMAN KL, 1994, INFECT IMMUN, V62, P1150, DOI 10.1128/IAI.62.4.1150-1155.1994; Lafontaine ER, 2000, J BACTERIOL, V182, P1364, DOI 10.1128/JB.182.5.1364-1373.2000; Lafontaine ER, 2001, J BACTERIOL, V183, P1540, DOI 10.1128/JB.183.5.1540-1551.2001; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Manolov T, 2008, J IMMUNOL METHODS, V333, P180, DOI 10.1016/j.jim.2007.12.012; McMichael JC, 1998, INFECT IMMUN, V66, P4374; Meier PS, 2006, FEMS MICROBIOL LETT, V262, P72, DOI 10.1111/j.1574-6968.2006.00365.x; Meier PS, 2005, VACCINE, V23, P2000, DOI 10.1016/j.vaccine.2004.09.036; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Nordstrom T, 2005, J IMMUNOL, V175, P3628, DOI 10.4049/jimmunol.175.6.3628; Nordstrom T, 2004, J IMMUNOL, V173, P4598, DOI 10.4049/jimmunol.173.7.4598; Parameswaran GI, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-178; Singh B, 2010, MOL MICROBIOL, V78, P545, DOI 10.1111/j.1365-2958.2010.07373.x; Spaniol V, 2009, J INFECT DIS, V200, P1593, DOI 10.1086/644640; Tan TT, 2006, J INFECT DIS, V194, P493, DOI 10.1086/505581; Tan TT, 2005, J INFECT DIS, V192, P1029, DOI 10.1086/432759; Verhaegh SJC, 2011, MICROBIOL-SGM, V157, P169, DOI 10.1099/mic.0.042929-0; Virji M, 1999, MOL MICROBIOL, V34, P538, DOI 10.1046/j.1365-2958.1999.01620.x; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Wirth T, 2007, GENOME RES, V17, P1647, DOI 10.1101/gr.6122607; Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101	54	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45452	10.1371/journal.pone.0045452	http://dx.doi.org/10.1371/journal.pone.0045452			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049802	gold, Green Submitted, Green Published			2022-12-27	WOS:000309556100050
J	Garcia, MN; Farias, MSD; Fazzi, L; Grasso, D; Rabinovich, RD; Avila, MM				Noe Garcia, Maria; dos Ramos Farias, Maria Sol; Fazzi, Lucia; Grasso, Daniel; Daniel Rabinovich, Roberto; Mercedes Avila, Maria			Presence of IgG Anti-gp160/120 Antibodies Confers Higher HIV Capture Capacity to Erythrocytes from HIV-Positive Individuals	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; RED-BLOOD-CELLS; IMMUNE-COMPLEXES; T-CELLS; COMPLEMENT; RECEPTOR; ANTIGEN; BINDING; INFECTION; PLASMA	Background: HIV binding has been demonstrated in erythrocytes from HIV-positive and HIV-negative individuals. However, the presence of immunoglobulins G anti-HIV (IgG anti-HIV) in erythrocytes from HIV-positive individuals is still to be elucidated. Moreover, the capacity of erythrocytes from HIV-positive individuals to capture an additional amount of HIV has not been studied. Indeed, it is unknown if HIV binding to erythrocytes in HIV-positive persons could have consequences on the cell-free infectious virus available. Methodology/Principal Findings: IgGs anti-HIV associated to erythrocytes were found in 77.3% (58/75) of the HIV-positive individuals studied and the IgGs anti-gp160 and anti-p24 were the most frequently found. We found a positive association between detectable plasma viral load (pVL) and presence of IgGs anti-HIV associated to erythrocyte (p < 0.005), though the anti-p24/160 were present with or without detectable pVL. The HIV capture capacity was higher in erythrocytes from HIV-positive than HIV-negative individuals (p < 0.0001). Furthermore, among the HIV-positive individuals the higher viral capture capacity was associated with the presence of anti-gp160/gp120 on erythrocytes. Moreover, the viral capture by erythrocytes was independent of pVL (rho = 0.022, p = 0.8817). Additionally, reduction of cell-free infectious virus and available viral load was observed in the presence of erythrocytes from HIV-positive individuals. Conclusions/Significance: Results suggest that in HIV-positive individuals, erythrocytes are capable of capturing high amounts of HIV by the presence of IgGs anti-gp160/120 on their membranes and this may produce a reduction in the available free virus. Finally, the current measurement of pVL would underestimate the real viral quantity due to the HIV binding through specific antibodies to erythrocytes.	[Noe Garcia, Maria; dos Ramos Farias, Maria Sol; Fazzi, Lucia; Daniel Rabinovich, Roberto; Mercedes Avila, Maria] Univ Buenos Aires, Sch Med, Dept Microbiol, Natl Reference Ctr AIDS, Buenos Aires, DF, Argentina; [Grasso, Daniel] Univ Buenos Aires, Sch Pharm & Biochem, Dept Pathophysiol, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Garcia, MN (corresponding author), Univ Buenos Aires, Sch Med, Dept Microbiol, Natl Reference Ctr AIDS, Buenos Aires, DF, Argentina.	mnoegarcia@gmail.com		GRASSO, DANIEL/0000-0002-8932-716X; Garcia, Maria Noe/0000-0002-2167-1298	Argentina's National Agency for Promotion of Science and Technology [PICT 2067]	Argentina's National Agency for Promotion of Science and Technology(ANPCyT)	This work was supported by grants from Argentina's National Agency for Promotion of Science and Technology (www.agencia.gov.ar) (PICT 2067 to MMA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banki Z, 2006, J IMMUNOL, V177, P3469, DOI 10.4049/jimmunol.177.5.3469; Beck Z, 2011, VIROLOGY, V412, P441, DOI 10.1016/j.virol.2011.01.037; Beck Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008297; Bonsch C, 2008, J VIROL, V82, P11784, DOI 10.1128/JVI.01399-08; Carlisle RC, 2009, BLOOD, V113, P1909, DOI 10.1182/blood-2008-09-178459; Farias MSD, 2009, J VIROL METHODS, V158, P6, DOI 10.1016/j.jviromet.2009.01.010; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Hess C, 2002, LANCET, V359, P2230, DOI 10.1016/S0140-6736(02)09291-7; Horakova E, 2004, J IMMUNOL, V173, P4236, DOI 10.4049/jimmunol.173.6.4236; Huber M, 2006, PLOS MED, V3, P2078, DOI 10.1371/journal.pmed.0030441; Lachgar A, 1998, BIOMED PHARMACOTHER, V52, P436, DOI 10.1016/S0753-3322(99)80021-3; MONTEFIORI DC, 1994, J INFECT DIS, V170, P429, DOI 10.1093/infdis/170.2.429; NELSON RA, 1953, SCIENCE, V118, P733, DOI 10.1126/science.118.3077.733; Garcia MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014544; Olinger GG, 2000, J VIROL, V74, P8550, DOI 10.1128/JVI.74.18.8550-8557.2000; SCHIFFERLI JA, 1986, NEW ENGL J MED, V315, P488; SCHIFFERLI JA, 1988, J IMMUNOL, V140, P899; Schupbach J, 2005, JAIDS-J ACQ IMM DEF, V40, P250, DOI 10.1097/01.qai.0000181281.75670.56; Schupbach Jorg, 2002, AIDS Reviews, V4, P83; Zhou JT, 1996, VIROLOGY, V226, P13, DOI 10.1006/viro.1996.0623	20	2	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45808	10.1371/journal.pone.0045808	http://dx.doi.org/10.1371/journal.pone.0045808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049866	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100083
J	Penalosa-Ruiz, G; Aranda, C; Ongay-Larios, L; Colon, M; Quezada, H; Gonzalez, A				Penalosa-Ruiz, Georgina; Aranda, Cristina; Ongay-Larios, Laura; Colon, Maritrini; Quezada, Hector; Gonzalez, Alicia			Paralogous ALT1 and ALT2 Retention and Diversification Have Generated Catalytically Active and Inactive Aminotransferases in Saccharomyces cerevisiae	PLOS ONE			English	Article							OMEGA-AMIDASE PATHWAY; ALANINE AMINOTRANSFERASE; METABOLIC-FLUX; GENE; GLUTAMINE; DEHYDROGENASE; PURIFICATION; DUPLICATION; EXPRESSION; MODEL	Background: Gene duplication and the subsequent divergence of paralogous pairs play a central role in the evolution of novel gene functions. S. cerevisiae possesses two paralogous genes (ALT1/ALT2) which presumably encode alanine aminotransferases. It has been previously shown that Alt1 encodes an alanine aminotransferase, involved in alanine metabolism; however the physiological role of Alt2 is not known. Here we investigate whether ALT2 encodes an active alanine aminotransferase. Principal Findings: Our results show that although ALT1 and ALT2 encode 65% identical proteins, only Alt1 displays alanine aminotransferase activity; in contrast ALT2 encodes a catalytically inert protein. ALT1 and ALT2 expression is modulated by Nrg1 and by the intracellular alanine pool. ALT1 is alanine-induced showing a regulatory profile of a gene encoding an enzyme involved in amino acid catabolism, in agreement with the fact that Alt1 is the sole pathway for alanine catabolism present in S. cerevisiae. Conversely, ALT2 expression is alanine-repressed, indicating a role in alanine biosynthesis, although the encoded-protein has no alanine aminotransferase enzymatic activity. In the ancestral-like yeast L. kluyveri, the alanine aminotransferase activity was higher in the presence of alanine than in the presence of ammonium, suggesting that as for ALT1, LkALT1 expression could be alanine-induced. ALT2 retention poses the questions of whether the encoded protein plays a particular function, and if this function was present in the ancestral gene. It could be hypotesized that ALT2 diverged after duplication, through neo-functionalization or that ALT2 function was present in the ancestral gene, with a yet undiscovered function. Conclusions: ALT1 and ALT2 divergence has resulted in delegation of alanine aminotransferase activity to Alt1. These genes display opposed regulatory profiles: ALT1 is alanine-induced, while ALT2 is alanine repressed. Both genes are negatively regulated by the Nrg1 repressor. Presented results indicate that alanine could act as ALT2 Nrg1-co-repressor.	[Penalosa-Ruiz, Georgina; Aranda, Cristina; Colon, Maritrini; Gonzalez, Alicia] Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estruct, Div Ciencia Basica, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Ongay-Larios, Laura] Univ Nacl Autonoma Mexico, Unidad Biol Mol, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Quezada, Hector] Inst Nacl Cardiol, Dept Bioquim, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; National Institute of Cardiology - Mexico	Gonzalez, A (corresponding author), Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estruct, Div Ciencia Basica, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	amanjarr@ifc.unam.mx	Quezada, Hector/AAJ-8486-2021	Quezada, Hector/0000-0003-2663-4696; Colon-Gonzalez, Maritrini/0000-0001-6821-1726; Penalosa Ruiz, Georgina/0000-0002-7148-6613; Gonzalez, Alicia/0000-0002-1276-5719	Direccion General de Asuntos del Personal Academico, UNAM [IN2042093]; Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico [PIFUTP08-1654]; Consejo Nacional de Ciencia y Tecnologia [152448]; International Centre for Genetic Engineering and Biotechnology [CRP/MEX10-03]	Direccion General de Asuntos del Personal Academico, UNAM(Universidad Nacional Autonoma de Mexico); Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); International Centre for Genetic Engineering and Biotechnology	This study was funded by Direccion General de Asuntos del Personal Academico, UNAM, grant IN2042093 (http://dgapa.unam.mx); Instituto de Ciencia y Tecnologia del Distrito Federal, Mexico, grant PIFUTP08-1654 (http://www.icyt.df.gob.mx), Consejo Nacional de Ciencia y Tecnologia grant 152448, and grant NoCRP/MEX10-03 from the International Centre for Genetic Engineering and Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blank LM, 2005, FEMS YEAST RES, V5, P545, DOI 10.1016/j.femsyr.2004.09.008; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; CALDERON J, 1985, J BACTERIOL, V161, P807; CHICO E, 1978, A VAN LEEUW J MICROB, V44, P193, DOI 10.1007/BF00643222; Colon M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016099; COOPER AJL, 1977, CRC CR REV BIOCH MOL, V4, P281, DOI 10.3109/10409237709102560; de Sousa CAF, 2003, ENVIRON EXP BOT, V50, P1, DOI 10.1016/S0098-8472(02)00108-9; DeLuna A, 2001, J BIOL CHEM, V276, P43775, DOI 10.1074/jbc.M107986200; DEROSA G, 1975, J BIOL CHEM, V250, P7961; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; DOPAZO J, 1994, J MOL EVOL, V38, P300, DOI 10.1007/BF00176092; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; DURAN S, 1995, MICROBIOL-UK, V141, P2883, DOI 10.1099/13500872-141-11-2883; FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2; Feng ZY, 2002, J BACTERIOL, V184, P5001, DOI 10.1128/JB.184.18.5001-5010.2002; Garcia-Campusano F, 2009, CAN J MICROBIOL, V55, P368, DOI [10.1139/W08-150, 10.1139/w08-150]; GATEHOUSE PW, 1967, J BIOL CHEM, V242, P2319; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Ismond KP, 2003, PLANT PHYSIOL, V132, P1292, DOI 10.1104/pp.103.022244; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kursteiner O, 2003, PLANT PHYSIOL, V132, P968, DOI 10.1104/pp.102.016907; Liu L, 2008, PROTEIN EXPRES PURIF, V60, P225, DOI 10.1016/j.pep.2008.04.006; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MCCOWEN SM, 1974, J BACTERIOL, V118, P590, DOI 10.1128/JB.118.2.590-597.1974; MEHTA PK, 1993, EUR J BIOCHEM, V214, P549, DOI 10.1111/j.1432-1033.1993.tb17953.x; QIU HF, 1991, MOL CELL BIOL, V11, P2169, DOI 10.1128/MCB.11.4.2169; Quezada H, 2008, MICROBIOL-SGM, V154, P1656, DOI 10.1099/mic.0.2008/017103-0; Ricoult C, 2005, PHYSIOL PLANTARUM, V123, P30, DOI 10.1111/j.1399-3054.2005.00449.x; Ricoult C, 2006, J EXP BOT, V57, P3079, DOI 10.1093/jxb/erl069; Sato T, 2002, J EXP BOT, V53, P1847, DOI 10.1093/jxb/erf036; Scott EM, 2010, GENE DEV, V24, P1903, DOI 10.1101/gad.1935910; Sellick CA, 2005, TRENDS BIOCHEM SCI, V30, P405, DOI 10.1016/j.tibs.2005.05.007; SOBERON M, 1987, J GEN MICROBIOL, V133, P9; SOBERON M, 1989, J GEN MICROBIOL, V135, P2693; STRUHL K, 1981, J MOL BIOL, V152, P535, DOI 10.1016/0022-2836(81)90267-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UMEMURA I, 1994, BIOSCI BIOTECH BIOCH, V58, P283, DOI 10.1271/bbb.58.283; Vyas VK, 2005, EUKARYOT CELL, V4, P1882, DOI 10.1128/EC.4.11.1882-1891.2005; Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.3.CO;2-B; WANG MD, 1987, J BACTERIOL, V169, P5610, DOI 10.1128/jb.169.12.5610-5614.1987; Wang NC, 2006, APPL MICROBIOL BIOT, V73, P339, DOI 10.1007/s00253-006-0475-6; WEINSTOCK KG, 1993, YEAST, V9, P351, DOI 10.1002/yea.320090405; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yen KY, 2003, YEAST, V20, P1255, DOI 10.1002/yea.1037; Zhou H, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-5	52	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45702	10.1371/journal.pone.0045702	http://dx.doi.org/10.1371/journal.pone.0045702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049841	gold, Green Submitted, Green Published			2022-12-27	WOS:000309556100070
J	Suhr, F; Brenig, J; Muller, R; Behrens, H; Bloch, W; Grau, M				Suhr, Frank; Brenig, Julian; Mueller, Rebecca; Behrens, Hilke; Bloch, Wilhelm; Grau, Marijke			Moderate Exercise Promotes Human RBC-NOS Activity, NO Production and Deformability through Akt Kinase Pathway	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RED-BLOOD-CELLS; PRIMARY PULMONARY-HYPERTENSION; ERYTHROCYTE NA+/H+ EXCHANGE; INDUCED ATP RELEASE; ENDOTHELIAL-CELLS; SMOOTH-MUSCLE; CYCLIC-GMP; MECHANISMS; PHOSPHORYLATION	Background: Nitric oxide (NO) produced by nitric oxide synthase (NOS) in human red blood cells (RBCs) was shown to depend on shear stress and to exhibit important biological functions, such as inhibition of platelet activation. In the present study we hypothesized that exercise-induced shear stress stimulates RBC-NOS activation pathways, NO signaling, and deformability of human RBCs. Methods/Findings: Fifteen male subjects conducted an exercise test with venous blood sampling before and after running on a treadmill for 1 hour. Immunohistochemical staining as well as western blot analysis were used to determine phosphorylation and thus activation of Akt kinase and RBC-NOS as well as accumulation of cyclic guanylyl monophosphate (cGMP) induced by the intervention. The data revealed that activation of NO upstream located enzyme Akt kinase was significantly increased after the test. Phosphorylation of RBC-NOSSer(1177) was also significantly increased after exercise, indicating activation of RBC-NOS through Akt kinase. Total detectable RBC-NOS content and phosphorylation of RBC-NOSThr(495) were not affected by the intervention. NO production by RBCs, determined by DAF fluorometry, and RBC deformability, measured via laser-assisted-optical-rotational red cell analyzer, were also significantly increased after the exercise test. The content of the NO downstream signaling molecule cGMP increased after the test. Pharmacological inhibition of phosphatidylinositol 3 (PI3)-kinase/Akt kinase pathway led to a decrease in RBC-NOS activation, NO production and RBC deformability. Conclusion/Significance: This human in vivo study first-time provides strong evidence that exercise-induced shear stress stimuli activate RBC-NOS via the PI3-kinase/Akt kinase pathway. Actively RBC-NOS-produced NO in human RBCs is critical to maintain RBC deformability. Our data gain insights into human RBC-NOS regulation by exercise and, therefore, will stimulate new therapeutic exercise-based approaches for patients with microvascular disorders.	[Suhr, Frank; Brenig, Julian; Mueller, Rebecca; Behrens, Hilke; Bloch, Wilhelm; Grau, Marijke] German Sport Univ Cologne, Dept Mol & Cellular Sports Med, Cologne, Germany; [Suhr, Frank; Bloch, Wilhelm] German Sport Univ Cologne, German Res Ctr Elite Sport, Cologne, Germany	German Sport University Cologne; German Sport University Cologne	Grau, M (corresponding author), German Sport Univ Cologne, Dept Mol & Cellular Sports Med, Cologne, Germany.	m.grau@dshs-koeln.de	Suhr, Frank/AAU-5080-2021; Grau, Marijke/AAM-7025-2020	Suhr, Frank/0000-0002-9013-3944; Grau, Dr. Marijke/0000-0003-1980-9195	German Research Center of Elite Sport (momentum)	German Research Center of Elite Sport (momentum)	The research described in this article was supported by The German Research Center of Elite Sport (momentum). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstead WM, 1996, AM J PHYSIOL-HEART C, V270, pH423, DOI 10.1152/ajpheart.1996.270.2.H423; Baskurt OK, 2009, CLIN HEMORHEOL MICRO, V42, P75, DOI 10.3233/CH-2009-1202; Bateman RM, 2003, CRIT CARE, V7, P359, DOI 10.1186/cc2353; BOGLE RG, 1991, BIOCHEM BIOPH RES CO, V180, P926, DOI 10.1016/S0006-291X(05)81154-4; Bor-Kucukatay M, 2003, AM J PHYSIOL-HEART C, V284, pH1577, DOI 10.1152/ajpheart.00665.2002; BUSSE R, 1988, AM J PHYSIOL, V254, pH828, DOI 10.1152/ajpheart.1988.254.5.H828; Chmiel B, 2003, TRANSPLANT P, V35, P2163, DOI 10.1016/S0041-1345(03)00760-7; CHO HJ, 1992, J EXP MED, V176, P599, DOI 10.1084/jem.176.2.599; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Espey MG, 2001, J BIOL CHEM, V276, P30085, DOI 10.1074/jbc.M101723200; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; FORSTERMANN U, 1993, EUR HEART J, V14, P10; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Ghafourifar P, 1999, J BIOL CHEM, V274, P31185, DOI 10.1074/jbc.274.44.31185; Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038; Gladwin MT, 2004, FREE RADICAL BIO MED, V36, P707, DOI 10.1016/j.freeradbiomed.2003.11.032; Green DJ, 2004, J PHYSIOL-LONDON, V561, P1, DOI 10.1113/jphysiol.2004.068197; Hardeman MR, 2001, CLIN HEMORHEOL MICRO, V25, P1; Hofmann F, 2000, J CELL SCI, V113, P1671; Huang QB, 1997, AM J PHYSIOL-HEART C, V273, pH2442, DOI 10.1152/ajpheart.1997.273.5.H2442; Itoh Y, 2000, ANAL BIOCHEM, V287, P203, DOI 10.1006/abio.2000.4859; Jubelin BC, 1996, AM J HYPERTENS, V9, P1214, DOI 10.1016/S0895-7061(96)00257-9; Kabanova S, 2009, INT J MED SCI, V6, P156; Kaneko FT, 1998, AM J RESP CRIT CARE, V158, P917, DOI 10.1164/ajrccm.158.3.9802066; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Kroncke KD, 1997, NITRIC OXIDE-BIOL CH, V1, P107, DOI 10.1006/niox.1997.0118; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; LINCOLN TM, 1989, PHARMACOL THERAPEUT, V41, P479, DOI 10.1016/0163-7258(89)90127-7; Ludolph B, 2007, VASC HEALTH RISK MAN, V3, P1069; Malan D, 2004, FASEB J, V18, P1108, DOI 10.1096/fj.03-1158fje; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Mihov D, 2009, AM J PHYSIOL-CELL PH, V297, pC378, DOI 10.1152/ajpcell.00543.2008; Nakatsubo N, 1998, FEBS LETT, V427, P263, DOI 10.1016/S0014-5793(98)00440-2; Ozuyaman B, 2008, TRENDS MOL MED, V14, P314, DOI 10.1016/j.molmed.2008.05.002; de Oliveira S, 2008, CLIN HEMORHEOL MICRO, V39, P363, DOI 10.3233/CH-2008-1101; PETROV V, 1994, EUR J BIOCHEM, V221, P195, DOI 10.1111/j.1432-1033.1994.tb18729.x; Petrov V, 1996, AM J PHYSIOL-CELL PH, V271, pC1556, DOI 10.1152/ajpcell.1996.271.5.C1556; Pries AR, 2003, CLIN HEMORHEOL MICRO, V29, P143; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; Senturk UK, 2001, J APPL PHYSIOL, V91, P1999, DOI 10.1152/jappl.2001.91.5.1999; Sprague RS, 2006, DIABETES, V55, P3588, DOI 10.2337/db06-0555; Sprague RS, 2001, EXP BIOL MED, V226, P434, DOI 10.1177/153537020122600507; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Sprague RS, 1996, AM J PHYSIOL-HEART C, V271, pH2717, DOI 10.1152/ajpheart.1996.271.6.H2717; Suhr F, 2009, NITRIC OXIDE-BIOL CH, V20, P95, DOI 10.1016/j.niox.2008.10.004; SZYGULA Z, 1990, SPORTS MED, V10, P181, DOI 10.2165/00007256-199010030-00004; Ulker P, 2009, BIORHEOLOGY, V46, P121, DOI 10.3233/BIR-2009-0532; Ulker P, 2011, NITRIC OXIDE-BIOL CH, V24, P184, DOI 10.1016/j.niox.2011.03.003; Wan JD, 2008, P NATL ACAD SCI USA, V105, P16432, DOI 10.1073/pnas.0805779105; Yalcin O, 2000, J APPL PHYSIOL, V88, P2074, DOI 10.1152/jappl.2000.88.6.2074; Zhang QJ, 2009, J PHYSIOL-LONDON, V587, P3911, DOI 10.1113/jphysiol.2009.172916	54	76	77	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45982	10.1371/journal.pone.0045982	http://dx.doi.org/10.1371/journal.pone.0045982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049912	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100113
J	Topping, CJ; Dalkvist, T; Grimm, V				Topping, Christopher J.; Dalkvist, Trine; Grimm, Volker			Post-Hoc Pattern-Oriented Testing and Tuning of an Existing Large Model: Lessons from the Field Vole	PLOS ONE			English	Article							MICROTUS-AGRESTIS; SMALL MAMMALS; PERIODIC FLUCTUATIONS; INFORMATION CRITERION; SOCIAL-ORGANIZATION; POPULATION-DENSITY; ECOLOGICAL MODELS; SMALL RODENTS; LIFE-HISTORY; DYNAMICS	Pattern-oriented modeling (POM) is a general strategy for modeling complex systems. In POM, multiple patterns observed at different scales and hierarchical levels are used to optimize model structure, to test and select sub-models of key processes, and for calibration. So far, POM has been used for developing new models and for models of low to moderate complexity. It remains unclear, though, whether the basic idea of POM to utilize multiple patterns, could also be used to test and possibly develop existing and established models of high complexity. Here, we use POM to test, calibrate, and further develop an existing agent-based model of the field vole (Microtus agrestis), which was developed and tested within the ALMaSS framework. This framework is complex because it includes a high-resolution representation of the landscape and its dynamics, of the individual's behavior, and of the interaction between landscape and individual behavior. Results of fitting to the range of patterns chosen were generally very good, but the procedure required to achieve this was long and complicated. To obtain good correspondence between model and the real world it was often necessary to model the real world environment closely. We therefore conclude that post-hoc POM is a useful and viable way to test a highly complex simulation model, but also warn against the dangers of over-fitting to real world patterns that lack details in their explanatory driving factors. To overcome some of these obstacles we suggest the adoption of open-science and open-source approaches to ecological simulation modeling.	[Topping, Christopher J.; Dalkvist, Trine] Aarhus Univ, Dept Biosci, Ronde, Denmark; [Dalkvist, Trine] Roskilde Univ, Dept Environm Social & Spatial Change, Roskilde, Denmark; [Grimm, Volker] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modeling, Leipzig, Germany	Aarhus University; Roskilde University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Topping, CJ (corresponding author), Aarhus Univ, Dept Biosci, Ronde, Denmark.	cjt@dmu.dk	Topping, Christopher J/A-9167-2009	Topping, Christopher J/0000-0003-0874-7603	Danish National Research Council	Danish National Research Council(Danmarks Grundforskningsfond)	TD received financial support from the Danish National Research Council. There were no other external funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRELL J, 1995, BEHAV ECOL, V6, P182, DOI 10.1093/beheco/6.2.182; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; Bierman SM, 2006, AM NAT, V167, P583, DOI 10.1086/501076; Borowski Z, 2003, ACTA THERIOL, V48, P325, DOI 10.1007/BF03194172; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Christensen J.T., 1978, Natura Jutlandica, V20, P163; CLARKE JR, 1977, OIKOS, V29, P457, DOI 10.2307/3543587; Dalkvist T, 2009, ECOTOX ENVIRON SAFE, V72, P1663, DOI 10.1016/j.ecoenv.2008.10.002; Dalkvist T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022834; Dietterich T, 1995, ACM COMPUT SURV, V27, P326, DOI 10.1145/212094.212114; Dyczkowski J, 1998, MAMMAL REV, V28, P165, DOI 10.1046/j.1365-2907.1998.00032.x; Elton C., 1942, VOLES MICE LEMMINGS; Elton CS, 1924, BR J EXP BIOL, V2, P119; Flowerdew JR, 2004, MAMMAL REV, V34, P31, DOI 10.1046/j.0305-1838.2003.00025.x; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 1996, SCI TOTAL ENVIRON, V183, P151, DOI 10.1016/0048-9697(95)04966-5; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2012, PHILOS T R SOC B, V367, P298, DOI 10.1098/rstb.2011.0180; Grimm Volker, 2002, Natural Resource Modeling, V15, P23; HAKKARAINEN H, 1992, ANN ZOOL FENN, V29, P279; Hammershoj Mette, 1998, Flora og Fauna, V104, P1; HANSKI I, 1991, J ANIM ECOL, V60, P353, DOI 10.2307/5465; HANSSON L, 1985, OECOLOGIA, V67, P394, DOI 10.1007/BF00384946; Hansson L, 1999, OIKOS, V86, P159, DOI 10.2307/3546581; HANSSON L, 1968, OIKOS, V19, P53, DOI 10.2307/3564730; HANSSON L, 1975, OIKOS, V26, P398, DOI 10.2307/3543513; Hartig F, 2011, ECOL LETT, V14, P816, DOI 10.1111/j.1461-0248.2011.01640.x; Hendrichsen Ditte K., 2009, BMC Ecology, V9, P10, DOI 10.1186/1472-6785-9-10; HORNFELDT B, 1994, ECOLOGY, V75, P791, DOI 10.2307/1941735; Huitu O, 2003, ECOLOGY, V84, P2108, DOI 10.1890/02-0040; Huitu O, 2008, OECOLOGIA, V155, P53, DOI 10.1007/s00442-007-0885-x; Jaarola M, 2002, MOL ECOL, V11, P2613, DOI 10.1046/j.1365-294X.2002.01639.x; Jensen T.S., 2003, FLORA FAUNA, V109, P9; Jepsen JU, 2005, AGR ECOSYST ENVIRON, V105, P581, DOI 10.1016/j.agee.2004.08.007; Jepsen JU, 2005, ECOL MODEL, V181, P445, DOI 10.1016/j.ecolmodel.2003.11.019; Jepsen JU, 2004, CAN J ZOOL, V82, P1528, DOI 10.1139/Z04-131; Kleijnen J.P.C., 2008, DESIGN ANAL SIMULATI; KOSKELA E, 1995, BEHAV ECOL, V6, P311, DOI 10.1093/beheco/6.3.311; Lambin X, 2000, J ANIM ECOL, V69, P106, DOI 10.1046/j.1365-2656.2000.00380.x; Latombe G, 2011, ECOL MODEL, V222, P1557, DOI 10.1016/j.ecolmodel.2011.02.020; Lenth R., 2019, Journal of Statistical Software, V60, P1; Lopes JS, 2010, INFECT GENET EVOL, V10, P826, DOI 10.1016/j.meegid.2009.10.010; Loughran MFE, 2006, ACTA THERIOL, V51, P233, DOI 10.1007/BF03192675; MARCSTROM V, 1990, J ANIM ECOL, V59, P753, DOI 10.2307/4893; MYLLYMAKI A, 1977, OIKOS, V29, P468, DOI 10.2307/3543588; Nabe-Nielsen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008932; Piou C, 2009, ECOL MODEL, V220, P1957, DOI 10.1016/j.ecolmodel.2009.05.003; Railsback S.F., 2011, AGENT BASED INDIVIDU; Railsback SF, 2001, ECOL MODEL, V139, P47, DOI 10.1016/S0304-3800(01)00228-9; Ruger N, 2008, ECOSYSTEMS, V11, P868, DOI 10.1007/s10021-008-9166-8; Rykiel EJ, 1996, ECOL MODEL, V90, P229, DOI 10.1016/0304-3800(95)00152-2; Saltelli A., 2004, SENSITIVITY ANAL PRA, V1, DOI 10.1002/0470870958; SANDELL M, 1991, OECOLOGIA, V86, P153, DOI 10.1007/BF00317525; SANDELL M, 1990, OECOLOGIA, V83, P145, DOI 10.1007/BF00317745; Scheller RM, 2010, FRONT ECOL ENVIRON, V8, P253, DOI 10.1890/080141; Schmidt NM, 2005, BASIC APPL ECOL, V6, P57, DOI 10.1016/j.baae.2004.09.009; Schmidt NM, 2003, DJF RAPPORT MARKBRUG, V91, P157; Sitch S, 2000, THESIS LUND U LUND; Smith MJ, 2006, AM NAT, V167, P695, DOI 10.1086/503119; Stillman RA, 2010, BIOL REV, V85, P413, DOI 10.1111/j.1469-185X.2009.00106.x; Tattersall FH, 2000, BIOL CONSERV, V96, P123, DOI 10.1016/S0006-3207(99)00098-1; Topping C, 2003, ANN ZOOL FENN, V40, P255; Topping C, 2005, VEGETATION GROWTH SI; Topping CJ, 2010, ECOL MODEL, V221, P245, DOI 10.1016/j.ecolmodel.2009.09.014; Topping CJ, 2011, ECOL ENG, V37, P2009, DOI 10.1016/j.ecoleng.2011.08.010; Topping CJ, 2010, ECOL MODEL, V221, P729, DOI 10.1016/j.ecolmodel.2009.11.004; Topping CJ, 2005, ECOTOXICOLOGY, V14, P925, DOI 10.1007/s10646-005-0027-3; Topping CJ, 2004, ENVIRON TOXICOL CHEM, V23, P509, DOI 10.1897/02-524a; Topping CJ, 2003, ECOL MODEL, V167, P65, DOI 10.1016/S0304-3800(03)00173-X; Tyre AJ, 2001, ECOL APPL, V11, P1722, DOI 10.2307/3061091; Wheeler P, 2005, ACTA THERIOL, V50, P483, DOI 10.1007/BF03192641; Wheeler P, 2008, AGR ECOSYST ENVIRON, V123, P49, DOI 10.1016/j.agee.2007.04.003; Wiegand T, 2004, BIODIVERS CONSERV, V13, P53, DOI 10.1023/B:BIOC.0000004313.86836.ab; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; Zurell D, 2010, OIKOS, V119, P622, DOI 10.1111/j.1600-0706.2009.18284.x	76	24	24	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45872	10.1371/journal.pone.0045872	http://dx.doi.org/10.1371/journal.pone.0045872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049882	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100095
J	d'Onofrio, A; Manfredi, P; Poletti, P				d'Onofrio, Alberto; Manfredi, Piero; Poletti, Piero			The Interplay of Public Intervention and Private Choices in Determining the Outcome of Vaccination Programmes	PLOS ONE			English	Article							BEHAVIOR; GAME; INFORMATION; OSCILLATORITY; TRANSMISSION; AWARENESS; DYNAMICS; DISEASES; SPREAD; IMPACT	After a long period of stagnation, traditionally explained by the voluntary nature of the programme, a considerable increase in routine measles vaccine uptake has been recently observed in Italy after a set of public interventions aiming to promote MMR immunization, whilst retaining its voluntary aspect. To account for this take-off in coverage we propose a simple SIR transmission model with vaccination choice, where, unlike similar works, vaccinating behaviour spreads not only through the diffusion of "private'' information spontaneously circulating among parents of children to be vaccinated, which we call imitation, but also through public information communicated by the public health authorities. We show that public intervention has a stabilising role which is able to reduce the strength of imitation-induced oscillations, to allow disease elimination, and to even make the disease-free equilibrium where everyone is vaccinated globally attractive. The available Italian data are used to evaluate the main behavioural parameters, showing that the proposed model seems to provide a much more plausible behavioural explanation of the observed take-off of uptake of vaccine against measles than models based on pure imitation alone.	[Manfredi, Piero] Univ Pisa, Dept Stat & Appl Math, Pisa, Italy; [d'Onofrio, Alberto] European Inst Oncol, Dept Expt Oncol, Milan, Italy; [Poletti, Piero] Fdn Bruno Kessler, Trento, Italy; [Poletti, Piero] Bocconi Univ, DONDENA Ctr Res Social Dynam, Milan, Italy	University of Pisa; IRCCS European Institute of Oncology (IEO); Fondazione Bruno Kessler; Bocconi University	Manfredi, P (corresponding author), Univ Pisa, Dept Stat & Appl Math, Pisa, Italy.	manfredi@ec.unipi.it	d'Onofrio, Alberto/R-4683-2016	d'Onofrio, Alberto/0000-0002-2190-272X; Poletti, Piero/0000-0001-5453-5199				BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; Bauch CT, 2005, P ROY SOC B-BIOL SCI, V272, P1669, DOI 10.1098/rspb.2005.3153; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Bhattacharyya S, 2010, J THEOR BIOL, V267, P276, DOI 10.1016/j.jtbi.2010.09.005; Chen FH, 2009, MATH BIOSCI, V217, P125, DOI 10.1016/j.mbs.2008.11.005; Cornforth DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001062; d'Onofrio A, 2007, THEOR POPUL BIOL, V71, P301, DOI 10.1016/j.tpb.2007.01.001; d'Onofrio A, 2011, J THEOR BIOL, V273, P63, DOI 10.1016/j.jtbi.2010.12.029; d'Onofrio A, 2010, J THEOR BIOL, V264, P237, DOI 10.1016/j.jtbi.2010.02.007; D'Onofrio A, 2008, MATH MED BIOL, V25, P337, DOI 10.1093/imammb/dqn019; Del Valle S, 2005, MATH BIOSCI, V195, P228, DOI 10.1016/j.mbs.2005.03.006; Efimov DV, 2009, SIAM J CONTROL OPTIM, V48, P618, DOI 10.1137/070706963; Efimov DV, 2008, MATH BIOSCI, V216, P187, DOI 10.1016/j.mbs.2008.10.003; Ferguson N, 2007, NATURE, V446, P733, DOI 10.1038/446733a; Ferro A, 2008, Ann Ig, V20, P3; Funk S, 2010, J THEOR BIOL, V264, P501, DOI 10.1016/j.jtbi.2010.02.032; Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142; Funk S, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.036118; Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106; Geoffard PY, 1997, AM ECON REV, V87, P222; Hatzopoulos V, 2011, MATH BIOSCI, V231, P197, DOI 10.1016/j.mbs.2011.03.006; ICONA Working group, 2008, 0929 ICONA WORK GROU; ICONA Working group, 1998, 9833 ICONA WORK GROU; ICONA Working group, 2003, 0337 ICONA WORK GROU; Istituto Superiore di Sanita, 2003, 032 I SUP SAN; Kiss IZ, 2010, MATH BIOSCI, V225, P1, DOI 10.1016/j.mbs.2009.11.009; Manfredi P, 2009, VACCINE, V28, P98, DOI 10.1016/j.vaccine.2009.09.109; Perisic A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000280; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016460; Poletti P, 2009, J THEOR BIOL, V260, P31, DOI 10.1016/j.jtbi.2009.04.029; Reluga TC, 2006, MATH BIOSCI, V204, P185, DOI 10.1016/j.mbs.2006.08.015; Reluga TC, 2011, MATH BIOSCI, V230, P67, DOI 10.1016/j.mbs.2011.01.003; Reluga Timothy C., 2009, Journal of Biological Dynamics, V3, P515, DOI 10.1080/17513750802638399; Salmon DA, 2006, LANCET, V367, P436, DOI 10.1016/S0140-6736(06)68144-0; Shim E, 2009, MATH BIOSCI ENG, V6, P839, DOI 10.3934/mbe.2009.6.839; South Staffordshire NHS, 2010, DIR ENH SERV CHILDH; UK Department of Health, 2011, GREEN BOOK IMM; Vardavas Raffaele, 2010, BMC Res Notes, V3, P92, DOI 10.1186/1756-0500-3-92	38	45	45	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45653	10.1371/journal.pone.0045653	http://dx.doi.org/10.1371/journal.pone.0045653			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049682	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388500009
J	Ringelhan, M; Schmid, RM; Geisler, F				Ringelhan, Marc; Schmid, Roland M.; Geisler, Fabian			The NF-kappa B Subunit RelA/p65 Is Dispensable for Successful Liver Regeneration after Partial Hepatectomy in Mice	PLOS ONE			English	Article							TNF-INDUCED APOPTOSIS; IKK-BETA; INTERLEUKIN-6-DEFICIENT MICE; MOUSE HEPATOCYTES; C-JUN; ACTIVATION; PROLIFERATION; INHIBITION; DELETION; GROWTH	Background: The transcription factor NF-kappa B consisting of the subunits RelA/p65 and p50 is known to be quickly activated after partial hepatectomy (PH), the functional relevance of which is still a matter of debate. Current concepts suggest that activation of NF-kappa B is especially critical in non-parenchymal cells to produce cytokines (TNF, IL-6) to adequately prime hepatocytes to proliferate after PH, while NF-kappa B within hepatocytes mainly bears cytoprotective functions. Methods: To study the role of the NF-kappa B pathway in different liver cell compartments, we generated conditional knockout mice in which the transactivating NF-kappa B subunit RelA/p65 can be inactivated specifically in hepatocytes (Rela(F/F)AlbCre) or both in hepatocytes plus non-parenchymal cells including Kupffer cells (Rela(F/F)MxCre). 2/3 and 80% PH were performed in controls (Rela(F/F)) and conditional knockout mice (Rela(F/F)AlbCre and Rela(F/F)MxCre) and analyzed for regeneration. Results: Hepatocyte-specific deletion of RelA/p65 in Rela(F/F)AlbCre mice resulted in an accelerated cell cycle progression without altering liver mass regeneration after 2/3 PH. Surprisingly, hepatocyte apoptosis or liver damage were not enhanced in Rela(F/F)AlbCre mice, even when performing 80% PH. The additional inactivation of RelA/p65 in non-parenchymal cells in Rela(F/F)MxCre mice reversed the small proliferative advantage observed after hepatocyte-specific deletion of RelA/p65 so that Rela(F/F)MxCre mice displayed normal cell cycle progression, DNA-synthesis and liver mass regeneration. Conclusion: The NF-kappa B subunit RelA/p65 fulfills opposite functions in different liver cell compartments in liver regeneration after PH. However, the effects observed after conditional deletion of RelA/p65 are small and do not alter liver mass regeneration after PH. We therefore do not consider RelA/p65-containing canonical NF-kappa B signalling to be essential for successful liver regeneration after PH.	[Ringelhan, Marc; Schmid, Roland M.; Geisler, Fabian] Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-8000 Munich, Germany	Technical University of Munich	Geisler, F (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Med 2, D-8000 Munich, Germany.	fabian.geisler@lrz.tum.de		Ringelhan, Marc/0000-0003-3131-5657	Else Kroner-Fresenius-Stiftung (EKFS) [P10/07]	Else Kroner-Fresenius-Stiftung (EKFS)	This work has been supported by a grant from the Else Kroner-Fresenius-Stiftung (EKFS, grant P10/07 to F.G. and R.M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algul H, 2007, J CLIN INVEST, V117, P1490, DOI 10.1172/JCI29882; Beraza N, 2007, GASTROENTEROLOGY, V132, P2504, DOI 10.1053/j.gastro.2007.03.045; Bettermann K, CANC CELL, V17, P481; Blindenbacher A, 2003, HEPATOLOGY, V38, P674, DOI 10.1053/jhep.2003.50378; Boyce S, 2008, LAB ANIMAL, V37, P529, DOI 10.1038/laban1108-529; Campbell JS, 2006, J IMMUNOL, V176, P2522, DOI 10.4049/jimmunol.176.4.2522; Cataldegirmen G, 2005, J EXP MED, V201, P473, DOI 10.1084/jem.20040934; Chaisson ML, 2002, J CLIN INVEST, V110, P193, DOI 10.1172/JCI200215295; Chakraborty JB, 2010, J HEPATOL, V52, P285, DOI 10.1016/j.jhep.2009.10.030; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; CRESSMAN DE, 1994, J BIOL CHEM, V269, P30429; Doerr RJ, 1990, CLIN ANAT, V3, P279; Factor VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012739; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2000, J HEPATOL, V32, P19, DOI 10.1016/S0168-8278(00)80412-2; Fujita J, 2001, SURGERY, V129, P48, DOI 10.1067/msy.2001.109120; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Geisler F, 2007, GASTROENTEROLOGY, V132, P2489, DOI 10.1053/j.gastro.2007.03.033; Greene AK, 2003, J INVEST SURG, V16, P99, DOI 10.1080/08941930390194424; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hayashi H, 2005, LIVER INT, V25, P162, DOI 10.1111/j.1478-3231.2005.01029.x; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Koch KS, 2009, BIOCHEM BIOPH RES CO, V380, P349, DOI 10.1016/j.bbrc.2009.01.085; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Liu HL, 2002, HEPATOLOGY, V35, P772, DOI 10.1053/jhep.2002.32534; Luedde T, 2005, J CLIN INVEST, V115, P849, DOI 10.1172/JCI200523493; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Malato Y, 2009, J HEPATOL, V50, pS310, DOI 10.1016/S0168-8278(09)60853-9; Malato Y, 2008, HEPATOLOGY, V47, P2036, DOI 10.1002/hep.22264; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Paulsen J E, 1990, In Vivo, V4, P235; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Sakamoto T, 1999, HEPATOLOGY, V29, P403, DOI 10.1002/hep.510290244; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Seki E, 2005, HEPATOLOGY, V41, P443, DOI 10.1002/hep.20603; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Trautwein C, 1996, GASTROENTEROLOGY, V110, P1854, DOI 10.1053/gast.1996.v110.pm8964411; Vaquero J, 2011, HEPATOLOGY, V54, P597, DOI 10.1002/hep.24420; Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568; Wuestefeld T, 2003, J BIOL CHEM, V278, P11281, DOI 10.1074/jbc.M208470200; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yang L, 2005, AM J PHYSIOL-GASTR L, V289, pG530, DOI 10.1152/ajpgi.00526.2004; YOKOYAMA HO, 1953, CANCER RES, V13, P80	51	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46469	10.1371/journal.pone.0046469	http://dx.doi.org/10.1371/journal.pone.0046469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049704	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388500031
J	Edinger, RS; Bertrand, CA; Rondandino, C; Apodaca, GA; Johnson, JP; Butterworth, MB				Edinger, Robert S.; Bertrand, Carol A.; Rondandino, Christine; Apodaca, Gerard A.; Johnson, John P.; Butterworth, Michael B.			The Epithelial Sodium Channel (ENaC) Establishes a Trafficking Vesicle Pool Responsible for Its Regulation	PLOS ONE			English	Article							POLYMERIC IMMUNOGLOBULIN RECEPTOR; CELL-SURFACE EXPRESSION; COLLECTING DUCT CELLS; NA+ CHANNELS; UREA TRANSPORTERS; PLASMA-MEMBRANE; SERINE PROTEASES; AQUAPORIN-2 TRAFFICKING; ACCESSORY PROTEINS; APICAL MEMBRANE	The epithelial sodium channel (ENaC) is the rate-limiting step for sodium reabsorption across tight epithelia. Cyclic-AMP (cAMP) stimulation promotes ENaC trafficking to the apical surface to increase channel number and transcellular Na+ transport. Removal of corticosteroid supplementation in a cultured cortical collecting duct cell line reduced ENaC expression. Concurrently, the number of vesicles trafficked in response to cAMP stimulation, as measured by a change in membrane capacitance, also decreased. Stimulation with aldosterone restored both the basal and cAMP-stimulated ENaC activity and increased the number of exocytosed vesicles. Knocking down ENaC directly decreased both the cAMP-stimulated short-circuit current and capacitance response in the presence of aldosterone. However, constitutive apical recycling of the Immunoglobulin A receptor was unaffected by alterations in ENaC expression or trafficking. Fischer Rat Thyroid cells, transfected with alpha,beta,gamma-mENaC had a significantly greater membrane capacitance response to cAMP stimulation compared to non-ENaC controls. Finally, immunofluorescent labeling and quantitation revealed a smaller number of vesicles in cells where ENaC expression was reduced. These findings indicate that ENaC is not a passive passenger in regulated epithelial vesicle trafficking, but plays a role in establishing and maintaining the pool of vesicles that respond to cAMP stimulation.	[Bertrand, Carol A.; Apodaca, Gerard A.; Johnson, John P.; Butterworth, Michael B.] Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA; [Edinger, Robert S.; Rondandino, Christine; Apodaca, Gerard A.; Johnson, John P.] Univ Pittsburgh, Sch Med, Dept Med, Renal Electrolyte Div, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Butterworth, MB (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol, Pittsburgh, PA 15260 USA.	michael7@pitt.edu	Apodaca, Gerard/HCJ-0048-2022; Rondanino, Christine/S-6880-2018	Rondanino, Christine/0000-0002-1100-9401; Butterworth, Michael/0000-0002-2173-8333	National Institutes of Health [R00DK078917, R37DK54425, R01DK077777, R01DK047874, P30DK079307]; CFF grant [BERTRA12G0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047874, R01DK077777, R01DK054814, P30DK079307, R37DK054425, R00DK078917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFF grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the following grants: National Institutes of Health grants R00DK078917 to MBB, R37DK54425 and R01DK077777 to GAA and R01DK047874 to JPP and by P30DK079307 for imaging and electrophysiological cores. CFF grant BERTRA12G0 to CAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebamiro A, 2005, J GEN PHYSIOL, V126, P339, DOI 10.1085/jgp.200509285; Adebamiro A, 2007, J GEN PHYSIOL, V130, P611, DOI 10.1085/jgp.200709781; APODACA G, 1991, J CLIN INVEST, V87, P1877, DOI 10.1172/JCI115211; APODACA G, 1993, J BIOL CHEM, V268, P23712; Bagnasco SM, 2005, PFLUG ARCH EUR J PHY, V450, P217, DOI 10.1007/s00424-005-1403-9; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; BRADBURY NA, 1992, SCIENCE, V256, P530, DOI 10.1126/science.1373908; Brown D, 2003, AM J PHYSIOL-RENAL, V284, pF893, DOI 10.1152/ajprenal.00387.2002; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Butterworth MB, 2005, AM J PHYSIOL-RENAL, V289, pF969, DOI 10.1152/ajprenal.00390.2003; Butterworth MB, 2005, J GEN PHYSIOL, V125, P81, DOI 10.1085/jgp.2004.09124; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Butterworth MB, 2012, AM J PHYSIOL-RENAL, V302, pF581, DOI 10.1152/ajprenal.00304.2011; Butterworth MB, 2010, BBA-MOL BASIS DIS, V1802, P1166, DOI 10.1016/j.bbadis.2010.03.010; Butterworth MB, 2009, AM J PHYSIOL-RENAL, V296, pF10, DOI 10.1152/ajprenal.90248.2008; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Castle A, 2005, J CELL SCI, V118, P3769, DOI 10.1242/jcs.02503; Christensen BM, 1998, AM J PHYSIOL-RENAL, V275, pF285, DOI 10.1152/ajprenal.1998.275.2.F285; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Ecelbarger CA, 2001, EXP NEUROL, V171, P227, DOI 10.1006/exnr.2001.7775; Ecelbarger CA, 1999, FASEB J, V13, pA392; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Fosch H, 2008, CURR OPIN CELL BIOL, V20, P208, DOI 10.1016/j.ceb.2008.01.003; Frindt G, 2008, J GEN PHYSIOL, V131, P617, DOI 10.1085/jgp.200809989; Frindt G, 2010, AM J PHYSIOL-RENAL, V299, pF890, DOI 10.1152/ajprenal.00323.2010; Frindt G, 2009, AM J PHYSIOL-RENAL, V297, pF1249, DOI 10.1152/ajprenal.00401.2009; Frokiaer J, 2005, J AM SOC NEPHROL, V16, P2827, DOI 10.1681/ASN.2005080850; Gormley K, 2003, BIOCHEM J, V371, P1, DOI 10.1042/BJ20021375; Hamm LL, 2010, CURR OPIN NEPHROL HY, V19, P98, DOI 10.1097/MNH.0b013e328332bda4; Hill WG, 2007, J BIOL CHEM, V282, P37402, DOI 10.1074/jbc.M704084200; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Hughey RP, 2004, J BIOL CHEM, V279, P48491, DOI 10.1074/jbc.C400460200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Inoue T, 1999, AM J PHYSIOL-RENAL, V276, pF559, DOI 10.1152/ajprenal.1999.276.4.F559; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Karpushev AV, 2008, BIOCHEM BIOPH RES CO, V377, P521, DOI 10.1016/j.bbrc.2008.10.014; Kleyman TR, 2006, KIDNEY INT, V70, P1391, DOI 10.1038/sj.ki.5001860; Knight KK, 2006, P NATL ACAD SCI USA, V103, P2805, DOI 10.1073/pnas.0511184103; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; Leonard D, 2008, J CELL SCI, V121, P3445, DOI 10.1242/jcs.031484; Leung SM, 2000, MOL BIOL CE IN PRESS; Liang X, 2008, J BIOL CHEM; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; LINDSTEDT R, 1993, J BIOL CHEM, V268, P11750; Liu L, 2002, HYPERTENSION, V39, P860, DOI 10.1161/01.HYP.0000013055.48885.8D; McDonald FJ, 2002, AM J PHYSIOL-RENAL, V283, pF431, DOI 10.1152/ajprenal.00080.2002; MOSTOV K, 1992, J CELL BIOL, V116, P577, DOI 10.1083/jcb.116.3.577; Myerburg MM, 2006, J BIOL CHEM, V281, P27942, DOI 10.1074/jbc.M606449200; Noda Y, 2005, BIOL CELL, V97, P885; Ohara M, 2002, BIOCHEM BIOPH RES CO, V299, P285, DOI 10.1016/S0006-291X(02)02634-7; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Planes C, 2007, CURR TOP DEV BIOL, V78, P23, DOI 10.1016/S0070-2153(06)78002-4; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; Rojas R, 2002, NAT REV MOL CELL BIO, V3, P944, DOI 10.1038/nrm972; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Rossier BC, 2009, ANNU REV PHYSIOL, V71, P361, DOI 10.1146/annurev.physiol.010908.163108; Rotin D, 2000, CURR OPIN NEPHROL HY, V9, P529, DOI 10.1097/00041552-200009000-00012; Rotin D, 2001, AM J PHYSIOL-RENAL, V281, pF391, DOI 10.1152/ajprenal.2001.281.3.F391; Sands JM, 2004, CURR OPIN NEPHROL HY, V13, P525, DOI 10.1097/00041552-200409000-00008; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; SONG WX, 1994, J BIOL CHEM, V269, P29474; Soundararajan R, 2009, P NATL ACAD SCI USA, V106, P7804, DOI 10.1073/pnas.0809892106; Staub O, 2000, KIDNEY INT, V57, P809, DOI 10.1046/j.1523-1755.2000.00919.x; Tahirovic S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001644; Tajika Y, 2004, ENDOCRINOLOGY, V145, P4375, DOI 10.1210/en.2004-0073; Valenti G, 2005, ENDOCRINOLOGY, V146, P5063, DOI 10.1210/en.2005-0868; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Wang H, 2006, J BIOL CHEM, V281, P14129, DOI 10.1074/jbc.M512511200; Wang WD, 2006, AM J PHYSIOL-RENAL, V290, pF530, DOI 10.1152/ajprenal.00070.2005; Wang WH, 2006, AM J PHYSIOL-RENAL, V290, pF14, DOI 10.1152/ajprenal.00093.2005; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615; Wiemuth D, 2007, BIOCHEM J, V405, P147, DOI 10.1042/BJ20060747; Yoo D, 2003, J BIOL CHEM, V278, P23066, DOI 10.1074/jbc.M212301200; Yudowski GA, 2009, MOL BIOL CELL, V20, P2774, DOI 10.1091/mbc.E08-08-0892; Zhou R, 2007, J BIOLCHEM; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200; Zhou RF, 2010, J BIOL CHEM, V285, P30523, DOI 10.1074/jbc.M110.150755	81	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46593	10.1371/journal.pone.0046593	http://dx.doi.org/10.1371/journal.pone.0046593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029554	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000309973900188
J	Kroepil, F; Fluegen, G; Totikov, Z; Baldus, SE; Vay, C; Schauer, M; Topp, SA; Esch, JSA; Knoefel, WT; Stoecklein, NH				Kroepil, Feride; Fluegen, Georg; Totikov, Zaurbek; Baldus, Stephan E.; Vay, Christian; Schauer, Matthias; Topp, Stefan A.; Esch, Jan Schulte Am; Knoefel, Wolfram T.; Stoecklein, Nikolas H.			Down-Regulation of CDH1 Is Associated with Expression of SNAI1 in Colorectal Adenomas	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; N-CADHERIN; CELLS DISSEMINATE; REPRESSOR SNAIL; BONE-MARROW; STEM-CELLS; CANCER; OVEREXPRESSION; PROGRESSION	Introduction: Down-regulation of E-cadherin (CDH1) and epithelial-mesenchymal transition (EMT) are considered critical events for invasion and metastasis of colorectal carcinoma. Here we tested whether the important regulators of E-cadherin expression SNAI1 and TWIST1 are already detectable in human colorectal adenomas. Methods: RNA was extracted from a set of randomly selected formalin-fixed and paraffin-embedded (FFPE) colorectal adenomas (n = 41) and normal colon mucosa (n = 10). Subsequently mRNA expression of CDH1, CDH2, SNAI1 and TWIST1 was analysed by quantitative RT-PCR analysis. CDH1 as well as SNAI1 protein expression were assessed by immunohistochemistry (IHC). Results: SNAI1 mRNA was expressed in 78% (n = 32/41), TWIST1 mRNA in 41% (n = 17/41) and CDH2 mRNA in 41% (n = 17/41) of the colorectal adenoma tissue, while normal colon mucosa was negative for these transcription factors. We found a significant correlation between reduced CDH1 and the presence of SNAI1 mRNA expression and for combined SNAI1 and TWIST1 mRNA expression, respectively. A correlation between CDH2 mRNA expression and reduced CDH1 expression was not observed. We confirmed the relationship between SNAI1 expression and reduced E-cadherin expression on the protein level via IHC. Conclusion: Our data show that SNAI1 and Twist1 are already expressed in benign precursor lesions of colorectal cancer and that SNAI1 expression was significantly correlated with lower expression of CDH1. Whether these findings reflect true EMT and/or are a sign of a more aggressive biology need to be investigated in further studies.	[Kroepil, Feride; Fluegen, Georg; Totikov, Zaurbek; Vay, Christian; Schauer, Matthias; Topp, Stefan A.; Esch, Jan Schulte Am; Knoefel, Wolfram T.; Stoecklein, Nikolas H.] Univ Hosp Dusseldorf, Dept Gen Visceral & Pediat Surg, Dusseldorf, Germany; [Baldus, Stephan E.] Univ Hosp Dusseldorf, Inst Pathol, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Stoecklein, NH (corresponding author), Univ Hosp Dusseldorf, Dept Gen Visceral & Pediat Surg, Dusseldorf, Germany.	nikolas.stoecklein@uni-duesseldorf.de	Esch, Jan Schulte am/AAL-9904-2021; Kroepil, Feride/M-9755-2013	Esch, Jan Schulte am/0000-0002-2101-5012; 	Forschungskommission der Medizinischen Fakultat Dusseldorf [9772354]; Rudolf Bartling Stiftung [II/89]	Forschungskommission der Medizinischen Fakultat Dusseldorf; Rudolf Bartling Stiftung	This study was supported by a grant from the Forschungskommission (grant number 9772354) der Medizinischen Fakultat Dusseldorf (to F. Kroepil, S.E. Baldus and N.H. Stoecklein) and by a grant from the Rudolf Bartling Stiftung (II/89)(to N.H. Stoecklein). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blechschmidt K, 2008, BRIT J CANCER, V98, P489, DOI 10.1038/sj.bjc.6604115; Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Franci C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005595; GAGLIARDI G, 1995, VIRCHOWS ARCH, V426, P149; Gomez I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018023; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao XP, 1997, ANTICANCER RES, V17, P2241; Hazan RB, 2004, ANN NY ACAD SCI, V1014, P155, DOI 10.1196/annals.1294.016; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Larriba MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010221; Jungck M, 2004, INT J COLORECTAL DIS, V19, P438, DOI 10.1007/s00384-003-0575-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Marsman WA, 2005, GUT, V54, P1821, DOI 10.1136/gut.2005.078774; McDonald SAC, 2006, NAT CLIN PRACT GASTR, V3, P267, DOI 10.1038/ncpgasthep0473; Medema JP, 2011, NATURE, V474, P318, DOI 10.1038/nature10212; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Oda H, 1998, DEV BIOL, V203, P435, DOI 10.1006/dbio.1998.9047; Okada T, 2010, GENE CHROMOSOME CANC, V49, P452, DOI 10.1002/gcc.20755; Pantel K, 2011, CLIN CHEM; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Raffel A, 2010, EUR J ENDOCRINOL, V162, P391, DOI 10.1530/EJE-08-0916; Risio M, 2010, BEST PRACT RES CL GA, V24, P397, DOI 10.1016/j.bpg.2010.08.002; Rosivatz E, 2004, INT J CANCER, V111, P711, DOI 10.1002/ijc.20317; Rosivatz E, 2002, AM J PATHOL, V161, P1881, DOI 10.1016/S0002-9440(10)64464-1; Roussos ET, 2010, CANCER RES, V70, P7360, DOI 10.1158/0008-5472.CAN-10-1208; Roy HK, 2005, DIGEST DIS SCI, V50, P42, DOI 10.1007/s10620-005-1275-z; Sanger N, 2011, INT J CANC; Savagner P, 2005, J CELL PHYSIOL, V202, P858, DOI 10.1002/jcp.20188; Schmelzle M, 2011, PROSTAG OTH LIPID M, V94, P25, DOI 10.1016/j.prostaglandins.2010.12.001; Steinert R, 2005, GUT, V54, P1045, DOI 10.1136/gut.2004.062216; Tannapfel A, 2010, DTSCH ARZTEBL INT, V107, P760, DOI 10.3238/arztebl.2010.0760; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Valdes-Mora F, 2009, ANN SURG ONCOL, V16, P78, DOI 10.1245/s10434-008-0166-x; Valizadeh A, 1997, AM J PATHOL, V150, P1977	38	47	47	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46665	10.1371/journal.pone.0046665	http://dx.doi.org/10.1371/journal.pone.0046665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029563	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900197
J	Tirado-Velez, JM; Joumady, I; Saez-Benito, A; Cozar-Castellano, I; Perdomo, G				Manuel Tirado-Velez, Jose; Joumady, Insaf; Saez-Benito, Ana; Cozar-Castellano, Irene; Perdomo, German			Inhibition of Fatty Acid Metabolism Reduces Human Myeloma Cells Proliferation	PLOS ONE			English	Article							INSULIN SENSITIVITY; CYCLE PROGRESSION; MULTIPLE-MYELOMA; LIPID-METABOLISM; BETA-OXIDATION; CANCER; ETOMOXIR; SYNTHASE; APOPTOSIS; ORLISTAT	Multiple myeloma is a haematological malignancy characterized by the clonal proliferation of plasma cells. It has been proposed that targeting cancer cell metabolism would provide a new selective anticancer therapeutic strategy. In this work, we tested the hypothesis that inhibition of beta-oxidation and de novo fatty acid synthesis would reduce cell proliferation in human myeloma cells. We evaluated the effect of etomoxir and orlistat on fatty acid metabolism, glucose metabolism, cell cycle distribution, proliferation, cell death and expression of G1/S phase regulatory proteins in myeloma cells. Etomoxir and orlistat inhibited beta-oxidation and de novo fatty acid synthesis respectively in myeloma cells, without altering significantly glucose metabolism. These effects were associated with reduced cell viability and cell cycle arrest in G0/G1. Specifically, etomoxir and orlistat reduced by 40-70% myeloma cells proliferation. The combination of etomoxir and orlistat resulted in an additive inhibitory effect on cell proliferation. Orlistat induced apoptosis and sensitized RPMI-8226 cells to apoptosis induction by bortezomib, whereas apoptosis was not altered by etomoxir. Finally, the inhibitory effect of both drugs on cell proliferation was associated with reduced p21 protein levels and phosphorylation levels of retinoblastoma protein. In conclusion, inhibition of fatty acid metabolism represents a potential therapeutic approach to treat human multiple myeloma.	[Manuel Tirado-Velez, Jose; Cozar-Castellano, Irene; Perdomo, German] Hosp Univ Puerta del Mar, Unidad Invest, Cadiz, Spain; [Joumady, Insaf; Saez-Benito, Ana] Hosp Univ Puerta del Mar, Clin Lab Dept, Cadiz, Spain	Universidad de Cadiz; Hospital Universitario Puerta del Mar; Universidad de Cadiz; Hospital Universitario Puerta del Mar	Perdomo, G (corresponding author), Hosp Univ Puerta del Mar, Unidad Invest, Cadiz, Spain.	perdomogm@yahoo.com	Cozar-Castellano, Irene/B-5625-2015; Godino, Ana Saez-Benito/K-6357-2013; Tirado-Velez, JM/K-2317-2014; Perdomo, German/K-6703-2014	Cozar-Castellano, Irene/0000-0002-6065-5362; Godino, Ana Saez-Benito/0000-0002-7864-9147; Tirado-Velez, JM/0000-0002-6654-4735; Perdomo, German/0000-0002-2301-0012	Carlos III Health Institute [CP08/00106]; Spanish Ministry of Science and Innovation [SAF2009-11282]; European Community through the regional development funding program (FEDER); "Puerta del Mar Foundation'' (Spain);  [IRG-247835]	Carlos III Health Institute(Instituto de Salud Carlos III); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community through the regional development funding program (FEDER); "Puerta del Mar Foundation'' (Spain); 	This work was supported by grants from the Carlos III Health Institute (CP08/00106), the Spanish Ministry of Science and Innovation (SAF2009-11282) and the FP7-PEOPLE-2009-RG (PIRG06-GA-2009-25369) to GP, and the FP7-PEOPLE-2009-RG (IRG-247835) to ICC. The authors' Research Unit facilities at the HUPM received support from the European Community through the regional development funding program (FEDER). JMTV was supported by the "Puerta del Mar Foundation'' (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berge K, 2003, J LIPID RES, V44, P118, DOI 10.1194/jlr.M200312-JLR200; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bristow M, 2000, LANCET, V356, P1621, DOI 10.1016/S0140-6736(00)03149-4; Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Cozar-Castellano I, 2004, DIABETES, V53, P149, DOI 10.2337/diabetes.53.1.149; Cozar-Castellano I, 2008, DIABETES, V57, P3056, DOI 10.2337/db08-0393; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Hernlund E, 2008, INT J CANCER, V123, P476, DOI 10.1002/ijc.23525; HUBINGER A, 1992, HORM METAB RES, V24, P115, DOI 10.1055/s-2007-1003271; Hubinger A, 1997, HORM METAB RES, V29, P436, DOI 10.1055/s-2007-979072; Hungria VTM, 2004, CANCER CHEMOTH PHARM, V53, P51, DOI 10.1007/s00280-003-0692-y; Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645; Lupu R, 2006, CURR PHARM BIOTECHNO, V7, P483, DOI 10.2174/138920106779116928; Tirado-Velez JM, 2012, ANN HEMATOL, V91, P83, DOI 10.1007/s00277-011-1246-8; Menendez JA, 2005, ANN ONCOL, V16, P1253, DOI 10.1093/annonc/mdi239; Ortega AD, 2009, CANCER LETT, V276, P125, DOI 10.1016/j.canlet.2008.08.007; Pallasch CP, 2008, LEUKEMIA, V22, P585, DOI 10.1038/sj.leu.2405058; Perdomo G, 2004, J BIOL CHEM, V279, P27177, DOI 10.1074/jbc.M403566200; Quinn J, 2011, BLOOD, V117, P890, DOI 10.1182/blood-2010-01-264424; Samudio I, 2008, CANCER RES, V68, P5198, DOI 10.1158/0008-5472.CAN-08-0555; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Schmidt-Schweda S, 2000, CLIN SCI, V99, P27, DOI 10.1042/CS19990235; Thupari JN, 2002, P NATL ACAD SCI USA, V99, P9498, DOI 10.1073/pnas.132128899; Tirado-Velez JM, 2011, ANN HEMATOL; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vetter ML, 2010, NAT REV ENDOCRINOL, V6, P578, DOI 10.1038/nrendo.2010.121; Wang WQ, 2008, J ZHEJIANG UNIV-SC B, V9, P441, DOI 10.1631/jzus.B0740640; WARBURG O, 1956, SCIENCE, V124, P269; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yecies JL, 2010, CELL, V140, P28, DOI 10.1016/j.cell.2009.12.037; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	36	79	83	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46484	10.1371/journal.pone.0046484	http://dx.doi.org/10.1371/journal.pone.0046484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029529	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900169
J	Fang, TC; Pang, CY; Chiu, SC; Ding, DC; Tsai, RK				Fang, Te-Chao; Pang, Cheng-Yoong; Chiu, Sheng-Chun; Ding, Dah-Ching; Tsai, Rong-Kung			Renoprotective Effect of Human Umbilical Cord-Derived Mesenchymal Stem Cells in Immunodeficient Mice Suffering from Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; OPTIC-NERVE CRUSH; FACTOR G-CSF; BONE-MARROW; TUBULAR EPITHELIUM; RICH SOURCE; REPAIR; DIFFERENTIATION; TRANSPLANTATION; BLOOD	It is unknown whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) can improve the renal function of patients suffering from acute kidney injury. Moreover, before beginning clinical trials, it is necessary to investigate this renoprotective effect of hUC-MSCs in a xenogeneic model of acute kidney injury. However, no previous studies have examined the application of hUC-MSCs to immunodeficient mice suffering from acute kidney injury. The objectives of this study were to examine whether hUC-MSCs could improve renal function in nonobese diabetic-severe combined immune deficiency (NOD-SCID) mice suffering from acute kidney injury, and to investigate the mechanism(s) for hUC-MSCs to improve renal function in this xenogeneic model. Early (3 hr) and late (12 hr) administrations of hUC-MSCs (10(6) cells) were performed via the external jugular vein into NOD-SCID mice suffering from either folic acid (FA) (250 mg/kg body weight) or vehicle. The results showed that early administration of hUC-MSCs improved the renal function of NOD-SCID mice suffering from FA-induced acute kidney injury, as evidenced by decreased serum urea nitrogen and serum creatinine levels, as well as a reduced tubular injury score. The beneficial effects of hUC-MSCs were through reducing apoptosis and promoting proliferation of renal tubular cells. These benefits were independent of inflammatory cytokine effects and transdifferentiation. Furthermore, this study is the first one to show that the reduced apoptosis of renal tubular cells by hUC-MSCs in this xenogeneic model is mediated through the mitochondrial pathway, and through the increase of Akt phosphorylation.	[Fang, Te-Chao; Pang, Cheng-Yoong; Chiu, Sheng-Chun; Ding, Dah-Ching; Tsai, Rong-Kung] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Fang, Te-Chao] Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan; [Fang, Te-Chao] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Pang, Cheng-Yoong; Chiu, Sheng-Chun] Buddhist Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan; [Ding, Dah-Ching] Buddhist Tzu Chi Gen Hosp, Dept Obstet & Gynecol, Hualien, Taiwan; [Tsai, Rong-Kung] Buddhist Tzu Chi Gen Hosp, Dept Ophthalmol, Hualien, Taiwan	Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Fang, TC (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	fangtechao@yahoo.com.tw	DING, DAH-CHING/Y-3592-2019; Pang, Cheng-Yoong/R-4990-2019; Chiu, Sheng-Chun/F-9493-2015; Pang, Cheng-Yoong/AFO-1562-2022	Pang, Cheng-Yoong/0000-0002-9063-2858; Chiu, Sheng-Chun/0000-0002-5927-8088	National Science Council, Taiwan [NSC 95-2745-B-303-001]; Tzu Chi General Hospital, Hualien, Taiwan [TCRD 98-24, TCRD 99-17]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Tzu Chi General Hospital, Hualien, Taiwan	This study was supported by research grants from the National Science Council, Taiwan (NSC 95-2745-B-303-001) to TCF, and from the Tzu Chi General Hospital, Hualien, Taiwan (TCRD 98-24 and TCRD 99-17) to TCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; Burst VR, 2010, NEPHRON EXP NEPHROL, V114, pE107, DOI 10.1159/000262318; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Cao HL, 2010, BIOTECHNOL LETT, V32, P725, DOI 10.1007/s10529-010-0207-y; Capelli C, 2011, CYTOTHERAPY, V13, P786, DOI 10.3109/14653249.2011.563294; Chen YA, 2011, STEM CELLS DEV, V20, P103, DOI 10.1089/scd.2009.0495; D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115; Ding DC, 2007, NEUROBIOL DIS, V27, P339, DOI 10.1016/j.nbd.2007.06.010; Duffield JS, 2005, KIDNEY INT, V68, P1956, DOI 10.1111/j.1523-1755.2005.00629.x; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Ende N, 2004, BIOCHEM BIOPH RES CO, V321, P168, DOI 10.1016/j.bbrc.2004.06.121; Fang TC, 2005, J AM SOC NEPHROL, V16, P1723, DOI 10.1681/ASN.2004121089; Fang Te-Chao, 2003, Birth Defects Research, V69, P238, DOI 10.1002/bdrc.10019; Fernandez M, 2004, J MOL ENDOCRINOL, V33, P155, DOI 10.1677/jme.0.0330155; FIDLER IJ, 1986, CANCER METAST REV, V5, P29, DOI 10.1007/BF00049529; Gupta A, 2012, EXP TOXICOL PATHOL, V64, P225, DOI 10.1016/j.etp.2010.08.010; Herrera MB, 2004, INT J MOL MED, V14, P1035; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Hotchkiss RS, 2009, NEW ENGL J MED, V361, P1570, DOI 10.1056/NEJMra0901217; Kim JW, 2004, ANN HEMATOL, V83, P733, DOI 10.1007/s00277-004-0918-z; Lange C, 2005, KIDNEY INT, V68, P1613, DOI 10.1111/j.1523-1755.2005.00573.x; Lataillade JJ, 2006, HAEMATOLOGICA, V91, p1009A; Lin FM, 2005, J CLIN INVEST, V115, P1756, DOI 10.1172/JCI23015; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Morigi M, 2008, STEM CELLS, V26, P2075, DOI 10.1634/stemcells.2007-0795; Morigi M, 2010, STEM CELLS, V28, P513, DOI 10.1002/stem.293; Nangaku M, 1999, J AM SOC NEPHROL, V10, P2323; Nangaku M, 1998, J AM SOC NEPHROL, V9, P590; Ortiz A, 2000, KIDNEY INT, V57, P969, DOI 10.1046/j.1523-1755.2000.00925.x; Perin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009357; Qian H, 2008, INT J MOL MED, V22, P325, DOI 10.3892/ijmm_00000026; Rao MS, 2001, MECH AGEING DEV, V122, P713, DOI 10.1016/S0047-6374(01)00224-X; Schrier RW, 2004, J CLIN INVEST, V114, P5, DOI 10.1172/JC1200422353; Semedo P, 2007, TRANSPL P, V39, P421, DOI 10.1016/j.transproceed.2007.01.036; Semedo P, 2009, INT IMMUNOPHARMACOL, V9, P677, DOI 10.1016/j.intimp.2008.12.008; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Terai S, 2003, J BIOCHEM, V134, P551, DOI 10.1093/jb/mvg173; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Tsai RK, 2008, EXP EYE RES, V87, P242, DOI 10.1016/j.exer.2008.06.004; Tsai RK, 2010, EXP EYE RES, V90, P537, DOI 10.1016/j.exer.2010.01.004; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x	45	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46504	10.1371/journal.pone.0046504	http://dx.doi.org/10.1371/journal.pone.0046504			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029541	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517500106
J	Wagegg, M; Gaber, T; Lohanatha, FL; Hahne, M; Strehl, C; Fangradt, M; Tran, CL; Schonbeck, K; Hoff, P; Ode, A; Perka, C; Duda, GN; Buttgereit, F				Wagegg, Markus; Gaber, Timo; Lohanatha, Ferenz L.; Hahne, Martin; Strehl, Cindy; Fangradt, Monique; Tran, Cam Loan; Schoenbeck, Kerstin; Hoff, Paula; Ode, Andrea; Perka, Carsten; Duda, Georg N.; Buttgereit, Frank			Hypoxia Promotes Osteogenesis but Suppresses Adipogenesis of Human Mesenchymal Stromal Cells in a Hypoxia-Inducible Factor-1 Dependent Manner	PLOS ONE			English	Article							HUMAN BONE-MARROW; STEM-CELLS; OXYGEN; DIFFERENTIATION; CAPACITY; THERAPY; BIOLOGY; REPAIR; HIF	Background: Bone fracture initiates a series of cellular and molecular events including the expression of hypoxia-inducible factor (HIF)-1. HIF-1 is known to facilitate recruitment and differentiation of multipotent human mesenchymal stromal cells (hMSC). Therefore, we analyzed the impact of hypoxia and HIF-1 on the competitive differentiation potential of hMSCs towards adipogenic and osteogenic lineages. Methodology/Principal Findings: Bone marrow derived primary hMSCs cultured for 2 weeks either under normoxic (app. 18% O-2) or hypoxic (less than 2% O-2) conditions were analyzed for the expression of MSC surface markers and for expression of the genes HIF1A, VEGFA, LDHA, PGK1, and GLUT1. Using conditioned medium, adipogenic or osteogenic differentiation as verified by Oil-Red-O or von-Kossa staining was induced in hMSCs under either normoxic or hypoxic conditions. The expression of HIF1A and VEGFA was measured by qPCR. A knockdown of HIF-1 alpha by lentiviral transduction was performed, and the ability of the transduced hMSCs to differentiate into adipogenic and osteogenic lineages was analyzed. Hypoxia induced HIF-1 alpha and HIF-1 target gene expression, but did not alter MSC phenotype or surface marker expression. Hypoxia (i) suppressed adipogenesis and associated HIF1A and PPARG gene expression in hMSCs and (ii) enhanced osteogenesis and associated HIF1A and RUNX2 gene expression. shRNA-mediated knockdown of HIF-1 alpha enhanced adipogenesis under both normoxia and hypoxia, and suppressed hypoxia-induced osteogenesis. Conclusions/Significance: Hypoxia promotes osteogenesis but suppresses adipogenesis of human MSCs in a competitive and HIF-1-dependent manner. We therefore conclude that the effects of hypoxia are crucial for effective bone healing, which may potentially lead to the development of novel therapeutic approaches.	[Wagegg, Markus; Gaber, Timo; Lohanatha, Ferenz L.; Hahne, Martin; Strehl, Cindy; Fangradt, Monique; Tran, Cam Loan; Schoenbeck, Kerstin; Hoff, Paula; Buttgereit, Frank] Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany; [Wagegg, Markus; Gaber, Timo; Lohanatha, Ferenz L.; Hahne, Martin; Strehl, Cindy; Fangradt, Monique; Tran, Cam Loan; Schoenbeck, Kerstin; Hoff, Paula; Buttgereit, Frank] German Arthrit Res Ctr, Berlin, Germany; [Wagegg, Markus; Gaber, Timo; Lohanatha, Ferenz L.; Ode, Andrea; Duda, Georg N.; Buttgereit, Frank] Charite, Berlin Brandenburg Ctr Regenerat Therapies, Berlin, Germany; [Ode, Andrea; Duda, Georg N.] Charite, Julius Wolff Inst, Berlin, Germany; [Ode, Andrea; Duda, Georg N.] Charite, Ctr Musculoskeletal Surg, Berlin, Germany; [Perka, Carsten] Charite, Dept Orthopaed, Berlin, Germany; [Hahne, Martin] Charite, Berlin Brandenburg Sch Regenerat Therapies, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Gaber, T (corresponding author), Charite, Dept Rheumatol & Clin Immunol, Berlin, Germany.	gaber@drfz.de	Perka, Carsten/ABG-6505-2021; Duda, Georg N/H-2085-2016; Ode, Andrea/B-6805-2015	Duda, Georg N/0000-0001-7605-3908; Perka, Carsten/0000-0002-0993-581X; Buttgereit, Frank/0000-0003-2534-550X	Bundesministerium fur Bildung und Forschung (BMBF); State of Berlin, BCRT-Grant II; European Commission [2/2010-1/2014]; Deutsche Forschungsgemeinschaft (DFG) through Berlin-Brandenburg School for Regenerative Therapies [GSC 203]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Berlin, BCRT-Grant II; European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Forschungsgemeinschaft (DFG) through Berlin-Brandenburg School for Regenerative Therapies(German Research Foundation (DFG))	This work has been supported in part by the Bundesministerium fur Bildung und Forschung (BMBF) and the State of Berlin, BCRT-Grant II to FB and TG. MW and TG have been supported in part by the project NMP4-LA-2009-228929 ("Nanosciences, Nanotechnologies, Materials and new Production Technologies''; 2/2010-1/2014) funded by the European Commission through the 7th Framework Programme for Research. MH has been supported by Deutsche Forschungsgemeinschaft (DFG) funding through the Berlin-Brandenburg School for Regenerative Therapies GSC 203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; Gaber T, 2005, ANN RHEUM DIS, V64, P971, DOI 10.1136/ard.2004.031641; Gaber T, 2009, J RHEUMATOL, V36, P2655, DOI 10.3899/jrheum.090255; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Giannoudis PV, 2007, INJURY, V38, pS3, DOI 10.1016/S0020-1383(08)70003-2; Ham AW, 1930, J BONE JOINT SURG, V12, P827; Hoff P, 2011, IMMUNOL RES; Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11; Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249; Kolar P, 2011, CLIN ORTHOP RELAT R, V469, P3118, DOI 10.1007/s11999-011-1865-3; Lavrentieva A, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-18; Ma T, 2009, BIOTECHNOL PROGR, V25, P32, DOI 10.1002/btpr.128; Markway BD, 2010, CELL TRANSPLANT, V19, P29, DOI 10.3727/096368909X478560; MCKIBBIN B, 1978, J BONE JOINT SURG BR, V60, P150, DOI 10.1302/0301-620X.60B2.350882; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Muller J, 2011, CELL TRANSPLANT; Ode A, 2011, EUR CELLS MATER, V22, P26, DOI 10.22203/eCM.v022a03; Ontiveros C, 2004, J CELL PHYSIOL, V200, P169, DOI 10.1002/jcp.20054; Park JH, 2002, MOL CELL ENDOCRINOL, V192, P197, DOI 10.1016/S0303-7207(02)00036-9; Polykandriotis E, 2006, HANDCHIR MIKROCHIR P, V38, P217, DOI 10.1055/s-2006-924419; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Schmidt-Bleek K., 2012, J TISSUE ENG REGEN M; Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Shomento SH, 2010, J CELL BIOCHEM, V109, P196, DOI 10.1002/jcb.22396; Tamama K, 2011, J CELL BIOCHEM, V112, P804, DOI 10.1002/jcb.22961; Tamiya H, 2008, GENE, V416, P53, DOI 10.1016/j.gene.2008.03.003; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; Wan C, 2010, ANN NY ACAD SCI, V1192, P322, DOI 10.1111/j.1749-6632.2009.05238.x	34	138	147	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46483	10.1371/journal.pone.0046483	http://dx.doi.org/10.1371/journal.pone.0046483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029528	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500103
J	Gelman, BB; Chen, TS; Lisinicchia, JG; Soukup, VM; Carmical, JR; Starkey, JM; Masliah, E; Commins, DL; Brandt, D; Grant, I; Singer, EJ; Levine, AJ; Miller, J; Winkler, JM; Fox, HS; Luxon, BA; Morgello, S				Gelman, Benjamin B.; Chen, Tiansheng; Lisinicchia, Joshua G.; Soukup, Vicki M.; Carmical, J. Russ; Starkey, Jonathan M.; Masliah, Eliezer; Commins, Deborah L.; Brandt, Dianne; Grant, Igor; Singer, Elyse J.; Levine, Andrew J.; Miller, Jeremy; Winkler, Jessica M.; Fox, Howard S.; Luxon, Bruce A.; Morgello, Susan		Natl NeuroAIDS Tissue Consortium	The National NeuroAIDS Tissue Consortium Brain Gene Array: Two Types of HIV-Associated Neurocognitive Impairment	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; WHITE-MATTER; ENDOTHELIAL-CELLS; EXPRESSION ANALYSIS; INTERFERON-GAMMA; INFECTED BRAIN; RNA INTEGRITY; AIDS DEMENTIA; GROWTH-FACTOR	Background: The National NeuroAIDS Tissue Consortium (NNTC) performed a brain gene expression array to elucidate pathophysiologies of Human Immunodeficiency Virus type 1 (HIV-1)-associated neurocognitive disorders. Methods: Twenty-four human subjects in four groups were examined A) Uninfected controls; B) HIV-1 infected subjects with no substantial neurocognitive impairment (NCI); C) Infected with substantial NCI without HIV encephalitis (HIVE); D) Infected with substantial NCI and HIVE. RNA from neocortex, white matter, and neostriatum was processed with the Affymetrix (R) array platform. Results: With HIVE the HIV-1 RNA load in brain tissue was three log(10) units higher than other groups and over 1,900 gene probes were regulated. Interferon response genes (IFRGs), antigen presentation, complement components and CD163 antigen were strongly upregulated. In frontal neocortex downregulated neuronal pathways strongly dominated in HIVE, including GABA receptors, glutamate signaling, synaptic potentiation, axon guidance, clathrin-mediated endocytosis and 14-3-3 protein. Expression was completely different in neuropsychologically impaired subjects without HIVE. They had low brain HIV-1 loads, weak brain immune responses, lacked neuronally expressed changes in neocortex and exhibited upregulation of endothelial cell type transcripts. HIV-1-infected subjects with normal neuropsychological test results had upregulation of neuronal transcripts involved in synaptic transmission of neostriatal circuits. Interpretation: Two patterns of brain gene expression suggest that more than one pathophysiological process occurs in HIV-1-associated neurocognitive impairment. Expression in HIVE suggests that lowering brain HIV-1 replication might improve NCI, whereas NCI without HIVE may not respond in kind; array results suggest that modulation of transvascular signaling is a potentially promising approach. Striking brain regional differences highlighted the likely importance of circuit level disturbances in HIV/AIDS. In subjects without impairment regulation of genes that drive neostriatal synaptic plasticity reflects adaptation. The array provides an infusion of public resources including brain samples, clinicopathological data and correlative gene expression data for further exploration (http://www.nntc.org/gene-array-project).	[Gelman, Benjamin B.; Chen, Tiansheng; Lisinicchia, Joshua G.] Univ Texas Med Branch, Dept Pathol, Galveston, TX USA; [Soukup, Vicki M.] Univ Texas Med Branch, Dept Neurol, Galveston, TX USA; [Carmical, J. Russ; Luxon, Bruce A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX USA; [Starkey, Jonathan M.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Commins, Deborah L.] Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA; [Brandt, Dianne] EMMES Corp, Bethesda, MD USA; [Grant, Igor] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Singer, Elyse J.; Levine, Andrew J.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Miller, Jeremy] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA USA; [Winkler, Jessica M.; Fox, Howard S.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Morgello, Susan] Mt Sinai Med Ctr, Dept Neurol, New York, NY 10029 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California San Diego; University of Southern California; Emmes Corporation; University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Nebraska System; University of Nebraska Medical Center; Icahn School of Medicine at Mount Sinai	Gelman, BB (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX USA.	bgelman@utmb.edu	Luxon, Bruce A/C-9140-2012; Levine, Andrew/ABD-7628-2021	Starkey, Jonathan/0000-0002-9083-6455; Fox, Howard/0000-0003-2032-374X	US National Institutes of Health [U01MH083507, U01MH083501, U01MH083500, U01MH083506, U01MH083545]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH083545, U01MH083507, U01MH083506, U24MH100929, U01MH083501, U01MH083500] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Financial support was provided through the following cooperative agreements from the US National Institutes of Health U01MH083507; U01MH083501; U01MH083500; U01MH083506; U01MH083545. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the five cooperative agreements was with the EMMES Corporation. The EMMES Corporation in cooperation with the United States National Institutes of Health maintains the integrity of databases pertaining to this study, including patient confidentiality and compliance with regulations pertaining to health record information.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; ACHIM CL, 1994, J NEUROPATH EXP NEUR, V53, P284, DOI 10.1097/00005072-199405000-00010; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Alirezaei M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002906; An SF, 1997, J NEUROPATH EXP NEUR, V56, P1262, DOI 10.1097/00005072-199711000-00011; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Baldeweg T, 1997, INT J PSYCHOPHYSIOL, V26, P431, DOI 10.1016/S0167-8760(97)00780-0; Banks WA, 2006, CURR HIV RES, V4, P259, DOI 10.2174/157016206777709447; Banks WA, 2006, PHYSIOL BEHAV, V89, P472, DOI 10.1016/j.physbeh.2006.07.004; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Borjabad A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002213; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; BROOIMANS RA, 1989, J IMMUNOL, V142, P2024; Budka H, 1991, BRAIN PATHOL, V1, P163, DOI 10.1111/j.1750-3639.1991.tb00656.x; Buesa C, 2004, J NEUROPATH EXP NEUR, V63, P1003, DOI 10.1093/jnen/63.10.1003; Burdo TH, 2008, J INFECT DIS, V198, P715, DOI 10.1086/590504; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; de Chaldee M, 2003, GENOME RES, V13, P1646, DOI 10.1101/gr.1173403; de Larranaga GF, 2003, THROMB RES, V110, P93, DOI 10.1016/S0049-3848(03)00291-3; Deutch AY, 2007, PARKINSONISM RELAT D, V13, pS251, DOI 10.1016/S1353-8020(08)70012-9; Ernst T, 2002, NEUROLOGY, V59, P1343, DOI 10.1212/01.WNL.0000031811.45569.B0; Ervin JF, 2007, J NEUROPATH EXP NEUR, V66, P1093, DOI 10.1097/nen.0b013e31815c196a; Everall I, 2005, J NEUROIMMUNOL, V170, P158, DOI 10.1016/j.jneuroim.2005.09.009; Everall I, 2009, J NEUROVIROL, V15, P360, DOI 10.3109/13550280903131915; Fox HS, 2008, J NEUROVIROL, V14, P286, DOI 10.1080/13550280802132824; Furman C, 2007, J CELL BIOL, V179, P761, DOI 10.1083/jcb.200705002; Gelman BB, 2004, J NEUROIMMUNOL, V157, P111, DOI 10.1016/j.jneuroim.2004.08.044; Gelman BB, 2005, JAIDS-J ACQ IMM DEF, V39, P422, DOI 10.1097/01.qai.0000164250.41475.f2; Gelman BB, 2006, J NEUROIMMUNE PHARM, V1, P410, DOI 10.1007/s11481-006-9030-6; Gelman Benjamin B, 2007, Handb Clin Neurol, V85, P301, DOI 10.1016/S0072-9752(07)85018-4; Gelman BB, 2010, J NEUROIMMUNE PHARM, V5, P92, DOI 10.1007/s11481-009-9168-0; GLASS JD, 1993, NEUROLOGY, V43, P2230, DOI 10.1212/WNL.43.11.2230; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gray F, 2003, J NEUROPATH EXP NEUR, V62, P429, DOI 10.1093/jnen/62.5.429; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; Hashimoto T, 2008, AM J PSYCHIAT, V165, P479, DOI 10.1176/appi.ajp.2007.07081223; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; JAHROUDI N, 1994, MOL CELL BIOL, V14, P999, DOI 10.1128/MCB.14.2.999; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Jernigan TL, 2011, J NEUROVIROL, V17, P248, DOI 10.1007/s13365-011-0032-7; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Ke Y, 2004, PSYCHIAT RES-NEUROIM, V130, P283, DOI 10.1016/j.pscychresns.2003.12.001; Kristoffersen US, 2009, HIV MED, V10, P79, DOI 10.1111/j.1468-1293.2008.00661.x; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Langford TD, 2002, AIDS, V16, P1019, DOI 10.1097/00002030-200205030-00008; Lee J, 2005, FASEB J, V19, P1356, DOI 10.1096/fj.04-3552fje; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MASLIAH E, 1995, J NEUROPATH EXP NEUR, V54, P350, DOI 10.1097/00005072-199505000-00008; Masliah E, 2000, AIDS, V14, P69, DOI 10.1097/00002030-200001070-00008; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Masliah E, 2004, J NEUROIMMUNOL, V157, P163, DOI 10.1016/j.jneuroim.2004.08.026; MASLIAH E, 1992, J NEUROPATH EXP NEUR, V51, P585; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; McCarthy MJ, 1998, FEBS LETT, V423, P334, DOI 10.1016/S0014-5793(98)00122-7; Melendez MM, 2008, CLIN INFECT DIS, V46, P775, DOI 10.1086/527563; Melrose RJ, 2008, BEHAV BRAIN RES, V188, P337, DOI 10.1016/j.bbr.2007.11.021; Morgello S, 2002, ARCH PATHOL LAB MED, V126, P182; Morgello S, 2001, NEUROPATH APPL NEURO, V27, P326, DOI 10.1046/j.0305-1846.2001.00334.x; Nath A, 2000, J PSYCHOPHARMACOL, V14, P222, DOI 10.1177/026988110001400305; OHNO M, 1995, J CLIN INVEST, V95, P1363, DOI 10.1172/JCI117787; Oide T, 2006, NEUROPATH APPL NEURO, V32, P170, DOI 10.1111/j.1365-2990.2006.00710.x; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Paul RH, 2007, J NEUROPSYCH CLIN N, V19, P283, DOI 10.1176/appi.neuropsych.19.3.283; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; POWER C, 1993, ANN NEUROL, V34, P339, DOI 10.1002/ana.410340307; RIPOCHE J, 1988, J EXP MED, V168, P1917, DOI 10.1084/jem.168.5.1917; Roberts ES, 2006, J NEUROSCI, V26, P4577, DOI 10.1523/JNEUROSCI.4504-05.2006; Roberts ES, 2004, J NEUROIMMUNOL, V157, P81, DOI 10.1016/j.jneuroim.2004.08.030; Roberts ES, 2004, J NEUROPATH EXP NEUR, V63, P1255, DOI 10.1093/jnen/63.12.1255; Roberts ES, 2003, AM J PATHOL, V162, P2041, DOI 10.1016/S0002-9440(10)64336-2; Ross AC, 2008, JAIDS-J ACQ IMM DEF, V49, P499, DOI 10.1097/QAI.0b013e318189a794; Sas AR, 2007, AIDS, V21, P2151, DOI 10.1097/QAD.0b013e3282f08c2f; SCHMIDBAUER M, 1992, NEUROPATH APPL NEURO, V18, P489, DOI 10.1111/j.1365-2990.1992.tb00816.x; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sequeira A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006585; Sibille E, 2011, INT J NEUROPSYCHOPH, V14, P721, DOI 10.1017/S1461145710001616; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Tar K, 2004, J CELL BIOCHEM, V92, P534, DOI 10.1002/jcb.20036; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Toborek M, 2005, CELL MOL NEUROBIOL, V25, P181, DOI 10.1007/s10571-004-1383-x; Vastag M, 1998, IMMUNOBIOLOGY, V199, P5, DOI 10.1016/S0171-2985(98)80059-4; Wang GJ, 2004, BRAIN, V127, P2452, DOI 10.1093/brain/awh269; Wang Q, 2008, ENDOCRINOLOGY, V149, P3920, DOI 10.1210/en.2007-1626; WILEY CA, 1994, ANN NEUROL, V36, P673, DOI 10.1002/ana.410360422; Williams KC, 2002, ANNU REV NEUROSCI, V25, P537, DOI 10.1146/annurev.neuro.25.112701.142822; Woods SP, 2004, J CLIN EXP NEUROPSYC, V26, P759, DOI 10.1080/13803390490509565; Xing HQ, 2003, J NEUROVIROL, V9, P508, DOI 10.1080/13550280390218904; Zhao BT, 2001, AM J PHYSIOL-CELL PH, V281, pC1587, DOI 10.1152/ajpcell.2001.281.5.C1587; Zink MC, 2010, J INFECT DIS, V202, P161, DOI 10.1086/653213	95	111	117	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46178	10.1371/journal.pone.0046178	http://dx.doi.org/10.1371/journal.pone.0046178			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049970	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300094
J	Hu, WG; Yin, JF; Chau, D; Negrych, LM; Cherwonogrodzky, JW				Hu, Wei-Gang; Yin, Junfei; Chau, Damon; Negrych, Laurel M.; Cherwonogrodzky, John W.			Humanization and Characterization of an Anti-Ricin Neutralization Monoclonal Antibody	PLOS ONE			English	Article							RESHAPING HUMAN-ANTIBODIES; EQUINE ENCEPHALITIS-VIRUS; HYPERVARIABLE REGIONS; COMBINING SITE; TOXIN; IMMUNOGENICITY; EXPRESSION; MECHANISM; THERAPY; RIBOSOMES	Ricin is regarded as a high terrorist risk for the public due to its high toxicity and ease of production. Currently, there is no therapeutic or vaccine available against ricin. D9, a murine monoclonal antibody developed previously in our laboratory, can strongly neutralize ricin and is therefore a good candidate for humanization. Humanization of D9 variable regions was achieved by a complementarity-determining region grafting approach. The humanized D9 (hD9) variable regions were further grafted onto human heavy and light chain constant regions to assemble the complete antibody gene. A foot-and-mouth-disease virus-derived 2A self-processing sequence was introduced between heavy and light chain DNA sequences to cleave the recombinant protein into a functional full-length antibody molecule from a single open reading frame driven by a single promoter in an adenoviral vector. After expression in mammalian cells and purification, the hD9 was demonstrated to have equimolar expression of the full-length antibody heavy and light chains. More importantly, the hD9 exhibited high affinity to ricin with K-D of 1.63 nM, comparable to its parental murine D9 (2.55 nM). In a mouse model, intraperitoneal (i.p.) administration of hD9, at a low dose of 5 mu g per mouse, 4 hours after the i.p. challenge with 5xLD50 ricin was found to rescue 100% of the mice. In addition, administered 6 hours post-challenge, hD9 could still rescue 50% of the mice. The hD9 has the potential to be used for prophylactic or therapeutic purposes against ricin poisoning.	[Hu, Wei-Gang; Yin, Junfei; Chau, Damon; Negrych, Laurel M.; Cherwonogrodzky, John W.] Def Res & Dev Canada Suffield, Medicine Hat, AB, Canada		Hu, WG (corresponding author), Def Res & Dev Canada Suffield, Medicine Hat, AB, Canada.	wei-gang.hu@drdc-rddc.gc.ca			Chemical, Biological, Radiological, and Nuclear Research and Technology Initiative (CRTI), Defence Research and Development Canada [08-0112TA]	Chemical, Biological, Radiological, and Nuclear Research and Technology Initiative (CRTI), Defence Research and Development Canada	This study was supported by the Chemical, Biological, Radiological, and Nuclear Research and Technology Initiative (CRTI), Defence Research and Development Canada (Project 08-0112TA). The content of this publication is solely the responsibility of the authors and does not necessarily represent the official views or policies of the CRTI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; Binder P, 2003, COMP IMMUNOL MICROB, V26, P401, DOI 10.1016/S0147-9571(03)00023-7; BRUGGEMANN M, 1989, J EXP MED, V170, P2153, DOI 10.1084/jem.170.6.2153; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; ENDO Y, 1987, J BIOL CHEM, V262, P5908; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Hu WG, 2008, HUM VACCINES, V4, P74, DOI 10.4161/hv.4.1.4778; Hu WG, 2007, VACCINE, V25, P3210, DOI 10.1016/j.vaccine.2007.01.034; Hu WG, 2010, VACCINE, V28, P5558, DOI 10.1016/j.vaccine.2010.06.038; Hu WG, 2010, APPL BIOCHEM BIOTECH, V160, P1206, DOI 10.1007/s12010-009-8657-1; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; Hwang WYK, 2005, METHODS, V36, P35, DOI 10.1016/j.ymeth.2005.01.004; Kabat EA, 1984, FUNDAMENTAL IMMUNOLO, P595; KANTHA S S, 1991, Keio Journal of Medicine, V40, P35; Mabry R, 2005, INFECT IMMUN, V73, P8362, DOI 10.1128/IAI.73.12.8362-8368.2005; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; Mantis NJ, 2006, INFECT IMMUN, V74, P3455, DOI 10.1128/IAI.02088-05; Marks JD, 2004, MOVEMENT DISORD, V19, pS101, DOI 10.1002/mds.20023; Mirick GR, 2004, Q J NUCL MED MOL IM, V48, P251; MONTANARO L, 1973, BIOCHEM J, V136, P677, DOI 10.1042/bj1360677; Nakanishi T, 2008, PROTEIN SCI, V17, P261, DOI 10.1110/ps.073156708; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; NEUBERGER MS, 1995, CURR OPIN IMMUNOL, V7, P248, DOI 10.1016/0952-7915(95)80010-7; NICOLSON GL, 1975, CANCER RES, V35, P144; Nussenzweig MC, 2004, NAT MED, V10, P1304, DOI 10.1038/nm1204-1304; O'Hara JM, 2012, VACCINE, V30, P1239, DOI 10.1016/j.vaccine.2011.12.058; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; PADLAN EA, 1991, MOL IMMUNOL, V28, P489, DOI 10.1016/0161-5890(91)90163-E; Pelat T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-60; Prigent J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020166; Reichert JM, 2008, CURR PHARM BIOTECHNO, V9, P423, DOI 10.2174/138920108786786358; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Roche JK, 2008, LAB INVEST, V88, P1178, DOI 10.1038/labinvest.2008.83; SIMMONS BM, 1986, J BIOL CHEM, V261, P7912; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; TAKAHASHI H, 1994, J MOL BIOL, V243, P494, DOI 10.1006/jmbi.1994.1675; Tamura M, 2000, J IMMUNOL, V164, P1432, DOI 10.4049/jimmunol.164.3.1432; Thullier P, 2010, J MOL BIOL, V396, P1439, DOI 10.1016/j.jmb.2009.12.041; Tsurushita N, 2005, METHODS, V36, P69, DOI 10.1016/j.ymeth.2005.01.007; VERHOEYEN M, 1988, SCIENCE, V239, P1534, DOI 10.1126/science.2451287; Wang YG, 2007, BIOTECHNOL LETT, V29, P1811, DOI 10.1007/s10529-007-9478-3; Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665; Wu Feng, 2010, World J Biol Chem, V1, P188, DOI 10.4331/wjbc.v1.i5.188; YOULE RJ, 1987, J BIOL CHEM, V262, P4676; Zimmermann J, 2006, P NATL ACAD SCI USA, V103, P13722, DOI 10.1073/pnas.0603282103	50	25	31	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45595	10.1371/journal.pone.0045595	http://dx.doi.org/10.1371/journal.pone.0045595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049820	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300036
J	Manikkam, M; Tracey, R; Guerrero-Bosagna, C; Skinner, MK				Manikkam, Mohan; Tracey, Rebecca; Guerrero-Bosagna, Carlos; Skinner, Michael K.			Dioxin (TCDD) Induces Epigenetic Transgenerational Inheritance of Adult Onset Disease and Sperm Epimutations	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; POLYCYSTIC-OVARY-SYNDROME; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; IN-UTERO; LACTATIONAL EXPOSURE; FEMALE RATS; 2,4,5-TRICHLOROPHENOXYACETIC ACID; POLYCHLORINATED-BIPHENYLS; ENVIRONMENTAL-FACTORS; PERINATAL EXPOSURE	Environmental compounds can promote epigenetic transgenerational inheritance of adult-onset disease in subsequent generations following ancestral exposure during fetal gonadal sex determination. The current study examined the ability of dioxin (2,3,7,8-tetrachlorodibenzo[p]dioxin, TCDD) to promote epigenetic transgenerational inheritance of disease and DNA methylation epimutations in sperm. Gestating F0 generation females were exposed to dioxin during fetal day 8 to 14 and adult-onset disease was evaluated in F1 and F3 generation rats. The incidences of total disease and multiple disease increased in F1 and F3 generations. Prostate disease, ovarian primordial follicle loss and polycystic ovary disease were increased in F1 generation dioxin lineage. Kidney disease in males, pubertal abnormalities in females, ovarian primordial follicle loss and polycystic ovary disease were increased in F3 generation dioxin lineage animals. Analysis of the F3 generation sperm epigenome identified 50 differentially DNA methylated regions (DMR) in gene promoters. These DMR provide potential epigenetic biomarkers for transgenerational disease and ancestral environmental exposures. Observations demonstrate dioxin exposure of a gestating female promotes epigenetic transgenerational inheritance of adult onset disease and sperm epimutations.	[Manikkam, Mohan; Tracey, Rebecca; Guerrero-Bosagna, Carlos; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Skinner, MK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu	Guerrero-Bosagna, Carlos/W-7319-2019	Guerrero-Bosagna, Carlos/0000-0003-1935-5875	USA Department of Defense (DOD); NIH, NIEHS	USA Department of Defense (DOD); NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support of the USA Department of Defense (DOD) and NIH, NIEHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Baccarelli A, 2008, PLOS MED, V5, P1133, DOI 10.1371/journal.pmed.0050161; Bruner-Tran KL, 2011, REPROD TOXICOL, V31, P344, DOI 10.1016/j.reprotox.2010.10.003; Carpenter David O., 2006, Reviews on Environmental Health, V21, P1; COURTNEY KD, 1971, TOXICOL APPL PHARM, V20, P396, DOI 10.1016/0041-008X(71)90282-1; COUTURE LA, 1990, TERATOLOGY, V42, P619, DOI 10.1002/tera.1420420606; Davis BJ, 2000, CANCER RES, V60, P5414; DiVall SA, 2009, CURR OPIN ENDOCRINOL, V16, P1, DOI 10.1097/MED.0b013e3283207937; Eskenazi B, 2005, ENVIRON HEALTH PERSP, V113, P858, DOI 10.1289/ehp.7820; Eskenazi B, 2004, ENVIRON HEALTH PERSP, V112, P22, DOI 10.1289/ehp.6573; Flaws JA, 1997, TOXICOL APPL PHARM, V147, P351, DOI 10.1006/taap.1997.8295; Gao X, 2000, TOXICOLOGY, V147, P15, DOI 10.1016/S0300-483X(00)00161-X; Gao X, 1999, TOXICOL APPL PHARM, V157, P107, DOI 10.1006/taap.1999.8649; Gehrs BC, 1997, TOXICOLOGY, V122, P229, DOI 10.1016/S0300-483X(97)00099-1; Gray LE, 1997, TOXICOL APPL PHARM, V146, P11, DOI 10.1006/taap.1997.8223; GRAY LE, 1995, TOXICOL APPL PHARM, V133, P285, DOI 10.1006/taap.1995.1153; Greer EL, 2011, NATURE, V479, P365, DOI 10.1038/nature10572; Guerrero-Bosagna C, 2012, REPROD TOXI IN PRESS; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Guo YL, 2000, LANCET, V356, P1240, DOI 10.1016/S0140-6736(00)02792-6; Hart R, 2004, BEST PRACT RES CL OB, V18, P671, DOI 10.1016/j.bpobgyn.2004.05.001; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Heimler I, 1998, REPROD TOXICOL, V12, P69, DOI 10.1016/S0890-6238(97)00101-9; Huang L, 2011, J TOXICOL SCI, V36, P713, DOI 10.2131/jts.36.713; IOM, 2010, VET AG OR UPD 2010; Jacobson-Dickman E, 2009, CURR OPIN ENDOCRINOL, V16, P25, DOI 10.1097/MED.0b013e328320d560; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kakeyama M, 2008, J ENDOCRINOL, V197, P351, DOI 10.1677/JOE-08-0062; KOCIBA RJ, 1976, TOXICOL APPL PHARM, V35, P553, DOI 10.1016/0041-008X(76)90078-8; LI XL, 1995, TOXICOL APPL PHARM, V133, P321, DOI 10.1006/taap.1995.1157; Lu CF, 2009, ARCH ENVIRON CON TOX, V57, P767, DOI 10.1007/s00244-009-9323-x; Manikkam M, 2012, PLASTICS DERIV UNPUB; Manikkam M, 2012, REPROD TOXICOL UNPUB; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; MATTISON DR, 1980, TOXICOL APPL PHARM, V53, P249, DOI 10.1016/0041-008X(80)90424-X; Meredith S, 2000, J REPROD FERTIL, V119, P43, DOI 10.1530/reprod/119.1.43; Moran FM, 2001, REPROD TOXICOL, V15, P377, DOI 10.1016/S0890-6238(01)00138-1; Mustafa A, 2011, BIRTH DEFECTS RES B, V92, P82, DOI 10.1002/bdrb.20285; Ni HG, 2010, ENVIRON TOXICOL CHEM, V29, P1237, DOI 10.1002/etc.160; Nilsson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036129; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Nilsson EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020087; Nishimura N, 2008, TOXICOL APPL PHARM, V231, P374, DOI 10.1016/j.taap.2008.05.012; Pembrey ME, 2010, HUM FERTIL, V13, P268, DOI 10.3109/14647273.2010.524721; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Roby KF, 2000, BIOL REPROD, V62, P284; Roby KF, 2001, ENDOCRINOLOGY, V142, P2328, DOI 10.1210/en.142.6.2328; Ruden DM, 2008, CURR GENOMICS, V9, P500, DOI 10.2174/138920208786241207; Salian S, 2009, LIFE SCI, V85, P742, DOI 10.1016/j.lfs.2009.10.004; Salisbury TB, 2002, BIOL REPROD, V66, P1621, DOI 10.1095/biolreprod66.6.1621; SILBERGELD EK, 1987, AM J IND MED, V11, P131, DOI 10.1002/ajim.4700110203; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; Son DS, 1999, REPROD TOXICOL, V13, P521, DOI 10.1016/S0890-6238(99)00048-9; Spaulding SW, 2011, CURR OPIN ENDOCRINOL, V18, P315, DOI 10.1097/MED.0b013e32834a8764; Stouder C, 2010, REPRODUCTION, V139, P373, DOI 10.1530/REP-09-0340; Tateno H, 2000, BIOL REPROD, V63, P341, DOI 10.1095/biolreprod63.1.341; Tracey R, 2012, REPROD TOXICOL UNPUB; Traggiai C, 2003, BEST PRACT RES CL OB, V17, P41, DOI 10.1053/ybeog.2003.0360; Tsukimori K, 2012, ENVIRON INT, V38, P79, DOI 10.1016/j.envint.2011.08.010; UMBREIT TH, 1987, ARCH ENVIRON CON TOX, V16, P461, DOI 10.1007/BF01055268; van Leeuwen FXR, 2000, CHEMOSPHERE, V40, P1095, DOI 10.1016/S0045-6535(99)00358-6; Vujovic Svetlana, 2009, Menopause Int, V15, P72, DOI 10.1258/mi.2009.009020; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Ward WS, 1999, BIOL REPROD, V60, P702, DOI 10.1095/biolreprod60.3.702; Warner M, 2004, ENVIRON HEALTH PERSP, V112, P1289, DOI 10.1289/ehp.7004; Waterland RA, 2008, INT J OBESITY, V32, P1373, DOI 10.1038/ijo.2008.100; Wolff MS, 2005, ENVIRON HEALTH PERSP, V113, pA17, DOI 10.1289/ehp.113-a17; Xu N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027286; Xu N, 2010, FERTIL STERIL, V94, P781, DOI 10.1016/j.fertnstert.2009.10.020; York Geoffrey, 2008, GLOBE MAIL	73	170	178	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46249	10.1371/journal.pone.0046249	http://dx.doi.org/10.1371/journal.pone.0046249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049995	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300100
J	Martin, S; Fernandez-Rojo, MA; Stanley, AC; Bastiani, M; Okano, S; Nixon, SJ; Thomas, G; Stow, JL; Parton, RG				Martin, Sally; Fernandez-Rojo, Manuel A.; Stanley, Amanda C.; Bastiani, Michele; Okano, Satomi; Nixon, Susan J.; Thomas, Gethin; Stow, Jennifer L.; Parton, Robert G.			Caveolin-1 Deficiency Leads to Increased Susceptibility to Cell Death and Fibrosis in White Adipose Tissue: Characterization of a Lipodystrophic Model	PLOS ONE			English	Article							INTERLEUKIN-6 STIMULATES LIPOLYSIS; TRANSCRIPT-RELEASE FACTOR; LIVER-REGENERATION; INSULIN-RESISTANCE; LIPID TRAFFICKING; DROPLET PROTEINS; POLYMERASE-I; TNF-ALPHA; ADIPOCYTES; PERILIPIN	Caveolin-1 (CAV1) is an important regulator of adipose tissue homeostasis. In the present study we examined the impact of CAV1 deficiency on the properties of mouse adipose tissue both in vivo and in explant cultures during conditions of metabolic stress. In CAV1(-/-) mice fasting caused loss of adipose tissue mass despite a lack of hormone-sensitive lipase (HSL) phosphorylation. In addition, fasting resulted in increased macrophage infiltration, enhanced deposition of collagen, and a reduction in the level of the lipid droplet protein perilipin A (PLIN1a). Explant cultures of CAV1(-/-) adipose tissue also showed a loss of PLIN1a during culture, enhanced secretion of IL-6, increased release of lactate dehydrogenase, and demonstrated increased susceptibility to cell death upon collagenase treatment. Attenuated PKA-mediated signaling to HSL, loss of PLIN1a and increased secretion of IL-6 were also observed in adipose tissue explants of CAV1(+/+) mice with diet-induced obesity. Together these results suggest that while alterations in adipocyte lipid droplet biology support adipose tissue metabolism in the absence of PKA-mediated pro-lipolytic signaling in CAV1(-/-) mice, the tissue is intrinsically unstable resulting in increased susceptibility to cell death, which we suggest underlies the development of fibrosis and inflammation during periods of metabolic stress.	[Martin, Sally; Fernandez-Rojo, Manuel A.; Stanley, Amanda C.; Bastiani, Michele; Okano, Satomi; Nixon, Susan J.; Stow, Jennifer L.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Thomas, Gethin] Univ Queensland, Diamantina Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Martin, S (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	s.martin@uq.edu.au; R.Parton@imb.uq.edu.au	Okano, Satomi/AAX-9546-2021; Thomas, Gethin P/A-3624-2011; Martin, Sally/A-7150-2010; Fernandez-Rojo, Manuel Alejandro/P-2981-2014; Stow, Jennifer L/I-4723-2013; Parton, Robert G/C-5673-2009; Bastiani, Michele/J-1823-2014; Nixon, Susan/D-4588-2017	Okano, Satomi/0000-0003-4913-9612; Martin, Sally/0000-0001-9294-5404; Fernandez-Rojo, Manuel Alejandro/0000-0002-2240-1951; Stow, Jennifer L/0000-0002-5409-9101; Parton, Robert G/0000-0002-7494-5248; Bastiani, Michele/0000-0001-6752-4157; Thomas, Gethin/0000-0001-9081-3686; Nixon, Susan/0000-0003-0346-9683	National Health and Medical Research Council of Australia [511005, 569452, 455865]; Diabetes Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia	This work was supported by grants from the National Health and Medical Research Council of Australia (to RGP, grant numbers 511005 and 569452, and RGP and SM, grant number 455865) (www.nhmrc.gov.au) and Diabetes Australia (SM) (www.diabetesaustralia.com.au). MAF was an MEC/Fulbright Postdoctoral Fellow (Ministry of Education and Science, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulaich N, 2011, DIABETES, V60, P757, DOI 10.2337/db10-0744; Asterholm IW, 2012, CELL METAB, V15, P171, DOI 10.1016/j.cmet.2012.01.004; Barnes TC, 2011, INT J RHEUMATOL, V2011, DOI DOI 10.1155/2011/721608; Bastiani M, 2010, J CELL SCI, V123, P3831, DOI 10.1242/jcs.070102; Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bezaire V, 2009, P NUTR SOC, V68, P350, DOI 10.1017/S0029665109990279; Bezaire V, 2009, FEBS LETT, V583, P3045, DOI 10.1016/j.febslet.2009.08.019; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Briand N, 2011, DIABETES, V60, P448, DOI 10.2337/db10-0856; Capeau J, 2010, ENDOCR DEV, V19, P1, DOI 10.1159/000316893; Cohen AW, 2004, DIABETES, V53, P1261, DOI 10.2337/diabetes.53.5.1261; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; FAN JY, 1983, J CELL SCI, V61, P219; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Fernandez-Rojo MA, 2011, HEPATOLOGY; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hasegawa T, 2000, BIOCHEM J, V347, P55, DOI 10.1042/0264-6021:3470055; Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Holm C, 2003, BIOCHEM SOC T, V31, P1120, DOI 10.1042/BST0311120; Jensen MD, 2008, J CLIN ENDOCR METAB, V93, pS57, DOI 10.1210/jc.2008-1585; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kim CA, 2008, J CLIN ENDOCR METAB, V93, P1129, DOI 10.1210/jc.2007-1328; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Kovsan J, 2007, J BIOL CHEM, V282, P21704, DOI 10.1074/jbc.M702223200; Langin D, 2006, TRENDS ENDOCRIN MET, V17, P314, DOI 10.1016/j.tem.2006.08.003; LAWRENCE JC, 1990, J BIOL CHEM, V265, P19768; Liu LB, 2008, J BIOL CHEM, V283, P4314, DOI 10.1074/jbc.M707890200; Martin S, 2009, J BIOL CHEM, V284, P32097, DOI 10.1074/jbc.M109.002675; Mattsson CL, 2010, AM J PHYSIOL-ENDOC M, V299, pE374, DOI 10.1152/ajpendo.00071.2010; Mattsson CL, 2011, BIOCHIM BIOPHYS ACTA, V1803, P983; Mayoral R, 2007, HEPATOLOGY, V46, P813, DOI 10.1002/hep.21746; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; Meshulam T, 2011, J LIPID RES, V52, P1526, DOI 10.1194/jlr.M015628; NAPOLITANO L, 1963, J CELL BIOL, V18, P663, DOI 10.1083/jcb.18.3.663; Ost A, 2005, J BIOL CHEM, V280, P5, DOI 10.1074/jbc.C400429200; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pilch PF, 2011, TRENDS ENDOCRIN MET, V22, P318, DOI 10.1016/j.tem.2011.04.001; Plomgaard P, 2008, J CLIN ENDOCR METAB, V93, P543, DOI 10.1210/jc.2007-1761; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Thompson BR, 2010, MOL CELL ENDOCRINOL, V318, P24, DOI 10.1016/j.mce.2009.08.015; Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI [10.1042/BST0331078, 10.1042/BST20051078]; van Hall G, 2003, J CLIN ENDOCR METAB, V88, P3005, DOI 10.1210/jc.2002-021687; VERNON RG, 1992, P NUTR SOC, V51, P397, DOI 10.1079/PNS19920053; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Yang YQ, 2008, ENDOCRINE, V33, P261, DOI 10.1007/s12020-008-9085-7; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	53	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46242	10.1371/journal.pone.0046242	http://dx.doi.org/10.1371/journal.pone.0046242			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049990	Green Submitted, gold, Green Published			2022-12-27	WOS:000309517300099
J	Shou, WH; Wang, DZ; Zhang, KY; Wang, BL; Wang, ZM; Shi, JX; Huang, W				Shou, Weihua; Wang, Dazhi; Zhang, Kaiyue; Wang, Beilan; Wang, Zhimin; Shi, Jinxiu; Huang, Wei			Gene-Wide Characterization of Common Quantitative Trait Loci for ABCB1 mRNA Expression in Normal Liver Tissues in the Chinese Population	PLOS ONE			English	Article							MDR1 P-GLYCOPROTEIN; MULTIDRUG-RESISTANCE; HUMAN PLACENTA; ASSOCIATION; POLYMORPHISMS; HAPLOTYPES; GENOME; PHARMACOKINETICS; GENOTYPE; PROTEIN	In order to comprehensively screen genetic variants leading to differential expression of the important human ABCB1 gene in the primary drug-metabolizing organ, ABCB1 mRNA expression levels were measured in 73 normal liver tissue samples from Chinese subjects. A set of Tag SNPs. were genotyped. In addition, imputation was performed within a 500 kb region around the ABCB1 gene using the reference panels of 1,000 Genome project and HapMap III. Bayesian regression was used to assess the strength of associations by compute Bayes Factors for imputed SNPs. Through imputation and linkage disequilibrium analysis, the imputed loci rs28373093, rs1002205, rs1029421, rs2285647, and rs10235835, may represent independent and strong association signals. rs28373093, a polymorphism 1.5 kb upstream from the ABCB1 transcription start site, has the strongest association. 2677 G>A/T and 3435C>T confer a clear gene-dosage effect on ABCB1 mRNA expression. The systematic characterization of gene-wide common quantitative trait loci associated with ABCB1 mRNA expression in normal liver tissues would provide the candidate markers to ABCB1-relevant clinical phenotypes in Chinese population.	[Shou, Weihua; Wang, Dazhi; Zhang, Kaiyue; Wang, Beilan; Wang, Zhimin; Shi, Jinxiu; Huang, Wei] Chinese Natl Human Genome Ctr, Dept Genet, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China; [Shou, Weihua; Huang, Wei] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Shi, JX (corresponding author), Chinese Natl Human Genome Ctr, Dept Genet, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai, Peoples R China.	shijx@chgc.sh.cn; weihuangsh@gmail.com			Chinese High-Tech Program [2009AA022709]; Ministry of Health [201202008]; Chinese National Natural Science Fund for Distinguished Young Scholars [30625019]; Chinese National Natural Science Fund for Youth [30900828]	Chinese High-Tech Program; Ministry of Health; Chinese National Natural Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Chinese National Natural Science Fund for Youth	This work was supported by grants from the Chinese High-Tech Program (2009AA022709), Special Fund for Public Benefit Research from Ministry of Health (201202008), Chinese National Natural Science Fund for Distinguished Young Scholars (30625019) and Chinese National Natural Science Fund for Youth (30900828). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcerczak E, 2010, INT J COLORECTAL DIS, V25, P1167, DOI 10.1007/s00384-010-0961-2; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bercovich D, 2006, ATHEROSCLEROSIS, V185, P97, DOI 10.1016/j.atherosclerosis.2005.05.025; Campino S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004105; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; De Luca V, 2003, PHARMACOGENOMICS J, V3, P297, DOI 10.1038/sj.tpj.6500196; Fellay J, 2002, LANCET, V359, P30, DOI 10.1016/S0140-6736(02)07276-8; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Haenisch S, 2007, PHARMACOGENOMICS J, V7, P56, DOI 10.1038/sj.tpj.6500403; Hitzl M, 2004, PHARMACOGENETICS, V14, P309, DOI 10.1097/00008571-200405000-00006; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jamroziak Krzysztof, 2004, Hematology, V9, P91, DOI 10.1080/10245330310001638974; Koyama T, 2006, BIOL PHARM BULL, V29, P1449, DOI 10.1248/bpb.29.1449; Kwan P, 2009, PHARMACOGENOMICS, V10, P723, DOI [10.2217/pgs.09.32, 10.2217/PGS.09.32]; Leith CP, 1999, BLOOD, V94, P1086; Leschziner GD, 2007, PHARMACOGENOMICS J, V7, P154, DOI 10.1038/sj.tpj.6500413; Leschziner G, 2006, PHARMACOGENET GENOM, V16, P439, DOI 10.1097/01.fpc.0000197467.21964.67; Loeuillet C, 2007, PHARMACOGENET GENOM, V17, P951, DOI 10.1097/FPC.0b013e3282eff934; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Marzolini C, 2004, CLIN PHARMACOL THER, V75, P13, DOI 10.1016/j.clpt.2003.09.012; Nakamura T, 2002, CLIN PHARMACOL THER, V71, P297, DOI 10.1067/mcp.2002.122055; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Potocnik U, 2008, CANCER GENET CYTOGEN, V183, P28, DOI 10.1016/j.cancergencyto.2008.01.023; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rao VV, 1999, P NATL ACAD SCI USA, V96, P3900, DOI 10.1073/pnas.96.7.3900; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Roy JN, 2006, PHARMACOGENET GENOM, V16, P659, DOI 10.1097/01.fpc.0000220571.20961.dd; Sakaeda T, 2003, PHARMACOGENOMICS, V4, P397, DOI 10.1517/phgs.4.4.397.22747; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schinkel AH, 1997, SEMIN CANCER BIOL, V8, P161, DOI 10.1006/scbi.1997.0068; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Siddiqui A, 2003, NEW ENGL J MED, V348, P1442, DOI 10.1056/NEJMoa021986; Siegsmund M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019412.87412.BC; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Tanabe M, 2001, J PHARMACOL EXP THER, V297, P1137; Tanigawara Y, 2000, THER DRUG MONIT, V22, P137, DOI 10.1097/00007691-200002000-00029; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Uhr M, 2008, NEURON, V57, P203, DOI 10.1016/j.neuron.2007.11.017; Uwal Y, 2004, J HUM GENET, V49, P40; Verstuyft C, 2003, EUR J CLIN PHARMACOL, V58, P809, DOI 10.1007/s00228-003-0567-5; Wang BS, 2006, MOL PHARMACOL, V70, P267, DOI 10.1124/mol.105.019810; Wang DX, 2006, AAPS J, V8, pE515, DOI 10.1208/aapsj080361; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Yusuf RZ, 2003, CURR CANCER DRUG TAR, V3, P1, DOI 10.2174/1568009033333754; Zheng HX, 2005, J CLIN PHARMACOL, V45, P404, DOI 10.1177/0091270005274507	48	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46295	10.1371/journal.pone.0046295	http://dx.doi.org/10.1371/journal.pone.0046295			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050008	gold, Green Submitted, Green Published			2022-12-27	WOS:000309517300106
J	Viswanathan, K; Bot, I; Liu, LY; Dai, EB; Turner, PC; Togonu-Bickersteth, B; Richardson, J; Davids, JA; Williams, JM; Bartee, MY; Chen, H; van Berkel, TJC; Biessen, EAL; Moyer, RW; Lucas, AR				Viswanathan, Kasinath; Bot, Ilze; Liu, Liying; Dai, Erbin; Turner, Peter C.; Togonu-Bickersteth, Babajide; Richardson, Jakob; Davids, Jennifer A.; Williams, Jennifer M.; Bartee, Mee Y.; Chen, Hao; van Berkel, Theo J. C.; Biessen, Erik A. L.; Moyer, Richard W.; Lucas, Alexandra R.			Viral Cross-Class Serpin Inhibits Vascular Inflammation and T Lymphocyte Fratricide; A Study in Rodent Models In Vivo and Human Cell Lines In Vitro	PLOS ONE			English	Article							MYXOMA-VIRUS SERP2; GRANZYME-B; INTERLEUKIN-1-BETA-CONVERTING ENZYME; APOPTOSIS; FAS; ATHEROSCLEROSIS; ACTIVATION; MECHANISMS; EXPRESSION; CRMA	Poxviruses express highly active inhibitors, including serine proteinase inhibitors (serpins), designed to target host immune defense pathways. Recent work has demonstrated clinical efficacy for a secreted, myxomaviral serpin, Serp-1, which targets the thrombotic and thrombolytic proteases, suggesting that other viral serpins may have therapeutic application. Serp-2 and CrmA are intracellular cross-class poxviral serpins, with entirely distinct functions from the Serp-1 protein. Serp-2 and CrmA block the serine protease granzyme B (GzmB) and cysteine proteases, caspases 1 and 8, in apoptotic pathways, but have not been examined for extracellular anti-inflammatory activity. We examined the ability of these cross-class serpins to inhibit plaque growth after arterial damage or transplant and to reduce leukocyte apoptosis. We observed that purified Serp-2, but not CrmA, given as a systemic infusion after angioplasty, transplant, or cuff-compression injury markedly reduced plaque growth in mouse and rat models in vivo. Plaque growth was inhibited both locally at sites of surgical trauma, angioplasty or transplant, and systemically at non-injured sites in ApoE-deficient hyperlipidemic mice. With analysis in vitro of human cells in culture, Serp-2 selectively inhibited T cell caspase activity and blocked cytotoxic T cell (CTL) mediated killing of T lymphocytes (termed fratricide). Conversely, both Serp-2 and CrmA inhibited monocyte apoptosis. Serp-2 inhibitory activity was significantly compromised either in vitro with GzmB antibody or in vivo in ApoE/GzmB double knockout mice. Conclusions The viral cross-class serpin, Serp-2, that targets both apoptotic and inflammatory pathways, reduces vascular inflammation in a GzmB-dependent fashion in vivo, and inhibits human T cell apoptosis in vitro. These findings indicate that therapies targeting Granzyme B and/or T cell apoptosis may be used to inhibit T lymphocyte apoptosis and inflammation in response to arterial injury.	[Viswanathan, Kasinath; Liu, Liying; Dai, Erbin; Togonu-Bickersteth, Babajide; Richardson, Jakob; Lucas, Alexandra R.] Robarts Res Inst, Vasc Biol Res Grp, London, ON N6A 5C1, Canada; [Bot, Ilze; van Berkel, Theo J. C.; Biessen, Erik A. L.] Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands; [Bot, Ilze; van Berkel, Theo J. C.; Biessen, Erik A. L.] Univ Maastracht, Maastracht, Netherlands; [Liu, Liying; Dai, Erbin; Togonu-Bickersteth, Babajide; Williams, Jennifer M.; Bartee, Mee Y.; Chen, Hao; Lucas, Alexandra R.] Univ Florida, Dept Med, Div Cardiovasc Med, Gainesville, FL USA; [Liu, Liying; Dai, Erbin; Togonu-Bickersteth, Babajide; Williams, Jennifer M.; Bartee, Mee Y.; Chen, Hao; Lucas, Alexandra R.] Univ Florida, Div Rheumatol, Gainesville, FL USA; [Turner, Peter C.; Davids, Jennifer A.; Bartee, Mee Y.; Moyer, Richard W.; Lucas, Alexandra R.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	Western University (University of Western Ontario); Leiden University; Leiden University - Excl LUMC; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lucas, AR (corresponding author), Robarts Res Inst, Vasc Biol Res Grp, London, ON N6A 5C1, Canada.	alexandra.lucas@medicine.ufl	Van Berkel, Theo/ABD-7677-2021	Bot, Ilze/0000-0002-1242-1959; Biessen, Erik/0000-0002-6454-8548; Turner, Peter/0000-0002-7706-4593	Canadian Institutes of Health research (CIHR); Heart and Stroke foundation of Ontario (HSFO); National Institutes of Health (NIH) ARRA [1RC1HL100202-01]; American Heart Association (AHA) [0855421 E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100202] Funding Source: NIH RePORTER	Canadian Institutes of Health research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke foundation of Ontario (HSFO)(Heart & Stroke Foundation of Ontario); National Institutes of Health (NIH) ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by research grants from the Canadian Institutes of Health research (CIHR), the Heart and Stroke foundation of Ontario (HSFO), the National Institutes of Health (NIH) ARRA grant 1RC1HL100202-01, and the American Heart Association (AHA) grant 0855421 E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2005, J BIOL CHEM, V280, P4663, DOI 10.1074/jbc.M410915200; Akyurek LM, 1998, J CLIN INVEST, V101, P2889, DOI 10.1172/JCI1177; Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; Alcouffe J, 2004, FASEB J, V18, P122, DOI 10.1096/fj.02-0808fje; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Bot I, 2003, CIRC RES, V93, P464, DOI 10.1161/01.RES.0000090993.01633.D4; Callard RE, 2003, TRENDS IMMUNOL, V24, P370, DOI 10.1016/S1471-4906(03)00164-9; Choy JC, 2005, AM J TRANSPLANT, V5, P494, DOI 10.1111/j.1600-6143.2004.00710.x; Dai EB, 2006, J BIOL CHEM, V281, P8041, DOI 10.1074/jbc.M509454200; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; FOX WM, 1993, HUM PATHOL, V24, P477, DOI 10.1016/0046-8177(93)90159-E; Gerner C, 2000, J BIOL CHEM, V275, P39018, DOI 10.1074/jbc.M006495200; Gorak-Stolinska P, 2001, J LEUKOCYTE BIOL, V70, P756; Gramling MW, 2010, THROMB RES, V125, P377, DOI 10.1016/j.thromres.2009.11.034; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hassa PO, 2003, J BIOL CHEM, V278, P45145, DOI 10.1074/jbc.M307957200; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; KOMIYAMA T, 1994, J BIOL CHEM, V269, P19331; Korkmaz B, 2002, J BIOL CHEM, V277, P39074, DOI 10.1074/jbc.M202918200; Lieberman J, 2003, NAT REV IMMUNOL, V3, P361, DOI 10.1038/nri1083; Littlewood TD, 2003, CURR OPIN LIPIDOL, V14, P469, DOI 10.1097/00041433-200310000-00007; Liu LY, 2000, J CLIN INVEST, V105, P1613, DOI 10.1172/JCI8934; Liu ZX, 2001, J IMMUNOL, V166, P3035, DOI 10.4049/jimmunol.166.5.3035; Lucas A, 1996, CIRCULATION, V94, P2890, DOI 10.1161/01.CIR.94.11.2890; Lucas A, 2009, ADV EXP MED BIOL, V666, P132; Malanga M, 2004, J BIOL CHEM, V279, P5244, DOI 10.1074/jbc.C300437200; Medema JP, 2001, J EXP MED, V194, P657, DOI 10.1084/jem.194.5.657; Messud-Petit F, 1998, J VIROL, V72, P7830, DOI 10.1128/JVI.72.10.7830-7839.1998; Nathaniel R, 2004, J GEN VIROL, V85, P1267, DOI 10.1099/vir.0.79905-0; Opal SM, 2003, CRIT CARE, V7, P23, DOI 10.1186/cc1854; Rasheed ZA, 2003, ONCOGENE, V22, P7296, DOI 10.1038/sj.onc.1206935; Rogge L, 2000, NAT GENET, V25, P96, DOI 10.1038/75671; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rossig L, 2001, BASIC RES CARDIOL, V96, P11, DOI 10.1007/s003950170073; Schneider DF, 2007, J BURN CARE RES, V28, P365, DOI 10.1097/BCR.0B013E318053D40B; Seto T, 2010, J HEART LUNG TRANSPL, V29, P352, DOI 10.1016/j.healun.2009.09.008; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Solovyan VT, 2002, J BIOL CHEM, V277, P21458, DOI 10.1074/jbc.M110621200; Stoneman VEA, 2004, CLIN SCI, V107, P343, DOI 10.1042/CS20040086; Tardif JC, 2010, CIRC-CARDIOVASC INTE, V3, P543, DOI 10.1161/CIRCINTERVENTIONS.110.953885; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; Turner PC, 1999, J VIROL, V73, P6394, DOI 10.1128/JVI.73.8.6394-6404.1999; Turner PC, 2001, ASM NEWS, V67, P201; Viswanathan K, 2009, J LEUKOCYTE BIOL, V85, P418, DOI 10.1189/jlb.0808506; Waggoner SN, 2010, J CLIN INVEST, V120, P1925, DOI 10.1172/JCI41264; Yang J, 2004, ARTERIOSCL THROM VAS, V24, P1466, DOI 10.1161/01.ATV.0000134402.94963.2f; Zadelaar ASM, 2005, ATHEROSCLEROSIS, V183, P244, DOI 10.1016/j.atherosclerosis.2005.03.044	48	25	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e44694	10.1371/journal.pone.0044694	http://dx.doi.org/10.1371/journal.pone.0044694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049756	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300011
J	Szolajska, E; Burmeister, WP; Zochowska, M; Nerlo, B; Andreev, I; Schoehn, G; Andrieu, JP; Fender, P; Naskalska, A; Zubieta, C; Cusack, S; Chroboczek, J				Szolajska, Ewa; Burmeister, Wim P.; Zochowska, Monika; Nerlo, Barbara; Andreev, Igor; Schoehn, Guy; Andrieu, Jean-Pierre; Fender, Pascal; Naskalska, Antonina; Zubieta, Chloe; Cusack, Stephen; Chroboczek, Jadwiga			The Structural Basis for the Integrity of Adenovirus Ad3 Dodecahedron	PLOS ONE			English	Article							PROTEIN TRANSDUCTION; CRYSTAL-STRUCTURE; VIRUS; INTEGRATION; ANTIGENS; DELIVERY; SEQUENCE; REVEALS; DOMAINS; TYPE-3	During the viral life cycle adenoviruses produce excess capsid proteins. Human adenovirus serotype 3 (Ad3) synthesizes predominantly an excess of free pentons, the complexes of pentameric penton base and trimeric fiber proteins, which are responsible for virus penetration. In infected cells Ad3 pentons spontaneously assemble into dodecahedral virus-like nano-particles containing twelve pentons. They also form in insect cells during expression in the baculovirus system. Similarly, in the absence of fiber protein dodecahedric particles built of 12 penton base pentamers can be produced. Both kinds of dodecahedra show remarkable efficiency of intracellular penetration and can be engineered to deliver several millions of foreign cargo molecules to a single target cell. For this reason, they are of great interest as a delivery vector. In order to successfully manipulate this potential vector for drug and/or gene delivery, an understanding of the molecular basis of vector assembly and integrity is critical. Crystallographic data in conjunction with site-directed mutagenesis and biochemical analysis provide a model for the molecular determinants of dodecamer particle assembly and the requirements for stability. The 3.8 angstrom crystal structure of Ad3 penton base dodecamer (Dd) shows that the dodecahedric structure is stabilized by strand-swapping between neighboring penton base molecules. Such N-terminal strand-swapping does not occur for Dd of Ad2, a serotype which does not form Dd under physiological conditions. This unique stabilization of the Ad3 dodecamer is controlled by residues 59-61 located at the site of strand switching, the residues involved in putative salt bridges between pentamers and by the disordered N-terminus (residues 1-47), as confirmed by site directed mutagenesis and biochemical analysis of mutant and wild type protein. We also provide evidence that the distal N-terminal residues are externally exposed and available for attaching cargo.	[Szolajska, Ewa; Zochowska, Monika; Nerlo, Barbara; Naskalska, Antonina; Chroboczek, Jadwiga] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Burmeister, Wim P.; Schoehn, Guy; Fender, Pascal; Cusack, Stephen] UJF Grenoble 1, Unit Virus Host Cell Interact, EMBL, Ctr Natl Rech Sci,CNRS UMI 3265, Grenoble, France; [Andreev, Igor] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine; [Schoehn, Guy; Andrieu, Jean-Pierre] Commissariat Energie Atom, Inst Biol Struct Jean Pierre Ebel IBS, Grenoble, France; [Zubieta, Chloe] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Zubieta, Chloe; Cusack, Stephen] EMBL, Grenoble Outstn, Grenoble, France; [Chroboczek, Jadwiga] UJF Grenoble 1, Tech Ingn Med & Complexite Informat Math & Applic, UMR CNRS 5525, La Tronche, France; [Schoehn, Guy; Andrieu, Jean-Pierre] UJF Grenoble 1, IBS, Grenoble, France; [Schoehn, Guy; Andrieu, Jean-Pierre] CNRS, IBS UMR 5075, Grenoble, France	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); European Synchrotron Radiation Facility (ESRF); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Szolajska, E (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	ewasz@ibb.waw.pl; wpb@embl.fr; jadwiga.chroboczek@imag.fr	Andreev, Igor/G-6194-2016; Chroboczek, Jadwiga/M-6554-2014	Andreev, Igor/0000-0002-3706-8514; Cusack, Stephen/0000-0002-9324-0796; Zubieta, Chloe/0000-0003-4558-9333; Burmeister, Wim/0000-0003-0876-6118; Naskalska, Antonina/0000-0002-5868-1000; Fender, Pascal/0000-0002-6698-3367; Szolajska, Ewa/0000-0002-7400-4333; Schoehn, Guy/0000-0002-1459-3201; Zochowska, Monika/0000-0002-3824-4962	Polish Ministry of Education and Computer Sciences (MNII) [2PO4B02329]; National Science Centre [N N302 505738]; MAE-French Atomic Energy Commission (CEA); NATO CLG grant	Polish Ministry of Education and Computer Sciences (MNII); National Science Centre(National Science Centre, Poland); MAE-French Atomic Energy Commission (CEA); NATO CLG grant(NATO (North Atlantic Treaty Organisation))	This work was in part supported by Polish Ministry of Education and Computer Sciences (MNII) grant 2PO4B02329, National Science Centre N N302 505738, MAE-French Atomic Energy Commission (CEA) and NATO CLG grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer I, 2011, CANCER RES, V71, P7080, DOI 10.1158/0008-5472.CAN-11-2009; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen PL, 2001, FEBS LETT, V500, P109, DOI 10.1016/S0014-5793(01)02598-4; Chen R, 2006, P NATL ACAD SCI USA, V103, P8048, DOI 10.1073/pnas.0600421103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fender P, 1997, NAT BIOTECHNOL, V15, P52, DOI 10.1038/nbt0197-52; Fender P, 2005, VIROLOGY, V340, P167, DOI 10.1016/j.virol.2005.06.030; Fender P, 2003, J VIROL, V77, P4960, DOI 10.1128/JVI.77.8.4960-4964.2003; Fender P, 2012, J VIROL, V86, P5380, DOI 10.1128/JVI.07127-11; Fuschiotti P, 2006, J MOL BIOL, V356, P510, DOI 10.1016/j.jmb.2005.11.048; Galinier R, 2002, BIOCHEMISTRY-US, V41, P14299, DOI 10.1021/bi020125b; GALLEGOS CO, 1989, VIROLOGY, V172, P616, DOI 10.1016/0042-6822(89)90204-3; Garcel A, 2006, J GENE MED, V8, P524, DOI 10.1002/jgm.862; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Gout E, 2010, J CELL BIOCHEM, V111, P699, DOI 10.1002/jcb.22756; Ishizu KI, 2001, J VIROL, V75, P61, DOI 10.1128/JVI.75.1.61-72.2001; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCarthy MP, 1998, J VIROL, V72, P32, DOI 10.1128/JVI.72.1.32-41.1998; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Naskalska A, 2009, VACCINE, V27, P7385, DOI 10.1016/j.vaccine.2009.09.021; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; NORRBY E, 1969, VIROLOGY, V37, P565, DOI 10.1016/0042-6822(69)90274-8; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Sirena D, 2005, VIROLOGY, V343, P283, DOI 10.1016/j.virol.2005.08.024; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; Villegas-Mendez A, 2010, MOL THER, V18, P1046, DOI 10.1038/mt.2010.16; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang HJ, 2011, J VIROL, V85, P6390, DOI 10.1128/JVI.00514-11; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Zochowska M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005569; Zubieta C, 2005, MOL CELL, V17, P121, DOI 10.1016/j.molcel.2004.11.041	38	20	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46075	10.1371/journal.pone.0046075	http://dx.doi.org/10.1371/journal.pone.0046075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049939	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100131
J	Toth, K; Sipos, F; Kalmar, A; Patai, AV; Wichmann, B; Stoehr, R; Golcher, H; Schellerer, V; Tulassay, Z; Molnar, B				Toth, Kinga; Sipos, Ferenc; Kalmar, Alexandra; Patai, Arpad V.; Wichmann, Barnabas; Stoehr, Robert; Golcher, Henriette; Schellerer, Vera; Tulassay, Zsolt; Molnar, Bela			Detection of Methylated SEPT9 in Plasma Is a Reliable Screening Method for Both Left- and Right-Sided Colon Cancers	PLOS ONE			English	Article							COLORECTAL-CANCER; CARCINOEMBRYONIC ANTIGEN; DNA METHYLATION; BLOOD; SERUM; SURVEILLANCE; BIOMARKER; MARKERS; STAGE; COLONOSCOPY	Background: Methylated Septin 9 (SEPT9) is a sensitive biomarker for colorectal cancer (CRC) from peripheral blood. However, its relationship to cancer localization, guaiac-based fecal occult blood test (gFOBT) and carcinoembryonic antigen (CEA) have not been described. Methodology/Principal Findings: Plasma samples were collected for SEPT9 analysis from patients with no evidence of disease (NED) (n = 92) before colonoscopy and CRC (n = 92) before surgical treatment. DNA was isolated and bisulfite-converted using Epi proColon kit 2.0. Qualitative determination was performed using Epi proColon 2.0 RT-PCR assay. Samples for gFOBT and CEA analysis were collected from NED (n = 17 and 27, respectively) and CRC (n = 22 and 27, respectively). SEPT9 test was positive in 15.2% (14/92) of NED and 95.6% (88/92) of CRC, including 100% (67/67) from stage II to stage IV CRC and 84% (21/25) of stage I CRC when a sample was called positive if 1 out of 3 PCR replicates was positive. In a second analysis (2 out of 3 PCR replicates) specificity improved to 99% (91/92) of NEDs, at a sensitivity of 79.3% (73/92) of SEPT9 positives in CRC. gFOBT was positive in 29.4% (5/17) of NED and 68.2% (15/22) of CRC and elevated CEA levels were detected in 14.8% (4/27) of NED and 51.8% (14/27) of CRC. Both SEPT9 (84.8%) and CEA (85.2%) showed higher specificity than gFOBT (70.6%). SEPT9 was positive in 96.4% (54/56) of left-sided colon cancer (LSCC) cases and 94.4% (34/36) of rightsided colon cancer (RSCC) cases. gFOBT was positive in 83.3% (10/12) of cases with LSCC and 50% (5/10) of cases with RSCC, elevated CEA was detected 60% (9/15) of LSCC and 41.7% (5/12) of RSCC. Conclusions/Significance: The high degree of sensitivity and specificity of SEPT9 in plasma makes it a better method to detect CRC than gFOBT and CEA, even for the more difficult to detect RSCC.	[Toth, Kinga; Sipos, Ferenc; Kalmar, Alexandra; Patai, Arpad V.; Tulassay, Zsolt; Molnar, Bela] Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary; [Wichmann, Barnabas; Tulassay, Zsolt; Molnar, Bela] Hungarian Acad Sci, Mol Med Res Unit, Budapest, Hungary; [Stoehr, Robert] Univ Klinikum Erlangen, Inst Pathol, Erlangen, Germany; [Golcher, Henriette; Schellerer, Vera] Univ Klinikum Erlangen, Dept Surg, Erlangen, Germany	Semmelweis University; Hungarian Academy of Sciences; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Toth, K (corresponding author), Semmelweis Univ, Dept Internal Med 2, H-1085 Budapest, Hungary.	drtothkinga@yahoo.com	Sipos, Ferenc/GYV-6182-2022		Epigenomics AG (Berlin, Germany)	Epigenomics AG (Berlin, Germany)	This study was supported by Epigenomics AG (Berlin, Germany). The sponsor has partially supplied the reagents for the study, performed technical training and support. Data collection, decision to publish and preparation of the manuscript were performed by the authors.; This study was supported by Epigenomics AG (Berlin, Germany). The sponsor has partially supplied the reagents for the study, performed technical training and support. The authors declare that they are not employed and not consultants at the funder. The authors have no share in patents, products in development or marketed products. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Bauer KM, 2012, MOL CARCINOGEN, V51, P411, DOI 10.1002/mc.20804; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Benedix F, 2011, EJSO-EUR J SURG ONC, V37, P134, DOI 10.1016/j.ejso.2010.12.004; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Chen JS, 2010, CLIN CHEM LAB MED, V48, P719, DOI 10.1515/CCLM.2010.123; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Ghazi S, 2012, J GASTROENTEROL, V47, P619, DOI 10.1007/s00535-011-0520-9; Goldstein MJ, 2005, CANCER INVEST, V23, P338, DOI 10.1081/CNV-200058878; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Hara M, 2010, J SURG ONCOL, V102, P154, DOI 10.1002/jso.21599; Haug U, 2011, BRIT J CANCER, V104, P1779, DOI 10.1038/bjc.2011.160; Hewitson P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001216.pub2; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Johnson CD, 2008, NEW ENGL J MED, V359, P1207, DOI 10.1056/NEJMoa0800996; Kapiteijn E, 2001, J PATHOL, V195, P171, DOI 10.1002/path.918; Komuro K, 2005, J SURG RES, V124, P216, DOI 10.1016/j.jss.2004.10.009; LEON SA, 1977, CANCER RES, V37, P646; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman D, 2009, CURR OPIN GASTROEN, V25, P422, DOI 10.1097/MOG.0b013e32832d1e2a; Lieberman DA, 2009, NEW ENGL J MED, V361, P1179, DOI 10.1056/NEJMcp0902176; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Meguid RA, 2008, ANN SURG ONCOL, V15, P2388, DOI 10.1245/s10434-008-0015-y; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; Nawa T, 2008, J GASTROEN HEPATOL, V23, P418, DOI 10.1111/j.1440-1746.2007.04923.x; Patai AV, 2012, DIGEST DIS, V30, P310, DOI 10.1159/000337004; Payne SR, 2010, EPIGENOMICS-UK, V2, P575, DOI [10.2217/epi.10.35, 10.2217/EPI.10.35]; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; Steele RJC, 2012, GUT, V61, P576, DOI 10.1136/gutjnl-2011-300535; Sugai T, 2006, J MOL DIAGN, V8, P193, DOI 10.2353/jmoldx.2006.050052; Tanzer M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009061; TAN EM, 1966, J CLIN INVEST, V45, P1732, DOI 10.1172/JCI105479; Tanaka J, 2007, J SURG ONCOL, V96, P611, DOI 10.1002/jso.20877; Thirunavukarasu P, 2011, JNCI-J NATL CANCER I, V103, P689, DOI 10.1093/jnci/djr078; Warren JD, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-133; Weiss JM, 2011, J CLIN ONCOL, V29, P4401, DOI 10.1200/JCO.2011.36.4414; Wild N, 2010, CLIN CANCER RES, V16, P6111, DOI 10.1158/1078-0432.CCR-10-0119	39	131	142	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46000	10.1371/journal.pone.0046000	http://dx.doi.org/10.1371/journal.pone.0046000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049919	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100117
J	Vanderschuren, H; Moreno, I; Anjanappa, RB; Zainuddin, IM; Gruissem, W				Vanderschuren, Herve; Moreno, Isabel; Anjanappa, Ravi B.; Zainuddin, Ima M.; Gruissem, Wilhelm			Exploiting the Combination of Natural and Genetically Engineered Resistance to Cassava Mosaic and Cassava Brown Streak Viruses Impacting Cassava Production in Africa	PLOS ONE			English	Article							NICOTIANA-BENTHAMIANA; EAST-AFRICA; DNA-A; DISEASE; RNA; TRANSFORMATION; SUPPRESSION; GEMINIVIRUSES; EPIDEMIOLOGY; IMPROVEMENT	Cassava brown streak disease (CBSD) and cassava mosaic disease (CMD) are currently two major viral diseases that severely reduce cassava production in large areas of Sub-Saharan Africa. Natural resistance has so far only been reported for CMD in cassava. CBSD is caused by two virus species, Cassava brown streak virus (CBSV) and Ugandan cassava brown streak virus (UCBSV). A sequence of the CBSV coat protein (CP) highly conserved between the two virus species was used to demonstrate that a CBSV-CP hairpin construct sufficed to generate immunity against both viral species in the cassava model cultivar (cv. 60444). Most of the transgenic lines showed high levels of resistance under increasing viral loads using a stringent top-grafting method of inoculation. No viral replication was observed in the resistant transgenic lines and they remained free of typical CBSD root symptoms 7 month post-infection. To generate transgenic cassava lines combining resistance to both CBSD and CMD the hairpin construct was transferred to a CMD-resistant farmer-preferred Nigerian landrace TME 7 (Oko-Iyawo). An adapted protocol allowed the efficient Agrobacterium-based transformation of TME 7 and the regeneration of transgenic lines with high levels of CBSV-CP hairpin-derived small RNAs. All transgenic TME 7 lines were immune to both CBSV and UCBSV infections. Further evaluation of the transgenic TME 7 lines revealed that CBSD resistance was maintained when plants were co-inoculated with East African cassava mosaic virus (EACMV), a geminivirus causing CMD. The innovative combination of natural and engineered virus resistance in farmer-preferred landraces will be particularly important to reducing the increasing impact of cassava viral diseases in Africa.	[Vanderschuren, Herve; Moreno, Isabel; Anjanappa, Ravi B.; Zainuddin, Ima M.; Gruissem, Wilhelm] ETH, Dept Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Vanderschuren, H (corresponding author), ETH, Dept Biol, Zurich, Switzerland.	hvanderschuren@ethz.ch	Vanderschuren, Hervé/AAF-5118-2021; Gruissem, Wilhelm/H-1752-2013	Gruissem, Wilhelm/0000-0002-1872-2998; Zainuddin, Ima Mulyama/0000-0002-2923-8691; Vanderschuren, Herve/0000-0003-2102-9737	Bill & Melinda Gates Foundation (BioCassava Plus Program); ETH Zurich; North-South Centre (ETH Zurich); Swiss Federal Commission for Scholarships for Foreign Students (FCS)	Bill & Melinda Gates Foundation (BioCassava Plus Program); ETH Zurich(ETH Zurich); North-South Centre (ETH Zurich)(ETH Zurich); Swiss Federal Commission for Scholarships for Foreign Students (FCS)	This work was partially funded by the Bill & Melinda Gates Foundation (BioCassava Plus Program) and ETH Zurich. RBA received a PhD fellowship from the North-South Centre (ETH Zurich) and IMZ received a scholarship from the Swiss Federal Commission for Scholarships for Foreign Students (FCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akano AO, 2002, THEOR APPL GENET, V105, P521, DOI 10.1007/s00122-002-0891-7; Akbergenov R, 2006, NUCLEIC ACIDS RES, V34, P462, DOI 10.1093/nar/gkj447; Alicai T, 2007, PLANT DIS, V91, P24, DOI 10.1094/PD-91-0024; Azevedo J, 2010, GENE DEV, V24, P904, DOI 10.1101/gad.1908710; Bonnet E, 2010, BIOINFORMATICS, V26, P1566, DOI 10.1093/bioinformatics/btq233; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Bucher E, 2006, J GEN VIROL, V87, P3697, DOI 10.1099/vir.0.82276-0; Bull SE, 2009, NAT PROTOC, V4, P1845, DOI 10.1038/nprot.2009.208; Collinge DB, 2010, ANNU REV PHYTOPATHOL, V48, P269, DOI 10.1146/annurev-phyto-073009-114430; Di Nicola-Negri E, 2010, PLANT CELL REP, V29, P1435, DOI 10.1007/s00299-010-0933-6; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Fargette D, 2006, ANNU REV PHYTOPATHOL, V44, P235, DOI 10.1146/annurev.phyto.44.120705.104644; Fregene M, 2000, THEOR APPL GENET, V100, P678, DOI 10.1007/s001220051339; Gonsalves D, 1998, ANNU REV PHYTOPATHOL, V36, P415, DOI 10.1146/annurev.phyto.36.1.415; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Legg JP, 2006, ADV VIRUS RES, V67, P355, DOI 10.1016/S0065-3527(06)67010-3; Legg JP, 2011, VIRUS RES, V159, P161, DOI 10.1016/j.virusres.2011.04.018; Legg JP, 2000, VIRUS RES, V71, P135, DOI 10.1016/S0168-1702(00)00194-5; Leibman D, 2011, MOL PLANT MICROBE IN, V24, P1220, DOI 10.1094/MPMI-05-11-0128; Liu J, 2011, J INTEGR PLANT BIOL, V53, P552, DOI 10.1111/j.1744-7909.2011.01048.x; Lokko Y, 2005, AFR J BIOTECHNOL, V4, P873; Mansoor S, 2006, TRENDS PLANT SCI, V11, P209, DOI 10.1016/j.tplants.2006.03.003; Mbanzibwa DR, 2011, J VIROL METHODS, V171, P394, DOI 10.1016/j.jviromet.2010.09.024; Mbanzibwa DR, 2011, J GEN VIROL, V92, P974, DOI 10.1099/vir.0.026922-0; Mbanzibwa DR, 2009, ARCH VIROL, V154, P353, DOI 10.1007/s00705-008-0301-9; Mbanzibwa DR, 2009, J VIROL, V83, P6934, DOI 10.1128/JVI.00537-09; Moreno I, 2011, J VIROL METHODS, V177, P49, DOI 10.1016/j.jviromet.2011.06.013; Niklaus Michael, 2011, GM Crops, V2, P193, DOI 10.4161/gmcr.2.3.18866; Ogwok E, 2010, J VIROL METHODS, V169, P296, DOI 10.1016/j.jviromet.2010.07.030; Okogbenin E, 2007, CROP SCI, V47, P1895, DOI 10.2135/cropsci2006.10.0688; Patil BL, 2011, MOL PLANT PATHOL, V12, P31, DOI 10.1111/j.1364-3703.2010.00650.x; Patil BL, 2009, MOL PLANT PATHOL, V10, P685, DOI [10.1111/j.1364-3703.2009.00559.x, 10.1111/J.1364-3703.2009.00559.X]; Raji A, 2008, J INTEGR PLANT BIOL, V50, P311, DOI 10.1111/j.1744-7909.2007.00606.x; Sayre R, 2011, ANNU REV PLANT BIOL, V62, P251, DOI 10.1146/annurev-arplant-042110-103751; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Senthil-Kumar M, 2007, NEW PHYTOL, V176, P782, DOI 10.1111/j.1469-8137.2007.02225.x; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Simon-Mateo C, 2011, BBA-GENE REGUL MECH, V1809, P722, DOI 10.1016/j.bbagrm.2011.05.011; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Syller J, 2012, MOL PLANT PATHOL, V13, P204, DOI 10.1111/j.1364-3703.2011.00734.x; Trinks D, 2005, J VIROL, V79, P2517, DOI 10.1128/JVI.79.4.2517-2527.2005; Vanderschuren H, 2007, PLANT MOL BIOL, V64, P549, DOI 10.1007/s11103-007-9175-6; Vanderschuren H, 2009, PLANT MOL BIOL, V70, P265, DOI 10.1007/s11103-009-9472-3; Vanitharani R, 2004, J VIROL, V78, P9487, DOI 10.1128/JVI.78.17.9487-9498.2004; Voinnet O, 1999, P NATL ACAD SCI USA, V96, P14147, DOI 10.1073/pnas.96.24.14147; Winter S, 2010, J GEN VIROL, V91, P1365, DOI 10.1099/vir.0.014688-0; Yadav JS, 2011, MOL PLANT PATHOL, V12, P677, DOI 10.1111/J.1364-3703.2010.00700.X; Zainuddin I, 2012, PLANT METHO IN PRESS; Zainuddin IM, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-24; Zhou XP, 1997, J GEN VIROL, V78, P2101, DOI 10.1099/0022-1317-78-8-2101	50	53	55	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45277	10.1371/journal.pone.0045277	http://dx.doi.org/10.1371/journal.pone.0045277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049780	Green Published, gold			2022-12-27	WOS:000309556100034
J	Xue, P; Niu, WQ; Jiang, ZY; Zheng, MH; Fei, J				Xue, Pei; Niu, Wen-Quan; Jiang, Zhao-Yan; Zheng, Min-Hua; Fei, Jian			A Meta-Analysis of Apolipoprotein E Gene epsilon 2/epsilon 3/epsilon 4 Polymorphism for Gallbladder Stone Disease	PLOS ONE			English	Article							TRIGLYCERIDE-RICH PARTICLES; GALLSTONE DISEASE; CHOLESTEROL GALLSTONE; SUSCEPTIBILITY FACTOR; APOPROTEIN-E; E GENOTYPE; CHOLELITHIASIS; RISK; EPIDEMIOLOGY; ASSOCIATION	Background: Numerous studies have investigated the relationship between apolipoprotein (Apo) E gene polymorphisms and gallbladder stone disease (GSD) across ethnic populations; however, the results are often inconsistent. This meta-analysis aims to comprehensively evaluate the influence of a common epsilon 2/epsilon 3/epsilon 4 polymorphism in Apo E gene on the risk of gallbladder stone disease. Method: Data were analyzed using the RevMan software (V5.1) and a random-effects model was applied irrespective of between-study heterogeneity. Publication bias was weighed using the fail-safe number. Results: There were 17 study populations totaling 1773 cases and 2751 controls for epsilon 2/epsilon 3/epsilon 4 polymorphism of Apo E gene. Overall comparison of alleles epsilon 2 with epsilon 3 in all study populations yielded a 16% decreased risk for GSD (95% confidence interval [95% CI]: 0.68-1.05; P = 0.31; I-2 = 13%), and comparison of alleles epsilon 4 with epsilon 3 yielded a 25% increased risk (95% confidence interval [95% CI]: 0.97-1.61; P = 0.0003; I-2 = 63%). Subgroup analysis by study design indicated that the magnitude of association in hospital-based studies was largely significantly strengthened for epsilon 4 allelic model (odds ratio [OR] = 1.46; 95% CI: 1.05-2.02; p = 0.0007; I-2 = 65%). Subgroup analysis by age of controls indicated a remarkably significant elevation in the magnitude of association in age > 50 subgroups in epsilon 4 allelic model (OR = 1.50; 95% CI: 1.03-2.19; p = 0.0009; I-2 = 72%). Moreover, subgroup analysis by cases gender indicated a reduction in the magnitude of association in male < 30% studies for E2/2 genotypic model (OR = 0.32; 95% CI: 0.07-1.49; p = 0.16; I-2 = 45%). Conclusions: Our results reveal that Apo E gene epsilon 4 allele is a risk factor of gallbladder stone disease, especially in elder people and Chinese population.	[Xue, Pei; Jiang, Zhao-Yan; Zheng, Min-Hua; Fei, Jian] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China; [Jiang, Zhao-Yan] Shanghai Inst Digest Surg, Shanghai, Peoples R China; [Niu, Wen-Quan] Shanghai Res Inst Hypertens, Shanghai, Peoples R China; [Xue, Pei; Zheng, Min-Hua] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai Minimally Invas Surg Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Fei, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Surg, Shanghai 200030, Peoples R China.	feijian@hotmail.com						Abu Abeid S, 2002, OBES SURG, V12, P354, DOI 10.1381/096089202321087850; Bertomeu A, 1996, GASTROENTEROLOGY, V111, P1603, DOI 10.1016/S0016-5085(96)70023-9; Buch S, 2007, NAT GENET, V39, P995, DOI 10.1038/ng2101; Cohn LD, 2003, PSYCHOL METHODS, V8, P243, DOI 10.1037/1082-989X.8.3.243; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DiPietro NA, 2010, PHARMACOTHERAPY, V30, P973, DOI 10.1592/phco.30.10.973; Dixit M, 2006, DIGEST LIVER DIS, V38, P397, DOI 10.1016/j.dld.2006.02.005; Everhart J E, 2001, J Assoc Acad Minor Phys, V12, P137; Hasegawa K, 2003, AM J GASTROENTEROL, V98, P1605, DOI 10.1016/S0002-9270(03)00309-5; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ho YY, 2000, BIOCHEMISTRY-US, V39, P4746, DOI 10.1021/bi992294a; Jaime SC, 2010, WORLD J GASTROENTERO, V16, P4685, DOI 10.3748/wjg.v16.i37.4685; Jiang ZY, 2008, J LIPID RES, V49, P464, DOI 10.1194/jlr.M700295-JLR200; Jiang ZY, 2004, WORLD J GASTROENTERO, V10, P1508; KERVINEN K, 1994, ATHEROSCLEROSIS, V105, P89, DOI 10.1016/0021-9150(94)90011-6; KESANIEMI YA, 1987, J CLIN INVEST, V80, P578, DOI 10.1172/JCI113107; Ko CW, 2000, HEPATOLOGY, V31, P18, DOI 10.1002/hep.510310105; Mella JG, 2007, J LIPID RES, V48, P1378, DOI 10.1194/jlr.M700059-JLR200; Niemi M, 1999, GUT, V44, P557, DOI 10.1136/gut.44.4.557; Niu WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024266; Niu WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017052; Niu WQ, 2009, HYPERTENS RES, V32, P1060, DOI 10.1038/hr.2009.164; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; SCHWIEGELSHOHN B, 1995, J BIOL CHEM, V270, P1761, DOI 10.1074/jbc.270.4.1761; Shaffer Eldon A, 2005, Curr Gastroenterol Rep, V7, P132; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; van Erpecum KJ, 2003, J HEPATOL, V39, P7, DOI 10.1016/S0168-8278(03)00177-6; WEINTRAUB MS, 1987, J CLIN INVEST, V80, P1571, DOI 10.1172/JCI113243	28	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45849	10.1371/journal.pone.0045849	http://dx.doi.org/10.1371/journal.pone.0045849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049877	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100090
J	Meisner, JK; Song, J; Price, RJ				Meisner, Joshua K.; Song, Ji; Price, Richard J.			Arteriolar and Venular Remodeling Are Differentially Regulated by Bone Marrow-Derived Cell-Specific CX3CR1 and CCR2 Expression	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; MONOCYTES; ARTERIOGENESIS; MACROPHAGE; HETEROGENEITY; ANGIOGENESIS; MIGRATION; ISCHEMIA; SUBSETS	The chemokine receptors CCR2 and CX3CR1 are critical for the recruitment of "inflammatory" and "resident" monocytes, respectively, subpopulations that differentially affect vascular remodeling in atherosclerosis. Here, we tested the hypothesis that bone marrow-derived cell (BMC)-specific CCR2 and CX3CR1 differentially control venular and arteriolar remodeling. Venular and arteriolar lumenal remodeling were observed by intravital microscopy in mice with either CCR2 or CX3CR1 deficient BMCs after implantation of a dorsal skinfold window chamber, a model in which arterioles and venules lumenally enlarge in wild-type (WT) mice. Arteriolar remodeling was abolished in mice with either CCR2 or CX3CR1-deficient BMCs. In contrast, the loss of CX3CR1 from BMCs, but not CCR2, significantly reduced small venule remodeling compared to WT controls. We conclude that microvascular remodeling is differentially regulated by BMC-expressed chemokine receptors. Both CCR2 and CX3CR1 regulate arteriole growth; however, only BMC-expressed CX3CR1 impacts small venule growth. These findings may provide a basis for additional investigations aimed at determining how patterns of monocyte subpopulation recruitment spatially influence microvascular remodeling.	[Meisner, Joshua K.; Price, Richard J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA; [Song, Ji; Price, Richard J.] Univ Virginia, Dept Radiol, Charlottesville, VA USA; [Price, Richard J.] Univ Virginia, Dept Radiat Oncol, Charlottesville, VA USA	University of Virginia; University of Virginia; University of Virginia	Price, RJ (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA.	rprice@virginia.edu		Meisner, Joshua/0000-0003-1049-8351	National Heart Lung and Blood Institute [R01 HL074082]; American Heart Association [10GRNT3490001, 09PRE2060385]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007267] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Heart Lung and Blood Institute Grant R01 HL074082, American Heart Association Grant-In-Aid 10GRNT3490001, and American Heart Association Pre-Doctoral Fellowhip 09PRE2060385. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Cai WJ, 2008, ACTA BIOCH BIOPH SIN, V40, P681, DOI 10.1111/j.1745-7270.2008.00436.x; Capoccia BJ, 2008, J LEUKOCYTE BIOL, V84, P760, DOI 10.1189/jlb.1107756; Doyle ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032815; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gregory AD, 2010, J LEUKOCYTE BIOL, V88, P123, DOI 10.1189/jlb.0709499; Heil M, 2004, CIRC RES, V95, P449, DOI 10.1161/01.RES.0000141145.78900.44; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Laschke MW, 2011, EUR CELLS MATER, V22, P147, DOI 10.22203/eCM.v022a12; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Meisner JK, 2010, MICROCIRCULATION, V17, P583, DOI 10.1111/j.1549-8719.2010.00051.x; Nickerson MM, 2009, ARTERIOSCL THROM VAS, V29, P1794, DOI 10.1161/ATVBAHA.109.194019; O'Neill TJ, 2005, CIRC RES, V97, P1027, DOI 10.1161/01.RES.0000189259.69645.25; PRIES AR, 1995, CIRC RES, V77, P1017, DOI 10.1161/01.RES.77.5.1017; Rege A, 2012, ANGIOGENESIS, V15, P87, DOI 10.1007/s10456-011-9245-x; Ryu J, 2008, CARDIOVASC RES, V78, P333, DOI 10.1093/cvr/cvm067; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Swirski FK, 2011, ARTERIOSCL THROM VAS, V31, P1517, DOI 10.1161/ATVBAHA.110.221150; Swirski FK, 2009, ARTERIOSCL THROM VAS, V29, P1424, DOI 10.1161/ATVBAHA.108.180521; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Uchida Y, 2012, INT HEART J, V53, P54, DOI 10.1536/ihj.53.54; Yang XP, 2007, CIRC RES, V101, P1001, DOI 10.1161/CIRCRESAHA.107.160812	26	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e46312	10.1371/journal.pone.0046312	http://dx.doi.org/10.1371/journal.pone.0046312			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029475	gold, Green Published			2022-12-27	WOS:000309554700121
J	Bansal, D; Undela, K; D'Cruz, S; Schifano, F				Bansal, Dipika; Undela, Krishna; D'Cruz, Sanjay; Schifano, Fabrizio			Statin Use and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies	PLOS ONE			English	Article							CHOLESTEROL-LOWERING DRUGS; FOLLOW-UP; ASSOCIATION; SIMVASTATIN; COHORT; CELLS	Background: Emerging evidence suggests that statins may decrease the risk of cancers. However, available evidence on prostate cancer (PCa) is conflicting. We therefore examined the association between statin use and risk of PCa by conducting a detailed meta-analysis of all observational studies published regarding this subject. Methods: Literature search in PubMed database was undertaken through February 2012 looking for observational studies evaluating the association between statin use and risk of PCa. Before meta-analysis, the studies were evaluated for publication bias and heterogeneity. Pooled relative risk (RR) estimates and 95% confidence intervals (CIs) were calculated using random-effects model (DerSimonian and Laird method). Subgroup analyses, sensitivity analysis and cumulative meta-analysis were also performed. Results: A total of 27 (15 cohort and 12 case-control) studies contributed to the analysis. There was heterogeneity among the studies but no publication bias. Statin use significantly reduced the risk of both total PCa by 7% (RR 0.93, 95% CI 0.87-0.99, p = 0.03) and clinically important advanced PCa by 20% (RR 0.80, 95% CI 0.70-0.90, p<0.001). Long-term statin use did not significantly affect the risk of total PCa (RR 0.94, 95% CI 0.84-1.05, p = 0.31). Stratification by study design did not substantially influence the RR. Furthermore, sensitivity analysis confirmed the stability of results. Cumulative meta-analysis showed a change in trend of reporting risk from positive to negative in statin users between 1993 and 2011. Conclusions: Our meta-analysis provides evidence supporting the hypothesis that statins reduce the risk of both total PCa and clinically important advanced PCa. Further research is needed to confirm these findings and to identify the underlying biological mechanisms.	[Bansal, Dipika; Undela, Krishna] Natl Inst Pharmaceut Educ & Res, Dept Pharm Practice, Sas Nagar Mohali, Punjab, India; [D'Cruz, Sanjay] Govt Med Coll & Hosp, Dept Gen Med, Chandigarh, India; [Schifano, Fabrizio] Univ Hertfordshire, Sch Pharm, Hatfield AL10 9AB, Herts, England	National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali); University of Hertfordshire	Bansal, D (corresponding author), Natl Inst Pharmaceut Educ & Res, Dept Pharm Practice, Sas Nagar Mohali, Punjab, India.	drdeep97@gmail.com	Undela, Krishna/K-1294-2016; Undela, Krishna/AAZ-5701-2020	Undela, Krishna/0000-0002-7480-8761				Agalliu I, 2008, AM J EPIDEMIOL, V168, P250, DOI 10.1093/aje/kwn141; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Armitage J, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-6; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blais L, 2000, ARCH INTERN MED, V160, P2363, DOI 10.1001/archinte.160.15.2363; Bonovas S, 2008, INT J CANCER, V123, P899, DOI 10.1002/ijc.23550; Boudreau DM, 2008, CANCER CAUSE CONTROL, V19, P767, DOI 10.1007/s10552-008-9139-4; Boudreau DM, 2010, EXPERT OPIN DRUG SAF, V9, P603, DOI 10.1517/14740331003662620; Breau RH, 2010, J UROLOGY, V184, P494, DOI 10.1016/j.juro.2010.03.149; Browning DRL, 2007, INT J CANCER, V120, P833, DOI 10.1002/ijc.22366; Buschemeyer WC, 2007, EUR UROL, V52, P331, DOI 10.1016/j.eururo.2007.04.069; Chang CC, 2011, PROSTATE, V71, P1818, DOI 10.1002/pros.21401; Coogan PF, 2007, EPIDEMIOLOGY, V18, P213, DOI 10.1097/01.ede.0000254694.03027.a1; Coogan PF, 2010, PHARMACOEPIDEM DR S, V19, P752, DOI 10.1002/pds.1970; Coogan PF, 2002, EPIDEMIOLOGY, V13, P262, DOI 10.1097/00001648-200205000-00005; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; DAVIGNON J, 1993, ARCH INTERN MED, V153, P1079; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Farwell WR, 2008, JNCI-J NATL CANCER I, V100, P134, DOI 10.1093/jnci/djm286; Farwell WR, 2011, JNCI-J NATL CANCER I, V103, P885, DOI 10.1093/jnci/djr108; Flick ED, 2007, CANCER EPIDEM BIOMAR, V16, P2218, DOI 10.1158/1055-9965.EPI-07-0197; Ford I, 2007, NEW ENGL J MED, V357, P1477, DOI 10.1056/NEJMoa065994; Fowke JH, 2011, CANCER CAUSE CONTROL, V22, P417, DOI 10.1007/s10552-010-9713-4; Friedman GD, 2008, PHARMACOEPIDEM DR S, V17, P27, DOI 10.1002/pds.1507; Friis S, 2005, INT J CANCER, V114, P643, DOI 10.1002/ijc.20758; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Hamilton Robert J, 2008, J Natl Cancer Inst, V100, P1511, DOI 10.1093/jnci/djn362; Haukka J, 2010, INT J CANCER, V126, P279, DOI 10.1002/ijc.24536; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hippisley-Cox Julia, 2010, BMJ, V340, pc2197, DOI 10.1136/bmj.c2197; Jacobs EJ, 2007, CANCER EPIDEM BIOMAR, V16, P2213, DOI 10.1158/1055-9965.EPI-07-0448; Jacobs EJ, 2011, CANCER RES, V71, P1763, DOI 10.1158/0008-5472.CAN-10-2953; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaye JA, 2004, BRIT J CANCER, V90, P635, DOI 10.1038/sj.bjc.6601566; Kuoppala J, 2008, EUR J CANCER, V44, P2122, DOI 10.1016/j.ejca.2008.06.025; Loeb S, 2010, BJU INT, V105, P1222, DOI 10.1111/j.1464-410X.2009.09007.x; Marcella SW, 2011, CANCER IN PRESS; Mondul AM, 2011, J UROLOGY, V185, P1268, DOI 10.1016/j.juro.2010.11.089; Mondul AM, 2010, CANCER CAUSE CONTROL, V21, P61, DOI 10.1007/s10552-009-9434-8; Murtola TJ, 2007, CANCER EPIDEM BIOMAR, V16, P2226, DOI 10.1158/1055-9965.EPI-07-0599; Murtola TJ, 2010, INT J CANCER, V127, P1650, DOI 10.1002/ijc.25165; Murtola TJ, 2009, PROSTATE, V69, P1017, DOI 10.1002/pros.20951; National Cancer Institute, 2011, SEER STAT FACT SHEET; Oh HY, 2010, BIOCHEM BIOPH RES CO, V393, P319, DOI 10.1016/j.bbrc.2010.01.133; Ottawa Hospital Research Institute, 2011, NEWCASTLE OTTAWA SCA; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Sato S, 2006, J EPIDEMIOL, V16, P201, DOI 10.2188/jea.16.201; Shannon J, 2005, AM J EPIDEMIOL, V162, P318, DOI 10.1093/aje/kwi203; Smeeth L, 2009, BRIT J CLIN PHARMACO, V67, P99, DOI 10.1111/j.1365-2125.2008.03308.x; Solomon KR, 2011, UROL CLIN N AM, V38, P243, DOI 10.1016/j.ucl.2011.04.001; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tan N, 2011, J UROLOGY, V186, P86, DOI 10.1016/j.juro.2011.03.004; World Health Organization, 2011, CANCERSTATS CANC WOR; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zheng X, 2010, CANCER PREV RES, V3, P114, DOI 10.1158/1940-6207.CAPR-09-0059	56	158	165	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46691	10.1371/journal.pone.0046691	http://dx.doi.org/10.1371/journal.pone.0046691			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049713	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388500040
J	Contarino, MF; Groot, PFC; van der Meer, JN; Bour, LJ; Speelman, JD; Nederveen, AJ; van den Munckhof, P; Tijssen, MAJ; Schuurman, PR; van Rootselaar, AF				Contarino, Maria Fiorella; Groot, Paul F. C.; van der Meer, Johan N.; Bour, Lo J.; Speelman, Johannes D.; Nederveen, Aart J.; van den Munckhof, Pepijn; Tijssen, Marina A. J.; Schuurman, Peter Rick; van Rootselaar, Anne-Fleur			Is There a Role for Combined EMG-fMRI in Exploring the Pathophysiology of Essential Tremor and Improving Functional Neurosurgery?	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; TERM-FOLLOW-UP; SUBTHALAMIC AREA; THALAMOTOMY; ACTIVATION; MOVEMENTS; THALAMUS; DISEASE	Background: Functional MRI combined with electromyography (EMG-fMRI) is a new technique to investigate the functional association of movement to brain activations. Thalamic stereotactic surgery is effective in reducing tremor. However, while some patients have satisfying benefit, others have only partial or temporary relief. This could be due to suboptimal targeting in some cases. By identifying tremor-related areas, EMG-fMRI could provide more insight into the pathophysiology of tremor and be potentially useful in refining surgical targeting. Objective: Aim of the study was to evaluate whether EMG-fMRI could detect blood oxygen level dependent brain activations associated with tremor in patients with Essential Tremor. Second, we explored whether EMG-fMRI could improve the delineation of targets for stereotactic surgery. Methods: Simultaneous EMG-fMRI was performed in six Essential Tremor patients with unilateral thalamotomy. EMG was recorded from the trembling arm (non-operated side) and from the contralateral arm (operated side). Protocols were designed to study brain activations related to voluntary muscle contractions and postural tremor. Results: Analysis with the EMG regressor was able to show the association of voluntary movements with activity in the contralateral motor cortex and supplementary motor area, and ipsilateral cerebellum. The EMG tremor frequency regressor showed an association between tremor and activity in the ipsilateral cerebellum and contralateral thalamus. The activation spot in the thalamus varied across patients and did not correspond to the thalamic nucleus ventralis intermedius. Conclusion: EMG-fMRI is potentially useful in detecting brain activations associated with tremor in patients with Essential Tremor. The technique must be further developed before being useful in supporting targeting for stereotactic surgery.	[Contarino, Maria Fiorella; van der Meer, Johan N.; Bour, Lo J.; Speelman, Johannes D.; Tijssen, Marina A. J.; van Rootselaar, Anne-Fleur] Univ Amsterdam, Acad Med Ctr, Dept Neurol Clin Neurophysiol, NL-1105 AZ Amsterdam, Netherlands; [Groot, Paul F. C.; Nederveen, Aart J.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [van den Munckhof, Pepijn; Schuurman, Peter Rick] Univ Amsterdam, Acad Med Ctr, Dept Neurosurg, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Contarino, MF (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol Clin Neurophysiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.f.contarino@amc.uva.nl; a.f.vanrootselaar@amc.uva.nl	Schuurman, Rick/ABE-9100-2021; Contarino, Maria Fiorella/J-4154-2012; van Rootselaar, Anne-Fleur/AAB-4711-2021; van den Munckhof, Pepijn/AAY-9259-2020	Contarino, Maria Fiorella/0000-0002-0312-184X; van Rootselaar, Anne-Fleur/0000-0002-8376-9098; 	ONWA (Onderzoekschool Neurowetenschappen Amsterdam - Graduate School Neurosciences Amsterdam Rotterdam) grant ABIP (Amsterdam Brain Imaging Platform)	ONWA (Onderzoekschool Neurowetenschappen Amsterdam - Graduate School Neurosciences Amsterdam Rotterdam) grant ABIP (Amsterdam Brain Imaging Platform)	This work was in part supported by ONWA (Onderzoekschool Neurowetenschappen Amsterdam - Graduate School Neurosciences Amsterdam Rotterdam) grant ABIP (Amsterdam Brain Imaging Platform)-2007-10 to AFvR and MFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basmajian J.V., 1985, MUSCLES ALIVE THEIR; Blomstedt P, 2010, MOVEMENT DISORD, V25, P1350, DOI 10.1002/mds.22758; Boecker H, 1998, MOVEMENT DISORD, V13, P64; Bucher SF, 1997, ANN NEUROL, V41, P32, DOI 10.1002/ana.410410108; COLEBATCH JG, 1990, LANCET, V336, P1028, DOI 10.1016/0140-6736(90)92489-5; Contarino MF, 2011, MOVEMENT DISORD, V26, P1366, DOI 10.1002/mds.23542; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Deuschl G, 2009, MOVEMENT DISORD, V24, P2033, DOI 10.1002/mds.22755; HALLETT M, 1993, J NEUROL SCI, V114, P45, DOI 10.1016/0022-510X(93)90047-3; Helmich RC, 2011, ANN NEUROL, V69, P269, DOI 10.1002/ana.22361; Herzog J, 2007, BRAIN, V130, P1608, DOI 10.1093/brain/awm077; JENKINS IH, 1993, ANN NEUROL, V34, P82, DOI 10.1002/ana.410340115; Kitagawa M, 2000, NEUROLOGY, V55, P114, DOI 10.1212/WNL.55.1.114; Kumar R, 2003, NEUROLOGY, V61, P1601, DOI 10.1212/01.WNL.0000096012.07360.1C; Lemieux L, 2007, MAGN RESON IMAGING, V25, P894, DOI 10.1016/j.mri.2007.03.009; Lind G, 2008, STEREOT FUNCT NEUROS, V86, P253, DOI 10.1159/000138769; Louis ED, 2011, CEREBELLUM, V10, P812, DOI 10.1007/s12311-011-0291-0; Louis ED, 2011, PARKINSONISM RELAT D, V17, P406, DOI 10.1016/j.parkreldis.2011.05.004; Miyagishima T, 2007, STEREOT FUNCT NEUROS, V85, P225, DOI 10.1159/000103261; Myers LJ, 2003, J NEUROSCI METH, V124, P157, DOI 10.1016/S0165-0270(03)00004-9; Nazzaro JM, 2012, J NEUROSURG, V117, P156, DOI 10.3171/2012.3.JNS112316; Papavassiliou E, 2004, NEUROSURGERY, V54, P1120, DOI 10.1227/01.NEU.0000119329.66931.9E; Perlmutter JS, 2002, NEUROLOGY, V58, P1388, DOI 10.1212/WNL.58.9.1388; Pilitsis JG, 2008, J NEUROSURG, V109, P640, DOI 10.3171/JNS/2008/109/10/0640; Plaha P, 2004, J NEUROSURG, V101, P48, DOI 10.3171/jns.2004.101.1.0048; Raethjen J, 2007, J NEUROPHYSIOL, V97, P3219, DOI 10.1152/jn.00477.2006; Richardson MP, 2006, NEUROIMAGE, V32, P558, DOI 10.1016/j.neuroimage.2006.04.183; Rincon Fred, 2005, Expert Opin Drug Saf, V4, P899, DOI 10.1517/14740338.4.5.899; Schnitzler A, 2009, MOVEMENT DISORD, V24, P1629, DOI 10.1002/mds.22633; Schuurman PR, 2008, MOVEMENT DISORD, V23, P1146, DOI 10.1002/mds.22059; van der Meer JN, 2010, CLIN NEUROPHYSIOL, V121, P766, DOI 10.1016/j.clinph.2009.12.035; Van Rootselaar AF, 2007, HUM BRAIN MAPP, V28, P1117, DOI 10.1002/hbm.20336; van Rootselaar AF, 2008, HUM BRAIN MAPP, V29, P1430, DOI 10.1002/hbm.20477; Velasco F, 2001, NEUROSURGERY, V49, P293, DOI 10.1097/00006123-200108000-00009; Woods RP, 1996, NEUROIMAGE, V4, pS84, DOI 10.1006/nimg.1996.0058	35	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46234	10.1371/journal.pone.0046234	http://dx.doi.org/10.1371/journal.pone.0046234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049695	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388500022
J	Wang, PJ; Gao, QY; Lin, XF; Zhang, SC; Hu, J; Liu, YQ; Xu, N; Ge, J				Wang, Peijuan; Gao, Qianying; Lin, Xiaofeng; Zhang, Shaochong; Hu, Jie; Liu, Yaqin; Xu, Nuo; Ge, Jian			Comprehensive Analysis of Inflammatory Immune Mediators of the Intraocular Fluid Aspirated from the Foldable Capsular Vitreous Body Filled-Eyes	PLOS ONE			English	Article							RETINAL-DETACHMENT; SILICONE OIL; PROLIFERATIVE VITREORETINOPATHY; IN-VITRO; VITRECTOMY; TAMPONADE; OUTCOMES; RELEASE; SURGERY; REPAIR	Purpose: To analyze the level of human inflammatory immune mediators in the intraocular fluid aspirated from foldable capsular vitreous body (FCVB) filled-eyes during FCVB removal surgery, 3 months after implantation. Methods: 8 samples of intra-FCVB fluids (n = 8) were collected from 8 FCVB filled patients in our previous FCVB exploratory clinical trial. The intra-FCVB fluids were aspirated from the FCVB filled-eyes during the FCVB removal surgeries at the third month. For the control groups, the vitreous fluids were collected from patients with idiopathic macular hole (n = 9) or rhegmatogenous retinal detachment (n = 6) during pars plana vitrectomy. A multiplex immunoassay was used to determine levels of 9 cytokines (IL-1 beta, IL-2, IL-6, IL-8, IL-10, IL-17, TNF-alpha, IFN-gamma and VEGF) in these samples. The VEGF level of some intra-FCVB fluids (n = 6) were re-tested using enzyme-linked immunosorbent assay (ELISA). Results: In the intra-FCVB fluids, 9 cytokines concentrations of most samples (n = 5) measured by Multiplex immunoassay showed low values, except for Patient 02, 06, and 09. The VEGF concentrations of some intra-FCVB fluids (n = 6) tested by ELISA were in accordance with Multiplex immunoassay results. For all eight patients (n = 8), the concentrations of IL-1 beta, IL-2, IL-6, TNF-alpha, IFN-gamma and VEGF were slightly higher as compared to the idiopathic macular hole control group. While, the concentrations of IL-8, IL-10, and IL-17 were not statistically significant different compared with the idiopathic macular hole control samples. Most cytokines concentrations (IL-2, IL-6, IL-8, IL-10, IL-17, TNF-alpha, IFN-gamma, VEGF) were not statistically significant different compared to the rhegmatogenous retinal detachment control group except IL-1 beta. Conclusions: The FCVB had sufficient porosity to allow cytokines to pass through. This study first discovered that the FCVB possesses favorable permeability of proteins in the human eye.	[Wang, Peijuan; Gao, Qianying; Lin, Xiaofeng; Zhang, Shaochong; Hu, Jie; Liu, Yaqin; Ge, Jian] Sun Yat Sen Univ, State key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Nuo] Fujian Prov Hosp, Dept Ophthalmol, Fujian Prov Clin Coll Med, Fuzhou, Peoples R China	Sun Yat Sen University; Fujian Provincial Hospital	Gao, QY (corresponding author), Sun Yat Sen Univ, State key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	gaoqy@mail.sysu.edu.cn		wang, peijuan/0000-0001-7368-427X	Combination of "Production, Teaching and Research" Program of China [2010A090200074]; National Natural Science Foundation of China [NSFC-30973258]	Combination of "Production, Teaching and Research" Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding provided by a Combination of "Production, Teaching and Research" Program of China (2010A090200074) http://cxy.gdstc.gov.cn/ and the National Natural Science Foundation of China (NSFC-30973258) http://isisn.nsfc.gov.cn/egrantweb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azen SP, 1998, OPHTHALMOLOGY, V105, P1587, DOI 10.1016/S0161-6420(98)99023-6; Boscia F, 2005, EUR J OPHTHALMOL, V15, P513, DOI 10.1177/112067210501500418; Castellarin A, 2003, BRIT J OPHTHALMOL, V87, P318, DOI 10.1136/bjo.87.3.318; Chen JJ, 2011, J BIOMED MATER RES B, V97B, P396, DOI 10.1002/jbm.b.31812; Colthurst MJ, 2000, BIOMATERIALS, V21, P649, DOI 10.1016/S0142-9612(99)00220-3; Gao Q, 2008, EYE, V22, P461, DOI 10.1038/sj.eye.6702875; Gao QY, 2009, INVEST OPHTH VIS SCI, V50, P3529, DOI 10.1167/iovs.08-2802; Jiang ZX, 2012, J OCUL PHARMACOL TH, V28, P33, DOI 10.1089/jop.2011.0109; Jiang ZX, 2012, INT J NANOMED, V7, P1, DOI 10.2147/IJN.S25268; Karel I, 1999, EUR J OPHTHALMOL, V9, P231, DOI 10.1177/112067219900900311; Karel I, 1994, Eur J Ophthalmol, V4, P52; La Heij EC, 2001, RETINA-J RET VIT DIS, V21, P107, DOI 10.1097/00006982-200104000-00002; Lin XF, 2011, INVEST OPHTH VIS SCI, V52, P374, DOI 10.1167/iovs.10-5869; Liu YQ, 2010, ARTIF ORGANS, V34, P836, DOI 10.1111/j.1525-1594.2010.01006.x; Liu YQ, 2010, INVEST OPHTH VIS SCI, V51, P1636, DOI 10.1167/iovs.09-4134; Mackiewicz J, 2007, INVEST OPHTH VIS SCI, V48, P1873, DOI 10.1167/iovs.06-0941; Majid MA, 2008, EYE, V22, P152, DOI 10.1038/sj.eye.6702784; Meng QL, 2010, GRAEF ARCH CLIN EXP, V248, P1091, DOI 10.1007/s00417-010-1351-8; Pastor JC, 1998, SURV OPHTHALMOL, V43, P3, DOI 10.1016/S0039-6257(98)00023-X; Quiram PA, 2006, OPHTHALMOLOGY, V113, P2041, DOI 10.1016/j.ophtha.2006.05.039; Rasier R, 2010, CURR EYE RES, V35, P505, DOI 10.3109/02713681003597248; Ricker LJAG, 2010, INVEST OPHTH VIS SCI, V51, P4143, DOI 10.1167/iovs.09-5057; Sandner D, 2007, GRAEF ARCH CLIN EXP, V245, P1097, DOI 10.1007/s00417-006-0496-y; Scott IU, 2005, ARCH OPHTHALMOL-CHIC, V123, P473, DOI 10.1001/archopht.123.4.473; Soman N, 2003, BIO-MED MATER ENG, V13, P59; Steijns Daan, 2009, Ned Tijdschr Geneeskd, V153, pA433; Yoon YH, 2003, RETINA-J RET VIT DIS, V23, P366, DOI 10.1097/00006982-200306000-00013; Zheng HH, 2012, GRAEF ARCH CLIN EXP, V250, P751, DOI 10.1007/s00417-011-1862-y	28	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46384	10.1371/journal.pone.0046384	http://dx.doi.org/10.1371/journal.pone.0046384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049699	Green Submitted, gold, Green Published			2022-12-27	WOS:000309388500026
J	Gao, JY; Tan, MY; Gu, MX; Marshall, C; Ding, J; Hu, G; Xiao, M				Gao, Junying; Tan, Meiyun; Gu, Minxia; Marshall, Charles; Ding, Jiong; Hu, Gang; Xiao, Ming			Cellular Localization of Aquaporin-1 in the Human and Mouse Trigeminal Systems	PLOS ONE			English	Article							IMMUNOREACTIVE ENTERIC NEURONS; PERIPHERAL NERVOUS-SYSTEM; WATER CHANNEL; SENSORY NEURONS; CHOROID-PLEXUS; GLIAL-CELLS; RAT-BRAIN; EXPRESSION; IDENTIFICATION; TRANSPORT	Previous studies reported that a subpopulation of mouse and rat trigeminal neurons express water channel aquaporin-1 (AQP1). In this study we make a comparative investigation of AQP1 localization in the human and mouse trigeminal systems. Immunohistochemistry and immunofluorescence results showed that AQP1 was localized to the cytoplasm and cell membrane of some medium and small-sized trigeminal neurons. Additionally, AQP1 was found in numerous peripheral trigeminal axons of humans and mice. In the central trigeminal root and brain stem, AQP1 was specifically expressed in astrocytes of humans, but was restricted to nerve fibers within the central trigeminal root and spinal trigeminal tract and nucleus in mice. Furthermore, AQP1 positive nerve fibers were present in the mucosal and submucosal layers of human and mouse oral tissues, but not in the muscular and subcutaneous layers. Fluorogold retrograde tracing demonstrated that AQP1 positive trigeminal neurons innervate the mucosa but not skin of cheek. These results reveal there are similarities and differences in the cellular localization of AQP1 between the human and mouse trigeminal systems. Selective expression of AQP1 in the trigeminal neurons innervating the oral mucosa indicates an involvement of AQP1 in oral sensory transduction.	[Gao, Junying; Tan, Meiyun; Gu, Minxia; Ding, Jiong; Hu, Gang; Xiao, Ming] Nanjing Med Univ, Dept Anat, Jiangsu Prov Key Lab Neurodegenerat, Nanjing, Jiangsu, Peoples R China; [Marshall, Charles] Univ Kentucky, Dept Rehabil Sci, Ctr Excellence Rural Hlth, Hazard, KY USA	Nanjing Medical University; University of Kentucky	Xiao, M (corresponding author), Nanjing Med Univ, Dept Anat, Jiangsu Prov Key Lab Neurodegenerat, Nanjing, Jiangsu, Peoples R China.	mingx@njmu.edu.cn		Xiao, Ming/0000-0001-5528-9102	National Natural Science Foundation of China [30971020]; Jiangsu Province Xinwei Project Key Discipline of Rehabilitation Medicine; PAPD Foundation of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Xinwei Project Key Discipline of Rehabilitation Medicine; PAPD Foundation of Jiangsu Higher Education Institutions	Funding was provided by the National Natural Science Foundation of China (30971020), the Jiangsu Province Xinwei Project Key Discipline of Rehabilitation Medicine, and the PAPD Foundation of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Arciszewski MB, 2011, ANN ANAT, V193, P81, DOI 10.1016/j.aanat.2010.11.003; Badaut J, 2003, ACTA NEUROCHIR SUPPL, V86, P495; Borsani E, 2010, ACTA HISTOCHEM, V112, P444, DOI 10.1016/j.acthis.2009.04.006; Borsani E, 2009, NEUROSCI LETT, V449, P183, DOI 10.1016/j.neulet.2008.11.014; Carbrey Jennifer M, 2009, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-540-79885-9_1; de Araujo IET, 2003, J NEUROPHYSIOL, V90, P1865, DOI 10.1152/jn.00297.2003; Delporte C, 2006, BBA-BIOMEMBRANES, V1758, P1061, DOI 10.1016/j.bbamem.2006.01.022; DENKER BM, 1988, J BIOL CHEM, V263, P15634; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; FRIGERI A, 1995, J CELL SCI, V108, P2993; Galeano RM, 2000, NEUROSCI LETT, V279, P89, DOI 10.1016/S0304-3940(99)00950-7; Gao HW, 2006, GLIA, V53, P783, DOI 10.1002/glia.20336; Gilbertson Timothy A., 2006, Journal of Water and Health, V4, P35; Hou MY, 2003, BRAIN RES, V964, P179, DOI 10.1016/S0006-8993(02)03927-6; Ichikawa H, 2006, BRAIN RES, V1082, P67, DOI 10.1016/j.brainres.2006.01.092; Ishihara E, 2008, AUTON NEUROSCI-BASIC, V138, P31, DOI 10.1016/j.autneu.2007.09.002; Larsen HS, 2009, EUR J ORAL SCI, V117, P655, DOI 10.1111/j.1600-0722.2009.00695.x; Li X, 2009, NEUROSCIENCE, V162, P67, DOI 10.1016/j.neuroscience.2009.04.044; Ma TH, 2011, ACTA PHARMACOL SIN, V32, P711, DOI 10.1038/aps.2011.63; Matsumoto I, 2004, MOL BRAIN RES, V126, P98, DOI 10.1016/j.molbrainres.2004.03.024; Moftakhar P, 2010, J NEUROPATH EXP NEUR, V69, P1201, DOI 10.1097/NEN.0b013e3181fd252c; Nagahama M, 2006, NEUROSCI LETT, V395, P206, DOI 10.1016/j.neulet.2005.10.092; Nandasena BGTL, 2007, BRAIN RES, V1157, P32, DOI 10.1016/j.brainres.2007.04.033; NIELSEN S, 1993, P NATL ACAD SCI USA, V90, P7275, DOI 10.1073/pnas.90.15.7275; Nielsen S, 1997, J NEUROSCI, V17, P171; Nieuwenhuys R., 1988, HUMAN CENTRAL NERVOU; Oshio K, 2006, BIOCHEM BIOPH RES CO, V341, P1022, DOI 10.1016/j.bbrc.2006.01.062; Perez E, 2007, BRAIN RES, V1128, P164, DOI 10.1016/j.brainres.2006.09.109; Praetorius J, 2006, AM J PHYSIOL-CELL PH, V291, pC59, DOI 10.1152/ajpcell.00433.2005; Satoh J, 2007, NEUROPATHOLOGY, V27, P245, DOI 10.1111/j.1440-1789.2007.00774.x; Shields SD, 2007, PAIN, V131, P8, DOI 10.1016/j.pain.2006.11.018; Shields SD, 2010, J COMP NEUROL, V518, P4329, DOI 10.1002/cne.22459; Thi MM, 2008, J NEUROSCI RES, V86, P448, DOI 10.1002/jnr.21496; Verkman A. S., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000690; Wen H, 1999, EUR J NEUROSCI, V11, P935, DOI 10.1046/j.1460-9568.1999.00502.x; Wu Q, 1998, AM J PHYSIOL-CELL PH, V275, pC1565, DOI 10.1152/ajpcell.1998.275.6.C1565; Zhang H, 2010, J BIOL CHEM, V285, P5896, DOI 10.1074/jbc.M109.090233	38	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46379	10.1371/journal.pone.0046379	http://dx.doi.org/10.1371/journal.pone.0046379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029502	Green Published, gold			2022-12-27	WOS:000309973900149
J	Ji, LJ; Zhou, JL; Zafar, R; Kantorovich, S; Jiang, RX; Carney, PR; Jiang, HB				Ji, Lijun; Zhou, Junli; Zafar, Rabia; Kantorovich, Svetlana; Jiang, Ruixin; Carney, Paul R.; Jiang, Huabei			Cortical Neurovascular Coupling Driven by Stimulation of Channelrhodopsin-2	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; OPTICAL CONTROL; HEMODYNAMIC SIGNALS; OXYGEN-METABOLISM; BOLD RESPONSE; TELL US; BRAIN; ACTIVATION; FREQUENCY; TISSUE	While functional imaging is widely used in studies of the brain, how well the hemodynamic signal represents the underlying neural activity is still unclear. And there is a debate on whether hemodynamic signal is more tightly related to synaptic activity or action potentials. This study intends to address these questions by examining neurovascular coupling driven by pyramidal cells in the motor cortex of rats. Pyramidal cells in the motor cortex of rats were selectively transduced with the light sensitive cation channel channelrhodopsin-2 (ChR2). Electrophysiological recordings and optical intrinsic signal imaging were performed simultaneously and synchronously to capture the neural activity and hemodynamics induced by optical stimulation of ChR2-expressing pyramidal cells. Our results indicate that both synaptic activity (local field potential, LFP) and action potentials (multi-unit activity, MUA) are tightly related to hemodynamic signals. While LFPs in c band are better in predicting hemodynamic signals elicited by short stimuli, MUA has better predictions to hemodynamic signals elicited by long stimuli. Our results also indicate that strong nonlinearity exists in neurovascular coupling.	[Ji, Lijun; Jiang, Ruixin; Carney, Paul R.; Jiang, Huabei] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA; [Zhou, Junli; Zafar, Rabia; Kantorovich, Svetlana; Carney, Paul R.] Univ Florida, Dept Pediat, Gainesville, FL USA; [Zhou, Junli; Carney, Paul R.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Zhou, Junli; Carney, Paul R.] Univ Florida, McKnight Brain Inst, Gainesville, FL USA; [Carney, Paul R.] Univ Florida, BJ & Eve Wilder Ctr Excellence Epilepsy Res, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Jiang, HB (corresponding author), Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.	hjiang@bme.ufl.edu			J. Crayton Pruitt Family Endowment; B.J and Eve Wilder Endowment; University of Florida Computational Biology Seed Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	J. Crayton Pruitt Family Endowment; B.J and Eve Wilder Endowment; University of Florida Computational Biology Seed Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was partially supported by the J. Crayton Pruitt Family Endowment (to HJ), B.J and Eve Wilder Endowment (to PRC), and the University of Florida Computational Biology Seed Grant (to PRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cauli B, 2004, J NEUROSCI, V24, P8940, DOI 10.1523/JNEUROSCI.3065-04.2004; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Devor A, 2003, NEURON, V39, P353, DOI 10.1016/S0896-6273(03)00403-3; DIRNAGL U, 1994, AM J PHYSIOL, V267, pH296, DOI 10.1152/ajpheart.1994.267.1.H296; Dunn AK, 2005, NEUROIMAGE, V27, P279, DOI 10.1016/j.neuroimage.2005.04.024; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Kahn I, 2011, J NEUROSCI, V31, P15086, DOI 10.1523/JNEUROSCI.0007-11.2011; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; Lee JH, 2010, NATURE, V465, P788, DOI 10.1038/nature09108; Li B, 2007, J NEUROSCI, V27, P10223, DOI 10.1523/JNEUROSCI.1505-07.2007; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Marota JJA, 1999, MAGNET RESON MED, V41, P247, DOI 10.1002/(SICI)1522-2594(199902)41:2<247::AID-MRM6>3.0.CO;2-U; Martindale J, 2005, J CEREBR BLOOD F MET, V25, P651, DOI 10.1038/sj.jcbfm.9600060; Ngai AC, 1999, BRAIN RES, V837, P221, DOI 10.1016/S0006-8993(99)01649-2; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; OGAWA S, 1990, MAGNET RESON MED, V14, P68, DOI 10.1002/mrm.1910140108; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pfeuffer J, 2003, NEUROIMAGE, V18, P990, DOI 10.1016/S1053-8119(03)00035-1; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Scott NA, 2012, PLOS ONE, V7, P176, DOI 10.1371/journal.pone.0029859; Sheth SA, 2004, NEURON, V42, P347, DOI 10.1016/S0896-6273(04)00221-1; Silva AC, 2000, J CEREBR BLOOD F MET, V20, P201, DOI 10.1097/00004647-200001000-00025; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Smith AJ, 2002, P NATL ACAD SCI USA, V99, P10765, DOI 10.1073/pnas.132272199; Soltysik DA, 2004, NEUROIMAGE, V22, P1117, DOI 10.1016/j.neuroimage.2004.03.024; Taga G, 2003, P NATL ACAD SCI USA, V100, P10722, DOI 10.1073/pnas.1932552100; Thompson JK, 2004, NAT NEUROSCI, V7, P919, DOI 10.1038/nn1308; Thompson JK, 2003, SCIENCE, V299, P1070, DOI 10.1126/science.1079220; Vazquez AL, 1998, NEUROIMAGE, V7, P108, DOI 10.1006/nimg.1997.0316; Viswanathan A, 2007, NAT NEUROSCI, V10, P1308, DOI 10.1038/nn1977; Yoshor D, 2007, J NEUROSCI, V27, P13205, DOI 10.1523/JNEUROSCI.2944-07.2007; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119	40	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46607	10.1371/journal.pone.0046607	http://dx.doi.org/10.1371/journal.pone.0046607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029556	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900190
J	Kwei, KA; Baker, JB; Pelham, RJ				Kwei, Kevin A.; Baker, Joffre B.; Pelham, Robert J.			Modulators of Sensitivity and Resistance to Inhibition of PI3K Identified in a Pharmacogenomic Screen of the NCI-60 Human Tumor Cell Line Collection	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; O-GLCNAC TRANSFERASE; INSULIN-RESISTANCE; DRUG-SENSITIVITY; AKT ACTIVATION; MESSENGER-RNA; CANCER-CELLS; PATHWAY; KINASE; POTENT	The phosphoinositide 3-kinase (PI3K) signaling pathway is significantly altered in a wide variety of human cancers, driving cancer cell growth and survival. Consequently, a large number of PI3K inhibitors are now in clinical development. To begin to improve the selection of patients for treatment with PI3K inhibitors and to identify de novo determinants of patient response, we sought to identify and characterize candidate genomic and phosphoproteomic biomarkers predictive of response to the selective PI3K inhibitor, GDC-0941, using the NCI-60 human tumor cell line collection. In this study, sixty diverse tumor cell lines were exposed to GDC-0941 and classified by GI(50) value as sensitive or resistant. The most sensitive and resistant cell lines were analyzed for their baseline levels of gene expression and phosphorylation of key signaling nodes. Phosphorylation or activation status of both the PI3K-Akt signaling axis and PARP were correlated with in vitro response to GDC-0941. A gene expression signature associated with in vitro sensitivity to GDC-0941 was also identified. Furthermore, in vitro siRNA-mediated silencing of two genes in this signature, OGT and DDN, validated their role in modulating sensitivity to GDC-0941 in numerous cell lines and begins to provide biological insights into their role as chemosensitizers. These candidate biomarkers will offer useful tools to begin a more thorough understanding of determinants of patient response to PI3K inhibitors and merit exploration in human cancer patients treated with PI3K inhibitors.	[Kwei, Kevin A.; Baker, Joffre B.; Pelham, Robert J.] Genom Hlth Inc, Redwood City, CA USA	Genomic Health	Pelham, RJ (corresponding author), Genom Hlth Inc, Redwood City, CA USA.	rpelham@genomichealth.com			Genomic Health, Inc.	Genomic Health, Inc.	Genomic Health, Inc. provided funding for this work. The funders had no role in study design, data collection and analysis, or preparation of the manuscript but approved the decision to publish.	Asanuma K, 2007, P NATL ACAD SCI USA, V104, P10134, DOI 10.1073/pnas.0700917104; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Dan S, 2010, CANCER RES, V70, P4982, DOI 10.1158/0008-5472.CAN-09-4172; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gmeiner WH, 2010, MOL CANCER THER, V9, P3105, DOI 10.1158/1535-7163.MCT-10-0674; Gould J, 2006, BIOINFORMATICS, V22, P1924, DOI 10.1093/bioinformatics/btl196; Harradine KA, 2011, MOL CANCER RES, V9, P173, DOI 10.1158/1541-7786.MCR-10-0412; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Lee JK, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r82; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Meric-Bernstam F, 2012, CLIN CANCER RES, V18, P1777, DOI 10.1158/1078-0432.CCR-11-2123; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100; O'Brien C, 2010, CLIN CANC RES; Raynaud FI, 2007, CANCER RES, V67, P5840, DOI 10.1158/0008-5472.CAN-06-4615; Shankavaram UT, 2007, MOL CANCER THER, V6, P820, DOI 10.1158/1535-7163.MCT-06-0650; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Simon R, 2005, J CLIN ONCOL, V23, P7332, DOI 10.1200/JCO.2005.02.8712; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsvetkov L, 2003, J BIOL CHEM, V278, P8468, DOI 10.1074/jbc.M211202200; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wallin JJ, 2011, MOL CANCER THER, V10, P2426, DOI 10.1158/1535-7163.MCT-11-0446; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Yaddanapudi S, 2011, J CLIN INVEST, V121, P3965, DOI 10.1172/JCI58552; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zeng LY, 2000, MOL CELL BIOL, V20, P9212, DOI 10.1128/MCB.20.24.9212-9224.2000; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	43	34	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46518	10.1371/journal.pone.0046518	http://dx.doi.org/10.1371/journal.pone.0046518			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029544	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900180
J	ter Haar, WM; Meester-Smoor, MA; van Wely, KHM; Schot, CCMM; Janssen, MJFW; Geverts, B; Bonten, J; Grosveld, GC; Houtsmuller, AB; Zwarthoff, EC				ter Haar, W. Martijn; Meester-Smoor, Magda A.; van Wely, Karel H. M.; Schot, Claudia C. M. M.; Janssen, Marjolein J. F. W.; Geverts, Bart; Bonten, Jacqueline; Grosveld, Gerard C.; Houtsmuller, Adriaan B.; Zwarthoff, Ellen C.			The Leukemia-Associated Fusion Protein MN1-TEL Blocks TEL-Specific Recognition Sequences	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; POLYMERASE-II TRANSCRIPTION; POLYCOMB GROUP PROTEIN; DNA-BINDING; CHROMATIN; GENE; OVEREXPRESSION; EXPRESSION; REPRESSOR; GROWTH	The leukemia-associated fusion protein MN1-TEL combines the transcription-activating domains of MN1 with the DNA-binding domain of the transcriptional repressor TEL. Quantitative photobleaching experiments revealed that similar to 20% of GFP-tagged MN1 and TEL is transiently immobilised, likely due to indirect or direct DNA binding, since transcription inhibition abolished immobilisation. Interestingly, similar to 50% of the MN1-TEL fusion protein was immobile with much longer binding times than unfused MN1 and TEL. MN1-TEL immobilisation was not observed when the TEL DNA-binding domain was disrupted, suggesting that MN1-TEL stably occupies TEL recognition sequences, preventing binding of factors required for proper transcription regulation, which may contribute to leukemogenesis.	[ter Haar, W. Martijn; Meester-Smoor, Magda A.; van Wely, Karel H. M.; Schot, Claudia C. M. M.; Janssen, Marjolein J. F. W.; Geverts, Bart; Houtsmuller, Adriaan B.; Zwarthoff, Ellen C.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Bonten, Jacqueline; Grosveld, Gerard C.] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	Erasmus University Rotterdam; Erasmus MC; St Jude Children's Research Hospital	Zwarthoff, EC (corresponding author), Erasmus MC, Dept Pathol, Rotterdam, Netherlands.	e.zwarthoff@erasmusmc.nl		van Wely, Karel Hermanus Martinus/0000-0001-8431-8072	Dutch Cancer Society [2003-2869]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by Dutch Cancer Society (grant 2003-2869). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett O, 2006, BIOCHEM SOC SYMP, V73, P67, DOI 10.1042/bss0730067; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; BUIJS A, 1995, ONCOGENE, V10, P1511; Buijs A, 2000, MOL CELL BIOL, V20, P9281, DOI 10.1128/MCB.20.24.9281-9293.2000; Carella C, 2007, LEUKEMIA, V21, P1679, DOI 10.1038/sj.leu.2404778; Carella C, 2006, LEUKEMIA, V20, P1582, DOI 10.1038/sj.leu.2404298; Chakrabarti SR, 1999, BIOCHEM BIOPH RES CO, V264, P871, DOI 10.1006/bbrc.1999.1605; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Farla P, 2005, J CELL SCI, V118, P4187, DOI 10.1242/jcs.02546; Farla P, 2004, J STRUCT BIOL, V147, P50, DOI 10.1016/j.jsb.2004.01.002; Fenrick R, 2000, MOL CELL BIOL, V20, P5828, DOI 10.1128/MCB.20.16.5828-5839.2000; Ficz G, 2005, DEVELOPMENT, V132, P3963, DOI 10.1242/dev.01950; Haaf T, 1996, EXP CELL RES, V224, P163, DOI 10.1006/excr.1996.0124; Heuser M, 2007, BLOOD, V110, P1639, DOI 10.1182/blood-2007-03-080523; Heuser M, 2006, BLOOD, V108, P3898, DOI 10.1182/blood-2006-04-014845; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Hoogstraten D, 2002, MOL CELL, V10, P1163, DOI 10.1016/S1097-2765(02)00709-8; Hu Y, 2009, J CELL BIOL, V185, P87, DOI 10.1083/jcb.200809196; JANSSEN JWG, 1995, BRIT J HAEMATOL, V90, P222, DOI 10.1111/j.1365-2141.1995.tb03407.x; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Kawagoe H, 2005, BLOOD, V106, P4278, DOI 10.1182/blood-2005-04-1674; Kawagoe H, 2005, BLOOD, V106, P4269, DOI 10.1182/blood-2005-04-1679; Kawamata N, 2012, ONCOGENE, V31, P966, DOI 10.1038/onc.2011.291; Lopez RG, 2003, J BIOL CHEM, V278, P41316, DOI 10.1074/jbc.M306435200; Meester-Smoor MA, 2008, CARCINOGENESIS, V29, P2025, DOI 10.1093/carcin/bgn168; Nguyen VT, 1996, NUCLEIC ACIDS RES, V24, P2924, DOI 10.1093/nar/24.15.2924; Roukens MG, 2008, MOL CELL BIOL, V28, P2342, DOI 10.1128/MCB.01159-07; Sutton ALM, 2005, MOL ENDOCRINOL, V19, P2234, DOI 10.1210/me.2005-0081; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; van Royen Martin E., 2008, V464, P363, DOI 10.1007/978-1-60327-461-6_20; van Wely K, 2007, ONCOGENE, V26, P5733, DOI 10.1038/sj.onc.1210382; van Wely KHM, 2003, ONCOGENE, V22, P699, DOI 10.1038/sj.onc.1206124; Wu Y, 2006, MOL CELL BIOL, V26, P6633, DOI 10.1128/MCB.01534-05; Xouri G, 2007, EMBO J, V26, P1303, DOI 10.1038/sj.emboj.7601597	35	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46085	10.1371/journal.pone.0046085	http://dx.doi.org/10.1371/journal.pone.0046085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049943	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300081
J	Wiggs, JL; Hewitt, AW; Fan, BJ; Wang, DY; Sena, DRF; O'Brien, C; Realini, A; Craig, JE; Dimasi, DP; Mackey, DA; Haines, JL; Pasquale, LR				Wiggs, Janey L.; Hewitt, Alex W.; Fan, Bao Jian; Wang, Dan Yi; Sena, Dayse R. Figueiredo; O'Brien, Colm; Realini, Anthony; Craig, Jamie E.; Dimasi, David P.; Mackey, David A.; Haines, Jonathan L.; Pasquale, Louis R.			The p53 Codon 72 PRO/PRO Genotype May Be Associated with Initial Central Visual Field Defects in Caucasians with Primary Open Angle Glaucoma	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; RETINAL GANGLION-CELL; GENOME-WIDE SCAN; RISK-FACTORS; INTRAOCULAR-PRESSURE; GENE-EXPRESSION; POLYMORPHISM; POPULATION; VARIANTS; RESPONSES	Background: Loss of vision in glaucoma is due to apoptotic retinal ganglion cell loss. While p53 modulates apoptosis, gene association studies between p53 variants and glaucoma have been inconsistent. In this study we evaluate the association between a p53 variant functionally known to influence apoptosis (codon 72 Pro/Arg) and the subset of primary open angle glaucoma (POAG) patients with early loss of central visual field. Methods: Genotypes for the p53 codon 72 polymorphism (Pro/Arg) were obtained for 264 POAG patients and 400 controls from the U. S. and in replication studies for 308 POAG patients and 178 controls from Australia (GIST). The glaucoma patients were divided into two groups according to location of initial visual field defect (either paracentral or peripheral). All cases and controls were Caucasian with European ancestry. Results: The p53-PRO/PRO genotype was more frequent in the U. S. POAG patients with early visual field defects in the paracentral regions compared with those in the peripheral regions or control group (p = 2.7x10(-5)). We replicated this finding in the GIST cohort (p = 7.3x10(-3), and in the pooled sample (p = 6.6x10(-7)) and in a meta-analysis of both the US and GIST datasets (1.3x10(-6), OR 2.17 (1.58-2.98 for the PRO allele). Conclusions: These results suggest that the p53 codon 72 PRO/PRO genotype is potentially associated with early paracentral visual field defects in primary open-angle glaucoma patients.	[Wiggs, Janey L.; Fan, Bao Jian; Wang, Dan Yi; Sena, Dayse R. Figueiredo; Pasquale, Louis R.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; [Hewitt, Alex W.] Univ Melbourne, Ctr Eye Res Australia, Royal Victorian Eye & Ear Hosp, Melbourne, Vic, Australia; [O'Brien, Colm] Univ Coll Dublin, Sch Med & Med Sci, Dublin 2, Ireland; [Realini, Anthony] W Virginia Univ, Dept Ophthalmol, Sch Med, Morgantown, WV 26506 USA; [Craig, Jamie E.; Dimasi, David P.] Flinders Univ S Australia, Dept Ophthalmol, Flinders Med Ctr, Adelaide, SA 5001, Australia; [Mackey, David A.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Lions Eye Inst, Perth, WA 6009, Australia; [Haines, Jonathan L.] Vanderbilt Univ, Sch Med, Ctr Human Genet Res, Nashville, TN 37212 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University College Dublin; West Virginia University; Flinders Medical Centre; Flinders University South Australia; Lions Eye Institute; University of Western Australia; Vanderbilt University	Wiggs, JL (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA.	janey_wiggs@meei.harvard.edu	Haines, Jonathan/C-3374-2012; Hewitt, Alex W/D-1936-2013; Sena, Dayse F/H-5232-2013; Mackey, David A/H-5340-2014	Haines, Jonathan/0000-0002-4351-4728; Hewitt, Alex W/0000-0002-5123-5999; Sena, Dayse F/0000-0002-9426-0166; Mackey, David A/0000-0001-7914-4709; Fan, Baojian/0000-0002-6851-2737; Craig, Jamie/0000-0001-9955-9696	National Institutes of Health/National Eye Institute [R01EY015872, R01EY015473, P30EY014104]; Research to Prevent Blindness; Harvard Glaucoma Center of Excellence; Massachusetts Lions Eye Research Fund; National Health & Medical Research Council [229960]; Ophthalmic Research Institute of Australia; Glaucoma Australia; NATIONAL EYE INSTITUTE [R21EY022766, P30EY014104, R01EY015872, R01EY015473] Funding Source: NIH RePORTER	National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Harvard Glaucoma Center of Excellence; Massachusetts Lions Eye Research Fund; National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Australia; Glaucoma Australia; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by National Institutes of Health/National Eye Institute grants: R01EY015872 (Wiggs), R01EY015473 (Pasquale), P30EY014104 (Wiggs), Research to Prevent Blindness (Wiggs, Pasquale, Realini), the Harvard Glaucoma Center of Excellence (Wiggs, Pasquale), The Massachusetts Lions Eye Research Fund (Wiggs, Pasquale), National Health & Medical Research Council Project grant 229960, the Ophthalmic Research Institute of Australia, and Glaucoma Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya M, 2002, MOL VIS, V8, P367; Anderson DR, 2003, AM J OPHTHALMOL, V136, P820, DOI 10.1016/S0002-9394(03)00478-1; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; Blanco-Marchite C, 2011, INVEST OPHTH VIS SCI, V52, P8467, DOI 10.1167/iovs.11-7489; Caprioli J, 2010, AM J OPHTHALMOL, V149, P704, DOI 10.1016/j.ajo.2010.01.018; Cheng JW, 2009, OPHTHALMOLOGY, V116, P1243, DOI 10.1016/j.ophtha.2009.01.036; Daugherty CL, 2009, MOL VIS, V15, P1939; Den Reijer PM, 2008, MECH AGEING DEV, V129, P175, DOI 10.1016/j.mad.2007.12.006; Deva NC, 2008, CLIN EXP OPHTHALMOL, V36, P217, DOI 10.1111/j.1442-9071.2008.01716.x; Di Donato S, 2009, J NEUROL, V256, P693, DOI 10.1007/s00415-009-5028-3; Dimasi DP, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032458; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Fan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1788, DOI 10.1167/iovs.10-6339; Fan BJ, 2010, INVEST OPHTH VIS SCI, V51, P4110, DOI 10.1167/iovs.09-4974; Golubnitschaja-Labudova O, 2000, CURR EYE RES, V21, P867, DOI 10.1076/ceyr.21.5.867.5534; Gordon MO, 2002, ARCH OPHTHALMOL-CHIC, V120, P714; Guo Y, 2012, INVEST OPHTH VIS SCI, V12, P9818; Guo Y, 2010, INVEST OPHTH VIS SCI, V51, P3003, DOI 10.1167/iovs.09-4663; Jeong BS, 2010, FASEB J, V24, P1347, DOI 10.1096/fj.09-146001; Katkoori VR, 2009, CLIN CANCER RES, V15, P2406, DOI 10.1158/1078-0432.CCR-08-1719; Kim NR, 2011, J GLAUCOMA; Lemmela S, 2007, INVEST OPHTH VIS SCI, V48, P4136, DOI 10.1167/iovs.06-1092; Levkovitch-Verbin H, 2006, INVEST OPHTH VIS SCI, V47, P2491, DOI 10.1167/iovs.05-0996; Li Y, 2002, MOL VIS, V8, P341; Lin HJ, 2002, BRIT J OPHTHALMOL, V86, P767, DOI 10.1136/bjo.86.7.767; Mabuchi F, 2009, MOL VIS, V15, P1045; Man CYYW, 2005, MED HYPOTHESES, V65, P1038, DOI 10.1016/j.mehy.2004.10.021; O'Connor JC, 2008, INVEST OPHTH VIS SCI, V49, P4237, DOI 10.1167/iovs.08-1963; Osborne NN, 2010, NEUROCHEM RES, V35, P2027, DOI 10.1007/s11064-010-0273-5; Park SC, 2011, OPHTHALMOLOGY, V118, P1782, DOI 10.1016/j.ophtha.2011.02.013; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Racette L, 2010, ARCH OPHTHALMOL-CHIC, V128, P551, DOI 10.1001/archophthalmol.2010.58; Ressiniotis T, 2004, J MED GENET, V41, P296, DOI 10.1136/jmg.2003.016089; Saglar E, 2009, MOL VIS, V15, P1270; Sansone P, 2007, BRIT J CANCER, V96, P1302, DOI 10.1038/sj.bjc.6603723; Silva RE, 2009, GENET MOL RES, V8, P268, DOI 10.4238/vol8-1gmr578; Stein JD, 2011, OPHTHALMOLOGY, V118, P1031, DOI 10.1016/j.ophtha.2010.10.024; Toffoli G, 2009, CLIN CANCER RES, V15, P3550, DOI 10.1158/1078-0432.CCR-08-2249; Umihira J, 2002, CURR EYE RES, V24, P147, DOI 10.1076/ceyr.24.2.147.8160; Viana RJS, 2010, CNS NEUROL DISORD-DR, V9, P679; Wang DY, 2010, INVEST OPHTH VIS SCI, V51, P4084, DOI 10.1167/iovs.09-4864; Wiggs JL, 2000, HUM MOL GENET, V9, P1109, DOI 10.1093/hmg/9.7.1109	42	43	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45613	10.1371/journal.pone.0045613	http://dx.doi.org/10.1371/journal.pone.0045613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049825	Green Published, gold			2022-12-27	WOS:000309517300039
J	Yau, KH; Mak, JCW; Leung, SWS; Yang, D; Vanhoutte, PM				Yau, Kwok-hei; Mak, Judith Choi-wo; Leung, Susan Wai-sum; Yang, Dan; Vanhoutte, Paul M.			A Synthetic Chloride Channel Relaxes Airway Smooth Muscle of the Rat	PLOS ONE			English	Article							GATED CALCIUM-CHANNELS; PIG TRACHEAL MYOCYTES; CYSTIC-FIBROSIS; ION CHANNELS; CL-SECRETION; CA2+ STORES; CURRENTS; CANINE; CELLS; CONTRACTION	Synthetic ion channels may have potential therapeutic applications, provided they possess appropriate biological activities. The present study was designed to examine the ability of small molecule-based synthetic Cl- channels to modulate airway smooth muscle responsiveness. Changes in isometric tension were measured in rat tracheal rings. Relaxations to the synthetic chloride channel SCC-1 were obtained during sustained contractions to KCl. The anion dependency of the effect of SCC-1 was evaluated by ion substitution experiments. The sensitivity to conventional Cl- transport inhibitors was also tested. SCC-1 caused concentration- dependent relaxations during sustained contractions to potassium chloride. This relaxing effect was dependent on the presence of extracellular Cl- and HCO3-. It was insensitive to conventional Cl- channels/transport inhibitors that blocked the cystic fibrosis transmembrane conductance regulator and calcium-activated Cl- channels. SCC-1 did not inhibit contractions induced by carbachol, endothelin-1, 5-hydroxytryptamine or the calcium ionophore A23187. SCC-1 relaxes airway smooth muscle during contractions evoked by depolarizing solutions. The Cl- conductance conferred by this synthetic compound is distinct from the endogenous transport systems for chloride anions.	[Mak, Judith Choi-wo; Leung, Susan Wai-sum; Vanhoutte, Paul M.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Yau, Kwok-hei; Yang, Dan] Univ Hong Kong, Fac Sci, Dept Chem, Morningside Lab Chem Biol, Hong Kong, Hong Kong, Peoples R China; [Mak, Judith Choi-wo] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Vanhoutte, PM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China.	vanhoutte.hku@hku.hk	YANG, Dan/HHD-2733-2022; /D-3151-2009	Mak, Judith/0000-0002-8234-1313; /0000-0002-1726-9335	University of Hong Kong; Hong Kong Research Grants Council Collaborative Research Fund [HKU2/06C, HKU8/CRF/10]	University of Hong Kong(University of Hong Kong); Hong Kong Research Grants Council Collaborative Research Fund(Hong Kong Research Grants Council)	This study was supported by grants from the University of Hong Kong and the Hong Kong Research Grants Council Collaborative Research Fund (HKU2/06C and HKU8/CRF/10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins JL, 2010, CHEM COMMUN, V46, P8166, DOI 10.1039/c0cc03138k; Barnes PJ, 1998, AM J RESP CRIT CARE, V158, pS123, DOI 10.1164/ajrccm.158.supplement_2.13tac800; BARNES PJ, 1985, BRIT J CLIN PHARMACO, V20, pS289, DOI 10.1111/j.1365-2125.1985.tb02815.x; Barnes PJ, 1998, PHARMACOL REV, V50, P515; BOURREAU JP, 1991, AM J PHYSIOL, V261, pC497, DOI 10.1152/ajpcell.1991.261.3.C497; BOURREAU JP, 1993, AM J PHYSIOL, V265, pC28, DOI 10.1152/ajpcell.1993.265.1.C28; Broughman JR, 2004, AM J PHYSIOL-CELL PH, V286, pC1312, DOI 10.1152/ajpcell.00426.2002; Broughman JR, 2001, AM J PHYSIOL-CELL PH, V280, pC451, DOI 10.1152/ajpcell.2001.280.3.C451; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chipperfield AR, 2000, PROG BIOPHYS MOL BIO, V74, P175, DOI 10.1016/S0079-6107(00)00024-9; COBURN RF, 1977, J PHARMACOL EXP THER, V201, P276; Dartois V, 2005, ANTIMICROB AGENTS CH, V49, P3302, DOI 10.1128/AAC.49.8.3302-3310.2005; FARLEY JM, 1977, J PHARMACOL EXP THER, V201, P199; Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601; Fyles TM, 2007, CHEM SOC REV, V36, P335, DOI 10.1039/b603256g; Gallos G, 2008, AM J PHYSIOL-LUNG C, V295, pL1040, DOI 10.1152/ajplung.90330.2008; Gleason NR, 2009, J APPL PHYSIOL, V106, P1257, DOI 10.1152/japplphysiol.91314.2008; Gokel GW, 2007, CHEM SOC REV, V36, P378, DOI 10.1039/b605910b; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; HOPPE M, 1992, J ALLERGY CLIN IMMUN, V89, P688, DOI 10.1016/0091-6749(92)90375-C; Ishiguro H, 2009, J GEN PHYSIOL, V133, P315, DOI 10.1085/jgp.200810122; ITO Y, 1989, BRIT J PHARMACOL, V98, P1249, DOI 10.1111/j.1476-5381.1989.tb12671.x; ITO Y, 1995, BRIT J PHARMACOL, V116, P2738, DOI 10.1111/j.1476-5381.1995.tb17235.x; Janssen LJ, 1997, AM J PHYSIOL-CELL PH, V272, pC1757, DOI 10.1152/ajpcell.1997.272.6.C1757; JANSSEN LJ, 1993, AM J PHYSIOL, V265, pC877, DOI 10.1152/ajpcell.1993.265.4.C877; Janssen LJ, 2002, AM J PHYSIOL-LUNG C, V282, pL1161, DOI 10.1152/ajplung.00452.2001; JANSSEN LJ, 1993, J PHYSIOL-LONDON, V465, P661, DOI 10.1113/jphysiol.1993.sp019699; JANSSEN LJ, 1992, J PHYSIOL-LONDON, V453, P197, DOI 10.1113/jphysiol.1992.sp019224; Jiang CW, 2001, AM J PHYSIOL-LUNG C, V281, pL1164, DOI 10.1152/ajplung.2001.281.5.L1164; KAMEI K, 1995, BRIT J PHARMACOL, V115, P1493, DOI 10.1111/j.1476-5381.1995.tb16642.x; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; KOTLIKOFF MI, 1988, AM J PHYSIOL, V254, pC793, DOI 10.1152/ajpcell.1988.254.6.C793; Leevy WM, 2002, J AM CHEM SOC, V124, P9022, DOI 10.1021/ja017052o; Li X, 2007, J AM CHEM SOC, V129, P7264, DOI 10.1021/ja071961h; Li X, 2009, J AM CHEM SOC, V131, P13676, DOI 10.1021/ja902352g; MARTHAN R, 1989, J APPL PHYSIOL, V66, P1706, DOI 10.1152/jappl.1989.66.4.1706; Matile S., 2011, CHEM SOC REV; Meir A, 1999, PHYSIOL REV, V79, P1019, DOI 10.1152/physrev.1999.79.3.1019; Mizuta K, 2008, AM J PHYSIOL-LUNG C, V294, pL1206, DOI 10.1152/ajplung.00287.2007; Shcheynikov N, 2004, J BIOL CHEM, V279, P21857, DOI 10.1074/jbc.M313323200; Sisson AL, 2006, CHEM SOC REV, V35, P1269, DOI 10.1039/b512423a; SOUHRADA M, 1993, J APPL PHYSIOL, V74, P1948, DOI 10.1152/jappl.1993.74.4.1948; Teixeira MCL, 2000, EUR J PHARMACOL, V394, P117, DOI 10.1016/S0014-2999(00)00089-3; Wallace DP, 2000, BBA-BIOMEMBRANES, V1464, P69, DOI 10.1016/S0005-2736(99)00248-5; WORLEY JF, 1990, AM J PHYSIOL, V259, pL468, DOI 10.1152/ajplung.1990.259.6.L468; Yim PD, 2011, FASEB J	46	1	1	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45340	10.1371/journal.pone.0045340	http://dx.doi.org/10.1371/journal.pone.0045340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049786	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300021
J	Bender, HS; Murchison, EP; Pickett, HA; Deakin, JE; Strong, MA; Conlan, C; McMillan, DA; Neumann, AA; Greider, CW; Hannon, GJ; Reddel, RR; Graves, JAM				Bender, Hannah S.; Murchison, Elizabeth P.; Pickett, Hilda A.; Deakin, Janine E.; Strong, Margaret A.; Conlan, Carly; McMillan, Daniel A.; Neumann, Axel A.; Greider, Carol W.; Hannon, Gregory J.; Reddel, Roger R.; Graves, Jennifer A. Marshall			Extreme Telomere Length Dimorphism in the Tasmanian Devil and Related Marsupials Suggests Parental Control of Telomere Length	PLOS ONE			English	Article							FACIAL-TUMOR DISEASE; GENE; TRANSMISSION; DIVERSITY; DEFECTS; BIOLOGY; ROLES; CELLS	Telomeres, specialised structures that protect chromosome ends, play a critical role in preserving chromosome integrity. Telomere dynamics in the Tasmanian devil (Sarcophilus harrisii) are of particular interest in light of the emergence of devil facial tumour disease (DFTD), a transmissible malignancy that causes rapid mortality and threatens the species with extinction. We used fluorescent in situ hybridisation to investigate telomere length in DFTD cells, in healthy Tasmanian devils and in four closely related marsupial species. Here we report that animals in the Order Dasyuromorphia have chromosomes characterised by striking telomere length dimorphism between homologues. Findings in sex chromosomes suggest that telomere length dimorphism may be regulated by events in the parental germlines. Long telomeres on the Y chromosome imply that telomere lengthening occurs during spermatogenesis, whereas telomere diminution occurs during oogenesis. Although found in several somatic cell tissue types, telomere length dimorphism was not found in DFTD cancer cells, which are characterised by uniformly short telomeres. This is, to our knowledge, the first report of naturally occurring telomere length dimorphism in any species and suggests a novel strategy of telomere length control. Comparative studies in five distantly related marsupials and a monotreme indicate that telomere dimorphism evolved at least 50 million years ago.	[Bender, Hannah S.; Deakin, Janine E.; Conlan, Carly; McMillan, Daniel A.; Graves, Jennifer A. Marshall] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Murchison, Elizabeth P.; Hannon, Gregory J.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Pickett, Hilda A.; Neumann, Axel A.; Reddel, Roger R.] Childrens Med Res Inst, Canc Res Unit, Westmead, NSW, Australia; [Pickett, Hilda A.; Neumann, Axel A.; Reddel, Roger R.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Strong, Margaret A.; Greider, Carol W.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Australian National University; Cold Spring Harbor Laboratory; Children's Medical Research Institute - Australia; University of Sydney; Johns Hopkins University	Bender, HS (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	hb78@cornell.edu	Hannon, Gregory/AAB-3568-2019; Reddel, Roger R/A-6635-2014; Deakin, Janine/A-1941-2008	Reddel, Roger R/0000-0002-6302-6107; Deakin, Janine/0000-0002-1259-3531; Strong, Margaret/0000-0002-0055-6573; Greider, Carol/0000-0002-5494-8126; Graves, Jennifer/0000-0001-6480-7856; Murchison, Elizabeth Proby/0000-0001-7462-8907; Bender, Hannah/0000-0001-9458-4964	Australian Research Council [LP0562190]; American Australian Association; National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); American Australian Association; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Australian Research Council (LP0562190, HSB, JAMG) the American Australian Association (EPM) and in part by grants from the National Institutes of Health (GJH) and generous gifts from Kathryn Davis and Dr. David Middleton (The devils' angels grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Amber Alsop (Walter and Eliza Hall Institute), Anne-Maree Pearse and Kate Swift (Tasmanian Department of Primary Industries, Parks, Water and Environment) for laboratory assistance and Elizabeth Blackburn and Denis O'Meally for helpful discussion. For their assistance collecting or providing tissue samples we acknowledge Drs Colette Harmsen, Jemma Bergfeld and Alan Marcus, as well as the staff and veterinarians at Taronga Zoo in Sydney and the National Zoo and Aquarium in Canberra. HSB was supported by the Australian Research Council and EPM by the American Australian Association. Thanks also to Kathryn Davis and Dr David Middleton (The devils' angels grant) for their generous contributions to this project.	Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Armanios M, 2009, AM J HUM GENET, V85, P823, DOI 10.1016/j.ajhg.2009.10.028; Atzmon G, 2010, P NATL ACAD SCI USA, V107, P1710, DOI 10.1073/pnas.0906191106; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Britt-Compton B, 2009, FEBS LETT, V583, P3076, DOI 10.1016/j.febslet.2009.08.029; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; Cheung I, 2006, NUCLEIC ACIDS RES, V34, P96, DOI 10.1093/nar/gkj417; Chiang YJ, 2010, P NATL ACAD SCI USA, V107, P10148, DOI 10.1073/pnas.0913125107; Deakin JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002483; Dejager L, 2009, TRENDS GENET, V25, P234, DOI 10.1016/j.tig.2009.03.007; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Fitzgerald MS, 1999, P NATL ACAD SCI USA, V96, P14813, DOI 10.1073/pnas.96.26.14813; Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x; Griner L, 1979, JNCI-J NATL CANCER I, V62; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Hathcock KS, 2002, P NATL ACAD SCI USA, V99, P3591, DOI 10.1073/pnas.012549799; Hemann MT, 2000, NUCLEIC ACIDS RES, V28, P4474, DOI 10.1093/nar/28.22.4474; Henson JD, 2005, CLIN CANCER RES, V11, P217; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Lansdorp PM, 2009, EMBO J, V28, P2532, DOI 10.1038/emboj.2009.172; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; McCallum H, 2008, TRENDS ECOL EVOL, V23, P631, DOI 10.1016/j.tree.2008.07.001; Metcalfe CJ, 2004, CHROMOSOME RES, V12, P405, DOI 10.1023/B:CHRO.0000034133.77878.88; Miller W, 2011, P NATL ACAD SCI USA, V108, P12348, DOI 10.1073/pnas.1102838108; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Nilsson MA, 2004, GENE, V340, P189, DOI 10.1016/j.gene.2004.07.040; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Oakwood M, 2001, P ROY SOC B-BIOL SCI, V268, P407, DOI 10.1098/rspb.2000.1369; Olsson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017473; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Pearse AM, 2012, CANCER GENET-NY, V205, P101, DOI 10.1016/j.cancergen.2011.12.001; Pickett HA, 2012, CELL CYCLE, V11, P1309, DOI 10.4161/cc.19632; Pyecroft SB, 2007, ECOHEALTH, V4, P346, DOI 10.1007/s10393-007-0126-0; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5; Schaetzlein S, 2004, P NATL ACAD SCI USA, V101, P8034, DOI 10.1073/pnas.0402400101; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; Siddle HV, 2010, P ROY SOC B-BIOL SCI, V277, P2001, DOI 10.1098/rspb.2009.2362; Surralles J, 1999, AM J HUM GENET, V65, P1617, DOI 10.1086/302665; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tomiyama AJ, 2012, PHYSIOL BEHAV, V106, P40, DOI 10.1016/j.physbeh.2011.11.016; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; Zhu LX, 1998, P NATL ACAD SCI USA, V95, P8648, DOI 10.1073/pnas.95.15.8648	52	20	21	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46195	10.1371/journal.pone.0046195	http://dx.doi.org/10.1371/journal.pone.0046195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049977	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000309556100152
J	Bundy, MGR; Thompson, OA; Sieger, MT; Shpak, ED				Bundy, Mark G. R.; Thompson, Olivia A.; Sieger, Matthew T.; Shpak, Elena D.			Patterns of Cell Division, Cell Differentiation and Cell Elongation in Epidermis and Cortex of Arabidopsis pedicels in the Wild Type and in erecta	PLOS ONE			English	Article							RECEPTOR-LIKE KINASES; FUNCTIONAL-ANALYSIS; FLOWER DEVELOPMENT; FRUIT-DEVELOPMENT; DEVELOPING LEAVES; GROWTH; PROLIFERATION; GIBBERELLIN; SHOOT; SIZE	Plant organ shape and size are established during growth by a predictable, controlled sequence of cell proliferation, differentiation, and elongation. To understand the regulation and coordination of these processes, we studied the temporal behavior of epidermal and cortex cells in Arabidopsis pedicels and used computational modeling to analyze cell behavior in tissues. Pedicels offer multiple advantages for such a study, as their growth is determinate, mostly one dimensional, and epidermis differentiation is uniform along the proximodistal axis. Three developmental stages were distinguished during pedicel growth: a proliferative stage, a stomata differentiation stage, and a cell elongation stage. Throughout the first two stages pedicel growth is exponential, while during the final stage growth becomes linear and depends on flower fertilization. During the first stage, the average cell cycle duration in the cortex and during symmetric divisions of epidermal cells was constant and cells divided at a fairly specific size. We also examined the mutant of ERECTA, a gene with strong influence on pedicel growth. We demonstrate that during the first two stages of pedicel development ERECTA is important for the rate of cell growth along the proximodistal axis and for cell cycle duration in epidermis and cortex. The second function of ERECTA is to prolong the proliferative phase and inhibit premature cell differentiation in the epidermis. Comparison of epidermis development in the wild type and erecta suggests that differentiation is a synchronized event in which the stomata differentiation and the transition of pavement cells from proliferation to expansion are intimately connected.	[Bundy, Mark G. R.; Thompson, Olivia A.; Sieger, Matthew T.; Shpak, Elena D.] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Shpak, ED (corresponding author), Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA.	eshpak@utk.edu	Sieger, Matthew/B-4261-2011	Sieger, Matthew/0000-0001-7387-3660; Shpak, Elena/0000-0002-5702-7517	National Science Foundation [IOS-0843340]; Division Of Integrative Organismal Systems [0843340] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation [IOS-0843340 to E.S]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2009, CURR BIOL, V19, P1188, DOI 10.1016/j.cub.2009.05.059; Andriankaja M, 2012, DEV CELL, V22, P64, DOI 10.1016/j.devcel.2011.11.011; Asl LK, 2011, PLANT PHYSIOL, V156, P2172, DOI 10.1104/pp.111.181180; Beemster GTS, 2003, TRENDS PLANT SCI, V8, P154, DOI 10.1016/S1360-1385(03)00046-3; Beemster GTS, 2002, PLANT PHYSIOL, V129, P854, DOI 10.1104/pp.002923; Das P, 2011, CURR OPIN GENET DEV, V21, P606, DOI 10.1016/j.gde.2011.07.002; David KM, 2007, PLANT J, V50, P197, DOI 10.1111/j.1365-313X.2007.03038.x; De Veylder L, 2002, EMBO J, V21, P1360, DOI 10.1093/emboj/21.6.1360; De Veylder L, 2001, PLANT CELL, V13, P1653, DOI 10.2307/3871392; Delgado D, 2011, ANN BOT-LONDON, V107, P1247, DOI 10.1093/aob/mcr060; Donnelly PM, 1999, DEV BIOL, V215, P407, DOI 10.1006/dbio.1999.9443; Dorcey E, 2009, PLANT J, V58, P318, DOI 10.1111/j.1365-313X.2008.03781.x; Douglas SJ, 2005, DEV BIOL, V284, P451, DOI 10.1016/j.ydbio.2005.06.011; Fleet CM, 2005, CURR OPIN PLANT BIOL, V8, P77, DOI 10.1016/j.pbi.2004.11.015; Gonzalez-Garcia MP, 2011, DEVELOPMENT, V138, P849, DOI 10.1242/dev.057331; HEMERLY A, 1995, EMBO J, V14, P3925, DOI 10.1002/j.1460-2075.1995.tb00064.x; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Johnson K, 2011, NEW PHYTOL, V191, P319, DOI 10.1111/j.1469-8137.2011.03737.x; Jurado S, 2010, PLANT CELL, V22, P3891, DOI 10.1105/tpc.110.078972; Karve R, 2011, RNA, V17, P1907, DOI 10.1261/rna.2825811; Kuchen EE, 2012, SCIENCE, V335, P1092, DOI 10.1126/science.1214678; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Morillo SA, 2006, CURR OPIN PLANT BIOL, V9, P460, DOI 10.1016/j.pbi.2006.07.009; Mundermann L, 2005, PLANT PHYSIOL, V139, P960, DOI 10.1104/pp.105.060483; Mussig C, 2005, PLANT BIOLOGY, V7, P110, DOI 10.1055/s-2005-837493; Nakaya M, 2002, PLANT CELL PHYSIOL, V43, P239, DOI 10.1093/pcp/pcf024; Nishimura C, 2004, PLANT CELL, V16, P1365, DOI 10.1105/tpc.021477; Pillitteri LJ, 2012, ANNU REV PLANT BIOL, V63, P591, DOI 10.1146/annurev-arplant-042811-105451; Potter CJ, 2001, CURR OPIN GENET DEV, V11, P279, DOI 10.1016/S0959-437X(00)00191-X; Ragni L, 2011, PLANT CELL, V23, P1322, DOI 10.1105/tpc.111.084020; RAYLE DL, 1970, P NATL ACAD SCI USA, V65, P184, DOI 10.1073/pnas.65.1.184; Roeder AHK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000367; Savaldi-Goldstein S, 2008, CURR OPIN PLANT BIOL, V11, P42, DOI 10.1016/j.pbi.2007.10.009; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Shpak ED, 2003, PLANT CELL, V15, P1095, DOI 10.1105/tpc.010413; Skirycz A, 2010, PLANT PHYSIOL, V152, P226, DOI 10.1104/pp.109.148965; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sundberg E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001628; Tisne S, 2011, ANN BOT-LONDON, V108, P159, DOI 10.1093/aob/mcr091; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Tsukaya H, 2002, INT REV CYTOL, V217, P1; Tsukaya H, 2008, PLOS BIOL, V6, P1373, DOI 10.1371/journal.pbio.0060174; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Uchida N, 2012, P NATL ACAD SCI USA, V109, P6337, DOI 10.1073/pnas.1117537109; Vivian-Smith A, 2001, DEVELOPMENT, V128, P2321; Wang H, 2000, ADV IND CON; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Yokoyama R, 1998, PLANT J, V15, P301, DOI 10.1046/j.1365-313X.1998.00203.x	49	17	17	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46262	10.1371/journal.pone.0046262	http://dx.doi.org/10.1371/journal.pone.0046262			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050000	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100171
J	Lai, YZ; Cheng, K; Kisaalita, W				Lai, Yinzhi; Cheng, Ke; Kisaalita, William			Three Dimensional Neuronal Cell Cultures More Accurately Model Voltage Gated Calcium Channel Functionality in Freshly Dissected Nerve Tissue	PLOS ONE			English	Article							3-D COLLAGEN HYDROGELS; LIPID RAFTS; SIGNALING MICRODOMAINS; POLYMER SCAFFOLDS; CA2+ CHANNELS; LIVING CELLS; ION CHANNELS; PROTEIN; LOCALIZATION; ORGANIZATION	It has been demonstrated that neuronal cells cultured on traditional flat surfaces may exhibit exaggerated voltage gated calcium channel (VGCC) functionality. To gain a better understanding of this phenomenon, primary neuronal cells harvested from mice superior cervical ganglion (SCG) were cultured on two dimensional (2D) flat surfaces and in three dimensional (3D) synthetic poly-L-lactic acid (PLLA) and polystyrene (PS) polymer scaffolds. These 2D- and 3D-cultured cells were compared to cells in freshly dissected SCG tissues, with respect to intracellular calcium increase in response to high K+ depolarization. The calcium increases were identical for 3D-cultured and freshly dissected, but significantly higher for 2D-cultured cells. This finding established the physiological relevance of 3D-cultured cells. To shed light on the mechanism behind the exaggerated 2D- cultured cells' functionality, transcriptase expression and related membrane protein distributions (caveolin-1) were obtained. Our results support the view that exaggerated VGCC functionality from 2D cultured SCG cells is possibly due to differences in membrane architecture, characterized by uniquely organized caveolar lipid rafts. The practical implication of use of 3D-cultured cells in preclinical drug discovery studies is that such platforms would be more effective in eliminating false positive hits and as such improve the overall yield from screening campaigns.	[Lai, Yinzhi; Cheng, Ke; Kisaalita, William] Univ Georgia, Coll Engn, Cellular Bioengn Lab, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Kisaalita, W (corresponding author), Univ Georgia, Coll Engn, Cellular Bioengn Lab, Athens, GA 30602 USA.	williamk@engr.uga.edu	Lai, Yinzhi/G-8892-2012	Lai, Yinzhi/0000-0003-0131-2172	National Science Foundation [0304340]; UGA Engineering Grants	National Science Foundation(National Science Foundation (NSF)); UGA Engineering Grants	This work was partly supported by National Science Foundation (0304340) and UGA Engineering Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873; Belletti S, 2002, J NEUROSCI RES, V70, P703, DOI 10.1002/jnr.10419; Benitah JP, 2010, J MOL CELL CARDIOL, V48, P26, DOI 10.1016/j.yjmcc.2009.07.026; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Blackstone C, 2002, FRONT BIOSCI, V7, pD872, DOI 10.2741/blacksto; Blackstone C, 1999, CELL CALCIUM, V26, P181, DOI 10.1054/ceca.1999.0071; Calder PC, 2007, J NUTR, V137, P545, DOI 10.1093/jn/137.3.545; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Cheng K, 2008, BIOMATERIALS, V29, P2802, DOI 10.1016/j.biomaterials.2008.03.015; Cheng ZJ, 2006, MOL MEMBR BIOL, V23, P101, DOI 10.1080/09687860500460041; Cosford NDP, 2002, CNS NEUROL DISORD-DR, V1, P81, DOI 10.2174/1568007023339463; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Denyer J, 1998, DRUG DISCOV TODAY, V3, P323, DOI 10.1016/S1359-6446(98)01199-4; Desai A, 2006, BIOSENS BIOELECTRON, V21, P1483, DOI 10.1016/j.bios.2005.07.005; Dolphin AC, 1999, ADV SEC MESS PHOSPH, V33, P153; Dolphin AC, 2006, BRIT J PHARMACOL, V147, pS56, DOI 10.1038/sj.bjp.0706442; DUNN GA, 1976, EXP CELL RES, V101, P1, DOI 10.1016/0014-4827(76)90405-5; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689; Freyman TM, 2001, PROG MATER SCI, V46, P273, DOI 10.1016/S0079-6425(00)00018-9; Godfraind T., 2004, MIL DRUG TH; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Jacob SN, 2005, J NEUROSCI, V25, P2853, DOI 10.1523/JNEUROSCI.4313-04.2005; JESSUP JM, 1993, J CELL BIOCHEM, V51, P290, DOI 10.1002/jcb.240510308; Joshi DC, 2011, NEUROCHEM INT, V59, P913, DOI 10.1016/j.neuint.2011.06.023; Kim S, 2007, J BIOL CHEM, V282, P32877, DOI 10.1074/jbc.M701418200; Kisaalita WS, 2009, 3 D CELL BASED BIOSE; Kiselyov K, 2006, CELL CALCIUM, V40, P451, DOI 10.1016/j.ceca.2006.08.009; Kunz-Schughart LA, 1998, INT J EXP PATHOL, V79, P1, DOI 10.1046/j.1365-2613.1998.00051.x; Lagrutta A.A., 2006, VOLTAGE GATED ION CH, P444; Lai YZ, 2012, JALA-J LAB AUTOM, V17, P284, DOI 10.1177/2211068212442503; Leitinger B, 2002, J CELL SCI, V115, P963; LEWIS ML, 1993, J CELL BIOCHEM, V51, P265, DOI 10.1002/jcb.240510305; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Lohn M, 2000, CIRC RES, V87, P1034, DOI 10.1161/01.RES.87.11.1034; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; MAINS RE, 1973, J CELL BIOL, V59, P329, DOI 10.1083/jcb.59.2.329; Mao C, 2004, BIOSENS BIOELECTRON, V19, P1075, DOI 10.1016/j.bios.2003.10.008; Martinez-Pinna J, 2002, BRAIN RES, V951, P227, DOI 10.1016/S0006-8993(02)03165-7; MEIER K, 1988, ENDOCRINOLOGY, V122, P2764, DOI 10.1210/endo-122-6-2764; MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8; MINTZ IM, 1992, NEURON, V9, P85, DOI 10.1016/0896-6273(92)90223-Z; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109, DOI 10.1152/ajpcell.1997.273.4.C1109; Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R; O'Connell KMS, 2004, TRENDS CARDIOVAS MED, V14, P37, DOI 10.1016/j.tcm.2003.10.002; O'Connor SM, 2000, BIOSENS BIOELECTRON, V14, P871, DOI 10.1016/S0956-5663(99)00055-X; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; Saino T, 2004, J ELECTRON MICROSC, V53, P49, DOI 10.1093/jmicro/53.1.49; Shitaka Y, 1996, J NEUROSCI, V16, P6476; Shu LM, 2000, ARCH BIOCHEM BIOPHYS, V373, P83, DOI 10.1006/abbi.1999.1553; Taverna E, 2004, J BIOL CHEM, V279, P5127, DOI 10.1074/jbc.M308798200; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Volonte D, 1999, FEBS LETT, V445, P431, DOI 10.1016/S0014-5793(99)00164-7; Wang LN, 2010, J BIOMED MATER RES B, V94B, P238, DOI 10.1002/jbm.b.31646; Wang SSS, 2001, J CELL BIOCHEM, V83, P574, DOI 10.1002/jcb.1252; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Webb K, 2003, BIOMATERIALS, V24, P4681, DOI 10.1016/S0142-9612(03)00368-5; Wu ZZ, 2006, BIOSENS BIOELECTRON, V22, P685, DOI 10.1016/j.bios.2006.02.003; Wu ZZ, 2006, COLLOID SURFACE B, V52, P14, DOI 10.1016/j.colsurfb.2006.06.001; Yamakage M, 2002, CAN J ANAESTH, V49, P151, DOI 10.1007/BF03020488; Yang L, 2009, J NEUROSCI, V29, P15660, DOI 10.1523/JNEUROSCI.4104-09.2009; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151	68	44	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45074	10.1371/journal.pone.0045074	http://dx.doi.org/10.1371/journal.pone.0045074			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049767	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100026
J	Deuschle, U; Schuler, J; Schulz, A; Schluter, T; Kinzel, O; Abel, U; Kremoser, C				Deuschle, Ulrich; Schueler, Julia; Schulz, Andreas; Schlueter, Thomas; Kinzel, Olaf; Abel, Ulrich; Kremoser, Claus			FXR Controls the Tumor Suppressor NDRG2 and FXR Agonists Reduce Liver Tumor Growth and Metastasis in an Orthotopic Mouse Xenograft Model	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; SMALL HETERODIMER PARTNER; ORPHAN NUCLEAR RECEPTOR; HUMAN COLON-CARCINOMA; BILE-ACID RECEPTOR; HEPATOCELLULAR-CARCINOMA; ACTIVATED RECEPTOR; REGULATORY CASCADE; CELL CARCINOMA; EXPRESSION	The farnesoid X receptor (FXR) is expressed predominantly in tissues exposed to high levels of bile acids and controls bile acid and lipid homeostasis. FXR-/- mice develop hepatocellular carcinoma (HCC) and show an increased prevalence for intestinal malignancies, suggesting a role of FXR as a tumor suppressor in enterohepatic tissues. The N-myc downstream-regulated gene 2 (NDRG2) has been recognized as a tumor suppressor gene, which is downregulated in human hepatocellular carcinoma, colorectal carcinoma and many other malignancies. We show reduced NDRG2 mRNA in livers of FXR-/- mice compared to wild type mice and both, FXR and NDRG2 mRNAs, are reduced in human HCC compared to normal liver. Gene reporter assays and Chromatin Immunoprecipitation data support that FXR directly controls NDRG2 transcription via IR1-type element(s) identified in the first introns of the human, mouse and rat NDRG2 genes. NDRG2 mRNA was induced by non-steroidal FXR agonists in livers of mice and the magnitude of induction of NDRG2 mRNA in three different human hepatoma cell lines was increased when ectopically expressing human FXR. Growth and metastasis of SK-Hep-1 cells was strongly reduced by non-steroidal FXR agonists in an orthotopic liver xenograft tumor model. Ectopic expression of FXR in SK-Hep1 cells reduced tumor growth and metastasis potential of corresponding cells and increased the anti-tumor efficacy of FXR agonists, which may be partly mediated via increased NDRG2 expression. FXR agonists may show a potential in the prevention and/or treatment of human hepatocellular carcinoma, a devastating malignancy with increasing prevalence and limited therapeutic options.	[Deuschle, Ulrich; Schulz, Andreas; Schlueter, Thomas; Kinzel, Olaf; Kremoser, Claus] Phenex Pharmaceut AG, Dept Res, Heidelberg, Germany; [Schueler, Julia] Oncotest GmbH, Dept Vivo Tumor Biol, Freiburg, Germany; [Abel, Ulrich] Merz Pharmaceut GmbH, Dept Med Chem, Frankfurt, Germany	Oncotest GmbH; Merz Pharmaceuticals GmbH	Deuschle, U (corresponding author), Phenex Pharmaceut AG, Dept Res, Heidelberg, Germany.	ulrich.deuschle@phenex-pharma.com		Schlueter, Thomas/0000-0001-5829-9381	German Federal Ministry of Education and Research [031547000]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The authors acknowledge the support by grant KMU-Innovative-2 #031547000 from the German Federal Ministry of Education and Research to Phenex Pharmaceuticals AG (http://www.bmbf.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel U, 2010, BIOORG MED CHEM LETT, V20, P4911, DOI 10.1016/j.bmcl.2010.06.084; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Chong HK, 2010, NUCLEIC ACIDS RES, V38, P6007, DOI 10.1093/nar/gkq397; Chu D, 2011, MOL CANCER THER, V10, P47, DOI 10.1158/1535-7163.MCT-10-0614; Dai JQ, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-41; De Gottardi A, 2004, DIGEST DIS SCI, V49, P982; Fiorucci S, 2005, J PHARMACOL EXP THER, V314, P584, DOI 10.1124/jpet.105.084905; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Guo XZ, 1998, HEPATOLOGY, V28, P1481, DOI 10.1002/hep.510280606; He N, 2008, GASTROENTEROLOGY, V134, P793, DOI 10.1053/j.gastro.2008.01.006; Higashiyama H, 2008, ACTA HISTOCHEM, V110, P86, DOI 10.1016/j.acthis.2007.08.001; Huang WD, 2006, SCIENCE, V312, P233, DOI 10.1126/science.1121435; Kim I, 2007, CARCINOGENESIS, V28, P940, DOI 10.1093/carcin/bgl249; Kim YJ, 2009, CARCINOGENESIS, V30, P598, DOI 10.1093/carcin/bgp047; Kremoser C., 2011, WO Pat., Patent No. [WO2011020615A1, 2011020615]; Laffitte BA, 2000, J BIOL CHEM, V275, P10638, DOI 10.1074/jbc.275.14.10638; Lax S, 2012, INT J CANCER, V130, P2232, DOI 10.1002/ijc.26293; Lee DC, 2008, CANCER RES, V68, P4210, DOI 10.1158/0008-5472.CAN-07-5040; Liu NA, 2012, MOL ENDOCRINOL, V26, P775, DOI 10.1210/me.2011-1383; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lorentzen A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-192; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Ma JJ, 2008, BIOL PHARM BULL, V31, P1316, DOI 10.1248/bpb.31.1316; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Maloney PR, 2000, J MED CHEM, V43, P2971, DOI 10.1021/jm0002127; Maran RRM, 2009, J PHARMACOL EXP THER, V328, P469, DOI 10.1124/jpet.108.145409; Martinez-Becerra P, 2012, MOL PHARMACEUT, V9, P1693, DOI 10.1021/mp300028a; Modica S, 2008, CANCER RES, V68, P9589, DOI 10.1158/0008-5472.CAN-08-1791; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Piepoli A, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-11; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Shi H, 2010, CANCER SCI, V101, P1292, DOI 10.1111/j.1349-7006.2010.01529.x; SHOUVAL D, 1988, VIRCHOWS ARCH A, V412, P595, DOI 10.1007/BF00844296; Smith DLH, 2010, CARCINOGENESIS, V31, P1100, DOI 10.1093/carcin/bgq050; Song SP, 2011, MED ONCOL, V2; Tanaka M, 2011, J EPIDEMIOL, V21, P401, DOI 10.2188/jea.JE20100190; Tepel M, 2008, INT J CANCER, V123, P2080, DOI 10.1002/ijc.23705; Thomas AM, 2010, HEPATOLOGY, V51, P1410, DOI 10.1002/hep.23450; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Wolfe A, 2011, J PHARMACOL EXP THER, V338, P12, DOI 10.1124/jpet.111.179390; Yang F, 2007, CANCER RES, V67, P863, DOI 10.1158/0008-5472.CAN-06-1078; Zhang SW, 2009, J HEPATOL, V51, P380, DOI 10.1016/j.jhep.2009.03.025; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zhang YX, 2008, HEPATOLOGY, V48, P289, DOI 10.1002/hep.22342; Zhao HD, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-303; Zheng J, 2010, ASIAN PAC J CANCER P, V11, P1817; Zhong XY, 2012, GENE, V493, P44, DOI 10.1016/j.gene.2011.11.028	51	63	70	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2012	7	10							e43044	10.1371/journal.pone.0043044	http://dx.doi.org/10.1371/journal.pone.0043044			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	021MR	23056173	Green Published, Green Submitted, gold			2022-12-27	WOS:000309889400002
J	Lombardo, E; van Roomen, CPAA; van Puijvelde, GH; Ottenhoff, R; van Eijk, M; Aten, J; Kuiper, J; Overkleeft, HS; Groen, AK; Verhoeven, AJ; Aerts, JMFG; Bietrix, F				Lombardo, Elisa; van Roomen, Cindy P. A. A.; van Puijvelde, Gijs H.; Ottenhoff, Roelof; van Eijk, Marco; Aten, Jan; Kuiper, Johan; Overkleeft, Herman S.; Groen, Albert K.; Verhoeven, Arthur J.; Aerts, Johannes M. F. G.; Bietrix, Florence			Correction of Liver Steatosis by a Hydrophobic Iminosugar Modulating Glycosphingolipids Metabolism	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; IMPROVES GLYCEMIC CONTROL; INSULIN SENSITIVITY; NONALCOHOLIC STEATOHEPATITIS; ANIMAL-MODELS; OBESE MICE; INFLAMMATORY RESPONSE; HEPATIC STEATOSIS; GANGLIOSIDE GM3; DISEASE	The iminosugar N-(5'-adamantane-1'-yl-methoxy)-pentyl-1-deoxynoijirimycin (AMP-DNM), an inhibitor of glycosphingolipid (GSL) biosynthesis is known to ameliorate diabetes, insulin sensitivity and to prevent liver steatosis in ob/ob mice. Thus far the effect of GSL synthesis inhibition on pre-existing NASH has not yet been assessed. To investigate it, LDLR(-/-) mice were kept on a western-type diet for 12 weeks to induce NASH. Next, the diet was continued for 6 weeks in presence or not of AMP-DNM in the diet. AMP-DNM treated mice showed less liver steatosis, inflammation and fibrosis. Induction of fatty acid beta-oxydation was observed, as well as a reduction of plasma lipids. Our study demonstrates that AMP-DNM treatment is able to significantly correct pre-existing NASH, suggesting that inhibiting GSL synthesis may represent a novel strategy for the treatment of this pathology.	[Lombardo, Elisa; van Roomen, Cindy P. A. A.; Ottenhoff, Roelof; van Eijk, Marco; Verhoeven, Arthur J.; Aerts, Johannes M. F. G.; Bietrix, Florence] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; [van Puijvelde, Gijs H.; Kuiper, Johan] Leiden Univ, Div Biopharmaceut, LACDR, Leiden, Netherlands; [Aten, Jan] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Overkleeft, Herman S.] Leiden Univ, Leiden Inst Chem, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands; [Groen, Albert K.] Univ Med Ctr Groningen, Dept Pediat, NL-9713 AV Groningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University - Excl LUMC; University of Groningen	Aerts, JMFG (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.m.aerts@amc.uva.nl	van Puijvelde, Gijs/AAM-9889-2020; Aerts, Johannes/A-1028-2009	Aerts, Johannes/0000-0001-8168-2565; Aten, Jan/0000-0002-0997-6777; van Eijk, Marco/0000-0001-7751-4112; Overkleeft, Herman/0000-0001-6976-7005	Netherlands Heart Foundation [2007B030]; Dutch Diabetes foundation [2009.80.016]	Netherlands Heart Foundation(Netherlands Heart Foundation); Dutch Diabetes foundation	Elisa Lombardo is supported by the Netherlands Heart Foundation, grant 2007B030. Marco van Eijk is supported by the Dutch Diabetes foundation, grant 2009.80.016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Bietrix F, 2010, ARTERIOSCL THROM VAS, V30, P931, DOI 10.1161/ATVBAHA.109.201673; Bijl N, 2009, HEPATOLOGY, V50, P1431, DOI 10.1002/hep.23175; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gastaldelli A, 2010, ALIMENT PHARM THER, V32, P769, DOI 10.1111/j.1365-2036.2010.04405.x; Jennemann R, 2010, HEPATOLOGY, V51, P1799, DOI 10.1002/hep.23545; Kabayama K, 2007, P NATL ACAD SCI USA, V104, P13678, DOI 10.1073/pnas.0703650104; Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2385, DOI 10.1271/bbb.100392; Kremer M, 2010, HEPATOLOGY, V51, P130, DOI 10.1002/hep.23292; Langeveld M, 2012, METABOLISM, V61, P99, DOI 10.1016/j.metabol.2011.05.013; Langeveld M, 2009, PROG LIPID RES, V48, P196, DOI 10.1016/j.plipres.2009.03.002; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Levels JHM, 2003, CRIT CARE MED, V31, P1647, DOI 10.1097/01.CCM.0000063260.07222.76; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Li ZP, 2005, HEPATOLOGY, V42, P880, DOI 10.1002/hep.20826; Mari M, 2006, CELL METAB, V4, P185, DOI 10.1016/j.cmet.2006.07.006; McCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Ozcan L, 2012, ANNU REV MED, V63, P317, DOI 10.1146/annurev-med-043010-144749; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Rull A, 2009, CYTOKINE, V48, P273, DOI 10.1016/j.cyto.2009.08.006; Shen C, 2004, INT IMMUNOPHARMACOL, V4, P939, DOI 10.1016/j.intimp.2004.04.008; Solga SF, 2006, BIOMARKERS, V11, P174, DOI 10.1080/13547500500421070; Tsuduki T, 2009, J AGR FOOD CHEM, V57, P11024, DOI 10.1021/jf903132r; van Eijk M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004723; van Rooyen DM, 2011, GASTROENTEROLOGY, V141, P1393, DOI 10.1053/j.gastro.2011.06.040; Varela-Rey M, 2009, INT J BIOCHEM CELL B, V41, P969, DOI 10.1016/j.biocel.2008.10.027; Vinaixa M, 2010, J PROTEOME RES, V9, P2527, DOI 10.1021/pr901203w; Wennekes T, 2007, J ORG CHEM, V72, P1088, DOI 10.1021/jo061280p; Wennekes T, 2010, J MED CHEM, V53, P689, DOI 10.1021/jm901281m; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yew NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011239; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719; Zhao HM, 2009, HEPATOLOGY, V50, P85, DOI 10.1002/hep.22970	42	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e38520	10.1371/journal.pone.0038520	http://dx.doi.org/10.1371/journal.pone.0038520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056165	Green Submitted, Green Published, gold			2022-12-27	WOS:000309831500001
J	Dean, PJA; Seiss, E; Sterr, A				Dean, Philip John Ainsley; Seiss, Ellen; Sterr, Annette			Motor Planning in Chronic Upper-Limb Hemiparesis: Evidence from Movement-Related Potentials	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; POSTSTROKE HEMIPARESIS; HAND MOVEMENTS; CORTICAL POTENTIALS; BRAIN ACTIVATION; CHRONIC STROKE; INTERHEMISPHERIC INTERACTIONS; IPSILATERAL ACTIVATION; UNAFFECTED HEMISPHERE; PREMOTOR CORTEX	Background: Chronic hemiplegia is a common long-term consequence of stroke, and subsequent motor recovery is often incomplete. Neurophysiological studies have focused on motor execution deficits in relatively high functioning patients. Much less is known about the influence exerted by processes related to motor preparation, particularly in patients with poor motor recovery. Methodology/Principal Findings: The current study investigates motor preparation using a modified response-priming experiment in a large sample of patients (n = 50) with moderate-to-severe chronic hemiparesis. The behavioural results revealed that hemiparetic patients had an increased response-priming effect compared to controls, but that their response times were markedly slower for both hands. Patients also demonstrated significantly enhanced midline late contingent negative variation (CNV) during paretic hand preparation, despite the absence of overall group differences when compared to controls. Furthermore, increased amplitude of the midline CNV correlated with a greater response-priming effect. We propose that these changes might reflect greater anticipated effort to respond in patients, and consequently that advance cueing of motor responses may be of benefit in these individuals. We further observed significantly reduced CNV amplitudes over the lesioned hemisphere in hemiparetic patients compared to controls during non-paretic hand preparation, preparation of both hands and no hand preparation. Two potential explanations for these CNV reductions are discussed: alterations in anticipatory attention or state changes in motor processing, for example an imbalance in interhemispheric inhibition. Conclusions/Significance: Overall, this study provides evidence that movement preparation could play a crucial role in hemiparetic motor deficits, and that advance motor cueing may be of benefit in future therapeutic interventions. In addition, it demonstrates the importance of monitoring both the non-paretic and paretic hand after stroke and during therapeutic intervention.	[Dean, Philip John Ainsley; Seiss, Ellen; Sterr, Annette] Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England	University of Surrey	Sterr, A (corresponding author), Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England.	a.sterr@surrey.ac.uk	Seiss, Ellen/Y-6216-2019	Sterr, Annette/0000-0003-4490-985X; Dean, Philip/0000-0002-2362-513X	Medical Research Council, UK [61501]; MRC [G0200128] Funding Source: UKRI; Medical Research Council [G0200128] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the Medical Research Council, UK. [Grant ID: 61501]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AW, 2000, CLIN REHABIL, V14, P79, DOI 10.1191/026921500673950113; Battaglia F, 2006, CLIN NEUROPHYSIOL, V117, P1009, DOI 10.1016/j.clinph.2006.01.008; Bestmann S, 2008, CEREB CORTEX, V18, P1281, DOI 10.1093/cercor/bhm159; Brunia CHM, 2001, INT J PSYCHOPHYSIOL, V43, P59, DOI 10.1016/S0167-8760(01)00179-9; Butefisch CM, 2006, J PHYSIOL-PARIS, V99, P437, DOI 10.1016/j.jphysparis.2006.03.001; Calautti C, 2003, STROKE, V34, P1553, DOI 10.1161/01.STR.0000071761.36075.A6; Calautti C, 2007, NEUROIMAGE, V34, P322, DOI 10.1016/j.neuroimage.2006.08.026; Caramia MD, 2000, CLIN NEUROPHYSIOL, V111, P1990, DOI 10.1016/S1388-2457(00)00430-2; Carey LM, 2006, NEUROREHAB NEURAL RE, V20, P24, DOI 10.1177/1545968305283053; Cramer SC, 1999, J NEUROPHYSIOL, V81, P383, DOI 10.1152/jn.1999.81.1.383; Cramer SC, 2000, NEUROPHARMACOLOGY, V39, P842, DOI 10.1016/S0028-3908(99)00258-0; Duque J, 2005, NEUROIMAGE, V28, P940, DOI 10.1016/j.neuroimage.2005.06.033; Fang Y, 2007, J NEUROL SCI, V256, P21, DOI 10.1016/j.jns.2007.01.078; Feydy A, 2002, STROKE, V33, P1610, DOI 10.1161/01.STR.0000017100.68294.52; Green JB, 1999, STROKE, V30, P2659, DOI 10.1161/01.STR.30.12.2659; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Honda M, 1997, J NEUROL SCI, V146, P117, DOI 10.1016/S0022-510X(96)00291-2; Hummel FC, 2009, NEUROLOGY, V72, P1766, DOI 10.1212/WNL.0b013e3181a609c5; Jankelowitz SK, 2005, EXP BRAIN RES, V161, P104, DOI 10.1007/s00221-004-2051-6; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Khedr EM, 2010, ACTA NEUROL SCAND, V121, P30, DOI 10.1111/j.1600-0404.2009.01195.x; Kitamura JI, 1996, ELECTROEN CLIN NEURO, V98, P149, DOI 10.1016/0013-4694(95)00218-9; Lefaucheur JP, 2006, NEUROPHYSIOL CLIN, V36, P105, DOI 10.1016/j.neucli.2006.08.011; Leiguarda RC, 2000, BRAIN, V123, P860, DOI 10.1093/brain/123.5.860; Leuthold H, 2001, COGNITIVE BRAIN RES, V12, P207, DOI 10.1016/S0926-6410(01)00052-0; Leuthold H, 2009, PSYCHOPHYSIOLOGY, V46, P539, DOI 10.1111/j.1469-8986.2009.00799.x; Lewis GN, 2007, CLIN NEUROPHYSIOL, V118, P2656, DOI 10.1016/j.clinph.2007.08.027; Lewis GN, 2007, CLIN NEUROPHYSIOL, V118, P2050, DOI 10.1016/j.clinph.2007.06.010; Liepert J, 2000, STROKE, V31, P1210, DOI 10.1161/01.STR.31.6.1210; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; Luft AR, 2004, NEUROIMAGE, V21, P924, DOI 10.1016/j.neuroimage.2003.10.026; Luke C, 2004, CLIN REHABIL, V18, P888, DOI 10.1191/0269215504cr793oa; Mathews S, 2006, CLIN NEUROPHYSIOL, V117, P2675, DOI 10.1016/j.clinph.2006.08.001; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Nelles G, 2011, J NEUROL, V258, P2168, DOI 10.1007/s00415-011-6085-y; Nowak DA, 2009, NEUROREHAB NEURAL RE, V23, P641, DOI 10.1177/1545968309336661; Platz T, 2000, BRAIN, V123, P2475, DOI 10.1093/brain/123.12.2475; Rehme AK, 2011, NEUROIMAGE; Riecker A, 2010, HUM BRAIN MAPP, V31, P1017, DOI 10.1002/hbm.20914; ROSENBAUM DA, 1982, ACTA PSYCHOL, V51, P223, DOI 10.1016/0001-6918(82)90036-1; Schaechter JD, 2008, CEREB CORTEX, V18, P638, DOI 10.1093/cercor/bhm096; Serrien DJ, 2004, EXP NEUROL, V190, P425, DOI 10.1016/j.expneurol.2004.08.004; Shimizu T, 2002, BRAIN, V125, P1896, DOI 10.1093/brain/awf183; Slobounov S, 2004, CLIN NEUROPHYSIOL, V115, P2391, DOI 10.1016/j.clinph.2004.05.021; Sterr A, 2006, BIOL PSYCHOL, V72, P154, DOI 10.1016/j.biopsycho.2005.09.002; Sterr A, 2004, BEHAV NEUROL, V15, P55, DOI 10.1155/2004/703746; Sterr A, 2002, BRAIN INJURY, V16, P1093, DOI 10.1080/02699050210155267; Sterr A, 2003, NEUROLOGY, V61, P842, DOI 10.1212/WNL.61.6.842; Sterr A, 2002, ARCH PHYS MED REHAB, V83, P1374, DOI 10.1053/apmr.2002.35108; Sterr A, 2008, EUR J NEUROSCI, V27, P254, DOI 10.1111/j.1460-9568.2007.05975.x; Sterr A, 2006, COGN BEHAV NEUROL, V19, P48, DOI 10.1097/00146965-200603000-00006; Sterr A, 2006, NEUROREHABILITATION, V21, P97; Takeuchi N, 2007, STROKE, V38, P1551, DOI 10.1161/STROKEAHA.106.470187; Taub E, 2002, NAT REV NEUROSCI, V3, P228, DOI 10.1038/nrn754; Verleger R, 2003, CLIN NEUROPHYSIOL, V114, P1468, DOI 10.1016/S1388-2457(03)00125-1; Verleger R, 2011, BRAIN COGN; Verstynen T, 2005, J NEUROPHYSIOL, V93, P1209, DOI 10.1152/jn.00720.2004; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Ward N, 2009, BRAIN REORGANISATION, V2009; Ward NS, 2006, ARCH PHYS MED REHAB, V87, pS30, DOI 10.1016/j.apmr.2006.08.334; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; Wiese H, 2005, STROKE, V36, P1474, DOI 10.1161/01.STR.0000170639.26891.30	62	21	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e44558	10.1371/journal.pone.0044558	http://dx.doi.org/10.1371/journal.pone.0044558			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049676	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000309388500003
J	Hyacinth, HI; Adekeye, OA; Ibeh, JN; Osoba, T				Hyacinth, Hyacinth I.; Adekeye, Oluwatoyosi A.; Ibeh, Joy N.; Osoba, Tolulope			Cervical Cancer and Pap Smear Awareness and Utilization of Pap Smear Test among Federal Civil Servants in North Central Nigeria	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; WOMEN; ATTITUDES; KNOWLEDGE	Cervical cancer is a leading cause of cancer death in women in developing countries. A key factor linked to the relatively high levels of cervical cancer in these populations is the lack of awareness and access to preventive methods. This study aimed to determine the level of awareness of cervical cancer and Papanicolaou test (Pap smear test) and factors associated with the utilization of Pap test among female civil servants in Jos. Data was obtained from female workers (n = 388) aged 18-65 years in a Nigerian Federal establishment. Participants were randomly approached and instructed to complete validated questionnaires. Data was analyzed using Chi-square, t-tests and logistic regression analysis to determine if there was an association between variables and identify any predictors of awareness and utilization of the Pap test. Cervical cancer and Pap smear test awareness was 50.9% and 38.6% respectively, with the media as the major source of information. Pap smear test utilization rate was 10.2%, with routine antenatal care (ANC) as the major reason for getting screened. Personal barriers to screening include the lack of awareness, and belief that cervical cancer is not preventable. Opportunistic screening, mass media campaigns and ANC education were suggested as ways of improving awareness and utilization of cervical cancer screening services.	[Hyacinth, Hyacinth I.] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [Adekeye, Oluwatoyosi A.] Morehouse Sch Med, Natl Ctr Primary Care, Atlanta, GA 30310 USA; [Ibeh, Joy N.] Univ Coll Ibadan Hosp, Dept Pediat, Ibadan, Nigeria; [Hyacinth, Hyacinth I.; Osoba, Tolulope] Univ Liverpool, Dept Publ Hlth, Fac Med, Liverpool L69 3BX, Merseyside, England	Morehouse School of Medicine; Morehouse School of Medicine; University of Liverpool	Hyacinth, HI (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	hhyacinth@msm.edu	Hyacinth, Hyacinth/U-5722-2017	Hyacinth, Hyacinth/0000-0002-1991-7463				Adewole IF, 2005, GYNECOL ONCOL, V99, pS209, DOI 10.1016/j.ygyno.2005.07.086; Al Sairafi M, 2009, MED PRIN PRACT, V18, P35, DOI 10.1159/000163044; Ayinde O A, 2004, Afr J Reprod Health, V8, P68, DOI 10.2307/3583394; Bastos J, 2010, INT J CANCER, V126, P2700, DOI 10.1002/ijc.24963; Bosch FX, 2006, INT J GYNECOL OBSTET, V94, pS8, DOI 10.1016/S0020-7292(07)60004-6; Bosch FX, 1997, BIOMED PHARMACOTHER, V51, P268, DOI 10.1016/S0753-3322(97)83542-1; Bosch FX, 2002, VIRUS RES, V89, P183, DOI 10.1016/S0168-1702(02)00187-9; Cyril CD, 2009, T R SOC TROP MED HYG, V103, P852, DOI [10.1016/j.trstmh.2009.03.020, DOI 10.1016/J.TRSTMH.2009.03.020]; Ezem BU, 2007, ANN AFR MED, V6, P94, DOI 10.4103/1596-3519.55727; Federal Ministry of Health of Nigeria, 2003, NAT HLTH POL STAT RE; Gharoro EP, 2006, INT J GYNECOL CANCER, V16, P1063, DOI 10.1111/j.1525-1438.2006.00579.x; Hyacinth IH, 2006, THESIS U JOS; Levi F, 2000, EUR J CANCER, V36, P2266, DOI 10.1016/S0959-8049(00)00346-4; Maaita M, 2002, J Obstet Gynaecol, V22, P421, DOI 10.1080/01443610220141416; Monga AK, 2000, GYNAECOLOGY 10 TEACH; Najem GR, 1996, AM J PREV MED, V12, P482, DOI 10.1016/S0749-3797(18)30272-1; National Cancer Institute, 2008, AP B SEL PLANN FRAM, P217; National Cancer Institute, 2005, SEER INC US MORT RAT; National Health Service, 2009, NHS CERV SCREEN PROG; Nwobodo E I, 2005, Niger Postgrad Med J, V12, P255; Obafunwa JO, 1991, TROP J OBSTET GYNAEC, V9, P16; Obiechina N J A, 2009, Niger J Med, V18, P384; Ogun GO, 2006, UN INT CANC CONTR UI, P8; Olaleye F, 2011, LAGOS NIG HLTH J; Onajole AT, 2004, NIG MED PRACTITIONER, V45, P52; Oyebode A, 2004, THESIS W AFRICAN COL; Programme on cancer control of the department of reproductive health and research, 2002, CERV CANC SCREEN DEV, P1; Ramirez AG, 2000, AM J HEALTH PROMOT, V14, P292, DOI 10.4278/0890-1171-14.5.292; Roy B, 2008, J CANCER EDUC, V23, P253, DOI 10.1080/08858190802189105; Sait KH, 2009, SAUDI MED J, V30, P1208; Schiavo, 2013, HLTH COMMUNICATION T; Schorge JO, 2008, WILLIAMS GYNECOLOGY; WHO, 2006, COMPR CERV CANC CONT; World Health Organization, 2004, GLOB BURD DIS REP CA	34	49	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46583	10.1371/journal.pone.0046583	http://dx.doi.org/10.1371/journal.pone.0046583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049708	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388500035
J	Delorme, V; Diomande, SV; Dedieu, L; Cavalier, JF; Carriere, F; Kremer, L; Leclaire, J; Fotiadu, F; Canaan, S				Delorme, Vincent; Diomande, Sadia V.; Dedieu, Luc; Cavalier, Jean-Francois; Carriere, Frederic; Kremer, Laurent; Leclaire, Julien; Fotiadu, Frederic; Canaan, Stephane			MmPPOX Inhibits Mycobacterium tuberculosis Lipolytic Enzymes Belonging to the Hormone-Sensitive Lipase Family and Alters Mycobacterial Growth	PLOS ONE			English	Article							CUTINASE-LIKE PROTEINS; FUSARIUM-SOLANI-PISI; GENOME SEQUENCE; IN-VITRO; TRIACYLGLYCEROL; IDENTIFICATION; ESTERASE; TETRAHYDROLIPSTATIN; EXPRESSION; MODEL	Lipid metabolism plays an important role during the lifetime of Mycobacterium tuberculosis, the causative agent of tuberculosis. Although M. tuberculosis possesses numerous lipolytic enzymes, very few have been characterized yet at a biochemical/pharmacological level. This study was devoted to the M. tuberculosis lipolytic enzymes belonging to the Hormone-Sensitive Lipase (HSL) family, which encompasses twelve serine hydrolases closely related to the human HSL. Among them, nine were expressed, purified and biochemically characterized using a broad range of substrates. In vitro enzymatic inhibition studies using the recombinant HSL proteins, combined with mass spectrometry analyses, revealed the potent inhibitory activity of an oxadiazolone compound, named MmPPOX. In addition, we provide evidence that MmPPOX alters mycobacterial growth. Overall, these findings suggest that the M. tuberculosis HSL family displays important metabolic functions, thus opening the way to further investigations linking the involvement of these enzymes in mycobacterial growth.	[Delorme, Vincent; Diomande, Sadia V.; Dedieu, Luc; Cavalier, Jean-Francois; Carriere, Frederic; Canaan, Stephane] Aix Marseille Univ, CNRS, UMR 7282, Marseille, France; [Delorme, Vincent; Leclaire, Julien; Fotiadu, Frederic] Univ Paul Cezanne, CNRS, UMR 7313, Ecole Cent Marseille,Equipe Chirosci, Marseille, France; [Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, INSERM,UMR 5235, Montpellier, France; [Kremer, Laurent] INSERM, DIMNP, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Canaan, S (corresponding author), Aix Marseille Univ, CNRS, UMR 7282, Marseille, France.	canaan@imm.cnrs.fr	Cavalier, JF/ABB-6445-2020; Kremer, Laurent/M-4935-2017; Carrière, Frédéric/E-8408-2010; Leclaire, Julien/AAD-8263-2020	Cavalier, JF/0000-0003-0864-8314; Kremer, Laurent/0000-0002-6604-4458; Carrière, Frédéric/0000-0003-4848-9418; Leclaire, Julien/0000-0001-7984-9055; Delorme, Vincent/0000-0001-5235-7069	Ministere de l'Enseignement Superieur et de la Recherche; CNRS; Agence Nationale de la Recherche Francaise [ANR PCV 2007-184840 PHELIN, ANR MIEN 2009-00904 FOAMY_TUB]; LISA Carnot Institute (Convention ANR) [07-CARN-009-01]; EGIDE	Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche Francaise(French National Research Agency (ANR)); LISA Carnot Institute (Convention ANR)(French National Research Agency (ANR)); EGIDE	V. Delorme was funded by a PhD fellowship from the Ministere de l'Enseignement Superieur et de la Recherche. This work was supported by the CNRS, the Agence Nationale de la Recherche Francaise (ANR PCV 2007-184840 PHELIN, ANR MIEN 2009-00904 FOAMY_TUB), by the LISA Carnot Institute (Convention ANR no07-CARN-009-01) and by EGIDE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Ali Y, 2006, BIOCHEMISTRY-US, V45, P14183, DOI 10.1021/bi0613978; Ben Ali Y, 2012, BIOCHIMIE, V94, P137, DOI 10.1016/j.biochi.2011.09.028; BORGSTROM B, 1988, BIOCHIM BIOPHYS ACTA, V962, P308, DOI 10.1016/0005-2760(88)90260-3; Brust B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025078; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Canaan S, 2004, EUR J BIOCHEM, V271, P3953, DOI 10.1111/j.1432-1033.2004.04335.x; Cavalier J-F, 2011, Patent No. [EP 11 305 911.7, 11305911]; Chakroborty Amitabha, 2011, Inflammopharmacology, V19, P131, DOI 10.1007/s10787-010-0072-2; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cotes K, 2008, APPL MICROBIOL BIOT, V78, P741, DOI 10.1007/s00253-008-1397-2; Cotes K, 2007, BIOCHEM J, V408, P417, DOI 10.1042/BJ20070745; Crellin PK, 2010, J BIOL CHEM, V285, P30050, DOI 10.1074/jbc.M110.150094; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Deb C, 2006, J BIOL CHEM, V281, P3866, DOI 10.1074/jbc.M505556200; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Dedieu L, 2012, BIOCHIMIE IN PRESS; Delorme V, 2011, PHARM RES-DORDR, V28, P1831, DOI 10.1007/s11095-010-0362-9; Dhouib R, 2011, FEBS J, V278, P97, DOI 10.1111/j.1742-4658.2010.07936.x; Dhouib R, 2011, BBA-MOL CELL BIOL L, V1811, P234, DOI 10.1016/j.bbalip.2011.01.001; Dhouib R, 2010, J BACTERIOL, V192, P4776, DOI 10.1128/JB.00261-10; Egmond MR, 2000, BIOCHIMIE, V82, P1015, DOI 10.1016/S0300-9084(00)01183-4; Garton NJ, 2002, MICROBIOL-SGM, V148, P2951, DOI 10.1099/00221287-148-10-2951; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Kremer L, 2005, MOL MICROBIOL, V57, P1113, DOI 10.1111/j.1365-2958.2005.04717.x; Lafontan M, 2009, PROG LIPID RES, V48, P275, DOI 10.1016/j.plipres.2009.05.001; Lampidonis AD, 2011, GENE, V477, P1, DOI 10.1016/j.gene.2011.01.007; Low KL, 2010, J BIOL CHEM, V285, P21662, DOI 10.1074/jbc.M110.135731; Masaki K, 2005, APPL ENVIRON MICROB, V71, P7548, DOI 10.1128/AEM.71.11.7548-7550.2005; Mishra KC, 2008, INFECT IMMUN, V76, P127, DOI 10.1128/IAI.00410-07; Muller-Santos M, 2009, BBA-MOL CELL BIOL L, V1791, P719, DOI 10.1016/j.bbalip.2009.03.006; N'Goma JCB, 2010, BBA-MOL CELL BIOL L, V1801, P1305, DOI 10.1016/j.bbalip.2010.08.007; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Parker SK, 2007, J BACTERIOL, V189, P4153, DOI 10.1128/JB.01909-06; Parker SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004281; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Philipp WJ, 1996, P NATL ACAD SCI USA, V93, P3132, DOI 10.1073/pnas.93.7.3132; PURDY RE, 1975, BIOCHEMISTRY-US, V14, P2832, DOI 10.1021/bi00684a007; Ransac S, 1997, METHOD ENZYMOL, V286, P190; RANSAC S, 1990, BIOCHIM BIOPHYS ACTA, V1043, P57, DOI 10.1016/0005-2760(90)90110-J; Sambandamurthy VK, 2006, VACCINE, V24, P6309, DOI 10.1016/j.vaccine.2006.05.097; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schoenafinger K, 2001, Patent No. [WO/2001/066, 531, 2001066531]; Schue M, 2010, FASEB J, V24, P1893, DOI 10.1096/fj.09-144766; Shen GM, 2012, INFECT IMMUN, V80, P243, DOI 10.1128/IAI.05541-11; Singh G, 2010, CRIT REV MICROBIOL, V36, P259, DOI 10.3109/1040841X.2010.482923; Sirakova TD, 2006, MICROBIOL-SGM, V152, P2717, DOI 10.1099/mic.0.28993-0; Tiss A, 2009, J MOL CATAL B-ENZYM, V58, P41, DOI 10.1016/j.molcatb.2008.11.003; VERGER R, 1976, ANNU REV BIOPHYS BIO, V5, P77, DOI 10.1146/annurev.bb.05.060176.000453; Verger R, 2006, Patent No. [WO/2006/085, 009, 2006085009]; Vincentelli R, 2004, PROTEIN SCI, V13, P2782, DOI 10.1110/ps.04806004; Vincentelli R, 2003, ACCOUNTS CHEM RES, V36, P165, DOI 10.1021/ar010130s; West NP, 2008, VACCINE, V26, P3853, DOI 10.1016/j.vaccine.2008.05.007; West NP, 2011, CHEM COMMUN, V47, P5166, DOI 10.1039/c0cc05635a; West NP, 2009, FASEB J, V23, P1694, DOI 10.1096/fj.08-114421; Yang PY, 2010, J AM CHEM SOC, V132, P656, DOI 10.1021/ja907716f; Zhang M, 2005, PROTEIN EXPRES PURIF, V42, P59, DOI 10.1016/j.pep.2005.03.022	58	43	44	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46493	10.1371/journal.pone.0046493	http://dx.doi.org/10.1371/journal.pone.0046493			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029536	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900174
J	Li, J; Ma, XS; Yu, W; Lou, ZQ; Mu, DL; Wang, Y; Shen, BZ; Qi, SH				Li, Jun; Ma, Xuesong; Yu, Wei; Lou, Zhangqun; Mu, Dunlan; Wang, Ying; Shen, Baozhong; Qi, Sihua			Reperfusion Promotes Mitochondrial Dysfunction following Focal Cerebral Ischemia in Rats	PLOS ONE			English	Article							DENSITY GRADIENT CENTRIFUGATION; SUPEROXIDE-DISMUTASE DEFICIENCY; PERMEABILITY TRANSITION PORE; CYTOCHROME-C RELEASE; CELL-DEATH; OXIDATIVE STRESS; NEURONAL DEATH; CYCLOPHILIN-D; MOLECULAR MECHANISMS; BRAIN MITOCHONDRIA	Background and Purpose: Mitochondrial dysfunction has been implicated in the cell death observed after cerebral ischemia, and several mechanisms for this dysfunction have been proposed. Reperfusion after transient cerebral ischemia may cause continued and even more severe damage to the brain. Many lines of evidence have shown that mitochondria suffer severe damage in response to ischemic injury. The purpose of this study was to observe the features of mitochondrial dysfunction in isolated mitochondria during the reperfusion period following focal cerebral ischemia. Methods: Male Wistar rats were subjected to focal cerebral ischemia. Mitochondria were isolated using Percoll density gradient centrifugation. The isolated mitochondria were fixed for electron microscopic examination; calcium-induced mitochondrial swelling was quantified using spectrophotometry. Cyclophilin D was detected by Western blotting. Fluorescent probes were used to selectively stain mitochondria to measure their membrane potential and to measure reactive oxidative species production using flow cytometric analysis. Results: Signs of damage were observed in the mitochondrial morphology after exposure to reperfusion. The mitochondrial swelling induced by Ca2+ increased gradually with the increasing calcium concentration, and this tendency was exacerbated as the reperfusion time was extended. Cyclophilin D protein expression peaked after 24 hours of reperfusion. The mitochondrial membrane potential was decreased significantly during the reperfusion period, with the greatest decrease observed after 24 hours of reperfusion. The surge in mitochondrial reactive oxidative species occurred after 2 hours of reperfusion and was maintained at a high level during the reperfusion period. Conclusions: Reperfusion following focal cerebral ischemia induced significant mitochondrial morphological damage and Ca2+-induced mitochondrial swelling. The mechanism of this swelling may be mediated by the upregulation of the Cyclophilin D protein, the destruction of the mitochondrial membrane potential and the generation of excessive reactive oxidative species.	[Shen, Baozhong] Mol Imaging Key Lab Gen Univ & Coll Heilongjiang, Harbin, Peoples R China; [Li, Jun; Ma, Xuesong; Yu, Wei; Lou, Zhangqun; Mu, Dunlan; Wang, Ying; Qi, Sihua] Harbin Med Univ, Dept Anesthesiol, Affiliated Hosp 4, Harbin, Peoples R China	Harbin Medical University	Qi, SH (corresponding author), Harbin Med Univ, Dept Anesthesiol, Affiliated Hosp 4, Harbin, Peoples R China.	baozhongshen1961@163.com; sihuaqi2009@hotmail.com			Natural Science Foundation of Heilongjiang Province [ZD201017]	Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This project was supported by grants from the Natural Science Foundation of Heilongjiang Province (ZD201017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adembri C, 2006, ANESTHESIOLOGY, V104, P80, DOI 10.1097/00000542-200601000-00014; Anderson MF, 1999, J NEUROCHEM, V73, P1189, DOI 10.1046/j.1471-4159.1999.0731189.x; Borutaite V, 1999, BBA-MOL BASIS DIS, V1453, P41, DOI 10.1016/S0925-4439(98)00082-9; BROWN AW, 1972, J NEUROL SCI, V16, P59, DOI 10.1016/0022-510X(72)90102-5; Canevari L, 1997, J CEREBR BLOOD F MET, V17, P1166, DOI 10.1097/00004647-199711000-00005; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Doyle KP, 2008, NEUROPHARMACOLOGY, V55, P310, DOI 10.1016/j.neuropharm.2008.01.005; Feng ZC, 1998, RESUSCITATION, V37, P33, DOI 10.1016/S0300-9572(98)00031-8; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; GARCIA JH, 1978, ACTA NEUROPATHOL, V43, P85; GARCIA JH, 1975, HUM PATHOL, V6, P583, DOI 10.1016/S0046-8177(75)80043-8; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hou ST, 2002, INT REV CYTOL, V221, P93; Iijima T, 2003, NEUROCHEM INT, V43, P263, DOI 10.1016/S0197-0186(02)00228-0; Iijima T, 2003, BRAIN RES, V993, P140, DOI 10.1016/j.brainres.2003.09.041; Iijima T, 2006, NEUROSCI RES, V55, P234, DOI 10.1016/j.neures.2006.04.005; KALIMO H, 1977, VIRCHOWS ARCH B, V25, P207; Kim GW, 2002, STROKE, V33, P809, DOI 10.1161/hs0302.103745; Kobayashi T, 2003, BRAIN RES, V960, P62, DOI 10.1016/S0006-8993(02)03767-8; Kowaltowski A, 2000, CELL DEATH DIFFER, V7, P903, DOI 10.1038/sj.cdd.4400722; Kristal BS, 1997, J NEUROCHEM, V69, P524; Kristian T, 1998, STROKE, V29, P705, DOI 10.1161/01.STR.29.3.705; Liu YB, 1998, STROKE, V29, P1679, DOI 10.1161/01.STR.29.8.1679; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Lust WD, 2002, METAB BRAIN DIS, V17, P113, DOI 10.1023/A:1015420222334; MCGEERUSSELL SM, 1970, BRAIN RES, V20, P193, DOI 10.1016/0006-8993(70)90288-X; Murakami K, 1998, J NEUROSCI, V18, P205; Murphy AN, 1999, J CEREBR BLOOD F MET, V19, P231, DOI 10.1097/00004647-199903000-00001; MYERS KM, 1995, J NEUROCHEM, V65, P2432; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Niizuma K, 2009, J NEUROCHEM, V109, P133, DOI 10.1111/j.1471-4159.2009.05897.x; Peinado MA, 1997, ANAT REC, V247, P420; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Schaller B, 2004, J CEREBR BLOOD F MET, V24, P351, DOI 10.1097/00004647-200404000-00001; Schild L, 2005, FEBS J, V272, P3593, DOI 10.1111/j.1742-4658.2005.04781.x; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Shimamura N, 2006, J NEUROSCI METH, V156, P161, DOI 10.1016/j.jneumeth.2006.02.017; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Sims NR, 2002, NEUROCHEM INT, V40, P511, DOI 10.1016/S0197-0186(01)00122-X; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; SIMS NR, 1995, INT J BIOCHEM CELL B, V27, P531, DOI 10.1016/1357-2725(95)00026-L; Solenski NJ, 2002, STROKE, V33, P816, DOI 10.1161/hs0302.104541; Solenski NJ, 1997, STROKE, V28, P2545, DOI 10.1161/01.STR.28.12.2545; Tsujimoto Y, 2006, BBA-BIOENERGETICS, V1757, P1297, DOI 10.1016/j.bbabio.2006.03.017; Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Zaidan E, 1997, BRAIN RES, V772, P23, DOI 10.1016/S0006-8993(97)00833-0; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	52	41	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46498	10.1371/journal.pone.0046498	http://dx.doi.org/10.1371/journal.pone.0046498			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029539	gold, Green Submitted, Green Published			2022-12-27	WOS:000309973900177
J	Murakami, H; Nakao, T; Matsunaga, M; Kasuya, Y; Shinoda, J; Yamada, J; Ohira, H				Murakami, Hiroki; Nakao, Takashi; Matsunaga, Masahiro; Kasuya, Yukinori; Shinoda, Jun; Yamada, Jitsuhiro; Ohira, Hideki			The Structure of Mindful Brain	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GRAY-MATTER; AMYGDALA; EMOTION; SUPPRESSION; THERAPY; VOLUME	Mindfulness is currently attracting a great deal of attention as a psychotherapy technique. It is defined as bringing one's complete attention to the experiences occurring in the present moment in a nonjudgmental or accepting way. The Five Facet Mindfulness Questionnaire (FFMQ) was developed to assess individual differences in mindfulness states. The FFMQ is composed of five facets representing elements of mindfulness: non-reactivity to inner experience, non-judging, acting with awareness, describing, and observing. In the present study, we applied voxel-based morphometry to investigate the relationship between the brain structure and each facet as measured by the FFMQ. The results showed a positive association between the describing facet of mindfulness on the FFMQ and gray matter volume in the right anterior insula and the right amygdala. In conclusion, mindfulness was related with development in parts of the somatic marker circuit of the brain.	[Murakami, Hiroki] Natl Ctr Neurol & Psychiat, Dept Clin Neuroimaging, Integrat Brain Imaging Ctr, Tokyo, Japan; [Nakao, Takashi] Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima, Japan; [Matsunaga, Masahiro] Natl Inst Physiol Sci, Div Cerebral Integrat, Dept Cerebral Res, Okazaki, Aichi 444, Japan; [Kasuya, Yukinori; Shinoda, Jun; Yamada, Jitsuhiro] Kizawa Mem Hosp, Chubu Med Ctr Prolonged Traumat Brain Dysfunct, Minokamo, Japan; [Ohira, Hideki] Nagoya Univ, Dept Psychol, Grad Sch Environm Studies, Nagoya, Aichi 4648601, Japan	National Center for Neurology & Psychiatry - Japan; Hiroshima University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Nagoya University	Murakami, H (corresponding author), Natl Ctr Neurol & Psychiat, Dept Clin Neuroimaging, Integrat Brain Imaging Ctr, Tokyo, Japan.	hmurakami@ncnp.go.jp	nakao, takashi/U-7188-2017	nakao, takashi/0000-0002-2227-4526	Japan Society for the Promotion of Science [20330148];  [208551];  [20821]; Grants-in-Aid for Scientific Research [22530743] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for JSPS Fellows (No. 208551 and No. 20821) and by a Grant-in-Aid for Scientific Research (B) (No. 20330148) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Cannonieri GC, 2007, NEUROREPORT, V18, P1063, DOI 10.1097/WNR.0b013e3281a030e5; Carlson LE, 2007, BRAIN BEHAV IMMUN, V21, P1038, DOI 10.1016/j.bbi.2007.04.002; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Draganski B, 2006, J NEUROSCI, V26, P6314, DOI 10.1523/JNEUROSCI.4628-05.2006; Gianaros PJ, 2008, J NEUROSCI, V28, P990, DOI 10.1523/JNEUROSCI.3606-07.2008; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hayes AM, 2004, CLIN PSYCHOL-SCI PR, V11, P255, DOI 10.1093/clipsy/bph080; Holzel BK, 2008, SOC COGN AFFECT NEUR, V3, P55, DOI 10.1093/scan/nsm038; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Holzel BK, 2010, SOC COGN AFFECT NEUR, V5, P11, DOI 10.1093/scan/nsp034; Larsen JK, 2003, J PSYCHOSOM RES, V54, P533, DOI 10.1016/S0022-3999(02)00466-X; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Luders E, 2009, NEUROIMAGE, V45, P672, DOI 10.1016/j.neuroimage.2008.12.061; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Naqvi N, 2006, CURR DIR PSYCHOL SCI, V15, P260, DOI 10.1111/j.1467-8721.2006.00448.x; Ohira H, 2006, NEUROIMAGE, V29, P721, DOI 10.1016/j.neuroimage.2005.08.047; Reimold M, 2006, J CEREBR BLOOD F MET, V26, P751, DOI 10.1038/sj.jcbfm.9600231; Rosenkranz JA, 2001, J NEUROSCI, V21, P4090, DOI 10.1523/JNEUROSCI.21-11-04090.2001; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Sugiura Y, 2012, MINDFULNESS, V3, P85, DOI 10.1007/s12671-011-0082-1; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013	27	47	47	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46377	10.1371/journal.pone.0046377	http://dx.doi.org/10.1371/journal.pone.0046377			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029500	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900147
J	Qian, WL; Meng, QL; Chen, L; Zhou, K				Qian, Wenli; Meng, Qianli; Chen, Lin; Zhou, Ke			Emotional Modulation of the Attentional Blink Is Awareness-Dependent	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; FACIAL EXPRESSIONS; AMYGDALA RESPONSES; FEARFUL FACES; TIME-COURSE; RESTRICTED AWARENESS; AROUSING DISTRACTORS; TEMPORAL ATTENTION; TASK; STIMULI	It is well known that emotion can modulate attentional processes. Previous studies have shown that even under restricted awareness, emotional facial expressions (especially threat-related) can guide the direction of spatial attention. However, it remains unclear whether emotional facial expressions under restricted awareness can affect temporal attention. To address this issue, we used a modified attentional blink (AB) paradigm in which masked (Experiment 1) or unmasked (Experiment 2) emotional faces (fearful or neutral) were presented before the AB sequence. We found that, in comparison with neutral faces, masked fearful faces significantly decreased the AB magnitude (Experiment 1), whereas unmasked fearful faces significantly increased the AB magnitude (Experiment 2). These results indicate that effects of emotional expression on the AB are modulated by the level of awareness.	[Qian, Wenli; Chen, Lin; Zhou, Ke] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China; [Qian, Wenli] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Qian, Wenli; Meng, Qianli] Chinese Acad Sci, Kunming Inst Zool, Lab Primate Cognit Neurosci, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Kunming Institute of Zoology	Chen, L (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100080, Peoples R China.	linchen@bcslab.ibp.ac.cn; kzhou.bcslab@gmail.com			National Nature Science Foundation of China [31171081]; National Key Basic Research Program of China (973 Program) [2012CB825502]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by a National Nature Science Foundation of China grant (31171081) and National Key Basic Research Program of China (973 Program) (2012CB825502). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Arend I, 2006, PSYCHON B REV, V13, P600, DOI 10.3758/BF03193969; Arnell KM, 2007, EMOTION, V7, P465, DOI 10.1037/1528-3542.7.3.465; Barnard PJ, 2005, VIS COGN, V12, P181, DOI 10.1080/13506280444000139; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; de Jong PJ, 2010, EMOTION, V10, P727, DOI 10.1037/a0019353; De Martino B, 2009, CEREB CORTEX, V19, P127, DOI 10.1093/cercor/bhn062; Dux PE, 2009, ATTEN PERCEPT PSYCHO, V71, P1683, DOI 10.3758/APP.71.8.1683; ESTEVES F, 1993, SCAND J PSYCHOL, V34, P1, DOI 10.1111/j.1467-9450.1993.tb01096.x; Ferlazzo F, 2007, EXP PSYCHOL, V54, P89, DOI 10.1027/1618-3169.54.2.89; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Fox E, 2002, COGNITION EMOTION, V16, P355, DOI 10.1080/02699930143000527; Hommel B, 2005, Q J EXP PSYCHOL-A, V58, P1415, DOI 10.1080/02724980443000647; IZARD CE, 1994, PSYCHOL BULL, V115, P288, DOI 10.1037/0033-2909.115.2.288; Jefferies LN, 2008, PSYCHOL SCI, V19, P290, DOI 10.1111/j.1467-9280.2008.02082.x; Jolicoeur P, 1998, COGNITIVE PSYCHOL, V36, P138, DOI 10.1006/cogp.1998.0684; Keil A, 2004, EMOTION, V4, P23, DOI 10.1037/1528-3542.4.1.23; Koster EHW, 2007, EMOTION, V7, P285, DOI 10.1037/1528-3542.7.2.285; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; MacLean MH, 2010, PSYCHON B REV, V17, P556, DOI 10.3758/PBR.17.4.556; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Matsumoto D, 1988, JAPANESE CAUCASIAN F; Meng M, 2011, ATTEN PERCEPT PSYCHO, V73, P440, DOI 10.3758/s13414-010-0052-z; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Most SB, 2005, PSYCHON B REV, V12, P654, DOI 10.3758/BF03196754; Most SB, 2007, COGNITION EMOTION, V21, P964, DOI 10.1080/02699930600959340; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Olivers CNL, 2005, PSYCHOL SCI, V16, P265, DOI 10.1111/j.0956-7976.2005.01526.x; Phillips ML, 2004, NEUROIMAGE, V21, P1484, DOI 10.1016/j.neuroimage.2003.12.013; Potter MC, 2002, J EXP PSYCHOL HUMAN, V28, P1149, DOI 10.1037//0096-1523.28.5.1149; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Pourtois G, 2005, NEUROIMAGE, V26, P149, DOI 10.1016/j.neuroimage.2005.01.015; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; SHAPIRO KL, 1994, J EXP PSYCHOL HUMAN, V20, P357, DOI 10.1037/0096-1523.20.2.357; Smith SD, 2006, EMOTION, V6, P523, DOI 10.1037/1528-3542.6.3.523; Srivastava P, 2010, ATTEN PERCEPT PSYCHO, V72, P369, DOI 10.3758/APP.72.2.369; Stein T, 2009, PSYCHON B REV, V16, P104, DOI 10.3758/PBR.16.1.104; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; Vermeulen N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007924; Vuilleumier P, 2002, NEUROPSYCHOLOGIA, V40, P2156, DOI 10.1016/S0028-3932(02)00045-3; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Vuilleumier P, 2001, NEUROLOGY, V56, P153, DOI 10.1212/WNL.56.2.153; Vuilleumier P, 2000, NEUROPSYCHOLOGIA, V38, P693, DOI 10.1016/S0028-3932(99)00107-4; Vuilleumier P, 2001, NEUROREPORT, V12, P1119, DOI 10.1097/00001756-200105080-00014; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Whalen PJ, 1998, J NEUROSCI, V18, P411; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154; Williams MA, 2004, J NEUROSCI, V24, P2898, DOI 10.1523/JNEUROSCI.4977-03.2004	52	3	3	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46394	10.1371/journal.pone.0046394	http://dx.doi.org/10.1371/journal.pone.0046394			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KQ	23029507	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517500097
J	Roger, F; Lamy, B; Jumas-Bilak, E; Kodjo, A; Marchandin, H				Roger, Frederic; Lamy, Brigitte; Jumas-Bilak, Estelle; Kodjo, Angeli; Marchandin, Helene		colBVH Study Grp	Ribosomal Multi-Operon Diversity: An Original Perspective on the Genus Aeromonas	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISM; SHARMANA SP-NOV.; RNA GENE; PHYLOGENETIC ANALYSIS; INTRAGENOMIC HETEROGENEITY; GENOME SEQUENCE; COPY NUMBER; IDENTIFICATION; EVOLUTION; STRAINS	16S rRNA gene (rrs) is considered of low taxonomic interest in the genus Aeromonas. Here, 195 Aeromonas strains belonging to populations structured by multilocus phylogeny were studied using an original approach that considered Ribosomal Multi-Operon Diversity. This approach associated pulsed-field gel electrophoresis (PFGE) to assess rrn operon number and distribution across the chromosome and PCR-temporal temperature gel electrophoresis (TTGE) to assess rrs V3 region heterogeneity. Aeromonads harbored 8 to 11 rrn operons, 10 operons being observed in more than 92% of the strains. Intraspecific variability was low or nul except for A. salmonicida and A. aquariorum suggesting that large chromosomic rearrangements might occur in these two species while being extremely rarely encountered in the evolution of other taxa. rrn operon number at 8 as well as PFGE patterns were shown valuable for taxonomic purpose allowing resolution of species complexes. PCR-TTGE revealed a high rate of strains (41.5%) displaying intragenomic rrs heterogeneity. Strains isolated from human samples more frequently displayed intragenomic heterogeneity than strains recovered from non-human and environmental specimens. Intraspecific variability ranged from 0 to 76.5% of the strains. The observation of species-specific TTGE bands, the recovery of identical V3 regions in different species and the variability of intragenomic heterogeneity (1-13 divergent nucleotides) supported the occurrence of mutations and horizontal transfer in aeromonad rrs evolution. Altogether, the presence of a high number of rrn operon, the high proportion of strains harboring divergent rrs V3 region and the previously demonstrated high level of genetic diversity argued in favor of highly adaptative capabilities of aeromonads. Outstanding features observed for A. caviae supported the ongoing process of adaptation to a specialized niche represented by the gut, previously hypothesized. 16S rRNA gene is an informative marker in the genus Aeromonas for both evolutionary and polyphasic taxonomic studies provided that multi-operon fingerprinting approaches are used.	[Roger, Frederic; Lamy, Brigitte; Jumas-Bilak, Estelle; Marchandin, Helene] Univ Montpellier I, UFR Sci Pharmaceut & Biol, Equipe Pathogenes & Environm, UMR ECOSYM 5119, Montpellier, France; [Lamy, Brigitte; Marchandin, Helene] Ctr Hosp Reg Univ Montpellier, Hop Arnaud Villeneuve, Bacteriol Lab, Montpellier, France; [Lamy, Brigitte; Kodjo, Angeli] Aeromonas GFA, Grp Etude Francais, Lyon, France; [Jumas-Bilak, Estelle] Ctr Hosp Reg Univ Montpellier, Lab Hygiene Hosp, Montpellier, France; [Kodjo, Angeli] Univ Claude Bernard Lyon 1, CNRS, UMR Ecol Microbienne 5557, Marcy Ietoile, France; [colBVH Study Grp] Virol & Hyg Hop Generaux, ColBVH, Coll Bacteriol, Le Chesnay, France	Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Marchandin, H (corresponding author), Univ Montpellier I, UFR Sci Pharmaceut & Biol, Equipe Pathogenes & Environm, UMR ECOSYM 5119, Montpellier, France.	helene.marchandin@univ-montp1.fr	MARCHANDIN, Hélène/AAM-8288-2021; Lamy, Brigitte/A-8401-2015; Roger, Frédéric/ABC-3458-2021	MARCHANDIN, Hélène/0000-0003-2130-6335; Lamy, Brigitte/0000-0003-2370-8186; Roger, Frédéric/0000-0001-7884-2791; Kodjo, Angeli/0000-0002-7247-9765; Auvray, Christelle/0000-0001-9782-170X	Association des Biologistes de l'Ouest; ADEREMPHA (Association pour la Recherche et le Developpement en Microbiologique Pharmacie)	Association des Biologistes de l'Ouest; ADEREMPHA (Association pour la Recherche et le Developpement en Microbiologique Pharmacie)	This work was supported by the Association des Biologistes de l'Ouest and by ADEREMPHA (Association pour la Recherche et le Developpement en Microbiologique & Pharmacie). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Alperi A, 2008, INT MICROBIOL, V11, P185, DOI 10.2436/20.1501.01.59; Alperi A, 2010, INT J SYST EVOL MICR, V60, P2048, DOI 10.1099/ijs.0.014621-0; Alperi A, 2010, INT J SYST EVOL MICR, V60, P72, DOI 10.1099/ijs.0.011643-0; Aujoulat F, 2012, GENES-BASEL, V3, P191, DOI 10.3390/genes3020191; Borrell N, 1997, J CLIN MICROBIOL, V35, P1671, DOI 10.1128/JCM.35.7.1671-1674.1997; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Coenye T, 2003, FEMS MICROBIOL LETT, V228, P45, DOI 10.1016/S0378-1097(03)00717-1; Dikow RB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-237; Dodd HN, 1998, MICROBIOL-SGM, V144, P3087, DOI 10.1099/00221287-144-11-3087; Figueras MJ, 2011, INT J SYST EVOL MICR, V61, P242, DOI 10.1099/ijs.0.016139-0; Figueras MJ, 2000, J CLIN MICROBIOL, V38, P2023; Georgiades K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00151; Graf J, 1999, J CLIN MICROBIOL, V37, P3194, DOI 10.1128/JCM.37.10.3194-3197.1999; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Holt HM, 2005, CLIN MICROBIOL INFEC, V11, P347, DOI 10.1111/j.1469-0691.2005.01108.x; Huys G, 2001, SYST APPL MICROBIOL, V24, P177, DOI 10.1078/0723-2020-00038; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Jensen S, 2009, FEMS MICROBIOL LETT, V294, P207, DOI 10.1111/j.1574-6968.2009.01567.x; Jumas-Bilak E, 2005, INT J SYST EVOL MICR, V55, P2471, DOI 10.1099/ijs.0.63715-0; Klappenbach JA, 2000, APPL ENVIRON MICROB, V66, P1328, DOI 10.1128/AEM.66.4.1328-1333.2000; Lamy B, 2010, CAN J MICROBIOL, V56, P217, DOI [10.1139/W10-006, 10.1139/w10-006]; Lamy B, 2009, J CLIN MICROBIOL, V47, P1234, DOI 10.1128/JCM.00155-09; Lee ZMP, 2009, NUCLEIC ACIDS RES, V37, pD489, DOI 10.1093/nar/gkn689; Li YX, 2011, J BACTERIOL, V193, P3389, DOI 10.1128/JB.00347-11; Liu SL, 1999, J BACTERIOL, V181, P6747, DOI 10.1128/JB.181.21.6747-6755.1999; LUCCHINI GM, 1992, INT J SYST BACTERIOL, V42, P384; Marchandin H, 2003, INT J SYST EVOL MICR, V53, P547, DOI 10.1099/ijs.0.02378-0; Martinez-Murcia AJ, 2008, INT J SYST EVOL MICR, V58, P1169, DOI 10.1099/ijs.0.65352-0; Martinez-Murcia AJ, 2007, INT MICROBIOL, V10, P61, DOI 10.2436/20.1501.01.9; Martinez-Murcia AJ, 2011, SYST APPL MICROBIOL, V34, P189, DOI 10.1016/j.syapm.2010.11.014; MARTINEZMURCIA AJ, 1992, INT J SYST BACTERIOL, V42, P412, DOI 10.1099/00207713-42-3-412; Martino ME, 2011, APPL ENVIRON MICROB, V77, P4986, DOI 10.1128/AEM.00708-11; Michon AL, 2010, MICROBIOL-SGM, V156, P2080, DOI 10.1099/mic.0.038224-0; Minana-Galbis D, 2010, SYST APPL MICROBIOL, V33, P15, DOI 10.1016/j.syapm.2009.11.002; Minana-Galbis D, 2009, INT J SYST EVOL MICR, V59, P1976, DOI 10.1099/ijs.0.005413-0; Miranda G, 1996, J CLIN MICROBIOL, V34, P3138, DOI 10.1128/JCM.34.12.3138-3141.1996; Morandi A, 2005, J BACTERIOL, V187, P6561, DOI 10.1128/JB.187.18.6561-6564.2005; Pidiyar VJ, 2003, DNA SEQUENCE, V14, P183, DOI 10.1080/1042517031000101257; Reith ME, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-427; Roger F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-62; Saavedra MJ, 2007, ANTON LEEUW INT J G, V91, P159, DOI 10.1007/s10482-006-9107-5; Saha P, 2006, INT J SYST EVOL MICR, V56, P1905, DOI 10.1099/ijs.0.63972-0; Santoyo G, 2005, FEMS MICROBIOL REV, V29, P169, DOI 10.1016/j.femsre.2004.10.004; Seshadri R, 2006, J BACTERIOL, V188, P8272, DOI 10.1128/JB.00621-06; Sharma Krishna Kanchan, 2010, J Lab Physicians, V2, P61, DOI 10.4103/0974-2727.72150; Silver AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016751; SNEATH PHA, 1993, INT J SYST BACTERIOL, V43, P626, DOI 10.1099/00207713-43-3-626; Soler L, 2004, INT J SYST EVOL MICR, V54, P1511, DOI 10.1099/ijs.0.03048-0; Tacao M, 2005, FEMS MICROBIOL LETT, V246, P11, DOI 10.1016/j.femsle.2005.03.033; Ueda K, 1999, J BACTERIOL, V181, P78, DOI 10.1128/JB.181.1.78-82.1999; Umelo E, 1998, MICROBIOL-SGM, V144, P2141, DOI 10.1099/00221287-144-8-2141; van Berkum P, 2003, J BACTERIOL, V185, P2988, DOI 10.1128/JB.185.10.2988-2998.2003; Yap WH, 1999, J BACTERIOL, V181, P5201, DOI 10.1128/JB.181.17.5201-5209.1999; Zheng JF, 2006, J ENVIRON SCI-CHINA, V18, P530	55	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46268	10.1371/journal.pone.0046268	http://dx.doi.org/10.1371/journal.pone.0046268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23032081	Green Submitted, gold, Green Published			2022-12-27	WOS:000309517500080
J	Flydal, MI; Chatfield, CH; Zheng, HX; Gunderson, FF; Aubi, O; Cianciotto, NP; Martinez, A				Flydal, Marte I.; Chatfield, Christa H.; Zheng, Huaixin; Gunderson, Felizza F.; Aubi, Oscar; Cianciotto, Nicholas P.; Martinez, Aurora			Phenylalanine Hydroxylase from Legionella pneumophila Is a Thermostable Enzyme with a Major Functional Role in Pyomelanin Synthesis	PLOS ONE			English	Article							AMINO-ACID HYDROXYLASES; II PROTEIN SECRETION; PSEUDOMONAS-AERUGINOSA; LEGIONNAIRES-DISEASE; VIBRIO-CHOLERAE; INTRACELLULAR MULTIPLICATION; CHROMOBACTERIUM-VIOLACEUM; CAENORHABDITIS-ELEGANS; THERMOPHILIC PROTEINS; AROMATIC CLUSTERS	Background: Legionella pneumophila is a pathogenic bacterium that can cause Legionnaires' disease and other non-pneumonic infections in humans. This bacterium produces a pyomelanin pigment, a potential virulence factor with ferric reductase activity. In this work, we have investigated the role of phenylalanine hydroxylase from L. pneumophila (lpPAH), the product of the phhA gene, in the synthesis of the pyomelanin pigment and the growth of the bacterium in defined compositions. Methodology/Principal Findings: Comparative studies of wild-type and phhA mutant corroborate that lpPAH provides the excess tyrosine for pigment synthesis. phhA and letA (gacA) appear transcriptionally linked when bacteria were grown in buffered yeast extract medium at 37 degrees C. phhA is expressed in L. pneumophila growing in macrophages. We also cloned and characterized lpPAH, which showed many characteristics of other PAHs studied so far, including Fe(II) requirement for activity. However, it also showed many particular properties such as dimerization, a high conformational thermal stability, with a midpoint denaturation temperature (T-m) = 79 +/- 0.5 degrees C, a high specific activity at 37 degrees C (10.2 +/- 0.3 mu mol L-Tyr/mg/min) and low affinity for the substrate (K-m (L-Phe) = 735 +/- 50 mu M. Conclusions/Significance: lpPAH has a major functional role in the synthesis of pyomelanin and promotes growth in low-tyrosine media. The high thermal stability of lpPAH might reflect the adaptation of the enzyme to withstand relatively high survival temperatures.	[Chatfield, Christa H.; Zheng, Huaixin; Gunderson, Felizza F.; Cianciotto, Nicholas P.] Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Flydal, Marte I.; Aubi, Oscar; Martinez, Aurora] Univ Bergen, Dept Biomed, Bergen, Norway	Northwestern University; University of Bergen	Cianciotto, NP (corresponding author), Northwestern Univ, Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.	n-cianciotto@northwestern.edu; aurora.martinez@biomed.uib.no	Martinez, Aurora/M-3088-2019	Martinez, Aurora/0000-0003-1643-6506; Flydal, Marte/0000-0002-4070-8367	Research Council of Norway [185181]; Meltzer Fond; Western Norway Health Authorities [911618]; NIH [AI089712, AI034937, T32 AI0007476]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034937, R21AI089712, T32AI007476] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); Meltzer Fond; Western Norway Health Authorities; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by The Research Council of Norway (grant 185181 to AM), the Meltzer Fond (to MIF) and the Western Norway Health Authorities (grant 911618 to AM), and by NIH grants AI089712 and AI034937 awarded to NPC FFG was partly supported by NIH training grant T32 AI0007476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGASHE VR, 1995, BIOCHEMISTRY-US, V34, P3286, DOI 10.1021/bi00010a019; Allard KA, 2006, J BACTERIOL, V188, P1351, DOI 10.1128/JB.188.4.1351-1363.2006; Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; BAINE WB, 1979, ANN INTERN MED, V90, P619, DOI 10.7326/0003-4819-90-4-619; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bogomolovas J, 2009, PROTEIN EXPRES PURIF, V64, P16, DOI 10.1016/j.pep.2008.10.003; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BORODOVSKY M, 1993, COMPUT CHEM, V17, P123, DOI 10.1016/0097-8485(93)85004-V; BYRD TF, 1989, J CLIN INVEST, V83, P1457, DOI 10.1172/JCI114038; Calvo AC, 2008, FASEB J, V22, P3046, DOI 10.1096/fj.08-108522; Campocasso A, 2012, INT J SYST IN PRESS; Carratala J, 2010, CURR OPIN INFECT DIS, V23, P152, DOI 10.1097/QCO.0b013e328336835b; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chatfield CH, 2007, INFECT IMMUN, V75, P4062, DOI 10.1128/IAI.00489-07; Chatfield CH, 2012, MICROBIOL-SGM, V158, P721, DOI 10.1099/mic.0.055533-0; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Cianciotto NP, 2007, BIOMETALS, V20, P323, DOI 10.1007/s10534-006-9057-4; CIANCIOTTO NP, 1989, INFECT IMMUN, V57, P1255, DOI 10.1128/IAI.57.4.1255-1262.1989; CIANCIOTTO NP, 1992, P NATL ACAD SCI USA, V89, P5188, DOI 10.1073/pnas.89.11.5188; D'Amico S, 2003, J BIOL CHEM, V278, P7891, DOI 10.1074/jbc.M212508200; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; DOSKELAND AP, 1984, J BIOL CHEM, V259, P1242; EDELSTEIN PH, 1981, J CLIN MICROBIOL, V14, P298, DOI 10.1128/JCM.14.3.298-303.1981; Ekstrom F, 2003, ACTA CRYSTALLOGR D, V59, P1310, DOI 10.1107/S090744490301014X; Erlandsen H, 2002, J MOL BIOL, V320, P645, DOI 10.1016/S0022-2836(02)00496-5; Erlandsen H, 1997, NAT STRUCT BIOL, V4, P995, DOI 10.1038/nsb1297-995; Fitzpatrick PF, 2000, ADV ENZYMOL RAMB, V74, P235; FLIERMANS CB, 1981, APPL ENVIRON MICROB, V41, P9, DOI 10.1128/AEM.41.1.9-16.1981; Flydal MI, 2010, AMINO ACIDS, V39, P1463, DOI 10.1007/s00726-010-0611-6; Gal-Mor O, 2003, MICROB PATHOGENESIS, V34, P187, DOI 10.1016/S0882-4010(03)00027-5; Hammer BK, 2002, MOL MICROBIOL, V44, P107, DOI 10.1046/j.1365-2958.2002.02884.x; Herrera MC, 2007, J MOL BIOL, V366, P1374, DOI 10.1016/j.jmb.2006.12.008; Hunter RC, 2010, J BACTERIOL, V192, P5962, DOI 10.1128/JB.01021-10; Kannan N, 2000, PROTEIN ENG, V13, P753, DOI 10.1093/protein/13.11.753; KAUFMAN S, 1993, ADV ENZYMOL RAMB, V67, P77; Keith KE, 2007, J BACTERIOL, V189, P9057, DOI 10.1128/JB.00436-07; Konishi T, 2006, J BIOSCI BIOENG, V101, P478, DOI 10.1263/jbb.101.478; KOTOB SI, 1995, APPL ENVIRON MICROB, V61, P1620, DOI 10.1128/AEM.61.4.1620-1622.1995; Kusnetsov JM, 1996, J APPL BACTERIOL, V81, P341; Leiros HKS, 2007, J BIOL CHEM, V282, P21973, DOI 10.1074/jbc.M610174200; Li WF, 2005, BIOTECHNOL ADV, V23, P271, DOI 10.1016/j.biotechadv.2005.01.002; LINDSTEDT S, 1977, BIOCHEMISTRY-US, V16, P3369, DOI 10.1021/bi00634a013; Loaiza A, 2008, INORG CHEM, V47, P4877, DOI 10.1021/ic800181q; MARSTON BJ, 1994, ARCH INTERN MED, V154, P2417, DOI 10.1001/archinte.154.21.2417; MARTINEZ A, 1995, BIOCHEM J, V306, P589, DOI 10.1042/bj3060589; MAUCHLINE WS, 1992, J GEN MICROBIOL, V138, P2371, DOI 10.1099/00221287-138-11-2371; MUDER RR, 1986, ARCH INTERN MED, V146, P1607, DOI 10.1001/archinte.146.8.1607; Olafsdottir S, 1999, J BIOL CHEM, V274, P6280, DOI 10.1074/jbc.274.10.6280; Olsson E, 2011, CHEM-EUR J, V17, P3746, DOI 10.1002/chem.201002910; ONISHI A, 1991, J BIOL CHEM, V266, P18454; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pearce MM, 2012, INT J SYST IN PRESS; Pey AL, 2009, J BIOL INORG CHEM, V14, P521, DOI 10.1007/s00775-009-0467-y; Plonka PM, 2006, ACTA BIOCHIM POL, V53, P429, DOI 10.18388/abp.2006_3314; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; Rossier O, 2004, INFECT IMMUN, V72, P310, DOI 10.1128/IAI.72.1.310-321.2004; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; Schroeder GN, 2010, J BACTERIOL, V192, P6001, DOI 10.1128/JB.00778-10; Scriver CR, 2007, HUM MUTAT, V28, P831, DOI 10.1002/humu.20526; Shuman HA, 1996, CURR TOP MICROBIOL, V209, P99; Siltberg-Liberles J, 2008, GENE, V427, P86, DOI 10.1016/j.gene.2008.09.005; Steinert M, 2001, FEMS MICROBIOL LETT, V203, P41, DOI 10.1111/j.1574-6968.2001.tb10818.x; Stewart CR, 2009, J BACTERIOL, V191, P1537, DOI 10.1128/JB.01531-08; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; SWINT L, 1993, PROTEIN SCI, V2, P2037, DOI 10.1002/pro.5560021205; Thorolfsson M, 2003, BIOCHEMISTRY-US, V42, P3419, DOI 10.1021/bi034021s; Thorolfsson M, 2002, BIOCHEMISTRY-US, V41, P7573, DOI 10.1021/bi0160720; Trebbi B, 2005, J PHYS CHEM B, V109, P18184, DOI 10.1021/jp052333u; Valeru SP, 2009, INFECT IMMUN, V77, P935, DOI 10.1128/IAI.00929-08; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Vilboux T, 2009, HUM MUTAT, V30, P1611, DOI 10.1002/humu.21120; Volner A, 2003, J BIOL INORG CHEM, V8, P121, DOI 10.1007/s00775-002-0395-6; Wang RB, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-109; WIATER LA, 1994, MOL MICROBIOL, V11, P641; WINTERMEYER E, 1994, INFECT IMMUN, V62, P1109, DOI 10.1128/IAI.62.3.1109-1117.1994; ZHAO GS, 1994, P NATL ACAD SCI USA, V91, P1366, DOI 10.1073/pnas.91.4.1366; Zoidakis J, 2005, J INORG BIOCHEM, V99, P771, DOI 10.1016/j.jinorgbio.2004.12.017; Zughaier SM, 1999, INFECT IMMUN, V67, P908, DOI 10.1128/IAI.67.2.908-913.1999	80	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46209	10.1371/journal.pone.0046209	http://dx.doi.org/10.1371/journal.pone.0046209			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049981	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300097
J	Hu, JL; Ji, M; Niu, C; Aini, A; Zhou, QN; Zhang, L; Jiang, T; Yan, Y; Hou, YM				Hu, Jialu; Ji, Meng; Niu, Conway; Aini, Asiyeguli; Zhou, Qina; Zhang, Ling; Jiang, Tao; Yan, Yan; Hou, Yuemei			Effects of Renal Sympathetic Denervation on Post-Myocardial Infarction Cardiac Remodeling in Rats	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; NERVE ACTIVITY; CLINICAL-IMPLICATIONS; SYSTEM; MECHANISM; DISEASE; TRIAL	Objective: To investigate the therapeutic effects of renal denervation (RD) on post-myocardial infarction (MI) cardiac remodeling in rats, the most optimal time for intervention and the sustainability of these effects. Methods: One hundred SPF male Wistar rats were randomly assigned to N group (Normal, n = 10), MI group(MI, n = 20), RD group (RD, n = 10), RD3+MI (MI three days after RD, n = 20), MI1+RD (RD one day after MI, n = 20), MI7+RD (RD seven days after MI, n = 20). MI was produced through thoracotomic ligation of the anterior descending artery. RD was performed through laparotomic stripping of the renal arteriovenous adventitial sympathetic nerve. Left ventricular function, hemodynamics, plasma BNP, urine volume, urine sodium excretion and other indicators were measured four weeks after MI. Results: (1) The left ventricular function of the MI group significantly declined (EF<40%), plasma BNP was elevated, urine output was significantly reduced, and 24-hour urine sodium excretion was significantly reduced. (2) Denervation can be achieved by surgically stripping the arteriovenous adventitia, approximately 3 mm from the abdominal aorta. (3) In rats with RD3+MI, MI1+RD and MI7+RD, compared with MI rats respectively, the LVEF was significantly improved (75 +/- 8.4%, 69 +/- 3.8%, 73 +/- 5.5%), hemodynamic indicators were significantly improved, plasma BNP was significantly decreased, and the urine output was significantly increased (21.3 +/- 5 ml, 23.8 +/- 5.4 ml, 25.2 +/- 8.7 ml). However, the urinary sodium excretion also increased but without significant difference. Conclusions: RD has preventive and therapeutic effects on post-MI cardiac remodeling. These effects can be sustained for at least four weeks, but there were no significant differences between denervation procedures performed at different times in the course of illness. Cardiac function, hemodynamics, urine volume and urine sodium excretion in normal rats were not affected by RD.	[Hu, Jialu; Yan, Yan] Fudan Univ, Dept Cardiol, Zhongshan Hosp, Shanghai 200433, Peoples R China; [Ji, Meng; Aini, Asiyeguli; Zhou, Qina; Zhang, Ling; Jiang, Tao] Xinjiang Med Univ, Dept Cardiol, Affiliated Hosp 1, Xinjiang, Peoples R China; [Niu, Conway] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Hou, Yuemei] Cent Hosp Fengxian Dist, Dept Cardiol, Shanghai, Peoples R China	Fudan University; Xinjiang Medical University; Fudan University	Yan, Y (corresponding author), Fudan Univ, Dept Cardiol, Zhongshan Hosp, Shanghai 200433, Peoples R China.	jackyan000@hotmail.com; houyuemei@sina.com	Zhou, Qina/L-1907-2017	Niu, Conway/0000-0002-0078-5173	National Science Foundation of China [30960132]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by grant from National Science Foundation of China (30960132, http://www.nsfc.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso S, 2009, INT J CARDIOL, V131, P240, DOI 10.1016/j.ijcard.2007.10.029; DIBONA GF, 1991, AM J PHYSIOL, V260, pR298, DOI 10.1152/ajpregu.1991.260.2.R298; Eisenhofer G, 1996, CIRCULATION, V93, P1667, DOI 10.1161/01.CIR.93.9.1667; Esler M, 2011, EXP PHYSIOL, V96, P1, DOI 10.1113/expphysiol.2011.052332; Goliasch G, 2010, WIEN KLIN WOCHENSCHR, V122, P723, DOI 10.1007/s00508-010-1486-y; Hjalmarson A, 1999, LANCET, V353, P2001; Kasama S, 2007, J NUCL MED, V48, P1993, DOI 10.2967/jnumed.107.045427; Krum H, 2011, LANCET, V378, P713, DOI 10.1016/S0140-6736(11)61038-6; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Lechat P, 1999, LANCET, V353, P9; Malpas SC, 2010, PHYSIOL REV, V90, P513, DOI 10.1152/physrev.00007.2009; Nozawa T, 2002, HEART VESSELS, V16, P51, DOI 10.1007/s380-002-8317-8; Nozawa Takashi, 2007, Nihon Rinsho, V65 Suppl 4, P257; OH BH, 1993, CIRCULATION, V87, P598, DOI 10.1161/01.CIR.87.2.598; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; PACKER M, 1992, J AM COLL CARDIOL, V20, P248, DOI 10.1016/0735-1097(92)90167-L; Petersson M, 2005, EUR HEART J, V26, P906, DOI 10.1093/eurheartj/ehi184; PETTERSSON A, 1989, ACTA PHYSIOL SCAND, V135, P487, DOI 10.1111/j.1748-1716.1989.tb08607.x; PFEFFER JM, 1991, AM J PHYSIOL, V260, pH1406, DOI 10.1152/ajpheart.1991.260.5.H1406; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Ramchandra R, 2009, P NATL ACAD SCI USA, V106, P924, DOI 10.1073/pnas.0811929106; RAYA TE, 1989, CIRC RES, V64, P330, DOI 10.1161/01.RES.64.2.330; Sobotka PA, 2011, CLIN RES CARDIOL, V100, P1049, DOI 10.1007/s00392-011-0335-y; Souza DRB, 2004, BRAZ J MED BIOL RES, V37, P285, DOI 10.1590/S0100-879X2004000200017; Triposkiadis F, 2009, J AM COLL CARDIOL, V54, P1747, DOI 10.1016/j.jacc.2009.05.015; Tsutamoto T, 2008, CIRC J, V72, P740, DOI 10.1253/circj.72.740; VILLARREAL D, 1994, AM J PHYSIOL, V266, pR1599, DOI 10.1152/ajpregu.1994.266.5.R1599	27	30	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45986	10.1371/journal.pone.0045986	http://dx.doi.org/10.1371/journal.pone.0045986			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049914	gold, Green Submitted, Green Published			2022-12-27	WOS:000309517300072
J	Lee, GQ; Swenson, LC; Poon, AFY; Martin, JN; Hatano, H; Deeks, SG; Harrigan, R				Lee, Guinevere Q.; Swenson, Luke C.; Poon, Art F. Y.; Martin, Jeffrey N.; Hatano, Hiroyu; Deeks, Steven G.; Harrigan, Richard			Prolonged and Substantial Discordance in Prevalence of Raltegravir-Resistant HIV-1 in Plasma versus PBMC Samples Revealed by 454 "Deep" Sequencing	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; DRUG-RESISTANCE; INTEGRASE INHIBITORS; GENOTYPIC RESISTANCE; MUTATIONS; EVOLUTION; STRAINS; RNA; FAILURE; ESCAPE	The evolution of drug resistance mutations in plasma samples is relatively well-characterized. However, the viral population and diversity in other body compartments such as peripheral blood mononuclear cells (PBMC) remains poorly understood. Previous studies have mostly focused on protease and reverse transcriptase drug resistance mutations (DRMs). In this study, we used 454 "deep" sequencing technology to observe and quantify longitudinally the prevalence of resistance mutations associated with the integrase inhibitor, raltegravir, in plasma versus PBMC samples from a San Francisco-based cohort. Four heavily treatment-experienced subjects were monitored in this study over a median of 1.2 years since the initiation of raltegravir-containing regimens. We observed a consistent discordance in the prevalence of DRMs, but not resistance pathway(s), in the plasma versus PBMC viral populations. In the final paired samples that were tested while the subjects were on a raltegravir-containing regimen, DRM prevalence reached 100% in plasma but remained 1% in PBMC on day 177 post-therapy in Subject 3180 (Q148H/G140S), 100% in plasma and 36% in PBMC on day 224 in Subject 3242 (N155H), 78% in plasma and 11-12% in PBMC on day 338 in Subject 3501 (Q148H/G140S), and 100% in plasma and 0% in PBMC on day 197 in Subject 3508 (Y143R). Furthermore, absolute sequence homology comparison between the two compartments revealed that 21% - 99% of PBMC sequences had no match in plasma, whereas 14% - 100% of plasma sequences had no match in PBMC. Overall, our observations suggested that plasma and PBMC hosted drastically different HIV-1 populations even after a prolonged exposure to raltegravir selection pressure.	[Lee, Guinevere Q.; Swenson, Luke C.; Poon, Art F. Y.; Harrigan, Richard] BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Lee, Guinevere Q.; Swenson, Luke C.; Poon, Art F. Y.; Harrigan, Richard] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Martin, Jeffrey N.; Hatano, Hiroyu; Deeks, Steven G.] Univ Calif San Francisco, San Francisco, CA 94143 USA	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of California System; University of California San Francisco	Harrigan, R (corresponding author), BC Ctr Excellence HIV AIDS, Vancouver, BC, Canada.	prharrigan@cfenet.ubc.ca	Lee, Guinevere Q./D-4436-2017; Poon, Art/W-9811-2019; Swenson, Luke/E-8549-2014	Lee, Guinevere Q./0000-0002-9412-886X; Poon, Art/0000-0003-3779-154X; Swenson, Luke/0000-0001-5381-7709	National Institute of Allergy and Infectious Diseases (NIAID) [RO1 AI087145, K24AI069994]; University of California, San Francisco (UCSF) Center for AIDS Research (CFAR) [P30 AI27763]; UCSF Clinical & Translational Science Institute (CTSI) [UL1 RR024131]; CFAR Network of Integrated Systems [R24 AI067039]; Canadian Institutes of Health Research (CIHR) [201009HOP-235256]; ViiV/Pfizer; Quest; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R24AI067039, P30AI027763, R01AI087145, K24AI069994] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of California, San Francisco (UCSF) Center for AIDS Research (CFAR)(University of California System); UCSF Clinical & Translational Science Institute (CTSI); CFAR Network of Integrated Systems; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); ViiV/Pfizer; Quest; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This SCOPE cohort was supported in part by the National Institute of Allergy and Infectious Diseases (NIAID) (RO1 AI087145, K24AI069994), the University of California, San Francisco (UCSF) Center for AIDS Research (CFAR) (P30 AI27763), the UCSF Clinical & Translational Science Institute (CTSI) (UL1 RR024131), and CFAR Network of Integrated Systems (R24 AI067039). AFYP is supported by a Canadian Institutes of Health Research (CIHR) Operating Grant (201009HOP-235256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PRH has received consulting fees from ViiV/Pfizer and Quest; holds stock options in Merck. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. All other authors: No competing interests exist.	Abbate I, 2011, CLIN MICROBIOL INFEC, V17, P725, DOI 10.1111/j.1469-0691.2010.03350.x; Armenia D, 2012, J INFECT DIS, V205, P557, DOI 10.1093/infdis/jir821; Baatz F, 2011, ANTIVIR RES, V92, P488, DOI 10.1016/j.antiviral.2011.10.003; Bi XQ, 2003, JAIDS-J ACQ IMM DEF, V34, P1, DOI 10.1097/00126334-200309010-00001; Bunnik EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002106; Canducci F, 2011, CLIN MICROBIOL INFEC, V17, P928, DOI 10.1111/j.1469-0691.2010.03375.x; Charpentier C, 2008, HIV MED, V9, P765, DOI 10.1111/j.1468-1293.2008.00628.x; Codoner FM, 2010, ANTIVIR RES, V88, P281, DOI 10.1016/j.antiviral.2010.09.016; da Silva D, 2010, J ANTIMICROB CHEMOTH, V65, P1262, DOI 10.1093/jac/dkq099; Dalmau J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032714; Devereux HL, 2000, AIDS RES HUM RETROV, V16, P1025, DOI 10.1089/08892220050075273; Ghosn J, 2006, AIDS, V20, P159, DOI 10.1097/01.aids.0000199820.47703.a0; Harrigan PR, 2002, 14 INT AIDS C BARC S; Hatano H, 2010, JAIDS-J ACQ IMM DEF, V54, P389, DOI 10.1097/QAI.0b013e3181c42ea4; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Johnson Victoria A, 2011, Top Antivir Med, V19, P156; Mukherjee R, 2011, AIDS, V25, P1951, DOI 10.1097/QAD.0b013e32834b34de; Nakahara K, 2009, ANTIVIR RES, V81, P141, DOI 10.1016/j.antiviral.2008.10.007; Paolucci S, 2001, J MED VIROL, V65, P207, DOI 10.1002/jmv.2022; Rozera G, 2009, AIDS, V23, P2541, DOI 10.1097/QAD.0b013e32832fd2e1; Rozera G, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-15; Saracino A, 2008, J MED VIROL, V80, P1695, DOI 10.1002/jmv.21261; Sarmati L, 2003, J CLIN MICROBIOL, V41, P1760, DOI 10.1128/JCM.41.4.1760-1762.2003; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Sichtig N, 2009, J ANTIMICROB CHEMOTH, V64, P25, DOI 10.1093/jac/dkp153; SIMMONDS P, 1991, J VIROL, V65, P6266, DOI 10.1128/JVI.65.11.6266-6276.1991; Soto-Ramirez LE, 2008, AIDS RES HUM RETROV, V24, P797, DOI 10.1089/aid.2007.0246; Swenson LC, 2010, JAIDS-J ACQ IMM DEF, V54, P506, DOI 10.1097/QAI.0b013e3181d0558f; Turriziani O, 2007, JAIDS-J ACQ IMM DEF, V44, P518, DOI 10.1097/QAI.0b013e3180315515; Wang YM, 2007, CURR HIV RES, V5, P235; Wirden M, 2011, J ANTIMICROB CHEMOTH, V66, P709, DOI 10.1093/jac/dkq544	31	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46181	10.1371/journal.pone.0046181	http://dx.doi.org/10.1371/journal.pone.0046181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049972	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300095
J	Blangy, A; Touaitahuata, H; Cres, G; Pawlak, G				Blangy, Anne; Touaitahuata, Heiani; Cres, Gaelle; Pawlak, Geraldine			Cofilin Activation during Podosome Belt Formation in Osteoclasts	PLOS ONE			English	Article							ACTIN DYNAMICS; REGULATES COFILIN; PHOSPHATASE SLINGSHOT; CULTURED OSTEOCLASTS; LIM-KINASE; PATHWAY; CORTACTIN; ORGANIZATION; INVADOPODIA; ADF/COFILIN	Podosomes are dynamic actin-based structures found constitutively in cells of monocytic origin such as macrophages, dendritic cells and osteoclasts. They have been involved in osteoclast cell adhesion, motility and matrix degradation, and all these functions rely on the ability of podosomes to form supra-molecular structures called podosome belts or sealing zones on mineralized substrates. Podosomes contain two distinct domains, an actin-rich core enriched in actin polymerization regulators, surrounded by a ring of signaling and plaque molecules. The organization of podosome arrays into belts is linked to actin dynamics. Cofilin is an actin-severing protein that is known to regulate cytoskeleton architecture and cell migration. Cofilin is present in lamellipodia and invadopodia where it regulates actin polymerization. In this report, we show that cofilin is a novel component of the podosome belt, the mature osteoclast adhesion structure. Time-course analysis demonstrated that cofilin is activated during primary osteoclast differentiation, at the time of podosome belt assembly. Immunofluorescence studies reveal a localization of active cofilin in the podosome core structure, whereas phosphorylated, inactive cofilin is concentrated in the podosome cloud. Pharmacological studies unraveled the role of a specific cofilin phosphatase to achieve cofilin activation during osteoclast differentiation. We ruled out the implication of PP1/PP2A and PTEN in this process, and rather provided evidence for the involvement of SSH1. In summary, our data involve cofilin as a regulator of podosome organization that is activated during osteoclast differentiation by a RANKL-mediated signaling pathway targeting the SSH1 phosphatase.	[Blangy, Anne; Touaitahuata, Heiani; Cres, Gaelle; Pawlak, Geraldine] Univ Montpellier, CNRS UMR 5237, Ctr Rech Biochim Macromol, F-34059 Montpellier, France; [Pawlak, Geraldine] Univ Grenoble 1, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Blangy, A (corresponding author), Univ Montpellier, CNRS UMR 5237, Ctr Rech Biochim Macromol, F-34059 Montpellier, France.	anne.blangy@crbm.cnrs.fr		BLANGY, Anne/0000-0001-7043-0784	Fondation pour la Recherche Medicale (FRM) [DVO20081013473]; Institut National du Cancer [INCa-4361]; Agence Nationale de la Recherche (ANR) [ANR-2011-BLAN-006]; Grants-in-Aid for Scientific Research [24592816] Funding Source: KAKEN	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Fondation pour la Recherche Medicale (FRM grant # DVO20081013473 to AB), the Institut National du Cancer (grant # INCa-4361 to AB) and the Agence Nationale de la Recherche (ANR grant # ANR-2011-BLAN-006 to AB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bravo-Cordero JJ, 2011, CURR BIOL, V21, P635, DOI 10.1016/j.cub.2011.03.039; Brazier H, 2006, J BONE MINER RES, V21, P1387, DOI 10.1359/JBMR.060613; Brazier H, 2009, INT J BIOCHEM CELL B, V41, P1391, DOI 10.1016/j.biocel.2008.12.007; Burgstaller G, 2004, J CELL SCI, V117, P223, DOI 10.1242/jcs.00839; Chabadel A, 2007, MOL BIOL CELL, V18, P4899, DOI 10.1091/mbc.E07-04-0378; Chellaiah M, 2000, J CELL BIOL, V148, P665, DOI 10.1083/jcb.148.4.665; Crimaldi L, 2009, EXP CELL RES, V315, P2581, DOI 10.1016/j.yexcr.2009.06.012; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Granot-Attas S, 2009, MOL BIOL CELL, V20, P4324, DOI 10.1091/mbc.E08-11-1158; Hammarfjord O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021615; Huang TY, 2006, CURR OPIN CELL BIOL, V18, P26, DOI 10.1016/j.ceb.2005.11.005; Kim JS, 2009, MOL BIOL CELL, V20, P2650, DOI 10.1091/mbc.E09-02-0131; Kurita S, 2008, J BIOL CHEM, V283, P32542, DOI 10.1074/jbc.M804627200; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Luxenburg C, 2006, EUR J CELL BIOL, V85, P203, DOI 10.1016/j.ejcb.2005.11.002; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; Luxenburg C, 2012, J CELL SCI, V125, P1666, DOI 10.1242/jcs.075903; Luxenburg C, 2006, J CELL SCI, V119, P4878, DOI 10.1242/jcs.03271; McMichael BK, 2010, J BIOL CHEM, V285, P9506, DOI 10.1074/jbc.M109.017269; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2004, J BIOL CHEM, V279, P7193, DOI 10.1074/jbc.M312591200; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Novack DV, 2011, AGEING RES REV, V10, P54, DOI 10.1016/j.arr.2009.09.005; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Ory S, 2008, EUR J CELL BIOL, V87, P469, DOI 10.1016/j.ejcb.2008.03.002; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Saltel F, 2011, EUR J CELL BIOL, V90, P100, DOI 10.1016/j.ejcb.2010.05.011; Serezani CH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002448; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Tang WW, 2011, DEV CELL, V21, P1038, DOI 10.1016/j.devcel.2011.10.023; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Vitolo MI, 2013, ONCOGENE, V32, P2200, DOI 10.1038/onc.2012.234; Wang LH, 2010, CANCER RES, V70, P9118, DOI 10.1158/0008-5472.CAN-10-1246; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076	46	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45909	10.1371/journal.pone.0045909	http://dx.doi.org/10.1371/journal.pone.0045909			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049890	Green Published, gold			2022-12-27	WOS:000309556100098
J	De Deyn, GB; Quirk, H; Oakley, S; Ostle, NJ; Bardgett, RD				De Deyn, Gerlinde B.; Quirk, Helen; Oakley, Simon; Ostle, Nick J.; Bardgett, Richard D.			Increased Plant Carbon Translocation Linked to Overyielding in Grassland Species Mixtures	PLOS ONE			English	Article							PRODUCTIVITY RELATIONSHIPS; NITROGEN FORMS; DIVERSITY; BIODIVERSITY; RICHNESS; COMPLEMENTARITY; COMMUNITIES; MECHANISMS; FERTILITY; SELECTION	Plant species richness and productivity often show a positive relationship, but the underlying mechanisms are not fully understood, especially at the plant species level. We examined how growing plants in species mixture influences intraspecific rates of short-term carbon(C-) translocation, and determined whether such short-term responses are reflected in biomass yields. We grew monocultures and mixtures of six common C3 grassland plant species in outdoor mesocosms, applied a C-13-CO2 pulse in situ to trace assimilated C through plants, into the soil, and back to the atmosphere, and quantified species-specific biomass. Pulse derived C-13 enrichment was highest in the legumes Lotus corniculatus and Trifolium repens, and relocation (i.e. transport from the leaves to other plant parts) of the recently assimilated C-13 was most rapid in T. repens grown in 6-species mixtures. The grass Anthoxanthum odoratum also showed high levels of C-13 enrichment in 6-species mixtures, while C-13 enrichment was low in Lolium perenne, Plantago lanceolata and Achillea millefolium. Rates of C loss through respiration were highest in monocultures of T. repens and relatively low in species mixtures, while the proportion of C-13 in the respired CO2 was similar in monocultures and mixtures. The grass A. odoratum and legume T. repens were most promoted in 6-species mixtures, and together with L. corniculatus, caused the net biomass increase in 6-species mixtures. These plant species also had highest rates of C-13- label translocation, and for A. odoratum and T. repens this effect was greatest in plant individuals grown in species mixtures. Our study reveals that short-term plant C translocation can be accelerated in plant individuals of legume and C3 grass species when grown in mixtures, and that this is strongly positively related to overyielding. These results demonstrate a mechanistic coupling between changes in intraspecific plant carbon physiology and increased community level productivity in grassland systems.	[De Deyn, Gerlinde B.; Quirk, Helen; Bardgett, Richard D.] Univ Lancaster, Lancaster Environm Ctr, Soil & Ecosyst Ecol Lab, Lancaster, England; [De Deyn, Gerlinde B.] Wageningen Univ, Dept Soil Qual, Wageningen, Netherlands; [Oakley, Simon; Ostle, Nick J.] Lancaster Environm Ctr, Ctr Ecol & Hydrol, Plant Soil Interact Grp, Lancaster, England	Lancaster University; Wageningen University & Research; Lancaster University; UK Centre for Ecology & Hydrology (UKCEH)	De Deyn, GB (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Soil & Ecosyst Ecol Lab, Lancaster, England.	gerlindede@gmail.com	Oakley, Simon/K-1857-2013; De Deyn, Gerlinde B/C-1593-2009; De Deyn, Gerlinde/AFI-8702-2022; Ostle, Nicholas J/E-4847-2014; Ostle, Nick J/K-6891-2012; De Deyn, Gerlinde/F-7080-2017	Oakley, Simon/0000-0002-5757-7420; De Deyn, Gerlinde B/0000-0003-4823-6912; De Deyn, Gerlinde/0000-0003-4823-6912; Ostle, Nicholas J/0000-0003-3263-3702; De Deyn, Gerlinde/0000-0003-4823-6912	BBSRC Agri-Food Committee; EU; Biotechnology and Biological Sciences Research Council [BB/I008969/1, BB/D003946/1] Funding Source: researchfish; Natural Environment Research Council [lsmsf010003, CEH010021] Funding Source: researchfish; BBSRC [BB/I008969/1, BB/D003946/1] Funding Source: UKRI; NERC [lsmsf010003] Funding Source: UKRI	BBSRC Agri-Food Committee(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by funds from the BBSRC Agri-Food Committee, awarded to RDB and NJO. GBDD acknowledges the EU for support by a Marie Curie Intra European Fellowship within the 7th European Community Framework Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSE F, 1983, J ECOL, V71, P379, DOI 10.2307/2259721; BOUTTON T W, 1991, P155; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; De Deyn GB, 2011, BIOGEOSCIENCES, V8, P1131, DOI 10.5194/bg-8-1131-2011; De Deyn GB, 2004, J ECOL, V92, P824, DOI 10.1111/j.0022-0477.2004.00924.x; De Deyn GB, 2011, BIOL LETTERS, V7, P75, DOI 10.1098/rsbl.2010.0575; De Deyn GB, 2009, J ECOL, V97, P864, DOI 10.1111/j.1365-2745.2009.01536.x; de Wit CT, 1965, J AGR SCI, V13, P212; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Fridley JD, 2010, ECOLOGY, V91, P2272, DOI 10.1890/09-1240.1; Fridley JD, 2001, OIKOS, V93, P514, DOI 10.1034/j.1600-0706.2001.930318.x; GRIME JP, 1975, J ECOL, V63, P393, DOI 10.2307/2258728; Gubsch M, 2011, ANN BOT-LONDON, V107, P157, DOI 10.1093/aob/mcq220; HARRIS D, 1985, NEW PHYTOL, V101, P427, DOI 10.1111/j.1469-8137.1985.tb02849.x; Harrison KA, 2007, ECOLOGY, V88, P989, DOI 10.1890/06-1018; Hartwig Ueli A., 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P92, DOI 10.1078/1433-8319-00054; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Kaschuk G, 2009, SOIL BIOL BIOCHEM, V41, P1233, DOI 10.1016/j.soilbio.2009.03.005; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Ostle N, 2007, SOIL BIOL BIOCHEM, V39, P768, DOI 10.1016/j.soilbio.2006.09.025; Ostle N, 2003, SOIL BIOL BIOCHEM, V35, P877, DOI 10.1016/S0038-0717(03)00117-2; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; RODWELL JS, 1992, BRIT PLANT COMMUNITI; Roscher C, 2011, OECOLOGIA, V165, P437, DOI 10.1007/s00442-010-1735-9; ROSS DJ, 1992, SOIL BIOL BIOCHEM, V24, P343, DOI 10.1016/0038-0717(92)90194-3; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Spehn EM, 2000, FUNCT ECOL, V14, P326, DOI 10.1046/j.1365-2435.2000.00437.x; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; von Felten S, 2009, ECOLOGY, V90, P1389, DOI 10.1890/08-0802.1; Ward SE, 2009, FUNCT ECOL, V23, P454, DOI 10.1111/j.1365-2435.2008.01521.x; Weigelt A, 2005, OECOLOGIA, V142, P627, DOI 10.1007/s00442-004-1765-2; Zahran HH, 1999, MICROBIOL MOL BIOL R, V63, P968, DOI 10.1128/MMBR.63.4.968-989.1999	37	16	17	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45926	10.1371/journal.pone.0045926	http://dx.doi.org/10.1371/journal.pone.0045926			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049893	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000309556100100
J	Garcia, JC; Crawford, AJ; Mendoza, AM; Ospina, O; Cardenas, H; Castro, F				Garcia, Juan C.; Crawford, Andrew J.; Maria Mendoza, Angela; Ospina, Oscar; Cardenas, Heiber; Castro, Fernando			Comparative Phylogeography of Direct-Developing Frogs (Anura: Craugastoridae: Pristimantis) in the Southern Andes of Colombia	PLOS ONE			English	Article							GENETIC DIFFERENTIATION; SPECIES RICHNESS; MOUNTAIN PASSES; COSTA-RICAN; POPULATION; DNA; DIVERSITY; ORIGIN; MITOCHONDRIAL; AMPLIFICATION	The Andes of South America hosts perhaps the highest amphibian species diversity in the world, and a sizable component of that diversity is comprised of direct-developing frogs of the genus Pristimantis (Anura: Craugastoridae). In order to better understand the initial stages of species formation in these frogs, this study quantified local-scale spatial genetic structuring in three species of Pristimantis. DNA sequences of two mitochondrial gene fragments (16S and COI) were obtained from P. brevifrons, P. palmeri and P. jubatus at different locations in the Cordillera Occidental. We found high levels of genetic diversity in the three species, with highly structured populations (as measured by F-ST) in P. brevifrons and P. palmeri while P. jubatus showed panmixia. Large effective population sizes, inferred from the high levels of genetic diversity, were found in the three species and two highly divergent lineages were detected within P. jubatus and P. palmeri. Estimated divergence times among populations within P. brevifrons and P. palmeri coincide with the Pleistocene, perhaps due to similar responses to climatic cycling or recent geological history. Such insights have important implications for linking alpha and beta diversity, suggesting regional scale patterns may be associated with local scale processes in promoting differentiation among populations in the Andes.	[Garcia, Juan C.; Maria Mendoza, Angela; Ospina, Oscar; Cardenas, Heiber; Castro, Fernando] Univ Valle, Dept Biol, Cali, Colombia; [Crawford, Andrew J.] Smithsonian Trop Res Inst, Panama City, Panama; [Crawford, Andrew J.] Univ Los Andes, Dept Biol Sci, Bogota, Colombia	Universidad del Valle; Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad de los Andes (Colombia)	Garcia, JC (corresponding author), Massey Univ, Inst Nat Resources, Palmerston North, New Zealand.	j.c.garciaramirez@massey.ac.nz	Crawford, Andrew J./G-6365-2012; Ospina, Oscar E/S-2918-2016; Garcia-R, Juan C./X-3399-2019; Mendoza-Henao, Angela M./D-6346-2013	Crawford, Andrew J./0000-0003-3153-6898; Ospina, Oscar E/0000-0001-5986-4207; Garcia-R, Juan C./0000-0002-6665-9671; Mendoza-Henao, Angela M./0000-0002-6752-9238; CASTRO HERRERA, FERNANDO/0000-0002-7626-0103	Universidad del Valle [CI-746]	Universidad del Valle	This research was supported by Universidad del Valle (Convocatoria Interna CI-746). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amphibia Web, 2012, INF AMPH BIOL CONS; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beavis AS, 2011, BIOL J LINN SOC, V104, P805, DOI 10.1111/j.1095-8312.2011.01753.x; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bermingham E, 1998, MOL ECOL, V7, P367, DOI 10.1046/j.1365-294x.1998.00424.x; Bernal MH, 2008, ZOOTAXA, P1, DOI 10.11646/zootaxa.1826.1.1; Bernal XE, 2005, HERPETOLOGICA, V61, P395, DOI 10.1655/04-87.1; Boulenger G. A., 1912, Annals & Magazine of Natural History, V10; Burney CW, 2009, AM NAT, V174, P358, DOI 10.1086/603613; Cadena C. D., 2011, P ROYAL SOC B, V279, P194, DOI DOI 10.1098/RSPB.2011.0720; Cadena CD, 2007, EVOLUTION, V61, P1120, DOI 10.1111/j.1558-5646.2007.00095.x; Cadena CD, 2011, P ROYAL SOC B; Crawford AJ, 2003, MOL ECOL, V12, P2525, DOI 10.1046/j.1365-294X.2003.01910.x; Crawford AJ, 2003, J MOL EVOL, V57, P636, DOI 10.1007/s00239-003-2513-7; Crawford AJ, 2010, P NATL ACAD SCI; Crawford AJ, 2007, MOL ECOL, V16, P4789, DOI 10.1111/j.1365-294X.2007.03524.x; Dawson MN, 2012, MOL ECOL, V21, P987, DOI 10.1111/j.1365-294X.2011.05417.x; de Porta J, 2003, REV ACAD COLOMB CIEN, VXXVII, P191; Dixo M, 2009, BIOL CONSERV, V142, P1560, DOI 10.1016/j.biocon.2008.11.016; Elmer KR, 2007, HEREDITY, V99, P506, DOI 10.1038/sj.hdy.6801025; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Garcia JC, 2006, ZOOTAXA, P39, DOI 10.11646/zootaxa.1171.1.4; Garcia-Paris M, 2000, P NATL ACAD SCI USA, V97, P1640, DOI 10.1073/pnas.97.4.1640; Garcia JC, 2005, CALDASIA, V27, P299; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Graham A, 2009, ANN MO BOT GARD, V96, P371, DOI 10.3417/2007146; Graham CH, 2010, J BIOGEOGR, V37, P1863, DOI 10.1111/j.1365-2699.2010.02356.x; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Guarnizo CE, 2009, MOL PHYLOGENET EVOL, V50, P84, DOI 10.1016/j.ympev.2008.10.005; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hubbell Stephen P., 2001, V32, pi; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jankowski JE, 2009, J ANIM ECOL, V78, P315, DOI 10.1111/j.1365-2656.2008.01487.x; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Kessing B., 2004, SPECIAL PUBLICATION; Kessler Michael, 2008, P35; KIMURA M, 1969, GENETICS, V61, P893; KLIMAN RM, 1993, GENETICS, V133, P375; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LYNCH J D, 1981, Occasional Papers of the Museum of Zoology University of Michigan, P1; Lynch JD, 1997, U KANSAS NATURAL HIS, V23, P1, DOI DOI 10.5962/BHL.TITLE.7951; Lynch John D., 1999, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V23, P143; Lynch John D., 1998, Revista de la Academia Colombiana de Ciencias Exactas Fisicas y Naturales, V22, P117; LYNCH M, 1990, MOL BIOL EVOL, V7, P377; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; OVASKA K, 1992, COPEIA, P569; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Pinto-Sanchez NR, 2012, MOL PHYLOGENET EVOL, V62, P954, DOI 10.1016/j.ympev.2011.11.022; Smith SA, 2007, EVOLUTION, V61, P1188, DOI 10.1111/j.1558-5646.2007.00085.x; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Streicher JW, 2009, MOL PHYLOGENET EVOL, V53, P620, DOI 10.1016/j.ympev.2009.07.011; TAJIMA F, 1989, GENETICS, V123, P585; Van der Hammen T, 2000, REV ACAD COLOMB CIEN, V24, P231; Velasquez-E BE, 2008, HERPETOTROPICOS, V4, P65; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vences M, 2003, J ZOOL SYST EVOL RES, V41, P205, DOI 10.1046/j.1439-0469.2003.00205.x; Vences M, 2012, DNA BARCODES METHODS, P79, DOI DOI 10.1007/978-1-61779-591-6; Vences Miguel, 2005, Front Zool, V2, P5, DOI 10.1186/1742-9994-2-5; Wang IJ, 2008, MOL PHYLOGENET EVOL, V47, P992, DOI 10.1016/j.ympev.2008.02.021; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2007, P ROY SOC B-BIOL SCI, V274, P919, DOI 10.1098/rspb.2006.0301; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	73	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46077	10.1371/journal.pone.0046077	http://dx.doi.org/10.1371/journal.pone.0046077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049941	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100133
J	Long, AR; O'Brien, CC; Alder, NN				Long, Ashley R.; O'Brien, Catherine C.; Alder, Nathan N.			The Cell-Free Integration of a Polytopic Mitochondrial Membrane Protein into Liposomes Occurs Cotranslationally and in a Lipid-Dependent Manner	PLOS ONE			English	Article							NASCENT POLYPEPTIDE-CHAINS; FREE EXPRESSION SYSTEMS; RIBOSOMAL EXIT TUNNEL; ADP/ATP CARRIER; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; FREE TRANSLATION; NUCLEOTIDE-BINDING; LACTOSE PERMEASE	The ADP/ATP Carrier (AAC) is the most abundant transporter of the mitochondrial inner membrane. The central role that this transporter plays in cellular energy production highlights the importance of understanding its structure, function, and the basis of its pathologies. As a means of preparing proteoliposomes for the study of membrane proteins, several groups have explored the use of cell-free translation systems to facilitate membrane protein integration directly into preformed unilamellar vesicles without the use of surfactants. Using AAC as a model, we report for the first time the detergent-free reconstitution of a mitochondrial inner membrane protein into liposomes using a wheat germ-based in vitro translation system. Using a host of independent approaches, we demonstrate the efficient integration of AAC into vesicles with an inner membrane-mimetic lipid composition and, more importantly, that the integrated AAC is functionally active in transport. By adding liposomes at different stages of the translation reaction, we show that this direct integration is obligatorily cotranslational, and by synthesizing stable ribosome-bound nascent chain intermediates, we show that the nascent AAC polypeptide interacts with lipid vesicles while ribosome-bound. Finally, we show that the presence of the phospholipid cardiolipin in the liposomes specifically enhances AAC translation rate as well as the efficiency of vesicle association and integration. In light of these results, the possible mechanisms of liposome-assisted membrane protein integration during cell-free translation are discussed with respect to the mode of integration and the role of specific lipids.	[Long, Ashley R.; O'Brien, Catherine C.; Alder, Nathan N.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA	University of Connecticut	Alder, NN (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA.	nathan.alder@uconn.edu		Alder, Nathan/0000-0003-4474-7803	Scientist Development Grant from the American Heart Association [09SDG2380019]	Scientist Development Grant from the American Heart Association(American Heart Association)	This work was funded by a Scientist Development Grant from the American Heart Association to NA (Grant #: 09SDG2380019) (http://www.heart.org). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder NN, 2008, CELL, V134, P439, DOI 10.1016/j.cell.2008.06.007; Alder NN, 2008, MOL BIOL CELL, V19, P159, DOI 10.1091/mbc.E07-07-0669; Alder NN, 2011, STRUCTURE BIOL MEMBR, P315; Babot M, 2012, J BIOL CHEM, V287, P10368, DOI 10.1074/jbc.M111.320697; Berrier C, 2004, BIOCHEMISTRY-US, V43, P12585, DOI 10.1021/bi049049y; Berrier C, 2011, BBA-BIOMEMBRANES, V1808, P41, DOI 10.1016/j.bbamem.2010.09.018; Bhushan S, 2010, NAT STRUCT MOL BIOL, V17, P313, DOI 10.1038/nsmb.1756; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; Bogdanov M, 1996, J BIOL CHEM, V271, P11615, DOI 10.1074/jbc.271.20.11615; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; Borel AC, 1996, CELL, V85, P379, DOI 10.1016/S0092-8674(00)81116-2; Cabrita LD, 2010, CURR OPIN STRUC BIOL, V20, P33, DOI 10.1016/j.sbi.2010.01.005; Cappuccio JA, 2009, METHODS MOL BIOL HIG; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Clemencon B, 2008, J BIOL CHEM, V283, P11218, DOI 10.1074/jbc.M709565200; COLBEAU A, 1971, BIOCHIM BIOPHYS ACTA, V249, P462, DOI 10.1016/0005-2736(71)90123-4; CROWLEY KS, 1993, CELL, V73, P1101, DOI 10.1016/0092-8674(93)90640-C; Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006; de Marcos-Lousa C, 2006, TRENDS BIOCHEM SCI, V31, P259, DOI 10.1016/j.tibs.2006.03.006; Dowhan W, 2012, BBA-BIOMEMBRANES, V1818, P1097, DOI 10.1016/j.bbamem.2011.09.013; ERICKSON AH, 1983, METHOD ENZYMOL, V96, P38; Flanagan JJ, 2003, J BIOL CHEM, V278, P18628, DOI 10.1074/jbc.M300173200; Goren MA, 2008, PROTEIN EXPRES PURIF, V62, P171, DOI 10.1016/j.pep.2008.08.002; Gropp T, 1999, BIOPHYS J, V77, P714, DOI 10.1016/S0006-3495(99)76926-2; HOFFMANN B, 1994, J BIOL CHEM, V269, P1940; Hovijitra NT, 2009, BIOTECHNOL BIOENG, V104, P40, DOI 10.1002/bit.22385; Ishihara G, 2005, PROTEIN EXPRES PURIF, V41, P27, DOI 10.1016/j.pep.2005.01.013; Jha S, 2011, BIOTECHNOL J, V6, P623, DOI 10.1002/biot.201000327; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Johnson AE, 2005, FEBS LETT, V579, P916, DOI 10.1016/j.febslet.2004.11.046; Junge F, 2011, NEW BIOTECHNOL, V28, P262, DOI 10.1016/j.nbt.2010.07.002; Kalmbach R, 2007, J MOL BIOL, V371, P639, DOI 10.1016/j.jmb.2007.05.087; Katzen F, 2005, TRENDS BIOTECHNOL, V23, P150, DOI 10.1016/j.tibtech.2005.01.003; Katzen F, 2008, J PROTEOME RES, V7, P3535, DOI 10.1021/pr800265f; Katzen F, 2009, TRENDS BIOTECHNOL, V27, P455, DOI 10.1016/j.tibtech.2009.05.005; Kawashima Y, 2008, J BIOL CHEM, V283, P24489, DOI 10.1074/jbc.M801812200; Kemper C, 2008, J CELL SCI, V121, P1990, DOI 10.1242/jcs.024034; Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x; Klingenberg M, 2008, BBA-BIOMEMBRANES, V1778, P1978, DOI 10.1016/j.bbamem.2008.04.011; KRIEG UC, 1989, J CELL BIOL, V109, P2033, DOI 10.1083/jcb.109.5.2033; Krishna AG, 2002, BIOCHEMISTRY-US, V41, P8298, DOI 10.1021/bi025534m; Kuruma Y, 2010, METHODS MOL BIOL, V607, P161, DOI 10.1007/978-1-60327-331-2_14; Liguori L, 2010, PROTEIN EXPRES PURIF, V69, P106, DOI 10.1016/j.pep.2009.07.004; Lionaki E, 2008, J BIOL CHEM, V283, P15747, DOI 10.1074/jbc.M800350200; Lobau S, 1998, BIOCHEMISTRY-US, V37, P10846, DOI 10.1021/bi9807153; Lousa CD, 2002, BIOCHEMISTRY-US, V41, P14412, DOI 10.1021/bi02641490; Lu JL, 2005, NAT STRUCT MOL BIOL, V12, P1123, DOI 10.1038/nsmb1021; Matthies D, 2011, J MOL BIOL, V413, P593, DOI 10.1016/j.jmb.2011.08.055; Merklinger E, 2012, BIOCHEM J, V442, P381, DOI 10.1042/BJ20111363; Moritani Y, 2010, FEBS J, V277, P3343, DOI 10.1111/j.1742-4658.2010.07736.x; Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nishiyama KI, 2006, J BIOL CHEM, V281, P35667, DOI 10.1074/jbc.M608228200; Nomura SIM, 2008, J BIOTECHNOL, V133, P190, DOI 10.1016/j.jbiotec.2007.08.023; Nozawa A, 2007, PLANT CELL PHYSIOL, V48, P1815, DOI 10.1093/pcp/pcm150; Nury H, 2006, ANNU REV BIOCHEM, V75, P713, DOI 10.1146/annurev.biochem.75.103004.142747; Nury H, 2005, FEBS LETT, V579, P6031, DOI 10.1016/j.febslet.2005.09.061; Pebay-Peyroula E, 2003, NATURE, V426, P39, DOI 10.1038/nature02056; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; Rajesh S, 2011, NEW BIOTECHNOL, V28, P250, DOI 10.1016/j.nbt.2010.07.011; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Ridder ANJA, 2001, EMBO REP, V2, P403; Savage DF, 2007, PROTEIN SCI, V16, P966, DOI 10.1110/ps.062696307; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Schwarz D, 2008, PROTEOMICS, V8, P3933, DOI 10.1002/pmic.200800171; Schwarz D, 2007, METHODS, V41, P355, DOI 10.1016/j.ymeth.2006.07.001; Sevova ES, 2010, J BIOL CHEM, V285, P20580, DOI 10.1074/jbc.M110.127662; SHI LB, 1995, BIOCHEMISTRY-US, V34, P8250, DOI 10.1021/bi00026a006; STANLOTTER H, 1986, EUR J BIOCHEM, V154, P321, DOI 10.1111/j.1432-1033.1986.tb09400.x; Tu LW, 2010, J MOL BIOL, V396, P1346, DOI 10.1016/j.jmb.2009.12.059; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; Vasiljev A, 2004, MOL BIOL CELL, V15, P1445, DOI 10.1091/mbc.E03-05-0272; Voss NR, 2006, J MOL BIOL, V360, P893, DOI 10.1016/j.jmb.2006.05.023; Walther DM, 2009, BBA-MOL CELL RES, V1793, P42, DOI 10.1016/j.bbamcr.2008.04.013; Wilson DN, 2011, CURR OPIN STRUC BIOL, V21, P274, DOI 10.1016/j.sbi.2011.01.007; Woolhead CA, 2004, CELL, V116, P725, DOI 10.1016/S0092-8674(04)00169-2; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zara V, 2009, BIOCHEM J, V419, P369, DOI 10.1042/BJ20082270; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602; Ziv G, 2005, P NATL ACAD SCI USA, V102, P18956, DOI 10.1073/pnas.0508234102	85	34	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46332	10.1371/journal.pone.0046332	http://dx.doi.org/10.1371/journal.pone.0046332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050015	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100179
J	Yan, LF; Zhao, L; Long, Y; Zou, P; Ji, GX; Gu, AH; Zhao, P				Yan, Lifeng; Zhao, Lin; Long, Yan; Zou, Peng; Ji, Guixiang; Gu, Aihua; Zhao, Peng			Association of the Maternal MTHFR C677T Polymorphism with Susceptibility to Neural Tube Defects in Offsprings: Evidence from 25 Case-Control Studies	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; FOLATE-RELATED GENES; SPINA-BIFIDA; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE; METHIONINE SYNTHASE; RISK-FACTOR; THERMOLABILE VARIANT; COLORECTAL-CANCER; HOMOCYSTEINE METABOLISM; POPULATION	Background: Methylenetetrahydrofolate reductase (MTHFR) is a critical enzyme in folate metabolism and is involved in DNA methylation, DNA synthesis, and DNA repair. In addition, it is a possible risk factor in neural tube defects (NTDs). The association of the C677T polymorphism in the MTHFR gene and NTD susceptibility has been widely demonstrated, but the results remain inconclusive. In this study, we performed a meta-analysis with 2429 cases and 3570 controls to investigate the effect of the MTHFR C677T polymorphism on NTDs. Methods: An electronic search of PubMed and Embase database for papers on the MTHFR C677T polymorphism and NTD risk was performed. All data were analysed with STATA (version 11). Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated to assess the association. Sensitivity analysis, test of heterogeneity, cumulative meta-analysis, and assessment of bias were performed in our meta-analysis. Results: A significant association between the MTHFR C677T polymorphism and NTD susceptibility was revealed in our meta-analysis (TT versus CC: OR = 2.022, 95% CI: 1.508, 2.712; CT+TT versus CC: OR = 1.303, 95% CI: 1.089, 1.558; TT versus CC+CT: OR = 1.716, 95% CI: 1.448, 2.033; 2TT+CT versus 2CC+CT: OR = 1.330, 95% CI: 1.160, 1.525). Moreover, an increased NTD risk was found after stratification of the MTHFR C677T variant data by ethnicity and source of controls. Conclusion: The results suggested the maternal MTHFR C677T polymorphism is a genetic risk factor for NTDs. Further functional studies to investigate folate-related gene polymorphisms, periconceptional multivitamin supplements, complex interactions, and the development of NTDs are warranted.	[Yan, Lifeng; Gu, Aihua] Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Yan, Lifeng; Gu, Aihua] Nanjing Med Univ, Sch Publ Hlth, Minist Educ, Key Lab Modern Toxicol, Nanjing, Jiangsu, Peoples R China; [Zhao, Lin; Zou, Peng; Zhao, Peng] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Long, Yan] China Pharmaceut Univ, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Ji, Guixiang] Nanjing Inst Environm Sci, Minist Environm Protect, Key Lab Pesticide Environm Assessment & Pollut Co, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; China Pharmaceutical University	Gu, AH (corresponding author), Nanjing Med Univ, Inst Toxicol, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	aihuagu@njmu.edu.cn; zhaopeng@njmu.edu.cn	Zhao, Peng/HDO-7507-2022		National Natural Science Foundation of China [81172694, 30901210]; Jiangsu Province's Natural Science Foundation [BK2009422]; Ministry of Education of China [20093234120001]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province's Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Ministry of Education of China(Ministry of Education, China); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work is supported by the National Natural Science Foundation of China (Grant No. 81172694 and 30901210); Jiangsu Province's Natural Science Foundation (Proj. no. BK2009422); Doctoral Fund of Ministry of Education of China (Grant No. 20093234120001); and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbour Laura, 2002, Int J Circumpolar Health, V61, P341; Boduroglu K, 1999, J CHILD NEUROL, V14, P159, DOI 10.1177/088307389901400305; Botto LD, 2000, AM J EPIDEMIOL, V151, P862; Botto LD, 1998, CLIN GENET, V53, P456; Candito M, 2008, AM J MED GENET A, V146A, P1128, DOI 10.1002/ajmg.a.32199; Ceyhan ST, 2008, INT J GYNECOL OBSTET, V101, P188, DOI 10.1016/j.ijgo.2007.10.006; Christensen B, 1999, AM J MED GENET, V84, P151, DOI 10.1002/(SICI)1096-8628(19990521)84:2<151::AID-AJMG12>3.3.CO;2-K; Dalal A, 2007, GYNECOL OBSTET INVES, V63, P146, DOI 10.1159/000096735; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; De Marco P, 2002, J HUM GENET, V47, P319, DOI 10.1007/s100380200043; de Villarreal LEM, 2001, ARCH MED RES, V32, P277, DOI 10.1016/S0188-4409(01)00292-2; Deb R, 2011, METAB BRAIN DIS, V26, P241, DOI 10.1007/s11011-011-9256-8; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Felix TM, 2004, BIRTH DEFECTS RES A, V70, P459, DOI 10.1002/bdra.20011; Godbole K, 2011, BIRTH DEFECTS RES A, V91, P848, DOI 10.1002/bdra.20841; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; Han D, 2012, MOL BIOL REP, V39, P805, DOI 10.1007/s11033-011-0802-6; Hosseini M, 2011, ARCH MED SCI, V7, P134, DOI 10.5114/aoms.2011.20618; Houcher B, 2009, PEDIATR NEUROSURG, V45, P472, DOI 10.1159/000283086; Kang SS, 1996, ATHEROSCLEROSIS, V119, P135, DOI 10.1016/0021-9150(95)05648-3; Koch MC, 1998, EUR J PEDIATR, V157, P487, DOI 10.1007/s004310050860; Lacasana M, 2012, PUBLIC HEALTH NUTR, P1, DOI DOI 10.1017/S1368980011003144; Li K, 2000, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V17, P76; Lucock M, 2000, MOL GENET METAB, V70, P27, DOI 10.1006/mgme.2000.2994; Ma J, 1999, CANCER EPIDEM BIOMAR, V8, P825; Ma J, 1997, CANCER RES, V57, P1098; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marini NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028408; Molloy AM, 1998, AM J MED GENET, V78, P155, DOI 10.1002/(SICI)1096-8628(19980630)78:2<155::AID-AJMG11>3.3.CO;2-Z; Molloy AM, 1997, LANCET, V349, P1591, DOI 10.1016/S0140-6736(96)12049-3; Morrison K, 1998, ANN HUM GENET, V62, P379, DOI 10.1046/j.1469-1809.1998.6250379.x; Munoz JB, 2007, MOL HUM REPROD, V13, P419, DOI 10.1093/molehr/gam017; Naushad SM, 2010, J PERINAT MED, V38, P63, DOI 10.1515/jpm.2009.119; O'Leary VB, 2005, AM J MED GENET A, V138A, P99, DOI 10.1002/ajmg.a.30846; Parle-McDermott A, 2003, J HUM GENET, V48, P190, DOI 10.1007/s10038-003-0008-4; Perez ABA, 2003, AM J MED GENET A, V119A, P20, DOI 10.1002/ajmg.a.10059; Rady PL, 2002, AM J MED GENET, V107, P162, DOI 10.1002/ajmg.10122; Relton CL, 2004, MOL GENET METAB, V81, P273, DOI 10.1016/j.ymgme.2003.12.010; Relton CL, 2004, J MED GENET, V41, P256, DOI 10.1136/jmg.2003.010694; Robien K, 2003, AM J EPIDEMIOL, V157, P571, DOI 10.1093/aje/kwg024; Rozen R, 1997, THROMB HAEMOSTASIS, V78, P523; Sameer AS, 2011, GENET MOL RES, V10, P1200, DOI 10.4238/vol10-2gmr1067; Shang YL, 2008, BIRTH DEFECTS RES A, V82, P3, DOI 10.1002/bdra.20416; Sharp L, 2004, AM J EPIDEMIOL, V159, P423, DOI 10.1093/aje/kwh066; Shields DC, 1999, AM J HUM GENET, V64, P1045, DOI 10.1086/302310; Speer MC, 1997, NEUROGENETICS, V1, P149, DOI 10.1007/s100480050022; Ubbink JB, 1999, METABOLISM, V48, P269, DOI 10.1016/S0026-0495(99)90046-X; Ueland PM, 2001, TRENDS PHARMACOL SCI, V22, P195, DOI 10.1016/S0165-6147(00)01675-8; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; van der Put NMJ, 2001, EXP BIOL MED, V226, P243, DOI 10.1177/153537020122600402; van der Put NMJ, 2000, EUR J OBSTET GYN R B, V92, P57, DOI 10.1016/S0301-2115(00)00426-7; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; vanderPut NMJ, 1996, J MOL MED, V74, P691, DOI 10.1007/s001090050073; Wang Fang, 2008, Zhonghua Liu Xing Bing Xue Za Zhi, V29, P771; Yu JM, 2000, HUM HERED, V50, P268, DOI 10.1159/000022929; Zeisel SH, 2009, AM J CLIN NUTR, V89, p673S, DOI 10.3945/ajcn.2008.26811D	57	53	57	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e41689	10.1371/journal.pone.0041689	http://dx.doi.org/10.1371/journal.pone.0041689			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056169	Green Published, Green Submitted, gold			2022-12-27	WOS:000309454000001
J	Bell, TG; Makondo, E; Martinson, NA; Kramvis, A				Bell, Trevor G.; Makondo, Euphodia; Martinson, Neil A.; Kramvis, Anna			Hepatitis B Virus Infection in Human Immunodeficiency Virus Infected Southern African Adults: Occult or Overt - That Is the Question	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RISK-FACTORS; POSITIVE PATIENTS; HIV; COINFECTION; PREVALENCE; HBV; EPIDEMIOLOGY; TRANSFUSION; GENOTYPES	Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) share transmission routes and are endemic in sub-Saharan Africa. The objective of the present study was to use the Taormina definition of occult HBV infection, together with stringent amplification conditions, to determine the prevalence and characteristics of HBV infection in antiretroviral treatment (ART)-naive HIV+ve adults in a rural cohort in South Africa. The presence of HBV serological markers was determined by enzyme linked immunoassay (ELISA) tests. HBV DNA-positivity was determined by polymerase chain reaction (PCR) of at least two of three different regions of the HBV genome. HBV viral loads were determined by real-time PCR. Liver fibrosis was determined using the aspartate aminotransferase-to-platelet ratio index. Of the 298 participants, 231 (77.5%) showed at least one HBV marker, with 53.7% HBV DNA(-ve) (resolved) and 23.8% HBV DNA(+ve) (current) [8.7% HBsAg(+ve) : 15.1% HBsAg(-ve)]. Only the total number of sexual partners distinguished HBV DNA(+ve) and HBV DNA(-ve) participants, implicating sexual transmission of HBV and/or HIV. It is plausible that sexual transmission of HBV and/or HIV may result in a new HBV infection, superinfection and re-activation as a consequence of immunesuppression. Three HBsAg(-ve) HBV DNA(+ve) participants had HBV viral loads <200 IU/ml and were therefore true occult HBV infections. The majority of HBsAg(-ve) HBV DNA(+ve) participants did not differ from HBsAg(+ve) HBV DNA(+ve) (overt) participants in terms of HBV viral loads, ALT levels or frequency of liver fibrosis. Close to a quarter of HIV+ve participants were HBV DNA(+ve), of which the majority were HBsAg(-ve) and were only detected using nucleic acid testing. Detection of HBsAg(-ve) HBV DNA(+ve) subjects is advisable considering they were clinically indistinguishable from HBsAg(+ve) HBV DNA(+ve) individuals and should not be overlooked, especially if lamivudine is included in the ART.	[Bell, Trevor G.; Makondo, Euphodia; Kramvis, Anna] Univ Witwatersrand, Dept Internal Med, Hepatitis Virus Divers Res Programme, Johannesburg, South Africa; [Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Martinson, Neil A.] Johns Hopkins Univ, Sch Med, Baltmore, MD USA	University of Witwatersrand; University of Witwatersrand; Johns Hopkins University	Kramvis, A (corresponding author), Univ Witwatersrand, Dept Internal Med, Hepatitis Virus Divers Res Programme, Johannesburg, South Africa.	Anna.Kramvis@wits.ac.za	Bell, Trevor Graham/B-7388-2016	Bell, Trevor Graham/0000-0003-2630-7513; Kramvis, Anna/0000-0001-6006-3765	South African Medical Research Council; National Research Foundation (NRF) [65530]; National Bioinformatics Network; Poliomyelitis Research Foundation (PRF); NRF	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation (NRF); National Bioinformatics Network; Poliomyelitis Research Foundation (PRF); NRF	This study was supported by grants received from the South African Medical Research Council and the National Research Foundation (NRF; GUN#65530) awarded to AK. TGB received bursaries from the National Bioinformatics Network, Poliomyelitis Research Foundation (PRF) and NRF. EM received a Belgium Technical Cooperation Fellowship and bursaries from the NRF and PRF. The funders had no role in study design, data collection and analysis, decision to publish.	Avettand-Fenoel V, 2006, J CLIN MICROBIOL, V44, P2250, DOI 10.1128/JCM.00234-06; Barth RE, 2011, J MED VIROL, V83, P929, DOI 10.1002/jmv.22026; Boyles TH, 2011, SAMJ S AFR MED J, V101, P470; Burnett RJ, 2007, INT J STD AIDS, V18, P152, DOI 10.1258/095646207780132523; Burnett RJ, 2005, LIVER INT, V25, P201, DOI 10.1111/j.1478-3231.2005.01054.x; Chu CM, 2012, CLIN INFECT DIS, V54, P88, DOI 10.1093/cid/cir755; Chun HM, 2012, J INFECT DIS, V205, P185, DOI 10.1093/infdis/jir720; Chung Raymond T, 2006, Top HIV Med, V14, P78; Firnhaber C, 2012, INT J INFECT DIS, V16, pE268, DOI 10.1016/j.ijid.2011.12.007; Firnhaber C, 2008, SAMJ S AFR MED J, V98, P541; Firnhaber C, 2009, INT J INFECT DIS, V13, P488, DOI 10.1016/j.ijid.2008.08.018; Gerlich WH, 2010, DIGEST DIS, V28, P116, DOI 10.1159/000282074; Gilson RJC, 1997, AIDS, V11, P597, DOI 10.1097/00002030-199705000-00007; Grinsztejn B, 2011, ANTIVIR THER, V16, P1057, DOI 10.3851/IMP1872; Hoffmann CJ, 2008, CLIN INFECT DIS, V47, P1479, DOI 10.1086/593104; Hollinger FB, 2008, TRANSFUSION, V48, P1001, DOI 10.1111/j.1537-2995.2008.01701.x; Iser DM, 2011, AIDS, V25, P197, DOI 10.1097/QAD.0b013e3283410ccb; Kew MC, 1996, GUT, V38, pS31, DOI 10.1136/gut.38.Suppl_2.S31; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Lebensztejn DM, 2005, HEPATOLOGY, V41, P1434, DOI 10.1002/hep.20736; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Lindh M, 1997, J INFECT DIS, V175, P1285, DOI 10.1086/516458; Lo Re V, 2007, JAIDS-J ACQ IMM DEF, V44, P315, DOI 10.1097/QAI.0b013e31802ea499; Lo Re V, 2007, JAIDS-J ACQ IMM DEF, V44, P344, DOI 10.1097/QAI.0b013e31802f12d3; Lukhwareni A, 2009, J MED VIROL, V81, P406, DOI 10.1002/jmv.21418; Makondo E, 2012, PLOSONE IN PRESS, DOI [10.1371/journal.pone.0046345, DOI 10.1371/JOURNAL.PONE.0046345]; Matthews GV, 2011, AIDS, V25, P1727, DOI 10.1097/QAD.0b013e328349bbf3; Mayaphi SH, 2012, SAMJ S AFR MED J, V102, P157, DOI 10.7196/SAMJ.4944; MELEGARI M, 1994, VIROLOGY, V199, P292, DOI 10.1006/viro.1994.1127; Mphahlele MJ, 2006, J CLIN VIROL, V35, P14, DOI 10.1016/j.jcv.2005.04.003; National Department of Health SA, 2004, NAT ANT TREATM GUID; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Shire NJ, 2004, JAIDS-J ACQ IMM DEF, V36, P869, DOI 10.1097/00126334-200407010-00015; Shisana O, 2009, S AFRICAN NATL HIV P; Soriano V, 2006, AIDS, V20, P451, DOI 10.1097/01.aids.0000200538.25103.3a; Stuart JWTC, 2009, J MED VIROL, V81, P441, DOI 10.1002/jmv.21422; Sun HY, 2010, J VIRAL HEPATITIS, V17, P578, DOI 10.1111/j.1365-2893.2009.01212.x; TAKAHASHI K, 1995, J GEN VIROL, V76, P3159, DOI 10.1099/0022-1317-76-12-3159; Tanaka Y, 2004, HEPATOLOGY, V40, P747, DOI 10.1002/hep.20365; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Thomas DL, 2006, HEPATOLOGY, V43, pS221, DOI 10.1002/hep.21033; Togashi H, 2008, J HEPATOL, V49, P17, DOI 10.1016/j.jhep.2008.03.019; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Vardas E, 1999, J MED VIROL, V58, P111, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;111::AID-JMV2&gt;3.0.CO;2-B; VENTO S, 1989, LANCET, V1, P332; Vermeulen M, 2012, TRANSFUSION, V52, P880, DOI 10.1111/j.1537-2995.2011.03355.x; Weinberger KM, 2000, J VIROL METHODS, V85, P75, DOI 10.1016/S0166-0934(99)00154-8	50	42	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45750	10.1371/journal.pone.0045750	http://dx.doi.org/10.1371/journal.pone.0045750			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049685	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388500012
J	Stanski, A; Hellwich, O				Stanski, Adam; Hellwich, Olaf			A Projection and Density Estimation Method for Knowledge Discovery	PLOS ONE			English	Article								A key ingredient to modern data analysis is probability density estimation. However, it is well known that the curse of dimensionality prevents a proper estimation of densities in high dimensions. The problem is typically circumvented by using a fixed set of assumptions about the data, e.g., by assuming partial independence of features, data on a manifold or a customized kernel. These fixed assumptions limit the applicability of a method. In this paper we propose a framework that uses a flexible set of assumptions instead. It allows to tailor a model to various problems by means of 1d-decompositions. The approach achieves a fast runtime and is not limited by the curse of dimensionality as all estimations are performed in 1d-space. The wide range of applications is demonstrated at two very different real world examples. The first is a data mining software that allows the fully automatic discovery of patterns. The software is publicly available for evaluation. As a second example an image segmentation method is realized. It achieves state of the art performance on a benchmark dataset although it uses only a fraction of the training data and very simple features.	[Stanski, Adam; Hellwich, Olaf] Tech Univ Berlin, Comp Vis & Remote Sensing Grp, Berlin, Germany	Technical University of Berlin	Stanski, A (corresponding author), Tech Univ Berlin, Comp Vis & Remote Sensing Grp, Franklinstr, Berlin, Germany.	stanski@mailbox.tu-berlin.de						Bellman R., 1961, ADAPTIVE CONTROL PRO; Bishop C. M., 2007, J ELECT IMAGING, V2nd, DOI 10.1117/1.2819119; Dollar P., 2006, P IEEE COMP SOC C CO, V2, P1964, DOI DOI 10.1109/CVPR.2006.298; Maire M, 2008, PROC CVPR IEEE, P611; Martin D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P416, DOI 10.1109/ICCV.2001.937655; Miller EG, 2003, PROC CVPR IEEE, P114; Pantofaru C, 2005, TECH REP; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Ren XF, 2008, LECT NOTES COMPUT SC, V5304, P533; Shi J, 2004, GRAPH BASED IMAGE SE; Silverman B.W., 1986, DENSITY ESTIMATION S; Vincent P, 2003, MANIFOLD PARZEN WIND	12	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e44495	10.1371/journal.pone.0044495	http://dx.doi.org/10.1371/journal.pone.0044495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049675	gold, Green Submitted, Green Published			2022-12-27	WOS:000309388500002
J	Zollner, AM; Abilez, OJ; Bol, M; Kuhl, E				Zoellner, Alexander M.; Abilez, Oscar J.; Boel, Markus; Kuhl, Ellen			Stretching Skeletal Muscle: Chronic Muscle Lengthening through Sarcomerogenesis	PLOS ONE			English	Article							SARCOMERE-LENGTH; CARDIAC GROWTH; FINITE GROWTH; GROWING SKIN; ADAPTATION; DISTRACTION; EXPANSION; STRESS; NUMBER; MODEL	Skeletal muscle responds to passive overstretch through sarcomerogenesis, the creation and serial deposition of new sarcomere units. Sarcomerogenesis is critical to muscle function: It gradually re-positions the muscle back into its optimal operating regime. Animal models of immobilization, limb lengthening, and tendon transfer have provided significant insight into muscle adaptation in vivo. Yet, to date, there is no mathematical model that allows us to predict how skeletal muscle adapts to mechanical stretch in silico. Here we propose a novel mechanistic model for chronic longitudinal muscle growth in response to passive mechanical stretch. We characterize growth through a single scalar-valued internal variable, the serial sarcomere number. Sarcomerogenesis, the evolution of this variable, is driven by the elastic mechanical stretch. To analyze realistic three-dimensional muscle geometries, we embed our model into a nonlinear finite element framework. In a chronic limb lengthening study with a muscle stretch of 1.14, the model predicts an acute sarcomere lengthening from 3.09 mu m to 3.51 mu m, and a chronic gradual return to the initial sarcomere length within two weeks. Compared to the experiment, the acute model error was 0.00% by design of the model; the chronic model error was 2.13%, which lies within the rage of the experimental standard deviation. Our model explains, from a mechanistic point of view, why gradual multi-step muscle lengthening is less invasive than single-step lengthening. It also explains regional variations in sarcomere length, shorter close to and longer away from the muscle-tendon interface. Once calibrated with a richer data set, our model may help surgeons to prevent muscle overstretch and make informed decisions about optimal stretch increments, stretch timing, and stretch amplitudes. We anticipate our study to open new avenues in orthopedic and reconstructive surgery and enhance treatment for patients with ill proportioned limbs, tendon lengthening, tendon transfer, tendon tear, and chronically retracted muscles.	[Zoellner, Alexander M.; Kuhl, Ellen] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Kuhl, Ellen] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Kuhl, Ellen] Stanford Univ, Dept Cardiothorac Surg, Stanford, CA 94305 USA; [Abilez, Oscar J.] Stanford Univ, Dept Surg, Stanford, CA 94305 USA; [Boel, Markus] TU Braunschweig, Dept Mech Engn, Braunschweig, Germany	Stanford University; Stanford University; Stanford University; Stanford University; Braunschweig University of Technology	Kuhl, E (corresponding author), Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA.	ekuhl@stanford.edu	Böl, Markus/P-8333-2019; Abilez, Oscar J./B-5014-2012; Kuhl, Ellen/G-4444-2011	Abilez, Oscar J./0000-0002-9991-400X; Kuhl, Ellen/0000-0002-6283-935X; Bol, Markus/0000-0003-1185-6309	National Science Foundation CAREER award [CMMI 0952021]; National Institutes of Health Grant [U54 GM072970]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM072970] Funding Source: NIH RePORTER	National Science Foundation CAREER award(National Science Foundation (NSF)); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation CAREER award CMMI 0952021 and National Institutes of Health Grant U54 GM072970. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi D, 2011, J MECH PHYS SOLIDS, V59, P863, DOI 10.1016/j.jmps.2010.12.011; Arnold AS, 2006, GAIT POSTURE, V23, P273, DOI 10.1016/j.gaitpost.2005.03.003; Arnold EM, 2011, PHILOS T R SOC B, V366, P1530, DOI 10.1098/rstb.2010.0345; BARNETT JG, 1980, AM J PHYSIOL, V239, pC39, DOI 10.1152/ajpcell.1980.239.1.C39; Bol M, 2012, INT J MULTISCALE COM, V10, P171, DOI 10.1615/IntJMultCompEng.2011002352; Bol M, 2011, COMPUT MECH, V47, P591, DOI 10.1007/s00466-010-0567-0; Bol M, 2009, COMPUT MECH, V43, P535, DOI 10.1007/s00466-008-0328-5; Bottinelli R, 2006, ADV MUSCLE RES, V2; Burkholder TJ, 2007, FRONT BIOSCI-LANDMRK, V12, P174, DOI 10.2741/2057; Burkholder TJ, 1998, J EXP BIOL, V201, P309; Caiozzo VJ, 2002, CLIN ORTHOP RELAT R, pS133, DOI 10.1097/blo.0000031971.69509.b3; Calvo B, 2010, J BIOMECH, V43, P318, DOI 10.1016/j.jbiomech.2009.08.032; Ehler E, 2008, SARCOMERE SKELETAL M; Epstein M, 2000, INT J PLASTICITY, V16, P951, DOI 10.1016/S0749-6419(99)00081-9; Garikipati K, 2009, APPL MECH REV, V62, DOI 10.1115/1.3090829; Gerber C, 2009, J SHOULDER ELB SURG, V18, P163, DOI 10.1016/j.jse.2008.09.003; Goktepe S, 2010, J MECH PHYS SOLIDS, V58, P1661, DOI 10.1016/j.jmps.2010.07.003; Goktepe S, 2010, J THEOR BIOL, V265, P433, DOI 10.1016/j.jtbi.2010.04.023; GOLDSPINK G, 1968, J CELL SCI, V3, P539; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Hayatsu K, 2001, J ORTHOPAED RES, V19, P897, DOI 10.1016/S0736-0266(01)00002-X; HERRING SW, 1984, MUSCLE NERVE, V7, P161, DOI 10.1002/mus.880070213; Himpel G, 2005, CMES-COMP MODEL ENG, V8, P119; HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0; Kerckhoffs RCP, 2012, MECH RES COMMUN, V42, P40, DOI 10.1016/j.mechrescom.2011.11.004; Klepach D, 2012, MECH RES COMMUN, V42, P134, DOI 10.1016/j.mechrescom.2012.03.005; Kober C, 2012, INT J MULTISCALE COM, V10, P131, DOI 10.1615/IntJMultCompEng.2011002392; Kuhl E, 2007, BIOMECH MODEL MECHAN, V6, P321, DOI 10.1007/s10237-006-0062-x; LEE EH, 1969, J APPL MECH, V36, P1, DOI 10.1115/1.3564580; Llewellyn ME, 2008, NATURE, V454, P784, DOI 10.1038/nature07104; Lubarda VA, 2002, INT J SOLIDS STRUCT, V39, P4627, DOI 10.1016/S0020-7683(02)00352-9; MATANO T, 1994, J ORTHOPAED RES, V12, P193, DOI 10.1002/jor.1100120207; Menzel A, 2005, BIOMECH MODEL MECHAN, V3, P147, DOI 10.1007/s10237-004-0047-6; Menzel A, 2012, MECH RES COMMUN, V42, P1, DOI 10.1016/j.mechrescom.2012.02.007; O'Sullivan K, 2012, BRIT J SPORT MED, V46, P838, DOI 10.1136/bjsports-2011-090835; Rausch MK, 2011, BIOMECH MODEL MECHAN, V10, P799, DOI 10.1007/s10237-010-0275-x; RODRIGUEZ EK, 1993, AM J PHYSIOL, V264, pH1048, DOI 10.1152/ajpheart.1993.264.4.H1048; RODRIGUEZ EK, 1994, J BIOMECH, V27, P455, DOI 10.1016/0021-9290(94)90021-3; Schmid H, 2012, COMPUT METHOD BIOMEC, V15, P547, DOI 10.1080/10255842.2010.548325; SPECTOR SA, 1982, EXP NEUROL, V76, P94, DOI 10.1016/0014-4886(82)90104-2; Taber L.A., 1995, APPL MECH REV, V48, P487, DOI [10.1115/1.3005109, DOI 10.1115/1.3005109]; Taylor RL., 2017, FEAP FINITE ELEMENT; Tepole AB, 2012, INT J NONLIN MECH, V47, P938, DOI 10.1016/j.ijnonlinmec.2011.07.006; Tepole AB, 2011, J MECH PHYS SOLIDS, V59, P2177, DOI 10.1016/j.jmps.2011.05.004; Tsamis A, 2012, J MECH BEHAV BIOMED, V8, P165, DOI 10.1016/j.jmbbm.2011.12.006; WILLIAMS PE, 1978, J ANAT, V127, P459; Zollner A, 2012, BIOMECH MODEL MECHAN, V11, P855, DOI 10.1007/s10237-011-0357-4; Zollner AM, 2012, J THEOR BIOL, V297, P166, DOI 10.1016/j.jtbi.2011.12.022; Zumstein MA, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-50	49	67	70	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45661	10.1371/journal.pone.0045661	http://dx.doi.org/10.1371/journal.pone.0045661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049683	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388500010
J	Gui, J; Yue, Y; Chen, RZ; Xu, W; Xiong, SD				Gui, Jun; Yue, Yan; Chen, Ruizhen; Xu, Wei; Xiong, Sidong			A20 (TNFAIP3) Alleviates CVB3-Induced Myocarditis via Inhibiting NF-kappa B Signaling	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; VIRAL MYOCARDITIS; VIRUS-INFECTION; ENZYME A20; COXSACKIEVIRUS; MICE; CARDIOMYOPATHY; INFLAMMATION; RESPONSES; CELLS	Background: Viral myocarditis, which is most prevalently caused by Coxsackievirus B3 (CVB3) infection, is a serious clinical condition characterized by cardiac inflammation. However, efficient therapies targeting inflammation are still lacking and much needed. A20, also known as tumor necrosis factor alpha induced protein 3 (TNFAIP3) is a key negative regulator of inflammation. But whether A20 may affect cardiac inflammation during acute viral myocarditis remains to be elucidated. The aim of this study was to investigate the potential protective effect of A20 on CVB3-induced myocarditis. Methodology/Principal Findings: Mice were intraperitoneally inoculated with CVB3 to establish acute viral myocarditis model. We found that the expression of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta, IL-6 and monocyte chemotactic protein-1 (MCP-1) were markedly and persistently increased during the progression of CVB3-induced myocarditis, and positively correlated with the disease severity. Notably, intravenous injection in vivo with adenovirus expressed A20 (Ad-A20) remarkably reduced CVB3-induced pro-inflammatory cytokines production and alleviated the severity of myocarditis. Further, we observed that nuclear factor-kappaB (NF-kappa B) signaling which mediates inflammatory response was significantly inhibited in CVB3-infected mice with Ad-A20 treatment. Finally, we revealed that A20 was required to inhibit CVB3-induced NF-kappa B signaling by restricting TNF receptor associated factor 6 (TRAF6) ubiquitylation. Conclusion/Significance: This study demonstrates the protective role of A20 against CVB3-induced myocarditis, which may provide a new therapeutic strategy for the treatment of viral myocarditis.	[Gui, Jun; Xiong, Sidong] Fudan Univ, Inst Immunobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Yue, Yan; Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Biol, Suzhou, Peoples R China; [Yue, Yan; Xu, Wei; Xiong, Sidong] Soochow Univ, Inst Med Sci, Suzhou, Peoples R China; [Chen, Ruizhen] Fudan Univ, Key Lab Viral Heart Dis, Shanghai Inst Cardiovasc Dis, Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University; Soochow University - China; Soochow University - China; Fudan University	Xiong, SD (corresponding author), Fudan Univ, Inst Immunobiol, Shanghai Med Coll, Shanghai 200433, Peoples R China.	sdxiongfd@126.com		Gui, Jun/0000-0002-8022-1203	National Natural Science Foundation of China [81072413, 31070786, 30890141]; Jiangsu "Pan-Deng" Project [BK2010004]; Major State Basic Research Development Program of China [2013CB530501]; Shanghai Science and Technology Commission [10JC1401400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu "Pan-Deng" Project; Major State Basic Research Development Program of China(National Basic Research Program of China); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants of National Natural Science Foundation of China (81072413, 31070786, 30890141), Jiangsu "Pan-Deng" Project (BK2010004), Major State Basic Research Development Program of China (2013CB530501), Shanghai Science and Technology Commission grant (10JC1401400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badorff C, 2000, CIRCULATION, V102, P2276; Bonci D, 2003, GENE THER, V10, P630, DOI 10.1038/sj.gt.3301936; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Calabrese F, 2003, CARDIOVASC RES, V60, P11, DOI 10.1016/S0008-6363(03)00475-9; Cook SA, 2003, CIRCULATION, V108, P664, DOI 10.1161/01.CIR.0000086978.95976.41; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Corsten MF, 2012, TRENDS MOL MED, V18, P426, DOI 10.1016/j.molmed.2012.05.005; Esfandiarei M, 2008, ANNU REV PATHOL-MECH, V3, P127, DOI 10.1146/annurev.pathmechdis.3.121806.151534; Esfandiarei M, 2007, CELL MICROBIOL, V9, P2358, DOI 10.1111/j.1462-5822.2007.00964.x; Fairweather D, 2007, METHODS, V41, P118, DOI 10.1016/j.ymeth.2006.07.009; Fan YH, 2011, VIROL J, V8, DOI [10.1186/1743-422X-8-492, 10.1186/1743-422X-8-17]; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Fuse K, 2005, CIRCULATION, V112, P2276, DOI 10.1161/CIRCULATIONAHA.105.536433; Garmaroudi FS, 2010, P NATL ACAD SCI USA, V107, P17053, DOI 10.1073/pnas.1006478107; Gay RT, 2006, P NATL ACAD SCI USA, V103, P13825, DOI 10.1073/pnas.0605507103; Grabie N, 2003, J CLIN INVEST, V111, P671, DOI 10.1172/JCI200316867; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; Grey ST, 1999, J EXP MED, V190, P1135, DOI 10.1084/jem.190.8.1135; Hah YS, 2010, ARTHRITIS RHEUM-US, V62, P2313, DOI 10.1002/art.27545; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Huber SA, 2006, CIRC RES, V99, P1109, DOI 10.1161/01.RES.0000249405.13536.49; Kang NI, 2009, J IMMUNOL, V183, P1488, DOI 10.4049/jimmunol.0900163; KLINGEL K, 1993, SCAND J INFECT DIS, P79; Kupfer R, 2002, J IMMUNOL METHODS, V266, P155, DOI 10.1016/S0022-1759(02)00146-1; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Leipner C, 2000, HERZ, V25, P245, DOI 10.1007/s000590050014; LEVINE B, 1990, NEW ENGL J MED, V323, P236, DOI 10.1056/NEJM199007263230405; Li HL, 2007, CIRCULATION, V115, P1885, DOI 10.1161/CIRCULATIONAHA.106.656835; Li K, 2009, CIRC RES, V105, P353, DOI 10.1161/CIRCRESAHA.109.195230; Lv K, 2011, CLIN IMMUNOL, V140, P92, DOI 10.1016/j.clim.2011.03.017; Maelfait J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002570; MATSUMORI A, 1994, BRIT HEART J, V72, P561; Matsumori A, 2004, EUR J HEART FAIL, V6, P137, DOI 10.1016/j.ejheart.2003.10.007; Onose A, 2006, EUR J PHARMACOL, V541, P198, DOI 10.1016/j.ejphar.2006.03.073; Pankuweit S, 2004, HERZ, V29, P788, DOI 10.1007/s00059-004-2626-9; Parvatiyar K, 2011, MICROBES INFECT, V13, P209, DOI 10.1016/j.micinf.2010.11.003; Schultz JC, 2009, MAYO CLIN PROC, V84, P1001, DOI [10.4065/84.11.1001, 10.1016/S0025-6196(11)60670-8]; Shen Y, 2004, J VIROL, V78, P12548, DOI 10.1128/JVI.78.22.12548-12556.2004; Song XT, 2008, NAT MED, V14, P258, DOI 10.1038/nm1721; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wolfrum S, 2007, P NATL ACAD SCI USA, V104, P18601, DOI 10.1073/pnas.0709011104; Yajima T, 2011, FUTURE MICROBIOL, V6, P551, DOI [10.2217/FMB.11.40, 10.2217/fmb.11.40]; YAMADA T, 1994, CIRCULATION, V89, P846, DOI 10.1161/01.CIR.89.2.846; Yue Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018186; Yue Y, 2011, MOL IMMUNOL, V48, P706, DOI 10.1016/j.molimm.2010.11.018	49	56	62	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46515	10.1371/journal.pone.0046515	http://dx.doi.org/10.1371/journal.pone.0046515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029542	gold, Green Submitted, Green Published			2022-12-27	WOS:000309973900179
J	van Gent, M; Bart, MJ; van der Heide, HGJ; Heuvelman, KJ; Mooi, FR				van Gent, Marjolein; Bart, Marieke J.; van der Heide, Han G. J.; Heuvelman, Kees J.; Mooi, Frits R.			Small Mutations in Bordetella pertussis Are Associated with Selective Sweeps	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; III SECRETION; VIRULENCE FACTORS; NEUTROPHIL RECRUITMENT; COMPARATIVE GENOMICS; PROTEIN PERTACTIN; TEMPORAL TRENDS; DISEASE BURDEN; GENE LOSS; VACCINE	Bordetella pertussis is the causative agent of pertussis, a highly contagious disease of the human respiratory tract. Despite high vaccination coverage, pertussis has resurged and has become one of the most prevalent vaccine-preventable diseases in developed countries. We have proposed that both waning immunity and pathogen adaptation have contributed to the persistence and resurgence of pertussis. Allelic variation has been found in virulence-associated genes coding for the pertussis toxin A subunit (ptxA), pertactin (prn), serotype 2 fimbriae (fim2), serotype 3 fimbriae (fim3) and the promoter for pertussis toxin (ptxP). In this study, we investigated how more than 60 years of vaccination has affected the Dutch B. pertussis population by combining data from phylogeny, genomics and temporal trends in strain frequencies. Our main focus was on the ptxA, prn, fim3 and ptxP genes. However, we also compared the genomes of 11 Dutch strains belonging to successful lineages. Our results showed that, between 1949 and 2010, the Dutch B. pertussis population has undergone as least four selective sweeps that were associated with small mutations in ptxA, prn, fim3 and ptxP. Phylogenetic analysis revealed a stepwise adaptation in which mutations accumulated clonally. Genomic analysis revealed a number of additional mutations which may have a contributed to the selective sweeps. Five large deletions were identified which were fixed in the pathogen population. However, only one was linked to a selective sweep. No evidence was found for a role of gene acquisition in pathogen adaptation. Our results suggest that the B. pertussis gene repertoire is already well adapted to its current niche and required only fine tuning to persist in the face of vaccination. Further, this work shows that small mutations, even single SNPs, can drive large changes in the populations of bacterial pathogens within a time span of six to 19 years.	[van Gent, Marjolein; Bart, Marieke J.; van der Heide, Han G. J.; Heuvelman, Kees J.; Mooi, Frits R.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Mooi, FR (corresponding author), Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, Ctr Infect Dis Control, NL-3720 BA Bilthoven, Netherlands.	frits.mooi@rivm.nl						Advani A, 2007, APMIS, V115, P736, DOI 10.1111/j.1600-0463.2007.apm_628.x; Advani A, 2011, VACCINE, V29, P3438, DOI 10.1016/j.vaccine.2011.02.070; Andreasen C, 2008, INFECT IMMUN, V76, P5139, DOI 10.1128/IAI.00895-08; Andreasen C, 2009, INFECT IMMUN, V77, P1182, DOI 10.1128/IAI.01150-08; Bart MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-627; Bedford T, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-220; Berbers GAM, 2009, HUM VACCINES, V5, P497, DOI 10.4161/hv.8112; Bottero D, 2007, CLIN VACCINE IMMUNOL, V14, P1490, DOI 10.1128/CVI.00177-07; Bouchez V, 2009, VACCINE, V27, P6034, DOI 10.1016/j.vaccine.2009.07.074; Bouchez V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002437; Carbonetti NH, 2003, INFECT IMMUN, V71, P6358, DOI 10.1128/IAI.71.11.6358-6366.2003; Carbonetti NH, 2007, INFECT IMMUN, V75, P1713, DOI 10.1128/IAI.01578-06; Cherry JD, 2005, PEDIATRICS, V115, P1422, DOI 10.1542/peds.2004-2648; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004; de Gouw D, 2011, FEMS MICROBIOL REV, V35, P441, DOI 10.1111/j.1574-6976.2010.00257.x; de Greeff SC, 2010, CLIN INFECT DIS, V50, P1339, DOI 10.1086/652281; de Greeff SC, 2008, PEDIATR INFECT DIS J, V27, P218, DOI 10.1097/INF.0b013e318161a2b9; Diavatopoulos DA, 2005, PLOS PATHOG, V1, P373, DOI 10.1371/journal.ooat.0010045; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Fry NK, 2001, INFECT IMMUN, V69, P5520, DOI 10.1128/IAI.69.9.5520-5528.2001; Gzyl A, 2004, VACCINE, V22, P2122, DOI 10.1016/j.vaccine.2003.12.006; Gzyl A, 2004, INT J EPIDEMIOL, V33, P358, DOI 10.1093/ije/dyh012; Hall-Baker Patsy A., 2011, Morbidity and Mortality Weekly Report, V58, P1; Hallander HO, 2009, APMIS, V117, P912, DOI 10.1111/j.1600-0463.2009.02554.x; Han HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017797; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; He QS, 2003, J INFECT DIS, V187, P1200, DOI 10.1086/368412; Heikkinen E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000904; Hijnen M, 2007, VACCINE, V25, P5902, DOI 10.1016/j.vaccine.2007.05.039; Hozbor D, 2009, J INFECTION, V59, P225, DOI 10.1016/j.jinf.2009.07.014; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Kallonen T, 2011, INFECT GENET EVOL; Kallonen T, 2009, EXPERT REV VACCINES, V8, P863, DOI [10.1586/erv.09.46, 10.1586/ERV.09.46]; Kerr JR, 1999, MICROB PATHOGENESIS, V27, P349, DOI 10.1006/mpat.1999.0307; King AJ, 2001, MICROBIOL-SGM, V147, P2885, DOI 10.1099/00221287-147-11-2885; King AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-64; King AJ, 2008, BMC GENOMICS, V9, P1, DOI 10.1186/1471-2164-9-311; Kirimanjeswara GS, 2005, J CLIN INVEST, V115, P3594, DOI 10.1172/JCI24609; Komatsu E, 2010, CLIN VACCINE IMMUNOL, V17, P807, DOI 10.1128/CVI.00449-09; Lam C, 2012, INFECT GENET EVOL; Lavine JS, 2011, P NATL ACAD SCI USA, V108, P7259, DOI 10.1073/pnas.1014394108; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lipsitch M, 2007, J R SOC INTERFACE, V4, P787, DOI 10.1098/rsif.2007.0229; Litt DJ, 2009, J CLIN MICROBIOL, V47, P680, DOI 10.1128/JCM.01838-08; Maharjan RP, 2008, RES MICROBIOL, V159, P602, DOI 10.1016/j.resmic.2008.08.004; Martcheva M, 2008, J R SOC INTERFACE, V5, P3, DOI 10.1098/rsif.2007.0236; Mascart F, 2007, VACCINE, V25, P391, DOI 10.1016/j.vaccine.2006.06.046; Mclntyre P, 2009, CURR OPIN INFECT DIS, V22, P215, DOI 10.1097/QCO.0b013e32832b3540; Moerman L, 2006, ISRAEL MED ASSOC J, V8, P308; Mooi FR, 1998, INFECT IMMUN, V66, P670, DOI 10.1128/IAI.66.2.670-675.1998; Mooi FR, 2001, EMERG INFECT DIS, V7, P526, DOI 10.3201/eid0707.017708; Mooi FR, 2010, INFECT GENET EVOL, V10, P36, DOI 10.1016/j.meegid.2009.10.007; Mooi FR, 2009, EMERG INFECT DIS, V15, P1206, DOI 10.3201/eid1508.081511; Octavia S, 2012, J INFECT DIS, V205, P1220, DOI 10.1093/infdis/jis178; Octavia S, 2011, MOL BIOL EVOL, V28, P707, DOI 10.1093/molbev/msq245; Otsuka N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031985; Panina EM, 2005, MOL MICROBIOL, V58, P267, DOI 10.1111/j.1365-2958.2005.04823.x; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pebody RG, 2005, EPIDEMIOL INFECT, V133, P159, DOI 10.1017/S0950268804003012; Petersen RF, 2012, EMERG INFEC IN PRESS; Rendi-Wagner P, 2010, VACCINE, V28, P3285, DOI 10.1016/j.vaccine.2010.02.104; Restif O, 2007, J R SOC INTERFACE, V4, P143, DOI 10.1098/rsif.2006.0167; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Spokes Paula J, 2010, N S W Public Health Bull, V21, P167, DOI 10.1071/NB10031; Stibitz S, 2007, BORDETELLA MOL MICRO, P47; Streefland M, 2007, VACCINE, V25, P2994, DOI 10.1016/j.vaccine.2007.01.015; Tsang RSW, 2004, J CLIN MICROBIOL, V42, P5364, DOI 10.1128/JCM.42.11.5364-5367.2004; van Amersfoorth SCM, 2005, J CLIN MICROBIOL, V43, P2837, DOI 10.1128/JCM.43.6.2837-2843.2005; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020340; van Gent M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018014; van Loo IHM, 1999, J INFECT DIS, V179, P915, DOI 10.1086/314690; van Loo IHM, 2002, J CLIN MICROBIOL, V40, P1994, DOI 10.1128/JCM.40.6.1994-2001.2002; Watanabe M, 2002, J HEALTH SCI, V48, P560, DOI 10.1248/jhs.48.560; WILLEMS R, 1990, EMBO J, V9, P2803, DOI 10.1002/j.1460-2075.1990.tb07468.x; Williamson P, 1996, FEMS IMMUNOL MED MIC, V13, P169, DOI 10.1016/0928-8244(95)00123-9; Yuk MH, 1998, MOL MICROBIOL, V28, P945, DOI 10.1046/j.1365-2958.1998.00850.x; Zhang SM, 2011, J BACTERIOL, V193, P4017, DOI 10.1128/JB.05184-11	78	63	63	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46407	10.1371/journal.pone.0046407	http://dx.doi.org/10.1371/journal.pone.0046407			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029513	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900155
J	Kagan, RM; Johnson, EP; Siaw, M; Biswas, P; Chapman, DS; Su, ZH; Platt, JL; Pesano, RL				Kagan, Ron M.; Johnson, Erik P.; Siaw, Martin; Biswas, Pinaki; Chapman, Douglass S.; Su, Zhaohui; Platt, Jamie L.; Pesano, Rick L.			A Genotypic Test for HIV-1 Tropism Combining Sanger Sequencing with Ultradeep Sequencing Predicts Virologic Response in Treatment-Experienced Patients	PLOS ONE			English	Article							TYPE-1 CORECEPTOR TROPISM; DISEASE PROGRESSION; ANTIRETROVIRAL THERAPY; ENHANCED SENSITIVITY; PHENOTYPIC ASSAY; CCR5 ANTAGONISTS; CELL TROPISM; V3 LOOP; MARAVIROC; USAGE	A tropism test is required prior to initiation of CCR5 antagonist therapy in HIV-1 infected individuals, as these agents are not effective in patients harboring CXCR4 (X4) coreceptor-using viral variants. We developed a clinical laboratory-based genotypic tropism test for detection of CCR5-using (R5) or X4 variants that utilizes triplicate population sequencing (TPS) followed by ultradeep sequencing (UDS) for samples classified as R5. Tropism was inferred using the bioinformatic algorithms geno2pheno([coreceptor]) and PSSMx4r5. Virologic response as a function of tropism readout was retrospectively assessed using blinded samples from treatment-experienced subjects who received maraviroc (N = 327) in the MOTIVATE and A4001029 clinical trials. MOTIVATE patients were classified as R5 and A4001029 patients were classified as non-R5 by the original Trofile test. Virologic response was compared between the R5 and non-R5 groups determined by TPS, UDS alone, the reflex strategy and the Trofile Enhanced Sensitivity (TF-ES) test. UDS had greater sensitivity than TPS to detect minority non-R5 variants. The median log(10) viral load change at week 8 was -2.4 for R5 subjects, regardless of the method used for classification; for subjects with non-R5 virus, median changes were -1.2 for TF-ES or the Reflex Test and -1.0 for UDS. The differences between R5 and non-R5 groups were highly significant in all 3 cases (p < 0.0001). At week 8, the positive predictive value was 66% for TF-ES and 65% for both the Reflex test and UDS. Negative predictive values were 59% for TF-ES, 58% for the Reflex Test and 61% for UDS. In conclusion, genotypic tropism testing using UDS alone or a reflex strategy separated maraviroc responders and non-responders as well as a sensitive phenotypic test, and both assays showed improved performance compared to TPS alone. Genotypic tropism tests may provide an alternative to phenotypic testing with similar discriminating ability.	[Kagan, Ron M.; Johnson, Erik P.; Siaw, Martin; Platt, Jamie L.; Pesano, Rick L.] Quest Diagnost Nichols Inst, Dept Infect Dis, San Juan Capistrano, CA USA; [Biswas, Pinaki] Pfizer, Collegeville, PA USA; [Chapman, Douglass S.] Pfizer, New York, NY USA; [Su, Zhaohui] Outcome Sci, Cambridge, MA USA	Nichols Institute; Pfizer; Pfizer	Kagan, RM (corresponding author), Quest Diagnost Nichols Inst, Dept Infect Dis, San Juan Capistrano, CA USA.	Ron.M.Kagan@questdiagnostics.com	Su, Zhaohui/HIK-0448-2022	Su, Zhaohui/0000-0003-2005-9504				Archer J, 2009, AIDS, V23, P1209, DOI 10.1097/QAD.0b013e32832b4399; Berger EA, 1998, NATURE, V391, P240, DOI 10.1038/34571; Buonaguro L, 2007, J VIROL, V81, P10209, DOI 10.1128/JVI.00872-07; Cho MW, 1998, J VIROL, V72, P2509, DOI 10.1128/JVI.72.3.2509-2515.1998; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Daar ES, 2007, CLIN INFECT DIS, V45, P643, DOI 10.1086/520650; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Goodenow MM, 2006, J LEUKOCYTE BIOL, V80, P965, DOI 10.1189/jlb.0306148; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Harrigan PR, 2011, AIDS, V25, P257, DOI 10.1097/QAD.0b013e32834113f9; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Irlbeck DM, 2008, AIDS, V22, P1425, DOI 10.1097/QAD.0b013e32830184ba; Jabara CB, 2011, P NATL ACAD SCI USA, V108, P20166, DOI 10.1073/pnas.1110064108; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Jensen Mark A., 2003, AIDS Reviews, V5, P104; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McGovern RA, 2010, J VISUALIZED EXPT JO; McGovern RA, 2010, AIDS, V24, P2512, DOI 10.1097/QAD.0b013e32833e6cfb; Nabatov AA, 2004, J VIROL, V78, P524, DOI 10.1128/JVI.78.1.524-530.2004; Poveda E, 2007, J MED VIROL, V79, P1040, DOI 10.1002/jmv.20900; Poveda E, 2009, J ANTIMICROB CHEMOTH, V63, P1006, DOI 10.1093/jac/dkp063; Prosperi MCF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-56; Ray N, 2006, CURR TOP MICROBIOL, V303, P97, DOI 10.1007/978-3-540-33397-5_5; Raymond S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-56; Raymond S, 2010, JAIDS-J ACQ IMM DEF, V53, P167, DOI 10.1097/QAI.0b013e3181c8413b; Raymond S, 2009, J CLIN MICROBIOL, V47, P2292, DOI 10.1128/JCM.02439-08; Recordon-Pinson P, 2010, ANTIMICROB AGENTS CH, V54, P3335, DOI 10.1128/AAC.00148-10; Reeves JD, 2009, J VIRAL ENTRY, V3, P94; SAAG M, 2008, 48 INT C ANT AG CHEM; Saag M, 2009, J INFECT DIS, V199, P1638, DOI 10.1086/598965; Seclen E, 2011, J CLIN MICROBIOL, V49, P3380, DOI 10.1128/JCM.00908-11; Seclen E, 2010, J ANTIMICROB CHEMOTH, V65, P1486, DOI 10.1093/jac/dkq137; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Sing T, 2007, ANTIVIR THER, V12, P1097; Su ZH, 2009, J INFECT DIS, V200, P1724, DOI 10.1086/648090; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Swenson LC, 2010, JAIDS-J ACQ IMM DEF, V54, P506, DOI 10.1097/QAI.0b013e3181d0558f; Thielen A, 2012, INTERVIROLOGY, V55, P113, DOI 10.1159/000332002; Tsibris AMN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005683; Vandekerckhove LPR, 2011, LANCET INFECT DIS, V11, P394, DOI 10.1016/S1473-3099(10)70319-4; Vandenbroucke Ina, 2008, Open Virol J, V2, P8, DOI 10.2174/1874357900802010008; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Weiser B, 2008, AIDS, V22, P469, DOI 10.1097/QAD.0b013e3282f4196c; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; Wilkin TJ, 2011, CLIN INFECT DIS, V52, P925, DOI 10.1093/cid/cir072	52	46	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46334	10.1371/journal.pone.0046334	http://dx.doi.org/10.1371/journal.pone.0046334			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029482	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517500090
J	Bouzas-Mosquera, A; Broullon, FJ; Alvarez-Garcia, N; Peteiro, J; Mosquera, VX; Castro-Beiras, A				Bouzas-Mosquera, Alberto; Broullon, Francisco J.; Alvarez-Garcia, Nemesio; Peteiro, Jesus; Mosquera, Victor X.; Castro-Beiras, Alfonso			Association of Left Ventricular Mass with All-Cause Mortality, Myocardial Infarction and Stroke	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ECHOCARDIOGRAPHIC-ASSESSMENT; PROGNOSTIC-SIGNIFICANCE; ESSENTIAL-HYPERTENSION; ELDERLY COHORT; HEART-DISEASE; SUDDEN-DEATH; HYPERTROPHY; RECOMMENDATIONS; SURVIVAL	Background: Our aim was to assess the association of left ventricular mass with mortality and nonfatal cardiovascular events. Methodology/Principal Findings: Left ventricular mass was measured by echocardiography in 40138 adult patients (mean age 61.1+/-16.4 years, 52.5% male). The primary endpoint was all-cause mortality. Secondary endpoints included nonfatal myocardial infarction and nonfatal stroke. During a mean follow-up period of 5.6+/-3.9 years, 9181 patients died, 901 patients had a nonfatal myocardial infarction, and 2139 patients had a nonfatal stroke. Cumulative 10-year mortality was 26.8%, 31.9%, 37.4% and 46.4% in patients with normal, mildly, moderately and severely increased left ventricular mass, respectively (p < 0.001). Ten-year rates of nonfatal myocardial infarction and stroke ranged from 3.2% and 6.7% in patients with normal left ventricular mass to 5.3% and 12.7% in those with severe increase in left ventricular mass, respectively. After multivariate adjustment, left ventricular mass remained an independent predictor of all-cause mortality (hazard ratio [HR] per 100 g increase 1.21, 95% confidence interval [CI] 1.14-1-27, p < 0.001 in women, and HR 1.09, 95% CI 1.04-1-13, p < 0.001 in men), myocardial infarction (HR 1.60, 95% CI 1.31-1.94, p < 0.001 in women and HR 1.15, 95% CI 1.02-1.29, p = 0.019 in men) and stroke (HR 1.26, 95% CI 1.13-1.40, p < 0.001 in women and HR 1.19, 95% CI 1.09-1.30, p < 0.001 in men). Conclusions/Significance: Left ventricular mass has a graded and independent association with all-cause mortality, myocardial infarction and stroke.	[Bouzas-Mosquera, Alberto; Alvarez-Garcia, Nemesio; Peteiro, Jesus; Castro-Beiras, Alfonso] Hosp Univ A Coruna, Dept Cardiol, La Coruna, Spain; [Bouzas-Mosquera, Alberto; Peteiro, Jesus; Castro-Beiras, Alfonso] Inst Salud Carlos III, Spanish Cooperat Cardiovasc Dis Res Network RECAV, Madrid, Spain; [Broullon, Francisco J.] Hosp Univ A Coruna, Dept Informat Technol, La Coruna, Spain; [Mosquera, Victor X.] Hosp Univ A Coruna, Dept Cardiac Surg, La Coruna, Spain	Complejo Hospitalario Universitario A Coruna; Instituto de Salud Carlos III; Complejo Hospitalario Universitario A Coruna; Complejo Hospitalario Universitario A Coruna	Bouzas-Mosquera, A (corresponding author), Hosp Univ A Coruna, Dept Cardiol, La Coruna, Spain.	alberto.bouzas.mosquera@sergas.es	Molanes, Francisco Javier Broullon/AAD-7490-2020; Bouzas-Mosquera, Alberto/S-3919-2018	Bouzas-Mosquera, Alberto/0000-0002-2741-732X				Alfakih K, 2004, EUR J RADIOL, V52, P103, DOI 10.1016/j.ejrad.2003.09.015; Baumgartner H, 2009, J AM SOC ECHOCARDIOG, V22, P1, DOI 10.1016/j.echo.2008.11.029; BIKKINA M, 1994, JAMA-J AM MED ASSOC, V272, P33, DOI 10.1001/jama.272.1.33; BOLOGNESE L, 1994, AM J CARDIOL, V73, P1, DOI 10.1016/0002-9149(94)90717-X; Devereux RB, 2004, JAMA-J AM MED ASSOC, V292, P2350, DOI 10.1001/jama.292.19.2350; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; East MA, 2003, J AM COLL CARDIOL, V41, P949, DOI 10.1016/S0735-1097(02)03006-1; Fagard RH, 2009, HYPERTENSION, V54, P1084, DOI 10.1161/HYPERTENSIONAHA.109.136655; Haider AW, 1998, J AM COLL CARDIOL, V32, P1454, DOI 10.1016/S0735-1097(98)00407-0; HOUGHTON JL, 1990, J AM COLL CARDIOL, V15, P43, DOI 10.1016/0735-1097(90)90173-M; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; LEVY D, 1989, ANN INTERN MED, V110, P101, DOI 10.7326/0003-4819-110-2-101; LIAO YL, 1995, JAMA-J AM MED ASSOC, V273, P1592, DOI 10.1001/jama.273.20.1592; LIAO YL, 1995, CIRCULATION, V92, P805, DOI 10.1161/01.CIR.92.4.805; PARFREY PS, 1990, NEPHRON, V55, P114, DOI 10.1159/000185937; Rodriguez CJ, 2006, HYPERTENSION, V48, P87, DOI 10.1161/01.HYP.0000223330.03088.58; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Swamy Rajiv S, 2010, Curr Cardiol Rep, V12, P277, DOI 10.1007/s11886-010-0104-y; Turakhia MP, 2008, AM J CARDIOL, V102, P1131, DOI 10.1016/j.amjcard.2008.06.036; Verdecchia P, 1998, J AM COLL CARDIOL, V31, P383, DOI 10.1016/S0735-1097(97)00493-2; Wolk R, 2000, EUROPACE, V2, P216, DOI 10.1053/eupc.2000.0110; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	25	40	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45570	10.1371/journal.pone.0045570	http://dx.doi.org/10.1371/journal.pone.0045570			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049815	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300033
J	Iranzo, J; Floria, LM; Moreno, Y; Sanchez, A				Iranzo, Jaime; Floria, Luis M.; Moreno, Yamir; Sanchez, Angel			Empathy Emerges Spontaneously in the Ultimatum Game: Small Groups and Networks	PLOS ONE			English	Article							EVOLUTION; BEHAVIOR; ALTRUISM	The Ultimatum game, in which one subject proposes how to share a pot and the other has veto power on the proposal, in which case both lose everything, is a paradigmatic scenario to probe the degree of cooperation and altruism in human subjects. It has been shown that if individuals are empathic, i.e., they play the game having in mind how their opponent will react by offering an amount that they themselves would accept, then non-rational large offers well above the smallest possible ones are evolutionarily selected. We here show that empathy itself may be selected and need not be exogenously imposed provided that interactions take place only with a fraction of the total population, and that the role of proposer or responder is randomly changed from round to round. These empathic agents, that displace agents with independent (uncorrelated) offers and proposals, behave far from what is expected rationally, offering and accepting sizable fractions of the amount to be shared. Specific values for the typical offer depend on the details of the interacion network and on the existence of hubs, but they are almost always significantly larger than zero, indicating that the mechanism at work here is quite general and could explain the emergence of empathy in very many different contexts.	[Iranzo, Jaime] CSIC, INTA, Ctr Astrobiol, Torrejon De Ardoz, Spain; [Iranzo, Jaime; Floria, Luis M.; Moreno, Yamir; Sanchez, Angel] Univ Zaragoza, Inst Biocomp & Fs Sistemas Complejos, Zaragoza, Spain; [Floria, Luis M.] Univ Zaragoza, Dept Fs Mat Condensada, Zaragoza, Spain; [Moreno, Yamir] Univ Zaragoza, Dept Fs Teor, Zaragoza, Spain; [Sanchez, Angel] Univ Carlos III Madrid, GISC, Leganes, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of Zaragoza; University of Zaragoza; University of Zaragoza; Universidad Carlos III de Madrid	Iranzo, J (corresponding author), CSIC, INTA, Ctr Astrobiol, Torrejon De Ardoz, Spain.	iranzosj@cab.inta-csic.es	Iranzo, Jaime/H-5197-2011; Sánchez, Angel/A-9229-2008; Floria, Luis Mario/L-7261-2014; Moreno, Yamir/A-1076-2009	Iranzo, Jaime/0000-0002-4538-7726; Sánchez, Angel/0000-0003-1874-2881; Floria, Luis Mario/0000-0002-1406-8810; Moreno, Yamir/0000-0002-0895-1893	Comunidad de Madrid (Spain); grant MODELICOCM (Comunidad de Madrid, Spain); MICINN, Spain [FIS2011-27569]; MICINN [FIS2011-25167]; Comunidad de Arag'on; MICINN (Ministerio de Ciencia e Innovaci'on) [FIS2011-25167, FIS2008-01240, FIS2009-13364-C02-01]; FET-Open project DYNANETS [233847]; European Commission; Comunidad de Arag'on (Spain) [FMI22/10]; MOSAICO; PRODIEVO; Complexity-NET RESINEE (Ministerio de Ciencia e Innovaci'on, Spain); MODELICO-CM (Comunidad de Madrid, Spain)	Comunidad de Madrid (Spain)(Comunidad de Madrid); grant MODELICOCM (Comunidad de Madrid, Spain); MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Comunidad de Arag'on(Comunidad de Madrid); MICINN (Ministerio de Ciencia e Innovaci'on)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FET-Open project DYNANETS; European Commission(European CommissionEuropean Commission Joint Research Centre); Comunidad de Arag'on (Spain)(Comunidad de Madrid); MOSAICO; PRODIEVO; Complexity-NET RESINEE (Ministerio de Ciencia e Innovaci'on, Spain); MODELICO-CM (Comunidad de Madrid, Spain)(Comunidad de Madrid)	JI was supported by a research contract of the Comunidad de Madrid (Spain), grant MODELICOCM (Comunidad de Madrid, Spain) and project FIS2011-27569 (MICINN, Spain). LMF is grateful to FIS2011-25167 from MICINN and to Comunidad de Arag'on. YM was partially supported by Spanish MICINN (Ministerio de Ciencia e Innovaci'on) projects FIS2008-01240, FIS2009-13364-C02-01, and FIS2011-25167, by the FET-Open project DYNANETS (grant no. 233847) funded by the European Commission, and by Comunidad de Arag'on (Spain) through the project FMI22/10. AS acknowledges grants MOSAICO, PRODIEVO and Complexity-NET RESINEE (Ministerio de Ciencia e Innovaci'on, Spain) and MODELICO-CM (Comunidad de Madrid, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boguna M, 2004, EUR PHYS J B, V38, P205, DOI 10.1140/epjb/e2004-00038-8; Bowles S, 2011, COOPERATIVE SPECIES: HUMAN RECIPROCITY AND ITS EVOLUTION, P1; Burnham TC, 2007, P ROY SOC B-BIOL SCI, V274, P2327, DOI 10.1098/rspb.2007.0546; Camerer C, 2003, BEHAV GAME THEORY; Cartwright J, 2000, EVOLUTION HUMAN BEHA; Cohen MD, 2001, RATION SOC, V13, P5, DOI 10.1177/104346301013001001; Eguiluz VM, 2009, ADV COMPLEX SYST, V12, P221, DOI 10.1142/S0219525909002179; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Gintis H, 2003, J THEOR BIOL, V220, P407, DOI 10.1006/jtbi.2003.3104; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hammerstein P., 2003, GENETIC CULTURAL EVO; HELBING D, 1992, PHYSICA A, V181, P29, DOI 10.1016/0378-4371(92)90195-V; Henrich J., 2005, FDN HUMAN SOCIALITY; Iranzo J, 2011, J THEOR BIOL, V278, P1, DOI 10.1016/j.jtbi.2011.02.020; Kagel JH, 1995, HDB EXPT EC; Killingback T, 2001, P ROY SOC B-BIOL SCI, V268, P1797, DOI 10.1098/rspb.2001.1697; Kuperman MN, 2008, EUR PHYS J B, V62, P233, DOI 10.1140/epjb/e2008-00133-x; Marlowe FW, 2008, P R SOC B, V275, P587, DOI 10.1098/rspb.2007.1517; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Oosterbeek H, 2004, EXP ECON, V7, P171, DOI 10.1023/B:EXEC.0000026978.14316.74; Page KM, 2000, P ROY SOC B-BIOL SCI, V267, P2177, DOI 10.1098/rspb.2000.1266; Page KM, 2002, B MATH BIOL, V64, P1101, DOI 10.1006/bulm.2002.0321; Page KM, 2001, J THEOR BIOL, V209, P173, DOI 10.1006/jtbi.2000.2251; Page KM, 2000, SPATIAL ULTIMATUM GA, P1116; Sanchez A, 2005, J THEOR BIOL, V235, P233, DOI 10.1016/j.jtbi.2005.01.006; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; Seymour RM, 2000, J MATH SOCIOL, V24, P193, DOI 10.1080/0022250X.2000.9990236; Sigmund K., 2010, CALCULUS SELFISHNESS; Sinatra R, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/09/P09012; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Van Schaik CP, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P3; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104; Wilson E.O., 1975, P1	35	23	23	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e43781	10.1371/journal.pone.0043781	http://dx.doi.org/10.1371/journal.pone.0043781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049740	Green Submitted, gold, Green Published			2022-12-27	WOS:000309517300007
J	Shibistova, O; Yohannes, Y; Boy, J; Richter, A; Wild, B; Watzka, M; Guggenberger, G				Shibistova, Olga; Yohannes, Yonas; Boy, Jens; Richter, Andreas; Wild, Birgit; Watzka, Margarethe; Guggenberger, Georg			Rate of Belowground Carbon Allocation Differs with Successional Habit of Two Afromontane Trees	PLOS ONE			English	Article							HIGH TEMPORAL RESOLUTION; ISOTOPE COMPOSITION; GAS-EXCHANGE; PHYSIOLOGICAL ECOLOGY; ORGANIC-COMPOUNDS; SOIL RESPIRATION; FAGUS-SYLVATICA; WATER RELATIONS; EUROPEAN BEECH; FOREST	Background: Anthropogenic disturbance of old-growth tropical forests increases the abundance of early successional tree species at the cost of late successional ones. Quantifying differences in terms of carbon allocation and the proportion of recently fixed carbon in soil CO2 efflux is crucial for addressing the carbon footprint of creeping degradation. Methodology: We compared the carbon allocation pattern of the late successional gymnosperm Podocarpus falcatus (Thunb.) Mirb. and the early successional (gap filling) angiosperm Croton macrostachyus Hochst. es Del. in an Ethiopian Afromontane forest by whole tree (CO2)-C-13 pulse labeling. Over a one-year period we monitored the temporal resolution of the label in the foliage, the phloem sap, the arbuscular mycorrhiza, and in soil-derived CO2. Further, we quantified the overall losses of assimilated C-13 with soil CO2 efflux. Principal Findings: C-13 in leaves of C. macrostachyus declined more rapidly with a larger size of a fast pool (64% vs. 50% of the assimilated carbon), having a shorter mean residence time (14 h vs. 55 h) as in leaves of P. falcatus. Phloem sap velocity was about 4 times higher for C. macrostachyus. Likewise, the label appeared earlier in the arbuscular mycorrhiza of C. macrostachyus and in the soil CO2 efflux as in case of P. falcatus (24 h vs. 72 h). Within one year soil CO2 efflux amounted to a loss of 32% of assimilated carbon for the gap filling tree and to 15% for the late successional one. Conclusions: Our results showed clear differences in carbon allocation patterns between tree species, although we caution that this experiment was unreplicated. A shift in tree species composition of tropical montane forests (e. g., by degradation) accelerates carbon allocation belowground and increases respiratory carbon losses by the autotrophic community. If ongoing disturbance keeps early successional species in dominance, the larger allocation to fast cycling compartments may deplete soil organic carbon in the long run.	[Shibistova, Olga; Yohannes, Yonas; Boy, Jens; Guggenberger, Georg] Leibniz Univ Hannover, Inst Soil Sci, Hannover, Germany; [Shibistova, Olga] Russian Acad Sci, Siberian Branch, VN Sukachev Inst Forest, Krasnoyarsk, Russia; [Yohannes, Yonas] Ethiopian Inst Agr Res, Addis Ababa, Ethiopia; [Richter, Andreas; Wild, Birgit; Watzka, Margarethe] Univ Vienna, Dept Chem Ecol & Ecosyst Res, Vienna, Austria	Leibniz University Hannover; Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Sukachev Institute of Forest, Siberian Branch, Russian Academy of Sciences; Ethiopian Institute of Agricultural Research (EIAR); University of Vienna	Shibistova, O (corresponding author), Leibniz Univ Hannover, Inst Soil Sci, Hannover, Germany.	olgas@ksc.krasn.ru	Richter, Andreas/D-8483-2012; Watzka, Margarete/C-3843-2014; Guggenberger, Georg/C-8423-2013; Boy, Jens/B-2926-2018; Wild, Birgit/E-6476-2012; Shibistova, Olga/AAP-1594-2020	Richter, Andreas/0000-0003-3282-4808; Watzka, Margarete/0000-0003-0334-1823; Guggenberger, Georg/0000-0002-6962-8264; Boy, Jens/0000-0002-2751-957X; Wild, Birgit/0000-0002-9611-0815; 	German Research Foundation [DFG Gu 406/19-1]	German Research Foundation(German Research Foundation (DFG))	Financial support was given by the German Research Foundation (to G. G., DFG Gu 406/19-1). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate A, 2004, THESIS U BAYREUTH; AERTS R, 1995, TRENDS ECOL EVOL, V10, P402, DOI 10.1016/S0169-5347(00)89156-9; Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; Andrews JA, 1999, SOIL SCI SOC AM J, V63, P1429, DOI 10.2136/sssaj1999.6351429x; [Anonymous], 2013, MEASUREMENTS TERREST; Ashagrie Y, 2007, SOIL TILL RES, V94, P101, DOI 10.1016/j.still.2006.07.005; Bahn M, 2009, NEW PHYTOL, V182, P451, DOI 10.1111/j.1469-8137.2008.02755.x; Barthel M, 2011, NEW PHYTOL, V192, P925, DOI 10.1111/j.1469-8137.2011.03848.x; BAZZAZ FA, 1979, ANNU REV ECOL SYST, V10, P351, DOI 10.1146/annurev.es.10.110179.002031; Bekele T., 1999, FOREST GENETIC RESOU, P39; Bombelli A, 2009, BIOGEOSCIENCES, V6, P2193, DOI 10.5194/bg-6-2193-2009; Brodribb TJ, 2007, PLANT PHYSIOL, V144, P1890, DOI 10.1104/pp.107.101352; BRUGGEMANN N, 2011, BIOGEOSCIENCES, V8, P3457, DOI DOI 10.5194/bg-8-3457-2011; Canadell JG, 2009, BIOGEOSCIENCES, V6, P463, DOI 10.5194/bg-6-463-2009; Carbone MS, 2007, GLOBAL CHANGE BIOL, V13, P466, DOI 10.1111/j.1365-2486.2006.01300.x; Cernusak Lucas A., 2011, Smithsonian Contributions to Botany, P189; Chambers JQ, 2001, NATURE, V410, P429, DOI 10.1038/35068624; Ciais P, 2011, PHILOS T R SOC A, V369, P2038, DOI 10.1098/rsta.2010.0328; Ciais P, 2009, BIOGEOSCIENCES, V6, P1935, DOI 10.5194/bg-6-1935-2009; Coomes David A., 2011, Smithsonian Contributions to Botany, P119; Dannoura M, 2011, NEW PHYTOL, V190, P181, DOI 10.1111/j.1469-8137.2010.03599.x; DOUDS DD, 1988, PLANT PHYSIOL, V86, P491, DOI 10.1104/pp.86.2.491; Ehleringer J.R., 1991, CARBON ISOTOPE TECHN, P187; Eissenstat DM., 2002, PLANT ROOTS HIDDEN H, V3, P221, DOI DOI 10.1201/9780203909423; Epron D, 2011, BIOGEOSCIENCES, V8, P1153, DOI 10.5194/bg-8-1153-2011; Epron D, 2012, TREE PHYSIOL, V32, P776, DOI 10.1093/treephys/tps057; *FAO ISRIC, 1998, WORLD REF BAS SOIL R; Fetene M, 2004, TREES-STRUCT FUNCT, V18, P428, DOI 10.1007/s00468-004-0321-3; Friies I., 1992, FORESTS FOREST TREES; Fritzsche F, 2007, CATENA, V70, P209, DOI 10.1016/j.catena.2006.09.005; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; GAMALEI Y, 1991, TREES-STRUCT FUNCT, V5, P50, DOI 10.1007/BF00225335; Gessler A, 2004, PLANT BIOLOGY, V6, P721, DOI 10.1055/s-2004-830350; Gifford RM, 2003, FUNCT PLANT BIOL, V30, P171, DOI 10.1071/FP02083; Gill RA, 2000, NEW PHYTOL, V147, P13, DOI 10.1046/j.1469-8137.2000.00681.x; Gindaba J, 2004, BIOL FERT SOILS, V40, P393, DOI 10.1007/s00374-004-0767-x; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hogberg MN, 2010, NEW PHYTOL, V187, P485, DOI 10.1111/j.1469-8137.2010.03274.x; Hogberg P, 2008, NEW PHYTOL, V177, P220, DOI 10.1111/j.1469-8137.2007.02238.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hogberg P, 2006, TRENDS ECOL EVOL, V21, P548, DOI 10.1016/j.tree.2006.06.004; HORWATH WR, 1994, TREE PHYSIOL, V14, P1163, DOI 10.1093/treephys/14.10.1163; Hughes JK, 2008, TRENDS PLANT SCI, V13, P583, DOI 10.1016/j.tplants.2008.08.010; KEELING CD, 1958, GEOCHIM COSMOCHIM AC, V13, P322, DOI 10.1016/0016-7037(58)90033-4; Keitel C, 2003, PLANT CELL ENVIRON, V26, P1157, DOI 10.1046/j.1365-3040.2003.01040.x; KOZLOWSKI TT, 1992, BOT REV, V58, P107, DOI 10.1007/BF02858600; Kuptz D, 2011, NEW PHYTOL, V191, P160, DOI 10.1111/j.1469-8137.2011.03676.x; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Langley JA, 2005, PLANT SOIL, V277, P335, DOI 10.1007/s11104-005-7932-3; LARCHER W, 1969, PHOTOSYNTHETICA, V3, P167; Lemenih M, 2004, GEODERMA, V123, P177, DOI 10.1016/j.geoderma.2004.02.004; Leuschner Christoph, 2006, Ecotropica (Bonn), V12, P151; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Lusk CH, 2003, NEW PHYTOL, V160, P329, DOI 10.1046/j.1469-8137.2003.00879.x; Lusk Christopher H., 2011, Smithsonian Contributions to Botany, P157; Luttge U, 2003, TREES-STRUCT FUNCT, V17, P40, DOI 10.1007/s00468-002-0201-7; MORDACQ L, 1986, PLANT CELL ENVIRON, V9, P735, DOI 10.1111/j.1365-3040.1986.tb02106.x; Negash L, 1995, INDIGENOUS TREES ETH; Olsson PA, 1999, FEMS MICROBIOL ECOL, V29, P303, DOI 10.1111/j.1574-6941.1999.tb00621.x; Phillips RP, 2006, ECOLOGY, V87, P1302, DOI 10.1890/0012-9658(2006)87[1302:TSAMAI]2.0.CO;2; Plain C, 2009, TREE PHYSIOL, V29, P1433, DOI 10.1093/treephys/tpp072; Poorter Hendrik, 1997, P39, DOI 10.1016/B978-012083490-7/50003-7; Pretzsch H, 2008, ANN BOT-LONDON, V101, P1065, DOI 10.1093/aob/mcm246; Pumpanen JS, 2009, TREES-STRUCT FUNCT, V23, P611, DOI 10.1007/s00468-008-0306-8; Ruehr NK, 2009, NEW PHYTOL, V184, P950, DOI 10.1111/j.1469-8137.2009.03044.x; RUNNING SW, 1988, ECOL MODEL, V42, P125, DOI 10.1016/0304-3800(88)90112-3; Ryan MG, 2005, BIOGEOCHEMISTRY, V73, P3, DOI 10.1007/s10533-004-5167-7; Schulze ED, 2006, BIOGEOSCIENCES, V3, P147, DOI 10.5194/bg-3-147-2006; Seyoum Y, 2012, TREES-STRUCT FUNCT, V26, P1495, DOI 10.1007/s00468-012-0723-6; Simard SW, 1997, PLANT SOIL, V191, P41, DOI 10.1023/A:1004205727882; Stephens BB, 2007, SCIENCE, V316, P1732, DOI 10.1126/science.1137004; Strobl S, 2011, TREES-STRUCT FUNCT, V25, P769, DOI 10.1007/s00468-011-0554-x; SVEJCAR TJ, 1990, AGRON J, V82, P18, DOI 10.2134/agronj1990.00021962008200010004x; Tamrat B., 1993, ACTA PHYTOGEOGRAPHIC, V79, P1; Teketay D, 1997, ACTA OECOL, V18, P557, DOI 10.1016/S1146-609X(97)80041-0; Tesfaye G, 2002, FLORA, V197, P461, DOI 10.1078/0367-2530-1210063; Tesfaye G, 2010, FLORA, V205, P135, DOI 10.1016/j.flora.2008.12.006; Tohjima Y, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011734; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; Valentine AJ, 2007, MYCORRHIZA, V17, P137, DOI 10.1007/s00572-006-0093-2; WHITMORE TC, 1989, ECOLOGY, V70, P536, DOI 10.2307/1940195; Wild B, 2010, J EXP BOT, V61, P1375, DOI 10.1093/jxb/erq006; Williams Christopher A, 2007, Carbon Balance Manag, V2, P3, DOI 10.1186/1750-0680-2-3; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wubet T, 2009, MYCOL PROG, V8, P317, DOI 10.1007/s11557-009-0602-8; Yohannes Y, 2011, FOREST ECOL MANAG, V261, P1090, DOI 10.1016/j.foreco.2010.12.032	87	10	10	2	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45540	10.1371/journal.pone.0045540	http://dx.doi.org/10.1371/journal.pone.0045540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049813	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300031
J	Vinas, M; Sawides, L; de Gracia, P; Marcos, S				Vinas, Maria; Sawides, Lucie; de Gracia, Pablo; Marcos, Susana			Perceptual Adaptation to the Correction of Natural Astigmatism	PLOS ONE			English	Article							NEURAL COMPENSATION; ORIENTATION; ABERRATIONS; CONTRAST; VISION; BLUR; SENSITIVITY; MECHANISMS; AMBLYOPIA	Background: The visual system adjusts to changes in the environment, as well as to changes within the observer, adapting continuously to maintain a match between visual coding and visual environment. We evaluated whether the perception of oriented blur is biased by the native astigmatism, and studied the time course of the after-effects following spectacle correction of astigmatism in habitually non-corrected astigmats. Methods and Findings: We tested potential shifts of the perceptual judgments of blur orientation in 21 subjects. The psychophysical test consisted on a single interval orientation identification task in order to measure the perceived isotropic point (astigmatism level for which the image did not appear oriented to the subject) from images artificially blurred with constant blur strength (B = 1.5 D), while modifying the orientation of the blur according to the axis of natural astigmatism of the subjects. Measurements were performed after neutral (gray field) adaptation on naked eyes under full correction of low and high order aberrations. Longitudinal measurements (up to 6 months) were performed in three groups of subjects: non-astigmats and corrected and uncorrected astigmats. Uncorrected astigmats were provided with proper astigmatic correction immediately after the first session. Non-astigmats did not show significant bias in their perceived neutral point, while in astigmatic subjects the perceived neutral point was significantly biased, typically towards their axis of natural astigmatism. Previously uncorrected astigmats shifted significantly their perceived neutral point towards more isotropic images shortly (2 hours) after astigmatic correction wear, and, once stabilized, remained constant after 6 months. The shift of the perceived neutral point after correction of astigmatism was highly correlated with the amount of natural astigmatism. Conclusions: Non-corrected astigmats appear to be naturally adapted to their astigmatism, and astigmatic correction significantly changes their perception of their neutral point, even after a brief period of adaptation.	[Vinas, Maria; Sawides, Lucie; de Gracia, Pablo; Marcos, Susana] CSIC, Inst Opt, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Optica (Daza de Valdes)	Vinas, M (corresponding author), CSIC, Inst Opt, Serrano 121, E-28006 Madrid, Spain.	maria.vinas@io.cfmac.csic.es	De Gracia, Pablo/B-2786-2017; Sawides, Lucie/O-1431-2016; vinas-pena, maria/C-1101-2012	Sawides, Lucie/0000-0002-8918-8753; vinas-pena, maria/0000-0003-1296-9508; De Gracia, Pablo/0000-0003-4319-2797	Consejo Superior de Investigaciones Cientificas (CSIC); Ministerio de Ciencia e Innovacion (MICINN) FPU; MICINN FPI; MICINN [FIS2008-02065, FIS2011-25637]; EURHORCs-ESF (European Heads of Research Councils) [EURYI-05-102-ES, ERC-2011-AdG-294099]	Consejo Superior de Investigaciones Cientificas (CSIC); Ministerio de Ciencia e Innovacion (MICINN) FPU; MICINN FPI(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); EURHORCs-ESF (European Heads of Research Councils)	The authors acknowledge funding from Consejo Superior de Investigaciones Cientificas (CSIC) JAE Predoctoral programs to MV and PdG; Ministerio de Ciencia e Innovacion (MICINN) FPU Predoctoral Fellowship to MV; and MICINN FPI Predoctoral Fellowship to LS. The study was supported by grants MICINN FIS2008-02065, FIS2011-25637; EURHORCs-ESF (European Heads of Research Councils); EURYI-05-102-ES (The European Young Investigator Awards) & ERC-2011-AdG-294099 (European Research Council) to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Artal P, 2004, J VISION, V4, P281, DOI 10.1167/4.4.4; Atchison DA, 2009, VISION RES, V49, P2393, DOI 10.1016/j.visres.2009.07.009; Borra T, 2010, PERCEPTION, V39, P909, DOI 10.1068/p6338; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CHARMAN WN, 1993, OPTOMETRY VISION SCI, V70, P111, DOI 10.1097/00006324-199302000-00005; Coninx A, 2011, PERCEPTION, V40, P114; de Gracia P, 2011, J VISION, V11, DOI [10.1167/11.2.5, 10.1167/11.12.5]; Dobson V, 2003, VISION RES, V43, P1081, DOI 10.1016/S0042-6989(03)00014-2; Ehrenstein WH, 1999, MODERN TECHNIQUES NE, P1211, DOI DOI 10.1007/978-3-642-58552-4_43; Gambra E, 2009, J VISION, V9, DOI 10.1167/9.6.4; George S, 2004, OPTOMETRY VISION SCI, V81, P543, DOI 10.1097/00006324-200407000-00016; Green S, 2005, HIGH QUALITY RENDE 3; Harvey EM, 2008, VISION RES, V48, P773, DOI 10.1016/j.visres.2007.12.007; Heeley DW, 1997, VISION RES, V37, P235, DOI 10.1016/S0042-6989(96)00097-1; Kohn A, 2007, J NEUROPHYSIOL, V97, P3155, DOI 10.1152/jn.00086.2007; Kompaniez E, 2011, J VIS, V11, P306; Liang JZ, 1997, J OPT SOC AM A, V14, P2873, DOI 10.1364/JOSAA.14.002873; Lu ZL, 2009, VISION RES, V49, P2531, DOI 10.1016/j.visres.2009.09.023; Marcos S, 2008, J VISION, V8, DOI 10.1167/8.13.1; McGarvey I, 2005, PERLIN NOISE GENERAT; McMahon MJ, 2003, J VISION, V3, P230, DOI 10.1167/3.3.4; MITCHELL DE, 1973, VISION RES, V13, P535, DOI 10.1016/0042-6989(73)90023-0; Mon-Williams M, 1998, P ROY SOC B-BIOL SCI, V265, P71, DOI 10.1098/rspb.1998.0266; Ohlendorf A, 2011, VISION RES, V51, P529, DOI 10.1016/j.visres.2011.01.010; PELI E, 1990, J OPT SOC AM A, V7, P2032, DOI 10.1364/JOSAA.7.002032; Pelli DG, 1995, HDB OPTICS; Perlin K., 1985, Computer Graphics, V19, P287, DOI 10.1145/325165.325247; PESUDOVS K, 1993, OPTOMETRY VISION SCI, V70, P528, DOI 10.1097/00006324-199307000-00002; Phipps Joanna A, 2001, Clin Exp Optom, V84, P264; Qi HJ, 2006, P NATL ACAD SCI USA, V103, P483, DOI 10.1073/pnas.0506728103; Rosenfield M, 1999, OPTOMETRY VISION SCI, V76, P303, DOI 10.1097/00006324-199905000-00018; Rossi EA, 2010, J VISION, V10, DOI 10.1167/10.12.11; Sabesan R, 2007, OPT LETT, V32, P1000, DOI 10.1364/OL.32.001000; Sabesan R, 2010, INVEST OPHTH VIS SCI, V51, P3835, DOI 10.1167/iovs.09-4558; Sabesan R, 2009, J VISION, V9, DOI 10.1167/9.5.6; Sawides L, 2012, J VISION, V12, DOI 10.1167/12.8.4; Sawides L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027031; Sawides L, 2011, J VISION, V11, DOI 10.1167/11.7.21; Sawides L, 2010, J VISION, V10, DOI 10.1167/10.12.22; Teich AF, 2003, J NEUROPHYSIOL, V89, P2086, DOI 10.1152/jn.00970.2002; Thibos LN, 1997, OPTOMETRY VISION SCI, V74, P367, DOI 10.1097/00006324-199706000-00019; VOGELS R, 1985, VISION RES, V25, P1679, DOI 10.1016/0042-6989(85)90140-3; Vul E, 2008, J VISION, V8, DOI 10.1167/8.12.4; Wark B, 2007, CURR OPIN NEUROBIOL, V17, P423, DOI 10.1016/j.conb.2007.07.001; Webster MA, 2002, NAT NEUROSCI, V5, P839, DOI 10.1038/nn906; Webster MA, 2011, J VISION, V11, DOI 10.1167/11.5.3; Wolffsohn JS, 2011, J CATARACT REFR SURG, V37, P454, DOI 10.1016/j.jcrs.2010.09.022; Yehezkel O, 2010, VISION RES, V50, P1550, DOI 10.1016/j.visres.2010.05.014	49	38	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46361	10.1371/journal.pone.0046361	http://dx.doi.org/10.1371/journal.pone.0046361			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23050021	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300111
J	Aguilera, MA; Navarrete, SA				Aguilera, Moises A.; Navarrete, Sergio A.			Interspecific Competition for Shelters in Territorial and Gregarious Intertidal Grazers: Consequences for Individual Behaviour	PLOS ONE			English	Article							INTRASPECIFIC COMPETITION; HERBIVORE ASSEMBLAGES; HUMAN EXCLUSION; LIMPET; PATTERNS; PATELLA; COEXISTENCE; HABITAT; AGGREGATION; VARIABILITY	Experiments have shown that interspecific interactions within consumer guilds can alter patterns of distribution, abundance and size of species. Plastic behavioural responses can be modulated by agonistic interactions. In many cases, consumers compete for space and shelters, and these interactions change the manner in which they exploit food. This study investigates the consequences of competition in the spatial and temporal organization of behaviour of intertidal grazers, which share algal resources and the use of rock crevices while resting, but exhibit different body sizes, spatial behaviour and foraging modes. We evaluate interaction strength between small gregarious Siphonaria lessoni and the larger territorial keyhole limpet Fissurella crassa and between S. lessoni and the medium-size gregarious chiton Chiton granosus. Using field manipulations and artificial arenas in the laboratory, we tested whether the use of crevices, micro-spatial distribution and activity are modified by the density of conspecifics and the presence of heterospecifics. Our results show that small-scale spatial segregation observed in the field between S. lessoni and C. granosus result from species-specific differences in habitat use. In turn, we found evidence that spatial segregation between F. crassa and S. lessoni results from highly asymmetric interference competition in the use of shelters. The presence of F. crassa reduced the use of crevices and growth rates of S. lessoni. Effects on growth rates are assumed to result from exposure to harsh environmental conditions rather than food limitation. Thus, neither gregarious behaviour nor differences in activity were sufficient to prevent competition with the larger grazer. Our study illustrates the importance of competition for shelters, which results in behavioural changes of the smaller-sized species, and how these plastic responses can translate into differences in growth rates. Use of shelters can thus be modulated by environmental conditions in a species-specific as well as an interactive manner within consumers' guilds.	[Aguilera, Moises A.] Univ Catolica Norte, CEAZA, Fac Ciencias Mar, Coquimbo, Chile; [Navarrete, Sergio A.] Pontificia Univ Catolica Chile, Ctr Marine Conservat, Santiago, Chile; [Navarrete, Sergio A.] Estn Costera Invest Marinas, Las Cruces, Chile	Universidad Catolica del Norte; Pontificia Universidad Catolica de Chile	Aguilera, MA (corresponding author), Univ Catolica Norte, CEAZA, Fac Ciencias Mar, Coquimbo, Chile.	moises.aguilera@ceaza.cl	Aguilera, Moisés/AAC-2981-2020; Navarrete, Sergio/D-4645-2013	Aguilera, Moisés/0000-0002-3517-6255; 	Centro de Estudios Avanzados en Zonas Aridas (CEAZA); Fondap Fondecyt [15001-0001]; Fondecyt [1070335]; ICM of Ministerio de Economia, Fomento y Turismo, Chile	Centro de Estudios Avanzados en Zonas Aridas (CEAZA)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT Regional/CEAZA); Fondap Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ICM of Ministerio de Economia, Fomento y Turismo, Chile	Funding was provided by Centro de Estudios Avanzados en Zonas Aridas (CEAZA), Fondap Fondecyt grant 15001-0001, Fondecyt grant 1070335 and funds from ICM of Ministerio de Economia, Fomento y Turismo, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera MA, 2007, J EXP MAR BIOL ECOL, V349, P84, DOI 10.1016/j.jembe.2007.05.002; Aguilera MA, 2012, ECOLOGY, V93, P75, DOI 10.1890/11-0434.1; Aguilera MA, 2011, MAR ECOL PROG SER, V431, P119, DOI 10.3354/meps09100; Basset A, 2007, OIKOS, V116, P1363, DOI 10.1111/j.2007.0030-1299.15702.x; Berlow EL, 1999, ECOLOGY, V80, P2206, DOI 10.1890/0012-9658(1999)080[2206:QVITSO]2.0.CO;2; Boaventura D, 2003, J ANIM ECOL, V72, P435, DOI 10.1046/j.1365-2656.2003.00713.x; BRANCH GM, 1976, J ANIM ECOL, V45, P507, DOI 10.2307/3888; BRANCH GM, 1975, J ANIM ECOL, V44, P575, DOI 10.2307/3612; Camus PA, 2008, MAR ECOL PROG SER, V361, P35, DOI 10.3354/meps07421; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; CAROTHERS JH, 1984, OIKOS, V42, P403, DOI 10.2307/3544413; Chapman MG, 2000, J EXP MAR BIOL ECOL, V250, P77, DOI 10.1016/S0022-0981(00)00180-5; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Coleman RA, 2010, J EXP MAR BIOL ECOL, V386, P113, DOI 10.1016/j.jembe.2010.02.011; COX TF, 1981, BIOMETRICS, V37, P367, DOI 10.2307/2530424; CREESE RG, 1982, OECOLOGIA, V53, P337, DOI 10.1007/BF00389010; Davies MS, 1998, ADV MAR BIOL, V34, P1, DOI 10.1016/S0065-2881(08)60210-2; DeLong JP, 2012, PLOS ONE, V7, P406, DOI 10.1371/journal.pone.0030081; EFRON B, 1991, SCIENCE, V253, P390, DOI 10.1126/science.253.5018.390; Finke R, 2007, MARINE ECOLOGY PROGR, V343, P57; Firth LB, 2010, OECOLOGIA, V162, P163, DOI 10.1007/s00442-009-1441-7; FLETCHER WJ, 1987, ECOLOGY, V68, P387, DOI 10.2307/1939270; FOCARDI S, 1990, J ANIM ECOL, V59, P347, DOI 10.2307/5177; GODOY C, 1989, OIKOS, V54, P101, DOI 10.2307/3565902; Harper KD, 2001, J ZOOL, V253, P293, DOI 10.1017/S0952836901000279; HAWKINS SJ, 1983, OCEANOGR MAR BIOL, V21, P195; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; IWASAKI K, 1992, ECOL RES, V7, P305, DOI 10.1007/BF02347099; Keough MJ, 1997, J EXP MAR BIOL ECOL, V215, P19, DOI 10.1016/S0022-0981(97)00027-0; LEVINGS SC, 1984, OECOLOGIA, V64, P152, DOI 10.1007/BF00376863; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LUBCHENCO J, 1981, ANNU REV ECOL SYST, V12, P405, DOI 10.1146/annurev.es.12.110181.002201; Macandza VA, 2012, OIKOS, V121, P891, DOI 10.1111/j.1600-0706.2012.20250.x; MARSHALL PA, 1994, J EXP MAR BIOL ECOL, V177, P121, DOI 10.1016/0022-0981(94)90147-3; Martins GM, 2010, BIOL CONSERV, V143, P203, DOI 10.1016/j.biocon.2009.10.004; Menge B, 1981, ECOL MONOGR, V21, P421; Moreira J, 2007, J EXP MAR BIOL ECOL, V347, P134, DOI 10.1016/j.jembe.2007.04.001; Munoz JLP, 2008, J THERM BIOL, V33, P149, DOI 10.1016/j.jtherbio.2007.10.002; Naeem S, 1998, CONSERV BIOL, V12, P39, DOI 10.1046/j.1523-1739.1998.96379.x; Nakano S, 1999, J ANIM ECOL, V68, P1079, DOI 10.1046/j.1365-2656.1999.00355.x; Nielsen KJ, 2004, ECOL LETT, V7, P31, DOI 10.1046/j.1461-0248.2003.00542.x; OLIVA D, 1986, MAR ECOL-P S Z N I, V7, P201, DOI 10.1111/j.1439-0485.1986.tb00158.x; PAINE RT, 1992, NATURE, V355, P73, DOI 10.1038/355073a0; Rivadeneira MM, 2002, MAR ECOL PROG SER, V245, P123, DOI 10.3354/meps245123; SANTELICES B, 1990, HYDROBIOLOGIA, V192, P35, DOI 10.1007/BF00006226; Santelices B, 1986, MONOGRAFIAS BIOLOGIC, P147; Santini G, 2005, ETHOL ECOL EVOL, V17, P65; Schmitt RJ, 1996, ECOLOGY, V77, P408, DOI 10.2307/2265618; Schmitz OJ, 2009, ECOLOGY, V90, P2339, DOI 10.1890/08-1919.1; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; SEBENS KP, 1982, AM NAT, V120, P189, DOI 10.1086/283982; Stafford R, 2012, MARINE ECOL IN PRESS; STIMSON J, 1973, ECOLOGY, V54, P1020, DOI 10.2307/1935568; Underwood AJ, 2004, J EXP MAR BIOL ECOL, V300, P161, DOI 10.1016/j.jembe.2003.12.006; UNDERWOOD AJ, 1978, OECOLOGIA, V33, P185, DOI 10.1007/BF00344847; UNDERWOOD AJ, 1984, OECOLOGIA, V64, P211, DOI 10.1007/BF00376873; Wieters EA, 2003, MAR ECOL PROG SER, V249, P93, DOI 10.3354/meps249093; WILLIAMS GA, 1995, MAR ECOL PROG SER, V124, P89, DOI 10.3354/meps124089; Wilson TL, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00247.1	62	21	22	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46205	10.1371/journal.pone.0046205	http://dx.doi.org/10.1371/journal.pone.0046205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049980	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100155
J	Altieri, P; Spallarossa, P; Barisione, C; Garibaldi, S; Garuti, A; Fabbi, P; Ghigliotti, G; Brunelli, C				Altieri, Paola; Spallarossa, Paolo; Barisione, Chiara; Garibaldi, Silvano; Garuti, Anna; Fabbi, Patrizia; Ghigliotti, Giorgio; Brunelli, Claudio			Inhibition of Doxorubicin-Induced Senescence by PPAR delta Activation Agonists in Cardiac Muscle Cells: Cooperation between PPAR delta and Bcl6	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; THERAPEUTIC TARGETS; ISCHEMIA/REPERFUSION INJURY; CARDIOMYOCYTE APOPTOSIS; PREMATURE SENESCENCE; H9C2 CARDIOMYOBLASTS; RECEPTOR-BETA/DELTA; DOWN-REGULATION; INFLAMMATION; EXPRESSION	Senescence and apoptosis are two distinct cellular programs that are activated in response to a variety of stresses. Low or high doses of the same stressor, i.e., the anticancer drug doxorubicin, may either induce apoptosis or senescence, respectively, in cardiac muscle cells. We have demonstrated that PPAR delta, a ligand-activated transcriptional factor that controls lipid metabolism, insulin sensitivity and inflammation, is also involved in the doxorubicin-induced senescence program. This occurs through its interference with the transcriptional repressor protein B cell lymphoma-6 (Bcl6). Low doses of doxorubicin increase the expression of PPAR delta that sequesters Bcl6, thus preventing it from exerting its anti-senescent effects. We also found that L-165041, a specific PPAR delta activator, is highly effective in protecting cardiomyocytes from doxorubicin-induced senescence through a Bcl6 related mechanism. In fact, L-165041 increases Bcl6 expression via p38, JNK and Akt activation, and at the same time it induces the release of Bcl6 from PPAR delta, thereby enabling Bcl6 to bind to its target genes. L-165041 also prevented apoptosis induced by higher doses of doxorubicin. However, while experiments performed with siRNA analysis techniques very clearly showed the weight of Bcl6 in the cellular senescence program, no role was found for Bcl6 in the anti-apoptotic effects of L-165041, thus confirming that senescence and apoptosis are two very distinct stress response cellular programs. This study increases our understanding of the molecular mechanism of anthracycline cardiotoxicity and suggests a potential role for PPAR delta agonists as cardioprotective agents.	[Altieri, Paola; Barisione, Chiara; Garibaldi, Silvano; Fabbi, Patrizia; Brunelli, Claudio] Univ Genoa, Res Ctr Cardiovasc Biol, Genoa, Italy; [Spallarossa, Paolo; Ghigliotti, Giorgio; Brunelli, Claudio] Univ Genoa, Div Cardiol, IRCCS Univ Hosp San Martino, Genoa, Italy; [Garuti, Anna] Univ Genoa, Dept Internal Med, Lab Cellular Therapies, I-16126 Genoa, Italy	University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa	Altieri, P (corresponding author), Univ Genoa, Res Ctr Cardiovasc Biol, Genoa, Italy.	Paola.Altieri@unige.it	Spallarossa, Paolo/AAC-8981-2019	Ghigliotti, Giorgio/0000-0001-8484-542X	University of Genova (cofinanziamento di Ateneo)	University of Genova (cofinanziamento di Ateneo)	This work was supported by grants from the University of Genova (cofinanziamento di Ateneo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albagli O, 1999, ONCOGENE, V18, P5063, DOI 10.1038/sj.onc.1202892; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Auner HW, 2001, CANCER RES, V61, P2335; Barnabe N, 2002, FREE RADICAL BIO MED, V33, P266, DOI 10.1016/S0891-5849(02)00873-0; Baron BW, 2002, P NATL ACAD SCI USA, V99, P2860, DOI 10.1073/pnas.042702599; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bishop-Bailey D, 2009, PHARMACOL THERAPEUT, V124, P141, DOI 10.1016/j.pharmthera.2009.06.011; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Chen XW, 2007, CIRC RES, V100, P536, DOI 10.1161/01.RES.0000259560.39234.99; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Dent AL, 2002, CRIT REV ONCOL HEMAT, V41, P1, DOI 10.1016/S1040-8428(01)00164-0; Di Paola R, 2010, J LEUKOCYTE BIOL, V88, P291, DOI 10.1189/jlb.0110053; Dimri GP, 1995, P NATL ACAD SCI USA, V92, P363; Ding GL, 2006, J MOL CELL CARDIOL, V40, P821, DOI 10.1016/j.yjmcc.2006.03.422; Fan YB, 2008, ARTERIOSCL THROM VAS, V28, P315, DOI 10.1161/ATVBAHA.107.149815; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Frias MA, 2010, CARDIOVASC RES, V85, P118, DOI 10.1093/cvr/cvp289; Gerland LM, 2003, EXP GERONTOL, V38, P887, DOI 10.1016/S0531-5565(03)00132-3; Glauser DA, 2009, J RECEPT SIG TRANSD, V29, P293, DOI 10.3109/10799890903241824; Gong J, 2007, LIFE SCI, V80, P1143, DOI 10.1016/j.lfs.2006.12.012; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He TR, 2011, HYPERTENSION, V58, P287, DOI 10.1161/HYPERTENSIONAHA.111.172189; Hershman DL, 2008, J CLIN ONCOL, V26, P3159, DOI 10.1200/JCO.2007.14.1242; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Karpe F, 2009, CURR OPIN LIPIDOL, V20, P333, DOI 10.1097/MOL.0b013e32832dd4b1; Kharroubi I, 2006, DIABETOLOGIA, V49, P2350, DOI 10.1007/s00125-006-0366-5; Kim HJ, 2011, BIOCHEM BIOPH RES CO, V406, P564, DOI 10.1016/j.bbrc.2011.02.091; Kim JY, 2011, VASCUL PHARM; Kojima S, 2001, DEVELOPMENT, V128, P57; Konorev EA, 2008, FREE RADICAL BIO MED, V45, P1723, DOI 10.1016/j.freeradbiomed.2008.09.006; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kumagai T, 1999, ONCOGENE, V18, P467, DOI 10.1038/sj.onc.1202306; Lee CH, 2003, SCIENCE, V302, P453, DOI 10.1126/science.1087344; Liang YJ, 2010, EUR J PHARMACOL, V643, P84, DOI 10.1016/j.ejphar.2010.06.031; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Maejima Y, 2008, AGING CELL, V7, P125, DOI 10.1111/j.1474-9726.2007.00358.x; Minamino T, 2003, CIRCULATION, V108, P2264, DOI 10.1161/01.CIR.0000093274.82929.22; Mossmann T., 1983, J IMMUNOL METHODS, V65, P55; Multani AS, 2000, NEOPLASIA, V2, P339, DOI 10.1038/sj.neo.7900105; Ottonello L, 2009, BRIT J PHARMACOL, V157, P294, DOI 10.1111/j.1476-5381.2009.00162.x; Pesant M, 2006, CARDIOVASC RES, V69, P440, DOI 10.1016/j.cardiores.2005.10.019; Planavila A, 2005, CARDIOVASC RES, V65, P832, DOI 10.1016/j.cardiores.2004.11.011; Plutzky J, 2003, SCIENCE, V302, P406, DOI 10.1126/science.1091172; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; Spallarossa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015583; Spallarossa P, 2010, J PHARMACOL EXP THER, V332, P87, DOI 10.1124/jpet.109.159525; Spallarossa P, 2009, AM J PHYSIOL-HEART C, V297, pH2169, DOI 10.1152/ajpheart.00068.2009; Stepp MA, 2007, J CELL SCI, V120, P2851, DOI 10.1242/jcs.03480; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; van Bilsen M, 2010, EXPERT OPIN THER TAR, V14, P1029, DOI 10.1517/14728222.2010.512917; Verzola D, 2004, KIDNEY INT, V65, P1252, DOI 10.1111/j.1523-1755.2004.00497.x; Vigneron A, 2005, CANCER RES, V65, P8927, DOI 10.1158/0008-5472.CAN-05-0461; Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Yamochi T, 1999, ONCOGENE, V18, P487, DOI 10.1038/sj.onc.1202334; Yu RYL, 2005, BLOOD, V105, P1777, DOI 10.1182/blood-2004-08-3171; Yue TL, 2008, J PHARMACOL EXP THER, V325, P466, DOI 10.1124/jpet.107.135327; Zingarelli B, 2010, AM J PATHOL, V177, P1834, DOI 10.2353/ajpath.2010.091010	62	22	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46126	10.1371/journal.pone.0046126	http://dx.doi.org/10.1371/journal.pone.0046126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049957	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100141
J	Jones, CM; Toe, HK; Sanou, A; Namountougou, M; Hughes, A; Diabate, A; Dabire, R; Simard, F; Ranson, H				Jones, Christopher M.; Toe, Hyacinthe K.; Sanou, Antoine; Namountougou, Moussa; Hughes, Angela; Diabate, Abdoulaye; Dabire, Roch; Simard, Frederic; Ranson, Hilary			Additional Selection for Insecticide Resistance in Urban Malaria Vectors: DDT Resistance in Anopheles arabiensis from Bobo-Dioulasso, Burkina Faso	PLOS ONE			English	Article							GATED SODIUM-CHANNEL; SUB-SAHARAN AFRICA; DAR-ES-SALAAM; GAMBIAE COMPLEX; MOLECULAR-BASIS; KDR MUTATIONS; DENGUE VECTOR; AEDES-AEGYPTI; IDENTIFICATION; WEST	In the city of Bobo-Dioulasso in Burkina Faso, Anopheles arabiensis has superseded Anopheles gambiae s.s. as the major malaria vector and the larvae are found in highly polluted habitats normally considered unsuitable for Anopheles mosquitoes. Here we show that An. gambiae s.l. adults emerging from a highly polluted site in the city centre (Dioulassoba) have a high prevalence of DDT resistance (percentage mortality after exposure to diagnostic dose = 65.8% in the dry season and 70.4% in the rainy season, respectively). An investigation into the mechanisms responsible found an unexpectedly high frequency of the 1014S kdr mutation (allele frequency = 0.4), which is found at very low frequencies in An. arabiensis in the surrounding rural areas, and an increase in transcript levels of several detoxification genes, notably from the glutathione transferase and cytochrome P450 gene families. A number of ABC transporter genes were also expressed at elevated levels in the DDT resistant An. arabiensis. Unplanned urbanisation provides numerous breeding grounds for mosquitoes. The finding that Anopheles mosquitoes adapted to these urban breeding sites have a high prevalence of insecticide resistance has important implications for our understanding of the selective forces responsible for the rapid spread of insecticide resistant populations of malaria vectors in Africa.	[Jones, Christopher M.; Toe, Hyacinthe K.; Hughes, Angela; Ranson, Hilary] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Toe, Hyacinthe K.; Namountougou, Moussa; Diabate, Abdoulaye; Dabire, Roch; Simard, Frederic] Inst Rech Sci Sante Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Toe, Hyacinthe K.; Sanou, Antoine] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Simard, Frederic] Inst Rech Dev, Montpellier, France	Liverpool School of Tropical Medicine; University of Liverpool; Institut de Recherche pour le Developpement (IRD)	Jones, CM (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England.	jonescm@liverpool.ac.uk	Jones, Christopher/U-1832-2017; Dabire, Roch Kounbobr/ABF-3525-2020; Frederic, SIMARD/AFV-5001-2022; Jones, Christopher M/S-5838-2019; SIMARD, Frederic/J-9489-2016	Jones, Christopher/0000-0002-6504-6224; Frederic, SIMARD/0000-0002-2871-5329; SIMARD, Frederic/0000-0002-2871-5329; Ranson, Hilary/0000-0003-2332-8247; Sanou, Antoine/0000-0002-3598-8800; DIABATE, Abdoulaye/0000-0002-9666-9395	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR)	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR)(World Health Organization)	This investigation received partial financial support from the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (WHO/TDR). No additional external funding received for this study. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alou LPA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-167; [Anonymous], 1998, WHOCDCMAL98; Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Burton MJ, 2011, INSECT BIOCHEM MOLEC, V41, P723, DOI 10.1016/j.ibmb.2011.05.004; Buss DS, 2008, PESTIC BIOCHEM PHYS, V90, P141, DOI 10.1016/j.pestbp.2007.12.001; CHINERY WA, 1984, J TROP MED HYG, V87, P75; Chiu TL, 2008, P NATL ACAD SCI USA, V105, P8855, DOI 10.1073/pnas.0709249105; Chouaibou M, 2008, TROP MED INT HEALTH, V13, P476, DOI 10.1111/j.1365-3156.2008.02025.x; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Diabate A, 2004, J AM MOSQUITO CONTR, V20, P195; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Djogbenou L, 2011, MED VET ENTOMOL, V25, P256, DOI 10.1111/j.1365-2915.2010.00925.x; Djogbenou L, 2008, AM J TROP MED HYG, V78, P298, DOI 10.4269/ajtmh.2008.78.298; Dongus S, 2009, GEOSPATIAL HEALTH, V3, P189, DOI 10.4081/gh.2009.220; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Donnelly MJ, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-12; Fournet F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-78; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; GRANT DF, 1991, INSECT BIOCHEM, V21, P421, DOI 10.1016/0020-1790(91)90009-4; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Himeidan YE, 2007, AM J TROP MED HYG, V77, P1066, DOI 10.4269/ajtmh.2007.77.1066; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109; Karunker I, 2008, INSECT BIOCHEM MOLEC, V38, P634, DOI 10.1016/j.ibmb.2008.03.008; Keiser J, 2004, AM J TROP MED HYG, V71, P118, DOI 10.4269/ajtmh.2004.71.118; Kerah-Hinzoumbe C., 2009, BMC INFECT DIS, V9, P71, DOI DOI 10.1186/1471-2334-9-71; Kristan M, 2003, MED VET ENTOMOL, V17, P326, DOI 10.1046/j.1365-2915.2003.00449.x; Lynd A, 2010, MOL BIOL EVOL, V27, P1117, DOI 10.1093/molbev/msq002; Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; Onyabe DY, 2001, MEM I OSWALDO CRUZ, V96, P1081, DOI 10.1590/S0074-02762001000800009; Poupardin R, 2012, AQUAT TOXICOL, V114, P49, DOI 10.1016/j.aquatox.2012.02.001; PRAPANTHADARA LA, 1993, PESTIC BIOCHEM PHYS, V47, P119, DOI 10.1006/pest.1993.1070; Protopopoff N, 2008, TROP MED INT HEALTH, V13, P1479, DOI 10.1111/j.1365-3156.2008.02164.x; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Ramphul U, 2009, T ROY SOC TROP MED H, V103, P1121, DOI 10.1016/j.trstmh.2009.02.014; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Sattler MA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-4; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Stevenson BJ, 2011, INSECT BIOCHEM MOLEC, V41, P492, DOI 10.1016/j.ibmb.2011.02.003; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; TANG AH, 1994, J BIOL CHEM, V269, P27876; Tarr PT, 2009, BBA-MOL CELL BIOL L, V1791, P584, DOI 10.1016/j.bbalip.2009.01.007; van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340; Vontas J, 2007, INSECT MOL BIOL, V16, P315, DOI 10.1111/j.1365-2583.2007.00728.x; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066	65	79	84	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45995	10.1371/journal.pone.0045995	http://dx.doi.org/10.1371/journal.pone.0045995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049917	gold, Green Accepted, Green Published			2022-12-27	WOS:000309556100116
J	Larghi, P; Porta, C; Riboldi, E; Totaro, MG; Carraro, L; Orabona, C; Sica, A				Larghi, Paola; Porta, Chiara; Riboldi, Elena; Totaro, Maria Grazia; Carraro, Lorenzo; Orabona, Ciriana; Sica, Antonio			The p50 Subunit of NF-kappa B Orchestrates Dendritic Cell Lifespan and Activation of Adaptive Immunity	PLOS ONE			English	Article							T-CELL; IN-VIVO; PERIPHERAL TOLERANCE; ANTIGEN PRESENTATION; STEADY-STATE; EXPRESSION; MATURATION; IMMUNOTHERAPY; MACROPHAGES; RECEPTORS	Dendritic cells play a central role in keeping the balance between immunity and immune tolerance. A key factor in this equilibrium is the lifespan of DC, as its reduction restrains antigen availability leading to termination of immune responses. Here we show that lipopolysaccharide-driven DC maturation is paralleled by increased nuclear levels of p50 NF-kappa B, an event associated with DC apoptosis. Lack of p50 in murine DC promoted increased lifespan, enhanced level of maturation associated with increased expression of the proinflammatory cytokines IL-1, IL-18 and IFN-beta, enhanced capacity of activating and expanding CD4(+) and CD8(+) T cells in vivo and decreased ability to induce differentiation of FoxP3(+) regulatory T cells. In agreement, vaccination of melanoma-bearing mice with antigen-pulsed LPS-treated p50(-/-) BM-DC boosted antitumor immunity and inhibition of tumor growth. We propose that nuclear accumulation of the p50 NF-kappa B subunit in DC, as occurring during lipopolysaccharide-driven maturation, is a homeostatic mechanism tuning the balance between uncontrolled activation of adaptive immunity and immune tolerance.	[Larghi, Paola; Totaro, Maria Grazia; Sica, Antonio] Humanitas Clin & Res Ctr, Milan, Italy; [Porta, Chiara; Riboldi, Elena; Carraro, Lorenzo; Sica, Antonio] Univ Piemonte Orientale, Dipartimento Sci Farmaco, Novara, Italy; [Orabona, Ciriana] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Perugia	Sica, A (corresponding author), Humanitas Clin & Res Ctr, Milan, Italy.	antonio.sica@humanitasresearch.it	Orabona, Ciriana/L-8725-2015; Sica, Antonio/AAB-9546-2020; Larghi, Paola/K-6061-2016	Orabona, Ciriana/0000-0003-3113-0572; Larghi, Paola/0000-0001-7074-1590; PORTA, Chiara/0000-0002-7183-5561	Associazione Italiana Ricerca sul Cancro (AIRC), Italy; Fondazione Cariplo, Italy; Ministero Universita Ricerca (MIUR) e Salute, Italy; Regione Piemonte, Italy	Associazione Italiana Ricerca sul Cancro (AIRC), Italy(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo, Italy(Fondazione Cariplo); Ministero Universita Ricerca (MIUR) e Salute, Italy(Ministry of Education, Universities and Research (MIUR)); Regione Piemonte, Italy(Regione Piemonte)	This work was supported by Associazione Italiana Ricerca sul Cancro (AIRC), Italy; Fondazione Cariplo, Italy; Ministero Universita Ricerca (MIUR) e Salute, Italy; and Regione Piemonte, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Artis D, 2005, J IMMUNOL, V174, P7154, DOI 10.4049/jimmunol.174.11.7154; Banchereau J, 2003, ANN NY ACAD SCI, V987, P180, DOI 10.1111/j.1749-6632.2003.tb06047.x; Bellone M, 2000, J IMMUNOL, V165, P2651, DOI 10.4049/jimmunol.165.5.2651; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Chen M, 2007, MOL IMMUNOL, V44, P2558, DOI 10.1016/j.molimm.2006.12.020; Chen Z, 2008, IMMUNOL RES, V41, P87, DOI 10.1007/s12026-007-8014-9; Dai J, 2007, EUR J IMMUNOL, V37, P706, DOI 10.1002/eji.200636643; Daro E, 2000, J IMMUNOL, V165, P49, DOI 10.4049/jimmunol.165.1.49; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; De Gregorio E, 2009, CURR OPIN IMMUNOL, V21, P339, DOI 10.1016/j.coi.2009.05.003; de Weerd NA, 2007, J BIOL CHEM, V282, P20053, DOI 10.1074/jbc.R700006200; Diebold SS, 2001, GENE THER, V8, P487, DOI 10.1038/sj.gt.3301433; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dissanayake D, 2011, NAT MED, V17, P1663, DOI 10.1038/nm.2556; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Fallarino F, 2011, CURR MED CHEM, V18, P2215, DOI 0929-8673/11 $58.00+.00; Fallarino F, 2002, INT IMMUNOL, V14, P65, DOI 10.1093/intimm/14.1.65; Gao K, 2006, CANCER RES, V66, P8382, DOI 10.1158/0008-5472.CAN-05-4402; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; GHOSH P, 1994, CANCER RES, V54, P2969; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Grohmann U, 2003, TRENDS IMMUNOL, V24, P242, DOI 10.1016/S1471-4906(03)00072-3; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hou WS, 2004, NAT IMMUNOL, V5, P583, DOI 10.1038/ni1071; Huang L, 2010, INT REV IMMUNOL, V29, P133, DOI 10.3109/08830180903349669; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kim JH, 2005, GENE THER, V12, P1517, DOI 10.1038/sj.gt.3302584; KONO S, 1994, ENDOCRINOLOGY, V135, P1529, DOI 10.1210/en.135.4.1529; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Laderach D, 2003, J IMMUNOL, V171, P1750, DOI 10.4049/jimmunol.171.4.1750; Lanzavecchia A, 2004, NAT IMMUNOL, V5, P1201, DOI 10.1038/ni1204-1201; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Liu YJ, 2001, NAT IMMUNOL, V2, P585, DOI 10.1038/89726; Lu LN, 1997, J IMMUNOL, V158, P5676; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Mueller DL, 2010, NAT IMMUNOL, V11, P21, DOI 10.1038/ni.1817; Palucka K, 2011, J IMMUNOL, V186, P1325, DOI 10.4049/jimmunol.0902539; Park D, 2006, NAT BIOTECHNOL, V24, P1581, DOI 10.1038/nbt1262; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Radhakrishnan S, 2007, J IMMUNOL, V178, P1426, DOI 10.4049/jimmunol.178.3.1426; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175; Riboldi E, 2003, BRIT J PHARMACOL, V140, P377, DOI 10.1038/sj.bjp.0705428; Saccani A, 2006, CANCER RES, V66, P11432, DOI 10.1158/0008-5472.CAN-06-1867; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15056, DOI 10.1073/pnas.96.26.15056; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Zanoni I, 2011, AUTOIMMUNITY, V44, P23, DOI 10.3109/08916931003782148; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Ziegler-Heitbrock HWL, 1997, IMMUNOBIOLOGY, V198, P73; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	60	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45279	10.1371/journal.pone.0045279	http://dx.doi.org/10.1371/journal.pone.0045279			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049782	gold, Green Submitted, Green Published			2022-12-27	WOS:000309556100036
J	Leukel, C; Lundbye-Jensen, J; Christensen, MS; Gollhofer, A; Nielsen, JB; Taube, W				Leukel, Christian; Lundbye-Jensen, Jesper; Christensen, Mark Schram; Gollhofer, Albert; Nielsen, Jens Bo; Taube, Wolfgang			Subconscious Visual Cues during Movement Execution Allow Correct Online Choice Reactions	PLOS ONE			English	Article							MOTOR CONTROL; STIMULATION; INHIBITION; PERCEPTION; STIMULUS; CORTEX; MONKEY	Part of the sensory information is processed by our central nervous system without conscious perception. Subconscious processing has been shown to be capable of triggering motor reactions. In the present study, we asked the question whether visual information, which is not consciously perceived, could influence decision-making in a choice reaction task. Ten healthy subjects (28 +/- 5 years) executed two different experimental protocols. In the Motor reaction protocol, a visual target cue was shown on a computer screen. Depending on the displayed cue, subjects had to either complete a reaching movement (go-condition) or had to abort the movement (stop-condition). The cue was presented with different display durations (20-160 ms). In the second Verbalization protocol, subjects verbalized what they experienced on the screen. Again, the cue was presented with different display durations. This second protocol tested for conscious perception of the visual cue. The results of this study show that subjects achieved significantly more correct responses in the Motor reaction protocol than in the Verbalization protocol. This difference was only observed at the very short display durations of the visual cue. Since correct responses in the Verbalization protocol required conscious perception of the visual information, our findings imply that the subjects performed correct motor responses to visual cues, which they were not conscious about. It is therefore concluded that humans may reach decisions based on subconscious visual information in a choice reaction task.	[Leukel, Christian; Gollhofer, Albert] Univ Freiburg, Dept Sport Sci, D-79106 Freiburg, Germany; [Leukel, Christian; Taube, Wolfgang] Univ Fribourg, Dept Med Movement & Sport Sci, CH-1700 Fribourg, Switzerland; [Lundbye-Jensen, Jesper; Christensen, Mark Schram; Nielsen, Jens Bo] Univ Copenhagen, Dept Exercise & Sport Sci, Copenhagen, Denmark; [Lundbye-Jensen, Jesper; Christensen, Mark Schram; Nielsen, Jens Bo] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Christensen, Mark Schram] Univ Copenhagen, Hvidovre Hosp, Danish Res Ctr Magnet Resonance, Copenhagen, Denmark	University of Freiburg; University of Fribourg; University of Copenhagen; University of Copenhagen; University of Copenhagen	Leukel, C (corresponding author), Univ Freiburg, Dept Sport Sci, Hugstetter Str 55, D-79106 Freiburg, Germany.	christian.leukel@sport.uni-freiburg.de	Albert, Gollhofer/V-3291-2019; Nielsen, Jens Bo/C-7632-2015; Taube, Wolfgang/E-4018-2012; Gollhofer, Albert/ABF-5766-2020; Lundbye-Jensen, Jesper/ABH-4025-2020	Nielsen, Jens Bo/0000-0001-5568-2916; Taube, Wolfgang/0000-0002-8802-2065; Lundbye-Jensen, Jesper/0000-0003-3144-861X	German Research Foundation (DFG); Albert-Ludwigs University Freiburg (funding program Open Access Publishing)	German Research Foundation (DFG)(German Research Foundation (DFG)); Albert-Ludwigs University Freiburg (funding program Open Access Publishing)	The German Research Foundation (DFG) and the Albert-Ludwigs University Freiburg (funding program Open Access Publishing) funded the article processing charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstermark B, 2007, ACTA PHYSIOL, V189, P123, DOI 10.1111/j.1748-1716.2006.01655.x; AMASSIAN VE, 1989, ELECTROEN CLIN NEURO, V74, P458, DOI 10.1016/0168-5597(89)90036-1; Bargh JA, 2008, PERSPECT PSYCHOL SCI, V3, P73, DOI 10.1111/j.1745-6916.2008.00064.x; Christensen MS, 2008, P NATL ACAD SCI USA, V105, P1353, DOI 10.1073/pnas.0705858105; Day BL, 2001, BRAIN, V124, P1832, DOI 10.1093/brain/124.9.1832; Eimer M, 1998, J EXP PSYCHOL HUMAN, V24, P1737, DOI 10.1037/0096-1523.24.6.1737; Eimer M, 2003, BIOL PSYCHOL, V64, P7, DOI 10.1016/S0301-0511(03)00100-5; Eimer M, 2002, NEUROPSYCHOLOGIA, V40, P2438, DOI 10.1016/S0028-3932(02)00079-9; Eimer M, 2002, PSYCHON B REV, V9, P514, DOI 10.3758/BF03196307; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Harris KD, 2011, NAT REV NEUROSCI, V12, P509, DOI 10.1038/nrn3084; Hesse C, 2011, SEEING PERCEIVING, V24, P151, DOI 10.1163/187847511X570105; KLOTZ W, 1995, PSYCHOL RES-PSYCH FO, V58, P92, DOI 10.1007/BF00571098; LEMON RN, 1989, J PHYSIOL-LONDON, V413, P351, DOI 10.1113/jphysiol.1989.sp017658; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Li W, 2007, PSYCHOL SCI, V18, P1044, DOI 10.1111/j.1467-9280.2007.02023.x; MILNER AD, 1993, PROG BRAIN RES, V95, P317, DOI 10.1016/S0079-6123(08)60379-9; MISHKIN M, 1982, BEHAV BRAIN RES, V6, P57, DOI 10.1016/0166-4328(82)90081-X; Neumann O, 1994, ATTENTIION PERFORMAN; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pessiglione M, 2008, NEURON, V59, P561, DOI 10.1016/j.neuron.2008.07.005; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; Schenk T, 2011, VISION RES, V51, P812, DOI 10.1016/j.visres.2011.02.003; Schmidt Filipp, 2011, Adv Cogn Psychol, V7, P120, DOI 10.2478/v10053-008-0092-2; Taylor JL, 1996, EXP BRAIN RES, V110, P62	25	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44496	10.1371/journal.pone.0044496	http://dx.doi.org/10.1371/journal.pone.0044496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049749	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100014
J	Saroussi, S; Schushan, M; Ben-Tal, N; Junge, W; Nelson, N				Saroussi, Shai; Schushan, Maya; Ben-Tal, Nir; Junge, Wolfgang; Nelson, Nathan			Structure and Flexibility of the C-Ring in the Electromotor of Rotary FoF1-ATPase of Pea Chloroplasts	PLOS ONE			English	Article							ELASTIC POWER TRANSMISSION; NORMAL-MODE ANALYSIS; COLI ATP SYNTHASE; CRYSTAL-STRUCTURE; ROTOR RING; VISCOELASTIC DYNAMICS; NA+-ATPASE; F-ATPASE; MECHANISM; PROTEIN	A ring of 8-15 identical c-subunits is essential for ion-translocation by the rotary electromotor of the ubiquitous FOF1-ATPase. Here we present the crystal structure at 3.4 angstrom resolution of the c-ring from chloroplasts of a higher plant (Pisum sativum), determined using a native preparation. The crystal structure was found to resemble that of an (ancestral) cyanobacterium. Using elastic network modeling to investigate the ring's eigen-modes, we found five dominant modes of motion that fell into three classes. They revealed the following deformations of the ring: (I) ellipsoidal, (II) opposite twisting of the luminal circular surface of the ring against the stromal surface, and (III) kinking of the hairpin-shaped monomers in the middle, resulting in bending/stretching of the ring. Extension of the elastic network analysis to rings of different cn-symmetry revealed the same classes of dominant modes as in P. sativum (c(14)). We suggest the following functional roles for these classes: The first and third classes of modes affect the interaction of the c-ring with its counterparts in F-O, namely subunits a and bb'. These modes are likely to be involved in ion-translocation and torque generation. The second class of deformation, along with deformations of subunits gamma and epsilon might serve to elastically buffer the torque transmission between F-O and F-1.	[Saroussi, Shai; Schushan, Maya; Ben-Tal, Nir; Nelson, Nathan] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, Ramat Aviv, Israel; [Junge, Wolfgang] Univ Osnabruck, Div Biophys, Osnabruck, Germany	Tel Aviv University; University Osnabruck	Nelson, N (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, Ramat Aviv, Israel.	nelson@post.tau.ac.il	Junge, Wolfgang/F-6289-2012; Saroussi, Shai/Y-2163-2019	Saroussi, Shai/0000-0003-0422-6165; Ben-Tal, Nir/0000-0001-6901-832X; Nelson, Nathan/0000-0003-3588-7265	Israel Science Foundation (ISF) [204-10, 1331/11]; United States-Israel Agricultural Research and Development Fund (BARD) Research grant [IS-4229-09]; Eshkol Foundation; Israeli Ministry of Science; Edmond J. Safra Bioinformatics program at Tel-Aviv University	Israel Science Foundation (ISF)(Israel Science Foundation); United States-Israel Agricultural Research and Development Fund (BARD) Research grant; Eshkol Foundation; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Edmond J. Safra Bioinformatics program at Tel-Aviv University	This work was supported by the Israel Science Foundation Grant 204-10 (ISF) and by the United States-Israel Agricultural Research and Development Fund (BARD) Research grant No. IS-4229-09. S.S. was supported by the Eshkol Foundation, the Israeli Ministry of Science. M.S. was supported by the Edmond J. Safra Bioinformatics program at Tel-Aviv University. N.B.-T. acknowledges the support of grant 1331/11 from the Israel Science Foundation. Eshkol Foundation, the Israeli Ministry of Science URL: http://www.most.gov.il/nr/exeres/8F309A05-C3FC-498D-AF16-DB2456D8AC4A.htm, Edmond J. Safra Bioinformatics program URL: http://safrabio.cs.tau.ac.il/, Israel Science Foundation grant 1331/11 URL: http://www.isf.org.il/english/default.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amunts A, 2005, PHOTOCH PHOTOBIO SCI, V4, P1011, DOI 10.1039/b506132f; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Bahar I, 2010, CHEM REV, V110, P1463, DOI 10.1021/cr900095e; Ballhausen B, 2009, J BACTERIOL, V191, P2400, DOI 10.1128/JB.01390-08; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; Cherepanov DA, 2001, BIOPHYS J, V81, P1234, DOI 10.1016/S0006-3495(01)75781-5; Dautant A, 2010, J BIOL CHEM, V285, P29502, DOI 10.1074/jbc.M110.124529; Duser MG, 2009, EMBO J, V28, P2689, DOI 10.1038/emboj.2009.213; Echeverria C, 2011, PHYS CHEM CHEM PHYS, V13, P10527, DOI 10.1039/c1cp00003a; Emekli U, 2008, PROTEINS, V70, P1219, DOI 10.1002/prot.21613; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Feniouk BA, 2004, BIOPHYS J, V86, P4094, DOI 10.1529/biophysj.103.036962; Franklin MJ, 2004, BIOPHYS J, V87, P3594, DOI 10.1529/biophysj.104.044248; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Haliloglu T, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000164; Ishmukhametov R, 2010, EMBO J, V29, P3911, DOI 10.1038/emboj.2010.259; Junge W, 2005, SCIENCE, V308, P642, DOI 10.1126/science.1112617; Junge W, 2001, FEBS LETT, V504, P152, DOI 10.1016/S0014-5793(01)02745-4; Junge W, 1997, TRENDS BIOCHEM SCI, V22, P420, DOI 10.1016/S0968-0004(97)01129-8; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kessel A, 2002, CURR TOP MEMBR, V52, P205; Krah A, 2010, J MOL BIOL, V395, P20, DOI 10.1016/j.jmb.2009.10.059; Krebstakies T, 2008, BIOCHEMISTRY-US, V47, P6907, DOI 10.1021/bi800173a; Lau WCY, 2012, NATURE, V481, P214, DOI 10.1038/nature10699; Lezon TR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000496; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199; Meier T, 2003, J MOL BIOL, V325, P389, DOI 10.1016/S0022-2836(02)01204-4; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Panke O, 2001, BIOPHYS J, V81, P1220, DOI 10.1016/S0006-3495(01)75780-3; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2007, J BACTERIOL, V189, P5895, DOI 10.1128/JB.00581-07; Pogoryelov D, 2010, NAT CHEM BIOL, V6, P891, DOI 10.1038/NCHEMBIO.457; Pogoryelov D, 2009, NAT STRUCT MOL BIOL, V16, P1068, DOI 10.1038/nsmb.1678; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; SCHOENKNECHT G, 1986, FEBS LETT, V203, P289, DOI 10.1016/0014-5793(86)80760-8; Schushan M, 2010, P NATL ACAD SCI USA, V107, P10908, DOI 10.1073/pnas.0914717107; Seelert H, 2000, NATURE, V405, P418, DOI 10.1038/35013148; Shrivastava IH, 2006, BIOPHYS J, V90, P3929, DOI 10.1529/biophysj.105.080093; Sielaff H, 2008, P NATL ACAD SCI USA, V105, P17760, DOI 10.1073/pnas.0807683105; Stock D, 2000, CURR OPIN STRUC BIOL, V10, P672, DOI 10.1016/S0959-440X(00)00147-0; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Taly JF, 2011, NAT PROTOC, V6, P1669, DOI 10.1038/nprot.2011.393; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VIK SB, 1994, J BIOL CHEM, V269, P30364; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Wachter A, 2011, P NATL ACAD SCI USA, V108, P3924, DOI 10.1073/pnas.1011581108; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; Yeheskel A, 2010, BIOPHYS J, V98, P2179, DOI 10.1016/j.bpj.2010.01.049	63	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e43045	10.1371/journal.pone.0043045	http://dx.doi.org/10.1371/journal.pone.0043045			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049735	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100007
J	Spiering, R; van der Zee, R; Wagenaar, J; Kapetis, D; Zolezzi, F; van Eden, W; Broere, F				Spiering, Rachel; van der Zee, Ruurd; Wagenaar, Josee; Kapetis, Dimos; Zolezzi, Francesca; van Eden, Willem; Broere, Femke			Tolerogenic Dendritic Cells That Inhibit Autoimmune Arthritis Can Be Induced by a Combination of Carvacrol and Thermal Stress	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; REGULATORY T-CELLS; EXTRACELLULAR METALLOTHIONEIN; IMMUNOMODULATORY ACTIVITIES; INTERLEUKIN-10 PRODUCTION; RHEUMATOID-ARTHRITIS; BONE-MARROW; IN-VITRO; INDUCTION; ALPHA	Tolerogenic dendritic cells (DCs) can induce regulatory T cells and dampen pathogenic T cell responses. Therefore, they are possible therapeutic targets in autoimmune diseases. In this study we investigated whether mouse tolerogenic DCs are induced by the phytonutrient carvacrol, a molecule with known anti-inflammatory properties, in combination with a physiological stress. We show that treatment of DCs with carvacrol and thermal stress led to the mRNA expression of both pro- and anti-inflammatory mediators. Interestingly, treated DCs with this mixed gene expression profile had a reduced ability to activate pro-inflammatory T cells. Furthermore, these DCs increased the proportion of FoxP3(+) regulatory T cells. In vivo, prophylactic injection of carvacrol-thermal stress treated DCs pulsed with the disease inducing antigen was able to suppress disease in a mouse model of arthritis. These findings suggest that treatment of mouse bone marrow derived DCs with carvacrol and thermal stress induce a functionally tolerogenic DC that can suppress autoimmune arthritis. Herewith carvacrol seems to offer novel opportunities for the development of a dietary based intervention in chronic inflammatory diseases.	[Spiering, Rachel; van der Zee, Ruurd; Wagenaar, Josee; van Eden, Willem; Broere, Femke] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Kapetis, Dimos; Zolezzi, Francesca] Univ Milano Bicocca, Genopolis, Dept Biotechnol & Biosci, Milan, Italy	Utrecht University; University of Milano-Bicocca	Broere, F (corresponding author), Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands.	f.broere@uu.nl	van der Zee, Ruurd/O-5256-2015	van der Zee, Ruurd/0000-0002-4331-2755; Broere, Femke/0000-0001-9343-0111; van Eden, Willem/0000-0003-1272-704X	Innovatiegerichte Onderzoeksprogramma (IOP) Genomics [IGE07004]; European Union FP7 TOLERAGE [HEALTH-F4-2008-20215]; Dutch Arthritis Association	Innovatiegerichte Onderzoeksprogramma (IOP) Genomics; European Union FP7 TOLERAGE; Dutch Arthritis Association	Innovatiegerichte Onderzoeksprogramma (IOP) Genomics: IGE07004 (http://www.agentschapnl.nl/en) European Union FP7 TOLERAGE: HEALTH-F4-2008-20215 (http://www.tolerage.eu/) Dutch Arthritis Association (http://www.reumafonds.nl/informatie-voor-doelgroepen/professionals/research-funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bles N, 2010, BLOOD, V116, P3219, DOI 10.1182/blood-2010-01-265611; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Broere F, 2008, J IMMUNOL, V181, P899, DOI 10.4049/jimmunol.181.2.899; Bruhl H, 2004, J IMMUNOL, V172, P890, DOI 10.4049/jimmunol.172.2.890; Charbonnier LM, 2006, J IMMUNOL, V177, P3806, DOI 10.4049/jimmunol.177.6.3806; deSchoolmeester ML, 2003, J IMMUNOL, V170, P4693, DOI 10.4049/jimmunol.170.9.4693; Detanico T, 2004, CLIN EXP IMMUNOL, V135, P336, DOI 10.1111/j.1365-2249.2004.02351.x; Driesen J, 2008, IMMUNOBIOLOGY, V213, P849, DOI 10.1016/j.imbio.2008.07.026; Hanyecz A, 2004, ARTHRITIS RHEUM-US, V50, P1665, DOI 10.1002/art.20180; Healy Louise J, 2008, Open Rheumatol J, V2, P71, DOI 10.2174/1874312900802010071; Hotta M, 2010, J LIPID RES, V51, P132, DOI 10.1194/jlr.M900255-JLR200; Huh S, 2007, J MICROBIOL BIOTECHN, V17, P348; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Landa P, 2009, ARCH PHARM RES, V32, P75, DOI 10.1007/s12272-009-1120-6; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; LYNES MA, 1993, TOXICOLOGY, V85, P161, DOI 10.1016/0300-483X(93)90040-Y; Morita Y, 2001, J CLIN INVEST, V107, P1275, DOI 10.1172/JCI11490; Motta A, 2007, IMMUNOLOGY, V121, P462, DOI 10.1111/j.1365-2567.2007.02564.x; Ostberg JR, 2006, CANCER IMMUNOL IMMUN, V55, P292, DOI 10.1007/s00262-005-0689-y; Reus IS, 2003, J BIOCHEM MOL TOXIC, V17, P161, DOI 10.1002/jbt.10074; Salazar L, 2008, ANN RHEUM DIS, V67, P1235, DOI 10.1136/ard.2007.072199; Singh IS, 2002, J BIOL CHEM, V277, P4981, DOI 10.1074/jbc.M108154200; Singh IS, 2000, J BIOL CHEM, V275, P9841, DOI 10.1074/jbc.275.13.9841; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stoop JN, 2011, ANN RHEUM DIS, V70, P1526, DOI 10.1136/ard.2011.151654; Stoop JN, 2010, ARTHRITIS RHEUM-US, V62, P3656, DOI 10.1002/art.27756; Thomson AW, 2008, ANN RHEUM DIS, V67, P90, DOI 10.1136/ard.2008.099176; Torres-Aguilar H, 2010, AUTOIMMUN REV, V10, P8, DOI 10.1016/j.autrev.2010.07.015; van Duivenvoorde LM, 2007, J IMMUNOL, V179, P1506, DOI 10.4049/jimmunol.179.3.1506; Wieten L, 2010, ARTHRITIS RHEUM-US, V62, P1026, DOI 10.1002/art.27344; Wieten L, 2010, CELL STRESS CHAPERON, V15, P25, DOI 10.1007/s12192-009-0119-8; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xu J, 2008, LETT APPL MICROBIOL, V47, P174, DOI 10.1111/j.1472-765X.2008.02407.x; Yamane S, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-5; Yanishlieva NV, 1999, FOOD CHEM, V64, P59, DOI 10.1016/S0308-8146(98)00086-7; Yoo CG, 2000, J IMMUNOL, V164, P5416, DOI 10.4049/jimmunol.164.10.5416; YOUN J, 1995, J TOXICOL ENV HEALTH, V45, P397, DOI 10.1080/15287399509532004; Youn J, 1999, TOXICOL SCI, V52, P199, DOI 10.1093/toxsci/52.2.199; Youn J, 2002, CLIN EXP IMMUNOL, V129, P232, DOI 10.1046/j.1365-2249.2002.01922.x	41	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46336	10.1371/journal.pone.0046336	http://dx.doi.org/10.1371/journal.pone.0046336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050016	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100180
J	Hammerschlag, N; Luo, JG; Irschick, DJ; Ault, JS				Hammerschlag, Neil; Luo, Jiangang; Irschick, Duncan J.; Ault, Jerald S.			A Comparison of Spatial and Movement Patterns between Sympatric Predators: Bull Sharks (Carcharhinus leucas) and Atlantic Tarpon (Megalops atlanticus)	PLOS ONE			English	Article							ECOLOGICAL CONSEQUENCES; FRACTAL DIMENSION; HABITAT USE; RISK; CONSERVATION; FLORIDA; FISH; OSMOREGULATION; ELASMOBRANCHS; COMMUNITIES	Background: Predators can impact ecosystems through trophic cascades such that differential patterns in habitat use can lead to spatiotemporal variation in top down forcing on community dynamics. Thus, improved understanding of predator movements is important for evaluating the potential ecosystem effects of their declines. Methodology/Principal Findings: We satellite-tagged an apex predator (bull sharks, Carcharhinus leucas) and a sympatric mesopredator (Atlantic tarpon, Megalops atlanticus) in southern Florida waters to describe their habitat use, abundance and movement patterns. We asked four questions: (1) How do the seasonal abundance patterns of bull sharks and tarpon compare? (2) How do the movement patterns of bull sharks and tarpon compare, and what proportion of time do their respective primary ranges overlap? (3) Do tarpon movement patterns (e.g., straight versus convoluted paths) and/or their rates of movement (ROM) differ in areas of low versus high bull shark abundance? and (4) Can any general conclusions be reached concerning whether tarpon may mitigate risk of predation by sharks when they are in areas of high bull shark abundance? Conclusions/Significance: Despite similarities in diet, bull sharks and tarpon showed little overlap in habitat use. Bull shark abundance was high year-round, but peaked in winter; while tarpon abundance and fishery catches were highest in late spring. However, presence of the largest sharks (>230 cm) coincided with peak tarpon abundance. When moving over deep open waters (areas of high shark abundance and high food availability) tarpon maintained relatively high ROM in directed lines until reaching shallow structurally-complex areas. At such locations, tarpon exhibited slow tortuous movements over relatively long time periods indicative of foraging. Tarpon periodically concentrated up rivers, where tracked bull sharks were absent. We propose that tarpon trade-off energetic costs of both food assimilation and osmoregulation to reduce predation risk by bull sharks.	[Hammerschlag, Neil; Luo, Jiangang; Ault, Jerald S.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [Hammerschlag, Neil] Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33124 USA; [Hammerschlag, Neil] Univ Miami, RJ Dunlap Marine Conservat Program, Miami, FL USA; [Irschick, Duncan J.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA	University of Miami; University of Miami; University of Miami; University of Massachusetts System; University of Massachusetts Amherst	Hammerschlag, N (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	nhammerschlag@rsmas.miami.edu	Ault, Jerald S/A-5241-2008	Ault, Jerald S/0000-0001-9657-8007	Batchelor Foundation; Wells-Fargo; RJ Dunlap Marine Conservation Program at the University of Miami (UM); Tarpon and Bonefish Research Center; Bonefish Tarpon Trust; Robertson Foundation	Batchelor Foundation; Wells-Fargo; RJ Dunlap Marine Conservation Program at the University of Miami (UM); Tarpon and Bonefish Research Center; Bonefish Tarpon Trust; Robertson Foundation	Funding for shark research was provided by the Batchelor Foundation, Wells-Fargo and the RJ Dunlap Marine Conservation Program at the University of Miami (UM); tarpon research was supported at the UM by the Tarpon and Bonefish Research Center through funding provided by the Bonefish & Tarpon Trust and the Robertson Foundation. The Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis D, 2009, ESTUAR COAST SHELF S, V85, P525, DOI 10.1016/j.ecss.2009.09.001; [Anonymous], [No title captured]; Ault J. S., 2010, PASSION TARPON, P266; Ault J.S, 2008, BIOL MANAGEMENT WORL; Ault JS, FISH RES IN PRESS; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Bernard Y., 2010, IMPROVING ARGOS DOPP; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Brunnschweiler JM, 2010, J FISH BIOL, V77, P1343, DOI 10.1111/j.1095-8649.2010.02757.x; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Cass-Calay Shannon L., 2009, Endangered Species Research, V7, P183, DOI 10.3354/esr00139; Compagno L.J.V., 2005, SHARKS WORLD; Cosner C, 1999, THEOR POPUL BIOL, V56, P65, DOI 10.1006/tpbi.1999.1414; Creel S, 2008, TRENDS ECOL EVOL, V23, P194, DOI 10.1016/j.tree.2007.12.004; Curtis TH, 2011, T AM FISH SOC, V140, P1213, DOI 10.1080/00028487.2011.618352; Depczynski M, 2007, OECOLOGIA, V153, P111, DOI 10.1007/s00442-007-0714-2; Dill LM, 2003, ECOLOGY, V84, P1151, DOI 10.1890/0012-9658(2003)084[1151:BMIIIM]2.0.CO;2; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; FEBRY R, 1987, J EXP BIOL, V128, P63; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fox J, 2008, APPL REGRESSION ANAL; Gaines SD, 2007, OCEANOGRAPHY, V20, P90, DOI 10.5670/oceanog.2007.32; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hammerschlag N, 2006, MAR FRESHW BEHAV PHY, V39, P209, DOI 10.1080/10236240600815820; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Hammerschlag Neil, 2011, Endangered Species Research, V13, P111, DOI 10.3354/esr00332; Hanson M. B., 2001, EVALUATION RELATIONS; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2009, J ANIM ECOL, V78, P556, DOI 10.1111/j.1365-2656.2008.01512.x; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Heupel MR, 2004, ENVIRON BIOL FISH, V71, P135, DOI 10.1023/B:EBFI.0000045710.18997.f7; Jayne BC, 2000, ECOLOGY, V81, P2969, DOI 10.2307/177394; Katajisto J, 2006, ECOL MODEL, V194, P405, DOI 10.1016/j.ecolmodel.2005.11.001; KENAGY GJ, 1989, ECOLOGY, V70, P1834, DOI 10.2307/1938116; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Luo JG, 2008, MAR ECOL PROG SER, V357, P101, DOI 10.3354/meps07288; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1049, DOI 10.1017/S0025315405012105; Mather F.J., 1963, INT COMM NW ATL FISH, V4, P288; Mill A, 2010, PASSION TARPON; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Nams VO, 1996, LANDSCAPE ECOL, V11, P289, DOI 10.1007/BF02059856; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Papastamatiou YP, 2012, J FISH BIOL, V80, P1342, DOI 10.1111/j.1095-8649.2012.03232.x; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Pillans RD, 2004, COMP BIOCHEM PHYS A, V138, P363, DOI 10.1016/j.cbpb.2004.05.006; Scott E. L., 1990, AM FISH SOC S, V7, P841; Sibert J, 2006, SCIENCE, V314, P1773, DOI 10.1126/science.1135347; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; Simpfendorfer CA, 2010, BIOL CONSERV, V143, P1460, DOI 10.1016/j.biocon.2010.03.021; Sims DW, 2010, CRC MAR BIOL SER, P351; STAMPS J, 1995, AM NAT, V146, P41, DOI 10.1086/285786; Torres LG, 2006, HYDROBIOLOGIA, V569, P449, DOI 10.1007/s10750-006-0148-6; Tremblay Y, 2006, J EXP BIOL, V209, P128, DOI 10.1242/jeb.01970; Tuma RE, 1973, INVESTIGATIONS ICHTH, P533; Weng KC, 2005, SCIENCE, V310, P104, DOI 10.1126/science.1114616; Weng KC, 2008, MAR ECOL PROG SER, V372, P253, DOI 10.3354/meps07706; WORTON BJ, 1995, J WILDLIFE MANAGE, V59, P794, DOI 10.2307/3801959	59	48	48	0	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45958	10.1371/journal.pone.0045958	http://dx.doi.org/10.1371/journal.pone.0045958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049904	Green Submitted, gold, Green Published			2022-12-27	WOS:000309517300067
J	Hu, JJ; Guo, H; Li, HY; Liu, Y; Liu, JJ; Chen, LW; Zhang, J; Zhang, N				Hu, Jiajia; Guo, Hua; Li, Hongyan; Liu, Yan; Liu, Jingjing; Chen, Liwei; Zhang, Jin; Zhang, Ning			MiR-145 Regulates Epithelial to Mesenchymal Transition of Breast Cancer Cells by Targeting Oct4	PLOS ONE			English	Article							EXPRESSION; INDUCTION; METASTASIS; MICRORNAS; CARCINOMA; INVASION; MICHIP; ARRAY; ZEB1; ZETA	MiR-145 could regulate tumor growth, apoptosis, migration, and invasion. In our present study, we investigated its role in epithelial-mesenchymal transition (EMT). Expression of miR-145 was decreased in breast tumor tissues at T3&4 stages in comparison with those at T1&2. Over-expression of miR-145 mimics enhanced protein levels of E-cadherin and dampened those of alpha-SMA and Fibronectin, indicative of its inhibitory role in EMT occurrence. Mechanistic studies showed that miR-145 mimics inhibited Oct4 expression and miR-145 inhibitor enhanced it. Over-expression of Oct4 reversed miR-145-regulated expression of EMT markers, suggesting that Oct4 mediated the inhibitory effects of miR-145. MiR-145 could inhibite the expression of Snail, ZEB1, and ZEB2, while over-expression of Oct4 rescued the effects. Furthermore, Oct-4 induced overexpression of transcription factor Snail, ZEB1 and ZEB2 was mediated by beta-catenin. Expression of Slug and Twist were not altered by miR-145/Oct4. Taken together, our results have revealed a novel role of miR-145 on EMT. It inhibits EMT by blocking the expression of Oct4, and downstream transcriptional factors, Snail, ZEB1 and ZEB2.	[Hu, Jiajia; Zhang, Ning] Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China; [Guo, Hua; Li, Hongyan; Liu, Yan; Chen, Liwei; Zhang, Ning] Canc Inst & Hosp, Canc Cell Biol Lab, Key Lab Breast Canc Prevent & Therapy, Tianjin, Peoples R China; [Liu, Jingjing; Zhang, Jin] Canc Inst & Hosp, Dept Breast Canc 3, Tianjin, Peoples R China	Tianjin Medical University	Zhang, N (corresponding author), Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China.	nzhangchina@yahoo.com			founders of the National Scientific Foundation of China (NSFC) [81072160]; 973 program [2011CB933100, 2010CB933900]; founders of the Changjiang Scholars and Innovative Research Team in University in China [IRT 1076]	founders of the National Scientific Foundation of China (NSFC); 973 program(National Basic Research Program of China); founders of the Changjiang Scholars and Innovative Research Team in University in China	The founders of the National Scientific Foundation of China (NSFC #81072160) and 973 program grants (#2011CB933100 and #2010CB933900) had roles in providing financial support. The founders of Tianjin Science and Technology Higher Education Development fund (#20090138), The Key (Key grant) Project of Chinese Ministry of Education (#211010), Tianjin Health Bureau Technology Fund (#2010KZ73) had roles in study design. The founders of the Changjiang Scholars and Innovative Research Team in University in China (Grant IRT 1076), Tianjin Medical University Innovation Fund 146-200007 had roles in providing reagents and materials.	Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Castoldi M, 2008, NAT PROTOC, V3, P321, DOI 10.1038/nprot.2008.4; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen J, 2011, GYNECOL ONCOL, V121, P200, DOI 10.1016/j.ygyno.2010.12.339; Chen XQ, 2010, CANCER RES, V70, P2728, DOI 10.1158/0008-5472.CAN-09-3718; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Deng Y, 2011, INT J BIOL SCI, V7, P133, DOI 10.7150/ijbs.7.133; Divijendra S, 2009, CANCER RES, V69, P5639, DOI 10.1158/0008-5472.CAN-09-0898; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Gotte M, 2010, ONCOGENE, V29, P6569, DOI 10.1038/onc.2010.386; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hammond SM, 2007, NAT GENET, V39, P582, DOI 10.1038/ng0507-582; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Huang FI, 2012, CARCINOGENESIS; Islam AMMK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024023; Kurasawa Y, 2011, ONCOGENE; La Rocca G, 2009, J CELL PHYSIOL, V220, P485, DOI 10.1002/jcp.21796; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Oliveras-Ferraros C, 2011, CELL CYCLE, V10, P1144, DOI 10.4161/cc.10.7.15210; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Sun RH, 2005, CANCER RES, V65, P1433, DOI 10.1158/0008-5472.CAN-04-1163; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Valastyan S, 2011, GENE DEV, V25, P646, DOI 10.1101/gad.2004211; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zhang F, 2010, CANCER RES, V70, P9360, DOI 10.1158/0008-5472.CAN-10-0207	36	67	70	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45965	10.1371/journal.pone.0045965	http://dx.doi.org/10.1371/journal.pone.0045965			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049906	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300068
J	Kreuzer, PM; Landgrebe, M; Schecklmann, M; Staudinger, S; Langguth, B				Kreuzer, Peter M.; Landgrebe, Michael; Schecklmann, Martin; Staudinger, Susanne; Langguth, Berthold		TRI Database Study Grp	Trauma-Associated Tinnitus: Audiological, Demographic and Clinical Characteristics	PLOS ONE			English	Article							OPERATION IRAQI FREEDOM; BRAIN-INJURY; DEPRESSION; ANXIETY; SEVERITY; SENSITIVITY; DYSFUNCTION; INVENTORY; ANNOYANCE; ATTENTION	Background: Tinnitus can result from different etiologies. Frequently, patients report the development of tinnitus after traumatic injuries. However, to which extent this specific etiologic factor plays a role for the phenomenology of tinnitus is still incompletely understood. Additionally, it remains a matter of debate whether the etiology of tinnitus constitutes a relevant criterion for defining tinnitus subtypes. Objective: By investigating a worldwide sample of tinnitus patients derived from the Tinnitus Research Initiative (TRI) Database, we aimed to identify differences in demographic, clinical and audiological characteristics between tinnitus patients with and without preceding trauma. Materials: A total of 1,604 patients were investigated. Assessment included demographic data, tinnitus related clinical data, audiological data, the Tinnitus Handicap Inventory, the Tinnitus Questionnaire, the Beck Depression Inventory, various numeric tinnitus rating scales, and the World Health Organisation Quality of Life Scale (WHOQoL). Results: Our data clearly indicate differences between tinnitus patients with and without trauma at tinnitus onset. Patients suffering from trauma-associated tinnitus suffer from a higher mental burden than tinnitus patients presenting with phantom perceptions based on other or unknown etiologic factors. This is especially the case for patients with whiplash and head trauma. Patients with posttraumatic noise-related tinnitus experience more frequently hyperacousis, were younger, had longer tinnitus duration, and were more frequently of male gender. Conclusions: Trauma before tinnitus onset seems to represent a relevant criterion for subtypization of tinnitus. Patients with posttraumatic tinnitus may require specific diagnostic and therapeutic management. A more systematic and - at best standardized assessment for hearing related sequelae of trauma is needed for a better understanding of the underlying pathophysiology and for developing more tailored treatment approaches as well.	[Kreuzer, Peter M.; Landgrebe, Michael; Schecklmann, Martin; Staudinger, Susanne; Langguth, Berthold] Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany; [Landgrebe, Michael] Sozialstiftung Bamberg, Dept Psychiat Psychosomat Med & Psychotherapy, Bamberg, Germany	University of Regensburg	Kreuzer, PM (corresponding author), Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany.	peter.kreuzer@medbo.de	Langguth, Berthold/AAP-2638-2021; Kleinjung, Tobias/AAJ-3141-2020; Coelho, Claudia/J-6250-2016	Kleinjung, Tobias/0000-0003-3867-234X; Coelho, Claudia/0000-0002-2441-0739; Vanneste, Sven/0000-0003-1513-5752	Tinnitus Research Initiative/TRI	Tinnitus Research Initiative/TRI	The study was supported by the Tinnitus Research Initiative/TRI (www.tinnitusresearch.org). All authors confirm no conflicts of interest in regard to the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamchic L, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00018; Andersson G, 2009, J AM ACAD AUDIOL, V20, P315, DOI 10.3766/jaaa.20.5.5; AXELSSON A, 1985, British Journal of Audiology, V19, P271, DOI 10.3109/03005368509078983; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Belli S, 2008, EUR ARCH OTO-RHINO-L, V265, P279, DOI 10.1007/s00405-007-0440-8; Boniver Raymond, 2002, Int Tinnitus J, V8, P129; Budd RJ, 1996, J PSYCHOSOM RES, V41, P327, DOI 10.1016/S0022-3999(96)00171-7; Crocetti A, 2009, OTOLARYNG HEAD NECK, V140, P403, DOI 10.1016/j.otohns.2008.11.036; Cronlein T, 2007, PROG BRAIN RES, V166, P227, DOI 10.1016/S0079-6123(07)66021-X; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Dobie RA, 2003, OTOLARYNG CLIN N AM, V36, P383, DOI 10.1016/S0030-6665(02)00168-8; Fausti SA, 2009, J REHABIL RES DEV, V46, P797, DOI 10.1682/JRRD.2008.09.0118; Folmer RL, 2003, LARYNGOSCOPE, V113, P821, DOI 10.1097/00005537-200305000-00010; Folmer RL, 1999, OTOLARYNG HEAD NECK, V121, P48, DOI 10.1016/S0194-5998(99)70123-3; Geckle L, 2004, SOLDIER PERCEPTIONS; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; HALFORD JBS, 1991, J PSYCHOSOM RES, V35, P383, DOI 10.1016/0022-3999(91)90033-K; HALLAM RS, 1988, BRIT J CLIN PSYCHOL, V27, P213, DOI 10.1111/j.2044-8260.1988.tb00778.x; Hesser H, 2009, INT J AUDIOL, V48, P295, DOI 10.1080/14992020802635325; Hiller W, 2006, ARCH OTOLARYNGOL, V132, P1323, DOI 10.1001/archotol.132.12.1323; Hinton DE, 2006, J TRAUMA STRESS, V19, P541, DOI 10.1002/jts.20138; Jacobson G P, 2001, J Am Acad Audiol, V12, P493; Jury MA, 2001, NEW ZEAL MED J, V114, P286; Landgrebe M, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-42; Langguth B, 2007, PROG BRAIN RES, V166, P221, DOI 10.1016/S0079-6123(07)66020-8; Langguth B, 2011, WORLD J BIOL PSYCHIA, V12, P489, DOI 10.3109/15622975.2011.575178; Leske M C, 1981, ASHA, V23, P229; Lew HL, 2007, J REHABIL RES DEV, V44, P921, DOI 10.1682/JRRD.2007.09.0140; Lewis J E, 2002, J Am Acad Audiol, V13, P339; LEWIS JE, 1994, CLIN OTOLARYNGOL, V19, P50, DOI 10.1111/j.1365-2273.1994.tb01147.x; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; MacGregor AJ, 2010, J HEAD TRAUMA REHAB, V25, P1, DOI 10.1097/HTR.0b013e3181c2993d; Malouff JM, 2011, CURR PSYCHIAT REP, V13, P31, DOI 10.1007/s11920-010-0163-1; Mao J. C., 2011, J NEUROTRAUMA; Marciano E, 2003, INT J AUDIOL, V42, P4, DOI 10.3109/14992020309056079; Moller AR, 2011, TEXTBOOK OF TINNITUS, P1; Nageris Ben I., 2008, Journal of Basic and Clinical Physiology and Pharmacology, V19, P185; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Nicolas-Puel Cecile, 2006, Int Tinnitus J, V12, P64; Nolle C, 2004, J NEUROTRAUM, V21, P251, DOI 10.1089/089771504322972040; Potier M, 2009, EAR HEARING, V30, P291, DOI 10.1097/AUD.0b013e31819769fc; Quintanilla-Dieck MD, 2009, J PEDIATR-US, V155, P550, DOI 10.1016/j.jpeds.2009.04.053; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Schlee W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027379; Shida S, 1990, Nihon Jibiinkoka Gakkai Kaiho, V93, P1823; Sindhusake Doungkamol, 2004, J Am Acad Audiol, V15, P269; STEER RA, 1986, J CLIN PSYCHOL, V42, P475, DOI 10.1002/1097-4679(198605)42:3<475::AID-JCLP2270420311>3.0.CO;2-D; Stevens C, 2007, INT J AUDIOL, V46, P208, DOI 10.1080/14992020601102329; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Turner Oliver, 2007, Ann Gen Psychiatry, V6, P26, DOI 10.1186/1744-859X-6-26; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; World Health Organization [WHO], 1996, WHOQOL BREF INTR ADM; Yankaskas K, 2012, HEAR RES	55	28	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45599	10.1371/journal.pone.0045599	http://dx.doi.org/10.1371/journal.pone.0045599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049821	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300037
J	Leoncini, E; Prata, C; Malaguti, M; Marotti, I; Segura-Carretero, A; Catizone, P; Dinelli, G; Hrelia, S				Leoncini, Emanuela; Prata, Cecilia; Malaguti, Marco; Marotti, Ilaria; Segura-Carretero, Antonio; Catizone, Pietro; Dinelli, Giovanni; Hrelia, Silvana			Phytochemical Profile and Nutraceutical Value of Old and Modern Common Wheat Cultivars	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; TRITICUM-AESTIVUM L.; PHASE-II ENZYMES; ANTIOXIDANT ACTIVITY; PHENOLIC-COMPOUNDS; OXIDATIVE STRESS; HEALTH-BENEFITS; NEURODEGENERATIVE DISEASES; CEREAL-GRAINS; WHOLE GRAINS	Among health-promoting phytochemicals in whole grains, phenolic compounds have gained attention as they have strong antioxidant properties and can protect against many degenerative diseases. Aim of this study was to profile grain phenolic extracts of one modern and five old common wheat (Triticum aestivum L.) varieties and to evaluate their potential antiproliferative or cytoprotective effect in different cell culture systems. Wheat extracts were characterized in terms of antioxidant activity and phenolic composition (HPLC/ESI-TOF-MS profile, polyphenol and flavonoid contents). Results showed that antioxidant activity (FRAP and DPPH) is mostly influenced by flavonoid (both bound and free) content and by the ratio flavonoids/polyphenols. Using a leukemic cell line, HL60, and primary cultures of neonatal rat cardiomyocytes, the potential antiproliferative or cytoprotective effects of different wheat genotypes were evaluated in terms of intracellular reactive oxygen species levels and cell viability. All tested wheat phenolic extracts exerted dose-dependent cytoprotective and antiproliferative effects on cardiomyocytes and HL60 cells, respectively. Due to the peculiar phenolic pattern of each wheat variety, a significant genotype effect was highlighted. On the whole, the most relevant scavenging effect was found for the old variety Verna. No significant differences in terms of anti-proliferative activities among wheat genotypes was observed. Results reported in this study evidenced a correspondence between the in vitro antioxidant activity and potential healthy properties of different extracts. This suggests that an increased intake of wheat grain derived products could represent an effective strategy to achieve both chemoprevention and protection against oxidative stress related diseases.	[Leoncini, Emanuela; Prata, Cecilia; Malaguti, Marco; Hrelia, Silvana] Univ Bologna, Dept Biochem, I-40126 Bologna, Italy; [Marotti, Ilaria; Catizone, Pietro; Dinelli, Giovanni] Univ Bologna, Dept Agroenvironm Sci & Technol, Bologna, Italy; [Segura-Carretero, Antonio] Univ Granada, Dept Analyt Chem, E-18071 Granada, Spain	University of Bologna; University of Bologna; University of Granada	Hrelia, S (corresponding author), Univ Bologna, Dept Biochem, I-40126 Bologna, Italy.	silvana.hrelia@unibo.it	Carretero, Antonio Segura/B-6867-2014; Hrelia, Silvana/P-2864-2015; Malaguti, Marco/K-5994-2015	Carretero, Antonio Segura/0000-0002-5564-5338; Hrelia, Silvana/0000-0001-7857-4512; Malaguti, Marco/0000-0003-0349-7772; Dinelli, Giovanni/0000-0003-1740-3511	Italian Ministry of Economic Development, Emilia Romagna region, Italy [CUP J31J09000430002]; Italian Ministry of Agriculture [CUP 31J09000370001]; Fondazione del Monte di Bologna e Ravenna (Italy)	Italian Ministry of Economic Development, Emilia Romagna region, Italy; Italian Ministry of Agriculture; Fondazione del Monte di Bologna e Ravenna (Italy)(Fondazione del Monte di Bologna e Ravenna)	This work was supported by grants from the Italian Ministry of Economic Development (Project "Made in Italy-over 50"), Emilia Romagna region, Italy (Project "BioPane", CUP J31J09000430002) and the Italian Ministry of Agriculture (Project "Pane della salute" MiPAF-OIGA, CUP 31J09000370001) and by Fondazione del Monte di Bologna e Ravenna (Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adom KK, 2003, J AGR FOOD CHEM, V51, P7825, DOI 10.1021/jf030404l; Adom KK, 2002, J AGR FOOD CHEM, V50, P6182, DOI 10.1021/jf0205099; Angeloni C, 2008, AM J PHYSIOL-HEART C, V294, pH1233, DOI 10.1152/ajpheart.01091.2007; Angeloni C, 2007, BIOCHIMIE, V89, P73, DOI 10.1016/j.biochi.2006.09.006; Angeloni C, 2011, AM J PHYSIOL-HEART C, V300, pH2196, DOI 10.1152/ajpheart.00934.2010; Angeloni C, 2009, J AGR FOOD CHEM, V57, P5615, DOI 10.1021/jf900549c; Bach-Faig A, 2011, PUBLIC HEALTH NUTR, V14, P2274, DOI 10.1017/S1368980011002515; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bilodeau M, 2002, J MULTIVARIATE ANAL, V82, P457, DOI 10.1006/jmva.2001.2027; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Bonfili L, 2009, BIOCHIMIE, V91, P1131, DOI 10.1016/j.biochi.2009.06.001; Chen CM, 2008, J NEUROSCI RES, V86, P2696, DOI 10.1002/jnr.21706; Chen LJ, 2003, CHEM RES TOXICOL, V16, P1155, DOI 10.1021/tx0340605; Chlopicka J, 2012, LWT-FOOD SCI TECHNOL, V46, P548, DOI 10.1016/j.lwt.2011.11.009; Clerkin JS, 2008, CANCER LETT, V266, P30, DOI 10.1016/j.canlet.2008.02.029; Danielson SR, 2008, FREE RADICAL BIO MED, V44, P1787, DOI 10.1016/j.freeradbiomed.2008.03.005; de Munter JSL, 2007, PLOS MED, V4, P1385, DOI 10.1371/journal.pmed.0040261; Di Silvestro R, 2012, J SCI FOOD AGR, V92, P2800, DOI 10.1002/jsfa.5590; Dinelli G, 2007, ELECTROPHORESIS, V28, P4212, DOI 10.1002/elps.200700301; Dinelli G, 2011, J CHROMATOGR A, V1218, P7670, DOI 10.1016/j.chroma.2011.05.065; Dinelli G, 2009, J CHROMATOGR A, V1216, P7229, DOI 10.1016/j.chroma.2009.08.041; Diplock AT, 1999, BRIT J NUTR, V81, pS1, DOI 10.1017/S0007114599000471; Dykes L, 2007, CEREAL FOOD WORLD, V52, P105, DOI 10.1094/CFW-52-3-0105; Eilat-Adar S, 2010, NUTR METAB CARDIOVAS, V20, P459, DOI 10.1016/j.numecd.2010.01.011; Fardet A, 2010, NUTR RES REV, V23, P65, DOI 10.1017/S0954422410000041; Felice F, 2012, EUR J PHARM BIOPHARM, V80, P176, DOI 10.1016/j.ejpb.2011.09.002; FENG Y, 1988, CEREAL CHEM, V65, P452; Flight I, 2006, EUR J CLIN NUTR, V60, P1145, DOI 10.1038/sj.ejcn.1602435; Fraga CG, 2010, MOL ASPECTS MED, V31, P435, DOI 10.1016/j.mam.2010.09.006; Halliwell B., 2007, FREE RADICAL BIOL ME; Harris KA, 2010, CURR ATHEROSCLER REP, V12, P368, DOI 10.1007/s11883-010-0136-1; Heimler D, 2010, J AGR FOOD CHEM, V58, P7329, DOI 10.1021/jf1010534; Jambu M, 1991, STAT MODELING DECISI; Jonnalagadda SS, 2011, J NUTR, V141, p1011S, DOI 10.3945/jn.110.132944; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kutala VK, 2007, ANTIOXID REDOX SIGN, V9, P1193, DOI 10.1089/ars.2007.1636; Lacikova L, 2009, MOLECULES, V14, P3259, DOI 10.3390/molecules14093259; LAM TBT, 1990, PHYTOCHEMISTRY, V29, P429, DOI 10.1016/0031-9422(90)85091-S; Leifert WR, 2008, NUTR RES, V28, P729, DOI 10.1016/j.nutres.2008.09.001; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Mattila P, 2005, J AGR FOOD CHEM, V53, P8290, DOI 10.1021/jf051437z; Matus-Cadiz MA, 2008, J AGR FOOD CHEM, V56, P1644, DOI 10.1021/jf072970c; MCCALLUM JA, 1990, CEREAL CHEM, V67, P282; Middleton E, 2000, PHARMACOL REV, V52, P673; Okarter N, 2010, CRIT REV FOOD SCI, V50, P193, DOI 10.1080/10408390802248734; Olenichenko NA, 2006, RUSS J PLANT PHYSL+, V53, P495, DOI 10.1134/S1021443706040108; Pauwels EKJ, 2010, MED PRIN PRACT, V20, P103, DOI 10.1159/000321197; Prata C, 2010, LEUKEMIA RES, V34, P1630, DOI 10.1016/j.leukres.2010.02.032; Price RK, 2012, BR J NUTR, P1; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; Serpen A, 2008, J AGR FOOD CHEM, V56, P7285, DOI 10.1021/jf8010855; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Tabachnick B. G., 2001, USING MULTIVARIATE S; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; van den Broeck HC, 2010, THEOR APPL GENET, V121, P1527, DOI 10.1007/s00122-010-1408-4; Yu LL, 2002, J AGR FOOD CHEM, V50, P1619, DOI 10.1021/jf010964p	58	56	58	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45997	10.1371/journal.pone.0045997	http://dx.doi.org/10.1371/journal.pone.0045997			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049918	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300073
J	Veracx, A; Rivet, R; McCoy, KD; Brouqui, P; Raoult, D				Veracx, Aurelie; Rivet, Romain; McCoy, Karen D.; Brouqui, Philippe; Raoult, Didier			Evidence That Head and Body Lice on Homeless Persons Have the Same Genotype	PLOS ONE			English	Article							BARTONELLA-QUINTANA; POPULATION-GENETICS; MITOCHONDRIAL-DNA; PHTHIRAPTERA; PEDICULIDAE; HUMANS; ORIGIN	Human head lice and body lice are morphologically and biologically similar but have distinct ecologies. They were shown to have almost the same basic genetic content (one gene is absent in head lice), but differentially express certain genes, presumably responsible for the vector competence. They are now believed to be ecotypes of the same species (Pediculus humanus) and based on mitochondrial studies, body lice have been included with head lice in one of three clades of human head lice (Clade A). Here, we tested whether head and body lice collected from the same host belong to the same population by examining highly polymorphic intergenic spacers. This study was performed on lice collected from five homeless persons living in the same shelter in which Clade A lice are prevalent. Lice were individually genotyped at four spacer loci. The genetic identity and diversity of lice from head and body populations were compared for each homeless person. Population genetic structure was tested between lice from the two body regions and between the lice from different host individuals. We found two pairs of head and body lice on the same homeless person with identical multi locus genotypes. No difference in genetic diversity was found between head and body louse populations and no evidence of significant structure between the louse populations was found, even after controlling for a possible effect of the host individual. More surprisingly, no structure was obvious between lice of different homeless persons. We believe that the head and body lice collected from our five subjects belong to the same population and are shared between people living in the same shelter. These findings confirm that head and body lice are two ecotypes of the same species and show the importance of implementing measures to prevent lice transmission between homeless people in shelters.	[Veracx, Aurelie; Rivet, Romain; Brouqui, Philippe; Raoult, Didier] Univ Aix Marseille, URMITE UMR 6236, CNRS IRD, Fac Med, Marseille, France; [McCoy, Karen D.] Ctr IRD, MIVEGEC UMR 5290, CNRS IRD UM1 UM2, Montpellier, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Raoult, D (corresponding author), Univ Aix Marseille, URMITE UMR 6236, CNRS IRD, Fac Med, Marseille, France.	Didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008; Brouqui, Philippe/P-5771-2016; McCoy, Karen D/F-7061-2012	RAOULT, Didier/0000-0002-0633-5974; McCoy, Karen D/0000-0002-8972-3808; RIVET, Romain/0000-0002-7290-6069				Amevigbe MDD, 2000, MED VET ENTOMOL, V14, P419, DOI 10.1046/j.1365-2915.2000.00260.x; Angelakis E, 2011, EMERG INFECT DIS, V17, P2357, DOI 10.3201/eid1712.110453; Angelakis E, 2011, FEMS IMMUNOL MED MIC, V62, P244, DOI 10.1111/j.1574-695X.2011.00804.x; Badiaga S, 2009, EUR J PUBLIC HLTH, V19; Badiaga S, 2008, EMERG INFECT DIS, V14, P1353, DOI 10.3201/eid1409.080204; Badiaga S, 2008, J ANTIMICROB CHEMOTH, V62, P404, DOI 10.1093/jac/dkn161; Bonilla DL, 2009, EMERG INFECT DIS, V15, P912, DOI 10.3201/eid1506.090054; Brouqui P, 2005, MEDICINE BALTIMORE, V84; Busvine J., 1985, CUTANEOUS INFESTATIO, P163; Busvine J. R., 1944, PROC ROY ENT SOC LONDON SER A, V19, P22; BUSVINE JR, 1978, SYST ENTOMOL, V3, P1, DOI 10.1111/j.1365-3113.1978.tb00383.x; BUXTON PA, 1946, LOUSE ACCOUNT LICE W; Cutler SJ, 2009, CLIN MICROBIOL INFEC, V15; de Meeus T, 2007, INFECT GENET EVOL, V7, P308, DOI 10.1016/j.meegid.2006.07.003; Durden Lance A., 2002, P45, DOI 10.1016/B978-012510451-7/50006-2; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Kim JH, 2011, INSECT BIOCHEM MOLEC, V41, P332, DOI 10.1016/j.ibmb.2011.01.011; Kittler R, 2003, CURR BIOL, V13, P1414, DOI 10.1016/S0960-9822(03)00507-4; Leo NP, 2005, HEREDITY, V95, P34, DOI 10.1038/sj.hdy.6800663; Leo NP, 2002, J MED ENTOMOL, V39, P662, DOI 10.1603/0022-2585-39.4.662; Li WJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000641; Light JE, 2008, MOL PHYLOGENET EVOL, V47, P1203, DOI 10.1016/j.ympev.2008.03.014; McMeniman CJ, 2006, HEREDITY, V96, P63, DOI 10.1038/sj.hdy.6800760; Nuttall G. H. F., 1920, Parasitology Cambridge, V12, DOI 10.1017/S0031182000014098; Olds BP, 2012, INSECT MOL BIOL, V21, P257, DOI 10.1111/j.1365-2583.2012.01132.x; Raoult D, 1999, CLIN INFECT DIS, V29; Raoult D, 2008, J INFECT DIS, P197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Sasaki T, 2006, J MED ENTOMOL, V43, P110, DOI 10.1603/0022-2585(2006)043[0110:FMEOBQ]2.0.CO;2; Sasaki-Fukatsu K, 2006, APPL ENV MICROBIOL, V72; Schaefer CW, 1978, T R SOC TROP MED HYG, V72; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Toups MA, 2011, MOL BIOL EVOL, V28, P29, DOI 10.1093/molbev/msq234; Veracx A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037804; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yong Z, 2003, C R BIOL, V326	40	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45903	10.1371/journal.pone.0045903	http://dx.doi.org/10.1371/journal.pone.0045903			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049889	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300063
J	Bernard, JA; Seidler, RD				Bernard, Jessica A.; Seidler, Rachael D.			Hand Dominance and Age Have Interactive Effects on Motor Cortical Representations	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INTERHEMISPHERIC-TRANSFER TIME; HUMAN CORPUS-CALLOSUM; INTRACORTICAL INHIBITION; HEMISPHERIC-ASYMMETRY; EVOKED POTENTIALS; OLDER-ADULTS; HANDEDNESS; MUSCLE; PREFERENCE	Older adults exhibit more bilateral motor cortical activity during unimanual task performance than young adults. Interestingly, a similar pattern is seen in young adults with reduced hand dominance. However, older adults report stronger hand dominance than young adults, making it unclear how handedness is manifested in the aging motor cortex. Here, we investigated age differences in the relationships between handedness, motor cortical organization, and interhemispheric communication speed. We hypothesized that relationships between these variables would differ for young and older adults, consistent with our recent proposal of an age-related shift in interhemispheric interactions. We mapped motor cortical representations of the right and left first dorsal interosseous muscles using transcranial magnetic stimulation (TMS) in young and older adults recruited to represent a broad range of the handedness spectrum. We also measured interhemispheric communication speed and bimanual coordination. We observed that more strongly handed older adults exhibited more ipsilateral motor activity in response to TMS; this effect was not present in young adults. Furthermore, we found opposing relationships between interhemispheric communication speed and bimanual performance in the two age groups. Thus, handedness manifests itself differently in the motor cortices of young and older adults and has interactive effects with age.	[Bernard, Jessica A.; Seidler, Rachael D.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Seidler, Rachael D.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Bernard, JA (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	jessbern@umich.edu		Seidler, Rachael/0000-0003-2452-9024	National Institute on Aging [T32 AG000114]; UM Claude D. Pepper Older American Independence Center; NATIONAL INSTITUTE ON AGING [T32AG000114] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UM Claude D. Pepper Older American Independence Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J.A.B. is supported by National Institute on Aging T32 AG000114 (R. Miller, PI). This research was also supported by the UM Claude D. Pepper Older American Independence Center (human subjects' core). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 1996, EXP BRAIN RES, V111, P465; Bernard JA, 2012, NEUROBIOL AGING, V33, P1890, DOI 10.1016/j.neurobiolaging.2011.06.021; Bernard JA, 2011, J NEUROPHYSIOL, V105, P88, DOI 10.1152/jn.00512.2010; BIEGON A, 1994, NEUROBIOL AGING, V15, P393, DOI 10.1016/0197-4580(94)90070-1; BRINKMAN J, 1973, BRAIN, V96, P653, DOI 10.1093/brain/96.4.653; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Christie A, 2007, J NEUROSCI METH, V164, P320, DOI 10.1016/j.jneumeth.2007.05.011; Dassonville P, 1997, P NATL ACAD SCI USA, V94, P14015, DOI 10.1073/pnas.94.25.14015; Dittmar M, 2002, HUM BIOL, V74, P569, DOI 10.1353/hub.2002.0040; Fling BW, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00038; Fling BW, 2011, J COGNITIVE NEUROSCI, V23, P2171, DOI 10.1162/jocn.2010.21600; Fling BW, HUMAN BRAIN IN PRESS; Fling BW, NEUROBIOL A IN PRESS; Fling BW, CEREB CORTE IN PRESS; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; GILBERT AN, 1992, NEUROPSYCHOLOGIA, V30, P601, DOI 10.1016/0028-3932(92)90065-T; Hopkins WD, 2007, CEREB CORTEX, V17, P1757, DOI 10.1093/cercor/bhl086; Jeeves MA, 1996, NEUROPSYCHOLOGIA, V34, P627, DOI 10.1016/0028-3932(95)00157-3; Jung P, 2006, MUSCLE NERVE, V34, P431, DOI 10.1002/mus.20604; Karusu T.B., 1976, GERIATRIC PSYCHIAT, P77; KIM SG, 1993, SCIENCE, V261, P615, DOI 10.1126/science.8342027; Koerte I, 2010, DEV MED CHILD NEUROL, V52, P1106, DOI 10.1111/j.1469-8749.2010.03766.x; Langan J, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00017; Luders E, 2010, NEUROIMAGE, V52, P43, DOI 10.1016/j.neuroimage.2010.04.016; Manson SC, 2006, EXP BRAIN RES, V174, P728, DOI 10.1007/s00221-006-0517-4; Marzi CA, 1999, BRAIN RES BULL, V50, P421, DOI 10.1016/S0361-9230(99)00174-4; Mattay VS, 2002, NEUROLOGY, V58, P630, DOI 10.1212/WNL.58.4.630; McGinley M, 2010, EXP GERONTOL, V45, P671, DOI 10.1016/j.exger.2010.04.005; Naccarato M, 2006, NEUROIMAGE, V32, P1250, DOI 10.1016/j.neuroimage.2006.05.003; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ota M, 2006, NEUROIMAGE, V31, P1445, DOI 10.1016/j.neuroimage.2006.02.008; Poffenberger AT., 1912, ARCH PSYCHOL, V23, P1; PORAC C, 1993, CAN J EXP PSYCHOL, V47, P697, DOI 10.1037/h0078873; Reuter-Lorenz PA, 2005, CURR OPIN NEUROBIOL, V15, P245, DOI 10.1016/j.conb.2005.03.016; Reuter-Lorenz PA, 1999, PSYCHOL SCI, V10, P494, DOI 10.1111/1467-9280.00195; Reuter-Lorenz PA, 2002, TRENDS COGN SCI, V6, P394, DOI 10.1016/S1364-6613(02)01957-5; Saron CD, 2002, IS CL CO NE, P171; Schulte T, 2004, NEUROPSYCHOLOGIA, V42, P257, DOI 10.1016/S0028-3932(03)00155-6; Schulte T, 2010, NEUROPSYCHOL REV, V20, P174, DOI 10.1007/s11065-010-9130-1; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; Shinohara M, 2003, J APPL PHYSIOL, V94, P966, DOI 10.1152/japplphysiol.00836.2002; Siebner HR, 2002, J NEUROSCI, V22, P2816, DOI 10.1523/JNEUROSCI.22-07-02816.2002; Soteropoulos DS, 2011, J NEUROSCI, V31, P11208, DOI 10.1523/JNEUROSCI.0257-11.2011; Sparing R, 2008, HUM BRAIN MAPP, V29, P82, DOI 10.1002/hbm.20360; STEINGRUBER HJ, 1971, Z EXP ANGEW PSYCHOL, V18, P337; Stinear CM, 2003, J NEUROPHYSIOL, V89, P2014, DOI 10.1152/jn.00925.2002; Sullivan EV, 2010, NEUROBIOL AGING, V31, P464, DOI 10.1016/j.neurobiolaging.2008.04.007; Talelli P, 2008, NEUROIMAGE, V40, P1772, DOI 10.1016/j.neuroimage.2008.01.039; Talelli P, 2008, EXP BRAIN RES, V186, P59, DOI 10.1007/s00221-007-1205-8; Tettamanti M, 2002, J NEUROPHYSIOL, V88, P1051, DOI 10.1152/jn.2002.88.2.1051; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; TRIGGS WJ, 1994, BRAIN RES, V636, P270, DOI 10.1016/0006-8993(94)91026-X; Triggs WJ, 1999, BRAIN RES, V835, P324, DOI 10.1016/S0006-8993(99)01629-7; Wahl M, 2007, J NEUROSCI, V27, P12132, DOI 10.1523/JNEUROSCI.2320-07.2007; WASSERMANN EM, 1992, ELECTROEN CLIN NEURO, V85, P1, DOI 10.1016/0168-5597(92)90094-R; Westerhausen R, 2006, NEUROSCI LETT, V409, P140, DOI 10.1016/j.neulet.2006.09.028; WITELSON SF, 1985, SCIENCE, V229, P665, DOI 10.1126/science.4023705; WITELSON SF, 1989, BRAIN, V112, P799, DOI 10.1093/brain/112.3.799; Zaidel E, 2002, IS CL CO NE, P319; Ziemann U, 1999, J PHYSIOL-LONDON, V518, P895, DOI 10.1111/j.1469-7793.1999.0895p.x	61	13	14	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45443	10.1371/journal.pone.0045443	http://dx.doi.org/10.1371/journal.pone.0045443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049800	gold, Green Submitted, Green Published			2022-12-27	WOS:000309556100048
J	Chen, MB; Wu, XY; Yu, R; Li, C; Wang, LQ; Shen, W; Lu, PH				Chen, Min-Bin; Wu, Xiao-Yang; Yu, Rong; Li, Chen; Wang, Li-Qiang; Shen, Wei; Lu, Pei-Hua			P53 Status as a Predictive Biomarker for Patients Receiving Neoadjuvant Radiation-Based Treatment: A Meta-Analysis in Rectal Cancer	PLOS ONE			English	Article							PREOPERATIVE RADIOTHERAPY; TUMOR-REGRESSION; HISTOPATHOLOGIC RESPONSE; CHEMORADIATION THERAPY; THYMIDYLATE SYNTHASE; IONIZING-RADIATION; INDUCED APOPTOSIS; CHEMORADIOTHERAPY; EXPRESSION; CARCINOMA	Background: Numerous studies have yielded inconsistent results regarding the relationship between p53 status and the response to neoadjuvant radiation-based therapy in patients with rectal cancer. We conducted a meta-analysis to clarify the relationship between p53 status and response to radiation-based therapy in rectal cancer. Methods/Findings: A total of 30 previously published eligible studies including 1,830 cases were identified and included in this meta-analysis. Wild-type form of p53 status (low expression of p53 protein and/or wild-type p53 gene) was associated with pathologic response in rectal cancer patients who received neoadjuvant radiation-based therapy (good response: risk ratio [RR] = 1.30; 95% confidence intervals [CI] = 1.14-1.49; p<0.001; complete response RR = 1.65; 95% CI = 1.19-2.30; p = 0.003; poor response RR = 0.85; 95% CI = 0.75-0.96; p = 0.007). In further stratified analyses, this association remained for sub-groups of good and poor response in neoadjuvant radiotherapy (RT) setting, good and complete response in chemoradiotherapy (CRT) setting. And the association between response and the presence of p53 gene mutations was stronger than that between response and protein positivity. Conclusion: The results of the present meta-analysis indicate that P53 status is a predictive factor for response in rectal cancer patient undergoing neoadjuvant radiation-based therapy.	[Shen, Wei; Lu, Pei-Hua] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Gen Surg, Wuxi City, Jiangsu, Peoples R China; [Chen, Min-Bin; Wang, Li-Qiang] Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Med Oncol, Kunshan, Jiangsu, Peoples R China; [Wu, Xiao-Yang] Jiangsu Univ, Kunshan Peoples Hosp 1, Dept Surg Oncol, Kunshan, Jiangsu, Peoples R China; [Yu, Rong] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou Municipal Hosp, Dept Oncol, Suzhou, Jiangsu, Peoples R China; [Li, Chen] Nanjing Univ Chinese Med, Xuzhou Chinese Med Hosp, Dept Gastroenterol, Xuzhou, Jiangsu, Peoples R China	Jiangnan University; Nanjing Medical University; Jiangsu University; Jiangsu University; Nanjing Medical University; Nanjing University of Chinese Medicine	Lu, PH (corresponding author), Nanjing Med Univ, Wuxi Peoples Hosp, Dept Gen Surg, Wuxi City, Jiangsu, Peoples R China.	lphty1_1@yahoo.com.cn		Lu, Peihua/0000-0002-4622-3061	Natural Science Foundation of Jiangsu Province [BK2010160, BK2011374]; National Natural Science Foundation [81108676, 81101801]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of Jiangsu Province (BK2010160, BK2011374) and the National Natural Science Foundation (81108676, 81101801). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brophy S, 2009, INT J CANCER, V125, P2778, DOI 10.1002/ijc.24693; Charara M, 2004, ANTICANCER RES, V24, P3161; Chen MF, 2010, INT J RADIAT ONCOL, V78, P868, DOI 10.1016/j.ijrobp.2010.05.025; Chen ZB, 2011, J AM COLL SURGEONS, V212, P1008, DOI 10.1016/j.jamcollsurg.2011.02.024; Cuddihy AR, 2004, CANCER METAST REV, V23, P237, DOI 10.1023/B:CANC.0000031764.81141.e4; Diez M, 2003, ONCOLOGY-BASEL, V64, P213, DOI 10.1159/000069307; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Elsaleh H, 2000, RADIOTHER ONCOL, V56, P239, DOI 10.1016/S0167-8140(00)00184-5; Fu CG, 1998, DIS COLON RECTUM, V41, P68, DOI 10.1007/BF02236898; Huerta S, 2009, EXPERT REV MOL DIAGN, V9, P469, DOI 10.1586/ERM.09.26; Jakob C, 2008, WORLD J GASTROENTERO, V14, P1060, DOI 10.3748/wjg.14.1060; JapaneseSocietyforCanceroftheColonandRectum, 1994, GEN ROL CLIN PATH ST, P42; Kandioler D, 2002, ANN SURG, V235, P493, DOI 10.1097/00000658-200204000-00006; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Kelley Scott T, 2005, Clin Colorectal Cancer, V5, P114, DOI 10.3816/CCC.2005.n.023; Kobayashi H, 2007, DIS COLON RECTUM, V50, P1354, DOI 10.1007/s10350-006-0881-y; Komuro Y, 2005, HEPATO-GASTROENTEROL, V52, P666; Komuro Y, 2003, J EXP CLIN CANC RES, V22, P223; Lopez-Crapez E, 2005, BRIT J CANCER, V92, P2114, DOI 10.1038/sj.bjc.6602622; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Luna-Perez P, 1998, ANN SURG ONCOL, V5, P203, DOI 10.1007/BF02303772; MANDARD AM, 1994, CANCER, V73, P2680, DOI 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C; MERRITT AJ, 1994, CANCER RES, V54, P614; Moral M, 2009, PATHOL RES PRACT, V205, P695, DOI 10.1016/j.prp.2009.04.006; Garcia VM, 2011, COLORECTAL DIS, V13, P989, DOI 10.1111/j.1463-1318.2010.02386.x; Nasierowska-Guttmejer Anna, 2001, Polish Journal of Pathology, V52, P53; Negri FV, 2008, BRIT J CANCER, V98, P143, DOI 10.1038/sj.bjc.6604131; Rebischung C, 2002, INT J CANCER, V100, P131, DOI 10.1002/ijc.10480; Rodel C, 2005, J CLIN ONCOL, V23, P8688, DOI 10.1200/JCO.2005.02.1329; Rodel C, 2002, INT J RADIAT ONCOL, V52, P294, DOI 10.1016/S0360-3016(01)02643-8; Sadahiro S, 2007, HEPATO-GASTROENTEROL, V54, P1107; Sakakura C, 1998, BRIT J CANCER, V77, P159, DOI 10.1038/bjc.1998.25; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Saw RPM, 2003, DIS COLON RECTUM, V46, P192, DOI 10.1007/s10350-004-6524-2; Scott N, 1998, EUR J SURG ONCOL, V24, P169, DOI 10.1016/S0748-7983(98)92861-X; Shinto E, 2011, DIS COLON RECTUM, V54, P1098, DOI 10.1097/DCR.0b013e3182218155; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Smith FM, 2006, EJSO-EUR J SURG ONC, V32, P55, DOI 10.1016/j.ejso.2005.09.010; Spitz FR, 1997, CLIN CANCER RES, V3, P1685; Spitz FR, 1996, CLIN CANCER RES, V2, P1665; Suzuki T, 2004, JPN J CLIN ONCOL, V34, P740, DOI 10.1093/jjco/hyh140; Takeuchi K, 2007, HEPATO-GASTROENTEROL, V54, P367; Terzi C, 2008, INT J COLORECTAL DIS, V23, P37, DOI 10.1007/s00384-007-0376-x; Tewari M, 2008, SURG ONCOL, V17, P301, DOI 10.1016/j.suronc.2008.03.003; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wheeler JMD, 2002, DIS COLON RECTUM, V45, P1051, DOI 10.1007/s10350-004-6359-x; Wong RKS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002102.pub2; Zlobec I, 2008, BRIT J CANCER, V98, P450, DOI 10.1038/sj.bjc.6604172	50	51	56	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45388	10.1371/journal.pone.0045388	http://dx.doi.org/10.1371/journal.pone.0045388			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049793	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100043
J	Dalkmann, P; Broszat, M; Siebe, C; Willaschek, E; Sakinc, T; Huebner, J; Amelung, W; Grohmann, E; Siemens, J				Dalkmann, Philipp; Broszat, Melanie; Siebe, Christina; Willaschek, Elisha; Sakinc, Tuerkan; Huebner, Johannes; Amelung, Wulf; Grohmann, Elisabeth; Siemens, Jan			Accumulation of Pharmaceuticals, Enterococcus, and Resistance Genes in Soils Irrigated with Wastewater for Zero to 100 Years in Central Mexico	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; POTENTIAL ENDOCRINE; ACIDIC PHARMACEUTICALS; DISRUPTING COMPOUNDS; ORGANIC-MATTER; MANURE; SORPTION; FATE; MASS; CARBAMAZEPINE	Irrigation with wastewater releases pharmaceuticals, pathogenic bacteria, and resistance genes, but little is known about the accumulation of these contaminants in the environment when wastewater is applied for decades. We sampled a chronosequence of soils that were variously irrigated with wastewater from zero up to 100 years in the Mezquital Valley, Mexico, and investigated the accumulation of ciprofloxacin, enrofloxacin, sulfamethoxazole, trimethoprim, clarithromycin, carbamazepine, bezafibrate, naproxen, diclofenac, as well as the occurrence of Enterococcus spp., and sul and qnr resistance genes. Total concentrations of ciprofloxacin, sulfamethoxazole, and carbamazepine increased with irrigation duration reaching 95% of their upper limit of 1.4 mu g/kg (ciprofloxacin), 4.3 mu g/kg (sulfamethoxazole), and 5.4 mu g/kg (carbamazepine) in soils irrigated for 19-28 years. Accumulation was soil-type-specific, with largest accumulation rates in Leptosols and no time-trend in Vertisols. Acidic pharmaceuticals (diclofenac, naproxen, bezafibrate) were not retained and thus did not accumulate in soils. We did not detect qnrA genes, but qnrS and qnrB genes were found in two of the irrigated soils. Relative concentrations of sul1 genes in irrigated soils were two orders of magnitude larger (3.15x10(-3)+/- 0.22x10(-3) copies/16S rDNA) than in non-irrigated soils (4.35x10(-5)+/- 1.00x10(-5) copies/16S rDNA), while those of sul2 exceeded the ones in nonirrigated soils still by a factor of 22 (6.61x10(-4)+/- 0.59x10(-4) versus 2.99x10(-5)+/- 0.26x10(-5) copies/16S rDNA). Absolute numbers of sul genes continued to increase with prolonging irrigation together with Enterococcus spp. 23S rDNA and total 16S rDNA contents. Increasing total concentrations of antibiotics in soil are not accompanied by increasing relative abundances of resistance genes. Nevertheless, wastewater irrigation enlarges the absolute concentration of resistance genes in soils due to a long-term increase in total microbial biomass.	[Dalkmann, Philipp; Willaschek, Elisha; Amelung, Wulf; Siemens, Jan] Univ Bonn, Inst Crop Sci & Resource Conservat Soil Sci & Soi, Bonn, Germany; [Broszat, Melanie; Sakinc, Tuerkan; Huebner, Johannes; Grohmann, Elisabeth] Univ Hosp Freiburg, Dept Infect Dis, Freiburg, Germany; [Broszat, Melanie] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Siebe, Christina] Univ Nacl Autonoma Mexico, Inst Geol, Mexico City 04510, DF, Mexico	University of Bonn; University of Freiburg; University of Freiburg; Universidad Nacional Autonoma de Mexico	Dalkmann, P (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat Soil Sci & Soi, Bonn, Germany.	philipp.dalkmann@uni-bonn.de	Amelung, Wulf/H-2136-2013	Amelung, Wulf/0000-0002-4920-4667; Grohmann, Elisabeth/0000-0003-3061-6490; Huebner, Johannes/0000-0003-1232-4646; Siebe, Christina/0000-0002-2636-6778	German Research Foundation (DFG) [FI1106/5-1, GR1792/4-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants ( FI1106/5-1 and GR1792/4-1) from the German Research Foundation (DFG;http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abriouel H, 2008, INT J FOOD MICROBIOL, V123, P38, DOI 10.1016/j.ijfoodmicro.2007.11.067; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Ansari MI, 2008, J APPL MICROBIOL, V104, P1774, DOI 10.1111/j.1365-2672.2008.03736.x; Arsene S, 2007, ANTIMICROB AGENTS CH, V51, P3254, DOI 10.1128/AAC.00274-07; Baquero F, 2009, ENV MICROBIOL REP, V1, P469, DOI 10.1111/j.1758-2229.2009.00053.x; Barron L, 2009, ANALYST, V134, P663, DOI 10.1039/b817822d; Binh CTT, 2008, FEMS MICROBIOL ECOL, V66, P25, DOI 10.1111/j.1574-6941.2008.00526.x; Byrne-Bailey KG, 2009, ANTIMICROB AGENTS CH, V53, P696, DOI 10.1128/AAC.00652-07; Canton R, 2009, CLIN MICROBIOL INFEC, V15, P20, DOI 10.1111/j.1469-0691.2008.02679.x; Carballa M, 2007, WATER RES, V41, P2139, DOI 10.1016/j.watres.2007.02.012; Chavez A, 2011, ENVIRON POLLUT, V159, P1354, DOI 10.1016/j.envpol.2011.01.008; Chefetz B, 2008, CHEMOSPHERE, V73, P1335, DOI 10.1016/j.chemosphere.2008.06.070; Chen F, 2011, ENVIRON POLLUT, V159, P1490, DOI 10.1016/j.envpol.2011.03.016; Conkle JL, 2010, CHEMOSPHERE, V80, P1353, DOI 10.1016/j.chemosphere.2010.06.012; Cummings DE, 2011, ENVIRON SCI TECHNOL, V45, P447, DOI 10.1021/es1029206; da Silva MF, 2006, FEMS MICROBIOL ECOL, V55, P322, DOI 10.1111/j.1574-6941.2005.00032.x; Dashti AA, 2006, INT J ANTIMICROB AG, V27, P73, DOI 10.1016/j.ijantimicag.2005.09.007; Duran-Alvarez JC, 2012, CHEMOSPHERE, V88, P84, DOI 10.1016/j.chemosphere.2012.02.067; Duran-Alvarez JC, 2009, TALANTA, V78, P1159, DOI 10.1016/j.talanta.2009.01.035; FAO, 2007, STAT FOOD AGR 2007 2, P119; Figueroa-Diva RA, 2010, CHEMOSPHERE, V79, P786, DOI 10.1016/j.chemosphere.2010.03.017; Frahm E, 2003, J MICROBIOL METH, V52, P123, DOI 10.1016/S0167-7012(02)00150-1; Frank T, 2007, J ANTIMICROB CHEMOTH, V59, P742, DOI 10.1093/jac/dkl538; Friedel JK, 2000, BIOL FERT SOILS, V31, P414, DOI 10.1007/s003749900188; Gibson R, 2007, J CHROMATOGR A, V1169, P31, DOI 10.1016/j.chroma.2007.08.056; Gibson R, 2010, CHEMOSPHERE, V81, P1437, DOI 10.1016/j.chemosphere.2010.09.006; Gobel A, 2005, J CHROMATOGR A, V1085, P179, DOI 10.1016/j.chroma.2005.05.051; Golet EM, 2002, ANAL CHEM, V74, P5455, DOI 10.1021/ac025762m; Gulde S, 2008, SOIL SCI SOC AM J, V72, P605, DOI 10.2136/sssaj2007.0251; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Heuer H, 2008, SOIL BIOL BIOCHEM, V40, P1892, DOI 10.1016/j.soilbio.2008.03.014; Heuer H, 2007, ENVIRON MICROBIOL, V9, P657, DOI 10.1111/j.1462-2920.2006.01185.x; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Heuer H, 2011, APPL ENVIRON MICROB, V77, P2527, DOI 10.1128/AEM.02577-10; Igbinosa EO, 2011, INT J ENVIRON HEAL R, V21, P402, DOI 10.1080/09603123.2011.572278; IMS, 2008, IMS CHEM COUNTR PROF; IUSS, 2006, WORK GROUP WRB WORLD; Jimenez B, 2004, WATER SCI TECHNOL, V50, P269; JimenezCisneros B, 1995, WATER SCI TECHNOL, V32, P173, DOI 10.1016/0273-1223(96)00152-7; Juarez-Figueroa LA, 2003, SALUD PUBLICA MEXICO, V45, P389; Kinney CA, 2006, ENVIRON TOXICOL CHEM, V25, P317, DOI 10.1897/05-187R.1; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Kuhn I, 2003, INT J FOOD MICROBIOL, V88, P133, DOI 10.1016/S0168-1605(03)00176-4; Liu F, 2010, ENVIRON CHEM, V7, P370, DOI 10.1071/EN09160; Lobe I, 2005, SOIL BIOL BIOCHEM, V37, P1898, DOI 10.1016/j.soilbio.2005.02.030; da Costa PM, 2006, WATER RES, V40, P1735, DOI 10.1016/j.watres.2006.02.025; Mazari-Hiriart M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002305; Miao XS, 2005, ENVIRON SCI TECHNOL, V39, P7469, DOI 10.1021/es050261e; Monteiro SC, 2010, REV ENVIRON CONTAM T, V202, P53, DOI 10.1007/978-1-4419-1157-5_2; Munir M, 2011, J ENVIRON QUAL, V40, P248, DOI 10.2134/jeq2010.0209; Nordmann P, 2005, J ANTIMICROB CHEMOTH, V56, P463, DOI 10.1093/jac/dki245; Oyamada Y, 2006, J MED MICROBIOL, V55, P1395, DOI 10.1099/jmm.0.46636-0; Preger AC, 2010, EUR J SOIL SCI, V61, P551, DOI 10.1111/j.1365-2389.2010.01248.x; Raschid-Sally L., 2008, INT WATER MANAGEMENT; Rosendahl I, 2012, J ENVIRON QUAL, V41, P1275, DOI 10.2134/jeq2011.0459; Rysz M, 2004, WATER RES, V38, P3705, DOI 10.1016/j.watres.2004.06.015; Sava IG, 2010, J MED MICROBIOL, V59, P1001, DOI 10.1099/jmm.0.020578-0; Schluter A, 2003, MICROBIOL-SGM, V149, P3139, DOI 10.1099/mic.0.26570-0; Siebe C, 1998, SOIL USE MANAGE, V14, P119, DOI 10.1111/j.1475-2743.1998.tb00628.x; Siebe C, 1994, AKKUMULATION MOBILIT; Siebe Christina, 1995, International Journal of Environmental Health Research, V5, P161, DOI 10.1080/09603129509356845; Siemens J, 2008, WATER RES, V42, P2124, DOI 10.1016/j.watres.2007.11.019; Siemens J, 2010, J ENVIRON QUAL, V39, P1201, DOI 10.2134/jeq2009.0105; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Tamtam F, 2011, SCI TOTAL ENVIRON, V409, P540, DOI 10.1016/j.scitotenv.2010.10.033; Ternes TA, 2007, CHEMOSPHERE, V66, P894, DOI 10.1016/j.chemosphere.2006.06.035; Theilacker C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017839; UN/WWAP, 2006, 2 UNWWAP UNESCO; Vasudevan D, 2009, GEODERMA, V151, P68, DOI 10.1016/j.geoderma.2009.03.007; Verlicchi P, 2010, J HYDROL, V389, P416, DOI 10.1016/j.jhydrol.2010.06.005; Vincent Jean-Louis, 2009, Crit Care Med, V37, pS296, DOI 10.1097/CCM.0b013e3181b6f1e1; Wang AH, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-68; Wang CJ, 2010, J HAZARD MATER, V183, P309, DOI 10.1016/j.jhazmat.2010.07.025; Werner G, 2008, Euro Surveill, V13; Wright GD, 2010, CURR OPIN MICROBIOL, V13, P589, DOI 10.1016/j.mib.2010.08.005; Wu CX, 2008, CHEMOSPHERE, V73, P511, DOI 10.1016/j.chemosphere.2008.06.026	76	120	125	5	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45397	10.1371/journal.pone.0045397	http://dx.doi.org/10.1371/journal.pone.0045397			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049795	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100044
J	Fedarovich, A; Djordjevic, KA; Swanson, SM; Peterson, YK; Nicholas, RA; Davies, C				Fedarovich, Alena; Djordjevic, Kevin A.; Swanson, Shauna M.; Peterson, Yuri K.; Nicholas, Robert A.; Davies, Christopher			High-Throughput Screening for Novel Inhibitors of Neisseria gonorrhoeae Penicillin-Binding Protein 2	PLOS ONE			English	Article							MIMETIC BETA-LACTAMS; MOSAIC-LIKE STRUCTURE; ANTIBIOTIC-RESISTANCE; DECREASED SUSCEPTIBILITY; SPECTRUM CEPHALOSPORINS; REDUCED SUSCEPTIBILITY; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; LEVEL RESISTANCE; TRANSITION-STATE	The increasing prevalence of N. gonorrhoeae strains exhibiting decreased susceptibility to third-generation cephalosporins and the recent isolation of two distinct strains with high-level resistance to cefixime or ceftriaxone heralds the possible demise of beta-lactam antibiotics as effective treatments for gonorrhea. To identify new compounds that inhibit penicillin-binding proteins (PBPs), which are proven targets for b-lactam antibiotics, we developed a high-throughput assay that uses fluorescence polarization (FP) to distinguish the fluorescent penicillin, Bocillin-FL, in free or PBP-bound form. This assay was used to screen a 50,000 compound library for potential inhibitors of N. gonorrhoeae PBP 2, and 32 compounds were identified that exhibited >50% inhibition of Bocillin-FL binding to PBP 2. These included a cephalosporin that provided validation of the assay. After elimination of compounds that failed to exhibit concentration-dependent inhibition, the antimicrobial activity of the remaining 24 was tested. Of these, 7 showed antimicrobial activity against susceptible and penicillin-or cephalosporin-resistant strains of N. gonorrhoeae. In molecular docking simulations using the crystal structure of PBP 2, two of these inhibitors docked into the active site of the enzyme and each mediate interactions with the active site serine nucleophile. This study demonstrates the validity of a FP-based assay to find novel inhibitors of PBPs and paves the way for more comprehensive high-throughput screening against highly resistant strains of N. gonorrhoeae. It also provides a set of lead compounds for optimization of anti-gonococcal agents.	[Fedarovich, Alena; Djordjevic, Kevin A.; Davies, Christopher] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Swanson, Shauna M.; Nicholas, Robert A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Peterson, Yuri K.] Med Univ S Carolina, Dept Pharmaceut & Biomed Sci, Charleston, SC 29425 USA; [Nicholas, Robert A.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA	Medical University of South Carolina; University of North Carolina; University of North Carolina Chapel Hill; Medical University of South Carolina; University of North Carolina; University of North Carolina Chapel Hill	Fedarovich, A (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	fedorove@musc.edu; davies@musc.edu			National Institutes of Health [GM66861, AI36901]; MUSC Hollings Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MUSC Hollings Cancer Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health grants GM66861 to C.D. and AI36901 to R.A.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Charles D. Smith for technical advice. The MUSC Drug Discovery Shared Resource is supported by the MUSC Hollings Cancer Center.	Akasaka S, 2001, J Infect Chemother, V7, P49, DOI 10.1007/s101560170034; Ameyama S, 2002, ANTIMICROB AGENTS CH, V46, P3744, DOI 10.1128/AAC.46.12.3744-3749.2002; [Anonymous], EURO SURVEILL; BARBOUR AG, 1981, ANTIMICROB AGENTS CH, V19, P316, DOI 10.1128/AAC.19.2.316; BAUER AW, 1959, ARCH INTERN MED, V104, P208, DOI 10.1001/archinte.1959.00270080034004; BRANNIGAN JA, 1990, MOL MICROBIOL, V4, P913, DOI 10.1111/j.1365-2958.1990.tb00664.x; DANIELSSON D, 1986, INFECT IMMUN, V52, P529, DOI 10.1128/IAI.52.2.529-533.1986; del Rio C., 2007, Morbidity and Mortality Weekly Report, V56, P332; DOWSON CG, 1989, MOL MICROBIOL, V3, P35, DOI 10.1111/j.1365-2958.1989.tb00101.x; Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77; Ghosh AS, 2008, TRENDS MICROBIOL, V16, P309, DOI 10.1016/j.tim.2008.04.006; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Golparian D, 2010, SEX TRANSM INFECT, V86, P454, DOI 10.1136/sti.2010.045377; Inglis SR, 2009, J MED CHEM, V52, P6097, DOI 10.1021/jm9009718; Ito M, 2005, ANTIMICROB AGENTS CH, V49, P137, DOI 10.1128/AAC.49.1.137-143.2005; Josephine HR, 2006, BIOCHEMISTRY-US, V45, P15873, DOI 10.1021/bi061804f; Josephine HR, 2004, J AM CHEM SOC, V126, P8122, DOI 10.1021/ja048850s; Kumar I, 2007, ACS CHEM BIOL, V2, P620, DOI 10.1021/cb7001347; Lindberg R, 2007, ANTIMICROB AGENTS CH, V51, P2117, DOI 10.1128/AAC.01604-06; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; MANESS MJ, 1973, J INFECT DIS, V128, P321, DOI 10.1093/infdis/128.3.321; Miguet L, 2009, J MED CHEM, V52, P5926, DOI 10.1021/jm900625q; Muratani T, 2001, ANTIMICROB AGENTS CH, V45, P3603, DOI 10.1128/AAC.45.12.3603-3606.2001; Nicholas RA, 2012, ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2, P397, DOI 10.1007/978-1-4614-1400-1_11; Nicola G, 2005, BIOCHEMISTRY-US, V44, P8207, DOI 10.1021/bi0473004; NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625; Ochiai S, 2007, J ANTIMICROB CHEMOTH, V60, P54, DOI 10.1093/jac/dkm166; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; Ohnishi M, 2011, EMERG INFECT DIS, V17, P148, DOI 10.3201/eid1701.100397; Olesky M, 2002, ANTIMICROB AGENTS CH, V46, P2811, DOI 10.1128/AAC.46.9.2811-2820.2002; Pechenov A, 2003, BIOCHEMISTRY-US, V42, P579, DOI 10.1021/bi026726k; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Powell AJ, 2009, J BIOL CHEM, V284, P1202, DOI 10.1074/jbc.M805761200; Ropp PA, 2002, ANTIMICROB AGENTS CH, V46, P769, DOI 10.1128/AAC.46.3.769-777.2002; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Shafer WM, 2010, NEISSERIA: MOLECULAR MECHANISMS OF PATHOGENESIS, P245; Shoichet BK, 2006, DRUG DISCOV TODAY, V11, P607, DOI 10.1016/j.drudis.2006.05.014; Silvaggi NR, 2003, BIOCHEMISTRY-US, V42, P1199, DOI 10.1021/bi0268955; Stefanova ME, 2003, BIOCHEMISTRY-US, V42, P14614, DOI 10.1021/bi0350607; Tapsall J, 2009, J MED MICROBIOL, V58, P683, DOI 10.1099/jmm.0.007641-0; Tomberg J, 2010, BIOCHEMISTRY-US, V49, P8062, DOI 10.1021/bi101167x; Turk S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019418; Unemo M, 2010, EURO SURVEILL, V15; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Zervosen A, 2004, ANTIMICROB AGENTS CH, V48, P961, DOI 10.1128/AAC.48.3.961-969.2004; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124	48	20	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44918	10.1371/journal.pone.0044918	http://dx.doi.org/10.1371/journal.pone.0044918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049763	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100024
J	Gropp, M; Shilo, V; Vainer, G; Gov, M; Gil, Y; Khaner, H; Matzrafi, L; Idelson, M; Kopolovic, J; Zak, NB; Reubinoff, BE				Gropp, Michal; Shilo, Vitali; Vainer, Gilad; Gov, Miri; Gil, Yaniv; Khaner, Hanita; Matzrafi, Limor; Idelson, Maria; Kopolovic, Juri; Zak, Naomi B.; Reubinoff, Benjamin E.			Standardization of the Teratoma Assay for Analysis of Pluripotency of Human ES Cells and Biosafety of Their Differentiated Progeny	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN BLASTOCYSTS; LINES; TUMORIGENICITY	Teratoma tumor formation is an essential criterion in determining the pluripotency of human pluripotent stem cells. However, currently there is no consistent protocol for assessment of teratoma forming ability. Here we present detailed characterization of a teratoma assay that is based on subcutaneous co-transplantation of defined numbers of undifferentiated human embryonic stem cells (hESCs) with mitotically inactivated feeder cells and Matrigel into immunodeficient mice. The assay was highly reproducible and 100% efficient when 100,000 hESCs were transplanted. It was sensitive, promoting teratoma formation after transplantation of 100 hESCs, though larger numbers of animals and longer follow-up were required. The assay could detect residual teratoma forming cells within differentiated hESC populations however its sensitivity was decreased in the presence of differentiated cells. Our data lay the foundation, for standardization of a teratoma assay for pluripotency analysis. The assay can also be used for bio-safety analysis of pluripotent stem cellderived differentiated progeny.	[Gropp, Michal; Gil, Yaniv; Khaner, Hanita; Idelson, Maria; Reubinoff, Benjamin E.] Hadassah Hebrew Univ, Med Ctr, Hadassah Human Embryon Stem Cell Res Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel; [Gropp, Michal; Gil, Yaniv; Khaner, Hanita; Idelson, Maria; Reubinoff, Benjamin E.] Hadassah Hebrew Univ, Med Ctr, Dept Gynecol, Jerusalem, Israel; [Shilo, Vitali; Gov, Miri; Matzrafi, Limor; Zak, Naomi B.] CellCure NeuroSci Ltd, Jerusalem, Israel; [Vainer, Gilad; Kopolovic, Juri] Hadassah Hebrew Univ, Med Ctr, Dept Pathol, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Reubinoff, BE (corresponding author), Hadassah Hebrew Univ, Med Ctr, Hadassah Human Embryon Stem Cell Res Ctr, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	benjaminr@ekmd.hugi.ac.il	Vainer, Gilad W./ABH-8314-2020	Vainer, Gilad W./0000-0002-8828-8138; Reubinoff, Benjamin/0000-0003-0353-1299	Cell Cure Neurosciences Ltd.; Bereshith (Genesis) Magnet Consortium of the Israel Office of the Chief Scientist of the Minister of Industry, Trade, and Labor	Cell Cure Neurosciences Ltd.; Bereshith (Genesis) Magnet Consortium of the Israel Office of the Chief Scientist of the Minister of Industry, Trade, and Labor	This work was supported by Cell Cure Neurosciences Ltd., and by a grant to the company from the Bereshith (Genesis) Magnet Consortium of the Israel Office of the Chief Scientist of the Minister of Industry, Trade, and Labor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews PW, 2009, STEM CELL REV REP, V5, P301, DOI 10.1007/s12015-009-9085-x; Andrews PW, 2005, BIOCHEM SOC T, V33, P1526, DOI 10.1042/BST0331526; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Ben-Dor I, 2006, MOL THER, V14, P255, DOI 10.1016/j.ymthe.2006.02.010; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Blum B, 2009, CELL CYCLE, V8, P3822, DOI 10.4161/cc.8.23.10067; Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; Chang YG, 2007, J CELL SCI, V120, P3053, DOI 10.1242/jcs.006361; Cohen M. A., 2007, CURR PROTOC CELL BIO; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Drukker M, 2006, STEM CELLS, V24, P221, DOI 10.1634/stemcells.2005-0188; Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712; Goldring CE, CELL STEM CELL, V8, P618; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Lawrenz B, 2004, CYTOTHERAPY, V6, P212, DOI 10.1080/14653240410006031; Lee AS, 2009, CELL CYCLE, V8, P2608, DOI 10.4161/cc.8.16.9353; Lensch MW, 2007, NAT BIOTECHNOL, V25, P1211, DOI 10.1038/nbt1107-1211a; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; MAYOR S, 2010, BRIT MED J, V341, pE5724; Muller FJ, 2010, CELL STEM CELL, V6, P412, DOI 10.1016/j.stem.2010.04.009; Prokhorova TA, 2009, STEM CELLS DEV, V18, P47, DOI 10.1089/scd.2007.0266; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Shih CC, 2007, STEM CELLS DEV, V16, P893, DOI 10.1089/scd.2007.0070; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516	29	79	85	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45532	10.1371/journal.pone.0045532	http://dx.doi.org/10.1371/journal.pone.0045532			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049812	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100055
J	Pagonas, N; Vautz, W; Seifert, L; Slodzinski, R; Jankowski, J; Zidek, W; Westhoff, TH				Pagonas, Nikolaos; Vautz, Wolfgang; Seifert, Luzia; Slodzinski, Rafael; Jankowski, Joachim; Zidek, Walter; Westhoff, Timm H.			Volatile Organic Compounds in Uremia	PLOS ONE			English	Article							BREATH AMMONIA; HEMODIALYSIS; CREATININE	Background: Although "uremic fetor'' has long been felt to be diagnostic of renal failure, the compounds exhaled in uremia remain largely unknown so far. The present work investigates whether breath analysis by ion mobility spectrometry can be used for the identification of volatile organic compounds retained in uremia. Methods: Breath analysis was performed in 28 adults with an eGFR >= 60 ml/min per 1.73 m(2), 26 adults with chronic renal failure corresponding to an eGFR of 10-59 ml/min per 1.73 m(2), and 28 adults with end-stage renal disease (ESRD) before and after a hemodialysis session. Breath analysis was performed by ion mobility spectrometry after gas-chromatographic preseparation. Identification of the compounds of interest was performed by thermal desorption gas chromatography/mass spectrometry. Results: Breath analyses revealed significant differences in the spectra of patients with and without renal failure. Thirteen compounds were chosen for further evaluation. Some compounds including hydroxyacetone, 3-hydroxy-2-butanone and ammonia accumulated with decreasing renal function and were eliminated by dialysis. The concentrations of these compounds allowed a significant differentiation between healthy, chronic renal failure with an eGFR of 10-59 ml/min, and ESRD (p<0.05 each). Other compounds including 4-heptanal, 4-heptanone, and 2-heptanone preferentially or exclusively occurred in patients undergoing hemodialysis. Conclusion: Impairment of renal function induces a characteristic fingerprint of volatile compounds in the breath. The technique of ion mobility spectrometry can be used for the identification of lipophilic uremic retention molecules.	[Pagonas, Nikolaos; Jankowski, Joachim; Zidek, Walter; Westhoff, Timm H.] Charite Campus Benjamin Franklin, Deparment Nephrol, Berlin, Germany; [Vautz, Wolfgang; Seifert, Luzia; Slodzinski, Rafael] Leibniz Inst Analyt Wissensch ISAS eV, Dortmund, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS)	Westhoff, TH (corresponding author), Charite Campus Benjamin Franklin, Deparment Nephrol, Berlin, Germany.	timm.westhoff@charite.de	Pagonas, Nikolaos/V-2241-2019	Westhoff, Timm H./0000-0001-5797-834X	European Union [217967]; German Bundesministerium fur Bildung und Forschung; Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen	European Union(European Commission); German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen	European Union (Project 217967: Second Generation Locator for Urban Search and Rescue Operations), the German Bundesministerium fur Bildung und Forschung and the Ministerium fur Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, ION MOBILITY SPECTRO; Bain MA, 2006, NEPHROL DIAL TRANSPL, V21, P1300, DOI 10.1093/ndt/gfk056; Bodeker B, 2008, INT J ION MOBIL SPEC, V11, P89, DOI 10.1007/s12127-008-0013-6; Bunkowski A, 2010, INT J ION MOBIL SPEC, V13, P169, DOI 10.1007/s12127-010-0045-6; Hariharan CB, 2011, INT J ION MOBIL SPEC, V14, P31, DOI 10.1007/s12127-011-0059-8; Hippokrates Oeuvres Completes d'Hippocrate, 1979, HIPPOKRATES OEUVRES, V5, P11; Hippokrates Oeuvres Completes d'Hippocrate, 1979, HIPPOKRATES OEUVRES, V4, P17; Ishida H, 2008, BIO-MED MATER ENG, V18, P99, DOI 10.3233/BME-2008-0513; Jourde-Chiche N, 2009, SEMIN DIALYSIS, V22, P334, DOI 10.1111/j.1525-139X.2009.00576.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Loyek C, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-158; Narasimhan LR, 2001, P NATL ACAD SCI USA, V98, P4617, DOI 10.1073/pnas.071057598; PAULING L, 1971, P NATL ACAD SCI USA, V68, P2374, DOI 10.1073/pnas.68.10.2374; Phillips M, 2003, CHEST, V123, P2115, DOI 10.1378/chest.123.6.2115; Qin T, CANC EPIDEMIOL BIOMA, V19, P2247; SIMENHOFF ML, 1977, NEW ENGL J MED, V297, P132, DOI 10.1056/NEJM197707212970303; Song G, LUNG CANC, V67, P227; Vautz W, 2010, INT J ION MOBIL SPEC, V13, P41, DOI 10.1007/s12127-010-0039-4; Vautz W, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/3/036004; Wahl HG, 2004, NEPHROL DIAL TRANSPL, V19, P2576, DOI 10.1093/ndt/gfh425	20	39	39	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46258	10.1371/journal.pone.0046258	http://dx.doi.org/10.1371/journal.pone.0046258			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049998	Green Submitted, gold, Green Published			2022-12-27	WOS:000309556100169
J	Schoormans, D; Radonic, T; de Witte, P; Groenink, M; Azim, D; Lutter, R; Mulder, BJM; Sprangers, MAG; Zwinderman, AH				Schoormans, Dounya; Radonic, Teodora; de Witte, Piet; Groenink, Maarten; Azim, Donija; Lutter, Rene; Mulder, Barbara J. M.; Sprangers, Mirjam A. G.; Zwinderman, Aeilko H.			Mental Quality of Life Is Related to a Cytokine Genetic Pathway	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; CHRONIC HEART-FAILURE; CHRONIC HEPATITIS-C; SF-36 HEALTH SURVEY; MARFAN-SYNDROME; CANCER SURVIVORS; POLYMORPHISMS; FATIGUE; PATIENT; ASSOCIATION	Background: Quality of life (QoL) in patients with chronic disease is impaired and cannot be solely explained by disease severity. We explored whether genetic variability and activity contributes to QoL in patients with Marfan syndrome (MFS), a genetic connective tissue disorder. Methodology/Principal Findings: In 121 MFS patients, patient characteristics (i.e. demographics and MFS-related symptoms) were assessed. Patients completed the SF-36 to measure QoL. In addition, transcriptome wide gene expression and 484 Single Nucleotide Polymorphysms (SNPs) in cytokine genes were available. QoL was first analyzed and associated with patient characteristics. Patients' physical QoL was impaired and weakly related with age and scoliosis, whereas mental quality of life (MCS) was normal. To explain a largely lacking correlation between disease severity and QoL, we related genome wide gene expression to QoL. Patients with lower MCS scores had high expression levels of CXCL9 and CXCL11 cytokine-related genes (p = 0.001; p = 0.002); similarly, patients with low vitality scores had high expression levels of CXCL9, CXCL11 and IFNA6 cytokine-related genes (p = 0.02; p = 0.02; p = 0.04), independent of patient characteristics. Subsequently, we associated cytokine related SNPs to mental QoL (MCS and vitality). SNP-cluster in the IL4R gene showed a weak association with MCS and vitality (strongest association p = 0.0017). Although overall mental QoL was normal, >10% of patients had low scores for MCS and vitality. Post-hoc analysis of systemic inflammatory mediators showed that patients with lowest MCS and vitality scores had high levels of CCL11 cytokine (p = 0.03; p = 0.04). Conclusions/Significance: Variation in the cytokine genetic pathway and its activation is related to mental QoL. These findings might allow us to identify and, ultimately, treat patients susceptible to poor QoL.	[Radonic, Teodora; Azim, Donija; Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1105 AZ Amsterdam, Netherlands; [Schoormans, Dounya; Azim, Donija; Sprangers, Mirjam A. G.; Zwinderman, Aeilko H.] Univ Amsterdam, Acad Med Ctr, Dept Med Psychol, NL-1105 AZ Amsterdam, Netherlands; [Schoormans, Dounya; Radonic, Teodora; de Witte, Piet; Groenink, Maarten; Mulder, Barbara J. M.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands; [Schoormans, Dounya; Radonic, Teodora; de Witte, Piet; Mulder, Barbara J. M.] Interuniv Cardiol Inst Netherlands, Utrecht, Netherlands; [Groenink, Maarten] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands; [Lutter, Rene] Univ Amsterdam, Acad Med Ctr, Dept Pulmonol, NL-1105 AZ Amsterdam, Netherlands; [Lutter, Rene] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Interuniversity Cardiology Institute of the Netherlands; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Zwinderman, AH (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	a.h.zwinderman@amc.uva.nl	Radonic, Teodora/HGU-0171-2022	Radonic, Teodora/0000-0002-6015-5202	The Netherlands Heart Foundation [2008B115]; Fighting Aneurysmal Disease (FAD) project; Interuniversity Cardiology Institute of The Netherlands [03607]	The Netherlands Heart Foundation(Netherlands Heart Foundation); Fighting Aneurysmal Disease (FAD) project; Interuniversity Cardiology Institute of The Netherlands	This study is funded by The Netherlands Heart Foundation (grant 2008B115) [www.hartstichting.nl], the Fighting Aneurysmal Disease (FAD) project [www.fighting-aneurysm.org], and The Interuniversity Cardiology Institute of The Netherlands (grant 03607) [www.icin.nl]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bluthe RM, 2002, NEUROPSYCHOPHARMACOL, V26, P86, DOI 10.1016/S0893-133X(01)00305-0; Bottema RWB, 2010, INT ARCH ALLERGY IMM, V153, P259, DOI 10.1159/000314366; Brietzke E, 2009, BRAIN BEHAV IMMUN, V23, P1079, DOI 10.1016/j.bbi.2009.04.008; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; Falasca K, 2009, CLIN INVEST MED, V32, pE212; Foran JRH, 2005, AM J MED GENET A, V134A, P58, DOI 10.1002/ajmg.a.30525; Fusar-Poli P, 2008, PSYCHOSOMATICS, V49, P243, DOI 10.1176/appi.psy.49.3.243; Groenink M, 1999, HEART, V82, P499, DOI 10.1136/hrt.82.4.499; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Judge DP, 2005, LANCET, V366, P1965, DOI 10.1016/S0140-6736(05)67789-6; Kim YK, 2007, PROG NEURO-PSYCHOPH, V31, P1044, DOI 10.1016/j.pnpbp.2007.03.004; Kullowatz A, 2007, RESP MED, V101, P638, DOI 10.1016/j.rmed.2006.06.002; Lalchandani S, 2003, EUR J OBSTET GYN R B, V110, P125, DOI 10.1016/S0301-2115(03)00151-9; Lopez-Leon S, 2008, MOL PSYCHIATR, V13, P772, DOI 10.1038/sj.mp.4002088; Macedo JA, 2007, J NEUROIMMUNOL, V188, P159, DOI 10.1016/j.jneuroim.2007.06.002; Majer M, 2008, BRAIN BEHAV IMMUN, V22, P870, DOI 10.1016/j.bbi.2007.12.009; Malik UR, 2001, CANCER, V92, P1664, DOI 10.1002/1097-0142(20010915)92:6+<1664::AID-CNCR1494>3.0.CO;2-9; Mommersteeg PMC, 2010, BRAIN BEHAV IMMUN, V24, P615, DOI 10.1016/j.bbi.2010.01.004; Montinaro V, 2010, CLIN NEPHROL, V73, P36, DOI 10.2379/CNX06364; Muller M, 2010, NEUROPATH APPL NEURO, V36, P368, DOI 10.1111/j.1365-2990.2010.01089.x; Nes RB, 2006, PSYCHOL MED, V36, P1033, DOI 10.1017/S0033291706007409; Panju AH, 2009, SUPPORT CARE CANCER, V17, P539, DOI 10.1007/s00520-008-0512-3; Pelle AJ, 2009, QUAL LIFE RES, V18, P689, DOI 10.1007/s11136-009-9485-z; Pryce H, 2010, INT J AUDIOL, V49, P473, DOI 10.3109/14992021003627892; Radonic T, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-3; Rand-Hendriksen S, 2010, GENET MED, V12, P517, DOI 10.1097/GIM.0b013e3181ea4c1c; Rausch SM, 2010, CANCER-AM CANCER SOC, V116, P4103, DOI 10.1002/cncr.25255; Reinertsen KV, 2011, BRAIN BEHAV IMMUN, V25, P1376, DOI 10.1016/j.bbi.2011.04.001; Ryan JL, 2007, ONCOLOGIST, V12, P22, DOI 10.1634/theoncologist.12-S1-22; Simon NM, 2008, EUR NEUROPSYCHOPHARM, V18, P230, DOI 10.1016/j.euroneuro.2007.06.004; Solovieva S, 2004, PAIN, V109, P8, DOI 10.1016/j.pain.2003.10.020; Sprangers MAG, 2002, ACTA ONCOL, V41, P229, DOI 10.1080/02841860260088764; Sprangers MAG, 2010, QUAL LIFE RES, V19, P1429, DOI 10.1007/s11136-010-9652-2; Sprangers MAG, 2010, QUAL LIFE RES, V19, P1395, DOI 10.1007/s11136-010-9759-5; Sprangers MAG, 2009, TWIN RES HUM GENET, V12, P301, DOI 10.1375/twin.12.3.301; Svedberg P, 2005, J GERONTOL B-PSYCHOL, V60, pS331, DOI 10.1093/geronb/60.6.S331; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Dijk N, 2008, CLIN AUTON RES, V18, P187, DOI 10.1007/s10286-008-0475-y; Verbraecken J, 2001, CLIN GENET, V60, P360, DOI 10.1034/j.1399-0004.2001.600507.x; Wald A, 2011, BEST PRACT RES CL GA, V25, P19, DOI 10.1016/j.bpg.2010.12.004; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Wong ML, 2008, MOL PSYCHIATR, V13, P800, DOI 10.1038/mp.2008.59	45	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45126	10.1371/journal.pone.0045126	http://dx.doi.org/10.1371/journal.pone.0045126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049769	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100028
J	Zhu, ZL; Zhao, CX; Hou, YK				Zhu, Zhengli; Zhao, Chunxia; Hou, Yingkun			Research on Similarity Measurement for Texture Image Retrieval	PLOS ONE			English	Article							CLASSIFICATION	A complete texture image retrieval system includes two techniques: texture feature extraction and similarity measurement. Specifically, similarity measurement is a key problem for texture image retrieval study. In this paper, we present an effective similarity measurement formula. The MIT vision texture database, the Brodatz texture database, and the Outex texture database were used to verify the retrieval performance of the proposed similarity measurement method. Dual-tree complex wavelet transform and nonsubsampled contourlet transform were used to extract texture features. Experimental results show that the proposed similarity measurement method achieves better retrieval performance than some existing similarity measurement methods.	[Zhu, Zhengli; Zhao, Chunxia; Hou, Yingkun] Nanjing Univ Sci & Technol, Sch Comp Sci & Technol, Nanjing, Peoples R China; [Zhu, Zhengli] Nanjing Forestry Univ, Coll Informat Sci & Technol, Nanjing, Peoples R China; [Hou, Yingkun] Taishan Univ, Sch Informat Sci & Technol, Tai An 271021, Shandong, Peoples R China	Nanjing University of Science & Technology; Nanjing Forestry University; Taishan University	Zhu, ZL (corresponding author), Nanjing Univ Sci & Technol, Sch Comp Sci & Technol, Nanjing, Peoples R China.	haitian2001@163.com		Hou, Yingkun/0000-0003-2153-9040	National Science Foundation of China [90820306, 61072148]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Science Foundation of China under Grants 90820306 and 61072148. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brodatz P., 1996, TEXTURES PHOTOGRAPHI; da Cunha AL, 2006, IEEE T IMAGE PROCESS, V15, P3089, DOI 10.1109/TIP.2006.877507; de Rivaz P., 1999, Proceedings 1999 International Conference on Image Processing (Cat. 99CH36348), P109, DOI 10.1109/ICIP.1999.821576; de Ves E, 2007, LECT NOTES COMPUT SC, V4673, P895; Do MN, 2002, IEEE T IMAGE PROCESS, V11, P146, DOI 10.1109/83.982822; Kingsbury, 2015, 9 EUR SIGN PROC C EU, DOI DOI 10.5281/ZENODO.36900; Kokare M, 2005, IEEE T SYST MAN CY B, V35, P1168, DOI 10.1109/TSMCB.2005.850176; Kokare M, 2003, TENCON IEEE REGION, P571, DOI 10.1109/TENCON.2003.1273228; LAINE A, 1993, IEEE T PATTERN ANAL, V15, P1186, DOI 10.1109/34.244679; MIT Vision and Modeling Group, VIS TEXT; Randen T, 1999, IEEE T PATTERN ANAL, V21, P291, DOI 10.1109/34.761261; Selesnick IW, 2005, IEEE SIGNAL PROC MAG, V22, P123, DOI 10.1109/MSP.2005.1550194; Shutao L, 2004, JOINT IAPR INT WORKS, V3138, P1126; UNSER M, 1995, IEEE T IMAGE PROCESS, V4, P1549, DOI 10.1109/83.469936; Van de Wouwer G, 1999, IEEE T IMAGE PROCESS, V8, P592, DOI 10.1109/83.753747; Zhou JP, 2005, IEEE INT C IMAGE PRO, V1, P469	17	4	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45302	10.1371/journal.pone.0045302	http://dx.doi.org/10.1371/journal.pone.0045302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049785	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100038
J	Kang, DZ; Wang, JJ; Zhang, WY; Song, YL; Li, XL; Zou, Y; Zhu, MT; Zhu, Z; Chen, FY; Yang, CJ				Kang, Dezhi; Wang, Jiangjie; Zhang, Weiyun; Song, Yanling; Li, Xilan; Zou, Yuan; Zhu, Mingtao; Zhu, Zhi; Chen, Fuyong; Yang, Chaoyong James			Selection of DNA Aptamers against Glioblastoma Cells with High Affinity and Specificity	PLOS ONE			English	Article							NUCLEIC-ACID APTAMERS; CANCER-CELLS; MOLECULAR RECOGNITION; SYSTEMATIC EVOLUTION; BRAIN-TUMORS; LIVE CELLS; SELEX; STRATEGIES; SURVIVAL; THERAPY	Background: Glioblastoma is the most common and most lethal form of brain tumor in human. Unfortunately, there is still no effective therapy to this fatal disease and the median survival is generally less than one year from the time of diagnosis. Discovery of ligands that can bind specifically to this type of tumor cells will be of great significance to develop early molecular imaging, targeted delivery and guided surgery methods to battle this type of brain tumor. Methodology/Principal Findings: We discovered two target-specific aptamers named GBM128 and GBM131 against cultured human glioblastoma cell line U118-MG after 30 rounds selection by a method called cell-based Systematic Evolution of Ligands by EXponential enrichment (cell-SELEX). These two aptamers have high affinity and specificity against target glioblastoma cells. They neither recognize normal astraglial cells, nor do they recognize other normal and cancer cell lines tested. Clinical tissues were also tested and the results showed that these two aptamers can bind to different clinical glioma tissues but not normal brain tissues. More importantly, binding affinity and selectivity of these two aptamers were retained in complicated biological environment. Conclusion/Significance: The selected aptamers could be used to identify specific glioblastoma biomarkers. Methods of molecular imaging, targeted drug delivery, ligand guided surgery can be further developed based on these ligands for early detection, targeted therapy, and guided surgery of glioblastoma leading to effective treatment of glioblastoma.	[Kang, Dezhi; Wang, Jiangjie; Zhu, Mingtao; Chen, Fuyong] Fujian Med Univ, Dept Neurosurg, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China; [Zhang, Weiyun; Song, Yanling; Li, Xilan; Zou, Yuan; Zhu, Zhi; Yang, Chaoyong James] Xiamen Univ, Coll Chem & Chem Engn, Dept Biol Chem, Xiamen, Fujian, Peoples R China; [Zhang, Weiyun; Song, Yanling; Li, Xilan; Zou, Yuan; Zhu, Zhi; Yang, Chaoyong James] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Analyt Sci, State Key Lab Phys Chem Solid Surfaces,Key Lab Ch, Xiamen, Fujian, Peoples R China	Fujian Medical University; Xiamen University; Xiamen University	Kang, DZ (corresponding author), Fujian Med Univ, Dept Neurosurg, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China.	kdz99988@sina.com; cyyang@xmu.edu.cn	Yang, Chaoyong/Q-5734-2019; Song, Yanling/ABB-7055-2021; Zhu, Zhi/D-3721-2011; yang, chaoyong/F-9741-2010; Song, Yanling/AAT-7783-2020	Yang, Chaoyong/0000-0002-2374-5342; Zhu, Zhi/0000-0002-3287-4920; yang, chaoyong/0000-0002-2374-5342; 	National Basic Research Program of China [2010CB732402]; National Instrumentation Program [2011YQ03012412]; Natural Science Foundation of Fujian Province for Distinguished Young Scholars [2010 J06004]; Key Laboratory for Chemical Biology of Fujian Province	National Basic Research Program of China(National Basic Research Program of China); National Instrumentation Program; Natural Science Foundation of Fujian Province for Distinguished Young Scholars; Key Laboratory for Chemical Biology of Fujian Province	This work was supported by the National Basic Research Program of China (2010CB732402), National Instrumentation Program (2011YQ03012412), the Natural Science Foundation of Fujian Province for Distinguished Young Scholars (2010 J06004), and the Key Laboratory for Chemical Biology of Fujian Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayrac AT, 2011, ACS CHEM NEUROSCI, V2, P175, DOI 10.1021/cn100114k; Blank M, 2001, J BIOL CHEM, V276, P16464, DOI 10.1074/jbc.M100347200; Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031; Castro MG, 2003, PHARMACOL THERAPEUT, V98, P71, DOI 10.1016/S0163-7258(03)00014-7; Chen HW, 2008, CHEMMEDCHEM, V3, P991, DOI 10.1002/cmdc.200800030; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; Dua P, 2011, METHODS, V54, P215, DOI 10.1016/j.ymeth.2011.02.002; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Fang XH, 2010, ACCOUNTS CHEM RES, V43, P48, DOI 10.1021/ar900101s; Guo KT, 2006, STEM CELLS, V24, P2220, DOI 10.1634/stemcells.2006-0015; Iliuk AB, 2011, ANAL CHEM, V83, P4440, DOI 10.1021/ac201057w; Ireson CR, 2006, MOL CANCER THER, V5, P2957, DOI 10.1158/1535-7163.MCT-06-0172; Jiang YX, 2003, ANAL CHEM, V75, P2112, DOI 10.1021/ac026182s; LAPERRIERE NJ, 1994, CA-CANCER J CLIN, V44, P96, DOI 10.3322/canjclin.44.2.96; Mallikaratchy P, 2007, MOL CELL PROTEOMICS, V6, P2230, DOI 10.1074/mcp.M700026-MCP200; Navani NK, 2006, CURR OPIN CHEM BIOL, V10, P272, DOI 10.1016/j.cbpa.2006.04.003; Ng HK, 1998, PATHOLOGY, V30, P196, DOI 10.1080/00313029800169236; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; Osborne SE, 1997, CHEM REV, V97, P349, DOI 10.1021/cr960009c; Pu Y, 2010, ANAL BIOANAL CHEM, V397, P3225, DOI 10.1007/s00216-010-3715-7; Rupcich N, 2006, J AM CHEM SOC, V128, P780, DOI 10.1021/ja053336n; Sefah K, 2010, NAT PROTOC, V5, P1169, DOI 10.1038/nprot.2010.66; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Shangguan D, 2006, P NATL ACAD SCI USA, V103, P11838, DOI 10.1073/pnas.0602615103; SOULE HD, 1990, CANCER RES, V50, P6075; Tang ZW, 2007, ANAL CHEM, V79, P4900, DOI 10.1021/ac070189y; Thiel WH, 2011, NUCLEIC ACID THER, V21, P253, DOI 10.1089/nat.2011.0288; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Zhao ZL, 2009, ANALYST, V134, P1808, DOI 10.1039/b904476k	33	41	48	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2012	7	10							e42731	10.1371/journal.pone.0042731	http://dx.doi.org/10.1371/journal.pone.0042731			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NG	23056171	Green Published, gold, Green Submitted			2022-12-27	WOS:000309452600001
J	Chen, W; Xia, YP; Zhao, XL; Wang, H; Chen, WJ; Yu, MH; Li, YM; Ye, HY; Zhang, Y				Chen, Wei; Xia, Yanping; Zhao, Xuelan; Wang, Hao; Chen, Wenjie; Yu, Maohua; Li, Yiming; Ye, Hongying; Zhang, Yu			The Critical Role of Astragalus Polysaccharides for the Improvement of PPRA alpha-Mediated Lipotoxicity in Diabetic Cardiomyopathy	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; ACTIVATED RECEPTOR-ALPHA; CARDIAC-HYPERTROPHY; CONTRACTILE DYSFUNCTION; HEART; MICE; 1,2-DIACYLGLYCEROL; DISORDER; GLUCOSE; DB/DB	Background: Obesity-related diabetes mellitus leads to increased myocardial uptake and oxidation of fatty acids, resulting in a form of cardiac dysfunction referred to as lipotoxic cardiomyopathy. We have shown previously that Astragalus polysaccharides (APS) administration was sufficient to improve the systemic metabolic disorder and cardiac dysfunction in diabetic models. Methodology/Principal Findings: To investigate the precise role of APS therapy in the pathogenesis of myocardial lipotoxity in diabetes, db/db diabetic mice and myosin heavy chain (MHC)- peroxisome proliferator-activated receptor (PPAR) alpha mice were characterized and administrated with or without APS with C57 wide- type mice as normal control. APS treatment strikingly improved the myocyte triacylglyceride accumulation and cardiac dysfunction in both db/db mice and MHC-PPAR alpha mice, with the normalization of energy metabolic derangements in both db/db diabetic hearts and MHC-PPAR alpha hearts. Consistently, the activation of PPAR alpha target genes involved in myocardial fatty acid uptake and oxidation in both db/db diabetic hearts and MHC-PPAR alpha hearts was reciprocally repressed by APS administration, while PPAR alpha-mediated suppression of genes involved in glucose utilization of both diabetic hearts and MHC-PPAR alpha hearts was reversed by treatment with APS. Conclusions: We conclude that APS therapy could prevent the development of diabetic cardiomyopathy through a mechanism mainly dependent on the cardiac PPAR alpha-mediated regulatory pathways.	[Chen, Wei; Xia, Yanping; Zhao, Xuelan; Chen, Wenjie; Yu, Maohua; Zhang, Yu] Fudan Univ, Hushan Hosp, Dept Geriatr, Sch Med, Shanghai 200433, Peoples R China; [Wang, Hao] Fudan Univ, Core Ctr Anim Facil, Sch Med, Shanghai 200433, Peoples R China; [Li, Yiming; Ye, Hongying] Fudan Univ, Huashan Hosp, Dept Endocrinol, Sch Med, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Zhang, Y (corresponding author), Fudan Univ, Hushan Hosp, Dept Geriatr, Sch Med, Shanghai 200433, Peoples R China.	dryehongying@hotmail.com; billycai56@yahoo.com.cn			Chinese State Natural Science Funds Commission [81001568]; Shanghai Health Bureau Science Funds for Chinese Medicine [2010QJ033A]	Chinese State Natural Science Funds Commission; Shanghai Health Bureau Science Funds for Chinese Medicine	This work was supported by Chinese State Natural Science Funds Commission (Grant No: 81001568), and Shanghai Health Bureau Science Funds for Chinese Medicine (Grant No: 2010QJ033A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battiprolu PK., 2010, DRUG DISCOV TODAY DI, V7, pE135, DOI [10.1016/j.ddmec.2010.08.001, DOI 10.1016/J.DDMEC.2010.08.001]; Belke DD, 2000, AM J PHYSIOL-ENDOC M, V279, pE1104, DOI 10.1152/ajpendo.2000.279.5.E1104; Belke DD, 1999, AM J PHYSIOL-REG I, V277, pR1210, DOI 10.1152/ajpregu.1999.277.4.R1210; Buchanan J, 2005, ENDOCRINOLOGY, V146, P5341, DOI 10.1210/en.2005-0938; Carley AN, 2005, BBA-MOL CELL BIOL L, V1734, P112, DOI 10.1016/j.bbalip.2005.03.005; Chen W, 2008, EXP CLIN ENDOCR DIAB, V116, P468, DOI 10.1055/s-2008-1058081; Chen W, 2010, J DIABETES COMPLICAT, V24, P199, DOI 10.1016/j.jdiacomp.2008.12.003; Chen W, 2010, ACTA DIABETOL, V47, pS35, DOI 10.1007/s00592-009-0116-5; Duncan JG, 2007, CIRCULATION, V115, P909, DOI 10.1161/CIRCULATIONAHA.106.662296; Finck BN, 2003, P NATL ACAD SCI USA, V100, P1226, DOI 10.1073/pnas.0336724100; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; GAMBLE J, 1994, BBA-MOL BASIS DIS, V1225, P191, DOI 10.1016/0925-4439(94)90078-7; Lopaschuk Gary D, 2002, Heart Fail Rev, V7, P149; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rogers JH, 1999, J CLIN INVEST, V104, P567, DOI 10.1172/JCI6713; RUBLER S, 1972, AM J CARDIOL, V30, P595, DOI 10.1016/0002-9149(72)90595-4; Saburi Y, 2003, CARDIOVASC RES, V57, P92, DOI 10.1016/S0008-6363(02)00608-9; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Semeniuk LM, 2002, AM J PHYSIOL-HEART C, V283, pH976, DOI 10.1152/ajpheart.00088.2002; Stanley William C, 2002, Heart Fail Rev, V7, P115, DOI 10.1023/A:1015320423577; Taegtmeyer H, 2002, CIRCULATION, V105, P1727, DOI 10.1161/01.CIR.0000012466.50373.E8; Takahashi R, 2003, CARDIOVASC RES, V58, P565, DOI 10.1016/S0008-6363(03)00291-8; Thrainsdottir IS, 2004, J CARDIOVASC PHARM, V44, P101, DOI 10.1097/00005344-200407000-00014; Watanabe K, 2000, J BIOL CHEM, V275, P22293, DOI 10.1074/jbc.M000248200; Witteles RM, 2008, J AM COLL CARDIOL, V51, P93, DOI 10.1016/j.jacc.2007.10.021; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Young ME, 2001, J BIOL CHEM, V276, P44390, DOI 10.1074/jbc.M103826200	28	20	29	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45541	10.1371/journal.pone.0045541	http://dx.doi.org/10.1371/journal.pone.0045541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049681	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388500008
J	Wong, DM; Li, JY; Chen, QH; Han, Q; Mutunga, JM; Wysinski, A; Anderson, TD; Ding, HZ; Carpenetti, TL; Verma, A; Islam, R; Paulson, SL; Lam, PCH; Totrov, M; Bloomquist, JR; Carlier, PR				Wong, Dawn M.; Li, Jianyong; Chen, Qiao-Hong; Han, Qian; Mutunga, James M.; Wysinski, Ania; Anderson, Troy D.; Ding, Haizhen; Carpenetti, Tiffany L.; Verma, Astha; Islam, Rafique; Paulson, Sally L.; Lam, Polo C. -H.; Totrov, Maxim; Bloomquist, Jeffrey R.; Carlier, Paul R.			Select Small Core Structure Carbamates Exhibit High Contact Toxicity to "Carbamate-Resistant" Strain Malaria Mosquitoes, Anopheles gambiae (Akron)	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; CONFERS INSECTICIDE RESISTANCE; ANHYDRIDE HYDROLASE ACTIVITY; HUMAN ACETYLCHOLINESTERASE; HUMAN BUTYRYLCHOLINESTERASE; CULEX-QUINQUEFASCIATUS; EXPRESSION; DIPTERA; METABOLISM; INHIBITION	Acetylcholinesterase (AChE) is a proven target for control of the malaria mosquito (Anopheles gambiae). Unfortunately, a single amino acid mutation (G119S) in An. gambiae AChE-1 (AgAChE) confers resistance to the AChE inhibitors currently approved by the World Health Organization for indoor residual spraying. In this report, we describe several carbamate inhibitors that potently inhibit G119S AgAChE and that are contact-toxic to carbamate-resistant An. gambiae. PCR-RFLP analysis was used to confirm that carbamate-susceptible G3 and carbamate-resistant Akron strains of An. gambiae carry wild-type (WT) and G119S AChE, respectively. G119S AgAChE was expressed and purified for the first time, and was shown to have only 3% of the turnover number (k(cat)) of the WT enzyme. Twelve carbamates were then assayed for inhibition of these enzymes. High resistance ratios (>2,500-fold) were observed for carbamates bearing a benzene ring core, consistent with the carbamate-resistant phenotype of the G119S enzyme. Interestingly, resistance ratios for two oxime methylcarbamates, and for five pyrazol-4-yl methylcarbamates were found to be much lower (4- to 65-fold). The toxicities of these carbamates to live G3 and Akron strain An. gambiae were determined. As expected from the enzyme resistance ratios, carbamates bearing a benzene ring core showed low toxicity to Akron strain An. gambiae (LC50>5,000 mu g/mL). However, one oxime methylcarbamate (aldicarb) and five pyrazol-4-yl methylcarbamates (4a-e) showed good to excellent toxicity to the Akron strain (LC50 = 32-650 mu g/mL). These results suggest that appropriately functionalized "small-core" carbamates could function as a resistance-breaking anticholinesterase insecticides against the malaria mosquito.	[Wong, Dawn M.; Chen, Qiao-Hong; Verma, Astha; Carlier, Paul R.] Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA; [Li, Jianyong; Han, Qian; Ding, Haizhen] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Mutunga, James M.; Wysinski, Ania; Anderson, Troy D.; Carpenetti, Tiffany L.; Paulson, Sally L.; Bloomquist, Jeffrey R.] Virginia Tech, Dept Entomol, Blacksburg, VA USA; [Islam, Rafique; Bloomquist, Jeffrey R.] Univ Florida, Dept Entomol & Nematol, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Lam, Polo C. -H.; Totrov, Maxim] Molsoft LLC, San Diego, CA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; State University System of Florida; University of Florida	Wong, DM (corresponding author), Virginia Tech, Dept Chem, Blacksburg, VA 24061 USA.	pcarlier@vt.edu	Han, Qian/J-8696-2014; Chen, QH/GXH-3158-2022; Han, Qian/AAS-2134-2020	Han, Qian/0000-0001-6245-5252; Anderson, Troy/0000-0002-9403-2833; totrov, maxim/0000-0001-8594-274X; Mutunga, James/0000-0002-7321-3176; Carlier, Paul/0000-0002-6683-285X; Wong, Dawn/0000-0003-0153-2589	National Institutes of Health [1R01AI082581]; Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative [GCGH-1497]; Innovative Vector Control Consortium; Virginia Tech College of Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082581] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative; Innovative Vector Control Consortium; Virginia Tech College of Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health (1R01AI082581), the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative (GCGH-1497), the Innovative Vector Control Consortium, and the Virginia Tech College of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abagyan R A, 2012, ICM SOFTWARE MANUAL; Akogbeto M, 2010, MALARIA J, V9, P1475; Alout H, 2008, CHEM-BIOL INTERACT, V175, P138, DOI 10.1016/j.cbi.2008.03.018; Alout H, 2008, COMP BIOCHEM PHYS B, V150, P271, DOI 10.1016/j.cbpb.2008.03.008; Alout H, 2007, INSECT BIOCHEM MOLEC, V37, P41, DOI 10.1016/j.ibmb.2006.10.001; Alout H, 2009, INSECT BIOCHEM MOLEC, V39, P884, DOI 10.1016/j.ibmb.2009.10.005; Altman RA, 2008, J ORG CHEM, V73, P284, DOI 10.1021/jo702024p; Andraos J, 1996, J CHEM EDUC, V73, P150, DOI 10.1021/ed073p150; [Anonymous], 2006, PESTICIDES THEIR APP; Bar-On P, 2002, BIOCHEMISTRY-US, V41, P3555, DOI 10.1021/bi020016x; Benedict MQ, 2003, J HERED, V94, P227, DOI 10.1093/jhered/esg056; Bourguet D, 1996, J NEUROCHEM, V67, P2115, DOI 10.1046/j.1471-4159.1996.67052115.x; Bourne Y, 2006, J BIOL CHEM, V281, P29256, DOI 10.1074/jbc.M603018200; BULL DL, 1967, J AGR FOOD CHEM, V15, P610, DOI 10.1021/jf60152a019; Canales M, 1998, ENZYME MICROB TECH, V23, P58, DOI 10.1016/S0141-0229(98)00012-X; CARDOZO T, 1995, PROTEINS, V23, P403, DOI 10.1002/prot.340230314; Carlier PR, 2008, CHEM-BIOL INTERACT, V175, P368, DOI 10.1016/j.cbi.2008.04.037; Casida JE, 2009, CHEM RES TOXICOL, V22, P609, DOI 10.1021/tx8004949; Djogbenou L, 2007, J MED ENTOMOL, V44, P805, DOI 10.1603/0022-2585(2007)44[805:COIAAI]2.0.CO;2; Djogbenou L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-12; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Drummond A., 2011, GENEIOUS V5 5; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Enserink M, 2008, SCIENCE, V321, P1620, DOI 10.1126/science.321.5896.1620b; Geyer BC, 2005, CHEM-BIOL INTERACT, V157, P331, DOI 10.1016/j.cbi.2005.10.097; Guillet P, 2001, MED VET ENTOMOL, V15, P105, DOI 10.1046/j.1365-2915.2001.00288.x; Harel M, 1996, J AM CHEM SOC, V118, P2340, DOI 10.1021/ja952232h; Hartsel JA, 2012, BIOORG MED CHEM LETT, V22, P4593, DOI 10.1016/j.bmcl.2012.05.103; Huchard E, 2006, P R SOC B, V273, P2595, DOI 10.1098/rspb.2006.3621; Jiang HB, 2009, INSECT BIOCHEM MOLEC, V39, P646, DOI 10.1016/j.ibmb.2009.07.002; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Kim MM, 2008, TETRAHEDRON LETT, V49, P4026, DOI 10.1016/j.tetlet.2008.04.082; KUHR RJ, 1977, PESTIC BIOCHEM PHYS, V7, P301, DOI 10.1016/0048-3575(77)90033-5; Lockridge O, 1997, BIOCHEMISTRY-US, V36, P786, DOI 10.1021/bi961412g; Manulis S, 1981, PESTIC BIOCHEM PHYS, V15, P261; Millard CB, 1995, BIOCHEMISTRY-US, V34, P15925, DOI 10.1021/bi00049a007; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; N'Guessan R, 2009, TROP MED INT HEALTH, V14, P389, DOI 10.1111/j.1365-3156.2009.02245.x; Nauen R, 2006, PUBLIC HLTH BAYER EN, V18, P8; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; O'Brien R.D., 1967, INSECTICIDES ACTION; Ordentlich A, 1998, J BIOL CHEM, V273, P19509, DOI 10.1074/jbc.273.31.19509; Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006851; Paul R., 2012, Patent No. [8,129,428, 8129428]; Poyot T, 2006, BBA-PROTEINS PROTEOM, V1764, P1470, DOI 10.1016/j.bbapap.2006.07.008; Radic Z, 2006, TOXICOLOGY ORGANOPHO, P161; RAFFA K F, 1985, Journal of Agricultural Entomology, V2, P27; REGUPATHY A, 1982, INDIAN J AGR SCI, V52, P130; REINER E, 1967, BIOCHEM J, V105, P171, DOI 10.1042/bj1050171; ROSENBERRY TL, 1975, ADV ENZYMOL RAMB, V43, P103; Scott MP, 2007, P NATL ACAD SCI USA, V104, P11865, DOI 10.1073/pnas.0704795104; SHAFFERMAN A, 1992, J BIOL CHEM, V267, P17640; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Thompson CM, 2004, PESTICIDE TOXICOLOGY, P89; TOUTANT JP, 1989, PROG NEUROBIOL, V32, P423, DOI 10.1016/0301-0082(89)90031-2; VELAN B, 1994, J BIOL CHEM, V269, P22719; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; WHO, WORLD MAL REP 2011	61	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46712	10.1371/journal.pone.0046712	http://dx.doi.org/10.1371/journal.pone.0046712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049714	Green Submitted, Green Published, gold			2022-12-27	WOS:000309388500041
J	Lee, JH; Fischer, JA				Lee, Ji-Hoon; Fischer, Janice A.			Drosophila Tel2 Is Expressed as a Translational Fusion with EpsinR and Is a Regulator of Wingless Signaling	PLOS ONE			English	Article							ENTH-DOMAIN PROTEIN; RETROMER COMPLEX; LIQUID FACETS; BETA-CATENIN; FAT-FACETS; E-CADHERIN; BINDING; ENDOCYTOSIS; ACTIVATION; SECRETION	Tel2, a protein conserved from yeast to vertebrates, is an essential regulator of diverse cellular processes including telomere maintenance, DNA damage checkpoints, DNA repair, biological clocks, and cell signaling. The Drosophila Tel2 protein is produced as a translational fusion with EpsinR, a Clathrin adapter that facilitates vesicle trafficking between the Golgi and endosomes. EpsinR and Tel2 are encoded by a Drosophila gene called lqfR. lqfR is required for viability, and its specific roles include cell growth, proliferation, and planar cell polarity. We find that all of these functions of lqfR are attributed entirely to Tel2, not EpsinR. In addition, we find that Drosophila LqfR/Tel2 is a component of one or more protein complexes that contain E-cadherin and Armadillo. Moreover, Tel2 modulates E-cadherin and Armadillo cellular dynamics. We propose that at least one of the functions of Drosophila Tel2 is regulation of Wingless signaling.	[Lee, Ji-Hoon; Fischer, Janice A.] Univ Texas Austin, Sect Mol Cell & Dev Biol, Inst Cell & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Fischer, JA (corresponding author), Univ Texas Austin, Sect Mol Cell & Dev Biol, Inst Cell & Mol Biol, Austin, TX 78712 USA.	jaf@mail.utexas.edu			National Institute of Child Health and Human Development (NICHD) [RO1-HD30680]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD030680] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institute of Child Health and Human Development (NICHD) Grant RO1-HD30680. The funders had no role in study design, data collection and alaysis, decision to publish, or preparation of the manuscript.	Aguilar RC, 2005, P NATL ACAD SCI USA, V103, P4116; Ahmed S, 2001, CURR BIOL, V11, P1934, DOI 10.1016/S0960-9822(01)00604-2; Anderson CM, 2008, GENE DEV, V22, P854, DOI 10.1101/gad.1646208; Anderson CM, 2008, CELL CYCLE, V7, P3695, DOI 10.4161/cc.7.23.7154; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Benard C, 2001, DEVELOPMENT, V128, P4045; Chang M, 2008, SCIENCE, V320, P60, DOI 10.1126/science.1155132; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; Dodd ME, 2009, DEVELOPMENT, V136, P2591, DOI 10.1242/dev.038448; Duncan MC, 2003, TRENDS CELL BIOL, V13, P211, DOI 10.1016/S0962-8924(03)00076-X; Duncan MC, 2003, NAT CELL BIOL, V5, P77, DOI 10.1038/ncb901; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Garcia-Muse T, 2005, EMBO J, V24, P4345, DOI 10.1038/sj.emboj.7600896; Glatter T, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.79; Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Horejsi Z, 2010, MOL CELL, V39, P839, DOI 10.1016/j.molcel.2010.08.037; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Hurov KE, 2010, GENE DEV, V24, P1939, DOI 10.1101/gad.1934210; Jenny A, 2010, CURR TOP DEV BIOL, V93, P189, DOI [10.1016/B978-0-12-385044-7.00007-2, 10.1016/S0070-2153(10)93007-X]; Jiang N, 2003, J BIOL CHEM, V278, P21678, DOI 10.1074/jbc.M300286200; Kaizuka T, 2010, J BIOL CHEM, V285, P20109, DOI 10.1074/jbc.M110.121699; Kalthoff C, 2002, MOL BIOL CELL, V13, P4060, DOI 10.1091/mbc.E02-03-0171; Kemler R, 1992, Semin Cell Biol, V3, P149; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; Lee JH, 2009, DEV BIOL, V331, P1, DOI 10.1016/j.ydbio.2009.03.029; Legendre-Guillemin V, 2004, J CELL SCI, V117, P9, DOI 10.1242/jcs.00928; Leventis PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025466; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Moser SC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000451; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Overstreet E, 2003, CURR BIOL, V13, P854, DOI 10.1016/S0960-9822(03)00326-9; Overstreet E, 2005, THESIS U TEXAS AUSTI; Parker DS, 2002, DEVELOPMENT, V129, P2565; Platta HW, 2011, CURR OPIN CELL BIOL, V23, P393, DOI 10.1016/j.ceb.2011.03.008; Popoff V, 2007, J CELL SCI, V120, P2022, DOI 10.1242/jcs.003020; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0; Seppa MJ, 2008, DEV BIOL, V318, P1, DOI 10.1016/j.ydbio.2008.02.022; Shikata M, 2007, J BIOL CHEM, V282, P5346, DOI 10.1074/jbc.M607432200; Takahisa M, 1996, GENE DEV, V10, P1783, DOI 10.1101/gad.10.14.1783; Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052; Takai H, 2010, GENE DEV, V24, P2019, DOI 10.1101/gad.1956410; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Wendland B, 2002, NAT REV MOL CELL BIO, V3, P971, DOI 10.1038/nrm970; Xie XH, 2012, DEV BIOL, V363, P399, DOI 10.1016/j.ydbio.2012.01.004; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1	59	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46357	10.1371/journal.pone.0046357	http://dx.doi.org/10.1371/journal.pone.0046357			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029494	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900142
J	Sulaiman, L; Haglund, F; Hashemi, J; Obara, T; Nordenstrom, J; Larsson, C; Juhlin, CC				Sulaiman, Luqman; Haglund, Felix; Hashemi, Jamileh; Obara, Takao; Nordenstrom, Jorgen; Larsson, Catharina; Juhlin, C. Christofer			Genome-Wide and Locus Specific Alterations in CDC73/HRPT2-Mutated Parathyroid Tumors	PLOS ONE			English	Article							FAMILIAL ISOLATED HYPERPARATHYROIDISM; NUCLEAR-LOCALIZATION; SUPPRESSOR PROTEIN; HRPT2 GENE; HUMAN PAF1; PARAFIBROMIN; MUTATIONS; EXPRESSION; GERMLINE; HYBRIDIZATION	Mutations in the hyperparathyroidism type 2 (HRPT2/CDC73) gene and alterations in the parafibromin protein have been established in the majority of parathyroid carcinomas and in subsets of parathyroid adenomas. While it is known that CDC73-mutated parathyroid tumors display specific gene expression changes compared to CDC73 wild-type cases, the molecular cytogenetic profile in CDC73-mutated cases compared to unselected adenomas (with an expected very low frequency of CDC73 mutations) remains unknown. For this purpose, nine parathyroid tumors with established CDC73 gene inactivating mutations (three carcinomas, one atypical adenoma and five adenomas) were analyzed for copy number alterations and loss of heterozygosity using array-comparative genomic hybridization (a-CGH) and single nucleotide polymorphism (SNP) microarrays, respectively. Furthermore, CDC73 gene promoter methylation levels were assessed using bisulfite Pyrosequencing. The panel included seven tumors with single mutation and three with double mutations of the CDC73 gene. The carcinomas displayed copy number alterations in agreement with previous studies, whereas the CDC73-mutated adenomas did not display the same pattern of alterations at loci frequently deleted in unselected parathyroid tumors. Furthermore, gross losses of chromosomal material at 1p and 13 were significantly (p = 0.012) associated with parathyroid carcinomas as opposed to adenomas. Quantitative PCR-based copy number loss regarding CDC73 was observed in three adenomas, while all the carcinomas were diploid or showed copy number gain for CDC73 gene. Hypermethylation of the CDC73 gene promoter was not observed. Our data could suggest that CDC73-mutated parathyroid adenomas exhibit a partly unique cytogenetic profile in addition to that of carcinomas and unselected adenomas. Furthermore, CDC73-mutated carcinomas displayed losses at 1p and 13 which are not seen in CDC73-mutated adenomas, making these regions of interest for further studies regarding malignant properties in tumors from CDC73-mutated cases. However, due to the small sample size, validation of the results in a larger cohort is warranted.	[Sulaiman, Luqman; Juhlin, C. Christofer] Karolinska Univ Hosp, Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Haglund, Felix; Hashemi, Jamileh; Larsson, Catharina] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Med Genet Unit, Stockholm, Sweden; [Obara, Takao] Tokyo Womens Med Univ Hosp, Dept Endocrine Surg, Tokyo, Japan; [Nordenstrom, Jorgen] Karolinska Univ Hosp, Karolinska Inst, Endocrine Surg Unit, Dept Mol Med & Surg, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Tokyo Women's Medical University; Karolinska Institutet; Karolinska University Hospital	Sulaiman, L (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.	Luqman.Sulaiman@ki.se; Catharina.Larsson@ki.se	Juhlin, Carl Christofer/C-1125-2016	Juhlin, Carl Christofer/0000-0002-5945-9081	Swedish Cancer Society; Swedish Research Council [5210-2010-3518]; Gustav V Jubilee Foundation; Karolinska Institutet; Stockholm County Council	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Gustav V Jubilee Foundation; Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council)	The study was financially supported by Swedish Cancer Society, Swedish Research Council (No. 5210-2010-3518), Gustav V Jubilee Foundation, Karolinska Institutet and Stockholm County Council. LS is supported by a research stipend donated from Mr. Ahmad Ismail Nanakaly. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 1998, CANCER GENET CYTOGEN, V106, P30, DOI 10.1016/S0165-4608(98)00049-1; Bradley KJ, 2007, ONCOGENE, V26, P1213, DOI 10.1038/sj.onc.1209893; Bradley KJ, 2006, CLIN ENDOCRINOL, V64, P299, DOI 10.1111/j.1365-2265.2006.02460.x; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Cavaco BM, 2004, J CLIN ENDOCR METAB, V89, P1747, DOI 10.1210/jc.2003-031016; Cetani F, 2004, J CLIN ENDOCR METAB, V89, P5583, DOI 10.1210/jc.2004-0294; Cetani F, 2007, EUR J ENDOCRINOL, V156, P547, DOI 10.1530/EJE-06-0720; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; CRYNS VL, 1995, GENE CHROMOSOME CANC, V13, P9, DOI 10.1002/gcc.2870130103; Farber LJ, 2010, MOL CARCINOGEN, V49, P215, DOI 10.1002/mc.20591; Farnebo F, 1999, J CLIN ENDOCR METAB, V84, P3775, DOI 10.1210/jc.84.10.3775; Gill AJ, 2006, AM J SURG PATHOL, V30, P1140; Hahn MA, 2010, ENDOCR-RELAT CANCER, V17, P273, DOI 10.1677/ERC-09-0291; Haven CJ, 2004, CANCER RES, V64, P7405, DOI 10.1158/0008-5472.CAN-04-2063; Howell VM, 2003, J MED GENET, V40, P657, DOI 10.1136/jmg.40.9.657; Juhlin C, 2006, ENDOCR-RELAT CANCER, V13, P509, DOI 10.1677/erc.1.01058; Juhlin CC, 2007, ENDOCR-RELAT CANCER, V14, P501, DOI 10.1677/ERC-07-0021; Juhlin CC, 2011, VIRCHOWS ARCH, V459, P47, DOI 10.1007/s00428-010-1032-3; Juhlin CC, 2010, ENDOCR PATHOL, V21, P166, DOI 10.1007/s12022-010-9121-z; Juhlin CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009472; Krebs LJ, 2005, J CLIN ENDOCR METAB, V90, P5015, DOI 10.1210/jc.2005-0717; Kytola S, 2000, AM J PATHOL, V157, P579, DOI 10.1016/S0002-9440(10)64568-3; Lin L, 2007, MOL CANCER RES, V5, P183, DOI 10.1158/1541-7786.MCR-06-0129; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Palanisamy N, 1998, J CLIN ENDOCR METAB, V83, P1766, DOI 10.1210/jc.83.5.1766; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Shane E, 2001, J CLIN ENDOCR METAB, V86, P485, DOI 10.1210/jc.86.2.485; Shattuck TM, 2003, NEW ENGL J MED, V349, P1722, DOI 10.1056/NEJMoa031237; Simonds WF, 2004, J CLIN ENDOCR METAB, V89, P96, DOI 10.1210/jc.2003-030675; Sulaiman L, 2012, ENDOCRINE RELATED CA; Valimaki S, 2002, INT J ONCOL, V21, P727; Villablanca A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012369; Woodard GE, 2005, ONCOGENE, V24, P1272, DOI 10.1038/sj.onc.1208274; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yang YJ, 2010, NUCLEIC ACIDS RES, V38, P382, DOI 10.1093/nar/gkp991; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Yi Y, 2008, GENE CHROMOSOME CANC, V47, P639, DOI 10.1002/gcc.20565	37	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46325	10.1371/journal.pone.0046325	http://dx.doi.org/10.1371/journal.pone.0046325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029479	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900134
J	Dicksved, J; Schreiber, O; Willing, B; Petersson, J; Rang, S; Phillipson, M; Holm, L; Roos, S				Dicksved, Johan; Schreiber, Olof; Willing, Ben; Petersson, Joel; Rang, Sara; Phillipson, Mia; Holm, Lena; Roos, Stefan			Lactobacillus reuteri Maintains a Functional Mucosal Barrier during DSS Treatment Despite Mucus Layer Dysfunction	PLOS ONE			English	Article							CROHNS-DISEASE; ESCHERICHIA-COLI; ILEAL MUCOSA; MICROBIOTA; IMBALANCES; DYSBIOSIS; ADHERENCE; BACTERIA; STRAINS; MODEL	Treatment with the probiotic bacterium Lactobacillus reuteri has been shown to prevent dextran sodium sulfate (DSS)-induced colitis in rats. This is partly due to reduced P-selectin-dependent leukocyte-and platelet-endothelial cell interactions, however, the mechanism behind this protective effect is still unknown. In the present study a combination of culture dependent and molecular based T-RFLP profiling was used to investigate the influence of L. reuteri on the colonic mucosal barrier of DSS treated rats. It was first demonstrated that the two colonic mucus layers of control animals had different bacterial community composition and that fewer bacteria resided in the firmly adherent layer. During DSS induced colitis, the number of bacteria in the inner firmly adherent mucus layer increased and bacterial composition of the two layers no longer differed. In addition, induction of colitis dramatically altered the microbial composition in both firmly and loosely adherent mucus layers. Despite protecting against colitis, treatment with L. reuteri did not improve the integrity of the mucus layer or prevent distortion of the mucus microbiota caused by DSS. However, L. reuteri decreased the bacterial translocation from the intestine to mesenteric lymph nodes during DSS treatment, which might be an important part of the mechanisms by which L. reuteri ameliorates DSS induced colitis.	[Dicksved, Johan; Willing, Ben; Roos, Stefan] Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, S-75007 Uppsala, Sweden; [Schreiber, Olof; Petersson, Joel; Rang, Sara; Phillipson, Mia; Holm, Lena] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Willing, Ben] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Rang, Sara] Lund Univ, Ctr Chem & Chem Engn, Lund, Sweden	Swedish University of Agricultural Sciences; Uppsala University; University of British Columbia; Lund University	Roos, S (corresponding author), Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, Box 7025, S-75007 Uppsala, Sweden.	stefan.roos@slu.se		Dicksved, Johan/0000-0002-7515-4480; Roos, Stefan/0000-0002-1606-1794; Phillipson, Mia/0000-0002-2387-0266	Swedish Research Council [04X-08646, 57P-20680-01-4, 57x-20675-01-4]; Swedish Research Council for Environment, Agricultural Science and Spatial Planning [222-2006-454]; Nanna Svartz Foundation; Ruth and Richard Julins Foundation; Biogaia AB Stockholm, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agricultural Science and Spatial Planning(Swedish Research Council Formas); Nanna Svartz Foundation; Ruth and Richard Julins Foundation; Biogaia AB Stockholm, Sweden	The study was supported by grants from the Swedish Research Council (04X-08646, 57P-20680-01-4, 57x-20675-01-4), http://www.vr.se/; Swedish Research Council for Environment, Agricultural Science and Spatial Planning (222-2006-454), http://www.formas.se/; Nanna Svartz Foundation, http://www.uadm.uu.se/resursen/utlys/utlysning.php?uid = 758&col = 2&dir = 0&offset = 0; Ruth and Richard Julins Foundation, http://ki.se/ki/jsp/polopoly.jsp?d = 20152&a = 134578&l = en; and Biogaia AB Stockholm, Sweden, http://www.biogaia.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Baumgart M, 2007, ISME J, V1, P403, DOI 10.1038/ismej.2007.52; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; COOPER HS, 1993, LAB INVEST, V69, P238; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Jager S, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/910283; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Lamine F, 2004, SCAND J GASTROENTERO, V39, P1250, DOI 10.1080/00365520410007953; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Mack DR, 2003, GUT, V52, P827, DOI 10.1136/gut.52.6.827; Mack DR, 1999, AM J PHYSIOL-GASTR L, V276, pG941, DOI 10.1152/ajpgi.1999.276.4.G941; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Mennigen R, 2009, AM J PHYSIOL-GASTR L, V296, pG1140, DOI 10.1152/ajpgi.90534.2008; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Petersson J, 2011, AM J PHYSIOL-GASTR L, V300, pG327, DOI 10.1152/ajpgi.00422.2010; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schreiber O, 2009, AM J PHYSIOL-GASTR L, V296, pG534, DOI 10.1152/ajpgi.90470.2008; Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237; Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Ye JX, 2008, INFLAMM BOWEL DIS, V14, P1041, DOI 10.1002/ibd.20442	27	88	92	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46399	10.1371/journal.pone.0046399	http://dx.doi.org/10.1371/journal.pone.0046399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029509	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500099
J	Kraehenmann, R; Vollenweider, FX; Seifritz, E; Kometer, M				Kraehenmann, Rainer; Vollenweider, Franz X.; Seifritz, Erich; Kometer, Michael			Crowding Deficits in the Visual Periphery of Schizophrenia Patients	PLOS ONE			English	Article							TO-NOISE RATIO; PERCEPTUAL ORGANIZATION; EYE-MOVEMENTS; CONTRAST SENSITIVITY; OBJECT-RECOGNITION; SPATIAL-RESOLUTION; BACKWARD-MASKING; ATTENTION; INFORMATION; SEARCH	Accumulating evidence suggests that basic visual information processing is impaired in schizophrenia. However, deficits in peripheral vision remain largely unexplored. Here we hypothesized that sensory processing of information in the visual periphery would be impaired in schizophrenia patients and, as a result, crowding - the breakdown in target recognition that occurs in cluttered visual environments - would be stronger. Therefore, we assessed visual crowding in the peripheral vision of schizophrenia patients and healthy controls. Subjects were asked to identify a target letter that was surrounded by distracter letters of similar appearance. Targets and distracters were displayed at 8 degrees and 10 degrees of visual angle from the fixation point (eccentricity), and target-distracter spacing was 2 degrees, 3 degrees, 4 degrees, 5 degrees, 6 degrees, 7 degrees or 8 degrees of visual angle. Eccentricity and target-distracter spacing were randomly varied. Accuracy was defined as the proportion of correctly identified targets. Critical spacing was defined as the spacing at which target identification accuracy began to deteriorate, and was assessed at viewing eccentricities of 8 degrees and 10 degrees. Schizophrenia patients were less accurate and showed a larger critical spacing than healthy individuals. These results indicate that crowding is stronger and sensory processing of information in the visual periphery is impaired in schizophrenia. This is in line with previous reports of preferential magnocellular dysfunction in schizophrenia. Thus, deficits in peripheral vision may account for perceptual alterations and contribute to cognitive dysfunction in schizophrenia.	[Kraehenmann, Rainer; Vollenweider, Franz X.; Kometer, Michael] Univ Zurich, Clin Affect Disorders & Gen Psychiat, Neuropsychopharmacol & Brain Imaging & Heffter Re, Psychiat Univ Hosp, Zurich, Switzerland	University of Zurich	Kometer, M (corresponding author), Univ Zurich, Clin Affect Disorders & Gen Psychiat, Neuropsychopharmacol & Brain Imaging & Heffter Re, Psychiat Univ Hosp, Zurich, Switzerland.	michael.kometer@bli.uzh.ch	Krähenmann, Rainer/E-9363-2010		Foundation for Medical Research of the University of Zurich	Foundation for Medical Research of the University of Zurich	The study was funded in part by a restricted grant of the Foundation for Medical Research of the University of Zurich (RK). The Foundation for Medical Research of the University of Zurich had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anderson EJ, 2012, CURR BIOL, V22, P1199, DOI 10.1016/j.cub.2012.04.063; Andreasen NC, 2010, BIOL PSYCHIAT, V67, P255, DOI 10.1016/j.biopsych.2009.08.040; ARMAN AC, 2006, J VISION, V6, P804; Bach DR, 2011, SCHIZOPHRENIA BULL, V37, P426, DOI 10.1093/schbul/sbp092; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Balas B, 2009, J VISION, V9, DOI [10.1167/9.2.16, 10.1167/9.12.13]; Baldassi S, 2006, PLOS BIOL, V4, P387, DOI 10.1371/journal.pbio.0040056; Behrendt RP, 2004, BEHAV BRAIN SCI, V27, P771, DOI 10.1017/S0140525X04000184; Brenner CA, 2009, SCHIZOPHRENIA BULL, V35, P1065, DOI 10.1093/schbul/sbp091; Butler PD, 2008, SCHIZOPHR RES, V103, P283, DOI 10.1016/j.schres.2008.03.007; Butler PD, 2008, BIOL PSYCHIAT, V64, P40, DOI 10.1016/j.biopsych.2008.03.023; Butler PD, 2007, BRAIN, V130, P417, DOI 10.1093/brain/awl233; Butler PD, 2010, SCHIZOPHR RES, V118, P20, DOI 10.1016/j.schres.2010.01.005; Butler PD, 2005, ARCH GEN PSYCHIAT, V62, P495, DOI 10.1001/archpsyc.62.5.495; Campanella S, 2006, NEUROPHYSIOL CLIN, V36, P71, DOI 10.1016/j.neucli.2006.04.005; CARRASCO M, 1995, PERCEPT PSYCHOPHYS, V57, P1241, DOI 10.3758/BF03208380; CEGALIS JA, 1981, J NERV MENT DIS, V169, P751, DOI 10.1097/00005053-198112000-00002; Chakravarthi R, 2011, J VISION, V11, DOI 10.1167/11.8.10; CHAPMAN J, 1966, BRIT J PSYCHIAT, V112, P225, DOI 10.1192/bjp.112.484.225; Chen Y, 2008, COGN AFFECT BEHAV NE, V8, P293, DOI 10.3758/CABN.8.3.293; Chen Y, 2008, SCHIZOPHRENIA BULL, V34, P367, DOI 10.1093/schbul/sbm071; Chkonia E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014268; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; CONNOLLY M, 1984, J COMP NEUROL, V226, P544, DOI 10.1002/cne.902260408; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dakin S, 2005, CURR BIOL, V15, pR822, DOI 10.1016/j.cub.2005.10.015; Doniger GM, 2001, AM J PSYCHIAT, V158, P1818, DOI 10.1176/appi.ajp.158.11.1818; Elahipanah A, 2011, NEUROPSYCHOLOGIA, V49, P3370, DOI 10.1016/j.neuropsychologia.2011.08.011; Elahipanah A, 2010, NEUROPSYCHOLOGY, V24, P192, DOI 10.1037/a0017523; ELKINS IJ, 1992, J ABNORM PSYCHOL, V101, P53, DOI 10.1037/0021-843X.101.1.53; Ethridge L, 2011, SCHIZOPHR RES, V133, P106, DOI 10.1016/j.schres.2011.07.016; Fang F, 2008, J VISION, V8, P9; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Foxe JJ, 2005, CEREB CORTEX, V15, P1914, DOI 10.1093/cercor/bhi069; Franceschini S, 2012, CURR BIOL, V22, P814, DOI 10.1016/j.cub.2012.03.013; Freeman J, 2011, NAT NEUROSCI, V14, P1195, DOI 10.1038/nn.2889; Granholm E, 2004, INT J PSYCHOPHYSIOL, V52, P37, DOI 10.1016/j.ijpsycho.2003.12.004; Granholm E, 1996, J ABNORM PSYCHOL, V105, P17; GREEN MF, 1994, ARCH GEN PSYCHIAT, V51, P939; Green MF, 2009, SCHIZOPHRENIA BULL, V35, P163, DOI 10.1093/schbul/sbn156; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Greenwood JA, 2009, P NATL ACAD SCI USA, V106, P13130, DOI 10.1073/pnas.0901352106; Gross J, 2009, CURR BIOL, V19, pR847, DOI 10.1016/j.cub.2009.07.023; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Hess RF, 1997, NATURE, V390, P602, DOI 10.1038/37593; Intriligator J, 2001, COGNITIVE PSYCHOL, V43, P171, DOI 10.1006/cogp.2001.0755; Javitt DC, 2009, ANNU REV CLIN PSYCHO, V5, P249, DOI 10.1146/annurev.clinpsy.032408.153502; Jeste DV, 2007, ARCH GEN PSYCHIAT, V64, P966, DOI 10.1001/archpsyc.64.8.966; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kelly SP, 2008, CEREB CORTEX, V18, P2629, DOI 10.1093/cercor/bhn022; Keri S, 2007, VISUAL NEUROSCI, V24, P183, DOI 10.1017/S0952523807070253; Klosterkotter J, 2001, ARCH GEN PSYCHIAT, V58, P158, DOI 10.1001/archpsyc.58.2.158; Knebel JF, 2011, PSYCHIAT RES-NEUROIM, V193, P168, DOI 10.1016/j.pscychresns.2011.02.006; KOOI FL, 1994, SPATIAL VISION, V8, P255, DOI 10.1163/156856894X00350; Kroken RA, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-24; Kurylo DD, 2007, SCHIZOPHR RES, V95, P205, DOI 10.1016/j.schres.2007.07.001; Kyllingsbaek S, 2007, PERCEPT PSYCHOPHYS, V69, P1040, DOI 10.3758/BF03193942; LEPINE JP, 1989, PSYCHIAT TODAY ACCOM; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Li ZP, 1999, P NATL ACAD SCI USA, V96, P10530, DOI 10.1073/pnas.96.18.10530; LIEB K, 1994, SCHIZOPHR RES, V14, P47, DOI 10.1016/0920-9964(94)90008-6; LIVINGSTONE MS, 1988, J NEUROSCI, V8, P4334; MAHER BA, 1974, J INDIV PSYCHOL, V30, P98; Martelli M, 2005, J VISION, V5, P58, DOI 10.1167/5.1.6; Martelli M, 2009, J VISION, V9, DOI 10.1167/9.4.14; Martinez A, 2008, J NEUROSCI, V28, P7492, DOI 10.1523/JNEUROSCI.1852-08.2008; Martinez A, 2012, CEREB CORTEX, V22, P1282, DOI 10.1093/cercor/bhr195; Matsuda Y, 2011, PERCEPT MOTOR SKILL, V112, P369, DOI 10.2466/15.19.22.27.PMS.112.2.369-381; May KA, 2007, J VISION, V7, DOI 10.1167/7.13.9; MCGHIE A, 1961, BRIT J MED PSYCHOL, V34, P103, DOI 10.1111/j.2044-8341.1961.tb00936.x; Merz J, 1975, Psychiatr Neurol Med Psychol (Leipz), V27, P423; MILLER MB, 1990, J ABNORM PSYCHOL, V99, P313, DOI 10.1037/0021-843X.99.3.313; Morrison AP, 2002, BRIT J CLIN PSYCHOL, V41, P259, DOI 10.1348/014466502760379127; Motter BC, 2008, VISION RES, V48, P2382, DOI 10.1016/j.visres.2008.07.020; Must A, 2004, NEUROSCI LETT, V357, P131, DOI 10.1016/j.neulet.2003.12.046; NEALE JM, 1971, J ABNORM PSYCHOL, V77, P196, DOI 10.1037/h0030751; Neri P, 2006, J NEUROPHYSIOL, V96, P142, DOI 10.1152/jn.01261.2005; NUECHTERLEIN KH, 1984, SCHIZOPHRENIA BULL, V10, P160, DOI 10.1093/schbul/10.2.160; Olevitch BA, 1996, INT J NEUROSCI, V88, P249, DOI 10.3109/00207459609000618; Omtzigt D, 2002, NEUROPSYCHOLOGIA, V40, P1881, DOI 10.1016/S0028-3932(02)00069-6; PANDYA DN, 1990, PROG BRAIN RES, V85, P63; Parkes L, 2001, NAT NEUROSCI, V4, P739, DOI 10.1038/89532; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Prado C, 2007, VISION RES, V47, P2521, DOI 10.1016/j.visres.2007.06.001; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rahnev D, 2012, J NEUROPHYSIOL, V107, P1556, DOI 10.1152/jn.00985.2011; Rassovsky Y, 2011, PSYCHOL MED, V41, P487, DOI 10.1017/S0033291710001054; Reddy L, 2007, J VISION, V7, DOI 10.1167/7.2.3; Ress D, 2003, NAT NEUROSCI, V6, P414, DOI 10.1038/nn1024; Revheim N, 2006, SCHIZOPHR RES, V87, P238, DOI 10.1016/j.schres.2006.06.022; RICHARDSON AJ, 1994, INT J PSYCHOPHYSIOL, V18, P227, DOI 10.1016/0167-8760(94)90009-4; RICHARDSON AJ, 1994, INT J PSYCHOPHYSIOL, V18, P251, DOI 10.1016/0167-8760(94)90011-6; Robertshaw E, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/475017; Rosenholtz R, 2012, J VISION, V12, DOI 10.1167/12.4.14; Saarela TP, 2009, J VISION, V9, DOI 10.1167/9.2.5; Saj A, 2011, CORTEX, P1; Saunders JA, 2012, NEUROBIOL DIS, V46, P93, DOI 10.1016/j.nbd.2011.12.049; Schade U, 2011, VISION RES, V51, P1, DOI 10.1016/j.visres.2010.09.010; Scolari M, 2007, J VISION, V7, DOI 10.1167/7.2.7; Sehatpour P, 2010, ARCH GEN PSYCHIAT, V67, P772, DOI 10.1001/archgenpsychiatry.2010.85; SERENO AB, 1995, BIOL PSYCHIAT, V37, P394, DOI 10.1016/0006-3223(94)00127-O; Shapleske J, 1999, BRAIN RES REV, V29, P26, DOI 10.1016/S0165-0173(98)00047-2; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shin YW, 2008, SCHIZOPHRENIA BULL, V34, P538, DOI 10.1093/schbul/sbm118; Silverstein SM, 2000, SCHIZOPHR RES, V43, P11, DOI 10.1016/S0920-9964(99)00180-2; Silverstein SM, 1996, J ABNORM PSYCHOL, V105, P410, DOI 10.1037/0021-843X.105.3.410; Slaghuis WL, 2003, NEUROPSYCHOLOGIA, V41, P968, DOI 10.1016/S0028-3932(02)00321-4; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Tjan BS, 2006, J NEUROPHYSIOL, V96, P1556, DOI 10.1152/jn.01367.2005; To MPS, 2011, VISION RES, V51, P1686, DOI 10.1016/j.visres.2011.05.010; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; TREVARTHEN CB, 1968, PSYCHOL FORSCH, V31, P299, DOI 10.1007/BF00422717; Uhlhaas PJ, 2008, SCHIZOPHRENIA BULL, V34, P927, DOI 10.1093/schbul/sbn062; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; van Assche M, 2011, SCHIZOPHRENIA BULL, V37, P394, DOI 10.1093/schbul/sbp084; Verghese P, 2004, VISION RES, V44, P1217, DOI 10.1016/j.visres.2003.12.006; Vlaskamp BNS, 2006, VISION RES, V46, P417, DOI 10.1016/j.visres.2005.04.006; Wertheim AH, 2006, EXP BRAIN RES, V170, P387, DOI 10.1007/s00221-005-0221-9; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; Williams LE, 2010, NEUROPSYCHOLOGIA, V48, P3128, DOI 10.1016/j.neuropsychologia.2010.06.028; Winterer G, 2002, BIOL PSYCHIAT, V51, p151S; Yeshurun Y, 2010, J VISION, V10, DOI 10.1167/10.10.16; Yeterian EH, 2010, J COMP NEUROL, V518, P3725, DOI 10.1002/cne.22420; Yoon JH, 2006, PSYCHIAT RES-NEUROIM, V148, P205, DOI 10.1016/j.pscychresns.2006.06.002; Zhang XL, 2012, NEURON, V73, P183, DOI 10.1016/j.neuron.2011.10.035	127	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45884	10.1371/journal.pone.0045884	http://dx.doi.org/10.1371/journal.pone.0045884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049884	Green Published, gold, Green Accepted			2022-12-27	WOS:000309517300060
J	Maxwell, E; Tan, Y; Tan, YX; Hu, H; Benson, G; Aizikov, K; Conley, S; Staples, GO; Slysz, GW; Smith, RD; Zaia, J				Maxwell, Evan; Tan, Yan; Tan, Yuxiang; Hu, Han; Benson, Gary; Aizikov, Konstantin; Conley, Shannon; Staples, Gregory O.; Slysz, Gordon W.; Smith, Richard D.; Zaia, Joseph			GlycReSoft: A Software Package for Automated Recognition of Glycans from LC/MS Data	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; CHROMATOGRAPHY/MASS SPECTROMETRY; NONREDUCING END; OLIGOSACCHARIDES; PROTEOME; HEPARIN; IDENTIFICATIONS; DATABASES; SPECTRA; CHIP	Glycosylation modifies the physicochemical properties and protein binding functions of glycoconjugates. These modifications are biosynthesized in the endoplasmic reticulum and Golgi apparatus by a series of enzymatic transformations that are under complex control. As a result, mature glycans on a given site are heterogeneous mixtures of glycoforms. This gives rise to a spectrum of adhesive properties that strongly influences interactions with binding partners and resultant biological effects. In order to understand the roles glycosylation plays in normal and disease processes, efficient structural analysis tools are necessary. In the field of glycomics, liquid chromatography/mass spectrometry (LC/MS) is used to profile the glycans present in a given sample. This technology enables comparison of glycan compositions and abundances among different biological samples, i.e. normal versus disease, normal versus mutant, etc. Manual analysis of the glycan profiling LC/MS data is extremely time-consuming and efficient software tools are needed to eliminate this bottleneck. In this work, we have developed a tool to computationally model LC/MS data to enable efficient profiling of glycans. Using LC/MS data deconvoluted by Decon2LS/DeconTools, we built a list of unique neutral masses corresponding to candidate glycan compositions summarized over their various charge states, adducts and range of elution times. Our work aims to provide confident identification of true compounds in complex data sets that are not amenable to manual interpretation. This capability is an essential part of glycomics work flows. We demonstrate this tool, GlycReSoft, using an LC/MS dataset on tissue derived heparan sulfate oligosaccharides. The software, code and a test data set are publically archived under an open source license.	[Maxwell, Evan; Tan, Yan; Tan, Yuxiang; Hu, Han; Benson, Gary; Zaia, Joseph] Boston Univ, Ctr Biomed Mass Spectrometry, Bioinformat Program, Boston, MA 02215 USA; [Maxwell, Evan] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Slysz, Gordon W.; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Slysz, Gordon W.; Smith, Richard D.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Tan, Yan] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA	Boston University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Zaia, J (corresponding author), Boston Univ, Ctr Biomed Mass Spectrometry, Bioinformat Program, Boston, MA 02215 USA.	jzaia@bu.edu	Zaia, Joseph/U-7850-2019; Tan, Yuxiang/AFQ-4637-2022; Smith, Richard D/J-3664-2012	Zaia, Joseph/0000-0001-9497-8701; Tan, Yuxiang/0000-0002-1704-1293; Smith, Richard D/0000-0002-2381-2349; Slysz, Gordon/0000-0001-6668-6576	NIH [P41RR10888, P41GM104603, R01HL098950]; NSF (National Science Foundation); NIH National Center for Research Resources [RR018522]; W.R. Wiley Environmental Molecular Science Laboratory; US Department of Energy's Office of Biological and Environmental Research; National Institute of Allergy and Infectious Diseases (NIH/DHHS) [Y1-AI-4894-01]; US Department of Energy [DE-AC05-76RL0 1830]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522, P41RR010888] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM104603] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF (National Science Foundation)(National Science Foundation (NSF)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); W.R. Wiley Environmental Molecular Science Laboratory; US Department of Energy's Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of Allergy and Infectious Diseases (NIH/DHHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants P41RR10888, P41GM104603, and R01HL098950 and by an NSF (National Science Foundation) Integrative Graduate Education and Research Traineeship. This research utilized the Decon2LS and DeconTools software developed by the Pacific Northwest National Laboratory, supported by the NIH National Center for Research Resources (Grant RR018522), the W.R. Wiley Environmental Molecular Science Laboratory (a national scientific user facility sponsored by the US Department of Energy's Office of Biological and Environmental Research and located at PNNL), and the National Institute of Allergy and Infectious Diseases (NIH/DHHS through interagency agreement Y1-AI-4894-01). PNNL is operated by Battelle Memorial Institute for the US Department of Energy under contract DE-AC05-76RL0 1830. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Cargile BJ, 2004, J PROTEOME RES, V3, P1082, DOI 10.1021/pr049946o; Ceroni A, 2008, J PROTEOME RES; Cooper CA, 2001, PROTEOMICS, V1, P340, DOI 10.1002/1615-9861(200102)1:2<340::AID-PROT340>3.0.CO;2-B; Dreyfuss JM, 2011, ANAL BIOANAL CHEM, V399, P727, DOI 10.1007/s00216-010-4235-1; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Goldberg D, 2005, PROTEOMICS, V5, P865, DOI 10.1002/pmic.200401071; Henriksen J, 2004, J MASS SPECTROM, V39, P1305, DOI 10.1002/jms.723; Horn DM, 2000, J AM SOC MASS SPECTR, V11, P320, DOI 10.1016/S1044-0305(99)00157-9; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Karlsson NG, 2004, RAPID COMMUN MASS SP, V18, P2282, DOI 10.1002/rcm.1626; Kuberan B, 2002, J AM CHEM SOC, V124, P8707, DOI 10.1021/ja0178867; Moore RE, 2002, J AM SOC MASS SPECTR, V13, P378, DOI 10.1016/S1044-0305(02)00352-5; Naimy H, 2008, BIOCHEMISTRY-US, V47, P3155, DOI 10.1021/bi702043e; Naimy H, 2011, J BIOL CHEM, V286, P19311, DOI 10.1074/jbc.M110.204693; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Shi XF, 2009, J BIOL CHEM, V284, P11806, DOI 10.1074/jbc.M809637200; Slysz G.W., 2010, P 58 ASMS C MASS SPE; Staples GO, 2010, J BIOL CHEM, V285, P18336, DOI 10.1074/jbc.M110.101592; Staples GO, 2010, ANAL CHEM, V82, P516, DOI 10.1021/ac901706f; Staples GO, 2009, PROTEOMICS, V9, P686, DOI 10.1002/pmic.200701008; Thanawiroon C, 2004, J BIOL CHEM, V279, P2608, DOI 10.1074/jbc.M304772200; Yu LR, 2004, MOL CELL PROTEOMICS, V3, P896, DOI 10.1074/mcp.M400034-MCP200; Zaia J, 2009, MASS SPECTROM REV, V28, P254, DOI 10.1002/mas.20200	27	106	107	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45474	10.1371/journal.pone.0045474	http://dx.doi.org/10.1371/journal.pone.0045474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049804	gold, Green Published, Green Submitted			2022-12-27	WOS:000309517300027
J	Sela, I; Karni, A				Sela, Itamar; Karni, Avi			Differences in Learning Volitional (Manual) and Non-Volitional (Posture) Aspects of a Complex Motor Skill in Young Adult Dyslexic and Skilled Readers	PLOS ONE			English	Article							DEVELOPMENTAL DYSLEXIA; SUPPORT-SURFACE; CHILDREN; DEFICITS; BALANCE; ACQUISITION; PERFORMANCE; AUTOMATIZATION; CEREBELLUM; MOVEMENT	The 'Cerebellar Deficit Theory' of developmental dyslexia proposes that a subtle developmental cerebellar dysfunction leads to deficits in attaining 'automatic' procedures and therefore manifests as subtle motor impairments (e. g., balance control, motor skill learning) in addition to the reading and phonological difficulties. A more recent version of the theory suggests a core deficit in motor skill acquisition. This study was undertaken to compare the time-course and the nature of practice-related changes in volitional (manual) and non-volitional (posture) motor performance in dyslexic and typical readers while learning a new movement sequence. Seventeen dyslexic and 26 skilled young adult readers underwent a three-session training program in which they practiced a novel sequence of manual movements while standing in a quiet stance position. Both groups exhibited robust and well-retained gains in speed, with no loss of accuracy, on the volitional, manual, aspects of the task, with a time-course characteristic of procedural learning. However, the dyslexic readers exhibited a pervasive slowness in the initiation of volitional performance. In addition, while typical readers showed clear and well-retained task-related adaptation of the balance and posture control system, the dyslexic readers had significantly larger sway and variance of sway throughout the three sessions and were less efficient in adapting the posture control system to support the acquisition of the novel movement sequence. These results support the notion of a non-language-related deficit in developmental dyslexia, one related to the recruitment of motor systems for effective task performance rather than to a general motor learning disability.	[Sela, Itamar; Karni, Avi] Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, IL-31999 Haifa, Israel; [Karni, Avi] Univ Haifa, Fac Nat Sci, Segol Dept Neurobiol & Ethol, IL-31999 Haifa, Israel; [Karni, Avi] Univ Haifa, Fac Nat Sci, Dept Human Biol, IL-31999 Haifa, Israel	University of Haifa; University of Haifa; University of Haifa	Sela, I (corresponding author), Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, IL-31999 Haifa, Israel.	isela01@campus.haifa.ac.il			Edmond J. Safra Philanthropic Foundation	Edmond J. Safra Philanthropic Foundation	This research was funded by the Edmond J. Safra Philanthropic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adi-Japha E, 2008, J EXP PSYCHOL LEARN, V34, P1544, DOI 10.1037/a0013217; Adi-Japha E, 2011, RES DEV DISABIL, V32, P1011, DOI 10.1016/j.ridd.2011.01.048; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Berret B, 2009, J NEUROSCI, V29, P191, DOI 10.1523/JNEUROSCI.3426-08.2009; Bishop DVM, 2002, CORTEX, V38, P491, DOI 10.1016/S0010-9452(08)70018-2; Bock O, 2001, ACTA PHYSL PHARM BUL, V26, P761; Breznitz Z, 2003, BRAIN LANG, V85, P486, DOI 10.1016/S0093-934X(03)00071-3; Breznitz Z., 2006, FLUENCY READING SYNC; Chein JM, 2005, COGNITIVE BRAIN RES, V25, P607, DOI 10.1016/j.cogbrainres.2005.08.013; Chong RKY, 1999, J GERONTOL A-BIOL, V54, pM129, DOI 10.1093/gerona/54.3.M129; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Cohen RG, 2009, EXP BRAIN RES, V193, P69, DOI 10.1007/s00221-008-1596-1; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Doyon J, 2002, P NATL ACAD SCI USA, V99, P1017, DOI 10.1073/pnas.022615199; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Doyon J., 2002, NEUROPSYCHOLOGY MEMO, V3rd ed., P225; Elion O, 2008, 2008 VIRTUAL REHABILITATION, P50, DOI 10.1109/ICVR.2008.4625121; Engel KC, 1997, EXP BRAIN RES, V113, P189, DOI 10.1007/BF02450317; FAWCETT AJ, 1992, PERCEPT MOTOR SKILL, V75, P507, DOI 10.2466/pms.1992.75.2.507; Fawcett AJ., 2008, SAGE HDB DYSLEXIA, P11; Fischer S, 2002, P NATL ACAD SCI USA, V99, P11987, DOI 10.1073/pnas.182178199; Galgon AK, 2010, GAIT POSTURE, V31, P265, DOI 10.1016/j.gaitpost.2009.11.002; Gilbert CD, 2009, J PHYSIOL-LONDON, V587, P2743, DOI 10.1113/jphysiol.2009.171488; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hauptmann B, 2005, COGNITIVE BRAIN RES, V24, P181, DOI 10.1016/j.cogbrainres.2005.01.012; Hauptmann B, 2002, COGNITIVE BRAIN RES, V13, P313, DOI 10.1016/S0926-6410(01)00124-0; Hikosaka O, 1999, TRENDS NEUROSCI, V22, P464, DOI 10.1016/S0166-2236(99)01439-3; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; HORAK FB, 1989, J NEUROPHYSIOL, V62, P841, DOI 10.1152/jn.1989.62.4.841; Ivry RB, 2001, TRENDS NEUROSCI, V24, P513, DOI 10.1016/S0166-2236(00)01897-X; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1995, LANCET, V345, P395, DOI 10.1016/S0140-6736(95)90386-0; Karni A, 1998, P NATL ACAD SCI USA, V95, P861, DOI 10.1073/pnas.95.3.861; Kelly Steve W, 2002, Dyslexia, V8, P43, DOI 10.1002/dys.208; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Lacquaniti F, 1992, Curr Opin Neurobiol, V2, P807, DOI 10.1016/0959-4388(92)90138-B; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; LOGAN GD, 1988, PSYCHOL REV, V95, P492, DOI 10.1037/0033-295X.95.4.492; Maquet P, 2003, LEARN MEMORY, V10, P237, DOI 10.1101/lm.64303; Massion J, 1996, CLIN DISORDERS BALAN, P10; MATAL, 2007, DIAGN BATT ASS LEARN; Menghini D, 2006, NEUROIMAGE, V33, P1218, DOI 10.1016/j.neuroimage.2006.08.024; Menghini D, 2008, ANN NY ACAD SCI, V1145, P212, DOI 10.1196/annals.1416.010; Nicolson RI, 2010, DYSLEXIA, V16, P194, DOI 10.1002/dys.408; Nicolson RI, 2005, J NEURAL TRANSM-SUPP, P19; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; NICOLSON RI, 1990, COGNITION, V35, P159, DOI 10.1016/0010-0277(90)90013-A; Nicolson RI, 2008, SAGE HDB DYSLEXIA, P11; Nicolson RI, 2007, TRENDS NEUROSCI, V30, P135, DOI 10.1016/j.tins.2007.02.003; Nicolson RI, 2011, CORTEX, V47, P117, DOI 10.1016/j.cortex.2009.08.016; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; Raberger T, 2003, NEUROPSYCHOLOGIA, V41, P1493, DOI 10.1016/S0028-3932(03)00078-2; Ramus F, 2003, CURR OPIN NEUROBIOL, V13, P212, DOI 10.1016/S0959-4388(03)00035-7; Raven J.C., 1960, GUIDE STANDARD PROGR; Reiter A, 2005, DYSLEXIA, V11, P116, DOI 10.1002/dys.289; Robertson EM, 2009, PLOS BIOL, V7, P11, DOI 10.1371/journal.pbio.1000019; Rosenblum S, 2003, PERCEPT MOTOR SKILL, V96, P933, DOI 10.2466/PMS.96.3.933-954; Roth DAE, 2005, LEARN MEMORY, V12, P159, DOI 10.1101/87505; Savage R., 2004, READING WRITING INTE, V17, P301, DOI [DOI 10.1023/B:READ.0000017688.67137.80, 10.1023/B:READ.0000017688.67137.80]; Shany M., 2006, TEL AVIV; Song JH, 2009, TRENDS COGN SCI, V13, P360, DOI 10.1016/j.tics.2009.04.009; Sosnik R, 2004, EXP BRAIN RES, V156, P422, DOI 10.1007/s00221-003-1799-4; Sosnik R, 2007, EXP BRAIN RES, V176, P311, DOI 10.1007/s00221-006-0617-1; Stein J, 2001, Dyslexia, V7, P12, DOI 10.1002/dys.186; Stelmach GE, 1996, ACQUISITION OF MOTOR BEHAVIOR IN VERTEBRATES, P391; Stoodley CJ, 2005, EXP BRAIN RES, V167, P370, DOI 10.1007/s00221-005-0042-x; The Center of Psychometric Tests, 1994, OR SIL COMPR TEST; Vernazza-Martin S, 2006, EXP BRAIN RES, V173, P62, DOI 10.1007/s00221-006-0364-3; VERWEY WB, 1993, ACTA PSYCHOL, V84, P179, DOI 10.1016/0001-6918(93)90026-N; Vicari S, 2005, J NEUROL NEUROSUR PS, V76, P1392, DOI 10.1136/jnnp.2004.061093; Waber DP, 2003, J EXP CHILD PSYCHOL, V84, P338, DOI 10.1016/S0022-0965(03)00030-4; Walker MP, 2002, NEURON, V35, P205, DOI 10.1016/S0896-6273(02)00746-8; Warren WH, 2006, PSYCHOL REV, V113, P358, DOI 10.1037/0033-295X.113.2.358; Wechsler D., 1997, WECHSLER ADULT INTEL; White S, 2006, DEVELOPMENTAL SCI, V9, P237, DOI 10.1111/j.1467-7687.2006.00483.x; Wimmer H, 1999, J LEARN DISABIL, V32, P473, DOI 10.1177/002221949903200513; Wimmer H., 1998, SCI STUD READ, V2, P321, DOI [10.1207/s1532799xssr0204_2, DOI 10.1207/S1532799XSSR0204_2]; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; WINTER DA, 1990, MED PROG TECHNOL, V16, P31; Wulf G, 2010, Q J EXPT PSYCHOL A, V54, P1143; Zeffiro T, 2001, TRENDS NEUROSCI, V24, P512, DOI 10.1016/S0166-2236(00)01898-1	83	5	5	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e43488	10.1371/journal.pone.0043488	http://dx.doi.org/10.1371/journal.pone.0043488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049736	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300005
J	Ancelet, LR; Aldwell, FE; Rich, FJ; Kirman, JR				Ancelet, Lindsay R.; Aldwell, Frank E.; Rich, Fenella J.; Kirman, Joanna R.			Oral Vaccination with Lipid-Formulated BCG Induces a Long-lived, Multifunctional CD4(+) T Cell Memory Immune Response	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; BACILLE CALMETTE-GUERIN; DELAYED-TYPE HYPERSENSITIVITY; TUBERCULOSIS INFECTION; INTERFERON-GAMMA; PROTECTIVE IMMUNITY; AEROSOL CHALLENGE; LEISHMANIA-MAJOR; MICE; LUNG	Oral delivery of BCG in a lipid formulation (Liporale (TM)-BCG) targets delivery of viable bacilli to the mesenteric lymph nodes and confers protection against an aerosol Mycobacterium tuberculosis challenge. The magnitude, quality and duration of the effector and memory immune response induced by Liporale (TM)-BCG vaccination is unknown. Therefore, we compared the effector and memory CD4(+) T cell response in the spleen and lungs of mice vaccinated with Liporale (TM)-BCG to the response induced by subcutaneous BCG vaccination. Liporale (TM)-BCG vaccination induced a long-lived CD4(+) T cell response, evident by the detection of effector CD4(+) T cells in the lungs and a significant increase in the number of Ag85B tetramer-specific CD4(+) T cells in the spleen up to 30 weeks post vaccination. Moreover, following polyclonal stimulation, Liporale (TM)-BCG vaccination, but not s.c. BCG vaccination, induced a significant increase in both the percentage of CD4(+) T cells in the lungs capable of producing IFN gamma and the number of multifunctional CD4(+) T cells in the lungs at 30 weeks post vaccination. These results demonstrate that orally delivered Liporale (TM)-BCG vaccine induces a long-lived multifunctional immune response, and could therefore represent a practical and effective means of delivering novel BCG-based TB vaccines.	[Kirman, Joanna R.] Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand; [Ancelet, Lindsay R.; Rich, Fenella J.] Malaghan Inst Med Res, Infect Dis Grp, Wellington, New Zealand; [Aldwell, Frank E.] Univ Otago, Immune Solut Ltd, Ctr Innovat, Dunedin, New Zealand	University of Otago; Malaghan Institute; Victoria University Wellington; University of Otago	Kirman, JR (corresponding author), Univ Otago, Dept Microbiol & Immunol, Dunedin, New Zealand.	jo.kirman@otago.ac.nz		Kirman, Joanna/0000-0002-4802-7048	Wellington Medical Research Foundation Malaghan Haematology Fellowship; University of Otago; Otago Innovations Ltd	Wellington Medical Research Foundation Malaghan Haematology Fellowship; University of Otago; Otago Innovations Ltd	Financial support was recieved through the Wellington Medical Research Foundation Malaghan Haematology Fellowship (JRK), the University of Otago (LRA), and Otago Innovations Ltd (FEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agace WW, 2006, NAT REV IMMUNOL, V6, P682, DOI 10.1038/nri1869; Ainslie MP, 2002, THORAX, V57, P1054, DOI 10.1136/thorax.57.12.1054; Aldwell FE, 2006, VACCINE, V24, P2071, DOI 10.1016/j.vaccine.2005.11.017; Aldwell FE, 2005, IMMUNOL CELL BIOL, V83, P549, DOI 10.1111/j.1440-1711.2005.01369.x; Aldwell FE, 2005, INFECT IMMUN, V73, P1903, DOI 10.1128/IAI.73.3.1903-1905.2005; Ancelet Lindsay, 2012, Biomol Concepts, V3, P13, DOI 10.1515/bmc.2011.051; Bekker LG, 2001, J IMMUNOL, V166, P6728, DOI 10.4049/jimmunol.166.11.6728; Bingaman AW, 2005, EUR J IMMUNOL, V35, P3173, DOI 10.1002/eji.200526004; Buddle BM, 2005, VACCINE, V23, P3581, DOI 10.1016/j.vaccine.2005.01.150; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Campbell DJ, 2002, J EXP MED, V195, P135, DOI 10.1084/jem.20011502; Clark S, 2008, INFECT IMMUN, V76, P3771, DOI 10.1128/IAI.00052-08; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Connor LM, 2010, EUR J IMMUNOL, V40, P2482, DOI 10.1002/eji.200940279; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; Cooper AM, 2009, CURR OPIN IMMUNOL, V21, P378, DOI 10.1016/j.coi.2009.06.004; Corner LAL, 2010, VACCINE, V28, P6265, DOI 10.1016/j.vaccine.2010.06.120; Cosgrove CA, 2006, INFECT IMMUN, V74, P2449, DOI 10.1128/IAI.74.4.2449-2452.2006; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Derrick SC, 2011, VACCINE, V29, P2902, DOI 10.1016/j.vaccine.2011.02.010; Dorer DE, 2007, CELL MICROBIOL, V9, P544, DOI 10.1111/j.1462-5822.2006.00810.x; Feng CG, 2000, J IMMUNOL, V164, P4853, DOI 10.4049/jimmunol.164.9.4853; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Forbes EK, 2008, J IMMUNOL, V181, P4955, DOI 10.4049/jimmunol.181.7.4955; Gallegos AM, 2008, J EXP MED, V205, P2359, DOI 10.1084/jem.20080353; GHEORGHIU M, 1994, INT J IMMUNOPHARMACO, V16, P435, DOI 10.1016/0192-0561(94)90033-7; Goldsack L, 2007, TUBERCULOSIS, V87, P465, DOI 10.1016/j.tube.2007.07.001; Haile M, 2004, VACCINE, V22, P1498, DOI 10.1016/j.vaccine.2003.10.016; Hoft DF, 2000, CLIN INFECT DIS, V30, pS217, DOI 10.1086/313864; Jung YJ, 2005, J EXP MED, V201, P1915, DOI 10.1084/jem.20050265; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Lee WT, 1998, CELL IMMUNOL, V188, P1, DOI 10.1006/cimm.1998.1341; Lefrancois L, 2006, ANNU REV IMMUNOL, V24, P681, DOI 10.1146/annurev.immunol.24.021605.090650; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; McShane H, 2011, PHILOS T R SOC B, V366, P2782, DOI 10.1098/rstb.2011.0097; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Nol P, 2008, J WILDLIFE DIS, V44, P247, DOI 10.7589/0090-3558-44.2.247; ORME IM, 1988, INFECT IMMUN, V56, P3310, DOI 10.1128/IAI.56.12.3310-3312.1988; Ozeki Y, 2011, VACCINE, V29, P6881, DOI 10.1016/j.vaccine.2011.07.051; Partnership WST, 2010, GLOB PLAN STOP TB 20; Ramsey DSL, 2009, TUBERCULOSIS, V89, P163, DOI 10.1016/j.tube.2008.11.002; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Scanga CA, 2000, J EXP MED, V192, P347, DOI 10.1084/jem.192.3.347; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Tompkins DM, 2009, P ROY SOC B-BIOL SCI, V276, P2987, DOI 10.1098/rspb.2009.0414; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Vipond J, 2008, MICROBES INFECT, V10, P1577, DOI 10.1016/j.micinf.2008.09.004; Weir RE, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-9; Zaph C, 2004, NAT MED, V10, P1104, DOI 10.1038/nm1108	51	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45888	10.1371/journal.pone.0045888	http://dx.doi.org/10.1371/journal.pone.0045888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049885	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100096
J	Chen, YT; Tsai, MS; Yang, TL; Ku, AT; Huang, KH; Huang, CY; Chou, FJ; Fan, HH; Hong, JB; Yen, ST; Wang, WL; Lin, CC; Hsu, YC; Su, KY; Su, IC; Jang, CW; Behringer, RR; Favaro, R; Nicolis, SK; Chien, CL; Lin, SW; Yu, IS				Chen, You-Tzung; Tsai, Ming-Shian; Yang, Tsung-Lin; Ku, Amy Tsu; Huang, Ke-Han; Huang, Cheng-Yen; Chou, Fu-Ju; Fan, Hsiang-Hsuan; Hong, Jin-Bon; Yen, Shuo-Ting; Wang, Wei-Le; Lin, Chang-Ching; Hsu, Yu-Chen; Su, Kang-Yi; Su, I-Chang; Jang, Chuan-Wei; Behringer, Richard R.; Favaro, Rebecca; Nicolis, Silvia K.; Chien, Chung-Liang; Lin, Shu-Wha; Yu, I-Shing			R26R-GR: A Cre-Activable Dual Fluorescent Protein Reporter Mouse	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; GPI-ANCHORED PROTEINS; TARGETING VECTORS; ROSA26 LOCUS; EXPRESSION; RECOMBINASE; TRANSPORT; LINE; GFP; ACTIVATION	Green fluorescent protein (GFP) and its derivatives are the most widely used molecular reporters for live cell imagining. The development of organelle-specific fusion fluorescent proteins improves the labeling resolution to a higher level. Here we generate a R26 dual fluorescent protein reporter mouse, activated by Cre-mediated DNA recombination, labeling target cells with a chromatin-specific enhanced green fluorescence protein (EGFP) and a plasma membrane-anchored monomeric cherry fluorescent protein (mCherry). This dual labeling allows the visualization of mitotic events, cell shapes and intracellular vesicle behaviors. We expect this reporter mouse to have a wide application in developmental biology studies, transplantation experiments as well as cancer/stem cell lineage tracing.	[Tsai, Ming-Shian; Hsu, Yu-Chen; Lin, Shu-Wha] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei 10764, Taiwan; [Chen, You-Tzung; Ku, Amy Tsu; Huang, Ke-Han; Chou, Fu-Ju; Fan, Hsiang-Hsuan; Hong, Jin-Bon; Yen, Shuo-Ting; Wang, Wei-Le; Lin, Chang-Ching] Natl Taiwan Univ, Grad Inst Med Genom & Prote, Coll Med, Taipei 10764, Taiwan; [Chen, You-Tzung; Su, I-Chang] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei 10764, Taiwan; [Yang, Tsung-Lin] Natl Taiwan Univ, Dept Otolaryngol, Taipei 10764, Taiwan; [Huang, Cheng-Yen] Natl Taiwan Univ, Core Lab 1, Branch Off Med Res & Dev, Coll Med, Taipei 10764, Taiwan; [Hsu, Yu-Chen; Su, Kang-Yi] Natl Taiwan Univ, Div Genom Med, NTU Ctr Genom Med, Taipei 10764, Taiwan; [Su, Kang-Yi] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Jang, Chuan-Wei; Behringer, Richard R.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Jang, Chuan-Wei; Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Jang, Chuan-Wei; Behringer, Richard R.] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Houston, TX 77030 USA; [Favaro, Rebecca; Nicolis, Silvia K.] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Chien, Chung-Liang] Natl Taiwan Univ, Grad Inst Anat & Cell Biol, Coll Med, Taipei 10764, Taiwan; [Lin, Shu-Wha] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Yu, I-Shing] Natl Taiwan Univ, Transgen Mouse Model Core Facil, Natl Res Program Genom Med, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Milano-Bicocca; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lin, SW (corresponding author), Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei 10764, Taiwan.	mtshuwha@ntu.edu.tw; oxfo@tpts6.seed.net.tw	SU, KANG-YI/GNM-5753-2022; Favaro, Rebecca/HHZ-8978-2022	SU, KANG-YI/0000-0002-6538-9526; Favaro, Rebecca/0000-0002-6195-5711; CHEN, YOU-TZUNG/0000-0001-6510-3420; CHIEN, CHUNG-LIANG/0000-0001-9806-486X; Lin, Chang-Ching/0000-0001-6659-5543; Yen, Shuo-Ting/0000-0003-4277-1965; LIN, SHU-WHA/0000-0001-6748-5581; NICOLIS, SILVIA KIRSTEN/0000-0003-0378-3808; Hong, Jin-Bon/0000-0001-9467-6463; YANG, TSUNG-LIN/0000-0001-6521-8631	National Taiwan University (NTU), NTU Hospital; National Science Council (NSC) in Taiwan [NTU CESRP-10R71602C6, NSC 100-2320-B-002-093-, NSC 100-2321-B-002-049-, NTUH 100-S1499, NSC 99-2627-B-002-005-]; National Institutes of Health [HD30284]; Ben F. Love Endowment; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD030284] Funding Source: NIH RePORTER	National Taiwan University (NTU), NTU Hospital; National Science Council (NSC) in Taiwan(Ministry of Science and Technology, Taiwan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ben F. Love Endowment; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by grants from National Taiwan University (NTU), NTU Hospital, and National Science Council (NSC) in Taiwan to Y.T.C. (NTU CESRP-10R71602C6, NSC 100-2320-B-002-093-, and NSC 100-2321-B-002-049-), to T.L.Y. (NTUH 100-S1499), and to S.W.L. (NSC 99-2627-B-002-005-), the National Institutes of Health HD30284 and the Ben F. Love Endowment to R.R.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen YT, 2010, STEM CELLS DEV, V19, P763, DOI 10.1089/scd.2009.0118; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Drogat B, 2010, BLOOD, V116, P2141, DOI 10.1182/blood-2010-01-264143; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Hadjantonakis AK, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-33; Hadjieconomou D, 2011, NAT METHODS, V8, P260, DOI 10.1038/NMETH.1567; Hampel S, 2011, NAT METHODS, V8, P253, DOI 10.1038/NMETH.1566; Hayashi S, 2002, MECH DEVELOP, V119, pS97, DOI 10.1016/S0925-4773(03)00099-6; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Kondoh G, 1999, FEBS LETT, V458, P299, DOI 10.1016/S0014-5793(99)01172-2; Lakhan SE, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-93; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Mao XH, 2001, BLOOD, V97, P324, DOI 10.1182/blood.V97.1.324; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; McDowell MA, 1998, BIOCHEM J, V335, P681, DOI 10.1042/bj3350681; Meilhac SM, 2009, DEV BIOL, V331, P210, DOI 10.1016/j.ydbio.2009.04.036; Misgeld T, 2007, NAT METHODS, V4, P559, DOI 10.1038/NMETH1055; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nagy A., 2003, MANIPULATING MOUSE E; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; Nowotschin S, 2009, GENESIS, V47, P330, DOI 10.1002/dvg.20500; Nowotschin S, 2009, TRENDS BIOTECHNOL, V27, P266, DOI 10.1016/j.tibtech.2009.02.006; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Rhee JM, 2006, GENESIS, V44, P202, DOI 10.1002/dvg.20203; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Shioi G, 2011, GENESIS, V49, P570, DOI 10.1002/dvg.20758; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stewart MD, 2010, METHOD ENZYMOL, V477, P145, DOI 10.1016/S0076-6879(10)77009-9; Stewart MD, 2009, GENESIS, V47, P708, DOI 10.1002/dvg.20565; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Trichas G, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-40; WILLIAMS AF, 1982, SCIENCE, V216, P696, DOI 10.1126/science.6177036; WOOD SA, 1993, P NATL ACAD SCI USA, V90, P4582, DOI 10.1073/pnas.90.10.4582; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	51	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46171	10.1371/journal.pone.0046171	http://dx.doi.org/10.1371/journal.pone.0046171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049968	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100146
J	Jain, S; Yoon, SY; Zhu, L; Brodbeck, J; Dai, J; Walker, D; Huang, YD				Jain, Sachi; Yoon, Seo Yeon; Zhu, Lei; Brodbeck, Jens; Dai, Jessica; Walker, David; Huang, Yadong			Arf4 Determines Dentate Gyrus-Mediated Pattern Separation by Regulating Dendritic Spine Development	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; GTPASE-ACTIVATING PROTEIN; ADP-RIBOSYLATION FACTORS; ALZHEIMERS-DISEASE; APOLIPOPROTEIN E4; DEPENDENT IMPAIRMENT; MOUSE MODELS; CLASS-I; ACTIN; DENSITY	The ability to distinguish between similar experiences is a critical feature of episodic memory and is primarily regulated by the dentate gyrus (DG) region of the hippocampus. However, the molecular mechanisms underlying such pattern separation tasks are poorly understood. We report a novel role for the small GTPase ADP ribosylation factor 4 (Arf4) in controlling pattern separation by regulating dendritic spine development. Arf4(+/-) mice at 4-5 months of age display severe impairments in a pattern separation task, as well as significant dendritic spine loss and smaller miniature excitatory postsynaptic currents (mEPSCs) in granule cells of the DG. Arf4 knockdown also decreases spine density in primary neurons, whereas Arf4 overexpression promotes spine development. A constitutively active form of Arf4, Arf4-Q71L, promotes spine density to an even greater extent than wildtype Arf4, whereas the inactive Arf4-T31N mutant does not increase spine density relative to controls. Arf4's effects on spine development are regulated by ASAP1, a GTPase-activating protein that modulates Arf4 GTPase activity. ASAP1 overexpression decreases spine density, and this effect is partially rescued by concomitant overexpression of wildtype Arf4 or Arf4-Q71L. In addition, Arf4 overexpression rescues spine loss in primary neurons from an Alzheimer's disease-related apolipoprotein (apo) E4 mouse model. Our findings suggest that Arf4 is a critical modulator of DG-mediated pattern separation by regulating dendritic spine development.	[Jain, Sachi; Yoon, Seo Yeon; Zhu, Lei; Brodbeck, Jens; Dai, Jessica; Walker, David; Huang, Yadong] Gladstone Inst Neurol Dis, San Francisco, CA USA; [Walker, David; Huang, Yadong] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Jain, Sachi; Huang, Yadong] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Huang, Yadong] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Huang, YD (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA USA.	yhuang@gladstone.ucsf.edu	Zhu, Lei/J-7210-2013; Brodbeck, Jens/AAB-9275-2020	Zhu, Lei/0000-0002-0898-8602; 	National Institute of Health [P01 AG022074, P30 NS065780, C06RR18928]; National Science Foundation; J. David Gladstone Institutes; Hellman Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS065780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); J. David Gladstone Institutes(University of California System); Hellman Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants from the National Institute of Health (P01 AG022074, P30 NS065780, and C06RR18928), the National Science Foundation, the J. David Gladstone Institutes, and gifts from the S.D. Bechtel, Jr. Foundation and the Hellman Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Andrews-Zwilling Y, 2010, J NEUROSCI, V30, P13707, DOI 10.1523/JNEUROSCI.4040-10.2010; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Brodbeck J, 2008, P NATL ACAD SCI USA, V105, P1343, DOI 10.1073/pnas.0709906104; Brodbeck J, 2011, J BIOL CHEM, V286, P17217, DOI 10.1074/jbc.M110.217380; Brown MT, 1998, MOL CELL BIOL, V18, P7038, DOI 10.1128/MCB.18.12.7038; Cao H, 2005, NAT CELL BIOL, V7, P483, DOI 10.1038/ncb1246; Carreno S, 2004, J CELL BIOL, V165, P781, DOI 10.1083/jcb.200403120; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Chen YG, 1996, J BIOL CHEM, V271, P5297, DOI 10.1074/jbc.271.10.5297; Choi S, 2006, J NEUROSCI, V26, P4811, DOI 10.1523/JNEUROSCI.4182-05.2006; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Crusio WE, 2001, BEHAV BRAIN RES, V125, P127, DOI 10.1016/S0166-4328(01)00280-7; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Deretic D, 2006, VISION RES, V46, P4427, DOI 10.1016/j.visres.2006.07.028; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Duijsings D, 2009, TRAFFIC, V10, P316, DOI 10.1111/j.1600-0854.2008.00868.x; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; DUNHAM NW, 1957, J AM PHARM ASSOC, V46, P208, DOI 10.1002/jps.3030460322; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Islam A, 2007, J BIOL CHEM, V282, P9591, DOI 10.1074/jbc.M607122200; Ji Y, 2003, NEUROSCIENCE, V122, P305, DOI 10.1016/j.neuroscience.2003.08.007; Kaneko M, 2012, J NEUROSCI, V32, P4790, DOI 10.1523/JNEUROSCI.4462-11.2012; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim SW, 2003, J BIOL CHEM, V278, P2661, DOI 10.1074/jbc.M205819200; Klassen MP, 2010, NEURON, V66, P710, DOI 10.1016/j.neuron.2010.04.033; Lippman J, 2005, J NEUROBIOL, V64, P47, DOI 10.1002/neu.20149; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Moore CD, 2007, J CELL SCI, V120, P2683, DOI 10.1242/jcs.006346; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Palmer A, 2011, BIOCHEM SOC T, V39, P902, DOI 10.1042/BST0390902; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Perez-Cruz C, 2011, J NEUROSCI, V31, P3926, DOI 10.1523/JNEUROSCI.6142-10.2011; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sakagami H, 2008, NEUROSCI RES, V60, P199, DOI 10.1016/j.neures.2007.10.013; Salmon David P, 2012, Curr Top Behav Neurosci, V10, P187, DOI 10.1007/7854_2011_171; Schmidt B, 2012, BEHAV BRAIN RES, V226, P56, DOI 10.1016/j.bbr.2011.08.039; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Suzuki I, 2001, MOL BRAIN RES, V88, P124, DOI 10.1016/S0169-328X(01)00036-5; Tackenberg C, 2009, CURR ALZHEIMER RES, V6, P261, DOI 10.2174/156720509788486554; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Treves A, 2008, NEUROSCIENCE, V154, P1155, DOI 10.1016/j.neuroscience.2008.04.073; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Vigers AJ, 2012, NEUROSCIENCE, V212, P1, DOI 10.1016/j.neuroscience.2012.03.031; Wilson IA, 2004, J NEUROSCI, V24, P3870, DOI 10.1523/JNEUROSCI.5205-03.2004; Woo IS, 2009, CANCER LETT, V276, P53, DOI 10.1016/j.canlet.2008.10.031; Yassa MA, 2011, TRENDS NEUROSCI, V34, P515, DOI 10.1016/j.tins.2011.06.006; Yassa MA, 2010, NEUROIMAGE, V51, P1242, DOI 10.1016/j.neuroimage.2010.03.040; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	69	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46340	10.1371/journal.pone.0046340	http://dx.doi.org/10.1371/journal.pone.0046340			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23050017	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100181
J	Liskova, P; Gwilliam, R; Filipec, M; Jirsova, K; Merjava, SR; Deloukas, P; Webb, TR; Bhattacharya, SS; Ebenezer, ND; Morris, AG; Hardcastle, AJ				Liskova, Petra; Gwilliam, Rhian; Filipec, Martin; Jirsova, Katerina; Merjava, Stanislava Reinstein; Deloukas, Panos; Webb, Tom R.; Bhattacharya, Shomi S.; Ebenezer, Neil D.; Morris, Alex G.; Hardcastle, Alison J.			High Prevalence of Posterior Polymorphous Corneal Dystrophy in the Czech Republic; Linkage Disequilibrium Mapping and Dating an Ancestral Mutation	PLOS ONE			English	Article							VSX1 GENE; LOCUS; RECOMBINATION; CHROMOSOME-20; ENDOTHELIUM; KERATOCONUS; POPULATION; EXPRESSION; REPRESSION; MAPS	Posterior polymorphous corneal dystrophy (PPCD) is a rare autosomal dominant genetically heterogeneous disorder. Nineteen Czech PPCD pedigrees with 113 affected family members were identified, and 17 of these kindreds were genotyped for markers on chromosome 20p12.1-20q12. Comparison of haplotypes in 81 affected members, 20 unaffected first degree relatives and 13 spouses, as well as 55 unrelated controls, supported the hypothesis of a shared ancestor in 12 families originating from one geographic location. In 38 affected individuals from nine of these pedigrees, a common haplotype was observed between D20S48 and D20S107 spanning approximately 23 Mb, demonstrating segregation of disease with the PPCD1 locus. This haplotype was not detected in 110 ethnically matched control chromosomes. Within the common founder haplotype, a core mini-haplotype was detected for D20S605, D20S182 and M189K2 in all 67 affected members from families 1-12, however alleles representing the core mini-haplotype were also detected in population matched controls. The most likely location of the responsible gene within the disease interval, and estimated mutational age, were inferred by linkage disequilibrium mapping (DMLE+2.3). The appearance of a disease-causing mutation was dated between 64-133 generations. The inferred ancestral locus carrying a PPCD1 disease-causing variant within the disease interval spans 60 Kb on 20p11.23, which contains a single known protein coding gene, ZNF133. However, direct sequence analysis of coding and untranslated exons did not reveal a potential pathogenic mutation. Microdeletion or duplication was also excluded by comparative genomic hybridization using a dense chromosome 20 specific array. Geographical origin, haplotype and statistical analysis suggest that in 14 unrelated families an as yet undiscovered mutation on 20p11.23 was inherited from a common ancestor. Prevalence of PPCD in the Czech Republic appears to be the highest worldwide and our data suggests that at least one other novel locus for PPCD also exists.	[Liskova, Petra; Jirsova, Katerina; Merjava, Stanislava Reinstein] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Dis, Lab Biol & Pathol Eye, Prague, Czech Republic; [Liskova, Petra; Jirsova, Katerina; Merjava, Stanislava Reinstein] Gen Univ Hosp, Prague, Czech Republic; [Liskova, Petra] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, Prague, Czech Republic; [Liskova, Petra; Webb, Tom R.; Bhattacharya, Shomi S.; Ebenezer, Neil D.; Hardcastle, Alison J.] UCL Inst Ophthalmol, London, England; [Gwilliam, Rhian; Deloukas, Panos] Wellcome Trust Res Labs, Sanger Inst, Hinxton, England; [Filipec, Martin] European Eye Clin Lexum, Prague, Czech Republic; [Morris, Alex G.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Div Brain Sci, London, England	Charles University Prague; General University Hospital Prague; Charles University Prague; University of London; University College London; Wellcome Trust Sanger Institute; Imperial College London	Liskova, P (corresponding author), Charles Univ Prague, Fac Med 1, Inst Inherited Metab Dis, Lab Biol & Pathol Eye, Prague, Czech Republic.	petra.liskova@lf1.cuni.cz	Reinstein Merjava, Stanislava/H-3573-2017; Bhattacharya, Shom/N-2926-2016; Webb, Tom/C-6237-2011; Webb, Tom/GMW-5311-2022; Deloukas, Panos/B-2922-2013; Liskova, Petra/C-9680-2011; Jirsova, Katerina/B-8301-2012	Reinstein Merjava, Stanislava/0000-0001-7478-0706; Bhattacharya, Shom/0000-0002-1601-6344; Deloukas, Panos/0000-0001-9251-070X; Liskova, Petra/0000-0001-7834-8486; Jirsova, Katerina/0000-0002-4625-6701; Hardcastle, Alison/0000-0002-0038-6770; Webb, Tom/0000-0001-5998-8226	GACR [P301/12/P591]; UNCE [204011]; Charles University in Prague [PRVOUK-P24/LF1/3]	GACR(Grant Agency of the Czech Republic); UNCE; Charles University in Prague	This work was supported by research grant GACR P301/12/P591. Institutional support was provided by UNCE 204011 and PRVOUK-P24/LF1/3 programs of the Charles University in Prague. AJH is a Faculty member of the National Institute for Health Research (NIHR) Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldave AJ, 2007, AM J MED GENET A, V143A, P2549, DOI 10.1002/ajmg.a.31978; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; CIBIS GW, 1977, ARCH OPHTHALMOL-CHIC, V95, P1529; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; DEFELICE GP, 1985, GRAEF ARCH CLIN EXP, V223, P265, DOI 10.1007/BF02153657; Gottsch JD, 2003, ARCH OPHTHALMOL-CHIC, V121, P252; Gwilliam R, 2005, INVEST OPHTH VIS SCI, V46, P4480, DOI 10.1167/iovs.05-0269; HENRIQUEZ AS, 1984, SURV OPHTHALMOL, V29, P139, DOI 10.1016/0039-6257(84)90171-1; HEON E, 1995, HUM MOL GENET, V4, P485, DOI 10.1093/hmg/4.3.485; Heon E, 2002, HUM MOL GENET, V11, P1029, DOI 10.1093/hmg/11.9.1029; Hosseini SM, 2008, MOL VIS, V14, P71; Jirsova K, 2007, EXP EYE RES, V84, P680, DOI 10.1016/j.exer.2006.12.006; Krachmer J H, 1985, Trans Am Ophthalmol Soc, V83, P413; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; LAGANOWSKI HC, 1991, CORNEA, V10, P224, DOI 10.1097/00003226-199105000-00008; Lai IN, 2010, MOL VIS, V16, P2829; Liskova P, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9495; Liskova P, 2007, MOL VIS, V13, P1887; Liskova P, 2010, OPHTHALMIC GENET, V31, P230, DOI 10.3109/13816810.2010.518577; Mahtani MM, 1998, GENOME RES, V8, P100, DOI 10.1101/gr.8.2.100; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; POLACK FM, 1980, AM J OPHTHALMOL, V89, P575, DOI 10.1016/0002-9394(80)90070-7; Rannala B, 2001, AM J HUM GENET, V69, P159, DOI 10.1086/321279; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; Sherwin JC, 2008, OPHTHALMIC GENET, V29, P149, DOI 10.1080/13816810802334341; Shimizu S, 2004, AM J MED GENET A, V130A, P372, DOI 10.1002/ajmg.a.30267; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Valleix S, 2006, INVEST OPHTH VIS SCI, V47, P48, DOI 10.1167/iovs.05-0479; Vincent AL, 2009, MOL VIS, V15, P2544; VISSING H, 1995, FEBS LETT, V369, P153, DOI 10.1016/0014-5793(95)00728-R; Yellore VS, 2007, GENET MED, V9, P228, DOI 10.1097/GIM.0b013e31803c4dc2	32	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45495	10.1371/journal.pone.0045495	http://dx.doi.org/10.1371/journal.pone.0045495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049806	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100051
J	Liu, B; Barbosa-Sampaio, H; Jones, PM; Persaud, SJ; Muller, DS				Liu, Bo; Barbosa-Sampaio, Helena; Jones, Peter M.; Persaud, Shanta J.; Muller, Dany S.			The CaMK4/CREB/IRS-2 Cascade Stimulates Proliferation and Inhibits Apoptosis of beta-Cells	PLOS ONE			English	Article							INSULIN GENE-EXPRESSION; CAM KINASE-IV; IRS-2 EXPRESSION; BINDING-PROTEIN; UP-REGULATION; IN-VIVO; GLUCOSE; SECRETION; RESISTANCE; SURVIVAL	Progressive reduction in beta-cell mass is responsible for the development of type 2 diabetes mellitus, and alteration in insulin receptor substrate 2 (IRS-2) abundance plays a critical role in this process. IRS-2 expression is stimulated by the transcription factor cAMP response element-binding protein (CREB) and we recently demonstrated that Ca2+/calmodulin dependent kinase 4 (CaMK4) is upstream of CREB activation in beta-cells. This study investigated whether CaMK4 is also a potential target to increase beta-cell mass through CREB-mediated IRS-2 expression, by quantifying mouse MIN6 beta-cell proliferation and apoptosis following IRS-2 knockdown, CaMKs inhibition and alterations in CaMK4 and CREB expression. Expression of constitutively active CaMK4 (Delta CaMK4) and CREB (CREBDIEDLM) significantly stimulated beta-cell proliferation and survival. In contrast, expression of their corresponding dominant negative forms (Delta(K75E)CaMK4 and CREBM1) and silencing of IRS-2 increased apoptosis and reduced beta-cell division. Moreover, CREBDIEDLM and CREBM1 expression completely abolished the effects of Delta(K75E)CaMK4 and of Delta CaMK4, respectively. Our results indicate that CaMK4 regulates beta-cell proliferation and apoptosis in a CREB-dependent manner and that CaMK4-induced IRS-2 expression is important in these processes.	[Liu, Bo; Barbosa-Sampaio, Helena; Jones, Peter M.; Persaud, Shanta J.; Muller, Dany S.] Kings Coll London, Diabet Res Grp, Sch Med, Div Diabet & Nutr Sci, London WC2R 2LS, England	University of London; King's College London	Persaud, SJ (corresponding author), Kings Coll London, Diabet Res Grp, Sch Med, Div Diabet & Nutr Sci, London WC2R 2LS, England.	shanta.persaud@kcl.ac.uk	Persaud, Shanta/AAH-3200-2021; Barbosa-Sampaio, Helena Cristina/L-2160-2019; Sampaio, Helena C. L. Barbosa/B-7083-2015	Barbosa-Sampaio, Helena Cristina/0000-0002-5244-889X; Sampaio, Helena C. L. Barbosa/0000-0002-5244-889X; Persaud, Shanta/0000-0002-4933-5958; Liu, Bo/0000-0002-8697-234X; Jones, Peter/0000-0003-1201-2335	Diabetes UK [06/0003387, 08/0003706]; Society for Endocrinology Early Career Grant	Diabetes UK(Diabetes UK); Society for Endocrinology Early Career Grant	This work was supported by Diabetes UK grants 06/0003387 and 08/0003706 and by a Society for Endocrinology Early Career Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacker-Francoys I, 2005, EXP CLIN ENDOCR DIAB, V113, P423, DOI 10.1055/s-2005-865803; Ban N, 2000, DIABETES, V49, P1142, DOI 10.2337/diabetes.49.7.1142; Bito H, 2003, CELL CALCIUM, V34, P425, DOI 10.1016/S0143-4160(03)00140-4; BOHM M, 1995, CELL GROWTH DIFFER, V6, P291; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; BONNERWEIR S, 1994, RECENT PROG HORM RES, V49, P91; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Buchanan TA, 2001, J CLIN ENDOCR METAB, V86, P989, DOI 10.1210/jc.86.3.989; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Chatila T, 1996, J BIOL CHEM, V271, P21542, DOI 10.1074/jbc.271.35.21542; Chiasson JL, 2004, DIABETES, V53, pS34, DOI 10.2337/diabetes.53.suppl_3.S34; Deng SP, 2004, DIABETES, V53, P624, DOI 10.2337/diabetes.53.3.624; Efanova IB, 1998, J BIOL CHEM, V273, P33501, DOI 10.1074/jbc.273.50.33501; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Flier SN, 2001, P NATL ACAD SCI USA, V98, P7475, DOI 10.1073/pnas.131192998; Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Hull R, 2005, DIABETOLOGIA, V48, P1350, DOI 10.1007/s00125-005-1772-9; Illario M, 2008, BLOOD, V111, P723, DOI 10.1182/blood-2007-05-091173; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Jones PM, 1998, ENDOCR REV, V19, P429, DOI 10.1210/er.19.4.429; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Krebs J, 1998, BBA-MOL CELL RES, V1448, P183, DOI 10.1016/S0167-4889(98)00142-6; Kubota N, 2000, DIABETES, V49, P1880, DOI 10.2337/diabetes.49.11.1880; Li D, 2008, DIABETES, V57, P635, DOI 10.2337/db07-0717; Lingohr MK, 2006, J BIOL CHEM, V281, P15884, DOI 10.1074/jbc.M600356200; Lingohr MK, 2003, MOL CELL ENDOCRINOL, V209, P17, DOI 10.1016/j.mce.2003.08.003; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Mohanty S, 2005, EXP CELL RES, V303, P68, DOI 10.1016/j.yexcr.2004.09.011; Muller D, 2006, FEBS LETT, V580, P6977, DOI 10.1016/j.febslet.2006.11.066; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Persaud SJ, 2011, DIABETOLOGIA, V54, P1109, DOI 10.1007/s00125-011-2050-7; Polonsky KS, 2000, INT J OBESITY, V24, pS29, DOI 10.1038/sj.ijo.0801273; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Sorenson RL, 1997, HORM METAB RES, V29, P301, DOI 10.1055/s-2007-979040; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yu X, 2004, DIABETES, V53, P1475, DOI 10.2337/diabetes.53.6.1475	43	36	37	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45711	10.1371/journal.pone.0045711	http://dx.doi.org/10.1371/journal.pone.0045711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049845	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100073
J	Machida, RJ; Knowlton, N				Machida, Ryuji J.; Knowlton, Nancy			PCR Primers for Metazoan Nuclear 18S and 28S Ribosomal DNA Sequences	PLOS ONE			English	Article							RNA GENES; BIODIVERSITY; DIVERSITY		[Machida, Ryuji J.] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan; [Knowlton, Nancy] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA	Academia Sinica - Taiwan; Smithsonian Institution; Smithsonian National Museum of Natural History	Machida, RJ (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	ryujimachida@gate.sinica.edu.tw			Alfred P. Sloan Foundation; Sant Chair of Marine Science discretionary funds	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Sant Chair of Marine Science discretionary funds	Financial support was provided by the Alfred P. Sloan Foundation and the Sant Chair of Marine Science discretionary funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral-Zettler LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006372; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bik HM, 2012, TRENDS ECOL EVOL, V27, P233, DOI 10.1016/j.tree.2011.11.010; Committee on Metagenomics National Research Council, 2007, CHALL FUNCT APPL NEW, P170; Costello MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012110; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Gillespie JJ, 2006, INSECT MOL BIOL, V15, P657, DOI 10.1111/j.1365-2583.2006.00689.x; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Machida RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035887; Machida RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010278; McIntyre A., 2010, LIFE WORLDS OCEANS D; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Pawlowski J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018169; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; PHILIPPE H, 1994, J EVOLUTION BIOL, V7, P247, DOI 10.1046/j.1420-9101.1994.7020247.x; Porazinska DL, 2010, MOL ECOL RESOUR, V10, P666, DOI 10.1111/j.1755-0998.2009.02819.x; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; VANDERAUWERA G, 1994, FEBS LETT, V338, P133, DOI 10.1016/0014-5793(94)80350-1; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007401; Yu DW, 2012, METHODS ECOL EVOL, V3, P613, DOI 10.1111/j.2041-210X.2012.00198.x	29	62	68	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46180	10.1371/journal.pone.0046180	http://dx.doi.org/10.1371/journal.pone.0046180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049971	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100148
J	Ribeiro, JMC; Assumpcao, TCF; Ma, DY; Alvarenga, PH; Pham, VM; Andersen, JF; Francischetti, IMB; Macaluso, KR				Ribeiro, Jose M. C.; Assumpcao, Teresa C. F.; Ma, Dongying; Alvarenga, Patricia H.; Pham, Van M.; Andersen, John F.; Francischetti, Ivo M. B.; Macaluso, Kevin R.			An Insight into the Sialotranscriptome of the Cat Flea, Ctenocephalides felis	PLOS ONE			English	Article							SALIVARY ADENOSINE-DEAMINASE; APYRASE ACTIVITY; ORAL SECRETION; BLACK FLY; DATABASE; IDENTIFICATION; SIALOME; PROTEIN; SIPHONAPTERA; PREDICTION	Background: Saliva of hematophagous arthropods contains a diverse mixture of compounds that counteracts host hemostasis. Immunomodulatory and antiinflammatory components are also found in these organisms' saliva. Blood feeding evolved at least ten times within arthropods, providing a scenario of convergent evolution for the solution of the salivary potion. Perhaps because of immune pressure from hosts, the salivary proteins of related organisms have considerable divergence, and new protein families are often found within different genera of the same family or even among subgenera. Fleas radiated with their vertebrate hosts, including within the mammal expansion initiated 65 million years ago. Currently, only one flea species-the rat flea Xenopsylla cheopis-has been investigated by means of salivary transcriptome analysis to reveal salivary constituents, or sialome. We present the analysis of the sialome of cat flea Ctenocephaides felis. Methodology and Critical Findings: A salivary gland cDNA library from adult fleas was randomly sequenced, assembled, and annotated. Sialomes of cat and rat fleas have in common the enzyme families of phosphatases (inactive), CD-39-type apyrase, adenosine deaminases, and esterases. Antigen-5 members are also common to both sialomes, as are defensins. FS-I/Cys7 and the 8-Cys families of peptides are also shared by both fleas and are unique to these organisms. The Gly-His-rich peptide similar to holotricin was found only in the cat flea, as were the abundantly expressed Cys-less peptide and a novel short peptide family. Conclusions/Significance: Fleas, in contrast to bloodsucking Nematocera (mosquitoes, sand flies, and black flies), appear to concentrate a good portion of their sialome in small polypeptides, none of which have a known function but could act as inhibitors of hemostasis or inflammation. They are also unique in expansion of a phosphatase family that appears to be deficient of enzyme activity and has an unknown function.	[Ribeiro, Jose M. C.; Assumpcao, Teresa C. F.; Ma, Dongying; Pham, Van M.; Andersen, John F.; Francischetti, Ivo M. B.] NIAID, Vector Biol Sect, Lab Malaria & Vector Res, Rockville, MD USA; [Alvarenga, Patricia H.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Lab Bioquim Resposta Estresse, Rio De Janeiro, Brazil; [Alvarenga, Patricia H.] INCT EM, Rio De Janeiro, Brazil; [Macaluso, Kevin R.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade Federal do Rio de Janeiro; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Ribeiro, JMC (corresponding author), NIAID, Vector Biol Sect, Lab Malaria & Vector Res, Rockville, MD USA.	jribeiro@niaid.nih.gov	Ribeiro, Jose/J-7011-2015; ma, dongying/D-8623-2012; Alvarenga, Patricia Hessab/I-2272-2012	Ribeiro, Jose/0000-0002-9107-0818; Hessab Alvarenga, Patricia/0000-0002-2236-6308	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health; NIAID grant [AI077784]; Fundacao de Amparo a Pesquisa do Rio de Janeiro Carlos Chagas Filho (FAPERJ); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077784, ZIAAI000810, ZIAAI001012] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health; NIAID grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fundacao de Amparo a Pesquisa do Rio de Janeiro Carlos Chagas Filho (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partly supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID) National Institutes of Health, by NIAID grant (AI077784 KRM) to Dr. Macaluso, and by Fundacao de Amparo a Pesquisa do Rio de Janeiro Carlos Chagas Filho (FAPERJ) to Dr. Alvarenga. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerstrom B, 2007, J BIOL CHEM, V282, P31493, DOI 10.1074/jbc.M702624200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen JF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-102; Andersen JF, 2009, J PROTEOME RES, V8, P1474, DOI 10.1021/pr8008429; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; BENJAMINI E, 1963, EXP PARASITOL, V13, P143, DOI 10.1016/0014-4894(63)90064-X; Charlab R, 2000, EXP PARASITOL, V95, P45, DOI 10.1006/expr.2000.4503; Cheeseman MT, 1998, INSECT BIOCHEM MOLEC, V28, P1025, DOI 10.1016/S0965-1748(98)00093-9; Cheeseman MT, 2001, INSECT BIOCHEM MOLEC, V31, P157, DOI 10.1016/S0965-1748(00)00113-2; Francischetti IMB, 2010, TOXICON, V56, P1130, DOI 10.1016/j.toxicon.2009.12.003; Francischetti IMB, 2009, FRONT BIOSCI-LANDMRK, V14, P2051, DOI 10.2741/3363; Frank GR, 1998, ADV VET DERMATOLOGY, V3, P201; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; GREENE WK, 1993, PARASITE IMMUNOL, V15, P69, DOI 10.1111/j.1365-3024.1993.tb00586.x; Grimaldi David, 2005, pi; Huang Diying, 2012, Nature, V483, P201, DOI 10.1038/nature10839; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kato H, 2007, J EXP BIOL, V210, P733, DOI 10.1242/jeb.001289; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lane RP., 1993, MED INSECTS ARACHNID, P723; Lawrence W, 2002, J VECTOR ECOL, V27, P39; Lee SE, 1997, PARASITE IMMUNOL, V19, P13, DOI 10.1046/j.1365-3024.1997.d01-140.x; LEE SY, 1994, J BIOCHEM-TOKYO, V115, P82, DOI 10.1093/oxfordjournals.jbchem.a124309; Liu CB, 2010, FREE RADICAL BIO MED, V48, P1173, DOI 10.1016/j.freeradbiomed.2010.01.036; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; McDermott MJ, 2000, MOL IMMUNOL, V37, P361, DOI 10.1016/S0161-5890(00)00061-4; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; RIBEIRO JMC, 1990, COMP BIOCHEM PHYS B, V95, P215, DOI 10.1016/0305-0491(90)90067-4; Ribeiro JMC, 2000, INSECT BIOCHEM MOLEC, V30, P279, DOI 10.1016/S0965-1748(99)00123-X; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143; Ribeiro JMC, 2001, J EXP BIOL, V204, P2001; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Ribeiro JMC, 2010, AM J TROP MED HYG, V82, P1060, DOI 10.4269/ajtmh.2010.09-0769; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TRUDEAU WL, 1993, CLIN EXP ALLERGY, V23, P377, DOI 10.1111/j.1365-2222.1993.tb00342.x; Volfova V, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000294; WADE SE, 1988, J MED ENTOMOL, V25, P186, DOI 10.1093/jmedent/25.3.186; Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062; Yamazaki Y, 2004, TOXICON, V44, P227, DOI 10.1016/j.toxicon.2004.05.023; YOUNG JD, 1963, EXP PARASITOL, V13, P155, DOI 10.1016/0014-4894(63)90065-1	46	17	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44612	10.1371/journal.pone.0044612	http://dx.doi.org/10.1371/journal.pone.0044612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049752	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100017
J	Sun, J; Li, H; Yuan, QP				Sun, Jie; Li, Hao; Yuan, Qipeng			Metabolic Regulation of Trisporic Acid on Blakeslea trispora Revealed by a GC-MS-Based Metabolomic Approach	PLOS ONE			English	Article							GAS CHROMATOGRAPHY/MASS SPECTROMETRY; BETA-CAROTENE; MICROBIOLOGICAL PRODUCTION; SACCHAROMYCES-CEREVISIAE; MICROBIAL METABOLOMICS; HORMONE SYNTHESIS; GENES; BIOSYNTHESIS; CAROTENOGENESIS; IMPROVEMENT	The zygomycete Blakeslea trispora is used commercially as natural source of a (a) over cap -carotene. Trisporic acid (TA) is secreted from the mycelium of B. trispora during mating between heterothallic strains and is considered as a mediator of the regulation of mating processes and an enhancer of carotene biosynthesis. Gas chromatography-mass spectrometry and multivariate analysis were employed to investigate TA-associated intracellular biochemical changes in B. trispora. By principal component analysis, the differential metabolites discriminating the control groups from the TA-treated groups were found, which were also confirmed by the subsequent hierarchical cluster analysis. The results indicate that TA is a global regulator and its main effects at the metabolic level are reflected on the content changes in several fatty acids, carbohydrates, and amino acids. The carbon metabolism and fatty acids synthesis are sensitive to TA addition. Glycerol, glutamine, and (a) over bar -aminobutyrate might play important roles in the regulation of TA. Complemented by two-dimensional electrophoresis, the results indicate that the actions of TA at the metabolic level involve multiple metabolic processes, such as glycolysis and the bypass of the classical tricarboxylic acid cycle. These results reveal that the metabolomics strategy is a powerful tool to gain insight into the mechanism of a microorganism's cellular response to signal inducers at the metabolic level.	[Sun, Jie; Li, Hao; Yuan, Qipeng] Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Coll Life Sci & Technol, Beijing, Peoples R China	Beijing University of Chemical Technology	Yuan, QP (corresponding author), Beijing Univ Chem Technol, State Key Lab Chem Resource Engn, Coll Life Sci & Technol, Beijing, Peoples R China.	yuanqp@mail.buct.edu.cn			Natural Science Foundation of China [20976009, 21176018]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by Natural Science Foundation of China (20976009 and 21176018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barsch Aiko, 2004, Functional & Integrative Genomics, V4, P219, DOI 10.1007/s10142-004-0117-y; Beecher CWW, 2003, METABOLIC PROFILING: ITS ROLE IN BIOMARKER DISCOVERY AND GENE FUNCTION ANALYSIS, P311; Bhosale P, 2004, APPL MICROBIOL BIOT, V63, P351, DOI 10.1007/s00253-003-1441-1; BOYLE SM, 1984, GENE, V30, P129, DOI 10.1016/0378-1119(84)90113-6; Burmester A, 2007, FUNGAL GENET BIOL, V44, P1096, DOI 10.1016/j.fgb.2007.07.008; CIEGLER A, 1959, APPL MICROBIOL, V7, P98, DOI 10.1128/AEM.7.2.98-101.1959; Hajjaj H, 1998, FEMS MICROBIOL LETT, V164, P195, DOI 10.1016/S0378-1097(98)00191-8; HESSELTINE CW, 1957, MYCOLOGIA, V49, P449, DOI 10.2307/3756153; Katayama H, 2001, RAPID COMMUN MASS SP, V15, P1416, DOI 10.1002/rcm.379; Koek MM, 2006, ANAL CHEM, V78, P1272, DOI 10.1021/ac051683+; Kumar S, 1997, MYCOL RES, V101, P403, DOI 10.1017/S0953756296002742; Kuzina V, 2008, CURR GENET, V54, P143, DOI 10.1007/s00294-008-0206-x; Li Q, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-44; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Nieto MJ, 2004, APPL MICROBIOL BIOT, V66, P153, DOI 10.1007/s00253-004-1669-4; Mantzouridou F, 2008, J AGR FOOD CHEM, V56, P2668, DOI 10.1021/jf703667d; Mashego MR, 2007, BIOTECHNOL LETT, V29, P1, DOI 10.1007/s10529-006-9218-0; Mendoza H, 1999, J APPL PHYCOL, V11, P15, DOI 10.1023/A:1008014332067; NIEUWENHUIS M, 1975, ARCH MICROBIOL, V102, P167, DOI 10.1007/BF00428363; RAO S, 1977, EXPERIENTIA, V33, P31, DOI 10.1007/BF01936735; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; Schachtschabel D, 2008, CHEMBIOCHEM, V9, P3004, DOI 10.1002/cbic.200800477; Schimek C, 2003, MYCOL RES, V107, P736, DOI 10.1017/S0953756203007949; Schmidt AD, 2005, APPL MICROBIOL BIOT, V67, P549, DOI 10.1007/s00253-005-1941-2; Shimada H, 1998, APPL ENVIRON MICROB, V64, P2676; Stephanopoulos G, 2004, NAT BIOTECHNOL, V22, P1261, DOI 10.1038/nbt1016; Strelkov S, 2004, BIOL CHEM, V385, P853, DOI 10.1515/BC.2004.111; SUTTER RP, 1973, J BACTERIOL, V114, P1074, DOI 10.1128/JB.114.3.1074-1082.1973; Szeto SSW, 2010, J PROTEOME RES, V9, P6729, DOI 10.1021/pr100880y; VANDENEN.H, 1972, ARCH MIKROBIOL, V86, P175; VANDENENDE H, 1968, J BACTERIOL, V96, P1298, DOI 10.1128/JB.96.4.1298-1303.1968; Verwaal R, 2007, APPL ENVIRON MICROB, V73, P4342, DOI 10.1128/AEM.02759-06; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; Wang GY, 2002, METAB ENG, V4, P193, DOI 10.1006/mben.2002.0225; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6	35	10	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46110	10.1371/journal.pone.0046110	http://dx.doi.org/10.1371/journal.pone.0046110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049952	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100137
J	Larrea, SCV; Haikarainen, T; Narwal, M; Schlesinger, M; Venkannagari, H; Flawia, MM; Villamil, SHF; Lehtio, L				Vilchez Larrea, Salome C.; Haikarainen, Teemu; Narwal, Mohit; Schlesinger, Mariana; Venkannagari, Harikanth; Flawia, Mirtha M.; Fernandez Villamil, Silvia H.; Lehtio, Lari			Inhibition of poly(ADP-ribose) Polymerase Interferes with Trypanosoma cruzi Infection and Proliferation of the Parasite	PLOS ONE			English	Article							NF-KAPPA-B; POTENT INHIBITORS; STRUCTURAL BASIS; PARP INHIBITOR; CHAGAS-DISEASE; DERIVATIVES; DISCOVERY; EXPRESSION; ALIGNMENT; ABT-888	Poly(ADP-ribosylation) is a post-translational covalent modification of proteins catalyzed by a family of enzymes termed poly(ADP-ribose) polymerases (PARPs). In the human genome, 17 different genes have been identified that encode members of the PARP superfamily. Poly (ADP-ribose) metabolism plays a role in a wide range of biological processes. In Trypanosoma cruzi, PARP enzyme appears to play a role in DNA repair mechanisms and may also be involved in controlling the different phases of cell growth. Here we describe the identification of potent inhibitors for T. cruzi PARP with a fluorescence-based activity assay. The inhibitors were also tested on T. cruzi epimastigotes, showing that they reduced ADPribose polymer formation in vivo. Notably, the identified inhibitors are able to reduce the growth rate of T. cruzi epimastigotes. The best inhibitor, Olaparib, is effective at nanomolar concentrations, making it an efficient chemical tool for chacterization of ADP-ribose metabolism in T. cruzi. PARP inhibition also decreases drastically the amount of amastigotes but interestingly has no effect on the amount of trypomastigotes in the cell culture. Knocking down human PARP-1 decreases both the amount of amastigotes and trypomastigotes in cell culture, indicating that the effect would be mainly due to inhibition of human PARP-1. The result suggests that the inhibition of PARP could be a potential way to interfere with T. cruzi infection.	[Vilchez Larrea, Salome C.; Schlesinger, Mariana; Flawia, Mirtha M.; Fernandez Villamil, Silvia H.] Univ Buenos Aires, Natl Inst Genet Engn & Mol Biol INGEBI CONICET, Buenos Aires, DF, Argentina; [Haikarainen, Teemu; Narwal, Mohit; Venkannagari, Harikanth; Lehtio, Lari] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Haikarainen, Teemu; Narwal, Mohit; Venkannagari, Harikanth; Lehtio, Lari] Univ Oulu, Dept Biochem, Oulu, Finland; [Narwal, Mohit; Venkannagari, Harikanth] Abo Akad Univ, Dept Biosci, Turku, Finland	University of Buenos Aires; University of Oulu; Finland National Institute for Health & Welfare; University of Oulu; Abo Akademi University	Villamil, SHF (corresponding author), Univ Buenos Aires, Natl Inst Genet Engn & Mol Biol INGEBI CONICET, Buenos Aires, DF, Argentina.	s.villamil@ingebi.conicet.gov.ar; lari.lehtio@oulu.fi	Venkannagari, Harikanth/AAX-6211-2021	Lehtio, Lari/0000-0001-7250-832X; Vilchez Larrea, Salome/0000-0001-8302-1509	Academy of Finland [128322]; Biocenter Oulu; Sigrid Juselius Foundation; European Molecular Biology Organization	Academy of Finland(Academy of Finland); Biocenter Oulu; Sigrid Juselius Foundation(Sigrid Juselius Foundation); European Molecular Biology Organization(European Molecular Biology Organization (EMBO))	The work was funded by Academy of Finland [grant no. 128322] (www.aka.fi), Biocenter Oulu (www.biocenter.oulu.fi), Sigrid Juselius Foundation (www.sigridjuselius.fi), and the European Molecular Biology Organization (www.embo.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba XQ, 2010, J BIOL CHEM, V285, P11596, DOI 10.1074/jbc.M109.076984; BANASIK M, 1992, J BIOL CHEM, V267, P1569; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Daunes S, 2001, J MED CHEM, V44, P2976, DOI 10.1021/jm000502n; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Eltze T, 2008, MOL PHARMACOL, V74, P1587, DOI 10.1124/mol.108.048751; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erdelyi K, 2009, FASEB J, V23, P3553, DOI 10.1096/fj.09-133264; Ferraris DV, 2010, J MED CHEM, V53, P4561, DOI 10.1021/jm100012m; Guhl F, 2007, MEM I OSWALDO CRUZ, V102, P29, DOI 10.1590/S0074-02762007005000099; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003; Huang H, 1999, INFECT IMMUN, V67, P5434, DOI 10.1128/IAI.67.10.5434-5440.1999; Iwashita A, 2005, FEBS LETT, V579, P1389, DOI 10.1016/j.febslet.2005.01.036; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jagtap PG, 2004, BIOORG MED CHEM LETT, V14, P81, DOI 10.1016/j.bmcl.2003.10.007; Karlberg T, 2010, BIOCHEMISTRY-US, V49, P1056, DOI 10.1021/bi902079y; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Loup G, 2011, CURR OPIN INFECT DIS, V24, P428, DOI 10.1097/QCO.0b013e32834a667f; Lehtio L, 2009, J MED CHEM, V52, P3108, DOI 10.1021/jm900052j; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Miyashiro J, 2009, BIOORG MED CHEM LETT, V19, P4050, DOI 10.1016/j.bmcl.2009.06.016; Nakajima H, 2005, J PHARMACOL EXP THER, V312, P472, DOI 10.1124/jpet.104.075465; Narwal M, 2012, J BIOMOL SCREEN, V17, P593, DOI 10.1177/1087057112436558; Narwal M, 2012, J MED CHEM, V55, P1360, DOI 10.1021/jm201510p; Penning TD, 2009, J MED CHEM, V52, P514, DOI 10.1021/jm801171j; Pinto AMT, 2011, CELL MICROBIOL, V13, P1518, DOI 10.1111/j.1462-5822.2011.01636.x; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Putt KS, 2004, ANAL BIOCHEM, V326, P78, DOI 10.1016/j.ab.2003.11.015; Ruf A, 1998, BIOCHEMISTRY-US, V37, P3893, DOI 10.1021/bi972383s; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Soeiro Maria de Nazare C, 2011, Open Med Chem J, V5, P21, DOI 10.2174/1874104501105010021; Thomas HD, 2007, MOL CANCER THER, V6, P945, DOI 10.1158/1535-7163.MCT-06-0552; Larrea SCV, 2011, INT J PARASITOL, V41, P405, DOI 10.1016/j.ijpara.2010.11.008; Villamil SHF, 2008, INT J PARASITOL, V38, P277, DOI 10.1016/j.ijpara.2007.08.003; WILLIAMS GT, 1984, J CELL BIOL, V99, P79, DOI 10.1083/jcb.99.1.79	38	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46063	10.1371/journal.pone.0046063	http://dx.doi.org/10.1371/journal.pone.0046063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049934	gold, Green Submitted, Green Published			2022-12-27	WOS:000309556100127
J	Todd, RG; Helikar, T				Todd, Robert G.; Helikar, Tomas			Ergodic Sets as Cell Phenotype of Budding Yeast Cell Cycle	PLOS ONE			English	Article							TRANSCRIPTION; NETWORKS; MODEL; GENE; CLN3; MORPHOGENESIS; CHECKPOINT; INHIBITOR; PROMOTERS; GROWTH	It has been suggested that irreducible sets of states in Probabilistic Boolean Networks correspond to cellular phenotype. In this study, we identify such sets of states for each phase of the budding yeast cell cycle. We find that these "ergodic sets" underly the cyclin activity levels during each phase of the cell cycle. Our results compare to the observations made in several laboratory experiments as well as the results of differential equation models. Dynamical studies of this model: (i) indicate that under stochastic external signals the continuous oscillating waves of cyclin activity and the opposing waves of CKIs emerge from the logic of a Boolean-based regulatory network without the need for specific biochemical/kinetic parameters; (ii) suggest that the yeast cell cycle network is robust to the varying behavior of cell size (e.g., cell division under nitrogen deprived conditions); (iii) suggest the irreversibility of the Start signal is a function of logic of the G1 regulon, and changing the structure of the regulatory network can render start reversible.	[Todd, Robert G.; Helikar, Tomas] Univ Nebraska, Dept Math, Omaha, NE 68182 USA	University of Nebraska System	Todd, RG (corresponding author), Univ Nebraska, Dept Math, Omaha, NE 68182 USA.	rtodd@unomaha.edu	Todd, Robert/GWM-4486-2022	Helikar, Tomas/0000-0003-3653-1906				Alberghina L, 2004, J CELL BIOL, V167, P433, DOI 10.1083/jcb.200405102; Alberghina L, 2009, J BIOTECHNOL, V144, P224, DOI 10.1016/j.jbiotec.2009.07.009; Ball DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026272; Barberis M, 2007, PLOS COMPUTATIONS BI, V3; Bardin AJ, 2001, NAT REV MOL CELL BIO, V2, P815, DOI 10.1038/35099020; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Bruna M, 2005, SIGNAL PROCESSING, V85; Charvin G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000284; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Chen RH, 2007, J BIOMED SCI, V14, P475, DOI 10.1007/s11373-007-9157-3; Ching WK, 2007, BIOINFORMATICS, V23, P1511, DOI 10.1093/bioinformatics/btm142; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Efroni S, 2007, PLOS COMPUT BIOL, V3, P127, DOI 10.1371/journal.pcbi.0030013; Faure A, 2009, MOL BIOSYST, V5, P1787, DOI [10.1039/b910101m, 10.1039/B910101m]; Ferrell JE, 2011, MOL CELL, V43, P497, DOI 10.1016/j.molcel.2011.08.002; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Ge H, 2008, MATH BIOSCI, V211, P132, DOI 10.1016/j.mbs.2007.10.003; Gilbert D, 2006, BRIEF BIOINFORM, V7, P339, DOI 10.1093/bib/bbl043; GRANDIN N, 1993, MOL CELL BIOL, V13, P2113, DOI 10.1128/MCB.13.4.2113; HASHIMOTO R. F., 2009, P IEEE INT WORKSHOP, P1, DOI DOI 10.1109/GENSIPS.2009.5174356; Helikar T, 2008, P NATL ACAD SCI USA, V105, P1913, DOI 10.1073/pnas.0705088105; Helikar T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-96; HEREFORD LM, 1974, J MOL BIOL, V84, P445, DOI 10.1016/0022-2836(74)90451-3; Hognas G., 1977, Journal of the Australian Mathematical Society, Series A (Pure Mathematics), V23, P481; Hood-DeGrenier JK, 2007, CURR GENET, V51, P1, DOI 10.1007/s00294-006-0102-1; Hunt T, 2011, PHILOS T R SOC B, V366, P3494, DOI 10.1098/rstb.2011.0274; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Irons DJ, 2009, J THEOR BIOL, V257, P543, DOI 10.1016/j.jtbi.2008.12.028; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; Kaizu K, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.73; Kim S, 2002, J BIOL SYST, V10, P337, DOI 10.1142/S0218339002000676; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lee KS, 2005, CELL CYCLE, V4, P1346, DOI 10.4161/cc.4.10.2049; Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; MAHER M, 1995, MOL CELL BIOL, V15, P3129; McInerny CJ, 1997, GENE DEV, V11, P1277, DOI 10.1101/gad.11.10.1277; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Rupes I, 2002, TRENDS GENET, V18, P479, DOI 10.1016/S0168-9525(02)02745-2; Schneider BL, 2004, MOL CELL BIOL, V24, P10802, DOI 10.1128/MCB.24.24.10802-10813.2004; Shmulevich I, 2003, COMP FUNCT GENOM, V4, P601, DOI 10.1002/cfg.342; Shmulevich I, 2002, BIOINFORMATICS, V18, P261, DOI 10.1093/bioinformatics/18.2.261; Strickfaden SC, 2007, CELL, V128, P519, DOI 10.1016/j.cell.2006.12.032; Uhlmann F, 2011, PHILOS T R SOC B, V366, P3572, DOI 10.1098/rstb.2011.0082; Weng GZ, 1999, SCIENCE, V284, P92, DOI 10.1126/science.284.5411.92; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; Zhang SQ, 2007, INT J DATA MINING BI, V1; Zhang YP, 2006, PHYSICA D, V219, P35, DOI 10.1016/j.physd.2006.05.009	50	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45780	10.1371/journal.pone.0045780	http://dx.doi.org/10.1371/journal.pone.0045780			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049686	Green Published, gold			2022-12-27	WOS:000309388500013
J	Fisher, JRB; Dills, B				Fisher, Jonathan R. B.; Dills, Benjamin			Do Private Conservation Activities Match Science-Based Conservation Priorities?	PLOS ONE			English	Article							AREAS; INVESTMENT; MANAGERS; GROWTH; RETURN; SIZE; GAPS	Background: Private land conservation is an essential strategy for biodiversity protection in the USA, where half of the federally listed species have at least 80% of their habitat on private lands. We investigated the alignment between private land protection conducted by the world's largest land trust (The Nature Conservancy) and the science driven identification of priority areas for conservation. This represents the first quantitative assessment of the influence of defining priority areas on the land acquisitions of a conservation non-governmental organization (NGO). Methodology/Principal Findings: The lands acquired by The Nature Conservancy (TNC) were analyzed using GIS to determine to what extent they were in areas defined as priorities for conservation. The spatial analysis of TNC lands was broken up into land known to be acquired in the last five years, five to ten years ago, prior to ten years ago, and anytime during the last sixty years (including previous sets of data plus acquisitions lacking a date). For the entire history of TNC the proportion of TNC lands within the priority areas was 74%. Prior to 10 years ago it was 80%, 5-10 years ago it was 76%, and in the last five years it was 81%. Conservation easements were found to have lower alignment with priority areas (64%) than outright fee simple acquisitions (86%). Conclusions/Significance: Overall the location of lands acquired was found to be well aligned with the priority areas. Since there was comparable alignment in lands acquired before and after formalized conservation planning had been implemented as a standard operating procedure, this analysis did not find evidence that defining priority areas has influenced land acquisition decisions.	[Fisher, Jonathan R. B.] Nature Conservancy, Worldwide Off, Arlington, VA USA; [Dills, Benjamin] George Washington Univ, Elliott Sch Int Affairs, Washington, DC 20052 USA	Nature Conservancy; George Washington University	Fisher, JRB (corresponding author), Nature Conservancy, Worldwide Off, 1815 N Lynn St, Arlington, VA USA.	jon_fisher@tnc.org		Fisher, Jonathan/0000-0001-5094-9730				ABELL R, 2002, SOURCEBOOK CONDUCTIN, V2; Armsworth PR, 2012, BIOSCIENCE, V62, P271, DOI 10.1525/bio.2012.62.3.8; BOTTRILL M, 2012, CONSERV BIO IN PRESS; Burgess N, 2000, WORKBOOK CONDUCTING; Carwardine J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002586; *CONS MEAS PARTN, 2004, OP STAND PRACT CONS; Conservation Measures Partnership, 2007, OP STAND PRACT CONS; Cowling RM, 2003, BIOL CONSERV, V112, P147, DOI 10.1016/S0006-3207(02)00397-X; Davies ZG, 2010, CONSERV LETT, V3, P29, DOI 10.1111/j.1755-263X.2009.00091.x; Fishburn IS, 2009, CONSERV LETT, V2, P74, DOI 10.1111/j.1755-263X.2008.00045.x; Fishburn IS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004996; Floberg J., 2004, WILLAMETTE VALLEY PU; Grantham HS, 2009, ECOL LETT, V12, P293, DOI 10.1111/j.1461-0248.2009.01287.x; Groves C.R., 2003, DRAFTING CONSERVATIO; GROVES CR, 2000, DES GEOGR HOP PRACT, V1; Haila Y, 1996, ECOGRAPHY, V19, P323, DOI 10.1111/j.1600-0587.1996.tb00243.x; Halpern BS, 2006, CONSERV BIOL, V20, P56, DOI 10.1111/j.1523-1739.2005.00258.x; Hayward MW, 2011, BIODIVERS CONSERV, V20, P2563, DOI 10.1007/s10531-011-0091-3; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Knight AT, 2011, BIOL CONSERV, V144, P2623, DOI 10.1016/j.biocon.2011.07.013; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Murdoch W, 2007, BIOL CONSERV, V139, P375, DOI 10.1016/j.biocon.2007.07.011; *NAT CONS, 1997, DES GEOGR HOP GUID E; *NAT CONS WORLD WI, 2006, STAND EC ASS BIOD VI; Possingham Hugh, 2000, P291, DOI 10.1007/0-387-22648-6_17; Prendergast JR, 1999, CONSERV BIOL, V13, P484, DOI 10.1046/j.1523-1739.1999.97428.x; Pressey RL, 1997, BIOL CONSERV, V80, P207, DOI 10.1016/S0006-3207(96)00045-6; SHORT J, 1994, J MAMMAL, V75, P288, DOI 10.2307/1382547; Soule ME, 1999, BIOSCIENCE, V49, P809, DOI 10.2307/1313572; Underwood EC, 2009, CONSERV LETT, V2, P130, DOI 10.1111/j.1755-263X.2008.00018.x; *US DEP INT, 2009, OUR END SPEC PROGR I; van Jaarsveld AS, 1998, SCIENCE, V279, P2106, DOI 10.1126/science.279.5359.2106; Williams PH, 2000, P ROY SOC B-BIOL SCI, V267, P1959, DOI 10.1098/rspb.2000.1236	34	20	20	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46429	10.1371/journal.pone.0046429	http://dx.doi.org/10.1371/journal.pone.0046429			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029516	gold, Green Published, Green Submitted			2022-12-27	WOS:000309973900157
J	Zhang, H; Yan, HM; Kendrick, KM; Li, CY				Zhang, Hao; Yan, Hong-Mei; Kendrick, Keith M.; Li, Chao-Yi			Both Lexical and Non-Lexical Characters Are Processed during Saccadic Eye Movements	PLOS ONE			English	Article							TIME; COMPRESSION; SUPPRESSION; SPACE	On average our eyes make 3-5 saccadic movements per second when we read, although their neural mechanism is still unclear. It is generally thought that saccades help redirect the retinal fovea to specific characters and words but that actual discrimination of information only occurs during periods of fixation. Indeed, it has been proposed that there is active and selective suppression of information processing during saccades to avoid experience of blurring due to the high-speed movement. Here, using a paradigm where a string of either lexical (Chinese) or non-lexical (alphabetic) characters are triggered by saccadic eye movements, we show that subjects can discriminate both while making saccadic eye movement. Moreover, discrimination accuracy is significantly better for characters scanned during the saccadic movement to a fixation point than those not scanned beyond it. Our results showed that character information can be processed during the saccade, therefore saccades during reading not only function to redirect the fovea to fixate the next character or word but allow pre-processing of information from the ones adjacent to the fixation locations to help target the next most salient one. In this way saccades can not only promote continuity in reading words but also actively facilitate reading comprehension.	[Zhang, Hao; Yan, Hong-Mei; Kendrick, Keith M.; Li, Chao-Yi] Univ Elect Sci & Technol China, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Li, Chao-Yi] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	University of Electronic Science & Technology of China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yan, HM (corresponding author), Univ Elect Sci & Technol China, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	hmyan@uestc.edu.cn		Kendrick, Keith/0000-0002-0371-5904	Major State Basic Research Program [2007CB311001]; Natural Science Foundations of China [90820301, 60972108, 91120013, 61075109]	Major State Basic Research Program(National Basic Research Program of China); Natural Science Foundations of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major State Basic Research Program (2007CB311001), and the Natural Science Foundations of China (90820301, 60972108, 91120013, 61075109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binda P, 2009, J NEUROSCI, V29, P13147, DOI 10.1523/JNEUROSCI.3723-09.2009; BRIDGEMAN B, 1995, PSYCHOL RES-PSYCH FO, V58, P163, DOI 10.1007/BF00419631; Brockmole JR, 2002, PERCEPT PSYCHOPHYS, V64, P867, DOI 10.3758/BF03196792; Burr DC, 2011, PHILOS T R SOC B, V366, P504, DOI 10.1098/rstb.2010.0244; Burr DC, 2010, TRENDS COGN SCI, V14, P528, DOI 10.1016/j.tics.2010.09.005; BURR DC, 1994, NATURE, V371, P511, DOI 10.1038/371511a0; Hall NJ, 2011, PHILOS T R SOC B, V366, P528, DOI 10.1098/rstb.2010.0248; Ibbotson MR, 2007, CEREB CORTEX, V17, P1129, DOI 10.1093/cercor/bhl022; Ibbotson MR, 2009, CURR BIOL, V19, pR493, DOI 10.1016/j.cub.2009.05.010; Irwin D. E., 2004, INTERFACE LANGUAGE V, P105; Irwin DE, 2007, PERCEPT PSYCHOPHYS, V69, P450, DOI 10.3758/BF03193765; Irwin DE, 2004, PSYCHOL SCI, V15, P467, DOI 10.1111/j.0956-7976.2004.00703.x; Irwin DE, 2000, PSYCHON B REV, V7, P654, DOI 10.3758/BF03213003; Irwin DE, 1998, COGNITIVE PSYCHOL, V36, P1, DOI 10.1006/cogp.1998.0682; Knoll J, 2011, J VISION, V11, DOI 10.1167/11.14.15; Lappe M, 2006, J VISION, V6, P1282, DOI 10.1167/6.11.11; MATIN E, 1993, PERCEPT PSYCHOPHYS, V53, P372, DOI 10.3758/BF03206780; Melcher D, 2005, CURR BIOL, V15, P1745, DOI 10.1016/j.cub.2005.08.044; Morrone C, 2008, COGNITIVE NEUROSCIEN; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; Potter M.C., 1984, NEW METHODS READING, P91; Radach R, 2004, EUR J COGN PSYCHOL, V16, P3, DOI 10.1080/09541440340000295; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Reichle ED, 2003, BEHAV BRAIN SCI, V26, P445, DOI 10.1017/S0140525X03000104; Rolfs M, 2011, NAT NEUROSCI, V14, P252, DOI 10.1038/nn.2711; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; Thiele A, 2002, SCIENCE, V295, P2460, DOI 10.1126/science.1068788; Thilo KV, 2004, NAT NEUROSCI, V7, P13, DOI 10.1038/nn1171; Vonk W, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P291, DOI 10.1016/B978-044451020-4/50017-7; Watson TL, 2009, CURR BIOL, V19, P1040, DOI 10.1016/j.cub.2009.04.052; Yatabe K, 2009, PSYCHON B REV, V16, P62, DOI 10.3758/PBR.16.1.62	31	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46383	10.1371/journal.pone.0046383	http://dx.doi.org/10.1371/journal.pone.0046383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	022PZ	23029504	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900151
J	Biswas, D; Pandya, V; Singh, AK; Mondal, AK; Kumaran, S				Biswas, Dipanwita; Pandya, Vaibhav; Singh, Appu Kumar; Mondal, Alok K.; Kumaran, S.			Co-Factor Binding Confers Substrate Specificity to Xylose Reductase from Debaryomyces hansenii	PLOS ONE			English	Article							ALDO-KETO REDUCTASE; CONFORMATIONAL-CHANGES; ACTIVE-SITE; ALLOSTERIC REGULATION; CATALYTIC MECHANISM; ENZYME DYNAMICS; XYLITOL; NADPH; YEAST; INSIGHTS	Binding of substrates into the active site, often through complementarity of shapes and charges, is central to the specificity of an enzyme. In many cases, substrate binding induces conformational changes in the active site, promoting specific interactions between them. In contrast, non-substrates either fail to bind or do not induce the requisite conformational changes upon binding and thus no catalysis occurs. In principle, both lock and key and induced-fit binding can provide specific interactions between the substrate and the enzyme. In this study, we present an interesting case where cofactor binding pre-tunes the active site geometry to recognize only the cognate substrates. We illustrate this principle by studying the substrate binding and kinetic properties of Xylose Reductase from Debaryomyces hansenii (DhXR), an AKR family enzyme which catalyzes the reduction of carbonyl substrates using NADPH as co-factor. DhXR reduces D-xylose with increased specificity and shows no activity towards "non-substrate" sugars like L-rhamnose. Interestingly, apo-DhXR binds to D-xylose and L-rhamnose with similar affinity (K-d similar to 5.0-10.0 mM). Crystal structure of apo-DhXR-rhamnose complex shows that L-rhamnose is bound to the active site cavity. L-rhamnose does not bind to holo-DhXR complex and thus, it cannot competitively inhibit D-xylose binding and catalysis even at 4-5 fold molar excess. Comparison of K-d values with K-m values reveals that increased specificity for D-xylose is achieved at the cost of moderately reduced affinity. The present work reveals a latent regulatory role for cofactor binding which was previously unknown and suggests that cofactor induced conformational changes may increase the complimentarity between D-xylose and active site similar to specificity achieved through induced-fit mechanism.	[Biswas, Dipanwita; Pandya, Vaibhav; Singh, Appu Kumar; Mondal, Alok K.; Kumaran, S.] CSIR, Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Kumaran, S (corresponding author), CSIR, Inst Microbial Technol, Chandigarh, India.	skumaran@imtech.res.in		Pandya, Vaibhav/0000-0002-8500-9009	Council of Scientific and Industrial Research (CSIR), New Delhi, India under NMITLI; CSIR, India	Council of Scientific and Industrial Research (CSIR), New Delhi, India under NMITLI; CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported in part by a grant from Council of Scientific and Industrial Research (CSIR), New Delhi, India under NMITLI project. Fellowships for DB, VP, and AKS were funded by CSIR, India. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berg J.M., 2007, BIOCHEMISTRY-US, V6th ed.; Breuer U, 2006, YEAST, V23, P415, DOI 10.1002/yea.1374; Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fieulaine S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001066; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Fischer JD, 2010, BIOINFORMATICS, V26, P2496, DOI 10.1093/bioinformatics/btq442; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Gruber TD, 2009, J MOL BIOL, V391, P327, DOI 10.1016/j.jmb.2009.05.081; GURGEL PV, 1995, BIORESOURCE TECHNOL, V52, P219, DOI 10.1016/0960-8524(95)00025-A; Hamill MJ, 2011, BIOCHEMISTRY-US, V50, P10159, DOI 10.1021/bi201340t; HEPPEL LA, 1951, J BIOL CHEM, V188, P665; HERSCHLAG D, 1988, BIOORG CHEM, V16, P62, DOI 10.1016/0045-2068(88)90038-7; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jurica MS, 1998, STRUCTURE, V6, P195, DOI 10.1016/S0969-2126(98)00021-5; Kaur H, 2011, BIOCHIMIE, V93, P175, DOI 10.1016/j.biochi.2010.09.008; Kavanagh KL, 2002, BIOCHEMISTRY-US, V41, P8785, DOI 10.1021/bi025786n; Khurana S, 1998, P NATL ACAD SCI USA, V95, P6768, DOI 10.1073/pnas.95.12.6768; Klimacek M, 2007, BIOCATAL BIOTRANSFOR, V25, P194, DOI 10.1080/10242420701379775; Knowles RR, 2010, P NATL ACAD SCI USA, V107, P20678, DOI 10.1073/pnas.1006402107; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Kratzer R, 2006, BIOCHEM J, V393, P51, DOI 10.1042/BJ20050831; Kratzer R, 2006, IUBMB LIFE, V58, P499, DOI 10.1080/15216540600818143; Kraut DA, 2006, PLOS BIOL, V4, P501, DOI 10.1371/journal.pbio.0040099; Lindner AB, 1999, J MOL BIOL, V285, P421, DOI 10.1006/jmbi.1998.2309; Ma BY, 2010, CURR OPIN CHEM BIOL, V14, P652, DOI 10.1016/j.cbpa.2010.08.012; Mayr P, 2002, BIOCHEM J, V366, P889, DOI 10.1042/BJ20020080; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Neuhauser W, 1998, BIOCHEMISTRY-US, V37, P1116, DOI 10.1021/bi9717800; NIGAM P, 1995, PROCESS BIOCHEM, V30, P117, DOI 10.1016/0032-9592(95)95709-R; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan R, 2010, J BIOL CHEM, V285, P22948, DOI 10.1074/jbc.M110.103549; Pandya V, 2011, ANAL BIOCHEM, V418, P134, DOI 10.1016/j.ab.2011.06.029; PARAJO JC, 1995, BIOPROCESS ENG, V13, P125, DOI 10.1007/BF00369695; Pauling L., 1946, CHEM ENG NEWS, V24, P1375, DOI [10.1021/cen-v024n010.p1375, DOI 10.1021/CEN-V024N010.P1375]; Peterson PE, 1999, STRUCTURE, V7, P769, DOI 10.1016/S0969-2126(99)80101-4; Picha KM, 1998, J BIOL CHEM, V273, P27315, DOI 10.1074/jbc.273.42.27315; Price AC, 2004, STRUCTURE, V12, P417, DOI 10.1016/j.str.2004.02.008; Pudney CR, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001222; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Sanli G, 2003, CELL BIOCHEM BIOPHYS, V38, P79, DOI 10.1385/CBB:38:1:79; Sanli G, 2001, J MOL BIOL, V309, P1209, DOI 10.1006/jmbi.2001.4739; Savir Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000468; SCHNEIDER H, 1989, CRIT REV BIOTECHNOL, V9, P1, DOI 10.1080/07388550490465817; WILSON DK, 1992, SCIENCE, V257, P81, DOI 10.1126/science.1621098; Wittung-Stafshede P, 2002, ACCOUNTS CHEM RES, V35, P201, DOI 10.1021/ar010106e; ZEREZ CR, 1987, J BACTERIOL, V169, P184, DOI 10.1128/jb.169.1.184-188.1987	51	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45525	10.1371/journal.pone.0045525	http://dx.doi.org/10.1371/journal.pone.0045525			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049810	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300030
J	Cendra, MD; Juarez, A; Torrents, E				del Mar Cendra, Maria; Juarez, Antonio; Torrents, Eduard			Biofilm Modifies Expression of Ribonucleotide Reductase Genes in Escherichia coli	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; STRESS; K-12; ACTIVATION; CLONING; OPERON; STRAIN; GROWTH; ENZYME; LEVEL	Ribonucleotide reductase (RNR) is an essential enzyme for all living organisms since is the responsible for the last step in the synthesis of the four deoxyribonucleotides (dNTPs) necessary for DNA replication and repair. In this work, we have investigated the expression of the three-RNR classes (Ia, Ib and III) during Escherichia coli biofilm formation. We show the temporal and spatial importance of class Ib and III RNRs during this process in two different E. coli wild-type strains, the commensal MG1655 and the enteropathogenic and virulent E2348/69, the prototype for the enteropathogenic E. coli (EPEC). We have established that class Ib RNR, so far considered cryptic, play and important role during biofilm formation. The implication of this RNR class under the specific growth conditions of biofilm formation is discussed.	[del Mar Cendra, Maria; Juarez, Antonio; Torrents, Eduard] Inst Bioengn Catalonia IBEC, Barcelona, Spain; [Juarez, Antonio] Univ Barcelona, Fac Biol, Dept Microbiol, Barcelona, Spain	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Barcelona	Torrents, E (corresponding author), Inst Bioengn Catalonia IBEC, Barcelona, Spain.	etorrents@ibecbarcelona.eu	Torrents, Eduard/C-7184-2008; Cendra, M/A-6821-2019; del Mar Cendra, Maria/AAX-8114-2020	Torrents, Eduard/0000-0002-3010-1609; Cendra, M/0000-0002-2100-2406; del Mar Cendra, Maria/0000-0002-2100-2406; Juarez, Antonio/0000-0002-5027-8778	ERA-NET Pathogenomics [BIO2008-04362-E]; Spanish Ministerio de Ciencia e Innovacion [PI081062, BFU2011-24066]; Consolider-Intermods from the Spanish MICINN [CDS2008-00013]	ERA-NET Pathogenomics; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consolider-Intermods from the Spanish MICINN	This work was supported by grants from the "ERA-NET Pathogenomics-BIO2008-04362-E" and from the Spanish Ministerio de Ciencia e Innovacion (PI081062) and (BFU2011-24066) to ET and Consolider-Intermods (CDS2008-00013) from the Spanish MICINN to ET and AJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Boal AK, 2010, SCIENCE, V329, P1526, DOI 10.1126/science.1190187; Boles BR, 2008, P NATL ACAD SCI USA, V105, P12503, DOI 10.1073/pnas.0801499105; Boston T, 2003, J BACTERIOL, V185, P5310, DOI 10.1128/JB.185.17.5310-5313.2003; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cotruvo JA, 2011, BIOCHEMISTRY-US, V50, P1672, DOI 10.1021/bi101881d; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4; Garriga X, 1996, BIOCHEM BIOPH RES CO, V229, P189, DOI 10.1006/bbrc.1996.1778; Horinouchi T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-579; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; Ito A, 2009, BIOTECHNOL BIOENG, V103, P975, DOI 10.1002/bit.22305; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lundin D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-589; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; McHugh JP, 2003, J BIOL CHEM, V278, P29478, DOI 10.1074/jbc.M303381200; Monje-Casas F, 2001, J BIOL CHEM, V276, P18031, DOI 10.1074/jbc.M011728200; Moreira CG, 2006, J BACTERIOL, V188, P3952, DOI 10.1128/JB.00177-06; O'Toole GA, 1999, METHOD ENZYMOL, V310, P91; Ren D, 2004, APPL MICROBIOL BIOT, V64, P515, DOI 10.1007/s00253-003-1517-y; Roca I, 2008, INT MICROBIOL, V11, P49, DOI 10.2436/20.1501.01.44; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schembri MA, 2003, MOL MICROBIOL, V48, P253, DOI 10.1046/j.1365-2958.2003.03432.x; Silhavy T.J., 1984, EXPT GENE FUSIONS; Sjoberg BM, 2011, INFECT IMMUN, V79, P2663, DOI 10.1128/IAI.01212-10; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Torrents E, 2000, CURR MICROBIOL, V41, P346, DOI 10.1007/s002840010147; Torrents E, 2008, RIBONUCLEOTIDE REDUC, P17; Torrents E, 2007, J BACTERIOL, V189, P5012, DOI 10.1128/JB.00440-07; Torrents E, 2010, BIOL CHEM, V391, P229, DOI [10.1515/BC.2010.017, 10.1515/bc.2010.017]; Varghese S, 2007, MOL MICROBIOL, V64, P822, DOI 10.1111/j.1365-2958.2007.05701.x; Vassinova N, 2000, MICROBIOL-SGM, V146, P3171, DOI 10.1099/00221287-146-12-3171; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Weiss-Muszkat M, 2010, APPL ENVIRON MICROB, V76, P1545, DOI 10.1128/AEM.01395-09	36	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46350	10.1371/journal.pone.0046350	http://dx.doi.org/10.1371/journal.pone.0046350			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050019	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300109
J	Nittono, H; Fukushima, M; Yano, A; Moriya, H				Nittono, Hiroshi; Fukushima, Michiko; Yano, Akihiro; Moriya, Hiroki			The Power of Kawaii: Viewing Cute Images Promotes a Careful Behavior and Narrows Attentional Focus	PLOS ONE			English	Article							POSITIVE EMOTIONS; INFANT FACES; BABY SCHEMA; HEAD SHAPE; BREADTH; PERCEPTION; INCREASES; PRECEDENCE; RESPONSES; STRESS	Kawaii (a Japanese word meaning "cute") things are popular because they produce positive feelings. However, their effect on behavior remains unclear. In this study, three experiments were conducted to examine the effects of viewing cute images on subsequent task performance. In the first experiment, university students performed a fine motor dexterity task before and after viewing images of baby or adult animals. Performance indexed by the number of successful trials increased after viewing cute images (puppies and kittens; M +/- SE = 43.9 +/- 10.3% improvement) more than after viewing images that were less cute (dogs and cats; 11.9 +/- 5.5% improvement). In the second experiment, this finding was replicated by using a non-motor visual search task. Performance improved more after viewing cute images (15.7 +/- 2.2% improvement) than after viewing less cute images (1.4 +/- 2.1% improvement). Viewing images of pleasant foods was ineffective in improving performance (1.2 +/- 2.1%). In the third experiment, participants performed a global-local letter task after viewing images of baby animals, adult animals, and neutral objects. In general, global features were processed faster than local features. However, this global precedence effect was reduced after viewing cute images. Results show that participants performed tasks requiring focused attention more carefully after viewing cute images. This is interpreted as the result of a narrowed attentional focus induced by the cuteness-triggered positive emotion that is associated with approach motivation and the tendency toward systematic processing. For future applications, cute objects may be used as an emotion elicitor to induce careful behavioral tendencies in specific situations, such as driving and office work.	[Nittono, Hiroshi; Fukushima, Michiko; Yano, Akihiro; Moriya, Hiroki] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Hiroshima, Japan	Hiroshima University	Nittono, H (corresponding author), Hiroshima Univ, Grad Sch Integrated Arts & Sci, Hiroshima, Japan.	nittono@hiroshima-u.ac.jp	Nittono, Hiroshi/C-4043-2009	Nittono, Hiroshi/0000-0001-5671-609X	KAKENHI [23330217]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) 23330217 to HN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PM, 2008, INVEST OPHTH VIS SCI, V49, P4210, DOI 10.1167/iovs.07-1587; ALLEY TR, 1983, MERRILL PALMER QUART, V29, P411; ALLEY TR, 1981, DEV PSYCHOL, V17, P650, DOI 10.1037/0012-1649.17.5.650; BERMAN PW, 1980, PSYCHOL BULL, V88, P668, DOI 10.1037/0033-2909.88.3.668; Botz-Bornstein T., 2011, COOL KAWAII AFRO JAP; Brosch T, 2008, PSYCHOL SCI, V19, P362, DOI 10.1111/j.1467-9280.2008.02094.x; Brosch T, 2007, EMOTION, V7, P685, DOI 10.1037/1528-3542.7.3.685; Cheok AD, 2010, ART AND TECHNOLOGY OF ENTERTAINMENT COMPUTING AND COMMUNICATION: ADVANCES IN INTERACTIVE NEW MEDIA FOR ENTERTAINMENT COMPUTING, P1, DOI 10.1007/978-1-84996-137-0_1; Eibl-Eibesfeldt Irenaus, 1970, LIEBE HASS NATURGESC; Fredrickson BL, 2005, COGNITION EMOTION, V19, P313, DOI 10.1080/02699930441000238; Gable P, 2010, COGNITION EMOTION, V24, P322, DOI 10.1080/02699930903378305; Gable PA, 2008, PSYCHOL SCI, V19, P476, DOI 10.1111/j.1467-9280.2008.02112.x; Gasper K, 2002, PSYCHOL SCI, V13, P34, DOI 10.1111/1467-9280.00406; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Glocker ML, 2009, ETHOLOGY, V115, P257, DOI 10.1111/j.1439-0310.2008.01603.x; Griskevicius V, 2010, EMOTION, V10, P190, DOI 10.1037/a0018421; Gueguen N, 2008, ANTHROZOOS, V21, P339, DOI 10.2752/175303708X371564; HILDEBRANDT KA, 1978, BEHAV PROCESS, V3, P159, DOI 10.1016/0376-6357(78)90042-6; Kinsella Sharon., 1995, WOMEN MEDIA CONSUMPT, P220; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Kuhbandner C, 2011, EMOTION, V11, P958, DOI 10.1037/a0024075; Lang J.P., 1999, A4 U FLOR CTR RES PS; Lobmaier JS, 2010, EVOL HUM BEHAV, V31, P16, DOI 10.1016/j.evolhumbehav.2009.05.004; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Maestripieri D, 2002, HUM NATURE-INT BIOS, V13, P327, DOI 10.1007/s12110-002-1018-1; Moriya H, 2011, NEUROPSYCHOLOGIA, V49, P1162, DOI 10.1016/j.neuropsychologia.2011.02.036; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; NAVON D, 1981, PSYCHOL RES-PSYCH FO, V43, P1, DOI 10.1007/BF00309635; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parsons CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020632; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; Schleidt M., 1980, MAN ENV SYSTEMS, V10, P73; Shaver PR, 1996, PERS RELATIONSHIP, V3, P81, DOI 10.1111/j.1475-6811.1996.tb00105.x; Sherman GD, 2011, EMOT REV, V3, P245, DOI 10.1177/1754073911402396; Sherman GD, 2009, EMOTION, V9, P282, DOI 10.1037/a0014904; Shiota MN, 2011, EMOTION, V11, P1368, DOI 10.1037/a0024278; Shogakukan, 2000, NIH KOK DAIJ; Soderstrom M, 2007, DEV REV, V27, P501, DOI 10.1016/j.dr.2007.06.002; Sprengelmeyer R, 2009, PSYCHOL SCI, V20, P149, DOI 10.1111/j.1467-9280.2009.02272.x; Wells DL, 2005, STRESS HEALTH, V21, P209, DOI 10.1002/smi.1057; Weppelman TL, 2003, LANG COMMUN, V23, P63, DOI 10.1016/S0271-5309(01)00023-4	41	114	118	11	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46362	10.1371/journal.pone.0046362	http://dx.doi.org/10.1371/journal.pone.0046362			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23050022	gold, Green Published			2022-12-27	WOS:000309517300112
J	Vanderkelen, L; Ons, E; Van Herreweghe, JM; Callewaert, L; Goddeeris, BM; Michiels, CW				Vanderkelen, Lise; Ons, Ellen; Van Herreweghe, Joris M.; Callewaert, Lien; Goddeeris, Bruno M.; Michiels, Chris W.			Role of Lysozyme Inhibitors in the Virulence of Avian Pathogenic Escherichia coli	PLOS ONE			English	Article							GOOSE-TYPE LYSOZYME; CHROMOSOMAL GENES; CHICKEN; AUTOTRANSPORTER; IDENTIFICATION; EXPRESSION; RESISTANCE; SURVIVAL; SEQUENCE; ADHESIN	Lysozymes are key effectors of the animal innate immunity system that kill bacteria by hydrolyzing peptidoglycan, their major cell wall constituent. Recently, specific inhibitors of the three major lysozyme families occuring in the animal kingdom (c-, g- and i-type) have been discovered in Gram-negative bacteria, and it has been proposed that these may help bacteria to evade lysozyme mediated lysis during interaction with an animal host. Escherichia coli produces two inhibitors that are specific for c-type lysozyme (Ivy, Inhibitor of vertebrate lysozyme; MliC, membrane bound lysozyme inhibitor of c-type lysozyme), and one specific for g-type lysozyme (PliG, periplasmic lysozyme inhibitor of g-type lysozyme). Here, we investigated the role of these lysozyme inhibitors in virulence of Avian Pathogenic E. coli (APEC) using a serum resistance test and a subcutaneous chicken infection model. Knock-out of mliC caused a strong reduction in serum resistance and in in vivo virulence that could be fully restored by genetic complementation, whereas ivy and pliG could be knocked out without effect on serum resistance and virulence. This is the first in vivo evidence for the involvement of lysozyme inhibitors in bacterial virulence. Remarkably, the virulence of a ivy mliC double knock-out strain was restored to almost wild-type level, and this strain also had a substantial residual periplasmic lysozyme inhibitory activity that was higher than that of the single knock-out strains. This suggests the existence of an additional periplasmic lysozyme inhibitor in this strain, and indicates a regulatory interaction in the expression of the different inhibitors.	[Vanderkelen, Lise; Van Herreweghe, Joris M.; Callewaert, Lien; Michiels, Chris W.] Katholieke Univ Leuven, Food Microbiol Lab, Louvain, Belgium; [Vanderkelen, Lise; Van Herreweghe, Joris M.; Callewaert, Lien; Michiels, Chris W.] Katholieke Univ Leuven, Leuven Food Sci & Nutr Res Ctr LFoRCe, Louvain, Belgium; [Ons, Ellen; Goddeeris, Bruno M.] Katholieke Univ Leuven, Lab Vaccine Design, Louvain, Belgium	KU Leuven; KU Leuven; KU Leuven	Michiels, CW (corresponding author), Katholieke Univ Leuven, Food Microbiol Lab, Louvain, Belgium.	Chris.Michiels@biw.kuleuven.be	Goddeeris, Bruno Maria/L-2440-2015; Michiels, Chris/I-6847-2013	Goddeeris, Bruno Maria/0000-0003-3729-7592; Michiels, Chris/0000-0002-7710-6802	Research Foundation Flanders (FWO-Vlaanderen) [G.0363.08]; Flemish Institute for the Promotion of Scientific Technological Research (IWT); KU Leuven Research Fund [METH/07/03]	Research Foundation Flanders (FWO-Vlaanderen)(FWO); Flemish Institute for the Promotion of Scientific Technological Research (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven Research Fund(KU Leuven)	This work was financially supported by the Research Foundation Flanders (FWO-Vlaanderen research project G.0363.08, postdoc fellowship to L. C. and PhD fellowship to J.V.H.) (www.fwo.be), the Flemish Institute for the Promotion of Scientific Technological Research (IWT; www.iwt.be) (doctoral fellowship to L. V.) and by the KU Leuven Research Fund (research project METH/07/03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Callewaert L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000019; Caza M, 2008, INFECT IMMUN, V76, P3539, DOI 10.1128/IAI.00455-08; Dai JJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-236; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Pace F, 2011, MICROBIOL-SGM, V157, P2954, DOI 10.1099/mic.0.050005-0; Deckers D, 2004, CELL MOL LIFE SCI, V61, P1229, DOI 10.1007/s00018-004-4066-3; Deckers D, 2008, APPL ENVIRON MICROB, V74, P4434, DOI 10.1128/AEM.00589-08; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Dho-Moulin M, 1999, VET RES, V30, P299; Dziva F, 2008, AVIAN PATHOL, V37, P355, DOI 10.1080/03079450802216652; Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856; IKE K, 1992, J VET MED SCI, V54, P1091, DOI 10.1292/jvms.54.1091; Kyomuhendo P, 2007, CELL MOL LIFE SCI, V64, P2841, DOI 10.1007/s00018-007-7372-8; Li GW, 2010, INFECT IMMUN, V78, P898, DOI 10.1128/IAI.00513-09; Mellata M, 2003, INFECT IMMUN, V71, P494, DOI 10.1128/IAI.71.1.494-503.2003; Monchois V, 2001, J BIOL CHEM, V276, P18437, DOI 10.1074/jbc.M010297200; Myers FA, 2006, NUCLEIC ACIDS RES, V34, P4025, DOI 10.1093/nar/gkl543; NAKANO T, 1991, BIOCHIM BIOPHYS ACTA, V1090, P273, DOI 10.1016/0167-4781(91)90118-6; Nile CJ, 2004, CELL MOL LIFE SCI, V61, P2760, DOI 10.1007/s00018-004-4345-z; Painbeni E, 1997, P NATL ACAD SCI USA, V94, P6712, DOI 10.1073/pnas.94.13.6712; REED L. J., 1938, AMER JOUR HYG, V27, P493; STONE BJ, 1995, MOL MICROBIOL, V17, P701, DOI 10.1111/j.1365-2958.1995.mmi_17040701.x; TAYLOR PW, 1983, MICROBIOL REV, V47, P46, DOI 10.1128/MMBR.47.1.46-83.1983; Van Herreweghe JM, 2010, CELL MOL LIFE SCI, V67, P1177, DOI 10.1007/s00018-009-0241-x; van Houdt R, 2006, FEMS MICROBIOL LETT, V262, P201, DOI 10.1111/j.1574-6968.2006.00391.x; Vandemaele F, 2005, AVIAN PATHOL, V34, P264, DOI 10.1080/03079450500112682; Vandemaele F, 2003, VET RES, V34, P153, DOI 10.1051/vetres:2002062; VANDENBOSCH JF, 1993, INFECT IMMUN, V61, P800, DOI 10.1128/IAI.61.3.800-806.1993; Vanderkelen L, 2011, CELL MOL LIFE SCI, V68, P1053, DOI 10.1007/s00018-010-0507-3; Vanderkelen L, 2011, APPL ENVIRON MICROB, V77, P4697, DOI 10.1128/AEM.00427-11; Voet A, 2011, BIOCHEM BIOPH RES CO, V405, P527, DOI 10.1016/j.bbrc.2011.01.053; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406	32	16	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45954	10.1371/journal.pone.0045954	http://dx.doi.org/10.1371/journal.pone.0045954			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049900	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300066
J	Yadav, DK; Pospisil, P				Yadav, Deepak Kumar; Pospisil, Pavel			Evidence on the Formation of Singlet Oxygen in the Donor Side Photoinhibition of Photosystem II: EPR Spin-Trapping Study	PLOS ONE			English	Article							MOLECULAR-OXYGEN; MANGANESE COMPLEX; QUALITY-CONTROL; CHARGE RECOMBINATION; ACID HYDROPEROXIDE; ELECTRON-TRANSPORT; IN-VIVO; PROTEIN; LIGHT; LIPIDS	When photosystem II (PSII) is exposed to excess light, singlet oxygen (O-1(2)) formed by the interaction of molecular oxygen with triplet chlorophyll. Triplet chlorophyll is formed by the charge recombination of triplet radical pair (3)[P680(center dot+)Pheo(center dot 2)] in the acceptor-side photoinhibition of PSII. Here, we provide evidence on the formation of O-1(2) in the donor side photoinhibition of PSII. Light- induced O-1(2) production in Tris-treated PSII membranes was studied by electron paramagnetic resonance (EPR) spin-trapping spectroscopy, as monitored by TEMPONE EPR signal. Light-induced formation of carbon-centered radicals (R-center dot) was observed by POBN-R adduct EPR signal. Increased oxidation of organic molecules at high pH enhanced the formation of TEMPONE and POBN-R adduct EPR signals in Tris-treated PSII membranes. Interestingly, the scavenging of R-center dot by propyl gallate significantly suppressed O-1(2). Based on our results, it is concluded that O-1(2) formation correlates with R-center dot formation on the donor side of PSII due to oxidation of organic molecules (lipids and proteins) by long-lived P680(center dot+)/TyrZ(center dot). It is proposed here that the Russell mechanism for the recombination of two peroxyl radicals formed by the interaction of R-center dot with molecular oxygen is a plausible mechanism for O-1(2) formation in the donor side photoinhibition of PSII.	[Yadav, Deepak Kumar; Pospisil, Pavel] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc	Pospisil, P (corresponding author), Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, Dept Biophys, CR-77147 Olomouc, Czech Republic.	pospip@prfnw.upol.cz	POSPÍŠIL, Pavel/AAH-4451-2019	POSPÍŠIL, Pavel/0000-0001-9126-2011; Yadav, Deepak Kumar/0000-0002-4555-3851	Centre of the Region Hana for Biotechnological and Agricultural Research [ED0007/01/01]; Operational Programme Education for Competitiveness from the Ministry of Education Youth and Sports, Czech Republic [CZ.1.07/2.3.00/20.0057]	Centre of the Region Hana for Biotechnological and Agricultural Research; Operational Programme Education for Competitiveness from the Ministry of Education Youth and Sports, Czech Republic	This work was supported by the grants no. ED0007/01/01 Centre of the Region Hana for Biotechnological and Agricultural Research and no. CZ.1.07/2.3.00/20.0057 Operational Programme Education for Competitiveness from the Ministry of Education Youth and Sports, Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allakhverdiev SI, 2010, P NATL ACAD SCI USA, V107, P3924, DOI 10.1073/pnas.0913460107; Anderson JM, 2002, PHILOS T R SOC B, V357, P1421, DOI 10.1098/rstb.2002.1138; Anderson JM, 1998, PHOTOSYNTH RES, V56, P1, DOI 10.1023/A:1005946808488; Angelin M, 2006, EUR J ORG CHEM, V2006, P4323, DOI 10.1002/ejoc.200600288; Arato A, 2004, BBA-BIOENERGETICS, V1608, P171, DOI 10.1016/j.bbabio.2003.12.003; ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Brudvig GW, 2008, PHILOS T R SOC B, V363, P1211, DOI 10.1098/rstb.2007.2217; Cardona T, 2012, BBA-BIOENERGETICS, V1817, P26, DOI 10.1016/j.bbabio.2011.07.012; Chow WS, 2005, ADV PHOTO RESPIRAT, V22, P627; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dean RT, 1997, BIOCHEM J, V324, P1; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fischer BB, 2007, FEBS LETT, V581, P5555, DOI 10.1016/j.febslet.2007.11.003; FORD RC, 1983, FEBS LETT, V160, P159, DOI 10.1016/0014-5793(83)80957-0; Grundmeier A, 2012, BBA-BIOENERGETICS, V1817, P88, DOI 10.1016/j.bbabio.2011.07.004; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Hakala M, 2005, BBA-BIOENERGETICS, V1706, P68, DOI 10.1016/j.bbabio.2004.09.001; HIDEG E, 1994, BBA-BIOENERGETICS, V1186, P143, DOI 10.1016/0005-2728(94)90173-2; HOWARD JA, 1968, J AM CHEM SOC, V90, P1056, DOI 10.1021/ja01006a037; Imre V, 2011, PHYSIOL PLANTARUM, V142, P6, DOI 10.1111/j.1399-3054.2011.01454.x; Ishikita H, 2005, BIOCHEMISTRY-US, V44, P4118, DOI 10.1021/bi047922p; Ivanov B, 2003, ANTIOXID REDOX SIGN, V5, P43, DOI 10.1089/152308603321223531; Kato Y, 2009, J BIOCHEM, V146, P463, DOI 10.1093/jb/mvp073; Kern J, 2011, J PHOTOCH PHOTOBIO B, V104, P19, DOI 10.1016/j.jphotobiol.2011.02.025; Khorobrykh SA, 2002, BIOCHEMISTRY-MOSCOW+, V67, P683, DOI 10.1023/A:1016154506817; Khorobrykh SA, 2011, BIOCHEMISTRY-US, V50, P10658, DOI 10.1021/bi200945v; Krieger A, 1998, BIOCHEMISTRY-US, V37, P16262, DOI 10.1021/bi981243v; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; MACPHERSON AN, 1993, BIOCHIM BIOPHYS ACTA, V1143, P301, DOI 10.1016/0005-2728(93)90201-P; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; MENDENHALL GD, 1991, J AM CHEM SOC, V113, P8976, DOI 10.1021/ja00023a073; Miyamoto S, 2003, J AM CHEM SOC, V125, P6172, DOI 10.1021/ja029115o; Miyamoto S, 2007, IUBMB LIFE, V59, P322, DOI 10.1080/15216540701242508; Mizusawa N, 2012, BBA-BIOENERGETICS, V1817, P194, DOI 10.1016/j.bbabio.2011.04.008; MOAN J, 1979, NATURE, V279, P450, DOI 10.1038/279450a0; Murata N, 2007, BBA-BIOENERGETICS, V1767, P414, DOI 10.1016/j.bbabio.2006.11.019; NIU QJ, 1992, J AM CHEM SOC, V114, P165, DOI 10.1021/ja00027a024; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; NORTH JA, 1992, J BIOL CHEM, V267, P5743; Ohira S, 2005, PHOTOSYNTH RES, V84, P29, DOI 10.1007/s11120-004-7310-7; Pospisil P, 2004, BIOCHEMISTRY-US, V43, P6783, DOI 10.1021/bi036219i; Pospisil P, 2006, BIOCHEM J, V397, P321, DOI 10.1042/BJ20060068; Pospisil P, 2012, BBA-BIOENERGETICS, V1817, P218, DOI 10.1016/j.bbabio.2011.05.017; Pospisil P, 2009, BBA-BIOENERGETICS, V1787, P1151, DOI 10.1016/j.bbabio.2009.05.005; Rappaport F, 2002, BIOCHEMISTRY-US, V41, P8518, DOI 10.1021/bi025725p; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; Renger G, 2005, ADV PHOTO RESPIRAT, V22, P139; Rinalducci S, 2004, BBA-BIOENERGETICS, V1608, P63, DOI 10.1016/j.bbabio.2003.10.009; RUSSELL GA, 1957, J AM CHEM SOC, V79, P3871, DOI 10.1021/ja01571a068; Rutherford AW, 2004, SCIENCE, V303, P1782, DOI 10.1126/science.1096767; Santabarbara S, 2002, PHOTOCHEM PHOTOBIOL, V75, P613, DOI 10.1562/0031-8655(2002)075<0613:PIVAIV>2.0.CO;2; Santabarbara S, 2001, FEBS LETT, V491, P109, DOI 10.1016/S0014-5793(01)02174-3; Sinha RK, 2012, PLANT CELL ENVIRON, V35, P806, DOI 10.1111/j.1365-3040.2011.02454.x; Stolze K, 2005, BIOCHEM PHARMACOL, V69, P297, DOI 10.1016/j.bcp.2004.09.021; Sun SN, 2007, BIOCHEMISTRY-US, V46, P6668, DOI 10.1021/bi700178u; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Takahashi S, 2011, TRENDS PLANT SCI, V16, P53, DOI 10.1016/j.tplants.2010.10.001; Telfer A, 2005, PHOTOCH PHOTOBIO SCI, V4, P950, DOI 10.1039/b507888c; TELFER A, 1994, J BIOL CHEM, V269, P13244; Tyystjarvi E, 2008, COORDIN CHEM REV, V252, P361, DOI 10.1016/j.ccr.2007.08.021; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VANMIEGHEM F, 1995, BIOCHEMISTRY-US, V34, P4798, DOI 10.1021/bi00014a038; VASS I, 1992, P NATL ACAD SCI USA, V89, P1408, DOI 10.1073/pnas.89.4.1408; Vass I, 2007, COMPR SER PHOTOCH, V8, P393; Vass I, 2012, BBA-BIOENERGETICS, V1817, P209, DOI 10.1016/j.bbabio.2011.04.014; Yadav DK, 2010, BBA-BIOENERGETICS, V1797, P1807, DOI 10.1016/j.bbabio.2010.07.003; Yamamoto Y, 2001, PLANT CELL PHYSIOL, V42, P121, DOI 10.1093/pcp/pce022; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4; Yanykin DV, 2010, BBA-BIOENERGETICS, V1797, P516, DOI 10.1016/j.bbabio.2010.01.014; Zein S, 2008, PHILOS T R SOC B, V363, P1167, DOI 10.1098/rstb.2007.2212; Zolla L, 2002, BIOCHEMISTRY-US, V41, P14391, DOI 10.1021/bi0265776	73	31	31	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45883	10.1371/journal.pone.0045883	http://dx.doi.org/10.1371/journal.pone.0045883			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049883	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300059
J	Bhardwaj, R; O'Shea, RP				Bhardwaj, Rishi; O'Shea, Robert P.			Temporal Analysis of Image-Rivalry Suppression	PLOS ONE			English	Article							BINOCULAR-RIVALRY; VISUAL CONSCIOUSNESS; SPATIAL-FREQUENCY; LUMINANCE; FUSION; MOTION; COLOR; DEPTH; TIME	During binocular rivalry, perception alternates between two different images presented one to each eye. At any moment, one image is visible, dominant, while the other is invisible, suppressed. Alternations in perception during rivalry could involve competition between eyes, eye-rivalry, or between images, image-rivalry, or both. We measured response criteria, sensitivities, and thresholds to brief contrast increments to one of the rival stimuli in conventional rivalry displays and in a display in which the rival stimuli swapped between the eyes every 333 ms-swap rivalry-that necessarily involves image rivalry. We compared the sensitivity and threshold measures in dominance and suppression to assess the strength of suppression. We found that response criteria are essentially the same during dominance and suppression for the two sorts of rivalry. Critically, we found that swap-rivalry suppression is weak after a swap and strengthens throughout the swap interval. We propose that image rivalry is responsible for weak initial suppression immediately after a swap and that eye rivalry is responsible for the stronger suppression that comes later.	[Bhardwaj, Rishi; O'Shea, Robert P.] Univ Otago, Dept Psychol, Dunedin, New Zealand; [Bhardwaj, Rishi] Univ Durham, Dept Psychol, Durham DH1 3LE, England; [Bhardwaj, Rishi] Nethradhama Sch Optometry, Bangalore, Karnataka, India; [O'Shea, Robert P.] So Cross Univ, Sch Hlth & Human Sci, Discipline Psychol, Coffs Harbour, Australia	University of Otago; Durham University; Southern Cross University	Bhardwaj, R (corresponding author), Univ Otago, Dept Psychol, Dunedin, New Zealand.	dr.rishi.bhardwaj@gmail.com	O'Shea, Robert P./C-5723-2008; Bhardwaj, Rishi/AAQ-4074-2020	O'Shea, Robert P./0000-0003-3132-7199; Bhardwaj, Rishi/0000-0003-0932-6931				Alais D, 2000, PERCEPTION, V29, P1437, DOI 10.1068/p3017; Alais D, 2010, CURR BIOL, V20, P1362, DOI 10.1016/j.cub.2010.06.015; Baker DH, 2010, CURR BIOL, V20, pR644, DOI 10.1016/j.cub.2010.06.010; Bartels A, 2010, J VISION, V10, DOI 10.1167/10.12.3; Bhardwaj R, 2008, J VISION, V8, DOI 10.1167/8.11.2; BLAKE R, 1980, PERCEPTION, V9, P223, DOI 10.1068/p090223; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; BLAKE R, 1974, VISION RES, V14, P687, DOI 10.1016/0042-6989(74)90065-0; Blake R, 2008, SCHOLARPEDIA, V3, P1578, DOI DOI 10.4249/SCH0LARPEDIA.1578; Bonneh YS, 2001, NATURE, V411, P798, DOI 10.1038/35081073; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Caetta F, 2007, J VISION, V7, DOI 10.1167/7.7.4; CAMPBELL FW, 1972, J PHYSIOL-LONDON, V225, pP19; Crick F, 1996, NATURE, V379, P485, DOI 10.1038/379485a0; FOX R, 1968, J EXP PSYCHOL, V78, P388, DOI 10.1037/h0026440; FOX R, 1966, PERCEPT PSYCHOPHYS, V1, P331, DOI 10.3758/BF03215798; Green DM, 1966, SIGNAL DETECTION THE; Khoe W, 2008, J VISION, V8, DOI 10.1167/8.3.18; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; LEHKY SR, 1988, PERCEPTION, V17, P215, DOI 10.1068/p170215; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Macmillan N. A., 1991, DETECTION THEORY USE; Naber M, 2010, VISION RES, V50, P818, DOI 10.1016/j.visres.2010.02.004; Necker L.A, 1832, LONDON EDINBURGH PHI, V1, P329, DOI 10.1080/14786443208647909; Nguyen VA, 2001, PERCEPT PSYCHOPHYS, V63, P348, DOI 10.3758/BF03194475; Nguyen VA, 2003, VISION RES, V43, P2003, DOI 10.1016/S0042-6989(03)00314-6; O'Shea RP, 2009, VISION RES, V49, P671, DOI 10.1016/j.visres.2009.01.020; Ooi TL, 1999, PERCEPTION, V28, P551, DOI 10.1068/p2923; OOI TL, 1994, VISION RES, V34, P2997, DOI 10.1016/0042-6989(94)90272-0; OSHEA RP, 1984, PERCEPT PSYCHOPHYS, V36, P266, DOI 10.3758/BF03206368; OSHEA RP, 1981, PERCEPTION, V10, P283, DOI 10.1068/p100283; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; SHIMOJO S, 1990, VISION RES, V30, P69, DOI 10.1016/0042-6989(90)90128-8; SMITH EL, 1982, SCIENCE, V218, P802, DOI 10.1126/science.7134975; Stuit SM, 2009, J VISION, V9, DOI 10.1167/9.11.17; Suzuki S, 2002, NEURON, V36, P143, DOI 10.1016/S0896-6273(02)00934-0; TANNER TA, 1970, J MATH PSYCHOL, V7, P259, DOI 10.1016/0022-2496(70)90048-9; WALES R, 1970, PERCEPT PSYCHOPHYS, V8, P90, DOI 10.3758/BF03210180; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; WOLFE JM, 1983, PERCEPTION, V12, P447, DOI 10.1068/p120447; WOLFE JM, 1986, PSYCHOL REV, V93, P269, DOI 10.1037/0033-295X.93.3.269	45	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45407	10.1371/journal.pone.0045407	http://dx.doi.org/10.1371/journal.pone.0045407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049797	Green Published, Green Accepted, gold			2022-12-27	WOS:000309556100045
J	Donat, U; Weibel, S; Hess, M; Stritzker, J; Hartl, B; Sturm, JB; Chen, NG; Gentschev, I; Szalay, AA				Donat, Ulrike; Weibel, Stephanie; Hess, Michael; Stritzker, Jochen; Haertl, Barbara; Sturm, Julia B.; Chen, Nanhai G.; Gentschev, Ivaylo; Szalay, Aladar A.			Preferential Colonization of Metastases by Oncolytic Vaccinia Virus Strain GLV-1h68 in a Human PC-3 Prostate Cancer Model in Nude Mice	PLOS ONE			English	Article							BREAST-TUMORS; CARCINOMA; THERAPY; ANGIOGENESIS; SUPPRESSION; XENOGRAFTS; REGRESSION; INFECTION; SURVIVAL; CELLS	Recently, we showed that the oncolytic vaccinia virus GLV-1h68 has a significant therapeutic potential in treating lymph node metastases of human PC-3 prostate carcinoma in tumor xenografts. In this study, underlying mechanisms of the virus-mediated metastases reduction were analyzed. Immunohistochemistry demonstrated that virus-treatment resulted in a drastically decrease of blood and lymph vessels, representing essential routes for PC-3 cell migration, in both tumors and metastases. Thus, GLV-1h68 drastically reduced essential routes for the metastatic spread of PC-3 cells. Furthermore, analysis of viral distribution in GLV-1h68-injected tumor-bearing mice by plaque assays, revealed significantly higher virus titers in metastases compared to solid tumors. To elucidate conditions potentially mediating the preferential viral colonization and eradication of metastases, microenvironmental components of uninfected tumors and metastases were compared by microscopic studies. These analyses revealed that PC-3 lymph node metastases showed increased vascular permeability, higher proliferation status of tumor cells as determined by BrdU-and Ki-67 assays and lesser necrosis of PC-3 cells than solid tumors. Moreover, an increased number of immune cells (MHCII+/CD68(+) macrophages, MHCII+/CD19(+) B lymphocytes) combined with an up-regulated expression of pro-inflammatory cytokines was observed in metastases in comparison to primary PC-3 tumors. We propose that these microenvironmental components mediated the metastatic tropism of GLV-1h68. Therefore, vaccinia virus-based oncolytic virotherapy might offer a novel treatment of metastatic prostate carcinomas in humans.	[Donat, Ulrike; Weibel, Stephanie; Hess, Michael; Stritzker, Jochen; Haertl, Barbara; Sturm, Julia B.; Gentschev, Ivaylo; Szalay, Aladar A.] Univ Wurzburg, Inst Biochem, D-8700 Wurzburg, Germany; [Stritzker, Jochen; Chen, Nanhai G.; Gentschev, Ivaylo; Szalay, Aladar A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA; [Chen, Nanhai G.; Szalay, Aladar A.] Univ Calif San Diego, Dept Radiat Oncol, Rebecca & John Moores Comprehens Canc Ctr, San Diego, CA 92103 USA; [Haertl, Barbara; Szalay, Aladar A.] Genelux GmbH, Bernried, Germany; [Szalay, Aladar A.] Univ Wurzburg, Rudolph Virchow Ctr Expt Biomed, Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany	University of Wurzburg; University of California System; University of California San Diego; University of Wurzburg; University of Wurzburg	Szalay, AA (corresponding author), Univ Wurzburg, Inst Biochem, Rontgenring 11, D-8700 Wurzburg, Germany.	aaszalay@genelux.com	Gentschev, Ivaylo/AAJ-5819-2021		University of Wurzburg	University of Wurzburg	Drs. Jochen Stritzker, Nanhai G. Chen, Ivaylo Gentschev and Aladar A. Szalay are employees of Genelux Corporation and have financial interests in Genelux Corporation. Dr. Barbara Hartl is an employee of Genelux GmbH. Genelux Corporation also provided a Service Grant to the University of Wurzburg. Dr. Ulrike Donat and Dr. Stephanie Weibel are recipients of a postdoctoral fellowship. Dr. Julia Sturm and Mr. Michael Hess are recipients of a graduate fellowship from the University of Wurzburg. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript. There are no patents or products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	APPLE JS, 1985, RADIOLOGY, V154, P601, DOI 10.1148/radiology.154.3.2578678; Breitbach CJ, 2007, MOL THER, V15, P1686, DOI 10.1038/sj.mt.6300215; Burton JB, 2008, CANCER RES, V68, P7828, DOI 10.1158/0008-5472.CAN-08-1488; CAVAILLON JM, 1994, BIOMED PHARMACOTHER, V48, P445, DOI 10.1016/0753-3322(94)90005-1; Chen ZT, 2005, CANCER RES, V65, P9004, DOI 10.1158/0008-5472.CAN-05-0885; FIDLER IJ, 1990, CANCER RES, V50, P6130; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Frantz S, 2005, CIRC RES, V96, P15, DOI 10.1161/01.RES.0000153188.68898.ac; Gentschev I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/489759; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ivanov VN, 2011, J CELL BIOCHEM, V112, P463, DOI 10.1002/jcb.22934; Kirn DH, 2007, PLOS MED, V4, P2001, DOI 10.1371/journal.pmed.0040353; LEWENHAUPT A, 1990, BRIT J UROL, V66, P182, DOI 10.1111/j.1464-410X.1990.tb14900.x; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Parato KA, 2011, MOL THER; Roger W, 1973, GRAYS ANATOMY, P588; Sanchez-Puig JM, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-10; Shen YQ, 2005, MOL THER, V11, P180, DOI 10.1016/j.ymthe.2004.10.015; Skvortsova I, 2008, PROTEOMICS, V8, P4521, DOI 10.1002/pmic.200800113; Sleeman J, 2010, EUR J CANCER, V46, P1177, DOI 10.1016/j.ejca.2010.02.039; SUIT HD, 1992, INT J RADIAT ONCOL, V23, P653, DOI 10.1016/0360-3016(92)90025-D; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Vaha-Koskela MJV, 2007, CANCER LETT, V254, P178, DOI 10.1016/j.canlet.2007.02.002; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Weibel S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-68; Worschech A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-301; WYNDER EL, 1971, CANCER, V28, P344, DOI 10.1002/1097-0142(197108)28:2<344::AID-CNCR2820280214>3.0.CO;2-#; Yu YA, 2009, MOL CANCER THER, V8, P141, DOI 10.1158/1535-7163.MCT-08-0533; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146; Zhang Q, 2009, MOL GENET GENOMICS, V282, P417, DOI 10.1007/s00438-009-0475-1	31	21	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45942	10.1371/journal.pone.0045942	http://dx.doi.org/10.1371/journal.pone.0045942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049897	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100104
J	Higuchi, A; Inoue, H; Kawakita, T; Ogishima, T; Tsubota, K				Higuchi, Akihiro; Inoue, Hiroyoshi; Kawakita, Tetsuya; Ogishima, Tadashi; Tsubota, Kazuo			Selenium Compound Protects Corneal Epithelium against Oxidative Stress	PLOS ONE			English	Article							DRY EYE MODEL; SELENOPROTEIN-P; OCULAR SURFACE; LACTOFERRIN; DAMAGE; IDENTIFICATION; INFLAMMATION; ANDROGEN; AGENTS	The ocular surface is strongly affected by oxidative stress, and anti-oxidative systems are maintained in corneal epithelial cells and tear fluid. Dry eye is recognized as an oxidative stress-induced disease. Selenium compound eye drops are expected to be a candidate for the treatment of dry eye. We estimated the efficacy of several selenium compounds in the treatment of dry eye using a dry eye rat model. All of the studied selenium compounds were uptaken into corneal epithelial cells in vitro. However, when the selenium compounds were administered as eye drops in the dry eye rat model, most of the selenium compounds did not show effectiveness except for Se-lactoferrin. Se-lactoferrin is a lactoferrin that we prepared that binds selenium instead of iron. Se-lactoferrin eye drops suppressed the up-regulated expression of heme oxygenase-1, cyclooxygenase-2, matrix metallopeptidase-9, and interleukin-6 and also suppressed 8-OHdG production in the cornea induced by surgical removal of the lacrimal glands. Compared with Se-lactoferrin, apolactoferrin eye drops weakly improved dry eye in high dose. The effect of Se-lactoferrin eye drops on dry eye is possibly due to the effect of selenium and also the effect of apolactoferrin. Se-lactoferrin is a candidate for the treatment of dry eye via regulation of oxidative stress in the corneal epithelium.	[Higuchi, Akihiro] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo, Japan; [Higuchi, Akihiro; Kawakita, Tetsuya; Tsubota, Kazuo] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Inoue, Hiroyoshi] Keio Univ, Sch Med, Dept Chem, Tokyo, Kanagawa, Japan; [Ogishima, Tadashi] Kyushu Univ, Fac Sci, Dept Chem, Fukuoka 812, Japan	Keio University; Keio University; Keio University; Kyushu University	Higuchi, A (corresponding author), Keio Univ, Sch Med, Ctr Integrated Med Res, Shinanomachi Res Pk 6N9, Tokyo, Japan.	ahiguchi@z6.keio.jp		Kawakita, Tetsuya/0000-0002-8665-7518	Kowa Company, Ltd.	Kowa Company, Ltd.	This work was supported by grants from Kowa Company, Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur JR, 2000, CELL MOL LIFE SCI, V57, P1825; BAYFIELD RF, 1985, ANAL BIOCHEM, V144, P569, DOI 10.1016/0003-2697(85)90155-1; BURK RF, 1994, J NUTR, V124, P1891, DOI 10.1093/jn/124.10.1891; Dogru M, 2007, OPHTHALMOLOGY, V114, P2366, DOI 10.1016/j.ophtha.2007.06.027; Fujihara T, 1998, J OCUL PHARMACOL TH, V14, P99, DOI 10.1089/jop.1998.14.99; Fujihara T, 2001, INVEST OPHTH VIS SCI, V42, P96; Fujihara T, 2000, CORNEA, V19, P207, DOI 10.1097/00003226-200003000-00015; Higuchi A, 2011, FREE RADICAL BIO MED, V51, P2210, DOI 10.1016/j.freeradbiomed.2011.09.025; Higuchi A, 2011, MOL VIS, V17, P2400; Higuchi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009911; Inoue H, 2005, PCT/JP2005/024286, Patent No. 2005024286; Inoue H, 2005, JP4634809, Patent No. 4634809; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Li N, 2010, J OCUL PHARMACOL TH, V26, P431, DOI 10.1089/jop.2010.0019; Luo LH, 2004, INVEST OPHTH VIS SCI, V45, P4293, DOI 10.1167/iovs.03-1145; MASSON PL, 1966, CLIN CHIM ACTA, V14, P735, DOI 10.1016/0009-8981(66)90004-0; Modis L, 1998, GRAEF ARCH CLIN EXP, V236, P86, DOI 10.1007/s004170050047; MOTSENBOCKER MA, 1982, BIOCHIM BIOPHYS ACTA, V719, P147, DOI 10.1016/0304-4165(82)90318-X; Nakamura S, 2007, INVEST OPHTH VIS SCI, V48, P1552, DOI 10.1167/iovs.06-1027; Offord EA, 1999, INVEST OPHTH VIS SCI, V40, P1091; Rocha EM, 2000, BRIT J OPHTHALMOL, V84, P76, DOI 10.1136/bjo.84.1.76; Schweizer U, 2004, BIOCHEM J, V378, P21, DOI 10.1042/BJ20031795; Sharif NA, 1998, INVEST OPHTH VIS SCI, V39, P2562; Shimmura S, 1998, INVEST OPHTH VIS SCI, V39, P1346; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Suzuki T, 2001, CURR EYE RES, V22, P28, DOI 10.1076/ceyr.22.1.28.6980; Tsubota K, 2000, INT OPHTHALMOL CLIN, V40, P113, DOI 10.1097/00004397-200010000-00009; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wickham LA, 2000, ACTA OPHTHALMOL SCAN, V78, P146, DOI 10.1034/j.1600-0420.2000.078002146.x; ZUCLICH JA, 1976, INVEST OPHTH VISUAL, V15, P760	31	42	45	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45612	10.1371/journal.pone.0045612	http://dx.doi.org/10.1371/journal.pone.0045612			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049824	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100059
J	Koumanov, F; Pereira, VJ; Whitley, PR; Holman, GD				Koumanov, Francoise; Pereira, Vinit J.; Whitley, Paul R.; Holman, Geoffrey D.			GLUT4 Traffic through an ESCRT-III-Dependent Sorting Compartment in Adipocytes	PLOS ONE			English	Article							SENSITIVE GLUCOSE-TRANSPORTER; HEAVY-CHAIN ISOFORM; RAT ADIPOSE-CELLS; STRUCTURAL BASIS; INSULIN; PROTEIN; UBIQUITIN; INTERACTS; MEMBRANE; AMSH	In insulin target tissues, GLUT4 is known to traffic through multiple compartments that may involve ubiquitin- and/or SUMO-dependent targeting. During these trafficking steps, GLUT4 is sorted into a storage reservoir compartment that is acutely released by insulin signalling processes that are downstream of PI 3-kinase associated changes in inositol phospholipids. As ESCRT components have recently been found to influence cellular sorting processes that are related to changes in both ubiquitination and inositol phospholipids, we have examined whether GLUT4 traffic is routed through ESCRT dependent sorting steps. Introduction of the dominant negative inhibitory constructs of the ESCRT-III components CHMP3 (CHMP3(1-179)) and Vps4 (GFP-Vps4(E235Q)) into rat adipocytes leads to the accumulation of GLUT4 in large, coalesced and extended vesicles structures that co-localise with the inhibitory constructs over large parts of the extended structure. A new swollen hybrid and extensively ubiquitinated compartment is produced in which GLUT4 co-localises more extensively with the endosomal markers including EEA1 and transferrin receptors but also with the TGN marker syntaxin6. These perturbations are associated with failure of insulin action on GLUT4 traffic to the cell surface and suggest impairment in an ESCRT-dependent sorting step used for GLUT4 traffic to its specialised reservoir compartment.	[Koumanov, Francoise; Pereira, Vinit J.; Whitley, Paul R.; Holman, Geoffrey D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Koumanov, F (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	f.koumanov@bath.ac.uk	Koumanov, Francoise/AAV-7654-2020	Koumanov, Francoise/0000-0002-9029-3390; Holman, Geoffrey/0000-0001-7045-1358	Wellcome Trust [081168/Z/06/Z]; Diabetes UK [08/0003788]; MRC [MR/J003417/1, G9225018, G0300415] Funding Source: UKRI; British Heart Foundation [PG/11/52/28989] Funding Source: researchfish; Medical Research Council [MR/J003417/1, G9225018, G0300415] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by Wellcome Trust (081168/Z/06/Z) and Diabetes UK (08/0003788). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Al-Hasani H, 1998, J BIOL CHEM, V273, P17504, DOI 10.1074/jbc.273.28.17504; Bache KG, 2006, MOL BIOL CELL, V17, P2513, DOI 10.1091/mbc.E05-10-0915; Baldys A, 2009, BIOCHEMISTRY-US, V48, P9321, DOI 10.1021/bi900865u; Berlin I, 2010, J BIOL CHEM, V285, P37895, DOI 10.1074/jbc.M110.129411; Berwick DC, 2004, J CELL SCI, V117, P5985, DOI 10.1242/jcs.01517; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bogan JS, 2003, NATURE, V425, P727, DOI 10.1038/nature01989; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Dukes JD, 2008, BIOCHEM J, V411, P233, DOI 10.1042/BJ20071296; Dukes JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028659; Esk C, 2010, J CELL BIOL, V188, P131, DOI 10.1083/jcb.200908057; Foley K, 2011, BIOCHEMISTRY-US, V50, P3048, DOI 10.1021/bi2000356; Giorgino F, 2000, P NATL ACAD SCI USA, V97, P1125, DOI 10.1073/pnas.97.3.1125; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2002, ENDOCRINOLOGY, V143, P4742, DOI 10.1210/en.2002-220615; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Karylowski O, 2004, MOL BIOL CELL, V15, P870, DOI 10.1091/mbc.E03-07-0517; Kato M, 2000, J BIOL CHEM, V275, P37481, DOI 10.1074/jbc.M007251200; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lalioti VS, 2009, J CELL PHYSIOL, V218, P416, DOI 10.1002/jcp.21614; Lalioti VS, 2002, J BIOL CHEM, V277, P19783, DOI 10.1074/jbc.M110294200; Lamb CA, 2010, TRAFFIC, V11, P1445, DOI 10.1111/j.1600-0854.2010.01113.x; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lee JA, 2009, AUTOPHAGY, V5, P1070, DOI 10.4161/auto.5.7.9823; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Ma YM, 2007, J BIOL CHEM, V282, P9805, DOI 10.1074/jbc.M611635200; Malide D, 1997, J HISTOCHEM CYTOCHEM, V45, P1083, DOI 10.1177/002215549704500806; Malide D, 2000, J CELL SCI, V113, P4203; Martin S, 1996, J CELL BIOL, V134, P625, DOI 10.1083/jcb.134.3.625; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Peel S, 2011, TRENDS BIOCHEM SCI, V36, P199, DOI 10.1016/j.tibs.2010.09.004; Pryor PR, 2000, BIOCHEM J, V348, P83, DOI 10.1042/0264-6021:3480083; Reid RJD, 2011, GENOME RES, V21, P477, DOI 10.1101/gr.109033.110; Risinger AL, 2008, MOL BIOL CELL, V19, P2962, DOI 10.1091/mbc.E07-06-0627; Row PE, 2007, J BIOL CHEM, V282, P30929, DOI 10.1074/jbc.M704009200; Rubio-Texeira M, 2006, MOL BIOL CELL, V17, P3031, DOI 10.1091/mbc.E05-07-0669; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Sandoval IV, 2000, J BIOL CHEM, V275, P39874, DOI 10.1074/jbc.M006261200; SARGEANT RJ, 1993, BIOCHEM J, V290, P913, DOI 10.1042/bj2900913; SATOH S, 1993, J BIOL CHEM, V268, P17820; Sbrissa D, 2012, AM J PHYSL CELL PHYS; Shields SB, 2011, TRAFFIC, V12, P1306, DOI 10.1111/j.1600-0854.2011.01242.x; Shields SB, 2009, J CELL BIOL, V185, P213, DOI 10.1083/jcb.200811130; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Shpetner H, 1996, J CELL BIOL, V132, P595, DOI 10.1083/jcb.132.4.595; Sierra MI, 2010, J BIOL CHEM, V285, P13990, DOI 10.1074/jbc.M109.061309; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; Stringer DK, 2011, J CELL BIOL, V192, P229, DOI 10.1083/jcb.201008121; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; TAYLOR LP, 1981, BIOCHIM BIOPHYS ACTA, V642, P325, DOI 10.1016/0005-2736(81)90449-1; Vassilopoulos S, 2009, SCIENCE, V324, P1192, DOI 10.1126/science.1171529; Whitley P, 2003, J BIOL CHEM, V278, P38786, DOI 10.1074/jbc.M306864200; Woodman PG, 2008, CURR OPIN CELL BIOL, V20, P408, DOI 10.1016/j.ceb.2008.04.001; Wright MH, 2011, CELL BIOCHEM BIOPHYS, V60, P39, DOI 10.1007/s12013-011-9181-9; Xu YK, 2011, J CELL BIOL, V193, P643, DOI 10.1083/jcb.201008135; Yu CF, 2007, J BIOL CHEM, V282, P7710, DOI 10.1074/jbc.M610824200; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	62	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e44141	10.1371/journal.pone.0044141	http://dx.doi.org/10.1371/journal.pone.0044141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049745	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100012
J	Kunte, DP; DelaCruz, M; Wali, RK; Menon, A; Du, HY; Stypula, Y; Patel, A; Backman, V; Roy, HK				Kunte, Dhananjay P.; DelaCruz, Mart; Wali, Ramesh K.; Menon, Ashwaty; Du, Hongyan; Stypula, Yolanda; Patel, Amir; Backman, Vadim; Roy, Hemant K.			Dysregulation of MicroRNAs in Colonic Field Carcinogenesis: Implications for Screening	PLOS ONE			English	Article							CPG ISLAND METHYLATION; COLORECTAL-CANCER; PLASMA MICRORNAS; EARLY EVENT; GENE; EXPRESSION; BIOMARKERS; HYPERMETHYLATION; SIGNATURES; NEOPLASIA	Colorectal cancer (CRC) screening tests often have a trade-off between efficacy and patient acceptability/cost. Fecal tests (occult blood, methylation) engender excellent patient compliance but lack requisite performance underscoring the need for better population screening tests. We assessed the utility of microRNAs (miRNAs) as markers of field carcinogenesis and their potential role for CRC screening using the azoxymethane (AOM)-treated rat model. We found that 63 miRNAs were upregulated and miR-122, miR-296-5p and miR-503# were downregulated in the uninvolved colonic mucosa of AOM rats. We monitored the expression of selected miRNAs in colonic biopsies of AOM rats at 16 weeks and correlated it with tumor development. We noted that the tumor bearing rats had significantly greater miRNA modulation compared to those without tumors. The miRNAs showed good diagnostic performance with an area under the receiver operator curve (AUROC) of >0.7. We also noted that the miRNA induction in the colonic mucosa was mirrorred in the mucus layer fecal colonocytes isolated from AOM rat stool and the degree of miRNA induction was greater in the tumor bearing rats compared to those without tumors. Lastly, we also noted significant miRNA modulation in the Pirc rats- the genetic model of colon carcinogenesis, both in the uninvolved colonic mucosa and the fecal colonocytes. We thus demonstrate that miRNAs are excellent markers of field carcinogenesis and could accurately predict future neoplasia. Based on our results, we propose an accurate, inexpensive, non-invasive miRNA test for CRC risk stratification based on rectal brushings or from abraded fecal colonocytes.	[Kunte, Dhananjay P.; DelaCruz, Mart; Wali, Ramesh K.; Menon, Ashwaty; Du, Hongyan; Patel, Amir; Roy, Hemant K.] NorthShore Univ HealthSyst, Dept Med, Evanston, IL USA; [Stypula, Yolanda; Backman, Vadim] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA	NorthShore University Health System; Northwestern University	Roy, HK (corresponding author), NorthShore Univ HealthSyst, Dept Med, Evanston, IL USA.	h-roy@northwestern.edu	Roy, Hemant/AAC-9096-2020; Backman, Vadim/B-6689-2009		National Institutes of Health [U01CA111257, R01CA156186, R42CA130508, R21CA141112, R21CA140936, R01CA128641]; NATIONAL CANCER INSTITUTE [R01CA156186, R21CA141112, R01CA128641, U01CA111257, R21CA140936, R42CA130508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health U01CA111257, R01CA156186, R42CA130508, R21CA141112, R21CA140936, R01CA128641. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist DA, 2008, ANN INTERN MED, V149, P441, DOI 10.7326/0003-4819-149-7-200810070-00004; Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Bariol C, 2003, AM J PATHOL, V162, P1361, DOI 10.1016/S0002-9440(10)63932-6; Chan AOO, 2002, AM J PATHOL, V160, P1823, DOI 10.1016/S0002-9440(10)61128-5; Chen LC, 2004, CANCER RES, V64, P3694, DOI 10.1158/0008-5472.CAN-03-3264; Davidson LA, 2009, CARCINOGENESIS, V30, P2077, DOI 10.1093/carcin/bgp245; Derks S, 2009, CARCINOGENESIS, V30, P1041, DOI 10.1093/carcin/bgp073; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Grady WM, 2008, ONCOGENE, V27, P3880, DOI 10.1038/onc.2008.10; Grady WM, 2010, GUT, V59, P706, DOI 10.1136/gut.2009.200022; Heavey PM, 2004, NUTR CANCER, V48, P124, DOI 10.1207/s15327914nc4802_2; Hesson LB, 2005, ONCOGENE, V24, P3987, DOI 10.1038/sj.onc.1208566; Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Keku TO, 2008, CANCER EPIDEM BIOMAR, V17, P306, DOI 10.1158/1055-9965.EPI-07-0066; Koga Y, 2010, CANCER PREV RES, V3, P1435, DOI 10.1158/1940-6207.CAPR-10-0036; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Narayan Satya, 2003, Mol Cancer, V2, P41, DOI 10.1186/1476-4598-2-41; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Samowitz WS, 2008, GENE CHROMOSOME CANC, V47, P835, DOI 10.1002/gcc.20584; Schee K, 2010, AM J PATHOL, V177, P1592, DOI 10.2353/ajpath.2010.100024; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schetter AJ, 2009, GUT, V58, P1318, DOI 10.1136/gut.2009.176875; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102; Tsuchiya N, 2007, CANCER RES, V67, P9568, DOI 10.1158/0008-5472.CAN-06-2707; Valeri N, 2010, P NATL ACAD SCI USA, V107, P6982, DOI 10.1073/pnas.1002472107; White V, 2009, CANCER EPIDEM BIOMAR, V18, P2006, DOI 10.1158/1055-9965.EPI-08-1145; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b	32	28	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45591	10.1371/journal.pone.0045591	http://dx.doi.org/10.1371/journal.pone.0045591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049818	Green Submitted, gold, Green Published			2022-12-27	WOS:000309556100057
J	Park, HY; Noh, EH; Chung, HM; Kang, MJ; Kim, EY; Park, SP				Park, Hyo Young; Noh, Eun Hyung; Chung, Hyung-Min; Kang, Man-Jong; Kim, Eun Young; Park, Se Pill			Efficient Generation of Virus-Free iPS Cells Using Liposomal Magnetofection	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; MAGNETIC FORCE; SOMATIC-CELLS; GENE DELIVERY; IN-VITRO; FIBROBLASTS; INDUCTION; DIFFERENTIATION; EXPRESSION	The generation of induced pluripotent stem (iPS) cells is a powerful tool in regenerative medicine, and advances in nanotechnology clearly have great potential to enhance stem cell research. Here, we introduce a liposomal magnetofection (LMF) method for iPS cell generation. Efficient conditions for generating virus-free iPS cells from mouse embryonic fibroblast (MEF) cells were determined through the use of different concentrations of CombiMag nanoparticle-DNA(pCX-OKS-2A and pCX-cMyc)-lipoplexes and either one or two cycles of the LMF procedure. The cells were prepared in a short reprogramming time period (<= 8 days, 0.032-0.040%). Among the seven LMF-iPS cell lines examined, two were confirmed to be integration-free, and an integration-free LMF-iPS cell line was produced under the least toxic conditions (single LMF cycle with a half-dose of plasmid). This cell line also displayed in vitro/in vivo pluripotency, including teratoma formation and chimeric mouse production. In addition, the safety of CombiMag-DNA lipoplexes for the transfection of MEF cells was confirmed through lactate dehydrogenase activity assay and transmission electron microscopy. These results demonstrated that the LMF method is simple, effective, and safe. LMF may represent a superior technique for the generation of virus-free or integration-free iPS cell lines that could lead to enhanced stem cell therapy in the future.	[Park, Hyo Young; Noh, Eun Hyung; Kim, Eun Young; Park, Se Pill] Mirae Biotech, Miraebio Res Inst, Seoul, South Korea; [Park, Hyo Young; Noh, Eun Hyung; Kim, Eun Young; Park, Se Pill] Jeju Natl Univ, Stem Cell Res Ctr, Cheju, South Korea; [Chung, Hyung-Min] Pochon CHA Univ, CHA Stem Cell Inst, Seoul, South Korea; [Chung, Hyung-Min] Pochon CHA Univ, CHA Biotech, Seoul, South Korea; [Kang, Man-Jong] Chonnam Natl Univ, Coll Agr & Life Sci, Dept Anim Sci & Technol, Kwangju, South Korea; [Park, Se Pill] Jeju Natl Univ, Coll Appl Life Sci, Fac Biotechnol, Cheju, South Korea	Jeju National University; Pochon Cha University; Pochon Cha University; Chonnam National University; Jeju National University	Kim, EY (corresponding author), Mirae Biotech, Miraebio Res Inst, Seoul, South Korea.	jlokey@daum.net; sppark@jejunu.ac.kr			Bio-industry Technology Development Program [308008-5]; Ministry for Food, Agriculture, Forestry and Fisheries, Next-Generation BioGreen 21 Program [PJ009075]; Cooperative Research Program for Agriculture Science & Technology Development [PJ009103]; Rural Development Administration, Republic of Korea	Bio-industry Technology Development Program; Ministry for Food, Agriculture, Forestry and Fisheries, Next-Generation BioGreen 21 Program; Cooperative Research Program for Agriculture Science & Technology Development(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This study was supported by grants from the Bio-industry Technology Development Program (308008-5); the Ministry for Food, Agriculture, Forestry and Fisheries, Next-Generation BioGreen 21 Program (PJ009075); and the Cooperative Research Program for Agriculture Science & Technology Development (PJ009103), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Ferreira L, 2008, CELL STEM CELL, V3, P136, DOI 10.1016/j.stem.2008.07.020; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Huth S, 2004, J GENE MED, V6, P923, DOI 10.1002/jgm.577; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Krotz F, 2003, J VASC RES, V40, P425, DOI 10.1159/000073901; Lee TH, 2010, CIRC RES, V106, P120, DOI 10.1161/CIRCRESAHA.109.207902; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Plank C, 2003, BIOL CHEM, V384, P737, DOI 10.1515/BC.2003.082; Prijic S, 2010, J MEMBRANE BIOL, V236, P167, DOI 10.1007/s00232-010-9271-4; Scherer F, 2002, GENE THER, V9, P102, DOI 10.1038/sj.gt.3301624; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	30	3	7	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45812	10.1371/journal.pone.0045812	http://dx.doi.org/10.1371/journal.pone.0045812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049868	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100084
J	Kushawaha, PK; Gupta, R; Tripathi, CDP; Khare, P; Jaiswal, AK; Sundar, S; Dube, A				Kushawaha, Pramod K.; Gupta, Reema; Tripathi, Chandra Dev Pati; Khare, Prashant; Jaiswal, Anil Kumar; Sundar, Shyam; Dube, Anuradha			Leishmania donovani Triose Phosphate Isomerase: A Potential Vaccine Target against Visceral Leishmaniasis	PLOS ONE			English	Article							CONFERS PROTECTIVE IMMUNITY; INTERFERON-GAMMA PRODUCTION; INTEGRAL MEMBRANE-PROTEINS; NITRIC-OXIDE SYNTHASE; CELLULAR-RESPONSES; REACTIVE NITROGEN; INFECTED PATIENTS; DNA VACCINATION; IFN-GAMMA; T-CELLS	Visceral leishmaniasis (VL) is one of the most important parasitic diseases with approximately 350 million people at risk. Due to the non availability of an ideal drug, development of a safe, effective, and affordable vaccine could be a solution for control and prevention of this disease. In this study, a potential Th1 stimulatory protein-Triose phosphate isomerase (TPI), a glycolytic enzyme, identified through proteomics from a fraction of Leishmania donovani soluble antigen ranging from 89.9-97.1 kDa, was assessed for its potential as a suitable vaccine candidate. The protein-L. donovani TPI (LdTPI) was cloned, expressed and purified which exhibited the homology of 99% with L. infantum TPI. The rLdTPI was further evaluated for its immunogenicity by lymphoproliferative response (LTT), nitric oxide (NO) production and estimation of cytokines in cured Leishmania patients/hamster. It elicited strong LTT response in cured patients as well as NO production in cured hamsters and stimulated remarkable Th1-type cellular responses including IFN-(a) over bar and IL-12 with extremely lower level of IL-10 in Leishmania-infected cured/exposed patients PBMCs in vitro. Vaccination with LdTPI-DNA construct protected naive golden hamsters from virulent L. donovani challenge unambiguously (similar to 90%). The vaccinated hamsters demonstrated a surge in IFN-a, TNF-a and IL-12 levels but extreme down-regulation of IL-10 and IL-4 along with profound delayed type hypersensitivity and increased levels of Leishmania-specific IgG2 antibody. Thus, the results are suggestive of the protein having the potential of a strong candidate vaccine.	[Kushawaha, Pramod K.; Gupta, Reema; Tripathi, Chandra Dev Pati; Khare, Prashant; Jaiswal, Anil Kumar; Dube, Anuradha] Cent Drug Res Inst, Div Parasitol, Lucknow 226001, Uttar Pradesh, India; [Sundar, Shyam] Benaras Hindu Univ, Dept Med, Inst Med Sci, Varanasi, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Banaras Hindu University (BHU)	Dube, A (corresponding author), Cent Drug Res Inst, Div Parasitol, Lucknow 226001, Uttar Pradesh, India.	anuradha_dube@hotmail.com	Jaiswal, Anil Kumar/I-1369-2019; TRIPATHI, CHANDRA DEV/S-5617-2019; Khare, Prashant/O-8447-2017	Jaiswal, Anil Kumar/0000-0002-8169-0335; Khare, Prashant/0000-0001-5792-3082; Dube, Anuradha/0000-0002-5122-400X	Department of Biotechnology, New Delhi [BT/PR11782/MED/29/113/2009]; CSIR-CDRI's Supra-institutional network project [SIP-0026, 8321]	Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India); CSIR-CDRI's Supra-institutional network project	This work was supported by the Department of Biotechnology, New Delhi (BT/PR11782/MED/29/113/2009) and CSIR-CDRI's Supra-institutional network project (SIP-0026, 8321). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Afrin F, 2002, INFECT IMMUN, V70, P6697, DOI 10.1128/IAI.70.12.6697-6706.2002; Aguilar-Be I, 2005, INFECT IMMUN, V73, P812, DOI 10.1128/IAI.73.2.812-819.2005; Ali N, 1997, J PARASITOL, V83, P70, DOI 10.2307/3284319; Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Armijos RX, 2004, VACCINE, V22, P1320, DOI 10.1016/j.vaccine.2003.06.002; ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; Bacellar O, 1996, J INFECT DIS, V173, P1515, DOI 10.1093/infdis/173.6.1515; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Bhowmick S, 2007, VACCINE, V25, P6544, DOI 10.1016/j.vaccine.2007.05.042; Bhowmick S, 2008, INFECT IMMUN, V76, P1003, DOI 10.1128/IAI.00611-07; Caldas A, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-113; Chakravarty J, 2011, VACCINE, V29, P3531, DOI 10.1016/j.vaccine.2011.02.096; Coler RN, 2007, INFECT IMMUN; Das A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00099; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DING AH, 1988, J IMMUNOL, V141, P2407; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Dube A, 2005, PARASITOL RES, V96, P216, DOI 10.1007/s00436-005-1339-1; Evans KJ, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/892817; Garg R, 2006, VACCINE, V24, P2900, DOI 10.1016/j.vaccine.2005.12.053; Garg R, 2005, CLIN EXP IMMUNOL, V140, P149, DOI 10.1111/j.1365-2249.2005.02745.x; Garg R, 2005, VACCINE, V23, P1189, DOI 10.1016/j.vaccine.2004.06.054; GHOSE AC, 1980, CLIN EXP IMMUNOL, V40, P318; Ghosh A, 2001, VACCINE, V20, P59, DOI 10.1016/S0264-410X(01)00322-X; GomezPuyou A, 1995, CHEM BIOL, V2, P847, DOI 10.1016/1074-5521(95)90091-8; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; Hailu A, 2001, J INFECT DIS, V184, P112, DOI 10.1086/320994; Handman E, 2001, CLIN MICROBIOL REV, V14, P229, DOI 10.1128/CMR.14.2.229-243.2001; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; HOWARD JG, 1984, PHILOS T R SOC B, V307, P87, DOI 10.1098/rstb.1984.0111; Kubar J, 2005, LANCET INFECT DIS, V5, P107, DOI 10.1016/S1473-3099(05)70085-2; Kumari S, 2008, VACCINE, V26, P5700, DOI 10.1016/j.vaccine.2008.08.021; Kumari S, 2008, VACCINE, V26, P4813, DOI 10.1016/j.vaccine.2008.06.102; Kushawaha PK, 2011, J IMMUNOL, V187, P6417, DOI 10.4049/jimmunol.1102081; LIEW FY, 1990, IMMUNOLOGY, V71, P556; LIEW FY, 1990, J IMMUNOL, V145, P4306; LIEW FY, 1991, EUR J IMMUNOL, V21, P3009, DOI 10.1002/eji.1830211216; Liu LM, 2005, STEROIDS, V70, P604, DOI 10.1016/j.steroids.2005.02.020; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maecker B., 2001, Current Molecular Medicine (Hilversum), V1, P609, DOI 10.2174/1566524013363447; Melby PC, 1998, INFECT IMMUN, V66, P2135, DOI 10.1128/IAI.66.5.2135-2142.1998; Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001; Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912; Modabber F, 1995, ANN TROP MED PARASIT, V89, P83, DOI 10.1080/00034983.1995.11813017; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; MURRAY HW, 1983, ANN INTERN MED, V98, P1016, DOI 10.7326/0003-4819-98-6-1016; Nylen S, 2009, FUTURE MICROBIOL, V4, P241, DOI 10.2217/17460913.4.2.241; Peruhype-Magalhaes V, 2005, SCAND J IMMUNOL, V62, P487, DOI 10.1111/j.1365-3083.2005.01686.x; Rafati S, 2006, VACCINE, V24, P2169, DOI 10.1016/j.vaccine.2005.11.011; REINER SL, 1994, J EXP MED, V179, P447, DOI 10.1084/jem.179.2.447; Samant M, 2009, J IMMUNOL, V183, P470, DOI 10.4049/jimmunol.0900265; SCHARTONKERSTEN T, 1995, J IMMUNOL, V154, P5320; SEDER RA, 1993, P NATL ACAD SCI USA, V90, P10188, DOI 10.1073/pnas.90.21.10188; Shedlock DJ, 2000, J LEUKOCYTE BIOL, V68, P793; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Sinha PK, 2005, INDIAN J MED RES, V121, P407; Stager S, 2000, J IMMUNOL, V165, P7064, DOI 10.4049/jimmunol.165.12.7064; Stanley AC, 2007, IMMUNOL CELL BIOL, V85, P138, DOI 10.1038/sj.icb7100011; STERN AS, 1990, P NATL ACAD SCI USA, V87, P6808, DOI 10.1073/pnas.87.17.6808; Sundar S, 1997, AM J TROP MED HYG, V56, P522, DOI 10.4269/ajtmh.1997.56.522; Tewary P, 2005, J INFECT DIS, V191, P2130, DOI 10.1086/430348; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRINCHIERI G, 1993, IMMUNOL TODAY, V14, P335, DOI 10.1016/0167-5699(93)90230-I; Velanker SS, 1997, STRUCTURE, V5, P751, DOI 10.1016/S0969-2126(97)00230-X; Vouldoukis I, 1997, EUR J IMMUNOL, V27, P860, DOI 10.1002/eji.1830270409; Wang YW, 2011, INFECT IMMUN, V79, P1124, DOI 10.1128/IAI.00658-10; Zhu Yinchang, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P518; Zhu Yinchang, 2002, Southeast Asian J Trop Med Public Health, V33, P207	70	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45766	10.1371/journal.pone.0045766	http://dx.doi.org/10.1371/journal.pone.0045766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23049855	gold, Green Published, Green Submitted			2022-12-27	WOS:000309554700069
J	Alves, CS; Konstantopoulos, K				Alves, Christina S.; Konstantopoulos, Konstantinos			PDGF Suppresses the Sulfation of CD44v and Potentiates CD44v-Mediated Binding of Colon Carcinoma Cells to Fibrin under Flow	PLOS ONE			English	Article							TUMOR-CELLS; VARIANT ISOFORMS; SELECTIN LIGANDS; VASCULAR INTERACTIONS; CANCER METASTASIS; PLATELETS; ADHESION; ANGIOGENESIS; INVOLVEMENT; MOLECULE	Fibrin(ogen) mediates sustained tumor cell adhesion and survival in the pulmonary vasculature, thereby facilitating the metastatic dissemination of tumor cells. CD44 is the major functional fibrin receptor on colon carcinoma cells. Growth factors, such as platelet-derived growth factor (PDGF), induce post-translational protein modifications, which modulate ligand binding activity. In view of the roles of PDGF, fibrin(ogen) and CD44 in cancer metastasis, we aimed to delineate the effect of PDGF on CD44-fibrin recognition. By immunoprecipitating CD44 from PDGF-treated and untreated LS174T colon carcinoma cells, which express primarily CD44v, we demonstrate that PDGF enhances the adhesion of CD44v-coated beads to immobilized fibrin. Enzymatic inhibition studies coupled with flow-based adhesion assays and autoradiography reveal that PDGF augments the binding of CD44v to fibrin by significantly attenuating the extent of CD44 sulfation primarily on chondroitin and dermatan sulfate chains. Surface plasmon resonance assays confirm that PDGF enhances the affinity of CD44v-fibrin binding by markedly reducing its dissociation rate while modestly increasing the association rate. PDGF mildly reduces the affinity of CD44v-hyaluronan binding without affecting selectin-CD44v recognition. The latter is attributed to the fact that CD44v binds to selectins via sialofucosylated O-linked residues independent of heparan, dermatan and chondroitin sulfates. Interestingly, PDGF moderately reduces the sulfation of CD44s and CD44s-fibrin recognition. Collectively, these data offer a novel perspective into the mechanism by which PGDF regulates CD44-dependent binding of metastatic colon carcinoma cells to fibrin(ogen).	[Alves, Christina S.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Ctr Oncol, Baltimore, MD 21205 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	konstant@jhu.edu	Konstantopoulos, Konstantinos/A-7045-2011		United States National Institutues of Health/National Cancer Institute [R01 CA101135, U54 CA143868]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA101135, U54CA143868] Funding Source: NIH RePORTER	United States National Institutues of Health/National Cancer Institute; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the United States National Institutues of Health/National Cancer Institute R01 CA101135 and U54 CA143868 (K.K.), and a predoctoral fellowship from the American Heart Association (C.S.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CS, 2008, AM J PHYSIOL-CELL PH, V294, pC907, DOI 10.1152/ajpcell.00463.2007; Alves CS, 2009, J BIOL CHEM, V284, P1177, DOI 10.1074/jbc.M805144200; Brown KL, 2001, J IMMUNOL, V167, P5367, DOI 10.4049/jimmunol.167.9.5367; Camerer E, 2004, BLOOD, V104, P397, DOI 10.1182/blood-2004-02-0434; Clark RAF, 2004, J INVEST DERMATOL, V122, P266, DOI 10.1046/j.0022-202X.2004.22205.x; Delcommenne M, 2002, GLYCOBIOLOGY, V12, P613, DOI 10.1093/glycob/cwf080; Greenfield B, 1999, J BIOL CHEM, V274, P2511, DOI 10.1074/jbc.274.4.2511; Hanley WD, 2006, FASEB J, V20, P337, DOI 10.1096/fj.05-4574fje; HONN KV, 1992, CANCER METAST REV, V11, P325, DOI 10.1007/BF01307186; Im JH, 2004, CANCER RES, V64, P8613, DOI 10.1158/0008-5472.CAN-04-2078; Konstantopoulos K, 2009, ANNU REV BIOMED ENG, V11, P177, DOI 10.1146/annurev-bioeng-061008-124949; Martin TA, 2003, CRIT REV ONCOL HEMAT, V46, P165, DOI 10.1016/S1040-8428(02)00172-5; MICHELACCI YM, 1975, BIOCHEM J, V151, P121, DOI 10.1042/bj1510121; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Nieswandt B, 1999, CANCER RES, V59, P1295; Palumbo JS, 2000, BLOOD, V96, P3302, DOI 10.1182/blood.V96.10.3302; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Palumbo JS, 2002, CANCER RES, V62, P6966; Pinedo HM, 1998, LANCET, V352, P1775, DOI 10.1016/S0140-6736(98)05095-8; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Raman PS, 2011, J CELL SCI, V124, P1903, DOI 10.1242/jcs.079814; Takahashi K, 1996, J BIOL CHEM, V271, P9490, DOI 10.1074/jbc.271.16.9490; Thomas SN, 2008, J BIOL CHEM, V283, P15647, DOI 10.1074/jbc.M800543200; Thomas SN, 2009, AM J PHYSIOL-CELL PH, V296, pC505, DOI 10.1152/ajpcell.00472.2008; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X	26	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2012	7	10							e41472	10.1371/journal.pone.0041472	http://dx.doi.org/10.1371/journal.pone.0041472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020RP	23056168	gold, Green Submitted, Green Published			2022-12-27	WOS:000309831500004
J	Schutz, C; Sort, J; Bacsik, Z; Oliynyk, V; Pellicer, E; Fall, A; Wagberg, L; Berglund, L; Bergstrom, L; Salazar-Alvarez, G				Schutz, Christina; Sort, Jordi; Bacsik, Zoltan; Oliynyk, Vitaliy; Pellicer, Eva; Fall, Andreas; Wagberg, Lars; Berglund, Lars; Bergstrom, Lennart; Salazar-Alvarez, German			Hard and Transparent Films Formed by Nanocellulose-TiO2 Nanoparticle Hybrids	PLOS ONE			English	Article							REFRACTIVE-INDEX; INORGANIC NANOCOMPOSITES; MECHANICAL-PROPERTIES; CELLULOSE; TITANIA; COMPOSITES; OXIDATION; NANOPAPER; POLYMERS; AEROGELS	The formation of hybrids of nanofibrillated cellulose and titania nanoparticles in aqueous media has been studied. Their transparency and mechanical behavior have been assessed by spectrophotometry and nanoindentation. The results show that limiting the titania nanoparticle concentration below 16 vol% yields homogeneous hybrids with a very high Young's modulus and hardness, of up to 44 GPa and 3.4 GPa, respectively, and an optical transmittance above 80%. Electron microscopy shows that higher nanoparticle contents result in agglomeration and an inhomogeneous hybrid nanostructure with a concomitant reduction of hardness and optical transmittance. Infrared spectroscopy suggests that the nanostructure of the hybrids is controlled by electrostatic adsorption of the titania nanoparticles on the negatively charged nanocellulose surfaces.	[Schutz, Christina; Bacsik, Zoltan; Oliynyk, Vitaliy; Bergstrom, Lennart; Salazar-Alvarez, German] Stockholm Univ, S-10691 Stockholm, Sweden; [Schutz, Christina; Wagberg, Lars; Berglund, Lars; Salazar-Alvarez, German] KTH, Wallenberg Wood Sci Ctr, Stockholm, Sweden; [Sort, Jordi] Univ Autonoma Barcelona, ICREA, Bellaterra, Spain; [Sort, Jordi; Pellicer, Eva] Univ Autonoma Barcelona, Dept Fs, Bellaterra, Spain; [Fall, Andreas; Wagberg, Lars; Berglund, Lars] KTH, Royal Inst Technol, Stockholm, Sweden	Stockholm University; Royal Institute of Technology; Autonomous University of Barcelona; ICREA; Autonomous University of Barcelona; Royal Institute of Technology	Salazar-Alvarez, G (corresponding author), Stockholm Univ, S-10691 Stockholm, Sweden.	german@mmk.su.se	Bergström, Lennart/ABH-1143-2021; Salazar-Alvarez, German/A-4802-2009; Bergström, Lennart/F-2938-2011; Berglund, Lars A/A-6971-2010; Schütz, Christina/AAA-8846-2019; MARTINEZ, ANTONIO PELLICER/C-4832-2015; Oliynyk, Viktor V./C-8555-2014; Sort, Jordi/GPP-6695-2022; Pellicer, Eva/G-2917-2014; Schütz, Christina/N-9628-2015; Sort, Jordi/F-6582-2014	Bergström, Lennart/0000-0002-5702-0681; Salazar-Alvarez, German/0000-0002-0671-435X; Bergström, Lennart/0000-0002-5702-0681; Berglund, Lars A/0000-0001-5818-2378; Schütz, Christina/0000-0003-0238-1639; Oliynyk, Viktor V./0000-0002-2959-6253; Pellicer, Eva/0000-0002-8901-0998; Schütz, Christina/0000-0003-0238-1639; Sort, Jordi/0000-0003-1213-3639	Wallenberg Wood Science Center (WWSC); Spanish MICINN [MAT2011-27380-C02-01]; ICREA Funding Source: Custom	Wallenberg Wood Science Center (WWSC); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA(ICREA)	This work was supported by Wallenberg Wood Science Center (WWSC) and Spanish MICINN grant MAT2011-27380-C02-01. The Knut and Alice Wallenberg Foundation is acknowledged for the electron microscopy facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7; Alonso B, 2010, ANGEW CHEM INT EDIT, V49, P8201, DOI 10.1002/anie.201002104; Banerjee S, 2002, NANO LETT, V2, P195, DOI 10.1021/nl015651n; Bartl MH, 2005, ACCOUNTS CHEM RES, V38, P263, DOI 10.1021/ar040177o; Beecher JF, 2007, NAT NANOTECHNOL, V2, P466, DOI 10.1038/nnano.2007.239; Caruso RA, 2001, CHEM MATER, V13, P400, DOI 10.1021/cm001175a; CERAM Research Ltd, TIT DIOX; Cervin NT, 2011, ABSTR PAP AM CHEM S, P241; Chen B, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.125406; Chen WC, 1999, J MAT CHEM, V9; Coakley KM, 2003, APPL PHYS LETT, V83, P3380, DOI 10.1063/1.1616197; Davis SA, 2001, CHEM MATER, V13, P3218, DOI 10.1021/cm011068w; Diez I, 2011, MACROMOL BIOSCI, V11, P1185, DOI 10.1002/mabi.201100099; Drew C, 2003, NANO LETT, V3, P143, DOI 10.1021/nl025850m; Feng W, 2000, B CHEM SOC JPN, V73, P2627, DOI 10.1246/bcsj.73.2627; Fischer-Cripps A.C., 2004, NANOINDENTATION; Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103; Gaillard Y, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/14/145305; Gebauer D, 2011, NANOSCALE, V3, P3563, DOI 10.1039/c1nr10681c; Gonzalez RJ, 1997, PHYS REV B, V55, P7014, DOI 10.1103/PhysRevB.55.7014; Gross RA, 2002, SCIENCE, V297, P803, DOI 10.1126/science.297.5582.803; Habibi Y, 2006, CELLULOSE, V13, P679, DOI 10.1007/s10570-006-9075-y; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Ifuku S, 2010, BIOMACROMOLECULES, V11, P1326, DOI 10.1021/bm100109a; Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e; Johnson RK, 2010, THESIS VIRGINIA TECH; Kedem S, 2005, LANGMUIR, V21, P5600, DOI 10.1021/la0502443; Kettunen M, 2011, ADV FUNCT MATER, V21, P510, DOI 10.1002/adfm.201001431; Kharlampieva E, 2010, ADV FUNCT MATER, V20, P840, DOI 10.1002/adfm.200901774; Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273; Korhonen JT, 2011, ACS APPL MATER INTER, V3, P1813, DOI 10.1021/am200475b; KRUG H, 1994, NEW J CHEM, V18, P1125; Kwak SY, 2001, ENVIRON SCI TECHNOL, V35, P2388, DOI 10.1021/es0017099; Lahiji RR, 2010, LANGMUIR, V26, P4480, DOI 10.1021/la903111j; Larena A, 2002, APPL SURF SCI, V187, P339, DOI 10.1016/S0169-4332(01)01044-3; Lee LH, 2001, CHEM MATER, V13, P1137, DOI 10.1021/cm000937z; Li GQ, 1999, CEMENT CONCRETE RES, V29, P1455, DOI 10.1016/S0008-8846(99)00119-2; Li J, 2006, POLYMER, V47, P7361, DOI 10.1016/j.polymer.2006.08.059; Li XW, 2003, APPL SURF SCI, V217, P16, DOI 10.1016/S0169-4332(03)00565-8; Liu AD, 2011, BIOMACROMOLECULES, V12, P633, DOI 10.1021/bm101296z; Mammeri F, 2005, J MATER CHEM, V15, P3787, DOI 10.1039/b507309j; Ng CB, 2001, ADV COMPOS LETT, V10, P101; Nogi M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2146056; Nussbaumer RJ, 2003, MACROMOL MATER ENG, V288, P44, DOI 10.1002/mame.200290032; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Olsson RT, 2010, NAT NANOTECHNOL, V5, P584, DOI [10.1038/NNANO.2010.155, 10.1038/nnano.2010.155]; Ray SS, 2003, PROG POLYM SCI, V28, P1539, DOI 10.1016/j.progpolymsci.2003.08.002; Roy BK, 2011, J AM CERAM SOC; Saito T, 2006, BIOMACROMOLECULES, V7, P1687, DOI 10.1021/bm060154s; Sasaki T, 2001, CHEM MATER, V13, P4661, DOI 10.1021/cm010478h; Schmidt H, 2000, J SOL-GEL SCI TECHN, V19, P39, DOI 10.1023/A:1008706003996; Sehaqui H, 2011, BIOMACROMOLECULES, V12, P3638, DOI 10.1021/bm2008907; Sehaqui H, 2010, SOFT MATTER, V6, P1824, DOI 10.1039/b927505c; Socrates G., 2004, INFRARED RAMAN CHARA; Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003; Sun ZC, 2006, CHEMPHYSCHEM, V7, P370, DOI 10.1002/cphc.200500340; Thanikaivelan P, 2012, SCI REP-UK, V2, DOI 10.1038/srep00230; WANG A, 1994, SOL ENERGY, V52, P459, DOI 10.1016/0038-092X(94)90653-X; Wojcieszak Damian, 2010, Proceedings of the 2010 International Students and Young Scientists Workshop "Photonics And Microsystems", P86, DOI 10.1109/STYSW.2010.5714178; Yoshida M, 1997, J MATER SCI, V32, P4047, DOI 10.1023/A:1018645722633; Zhang M, 2004, LANGMUIR, V20, P1420, DOI 10.1021/la030183d; ZHANG MH, 1991, ACI MATER J, V88, P240; Zimmermann T, 2005, ADV ENG MATER, V7, P1156, DOI 10.1002/adem.200500157; Zywitzki O, 2004, SURF COAT TECH, V180, P538, DOI 10.1016/j.surfcoat.2003.10.115	64	63	67	1	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45828	10.1371/journal.pone.0045828	http://dx.doi.org/10.1371/journal.pone.0045828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049689	Green Published, gold			2022-12-27	WOS:000309388500016
J	Sisodia, S; Singh, BN				Sisodia, Seema; Singh, Bashisth N.			Experimental Evidence for Nutrition Regulated Stress Resistance in Drosophila ananassae	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; STARVATION RESISTANCE; PHENOTYPIC PLASTICITY; TRADE-OFFS; RESOURCE-ALLOCATION; CERATITIS-CAPITATA; GENE-EXPRESSION; METABOLIC-RATE; DIET QUALITY; AMINO-ACIDS	Background: The amount and quality of nutrients consumed by organisms have a strong impact on stress resistance, life-history traits and reproduction. The balance between energy acquisition and expenditure is crucial to the survival and reproductive success of animals. The ability of organisms to adjust their development, physiology or behavior in response to environmental conditions, called phenotypic plasticity, is a defining property of life. One of the most familiar and important examples of phenotypic plasticity is the response of stress tolerance and reproduction to changes in developmental nutrition. Larval nutrition may affect a range of different life-history traits as well as responses to environmental stress in adult. Principal Findings: Here we investigate the effect of larval nutrition on desiccation, starvation, chill-coma recovery, heat resistance as well as egg to adult viability, egg production and ovariole number in Drosophila ananassae. We raised larvae on either protein rich diet or carbohydrate rich diet. We found that flies consuming protein rich diet have higher desiccation and heat shock resistance whereas flies developed on carbohydrate rich diet have higher starvation and cold resistance. Egg production was higher in females developed on protein rich diet and we also found trade-off between egg production and Egg to adult viability of the flies. Viability was higher in carbohydrate rich diet. However, sex specific viability was found in different nutritional regimes. Higher Egg production might be due to higher ovariole number in females of protein rich diet. Conclusion: Thus, Drosophila ananassae adapts different stress tolerance and life-history strategies according to the quality of the available diet, which are correlated with phenotypic adjustment at anatomical and physiological levels.	[Sisodia, Seema; Singh, Bashisth N.] Banaras Hindu Univ, Dept Zool, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Singh, BN (corresponding author), Banaras Hindu Univ, Dept Zool, Varanasi 221005, Uttar Pradesh, India.	bnsingh@bhu.ac.in			Department of Science and Technology, New Delhi [SR/WOS-A/LS-190/2010]	Department of Science and Technology, New Delhi(Department of Science & Technology (India))	Department of Science and Technology, New Delhi: Grant Number SR/WOS-A/LS-190/2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS TS, 1991, INVERTEBR REPROD DEV, V20, P49, DOI 10.1080/07924259.1991.9672177; Allard CM, 2005, ENVIRON ENTOMOL, V34, P6, DOI 10.1603/0046-225X-34.1.6; Andersen LH, 2010, J INSECT PHYSIOL, V56, P336, DOI 10.1016/j.jinsphys.2009.11.006; Ashby PD, 1998, AM ZOOL, V38, P561; Ayrinhac A, 2004, FUNCT ECOL, V18, P700, DOI 10.1111/j.0269-8463.2004.00904.x; Baldal EA, 2005, MECH AGEING DEV, V126, P407, DOI 10.1016/j.mad.2004.09.035; Ballard JWO, 2008, J INSECT PHYSIOL, V54, P1371, DOI 10.1016/j.jinsphys.2008.07.009; Bauerfeind SS, 2005, J INSECT PHYSIOL, V51, P545, DOI 10.1016/j.jinsphys.2005.02.002; Bewick V, 2004, CRIT CARE, V8, P389, DOI 10.1186/cc2955; Burger JMS, 2007, AGING CELL, V6, P63, DOI 10.1111/j.1474-9726.2006.00261.x; Chang CL, 2004, ANN ENTOMOL SOC AM, V97, P529, DOI 10.1603/0013-8746(2004)097[0529:EOAAOL]2.0.CO;2; CHIPPINDALE AK, 1993, J EVOLUTION BIOL, V6, P171, DOI 10.1046/j.1420-9101.1993.6020171.x; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; CLARKE A, 1987, MAR ECOL PROG SER, V38, P89, DOI 10.3354/meps038089; Cruz-Neto AP, 2004, PHYSIOL BIOCHEM ZOOL, V77, P877, DOI 10.1086/425187; Djawdan M, 1998, PHYSIOL ZOOL, V71, P584, DOI 10.1086/515963; Harshman LG, 1998, EVOLUTION, V52, P1679, DOI [10.2307/2411340, 10.1111/j.1558-5646.1998.tb02247.x]; Helland S, 2003, MAR BIOL, V142, P1141, DOI 10.1007/s00227-003-1045-4; HENDRICHS J, 1991, OECOLOGIA, V86, P223, DOI 10.1007/BF00317534; Hoffmann A.A., 1991, EVOLUTIONARY GENETIC; Hoffmann AA, 2001, EVOLUTION, V55, P1621, DOI 10.1111/j.0014-3820.2001.tb00681.x; Jones D, 1999, J EXP ZOOL, V284, P147, DOI 10.1002/(SICI)1097-010X(19990701)284:2&lt;147::AID-JEZ4&gt;3.0.CO;2-Z; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; KARASOV WH, 1986, TRENDS ECOL EVOL, V1, P101, DOI 10.1016/0169-5347(86)90034-0; Kennington WJ, 2001, HEREDITY, V87, P363, DOI 10.1046/j.1365-2540.2001.00925.x; KOEHN RK, 1989, BIOL J LINN SOC, V37, P157, DOI 10.1111/j.1095-8312.1989.tb02100.x; Kostal V, 2004, J EXP BIOL, V207, P1509, DOI 10.1242/jeb.00923; Kristensen TN, 2008, P NATL ACAD SCI USA, V105, P216, DOI 10.1073/pnas.0708074105; Kristensen TN, 2011, BIOL LETTERS, V7, P269, DOI 10.1098/rsbl.2010.0872; Kyneb A, 2004, J APPL ENTOMOL, V128, P658, DOI 10.1111/j.1439-0418.2004.00905.x; Lalouette L, 2007, FEBS J, V274, P1759, DOI 10.1111/j.1742-4658.2007.05723.x; Lee KP, 2008, FUNCT ECOL, V22, P1052, DOI 10.1111/j.1365-2435.2008.01459.x; LEROI AM, 1994, AM NAT, V144, P661, DOI 10.1086/285699; Lobe SL, 2006, J ANAT, V208, P795, DOI 10.1111/j.1469-7580.2006.00565.x; Markow TA, 1999, FUNCT ECOL, V13, P78, DOI 10.1046/j.1365-2435.1999.00285.x; Markow TA, 2001, P ROY SOC B-BIOL SCI, V268, P1527, DOI 10.1098/rspb.2001.1673; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Matzkin LM, 2007, FLY, V1, P268, DOI 10.4161/fly.5293; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Naya DE, 2007, J INSECT PHYSIOL, V53, P132, DOI 10.1016/j.jinsphys.2006.11.004; Nestel D, 2008, ENTOMOL EXP APPL, V126, P53, DOI 10.1111/j.1570-7458.2007.00639.x; Parkash R, 2008, FLY, V2, P111, DOI 10.4161/fly.6351; Piper MDW, 2005, EXP GERONTOL, V40, P857, DOI 10.1016/j.exger.2005.06.013; Pompermayer P, 2001, ENTOMOL EXP APPL, V99, P79, DOI 10.1023/A:1018979013928; POUGH FH, 1989, PHYSIOL ZOOL, V62, P199, DOI 10.1086/physzool.62.2.30156169; Raubenheimer D, 1999, ENTOMOL EXP APPL, V91, P67, DOI 10.1023/A:1003682921131; Reichling TD, 2000, J NUTR, V130, P2326, DOI 10.1093/jn/130.9.2326; Rion S, 2007, J EVOLUTION BIOL, V20, P1655, DOI 10.1111/j.1420-9101.2007.01405.x; Roff DA, 2003, J EVOLUTION BIOL, V16, P55, DOI 10.1046/j.1420-9101.2003.00480.x; Ryne C, 2004, J INSECT PHYSIOL, V50, P429, DOI 10.1016/j.jinsphys.2004.02.010; Schmidt PS, 2008, EVOLUTION, V62, P1204, DOI 10.1111/j.1558-5646.2008.00351.x; SIBLY RM, 1991, FUNCT ECOL, V5, P184, DOI 10.2307/2389256; SIBLY RM, 1989, BIOL J LINN SOC, V37, P101, DOI 10.1111/j.1095-8312.1989.tb02007.x; Simmons FH, 1997, J INSECT PHYSIOL, V43, P779, DOI 10.1016/S0022-1910(97)00037-1; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Sinclair BJ, 2007, INSECT MOL BIOL, V16, P435, DOI 10.1111/j.1365-2583.2007.00739.x; Singh BN, 2010, INDIAN J EXP BIOL, V48, P333; Singh BN, 2000, CURR SCI INDIA, V78, P391; Singh P, 2008, GENET RES, V90, P409, DOI 10.1017/S0016672308009737; Sisodia S, 2010, J EVOLUTION BIOL, V23, P1979, DOI 10.1111/j.1420-9101.2010.02061.x; Sisodia S, 2010, J THERM BIOL, V35, P117, DOI 10.1016/j.jtherbio.2010.01.001; Smith DC, 1998, HYDROBIOLOGIA, V378, P187, DOI 10.1023/A:1003210210032; Smith EM, 2007, J NUTR, V137, P2006, DOI 10.1093/jn/137.9.2006; Sorensen JG, 2007, EXP GERONTOL, V42, P1123, DOI 10.1016/j.exger.2007.09.001; Sorensen JG, 2005, CELL STRESS CHAPERON, V10, P312, DOI 10.1379/CSC-128R1.1; Sorensen JG, 2003, ECOL LETT, V6, P1025, DOI 10.1046/j.1461-0248.2003.00528.x; Sterner Robert W., 1998, Aquatic Ecology, V32, P261, DOI 10.1023/A:1009949400573; Tammariello SP, 1999, J INSECT PHYSIOL, V45, P933, DOI 10.1016/S0022-1910(99)00073-6; Taylor EN, 2005, OECOLOGIA, V144, P206, DOI 10.1007/s00442-005-0056-x; WANG L, 1995, BIOCHEM GENET, V33, P149, DOI 10.1007/BF00554727; Warbrick-Smith J, 2006, P NATL ACAD SCI USA, V103, P14045, DOI 10.1073/pnas.0605225103; Wenzel U, 2006, GENES NUTR, V1, P85, DOI 10.1007/BF02829950; White T. C. R., 1993, INADEQUATE ENV NITRO; Wilder SM, 2010, OIKOS, V119, P350, DOI 10.1111/j.1600-0706.2009.17819.x; Zera AJ, 1998, AM NAT, V152, P7, DOI 10.1086/286146	76	51	55	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e46131	10.1371/journal.pone.0046131	http://dx.doi.org/10.1371/journal.pone.0046131			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049693	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388500020
J	Tullin, S; Sams, A; Brandt, J; Dahl, K; Gong, W; Jeppesen, CB; Krogh, TN; Olsen, GS; Liu, Y; Pedersen, AA; Petersen, JM; Rolin, B; Wahlund, PO; Kalthoff, C				Tullin, Soren; Sams, Anette; Brandt, Jakob; Dahl, Kirsten; Gong, Wei; Jeppesen, Claus Bekker; Krogh, Thomas Nylandsted; Olsen, Grith Skytte; Liu, Yun; Pedersen, Anette Amstrup; Petersen, Jorn Meidahl; Rolin, Bidda; Wahlund, Per-Olof; Kalthoff, Christoph			Recombinant Adiponectin Does Not Lower Plasma Glucose in Animal Models of Type 2 Diabetes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ADIPOSE-SPECIFIC PROTEIN; FATTY-ACID OXIDATION; GLOBULAR DOMAIN; DEFICIENT MICE; OBESITY; EXPRESSION; ATHEROSCLEROSIS; ADIPOCYTES; DISEASE	Aims/Hypothesis: Several studies have shown that adiponectin can lower blood glucose in diabetic mice. The aim of this study was to establish an effective adiponectin production process and to evaluate the anti-diabetic potential of the different adiponectin forms in diabetic mice and sand rats. Methods: Human high molecular weight, mouse low molecular weight and mouse plus human globular adiponectin forms were expressed and purified from mammalian cells or yeast. The purified protein was administered at 10-30 mg/kg i.p. b.i.d. to diabetic db/db mice for 2 weeks. Furthermore, high molecular weight human and globular mouse adiponectin batches were administered at 5-15 mg/kg i.p. b.i.d. to diabetic sand rats for 12 days. Results: Surprisingly, none of our batches had any effect on blood glucose, HbA1c, plasma lipids or body weight in diabetic db/db mice or sand rats. In vitro biological, biochemical and biophysical data suggest that the protein was correctly folded and biologically active. Conclusions/Interpretation: Recombinant adiponectin is ineffective at lowering blood glucose in diabetic db/db mice or sand rats.	[Tullin, Soren; Sams, Anette; Brandt, Jakob; Dahl, Kirsten; Jeppesen, Claus Bekker; Krogh, Thomas Nylandsted; Olsen, Grith Skytte; Pedersen, Anette Amstrup; Petersen, Jorn Meidahl; Rolin, Bidda; Wahlund, Per-Olof; Kalthoff, Christoph] Novo Nordisk AS, Malov, Denmark; [Gong, Wei; Liu, Yun] Novo Nordisk RD Ctr China, Beijing, Peoples R China	Novo Nordisk; Novo Nordisk	Tullin, S (corresponding author), Novo Nordisk AS, Novo Nordisk Pk, Malov, Denmark.	stu@novonordisk.com	Sams, Anette/R-1764-2016	Sams, Anette/0000-0002-9203-4333; Jeppesen, Claus Bekker/0000-0003-2878-4348; /0000-0001-5063-1554				Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bauche IB, 2007, ENDOCRINOLOGY, V148, P1539, DOI 10.1210/en.2006-0838; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Egel-Mitani M, 2000, ENZYME MICROB TECH, V26, P671, DOI 10.1016/S0141-0229(00)00158-7; Fantuzzi G, 2008, J ALLERGY CLIN IMMUN, V121, P326, DOI 10.1016/j.jaci.2007.10.018; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Hara K, 2007, INT HEART J, V48, P149, DOI 10.1536/ihj.48.149; Harizi H, 2007, J NEUROIMMUNOL, V189, P59, DOI 10.1016/j.jneuroim.2007.06.019; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Kamio N, 2009, FEMS IMMUNOL MED MIC, V56, P241, DOI 10.1111/j.1574-695X.2009.00573.x; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kubota N, 2007, CELL METAB, V6, P55, DOI 10.1016/j.cmet.2007.06.003; Liu DG, 2007, BIOCHEM BIOPH RES CO, V363, P769, DOI 10.1016/j.bbrc.2007.09.025; Masaki T, 2003, DIABETES, V52, P2266, DOI 10.2337/diabetes.52.9.2266; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Radjainia M, 2008, J MOL BIOL, V381, P419, DOI 10.1016/j.jmb.2008.06.015; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schraw T, 2008, ENDOCRINOLOGY, V149, P2270, DOI 10.1210/en.2007-1561; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Shibata R, 2009, CIRC J, V73, P608, DOI 10.1253/circj.CJ-09-0057; Shklyaev S, 2003, P NATL ACAD SCI USA, V100, P14217, DOI 10.1073/pnas.2333912100; Sulpice T, 2009, ENDOCRINOLOGY, V150, P4493, DOI 10.1210/en.2008-1768; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Waki H, 2003, J BIOL CHEM, V278, P40352, DOI 10.1074/jbc.M300365200; Wu XD, 2003, DIABETES, V52, P1355, DOI 10.2337/diabetes.52.6.1355; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	34	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e44270	10.1371/journal.pone.0044270	http://dx.doi.org/10.1371/journal.pone.0044270			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049674	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388500001
J	Yiu, HH; Graham, AL; Stengel, RF				Yiu, Hao Hong; Graham, Andrea L.; Stengel, Robert F.			Dynamics of a Cytokine Storm	PLOS ONE			English	Article							PRO-INFLAMMATORY CYTOKINES; NEUTROPHILS; SECRETION; IMMUNITY; TGN1412; CELLS; INNATE; TRIAL	Six volunteers experienced severe inflammatory response during the Phase I clinical trial of a monoclonal antibody that was designed to stimulate a regulatory T cell response. Soon after the trial began, each volunteer experienced a "cytokine storm", a dramatic increase in cytokine concentrations. The monoclonal antibody, TGN1412, raised serum concentrations of both pro- and anti-inflammatory cytokines to very hi gamma h values during the first day, while lymphocyte and monocyte concentrations plummeted. Because the subjects were healthy and had no prior indications of immune deficiency, this event provided an unusual opportunity to study the dynamic interactions of cytokines and other measured parameters. Here, the response histories of nine cytokines have been modeled by a set of linear ordinary differential equations. A general search procedure identifies parameters of the model, whose response fits the data well during the five-day measurement period. The eighteenth-order model reveals plausible cause-and-effect relationships among the cytokines, showing how each cytokine induces or inhibits other cytokines. It suggests that perturbations in IL2, IL8, and IL10 have the most significant inductive effect, while IFN-gamma and IL12 have the greatest inhibiting effect on other cytokine concentrations. Although TNF-alpha is a major pro-inflammatory factor, IFN-gamma and three other cytokines have faster initial and median response to TGN1412 infusion. Principal-component analysis of the data reveals three clusters of similar cytokine responses: [TNF-alpha, IL1, IL10], [IFN-gamma, IL2, IL4, IL8, and IL12], and [IL6]. IL1, IL6, IL10, and TNF-alpha have the highest degree of variability in response to uncertain initial conditions, exogenous effects, and parameter estimates. This study illuminates details of a cytokine storm event, and it demonstrates the value of linear modeling for interpreting complex, coupled biological system dynamics from empirical data.	[Stengel, Robert F.] Princeton Univ, Dept Mech & Aerosp Engn, Sch Engn & Appl Sci, Princeton, NJ 08544 USA; [Graham, Andrea L.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Yiu, Hao Hong] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Stengel, RF (corresponding author), Princeton Univ, Dept Mech & Aerosp Engn, Sch Engn & Appl Sci, Princeton, NJ 08544 USA.	stengel@princeton.edu	Graham, Andrea L./A-8808-2010; Graham, Andrea/GON-8450-2022; Graham, Andrea L./P-7296-2019	Graham, Andrea L./0000-0002-6580-2755; Graham, Andrea L./0000-0002-6580-2755; , Hao/0000-0003-1221-5722				Alfano M, 2005, MOL IMMUNOL, V42, P161, DOI 10.1016/j.molimm.2004.06.016; Altstaedt J, 1996, IMMUNOLOGY, V89, P563, DOI 10.1046/j.1365-2567.1996.d01-784.x; [Anonymous], 2005, TGN1412 INVESTIGATOR; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Chatzidakis I, 2010, CURR DIR AUTOIMMUN, V11, P105, DOI 10.1159/000289200; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Coleman T, 2011, OPTIMIZATION TOOLBOX; Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110; DeSanctis JB, 1997, IMMUNOLOGY, V90, P526, DOI 10.1046/j.1365-2567.1997.00174.x; Drazen JM, 2006, NEW ENGL J MED, V355, P1060, DOI 10.1056/NEJMe068175; Duff G., 2006, FINAL REPORT 2006, P1; Frankenstein Z, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-32; Germain RN, 2001, SCIENCE, V293, P240, DOI 10.1126/science.1062946; Gerthoffer William T, 2002, Mol Interv, V2, P447, DOI 10.1124/mi.2.7.447; Gogishvili T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004643; Haque A, 2007, EMERG INFECT DIS, V13, P1512, DOI 10.3201/eid1310.061262; Hone A, 2007, 2007 IEEE SYMPOSIUM ON FOUNDATIONS OF COMPUTATIONAL INTELLIGENCE, VOLS 1 AND 2, P389, DOI 10.1109/FOCI.2007.371501; Iwasaki A, 2011, CELL, V146, P861, DOI 10.1016/j.cell.2011.08.027; Joliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kronin V, 2000, IMMUNOL CELL BIOL, V78, P214, DOI 10.1046/j.1440-1711.2000.00902.x; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; MANTOVANI A, 1989, IMMUNOL TODAY, V10, P370, DOI 10.1016/0167-5699(89)90270-3; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mosmann T, 2000, NAT IMMUNOL, V1, P465, DOI 10.1038/82707; Nikolaus S, 1998, GUT, V42, P470, DOI 10.1136/gut.42.4.470; Pearson K, 1904, PHILOS MAG, V2, P559; Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09; SAMPSON PM, 1992, J CLIN INVEST, V90, P1492, DOI 10.1172/JCI116017; Sandilands GP, 2010, CLIN EXP IMMUNOL, V162, P516, DOI 10.1111/j.1365-2249.2010.04264.x; SCHLEIMER RP, 1989, J IMMUNOL, V143, P1310; Senn S, 2008, PHARM STAT, V7, P294, DOI 10.1002/pst.322; Sharpe AH, 2006, NEW ENGL J MED, V355, P973, DOI 10.1056/NEJMp068087; Shen-Orr SS, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P439; St Clair EW, 2008, J CLIN INVEST, V118, P1344, DOI 10.1172/JCI35382; STADNYK AW, 1994, FASEB J, V8, P1041, DOI 10.1096/fasebj.8.13.7926369; Stebbings R, 2009, CURR OPIN BIOTECH, V20, P673, DOI 10.1016/j.copbio.2009.10.002; Stengel R. F., 1994, OPTIMAL CONTROL ESTI; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tufet M, 2008, NAT REV IMMUNOL, V8, P322, DOI [10.1038/nri2320, DOI 10.1038/NRI2320]; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Waibler Z, 2008, J ALLERGY CLIN IMMUN, V122, P890, DOI 10.1016/j.jaci.2008.07.049; Witko-Sarsat V, 2000, LAB INVEST, V80, P617, DOI 10.1038/labinvest.3780067; Zhu JF, 2010, IMMUNOL REV, V238, P247, DOI 10.1111/j.1600-065X.2010.00951.x	44	61	66	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45027	10.1371/journal.pone.0045027	http://dx.doi.org/10.1371/journal.pone.0045027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049677	gold, Green Published, Green Submitted			2022-12-27	WOS:000309388500004
J	Liu, B; Wang, XL; Chen, QC; Dong, QW; Lan, X				Liu, Bin; Wang, Xiaolong; Chen, Qingcai; Dong, Qiwen; Lan, Xun			Using Amino Acid Physicochemical Distance Transformation for Fast Protein Remote Homology Detection	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; DISCRIMINATIVE METHOD; FOLD RECOGNITION; STRUCTURAL CLASS; STRING KERNELS; PREDICTION; SERVER; SIMILARITY; ACCURATE; DATABASE	Protein remote homology detection is one of the most important problems in bioinformatics. Discriminative methods such as support vector machines (SVM) have shown superior performance. However, the performance of SVM-based methods depends on the vector representations of the protein sequences. Prior works have demonstrated that sequence-order effects are relevant for discrimination, but little work has explored how to incorporate the sequence-order information along with the amino acid physicochemical properties into the prediction. In order to incorporate the sequence-order effects into the protein remote homology detection, the physicochemical distance transformation (PDT) method is proposed. Each protein sequence is converted into a series of numbers by using the physicochemical property scores in the amino acid index (AAIndex), and then the sequence is converted into a fixed length vector by PDT. The sequence-order information can be efficiently included into the feature vector with little computational cost by this approach. Finally, the feature vectors are input into a support vector machine classifier to detect the protein remote homologies. Our experiments on a well-known benchmark show the proposed method SVM-PDT achieves superior or comparable performance with current state-of-the-art methods and its computational cost is considerably superior to those of other methods. When the evolutionary information extracted from the frequency profiles is combined with the PDT method, the profile-based PDT approach can improve the performance by 3.4% and 11.4% in terms of ROC score and ROC50 score respectively. The local sequence-order information of the protein can be efficiently captured by the proposed PDT and the physicochemical properties extracted from the amino acid index are incorporated into the prediction. The physicochemical distance transformation provides a general framework, which would be a valuable tool for protein-level study.	[Liu, Bin; Wang, Xiaolong; Chen, Qingcai] Harbin Inst Technol, Sch Comp Sci & Technol, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China; [Liu, Bin; Wang, Xiaolong; Chen, Qingcai] Harbin Inst Technol, Key Lab Network Oriented Intelligent Computat, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China; [Dong, Qiwen] Fudan Univ, Sch Comp Sci, Shanghai 200433, Peoples R China; [Lan, Xun] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA	Harbin Institute of Technology; University Town of Shenzhen; Harbin Institute of Technology; University Town of Shenzhen; Fudan University; University System of Ohio; Ohio State University	Liu, B (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Shenzhen Grad Sch, Shenzhen, Guangdong, Peoples R China.	bliu@insun.hit.edu.cn	Liu, Bin/E-9480-2013	Lan, Xun/0000-0002-6523-046X; Liu, Bin/0000-0002-8520-8374	National Natural Science Foundation of China [61173075, 61003090, 60973076]; Natural Scientific Research Innovation Foundation in Harbin Institute of Technology [HIT.NSRIF.2013103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Scientific Research Innovation Foundation in Harbin Institute of Technology(Harbin Institute of Technology)	This work was supported by the National Natural Science Foundation of China (No. 61173075, 61003090 and 60973076) and the Project HIT.NSRIF.2013103 supported by Natural Scientific Research Innovation Foundation in Harbin Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ben-Hur A, 2003, BIOINFORMATICS, V19, pi26, DOI 10.1093/bioinformatics/btg1002; Bernardes JS, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-83; Brandt BW, 2009, NUCLEIC ACIDS RES, V37, pW48, DOI 10.1093/nar/gkp279; Brenner SE, 2000, NUCLEIC ACIDS RES, V28, P254, DOI 10.1093/nar/28.1.254; Dong QW, 2009, BIOINFORMATICS, V25, P2655, DOI 10.1093/bioinformatics/btp500; Dong QW, 2005, PROCEEDINGS OF 2005 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-9, P3363; Dong QW, 2006, BIOINFORMATICS, V22, P285, DOI 10.1093/bioinformatics/bti801; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Grigoriev IV, 1999, P NATL ACAD SCI USA, V96, P14318, DOI 10.1073/pnas.96.25.14318; Handstad T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-23; Hochreiter S, 2007, BIOINFORMATICS, V23, P1728, DOI 10.1093/bioinformatics/btm247; Homaeian L, 2007, PROTEINS, V69, P486, DOI 10.1002/prot.21527; Hou Y, 2003, BIOINFORMATICS, V19, P2294, DOI 10.1093/bioinformatics/btg317; Hou YN, 2004, PROTEINS, V57, P518, DOI 10.1002/prot.20221; Jaroszewski L, 2011, NUCLEIC ACIDS RES, V39, pW38, DOI 10.1093/nar/gkr441; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Kedarisetti KD, 2006, BIOCHEM BIOPH RES CO, V348, P981, DOI 10.1016/j.bbrc.2006.07.141; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kuang Rui, 2005, Journal of Bioinformatics and Computational Biology, V3, P527, DOI 10.1142/S021972000500120X; Kurgan L, 2007, BIOCHEM BIOPH RES CO, V357, P453, DOI 10.1016/j.bbrc.2007.03.164; Lee MM, 2008, PROTEINS, V71, P1409, DOI 10.1002/prot.21830; LESLIE C, 2002, P PSB, V7, P566; Leslie CS, 2004, BIOINFORMATICS, V20, P467, DOI 10.1093/bioinformatics/btg431; Liao L, 2003, J COMPUT BIOL, V10, P857, DOI 10.1089/106652703322756113; Lin Z, 2001, J PROTEIN CHEM, V20, P217, DOI 10.1023/A:1010967008838; Lingner T, 2006, BIOINFORMATICS, V22, P2224, DOI 10.1093/bioinformatics/btl376; Lingner T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-259; Liu B, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-510; Liu X, 2011, COMPUT BIOL MED, V41, P640, DOI 10.1016/j.compbiomed.2011.05.015; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Margelevicius M, 2010, BIOINFORMATICS, V26, P1905, DOI 10.1093/bioinformatics/btq306; Nevill-Manning CG, 1998, P NATL ACAD SCI USA, V95, P5865, DOI 10.1073/pnas.95.11.5865; Noble WS, 2005, FEBS J, V272, P5119, DOI 10.1111/j.1742-4658.2005.04947.x; Ogul H, 2007, BIOSYSTEMS, V87, P75, DOI 10.1016/j.biosystems.2006.03.006; Qian B, 2004, BIOINFORMATICS, V20, P2175, DOI 10.1093/bioinformatics/bth181; Rangwala H, 2005, BIOINFORMATICS, V21, P4239, DOI 10.1093/bioinformatics/bti687; Sadreyev RI, 2009, NUCLEIC ACIDS RES, V37, pW90, DOI 10.1093/nar/gkp360; Saigo H, 2004, BIOINFORMATICS, V20, P1682, DOI 10.1093/bioinformatics/bth141; Shah AR, 2008, BIOINFORMATICS, V24, P783, DOI 10.1093/bioinformatics/btn028; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Tomii K, 2004, BIOINFORMATICS, V20, P594, DOI 10.1093/bioinformatics/btg474; Vapnik V., 1998, STAT LEARNING THEORY; Wang M, 2004, PROTEIN ENG DES SEL, V17, P509, DOI 10.1093/protein/gzh061; Webb-Robertson BJ, 2005, COMPUT BIOL CHEM, V29, P440, DOI 10.1016/j.compbiolchem.2005.09.006; Webb-Robertson BJM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-145; Yang YC, 2008, J THEOR BIOL, V252, P145, DOI 10.1016/j.jtbi.2008.01.028	49	85	86	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46633	10.1371/journal.pone.0046633	http://dx.doi.org/10.1371/journal.pone.0046633			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029559	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900193
J	Hintzsche, H; Jastrow, C; Kleine-Ostmann, T; Karst, U; Schrader, T; Stopper, H				Hintzsche, Henning; Jastrow, Christian; Kleine-Ostmann, Thomas; Kaerst, Uwe; Schrader, Thorsten; Stopper, Helga			Terahertz Electromagnetic Fields (0.106 THz) Do Not Induce Manifest Genomic Damage In Vitro	PLOS ONE			English	Article							SPINDLE DISTURBANCES; BIOLOGICAL-SYSTEMS; HUMAN-LYMPHOCYTES; OXIDATIVE STRESS; RADIATION; CELLS; EXPOSURE; FREQUENCY; VIVO; TECHNOLOGY	Terahertz electromagnetic fields are non-ionizing electromagnetic fields in the frequency range from 0.1 to 10 THz. Potential applications of these electromagnetic fields include the whole body scanners, which currently apply millimeter waves just below the terahertz range, but future scanners will use higher frequencies in the terahertz range. These and other applications will bring along human exposure to these fields. Up to now, only a limited number of investigations on biological effects of terahertz electromagnetic fields have been performed. Therefore, research is strongly needed to enable reliable risk assessment. Cells were exposed for 2 h, 8 h, and 24 h with different power intensities ranging from 0.04 mW/cm(2) to 2 mW/cm(2), representing levels below, at, and above current safety limits. Genomic damage on the chromosomal level was measured as micronucleus formation. DNA strand breaks and alkali-labile sites were quantified with the comet assay. No DNA strand breaks or alkali-labile sites were observed as a consequence of exposure to terahertz electromagnetic fields in the comet assay. The fields did not cause chromosomal damage in the form of micronucleus induction.	[Hintzsche, Henning; Stopper, Helga] Univ Wurzburg, Inst Pharmakol & Toxikol, Wurzburg, Germany; [Jastrow, Christian; Kleine-Ostmann, Thomas; Schrader, Thorsten] Phys Tech Bundesanstalt, Braunschweig, Germany; [Kaerst, Uwe] Helmholtz Zentrum Infekt Forsch, Braunschweig, Germany	University of Wurzburg; Physikalisch-Technische Bundesanstalt (PTB); Helmholtz Association; Helmholtz-Center for Infection Research	Stopper, H (corresponding author), Univ Wurzburg, Inst Pharmakol & Toxikol, Wurzburg, Germany.	Stopper@toxi.uni-wuerzburg.de			German Federal Office for Radiation Protection (Bundesamt fur Strahlenschutz); German Research Foundation (DFG); University of Wuerzburg	German Federal Office for Radiation Protection (Bundesamt fur Strahlenschutz); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This study was funded by the German Federal Office for Radiation Protection (Bundesamt fur Strahlenschutz). The publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov BS, 2011, BIOMED OPT EXPRESS, V2, P2679, DOI 10.1364/BOE.2.002679; Ammari M, 2008, TOXICOLOGY, V250, P70, DOI 10.1016/j.tox.2008.05.019; Berry E, 2003, J LASER APPL, V15, P192, DOI 10.2351/1.1585079; Bock J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015806; BOLLER K, 1970, HUMANGENETIK, V11, P35, DOI 10.1007/BF00296302; Dickhoff R, 2011, CHARACTERIZATION THZ, P1; Doria A, 2004, INFRARED PHYS TECHN, V45, P339, DOI 10.1016/j.infrared.2004.01.014; Feychting M, 2011, PROG BIOPHYS MOL BIO; Foster KR, 2000, IEEE T PLASMA SCI, V28, P15, DOI 10.1109/27.842819; Gallerano G. P., 2004, TERA HERTZ RAD BIOL; Guney M, 2007, TOXICOL IND HEALTH, V23, P411, DOI 10.1177/0748233707080906; Hintzsche H, 2011, RADIAT RES, V175, P569, DOI 10.1667/RR2406.1; Hintzsche H, 2012, CRIT REV ENV SCI TEC, V42, P2408, DOI 10.1080/10643389.2011.574206; Hintzsche H, 2010, TOXICOL LETT, V193, P124, DOI 10.1016/j.toxlet.2009.12.016; Hoyto A, 2008, RADIAT RES, V170, P235, DOI 10.1667/RR1322.1; Huang TQ, 2008, INT J RADIAT BIOL, V84, P909, DOI 10.1080/09553000802460123; Jastrow C, 2010, ADV RADIO SCI, V8, P1, DOI 10.5194/ars-8-1-2010; Khurana VG, 2008, MED PHYS, V35, P5203, DOI 10.1118/1.3013548; Korenstein-Ilan A, 2008, RADIAT RES, V170, P224, DOI 10.1667/RR0944.1; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; Ramundo-Orlando A, 2007, BIOELECTROMAGNETICS, V28, P587, DOI 10.1002/bem.20343; Ramundo-Orlando A, 2010, J INFRARED MILLIM TE, V31, P1400, DOI 10.1007/s10762-010-9731-z; Scarfi MR, 2003, J BIOL PHYS, V29, P171, DOI 10.1023/A:1024440708943; Schrader T, 2011, BIOELECTROMAGNETICS, V32, P291, DOI 10.1002/bem.20634; Schrader T, 2008, BIOELECTROMAGNETICS, V29, P626, DOI 10.1002/bem.20428; Siegel PH, 2004, IEEE T MICROW THEORY, V52, P2438, DOI 10.1109/TMTT.2004.835916; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smye SW, 2001, PHYS MED BIOL, V46, pR101, DOI 10.1088/0031-9155/46/9/201; Verschaeve L, 2010, MUTAT RES-REV MUTAT, V705, P252, DOI 10.1016/j.mrrev.2010.10.001; Wilmink GJ, 2010, LASERS SURG MED; Yadav AS, 2008, MUTAT RES-GEN TOX EN, V650, P175, DOI 10.1016/j.mrgentox.2007.11.005; Zeni O, 2007, HEALTH PHYS, V92, P349, DOI 10.1097/01.HP.0000251248.23991.35	32	33	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2012	7	9							e46397	10.1371/journal.pone.0046397	http://dx.doi.org/10.1371/journal.pone.0046397			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KQ	23029508	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517500098
J	Galanzha, EI; Shashkov, E; Sarimollaoglu, M; Beenken, KE; Basnakian, AG; Shirtliff, ME; Kim, JW; Smeltzer, MS; Zharov, VP				Galanzha, Ekaterina I.; Shashkov, Evgeny; Sarimollaoglu, Mustafa; Beenken, Karen E.; Basnakian, Alexei G.; Shirtliff, Mark E.; Kim, Jin-Woo; Smeltzer, Mark S.; Zharov, Vladimir P.			In Vivo Magnetic Enrichment, Photoacoustic Diagnosis, and Photothermal Purging of Infected Blood Using Multifunctional Gold and Magnetic Nanoparticles	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; PHOTODYNAMIC THERAPY; STREAM INFECTION; OXIDATIVE STRESS; CELLS; NANODIAGNOSTICS; NANOTECHNOLOGY; BACTEREMIA; CHALLENGES	Bacterial infections are a primary cause of morbidity and mortality worldwide. Bacteremia is a particular concern owing to the possibility of septic shock and the development of metastatic infections. Treatment of bacteremia is increasingly compromised by the emergence of antibiotic resistant strains, creating an urgent need for alternative therapy. Here, we introduce a method for in vivo photoacoustic (PA) detection and photothermal (PT) eradication of Staphylococcus aureus in tissue and blood. We show that this method could be applicable for label-free diagnosis and treatment of in the bloodstream using intrinsic near-infrared absorption of endogenous carotenoids with nonlinear PA and PT contrast enhancement. To improve sensitivity and specificity for detection of circulating bacteria cells (CBCs), two-color gold and multilayer magnetic nanoparticles with giant amplifications of PA and PT contrasts were functionalized with an antibody cocktail for molecular targeting of S. aureus surface-associated markers such as protein A and lipoprotein. With a murine model, the utility of this approach was demonstrated for ultrasensitive detection of CBCs with threshold sensitivity as low as 0.5 CBCs/mL, in vivo magnetic enrichment of CBCs, PT eradication of CBCs, and real-time monitoring of therapeutic efficacy by CBC counting. Our PA-PT nano-theranostic platform, which integrates in vivo multiplex targeting, magnetic enrichment, signal amplification, multicolor recognition, and feedback control, could be used as a biological tool to gain insights on dissemination pathways of CBCs, infection progression by bacteria re-seeding, and sepsis development and treatment, and could potentially be feasible in humans, especially using bypass schematic.	[Beenken, Karen E.; Smeltzer, Mark S.] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA; [Galanzha, Ekaterina I.; Shashkov, Evgeny; Sarimollaoglu, Mustafa; Zharov, Vladimir P.] Univ Arkansas Med Sci, Phillips Class Laser & Nanomed Labs, Little Rock, AR 72205 USA; [Galanzha, Ekaterina I.; Zharov, Vladimir P.] Univ Arkansas Med Sci, Arkansas Nanomed Ctr, Little Rock, AR 72205 USA; [Basnakian, Alexei G.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Shirtliff, Mark E.] Univ Maryland Baltimore, Sch Dent, Dept Mol Pathogenesis, Baltimore, MD USA; [Kim, Jin-Woo] Univ Arkansas, Inst Nanosci & Engn, Bio Nano Technol Lab, Fayetteville, AR 72701 USA; [Kim, Jin-Woo] Univ Arkansas, Dept Biol & Agr Engn, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University System of Maryland; University of Maryland Baltimore; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Smeltzer, MS (corresponding author), Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA.	smeltzermarks@uams.edu	Shirtliff, Mark E/H-2563-2017; Zharov, Vladimir/J-9728-2013; Shashkov, Evgeny V/H-7858-2018; Kim, Jin-Woo/H-5148-2011; Smeltzer, Mark/M-2009-2018	Shirtliff, Mark E/0000-0002-8913-3445; Shashkov, Evgeny V/0000-0003-0920-6366; Kim, Jin-Woo/0000-0002-7119-8208; Smeltzer, Mark/0000-0002-0878-0692; Zharov, Vladimir/0000-0003-4773-0548; Sarimollaoglu, Mustafa/0000-0003-0246-9702	National Institutes of Health [R01CA131164, R01 EB009230, R56-AI093126, R21CA139373]; National Science Foundation [DBI-0852737]; Department of Defense [W88XWH-10-2-0130, W81XWH-10-BCRP-CA, W81XWH-11-1-0129]; Arkansas Biosciences Institute; NATIONAL CANCER INSTITUTE [R01CA131164, R21CA139373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI093126, R01AI069568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009230] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0852737] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Department of Defense(United States Department of Defense); Arkansas Biosciences Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by the National Institutes of Health grants: R01CA131164, R01 EB009230, R56-AI093126, and R21CA139373, the National Science Foundation, grant number DBI-0852737, and Department of Defense grants: W88XWH-10-2-0130, W81XWH-10-BCRP-CA, and W81XWH-11-1-0129, and Arkansas Biosciences Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Ghiso JA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2561; Allaker RP, 2008, T ROY SOC TROP MED H, V102, P1, DOI 10.1016/j.trstmh.2007.07.003; Basnakian AG, 2005, J AM SOC NEPHROL, V16, P697, DOI 10.1681/ASN.2004060494; Beenken KE, 2004, J BACTERIOL, V186, P4665, DOI 10.1128/JB.186.14.4665-4684.2004; Blevins JS, 2003, INFECT IMMUN, V71, P516, DOI 10.1128/IAI.71.1.516-523.2003; Boucher HW, 2010, CLIN INFECT DIS, V50, pS4, DOI 10.1086/647937; Brady RA, 2007, APPL ENVIRON MICROB, V73, P6612, DOI 10.1128/AEM.00855-07; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Butler MS, 2011, J ANTIBIOT, V64, P413, DOI 10.1038/ja.2011.44; CALHOUN JH, 1991, ORTHOP CLIN N AM, V22, P467; Chen YS, 2011, NANO LETT, V11, P348, DOI 10.1021/nl1042006; de la Zerda A, 2011, CONTRAST MEDIA MOL I, V6, P346, DOI 10.1002/cmmi.455; Embleton ML, 2004, MICROB DRUG RESIST, V10, P92, DOI 10.1089/1076629041310000; Fowler VG, 2007, J INFECT DIS, V196, P738, DOI 10.1086/520088; Galanzha EI, 2012, METHODS IN PRESS; Galanzha EI, 2009, J BIOPHOTONICS, V2, P725, DOI 10.1002/jbio.200910078; Galanzha EI, 2009, NAT NANOTECHNOL, V4, P855, DOI [10.1038/nnano.2009.333, 10.1038/NNANO.2009.333]; Galanzha EI, 2009, CANCER RES, V69, P7926, DOI 10.1158/0008-5472.CAN-08-4900; Gootz TD, 2010, CRIT REV IMMUNOL, V30, P79, DOI 10.1615/CritRevImmunol.v30.i1.60; Grinhoic M, 2008, J PHOTOCH PHOTOBIO B, V90, P57, DOI 10.1016/j.jphotobiol.2007.11.002; Hamblin MR, 2004, PHOTOCH PHOTOBIO SCI, V3, P436, DOI 10.1039/b311900a; Hirsch LR, 2003, P NATL ACAD SCI USA, V100, P13549, DOI 10.1073/pnas.2232479100; Huang XH, 2011, ALEX J MED, V47, P1, DOI 10.1016/j.ajme.2011.01.001; Jori G, 2006, LASER SURG MED, V38, P468, DOI 10.1002/lsm.20361; Kennedy LC, 2011, SMALL, V7, P169, DOI 10.1002/smll.201000134; Kim JW, 2007, LASER SURG MED, V39, P622, DOI 10.1002/lsm.20534; Kim JW, 2010, CHEM COMMUN, V46, P7142, DOI 10.1039/c0cc00218f; Kim JW, 2009, NAT NANOTECHNOL, V4, P688, DOI 10.1038/nnano.2009.231; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Lambrechts SAG, 2005, PHOTOCH PHOTOBIO SCI, V4, P503, DOI 10.1039/b502125a; Lapotko D, 1999, CYTOMETRY, V37, P320, DOI 10.1002/(SICI)1097-0320(19991201)37:4<320::AID-CYTO10>3.0.CO;2-U; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Ma XP, 2009, MED HYPOTHESES, V73, P18, DOI 10.1016/j.mehy.2009.01.033; Manthe RL, 2010, MOL PHARMACEUT, V7, P1880, DOI 10.1021/mp1001944; Menyaev YA, 2006, P SOC PHOTO-OPT INS, V6087, P30; Napirei M, 2006, HEPATOLOGY, V43, P297, DOI 10.1002/hep.21034; Nederberg F, 2011, NAT CHEM, V3, P409, DOI [10.1038/nchem.1012, 10.1038/NCHEM.1012]; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Pissuwan D, 2010, TRENDS BIOTECHNOL, V28, P207, DOI 10.1016/j.tibtech.2009.12.004; Rasmussen RV, 2011, FUTURE MICROBIOL, V6, P43, DOI 10.2217/FMB.10.155; Sarkar A, 2011, TOXICOLOGY, V290, P208, DOI 10.1016/j.tox.2011.09.086; Sharma V, 2012, MUTAT RES-GEN TOX EN, V745, P84, DOI 10.1016/j.mrgentox.2011.12.009; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Tachibana K, 2008, ULTRASONICS, V48, P253, DOI 10.1016/j.ultras.2008.02.003; TSCHEPE J, 1994, P SOC PHOTO-OPT INS, V2084, P133, DOI 10.1117/12.167326; Wang LHV, 2012, SCIENCE, V335, P1458, DOI 10.1126/science.1216210; WILSON M, 1993, J APPL BACTERIOL, V75, P299, DOI 10.1111/j.1365-2672.1993.tb02780.x; Wyllie DH, 2005, BMJ-BRIT MED J, V331, P992, DOI 10.1136/bmj.38558.453310.8F; Yu M, 2011, J CELL BIOL, V192, P373, DOI 10.1083/jcb.201010021; Zharov Vladimir P., 1999, Proceedings of the SPIE - The International Society for Optical Engineering, V3829, P141, DOI 10.1117/12.353119; Zharov VP, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2793746; Zharov VP, 2011, NAT PHOTONICS, V5, P110, DOI [10.1038/nphoton.2010.280, 10.1038/NPHOTON.2010.280]; Zharov VP, 2006, BIOPHYS J, V90, P619, DOI 10.1529/biophysj.105.061895; Zharov VP, 2003, APPL PHYS LETT, V83, P4897, DOI 10.1063/1.1632546; Zharov VP, 2001, CRIT REV BIOMED ENG, V29, P111; ZHAROV VP, 1993, P SOC PHOTO-OPT INS, V1892, P38, DOI 10.1117/12.147504; ZHAROV VP, 2000, P SOC PHOTO-OPT INS, V1, P331	59	65	74	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45557	10.1371/journal.pone.0045557	http://dx.doi.org/10.1371/journal.pone.0045557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049814	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300032
J	Josse, G; Joseph, S; Bertasi, E; Giraud, AL				Josse, Goulven; Joseph, Sabine; Bertasi, Eric; Giraud, Anne-Lise			The Brain's Dorsal Route for Speech Represents Word Meaning: Evidence from Gesture	PLOS ONE			English	Article							HEALTHY-SUBJECTS; TEMPORAL CORTEX; PREMOTOR CORTEX; MOTOR CORTEX; TIME-SERIES; LANGUAGE; FMRI; PERCEPTION; ORGANIZATION; REPETITION	The dual-route model of speech processing includes a dorsal stream that maps auditory to motor features at the sublexical level rather than at the lexico-semantic level. However, the literature on gesture is an invitation to revise this model because it suggests that the premotor cortex of the dorsal route is a major site of lexico-semantic interaction. Here we investigated lexico-semantic mapping using word-gesture pairs that were either congruent or incongruent. Using fMRI-adaptation in 28 subjects, we found that temporo-parietal and premotor activity during auditory processing of single action words was modulated by the prior audiovisual context in which the words had been repeated. The BOLD signal was suppressed following repetition of the auditory word alone, and further suppressed following repetition of the word accompanied by a congruent gesture (e.g. ["grasp'' + grasping gesture]). Conversely, repetition suppression was not observed when the same action word was accompanied by an incongruent gesture (e.g. ["grasp'' + sprinkle]). We propose a simple model to explain these results: auditory and visual information converge onto premotor cortex where it is represented in a comparable format to determine (in) congruence between speech and gesture. This ability of the dorsal route to detect audiovisual semantic (in) congruence suggests that its function is not restricted to the sublexical level.	[Josse, Goulven] Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, Paris, France; [Joseph, Sabine] UCL, Inst Cognit Neurosci, Cognit Neurol Grp, London, England; [Bertasi, Eric] Univ Paris 06, Ctr NeuroImagerie Rech CENIR, Ctr Rech Inst Cerveau & Moelle, Hop La Pitie Salpetriere,INSERM UMRS 975,CNRS UMR, Paris, France; [Giraud, Anne-Lise] Ecole Normale Super, INSERM U960, Lab Neurosci Cognit, Dept Etud Cognit, F-75231 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Josse, G (corresponding author), Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, Paris, France.	goulvenjosse@gmail.com		, Sabine/0000-0002-1846-5303	Philippe Foundation; Agence Nationale de la Recherche attributed	Philippe Foundation; Agence Nationale de la Recherche attributed(French National Research Agency (ANR))	This study was supported by a grant from the Agence Nationale de la Recherche attributed to Anne-Lise Giraud (http://www.agence-nationale-recherche.fr/). Goulven Josse was also supported by the Philippe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2001, P NATL ACAD SCI USA, V98, P12301, DOI 10.1073/pnas.211209098; Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Baciu M, 2005, EUR J RADIOL, V55, P209, DOI 10.1016/j.ejrad.2004.11.004; Dax M., 1865, GAZETTE HEBDOMADAIRE, V17, P259; Demonet JF, 2005, PHYSIOL REV, V85, P49, DOI 10.1152/physrev.00049.2003; Devlin JT, 2000, NEUROIMAGE, V11, P589, DOI 10.1006/nimg.2000.0595; Dick AS, 2009, HUM BRAIN MAPP; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gentilucci M, 2001, J NEUROPHYSIOL, V86, P1685, DOI 10.1152/jn.2001.86.4.1685; Graziano M, 2006, ANNU REV NEUROSCI, V29, P105, DOI 10.1146/annurev.neuro.29.051605.112924; Griffiths TD, 2008, CURR BIOL, V18, pR387, DOI 10.1016/j.cub.2008.03.007; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2006, NEURON, V49, P170, DOI 10.1016/j.neuron.2006.01.004; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HECAEN H, 1981, BRAIN LANG, V12, P261, DOI 10.1016/0093-934X(81)90018-3; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2003, J COGNITIVE NEUROSCI, V15, P673, DOI 10.1162/089892903322307393; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Holle H, 2008, NEUROIMAGE, V39, P2010, DOI 10.1016/j.neuroimage.2007.10.055; Jancke L, 2002, NEUROIMAGE, V15, P733, DOI 10.1006/nimg.2001.1027; Kaplan Jonas T, 2007, Cogn Process, V8, P103, DOI 10.1007/s10339-007-0165-z; Kendon A., 2004, GESTURE VISIBLE ACTI, DOI DOI 10.1017/CBO9780511807572; Kohler E, 2002, SCIENCE, V297, P846, DOI 10.1126/science.1070311; Krauss RM, 1998, CURR DIR PSYCHOL SCI, V7, P54, DOI 10.1111/1467-8721.ep13175642; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; MAZOYER BM, 1993, J COGNITIVE NEUROSCI, V5, P467, DOI 10.1162/jocn.1993.5.4.467; McNeill D., 1992, HAND MIND WHAT GESTU; McNeill D., 2005, GESTURE THOUGHT, DOI 10.7208/chicago/9780226514642.001.0001; Meister IG, 2009, EUR J NEUROSCI, V29, P2074, DOI 10.1111/j.1460-9568.2009.06729.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Price CJ, 2010, ANN NEW YOR IN PRESS; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Rose M, 2002, APHASIOLOGY, V16, P1001, DOI 10.1080/02687030143000825; Rose M, 2001, APHASIOLOGY, V15, P977, DOI 10.1080/02687040143000339; Sawamura H, 2006, NEURON, V49, P307, DOI 10.1016/j.neuron.2005.11.028; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Skipper JI, 2007, CEREB CORTEX, V17, P2387, DOI 10.1093/cercor/bhl147; Skipper JI, 2009, CURR BIOL, V19, P661, DOI 10.1016/j.cub.2009.02.051; Skipper JI, 2005, NEUROIMAGE, V25, P76, DOI 10.1016/j.neuroimage.2004.11.006; Turk-Browne NB, 2007, CEREB CORTEX, V17, P425, DOI 10.1093/cercor/bhj159; Veltman DJ, 2002, NEUROIMAGE, V17, P1203, DOI 10.1006/nimg.2002.1242; Willems RM, 2007, CEREB CORTEX, V17, P2322, DOI 10.1093/cercor/bhl141; Willems RM, 2009, NEUROIMAGE, V47, P1992, DOI 10.1016/j.neuroimage.2009.05.066; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263	53	11	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46108	10.1371/journal.pone.0046108	http://dx.doi.org/10.1371/journal.pone.0046108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016KP	23049951	Green Submitted, Green Published, gold			2022-12-27	WOS:000309517300086
J	Poppinga, S; Hartmeyer, SRH; Seidel, R; Masselter, T; Hartmeyer, I; Speck, T				Poppinga, Simon; Hartmeyer, Siegfried Richard Heinrich; Seidel, Robin; Masselter, Tom; Hartmeyer, Irmgard; Speck, Thomas			Catapulting Tentacles in a Sticky Carnivorous Plant	PLOS ONE			English	Article							DROSERA TENTACLES; ACTION POTENTIALS; VENUS FLYTRAP; TRAP	Among trapping mechanisms in carnivorous plants, those termed 'active' have especially fascinated scientists since Charles Darwin's early works because trap movements are involved. Fast snap-trapping and suction of prey are two of the most spectacular examples for how these plants actively catch animals, mainly arthropods, for a substantial nutrient supply. We show that Drosera glanduligera, a sundew from southern Australia, features a sophisticated catapult mechanism: Prey animals walking near the edge of the sundew trigger a touch-sensitive snap-tentacle, which swiftly catapults them onto adjacent sticky glue-tentacles; the insects are then slowly drawn within the concave trap leaf by sticky tentacles. This is the first detailed documentation and analysis of such catapult-flypaper traps in action and highlights a unique and surprisingly complex mechanical adaptation to carnivory.	[Poppinga, Simon; Seidel, Robin; Masselter, Tom; Speck, Thomas] Univ Freiburg, Plant Biomech Grp, D-79106 Freiburg, Germany	University of Freiburg	Poppinga, S (corresponding author), Univ Freiburg, Plant Biomech Grp, Hugstetter Str 55, D-79106 Freiburg, Germany.	simon.poppinga@biologie.uni-freiburg.de	Poppinga, Simon/B-7260-2012; Speck, Thomas/N-9208-2013	Poppinga, Simon/0000-0001-5341-9188; Masselter, Tom/0000-0001-5465-8252	German Federal Ministry of Education and Research within BIONA; German Research Foundation (DFG); Albert Ludwigs University Freiburg	German Federal Ministry of Education and Research within BIONA; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert Ludwigs University Freiburg	This work was supported by the German Federal Ministry of Education and Research within the funding directive BIONA. http://www.bmbf.de/en/index.php. http://www.bionische-innovationen.de/#home.html. The article processing charge was (partly) funded by the German Research Foundation (DFG) and the Albert Ludwigs University Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHIDA JOJI, 1934, MEM COLL SCI KYOTO IMP UNIV SER B, V9, P141; Darwin C., 1875, INSECTIVOROUS PLANTS; Davion R, 1995, FLYTRAP NEWS, V8, P17; Davion R, 1999, FLYTRAP NEWS, V13, P10; Escalante-Perez M, 2011, P NATL ACAD SCI USA, V108, P15492, DOI 10.1073/pnas.1112535108; Forterre Y, 2005, NATURE, V433, P421, DOI 10.1038/nature03185; Gibson TC, 2009, NEW PHYTOL, V183, P575, DOI 10.1111/j.1469-8137.2009.02935.x; Hartmeyer I, 2010, CARNIVOROUS PLANT NE, V39, P101; Krol E, 2012, ANN BOT-LONDON, V109, P47, DOI 10.1093/aob/mcr249; Lloyd F.E., 1942, CARNIVOROUS PLANTS; Lowrie A., 1989, CARNIVOROUS PLANTS A, V2; Pereira CG, 2012, P NATL ACAD SCI USA, V109, P1154, DOI 10.1073/pnas.1114199109; Poppinga S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041928; Seine R., 1993, Beitrage zur Biologie der Pflanzen, V67, P345; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; VERBEEK NAM, 1993, AUST J ECOL, V18, P203, DOI 10.1111/j.1442-9993.1993.tb00444.x; WATSON AP, 1982, AUST J ECOL, V7, P13, DOI 10.1111/j.1442-9993.1982.tb01296.x; WILLIAMS SE, 1976, P AM PHILOS SOC, V120, P187; WILLIAMS SE, 1972, PLANTA, V103, P193, DOI 10.1007/BF00386844; WILLIAMS SE, 1972, PLANTA, V103, P222, DOI 10.1007/BF00386845	20	35	35	3	268	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45735	10.1371/journal.pone.0045735	http://dx.doi.org/10.1371/journal.pone.0045735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049849	gold, Green Submitted, Green Published			2022-12-27	WOS:000309517300047
J	Voedisch, S; Rochlitzer, S; Veres, TZ; Spies, E; Braun, A				Voedisch, Sabrina; Rochlitzer, Sabine; Veres, Tibor Z.; Spies, Emma; Braun, Armin			Neuropeptides Control the Dynamic Behavior of Airway Mucosal Dendritic Cells	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; T-CELLS; IN-VIVO; ASTHMA; INFLAMMATION; MURINE; RECEPTOR; LUNG; ACTIVATION; EXPRESSION	The airway mucosal epithelium is permanently exposed to airborne particles. A network of immune cells patrols at this interface to the environment. The interplay of immune cells is orchestrated by different mediators. In the current study we investigated the impact of neuronal signals on key functions of dendritic cells (DC). Using two-photon microscopic time-lapse analysis of living lung sections from CD11c-EYFP transgenic mice we studied the influence of neuropeptides on airway DC motility. Additionally, using a confocal microscopic approach, the phagocytotic capacity of CD11c(+) cells after neuropeptide stimulation was determined. Electrical field stimulation (EFS) leads to an unspecific release of neuropeptides from nerves. After EFS and treatment with the neuropeptides vasoactive intestinal peptide (VIP) or calcitonin gene-related peptide (CGRP), airway DC in living lung slices showed an altered motility. Furthermore, the EFS-mediated effect could partially be blocked by pre-treatment with the receptor antagonist CGRP(8-37). Additionally, the phagocytotic capacity of bone marrow-derived and whole lung CD11c(+) cells could be inhibited by neuropeptides CGRP, VIP, and Substance P. We then cross-linked these data with the in vivo situation by analyzing DC motility in two different OVA asthma models. Both in the acute and prolonged OVA asthma model altered neuropeptide amounts and DC motility in the airways could be measured. In summary, our data suggest that neuropeptides modulate key features motility and phagocytosis of mouse airway DC. Therefore altered neuropeptide levels in airways during allergic inflammation have impact on regulation of airway immune mechanisms and therefore might contribute to the pathophysiology of asthma.	[Voedisch, Sabrina; Rochlitzer, Sabine; Veres, Tibor Z.; Spies, Emma; Braun, Armin] German Ctr Lung Res, Dept Airway Immunol, Fraunhofer Inst Toxicol & Expt Med, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Voedisch, Sabrina; Spies, Emma; Braun, Armin] Hannover Med Sch MHH, Dept Immunol, Hannover, Germany; [Veres, Tibor Z.] Univ Turku, MediCity Res Lab, Turku, Finland	Fraunhofer Gesellschaft; Hannover Medical School; University of Turku	Braun, A (corresponding author), German Ctr Lung Res, Dept Airway Immunol, Fraunhofer Inst Toxicol & Expt Med, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany.	armin.braun@item.fraunhofer.de	Braun, Armin/B-8750-2009	Braun, Armin/0000-0002-1142-1463	Deutsche Forschungsgemeinschaft [SFB587/B4]; Fraunhofer ITEM (Fraunhofer Institute for Toxicology and Experimental Medicine)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fraunhofer ITEM (Fraunhofer Institute for Toxicology and Experimental Medicine)	This work was supported by Deutsche Forschungsgemeinschaft (SFB587/B4), Fraunhofer ITEM (Fraunhofer Institute for Toxicology and Experimental Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES PJ, 1986, AM REV RESPIR DIS, V134, P1289; Barnes PJ, 2001, RESP PHYSIOL, V125, P145, DOI 10.1016/S0034-5687(00)00210-3; BARNES PJ, 1986, LANCET, V1, P242; BOOMSMA JD, 1992, CHEST, V101, pS389, DOI 10.1378/chest.101.6_Supplement.389S; CARDELL LO, 1994, EUR RESPIR J, V7, P2169, DOI 10.1183/09031936.94.07122169; Dunzendorfer S, 2001, J IMMUNOL, V166, P2167, DOI 10.4049/jimmunol.166.4.2167; Fischer A, 1996, J CLIN INVEST, V98, P2284, DOI 10.1172/JCI119039; Fukai N, 2003, ENDOCRINOLOGY, V144, P447, DOI 10.1210/en.2002-220463; Fukai Nozomi, 2004, Nihon Rinsho, V62 Suppl 9, P189; Groneberg DA, 2004, ALLERGY, V59, P1139, DOI 10.1111/j.1398-9995.2004.00665.x; HOSOI J, 1993, NATURE, V363, P159, DOI 10.1038/363159a0; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kalamidas SA, 2006, J CELL SCI, V119, P3686, DOI 10.1242/jcs.03091; Kraneveld AD, 2001, INT IMMUNOPHARMACOL, V1, P1629, DOI 10.1016/S1567-5769(01)00099-6; Kuipers H, 2004, CURR OPIN IMMUNOL, V16, P702, DOI 10.1016/j.coi.2004.09.010; Lambrecht BN, 2000, J CLIN INVEST, V106, P551, DOI 10.1172/JCI8107; Lambrecht BN, 2003, NAT REV IMMUNOL, V3, P994, DOI 10.1038/nri1249; Lambrecht BN, 2001, RESP RES, V2, P133, DOI 10.1186/rr49; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Marriott I, 2001, J NEUROIMMUNOL, V114, P131, DOI 10.1016/S0165-5728(00)00466-5; Mikami N, 2011, J IMMUNOL, V186, P6886, DOI 10.4049/jimmunol.1100028; Path G, 2002, AM J RESP CRIT CARE, V166, P818, DOI 10.1164/rccm.200202-134OC; Rochlitzer S, 2011, CLIN EXP ALLERGY; Rose CE, 2010, CELL MOL IMMUNOL, V7, P361, DOI 10.1038/cmi.2010.31; Shah S, 1998, BRIT J PHARMACOL, V125, P510, DOI 10.1038/sj.bjp.0702068; Song L, 2011, J LIPID RES, V52, P1542, DOI 10.1194/jlr.M015412; Spina D, 2002, CURR OPIN PHARMACOL, V2, P283, DOI 10.1016/S1471-4892(02)00160-1; Springer J, 2003, PULM PHARMACOL THER, V16, P121, DOI 10.1016/S1094-5539(03)00049-X; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Van Rijt LS, 2005, CLIN EXP ALLERGY, V35, P1125, DOI 10.1111/j.1365-2222.2005.02321.x; Veres TZ, 2009, PHARMACOL THERAPEUT, V122, P203, DOI 10.1016/j.pharmthera.2009.02.007; Veres TZ, 2009, AM J PATHOL, V174, P808, DOI 10.2353/ajpath.2009.080800; Veres TZ, 2011, AM J PATHOL, V179, P603, DOI 10.1016/j.ajpath.2011.04.039; Wells JW, 2005, SCAND J IMMUNOL, V61, P251, DOI 10.1111/j.1365-3083.2005.01556.x	36	28	30	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e45951	10.1371/journal.pone.0045951	http://dx.doi.org/10.1371/journal.pone.0045951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23049899	Green Published, Green Submitted, gold			2022-12-27	WOS:000309517300065
J	Bukovinszky, T; Verschoor, AM; Helmsing, NR; Bezemer, TM; Bakker, ES; Vos, M; Domis, LND				Bukovinszky, Tibor; Verschoor, Antonie M.; Helmsing, Nico R.; Bezemer, T. Martijn; Bakker, Elisabeth S.; Vos, Matthijs; Domis, Lisette N. de Senerpont			The Good, the Bad and the Plenty: Interactive Effects of Food Quality and Quantity on the Growth of Different Daphnia Species	PLOS ONE			English	Article							LIFE-HISTORY; FRESH-WATER; AQUATIC HERBIVORES; BODY-SIZE; STOICHIOMETRY; ZOOPLANKTON; LIMITATION; PERFORMANCE; DIETS; CLADOCERANS	Effects of food quality and quantity on consumers are neither independent nor interchangeable. Although consumer growth and reproduction show strong variation in relation to both food quality and quantity, the effects of food quality or food quantity have usually been studied in isolation. In two experiments, we studied the growth and reproduction in three filter-feeding freshwater zooplankton species, i.e. Daphnia galeata x hyalina, D. pulicaria and D. magna, on their algal food (Scenedesmus obliquus), varying in carbon to phosphorus (C:P) ratios and quantities (concentrations). In the first experiment, we found a strong positive effect of the phosphorus content of food on growth of Daphnia, both in their early and late juvenile development. Variation in the relationship between the P-content of animals and their growth rate reflected interspecific differences in nutrient requirements. Although growth rates typically decreased as development neared maturation, this did not affect these species-specific couplings between growth rate and Daphnia P-content. In the second experiment, we examined the effects of food quality on Daphnia growth at different levels of food quantity. With the same decrease in P-content of food, species with higher estimated P-content at zero growth showed a larger increase in threshold food concentrations (i.e. food concentration sufficient to meet metabolic requirements but not growth). These results suggest that physiological processes such as maintenance and growth may in combination explain effects of food quality and quantity on consumers. Our study shows that differences in response to variation in food quality and quantity exist between species. As a consequence, species-specific effects of food quality on consumer growth will also determine how species deal with varying food levels, which has implications for resource-consumer interactions.	[Bukovinszky, Tibor; Verschoor, Antonie M.; Helmsing, Nico R.; Bakker, Elisabeth S.; Domis, Lisette N. de Senerpont] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Bukovinszky, Tibor; Bezemer, T. Martijn] Netherlands Inst Ecol NIOO KNAW, Dept Terr Ecol, Wageningen, Netherlands; [Verschoor, Antonie M.] Ingrepro Bv, Borculo, Netherlands; [Verschoor, Antonie M.] Ctr Excellence Sustainable Water Technol, Wetsus, Leeuwarden, Netherlands; [Vos, Matthijs] Univ Potsdam, Dept Ecol & Ecosyst Modeling, Potsdam, Germany	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); University of Potsdam	Bukovinszky, T (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands.	tibor.bukovinszki@wur.nl	Bakker, Elisabeth S/B-7185-2008; Bezemer, Martijn/A-4068-2009; Domis, Lisette N. de Senerpont/C-2902-2008; Vos, Matthijs/B-3802-2009; KNAW, NIOO-KNAW/A-4320-2012	Bakker, Elisabeth S/0000-0002-5900-9136; Bezemer, Martijn/0000-0002-2878-3479; Domis, Lisette N. de Senerpont/0000-0001-7509-9541; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organization for Scientific Research [817.01.007]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	LdSD was supported by the Netherlands Organization for Scientific Research (grant 817.01.007). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya K, 2004, LIMNOL OCEANOGR, V49, P656, DOI 10.4319/lo.2004.49.3.0656; Anderson TR, 2005, AM NAT, V165, P1, DOI 10.1086/426598; Boersma M, 2002, ECOLOGY, V83, P2552, DOI 10.1890/0012-9658(2002)083[2552:LATEIF]2.0.CO;2; Boersma M, 2006, ECOLOGY, V87, P1325, DOI 10.1890/0012-9658(2006)87[1325:TMOAGT]2.0.CO;2; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Cruz-Rivera E, 2000, ECOLOGY, V81, P201; DeMott WR, 1998, ECOLOGY, V79, P2463, DOI 10.2307/176836; DeMott WR, 2005, OECOLOGIA, V142, P20, DOI 10.1007/s00442-004-1716-y; Dudycha JL, 2005, EVOLUTION, V59, P565; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 2003, ECOL LETT, V6, P936, DOI 10.1046/j.1461-0248.2003.00518.x; GLIWICZ ZM, 1990, NATURE, V343, P638, DOI 10.1038/343638a0; HALL DJ, 1976, ANNU REV ECOL SYST, V7, P177, DOI 10.1146/annurev.es.07.110176.001141; Hessen DO, 2002, ECOLOGY, V83, P1886, DOI 10.2307/3071772; Hood JM, 2010, AM NAT, V176, P651, DOI 10.1086/656489; Huberty AF, 2006, OECOLOGIA, V149, P444, DOI 10.1007/s00442-006-0462-8; Jensen TC, 2004, FRESHWATER BIOL, V49, P1138, DOI 10.1111/j.1365-2427.2004.01255.x; Jeyasingh PD, 2009, ECOL LETT, V12, P1229, DOI 10.1111/j.1461-0248.2009.01368.x; Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; KOOIJMAN SALM, 1995, J THEOR BIOL, V177, P139; Kreutzer C, 1999, ECOLOGY, V80, P2348, DOI 10.2307/176915; Kyle M, 2006, FRESHWATER BIOL, V51, P2087, DOI 10.1111/j.1365-2427.2006.01639.x; Lampert W, 1996, FUNCT ECOL, V10, P631, DOI 10.2307/2390173; Lana RP, 2005, LIVEST PROD SCI, V98, P219, DOI 10.1016/j.livprodsci.2005.03.008; MCKEE MJ, 1987, FRESHWATER BIOL, V18, P341, DOI 10.1111/j.1365-2427.1987.tb01318.x; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; Nisbet RM, 2010, PHILOS T R SOC B, V365, P3541, DOI 10.1098/rstb.2010.0167; Plath K, 2001, ECOLOGY, V82, P1260, DOI 10.1890/0012-9658(2001)082[1260:MLOZSC]2.0.CO;2; ROTHHAUPT KO, 1990, FRESHWATER BIOL, V23, P561, DOI 10.1111/j.1365-2427.1990.tb00295.x; SaLM Kooijman, 2000, DYNAMIC ENERGY MASS, DOI 10.1017/CBO9780511565403; Seidendorf B, 2010, OECOLOGIA, V162, P349, DOI 10.1007/s00442-009-1452-4; Shimizu Y, 2008, OECOLOGIA, V155, P21, DOI 10.1007/s00442-007-0896-7; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; STERNER RW, 1994, LIMNOL OCEANOGR, V39, P1228, DOI 10.4319/lo.1994.39.5.1228; STERNER RW, 1994, ANNU REV ECOL SYST, V25, P1, DOI 10.1146/annurev.es.25.110194.000245; Sterner RW, 2001, LIMNOL OCEANOGR, V46, P410, DOI 10.4319/lo.2001.46.2.0410; Urabe J, 2001, FUNCT ECOL, V15, P165, DOI 10.1046/j.1365-2435.2001.00511.x; URABE J, 1992, LIMNOL OCEANOGR, V37, P244, DOI 10.4319/lo.1992.37.2.0244; van de Waal DB, 2010, FRONT ECOL ENVIRON, V8, P145, DOI 10.1890/080178; Van Donk E, 2008, LIMNOLOGICA, V38, P189, DOI 10.1016/j.limno.2008.05.005; VanDonk E, 1997, LIMNOL OCEANOGR, V42, P357; Verschoor AM, 2004, ECOL LETT, V7, P1143, DOI 10.1111/j.1461-0248.2004.00675.x; Vijverberg J, 2006, FRESHWATER BIOL, V51, P756, DOI 10.1111/j.1365-2427.2006.01528.x; Weider LJ, 2008, OECOLOGIA, V158, P47, DOI 10.1007/s00442-008-1126-7	45	19	19	0	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e42966	10.1371/journal.pone.0042966	http://dx.doi.org/10.1371/journal.pone.0042966			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049734	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100006
J	Dalet, A; Bonsacquet, J; Gaboyard-Niay, S; Calin-Jageman, I; Chidavaenzi, RL; Venteo, S; Desmadryl, G; Goldberg, JM; Lysakowski, A; Chabbert, C				Dalet, Antoine; Bonsacquet, Jeremie; Gaboyard-Niay, Sophie; Calin-Jageman, Irina; Chidavaenzi, Robstein L.; Venteo, Stephanie; Desmadryl, Gilles; Goldberg, Jay M.; Lysakowski, Anna; Chabbert, Christian			Glutamate Transporters EAAT4 and EAAT5 Are Expressed in Vestibular Hair Cells and Calyx Endings	PLOS ONE			English	Article							CEREBELLAR PURKINJE-CELLS; AMINO-ACID TRANSPORTERS; COMPARATIVE MORPHOLOGY; SYNAPTIC-TRANSMISSION; EXTRACELLULAR-MATRIX; CRISTAE AMPULLARES; AFFERENT SYNAPSES; RAT UTRICLE; RECEPTOR; ACTIVATION	Glutamate is the neurotransmitter released from hair cells. Its clearance from the synaptic cleft can shape neurotransmission and prevent excitotoxicity. This may be particularly important in the inner ear and in other sensory organs where there is a continually high rate of neurotransmitter release. In the case of most cochlear and type II vestibular hair cells, clearance involves the diffusion of glutamate to supporting cells, where it is taken up by EAAT1 (GLAST), a glutamate transporter. A similar mechanism cannot work in vestibular type I hair cells as the presence of calyx endings separates supporting cells from hair-cell synapses. Because of this arrangement, it has been conjectured that a glutamate transporter must be present in the type I hair cell, the calyx ending, or both. Using whole-cell patch-clamp recordings, we demonstrate that a glutamate-activated anion current, attributable to a high-affinity glutamate transporter and blocked by DL-TBOA, is expressed in type I, but not in type II hair cells. Molecular investigations reveal that EAAT4 and EAAT5, two glutamate transporters that could underlie the anion current, are expressed in both type I and type II hair cells and in calyx endings. EAAT4 has been thought to be expressed almost exclusively in the cerebellum and EAAT5 in the retina. Our results show that these two transporters have a wider distribution in mice. This is the first demonstration of the presence of transporters in hair cells and provides one of the few examples of EAATs in presynaptic elements.	[Dalet, Antoine; Bonsacquet, Jeremie; Gaboyard-Niay, Sophie; Venteo, Stephanie; Desmadryl, Gilles; Chabbert, Christian] INSERM, U1051, Inst Neurosci Montpellier, Montpellier, France; [Calin-Jageman, Irina] Dominican Univ, Dept Biol, River Forest, IL USA; [Chidavaenzi, Robstein L.; Lysakowski, Anna] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA; [Goldberg, Jay M.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago	Dalet, A (corresponding author), INSERM, U1051, Inst Neurosci Montpellier, Montpellier, France.	antoine.dalet@gmail.com; christian.chabbert@inserm.fr	Lysakowski, Anna/F-9534-2010	Lysakowski, Anna/0000-0001-6259-0294; Gaboyard-Niay, Sophie/0000-0001-8256-8692; Calin-Jageman, Irina/0000-0002-2529-4223	Centre National da'Etudes Spatiales; French Ministry of Research and New Technologies; National Institute on Deafness and Other Communication Disorders [DC2058]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R56DC002058, R01DC002058] Funding Source: NIH RePORTER	Centre National da'Etudes Spatiales; French Ministry of Research and New Technologies; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Centre National da'Etudes Spatiales, the French Ministry of Research and New Technologies (grants to AD and JB) and the National Institute on Deafness and Other Communication Disorders (DC2058 to JMG and AL) (http://www.nidcd.nih.gov/Pages/default.aspx, http://www.cnes.fr/web/CNES-fr/6919-cnes-tout-sur-l-espace.php, http://www.enseignementsup-recherche.gouv.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara SG, 2002, NEUROCHEM INT, V41, P313, DOI 10.1016/S0197-0186(02)00018-9; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Barnett NL, 2000, GLIA, V30, P64, DOI 10.1002/(SICI)1098-1136(200003)30:1<64::AID-GLIA7>3.0.CO;2-I; Bonsacquet J, 2006, J PHYSIOL-LONDON, V576, P63, DOI 10.1113/jphysiol.2006.116467; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Brugeaud A, 2007, J NEUROSCI, V27, P3503, DOI 10.1523/JNEUROSCI.5185-06.2007; Carroll P, 2001, MOL CELL NEUROSCI, V17, P611, DOI 10.1006/mcne.2001.0966; Chabbert C, 2003, J PHYSIOL-LONDON, V553, P113, DOI 10.1113/jphysiol.2003.043034; Chen JWY, 2000, J NEUROPHYSIOL, V84, P139, DOI 10.1152/jn.2000.84.1.139; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Desai SS, 2005, J NEUROPHYSIOL, V93, P267, DOI 10.1152/jn.00747.2003; Desai SS, 2005, J NEUROPHYSIOL, V93, P251, DOI 10.1152/jn.00746.2003; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dityatev A, 2010, NAT REV NEUROSCI, V11, P735, DOI 10.1038/nrn2898; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Fyk-Kolodziej B, 2004, J COMP NEUROL, V475, P518, DOI 10.1002/cne.20199; Gaboyard S, 2005, NEUROSCIENCE, V133, P253, DOI 10.1016/j.neuroscience.2005.02.011; Gameiro A, 2011, BIOPHYS J, V100, P2623, DOI 10.1016/j.bpj.2011.04.034; Gincel D, 2007, EXP NEUROL, V203, P205, DOI 10.1016/j.expneurol.2006.08.016; Glowatzki E, 2006, J NEUROSCI, V26, P7659, DOI 10.1523/JNEUROSCI.1545-06.2006; Grewer C, 2005, J MEMBRANE BIOL, V203, P1, DOI 10.1007/s00232-004-0731-6; Holt JC, 2007, J NEUROPHYSIOL, V98, P1083, DOI 10.1152/jn.00332.2007; Huang YHH, 2004, J NEUROSCI, V24, P103, DOI 10.1523/JNEUROSCI.4473-03.2004; Ishiyama G, 2002, BRAIN RES, V935, P16, DOI 10.1016/S0006-8993(02)02419-8; Lysakowski A, 1997, J COMP NEUROL, V389, P419, DOI 10.1002/(SICI)1096-9861(19971222)389:3<419::AID-CNE5>3.0.CO;2-3; Lysakowski A, 2011, J NEUROSCI, V31, P10101, DOI 10.1523/JNEUROSCI.0521-11.2011; Matsubara A, 1999, BRAIN RES, V819, P58, DOI 10.1016/S0006-8993(98)01345-6; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Ottersen OP, 1998, PROG NEUROBIOL, V54, P127, DOI 10.1016/S0301-0082(97)00054-3; Palmer MJ, 2003, J NEUROSCI, V23, P4831; PICAUD S, 1995, P NATL ACAD SCI USA, V92, P9417, DOI 10.1073/pnas.92.20.9417; Rauen T, 2004, NEUROCHEM INT, V45, P1095, DOI 10.1016/j.neuint.2004.04.006; Rennie KJ, 2006, J NEUROPHYSIOL, V95, P26, DOI 10.1152/jn.00641.2005; RENNIE KJ, 1994, J NEUROPHYSIOL, V71, P317, DOI 10.1152/jn.1994.71.1.317; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Takumi Y, 1997, NEUROSCIENCE, V79, P1137, DOI 10.1016/S0306-4522(97)00025-0; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tzingounis AV, 2007, NAT REV NEUROSCI, V8, P935, DOI 10.1038/nrn2274; Veruki ML, 2006, NAT NEUROSCI, V9, P1388, DOI 10.1038/nn1793; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; WERSALL J, 1956, Acta Otolaryngol Suppl, V126, P1; Wersinger E, 2006, J PHYSIOL-LONDON, V577, P221, DOI 10.1113/jphysiol.2006.118281; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	46	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46261	10.1371/journal.pone.0046261	http://dx.doi.org/10.1371/journal.pone.0046261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049999	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100170
J	Jiang, J; Jia, ZF; Cao, DH; Jin, MS; Kong, F; Suo, J; Cao, XY				Jiang, Jing; Jia, Zhifang; Cao, Donghui; Jin, Mei-Shan; Kong, Fei; Suo, Jian; Cao, Xueyuan			Polymorphisms of the DNA Methyltransferase 1 Associated with Reduced Risks of Helicobacter pylori Infection and Increased Risks of Gastric Atrophy	PLOS ONE			English	Article							T-CELLS; CANCER RISK; CPG ISLANDS; DNMT1 POLYMORPHISMS; SATELLITE REGIONS; MESSENGER-RNA; IFN-GAMMA; METHYLATION; EXPRESSION; GENE	Introduction: DNA methyltransferase-1(DNMT1) is an important enzyme in determining genomic methylation patterns in mammalian cells. We investigated the associations between SNPs in the DNMT1 gene and risks of developing H. pylori seropositivity, gastric atrophy and gastric cancer in the Chinese population. Methods: The study consisted of 447 patients with gastric cancer; 111 patients with gastric atrophy; and 961 healthy controls. Five SNPs, rs10420321, rs16999593, rs8101866, rs8111085 and rs2288349 of the DNMT1 gene were genotyped. Anti-H.pylori IgG was detected by ELISA. Gastric atrophy was screened by the level of serum pepsinogen Iand II and then confirmed by endoscopy and histopatholgical examinations. Results: The age- and sex-adjusted OR of H. pylori seropositivity was 0.67 (95%CI: 0.51-0.87) for rs8111085 TC/CC genotypes, significantly lower than the TT genotype in healthy controls. The adjusted OR of H. pylori seropositivity was 0.68 (95%CI: 0.52-0.89) for rs10420321 AG/GG genotypes. In addition, patients carrying rs2228349 AA genotype have a significantly increased risk for H. pylori seropositivity (OR = 1.67; 95%CI: 1.02-2.75). Further haplotype analyses also showed that the ATTTG and ATCTA are significantly associated with increased risks in H. pylori infection compared to the GTCCG haplotype (OR = 1.38, 95%CI: 1.08-1.77; OR = 1.40, 95%CI: 1.09-1.80). The adjusted ORs of gastric atrophy were 1.66 (95%CI: 1.06-2.61) for rs10420321 GG genotype, and 1.67 (95%CI 1.06-2.63, P = 0.03) for rs8111085 CC genotype, but no association was found between SNPs in the DNMT1 gene and risk of developing gastric cancer. Conclusions: Individuals with rs10420321 GG and rs8111085 CC genotype of the DNMT1 gene were associated with reduced risks for H. pylori infection. On the other hand, higher risks of gastric atrophy were found in the carriers with these two genotypes compared to other genotypes. Our results suggested that SNPs of DNMT1 could be used as genotypic markers for predicting genetic susceptibilities to H. pylori infection and risks in gastric atrophy.	[Suo, Jian; Cao, Xueyuan] Jilin Univ, Dept Gastr & Colorectal Surg, Hosp 1, Changchun 130023, Peoples R China; [Jiang, Jing; Jia, Zhifang; Cao, Donghui; Kong, Fei] Jilin Univ, Div Clin Epidemiol, Hosp 1, Changchun 130023, Peoples R China; [Jin, Mei-Shan] Jilin Univ, Div Pathol, Hosp 1, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Cao, XY (corresponding author), Jilin Univ, Dept Gastr & Colorectal Surg, Hosp 1, Changchun 130023, Peoples R China.	ccmzc32jdyycao@yahoo.com.cn			National Natural Science Foundation of China [30940060, 81072369]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study has been supported by National Natural Science Foundation of China (30940060 and 81072369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; [Anonymous], 2011, YB HLTH PEOPL REP CH; Bergman M, 2006, NAT REV MICROBIOL, V4, P151, DOI 10.1038/nrmicro1344; Bodger K, 1998, BRIT MED BULL, V54, P139; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Cao Q, 2007, J DIGEST DIS, V8, P15, DOI 10.1111/j.1443-9573.2007.00271.x; Cebrian A, 2006, CARCINOGENESIS, V27, P1661, DOI 10.1093/carcin/bgi375; Cedar H, 2012, ANNU REV BIOCHEM, V81, P97, DOI 10.1146/annurev-biochem-052610-091920; Chun JY, 2009, BMB REP, V42, P834, DOI 10.5483/BMBRep.2009.42.12.834; D'Elios MM, 2003, MICROBES INFECT, V5, P723, DOI 10.1016/S1286-4579(03)00114-X; De La Vega Francisco M, 2007, Methods Mol Biol, V376, P177; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Fitzpatrick DR, 1998, J EXP MED, V188, P103, DOI 10.1084/jem.188.1.103; Flach CF, 2011, INFECT IMMUN, V79, P879, DOI 10.1128/IAI.00756-10; Gao XA, 2010, CLIN BREAST CANCER, V10, P373, DOI 10.3816/CBC.2010.n.049; Haeberle HA, 1997, INFECT IMMUN, V65, P4229, DOI 10.1128/IAI.65.10.4229-4235.1997; Hamiliton SA, 2000, WHO CLASSIFICATION T; Harlid S, 2011, INT J CANCER, V129, P1689, DOI 10.1002/ijc.25786; Hishida A, 2010, WORLD J GASTRO ONCOL, V2, P369, DOI 10.4251/wjgo.v2.i10.369; Kabir S, 2009, HELICOBACTER, V14, P159, DOI 10.1111/j.1523-5378.2009.00677.x; Kanai Y, 2003, CANCER LETT, V192, P75, DOI 10.1016/S0304-3835(02)00689-4; Kanai Y, 2001, INT J CANCER, V91, P205, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1040>3.0.CO;2-2; Kelemen LE, 2008, CANCER RES, V68, P2498, DOI 10.1158/0008-5472.CAN-07-5165; Khatami F, 2009, ASIAN PAC J CANCER P, V10, P1183; Khatami F, 2009, ASIAN PAC J CANCER P, V10, P1177; Lee PH, 2009, BIOINFORMATICS, V25, P1048, DOI 10.1093/bioinformatics/btp103; Leng SG, 2008, CARCINOGENESIS, V29, P1380, DOI 10.1093/carcin/bgn121; Lin DY, 2005, GENET EPIDEMIOL, V29, P299, DOI 10.1002/gepi.20098; Lochhead P, 2007, BEST PRACT RES CL GA, V21, P281, DOI 10.1016/j.bpg.2007.02.002; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Makar KW, 2004, J IMMUNOL, V173, P4402, DOI 10.4049/jimmunol.173.7.4402; Makar KW, 2003, NAT IMMUNOL, V4, P1183, DOI 10.1038/ni1004; Nakajima T, 2009, INT J CANCER, V124, P905, DOI 10.1002/ijc.24018; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Park BL, 2004, J HUM GENET, V49, P642, DOI 10.1007/s10038-004-0192-x; Penix LA, 1996, J BIOL CHEM, V271, P31964, DOI 10.1074/jbc.271.50.31964; Saito Y, 2001, HEPATOLOGY, V33, P561, DOI 10.1053/jhep.2001.22507; Smythies LE, 2000, J IMMUNOL, V165, P1022, DOI 10.4049/jimmunol.165.2.1022; Snaith Ailsa, 2008, Expert Rev Gastroenterol Hepatol, V2, P577, DOI 10.1586/17474124.2.4.577; Svedruzic ZM, 2011, PROG MOL BIOL TRANSL, V101, P221, DOI 10.1016/B978-0-12-387685-0.00006-8; Ye CZ, 2010, BREAST CANCER RES TR, V121, P765, DOI 10.1007/s10549-009-0569-9; Zeng D, 2006, BIOSTATISTICS, V7, P486, DOI 10.1093/biostatistics/kxj021	42	48	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46058	10.1371/journal.pone.0046058	http://dx.doi.org/10.1371/journal.pone.0046058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049933	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100126
J	Stokholm, J; Schjorring, S; Pedersen, L; Bischoff, AL; Folsgaard, N; Carson, CG; Chawes, B; Bonnelykke, K; Molgaard, A; Krogfelt, KA; Bisgaard, H				Stokholm, Jakob; Schjorring, Susanne; Pedersen, Louise; Bischoff, Anne Louise; Folsgaard, Nilofar; Carson, Charlotte G.; Chawes, Bo; Bonnelykke, Klaus; Molgaard, Anne; Krogfelt, Karen A.; Bisgaard, Hans			Living with Cat and Dog Increases Vaginal Colonization with E. coli in Pregnant Women	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; ONSET NEONATAL SEPSIS; PATTERNS; PRETERM; BURDEN; ASTHMA; RISK	Background: Furred pets in the household are known reservoirs for pathogenic bacteria, but it is not known if transmission of bacteria between pet and owner leads to significantly increased rate of infections. We studied whether cats and dogs living in the household of pregnant women affect the commensal vaginal flora, and furthermore the need for oral antibiotics and rate of urinary tract infections during pregnancy. Methods: The novel unselected Copenhagen Prospective Study on Asthma in Childhood (COPSAC(2010)) pregnancy cohort of 709 women participated in this analysis. Detailed information on pet exposure, oral antibiotic prescriptions filled at pharmacy and urinary tract infection during pregnancy was obtained and verified prospectively during clinic visits. Vaginal cultures were obtained at pregnancy week 36. Results: Women, who had cat or dog in the home during pregnancy, had a different vaginal flora, in particular with increased Escherichia coli (E. coli) colonization; odds ratio after adjustment for lifestyle confounders and antibiotics 2.20, 95% CI, [1.27-3.80], p = 0.005.43% of women living with cat and/or dog in the home used oral antibiotics compared to 33% of women with no cat or dog; adjusted odds ratio 1.51, 95% CI, [1.08-2.12], p = 0.016. Women living with cat had increased frequency of self-reported urinary tract infection; adjusted odds ratio 1.57, 95% CI, [1.02-2.43], p = 0.042. Conclusions: The increased vaginal E. coli colonization in women living with cat or dog suggests a clinically important transmission of pathogenic bacteria from pet to owner substantiated by increased rate of antibiotic use and urinary tract infections which, which is of particular concern during pregnancy.	[Bischoff, Anne Louise; Folsgaard, Nilofar; Carson, Charlotte G.; Chawes, Bo; Bonnelykke, Klaus; Molgaard, Anne; Bisgaard, Hans] Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen, Denmark; [Stokholm, Jakob; Pedersen, Louise] Univ Copenhagen, Naestved Hosp, Naestved, Denmark; [Schjorring, Susanne; Krogfelt, Karen A.] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Statens Serum Institut	Bisgaard, H (corresponding author), Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen, Denmark.	bisgaard@copsac.com	Krogfelt, Karen Angeliki A/O-8145-2016; Kronow, Joern/B-1054-2011; Bisgaard, Hans/N-4761-2016; Krogfelt, Karen Angeliki/P-2430-2018	Krogfelt, Karen Angeliki A/0000-0001-7536-3453; Bisgaard, Hans/0000-0003-4131-7592; Schjorring, Susanne/0000-0001-5575-7252; Chawes, Bo/0000-0001-6846-6243; Bonnelykke, Klaus/0000-0003-2003-1018; Stokholm, Jakob/0000-0003-4989-9769	Lundbeck Foundation; Strategic Research Foundation; Pharmacy Foundation; Augustinus Foundation; Danish Medical Research Council; Danish Pediatric Asthma Centre	Lundbeck Foundation(Lundbeckfonden); Strategic Research Foundation; Pharmacy Foundation; Augustinus Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Pediatric Asthma Centre	COPSAC is funded by private and public research funds all listed on www.copsac.com. The Lundbeck Foundation; The Strategic Research Foundation; the Pharmacy Foundation of 1991; Augustinus Foundation; the Danish Medical Research Council and The Danish Pediatric Asthma Centre provided core support for COPSAC. No pharmaceutical companies were involved in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Anderson B, 2011, OBSTET GYNECOL, V117, P844, DOI 10.1097/AOG.0b013e318209dd57; Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050131; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Carey JC, 2005, AM J OBSTET GYNECOL, V192, P1341, DOI 10.1016/j.ajog.2004.12.069; Conde-Agudelo A, 2008, AM J OBSTET GYNECOL, V198, P7, DOI 10.1016/j.ajog.2007.07.040; CUNNINGHAM FG, 1994, BAILLIERE CLIN OB GY, V8, P353, DOI 10.1016/S0950-3552(05)80325-6; Damborg P, 2009, EPIDEMIOL INFECT, V137, P1457, DOI 10.1017/S095026880900226X; Forbes RL, 2011, THORAX; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Johnson JR, 2008, J INFECT DIS, V197, P218, DOI 10.1086/524844; Johnson JR, 2009, J CLIN MICROBIOL, V47, P3721, DOI 10.1128/JCM.01581-09; Johnson JR, 2008, J CLIN MICROBIOL, V46, P4078, DOI 10.1128/JCM.00980-08; Johnson JR, 2001, INFECT IMMUN, V69, P1306, DOI 10.1128/IAI.69.3.1306-1314.2001; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Macejko AM, 2007, UROL CLIN N AM, V34, P35, DOI 10.1016/j.ucl.2006.10.010; NADISAUSKIENE R, 1995, GYNECOL OBSTET INVES, V40, P179, DOI 10.1159/000292331; Schieve AH, AM J PUBLIC HLTH, V84, P405; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Weston EJ, 2011, PEDIATR INFECT DIS J, V30, P937, DOI 10.1097/INF.0b013e318223bad2	23	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46226	10.1371/journal.pone.0046226	http://dx.doi.org/10.1371/journal.pone.0046226			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049986	gold, Green Published, Green Submitted			2022-12-27	WOS:000309556100159
J	Su, HN; Chen, ZH; Song, XY; Chen, XL; Shi, M; Zhou, BC; Zhao, X; Zhang, YZ				Su, Hai-Nan; Chen, Zhi-Hua; Song, Xiao-Yan; Chen, Xiu-Lan; Shi, Mei; Zhou, Bai-Cheng; Zhao, Xian; Zhang, Yu-Zhong			Antimicrobial Peptide Trichokonin VI-Induced Alterations in the Morphological and Nanomechanical Properties of Bacillus subtilis	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; BACTERIAL VIABILITY; PEPTAIBOLS; CELLS; ANTIBIOTICS; ELASTICITY; CHITOSANS; STAIN	Antimicrobial peptides are promising alternative antimicrobial agents compared to conventional antibiotics. Understanding the mode of action is important for their further application. We examined the interaction between trichokonin VI, a peptaibol isolated from Trichoderma pseudokoningii, and Bacillus subtilis, a representative Gram-positive bacterium. Trichokonin VI was effective against B. subtilis with a minimal inhibitory concentration of 25 mu M. Trichokonin VI exhibited a concentration-and time-dependent effect against B. subtilis, which was studied using atomic force microscopy. The cell wall of B. subtilis collapsed and the roughness increased upon treatment with trichokonin VI. Nanoindentation experiments revealed a progressive decrease in the stiffness of the cells. Furthermore, the membrane permeabilization effect of trichokonin VI on B. subtilis was monitored, and the results suggest that the leakage of intracellular materials is a possible mechanism of action for trichokonin VI, which led to alterations in the morphological and nanomechanical properties of B. subtilis.	[Song, Xiao-Yan] Shandong Univ, State Key Lab Crystal Mat, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China; Shandong Univ, State Key Lab Microbial Technol, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China	Shandong University; Shandong University	Song, XY (corresponding author), Shandong Univ, State Key Lab Crystal Mat, Marine Biotechnol Res Ctr, Jinan 250100, Peoples R China.	xysong@sdu.edu.cn; zhangyz@sdu.edu.cn			Hi-Tech Research and Development Program of China [2011AA090704]; National Natural Science Foundation of China [30870047, 81071804]; Specialized Research Fund for the Doctoral Program of Higher Education [BA2009YY009]; Program of Shandong for Taishan Scholars; Natural Science Foundation of Shandong Province [JQ200910, 2008BS02019]; Independent Innovation Foundation of Shandong University [2009TS079, 2011DX002]	Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program of Shandong for Taishan Scholars; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Independent Innovation Foundation of Shandong University	The work was supported by Hi-Tech Research and Development Program of China (2011AA090704), National Natural Science Foundation of China (30870047, 81071804), Specialized Research Fund for the Doctoral Program of Higher Education (BA2009YY009), Program of Shandong for Taishan Scholars, Natural Science Foundation of Shandong Province (JQ200910, 2008BS02019) and Independent Innovation Foundation of Shandong University (2009TS079, 2011DX002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955; Arnoldi M, 2000, PHYS REV E, V62, P1034, DOI 10.1103/PhysRevE.62.1034; da Silva A, 2005, WORLD J MICROB BIOT, V21, P1103, DOI 10.1007/s11274-005-0077-y; Degenkolb T, 2007, CHEM BIODIVERS, V4, P1052, DOI 10.1002/cbdv.200790096; Domadia PN, 2010, J AM CHEM SOC, V132, P18417, DOI 10.1021/ja1083255; Dong XW, 2010, SPECTROSC SPECT ANAL, V30, P458, DOI 10.3964/j.issn.1000-0593(2010)02-0458-04; Duclohier H, 2004, EUR BIOPHYS J BIOPHY, V33, P169, DOI 10.1007/s00249-003-0383-y; Duclohier H, 2010, CURR PHARM DESIGN, V16, P3212, DOI 10.2174/138161210793292500; Dufrene YF, 2008, NAT REV MICROBIOL, V6, P674, DOI 10.1038/nrmicro1948; Eaton P, 2008, ULTRAMICROSCOPY, V108, P1128, DOI 10.1016/j.ultramic.2008.04.015; Fantner GE, 2010, NAT NANOTECHNOL, V5, P280, DOI [10.1038/NNANO.2010.29, 10.1038/nnano.2010.29]; Fernandes JC, 2009, ULTRAMICROSCOPY, V109, P854, DOI 10.1016/j.ultramic.2009.03.015; Formosa C, 2012, NANOMED-NANOTECHNOL, V8, P12, DOI 10.1016/j.nano.2011.09.009; Gaboriaud F, 2005, J BACTERIOL, V187, P3864, DOI 10.1128/JB.187.11.3864-3868.2005; Gaboriaud F, 2007, COLLOID SURFACE B, V54, P10, DOI 10.1016/j.colsurfb.2006.09.014; Hancock RD, 2001, COORDIN CHEM REV, V212, P1, DOI 10.1016/S0010-8545(00)00418-5; Hocquellet A, 2010, PEPTIDES, V31, P58, DOI 10.1016/j.peptides.2009.10.006; Kubicek CP, 2007, CHEM BIODIVERS, V4, P1068, DOI 10.1002/cbdv.200790097; Langsrud S, 1996, J APPL BACTERIOL, V81, P411; Lebaron P, 1998, APPL ENVIRON MICROB, V64, P2697; Li A, 2007, BBA-BIOMEMBRANES, V1768, P411, DOI 10.1016/j.bbamem.2006.12.010; Liu SB, 2010, NANOSCALE, V2, P2744, DOI 10.1039/c0nr00441c; Meincken A, 2005, ANTIMICROB AGENTS CH, V49, P4085, DOI 10.1128/AAC.49.10.4085-4092.2005; Mortensen NP, 2009, LANGMUIR, V25, P3728, DOI 10.1021/la803898g; Parisien A, 2008, J APPL MICROBIOL, V104, P1, DOI 10.1111/j.1365-2672.2007.03498.x; Peters BM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001067; Rossetto G, 2007, NANOMED-NANOTECHNOL, V3, P198, DOI 10.1016/j.nano.2007.06.002; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Scheuring S, 2010, MOL MICROBIOL, V75, P1327, DOI 10.1111/j.1365-2958.2010.07064.x; Shi M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-26; Silva ON, 2012, BIOPOLYMERS, V98, P322, DOI 10.1002/bip.22071; Song XY, 2006, FEMS MICROBIOL LETT, V260, P119, DOI 10.1111/j.1574-6968.2006.00316.x; Soon RL, 2009, ANTIMICROB AGENTS CH, V53, P4979, DOI 10.1128/AAC.00497-09; Velegol SB, 2002, LANGMUIR, V18, P5256, DOI 10.1021/la011818g; Whitmore L, 2004, EUR BIOPHYS J BIOPHY, V33, P233, DOI 10.1007/s00249-003-0348-1; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Yu PL, 2010, INT J ANTIMICROB AG, V35, P288, DOI 10.1016/j.ijantimicag.2009.10.017; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	38	36	37	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45818	10.1371/journal.pone.0045818	http://dx.doi.org/10.1371/journal.pone.0045818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049870	Green Submitted, gold, Green Published			2022-12-27	WOS:000309556100085
J	Hartigan, A; Dhand, NK; Rose, K; Slapeta, J; Phalen, DN				Hartigan, Ashlie; Dhand, Navneet K.; Rose, Karrie; Slapeta, Jan; Phalen, David N.			Comparative Pathology and Ecological Implications of Two Myxosporean Parasites in Native Australian Frogs and the Invasive Cane Toad	PLOS ONE			English	Article							WHIRLING DISEASE; MYXOBOLUS-CEREBRALIS; AMPHIBIAN METAMORPHOSIS; MYXOZOAN PARASITE; BRAIN; PHYLUM	Myxosporean parasites Cystodiscus axonis and C. australis are pathogens of native and exotic Australian frog species. The pathology and ecological outcomes of infection with these parasites were investigated in this study. Gliosis was correlated to Cystodiscus axonis plasmodia in the brains of (9/60) tadpoles and (3/9) adult endangered Green and golden bell frogs using ordinal regression. Severe host reactions to C. axonis (haemorrhage, necrosis, and vasulitis) were observed in the brains of threatened Southern bell frogs (8/8), critically endangered Booroolong frogs (15/44) and Yellow spotted bell frogs (3/3). Severe brain lesions were associated with behavioural changes, neurological dysfunction, and spontaneous death. Both C. axonis and C. australis develop in the bile ducts of tadpoles, the plasmodia were significantly associated with biliary hyperplasia, inflammation and the loss of hepatocytes in (34/72) Green and golden bell frog tadpoles using ordinal regression. These lesions were so severe that in some cases 70% of the total liver was diseased. Normal liver function in tadpoles is necessary for metamorphosis, metabolism, and immune function. We postulate that this extensive liver damage would have significant host health impacts. Severe hepatic myxosporidiosis was more prevalent in tadpoles examined in autumn and winter (overwintered), suggestive of delayed metamorphosis in infected tadpoles, which would have serious flow-on effects in small populations. We compared the sensitivity of histopathology and species-specific PCR in the detection of C. australis and C. axonis. PCR was determined to be the most sensitive method (detection limit 1 myxospore equivalent of ribosomal DNA). Histology, however, had the advantage of assessing the impact of the parasite on the host. It was concluded that these parasites have the potential for significant ecological impacts, because of their high prevalence of infection and their ability to cause disease in some frogs.	[Hartigan, Ashlie; Dhand, Navneet K.; Slapeta, Jan; Phalen, David N.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Rose, Karrie] Taronga Conservat Soc Australia, Australian Registry Wildlife Hlth, Mosman, NSW, Australia	University of Sydney	Phalen, DN (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	david.phalen@sydney.edu.au	Dhand, Navneet K/H-5762-2019; Hartigan, Ashlie/G-7310-2014	Dhand, Navneet K/0000-0002-4362-3596; Slapeta, Jan/0000-0003-1459-9117	Australian Academy of Science; University of Sydney	Australian Academy of Science; University of Sydney(University of Sydney)	This work was supported by the Australian Academy of Science (2009 Margaret Middleton Fund for the Conservation of Endangered Australian vertebrate species award) and The University of Sydney (WP Richards Bequest for Veterinary Pathology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Pellitero M. P., 1982, Bulletin of the European Association of Fish Pathologists, V2, P4; [Anonymous], STATUS TEMPERATE RIV; Anstis M., 2002, TADPOLES S E AUSTR G; Bartholomew JL, 2008, INT J PARASITOL, V38, P1199, DOI 10.1016/j.ijpara.2008.01.008; Bartholomew JL, 2002, AM FISH S S, V29, P3; Berger L, 1997, J WILDLIFE DIS, V33, P903, DOI 10.7589/0090-3558-33.4.903; BOUSTEAD NC, 1993, NEW ZEAL J MAR FRESH, V27, P431, DOI 10.1080/00288330.1993.9516584; Canning EU, 2004, ADV PARASIT, V56, P43, DOI 10.1016/S0065-308X(03)56002-X; Crawshaw GJ, 2000, SEMIN AVIAN EXOT PET, V9, P165, DOI 10.1053/ax.2000.7133; Cullen BR, 2002, DIS AQUAT ORGAN, V49, P83, DOI 10.3354/dao049083; Davis AK, 2007, ECOHEALTH, V4, P310, DOI 10.1007/s10393-007-0115-3; Dykova I., 1986, Bulletin of the European Association of Fish Pathologists, V6, P10; Dykova I, 2007, FOLIA PARASIT, V54, P272, DOI 10.14411/fp.2007.035; DZULINKSY K, 1994, CAN J ZOOL, V72, P1180, DOI 10.1139/z94-158; ELMATBOULI M, 1995, J FISH BIOL, V46, P919, DOI 10.1111/j.1095-8649.1995.tb01397.x; Feist Stephen W., 2006, P230, DOI 10.1079/9780851990156.0230; Frasca S, 1998, DIS AQUAT ORGAN, V32, P211, DOI 10.3354/dao032211; FRIEDEN E, 1958, ARCH BIOCHEM BIOPHYS, V73, P107, DOI 10.1016/0003-9861(58)90245-5; Friedrich C, 2000, PARASITOLOGY, V121, P483, DOI 10.1017/S0031182099006769; Hallett SL, 2009, DIS AQUAT ORGAN, V86, P39, DOI 10.3354/dao02104; HALLIDAY MM, 1976, J FISH BIOL, V9, P339, DOI 10.1111/j.1095-8649.1976.tb04683.x; Hamer AJ, 2010, ANIM CONSERV, V13, P275, DOI 10.1111/j.1469-1795.2009.00335.x; Hartigan A, 2012, PARASITOLOGY, V19, P1; Hartigan A, 2012, EMERG INFECT DIS, V18, P693, DOI 10.3201/eid1804.111606; Hartigan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018871; Hartigan A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-50; Hedrick R. P., 1993, Annual Review of Fish Diseases, V3, P277, DOI 10.1016/0959-8030(93)90039-E; Hedrick RP, 2008, J AQUAT ANIM HEALTH, V20, P116, DOI 10.1577/H07-042.1; Hedrick RP, 1998, IMMUNOL REV, V166, P365, DOI 10.1111/j.1600-065X.1998.tb01276.x; HOFFMAN G L, 1990, Journal of Aquatic Animal Health, V2, P30, DOI 10.1577/1548-8667(1990)002&lt;0030:MCAWCO&gt;2.3.CO;2; Holzer AS, 2006, PARASITOLOGY, V132, P193, DOI 10.1017/S0031182005008917; Jimenez-Guri E, 2007, SCIENCE, V317, P116, DOI 10.1126/science.1142024; Johnson PTJ, 2011, FUNCT ECOL, V25, P726, DOI 10.1111/j.1365-2435.2010.01830.x; KENT ML, 1984, J PROTOZOOL, V31, P91, DOI 10.1111/j.1550-7408.1984.tb04295.x; Levsen A, 2004, DIS AQUAT ORGAN, V59, P135, DOI 10.3354/dao059135; LOM J, 1987, PARASITOL TODAY, V3, P327, DOI 10.1016/0169-4758(87)90115-3; Lom J, 2006, FOLIA PARASIT, V53, P1, DOI 10.14411/fp.2006.001; Lom J, 1997, ACTA PROTOZOOL, V36, P83; Lom J., 1992, DEV AQUACULTURE FISH; Munoz G, 2011, PARASITOL RES, V109, P53, DOI 10.1007/s00436-010-2220-4; Munson L, 2005, J WILDLIFE DIS, V41, P542, DOI 10.7589/0090-3558-41.3.542; NEWMAN RA, 1992, BIOSCIENCE, V42, P671, DOI 10.2307/1312173; Prunescu CC, 2007, FOLIA PARASIT, V54, P159, DOI 10.14411/fp.2007.022; Pyke Graham H., 2001, Australian Zoologist, V31, P563; Raffel TR, 2011, OECOLOGIA, V165, P1031, DOI 10.1007/s00442-010-1776-0; Ransohoff RM, 2007, NAT NEUROSCI, V10, P1507, DOI 10.1038/nn1207-1507; Rollins-Smith LA, 1998, IMMUNOL REV, V166, P221, DOI 10.1111/j.1600-065X.1998.tb01265.x; Rose JD, 2000, J AQUAT ANIM HEALTH, V12, P107, DOI 10.1577/1548-8667(200006)012&lt;0107:WDBAIR&gt;2.0.CO;2; Rose K, 2005, WILDLIFE HLTH INVEST; Shi YB, 1996, BIOESSAYS, V18, P391, DOI 10.1002/bies.950180509; Siddall ME, 1995, J PARASITOL, V81, P961, DOI 10.2307/3284049; Skerratt LF, 2011, J HERPETOL, V45, P444, DOI 10.1670/10-193.1; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Stockwell MP, 2010, ANIM CONSERV, V13, P62, DOI 10.1111/j.1469-1795.2010.00407.x; Wassens Skye, 2008, Australian Zoologist, V34, P446; White Arthur W., 1996, Australian Zoologist, V30, P177	57	9	10	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 3	2012	7	10							e43780	10.1371/journal.pone.0043780	http://dx.doi.org/10.1371/journal.pone.0043780			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	015NU	23056175	Green Published, gold			2022-12-27	WOS:000309454000003
J	Maddalo, D; Neeb, A; Jehle, K; Schmitz, K; Muhle-Goll, C; Shatkina, L; Walther, TV; Bruchmann, A; Gopal, SM; Wenzel, W; Ulrich, AS; Cato, ACB				Maddalo, Danilo; Neeb, Antje; Jehle, Katja; Schmitz, Katja; Muhle-Goll, Claudia; Shatkina, Liubov; Walther, Tamara Vanessa; Bruchmann, Anja; Gopal, Srinivasa M.; Wenzel, Wolfgang; Ulrich, Anne S.; Cato, Andrew C. B.			A Peptidic Unconjugated GRP78/BiP Ligand Modulates the Unfolded Protein Response and Induces Prostate Cancer Cell Death	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CHAPERONE ACTIVITY; ANDROGEN RECEPTOR; SURFACE GRP78; UP-REGULATION; ACTIVATION; BAG-1; EXPRESSION; ANTIBODIES; PREDICTOR	The molecular chaperone GRP78/BiP is a key regulator of protein folding in the endoplasmic reticulum, and it plays a pivotal role in cancer cell survival and chemoresistance. Inhibition of its function has therefore been an important strategy for inhibiting tumor cell growth in cancer therapy. Previous efforts to achieve this goal have used peptides that bind to GRP78/BiP conjugated to pro-drugs or cell-death-inducing sequences. Here, we describe a peptide that induces prostate tumor cell death without the need of any conjugating sequences. This peptide is a sequence derived from the cochaperone Bag-1. We have shown that this sequence interacts with and inhibits the refolding activity of GRP78/BiP. Furthermore, we have demonstrated that it modulates the unfolded protein response in ER stress resulting in PARP and caspase-4 cleavage. Prostate cancer cells stably expressing this peptide showed reduced growth and increased apoptosis in in vivo xenograft tumor models. Amino acid substitutions that destroyed binding of the Bag-1 peptide to GRP78/BiP or downregulation of the expression of GRP78 compromised the inhibitory effect of this peptide. This sequence therefore represents a candidate lead peptide for anti-tumor therapy.	[Maddalo, Danilo; Neeb, Antje; Jehle, Katja; Shatkina, Liubov; Walther, Tamara Vanessa; Bruchmann, Anja; Cato, Andrew C. B.] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany; [Schmitz, Katja] Karlsruhe Inst Technol, Inst Organ Chem, Eggenstein Leopoldshafen, Germany; [Muhle-Goll, Claudia; Ulrich, Anne S.] Karlsruhe Inst Technol, Inst Biol Interfaces 2, Eggenstein Leopoldshafen, Germany; [Gopal, Srinivasa M.; Wenzel, Wolfgang] Karlsruhe Inst Technol, Inst Nanotechnol, Eggenstein Leopoldshafen, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology	Cato, ACB (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany.	andrew.cato@kit.edu	Wenzel, Wolfgang/B-3207-2009; Ulrich, Anne S/H-5519-2013; Muhle-Goll, Claudia/AAM-6070-2021; Schmitz, Katja/B-9342-2008; Cato, Andrew C. B./H-2071-2013	Wenzel, Wolfgang/0000-0001-9487-4689; Ulrich, Anne S/0000-0001-5571-9483; Cato, Andrew C. B./0000-0001-8508-3834; Maddalo, Danilo/0000-0002-3228-1703; Schmitz, Katja/0000-0001-9023-318X; Neeb, Antje/0000-0002-6516-2938	Association for International Cancer Research, United Kingdom; German Science Foundation; European Union 6th framework program PRIMA; Karlsruhe Institute of Technology; Marie Curie research fellowship CANCURE in the European Union 6th framework program	Association for International Cancer Research, United Kingdom; German Science Foundation(German Research Foundation (DFG)); European Union 6th framework program PRIMA; Karlsruhe Institute of Technology(Helmholtz Association); Marie Curie research fellowship CANCURE in the European Union 6th framework program	This work was supported by grants from the Association for International Cancer Research, United Kingdom; the German Science Foundation, the European Union 6th framework program PRIMA, and start-up funds from the Karlsruhe Institute of Technology. Danilo Maddalo was a recipient of a Marie Curie research fellowship CANCURE in the European Union 6th framework program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Rawashdeh FY, 2010, EUR J GASTROEN HEPAT, V22, P1099, DOI 10.1097/MEG.0b013e3283378405; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Bifulco G, 2012, GYNECOL ONCOL, V125, P220, DOI 10.1016/j.ygyno.2011.11.045; Bonomo J, 2010, BIOPHYS CHEM, V149, P58, DOI 10.1016/j.bpc.2010.04.001; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dey S, 2010, J BIOL CHEM, V285, P33165, DOI 10.1074/jbc.M110.167213; Dong DZ, 2008, CANCER RES, V68, P498, DOI 10.1158/0008-5472.CAN-07-2950; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; Fu Y, 2006, CANCER BIOL THER, V5, P741, DOI 10.4161/cbt.5.7.2970; Gonzalez-Gronow M, 2007, J BIOL CHEM, V282, P32811, DOI 10.1074/jbc.M703342200; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Gray MD, 2005, MOL PHARMACOL, V68, P1699, DOI 10.1124/mol.105.014753; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Holtrup F, 2011, BRIT J PHARMACOL, V162, P1045, DOI 10.1111/j.1476-5381.2010.01125.x; Hong M, 2005, J BIOL CHEM, V280, P16821, DOI 10.1074/jbc.M413753200; Hung WJ, 2003, MOL CELL BIOL, V23, P3477, DOI 10.1128/MCB.23.10.3477-3486.2003; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Kim Y, 2006, BIOCHEMISTRY-US, V45, P9434, DOI 10.1021/bi060264j; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Lee E, 2011, INT J CANCER, V128, P726, DOI 10.1002/ijc.25370; Luders J, 2000, J BIOL CHEM, V275, P4613, DOI 10.1074/jbc.275.7.4613; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Martin S, 2010, PIGM CELL MELANOMA R, V23, P675, DOI 10.1111/j.1755-148X.2010.00731.x; Mayer M, 2000, J BIOL CHEM, V275, P29421, DOI 10.1074/jbc.M002655200; Merksamer PI, 2010, J CELL SCI, V123, P1003, DOI 10.1242/jcs.035832; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Nollen EAA, 2000, MOL CELL BIOL, V20, P1083, DOI 10.1128/MCB.20.3.1083-1088.2000; Park HR, 2007, TOXICOLOGY, V229, P253, DOI 10.1016/j.tox.2006.11.049; Park HR, 2004, JNCI-J NATL CANCER I, V96, P1300, DOI 10.1093/jnci/djh243; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; Pootrakul L, 2006, CLIN CANCER RES, V12, P5987, DOI 10.1158/1078-0432.CCR-06-0133; Raiter A, 2010, J VASC RES, V47, P399, DOI 10.1159/000281580; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Scriven P, 2009, BRIT J CANCER, V101, P1692, DOI 10.1038/sj.bjc.6605365; Shatkina L, 2003, MOL CELL BIOL, V23, P7189, DOI 10.1128/MCB.23.20.7189-7197.2003; So A, 2009, CANCER METAST REV, V28, P219, DOI 10.1007/s10555-008-9180-5; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Suzuki T, 2007, ARCH BIOCHEM BIOPHYS, V468, P1, DOI 10.1016/j.abb.2007.09.004; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Tanaka S, 2000, J BIOL CHEM, V275, P10388, DOI 10.1074/jbc.275.14.10388; THASTRUP O, 1989, AGENTS ACTIONS, V27, P17, DOI 10.1007/BF02222186; Townsend PA, 2005, INT J BIOCHEM CELL B, V37, P251, DOI 10.1016/j.biocel.2004.03.016; Underhill MF, 2005, BIOTECHNOL BIOENG, V89, P805, DOI 10.1002/bit.20403; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Walther TV, 2012, JOVE-J VIS EXP, DOI 10.3791/3540; Wang HQ, 2007, ENDOCRINOLOGY, V148, P3258, DOI 10.1210/en.2006-1564; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Xing XM, 2006, CLIN CHIM ACTA, V364, P308, DOI 10.1016/j.cca.2005.07.016; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yamamuro A, 2011, J PHARMACOL SCI, V115, P239, DOI 10.1254/jphs.10217SC; Yang L, 2007, J CELL BIOCHEM, V102, P786, DOI 10.1002/jcb.21328; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445	63	26	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45690	10.1371/journal.pone.0045690	http://dx.doi.org/10.1371/journal.pone.0045690			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049684	Green Published, gold, Green Submitted			2022-12-27	WOS:000309388500011
J	Weissteiner, S; Huetteroth, W; Kollmann, M; Weissbecker, B; Romani, R; Schachtner, J; Schutz, S				Weissteiner, Sonja; Huetteroth, Wolf; Kollmann, Martin; Weissbecker, Bernhard; Romani, Roberto; Schachtner, Joachim; Schuetz, Stefan			Cockchafer Larvae Smell Host Root Scents in Soil	PLOS ONE			English	Article							MOTH MANDUCA-SEXTA; ANTENNAL-LOBE; PLANT VOLATILES; BACKGROUND ODOR; SELECTION; LOCATION; INSECTS; BEETLE; BRAIN; ORGANIZATION	In many insect species olfaction is a key sensory modality. However, examination of the chemical ecology of insects has focussed up to now on insects living above ground. Evidence for behavioral responses to chemical cues in the soil other than CO2 is scarce and the role played by olfaction in the process of finding host roots below ground is not yet understood. The question of whether soil-dwelling beetle larvae can smell their host plant roots has been under debate, but proof is as yet lacking that olfactory perception of volatile compounds released by damaged host plants, as is known for insects living above ground, occurs. Here we show that soil-dwelling larvae of Melolontha hippocastani are well equipped for olfactory perception and respond electrophysiologically and behaviorally to volatiles released by damaged host-plant roots. An olfactory apparatus consisting of pore plates at the antennae and about 70 glomeruli as primary olfactory processing units indicates a highly developed olfactory system. Damage induced host plant volatiles released by oak roots such as eucalyptol and anisol are detected by larval antennae down to 5 ppbv in soil air and elicit directed movement of the larvae in natural soil towards the odor source. Our results demonstrate that plant-root volatiles are likely to be perceived by the larval olfactory system and to guide soil-dwelling white grubs through the dark below ground to their host plants. Thus, to find below-ground host plants cockchafer larvae employ mechanisms that are similar to those employed by the adult beetles flying above ground, despite strikingly different physicochemical conditions in the soil.	[Weissteiner, Sonja; Weissbecker, Bernhard; Schuetz, Stefan] Univ Gottingen, Gottingen, Germany; [Huetteroth, Wolf; Kollmann, Martin; Schachtner, Joachim] Univ Marburg, Marburg, Germany; [Romani, Roberto] Univ Perugia, Dipartimento Sci Agr & Ambientali, I-06100 Perugia, Italy	University of Gottingen; Philipps University Marburg; University of Perugia	Schutz, S (corresponding author), Univ Gottingen, Gottingen, Germany.	stefan.schuetz@forst.uni-goettingen.de	Schachtner, Joachim/D-5522-2009; Huetteroth, Wolf/I-6661-2015; Schachtner, Joachim/AAG-1101-2020; Romani, Roberto/F-4157-2014; Huetteroth, Wolf/L-5252-2019; Romani, Roberto/O-4004-2019	Schachtner, Joachim/0000-0001-7268-0699; Romani, Roberto/0000-0002-2059-4702; Huetteroth, Wolf/0000-0003-3421-9935; Romani, Roberto/0000-0002-2059-4702	Cusanuswerk Scholarship; Deutsche Forschungsgemeinschaft (DFG) [SPP 1392]	Cusanuswerk Scholarship; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	SW is grateful for the financial support to the Cusanuswerk Scholarship. Support by the Deutsche Forschungsgemeinschaft (DFG) SPP 1392 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTNER H, 1977, CELL TISSUE RES, V176, P389, DOI 10.1007/BF00221796; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Bernklau EJ, 2009, J ECON ENTOMOL, V102, P558, DOI 10.1603/029.102.0213; Bezemer TM, 2004, J CHEM ECOL, V30, P53, DOI 10.1023/B:JOEC.0000013182.50662.2a; BOURGOIN T, 1994, INT J INSECT MORPHOL, V23, P159, DOI 10.1016/0020-7322(94)90008-6; Bricchi I, 2010, PLANTA, V232, P719, DOI 10.1007/s00425-010-1203-0; Delphia CM, 2007, J CHEM ECOL, V33, P997, DOI 10.1007/s10886-007-9273-6; Dreyer D, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/neuro.06.003.2010; El Jundi B, 2009, J COMP NEUROL, V517, P210, DOI 10.1002/cne.22150; Farbert P, 1997, ENVIRON ENTOMOL, V26, P1105, DOI 10.1093/ee/26.5.1105; Gosset V, 2009, J EXP BOT, V60, P1231, DOI 10.1093/jxb/erp015; Hasler T, 1986, THESIS ETH ZURICH; HIBBARD BE, 1994, J CHEM ECOL, V20, P3335, DOI 10.1007/BF02033730; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hiltpold I, 2008, J CHEM ECOL, V34, P628, DOI 10.1007/s10886-008-9467-6; Hu JH, 2011, ARTHROPOD STRUCT DEV, V40, P420, DOI 10.1016/j.asd.2011.03.003; Immler Thomas, 2008, Forstschutz Aktuell, V45, P17; Johnson SN, 2006, PHYSIOL ENTOMOL, V31, P1, DOI 10.1111/j.1365-3032.2005.00487.x; Jorgensen K, 2006, J COMP NEUROL, V496, P121, DOI 10.1002/cne.20908; Kent K.S., 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V315, P1, DOI 10.1098/rstb.1987.0001; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Lewis C. T, 1970, Tissue Cell, V2, P375, DOI 10.1016/S0040-8166(70)80038-6; Mumm R, 2005, CHEM SENSES, V30, P337, DOI 10.1093/chemse/bji028; Niinemets U, 2002, NEW PHYTOL, V153, P243, DOI 10.1046/j.0028-646X.2001.00323.x; Nishino H, 2005, J COMP NEUROL, V493, P291, DOI 10.1002/cne.20757; NORDENHEM H, 1994, J APPL ENTOMOL, V117, P457, DOI 10.1111/j.1439-0418.1994.tb00762.x; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Rasmann S, 2007, ECOL LETT, V10, P926, DOI 10.1111/j.1461-0248.2007.01084.x; Reinecke A, 2008, BASIC APPL ECOL, V9, P568, DOI 10.1016/j.baae.2007.10.002; Robert CAM, 2012, NEW PHYTOL, V194, P1061, DOI 10.1111/j.1469-8137.2012.04127.x; Ruther J, 2000, PHYSIOL ENTOMOL, V25, P172, DOI 10.1046/j.1365-3032.2000.00183.x; Satomura T, 2006, ECOL RES, V21, P741, DOI 10.1007/s11284-006-0182-x; Schachtner J, 2004, J EXP BIOL, V207, P2389, DOI 10.1242/jeb.01036; Schachtner J, 2005, ARTHROPOD STRUCT DEV, V34, P257, DOI 10.1016/j.asd.2005.04.003; Schroeder R, 2008, BIOSCIENCE, V58, P308, DOI 10.1641/B580406; Schutz S, 1999, BIOSENS BIOELECTRON, V14, P221, DOI 10.1016/S0956-5663(98)00092-X; Schutz S, 1997, NATURWISSENSCHAFTEN, V84, P212, DOI 10.1007/s001140050381; Schutz S, 2003, NOVA ACTA LEOPOLDINA, V328, P215; Soler R, 2005, J ANIM ECOL, V74, P1121, DOI 10.1111/j.1365-2656.2005.01006.x; Staudacher EM, 2005, ADV INSECT PHYSIOL, V32, P49, DOI 10.1016/S0065-2806(05)32002-9; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; Tholl D, 2006, PLANT J, V45, P540, DOI 10.1111/j.1365-313X.2005.02612.x; Thomas RS, 2008, SOIL BIOL BIOCHEM, V40, P207, DOI 10.1016/j.soilbio.2007.08.002; Utz S, 2008, DEV NEUROBIOL, V68, P123, DOI 10.1002/dneu.20579; Vrkocova P, 2000, BIOCHEM SYST ECOL, V28, P933, DOI 10.1016/S0305-1978(00)00042-9; Weissbecker B, 2004, J CHROMATOGR A, V1056, P209, DOI 10.1016/j.chroma.2004.06.120; Weissteiner S., 2006, Mitteilungen der Deutschen Gesellschaft fuer Allgemeine und Angewandte Entomologie, V15, P51	48	44	46	0	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45827	10.1371/journal.pone.0045827	http://dx.doi.org/10.1371/journal.pone.0045827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049688	Green Published, gold			2022-12-27	WOS:000309388500015
J	Cheng, JW; Cheng, SW; Ma, XY; Cai, JP; Li, Y; Lu, GC; Wei, RL				Cheng, Jin-Wei; Cheng, Shi-Wei; Ma, Xiao-Ye; Cai, Ji-Ping; Li, You; Lu, Guo-Cai; Wei, Rui-Li			Myocilin Polymorphisms and Primary Open-Angle Glaucoma: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; JAPANESE PATIENTS; CYP1B1 MUTATIONS; INDIAN PATIENTS; TIGR/MYOC GENE; OPTINEURIN; IDENTIFICATION; INDIVIDUALS; ASSOCIATION; POPULATION	Background: Glaucoma is the leading cause of irreversible blindness in the world. Recent evidence indicates a role for genetic susceptibility to primary open-angle glaucoma (POAG). The relation between myocilin polymorphisms and POAG susceptibility has been studied in different populations. Methods: A meta-analysis of 32 published genetic association case-control studies, which examined the relation between POAG and the R46X, R76K, Y347Y, T353I, and Q368X polymorphisms of the myocilin gene, was carried out. Results: In meta-analysis, significant associations were observed between POAG risk and two myocilin polymorphisms with summarized odds ratio of 4.68 (95% CI, 2.02-10.85) for Q368X and 2.17 (95% CI, 1.32-3.57) for T353I. Both Q368X and T353I were significantly associated with high-tension glaucoma, with summarized odds ratio of 4.26 (1.69, 10.73) and 2.26 (1.37-3.72). In Westerners, significant association was observed for Q368X mutation (odds ratio, 5.17; 95% CI, 2.16-12.40). However, in Asians it was for T353I (odds ratio, 2.17; 95% CI, 1.32-3.57). Conclusions: There is strong evidence that myocilin polymorphisms are associated with POAG susceptibility, and the prevalence of myocilin mutations might be ethnicity-dependent in Caucasians for Q368X and in Asians for T353I.	[Lu, Guo-Cai] Second Mil Med Univ, Ctr New Drug Evaluat, Inst Basic Med Sci, Shanghai, Peoples R China; [Cheng, Jin-Wei; Ma, Xiao-Ye; Cai, Ji-Ping; Li, You; Wei, Rui-Li] Second Mil Med Univ, Dept Ophthalmol, Shanghai Changzheng Hosp, Shanghai, Peoples R China; [Cheng, Shi-Wei] Ludong Univ, Sch Life Sci, Yantai, Peoples R China	Naval Medical University; Naval Medical University; Ludong University	Lu, GC (corresponding author), Second Mil Med Univ, Ctr New Drug Evaluat, Inst Basic Med Sci, Shanghai, Peoples R China.	newdrug@smmu.edu.cn; ruiliwei@126.com		Wei, Ruili/0000-0003-2696-6586	Shanghai Rising-Star Program [12QA1404600]; Shanghai Municipal Natural Science Foundation [10ZR1439300]; National Natural Science Foundation of China [81000374, 81170874]	Shanghai Rising-Star Program; Shanghai Municipal Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by Shanghai Rising-Star Program (grant No. 12QA1404600), Shanghai Municipal Natural Science Foundation (grant No. 10ZR1439300), and National Natural Science Foundation of China (grant No. 81000374 and 81170874). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allingham RR, 1998, INVEST OPHTH VIS SCI, V39, P2288; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Bayat B, 2008, MOL VIS, V14, P508; Bhattacharjee A, 2007, ARCH OPHTHALMOL-CHIC, V125, P823, DOI 10.1001/archopht.125.6.823; Challa P, 2002, J GLAUCOMA, V11, P416, DOI 10.1097/00061198-200210000-00008; Chen Jian-Hua, 2011, Zhonghua Yan Ke Za Zhi, V47, P122; Cheng JW, 2010, MED SCI MONITOR, V16, pCR369; Fan Bao-jian, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P70; Fan Baojian, 2002, Zhonghua Yi Xue Za Zhi, V82, P743; Fan BJ, 2005, MOL VIS, V11, P625; Fan BJ, 2004, CHINESE MED J-PEKING, V117, P706; Faucher M, 2002, HUM MOL GENET, V11, P2077, DOI 10.1093/hmg/11.18.2077; Fingert JH, 2002, SURV OPHTHALMOL, V47, P547, DOI 10.1016/S0039-6257(02)00353-3; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Funayama T, 2006, INVEST OPHTH VIS SCI, V47, P5368, DOI 10.1167/iovs.06-0196; Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074; Hulsman CAA, 2002, GRAEF ARCH CLIN EXP, V240, P468, DOI 10.1007/s00417-002-0455-1; Ishikawa K, 2004, J GLAUCOMA, V13, P466, DOI 10.1097/0.ijg.0000138204.6d; Izumi K, 2003, OPHTHAL RES, V35, P345, DOI 10.1159/000074075; Jansson Mattias, 2003, Ophthalmic Genet, V24, P103, DOI 10.1076/opge.24.2.103.13997; Jia LY, 2009, MOL VIS, V15, P89; Kubota R, 2000, HUM MUTAT, V16, DOI 10.1002/1098-1004(200009)16:3<270::AID-HUMU13>3.0.CO;2-M; Kumar A, 2007, MOL VIS, V13, P667; Lam DSC, 2000, INVEST OPHTH VIS SCI, V41, P1386; Liu T, 2008, MED SCI MONITOR, V14, pRA87; Liu Ting, 2007, Zhonghua Yan Ke Za Zhi, V43, P361; Lopez-Martinez F, 2007, MOL VIS, V13, P862; Mabuchi F, 2001, CLIN GENET, V59, P263, DOI 10.1034/j.1399-0004.2001.590408.x; Mataftsi A, 2001, Ophthalmic Genet, V22, P225, DOI 10.1076/opge.22.4.225.2218; Melki Rahma, 2003, Hum Mutat, V22, P179, DOI 10.1002/humu.9165; Melki Rahma, 2003, Ophthalmic Genet, V24, P153, DOI 10.1076/opge.24.3.153.15610; Mukhopadhyay A, 2002, MOL VIS, V8, P442; Orwig SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016347; Pang CP, 2002, INVEST OPHTH VIS SCI, V43, P3231; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Rakhmanov V V, 2005, Genetika, V41, P1567; Shields MB, 2008, CURR OPIN OPHTHALMOL, V19, P85, DOI 10.1097/ICU.0b013e3282f3919b; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Vazquez C M, 2000, Ophthalmic Genet, V21, P109; Weih LM, 2001, OPHTHALMOLOGY, V108, P1966, DOI 10.1016/S0161-6420(01)00799-0; Whigham BT, 2011, MOL VIS, V17, P1064; Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30; Yao Hong-yan, 2006, Zhonghua Yi Xue Za Zhi, V86, P554; Yen YC, 2007, MOL VIS, V13, P1627; Yoon SJK, 1999, AM J HUM GENET, V64, P1775, DOI 10.1086/302407	45	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46632	10.1371/journal.pone.0046632	http://dx.doi.org/10.1371/journal.pone.0046632			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029558	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900192
J	Gottesman, O; Drill, E; Lotay, V; Bottinger, E; Peter, I				Gottesman, Omri; Drill, Esther; Lotay, Vaneet; Bottinger, Erwin; Peter, Inga			Can Genetic Pleiotropy Replicate Common Clinical Constellations of Cardiovascular Disease and Risk?	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; COMPLEX DISEASES; METABOLIC SYNDROME; PATHWAY ANALYSIS; ASSOCIATION; OBESITY; TRAITS; EXPRESSION; SCAN; LOCI	The relationship between obesity, diabetes, hyperlipidemia, hypertension, kidney disease and cardiovascular disease (CVD) is established when looked at from a clinical, epidemiological or pathophysiological perspective. Yet, when viewed from a genetic perspective, there is comparatively little data synthesis that these conditions have an underlying relationship. We sought to investigate the overlap of genetic variants independently associated with each of these commonly co-existing conditions from the NHGRI genome-wide association study (GWAS) catalog, in an attempt to replicate the established notion of shared pathophysiology and risk. We used pathway-based analyses to detect subsets of pleiotropic genes involved in similar biological processes. We identified 107 eligible GWAS studies related to CVD and its established comorbidities and risk factors and assigned genes that correspond to the associated signals based on their position. We found 44 positional genes shared across at least two CVD-related phenotypes that independently recreated the established relationship between the six phenotypes, but only if studies representing non-European populations were included. Seven genes revealed pleiotropy across three or more phenotypes, mostly related to lipid transport and metabolism. Yet, many genes had no relationship to each other or to genes with established functional connection. Whilst we successfully reproduced established relationships between CVD risk factors using GWAS findings, interpretation of biological pathways involved in the observed pleiotropy was limited. Further studies linking genetic variation to gene expression, as well as describing novel biological pathways will be needed to take full advantage of GWAS results.	[Gottesman, Omri; Lotay, Vaneet; Bottinger, Erwin] Mt Sinai Sch Med, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Drill, Esther] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Peter, Inga] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Columbia University; Icahn School of Medicine at Mount Sinai	Gottesman, O (corresponding author), Mt Sinai Sch Med, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA.	omri.gottesman@mssm.edu			National Heart, Lung, and Blood Institute, National Institutes of Health [R01 HL090997]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000067]; Andrea and Charles Bronfman Philanthropies; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000067] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029887] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090997] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006380] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Andrea and Charles Bronfman Philanthropies; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported in part by R01 HL090997 from the National Heart, Lung, and Blood Institute, National Institutes of Health (to I.P.), UL1TR000067 from the National Center for Advancing Translational Sciences, National Institutes of Health (to I.P.) and by The Andrea and Charles Bronfman Philanthropies (to E.B. and O.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Bruno G, 2009, J HYPERTENS, V27, P2403, DOI 10.1097/HJH.0b013e3283310ee5; Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M; Collins AJ, 2003, AM J MED SCI, V325, P163, DOI 10.1097/00000441-200304000-00002; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Ejerblad E, 2006, J AM SOC NEPHROL, V17, P1695, DOI 10.1681/ASN.2005060638; Eknoyan G, 2011, NEFROLOGIA, V31, P397, DOI 10.3265/Nefrologia.pre2011.May.10963; Elbers CC, 2009, GENET EPIDEMIOL, V33, P419, DOI 10.1002/gepi.20395; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fox CS, 2005, DIABETES CARE, V28, P2436, DOI 10.2337/diacare.28.10.2436; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gu QP, 2010, AM J HYPERTENS, V23, P38, DOI 10.1038/ajh.2009.191; Hindorff LA, 2009, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Holmans P, 2010, ADV GENET, V72, P141, DOI [10.1016/S0065-2660(10)72007-1, 10.1016/B978-0-12-380862-2.00007-2]; Huang J, 2011, BIOINFORMATICS, V27, P1201, DOI 10.1093/bioinformatics/btr116; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Kannel W B, 1979, Diabetes Care, V2, P120, DOI 10.2337/diacare.2.2.120; Kaysen GA, 2007, INT J ARTIF ORGANS, V30, P987, DOI 10.1177/039139880703001107; Kitsios GD, 2011, CIRC-CARDIOVASC GENE, V4, P58, DOI 10.1161/CIRCGENETICS.110.957738; Kristiansson K, 2012, CIRC-CARDIOVASC GENE, V5, P242, DOI 10.1161/CIRCGENETICS.111.961482; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Navaneethan SD, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007784; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Pierce BL, 2011, CANCER RES, V71, P4352, DOI 10.1158/0008-5472.CAN-11-0124; Raychaudhuri S, 2011, BIOINFORMATICS, V27, P1589, DOI 10.1093/bioinformatics/btr185; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Reaven GM, 1996, NEW ENGL J MED, V334, P374, DOI 10.1056/NEJM199602083340607; Rexrode KM, 1996, CURR OPIN CARDIOL, V11, P490, DOI 10.1097/00001573-199609000-00007; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Wilson Peter W F, 2002, Am J Geriatr Cardiol, V11, P119; Yoon Sung Sug Sarah, 2010, NCHS Data Brief, P1; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	42	21	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46419	10.1371/journal.pone.0046419	http://dx.doi.org/10.1371/journal.pone.0046419			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029515	Green Published, gold, Green Submitted			2022-12-27	WOS:000309973900156
J	Nabavi, N; Pustylnik, S; Harrison, RE				Nabavi, Noushin; Pustylnik, Sofia; Harrison, Rene E.			Rab GTPase Mediated Procollagen Trafficking in Ascorbic Acid Stimulated Osteoblasts	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; POLYMERASE CHAIN-REACTION; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; PLASMA-MEMBRANE; BREFELDIN-A; COLLAGEN BIOSYNTHESIS; NUCLEOTIDE EXCHANGE; SECRETORY PROTEINS; GOLGI-APPARATUS	Despite advances in investigating functional aspects of osteoblast (OB) differentiation, especially studies on how bone proteins are deposited and mineralized, there has been little research on the intracellular trafficking of bone proteins during OB differentiation. Collagen synthesis and secretion is the major function of OBs and is markedly up-regulated upon ascorbic acid (AA) stimulation, significantly more so than in fibroblast cells. Understanding the mechanism by which collagen is mobilized in specialized OB cells is important for both basic cell biology and diseases involving defects in bone protein secretion and deposition. Protein trafficking along the exocytic and endocytic pathways is aided by many molecules, with Rab GTPases being master regulators of vesicle targeting. In this study, we used microarray analysis to identify the Rab GTPases that are up-regulated during a 5-day AA differentiation of OBs, namely Rab1, Rab3d, and Rab27b. Further, we investigated the role of identified Rabs in regulating the trafficking of collagen from the site of synthesis in the ER to the Golgi and ultimately to the plasma membrane utilizing Rab dominant negative (DN) expression. We also observed that experimental halting of biosynthetic trafficking by these mutant Rabs initiated proteasome-mediated degradation of procollagen and ceased global protein translation. Acute expression of Rab1 and Rab3d DN constructs partially alleviated this negative feedback mechanism and resulted in impaired ER to Golgi trafficking of procollagen. Similar expression of Rab27b DN constructs resulted in dispersed collagen vesicles which may represent failed secretory vesicles sequestered in the cytosol. A significant and strong reduction in extracellular collagen levels was also observed implicating the functional importance of Rab1, Rab3d and Rab27b in these major collagen-producing cells.	[Nabavi, Noushin; Harrison, Rene E.] Univ Tronto Scarborought, Dept Cell & Syst Biol, Toronto, ON, Canada; [Nabavi, Noushin; Pustylnik, Sofia; Harrison, Rene E.] Univ Toronto Scarborough, Dept Biol Sci, Toronto, ON, Canada	University of Toronto; University Toronto Scarborough; University of Toronto; University Toronto Scarborough	Harrison, RE (corresponding author), Univ Tronto Scarborought, Dept Cell & Syst Biol, Toronto, ON, Canada.	harrison@utsc.utoronto.ca		Nabavi, Noushin/0000-0002-5471-6229	Natural Science and Engineering Research Council (NSERC) [RGPIN 298538-09]; Ontario Early Researcher Award; Canadian Institutes of Health Research New Investigator Award; General Motors Women in Sciences and Mathematics; NSERC-CGS scholarship	Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Early Researcher Award(Ministry of Research and Innovation, Ontario); Canadian Institutes of Health Research New Investigator Award(Canadian Institutes of Health Research (CIHR)); General Motors Women in Sciences and Mathematics; NSERC-CGS scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Science and Engineering Research Council (NSERC) grant (RGPIN 298538-09) to REH who is also the recipient of an Ontario Early Researcher Award and a Canadian Institutes of Health Research New Investigator Award. NN is a recipient of a General Motors Women in Sciences and Mathematics and NSERC-CGS scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Alvarez C, 2003, SYNTHESE, V134, P1; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Beck GR, 2001, CELL GROWTH DIFFER, V12, P61; BERG RA, 1980, P NATL ACAD SCI-BIOL, V77, P4746, DOI 10.1073/pnas.77.8.4746; Bhattacharya M, 2006, EMBO J, V25, P2878, DOI 10.1038/sj.emboj.7601170; Billiard J, 2003, J CELL BIOCHEM, V89, P389, DOI 10.1002/jcb.10514; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Bowie AG, 2000, J IMMUNOL, V165, P7180, DOI 10.4049/jimmunol.165.12.7180; Brinckmann J., 2005, COLLAGEN PRIMER STRU; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; Carinci F, 2005, ARCH ORAL BIOL, V50, P481, DOI 10.1016/j.archoralbio.2004.11.006; Chen YR, 2003, P NATL ACAD SCI USA, V100, P14012, DOI 10.1073/pnas.2436350100; Christiansen HE, AM J HUMAN GENETICS, V86, P389; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Du LL, 2001, MOL BIOL CELL, V12, P1215, DOI 10.1091/mbc.12.5.1215; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Figueiredo AC, 2008, J BIOL CHEM, V283, P23209, DOI 10.1074/jbc.M804134200; Fitzgerald J, 1999, J BIOL CHEM, V274, P27392, DOI 10.1074/jbc.274.39.27392; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; GEETHAHABIB M, 1988, CELL, V54, P1053, DOI 10.1016/0092-8674(88)90120-1; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Jokinen J, 2004, J BIOL CHEM, V279, P31956, DOI 10.1074/jbc.M401409200; Kalies KU, 2005, EMBO J, V24, P2284, DOI 10.1038/sj.emboj.7600731; KIRK TZ, 1987, J BIOL CHEM, V262, P5540; Kitching R, 2002, J BONE MINER METAB, V20, P269, DOI 10.1007/s007740200039; Kivirikko K I, 1979, Int Rev Connect Tissue Res, V8, P23; Knop M, 2004, EMBO J, V23, P2982, DOI 10.1038/sj.emboj.7600319; KOIVU J, 1987, J BIOL CHEM, V262, P6447; Kresh J, 2011, PFLUGERS ARCH EUROPE, P1; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Le Goff C, 2006, DEVELOPMENT, V133, P1587, DOI 10.1242/dev.02308; LEBLOND CP, 1989, ANAT REC, V224, P123, DOI 10.1002/ar.1092240204; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYONS BL, 1984, NUCLEIC ACIDS RES, V12, P2569, DOI 10.1093/nar/12.5.2569; Mahoney TR, 2006, MOL BIOL CELL, V17, P2617, DOI 10.1091/mbc.E05-12-1170; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; McCray BA, 2010, HUM MOL GENET, V19, P1033, DOI 10.1093/hmg/ddp567; MURAD S, 1981, P NATL ACAD SCI-BIOL, V78, P2879, DOI 10.1073/pnas.78.5.2879; Muslin AJ, 2001, CIRC RES, V89, P1087, DOI 10.1161/res.89.12.1087; Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499; Nottingham RM, 2009, P NATL ACAD SCI USA, V106, P14185, DOI 10.1073/pnas.0907725106; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pratap J, 2005, MOL CELL BIOL, V25, P8581, DOI 10.1128/MCB.25.19.8581-8591.2005; RIPLEY CR, 1993, J BIOL CHEM, V268, P3677; Ripley CR, 1997, EXP CELL RES, V236, P147, DOI 10.1006/excr.1997.3707; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; Schluter OM, 2002, J BIOL CHEM, V277, P40919, DOI 10.1074/jbc.M203704200; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; SCHONBRUNNER ER, 1992, P NATL ACAD SCI USA, V89, P4510, DOI 10.1073/pnas.89.10.4510; SPIRO RG, 1969, J BIOL CHEM, V244, P602; Stavreva DA, 2006, MOL CELL BIOL, V26, P5131, DOI 10.1128/MCB.02227-05; Tabellini G, 2009, LOCALIZATION SMALL M; Tamaki H, 2002, J HISTOCHEM CYTOCHEM, V50, P1611, DOI 10.1177/002215540205001205; Tolmachova T, 2007, P NATL ACAD SCI USA, V104, P5872, DOI 10.1073/pnas.0609879104; Toomre D, 1999, J CELL SCI, V112, P21; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Tzaphlidou M, 2005, MICRON, V36, P593, DOI 10.1016/j.micron.2005.05.009; Valentijn JA, 2007, AM J PHYSIOL-GASTR L, V293, pG165, DOI 10.1152/ajpgi.00520.2006; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xing W, 2011, PHYSL GENOMICS; Zhu HP, 2007, MOL BIOL CELL, V18, P4119, DOI 10.1091/mbc.E07-02-0100	71	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2012	7	9							e46265	10.1371/journal.pone.0046265	http://dx.doi.org/10.1371/journal.pone.0046265			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016KP	23050002	Green Published, gold, Green Submitted			2022-12-27	WOS:000309517300101
J	Chen, Y; Dong, YM; Sandiford, S; Dimopoulos, G				Chen, Yang; Dong, Yuemei; Sandiford, Simone; Dimopoulos, George			Transcriptional Mediators Kto and Skd Are Involved in the Regulation of the IMD Pathway and Anti-Plasmodium Defense in Anopheles gambiae	PLOS ONE			English	Article							C-ELEGANS; MALARIA PARASITE; INNATE IMMUNITY; NEURAL CREST; COMPLEX; GENE; EXPRESSION; SUBUNITS; COACTIVATOR; INFECTION	The malarial parasite Plasmodium must complete a complex lifecycle in its Anopheles mosquito host, the main vector for Plasmodium. The mosquito resists infection with the human malarial parasite P. falciparum by engaging the NF-kappa B immune signaling pathway, IMD. Here we show that the conserved transcriptional mediators Kto and Skd are involved in the regulation of the mosquito IMD pathway. RNAi-mediated depletion of Kto and Skd in the Anopheles gambiae cell line L5-3 resulted in a decrease in the transcript abundance of Cec1, which is controlled by the IMD pathway. Silencing the two genes also resulted in an increased susceptibility of the mosquito to bacterial and Plasmodium falciparum infection, but not to infection with the rodent malaria parasite P. berghei. We also showed that Kto and Skd are not transcriptional co-activators of Rel2 or other key factors of the IMD pathway; however, they participate in the regulation of the IMD pathway, which is crucial for the mosquito's defense against P. falciparum.	[Chen, Yang; Dong, Yuemei; Sandiford, Simone; Dimopoulos, George] Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Dimopoulos, G (corresponding author), Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	gdimopou@jhsph.edu	Chen, Yang/F-3130-2013	Dong, Yuemei/0000-0002-7902-2899; Dimopoulos, George/0000-0001-6755-8111	NIH/NIAD [R01AI061576]	NIH/NIAD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant R01AI061576 from the NIH/NIAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonova Y, 2009, INSECT BIOCHEM MOLEC, V39, P303, DOI 10.1016/j.ibmb.2009.01.007; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Chen Y, 2008, INSECT SCI, V15, P45, DOI 10.1111/j.1744-7917.2008.00186.x; Chen Y, 2009, INSECT SCI, V16, P443, DOI 10.1111/j.1744-7917.2009.01296.x; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005; Clayton JE, 2008, DEV BIOL, V313, P603, DOI 10.1016/j.ydbio.2007.10.051; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458; Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; Huang Y, 2012, MOL CELL, V45, P459, DOI 10.1016/j.molcel.2011.12.022; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Lim J, 2007, DEV BIOL, V308, P322, DOI 10.1016/j.ydbio.2007.05.029; Lin H, 2007, INSECT SCI, V14, P185, DOI 10.1111/j.1744-7917.2007.00142.x; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Meister S, 2004, INT J PARASITOL, V34, P1473, DOI 10.1016/j.ijpara.2004.10.004; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Michel K, 2005, INSECT BIOCHEM MOLEC, V35, P677, DOI 10.1016/j.ibmb.2005.02.009; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; Moghal N, 2003, DEVELOPMENT, V130, P57, DOI 10.1242/dev.00189; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Rau MJ, 2006, DEV BIOL, V296, P83, DOI 10.1016/j.ydbio.2006.04.437; Riehle MM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003672; Treisman JE, 2001, DEVELOPMENT, V128, P603; Wang JC, 2004, J BIOL CHEM, V279, P29270, DOI 10.1074/jbc.M401242200; Wang X, 2006, P NATL ACAD SCI USA, V103, P17284, DOI 10.1073/pnas.0605414103; Yoda A, 2005, DEVELOPMENT, V132, P1885, DOI 10.1242/dev.01776; Zhang H, 2000, GENE DEV, V14, P2161, DOI 10.1101/gad.814700; Zheng XL, 2002, INSECT MOL BIOL, V11, P517, DOI 10.1046/j.1365-2583.2002.00360.x	38	8	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45580	10.1371/journal.pone.0045580	http://dx.doi.org/10.1371/journal.pone.0045580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049816	gold, Green Submitted, Green Published			2022-12-27	WOS:000309556100056
J	Hoegl, T; Heinrich, H; Barth, W; Losel, F; Moll, GH; Kratz, O				Hoegl, Thomas; Heinrich, Hartmut; Barth, Wolfgang; Loesel, Friedrich; Moll, Gunther H.; Kratz, Oliver			Time Course Analysis of Motor Excitability in a Response Inhibition Task According to the Level of Hyperactivity and Impulsivity in Children with ADHD	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRANSCRANIAL MAGNETIC STIMULATION; STOP-SIGNAL PARADIGM; INTRACORTICAL INHIBITION; TOURETTE-SYNDROME; VOLITIONAL INHIBITION; CORTEX; DEFICIT; METHYLPHENIDATE; MECHANISMS	Short interval intracortical inhibition (SICI) of motor cortex, measured by transcranial magnetic stimulation (TMS) in a passive (resting) condition, has been suggested as a neurophysiological marker of hyperactivity in attention-deficit/hyperactivity disorder (ADHD). The aim of this study was to determine motor excitability in a go/nogo task at stages of response preparation, activation and suppression in children with ADHD, depending on the level of hyperactivity and impulsivity. Motor evoked potentials were recorded in 29 typically developing children and 43 children with ADHD (subdivided in two groups with higher and lower levels of hyperactivity/impulsivity; H/I-high and H/I-low). In the H/I-high group, SICI was markedly reduced in the resting condition and during response preparation. Though these children were able to increase SICI when inhibiting a response, SICI was still reduced compared to typically developing children. Interestingly, SICI at rest and during response activation were comparable, which may be associated with their hypermotoric behaviour. In the H/I-low group, response activation was accompanied by a pronounced decrease of SICI, indicating reduced motor control in the context of a fast motor response. In summary, different excitability patterns were obtained for the three groups allowing a better understanding of dysfunctional response activation and inhibition processes within the motor cortex in children with ADHD.	[Hoegl, Thomas; Heinrich, Hartmut; Barth, Wolfgang; Moll, Gunther H.; Kratz, Oliver] Univ Erlangen Nurnberg, Dept Child & Adolescent Mental Hlth, D-91054 Erlangen, Germany; [Heinrich, Hartmut] Heckscher Klinikum Munchen, Munich, Germany; [Loesel, Friedrich] Univ Erlangen Nurnberg, Inst Psychol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Hoegl, T (corresponding author), Univ Erlangen Nurnberg, Dept Child & Adolescent Mental Hlth, D-91054 Erlangen, Germany.	thomas.hoegl@uk-erlangen.de		Heinrich, Hartmut/0000-0002-8156-489X				Aguiar A, 2010, ENVIRON HEALTH PERSP, V118, P1646, DOI 10.1289/ehp.1002326; Alderson RM, 2007, J ABNORM CHILD PSYCH, V35, P745, DOI 10.1007/s10802-007-9131-6; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Banaschewski T, 2004, J NEURAL TRANSM, V111, P841, DOI 10.1007/s00702-003-0040-8; Banaschewski T, 2003, J CHILD PSYCHOL PSYC, V44, P356, DOI 10.1111/1469-7610.00127; Band GPH, 2003, ACTA PSYCHOL, V112, P105, DOI 10.1016/S0001-6918(02)00079-3; BARKER AT, 1985, LANCET, V1, P1106; Barkley RA, 1997, J DEV BEHAV PEDIATR, V18, P271; Boroojerdi B, 2002, J CLIN NEUROPHYSIOL, V19, P255, DOI 10.1097/00004691-200208000-00002; Boylan LS, 2000, CLIN NEUROPHYSIOL, V111, P504, DOI 10.1016/S1388-2457(99)00280-1; Buchmann J, 2006, NEUROSCI LETT, V405, P14, DOI 10.1016/j.neulet.2006.06.026; Buchmann J, 2007, BIOL PSYCHIAT, V62, P963, DOI 10.1016/j.biopsych.2007.05.010; Burle B, 2002, PSYCHOPHYSIOLOGY, V39, P207, DOI 10.1017/S0048577201392119; Castellanos FX, 2002, NAT REV NEUROSCI, V3, P617, DOI 10.1038/nrn896; Coxon JP, 2006, J NEUROPHYSIOL, V95, P3371, DOI 10.1152/jn.01334.2005; Crosbie J, 2008, NEUROSCI BIOBEHAV R, V32, P40, DOI 10.1016/j.neubiorev.2007.05.002; Di Lazzaro V, 2006, J PHYSIOL-LONDON, V575, P721, DOI 10.1113/jphysiol.2006.114694; Dopfner M, 2000, DISYPS KJ DIAGNOSTIK; Fujiyama H, 2011, PSYCHOPHYSIOLOGY; Gilbert DL, 2011, NEUROLOGY, V76, P615, DOI 10.1212/WNL.0b013e31820c2ebd; Gilbert DL, 2005, BIOL PSYCHIAT, V57, P1597, DOI 10.1016/j.biopsych.2005.02.022; Gilbert DL, 2004, MOVEMENT DISORD, V19, P416, DOI 10.1002/mds.20044; Gilbert DL, 2006, BRAIN, V129, P2038, DOI 10.1093/brain/awl147; Groom MJ, 2010, BIOL PSYCHIAT, V67, P624, DOI 10.1016/j.biopsych.2009.09.029; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Heise KF, 2010, BRAIN, V133, P580, DOI 10.1093/brain/awp299; Hoegl T, 2011, INT J PSYCHOPHYSIOL, V81, P99, DOI 10.1016/j.ijpsycho.2011.05.004; Hoshiyama M, 1997, ELECTROMYOGR MOTOR C, V105, P255, DOI 10.1016/S0924-980X(97)00019-2; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Kratz O, 2011, J ECT, V27, P48, DOI 10.1097/YCT.0b013e3181d2ef85; Kratz O, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-12; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Leocani L, 2000, BRAIN, V123, P1161, DOI 10.1093/brain/123.6.1161; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Moll GH, 2000, NEUROSCI LETT, V284, P121, DOI 10.1016/S0304-3940(00)00980-0; Moll GH, 2001, ANN NEUROL, V49, P393, DOI 10.1002/ana.77; Mostofsky SH, 2008, J COGNITIVE NEUROSCI, V20, P751, DOI 10.1162/jocn.2008.20500; Nigg JT, 2005, BIOL PSYCHIAT, V57, P1224, DOI 10.1016/j.biopsych.2004.08.025; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peurala SH, 2008, CLIN NEUROPHYSIOL, V119, P2291, DOI 10.1016/j.clinph.2008.05.031; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Scheres A, 2001, CHILD NEUROPSYCHOL, V7, P172, DOI 10.1076/chin.7.3.172.8746; Shanahan MA, 2008, DEV NEUROPSYCHOL, V33, P137, DOI 10.1080/87565640701884238; Sohn YH, 2002, J NEUROPHYSIOL, V88, P333, DOI 10.1152/jn.2002.88.1.333; Solanto MV, 2001, J ABNORM CHILD PSYCH, V29, P215, DOI 10.1023/A:1010329714819; Sonuga-Barke EJS, 2010, BIOL PSYCHIAT, V67, P599, DOI 10.1016/j.biopsych.2010.01.017; Sonuga-Barke EJS, 2002, BEHAV BRAIN RES, V130, P29, DOI 10.1016/S0166-4328(01)00432-6; van den Wildenberg WPM, 2010, J COGNITIVE NEUROSCI, V22, P225, DOI 10.1162/jocn.2009.21248; Verbruggen F, 2008, J EXP PSYCHOL GEN, V137, P649, DOI 10.1037/a0013170; Vucic S, 2006, MUSCLE NERVE, V33, P477, DOI 10.1002/mus.20481; Vucic S, 2011, CEREB CORTEX, V21, P1639, DOI 10.1093/cercor/bhq235; Waldvogel D, 2000, NATURE, V406, P995, DOI 10.1038/35023171; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 1997, ELECTROMYOGR MOTOR C, V105, P430, DOI 10.1016/S0924-980X(97)00050-7	57	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46066	10.1371/journal.pone.0046066	http://dx.doi.org/10.1371/journal.pone.0046066			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	016YP	23049936	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100129
J	Kuo, WH; Chang, YY; Lai, LC; Tsai, MH; Hsiao, CK; Chang, KJ; Chuang, EY				Kuo, Wen-Hung; Chang, Yao-Yin; Lai, Liang-Chuan; Tsai, Mong-Hsun; Hsiao, Chuhsing Kate; Chang, King-Jen; Chuang, Eric Y.			Molecular Characteristics and Metastasis Predictor Genes of Triple-Negative Breast Cancer: A Clinical Study of Triple-Negative Breast Carcinomas	PLOS ONE			English	Article							BASAL-LIKE SUBTYPE; TGF-BETA; PORTRAITS; PHENOTYPE; TUMORS; MYC	Background: Triple-negative breast cancer is a subtype of breast cancer with aggressive tumor behavior and distinct disease etiology. Due to the lack of an effective targeted medicine, treatment options for triple-negative breast cancer are few and recurrence rates are high. Although various multi-gene prognostic markers have been proposed for the prediction of breast cancer outcome, most of them were proven clinically useful only for estrogen receptor-positive breast cancers. Reliable identification of triple-negative patients with a favorable prognosis is not yet possible. Methodology/Principal Findings: Clinicopathological information and microarray data from 157 invasive breast carcinomas were collected at National Taiwan University Hospital from 1995 to 2008. Gene expression data of 51 triple-negative and 106 luminal breast cancers were generated by oligonucleotide microarrays. Hierarchical clustering analysis revealed that the majority (94%) of triple-negative breast cancers were tightly clustered together carrying strong basal-like characteristics. A 45-gene prognostic signature giving 98% predictive accuracy in distant recurrence of our triple-negative patients was determined using the receiver operating characteristic analysis and leave-one-out cross validation. External validation of the prognostic signature in an independent microarray dataset of 59 early-stage triple-negative patients also obtained statistical significance (hazard ratio 2.29, 95% confidence interval (CI) 1.04-5.06, Cox P = 0.04), outperforming five other published breast cancer prognostic signatures. The 45-gene signature identified in this study revealed that TGF-beta signaling of immune/inflammatory regulation may play an important role in distant metastatic invasion of triple-negative breast cancer. Conclusions/Significance: Gene expression data and recurrence information of triple-negative breast cancer were collected and analyzed in this study. A novel set of 45-gene signature was found to be statistically predictive in disease recurrence of triple-negative breast cancer. The 45-gene signature, if further validated, may be a clinically useful tool in risk assessment of distant recurrence for early-stage triple-negative patients.	[Kuo, Wen-Hung; Chang, King-Jen] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei 10764, Taiwan; [Chang, Yao-Yin; Chuang, Eric Y.] Natl Taiwan Univ, Dept Elect Engn, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Chang, Yao-Yin; Chuang, Eric Y.] NTU Ctr Genom Med, Bioinformat & Biostat Core, Taipei, Taiwan; [Lai, Liang-Chuan] Natl Taiwan Univ, Dept Physiol, Coll Med, Taipei 10764, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Coll Bioresources & Agr, Taipei 10764, Taiwan; [Hsiao, Chuhsing Kate] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei 10764, Taiwan; [Chang, King-Jen] Cheng Ching Gen Hosp, Dept Surg, Taichung, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Chang, KJ (corresponding author), Natl Taiwan Univ, Coll Med, Dept Surg, Taipei 10764, Taiwan.	kingjen@ntu.edu.tw; chuangey@ntu.edu.tw	Lai, Liang-Chuan/B-4768-2009	Lai, Liang-Chuan/0000-0002-3913-5338; KUO, WEN-HUNG/0000-0002-9881-4605; hsiao, chuhsing kate/0000-0003-4905-8484; TSAI, MONG-HSUN/0000-0001-8777-5818; Chang, King jen/0000-0001-9811-3422	National Science Council of Taiwan [NSC97-2314-B-002-154-MY3]; Department of Health, Taiwan [DOH101-TD-C-111-001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Taiwan	This study was supported by the National Science Council of Taiwan (NSC97-2314-B-002-154-MY3) and the Department of Health, Taiwan (DOH101-TD-C-111-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates RC, 2003, MOL BIOL CELL, V14, P1790, DOI 10.1091/mbc.E02-09-0583; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Eger A, 2004, ONCOGENE, V23, P2672, DOI 10.1038/sj.onc.1207416; Fischer ANM, 2005, CARCINOGENESIS, V26, P931, DOI 10.1093/carcin/bgi043; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Frank NY, 2011, CANCER RES, V71, P1474, DOI 10.1158/0008-5472.CAN-10-1660; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1832; Kreike B, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1771; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Lund MJ, 2009, BREAST CANCER RES TR, V113, P357, DOI 10.1007/s10549-008-9926-3; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1827; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Rapp UR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006029; SMOLA MG, 1991, CANCER, V68, P1026, DOI 10.1002/1097-0142(19910901)68:5<1026::AID-CNCR2820680520>3.0.CO;2-H; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stead LA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2242; Tan DSP, 2008, BREAST CANCER RES TR, V111, P27, DOI 10.1007/s10549-007-9756-8; Teschendorff AE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r157; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	34	60	62	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45831	10.1371/journal.pone.0045831	http://dx.doi.org/10.1371/journal.pone.0045831			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049873	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100087
J	Namekar, M; Kumar, M; O'Connell, M; Nerurkar, VR				Namekar, Madhuri; Kumar, Mukesh; O'Connell, Maile; Nerurkar, Vivek R.			Effect of Serum Heat-Inactivation and Dilution on Detection of Anti-WNV Antibodies in Mice by West Nile Virus E-protein Microsphere Immunoassay	PLOS ONE			English	Article							ST-LOUIS-ENCEPHALITIS; PERSISTENCE; ASSAY; INTERFERENCE; INFECTIONS; VALIDATION; PROTECTION; VACCINE	Immunopathogenesis studies employing West Nile virus (WNV) mice model are important for the development of antivirals and vaccines against WNV. Since antibodies produced in mice early during WNV infection are essential for clearing virus from the periphery, it is important to detect early and persistent anti-WNV antibodies. ELISA and plaque reduction neutralization tests are traditionally used for detection of anti-WNV antibodies and WNV-neutralizing antibodies, respectively. Although these assays are sensitive and specific, they are expensive and time consuming. Microsphere immunoassays (MIA) are sensitive, specific, allow for high throughput, are cost effective, require less time to perform than other methods, and require low serum volumes. Several assay parameters such as serum heat-inactivation (HI) and dilution can alter WNV MIA sensitivity. We examined the effect of these parameters on WNV E-protein MIA (WNV E-MIA) for the enhanced detection of anti-WNV IgM and IgG antibodies. WNV E-MIA was conducted using serial dilutions of HI and non-HI (NHI) serum collected at various time points from mice inoculated with WNV. HI significantly enhanced detection of IgM and IgG antibodies as compared to NHI serum. WNV IgM and IgG antibodies in HI sera were detected earlier at day 3 and IgM antibodies persisted up to day 24 after infection. HI serum at 1: 20 dilution was found to be optimal for detection of both IgM and IgG antibodies as compared to higher-serum dilutions. Further, addition of exogenous complement to the HI serum decreased the WNV E-MIA sensitivity. These results suggest that serum-HI and optimal dilution enhance WNV E-MIA sensitivity by eliminating the complement interference, thereby detecting low-titer anti-WNV antibodies during early and late phases of infection. This improved MIA can also be readily employed for detection of low-titer antibodies for detection of other infectious agents and host proteins.	[Namekar, Madhuri; Kumar, Mukesh; O'Connell, Maile; Nerurkar, Vivek R.] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, Pacific Ctr Emerging Infect Dis Res, John A Burns Sch Med, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Nerurkar, VR (corresponding author), Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, Pacific Ctr Emerging Infect Dis Res, John A Burns Sch Med, Honolulu, HI 96822 USA.	nerurkar@hawaii.edu	Namekar, Madhuri/AAU-9421-2021; Nerurkar, Vivek R/F-5533-2011; Kumar, Mukesh/N-8814-2015; Kumar, Mukesh/AAI-1046-2019	Kumar, Mukesh/0000-0003-0970-4875; Kumar, Mukesh/0000-0003-0970-4875	Centers of Biomedical Research Excellence, National Institute of General Medical Sciences [P20GM103516]; National Institute of Allergy and Infectious Diseases, National Institutes of Health [U01AI078213]; Department of Defense, and Institutional Funds [W8IXWH0720073]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI078213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	Centers of Biomedical Research Excellence, National Institute of General Medical Sciences; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Defense, and Institutional Funds(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by grants (P20GM103516) from the Centers of Biomedical Research Excellence, National Institute of General Medical Sciences and (U01AI078213) from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, and (W8IXWH0720073) from the Department of Defense, and Institutional Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649; Balasuriya UBR, 2006, J VET DIAGN INVEST, V18, P392, DOI 10.1177/104063870601800413; Beasley DWC, 2011, IMMUNOTHERAPY-UK, V3, P269, DOI 10.2217/IMT.10.93; Bellisario R, 2001, EARLY HUM DEV, V64, P21, DOI 10.1016/S0378-3782(01)00167-0; Brinton MA, 2002, ANNU REV MICROBIOL, V56, P371, DOI 10.1146/annurev.micro.56.012302.160654; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P879; Diamond MS, 2009, FRONT BIOSCI-LANDMRK, V14, P3024, DOI 10.2741/3432; Diamond MS, 2003, J EXP MED, V198, P1853, DOI 10.1084/jem.20031223; Dias D, 2005, CLIN DIAGN LAB IMMUN, V12, P959, DOI 10.1128/CDLI.12.8.959-969.2005; Fang Y, 2009, AM J TROP MED HYG, V80, P862, DOI 10.4269/ajtmh.2009.80.862; Go YY, 2008, CLIN VACCINE IMMUNOL, V15, P76, DOI 10.1128/CVI.00388-07; Johnson AJ, 2005, CLIN DIAGN LAB IMMUN, V12, P566, DOI 10.1128/CDLI.12.5.566-574.2005; Johnson AJ, 2007, CLIN VACCINE IMMUNOL, V14, P1084, DOI 10.1128/CVI.00115-07; Jones LP, 2002, CLIN DIAGN LAB IMMUN, V9, P633, DOI 10.1128/CDLI.9.3.633-638.2002; Karakus R, 2005, J IMMUNOASS IMMUNOCH, V26, P109, DOI 10.1081/IAS-200051994; Ledizet M, 2005, VACCINE, V23, P3915, DOI 10.1016/j.vaccine.2005.03.006; Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09; Lowe D, 2007, INT J IMMUNOGENET, V34, P288; Martins TB, 2008, AM J CLIN PATHOL, V129, P34, DOI 10.1309/65VKWVNAQ38PHMGQ; MCHUGH TM, 1988, J CLIN MICROBIOL, V26, P1957, DOI 10.1128/JCM.26.10.1957-1961.1988; Papa A, 2011, J MED VIROL, V83, P1857, DOI 10.1002/jmv.22190; Papp K, 2007, MOL CELL PROTEOMICS, V6, P133, DOI 10.1074/mcp.T600036-MCP200; Perkins J, 2007, CLIN VACCINE IMMUNOL, V14, P1472, DOI 10.1128/CVI.00227-07; Prince HE, 2008, J CLIN VIROL, V43, P102, DOI 10.1016/j.jcv.2008.03.025; Roe K, 2012, J GEN VIROL; Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531; SCHETTERS T, 1988, J IMMUNOL METHODS, V109, P193, DOI 10.1016/0022-1759(88)90242-6; Schnaidt M, 2011, TRANSPLANTATION, V92, P510, DOI 10.1097/TP.0b013e31822872dd; Schwenk JM, 2011, METHODS MOL BIOL, V723, P29, DOI 10.1007/978-1-61779-043-0_3; Sitati E, 2007, J VIROL, V81, P9801, DOI 10.1128/JVI.00941-07; Stewart BS, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-6; Tate Jill, 2004, Clin Biochem Rev, V25, P105; Tesh RB, 2005, J INFECT DIS, V192, P287, DOI 10.1086/431153; Verma S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-66; Watson DS, 2009, J IMMUNOL METHODS, V340, P123, DOI 10.1016/j.jim.2008.10.007; WEBER TH, 1990, SCAND J CLIN LAB INV, V50, P77, DOI 10.3109/00365519009085803; Wong SJ, 2004, J CLIN MICROBIOL, V42, P65, DOI 10.1128/JCM.42.1.65-72.2004; Wong SJ, 2003, J CLIN MICROBIOL, V41, P4217, DOI 10.1128/JCM.41.9.4217-4223.2003	39	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45851	10.1371/journal.pone.0045851	http://dx.doi.org/10.1371/journal.pone.0045851			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049879	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100092
J	Zhu, GP; Petersen, MJ; Bu, WJ				Zhu, Gengping; Petersen, Matthew J.; Bu, Wenjun			Selecting Biological Meaningful Environmental Dimensions of Low Discrepancy among Ranges to Predict Potential Distribution of Bean Plataspid Invasion	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; NICHE CONSERVATISM; CLIMATIC NICHE; SHIFTS; UNCERTAINTY; GEOGRAPHY; ACCURACY; GARP	Background: The Bean plataspid (Megacopta cribraria) (Hemiptera: Pentatomidae), native to Asia, is becoming an invasive species in North America; its potential spread to soybean producing areas in the US is of great concern. Ecological niche modelling (ENM) has been used increasingly in predicting invasive species' potential distribution; however, poor niche model transferability was sometimes reported, leading to the artifactual conclusion of niche differentiation during species' invasion. Methodology/Principals: We aim to improve the geographical transferability of ENM via environmental variable selection to predict the potential distribution of Bean plataspid invasion. Sixteen environmental dimensions between native and introduced Bean plataspid populations were compared, and classified into two datasets with different degrees of discrepancy by the interquartile range (IQR) overlap in boxplot. Niche models based on these two datasets were compared in native model prediction and invading model projection. Classical niche model approaches (i.e., model calibrated on native range and transferred outside) were used to anticipate the potential distribution of Bean plataspid invasion. Conclusions/Significance: Niche models based on the two datasets showed little difference in native model predictions; however, when projecting onto the introduced area, models based on the environmental datasets showing low discrepancy among ranges recovered good model transferability in predicting the newly established population of Bean plataspid in the US. Recommendations were made for selecting biological meaningful environmental dimensions of low discrepancy among ranges to improve niche model transferability among these geographically separated areas. Outside of its native range, areas with invasion potential include the southeastern US in North America, southwestern Europe, southeastern South America, southern Africa, and the eastern coastal Australia.	[Zhu, Gengping] Nankai Univ, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China; [Zhu, Gengping; Bu, Wenjun] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Petersen, Matthew J.] Cornell Univ, Dept Entomol, Geneva, NY USA	Nankai University; Nankai University; Cornell University	Zhu, GP (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China.	gengpingzhu@hotmail.com	Zhu, Gengping/E-4730-2013; Zhu, Gengping/CAF-4192-2022	Zhu, Gengping/0000-0001-6823-5840	China Postdoctoral Science Foundation [2012M510744]; National Education Project in Basic Science for Special Subjects [J0930005]; National Natural Science Foundation of China [31071959]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Education Project in Basic Science for Special Subjects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the China Postdoctoral Science Foundation (2012M510744), the National Education Project in Basic Science for Special Subjects (Insect Systematics, no. J0930005) and National Natural Science Foundation of China (no. 31071959). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, GAZETTEER CHINA; APHIS, 2004, NAPIS PESTTRACKER PU; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Brito JC, 2008, BIOL J LINN SOC, V95, P790, DOI 10.1111/j.1095-8312.2008.01071.x; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Chen Q, 2009, J HENAN AGR SCI, V4, P88; Eger J.E. Jr., 2010, Insecta Mundi, V0121, P1; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Feeley KJ, 2011, DIVERS DISTRIB, V17, P1132, DOI 10.1111/j.1472-4642.2011.00813.x; Fent M, 2011, NORTH-WEST J ZOOL, V7, P72; Ficetola GF, 2009, DIVERS DISTRIB, V15, P108, DOI 10.1111/j.1472-4642.2008.00516.x; Fitzpatrick MC, 2007, GLOBAL ECOL BIOGEOGR, V16, P24, DOI 10.1111/j.1466-8238.2006.00258.x; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Fukatsu T, 2002, APPL ENVIRON MICROB, V68, P389, DOI 10.1128/AEM.68.1.389-396.2002; Gallagher RV, 2010, J ECOL, V98, P790, DOI 10.1111/j.1365-2745.2010.01677.x; Godsoe W, 2010, SYST BIOL, V59, P298, DOI 10.1093/sysbio/syq005; Grinnell J, 1924, ECOLOGY, V5, P225, DOI 10.2307/1929447; Grinnell J., 1917, Auk Cambridge Mass, V34; Heikkinen RK, 2012, ECOGRAPHY, V35, P276, DOI 10.1111/j.1600-0587.2011.06999.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Jenkins Tracie M., 2011, Insects, V2, P264, DOI 10.3390/insects2030264; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Kikuchi A, 2010, JPN J APPL ENTOMOL Z, V54, P37, DOI 10.1303/jjaez.2010.37; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Li YH, 2001, PLANT PROT TECHNOL E, V21, P11; Liu XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018429; Mandle L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015297; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Menke SB, 2009, GLOBAL ECOL BIOGEOGR, V18, P50, DOI 10.1111/j.1466-8238.2008.00420.x; Montandon A. L., 1896, Annales de la Societe Entomologique de Belgique, Vxl, P86; Montandon A L, 1897, ANN SOC ENTOMOLOGIQU, V1896, P436; Nunez MA, 2011, DIVERS DISTRIB, V17, P703, DOI 10.1111/j.1472-4642.2011.00772.x; PEARSON RG, 2007, SPECIES DISTRIBUTION; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x; Peterson AT, 2011, J BIOGEOGR, V38, P817, DOI 10.1111/j.1365-2699.2010.02456.x; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Peterson AT, 2003, Q REV BIOL, V78, P419, DOI 10.1086/378926; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Rabitsch W, 2008, ZOOTAXA, P1; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Rodder D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007843; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Sillero N, 2011, ECOL MODEL, V222, P1343, DOI 10.1016/j.ecolmodel.2011.01.018; Soberon J, 2011, REV MEX BIODIVERS, V82, P1348; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; Suiter DR, 2010, MEGACOPTA CRIBRARIA; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; TAYUTIVUTIKUL J, 1990, Japanese Journal of Entomology, V58, P533; Upton G., 1996, UNDERSTANDING STAT, P55; USDA, 2010, INV INS BEAN PLAT PO; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; YANG WE-I, 1934, BULL FAN MEM INST BIOL [ZOOL], V5, P137; Zhang S.M., 1985, EC INSECT FAUNA CHIN; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246; Zurell D, 2012, DIVERS DISTRIB, V18, P628, DOI 10.1111/j.1472-4642.2012.00887.x	69	11	14	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46247	10.1371/journal.pone.0046247	http://dx.doi.org/10.1371/journal.pone.0046247			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049993	Green Submitted, Green Published, gold			2022-12-27	WOS:000309556100165
J	Marco-Rius, F; Caballero, P; Moran, P; de Leaniz, CG				Marco-Rius, Francisco; Caballero, Pablo; Moran, Paloma; de Leaniz, Carlos Garcia			And the Last Shall Be First: Heterochrony and Compensatory Marine Growth in Sea Trout (Salmo trutta)	PLOS ONE			English	Article							SIZE-SELECTIVE MORTALITY; DENSITY-DEPENDENT GROWTH; POST-SMOLT GROWTH; ATLANTIC SALMON; BROWN TROUT; SOCKEYE-SALMON; PHENOTYPIC PLASTICITY; POPULATION REGULATION; SEXUAL-MATURATION; POSTSMOLT GROWTH	Early juvenile growth is a good indicator of growth later in life in many species because larger than average juveniles tend to have a competitive advantage. However, for migratory species the relationship between juvenile and adult growth remains obscure. We used scale analysis to reconstruct growth trajectories of migratory sea trout (Salmo trutta) from six neighbouring populations, and compared the size individuals attained in freshwater (before migration) with their subsequent growth at sea (after migration). We also calculated the coefficient of variation (CV) to examine how much body size varied across populations and life stages. Specifically, we tested the hypothesis that the CV on body size would differ between freshwater and marine environment, perhaps reflecting different trade-offs during ontogeny. Neighbouring sea trout populations differed significantly in time spent at sea and in age-adjusted size of returning adults, but not on size of seaward migration, which was surprisingly uniform and may be indicative of strong selection pressures. The CV on body size decreased significantly over time and was highest during the first 8 months of life (when juvenile mortality is highest) and lowest during the marine phase. Size attained in freshwater was negatively related to growth during the first marine growing season, suggesting the existence of compensatory growth, whereby individuals that grow poorly in freshwater are able to catch up later at sea. Analysis of 61 datasets indicates that negative or no associations between pre- and post-migratory growth are common amongst migratory salmonids. We suggest that despite a widespread selective advantage of large body size in freshwater, freshwater growth is a poor predictor of final body size amongst migratory fish because selection may favour growth heterochrony during transitions to a novel environment, and marine compensatory growth may negate any initial size advantage acquired in freshwater.	[de Leaniz, Carlos Garcia] Swansea Univ, Dept BioSci, Swansea, W Glam, Wales; [Caballero, Pablo] Xunta Galicia, Conselleria Medio Rural, Serv Conservac Nat, Pontevedra, Spain; [Marco-Rius, Francisco; Moran, Paloma] Univ Vigo, Dept Bioquim Genet & Inmunol, Vigo 36310, Spain	Swansea University; Universidade de Vigo	de Leaniz, CG (corresponding author), Swansea Univ, Dept BioSci, Swansea, W Glam, Wales.	c.garciadeleaniz@swansea.ac.uk	de Leaniz, Carlos Garcia/AAQ-4171-2020; Morán, Paloma/J-6877-2014; Caballero Javierre, Pablo/AHA-9013-2022	de Leaniz, Carlos Garcia/0000-0003-1650-2729; Morán, Paloma/0000-0002-3644-8507; Caballero Javierre, Pablo/0000-0002-2541-7684	Ministerio de Ciencia y Tecnologia [CGL2007-60572, CGL2010-14964]; Fondos FEDER [PGIDIT03PXIC30102PN, 2010/80]; Spanish Government [BES-2008-001973]	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fondos FEDER(European Commission); Spanish Government(Spanish GovernmentEuropean Commission)	This work was funded by grants from Ministerio de Ciencia y Tecnologia (CGL2007-60572 and CGL2010-14964), and Fondos FEDER (PGIDIT03PXIC30102PN; Grupos de Referencia Competitiva, 2010/80). Francisco Marco-Rius was supported by a pre-doctoral fellowship from the Spanish Government (BES-2008-001973). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Ali M, 2003, FISH FISH, V4, P147, DOI 10.1046/j.1467-2979.2003.00120.x; ANDERSON RO, 1996, FISHERIES TECHNIQUES; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], DEV PLASTICITY EVOLU; ARNOLD SJ, 1986, AM NAT, V128, P143, DOI 10.1086/284548; Bjorklund M, 2003, J EVOLUTION BIOL, V16, P543, DOI 10.1046/j.1420-9101.2003.00566.x; Bohlin T, 2001, J ANIM ECOL, V70, P112, DOI 10.1046/j.1365-2656.2001.00466.x; Bronmark C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001957; Campos JL, 2007, FRESHWATER BIOL, V52, P510, DOI 10.1111/j.1365-2427.2006.01721.x; Carlson SM, 2008, FUNCT ECOL, V22, P663, DOI 10.1111/j.1365-2435.2008.01416.x; Consuegra S, 2007, EVOL ECOL, V21, P229, DOI 10.1007/s10682-006-9001-7; Cross AD, 2009, MAR COAST FISH, V1, P57, DOI 10.1577/C08-005.1; Cucherousset J, 2005, CAN J FISH AQUAT SCI, V62, P1600, DOI 10.1139/F05-057; De Leaniz CG, 2000, FISHERIES MANAG ECOL, V7, P489, DOI 10.1046/j.1365-2400.2000.00223.x; Duffy EJ, 2011, CAN J FISH AQUAT SCI, V68, P232, DOI 10.1139/F10-144; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Einum S, 2002, J FISH BIOL, V60, P780, DOI 10.1111/j.1095-8649.2002.tb01704.x; Einum S, 2007, EVOLUTION, V61, P232, DOI 10.1111/j.1558-5646.2007.00020.x; Elliott J.M., 1994, QUANTITATIVE ECOLOGY; ELLIOTT JM, 1990, J ANIM ECOL, V59, P803, DOI 10.2307/5015; ELLIOTT JM, 1986, J ANIM ECOL, V55, P907, DOI 10.2307/4424; Elliott JM, 1998, J ANIM ECOL, V67, P280, DOI 10.1046/j.1365-2656.1998.00185.x; EMLEN JM, 1990, CAN J FISH AQUAT SCI, V47, P1765, DOI 10.1139/f90-200; FISHER JP, 1990, FISH B-NOAA, V88, P637; Friedland KD, 2006, FISH B-NOAA, V104, P149; Friedland KD, 2005, ICES J MAR SCI, V62, P1338, DOI 10.1016/j.icesjms.2005.04.013; Friedland KD, 1996, J FISH BIOL, V48, P1, DOI 10.1111/j.1095-8649.1996.tb01414.x; Friedland KD, 2009, CAN J FISH AQUAT SCI, V66, P1294, DOI 10.1139/F09-077; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Good SP, 2001, CAN J FISH AQUAT SCI, V58, P1187, DOI 10.1139/cjfas-58-6-1187; Gould S. J., 1977, ONTOGENY PHYLOGENY; Hansen LP, 1998, CAN J FISH AQUAT SCI, V55, P104, DOI 10.1139/cjfas-55-S1-104; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; HENDERSON MA, 1991, CAN J FISH AQUAT SCI, V48, P988, DOI 10.1139/f91-115; Hendry AP, 2003, CONSERV BIOL, V17, P795, DOI 10.1046/j.1523-1739.2003.02075.x; Holtmeier CL, 2001, EVOLUTION, V55, P330; Hutchings JA, 1998, CAN J FISH AQUAT SCI, V55, P22, DOI 10.1139/cjfas-55-S1-22; Jacobs MW, 2010, INTEGR COMP BIOL, V50, P630, DOI 10.1093/icb/icq091; Johnsson JI, 1997, CAN J FISH AQUAT SCI, V54, P430; JONSSON B, 1993, REV FISH BIOL FISHER, V3, P348, DOI 10.1007/BF00043384; Jonsson B, 2001, FUNCT ECOL, V15, P310, DOI 10.1046/j.1365-2435.2001.00528.x; JONSSON B, 1993, J FISH BIOL, V43, P1; Jonsson N, 2007, J FISH BIOL, V71, P245, DOI 10.1111/j.1095-8649.2007.01488.x; JONSSON N, 1991, J ANIM ECOL, V60, P937, DOI 10.2307/5423; Kinnison MT, 2003, J EVOLUTION BIOL, V16, P1257, DOI 10.1046/j.1420-9101.2003.00631.x; Klemetsen A, 2003, ECOL FRESHW FISH, V12, P1, DOI 10.1034/j.1600-0633.2003.00010.x; Kuparinen A, 2009, MAR ECOL PROG SER, V376, P245, DOI 10.3354/meps07789; MAISSE G, 1991, J FISH BIOL, V39, P705, DOI 10.1111/j.1095-8649.1991.tb04400.x; Mangel M, 2001, EVOL ECOL RES, V3, P583; Martin-Smith KM, 2002, J ANIM ECOL, V71, P413, DOI 10.1046/j.1365-2656.2002.00609.x; Martinson EC, 2008, MAR ECOL PROG SER, V370, P1, DOI 10.3354/meps07665; Mathisen Ole A., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P299; McCormick S.D., 1987, AM FISH SOC S, V1, P211; McCormick SD, 1998, CAN J FISH AQUAT SCI, V55, P77, DOI 10.1139/d98-011; McKeown Brian A., 1984, FISH MIGRATION; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; MilnerGulland EJ, 2011, ANIMAL MIGRATION: A SYNTHESIS, P1, DOI 10.1093/acprof:oso/9780199568994.001.0001; Nicieza A.G., 1993, Canadian Special Publication of Fisheries and Aquatic Sciences, V118, P225; NICIEZA AG, 1993, CAN J FISH AQUAT SCI, V50, P1632, DOI 10.1139/f93-184; Nicieza A, 2009, OECOLOGIA, V159, P27, DOI 10.1007/s00442-008-1194-8; Niva T, 2000, EVOL ECOL, V14, P111, DOI 10.1023/A:1011066912342; PARKER RR, 1971, J FISH RES BOARD CAN, V28, P1503, DOI 10.1139/f71-231; Parra I, 2011, FRESHWATER BIOL, V56, P530, DOI 10.1111/j.1365-2427.2010.02520.x; Parsons KJ, 2011, J EVOLUTION BIOL, V24, P1640, DOI 10.1111/j.1420-9101.2011.02301.x; Perez KO, 2010, EVOLUTION, V64, P2450, DOI 10.1111/j.1558-5646.2010.00994.x; POST JR, 1987, CAN J FISH AQUAT SCI, V44, P1840, DOI 10.1139/f87-228; Rifflart R, 2006, FISH RES, V78, P380, DOI 10.1016/j.fishres.2005.11.018; Ruggerone G., 2006, NPAFC TECH REP, V4, P56; Salminen M, 1997, J APPL ICHTHYOL, V13, P121, DOI 10.1111/j.1439-0426.1997.tb00111.x; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; SCARNECCHIA DL, 1984, CAN J FISH AQUAT SCI, V41, P917, DOI 10.1139/f84-107; SCARNECCHIA DL, 1989, T AM FISH SOC, V118, P482, DOI 10.1577/1548-8659(1989)118<0482:OARIOV>2.3.CO;2; Schroder V, 2011, BIOL INVASIONS, V13, P203, DOI 10.1007/s10530-010-9802-z; Shafer DJ, 2000, MAR ECOL PROG SER, V199, P217, DOI 10.3354/meps199217; SHEARER WM, 1992, 188 ICES, P46; SKILBREI OT, 1989, AQUACULTURE, V83, P95, DOI 10.1016/0044-8486(89)90064-1; Smith KK, 2001, BIOL J LINN SOC, V73, P169, DOI 10.1006/bijl.2001.0535; Snover ML, 2005, CAN J FISH AQUAT SCI, V62, P1219, DOI 10.1139/F05-058; TAYLOR LR, 1977, NATURE, V265, P415, DOI 10.1038/265415a0; Tiira K, 2009, J FISH BIOL, V74, P2374, DOI 10.1111/j.1095-8649.2009.02253.x; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; Venables WN., 2002, MODERN APPL STAT S 4; Vollestad LA, 2008, OIKOS, V117, P1752, DOI 10.1111/j.1600-0706.2008.16872.x; Yamamoto T, 1998, J FISH BIOL, V52, P281, DOI 10.1006/jfbi.1997.0580; Zabel RW, 2002, ECOL APPL, V12, P173, DOI 10.2307/3061144; [No title captured]	88	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2012	7	10							e45528	10.1371/journal.pone.0045528	http://dx.doi.org/10.1371/journal.pone.0045528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	014PQ	23049680	Green Published, Green Submitted, gold			2022-12-27	WOS:000309388500007
J	Smith, AB; Lopez-Villarejo, J; Diago-Navarro, E; Mitchenall, LA; Barendregt, A; Heck, AJ; Lemonnier, M; Maxwell, A; Diaz-Orejas, R				Smith, Andrew B.; Lopez-Villarejo, Juan; Diago-Navarro, Elizabeth; Mitchenall, Lesley A.; Barendregt, Arjan; Heck, Albert J.; Lemonnier, Marc; Maxwell, Anthony; Diaz-Orejas, Ramon			A Common Origin for the Bacterial Toxin-Antitoxin Systems parD and ccd, Suggested by Analyses of Toxin/Target and Toxin/Antitoxin Interactions	PLOS ONE			English	Article							PLASMID ADDICTION SYSTEM; ESCHERICHIA-COLI; DNA GYRASE; CRYSTAL-STRUCTURE; KID TOXIN; PROTEIN; R1; ANTIDOTE; STABILITY; CLEAVAGE	Bacterial toxin-antitoxin (TA) systems encode two proteins, a potent inhibitor of cell proliferation (toxin) and its specific antidote (antitoxin). Structural data has revealed striking similarities between the two model TA toxins CcdB, a DNA gyrase inhibitor encoded by the ccd system of plasmid F, and Kid, a site-specific endoribonuclease encoded by the parD system of plasmid R1. While a common structural fold seemed at odds with the two clearly different modes of action of these toxins, the possibility of functional crosstalk between the parD and ccd systems, which would further point to their common evolutionary origin, has not been documented. Here, we show that the cleavage of RNA and the inhibition of protein synthesis by the Kid toxin, two activities that are specifically counteracted by its cognate Kis antitoxin, are altered, but not inhibited, by the CcdA antitoxin. In addition, Kis was able to inhibit the stimulation of DNA gyrase-mediated cleavage of DNA by CcdB, albeit less efficiently than CcdA. We further show that physical interactions between the toxins and antitoxins of the different systems do occur and define the stoichiometry of the complexes formed. We found that CcdB did not degrade RNA nor did Kid have any reproducible effect on the tested DNA gyrase activities, suggesting that these toxins evolved to reach different, rather than common, cellular targets.	[Smith, Andrew B.; Mitchenall, Lesley A.; Maxwell, Anthony] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England; [Lopez-Villarejo, Juan; Diago-Navarro, Elizabeth; Lemonnier, Marc; Diaz-Orejas, Ramon] CSIC, Dept Mol Microbiol, Ctr Invest Biol, Madrid, Spain; [Barendregt, Arjan; Heck, Albert J.] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, Utrecht, Netherlands; [Barendregt, Arjan; Heck, Albert J.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Utrecht University; Utrecht University	Diaz-Orejas, R (corresponding author), CSIC, Dept Mol Microbiol, Ctr Invest Biol, Madrid, Spain.	ramondiaz@cib.csic.es	Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404; Diago Navarro, Elizabeth/0000-0001-7117-1796; Mitchenall, Lesley/0000-0002-0063-1991; Maxwell, Anthony/0000-0002-5756-6430; Lemonnier, Marc/0000-0002-8587-9864	Spanish MICINN [BFU 2008-01566/BMC y, CSD2008-00013]; PRIME-XS project [262067]; European Union 7th Framework Programme; Basque Country Government; BBSRC (UK); BBSRC-CASE studentship; BBSRC; GlaxoSmithKline; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201] Funding Source: researchfish	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); PRIME-XS project; European Union 7th Framework Programme; Basque Country Government(Basque Government); BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC-CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline(GlaxoSmithKline); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RDO acknowledges financial support from the Spanish MICINN (Granted projects BFU 2008-01566/BMC y and CSD2008-00013). EDN acknowledges support from the PRIME-XS project, grant agreement number 262067, funded by the European Union 7th Framework Programme and from the Basque Country Government. AM acknowledges support from the BBSRC (UK); ABS was supported by a BBSRC-CASE studentship, funded by the BBSRC and GlaxoSmithKline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; BERNARD P, 1993, J MOL BIOL, V234, P534, DOI 10.1006/jmbi.1993.1609; BERNARD P, 1991, MOL GEN GENET, V226, P297, DOI 10.1007/BF00273616; BRAVO A, 1987, MOL GEN GENET, V210, P101, DOI 10.1007/BF00337764; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Chatterji M, 2001, J ANTIMICROB CHEMOTH, V48, P479, DOI 10.1093/jac/48.4.479; Couturier M, 1998, TRENDS MICROBIOL, V6, P269, DOI 10.1016/S0966-842X(98)01311-0; Critchlow SE, 1997, J MOL BIOL, V273, P826, DOI 10.1006/jmbi.1997.1357; Dao-Thi MH, 2000, J MOL BIOL, V299, P1373, DOI 10.1006/jmbi.2000.3815; Dao-Thi MH, 2005, J MOL BIOL, V348, P1091, DOI 10.1016/j.jmb.2005.03.049; Dao-Thi MH, 2002, J BIOL CHEM, V277, P3733, DOI 10.1074/jbc.M105505200; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; Diago-Navarro E, 2010, FEBS J, V277, P3097, DOI 10.1111/j.1742-4658.2010.07722.x; Diago-Navarro E, 2009, FEBS J, V276, P4973, DOI 10.1111/j.1742-4658.2009.07199.x; Hargreaves D, 2002, STRUCTURE, V10, P1425, DOI 10.1016/S0969-2126(02)00856-0; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; Kamphuis MB, 2006, J MOL BIOL, V357, P115, DOI 10.1016/j.jmb.2005.12.033; Kamphuis MB, 2007, PROTEINS; Loris R, 2003, J BIOL CHEM, V278, P28252, DOI 10.1074/jbc.M302336200; Loris R, 1999, J MOL BIOL, V285, P1667, DOI 10.1006/jmbi.1998.2395; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; MASUDA YJ, 1993, J BACTERIOL, V175, P6850, DOI 10.1128/jb.175.21.6850-6856.1993; Maxwell A, 1999, METH MOL B, V94, P135; Monti MC, 2007, NUCLEIC ACIDS RES, V35, P1737, DOI 10.1093/nar/gkm073; Munoz-Gomez AJ, 2005, J BACTERIOL, V187, P3151, DOI 10.1128/JB.187.9.3151-3157.2005; Munoz-Gomez AJ, 2004, FEBS LETT, V567, P316, DOI 10.1016/j.febslet.2004.05.005; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; OGURA T, 1983, P NATL ACAD SCI-BIOL, V80, P4784, DOI 10.1073/pnas.80.15.4784; RUIZECHEVARRIA MJ, 1991, MOL MICROBIOL, V5, P2685, DOI 10.1111/j.1365-2958.1991.tb01977.x; RUIZECHEVARRIA MJ, 1991, MOL GEN GENET, V225, P355, DOI 10.1007/BF00261674; SALMON MA, 1994, MOL GEN GENET, V244, P530, DOI 10.1007/BF00583904; Santos-Sierra S, 2002, FEMS MICROBIOL LETT, V206, P115, DOI 10.1111/j.1574-6968.2002.tb10995.x; Sierra SS, 1998, FEMS MICROBIOL LETT, V168, P51; Smith AB, 2006, NUCLEIC ACIDS RES, V34, P4667, DOI 10.1093/nar/gkl636; Tartof K.D., 1987, BETHESDA RES LAB FOC, V9, P12; VanMelderen L, 1996, J BIOL CHEM, V271, P27730, DOI 10.1074/jbc.271.44.27730; Wilbaux M, 2007, J BACTERIOL, V189, P2712, DOI 10.1128/JB.01679-06; Zhang JJ, 2004, J BIOL CHEM, V279, P20678, DOI 10.1074/jbc.M314284200	38	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46499	10.1371/journal.pone.0046499	http://dx.doi.org/10.1371/journal.pone.0046499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029540	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900178
J	Sung, CK; Yim, H; Gu, HC; Li, DW; Andrews, E; Duraisamy, S; Li, C; Drapkin, R; Benjamin, T				Sung, Chang Kyoo; Yim, Hyungshin; Gu, Hongcang; Li, Dawei; Andrews, Erik; Duraisamy, Sekhar; Li, Cheng; Drapkin, Ronny; Benjamin, Thomas			The Polyoma Virus Large T Binding Protein p150 Is a Transcriptional Repressor of c-MYC	PLOS ONE			English	Article							RADIAL RAY SYNDROME; OVARIAN; EXPRESSION; MUTATIONS; P150(SAL2); NUMBER; SALL4; GENE; P53	p150, product of the SALL2 gene, is a binding partner of the polyoma virus large T antigen and a putative tumor suppressor. p150 binds to the nuclease hypersensitive element of the c-MYC promoter and represses c-MYC transcription. Overexpression of p150 in human ovarian surface epithelial cells leads to decreased expression, and downregulation to increased expression, of c-MYC. c-MYC is repressed upon restoration of p150 to ovarian carcinoma cells. Induction of apoptosis by etoposide results in recruitment of p150 to the c-MYC promoter and to repression of c-MYC. Analysis of data in The Cancer Genome Atlas shows negative correlations between SALL2 and c-MYC expression in four common solid tumor types.	[Sung, Chang Kyoo; Yim, Hyungshin; Gu, Hongcang; Li, Dawei; Andrews, Erik; Benjamin, Thomas] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Duraisamy, Sekhar; Drapkin, Ronny] Ctr Mol Oncol Pathol, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA; [Li, Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Drapkin, Ronny] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Benjamin, T (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	thomas_benjamin@hms.harvard.edu	Drapkin, Ronny/E-9944-2016	Drapkin, Ronny/0000-0002-6912-6977; Gu, Hongcang/0000-0002-1439-7606	National Cancer Institute [RO1 CA 092520]; NIH [R01 GM077122, P50 CA105009, K08 CA108748]; Ovarian Cancer Research Fund; Robert and Debra First Fund; Dana-Farber Women's Executive Council Genetic Fingerprinting Award; NATIONAL CANCER INSTITUTE [R01CA092520, K08CA108748, P50CA105009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077122] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ovarian Cancer Research Fund; Robert and Debra First Fund; Dana-Farber Women's Executive Council Genetic Fingerprinting Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Cancer Institute RO1 CA 092520 to TB, NIH grant R01 GM077122 to CL, and grants P50 CA105009 and K08 CA108748, the Ovarian Cancer Research Fund, the Robert and Debra First Fund, and the Dana-Farber Women's Executive Council Genetic Fingerprinting Award to RD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Baradie R, 2002, AM J HUM GENET, V71, P1195, DOI 10.1086/343821; Clauss A, 2010, NEOPLASIA, V12, P161, DOI 10.1593/neo.91542; Darcy KM, 2009, GYNECOL ONCOL, V114, P472, DOI 10.1016/j.ygyno.2009.05.012; Drapkin R, 2005, CANCER RES, V65, P2162, DOI 10.1158/0008-5472.CAN-04-3924; Gonzalez V, 2010, ANNU REV PHARMACOL, V50, P111, DOI 10.1146/annurev.pharmtox.48.113006.094649; Gorringe KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011408; Gu HC, 2011, BBA-GENE REGUL MECH, V1809, P276, DOI 10.1016/j.bbagrm.2011.02.002; Haverty PM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-21; Ho JSL, 2005, MOL CELL BIOL, V25, P7423, DOI 10.1128/MCB.25.17.7423-7431.2005; Hoffman B, 2008, ONCOGENE, V27, P6462, DOI 10.1038/onc.2008.312; Howley PM, 2009, VIROLOGY, V384, P256, DOI 10.1016/j.virol.2008.12.006; Kiefer SM, 2003, HUM MOL GENET, V12, P2221, DOI 10.1093/hmg/ddg233; Kohlhase J, 2005, HUM MUTAT, V26, P176, DOI 10.1002/humu.20215; Kohlhase J, 1999, AM J HUM GENET, V64, P435, DOI 10.1086/302238; Li DW, 2004, MOL CELL BIOL, V24, P3885, DOI 10.1128/MCB.24.9.3885-3893.2004; Li DW, 2001, P NATL ACAD SCI USA, V98, P14619, DOI 10.1073/pnas.251447198; Liu H, 2007, PLOS GENET, V3, P996, DOI 10.1371/journal.pgen.0030091; Ma YP, 2001, J BIOL CHEM, V276, P48223, DOI 10.1074/jbc.M106468200; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nowee ME, 2007, J PATHOL, V213, P46, DOI 10.1002/path.2217; Parroche P, 2011, VIROLOGY, V417, P443, DOI 10.1016/j.virol.2011.05.016; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; SHICHIRI M, 1993, CELL GROWTH DIFFER, V4, P93; Soucek L, 2010, CURR OPIN GENET DEV, V20, P91, DOI 10.1016/j.gde.2009.11.001; Sung CK, 2011, FASEB J, V25, P1275, DOI 10.1096/fj.10-173674; Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Yang DZ, 2006, NUCLEOS NUCLEOT NUCL, V25, P951, DOI 10.1080/15257770600809913	29	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46486	10.1371/journal.pone.0046486	http://dx.doi.org/10.1371/journal.pone.0046486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029531	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900170
J	Wu, D; Wang, M; Wang, XG; Yin, NB; Song, T; Li, HD; Zhang, F; Zhang, YB; Ye, ZQ; Yu, J; Wang, DM; Zhao, ZM				Wu, Di; Wang, Mei; Wang, Xingang; Yin, Ningbei; Song, Tao; Li, Haidong; Zhang, Feng; Zhang, Yongbiao; Ye, Zhenqing; Yu, Jun; Wang, Duen-Mei; Zhao, Zhenmin			Maternal Transmission Effect of a PDGF-C SNP on Nonsyndromic Cleft Lip with or without Palate from a Chinese Population	PLOS ONE			English	Article							LONG ARM; SCAN; GENE; EPIDEMIOLOGY; ASSOCIATION; SEQUENCE; MARKERS; ORIGIN; MAP	Cleft lip with or without palate (CL/P) is a common congenital anomaly with a high birth prevalence in China. Based on a previous linkage signal of nonsyndromic CL/P (NSCL/P) on the chromosomal region 4q31-q32 from the Chinese populations, we screened the 4q31-q32 region for susceptibility genes in 214 trios of Han Chinese. PDGF-C, an important developmental factor, resides in the region and has been implicated in NSCL/P. However, in our family-based association test (transmission disequilibrium test; TDT), we could not conclude an association between PDGF-C and NSCL/P as previously suggested. Instead, we found strong evidence for parent-of-origin effect at a PDGF-C SNP, rs17035464, by a likelihood ratio test (unadjusted p-value = 0.0018; I-m = 2.46). The location of rs17035464 is 13 kb downstream of a previously reported, NSCL/P-associated SNP, rs28999109. Furthermore, a patient from our sample trios was observed with a maternal segmental uniparental isodisomy (UPD) in a region containing rs17035464. Our findings support the involvement of PDGF-C in the development of oral clefts; moreover, the UPD case report contributes to the collective knowledge of rare variants in the human genome.	[Wang, Mei; Zhang, Feng; Zhang, Yongbiao; Ye, Zhenqing; Yu, Jun; Wang, Duen-Mei] Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Wu, Di; Yin, Ningbei; Song, Tao; Li, Haidong; Zhao, Zhenmin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wu, Di; Yin, Ningbei; Song, Tao; Li, Haidong; Zhao, Zhenmin] Chinese Acad Med Sci, Dept Cleft Lip & Palate, Plast Surg Hosp, Beijing 100730, Peoples R China; [Wang, Mei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Wang, Xingang] Capital Univ Med Sci, Dept Stomatol, Beijing Children Hosp, Beijing, Peoples R China; [Zhao, Zhenmin] Peoples Hosp Jincheng City, Jincheng, Shanxi, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Plastic Surgery Hospital - CAMS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Capital Medical University	Wang, DM (corresponding author), Chinese Acad Sci, Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China.	dmwang@usa.net; zhaozhenmin0098@gmail.com	Ye, Zhenqing/L-7954-2019; Ye, Zhenqing/ABF-1433-2020		Doctoral Program Foundation of Institutions of Higher Education of China [200800230021]; Beijing Municipal Natural Science Foundation [7092087]; National Basic Research Program of China [2007CB511901]; Chinese Academy of Sciences	Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Doctoral Program Foundation of Institutions of Higher Education of China (200800230021), Beijing Municipal Natural Science Foundation (7092087), National Basic Research Program of China (Grant No. 2007CB511901) and 100 Talents Program of the Chinese Academy of Sciences to DMW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BEIRAGHI S, 1994, CLIN GENET, V46, P255; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; Choi SJ, 2008, EUR J HUM GENET; Cooper ME, 2000, CLEFT PALATE-CRAN J, V37, P274, DOI 10.1597/1545-1569(2000)037<0274:DEONCL>2.3.CO;2; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Eberhart JK, 2007, NATURE GENETICS; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grun K, 2005, EUR HEART J, V26, P728, DOI 10.1093/eurheartj/ehi168; Harville EW, 2007, EUR J EPIDEMIOL, V22, P389, DOI 10.1007/s10654-007-9129-y; Jugessur A, 2005, CURR OPIN GENET DEV, V15, P270, DOI 10.1016/j.gde.2005.03.003; Juriloff DM, 2001, MAMM GENOME, V12, P426, DOI 10.1007/s003350010284; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; LIN AE, 1988, AM J MED GENET, V31, P533, DOI 10.1002/ajmg.1320310308; Lipsky RH, 2003, ANN NY ACAD SCI, V1003, P22, DOI 10.1196/annals.1300.003; Mangold E, 2009, AM J MED GENET A, V149A, P2680, DOI 10.1002/ajmg.a.33136; Marazita ML, 2002, AM J HUM GENET, V71, P349, DOI 10.1086/341944; MITCHELL LE, 1995, AM J HUM GENET, V57, P1130; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Murray JC, 2004, J CLIN INVEST, V113, P1676, DOI 10.1172/JCI200422154; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Paredes M, 1999, REV MED CHILE, V127, P1431; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Prescott NJ, 2002, J MED GENET, V39, P368, DOI 10.1136/jmg.39.5.368; Reigstad LJ, 2005, FEBS J, V272, P5723, DOI 10.1111/j.1742-4658.2005.04989.x; Reigstad LJ, 2003, J BIOL CHEM, V278, P17114, DOI 10.1074/jbc.M301728200; Salahshourifar I, 2010, AM J MED GENET A, V152A, P1818, DOI 10.1002/ajmg.a.33526; Schultz RE, 2004, AM J MED GENET A, V125A, P17, DOI 10.1002/ajmg.a.20424; Song R, 2003, CLEFT LIP PALATE REP; Sowpati DT, 2008, MECH DEVELOP, V125, P963, DOI 10.1016/j.mod.2008.08.002; Sull J, 2009, HUMAN GENETICS; Sull JW, 2008, GENET EPIDEMIOL, V32, P505, DOI 10.1002/gepi.20323; Ustach CV, 2004, CANCER RES, V64, P1722, DOI 10.1158/0008-5472.CAN-03-3047; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Wu X, 2007, GENESIS, V45, P653, DOI 10.1002/dvg.20339; Wyszynski DF, 2003, AM J MED GENET A, V123A, P140, DOI 10.1002/ajmg.a.20283; Zhao JH, 2007, J STAT SOFTW, V23	43	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46477	10.1371/journal.pone.0046477	http://dx.doi.org/10.1371/journal.pone.0046477			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029525	Green Published, Green Submitted, gold			2022-12-27	WOS:000309973900166
J	Bergougnoux, V; Zalabak, D; Jandova, M; Novak, O; Wiese-Klinkenberg, A; Fellner, M				Bergougnoux, Veronique; Zalabak, David; Jandova, Michaela; Novak, Ondrej; Wiese-Klinkenberg, Anika; Fellner, Martin			Effect of Blue Light on Endogenous Isopentenyladenine and Endoreduplication during Photomorphogenesis and De-Etiolation of Tomato (Solanum lycopersicum L.) Seedlings	PLOS ONE			English	Article							NUCLEAR-DNA CONTENT; ARABIDOPSIS-THALIANA; HYPOCOTYL GROWTH; CYTOKININ BIOSYNTHESIS; SIGNALING PATHWAYS; MASS-SPECTROMETRY; MERISTEM ACTIVITY; CELL-DIVISION; PLANT-GROWTH; MUTANT	Light is one of the most important factor influencing plant growth and development all through their life cycle. One of the well-known light-regulated processes is de-etiolation, i.e. the switch from skotomorphogenesis to photomorphogenesis. The hormones cytokinins (CKs) play an important role during the establishment of photomorphogenesis as exogenous CKs induced photomorphogenesis of dark-grown seedlings. Most of the studies are conducted on the plant model Arabidopsis, but no or few information are available for important crop species, such as tomato (Solanum lycopersicum L.). In our study, we analyzed for the first time the endogenous CKs content in tomato hypocotyls during skotomorphogenesis, photomorphogenesis and de-etiolation. For this purpose, two tomato genotypes were used: cv. Rutgers (wild-type; WT) and its corresponding mutant (7B-1) affected in its responses to blue light (BL). Using physiological and molecular approaches, we identified that the skotomorphogenesis is characterized by an endoreduplication-mediated cell expansion, which is inhibited upon BL exposure as seen by the accumulation of trancripts encoding CycD3, key regulators of the cell cycle. Our study showed for the first time that iP (isopentenyladenine) is the CK accumulated in the tomato hypocotyl upon BL exposure, suggesting its specific role in photomorphogenesis. This result was supported by physiological experiments and gene expression data. We propose a common model to explain the role and the relationship between CKs, namely iP, and endoreduplication during de-etiolation and photomorphogenesis.	[Bergougnoux, Veronique; Novak, Ondrej; Fellner, Martin] Palacky Univ, Fac Sci, Lab Growth Regulators, CR-77147 Olomouc, Czech Republic; [Bergougnoux, Veronique; Novak, Ondrej; Fellner, Martin] Inst Expt Bot AS CR, Vvi, Olomouc, Czech Republic; [Bergougnoux, Veronique; Zalabak, David] Palacky Univ, Fac Sci, Dept Mol Biol, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic; [Jandova, Michaela] Palacky Univ, Fac Sci, Dept Bot, CR-77147 Olomouc, Czech Republic; [Wiese-Klinkenberg, Anika] Forschungszentrum Julich, IBG Plant Sci 2, Inst Bio & Geosci, D-52425 Julich, Germany	Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; Palacky University Olomouc; Helmholtz Association; Research Center Julich	Bergougnoux, V (corresponding author), Palacky Univ, Fac Sci, Dept Mol Biol, Ctr Reg Hana Biotechnol & Agr Res, Slechtitelu 11, CR-77147 Olomouc, Czech Republic.	v.bergougnoux@yahoo.fr; martin.fellner@upol.cz	Bergougnoux, Veronique/GZK-3304-2022; Wiese-Klinkenberg, Anika/C-8196-2009; Fellner, Martin/B-2068-2010; NOVAK, Ondrej/F-7031-2014	NOVAK, Ondrej/0000-0003-3452-0154; Zalabak, David/0000-0002-4825-8321; Bergougnoux, Veronique/0000-0003-0681-311X	Ministry of Education, Youth and Sports of the Czech Republic [MSM6198959215]; Czech Science Foundation [P501/10/0785]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	This research was supported by a grant of the Ministry of Education, Youth and Sports of the Czech Republic (MSM6198959215) and a grant of the Czech Science Foundation (P501/10/0785). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergougnoux V, 2009, J EXP BOT, V60, P1219, DOI 10.1093/jxb/ern366; Boudolf V, 2004, PLANT CELL, V16, P2683, DOI 10.1105/tpc.104.024398; ChinAtkins AN, 1996, PLANTA, V198, P549, DOI 10.1007/BF00262641; Choi J, 2007, J PLANT BIOL, V50, P98, DOI 10.1007/BF03030617; CHORY J, 1994, PLANT PHYSIOL, V104, P339, DOI 10.1104/pp.104.2.339; Chory J, 1991, Symp Soc Exp Biol, V45, P21; Cluis CP, 2004, PLANT J, V38, P332, DOI 10.1111/j.1365-313X.2004.02052.x; COSGROVE DJ, 1981, PLANT PHYSIOL, V67, P584, DOI 10.1104/pp.67.3.584; Dewitte W, 2007, P NATL ACAD SCI USA, V104, P14537, DOI 10.1073/pnas.0704166104; DOLEZEL J, 1989, BIOL PLANTARUM, V31, P113, DOI 10.1007/BF02907241; DOLEZEL J, 1992, PHYSIOL PLANTARUM, V85, P625, DOI 10.1111/j.1399-3054.1992.tb04764.x; Fellner M, 2002, PLANTA, V214, P675, DOI 10.1007/s004250100671; Folta KM, 2001, PLANT J, V26, P471, DOI 10.1046/j.1365-313x.2001.01038.x; Gajdosova S, 2011, J EXP BOT, V62, P2827, DOI 10.1093/jxb/erq457; Galuszka P, 2007, J PLANT GROWTH REGUL, V26, P255, DOI 10.1007/s00344-007-9008-5; Gendreau E, 1998, PLANT J, V13, P221, DOI 10.1046/j.1365-313X.1998.00030.x; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Hirose N, 2008, J EXP BOT, V59, P75, DOI 10.1093/jxb/erm157; Inoue T, 2001, NATURE, V409, P1060, DOI 10.1038/35059117; Jacqmard A, 1999, PLANTA, V207, P496, DOI 10.1007/s004250050509; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Kuroha T, 2009, PLANT CELL, V21, P3152, DOI 10.1105/tpc.109.068676; Kusnetsov V, 1999, J BIOL CHEM, V274, P36009, DOI 10.1074/jbc.274.50.36009; Kvarnheden A, 2000, J EXP BOT, V51, P1789, DOI 10.1093/jexbot/51.352.1789; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Lochmanova G, 2008, J EXP BOT, V59, P3705, DOI 10.1093/jxb/ern220; MILLER CO, 1955, J AM CHEM SOC, V77, P1392, DOI 10.1021/ja01610a105; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Nisler J, 2010, PHYTOCHEMISTRY, V71, P823, DOI 10.1016/j.phytochem.2010.01.018; Novak O, 2003, ANAL CHIM ACTA, V480, P207, DOI 10.1016/S0003-2670(03)00025-4; Novak O, 2008, PHYTOCHEMISTRY, V69, P2214, DOI 10.1016/j.phytochem.2008.04.022; Perilli S, 2010, CURR OPIN PLANT BIOL, V13, P21, DOI 10.1016/j.pbi.2009.09.018; Perrot-Rechenmann C, 2010, BIOLOGY, DOI [10.1101/cshperspect.a001446., DOI 10.1101/CSHPERSPECT.A001446]; Poire R, 2010, J EXP BOT, V61, P1751, DOI 10.1093/jxb/erq049; Reid BR, 1995, PLANT HORMONES PHYSL, P4848; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; Sawhney VK, 1997, ADAS, P183; Schumacher K, 1999, GENE DEV, V13, P3259, DOI 10.1101/gad.13.24.3259; Sheoran IS, 2006, PHYSIOL PLANTARUM, V127, P681, DOI 10.1111/j.1399-3054.2006.00697.x; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P107, DOI 10.1093/pcp/pce037; Symons GM, 2003, J PLANT GROWTH REGUL, V22, P3, DOI 10.1007/s00344-003-0017-8; Traas J, 1998, CURR OPIN PLANT BIOL, V1, P498, DOI 10.1016/S1369-5266(98)80042-3; Vandenbussche F, 2005, BIOESSAYS, V27, P275, DOI 10.1002/bies.20199; Vandenbussche F, 2007, PLANT J, V49, P428, DOI 10.1111/j.1365-313X.2006.02973.x; Verkest A, 2005, PLANT PHYSIOL, V139, P1099, DOI 10.1104/pp.105.069906; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Werner T, 2009, CURR OPIN PLANT BIOL, V12, P527, DOI 10.1016/j.pbi.2009.07.002	50	15	15	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e45255	10.1371/journal.pone.0045255	http://dx.doi.org/10.1371/journal.pone.0045255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049779	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100033
J	He, D; Miao, M; Sitarz, EE; Muiznieks, LD; Reichheld, S; Stahl, RJ; Keeley, FW; Parkinson, J				He, David; Miao, Ming; Sitarz, Eva E.; Muiznieks, Lisa D.; Reichheld, Sean; Stahl, Richard J.; Keeley, Fred W.; Parkinson, John			Polymorphisms in the Human Tropoelastin Gene Modify In Vitro Self-Assembly and Mechanical Properties of Elastin-Like Polypeptides	PLOS ONE			English	Article							SEQUENCE; PROTEIN; ASSOCIATION; DISSECTION; DOMAIN; COACERVATION; DETERMINANTS; AGGREGATION; MORPHOLOGY; ANEURYSMS	Elastin is a major structural component of elastic fibres that provide properties of stretch and recoil to tissues such as arteries, lung and skin. Remarkably, after initial deposition of elastin there is normally no subsequent turnover of this protein over the course of a lifetime. Consequently, elastic fibres must be extremely durable, able to withstand, for example in the human thoracic aorta, billions of cycles of stretch and recoil without mechanical failure. Major defects in the elastin gene (ELN) are associated with a number of disorders including Supravalvular aortic stenosis (SVAS), Williams-Beuren syndrome (WBS) and autosomal dominant cutis laxa (ADCL). Given the low turnover of elastin and the requirement for the long term durability of elastic fibres, we examined the possibility for more subtle polymorphisms in the human elastin gene to impact the assembly and long-term durability of the elastic matrix. Surveys of genetic variation resources identified 118 mutations in human ELN, 17 being non-synonymous. Introduction of two of these variants, G422S and K463R, in elastin-like polypeptides as well as full-length tropoelastin, resulted in changes in both their assembly and mechanical properties. Most notably G422S, which occurs in up to 40% of European populations, was found to enhance some elastomeric properties. These studies reveal that even apparently minor polymorphisms in human ELN can impact the assembly and mechanical properties of the elastic matrix, effects that over the course of a lifetime could result in altered susceptibility to cardiovascular disease.	[He, David; Miao, Ming; Sitarz, Eva E.; Muiznieks, Lisa D.; Reichheld, Sean; Stahl, Richard J.; Keeley, Fred W.; Parkinson, John] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [He, David; Parkinson, John] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Keeley, Fred W.; Parkinson, John] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Parkinson, J (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	jparkin@sickkids.ca	Parkinson, John/A-4424-2008	Parkinson, John/0000-0001-9815-1189	Heart and Stroke Foundation of Ontario [T 6748, T 6725]; New Investigators Award from Canadian Institutes of Health Research and an Early Researchers; Ontario Ministry of Research and Innovation award from the Ontario Ministry of Research and Innovation; Hospital for Sick Children (Toronto, Ontario, Canada) Research Training Centre	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); New Investigators Award from Canadian Institutes of Health Research and an Early Researchers(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation award from the Ontario Ministry of Research and Innovation; Hospital for Sick Children (Toronto, Ontario, Canada) Research Training Centre	This work was supported by grants from the Heart and Stroke Foundation of Ontario (JP and FWK: # T 6748; FWK # T 6725). JP is additionally supported by a New Investigators Award from Canadian Institutes of Health Research and an Early Researchers award from the Ontario Ministry of Research and Innovation. DH is supported by the Hospital for Sick Children (Toronto, Ontario, Canada) Research Training Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagawa H, 2006, HUM MOL GENET, V15, P1722, DOI 10.1093/hmg/ddl096; Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512; Bellingham CM, 2001, BBA-PROTEIN STRUCT M, V1550, P6, DOI 10.1016/S0167-4838(01)00262-X; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Broekelmann TJ, 2005, J BIOL CHEM, V280, P40939, DOI 10.1074/jbc.M507309200; Callewaert B, 2011, HUM MUTAT, V32, P445, DOI 10.1002/humu.21462; Chung MIS, 2006, MATRIX BIOL, V25, P492, DOI 10.1016/j.matbio.2006.08.258; Cirulis JT, 2008, BIOCHEMISTRY-US, V47, P12601, DOI 10.1021/bi8005384; Cirulis JT, 2010, BIOCHEMISTRY-US, V49, P5726, DOI 10.1021/bi100468v; Dare EV, 2009, CELLS TISSUES ORGANS, V190, P313, DOI 10.1159/000209230; DAVIS EC, 1993, HISTOCHEMISTRY, V100, P17, DOI 10.1007/BF00268874; Deng LH, 2009, AM J HYPERTENS, V22, P656, DOI 10.1038/ajh.2009.53; Dyksterhuis LB, 2009, ARCH BIOCHEM BIOPHYS, V487, P79, DOI 10.1016/j.abb.2009.06.001; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOSLINE JM, 1978, BIOPOLYMERS, V17, P697, DOI 10.1002/bip.1978.360170312; Hanon O, 2001, HYPERTENSION, V38, P1185, DOI 10.1161/hy1101.096802; He D, 2007, MATRIX BIOL, V26, P524, DOI 10.1016/j.matbio.2007.05.005; Huntley D, 2006, BIOINFORMATICS, V22, P495, DOI 10.1093/bioinformatics/btk006; Kielty Cay M., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S146239940600007X; Kozel BA, 2006, J CELL PHYSIOL, V207, P87, DOI 10.1002/jcp.20546; LEFEVRE M, 1980, BIOCHIM BIOPHYS ACTA, V630, P519, DOI 10.1016/0304-4165(80)90006-9; LeMaire SA, 2011, NAT GENET ADV; Miao M, 2005, BIOCHEMISTRY-US, V44, P14367, DOI 10.1021/bi0510173; Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200; Milewicz DM, 2000, MATRIX BIOL, V19, P471, DOI 10.1016/S0945-053X(00)00099-8; Mithieux SM, 2005, ADV PROTEIN CHEM, V70, P437, DOI 10.1016/S0065-3233(05)70013-9; Mithieux SM, 2005, J STRUCT BIOL, V149, P282, DOI 10.1016/j.jsb.2004.11.005; Muiznieks LD, 2003, ARCH BIOCHEM BIOPHYS, V410, P317, DOI 10.1016/S0003-9861(02)00719-1; Muiznieks LD, 2010, BIOCHEM CELL BIOL, V88, P239, DOI [10.1139/O09-161, 10.1139/o09-161]; Onda H, 2001, AM J HUM GENET, V69, P804, DOI 10.1086/323614; Prakash SK, 2010, AM J HUM GENET, V87, P743, DOI 10.1016/j.ajhg.2010.09.015; Rauscher S, 2006, STRUCTURE, V14, P1667, DOI 10.1016/j.str.2006.09.008; Rauscher S, 2012, ADV EXP MED BIOL, V725, P159, DOI 10.1007/978-1-4614-0659-4_10; Rauscher S, 2010, BIOCHEM CELL BIOL, V88, P269, DOI [10.1139/O09-169, 10.1139/o09-169]; Ruigrok YM, 2004, STROKE, V35, P2064, DOI 10.1161/01.STR.0000139380.50649.5c; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Song HY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002406; Sung HW, 2003, BIOMATERIALS, V24, P1335, DOI 10.1016/S0142-9612(02)00509-4; Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P751, DOI 10.1163/156856299X00621; Tamburro AM, 2005, PATHOL BIOL, V53, P383, DOI 10.1016/j.patbio.2004.12.014; Tamburro AM, 2003, BIOCHEMISTRY-US, V42, P13347, DOI 10.1021/bi034837t; Tamburro AM, 2006, BIOCHEMISTRY-US, V45, P9518, DOI 10.1021/bi060289i; UITTO J, 1979, J INVEST DERMATOL, V72, P1, DOI 10.1111/1523-1747.ep12530093; Urban Z, 2002, AM J HUM GENET, V71, P30, DOI 10.1086/341035; Vieth S, 2007, BIOPOLYMERS, V85, P199, DOI 10.1002/bip.20619; Vrhovski B, 1997, EUR J BIOCHEM, V250, P92, DOI 10.1111/j.1432-1033.1997.00092.x; Wagenseil Jessica E., 2007, Birth Defects Research, V81, P229, DOI 10.1002/bdrc.20111; Wang XW, 2005, SURGERY, V138, P352, DOI 10.1016/j.surg.2005.06.006; Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003	49	19	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46130	10.1371/journal.pone.0046130	http://dx.doi.org/10.1371/journal.pone.0046130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049958	Green Published, Green Submitted, gold			2022-12-27	WOS:000309556100142
J	Katsumata, R; Ishigaki, S; Katsuno, M; Kawai, K; Sone, J; Huang, Z; Adachi, H; Tanaka, F; Urano, F; Sobue, G				Katsumata, Ryu; Ishigaki, Shinsuke; Katsuno, Masahisa; Kawai, Kaori; Sone, Jun; Huang, Zhe; Adachi, Hiroaki; Tanaka, Fumiaki; Urano, Fumihiko; Sobue, Gen			c-Abl Inhibition Delays Motor Neuron Degeneration in the G93A Mouse, an Animal Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; CHRONIC MYELOID-LEUKEMIA; BULBAR MUSCULAR-ATROPHY; TYROSINE KINASE; CELL-DEATH; IMATINIB MESYLATE; BLAST CRISIS; PHENOTYPIC-EXPRESSION; TRANSGENIC MICE; DNA-DAMAGE	Background: Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by progressive death of motor neurons. Although the pathogenesis of ALS remains unclear, several cellular processes are known to be involved, including apoptosis. A previous study revealed the apoptosis-related gene c-Abl to be upregulated in sporadic ALS motor neurons. Methodology/Findings: We investigated the possibility that c-Abl activation is involved in the progression of ALS and that c-Abl inhibition is potentially a therapeutic strategy for ALS. Using a mouse motor neuron cell line, we found that mutation of Cu/Zn-superoxide dismutase-1 (SOD1), which is one of the causative genes of familial ALS, induced the upregulation of c-Abl and decreased cell viability, and that the c-Abl inhibitor dasatinib inhibited cytotoxicity. Activation of c-Abl with a concomitant increase in activated caspase-3 was observed in the lumbar spine of G93A-SOD1 transgenic mice (G93A mice), a widely used model of ALS. The survival of G93A mice was improved by oral administration of dasatinib, which also decreased c-Abl phosphorylation, inactivated caspase-3, and improved the innervation status of neuromuscular junctions. In addition, c-Abl expression in postmortem spinal cord tissues from sporadic ALS patients was increased by 3-fold compared with non-ALS patients. Conclusions/Significance: The present results suggest that c-Abl is a potential therapeutic target for ALS and that the c-Abl inhibitor dasatinib has neuroprotective properties in vitro and in vivo.	[Katsumata, Ryu; Ishigaki, Shinsuke; Katsuno, Masahisa; Kawai, Kaori; Sone, Jun; Huang, Zhe; Adachi, Hiroaki; Tanaka, Fumiaki; Sobue, Gen] Nagoya Univ, Dept Neurol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4648601, Japan; [Ishigaki, Shinsuke; Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA USA; [Ishigaki, Shinsuke; Sobue, Gen] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Saitama, Japan; [Urano, Fumihiko] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA	Nagoya University; University of Massachusetts System; University of Massachusetts Worcester; Japan Science & Technology Agency (JST); University of Massachusetts System; University of Massachusetts Worcester	Sobue, G (corresponding author), Nagoya Univ, Dept Neurol, Grad Sch Med, Showa Ku, Tsurumai Cho, Nagoya, Aichi 4648601, Japan.	sobueg@med.nagoya-u.ac.jp	ISHIGAKI, Shinsuke/I-7305-2014; Adachi, Hiroaki/AAM-7812-2020; KATSUNO, MASAHISA/I-7502-2014; Urano, Fumihiko/AAF-4492-2020; Sone, Jun/M-5027-2014	Adachi, Hiroaki/0000-0002-9302-4663; KATSUNO, MASAHISA/0000-0001-9453-9311; Sone, Jun/0000-0002-9057-7609; Ishigaki, Shinsuke/0000-0002-9555-0659	Ministry of Education, Culture, Sports, Science and Technology of Japan; Grant-in-Aid for Scientific Research on Innovated Areas "Foundation of Synapse and Neurocircuit Pathology"; Ministry of Health, Labor and Welfare of Japan; Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grant-in-Aid for Scientific Research on Innovated Areas "Foundation of Synapse and Neurocircuit Pathology"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This work was supported by a Center-of-Excellence (COE) grant from the Ministry of Education, Culture, Sports, Science and Technology of Japan [http://w3serv.nagoya-u.ac.jp/coemed/en/index.html]; a Grant-in-Aid for Scientific Research on Innovated Areas "Foundation of Synapse and Neurocircuit Pathology" [http://www.tmd.ac.jp/mri/shingakujutu/index-e.html], and Grant-in-Aids from Ministry of Education, Culture, Sports, Science, and Technology of Japan [http://www.jsps.go.jp/english/e-grants/index.html]; grants from the Ministry of Health, Labor and Welfare of Japan [http://www.mhlw.go.jp/english/policy/other/research-projects/index.html]; and Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Agency (JST) [http://www.sss.jst.go.jp/english/index.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2001, HUM MOL GENET, V10, P1039, DOI 10.1093/hmg/10.10.1039; Adachi H, 2007, J NEUROSCI, V27, P5115, DOI 10.1523/JNEUROSCI.1242-07.2007; Agrawal M, 2010, CURR ONCOL REP, V12, P302, DOI 10.1007/s11912-010-0116-1; Aichberger KJ, 2007, EUR J CLIN INVEST, V37, P808, DOI 10.1111/j.1365-2362.2007.01859.x; Alvarez AR, 2008, FASEB J, V22, P3617, DOI 10.1096/fj.07-102715; Alvarez AR, 2004, NEUROBIOL DIS, V17, P326, DOI 10.1016/j.nbd.2004.06.007; An X, 2010, LEUKEMIA RES, V34, P1255, DOI 10.1016/j.leukres.2010.04.016; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Braconi C, 2008, CURR CANCER DRUG TAR, V8, P359, DOI 10.2174/156800908785133169; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bujassoum S, 2004, LEUKEMIA LYMPHOMA, V45, P401, DOI 10.1080/10428190310001593184; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Cancino GI, 2008, BRAIN, V131, P2425, DOI 10.1093/brain/awn125; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Chen TC, 2007, CELL MICROBIOL, V9, P2676, DOI 10.1111/j.1462-5822.2007.00988.x; Dangond F, 2004, PHYSIOL GENOMICS, V16, P229, DOI 10.1152/physiolgenomics.00087.2001; Emery A, 1982, HUMAN MOTOR NEURON D, P139; FAINSTEIN E, 1987, NATURE, V330, P386, DOI 10.1038/330386a0; Gonfloni S, 2010, ONCOGENE, V29, P6193, DOI 10.1038/onc.2010.410; Gu JJ, 2009, IMMUNOL REV, V228, P170, DOI 10.1111/j.1600-065X.2008.00751.x; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Inoue H, 2003, EMBO J, V22, P6665, DOI 10.1093/emboj/cdg634; Ishigaki S, 2002, J NEUROCHEM, V82, P576, DOI 10.1046/j.1471-4159.2002.00998.x; Isobe Y, 2009, INTERN MED J, V39, P408, DOI 10.1111/j.1445-5994.2009.01947.x; Ito Y, 2001, MOL CELL BIOL, V21, P6233, DOI 10.1128/MCB.21.18.6233-6242.2001; Jiang YM, 2005, ANN NEUROL, V57, P236, DOI 10.1002/ana.20379; Jiang YM, 2007, J NEUROPATH EXP NEUR, V66, P617, DOI 10.1097/nen.0b013e318093ece3; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kabashi E, 2006, BBA-MOL BASIS DIS, V1762, P1038, DOI 10.1016/j.bbadis.2006.06.006; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Katsuno M, 2002, NEURON, V35, P843, DOI 10.1016/S0896-6273(02)00834-6; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Lee JH, 2008, J BIOL CHEM, V283, P19826, DOI 10.1074/jbc.M706201200; Lombardo LJ, 2004, J MED CHEM, V47, P6658, DOI 10.1021/jm049486a; Lu W, 2007, BIOCHEM BIOPH RES CO, V352, P431, DOI 10.1016/j.bbrc.2006.11.028; Ludolph Albert C, 2007, Amyotroph Lateral Scler, V8, P217, DOI 10.1080/17482960701292837; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Martin LJ, 2010, PHARMACEUTICALS, V3, P839, DOI 10.3390/ph3040839; Matsuda M, 2005, INT J HEMATOL, V81, P307, DOI 10.1532/IJH97.04188; Minamiyama M, 2004, HUM MOL GENET, V13, P1183, DOI 10.1093/hmg/ddh131; Nowell PC, 1960, SCIENCE, V132, P1488; Pendergast AM, 2002, ADV CANCER RES, V85, P51, DOI 10.1016/S0065-230X(02)85003-5; Porkka K, 2008, BLOOD, V112, P1005, DOI 10.1182/blood-2008-02-140665; Rajappa S, 2004, HEMATOL ONCOL, V22, P179, DOI 10.1002/hon.737; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Simpson E, 2006, CLIN LAB HAEMATOL, V28, P215, DOI 10.1111/j.1365-2257.2006.00782.x; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; TYLER HR, 1991, HDB CLIN NEUROL, P169; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Wang JYJ, 2001, BIOCHEM SOC T, V29, P666, DOI 10.1042/0300-5127:0290666; WANG JYJ, 1984, CELL, V36, P349; Wang JYJ, 2000, ONCOGENE, V19, P5643, DOI 10.1038/sj.onc.1203878; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	58	24	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46185	10.1371/journal.pone.0046185	http://dx.doi.org/10.1371/journal.pone.0046185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049975	Green Published, gold, Green Submitted			2022-12-27	WOS:000309556100150
J	Ruhs, H; Becker, A; Drescher, A; Panetta, JC; Pui, CH; Relling, MV; Jaehde, U				Ruehs, Hauke; Becker, Achim; Drescher, Anne; Panetta, John C.; Pui, Ching-Hon; Relling, Mary V.; Jaehde, Ulrich			Population PK/PD Model of Homocysteine Concentrations after High-Dose Methotrexate Treatment in Patients with Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							PEDIATRIC-ONCOLOGY-GROUP; LIMITED SAMPLING STRATEGY; CENTRAL-NERVOUS-SYSTEM; PLASMA HOMOCYSTEINE; TRANSFER PATHWAY; IN-VIVO; CHILDREN; NEUROTOXICITY; PHARMACOKINETICS; NONMEM	Elevated homocysteine concentrations have been associated with methotrexate-induced neurotoxicity. Based on methotrexate and homocysteine plasma concentrations of 494 children with acute lymphoblastic leukemia treated with high-dose methotrexate in the TOTAL XV study, a pharmacokinetic/pharmacodynamic (PK/PD) model was built with NONMEM. Several compartment and indirect response models were investigated. The pharmacokinetic disposition of methotrexate was best described by a two-compartment model. Homocysteine concentrations were included by an indirect response model where methotrexate inhibition of the homocysteine elimination rate was described by an Emax model. The homocysteine baseline level was found to be age-dependent. Simulations revealed that folinate rescue therapy does not affect peak concentrations of homocysteine but leads to a modestly reduced homocysteine exposure. In conclusion, our PK/PD model describes the increase of methotrexate-induced HCY concentrations with satisfactory precision and can be applied to assess the effect of folinate regimens on the HCY concentration-time course.	[Ruehs, Hauke; Becker, Achim; Drescher, Anne; Jaehde, Ulrich] Univ Bonn, Dept Clin Pharm, Inst Pharm, Bonn, Germany; [Panetta, John C.; Relling, Mary V.] St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA	University of Bonn; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital	Jaehde, U (corresponding author), Univ Bonn, Dept Clin Pharm, Inst Pharm, Bonn, Germany.	u.jaehde@uni-bonn.de	Relling, Mary/N-5032-2018; Pui, Ching-Hon/N-8076-2018; Panetta, John/AAY-3850-2021	Pui, Ching-Hon/0000-0003-0303-5658; Panetta, John/0000-0003-1308-7208; Keunecke, Anne/0000-0001-7718-4598; Ruhs, Hauke/0000-0001-8543-7831	National Cancer Institute [CA 36401, CA 21765]; National Institutes of Health/National Institute of General Medical Sciences Pharmacogenomics Research Network [U01 GM92666]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [R01CA036401, R37CA036401, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092666] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/National Institute of General Medical Sciences Pharmacogenomics Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by National Cancer Institute grants CA 36401 and CA 21765 and the National Institutes of Health/National Institute of General Medical Sciences Pharmacogenomics Research Network (U01 GM92666), and by the American Lebanese Syrian Associated Charities (ALSAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Aumente D, 2006, CLIN PHARMACOKINET, V45, P1227, DOI 10.2165/00003088-200645120-00007; Beal SL, 1998, NONMEM USERS GUIDE; Becker A, 2007, INT J CLIN PHARM TH, V45, P504; Bisschops RHC, 2004, ATHEROSCLEROSIS, V174, P87, DOI 10.1016/j.atherosclerosis.2004.01.005; Bremner WF, 2000, AM J CARDIOL, V86, P1153, DOI 10.1016/S0002-9149(00)01181-4; BROXSON EH, 1989, CANCER RES, V49, P5879; Ceriotti F, 2008, CLIN CHEM, V54, P559, DOI 10.1373/clinchem.2007.099648; Crews KR, 2004, CANCER-AM CANCER SOC, V100, P1724, DOI 10.1002/cncr.20152; DAYNEKA NL, 1993, J PHARMACOKINET BIOP, V21, P457, DOI 10.1007/BF01061691; Dupuis C, 2008, ANTI-CANCER DRUG, V19, P267, DOI 10.1097/CAD.0b013e3282f21376; Faltaos DW, 2006, CANCER CHEMOTH PHARM, V58, P626, DOI 10.1007/s00280-006-0202-0; Frick B, 2004, CLIN BIOCHEM, V37, P684, DOI 10.1016/j.clinbiochem.2004.02.007; FRY DW, 1982, J BIOL CHEM, V257, P1890; Graham ML, 1996, CLIN CANCER RES, V2, P331; JAFFE N, 1985, CANCER, V56, P1356, DOI 10.1002/1097-0142(19850915)56:6<1356::AID-CNCR2820560623>3.0.CO;2-H; Jonsson EN, 1999, COMPUT METH PROG BIO, V58, P51, DOI 10.1016/S0169-2607(98)00067-4; Kishi S, 2003, J CLIN ONCOL, V21, P3084, DOI 10.1200/JCO.2003.07.056; Lindbom L, 2005, COMPUT METH PROG BIO, V79, P241, DOI 10.1016/j.cmpb.2005.04.005; Lindbom L, 2004, COMPUT METH PROG BIO, V75, P85, DOI 10.1016/j.cmpb.2003.11.003; Mahoney DH, 1998, J CLIN ONCOL, V16, P1712, DOI 10.1200/JCO.1998.16.5.1712; Masson E, 1996, J CLIN INVEST, V97, P73, DOI 10.1172/JCI118409; Matsubayashi J, 2009, NEUROPATHOLOGY, V29, P105, DOI 10.1111/j.1440-1789.2008.00945.x; Min Y, 2009, BIOPHARM DRUG DISPOS, V30, P437, DOI 10.1002/bdd.678; Piard C, 2007, CANCER CHEMOTH PHARM, V60, P609, DOI 10.1007/s00280-006-0394-3; Plotkin SR, 2004, CLIN CANCER RES, V10, P5643, DOI 10.1158/1078-0432.CCR-04-0159; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Quinn CT, 1997, J CLIN ONCOL, V15, P2800, DOI 10.1200/JCO.1997.15.8.2800; Rau T, 2006, CLIN PHARMACOL THER, V80, P468, DOI 10.1016/j.clpt.2006.08.012; REFSUM H, 1986, CANCER RES, V46, P5385; REFSUM H, 1991, CANCER RES, V51, P828; Rubnitz JE, 1998, LEUKEMIA, V12, P1176, DOI 10.1038/sj.leu.2401098; Semmler A, 2009, CLIN INVEST MED, V32, pE310; Shuper A, 2000, J CHILD NEUROL, V15, P573, DOI 10.1177/088307380001500902; Stanger O, 2009, EXPERT REV NEUROTHER, V9, P1393, DOI 10.1586/ERN.09.75; Surtees R, 1998, J CLIN ONCOL, V16, P1505, DOI 10.1200/JCO.1998.16.4.1505; SYNOLD TW, 1994, J CLIN INVEST, V94, P1996, DOI 10.1172/JCI117552; Takata R, 2005, CLIN CANCER RES, V11, P2625, DOI 10.1158/1078-0432.CCR-04-1988; Vezmar S, 2003, CHEMOTHERAPY, V49, P92, DOI 10.1159/000069773; Vezmar S, 2009, PEDIATR BLOOD CANCER, V52, P26, DOI 10.1002/pbc.21827; Whitehead VM, 1998, CLIN CANCER RES, V4, P183	41	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2012	7	9							e46015	10.1371/journal.pone.0046015	http://dx.doi.org/10.1371/journal.pone.0046015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YP	23049924	Green Submitted, gold, Green Published			2022-12-27	WOS:000309556100120
J	Sun, P; Mantri, N; Lou, HQ; Hu, Y; Sun, D; Zhu, YQ; Dong, TT; Lu, HF				Sun, Peng; Mantri, Nitin; Lou, Heqiang; Hu, Ya; Sun, Dan; Zhu, Yueqing; Dong, Tingting; Lu, Hongfei			Effects of Elevated CO2 and Temperature on Yield and Fruit Quality of Strawberry (Fragaria x ananassa Duch.) at Two Levels of Nitrogen Application	PLOS ONE			English	Article							CARBON-DIOXIDE; ANTIOXIDANT ACTIVITY; LEAF SENESCENCE; ARABIDOPSIS-THALIANA; PHENOLIC METABOLISM; HARVEST INDEX; SEED-SET; GROWTH; STRESS; WHEAT	We investigated if elevated CO2 could alleviate the negative effect of high temperature on fruit yield of strawberry (Fragaria x ananassa Duch. cv. Toyonoka) at different levels of nitrogen and also tested the combined effects of CO2, temperature and nitrogen on fruit quality of plants cultivated in controlled growth chambers. Results show that elevated CO2 and high temperature caused a further 12% and 35% decrease in fruit yield at low and high nitrogen, respectively. The fewer inflorescences and smaller umbel size during flower induction caused the reduction of fruit yield at elevated CO2 and high temperature. Interestingly, nitrogen application has no beneficial effect on fruit yield, and this may be because of decreased sucrose export to the shoot apical meristem at floral transition. Moreover, elevated CO2 increased the levels of dry matter-content, fructose, glucose, total sugar and sweetness index per dry matter, but decreased fruit nitrogen content, total antioxidant capacity and all antioxidant compounds per dry matter in strawberry fruit. The reduction of fruit nitrogen content and antioxidant activity was mainly caused by the dilution effect of accumulated non-structural carbohydrates sourced from the increased net photosynthetic rate at elevated CO2. Thus, the quality of strawberry fruit would increase because of the increased sweetness and the similar amount of fruit nitrogen content, antioxidant activity per fresh matter at elevated CO2. Overall, we found that elevated CO2 improved the production of strawberry (including yield and quality) at low temperature, but decreased it at high temperature. The dramatic fluctuation in strawberry yield between low and high temperature at elevated CO2 implies that more attention should be paid to the process of flower induction under climate change, especially in fruits that require winter chilling for reproductive growth.	[Sun, Peng; Lou, Heqiang; Hu, Ya; Sun, Dan; Zhu, Yueqing; Dong, Tingting; Lu, Hongfei] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China; [Mantri, Nitin] RMIT Univ, Hlth Innovat Res Inst, Sch Appl Sci, Melbourne, Vic, Australia	Zhejiang Normal University; Royal Melbourne Institute of Technology (RMIT)	Sun, P (corresponding author), Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China.	luhongfei63@yahoo.com.cn	Lu, Hongfei/F-9526-2013	Lu, Hongfei/0000-0001-9732-0833; Lan, Ruiting/0000-0001-9834-5258; Mantri, Nitin/0000-0002-7621-035X	Project of Scientific and Technological Research Plan of Jinhua [2010-3-078, 2010-3-079]	Project of Scientific and Technological Research Plan of Jinhua	This research was funded by the Project of Scientific and Technological Research Plan of Jinhua (2010-3-078, 2010-3-079). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2000, ADV ECOL RES, V30, P1, DOI 10.1016/S0065-2504(08)60016-1; AHMED FE, 1993, PLANT CELL ENVIRON, V16, P835, DOI 10.1111/j.1365-3040.1993.tb00505.x; American Society for Testing Materials, 2002, STAND TEST METH TOT; AVIGDORIAVIDOV H, 1977, ANN BOT-LONDON, V41, P927, DOI 10.1093/oxfordjournals.aob.a085389; BAKER JT, 1989, CROP SCI, V29, P98, DOI 10.2135/cropsci1989.0011183X002900010024x; Baldocchi D, 2008, CLIMATIC CHANGE, V87, pS153, DOI 10.1007/s10584-007-9367-8; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Bernier G., 1981, PHYSL FLOWERING, VI; Buchanan-Wollaston V, 2003, PLANT BIOTECHNOL J, V1, P3, DOI 10.1046/j.1467-7652.2003.00004.x; Caldwell CR, 2005, J AGR FOOD CHEM, V53, P1125, DOI 10.1021/jf0355351; CASANO LM, 1994, PLANT PHYSIOL, V106, P1033, DOI 10.1104/pp.106.3.1033; Chen K, 1997, J APPL BOT-ANGEW BOT, V71, P195; Chen K, 1997, J APPL BOT-ANGEW BOT, V71, P183; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Datta R, 2001, SEX PLANT REPROD, V14, P127, DOI 10.1007/s00497-001-0105-5; Deng X, 1998, ANN BOT-LONDON, V81, P67, DOI 10.1006/anbo.1997.0535; DIXON RA, 1994, ANNU REV PHYTOPATHOL, V32, P479, DOI 10.1146/annurev.py.32.090194.002403; Franzaring J, 2011, ENVIRON EXP BOT, V72, P284, DOI 10.1016/j.envexpbot.2011.04.003; Giorgi A, 2009, FOOD CHEM, V114, P204, DOI 10.1016/j.foodchem.2008.09.039; Goncalves B, 2009, J AGR FOOD CHEM, V57, P265, DOI 10.1021/jf8020199; Grindal G, 1998, J PLANT GROWTH REGUL, V17, P161, DOI 10.1007/PL00007030; Grossman A, 2001, ANNU REV PLANT PHYS, V52, P163, DOI 10.1146/annurev.arplant.52.1.163; Heinonen IM, 1998, J AGR FOOD CHEM, V46, P4107, DOI 10.1021/jf980181c; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Hikosaka K, 2011, J EXP BOT, V62, P1523, DOI 10.1093/jxb/erq401; IPCC, 2007, CLIMATE CHANGE 2007, DOI DOI 10.1260/095830507781076194; Jablonski LM, 2002, NEW PHYTOL, V156, P9, DOI 10.1046/j.1469-8137.2002.00494.x; Keutgen A, 2007, FOOD CHEM, V105, P1487, DOI 10.1016/j.foodchem.2007.05.033; Konsin M, 2001, J HORTIC SCI BIOTECH, V76, P77, DOI 10.1080/14620316.2001.11511330; Kovacik J, 2007, PLANT SOIL, V297, P255, DOI 10.1007/s11104-007-9346-x; Kumakura H, 1995, JARQ-JPN AGR RES Q, V29, P241; Ledesma NA, 2008, SCI HORTIC-AMSTERDAM, V116, P186, DOI 10.1016/j.scienta.2007.12.010; Levine LH, 2009, ADV SPACE RES, V44, P887, DOI 10.1016/j.asr.2009.06.017; Li WL, 2007, AGR WATER MANAGE, V87, P106, DOI 10.1016/j.agwat.2006.06.027; Lieten F, 1997, ACTA HORTIC, P583, DOI 10.17660/ActaHortic.1997.439.97; Lin YL, 2011, PLANT GROWTH REGUL, V64, P263, DOI 10.1007/s10725-011-9567-0; Lu HF, 2011, J FOOD ENG, V104, P149, DOI 10.1016/j.jfoodeng.2010.12.007; Lu HF, 2010, J AGR FOOD CHEM, V58, P2995, DOI 10.1021/jf903655a; Matsui T, 1997, FIELD CROP RES, V51, P213, DOI 10.1016/S0378-4290(96)03451-X; McConnaughay KDM, 1996, GLOB CHANGE BIOL, V2, P25, DOI 10.1111/j.1365-2486.1996.tb00046.x; MORISHITA M, 1993, J JPN SOC HORTIC SCI, V61, P857, DOI 10.2503/jjshs.61.857; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; NITSCH J. P., 1952, QUART REV BIOL, V27, P33, DOI 10.1086/398643; Porch TG, 2001, PLANT CELL ENVIRON, V24, P723, DOI 10.1046/j.1365-3040.2001.00716.x; Prasad PVV, 2006, AGR FOREST METEOROL, V139, P237, DOI 10.1016/j.agrformet.2006.07.003; Prasad PVV, 2006, FIELD CROP RES, V95, P398, DOI 10.1016/j.fcr.2005.04.008; Prasad PVV, 2003, GLOBAL CHANGE BIOL, V9, P1775, DOI [10.1046/j.1365-2486.2003.00708.x, 10.1046/j.1529-8817.2003.00708.x]; Prasad PVV, 2002, GLOBAL CHANGE BIOL, V8, P710, DOI 10.1046/j.1365-2486.2002.00508.x; Pressman E, 2002, ANN BOT-LONDON, V90, P631, DOI 10.1093/aob/mcf240; Quesada MA, 2009, PLANT PHYSIOL, V150, P1022, DOI 10.1104/pp.109.138297; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Reddy KR, 2000, CLIMATE CHANGE AND GLOBAL CROP PRODUCTIVITY, P161, DOI 10.1079/9780851994390.0161; SAINI HS, 1982, ANN BOT-LONDON, V49, P835, DOI 10.1093/oxfordjournals.aob.a086310; Santos BM, 2009, INT J FRUIT SCI, V9, P126, DOI 10.1080/15538360902991337; Sato S, 2000, PLANT CELL ENVIRON, V23, P719, DOI 10.1046/j.1365-3040.2000.00589.x; Su WR, 2001, PLANT PHYSIOL BIOCH, V39, P45, DOI 10.1016/S0981-9428(00)01218-3; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Suzuki K, 2001, J AM SOC HORTIC SCI, V126, P571, DOI 10.21273/JASHS.126.5.571; Taub DR, 2008, J INTEGR PLANT BIOL, V50, P1365, DOI 10.1111/j.1744-7909.2008.00754.x; TAYLOR DR, 1994, PLANT GROWTH REGUL, V15, P235, DOI 10.1007/BF00029896; vanTienderen PH, 1996, AM J BOT, V83, P169, DOI 10.2307/2445934; Wang SY, 2004, J SCI FOOD AGR, V84, P1464, DOI 10.1002/jsfa.1824; Wang SY, 2003, J AGR FOOD CHEM, V51, P4315, DOI 10.1021/jf021172d; Wheeler TR, 1996, J AGR SCI, V127, P37, DOI 10.1017/S0021859600077352; Xiao G., 2009, ACTA ECOL SIN, V29, P205, DOI [10.1016/j.chnaes.2009.08.002, DOI 10.1016/J.CHNAES.2009.08.002]; Xiong W, 2007, CLIMATIC CHANGE, V81, P205, DOI 10.1007/s10584-006-9123-5; Yamasaki A, 2000, J JPN SOC HORTIC SCI, V69, P40, DOI 10.2503/jjshs.69.40; Yoshida H, 2011, FIELD CROP RES, V124, P433, DOI 10.1016/j.fcr.2011.07.016; Zheng H, 2011, J AGR FOOD CHEM, V59, P592, DOI 10.1021/jf1032476; Zheng H, 2010, J FOOD ENG, V101, P402, DOI 10.1016/j.jfoodeng.2010.07.028; Zhu CW, 2009, FUNCT PLANT BIOL, V36, P291, DOI 10.1071/FP08269	71	61	62	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2012	7	7							e41000	10.1371/journal.pone.0041000	http://dx.doi.org/10.1371/journal.pone.0041000			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	978NX	23049947	Green Published, Green Submitted, gold			2022-12-27	WOS:000306751300020
J	Abdgawad, M; Pettersson, A; Gunnarsson, L; Bengtsson, AA; Geborek, P; Nilsson, L; Segelmark, M; Hellmark, T				Abdgawad, Mohamed; Pettersson, Asa; Gunnarsson, Lena; Bengtsson, Anders A.; Geborek, Pierre; Nilsson, Lars; Segelmark, Marten; Hellmark, Thomas			Decreased Neutrophil Apoptosis in Quiescent ANCA-Associated Systemic Vasculitis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INFLAMMATORY-BOWEL-DISEASE; GRANULOCYTE-MACROPHAGE; FACTOR-RECEPTOR; WEGENERS-GRANULOMATOSIS; CIRCULATING NEUTROPHILS; LUPUS-ERYTHEMATOSUS; ENDOTHELIAL-CELLS; TARGET-CELLS; PU.1 SPI-1	Background: ANCA-Associated Systemic Vasculitis (AASV) is characterized by leukocytoclasis, accumulation of unscavenged apoptotic and necrotic neutrophils in perivascular tissues. Dysregulation of neutrophil cell death may contribute directly to the pathogenesis of AASV. Methods: Neutrophils from Healthy Blood Donors (HBD), patients with AASV most in complete remission, Polycythemia Vera (PV), Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA) and renal transplant recipients (TP) were incubated in vitro, and the rate of spontaneous apoptosis was measured by FACS. Plasma levels of cytokines and sFAS were measured with cytometric bead array and ELISA. Expression of pro/anti-apoptotic factors, transcription factors C/EBP-alpha, C/EBP-beta and PU.1 and inhibitors of survival/JAK2-pathway were measured by real-time-PCR. Results: AASV, PV and RA neutrophils had a significantly lower rate of apoptosis compared to HBD neutrophils (AASV 50 +/- 14% vs. HBD 64 +/- 11%, p < 0.0001). In RA but not in AASV and PV, low apoptosis rate correlated with increased plasma levels of GM-CSF and high mRNA levels of anti-apoptotic factors Bcl-2A1 and Mcl-1. AASV patients had normal levels of G-CSF, GM-CSF and IL-3. Both C/EBP-alpha, C/EBP-beta were significantly higher in neutrophils from AASV patients than HBD. Levels of sFAS were significantly higher in AASV compared to HBD. Conclusion: Neutrophil apoptosis rates in vitro are decreased in AASV, RA and PV but mechanisms seem to differ. Increased mRNA levels of granulopoiesis-associated transcription factors and increased levels of sFAS in plasma were observed in AASV. Additional studies are required to define the mechanisms behind the decreased apoptosis rates, and possible connections with accumulation of dying neutrophils in regions of vascular lesions in AASV patients.	[Abdgawad, Mohamed; Pettersson, Asa; Gunnarsson, Lena; Segelmark, Marten; Hellmark, Thomas] Lund Univ, Dept Nephrol, S-22101 Lund, Sweden; [Bengtsson, Anders A.; Geborek, Pierre] Lund Univ, Dept Rheumatol, S-22101 Lund, Sweden; [Nilsson, Lars] Lund Univ, Dept Haematol, S-22101 Lund, Sweden; [Segelmark, Marten] Linkoping Univ, Dept Hlth & Med, Linkoping, Sweden	Lund University; Lund University; Lund University; Linkoping University	Abdgawad, M (corresponding author), Lund Univ, Dept Nephrol, S-22101 Lund, Sweden.	Mohamed.Abdgawad@med.lu.se	Hellmark, Thomas/U-6289-2017	Hellmark, Thomas/0000-0002-2952-1155; Segelmark, Marten/0000-0002-1221-0772; Phillipson, Mia/0000-0002-2387-0266	Swedish Research Council [71X-15152]; Crafoord Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation	This study was supported by Swedish Research Council (grant 71X-15152) and the Crafoord Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLIETTA M, 1993, STEM CELLS, V11, P83; AGLIETTA M, 1993, BLOOD, V82, P2054; Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Bijl M, 1998, J AUTOIMMUN, V11, P457, DOI 10.1006/jaut.1998.0233; Brannigan AE, 2000, SHOCK, V13, P361, DOI 10.1097/00024382-200005000-00003; Christensson M, 2002, J CLIN IMMUNOL, V22, P220, DOI 10.1023/A:1016040925295; Christensson M, 2000, CLIN NEPHROL, V54, P435; Chuang PI, 1998, BIOCHEM BIOPH RES CO, V249, P361, DOI 10.1006/bbrc.1998.9155; DAI CH, 1992, BLOOD, V80, P891; Dale DC, 1998, AM J HEMATOL, V57, P7, DOI 10.1002/(SICI)1096-8652(199801)57:1<7::AID-AJH2>3.0.CO;2-0; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; Durant S, 2004, J LEUKOCYTE BIOL, V75, P87, DOI 10.1189/jlb.0203079; FAUCI AS, 1978, ANN INTERN MED, V89, P660, DOI 10.7326/0003-4819-89-5-660; Fujimori K, 2008, GRAEF ARCH CLIN EXP, V246, P285, DOI 10.1007/s00417-007-0659-5; Geering B, 2011, CELL DEATH DIFFER, V18, P1457, DOI 10.1038/cdd.2011.75; Goldstein JI, 2011, GASTROENTEROLOGY, V141, P208, DOI 10.1053/j.gastro.2011.03.060; Harper L, 2001, KIDNEY INT, V59, P1729, DOI 10.1046/j.1523-1755.2001.0590051729.x; Harper Lorraine, 2006, Expert Rev Clin Immunol, V2, P237, DOI 10.1586/1744666X.2.2.237; Hasegawa T, 2003, BLOOD, V101, P1164, DOI 10.1182/blood-2002-05-1505; HENSHAW TJ, 1994, ARTHRITIS RHEUM, V37, P104, DOI 10.1002/art.1780370116; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Jimenez MF, 1997, ARCH SURG-CHICAGO, V132, P1263; Kallenberg CGM, 2002, KIDNEY INT, V61, P758, DOI 10.1046/j.1523-1755.2002.00179.x; Kantari C, 2007, BLOOD, V110, P4086, DOI 10.1182/blood-2007-03-080457; Kobayashi SD, 2005, ARCH IMMUNOL THER EX, V53, P505; LUQMANI RA, 1994, Q J MED, V87, P671; Moulding DA, 1998, BLOOD, V92, P2495, DOI 10.1182/blood.V92.7.2495.2495_2495_2502; MOUNTZ JD, 1994, ARTHRITIS RHEUM, V37, P1415, DOI 10.1002/art.1780371002; NAKABAYASHI I, 1993, CLIN NEPHROL, V40, P265; Ohlsson S, 2003, CLIN EXP IMMUNOL, V131, P528, DOI 10.1046/j.1365-2249.2003.02083.x; Patry YC, 2001, J AM SOC NEPHROL, V12, P1764, DOI 10.1681/ASN.V1281764; Pederzoli M, 2005, J IMMUNOL, V174, P6381, DOI 10.4049/jimmunol.174.10.6381; Pendergraft WF, 2000, KIDNEY INT, V57, P1981, DOI 10.1046/j.1523-1755.2000.00048.x; Ren Y, 2003, ARTHRITIS RHEUM, V48, P2888, DOI 10.1002/art.11237; Rosmarin AG, 2005, EXP HEMATOL, V33, P131, DOI 10.1016/j.exphem.2004.08.015; Santos-Beneit AM, 2000, J LEUKOCYTE BIOL, V67, P712, DOI 10.1002/jlb.67.5.712; Savill J, 1997, J LEUKOCYTE BIOL, V61, P375, DOI 10.1002/jlb.61.4.375; SAVILL J, 1995, SEMIN CELL BIOL, V6, P385, DOI 10.1016/S1043-4682(05)80009-1; Smith LT, 1996, BLOOD, V88, P1234, DOI 10.1182/blood.V88.4.1234.bloodjournal8841234; TRAVIS WD, 1991, AM J SURG PATHOL, V15, P315, DOI 10.1097/00000478-199104000-00001; Tsujimoto H, 2001, CLIN EXP IMMUNOL, V126, P355, DOI 10.1046/j.1365-2249.2001.01675.x; Vong L, 2007, J BIOL CHEM, V282, P29998, DOI 10.1074/jbc.M702876200; Wang QF, 2002, BLOOD, V99, P2776, DOI 10.1182/blood.V99.8.2776; Wang XP, 1999, BLOOD, V94, P560, DOI 10.1182/blood.V94.2.560.414k41_560_571; Watts R, 2007, ANN RHEUM DIS, V66, P222, DOI 10.1136/ard.2006.054593; Weinmann P, 2007, CLIN EXP RHEUMATOL, V25, P885; Witko-Sarsat V, 2011, TRENDS IMMUNOL, V32, P117, DOI 10.1016/j.it.2011.01.001; Witko-Sarsat V, 2010, J EXP MED, V207, P2631, DOI 10.1084/jem.20092241; Yang JJ, 1996, AM J PATHOL, V149, P1617; Yang JJ, 2000, CLIN EXP IMMUNOL, V121, P165, DOI 10.1046/j.1365-2249.2000.01228.x	51	229	230	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAR 5	2012	7	3							e32439	10.1371/journal.pone.0032439	http://dx.doi.org/10.1371/journal.pone.0032439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928WA	23049932	Green Published, gold, Green Submitted			2022-12-27	WOS:000303017700057
J	Yang, HC; Liang, YJ; Chen, JW; Chiang, KM; Chung, CM; Ho, HY; Ting, CT; Lin, TH; Sheu, SH; Tsai, WC; Chen, JH; Leu, HB; Yin, WH; Chiu, TY; Chern, CI; Lin, SJ; Tomlinson, B; Guo, YL; Sham, PC; Cherny, SS; Lam, TH; Thomas, N; Pan, WH				Yang, Hsin-Chou; Liang, Yu-Jen; Chen, Jaw-Wen; Chiang, Kuang-Mao; Chung, Chia-Min; Ho, Hung-Yun; Ting, Chih-Tai; Lin, Tsung-Hsien; Sheu, Sheng-Hsiung; Tsai, Wei-Chuan; Chen, Jyh-Hong; Leu, Hsin-Bang; Yin, Wei-Hsian; Chiu, Ting-Yu; Chern, Ching-Iuan; Lin, Shing-Jong; Tomlinson, Brian; Guo, Youling; Sham, Pak C.; Cherny, Stacey S.; Lam, Tai Hing; Thomas, Neil; Pan, Wen-Harn			Identification of IGF1, SLC4A4, WWOX, and SFMBT1 as Hypertension Susceptibility Genes in Han Chinese with a Genome-Wide Gene-Based Association Study	PLOS ONE			English	Article							FACTOR-I GENE; BLOOD-PRESSURE; PROMOTER REGION; GLUCOSE-HOMEOSTASIS; TUMOR-SUPPRESSOR; GROWTH; POLYMORPHISM; LINKAGE; MICE; LOCUS	Hypertension is a complex disorder with high prevalence rates all over the world. We conducted the first genome-wide gene-based association scan for hypertension in a Han Chinese population. By analyzing genome-wide single-nucleotide-polymorphism data of 400 matched pairs of young-onset hypertensive patients and normotensive controls genotyped with the Illumina HumanHap550-Duo BeadChip, 100 susceptibility genes for hypertension were identified and also validated with permutation tests. Seventeen of the 100 genes exhibited differential allelic and expression distributions between patient and control groups. These genes provided a good molecular signature for classifying hypertensive patients and normotensive controls. Among the 17 genes, IGF1, SLC4A4, WWOX, and SFMBT1 were not only identified by our gene-based association scan and gene expression analysis but were also replicated by a gene-based association analysis of the Hong Kong Hypertension Study. Moreover, cis-acting expression quantitative trait loci associated with the differentially expressed genes were found and linked to hypertension. IGF1, which encodes insulin-like growth factor 1, is associated with cardiovascular disorders, metabolic syndrome, decreased body weight/size, and changes of insulin levels in mice. SLC4A4, which encodes the electrogenic sodium bicarbonate cotransporter 1, is associated with decreased body weight/size and abnormal ion homeostasis in mice. WWOX, which encodes the WW domain-containing protein, is related to hypoglycemia and hyperphosphatemia. SFMBT1, which encodes the scm-like with four MBT domains protein 1, is a novel hypertension gene. GRB14, TMEM56 and KIAA1797 exhibited highly significant differential allelic and expressed distributions between hypertensive patients and normotensive controls. GRB14 was also found relevant to blood pressure in a previous genetic association study in East Asian populations. TMEM56 and KIAA1797 may be specific to Taiwanese populations, because they were not validated by the two replication studies. Identification of these genes enriches the collection of hypertension susceptibility genes, thereby shedding light on the etiology of hypertension in Han Chinese populations.	[Yang, Hsin-Chou; Liang, Yu-Jen] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Chiang, Kuang-Mao; Chung, Chia-Min; Pan, Wen-Harn] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Liang, Yu-Jen] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Chen, Jaw-Wen; Leu, Hsin-Bang; Lin, Shing-Jong] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Chen, Jaw-Wen; Leu, Hsin-Bang; Lin, Shing-Jong] Taipei Vet Gen Hosp, Taipei, Taiwan; [Chiang, Kuang-Mao] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Ho, Hung-Yun; Ting, Chih-Tai] Taichung Vet Gen Hosp, Ctr Cardiovasc, Taichung, Taiwan; [Lin, Tsung-Hsien; Sheu, Sheng-Hsiung] Kaohsiung Med Univ Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Tsai, Wei-Chuan; Chen, Jyh-Hong] Natl Cheng Kung Univ, Coll Med, Dept Internal Med, Tainan 70101, Taiwan; [Yin, Wei-Hsian] Cheng Hsin Rehabil Med Ctr, Div Cardiol, Taipei, Taiwan; [Chiu, Ting-Yu; Chern, Ching-Iuan] Min Sheng Gen Hosp, Div Cardiol, Tao Yuan, Taiwan; [Tomlinson, Brian] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Guo, Youling; Sham, Pak C.; Cherny, Stacey S.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak C.; Cherny, Stacey S.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Lam, Tai Hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Thomas, Neil] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham, W Midlands, England; [Pan, Wen-Harn] Natl Hlth Res Inst, Inst Populat Hlth Sci, Div Prevent Med & Hlth Serv Res, Miaoli, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Defense Medical Center; Taichung Veterans General Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Cheng Kung University; Chinese University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Birmingham; National Health Research Institutes - Taiwan	Yang, HC (corresponding author), Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan.	pan@ibms.sinica.edu.tw	Thomas, G. Neil/A-1879-2013; Cherny, Stacey S/B-3315-2008; Yang, Hsin-Chou/AAP-2547-2021; Pan, Wen-Harn/F-9972-2010; Tomlinson, Brian/P-5365-2015; Tomlinson, Brian/AAD-9404-2019	Thomas, G. Neil/0000-0002-2777-1847; Cherny, Stacey S/0000-0002-0269-3352; Yang, Hsin-Chou/0000-0001-6853-7881; Pan, Wen-Harn/0000-0001-9136-0658; Tomlinson, Brian/0000-0001-6717-5444; Chiang, Kuang-Mao/0000-0002-8745-2004; Lin, Tsung-Hsien/0000-0002-7226-8730	National Research Program for Genomic Medicine [NSC 97-3112-B-001-027, NSC 98-3112-B-001-013, NSC 99-3112-B001-009, NSC 99-3112-B-001-029]; National Science Council of Taiwan [NSC 97-2314-B-001-006-MY3, NSC 100-2314-B-001-005-MY3, NSC 100-2319-B-010002]; Career Development Award of Academia Sinica [AS-100-CDA-M03]; Academia Sinica Genomics and Proteomics Program [521023-92-81, 521023-93-81, 521023-94-19, 30-34-GSK]; Academia Sinica Genomic Medicine Multicenter Studies [40-05-GMM]; Wellcome Trust Funding Source: Medline	National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Career Development Award of Academia Sinica; Academia Sinica Genomics and Proteomics Program; Academia Sinica Genomic Medicine Multicenter Studies; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the National Research Program for Genomic Medicine (NSC 97-3112-B-001-027, NSC 98-3112-B-001-013, NSC 99-3112-B001-009, and NSC 99-3112-B-001-029), National Science Council grants (NSC 97-2314-B-001-006-MY3, NSC 100-2314-B-001-005-MY3, and NSC 100-2319-B-010002) of Taiwan, the Career Development Award of Academia Sinica (AS-100-CDA-M03), the Academia Sinica Genomics and Proteomics Program (2003-2006) (521023-92-81, 521023-93-81, 521023-94-19 and 30-34-GSK), and the Academia Sinica Genomic Medicine Multicenter Studies (2007-present) (40-05-GMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeyemo A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000564; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Angius A, 2002, AM J HUM GENET, V71, P893, DOI 10.1086/342929; Aqeilan RI, 2008, J BIOL CHEM, V283, P21629, DOI 10.1074/jbc.M800855200; Bansal V, 2010, NAT REV GENET, V11, P773, DOI 10.1038/nrg2867; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BONNARDEAUX A, 1994, HYPERTENSION, V24, P63, DOI 10.1161/01.HYP.24.1.63; Buil Alfonso, 2009, BMC Proc, V3 Suppl 7, pS130; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Fang YJ, 2010, J HYPERTENS, V28, P1203, DOI 10.1097/HJH.0b013e3283384b07; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Fox ER, 2011, HUM MOL GENET, V20, P2273, DOI 10.1093/hmg/ddr092; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Funke-Kaiser H, 2003, HUM MOL GENET, V12, P423, DOI 10.1093/hmg/ddg040; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; Goenaga D, 2009, MOL ENDOCRINOL, V23, P1043, DOI 10.1210/me.2008-0360; Gong ML, 2003, HUM MOL GENET, V12, P1273, DOI 10.1093/hmg/ddg135; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Guzman B, 2006, HYPERTENSION, V48, P883, DOI 10.1161/01.HYP.0000244085.52918.a0; Hanasaki H, 2009, HYPERTENS RES, V32, P261, DOI 10.1038/hr.2009.2; Hiura Y, 2010, CIRC J, V74, P2353, DOI 10.1253/circj.CJ-10-0353; Hong KW, 2011, J HUM GENET, V56, P205, DOI 10.1038/jhg.2010.167; Horio T, 2010, J HUM HYPERTENS, V24, P320, DOI 10.1038/jhh.2009.73; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hunt SC, 2006, HYPERTENSION, V47, P532, DOI 10.1161/01.HYP.0000196949.26088.3c; Jakobsson J, 2004, PHARMACOGENOMICS J, V4, P245, DOI 10.1038/sj.tpj.6500236; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Julier C, 1997, HUM MOL GENET, V6, P2077, DOI 10.1093/hmg/6.12.2077; Kato N, 2008, HUM MOL GENET, V17, P617, DOI 10.1093/hmg/ddm335; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Knight J, 2006, BEHAV GENET, V36, P665, DOI 10.1007/s10519-005-9016-9; Koivukoski L, 2004, HUM MOL GENET, V13, P2325, DOI 10.1093/hmg/ddh237; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Landmann E, 2006, PEDIATRICS, V118, P2374, DOI 10.1542/peds.2006-0146; Levy D, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S3; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Li-Hawkins J, 2000, J BIOL CHEM, V275, P16536, DOI 10.1074/jbc.M001811200; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Newton-Cheh C, 2009, NAT GENET, V41, P666, DOI 10.1038/ng.361; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Org E, 2009, HUM MOL GENET, V18, P2288, DOI 10.1093/hmg/ddp135; Padmanabhan S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001177; Pan WH, 2006, HUM HERED, V61, P27, DOI 10.1159/000091834; Pan WH, 2001, J HUM HYPERTENS, V15, P793, DOI 10.1038/sj.jhh.1001268; Peterson AJ, 2004, GENETICS, V167, P1225, DOI 10.1534/genetics.104.027474; PICKERING G, 1978, AM J MED, V65, P561, DOI 10.1016/0002-9343(78)90839-2; Pineda LL, 2003, PATHOL INT, V53, P390, DOI 10.1046/j.1440-1827.2003.01486.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Puig O, 2010, PHYSIOL GENOMICS, V42A, P24, DOI 10.1152/physiolgenomics.00010.2010; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rietveld I, 2006, EUR J ENDOCRINOL, V154, P715, DOI 10.1530/eje.1.02144; Rietveld I, 2004, CLIN ENDOCRINOL, V61, P195, DOI 10.1111/j.1365-2265.2004.02078.x; Riva A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-33; Roy D, 2011, BLOOD, V118, pE32, DOI 10.1182/blood-2010-12-323659; Ruigrok YM, 2005, J NEUROL, V252, P417, DOI 10.1007/s00415-005-0661-y; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; San Millan JL, 2004, J CLIN ENDOCR METAB, V89, P2640, DOI 10.1210/jc.2003-031252; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schut AFC, 2003, STROKE, V34, P1623, DOI 10.1161/01.STR.0000076013.00240.B0; Slavin TP, 2011, HUM GENET, V130, P725, DOI 10.1007/s00439-011-1009-6; Stratikopoulos E, 2008, P NATL ACAD SCI USA, V105, P19378, DOI 10.1073/pnas.0809223105; Sweeney C, 2005, CANCER EPIDEM BIOMAR, V14, P1802, DOI 10.1158/1055-9965.EPI-05-0149; t Hart LM, 2004, DIABETES, V53, pS26, DOI 10.2337/diabetes.53.2007.S26; Taylor JY, 2009, BIOL RES NURS, V11, P53, DOI 10.1177/1099800409334817; te Velde Saskia J, 2005, BMC Endocr Disord, V5, P5, DOI 10.1186/1472-6823-5-5; Telgmann R, 2009, FASEB J, V23, P1303, DOI 10.1096/fj.08-116863; Ueki I, 2000, P NATL ACAD SCI USA, V97, P6868, DOI 10.1073/pnas.120172697; Voorhoeve PG, 2006, EUR J ENDOCRINOL, V154, P379, DOI 10.1530/eje.1.02101; Wallace C, 2006, AM J HUM GENET, V79, P323, DOI 10.1086/506370; Wang K, 2011, PLOS ONE, V6; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106; Wiemuth D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012163; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Xu XP, 1999, AM J HUM GENET, V64, P1694, DOI 10.1086/302405; Yang HC, 2008, GENETICS, V179, P1057, DOI 10.1534/genetics.107.084616; Yang Hsin-Chou, 2009, BMC Proc, V3 Suppl 7, pS135; Yang HC, 2006, GENET EPIDEMIOL, V30, P531, DOI 10.1002/gepi.20165; Yang HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005459; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yazdanpanah M, 2006, AM J CARDIOL, V97, P1274, DOI 10.1016/j.amjcard.2005.11.069; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zhang MC, 2008, IMMUNOGENETICS, V60, P599, DOI 10.1007/s00251-008-0320-4	96	210	224	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32907	10.1371/journal.pone.0032907	http://dx.doi.org/10.1371/journal.pone.0032907			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	23029496	gold, Green Published			2022-12-27	WOS:000304523400009
J	He, L; Wang, Q; Jin, XK; Wang, Y; Chen, LL; Liu, LH; Wang, Y				He, Lin; Wang, Qun; Jin, Xinkun; Wang, Ying; Chen, Lili; Liu, Lihua; Wang, Yang			Transcriptome Profiling of Testis during Sexual Maturation Stages in Eriocheir sinensis Using Illumina Sequencing	PLOS ONE			English	Article							CHINESE MITTEN CRAB; HEAT-SHOCK PROTEINS; CDC2 KINASE; SPERMATOGENESIS; EXPRESSION; ACROSOME; DYNAMICS; HSP70-2; TOOL; HEPATOPANCREAS	The testis is a highly specialized tissue that plays dual roles in ensuring fertility by producing spermatozoa and hormones. Spermatogenesis is a complex process, resulting in the production of mature sperm from primordial germ cells. Significant structural and biochemical changes take place in the seminiferous epithelium of the adult testis during spermatogenesis. The gene expression pattern of testis in Chinese mitten crab (Eriocheir sinensis) has not been extensively studied, and limited genetic research has been performed on this species. The advent of high-throughput sequencing technologies enables the generation of genomic resources within a short period of time and at minimal cost. In the present study, we performed de novo transcriptome sequencing to produce a comprehensive transcript dataset for testis of E. sinensis. In two runs, we produced 25,698,778 sequencing reads corresponding with 2.31 Gb total nucleotides. These reads were assembled into 342,753 contigs or 141,861 scaffold sequences, which identified 96,311 unigenes. Based on similarity searches with known proteins, 39,995 unigenes were annotated based on having a Blast hit in the non-redundant database or ESTscan results with a cut-off E-value above 10(-5). This is the first report of a mitten crab transcriptome using high-throughput sequencing technology, and all these testes transcripts can help us understand the molecular mechanisms involved in spermatogenesis and testis maturation.	[He, Lin; Wang, Qun; Jin, Xinkun; Wang, Ying; Chen, Lili; Liu, Lihua; Wang, Yang] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University	He, L (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.	qwang@bio.ecnu.edu.cn	Jin, Xingkun/H-4366-2013; Wang, Qun/I-7778-2013	Jin, Xingkun/0000-0003-2454-1621; Wang, Qun/0000-0001-7929-7692; Wen, Daizong/0000-0002-4551-2646; HUA, YANJUN/0000-0001-6461-3576; Savini, Giacomo/0000-0003-0075-3582	National Natural Science Foundation of China [31172393]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 31172393) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 1994, MOL BIOL CELL, P787; Alekseev OM, 2009, BIOL REPROD, V81, P739, DOI 10.1095/biolreprod.109.076497; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An JY, 2010, P NATL ACAD SCI USA, V107, P1912, DOI 10.1073/pnas.0910267107; Betel D, 2007, PLOS COMPUT BIOL, V3, P2219, DOI 10.1371/journal.pcbi.0030222; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dix DJ, 1997, CELL STRESS CHAPERON, V2, P73, DOI 10.1379/1466-1268(1997)002<0073:HEAFDG>2.3.CO;2; Dix DJ, 1997, DEVELOPMENT, V124, P4595; Ecroyd H, 2003, BIOL REPROD, V69, P1801, DOI 10.1095/biolreprod.103.017350; Eddy EM, 2002, RECENT PROG HORM RES, V57, P103, DOI 10.1210/rp.57.1.103; Eddy EM, 1999, REV REPROD, V4, P23, DOI 10.1530/revreprod/4.1.23; Fan YS, 2012, MOL BIOL REP, V39, P4727, DOI 10.1007/s11033-011-1265-5; GEORGOPOULOS C, 1993, ANNU REV CELL BIOL, V9, P601, DOI 10.1146/annurev.cb.09.110193.003125; Griveau JF, 1997, INT J ANDROL, V20, P61, DOI 10.1046/j.1365-2605.1997.00044.x; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Herborg LM, 2006, J EXP MAR BIOL ECOL, V329, P1, DOI 10.1016/j.jembe.2005.08.001; Huang SY, 2005, THERIOGENOLOGY, V64, P1940, DOI 10.1016/j.theriogenology.2005.04.024; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jiang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011175; Jiang H, 2009, COMP BIOCHEM PHYS D, V4, P227, DOI 10.1016/j.cbd.2009.05.001; Jiang H, 2009, MAR BIOTECHNOL, V11, P317, DOI 10.1007/s10126-008-9146-1; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kierszenbaum AL, 2006, MOL REPROD DEV, V73, P939, DOI 10.1002/mrd.20536; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WW, 2010, FISH SHELLFISH IMMUN, V29, P1010, DOI 10.1016/j.fsi.2010.08.007; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022570; Lie PPY, 2009, TRENDS BIOCHEM SCI, V34, P366, DOI 10.1016/j.tibs.2009.03.005; Linschooten JO, 2011, REPROD TOXICOL, V32, P106, DOI 10.1016/j.reprotox.2011.05.004; Lu W, 2011, PEPTIDES, DOI [10.1016/j.physletb.2003.10.071, DOI 10.1016/J.PHYSLETB.2003.10.071]; Lui WY, 2003, J ANDROL, V24, P1; Luk JM, 2006, J CELL PHYSIOL, V209, P755, DOI 10.1002/jcp.20746; Ma PP, 2006, MOL REPROD DEV, V73, P774, DOI 10.1002/mrd.20468; Maier B, 2003, BIOL REPROD, V68, P67, DOI 10.1095/biolreprod.102.004143; Manandhar G, 2009, BIOL REPROD, V80, P1168, DOI 10.1095/biolreprod.108.071738; Merlo E, 2007, NEUROSCIENCE, V147, P46, DOI 10.1016/j.neuroscience.2007.04.022; Neuer A, 2000, HUM REPROD UPDATE, V6, P149, DOI 10.1093/humupd/6.2.149; Noguchi T, 2003, DEVELOPMENT, V130, P1805, DOI 10.1242/dev.00406; Obermann H, 2005, MOL HUM REPROD, V11, P53, DOI 10.1093/molehr/gah132; Qiu GF, 2008, ANIM REPROD SCI, V105, P209, DOI 10.1016/j.anireprosci.2007.03.005; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Rudnick DA, 2003, BASIC APPL ECOL, V4, P249, DOI 10.1078/1439-1791-00152; Sandmann T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r76; Sasagawa I, 2001, EUR J BIOCHEM, V268, P3053, DOI 10.1046/j.1432-1327.2001.02200.x; Sawada H, 2002, P NATL ACAD SCI USA, V99, P1223, DOI 10.1073/pnas.032389499; Seli E, FERTILITY PRESERVATI, P245, DOI [10.1007/978-1-4419-1783-6_19, DOI 10.1007/978-1-4419-1783-6_19]; Shen BL, 2009, MOL BIOL REP, V36, P1149, DOI 10.1007/s11033-008-9291-7; Sheng Y, 2006, J BIOL CHEM, V281, P35048, DOI 10.1074/jbc.M605086200; Shrivastava V, 2010, REPRODUCTION, V139, P999, DOI 10.1530/REP-09-0492; Stewart MJ, 2010, TISSUE CELL, V42, P137, DOI 10.1016/j.tice.2010.03.002; Sui L, 2007, AQUACULTURE, V273, P139, DOI 10.1016/j.aquaculture.2007.09.016; Takenaka K, 1997, J CELL BIOL, V136, P1091, DOI 10.1083/jcb.136.5.1091; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Wang DH, 2010, COMP BIOCHEM PHYS A, V157, P123, DOI 10.1016/j.cbpa.2010.05.015; Wang HZ, 2006, AQUACULTURE, V255, P456, DOI 10.1016/j.aquaculture.2006.01.005; WELCH WJ, 1992, PHYSIOL REV, V72, P1063, DOI 10.1152/physrev.1992.72.4.1063; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wu YJ, 2011, CELL TISSUE RES, V344, P355, DOI 10.1007/s00441-011-1151-4; Xiao Xiang, 2007, Journal of Zhejiang University-Science B, V8, P498, DOI 10.1631/jzus.2007.B0498; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Yin Y, 2011, DEV BIOL, V356, P51, DOI 10.1016/j.ydbio.2011.05.661; Yu KM, 2009, CELL TISSUE RES, V337, P113, DOI 10.1007/s00441-009-0800-3; Zhang W, 2011, GENET MOL BIOL, V34, P136, DOI 10.1590/S1415-47572010005000099; Zhu DH, 1997, DEVELOPMENT, V124, P3007	65	108	111	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 19	2012	7	3							e33735	10.1371/journal.pone.0033735	http://dx.doi.org/10.1371/journal.pone.0033735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939TA	23049823	Green Published, gold, Green Submitted			2022-12-27	WOS:000303836500061
J	Yang, HY; Zhang, W; Pan, H; Feldser, HG; Lainez, E; Miller, C; Leung, S; Zhong, Z; Zhao, HZ; Sweitzer, S; Considine, T; Riera, T; Suri, V; White, B; Ellis, JL; Vlasuk, GP; Loh, C				Yang, Hongying; Zhang, Wei; Pan, Heng; Feldser, Heidi G.; Lainez, Elden; Miller, Christine; Leung, Stewart; Zhong, Zhong; Zhao, Huizhen; Sweitzer, Sharon; Considine, Thomas; Riera, Thomas; Suri, Vipin; White, Brian; Ellis, James L.; Vlasuk, George P.; Loh, Christine			SIRT1 Activators Suppress Inflammatory Responses through Promotion of p65 Deacetylation and Inhibition of NF-kappa B Activity	PLOS ONE			English	Article							SMALL-MOLECULE ACTIVATORS; DEPENDENT GENE-EXPRESSION; CELL-SURVIVAL; NEGATIVE REGULATION; CYTOKINE RELEASE; IN-VIVO; ACETYLATION; PHOSPHORYLATION; P53; RESVERATROL	Chronic inflammation is a major contributing factor in the pathogenesis of many age-associated diseases. One central protein that regulates inflammation is NF-kappa B, the activity of which is modulated by post-translational modifications as well as by association with co-activator and co-repressor proteins. SIRT1, an NAD+-dependent protein deacetylase, has been shown to suppress NF-kappa B signaling through deacetylation of the p65 subunit of NF-kappa B resulting in the reduction of the inflammatory responses mediated by this transcription factor. The role of SIRT1 in the regulation of NF-kappa B provides the necessary validation for the development of pharmacological strategies for activating SIRT1 as an approach for the development of a new class of anti-inflammatory therapeutics. We report herein the development of a quantitative assay to assess compound effects on acetylated p65 protein in the cell. We demonstrate that small molecule activators of SIRT1 (STACs) enhance deacetylation of cellular p65 protein, which results in the suppression of TNF alpha-induced NF-kappa B transcriptional activation and reduction of LPS-stimulated TNF alpha secretion in a SIRT1-dependent manner. In an acute mouse model of LPS-induced inflammation, the STAC SRTCX1003 decreased the production of the proinflammatory cytokines TNF alpha and IL-12. Our studies indicate that increasing SIRT1-mediated NF-kappa B deacetylation using small molecule activating compounds is a novel approach to the development of a new class of therapeutic anti-inflammatory agents.	[Yang, Hongying; Feldser, Heidi G.; Lainez, Elden; Miller, Christine; Considine, Thomas; Riera, Thomas; Suri, Vipin; White, Brian; Ellis, James L.; Vlasuk, George P.; Loh, Christine] Sirtris, Cambridge, MA USA; [Zhang, Wei; Pan, Heng; Leung, Stewart; Zhong, Zhong] GlaxoSmithKline R&D China, Shanghai, Peoples R China; [Zhao, Huizhen; Sweitzer, Sharon] GlaxoSmithKline, Collegeville, PA USA	GlaxoSmithKline; GlaxoSmithKline	Yang, HY (corresponding author), Sirtris, Cambridge, MA USA.	Hongying.2.yang@gsk.com	Thomas, G. Neil/A-1879-2013; Cherny, Stacey S/B-3315-2008; Yang, Hsin-Chou/AAP-2547-2021; Pan, Wen-Harn/F-9972-2010; Tomlinson, Brian/P-5365-2015; Tomlinson, Brian/AAD-9404-2019	Thomas, G. Neil/0000-0002-2777-1847; Cherny, Stacey S/0000-0002-0269-3352; Yang, Hsin-Chou/0000-0001-6853-7881; Pan, Wen-Harn/0000-0001-9136-0658; Tomlinson, Brian/0000-0001-6717-5444; Chiang, Kuang-Mao/0000-0002-8745-2004; Lin, Tsung-Hsien/0000-0002-7226-8730	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aulakh R, 2008, INDIAN J PEDIATR, V75, P1067, DOI 10.1007/s12098-008-0211-6; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Baur JA, 2010, MECH AGEING DEV, V131, P261, DOI 10.1016/j.mad.2010.02.007; Beier UH, 2011, MOL CELL BIOL, V31, P1022, DOI 10.1128/MCB.01206-10; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Camu F, 1996, Acta Anaesthesiol Belg, V47, P143; Chen J, 2005, J BIOL CHEM; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2005, MOL CELL BIOL, V25, P7966, DOI 10.1128/MCB.25.18.7966-7975.2005; Chung HY, 2011, J DENT RES, V90, P830, DOI 10.1177/0022034510387794; Disch JS, 2010, 240 ACS NAT M MEDI, P70; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Gerhart-Hines Z, 2011, MOL CELL, V44, P851, DOI 10.1016/j.molcel.2011.12.005; Ghizzoni M, 2011, DRUG DISCOV TODAY, V16, P504, DOI 10.1016/j.drudis.2011.03.009; Goh FG, 2012, RHEUMATOLOGY, V51, P7, DOI 10.1093/rheumatology/ker257; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ishinaga H, 2007, EMBO J, V26, P1150, DOI 10.1038/sj.emboj.7601546; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Lysko PG, 1999, J PHARMACOL EXP THER, V289, P1277; Manabe I, 2011, CIRC J, V75, P2739, DOI 10.1253/circj.CJ-11-1184; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Minor RK, 2011, SCI REP-UK, V1, DOI 10.1038/srep00070; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Podolin PL, 2005, J PHARMACOL EXP THER, V312, P373, DOI 10.1124/jpet.104.074484; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Robers MB, 2011, MOL BIOSYST, V7, P59, DOI 10.1039/c0mb00026d; Rothgiesser KM, 2010, J CELL SCI, V123, P4251, DOI 10.1242/jcs.073783; Rothgiesser KM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-22; Satoh A, 2012, HDB EXP PHARM, V206, P125; Schug TT, 2010, MOL CELL BIOL, V30, P4712, DOI 10.1128/MCB.00657-10; Sheppard KA, 1998, J BIOL CHEM, V273, P29291, DOI 10.1074/jbc.273.45.29291; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Smith JJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-31; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Tang BL, 2011, TRANSL RES, V157, P276, DOI 10.1016/j.trsl.2010.11.006; van der Meer AJ, 2011, INFLAMM RES, V60, P82; vanderPoll T, 1997, J IMMUNOL, V158, P1971; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Vu C. B., 2010, Patent Appl., Patent No. [PCT WO 2010/003048, 2010003048]; Vu C. B., 2010, WO Patent, Patent No. [2010037129A1, 2010037129, PCT WO 2010/037129]; YAMAZAKI Y, 2009, AM J PHYSL ENDOCRINO; Yang Baichun, 2008, BMC Pharmacology, V8, P7, DOI 10.1186/1471-2210-8-7; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yang XD, 2010, MOL CELL BIOL, V30, P2170, DOI 10.1128/MCB.01343-09; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	65	210	224	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46364	10.1371/journal.pone.0046364	http://dx.doi.org/10.1371/journal.pone.0046364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	23029496	Green Submitted, Green Published, gold			2022-12-27	WOS:000309973900143
J	Wu, JY; Wang, YH; Wang, GJ; Ho, ML; Wang, CZ; Yeh, ML; Chen, CH				Wu, Jyun-Yi; Wang, Yan-Hsiung; Wang, Gwo-Jaw; Ho, Mei-Ling; Wang, Chau-Zen; Yeh, Ming-Long; Chen, Chia-Hsin			Low-Power GaAlAs Laser Irradiation Promotes the Proliferation and Osteogenic Differentiation of Stem Cells via IGF1 and BMP2	PLOS ONE			English	Article							RAT CALVARIAL CELLS; BONE-MARROW; IN-VITRO; GENE-EXPRESSION; THERAPY; OSTEOBLASTS; OSTEOPOROSIS; TGF-BETA-1; CULTURE; ARREST	Low-power laser irradiation (LPLI) has been found to induce various biological effects and cellular processes. Also, LPLI has been shown to promote fracture repair. Until now, it has been unclear how LPLI promotes bone formation and fracture healing. The aim of this study was to investigate the potential mechanism of LPLI-mediated enhancement of bone formation using mouse bone marrow mesenchymal stem cells (D1 cells). D1 cells were irradiated daily with a gallium-aluminum-arsenide (GaAlAs) laser at dose of 0, 1, 2, or 4 J/cm(2). The lactate dehydrogenase (LDH) assay showed no cytotoxic effects of LPLI on D1 cells, and instead, LPLI at 4 J/cm(2) significantly promoted D1 cell proliferation. LPLI also enhanced osteogenic differentiation in a dose-dependent manner and moderately increased expression of osteogenic markers. The neutralization experiments indicated that LPLI regulated insulin-like growth factor 1 (IGF1) and bone morphogenetic protein 2 (BMP2) signaling to promote cell proliferation and/or osteogenic differentiation. In conclusion, our study suggests that LPLI may induce IGF1 expression to promote both the proliferation and osteogenic differentiation of D1 cells, whereas it may induce BMP2 expression primarily to enhance osteogenic differentiation.	[Wu, Jyun-Yi; Yeh, Ming-Long] Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan; [Wang, Yan-Hsiung] Kaohsiung Med Univ, Sch Dent, Coll Dent Med, Kaohsiung, Taiwan; [Wang, Yan-Hsiung; Wang, Gwo-Jaw; Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Wang, Gwo-Jaw] Kaohsiung Med Univ, Dept Orthopaed, Coll Med, Kaohsiung, Taiwan; [Wang, Gwo-Jaw] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Orthopaed, Kaohsiung, Taiwan; [Wang, Gwo-Jaw] Univ Virginia, Dept Orthopaed Surg, Charlottesville, VA USA; [Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Dept Physiol, Coll Med, Kaohsiung, Taiwan; [Ho, Mei-Ling; Wang, Chau-Zen] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Dept Phys Med & Rehabil, Coll Med, Fac Med, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Municipal Tatung Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan	National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of Virginia; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital	Wu, JY (corresponding author), Natl Cheng Kung Univ, Inst Biomed Engn, Tainan 70101, Taiwan.	mlyeh@mail.ncku.edu.tw; chchen@kmu.edu.tw	Wang, Yan-Hsiung/ABD-4004-2020; Wang, Yan-Hsiung/C-8792-2009; Zhu, Zhi/D-3721-2011	Wang, Yan-Hsiung/0000-0001-8161-7472; Zhu, Zhi/0000-0002-3287-4920; Ho, Mei-Ling/0000-0001-8064-8488; Chen, Chia-Hsin/0000-0002-6557-9848	National Science Council [NSC 96-2221-E-006-259, NSC 96-2314-B-037-059]; National Health Research Institutes, Taiwan [NHRI-EX97-9615EP]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This study was supported by two grants from the National Science Council (NSC 96-2221-E-006-259, NSC 96-2314-B-037-059) and a grant from the National Health Research Institutes (NHRI-EX97-9615EP) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany PR, 2007, WOUND REPAIR REGEN, V15, P866, DOI 10.1111/j.1524-475X.2007.00306.x; Arisu HD, 2006, LASER MED SCI, V21, P175, DOI 10.1007/s10103-006-0398-6; Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827; BARUSHKA O, 1995, BONE, V16, P47, DOI 10.1016/S8756-3282(94)00006-9; Bouvet-Gerbettaz S, 2009, LASER SURG MED, V41, P291, DOI 10.1002/lsm.20759; Cen Shiqiang, 2008, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V22, P84; Chen CH, 2005, OSTEOPOROSIS INT, V16, P2039, DOI 10.1007/s00198-005-1995-0; Coombe A R, 2001, Clin Orthod Res, V4, P3, DOI 10.1034/j.1600-0544.2001.040102.x; Dahir GA, 2000, CLIN ORTHOP RELAT R, pS134; DIDUCH DR, 1993, J BONE JOINT SURG AM, V75A, P92, DOI 10.2106/00004623-199301000-00012; Eduardo FD, 2008, LASER SURG MED, V40, P433, DOI 10.1002/lsm.20646; Fukuhara E, 2006, CALCIFIED TISSUE INT, V79, P443, DOI 10.1007/s00223-006-0072-9; Gal P, 2009, LASER MED SCI, V24, P539, DOI 10.1007/s10103-008-0604-9; Hamajima S, 2003, LASER MED SCI, V18, P78, DOI 10.1007/s10103-003-0255-9; Horvat-Karajz K, 2009, LASER SURG MED, V41, P463, DOI 10.1002/lsm.20791; Hou JF, 2008, LASER SURG MED, V40, P726, DOI 10.1002/lsm.20709; Huang XM, 2003, FRONT BIOSCI-LANDMRK, V8, pS740, DOI 10.2741/1093; IIJIMA K, 1989, CLIN J PAIN, V5, P271; Jin Dong-mei, 2006, Zhejiang Da Xue Xue Bao Yi Xue Ban, V35, P55; Khadra M, 2005, BIOMATERIALS, V26, P3503, DOI 10.1016/j.biomaterials.2004.09.033; Khadra M, 2004, CLIN ORAL IMPLAN RES, V15, P325, DOI 10.1111/j.1600-0501.2004.00994.x; Mehler PS, 2009, INT J EAT DISORDER, V42, P195, DOI 10.1002/eat.20593; Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019; Mvula B, 2008, LASER MED SCI, V23, P277, DOI 10.1007/s10103-007-0479-1; Ninomiya T, 2003, J BONE MINER METAB, V21, P67, DOI 10.1007/s007740300011; Oliveira DAAP, 2008, PHOTOMED LASER SURG, V26, P401, DOI 10.1089/pho.2007.2101; Ozawa Y, 1998, BONE, V22, P347, DOI 10.1016/S8756-3282(97)00294-9; Pietschmann P, 2009, GERONTOLOGY, V55, P3, DOI 10.1159/000166209; Pretel H, 2007, LASER SURG MED, V39, P788, DOI 10.1002/lsm.20585; RIGGS BL, 1995, BONE, V17, pS505, DOI 10.1016/8756-3282(95)00258-4; Sakurai Y, 2000, EUR J ORAL SCI, V108, P29, DOI 10.1034/j.1600-0722.2000.00783.x; Schindl A, 2003, BRIT J DERMATOL, V148, P334, DOI 10.1046/j.1365-2133.2003.05070.x; Stein A, 2005, PHOTOMED LASER SURG, V23, P161, DOI 10.1089/pho.2005.23.161; Stein E, 2008, WIEN KLIN WOCHENSCHR, V120, P112, DOI 10.1007/s00508-008-0932-6; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Taniguchi D, 2009, LASER SURG MED, V41, P232, DOI 10.1002/lsm.20750; Totosy de Zepetnek JO, 2009, J REHABIL RES DEV, V46, P529, DOI 10.1682/JRRD.2008.09.0136; Tuby H, 2007, LASER SURG MED, V39, P373, DOI 10.1002/lsm.20492; Wang YH, 2009, MOL THER, V17, P302, DOI 10.1038/mt.2008.267; Wildemann B, 2003, J BIOMED MATER RES B, V65B, P150, DOI 10.1002/jbm.b.10512; Xu M, 2009, PHOTOMED LASER SURG, V27, P309, DOI 10.1089/pho.2008.2283	41	76	80	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44027	10.1371/journal.pone.0044027	http://dx.doi.org/10.1371/journal.pone.0044027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	23029506	Green Published, Green Submitted, gold			2022-12-27	WOS:000308577600024
J	Wang, LH; Lv, XJ; Zhai, YG; Fu, SH; Wang, D; Rayner, S; Tang, Q; Liang, GD				Wang, Lihua; Lv, Xinjun; Zhai, Yougang; Fu, Shihong; Wang, David; Rayner, Simon; Tang, Qing; Liang, Guodong			Genomic Characterization of a Novel Virus of the Family Tymoviridae Isolated from Mosquitoes	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; YELLOW-MOSAIC-VIRUS; MINUS-STRAND SYNTHESIS; RNA; GENUS; ORGANIZATION; INITIATION; MEMBER; LINE	Background: The family Tymoviridae comprises three plant virus genera, including Tymovirus, Marafivirus, and Maculavirus, which are found in most parts of the world and cause severe agricultural losses. We describe a putatively novel member of the family Tymoviridae, which is isolated from mosquitoes (Culex spp.), referred to as CuTLV. Methods and Results: The CuTLV was isolated by cell culture, which replicates and causes cytopathic effects in Aedes albopictus C6/36 cells, but not in mammalian BHK-21 or Vero cells. The complete 6471 nucleotide sequence of CuTLV was determined. The genome of CuTLV is predicted to contain three open reading frames (ORFs). The largest ORF1 is 5307 nucleotides (nt) in length and encodes a putative polypeptide of 1769 amino acids (aa), which contains the conserved motifs for the methyltransferase (MTR), Tymovirus endopeptidase (PRO), helicase (HEL), and RNA-dependent RNA polymerase (RdRp) of the replication-associated proteins (RPs) of positive-stranded RNA viruses. In contrast, the ORF1 sequence does not contain the so-called "tymobox'' or "marafibox'', the conserved subgenomic RNA promoter present in all tymoviruses or marafiviruses, respectively. ORF2 and ORF3 putatively encode a 248-aa coat protein (CP) and a proline-rich 149-aa polypeptide. The whole genomic nucleotide identity of CuTLV with other members of family Tymoviridae ranged from 46.2% (ChiYMV) to 52.4% (GFkV). Phylogenetic analysis based on the putative RP and CP genes of CuTLV demonstrated that the virus is most closely related to viruses in the genus Maculavirus. Conclusions: The CuTLV is a novel virus related to members of the family Tymoviridae, with molecular characters that are distinct from those of tymoviruses, marafiviruses, and other maculaviruses or macula-like viruses. This is the first report of the isolation of a Tymoviridae-like virus from mosquitoes. Further investigations are required to clarify the origin, replication strategy, and the public health or agricultural importance of the CuTLV.	[Wang, Lihua; Lv, Xinjun; Zhai, Yougang; Fu, Shihong; Tang, Qing; Liang, Guodong] Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Wang, David] Washington Univ, St Louis, MO USA; [Rayner, Simon] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Beijing 100864, Hubei, Peoples R China	Chinese Center for Disease Control & Prevention; Washington University (WUSTL); Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Wang, LH (corresponding author), Chinese Ctr Dis Control & Prevent, Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	gdliang@hotmail.com	rayner, simon/N-7715-2013; Shi, Feng/G-3247-2012; wang, li/O-1425-2015	rayner, simon/0000-0001-8703-9140; Shi, Feng/0000-0003-1522-9943; wang, li/0000-0001-8927-6772	Ministry of Science and Technology, People's Republic of China [2003BA712A08-01, 2011CB504702]; Development Grant of State Key Laboratory for Infectious Disease Prevention and Control [2008SKLID105]	Ministry of Science and Technology, People's Republic of China(Ministry of Science and Technology, China); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control	Funding was provided by the Ministry of Science and Technology, People's Republic of China (no. 2003BA712A08-01 and 2011CB504702); Development Grant of State Key Laboratory for Infectious Disease Prevention and Control (2008SKLID105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabdullah A, 2010, VIRUS RES, V152, P10, DOI 10.1016/j.virusres.2010.05.010; Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Deiman BALM, 1998, J VIROL, V72, P3965, DOI 10.1128/JVI.72.5.3965-3972.1998; DING S, 1990, NUCLEIC ACIDS RES, V18, P1181, DOI 10.1093/nar/18.5.1181; Dreher TW, 2004, MOL PLANT PATHOL, V5, P367, DOI 10.1111/j.1364-3703.2004.00236.X; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Hammond RW, 2001, VIROLOGY, V282, P338, DOI 10.1006/viro.2001.0859; Hellendoorn K, 1996, NUCLEIC ACIDS RES, V24, P4910, DOI 10.1093/nar/24.24.4910; Hollidge BS, 2010, J NEUROIMMUNE PHARM, V5, P428, DOI 10.1007/s11481-010-9234-7; Iwanaga M, 2012, J VIROL METHODS, V179, P316, DOI 10.1016/j.jviromet.2011.11.016; Izadpanah K, 2002, VIRUS GENES, V24, P131, DOI 10.1023/A:1014516515454; Jakubiec A, 2007, J VIROL, V81, P11402, DOI 10.1128/JVI.01428-07; Katsuma S, 2005, J VIROL, V79, P5577, DOI 10.1128/JVI.79.9.5577-5584.2005; King AMQ, 2011, 9 INT COMM TAX VIR, P944; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liang GD, 2000, J GEN VIROL, V81, P1347, DOI 10.1099/0022-1317-81-5-1347; Liu H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-68; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Martelli GP, 2002, ARCH VIROL, V147, P1837, DOI 10.1007/s007050200045; Martelli GP, 2002, ARCH VIROL, V147, P1847, DOI 10.1007/s007050200046; Matsuda D, 2004, VIROLOGY, V321, P36, DOI 10.1016/j.virol.2003.10.023; Muller G, 2005, MED VET ENTOMOL, V19, P413, DOI 10.1111/j.1365-2915.2005.00590.x; Sabanadzovic S, 2001, J GEN VIROL, V82, P2009, DOI 10.1099/0022-1317-82-8-2009; Sabanadzovic S, 2009, ARCH VIROL, V154, P1729, DOI 10.1007/s00705-009-0510-x; Singh RN, 1998, RNA, V4, P1083, DOI 10.1017/S1355838298980694; Stephan D, 2008, VIRUS GENES, V36, P231, DOI 10.1007/s11262-007-0181-1; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Zhai Y, 2010, J GEN VIROL, V91, P2836, DOI 10.1099/vir.0.024794-0; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	31	335	341	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 27	2012	7	7							e39845	10.1371/journal.pone.0039845	http://dx.doi.org/10.1371/journal.pone.0039845			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	981ER	23272162	Green Published, Green Submitted, gold			2022-12-27	WOS:000306950200014
J	Wang, L; Si, WN; Yao, YF; Tian, DC; Araki, H; Yang, SH				Wang, Long; Si, Weina; Yao, Yongfang; Tian, Dacheng; Araki, Hitoshi; Yang, Sihai			Genome-Wide Survey of Pseudogenes in 80 Fully Resequenced Arabidopsis thaliana Accessions	PLOS ONE			English	Article							PROCESSED PSEUDOGENES; GENETIC DIVERSITY; DNA; ASSOCIATION; POLYMORPHISMS; EVOLUTIONARY; ANNOTATION; MECHANISMS; RESISTANCE; PATTERNS	Pseudogenes (Psi s), including processed and non-processed Psi s, are ubiquitous genetic elements derived from originally functional genes in all studied genomes within the three kingdoms of life. However, systematic surveys of non-processed Psi s utilizing genomic information from multiple samples within a species are still rare. Here a systematic comparative analysis was conducted of Psi s within 80 fully re-sequenced Arabidopsis thaliana accessions, and 7546 genes, representing similar to 28% of the genomic annotated open reading frames (ORFs), were found with disruptive mutations in at least one accession. The distribution of these Psi s on chromosomes showed a significantly negative correlation between Psi s/ORFs and their local gene densities, suggesting a higher proportion of Psi s in gene desert regions, e. g. near centromeres. On the other hand, compared with the non-Psi loci, even the intact coding sequences (CDSs) in the Psi loci were found to have shorter CDS length, fewer exon number and lower GC content. In addition, a significant functional bias against the null hypothesis was detected in the Psi s mainly involved in responses to environmental stimuli and biotic stress as reported, suggesting that they are likely important for adaptive evolution to rapidly changing environments by pseudogenization to accumulate successive mutations.	[Wang, Long; Si, Weina; Yao, Yongfang; Tian, Dacheng; Araki, Hitoshi; Yang, Sihai] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Araki, Hitoshi] Swiss Fed Inst Aquat Sci & Technol, Ctr Ecol Evolut & Biogeochem, Kastanienbaum, Switzerland	Nanjing University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Araki, H (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	Hitoshi.Araki@eawag.ch; sihaiyang@nju.edu.cn	rayner, simon/N-7715-2013; Shi, Feng/G-3247-2012; wang, li/O-1425-2015	rayner, simon/0000-0001-8703-9140; Shi, Feng/0000-0003-1522-9943; wang, li/0000-0001-8927-6772	National Natural Science Foundation of China [30970198, J1103512]; NSFC of Jiangsu province [BK2011015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC of Jiangsu province	This work was supported by National Natural Science Foundation of China (30970198 and J1103512) and NSFC of Jiangsu province (BK2011015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benovoy D, 2006, J MOL EVOL, V62, P511, DOI 10.1007/s00239-005-0045-z; Borevitz JO, 2007, P NATL ACAD SCI USA, V104, P12057, DOI 10.1073/pnas.0705323104; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Du JC, 2008, GENE, V426, P1, DOI 10.1016/j.gene.2008.09.003; Freeling M, 2012, CURR OPIN PLANT BIOL, V15, P131, DOI 10.1016/j.pbi.2012.01.015; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; JACQ C, 1977, CELL, V12, P109, DOI 10.1016/0092-8674(77)90189-1; Karro JE, 2007, NUCLEIC ACIDS RES, V35, pD55, DOI 10.1093/nar/gkl851; Kawabe A, 2008, GENETICS, V179, P985, DOI 10.1534/genetics.107.085282; Khachane AN, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-38; Lafontaine I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-260; Laitinen RAE, 2010, PLANT PHYSIOL, V153, P652, DOI 10.1104/pp.110.156448; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Sangster TA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000648; Schmid KJ, 2005, GENETICS, V169, P1601, DOI 10.1534/genetics.104.033795; Sen K, 2010, FEBS LETT, V584, P4015, DOI 10.1016/j.febslet.2010.08.012; TAJIMA F, 1989, GENETICS, V123, P585; Takuno S, 2008, GENETICS, V180, P517, DOI 10.1534/genetics.108.091918; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Todesco M, 2010, NATURE, V465, P632, DOI 10.1038/nature09083; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; Weigel D, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-107; Yang LA, 2011, MOL BIOL EVOL, V28, P1193, DOI 10.1093/molbev/msq298; Yang S, 2012, P NATL ACAD SCI USA; Yang SH, 2006, PLANT MOL BIOL, V62, P181, DOI 10.1007/s11103-006-9012-3; Zhang YL, 2009, J MOL EVOL, V68, P393, DOI 10.1007/s00239-009-9217-6; Zhang ZL, 2004, TRENDS GENET, V20, P62, DOI 10.1016/j.tig.2003.12.005; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003; Zheng DY, 2007, TRENDS GENET, V23, P219, DOI 10.1016/j.tig.2007.03.003; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307; Zheng DY, 2005, J MOL BIOL, V349, P27, DOI 10.1016/j.jmb.2005.02.072; Zou C, 2009, PLANT PHYSIOL, V151, P3, DOI 10.1104/pp.109.140632	43	335	341	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2012	7	12							e51769	10.1371/journal.pone.0051769	http://dx.doi.org/10.1371/journal.pone.0051769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	055AH	23272162	Green Published, Green Submitted, gold			2022-12-27	WOS:000312386600039
